PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hodgkinson, CL; Morrow, CJ; Li, Y; Metcalf, RL; Rothwell, DG; Trapani, F; Polanski, R; Burt, DJ; Simpson, KL; Morris, K; Pepper, SD; Nonaka, D; Greystoke, A; Kelly, P; Bola, B; Krebs, MG; Antonello, J; Ayub, M; Faulkner, S; Priest, L; Carter, L; Tate, C; Miller, CJ; Blackhall, F; Brady, G; Dive, C				Hodgkinson, Cassandra L.; Morrow, Christopher J.; Li, Yaoyong; Metcalf, Robert L.; Rothwell, Dominic G.; Trapani, Francesca; Polanski, Radoslaw; Burt, Deborah J.; Simpson, Kathryn L.; Morris, Karen; Pepper, Stuart D.; Nonaka, Daisuke; Greystoke, Alastair; Kelly, Paul; Bola, Becky; Krebs, Matthew G.; Antonello, Jenny; Ayub, Mahmood; Faulkner, Suzanne; Priest, Lynsey; Carter, Louise; Tate, Catriona; Miller, Crispin J.; Blackhall, Fiona; Brady, Ged; Dive, Caroline			Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer	NATURE MEDICINE			English	Article							METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; PROSTATE-CANCER; CARCINOMA; MUTATIONS; HETEROGENEITY; CHEMOTHERAPY; PROGRESSION; SURVIVAL; GENOME	Small-cell lung cancer (SCLC), an aggressive neuroendocrine tumor with early dissemination and dismal prognosis, accounts for 15-20% of lung cancer cases and similar to 200,000 deaths each year. Most cases are inoperable, and biopsies to investigate SCLC biology are rarely obtainable. Circulating tumor cells (CTCs), which are prevalent in SCLC, present a readily accessible 'liquid biopsy'. Here we show that CTCs from patients with either chemosensitive or chemorefractory SCLC are tumorigenic in immune-compromised mice, and the resultant CTC-derived explants (CDXs) mirror the donor patient's response to platinum and etoposide chemotherapy. Genomic analysis of isolated CTCs revealed considerable similarity to the corresponding CDX. Most marked differences were observed between CDXs from patients with different clinical outcomes. These data demonstrate that CTC molecular analysis via serial blood sampling could facilitate delivery of personalized medicine for SCLC. CDXs are readily passaged, and these unique mouse models provide tractable systems for therapy testing and understanding drug resistance mechanisms.	[Hodgkinson, Cassandra L.; Morrow, Christopher J.; Metcalf, Robert L.; Rothwell, Dominic G.; Trapani, Francesca; Polanski, Radoslaw; Burt, Deborah J.; Simpson, Kathryn L.; Morris, Karen; Greystoke, Alastair; Kelly, Paul; Bola, Becky; Krebs, Matthew G.; Antonello, Jenny; Ayub, Mahmood; Faulkner, Suzanne; Priest, Lynsey; Carter, Louise; Tate, Catriona; Brady, Ged; Dive, Caroline] Univ Manchester, Canc Res UK Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England; [Li, Yaoyong; Miller, Crispin J.] Univ Manchester, Canc Res UK Manchester Inst, Computat Biol Support Grp, Manchester, Lancs, England; [Pepper, Stuart D.] Univ Manchester, Canc Res UK Manchester Inst, Mol Biol Core Facil, Manchester, Lancs, England; [Nonaka, Daisuke; Greystoke, Alastair; Blackhall, Fiona] Christie NHS Fdn Trust, Manchester, Lancs, England; [Greystoke, Alastair; Blackhall, Fiona] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Miller, Crispin J.] Univ Manchester, Canc Res UK Manchester Inst, RNA Biol Grp, Manchester, Lancs, England	Cancer Research UK; University of Manchester; Cancer Research UK; University of Manchester; Cancer Research UK; University of Manchester; Christie NHS Foundation Trust; University of Manchester; Cancer Research UK; University of Manchester	Dive, C (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England.	caroline.dive@cruk.manchester.ac.uk	Ayub, Mahmood/V-8792-2019; Blackhall, Fiona H/N-2186-2015	Ayub, Mahmood/0000-0002-2096-2704; Blackhall, Fiona H/0000-0001-8716-3395; Rothwell, Dominic/0000-0002-8757-3893; Miller, Crispin/0000-0003-4341-1283; Priest, Lynsey/0000-0003-3780-8508; Dive, Caroline/0000-0002-1726-8850; Bola, Becky/0000-0002-8985-9713; Carter, Louise/0000-0002-9854-2304; Krebs, Matthew/0000-0001-7540-3064; greystoke, alastair/0000-0001-9168-0387	Cancer Research UK [C5759/A12328]; Manchester Experimental Cancer Medicine Centre [C1467/A15578]; Manchester Cancer Research Centre [A12197]; European Union CHEMORES [LSHG-CT-2007-037665]; AstraZeneca; Academy of Medical Sciences (AMS) [AMS-SGCL7-Krebs] Funding Source: researchfish; Cancer Research UK [15675, 19278] Funding Source: researchfish; National Institute for Health Research [CL-2011-06-002] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Manchester Experimental Cancer Medicine Centre; Manchester Cancer Research Centre; European Union CHEMORES; AstraZeneca(AstraZeneca); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We are indebted to the patients who agreed to donate their blood samples for this study. We thank R. Marais, N. Jones and D. Ogilvie for their constructive comments on the manuscript. We thank M. Dawson, M. Lancashire, S. Bramley, J. Halstead and J. Castle, who enumerated CTCs using CellSearch. We thank A. Jardine for administrative support and M. Greaves, our laboratory manager. This research was supported by Cancer Research UK via core funding to the Cancer Research UK Manchester Institute (C5759/A12328), the Manchester Experimental Cancer Medicine Centre (C1467/A15578), the Manchester Cancer Research Centre (A12197) and their Translational Research Award for 2012. Funding to support this work was also provided via the European Union CHEMORES FP6 (contract number LSHG-CT-2007-037665). R.L.M. and L.C. were supported by education grants from Cancer Research UK and AstraZeneca.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Board RE, 2008, ANN NY ACAD SCI, V1137, P98, DOI 10.1196/annals.1448.020; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DAVENPORT RD, 1990, ACTA CYTOL, V34, P502; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; EINHORN LH, 1976, JAMA-J AM MED ASSOC, V235, P1225, DOI 10.1001/jama.235.12.1225; EVANS WK, 1985, J CLIN ONCOL, V3, P1471, DOI 10.1200/JCO.1985.3.11.1471; EVANS WK, 1984, CANCER, V53, P1461, DOI 10.1002/1097-0142(19840401)53:7<1461::AID-CNCR2820530706>3.0.CO;2-N; Fabbri F, 2013, CANCER LETT, V335, P225, DOI 10.1016/j.canlet.2013.02.015; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; GAZDAR AF, 1980, CANCER RES, V40, P3502; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hou JM, 2009, AM J PATHOL, V175, P808, DOI 10.2353/ajpath.2009.090078; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Joshi M, 2013, ADV EXP MED BIOL, V779, P385, DOI 10.1007/978-1-4614-6176-0_18; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; MORI N, 1990, ONCOGENE, V5, P1713; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; OBOSHI S, 1971, GANN, V62, P505; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; POUPON MF, 1993, J NATL CANCER I, V85, P2023, DOI 10.1093/jnci/85.24.2023; Pretlow TG, 2000, CANCER RES, V60, P4033; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; SIEROCKI JS, 1979, CANCER TREAT REP, V63, P1593; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; SZIJAN I, 1995, J MED GENET, V32, P475, DOI 10.1136/jmg.32.6.475; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738	45	496	530	7	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					897	903		10.1038/nm.3600	http://dx.doi.org/10.1038/nm.3600			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	24880617				2022-12-25	WOS:000340074600021
J	Krishnan, N; Koveal, D; Miller, DH; Xue, B; Akshinthala, SD; Kragelj, J; Jensen, MR; Gauss, CM; Page, R; Blackledge, M; Muthuswamy, SK; Peti, W; Tonks, NK				Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjobing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.			Targeting the disordered C terminus of PTP1B with an allosteric inhibitor	NATURE CHEMICAL BIOLOGY			English	Article							TYROSINE-PHOSPHATASE 1B; HUMAN BREAST-CANCER; ACQUIRED-RESISTANCE; BINDING-SITE; CONTRIBUTES; OVEREXPRESSION; MECHANISMS; INDUCTION; LAPATINIB; TUMORS	PTP1B, a validated therapeutic target for diabetes and obesity, has a critical positive role in HER2 signaling in breast tumorigenesis. Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chemical properties of the active site. We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B. We present what is to our knowledge the first ensemble structure of PTP1B containing this intrinsically disordered segment, within which we identified a binding site for the small-molecule inhibitor MSI-1436. We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state. MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer. This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small molecules.	[Krishnan, Navasona; Xue, Bin; Akshinthala, Sai Dipikaa; Gauss, Carla-Maria; Muthuswamy, Senthil K.; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Koveal, Dorothy; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Miller, Daniel H.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Miller, Daniel H.; Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Kragelj, Jaka; Jensen, Malene Ringkjobing; Blackledge, Martin] CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Muthuswamy, Senthil K.] Univ Toronto, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Dept Med Biophys, Toronto, ON M5S 1A1, Canada	Cold Spring Harbor Laboratory; Brown University; Brown University; Brown University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tonks, NK (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu	Akshinthala, Dipikaa/AGY-8204-2022; Muthuswamy, Senthil K/AGY-2834-2022; Peti, Wolfgang/L-3492-2014	Muthuswamy, Senthil K/0000-0001-6564-9634; Kragelj, Jaka/0000-0001-6472-8429; Jensen, Malene R./0000-0003-0419-2196; /0000-0002-4866-1145; Xue, Bin/0000-0002-5472-1300	US National Institutes of Health (NIH) [CA53840, GM55989]; Cold Spring Harbor Laboratory Cancer Centre Support Grant [CA45508]; NIH [GM100910, GM098482, S10-RR017269]; American Diabetes Association [1-14-ACN-31]; Brown University Research Seed Fund grant; French Agence Nationale de la Recherche (ANR) through ANR JCJC ProteinDisorder; ANR MALZ TAUSTRUCT; IDPbyNMR Marie Curie action of the European Commission [264257]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition; Glen Cove CARES; Constance Silveri, Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R01CA053840, R37CA053840, P30CA045508] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100910, R01GM055989, R01GM098482] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Centre Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Brown University Research Seed Fund grant; French Agence Nationale de la Recherche (ANR) through ANR JCJC ProteinDisorder(French National Research Agency (ANR)); ANR MALZ TAUSTRUCT(French National Research Agency (ANR)); IDPbyNMR Marie Curie action of the European Commission; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition; Glen Cove CARES; Constance Silveri, Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by US National Institutes of Health (NIH) grants CA53840 and GM55989 and the Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508 to N.K.T.; by NIH grants GM100910 and GM098482, American Diabetes Association grant 1-14-ACN-31 and a Brown University Research Seed Fund grant by the Vice President for Research to W.P.; and by financial support from the French Agence Nationale de la Recherche (ANR) through ANR JCJC ProteinDisorder to M.R.J. and ANR MALZ TAUSTRUCT to M.B. J.K. is a fellow of the IDPbyNMR Marie Curie action of the European Commission (contract no 264257).; The 800-MHz NMR data were recorded at Brandeis University; the instrument was purchased with support from NIH S10-RR017269. NMR data (500 MHz and 850 MHz) were recorded in the Brown University Structural Biology Facility, which is generously supported by Brown University N.K.T. is also grateful for support from the following foundations; The Gladowsky Breast Cancer Foundation, The Don Monti Memorial Research Foundation, Hansen Memorial Foundation, West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, Robertson Research Fund and the Masthead Cove Yacht Club Carol Marcincuk Fund. PTP1B inhibitor MSI-1436 was provided by Ohr Pharmaceuticals and Genaera Corporation.	Agulnik M, 2007, J CLIN ONCOL, V25, P3978, DOI 10.1200/JCO.2007.11.8612; Andersen JN, 2004, TOP CURR GENET, V5, P201; Balavenkatraman KK, 2011, MOL CANCER RES, V9, P1377, DOI 10.1158/1541-7786.MCR-11-0198; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; BROWNSHIMER S, 1990, P NATL ACAD SCI USA, V87, P5148, DOI 10.1073/pnas.87.13.5148; Cuchillo R, 2012, BIOCHEM SOC T, V40, P1004, DOI 10.1042/BST20120086; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; He RJ, 2013, FEBS J, V280, P731, DOI 10.1111/j.1742-4658.2012.08718.x; Hinow P, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-14; Janne PA, 2002, CANCER RES, V62, P5242; Johnson KJ, 2010, AM J PATHOL, V177, P2971, DOI 10.2353/ajpath.2010.090399; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Lessard L, 2012, CANCER RES, V72, P1529, DOI 10.1158/0008-5472.CAN-11-2602; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Sangwan V, 2011, J BIOL CHEM, V286, P45000, DOI 10.1074/jbc.M111.270934; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; TIWARI RK, 1992, ANTICANCER RES, V12, P419; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang JG, 2012, MED ONCOL, V29, P948, DOI 10.1007/s12032-011-9911-2; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	43	229	232	2	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					558	566		10.1038/NCHEMBIO.1528	http://dx.doi.org/10.1038/NCHEMBIO.1528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24845231	Green Accepted			2022-12-25	WOS:000337871200014
J	Kohsaka, S; Shukla, N; Ameur, N; Ito, T; Ng, CKY; Wang, L; Lim, D; Marchetti, A; Viale, A; Pirun, M; Socci, ND; Qin, LX; Sciot, R; Bridge, J; Singer, S; Meyers, P; Wexler, LH; Barr, FG; Dogan, S; Fletcher, JA; Reis, JS; Ladanyi, M				Kohsaka, Shinji; Shukla, Neerav; Ameur, Nabahet; Ito, Tatsuo; Ng, Charlotte K. Y.; Wang, Lu; Lim, Diana; Marchetti, Angela; Viale, Agnes; Pirun, Mono; Socci, Nicholas D.; Qin, Li-Xuan; Sciot, Raf; Bridge, Julia; Singer, Samuel; Meyers, Paul; Wexler, Leonard H.; Barr, Frederic G.; Dogan, Snjezana; Fletcher, Jonathan A.; Reis-Filho, Jorge S.; Ladanyi, Marc			A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations	NATURE GENETICS			English	Article							TUMOR ALVEOLAR RHABDOMYOSARCOMA; SPINDLE-CELL RHABDOMYOSARCOMA; GENOME-WIDE IDENTIFICATION; CHILDRENS ONCOLOGY GROUP; TARGET GENES; SIGNALING PATHWAYS; STEM-CELLS; NEUROBLASTOMA; FUSION; DIFFERENTIATION	Rhabdomyosarcoma, a cancer of skeletal muscle lineage, is the most common soft-tissue sarcoma in children(1). Major subtypes of rhabdomyosarcoma include alveolar (ARMS) and embryonal (ERMS) tumors(2,3). Whereas ARMS tumors typically contain translocations generating PAX3-FOXO1 or PAX7-FOXO1 fusions that block terminal myogenic differentiation(4-6), no functionally comparable genetic event has been found in ERMS tumors. Here we report the discovery, through whole-exome sequencing, of a recurrent somatic mutation encoding p.Leu122Arg in the myogenic transcription factor MYOD1 in a distinct subset of ERMS tumors with poor outcomes that also often contain mutations altering PI3K-AKT pathway components. Previous mutagenesis studies had shown that MYOD1 with a p.Leu122Arg substitution can block wild-type MYOD1 function and bind to MYC consensus sequences(7), suggesting a possible switch from differentiation to proliferation. Our functional data now confirm this prediction. Thus, MYOD1 p.Leu122Arg defines a subset of rhabdomyosarcomas eligible for high-risk protocols and the development of targeted therapeutics.	[Kohsaka, Shinji; Ameur, Nabahet; Ito, Tatsuo; Ng, Charlotte K. Y.; Wang, Lu; Lim, Diana; Marchetti, Angela; Dogan, Snjezana; Reis-Filho, Jorge S.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Kohsaka, Shinji; Ameur, Nabahet; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Shukla, Neerav; Meyers, Paul; Wexler, Leonard H.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Pirun, Mono; Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Facil, New York, NY 10021 USA; [Qin, Li-Xuan] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Sciot, Raf] Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium; [Sciot, Raf] Univ Louvain, Louvain, Belgium; [Bridge, Julia] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Barr, Frederic G.] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; KU Leuven; University Hospital Leuven; University of Nebraska System; University of Nebraska Medical Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital	Ladanyi, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	laaanyim@mskcc.org	Wang, Lu/N-8128-2018; Ng, Charlotte K Y/AAY-3178-2021; Ng, Charlotte K Y/AAA-1670-2020; Ladanyi, Marc/AAG-8585-2019	Wang, Lu/0000-0002-0073-0666; Ng, Charlotte K Y/0000-0002-6100-0026; Singer, Samuel/0000-0001-9713-8230; Meyers, Paul/0000-0001-6146-6101; sciot, raf/0000-0003-2244-5839	NIH [P01 CA047179]; NCI [P50 CA140146]; National Center for Research Resources (NCRR) Clinical Translational Science Center grant; Virginia and Daniel K. Ludwig Trust for Cancer Research; Yasuda Medical Foundation; HIROKO International Academic Exchange Foundation; Intramural Research Program of the National Cancer Institute; Anbinder Fund; Cancer Center Core [NCI P30 CA008748]; NATIONAL CANCER INSTITUTE [ZIABC011387, P50CA140146, P30CA008748, P50CA127003, P01CA047179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR) Clinical Translational Science Center grant; Virginia and Daniel K. Ludwig Trust for Cancer Research; Yasuda Medical Foundation; HIROKO International Academic Exchange Foundation; Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anbinder Fund; Cancer Center Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Hosoi (Kyoto Prefectural University of Medicine) and S. Tanaka and M. Tsuda (both at Hokkaido University) for providing cell lines. We also thank T. Akagi and K. Sasai (both at KAN Research Institute, Inc.) for providing the pcx4bleo plasmid. We are also grateful to J. Zhao for technical assistance with microarray analysis, to L. Borsu for assistance with Sequenom analyses and to E. de Stanchina and R. Tieu for the xenograft studies. This work was supported by a generous donation from M.B. Zuckerman (M.L.), by NIH P01 CA047179 (S.S.), by NCI P50 CA140146 (M.L., N.D.S. and S.S.), by a National Center for Research Resources (NCRR) Clinical Translational Science Center grant (M.P. and N.D.S.) and by the Virginia and Daniel K. Ludwig Trust for Cancer Research (J.A.F.). S.K. was supported in part by the Yasuda Medical Foundation and the HIROKO International Academic Exchange Foundation. F.G.B. is supported by the Intramural Research Program of the National Cancer Institute.; The Memorial Sloan Kettering Cancer Center Sequenom facility was supported by the Anbinder Fund, and the Genomics and Bioinformatics Cores are supported by Cancer Center Core grant NCI P30 CA008748.	Ahn EH, 2013, ONCOL REP, V30, P968, DOI 10.3892/or.2013.2513; ANAND G, 1994, J CLIN INVEST, V93, P5, DOI 10.1172/JCI116982; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Calhabeu F, 2013, ONCOGENE, V32, P651, DOI 10.1038/onc.2012.73; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Carroll SJ, 2013, ARCH PATHOL LAB MED, V137, P1155, DOI 10.5858/arpa.2012-0465-RS; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; CRESCENZI M, 1994, J CELL BIOL, V125, P1137, DOI 10.1083/jcb.125.5.1137; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; DAVIS RJ, 1994, CANCER RES, V54, P2869; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; LEDENT V, 2002, GENOME BIOL, V3; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Nascimento AF, 2005, AM J SURG PATHOL, V29, P1106; SCRABLE HJ, 1990, P NATL ACAD SCI USA, V87, P2182, DOI 10.1073/pnas.87.6.2182; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; STRATTON MR, 1989, CANCER RES, V49, P6324; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; VANANTWERP ME, 1992, P NATL ACAD SCI USA, V89, P9010, DOI 10.1073/pnas.89.19.9010; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	27	100	103	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					595	600		10.1038/ng.2969	http://dx.doi.org/10.1038/ng.2969			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24793135	Green Accepted			2022-12-25	WOS:000336870700016
J	Perdomini, M; Belbellaa, B; Monassier, L; Reutenauer, L; Messaddeq, N; Cartier, N; Crystal, RG; Aubourg, P; Puccio, H				Perdomini, Morgane; Belbellaa, Brahim; Monassier, Laurent; Reutenauer, Laurence; Messaddeq, Nadia; Cartier, Nathalie; Crystal, Ronald G.; Aubourg, Patrick; Puccio, Helene			Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia	NATURE MEDICINE			English	Article							FE-S PROTEINS; IN-VIVO; CARDIAC-HYPERTROPHY; HUMAN FRATAXIN; IRON; DYSFUNCTION; DEFICIENCY; DISEASE; EXPRESSION; MATURATION	Cardiac failure is the most common cause of mortality in Friedreich's ataxia (FRDA), a mitochondrial disease characterized by neurodegeneration, hypertrophic cardiomyopathy and diabetes(1-3). FRDA is caused by reduced levels of frataxin (FXN), an essential mitochondrial protein involved in the biosynthesis of iron-sulfur (Fe-S) clusters(4-8). Impaired mitochondrial oxidative phosphorylation, bioenergetics imbalance, deficit of Fe-S cluster enzymes and mitochondrial iron overload occur in the myocardium of individuals with FRDA(9-12). No treatment exists as yet for FRDA cardiomyopathy(13,14). A conditional mouse model with complete frataxin deletion in cardiac and skeletal muscle (Mck-Cre-Fxn(L3/L-) mice) recapitulates most features of FRDA cardiomyopathy, albeit with a more rapid and severe course(15,16). Here we show that adeno-associated virus rh10 vector expressing human FXN injected intravenously in these mice fully prevented the onset of cardiac disease. Moreover, later administration of the frataxin-expressing vector, after the onset of heart failure, was able to completely reverse the cardiomyopathy of these mice at the functional, cellular and molecular levels within a few days. Our results demonstrate that cardiomyocytes with severe energy failure and ultrastructure disorganization can be rapidly rescued and remodeled by gene therapy and establish the preclinical proof of concept for the potential of gene therapy in treating FRDA cardiomyopathy.	[Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] IGBMC, Dept Med Translat & Neurogenet, Illkirch Graffenstaden, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] INSERM, U596, Illkirch Graffenstaden, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] CNRS, UMR7104, Illkirch Graffenstaden, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] Univ Strasbourg, Strasbourg, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France; [Monassier, Laurent] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Fac Med, Strasbourg, France; [Cartier, Nathalie; Aubourg, Patrick] INSERM, U986, F-94275 Le Kremlin Bicetre, France; [Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Aubourg, Patrick] Univ Paris 11, Paris, France; [Aubourg, Patrick] AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Cornell University; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP)	Puccio, H (corresponding author), IGBMC, Dept Med Translat & Neurogenet, Illkirch Graffenstaden, France.	patrick.aubourg@inserm.fr; hpuccio@igbmc.fr	Puccio, Hélène/G-1717-2013; cartier, nathalie/C-3103-2012; BELBELLAA, Brahim/AAR-6417-2020	Puccio, Hélène/0000-0003-4711-2248; cartier, nathalie/0000-0003-2298-5261; 	Association Francaise contre les Myopathies; US Friedreich Ataxia Research Alliance; European Community under the European Research Council [206634/ISCATAXIA]; Seventh Framework Programme [242193/EFACTS]; Association the Fondation Simone et Cino del Duca; Institut de France; Ledru family; French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled [ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT]; Association Francaise pour l'Ataxie de Friedreich	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); US Friedreich Ataxia Research Alliance; European Community under the European Research Council; Seventh Framework Programme(European Commission); Association the Fondation Simone et Cino del Duca; Institut de France; Ledru family; French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled(French National Research Agency (ANR)); Association Francaise pour l'Ataxie de Friedreich	We thank A. Martelli for help in vector construction and for fruitful discussions, P. Bougneres for fruitful discussions and insightful comments on the manuscript, and V. Blouin and P. Moullier (Institut de Recherche Therapeutique, INSERM UMR 1089) for vector production. This work was supported by the Association Francaise contre les Myopathies (to H.P.), the US Friedreich Ataxia Research Alliance (to H.P.), the European Community under the European Research Council (206634/ISCATAXIA; to H.P.), the Seventh Framework Programme (242193/EFACTS; to H.P.), the Association the Fondation Simone et Cino del Duca (to P.A.) and the Institut de France (to P.A.), by a personal donation from the Ledru family (to H.P.) and by a French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled ANR-10-IDEX-0002-02 (ANR-10-LABX-0030-INRT). M.P. is a recipient of a PhD fellowship from the Association Francaise pour l'Ataxie de Friedreich.	BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Dedobbeleer C, 2012, EUR HEART J-CARD IMG, V13, P346, DOI 10.1093/ejechocard/jer267; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hu CH, 2010, J GENE MED, V12, P766, DOI 10.1002/jgm.1496; Huang MLH, 2013, AM J PATHOL, V183, P745, DOI 10.1016/j.ajpath.2013.05.032; Lamarche J., 1993, HDB CEREBELLAR DIS, P453; Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Perlman SL, 2012, J CHILD NEUROL, V27, P1217, DOI 10.1177/0883073812453872; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sedlak TL, 2004, J HEART LUNG TRANSPL, V23, P1304, DOI 10.1016/j.healun.2003.09.015; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Sutton MS, 2014, ECHOCARDIOGR-J CARD, V31, P50, DOI 10.1111/echo.12287; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Vorgerd M, 2000, NEUROMUSCULAR DISORD, V10, P430, DOI 10.1016/S0960-8966(00)00108-5; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wang G, 2010, CANCER GENE THER, V17, P559, DOI 10.1038/cgt.2010.11; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilson RB, 2012, J CHILD NEUROL, V27, P1212, DOI 10.1177/0883073812449691	34	135	150	0	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					546	551		10.1038/nm.3510	http://dx.doi.org/10.1038/nm.3510			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24705334				2022-12-25	WOS:000335710700027
J	Qian, K; Zheng, YG				Qian, Kun; Zheng, Yujun George			Palladium brings proteins to life	NATURE CHEMICAL BIOLOGY			English	News Item							SMALL MOLECULES		[Qian, Kun; Zheng, Yujun George] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Qian, K (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	yzheng@uga.edu	Zheng, Yujun/P-8975-2014	Zheng, Yujun/0000-0001-7116-3067; Qian, Kun/0000-0003-1132-2374	NIGMS NIH HHS [R01 GM086717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop Anthony C, 2009, J Chem Biol, V2, P1, DOI 10.1007/s12154-008-0012-4; Carlson SM, 2011, ACS CHEM BIOL, V6, P75, DOI 10.1021/cb1002834; Garner AL, 2009, J AM CHEM SOC, V131, P5163, DOI 10.1021/ja808385a; Li J, 2014, NAT CHEM, V6, P352, DOI [10.1038/NCHEM.1887, 10.1038/nchem.1887]; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Santra M, 2010, CHEM COMMUN, V46, P3964, DOI 10.1039/c001922d; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; Tarrant MK, 2009, ANNU REV BIOCHEM, V78, P797, DOI 10.1146/annurev.biochem.78.070907.103047; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	10	1	1	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					328	330		10.1038/nchembio.1507	http://dx.doi.org/10.1038/nchembio.1507			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24743256				2022-12-25	WOS:000334672700004
J	Sasikaran, J; Ziemski, M; Zadora, PK; Fleig, A; Berg, IA				Sasikaran, Jahminy; Ziemski, Michal; Zadora, Piotr K.; Fleig, Angela; Berg, Ivan A.			Bacterial itaconate degradation promotes pathogenicity	NATURE CHEMICAL BIOLOGY			English	Article							ISOCITRATE LYASE; YERSINIA-PESTIS; MYCOBACTERIUM-TUBERCULOSIS; SECRETORY PRODUCTS; GENOME SEQUENCE; PSEUDOMONAS; ACID; METABOLISM; MACROPHAGE; CITRATE	Itaconate (methylenesuccinate) was recently identified as a mammalian metabolite whose production is substantially induced during macrophage activation. This compound is a potent inhibitor of isocitrate lyase, a key enzyme of the glyoxylate cycle, which is a pathway required for the survival of many pathogens inside the eukaryotic host. Here we show that numerous bacteria, notably many pathogens such as Yersinia pestis and Pseudomonas aeruginosa, have three genes for itaconate degradation. They encode itaconate coenzyme A (CoA) transferase, itaconyl-CoA hydratase and (S)-citramalyl-CoA lyase, formerly referred to as CitE-like protein. These genes are known to be crucial for survival of some pathogens in macrophages. The corresponding enzymes convert itaconate into the cellular building blocks pyruvate and acetyl-CoA, thus enabling the bacteria to metabolize itaconate and survive in macrophages. The itaconate degradation and detoxification pathways of Yersinia and Pseudomonas are the result of convergent evolution. This work revealed a common persistence factor operating in many pathogenic bacteria.	[Sasikaran, Jahminy; Ziemski, Michal; Zadora, Piotr K.; Fleig, Angela; Berg, Ivan A.] Univ Freiburg, Fak Biol, D-79106 Freiburg, Germany; [Zadora, Piotr K.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	University of Freiburg; Max Planck Society	Sasikaran, J (corresponding author), Univ Freiburg, Fak Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ivan.berg@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020	Berg, Ivan/0000-0002-1864-4969; Ziemski, Michal/0000-0001-6285-8852; Zadora, Piotr/0000-0001-9040-1227	Deutsche Forschungsgemeinschaft [BE 4822/2-1]; Heisenberg fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg fellowship(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (BE 4822/2-1 and Heisenberg fellowship to I.A.B.). We thank B. Alber, R. Teufel, J. Zarzycki and M. Carter for critical reading the manuscript; W. Buckel for the discussions of the Ich mechanism and G. Fuchs for constant support and discussions during the work and for critically reading the manuscript.	ADLER J, 1957, J BIOL CHEM, V229, P865; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKEL W, 1973, EUR J BIOCHEM, V37, P295, DOI 10.1111/j.1432-1033.1973.tb02988.x; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chavez-Aviles M, 2009, FEMS MICROBIOL LETT, V296, P117, DOI 10.1111/j.1574-6968.2009.01624.x; COOPER RA, 1964, BIOCHEM J, V91, P82, DOI 10.1042/bj0910082; COOPER RA, 1965, BIOCHEM J, V94, P25, DOI 10.1042/bj0940025; Costa-Ramos C, 2004, APPL ENVIRON MICROB, V70, P729, DOI 10.1128/AEM.70.2.729-735.2004; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DIMROTH P, 1977, EUR J BIOCHEM, V80, P469, DOI 10.1111/j.1432-1033.1977.tb11902.x; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; FURUYA E, 1981, J BIOL CHEM, V256, P7109; Goulding CW, 2007, J MOL BIOL, V365, P275, DOI 10.1016/j.jmb.2006.09.086; He YQ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00002; HILLIER S, 1981, J BACTERIOL, V145, P452, DOI 10.1128/JB.145.1.452-458.1981; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; MARTIN WR, 1961, J BACTERIOL, V82, P905, DOI 10.1128/JB.82.6.905-908.1961; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mittal R, 2009, FEMS IMMUNOL MED MIC, V57, P156, DOI 10.1111/j.1574-695X.2009.00591.x; Morikawa J, 2001, BIOCHEM BIOPH RES CO, V289, P1282, DOI 10.1006/bbrc.2001.6125; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Okabe M, 2009, APPL MICROBIOL BIOT, V84, P597, DOI 10.1007/s00253-009-2132-3; Periaswamy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045433; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Sakai A, 2004, NUTRITION, V20, P997, DOI 10.1016/j.nut.2004.08.007; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schurmann M, 2011, J BACTERIOL, V193, P3078, DOI 10.1128/JB.00049-11; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sugimoto M, 2012, METABOLOMICS, V8, P624, DOI 10.1007/s11306-011-0353-9; Torres R, 2012, ACTA CRYSTALLOGR F, V68, P2, DOI 10.1107/S1744309111048056; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025084; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; van Schaik EJ, 2009, INFECT IMMUN, V77, P4275, DOI 10.1128/IAI.00609-09; Vosloo A, 1996, COMP BIOCHEM PHYS B, V113, P823, DOI 10.1016/0305-0491(96)87671-1; WANG SF, 1961, J BIOL CHEM, V236, P26; WILLIAMS JO, 1971, BIOCHEMISTRY-US, V10, P1384; Zarzycki J, 2009, P NATL ACAD SCI USA, V106, P21317, DOI 10.1073/pnas.0908356106; ZEHR BD, 1989, ANAL BIOCHEM, V182, P157, DOI 10.1016/0003-2697(89)90734-3; Zhao YX, 2002, INFECT IMMUN, V70, P5319, DOI 10.1128/IAI.70.9.5319-5321.2002	60	105	108	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					371	U82		10.1038/nchembio.1482	http://dx.doi.org/10.1038/nchembio.1482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24657929				2022-12-25	WOS:000334672700011
J	Garside, EL; MacMillan, AM				Garside, Erin L.; MacMillan, Andrew M.			Cas9 in close-up	NATURE BIOTECHNOLOGY			English	Editorial Material							RNA; DNA; ENDONUCLEASE; IMMUNITY; SYSTEMS		[Garside, Erin L.; MacMillan, Andrew M.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta	Garside, EL (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	andrew.macmillan@ualberta.ca			Alberta Innovates [201001348] Funding Source: researchfish	Alberta Innovates		Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	11	3	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					338	340		10.1038/nbt.2872	http://dx.doi.org/10.1038/nbt.2872			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714483				2022-12-25	WOS:000334340800017
J	Polyak, K				Polyak, Kornelia			A case for Darwinian tumor evolution	NATURE MEDICINE			English	Editorial Material							ENDOCRINE RESISTANCE; MUTATIONS		[Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	kornelia_polyak@dfci.harvard.edu						Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; KARNIK PS, 1994, CANCER RES, V54, P349; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Swaby RF, 2007, REV ENDOCR METAB DIS, V8, P229, DOI 10.1007/s11154-007-9034-4; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Zhang QX, 1997, CANCER RES, V57, P1244	15	49	50	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					344	346		10.1038/nm.3518	http://dx.doi.org/10.1038/nm.3518			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710378				2022-12-25	WOS:000334361500014
J	Piao, HL; Yuan, Y; Wang, M; Sun, YT; Liang, H; Ma, L				Piao, Hai-long; Yuan, Yuan; Wang, Min; Sun, Yutong; Liang, Han; Ma, Li			alpha-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-kappa B signalling	NATURE CELL BIOLOGY			English	Article							MOLECULAR PORTRAITS; ACTIVATION; GENE; TRANSCRIPTION; PATHWAYS; CELLS; YAP1; TRANSFORMATION; PROLIFERATION; INACTIVATION	Basal-like breast cancer is a highly aggressive tumour subtype associated with poor prognosis. Aberrant activation of NF-kappa B signalling is frequently found in triple-negative basal-like breast cancer cells, but the cause of this activation has remained elusive. Here we report that alpha-catenin functions as a tumour suppressor in E-cadherin-negative basal-like breast cancer cells by inhibiting NF-kappa B signalling. Mechanistically, alpha-catenin interacts with the I kappa B alpha protein, and stabilizes I kappa B alpha by inhibiting its ubiquitylation and its association with the proteasome. This stabilization in turn prevents nuclear localization of RelA and p50, leading to decreased expression of TNF-alpha, IL-8 and RelB. In human breast cancer, CTNNA1 expression is specifically downregulated in the basal-like subtype, correlates with clinical outcome and inversely correlates with TNF and RELB expression. Taken together, these results uncover a previously undescribed mechanism by which the NF-kappa B pathway is activated in E-cadherin-negative basal-like breast cancer.	[Piao, Hai-long; Wang, Min; Ma, Li] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Yuan, Yuan; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Yuan, Yuan] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Sun, Yutong] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ma, Li] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	lma4@mdanderson.org	Yuan, Yuan/H-4007-2013; Ma, Li/GQR-1313-2022	Yuan, Yuan/0000-0003-4706-7897; Ma, Li/0000-0001-9965-989X; Sun, Yutong/0000-0002-9368-2957	US National Institutes of Health [R00CA138572, R01CA166051]; Cancer Prevention and Research Institute of Texas [R1004]; NATIONAL CANCER INSTITUTE [R00CA138572, P30CA016672, P50CA098258, R01CA166051] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Ethier (Medical University of South Carolina, USA) for the SUM159 cell line; J. Chen (The University of Texas MD Anderson Cancer Center, USA) for plasmids; the shRNA and ORFeome Core and the Histology Core at The University of Texas MD Anderson Cancer Center for technical assistance; J. Zhang and J. Chen for assistance with graphics; J.M. Rosen, X. Lin, W. Wang and members of the Ma laboratory for discussion; and H-l. Piao, C. Chu and A. Gelmis for editing the manuscript. This work is supported by US National Institutes of Health grants R00CA138572 (to L.M.) and R01CA166051 (to L.M.) and a Cancer Prevention and Research Institute of Texas Scholar Award R1004 (to L.M.)	Bajpai S, 2009, J BIOL CHEM, V284, P18252, DOI 10.1074/jbc.M109.000661; Baltimore D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000026; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hollestelle A, 2010, BREAST CANCER RES TR, V122, P125, DOI 10.1007/s10549-009-0545-4; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ji HT, 2011, J NEURO-ONCOL, V103, P445, DOI 10.1007/s11060-010-0413-4; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lien WH, 2008, J CELL BIOL, V183, P989, DOI 10.1083/jcb.200805041; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Matluk N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-7; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rakha EA, 2009, BREAST CANCER RES TR, V113, P411, DOI 10.1007/s10549-008-9952-1; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yan J, 2013, CELL, V152, P304, DOI 10.1016/j.cell.2012.12.021; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	46	57	57	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					245	+		10.1038/ncb2909	http://dx.doi.org/10.1038/ncb2909			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24509793	Green Accepted			2022-12-25	WOS:000332124000011
J	Reffay, M; Parrini, MC; Cochet-Escartin, O; Ladoux, B; Buguin, A; Coscoy, S; Amblard, F; Camonis, J; Silberzan, P				Reffay, M.; Parrini, M. C.; Cochet-Escartin, O.; Ladoux, B.; Buguin, A.; Coscoy, S.; Amblard, F.; Camonis, J.; Silberzan, P.			Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells	NATURE CELL BIOLOGY			English	Article							LEADING-EDGE; ACTIVATION; DYNAMICS; MORPHOGENESIS; GUIDANCE; ORGANIZATION; PROTRUSION; MEMBRANE; MOVEMENT; POLARITY	The leading front of a collectively migrating epithelium often destabilizes into multicellular migration fingers where a cell initially similar to the others becomes a leader cell while its neighbours do not alter. The determinants of these leader cells include mechanical and biochemical cues, often under the control of small GTPases. However, an accurate dynamic cartography of both mechanical and biochemical activities remains to be established. Here, by mapping the mechanical traction forces exerted on the surface by MDCK migration fingers, we show that these structures are mechanical global entities with the leader cells exerting a large traction force. Moreover, the spatial distribution of RhoA differential activity at the basal plane strikingly mirrors this force cartography. We propose that RhoA controls the development of these fingers through mechanical cues: the leader cell drags the structure and the peripheral pluricellular acto-myosin cable prevents the initiation of new leader cells.	[Reffay, M.; Cochet-Escartin, O.; Buguin, A.; Coscoy, S.; Amblard, F.; Silberzan, P.] UPMC, CNRS, Inst Curie, Lab Physicochim Curie,Ctr Rech,UMR 168, F-75248 Paris, France; [Reffay, M.; Ladoux, B.] Univ Paris Diderot, CNRS, Lab Mat & Syst, UMR 7057, F-75251 Paris, France; [Parrini, M. C.; Camonis, J.] Inst Curie, Ctr Rech, INSERM, Anal Transduct Pathways Grp,U830, F-75248 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Camonis, J (corresponding author), Inst Curie, Ctr Rech, INSERM, Anal Transduct Pathways Grp,U830, F-75248 Paris, France.	jacques.camonis@curie.fr; pascal.silberzan@curie.fr	REFFAY, Myriam/D-3736-2018; Amblard, Francois/F-4552-2015; Parrini, Maria Carla/J-5390-2016; Silberzan, Pascal/L-5934-2016	Amblard, Francois/0000-0002-7247-3873; Parrini, Maria Carla/0000-0002-7082-9792; Silberzan, Pascal/0000-0002-8554-882X; Reffay, Myriam/0000-0002-3695-2789; Coscoy, Sylvie/0000-0003-3963-3609; Cochet-Escartin, Olivier/0000-0001-7924-702X; Ladoux, Benoit/0000-0003-2086-1556; Buguin, Axel/0000-0002-1246-4422	C'nano Ile de France; Association Christelle Bouillot; Association pour la Recherche sur le Cancer; Labex CelTisPhyBio; Institut Curie Programme Incitatif et Cooperatif 'Physique de la Cellule'	C'nano Ile de France(Region Ile-de-France); Association Christelle Bouillot; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Labex CelTisPhyBio; Institut Curie Programme Incitatif et Cooperatif 'Physique de la Cellule'	It is a pleasure to thank G. Duclos for his help in several experiments, the members of the Biology-Inspired Physics at Mesoscales group and D. Louvard (Institut Curie) for discussions and support, M. Matsuda (Kyoto University) for sharing with us the FRET plasmids and for a critical analysis of our data, and W. J. Nelson (Stanford University) for the GFP-modified cell lines. We thank the Institut Curie-CNRS Nikon Imaging Center and the BDD imaging centre and particularly V. Fraisier, O. Leroy and L. Sengmanivong for technical support. We gratefully acknowledge financial support from the C'nano Ile de France, the Association Christelle Bouillot, the Association pour la Recherche sur le Cancer, the Labex CelTisPhyBio and the Institut Curie Programme Incitatif et Cooperatif 'Physique de la Cellule'.	Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; BELLUSCI S, 1994, J CELL SCI, V107, P1277; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Deforet M, 2012, NAT METHODS, V9, P1081, DOI [10.1038/NMETH.2209, 10.1038/nmeth.2209]; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Eichorst JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004082; El-Sibai M, 2008, EXP CELL RES, V314, P1540, DOI 10.1016/j.yexcr.2008.01.016; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Gopalakrishnan S, 1998, AM J PHYSIOL-CELL PH, V275, pC798, DOI 10.1152/ajpcell.1998.275.3.C798; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Klarlund JK, 2012, P NATL ACAD SCI USA, V109, P15799, DOI 10.1073/pnas.1210992109; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lessey EC, 2012, BIOCHEMISTRY-US, V51, P7420, DOI 10.1021/bi300758e; Lim JI, 2010, EXP CELL RES, V316, P2027, DOI 10.1016/j.yexcr.2010.04.011; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mark S, 2010, BIOPHYS J, V98, P361, DOI 10.1016/j.bpj.2009.10.022; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Omelchenko T, 2012, CURR BIOL, V22, P278, DOI 10.1016/j.cub.2012.01.014; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Rasband W.S., 1997, IMAGEJ V1 46B; Reffay M, 2011, BIOPHYS J, V100, P2566, DOI 10.1016/j.bpj.2011.04.047; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Sutton TA, 2001, AM J PHYSIOL-RENAL, V281, pF810, DOI 10.1152/ajprenal.2001.281.5.F810; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	55	223	224	0	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					217	+		10.1038/ncb2917	http://dx.doi.org/10.1038/ncb2917			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24561621				2022-12-25	WOS:000332124000005
J	Tsai, FC; Seki, A; Yang, HW; Hayer, A; Carrasco, S; Malmersjo, S; Meyer, T				Tsai, Feng-Chiao; Seki, Akiko; Yang, Hee Won; Hayer, Arnold; Carrasco, Silvia; Malmersjoe, Seth; Meyer, Tobias			A polarized Ca2+, diacylglycerol and STIM1 signalling system regulates directed cell migration	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL SHEET MIGRATION; FOCAL ADHESION FORMATION; T-LYMPHOCYTE ACTIVATION; ACTIN CYTOSKELETON; CALCIUM INFLUX; PHAGOCYTOSIS; CANCER; CHEMOTAXIS; MUSCLE	Ca2+ signals control cell migration by regulating forward movement and cell adhesion. However, it is not well understood how Ca2+-regulatory proteins and second messengers are spatially organized in migrating cells. Here we show that receptor tyrosine kinase and phospholipase C signalling are restricted to the front of migrating endothelial leader cells, triggering local Ca2+ pulses, local depletion of Ca2+ in the endoplasmic reticulum and local activation of STIM1, supporting pulsatile front retraction and adhesion. At the same time, the mediator of store-operated Ca2+ influx, STIM1, is transported by microtubule plus ends to the front. Furthermore, higher Ca2+ pump rates in the front relative to the back of the plasma membrane enable effective local Ca2+ signalling by locally decreasing basal Ca2+ Finally, polarized phospholipase C signalling generates a diacylglycerol gradient towards the front that promotes persistent forward migration. Thus, cells employ an integrated Ca2+ control system with polarized Ca2+ signalling proteins and second messengers to synergistically promote directed cell migration.	[Tsai, Feng-Chiao] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Tsai, Feng-Chiao; Seki, Akiko; Yang, Hee Won; Hayer, Arnold; Carrasco, Silvia; Malmersjoe, Seth; Meyer, Tobias] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Tsai, Feng-Chiao] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 100, Taiwan	Stanford University; Stanford University; National Taiwan University	Tsai, FC (corresponding author), Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA.	tsaifc@ntu.edu.tw; tobias1@stanford.edu	Hayer, Arnold/W-8863-2019; Malmersjö, Seth/D-2454-2010	Hayer, Arnold/0000-0001-7808-8880; Malmersjö, Seth/0000-0002-1519-8916; Tsai, Feng-Chiao/0000-0001-9615-6023; Yang, Hee Won/0000-0002-0000-8091; Meyer, Tobias/0000-0003-4339-3804	Stanford Graduate Fellowship; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM030179, R01GM063702] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. R. Collins, M. Galic and R. Wollman for technical support and discussions, S. Bandara for the TIER construct, N. Borghi for the paxillin construct, X. Ge for the CD4 construct, C. J. Lin for H1299 cells, E. E. Strehler for the PMCA constructs and A. Winans for critical reading of the manuscript. The research was supported by a Stanford Graduate Fellowship (F-C.T.) and the NIGMS (T.M.)	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Almena M, 2011, TRENDS BIOCHEM SCI, V36, P593, DOI 10.1016/j.tibs.2011.06.005; Arisz SA, 2009, BBA-MOL CELL BIOL L, V1791, P869, DOI 10.1016/j.bbalip.2009.04.006; Bandara S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003649; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; de Jong APH, 2009, CURR OPIN NEUROBIOL, V19, P245, DOI 10.1016/j.conb.2009.06.005; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; GILBERT SH, 1994, J CELL BIOL, V127, P489, DOI 10.1083/jcb.127.2.489; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; JAMES P, 1989, J BIOL CHEM, V264, P8289; KASTURI R, 1993, J BIOL CHEM, V268, P7958; Kim K, 2010, J NEUROCHEM, V112, P577, DOI 10.1111/j.1471-4159.2009.06499.x; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Ludowyke RI, 2006, J IMMUNOL, V177, P1492, DOI 10.4049/jimmunol.177.3.1492; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; May RC, 2001, J CELL SCI, V114, P1061; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Schafer C, 2012, J BIOL CHEM, V287, P40745, DOI 10.1074/jbc.M112.407155; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; SMALLWOOD JI, 1988, J BIOL CHEM, V263, P2195; Smith G, 2008, BIOPHYS J, V95, P1005, DOI 10.1529/biophysj.108.133926; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tkachenko E., NAT CELL BIOL, V13, P660; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vitorino P, 2011, MOL CELL BIOL, V31, P342, DOI 10.1128/MCB.00800-10; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WOODS A, 1992, J CELL SCI, V101, P277; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	58	157	159	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2014	16	2					133	144		10.1038/ncb2906	http://dx.doi.org/10.1038/ncb2906			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA5TB	24463606	Green Accepted			2022-12-25	WOS:000331161400003
J	Clement, LC; Mace, C; Avila-Casado, C; Joles, JA; Kersten, S; Chugh, SS				Clement, Lionel C.; Mace, Camille; Avila-Casado, Carmen; Joles, Jaap A.; Kersten, Sander; Chugh, Sumant S.			Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome	NATURE MEDICINE			English	Article							LIPOPROTEIN-LIPASE; GENE-EXPRESSION; FATTY-ACIDS; ANGPTL4; GLOMERULI; INSIGHTS; ALBUMIN; BINDING; SERUM; MICE	The molecular link between proteinuria and hyperlipidemia in nephrotic syndrome is not known. We show in the present study that plasma angiopoietin-like 4 (Angptl4) links proteinuria with hypertriglyceridemia through two negative feedback loops. In previous studies in a rat model that mimics human minimal change disease, we observed localized secretion by podocytes of hyposialylated Angptl4, a pro-proteinuric form of the protein. But in this study we noted high serum levels of Angptl4 (presumably normosialylated based on a neutral isoelectric point) in other glomerular diseases as well. Circulating Angptl4 was secreted by extrarenal organs in response to an elevated plasma ratio of free fatty acids (FFAs) to albumin when proteinuria reached nephrotic range. In a systemic feedback loop, these circulating pools of Angptl4 reduced proteinuria by interacting with glomerular endothelial alpha(v)beta(5) integrin. Blocking the Angptl4-beta(5) integrin interaction or global knockout of Angptl4 or beta(5) integrin delayed recovery from peak proteinuria in animal models. But at the same time, in a local feedback loop, the elevated extrarenal pools of Angptl4 reduced tissue FFA uptake in skeletal muscle, heart and adipose tissue, subsequently resulting in hypertriglyceridemia, by inhibiting lipoprotein lipase (LPL)-mediated hydrolysis of plasma triglycerides to FFAs. Injecting recombinant human ANGPTL4 modified at a key LPL interacting site into nephrotic Buffalo Mna and Zucker Diabetic Fatty rats reduced proteinuria through the systemic loop but, by bypassing the local loop, without increasing plasma triglyceride levels. These data show that increases in circulating Angptl4 in response to nephrotic-range proteinuria reduces the degree of this pathology, but at the cost of inducing hypertriglyceridemia, while also suggesting a possible therapy to treat these linked pathologies.	[Clement, Lionel C.; Mace, Camille; Chugh, Sumant S.] Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA; [Avila-Casado, Carmen] Univ Toronto, Toronto Gen Hosp, Dept Pathol, Toronto, ON M5G 1L7, Canada; [Avila-Casado, Carmen] Inst Nacl Cardiol, Dept Pathol, Mexico City, DF, Mexico; [Joles, Jaap A.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands	University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; National Institute of Cardiology - Mexico; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Chugh, SS (corresponding author), Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA.	chugh@uab.edu	Joles, Jaap/AAX-3249-2020; Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734	US National Institutes of Health [R01DK077073, R01DK090035, K01DK096127, T32DK007545]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077073, R01DK101637, K01DK096127, P30DK079337, R01DK090035, T32DK007545] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank investigators of the FSGS clinical trial for providing baseline plasma and urine samples from patients with FSGS; M. del Nogal-Avila (University of Alabama at Birmingham (UAB)) for selected real-time PCR studies; H. Donoro (UAB) for assistance with animal colony management; E. Soria (Instituto Nacional de Cardiologia) for immunogold electron microscopy studies; H. Chung (UAB) for advice on LPL assays; V. Kumar (UAB) for help in collecting Institutional Review Board-approved patient sera from transplant patients; D. Salant (Boston University) for gamma 2-NTS; A. Koster (Eli Lilly) for Angptl4<SUP>-/-</SUP> mice; M. Mitsuyama (Kyoto University) for Buffalo Mna rats; J. Brunzell (University of Washington) for 5D2 monoclonal antibody; F. Danesh (MD Anderson Cancer Center) for cultured rat glomerular endothelial cells; UAB-University of California-San Diego George O'Brien Center Core C for measuring urine and serum creatinine by mass spectrometry; UAB Nephrology Research and Training Center for equipment use; and UAB Research Foundation for filing patent PCT/US2011/039255 for the use of ANGPTL4 mutants as therapeutic agents for nephrotic syndrome. This work is supported by the US National Institutes of Health (R01DK077073 and R01DK090035 to S.S.C., K01DK096127 to L.C.C. and T32DK007545 to C.M.).	Avila-Casado MD, 2004, KIDNEY INT, V66, P133, DOI 10.1111/j.1523-1755.2004.00715.x; Bengtsson-Olivecrona G., 1992, PRACTICAL APPROACH S, P169; Chang SF, 1998, J LIPID RES, V39, P2350; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Clement LC, 2007, KIDNEY INT, V72, P337, DOI 10.1038/sj.ki.5002302; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Ferris M, 2013, CTS-CLIN TRANSL SCI, V6, P13, DOI 10.1111/cts.12003; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; GHIGGERI GM, 1987, KIDNEY INT, V32, P547, DOI 10.1038/ki.1987.243; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; KIKUCHI H, 1983, BIOCHIM BIOPHYS ACTA, V744, P165, DOI 10.1016/0167-4838(83)90086-9; Le Berre L, 2002, J CLIN INVEST, V109, P491, DOI 10.1172/JCI200212858; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; MARSH JB, 1960, METABOLISM, V9, P946; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; NAGASE S, 1979, SCIENCE, V205, P590, DOI 10.1126/science.451621; NAKAMURA T, 1986, NEPHRON, V43, P50, DOI 10.1159/000183718; Neuger Lucyna, 2004, BMC Physiol, V4, P13, DOI 10.1186/1472-6793-4-13; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shearer GC, 2006, KIDNEY INT, V70, P647, DOI 10.1038/sj.ki.5000318; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Vaziri ND, 2003, KIDNEY INT, V63, P1964, DOI 10.1046/j.1523-1755.2003.00941.x; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; ZILLERUELO G, 1984, J PEDIATR-US, V104, P61, DOI 10.1016/S0022-3476(84)80590-9	33	101	118	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					37	+		10.1038/nm.3396	http://dx.doi.org/10.1038/nm.3396			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317117	Green Accepted			2022-12-25	WOS:000329349400017
J	Jeong, M; Sun, DQ; Luo, M; Huang, Y; Challen, GA; Rodriguez, B; Zhang, XT; Chavez, L; Wang, H; Hannah, R; Kim, SB; Yang, LB; Ko, M; Chen, R; Gottgens, B; Lee, JS; Gunaratne, P; Godley, LA; Darlington, GJ; Rao, A; Li, W; Goodell, MA				Jeong, Mira; Sun, Deqiang; Luo, Min; Huang, Yun; Challen, Grant A.; Rodriguez, Benjamin; Zhang, Xiaotian; Chavez, Lukas; Wang, Hui; Hannah, Rebecca; Kim, Sang-Bae; Yang, Liubin; Ko, Myunggon; Chen, Rui; Goettgens, Berthold; Lee, Ju-Seog; Gunaratne, Preethi; Godley, Lucy A.; Darlington, Gretchen J.; Rao, Anjana; Li, Wei; Goodell, Margaret A.			Large conserved domains of low DNA methylation maintained by Dnmt3a	NATURE GENETICS			English	Article							CANCER GENOME; 5-HYDROXYMETHYLCYTOSINE; MUTATIONS; CHROMATIN; 5-METHYLCYTOSINE; METHYLOME; GENES; CELLS; TET2	Gains and losses in DNA methylation are prominent features of mammalian cell types. To gain insight into the mechanisms that promote shifts in DNA methylation and contribute to changes in cell fate, including malignant transformation, we performed genome-wide mapping of 5-methylcytosine and 5-hydroxymethylcytosine in purified mouse hematopoietic stem cells. We discovered extended regions of low methylation (canyons) that span conserved domains frequently containing transcription factors and are distinct from CpG islands and shores. About half of the genes in these methylation canyons are coated with repressive histone marks, whereas the remainder are covered by activating histone marks and are highly expressed in hematopoietic stem cells (HSCs). Canyon borders are demarked by 5-hydroxymethylcytosine and become eroded in the absence of DNA methyltransferase 3a (Dnmt3a). Genes dysregulated in human leukemias are enriched for canyon-associated genes. The new epigenetic landscape we describe may provide a mechanism for the regulation of hematopoiesis and may contribute to leukemia development.	[Jeong, Mira; Luo, Min; Challen, Grant A.; Zhang, Xiaotian; Yang, Liubin; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat & Mol & Human Genet, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Sun, Deqiang; Rodriguez, Benjamin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Sun, Deqiang; Rodriguez, Benjamin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Huang, Yun; Chavez, Lukas; Ko, Myunggon; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA USA; [Wang, Hui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Hannah, Rebecca; Goettgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Hematol, Cambridge, England; [Hannah, Rebecca; Goettgens, Berthold] Univ Cambridge, Wellcome Trust & Med Res Council Cambridge, Stem Cell Inst, Cambridge, England; [Kim, Sang-Bae; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Syst Biol, Houston, TX 77030 USA; [Gunaratne, Preethi] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Gunaratne, Preethi] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Godley, Lucy A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; La Jolla Institute for Immunology; Baylor College of Medicine; University of Cambridge; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Houston System; University of Houston; University of Chicago; Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Dept Pediat & Mol & Human Genet, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	wl1@bcm.edu; goodell@bcm.edu	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753; Goodell, Margaret A./0000-0003-1111-2932; Ko, Myunggon/0000-0002-6007-2570; sun, deqiang/0000-0002-5806-7289; luo, min/0000-0003-4883-4189; Gottgens, Berthold/0000-0001-6302-5705; Chavez, Lukas/0000-0002-8718-8848; Li, Wei/0000-0001-9931-5990; Huang, Yun/0000-0001-5950-9168; Zhang, Xiaotian/0000-0002-9533-4761	US National Institutes of Health (NIH) [AG036562, CA126752, DK092883, CA125123, DK084259, AI07495]; Ellison Medical Foundation; Cancer Prevention Research Institute of Texas (CPRIT) [RP110028]; Samuel Waxman Foundation; CPRIT [RP110471]; NIH [RO1HG007538]; DOD [PC094421]; Leukemia and Lymphoma Society [6187-12];  [CA151535];  [CIRM RM1-01729]; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0900951] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535, P50CA126752, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK084259, R01DK092883, R00DK084259, R56DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0900951, MC_PC_12009] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Cancer Prevention Research Institute of Texas (CPRIT); Samuel Waxman Foundation; CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	We thank T. Chen, J.P. Issa, J. Gilbert and members of the Goodell laboratory for helpful discussions. This work was supported by US National Institutes of Health (NIH) grants AG036562, CA126752, DK092883, CA125123, DK084259 and AI07495, the Ellison Medical Foundation, Cancer Prevention Research Institute of Texas (CPRIT) grant RP110028 and the Samuel Waxman Foundation (M. A. G.): by CPRIT RP110471, NIH grant RO1HG007538 and DOD PC094421 (W. L.); and by grants CA151535 and CIRM RM1-01729 and Leukemia and Lymphoma Society award 6187-12 (A. R.). Y.H. and M. K. are supported by Leukemia and Lymphoma Society fellowships.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuhn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-26; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin X., 2013, BIOINFORMATICS, DOI [10.1093/bioinformatics/btt548, DOI 10.1093/BI0INF0RMATICS/BTT548]; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roller A, 2013, LEUKEMIA, V27, P1573, DOI 10.1038/leu.2013.65; Simon R, 2007, CANCER INFORM, V3, P11; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	47	225	228	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					17	+		10.1038/ng.2836	http://dx.doi.org/10.1038/ng.2836			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24270360	Green Accepted			2022-12-25	WOS:000329113500007
J	Tang, HY; Jin, X; Li, Y; Jiang, H; Tang, XF; Yang, X; Cheng, H; Qiu, Y; Chen, G; Mei, JP; Zhou, FS; Wu, RH; Zuo, XB; Zhang, Y; Zheng, XD; Cai, Q; Yin, XY; Quan, C; Shao, HJ; Cui, Y; Tian, FZ; Zhao, X; Liu, H; Xiao, FL; Xu, FP; Han, JW; Shi, DM; Zhang, AP; Zhou, C; Li, QB; Fan, X; Lin, LY; Tian, HQ; Wang, ZX; Fu, HL; Wang, F; Yang, BQ; Huang, SW; Liang, B; Xie, XF; Ren, YQ; Gu, QQ; Wen, GD; Sun, YL; Wu, XL; Dang, L; Xia, M; Shan, JJ; Li, TH; Yang, L; Zhang, XY; Li, YZ; He, CD; Xu, A; Wei, LP; Zhao, XH; Gao, XH; Xu, JH; Zhang, FR; Zhang, JZ; Li, YR; Sun, LD; Liu, JJ; Chen, RS; Yang, S; Wang, J; Zhang, XJ				Tang, Huayang; Jin, Xin; Li, Yang; Jiang, Hui; Tang, Xianfa; Yang, Xu; Cheng, Hui; Qiu, Ying; Chen, Gang; Mei, Junpu; Zhou, Fusheng; Wu, Renhua; Zuo, Xianbo; Zhang, Yong; Zheng, Xiaodong; Cai, Qi; Yin, Xianyong; Quan, Cheng; Shao, Haojing; Cui, Yong; Tian, Fangzhen; Zhao, Xia; Liu, Hong; Xiao, Fengli; Xu, Fengping; Han, Jianwen; Shi, Dongmei; Zhang, Anping; Zhou, Cheng; Li, Qibin; Fan, Xing; Lin, Liya; Tian, Hongqing; Wang, Zaixing; Fu, Huiling; Wang, Fang; Yang, Baoqi; Huang, Shaowei; Liang, Bo; Xie, Xuefeng; Ren, Yunqing; Gu, Qingquan; Wen, Guangdong; Sun, Yulin; Wu, Xueli; Dang, Lin; Xia, Min; Shan, Junjun; Li, Tianhang; Yang, Lin; Zhang, Xiuyun; Li, Yuzhen; He, Chundi; Xu, Aie; Wei, Liping; Zhao, Xiaohang; Gao, Xinghua; Xu, Jinhua; Zhang, Furen; Zhang, Jianzhong; Li, Yingrui; Sun, Liangdan; Liu, Jianjun; Chen, Runsheng; Yang, Sen; Wang, Jun; Zhang, Xuejun			A large-scale screen for coding variants predisposing to psoriasis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; SUSCEPTIBILITY LOCI; RARE VARIANTS; MISSING HERITABILITY; LOW-FREQUENCY; SEQUENCE; DISEASE; IDENTIFICATION; METAANALYSIS	To explore the contribution of functional coding variants to psoriasis, we analyzed nonsynonymous single-nucleotide variants (SNVs) across the genome by exome sequencing in 781 psoriasis cases and 676 controls and through follow-up validation in 1,326 candidate genes by targeted sequencing in 9,946 psoriasis cases and 9,906 controls from the Chinese population. We discovered two independent missense SNVs in IL23R and GJB2 of low frequency and five common missense SNVs in LCE3D, ERAP1, CARD14 and ZNF816A associated with psoriasis at genome-wide significance. Rare missense SNVs in FUT2 and TARBP1 were also observed with suggestive evidence of association. Single-variant and gene-based association analyses of nonsynonymous SNVs did not identify newly associated genes for psoriasis in the regions subjected to targeted resequencing. This suggests that coding variants in the 1,326 targeted genes contribute only a limited fraction of the overall genetic risk for psoriasis.	[Tang, Huayang; Li, Yang; Tang, Xianfa; Cheng, Hui; Chen, Gang; Zhou, Fusheng; Zuo, Xianbo; Zheng, Xiaodong; Yin, Xianyong; Quan, Cheng; Cui, Yong; Xiao, Fengli; Fan, Xing; Wang, Zaixing; Liang, Bo; Ren, Yunqing; Sun, Liangdan; Liu, Jianjun; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Jin, Xin; Jiang, Hui; Yang, Xu; Mei, Junpu; Wu, Renhua; Zhang, Yong; Shao, Haojing; Zhao, Xia; Xiao, Fengli; Li, Qibin; Lin, Liya; Fu, Huiling; Huang, Shaowei; Xie, Xuefeng; Gu, Qingquan; Wu, Xueli; Xia, Min; Yang, Lin; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Tian, Fangzhen; Shi, Dongmei] Jining 1 Peoples Hosp, Dept Dermatol, Jining, Shandong, Peoples R China; [Cai, Qi] Second Hosp, Dept Dermatol, Chengdu, Peoples R China; [Liu, Hong; Tian, Hongqing; Yang, Baoqi] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Han, Jianwen] Inner Mongolia Med Coll, Affiliated Hosp, Dept Dermatol, Hohhot, Peoples R China; [Zhou, Cheng; Wang, Fang; Wen, Guangdong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100871, Peoples R China; [Sun, Yulin; Zhao, Xiaohang] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Sun, Yulin; Zhao, Xiaohang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yulin; Zhao, Xiaohang] Navy Gen Hosp, Ctr Basic Med Sci, Beijing, Peoples R China; [Dang, Lin; Li, Yuzhen] Harbin Med Univ, Affiliated Hosp 2, Dept Dermatol, Harbin, Peoples R China; [Shan, Junjun; Xu, Aie] Third Peoples Hosp Hangzhou, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [He, Chundi; Gao, Xinghua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Peoples R China; [Wei, Liping] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Xu, Jinhua; Zhang, Xuejun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Anhui Medical University; Beijing Genomics Institute (BGI); South China University of Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Inner Mongolia Medical University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sixth Medical Center of Chinese PLA General Hospital; Harbin Medical University; China Medical University; Peking University; Fudan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Zhang, XJ (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Peoples R China.	wangj@genomics.cn; ayzxj@vip.sina.com	Cui, Yong/AAF-9300-2020; Wang, Jun/A-7261-2013; Fang, Xiaodong/K-6743-2018; Shao, Haojing/C-5429-2017; Zhou, Cheng/GMW-6255-2022; Li, Yingrui/K-1064-2015; Liu, Jianjun/AAK-4989-2020; Chen, Gang/G-2722-2010; wang, fang/GYD-4295-2022; Jin, Xin/ABF-1329-2020; xu, fengping/AAE-6072-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Fang, Xiaodong/0000-0001-7061-3337; Shao, Haojing/0000-0002-8806-197X; Liu, Jianjun/0000-0002-3255-3019; Jin, Xin/0000-0001-7554-4975; Zhou, Cheng/0000-0002-4091-4777; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	National Natural Science Foundation of China [81130031, 81072461, 30971644, 31171224, 31000528, 81000692, 81071285, 81172866, 81172591, 31200939]; National Science Fund for Excellent Young Scholars [81222022]; Outstanding Talents of Organization Department of the CPC (Communist Party of China) Central Committee program; Ministry of Finance of China; New Century Excellent Talents in University [NCET-11-0889]; Science and Technological Fund of Anhui Province for Outstanding Youth [1108085J10]; Pre-National Basic Research Program of China (973 Plan) [2012CB722404]; National Basic Research Program of China (973 Plan) [2009CB825404]; State Key Development Program for Basic Research of China (973 Program) [2011CB809203]; Chinese High-Tech (863) Program [2012AA02A201]; Enterprise Key Laboratory; Guangdong Province; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; National High-Tech Research & Development Program [2012AA020206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Outstanding Talents of Organization Department of the CPC (Communist Party of China) Central Committee program; Ministry of Finance of China; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technological Fund of Anhui Province for Outstanding Youth; Pre-National Basic Research Program of China (973 Plan)(National Basic Research Program of China); National Basic Research Program of China (973 Plan)(National Basic Research Program of China); State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Chinese High-Tech (863) Program(National High Technology Research and Development Program of China); Enterprise Key Laboratory; Guangdong Province; Shenzhen Key Laboratory of Transomics Biotechnologies; National High-Tech Research & Development Program(National High Technology Research and Development Program of China)	We thank the individuals who participated in this project and their families. We also want to thank L. Wu, D. Li, Y. Shi, J. Shen, L. Song, Y. Xue, J. Jv, Y. Sheng and J. Gao who participated in the analysis of exome sequencing data. We thank the State Key Laboratory Incubation Base of Dermatology, Ministry of National Science and Technology (Hefei, China). This study was funded by the Key Program of the National Natural Science Foundation of China (81130031), the National Science Fund for Excellent Young Scholars (81222022), the Outstanding Talents of Organization Department of the CPC (Communist Party of China) Central Committee program, the Local Universities Characteristics and Advantages of Discipline Development Program of the Ministry of Finance of China and the General Program of the National Natural Science Foundation of China (81072461, 30971644, 31171224, 31000528, 81000692, 81071285, 81172866, 81172591 and 31200939), New Century Excellent Talents in University (NCET-11-0889), and the Science and Technological Fund of Anhui Province for Outstanding Youth (1108085J10) as well as the Pre-National Basic Research Program of China (973 Plan; 2012CB722404), the National Basic Research Program of China (973 Plan; 2009CB825404), the State Key Development Program for Basic Research of China (973 Program; 2011CB809203), the Chinese High-Tech (863) Program (2012AA02A201), the Enterprise Key Laboratory, supported by Guangdong Province, and the Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A), and the National High-Tech Research & Development Program (2012AA020206).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Dering C, 2011, GENET EPIDEMIOL, V35, pS12, DOI 10.1002/gepi.20643; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ellinghaus E, 2012, J INVEST DERMATOL, V132, P1133, DOI 10.1038/jid.2011.415; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Madsen B.E., 2009, PLOS GENET, V5; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; WALLENSTEIN S, 1993, BIOMETRICS, V49, P1077, DOI 10.2307/2532249; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zeggini E, 2011, NAT GENET, V43, P287, DOI 10.1038/ng0411-287; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhang XJ, 2012, J DERMATOL SCI, V66, P89, DOI 10.1016/j.jdermsci.2012.02.017	54	141	149	6	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					45	+		10.1038/ng.2827	http://dx.doi.org/10.1038/ng.2827			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24212883				2022-12-25	WOS:000329113500011
J	Jiao, YC; Pawlik, TM; Anders, RA; Selaru, FM; Streppel, MM; Lucas, DJ; Niknafs, N; Guthrie, VB; Maitra, A; Argani, P; Offerhaus, GJA; Roa, JC; Roberts, LR; Gores, GJ; Popescu, I; Alexandrescu, ST; Dima, S; Fassan, M; Simbolo, M; Mafficini, A; Capelli, P; Lawlor, RT; Ruzzenente, A; Guglielmi, A; Tortora, G; de Braud, F; Scarpa, A; Jarnagin, W; Klimstra, D; Karchin, R; Velculescu, VE; Hruban, RH; Vogelstein, B; Kinzler, KW; Papadopoulos, N; Wood, LD				Jiao, Yuchen; Pawlik, Timothy M.; Anders, Robert A.; Selaru, Florin M.; Streppel, Mirte M.; Lucas, Donald J.; Niknafs, Noushin; Guthrie, Violeta Beleva; Maitra, Anirban; Argani, Pedram; Offerhaus, G. Johan A.; Roa, Juan Carlos; Roberts, Lewis R.; Gores, Gregory J.; Popescu, Irinel; Alexandrescu, Sorin T.; Dima, Simona; Fassan, Matteo; Simbolo, Michele; Mafficini, Andrea; Capelli, Paola; Lawlor, Rita T.; Ruzzenente, Andrea; Guglielmi, Alfredo; Tortora, Giampaolo; de Braud, Filippo; Scarpa, Aldo; Jarnagin, William; Klimstra, David; Karchin, Rachel; Velculescu, Victor E.; Hruban, Ralph H.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas; Wood, Laura D.			Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas	NATURE GENETICS			English	Article							CANCERS; GALLBLADDER; CARCINOMA; PATHWAY; LIVER; OCCUR; IDH2	Through exomic sequencing of 32 intrahepatic cholangiocarcinomas, we discovered frequent inactivating mutations in multiple chromatin-remodeling genes (including BAP1, ARID1A and PBRM1), and mutation in one of these genes occurred in almost half of the carcinomas sequenced. We also identified frequent mutations at previously reported hotspots in the IDH1 and IDH2 genes encoding metabolic enzymes in intrahepatic cholangiocarcinomas. In contrast, TP53 was the most frequently altered gene in a series of nine gallbladder carcinomas. These discoveries highlight the key role of dysregulated chromatin remodeling in intrahepatic cholangiocarcinomas.	[Jiao, Yuchen; Velculescu, Victor E.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Univ, Ludwig Ctr, Baltimore, MD USA; [Jiao, Yuchen; Velculescu, Victor E.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD USA; [Jiao, Yuchen; Pawlik, Timothy M.; Anders, Robert A.; Maitra, Anirban; Argani, Pedram; Velculescu, Victor E.; Hruban, Ralph H.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Pawlik, Timothy M.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Anders, Robert A.; Streppel, Mirte M.; Maitra, Anirban; Argani, Pedram; Hruban, Ralph H.; Wood, Laura D.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Selaru, Florin M.] Johns Hopkins Univ, Dept Gastroenterol & Hepatol, Baltimore, MD USA; [Lucas, Donald J.] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA; [Niknafs, Noushin; Guthrie, Violeta Beleva; Karchin, Rachel] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD USA; [Offerhaus, G. Johan A.] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands; [Roa, Juan Carlos] Univ La Frontera, Dept Pathol, Temuco, Chile; [Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Popescu, Irinel; Alexandrescu, Sorin T.; Dima, Simona] Fundeni Clin Inst, Dan Setlacec Ctr Gen Surg & Liver Transplantat, Bucharest, Romania; [Fassan, Matteo; Simbolo, Michele; Mafficini, Andrea; Lawlor, Rita T.; Scarpa, Aldo] Univ Verona, Miriam Cherubini Res Ctr, Appl Res Canc Network, I-37100 Verona, Italy; [Fassan, Matteo; Simbolo, Michele; Capelli, Paola; Lawlor, Rita T.; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Ruzzenente, Andrea; Guglielmi, Alfredo] Univ Verona, Dept Surg, I-37100 Verona, Italy; [Tortora, Giampaolo] Univ Verona, Dept Med, Med Oncol Unit, I-37100 Verona, Italy; [de Braud, Filippo] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Med Oncol Unit 1, I-20133 Milan, Italy; [Jarnagin, William] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Klimstra, David] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Walter Reed National Military Medical Center; Johns Hopkins University; Utrecht University; Utrecht University Medical Center; Universidad de La Frontera; Mayo Clinic; Institutul Clinic Fundeni; University of Verona; University of Verona; University of Verona; University of Verona; Fondazione IRCCS Istituto Nazionale Tumori Milan; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Scarpa, A (corresponding author), Univ Verona, Miriam Cherubini Res Ctr, Appl Res Canc Network, I-37100 Verona, Italy.	aldo.scarpa@univr.it; kinzlke@jhmi.edu; npapado1@jhmi.edu; ldwood@jhmi.edu	Tortora, Giampaolo/HGB-6261-2022; Wood, Laura/ABF-1531-2020; ALEXANDRESCU, SORIN/AAJ-3660-2021; Velculescu, Victor/ABF-4846-2020; Pawlik, Timothy/AAO-9335-2020; Roa, Juan C./K-4749-2014; Dima, Simona/P-5582-2019; Tortora, Giampaolo/AAA-1252-2019; scarpa, aldo/K-6832-2016; Simbolo, Michele/AAB-1851-2019; Ruzzenente, Andrea/R-5850-2019; Dima, Simona Olimpia/B-8822-2017; de Braud, Filippo/B-9997-2017; Fassan, Matteo/F-5152-2012; POPESCU, IRINEL/B-3048-2008; Karchin, Rachel/A-3385-2010; Popescu, Irinel/S-9228-2019; Mafficini, Andrea/AAK-8158-2020	ALEXANDRESCU, SORIN/0000-0002-2783-2769; Velculescu, Victor/0000-0003-1195-438X; Roa, Juan C./0000-0001-8313-8774; Dima, Simona/0000-0001-5275-8938; scarpa, aldo/0000-0003-1678-739X; Simbolo, Michele/0000-0002-0866-4499; Ruzzenente, Andrea/0000-0001-6911-563X; de Braud, Filippo/0000-0003-0103-730X; Fassan, Matteo/0000-0001-6515-5482; Mafficini, Andrea/0000-0002-7471-3121; lawlor, Rita/0000-0003-3160-0634; Selaru, Florin/0000-0001-7990-8238; GUGLIELMI, Alfredo/0000-0003-1713-4307; Tortora, Giampaolo/0000-0002-1378-4962; Karchin, Rachel/0000-0002-5069-1239; Jiao, Yuchen/0000-0001-7917-8810; Roberts, Lewis/0000-0001-7885-8574	D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; US National Institutes of Health (NIH) [P50 CA62924, K08DK090154, EDRN U01CA086402]; Associazione Italiana Ricerca Cancro (AIRC) [12182, 11930, 6421, IG 12214]; Italian Cancer Genome Project [FIRB RBAP10AHJB]; NATIONAL CANCER INSTITUTE [P30CA015083, R37CA043460, U01CA086402, P30CA006973, R01CA121113, P50CA062924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090154] Funding Source: NIH RePORTER	D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Cancer Genome Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to acknowledge the following funding sources: the Virginia and D.K. Ludwig Fund for Cancer Research; the Lustgarten Foundation for Pancreatic Cancer Research; US National Institutes of Health (NIH) grants P50 CA62924, K08DK090154 and EDRN U01CA086402; Associazione Italiana Ricerca Cancro (AIRC grants 12182, 11930, 6421 and IG 12214); and Italian Cancer Genome Project FIRB RBAP10AHJB.	Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Chuang SC, 2004, WORLD J SURG, V28, P995, DOI 10.1007/s00268-004-7447-8; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Mielke PW, 2004, PSYCHOL REP, V95, P449, DOI 10.2466/pr0.95.2.449-458; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Parwani AV, 2003, MODERN PATHOL, V16, P299, DOI 10.1097/01.MP.0000062656.60581.AA; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tannapfel A, 2002, J PATHOL, V197, P624, DOI 10.1002/path.1139; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Voss JS, 2013, HUM PATHOL, V44, P1216, DOI 10.1016/j.humpath.2012.11.006; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xu RF, 2011, BIOMED PHARMACOTHER, V65, P22, DOI 10.1016/j.biopha.2010.06.009; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yanagisawa N, 2001, CANCER RES, V61, P19	21	481	500	5	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1470	U93		10.1038/ng.2813	http://dx.doi.org/10.1038/ng.2813			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24185509	Green Accepted			2022-12-25	WOS:000327715800013
J	Levine, DM; Ek, WE; Zhang, R; Liu, XX; Onstad, L; Sather, C; Lao-Sirieix, P; Gammon, MD; Corley, DA; Shaheen, NJ; Bird, NC; Hardie, LJ; Murray, LJ; Reid, BJ; Chow, WH; Risch, HA; Nyren, O; Ye, WM; Liu, G; Romero, Y; Bernstein, L; Wu, AH; Casson, AG; Chanock, SJ; Harrington, P; Caldas, I; Debiram-Beecham, I; Caldas, C; Hayward, NK; Pharoah, PD; Fitzgerald, RC; MacGregor, S; Whiteman, DC; Vaughan, TL				Levine, David M.; Ek, Weronica E.; Zhang, Rui; Liu, Xinxue; Onstad, Lynn; Sather, Cassandra; Lao-Sirieix, Pierre; Gammon, Marilie D.; Corley, Douglas A.; Shaheen, Nicholas J.; Bird, Nigel C.; Hardie, Laura J.; Murray, Liam J.; Reid, Brian J.; Chow, Wong-Ho; Risch, Harvey A.; Nyren, Olof; Ye, Weimin; Liu, Geoffrey; Romero, Yvonne; Bernstein, Leslie; Wu, Anna H.; Casson, Alan G.; Chanock, Stephen J.; Harrington, Patricia; Caldas, Isabel; Debiram-Beecham, Irene; Caldas, Carlos; Hayward, Nicholas K.; Pharoah, Paul D.; Fitzgerald, Rebecca C.; MacGregor, Stuart; Whiteman, David C.; Vaughan, Thomas L.			A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus	NATURE GENETICS			English	Article							EPIDERMAL-GROWTH-FACTOR; GASTROESOPHAGEAL-REFLUX; QUALITY-CONTROL; CANCER; RISK; POLYMORPHISM; METAANALYSIS; POPULATION; CARCINOMA; VARIANTS	Esophageal adenocarcinoma is a cancer with rising incidence and poor survival. Most such cancers arise in a specialized intestinal metaplastic epithelium, which is diagnostic of Barrett's esophagus. In a genome-wide association study, we compared esophageal adenocarcinoma cases (n = 2,390) and individuals with precancerous Barrett's esophagus (n = 3,175) with 10,120 controls in 2 phases. For the combined case group, we identified three new associations. The first is at 19p13 (rs10419226: P = 3.6 x 10(-10)) in CRTC1 (encoding CREB-regulated transcription coactivator), whose aberrant activation has been associated with oncogenic activity. A second is at 9q22 (rs11789015: P = 1.0 x 10(-9)) in BARX1, which encodes a transcription factor important in esophageal specification. A third is at 3p14 (rs2687201: P = 5.5 x 10(-9)) near the transcription factor FOXP1, which regulates esophageal development. We also refine a previously reported association with Barrett's esophagus near the putative tumor suppressor gene FOXF1 at 16q24 and extend our findings to now include esophageal adenocarcinoma.	[Levine, David M.; Zhang, Rui] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Ek, Weronica E.; MacGregor, Stuart; Whiteman, David C.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Liu, Xinxue; Lao-Sirieix, Pierre; Debiram-Beecham, Irene; Fitzgerald, Rebecca C.] Hutchison MRC Res Ctr, Med Res Council MRC Canc Cell Unit, Cambridge, England; [Liu, Xinxue; Lao-Sirieix, Pierre; Debiram-Beecham, Irene; Fitzgerald, Rebecca C.] Univ Cambridge, Cambridge, England; [Onstad, Lynn; Reid, Brian J.; Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Sather, Cassandra] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gammon, Marilie D.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Corley, Douglas A.] Kaiser Permanente No Calif, San Francisco Med Ctr, San Francisco, CA USA; [Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bird, Nigel C.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Murray, Liam J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Nyren, Olof; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Geoffrey] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Romero, Yvonne] Mayo Clin, Romero Registry, Rochester, MN USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Wu, Anna H.] Univ So Calif, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Harrington, Patricia; Pharoah, Paul D.] Univ Cambridge, Dept Publ Hlth, Cambridge, England; [Harrington, Patricia; Pharoah, Paul D.] Univ Cambridge, Dept Primary Care, Cambridge, England; [Harrington, Patricia; Caldas, Isabel; Caldas, Carlos; Pharoah, Paul D.] Univ Cambridge, Dept Oncol, Cambridge, England; [Caldas, Carlos] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Oncogen Lab, Brisbane, Qld, Australia	University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; University of Cambridge; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sheffield; University of Leeds; Queens University Belfast; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University; Karolinska Institutet; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; Mayo Clinic; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Southern California; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; QIMR Berghofer Medical Research Institute	Vaughan, TL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	tvaughan@u.washington.edu	Macgregor, Stuart/C-6442-2009; Facility, Biospecimen Processing/AAC-7837-2022; hayward, nick/AAV-8802-2020; Pharoah, Paul/V-6658-2019; Caldas, Carlos/U-7250-2019; Liu, Geoffrey/N-4421-2016; Hardie, Laura/AAY-6724-2020; hayward, nicholas k/C-1367-2015; Whiteman, David C/P-2728-2014	Macgregor, Stuart/0000-0001-6731-8142; Pharoah, Paul/0000-0001-8494-732X; Caldas, Carlos/0000-0003-3547-1489; Hardie, Laura/0000-0001-5039-2100; hayward, nicholas k/0000-0003-4760-1033; Whiteman, David C/0000-0003-2563-9559; Liu, Geoffrey/0000-0002-2603-7296; Fitzgerald, Rebecca/0000-0002-3434-3568; Liu, Xinxue/0000-0003-1107-0365	US National Institutes of Health (NIH) [R01CA136725]; Australian Research Council [FT0990987]; Australian National Health and Medical Research Council (NHMRC); NHMRC of Australia; US NIH [NIDDK 02956, R01DK63616, R01CA59636, R01CA100264, P30CA016672, R01CA133996, HHSN268200782096C, U01CA57949, U01CA57983, U01CA57923]; Robert Wood Johnson Foundation; Fraternal Order of the Eagles; National Cancer Institute [R01 CA57947-03]; Swedish Cancer Society [4559-B01-01XAA, 4758-B02-01XAB]; California Tobacco-Related Research Program [3RT-0122, 10RT-0251]; Medical Research Council; Cancer Research UK; Cambridge National Institute for Health Research Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Cancer Research UK [C490/A10119, C490/A10124]; UTMDACC NIH SPORE in Melanoma [2P50CA093459]; Marit Peterson Fund for Melanoma Research; Wellcome Trust [076113]; American Digestive Health Foundation Endoscopic Research Award; American College of Gastroenterology Junior Faculty Development Award; Glaxo Wellcome, Inc.; Institute for Digestive Health Clinical Research Award; Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic (Rochester, Minnesota);  [K05CA124911]; NATIONAL CANCER INSTITUTE [U01CA057923, U01CA057949, P30CA016672, R01CA133996, R01CA072866, R01CA059636, K05CA124911, P30CA016086, P01CA091955, R01CA057947, U01CA057983, P50CA093459, R01CA136725, R01CA100264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063616] Funding Source: NIH RePORTER; Cancer Research UK [16561, 16942] Funding Source: researchfish; Medical Research Council [MC_U105365007] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-011, NF-SI-0611-10154] Funding Source: researchfish; The Francis Crick Institute [10119, 10124] Funding Source: researchfish; MRC [MC_U105365007] Funding Source: UKRI	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Fraternal Order of the Eagles; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); California Tobacco-Related Research Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); UTMDACC NIH SPORE in Melanoma; Marit Peterson Fund for Melanoma Research; Wellcome Trust(Wellcome Trust); American Digestive Health Foundation Endoscopic Research Award; American College of Gastroenterology Junior Faculty Development Award; Glaxo Wellcome, Inc.; Institute for Digestive Health Clinical Research Award; Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic (Rochester, Minnesota); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was primarily funded by a US National Institutes of Health (NIH) grant (R01CA136725) to T. L. V. and D. C. W. T. L. V. is also supported by grant K05CA124911. D. C. W. is supported by a Future Fellowship (FT0990987) from the Australian Research Council. S. M. is supported by an Australian National Health and Medical Research Council (NHMRC) Career Development Award. N.K.H. is supported by Research Fellowships from the NHMRC of Australia. Y.R. is supported in part by a grant from the US NIH (NIDDK 02956), the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program and the Fraternal Order of the Eagles.; The Swedish Esophageal Cancer Study was funded by grants (R01 CA57947-03) from the National Cancer Institute and the Swedish Cancer Society (4559-B01-01XAA and 4758-B02-01XAB). The Kaiser-Permanente Study was supported by grants from the US NIH (R01DK63616 and R01CA59636) and from the California Tobacco-Related Research Program (3RT-0122 and 10RT-0251). The UK Barrett's oesophagus gene study was funded by a Medical Research Council Programme grant, and the UK SOCS study was funded by Cancer Research UK as well as by the Cambridge National Institute for Health Research Biomedical Research Centre and the Cambridge Experimental Cancer Medicine Centre. The SEARCH grant was funded by Cancer Research UK grants C490/A10119 and C490/A10124.; Genotyping of MD Anderson controls (C. Amos, PI) was performed through the University of Texas MD Anderson Cancer Center (UTMDACC) and the Johns Hopkins University Center for Inherited Disease Research (CIDR), supported in part by US NIH grants R01CA100264, P30CA016672 and R01CA133996 and the UTMDACC NIH SPORE in Melanoma 2P50CA093459, as well as by the Marit Peterson Fund for Melanoma Research. CIDR is supported by contract HHSN268200782096C from the US NIH.; This study made use of data generated by the Wellcome Trust Case Control Consortium. Funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the website (see URLs).; The Romero Registry is supported in part by the American Digestive Health Foundation Endoscopic Research Award, the American College of Gastroenterology Junior Faculty Development Award, the Glaxo Wellcome, Inc., Institute for Digestive Health Clinical Research Award and the Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic (Rochester, Minnesota). The Romero Registry also receives charitable gifts from five industry partners (Affymetrix, AstraZeneca, Santarus, Takeda and Wyeth). The US Multicenter Study was funded by grants U01CA57949, U01CA57983 and U01CA57923 from the US NIH.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chak A, 2004, AM J GASTROENTEROL, V99, P2107, DOI 10.1111/j.1572-0241.2004.40464.x; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cortes I, 2012, P NATL ACAD SCI USA, V109, P11318, DOI 10.1073/pnas.1118138109; CRABB DW, 1985, ANN INTERN MED, V103, P52, DOI 10.7326/0003-4819-103-1-52; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dura P, 2013, INT J CANCER, V133, P1751, DOI 10.1002/ijc.28160; Ek W.E., J NATL CANC IN PRESS; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fitzgerald RC, 2005, CLIN GASTROENTEROL H, V3, P529, DOI 10.1016/S1542-3565(05)00248-X; Gogarten SM, 2012, BIOINFORMATICS, V28, P3329, DOI 10.1093/bioinformatics/bts610; Groves C, 2005, SCAND J GASTROENTERO, V40, P1127, DOI 10.1080/00365520510023189; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; JANKOWSKI J, 1993, DIGEST DIS, V11, P1, DOI 10.1159/000171396; JOCHEM VJ, 1992, GASTROENTEROLOGY, V102, P1400; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Melzer E, 2006, AM J GASTROENTEROL, V101, P677, DOI 10.1111/j.1572-0241.2006.473_7.x; Menke V, 2012, J HUM GENET, V57, P26, DOI 10.1038/jhg.2011.124; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Poynton AR, 1996, AM J GASTROENTEROL, V91, P1855; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2006, R LANG ENV STAT COMP; Romero Y, 1997, GASTROENTEROLOGY, V113, P1449, DOI 10.1053/gast.1997.v113.pm9352846; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2012, NAT GENET, V44, P1131, DOI 10.1038/ng.2408; Trudgill NJ, 1999, AM J GASTROENTEROL, V94, P1172, DOI 10.1016/S0002-9270(99)00116-1; Venturi Sebastiano, 2009, Nutrition and Health (Bicester), V20, P119; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Woo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022493; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	39	142	144	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1487	U119		10.1038/ng.2796	http://dx.doi.org/10.1038/ng.2796			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24121790	Green Submitted, Green Accepted			2022-12-25	WOS:000327715800017
J	Wu, XB; Scott, DA; Kriz, AJ; Chiu, AC; Hsu, PD; Dadon, DB; Cheng, AW; Trevino, AE; Konermann, S; Chen, SD; Jaenisch, R; Zhang, F; Sharp, PA				Wu, Xuebing; Scott, David A.; Kriz, Andrea J.; Chiu, Anthony C.; Hsu, Patrick D.; Dadon, Daniel B.; Cheng, Albert W.; Trevino, Alexandro E.; Konermann, Silvana; Chen, Sidi; Jaenisch, Rudolf; Zhang, Feng; Sharp, Phillip A.			Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							RNA-POLYMERASE III; TRANSCRIPTION TERMINATION; DNA ENDONUCLEASE; TARGET DNA; SYSTEM; SPECIFICITY; ACTIVATION; BACTERIA; GENES; MOUSE	Bacterial type II CRISPR-Cas9 systems have been widely adapted for RNA-guided genome editing and transcription regulation in eukaryotic cells, yet their in vivo target specificity is poorly understood. Here we mapped genome-wide binding sites of a catalytically inactive Cas9 (dCas9) from Streptococcus pyogenes loaded with single guide RNAs (sgRNAs) in mouse embryonic stem cells (mESCs). Each of the four sgRNAs we tested targets dCas9 to between tens and thousands of genomic sites, frequently characterized by a 5-nucleotide seed region in the sgRNA and an NGG protospacer adjacent motif (PAM). Chromatin inaccessibility decreases dCas9 binding to other sites with matching seed sequences; thus 70% of off-target sites are associated with genes. Targeted sequencing of 295 dCas9 binding sites in mESCs transfected with catalytically active Cas9 identified only one site mutated above background levels. We propose a two-state model for Cas9 binding and cleavage, in which a seed match triggers binding but extensive pairing with target DNA is required for cleavage.	[Wu, Xuebing; Chiu, Anthony C.; Chen, Sidi; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wu, Xuebing; Cheng, Albert W.] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Scott, David A.; Hsu, Patrick D.; Trevino, Alexandro E.; Konermann, Silvana; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Scott, David A.; Hsu, Patrick D.; Trevino, Alexandro E.; Konermann, Silvana; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol Engn, Cambridge, MA 02139 USA; [Kriz, Andrea J.; Chiu, Anthony C.; Dadon, Daniel B.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA USA; [Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dadon, Daniel B.; Cheng, Albert W.; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org; sharppa@mit.edu	Hsu, Patrick/ABD-5749-2021; Wu, Xuebing/C-9152-2013; Macrae, Rhiannon/AAX-1536-2020; CHEN, SIDI/D-8284-2016	Wu, Xuebing/0000-0003-0369-5269; CHEN, SIDI/0000-0002-3819-5005; Hsu, Patrick/0000-0002-9380-2648; Cheng, Albert/0000-0003-2653-5743	United States Public Health Service from the National Institutes of Health [RO1-GM34277, R01-CA133404]; National Cancer Institute [PO1-CA42063]; Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]; US National Institutes of Health Director's Pioneer Award [1DP1-MH100706]; Keck Foundation; McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404, P01CA042063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034277, R01GM034277, T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	United States Public Health Service from the National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support (core) grant from the National Cancer Institute; US National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank J. Zamudio and T. Kelly for optimizing the ChIP protocol, and the entire Sharp lab for support and discussion. We also thank the Core Facility in the Swanson Biotechnology Center at the David H. Koch Institute for Integrative Cancer Research at MIT for their assistance with high-throughput sequencing. This work was supported by United States Public Health Service grants RO1-GM34277, R01-CA133404 from the National Institutes of Health, and PO1-CA42063 from the National Cancer Institute to P. A. S., and partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by an US National Institutes of Health Director's Pioneer Award (1DP1-MH100706), the Keck, McKnight, Poitras, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, and Jane Pauley. X. W. is a Howard Hughes Medical Institute International Student Research Fellow. S. C. is a Damon Runyon Fellow (DRG-2117-12). P. D. H. is a James Mills Pierce Fellow. D. A. S. is an US National Science Foundation pre-doctoral fellow.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2013, TRENDS MICROBIOL, V21, P562, DOI 10.1016/j.tim.2013.09.001; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	617	755	7	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					670	+		10.1038/nbt.2889	http://dx.doi.org/10.1038/nbt.2889			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24752079	Green Accepted, Green Submitted			2022-12-25	WOS:000338705900033
J	Buenrostro, JD; Araya, CL; Chircus, LM; Layton, CJ; Chang, HY; Snyder, MP; Greenleaf, WJ				Buenrostro, Jason D.; Araya, Carlos L.; Chircus, Lauren M.; Layton, Curtis J.; Chang, Howard Y.; Snyder, Michael P.; Greenleaf, William J.			Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes	NATURE BIOTECHNOLOGY			English	Article							LONG NONCODING RNA; R17 COAT PROTEIN; SECONDARY STRUCTURE; BINDING; EPISTASIS; AFFINITY; SPECIFICITY; MUTATIONS; COMPLEXES; CHROMATIN	RNA-protein interactions drive fundamental biological processes and are targets for molecular engineering, yet quantitative and comprehensive understanding of the sequence determinants of affinity remains limited. Here we repurpose a high-throughput sequencing instrument to quantitatively measure binding and dissociation of a fluorescently labeled protein to > 10(7) RNA targets generated on a flow cell surface by in situ transcription and intermolecular tethering of RNA to DNA. Studying the MS2 coat protein, we decompose the binding energy contributions from primary and secondary RNA structure, and observe that differences in affinity are often driven by sequence-specific changes in both association and dissociation rates. By analyzing the biophysical constraints and modeling mutational paths describing the molecular evolution of MS2 from low-to high-affinity hairpins, we quantify widespread molecular epistasis and a long-hypothesized, structure-dependent preference for G: U base pairs over C: A intermediates in evolutionary trajectories. Our results suggest that quantitative analysis of RNA on a massively parallel array (RNA-MaP) provides generalizable insight into the biophysical basis and evolutionary consequences of sequence-function relationships.	[Buenrostro, Jason D.; Araya, Carlos L.; Chircus, Lauren M.; Layton, Curtis J.; Snyder, Michael P.; Greenleaf, William J.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Chircus, Lauren M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Buenrostro, Jason D.; Araya, Carlos L.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	wjg@stanford.edu	, 周一珉/AAQ-9453-2020	Layton, Curtis/0000-0003-2689-907X; Snyder, Michael/0000-0003-0784-7987; Chircus, Lauren/0000-0003-3082-605X; Araya, Carlos/0000-0002-5512-3062	National Institutes of Health (NIH) [NIH R01- HG004361]; National Science Foundation Graduate Research Fellowships; NIH training grant [T32HG000044, T32GM067586]; National Science Foundation graduate research fellowship; National Human Genome Research Institute (NHGRI) [5U54HG00455805]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, T32HG000044, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) NIH R01- HG004361 (to H.Y.C.); H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. J.D.B. and L.M.C. acknowledge support from the National Science Foundation Graduate Research Fellowships. J.D.B. also acknowledges support from NIH training grant T32HG000044. L.M.C. acknowledges support from NIH training grant T32GM067586. J.D.B. and L.M.C. each acknowledge support of a National Science Foundation graduate research fellowship. M.P.S. and C.L.A. acknowledge the NIH and the National Human Genome Research Institute (NHGRI) for funding through 5U54HG00455805. We thank D. Herschlag for feedback and advice throughout the methods development, and G. Sherlock and D. Herschlag for critical readings of earlier versions of this manuscript. We thank R. Landick for discussions regarding the design of our synthetic DNA library and K. Bajaj for discussions regarding quantification of cluster fluorescence. We also thank O.D. Phanstiel, M. Sikora and O. Cornejo for discussions on the modeling and evolutionary analyses.	Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARDWELL VJ, 1990, NUCLEIC ACIDS RES, V18, P6587, DOI 10.1093/nar/18.22.6587; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; CAREY J, 1983, BIOCHEMISTRY-US, V22, P4723, DOI 10.1021/bi00289a017; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Gell C, 2008, J MOL BIOL, V384, P264, DOI 10.1016/j.jmb.2008.08.088; Grahn E, 2001, RNA, V7, P1616; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Guenther UP, 2013, NATURE, V502, P385, DOI 10.1038/nature12543; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hobson D, 2006, J MOL BIOL, V356, P613, DOI 10.1016/j.jmb.2005.11.046; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Martin L, 2012, NAT METHODS, V9, P1192, DOI [10.1038/NMETH.2225, 10.1038/nmeth.2225]; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; McCandlish DM, 2013, NATURE, V497, pE1, DOI 10.1038/nature12219; Myllykangas S, 2011, NAT BIOTECHNOL, V29, P1024, DOI 10.1038/nbt.1996; Natarajan C, 2013, SCIENCE, V340, P1324, DOI 10.1126/science.1236862; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; ROUSSET F, 1991, P NATL ACAD SCI USA, V88, P10032, DOI 10.1073/pnas.88.22.10032; SantaLucia J, 1997, BIOPOLYMERS, V44, P309, DOI 10.1002/(SICI)1097-0282(1997)44:3<309::AID-BIP8>3.3.CO;2-Y; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Valegard K, 1997, J MOL BIOL, V270, P724, DOI 10.1006/jmbi.1997.1144; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	50	134	137	5	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					562	+		10.1038/nbt.2880	http://dx.doi.org/10.1038/nbt.2880			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24727714	Green Accepted			2022-12-25	WOS:000337233800019
J	Jelinic, P; Mueller, JJ; Olveral, N; Dao, F; Scott, SN; Shah, R; Gao, J; Schultz, N; Gonen, M; Soslow, RA; Berger, MF; Levine, DA				Jelinic, Petar; Mueller, Jennifer J.; Olveral, Narciso; Dao, Fanny; Scott, Sasinya N.; Shah, Ronak; Gao, JianJiong; Schultz, Nikolaus; Gonen, Mithat; Soslow, Robert A.; Berger, Michael F.; Levine, Douglas A.			Recurrent SMARCA4 mutations in small cell carcinoma of the ovary	NATURE GENETICS			English	Article							CHROMATIN REMODELING FACTOR; HYPERCALCEMIC TYPE; BRG1; CANCERS	Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare, highly aggressive form of ovarian cancer primarily diagnosed in young women. We identified inactivating biallelic SMARCA4 mutations in 100% of the 12 SCCOHT tumors examined. Protein studies confirmed loss of SMARCA4 expression, suggesting a key role for the SWI/SNF chromatin-remodeling complex in SCCOHT.	[Jelinic, Petar; Mueller, Jennifer J.; Olveral, Narciso; Dao, Fanny; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Scott, Sasinya N.; Shah, Ronak; Soslow, Robert A.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Gao, JianJiong; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Levine, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	levine2@mskcc.org	Gonen, Mithat/E-4826-2012; Gao, JianJiong/B-5673-2016; Shah, Ronak H/H-9726-2017; Schultz, Nikolaus/ABE-6347-2020	Gonen, Mithat/0000-0001-8683-8477; Gao, JianJiong/0000-0002-5739-1781; Shah, Ronak H/0000-0001-9042-6213; Levine, Douglas/0000-0003-1038-8232; Mueller, Jennifer/0000-0003-0365-7510; Soslow, Robert/0000-0002-7269-5898; Schultz, Nikolaus/0000-0002-0131-4904	Katie Oppo Research Fund; Chia Family Foundation; Geoffrey Beene Cancer Research Center; Farmer Family Foundation; Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment InduStry Foundation [SU2C-AACR-DT0209]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Katie Oppo Research Fund; Chia Family Foundation; Geoffrey Beene Cancer Research Center; Farmer Family Foundation; Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment InduStry Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate the assistance of the Small Cell Ovarian Cancer Foundation with recruitment. We are grateful to all the patients and family members who generously donated biospecimens so that we could conduct this study. We thank G. Monemvasitis for editorial assistance. This work was supported by the Katie Oppo Research Fund, the Chia Family Foundation, the Geoffrey Beene Cancer Research Center, the Farmer Family Foundation and a Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment InduStry Foundation (SU2C-AACR-DT0209).	Estel R, 2011, ARCH GYNECOL OBSTET, V284, P1277, DOI 10.1007/s00404-011-1846-5; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Harrison ML, 2006, GYNECOL ONCOL, V100, P233, DOI 10.1016/j.ygyno.2005.10.024; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Kupryjanczyk J, 2013, POL J PATHOL, V64, P238, DOI 10.5114/PJP.2013.39331; Longy M, 1996, J MED GENET, V33, P333, DOI 10.1136/jmg.33.4.333; McCluggage WG, 2004, ADV ANAT PATHOL, V11, P288, DOI 10.1097/01.pap.0000138146.357376.1e; McDonald JM, 2012, J PEDIATR SURG, V47, P588, DOI 10.1016/j.jpedsurg.2011.12.004; Napolitano MA, 2007, J CELL SCI, V120, P2904, DOI 10.1242/jcs.004002; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Pautier P, 2007, ANN ONCOL, V18, P1985, DOI 10.1093/annonc/mdm376; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; SEIDMAN JD, 1995, GYNECOL ONCOL, V59, P283; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004	15	220	228	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					424	426		10.1038/ng.2922	http://dx.doi.org/10.1038/ng.2922			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24658004	Green Accepted			2022-12-25	WOS:000335422900005
J	Knoechel, B; Roderick, JE; Williamson, KE; Zhu, J; Lohr, JG; Cotton, MJ; Gillespie, SM; Fernandez, D; Ku, M; Wang, H; Piccioni, F; Silver, SJ; Jain, M; Pearson, D; Kluk, MJ; Ott, CJ; Shultz, LD; Brehm, MA; Greiner, DL; Gutierrez, A; Stegmaier, K; Kung, AL; Root, DE; Bradner, JE; Aster, JC; Kelliher, MA; Bernstein, BE				Knoechel, Birgit; Roderick, Justine E.; Williamson, Kaylyn E.; Zhu, Jiang; Lohr, Jens G.; Cotton, Matthew J.; Gillespie, Shawn M.; Fernandez, Daniel; Ku, Manching; Wang, Hongfang; Piccioni, Federica; Silver, Serena J.; Jain, Mohit; Pearson, Daniel; Kluk, Michael J.; Ott, Christopher J.; Shultz, Leonard D.; Brehm, Michael A.; Greiner, Dale L.; Gutierrez, Alejandro; Stegmaier, Kimberly; Kung, Andrew L.; Root, David E.; Bradner, James E.; Aster, Jon C.; Kelliher, Michelle A.; Bernstein, Bradley E.			An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							LENTIVIRAL RNAI LIBRARY; ACUTE MYELOID-LEUKEMIA; C-MYC; NOTCH1; CANCER; INHIBITION; CHROMATIN; GENOME; GENES; PATHWAY	The identification of activating NOTCH1 mutations in T cell acute lymphoblastic leukemia (T-ALL) led to clinical testing of g-secretase inhibitors (GSIs) that prevent NOTCH1 activation1-4. However, responses to these inhibitors have been transient5, suggesting that resistance limits their clinical efficacy. Here we modeled T-ALL resistance, identifying GSI-tolerant ` persister' cells that expand in the absence of NOTCH1 signaling. Rare persisters are already present in naive T-ALL populations, and the reversibility of their phenotype suggests an epigenetic mechanism. Relative to GSI-sensitive cells, persister cells activate distinct signaling and transcriptional programs and exhibit chromatin compaction. A knockdown screen identified chromatin regulators essential for persister viability, including BRD4. BRD4 binds enhancers near critical T-ALL genes, including MYC and BCL2. The BRD4 inhibitor JQ1 downregulates expression of these targets and induces growth arrest and apoptosis in persister cells, at doses well tolerated by GSI-sensitive cells. Consistently, the GSI-JQ1 combination was found to be effective against primary human leukemias in vivo. Our findings establish a role for epigenetic heterogeneity in leukemia resistance that may be addressed by incorporating epigenetic modulators in combination therapy.	[Knoechel, Birgit; Williamson, Kaylyn E.; Zhu, Jiang; Cotton, Matthew J.; Gillespie, Shawn M.; Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Knoechel, Birgit; Williamson, Kaylyn E.; Zhu, Jiang; Lohr, Jens G.; Cotton, Matthew J.; Gillespie, Shawn M.; Fernandez, Daniel; Ku, Manching; Piccioni, Federica; Silver, Serena J.; Jain, Mohit; Root, David E.; Bradner, James E.; Bernstein, Bradley E.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Knoechel, Birgit; Williamson, Kaylyn E.; Zhu, Jiang; Lohr, Jens G.; Cotton, Matthew J.; Gillespie, Shawn M.; Fernandez, Daniel; Ku, Manching; Piccioni, Federica; Silver, Serena J.; Jain, Mohit; Root, David E.; Bradner, James E.; Bernstein, Bradley E.] Harvard, Cambridge, MA USA; [Knoechel, Birgit; Gutierrez, Alejandro; Stegmaier, Kimberly; Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Knoechel, Birgit; Pearson, Daniel; Gutierrez, Alejandro; Stegmaier, Kimberly; Kung, Andrew L.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Knoechel, Birgit; Williamson, Kaylyn E.; Zhu, Jiang; Cotton, Matthew J.; Gillespie, Shawn M.; Ku, Manching; Wang, Hongfang; Pearson, Daniel; Kluk, Michael J.; Gutierrez, Alejandro; Stegmaier, Kimberly; Kung, Andrew L.; Aster, Jon C.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA USA; [Roderick, Justine E.; Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Williamson, Kaylyn E.; Zhu, Jiang; Cotton, Matthew J.; Gillespie, Shawn M.; Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Williamson, Kaylyn E.; Zhu, Jiang; Cotton, Matthew J.; Gillespie, Shawn M.; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lohr, Jens G.; Ott, Christopher J.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fernandez, Daniel] Harvard Univ, Biostat Grad Program, Cambridge, MA 02138 USA; [Wang, Hongfang; Kluk, Michael J.; Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jain, Mohit] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jain, Mohit] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Pearson, Daniel] Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Boston, MA USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Brehm, Michael A.; Greiner, Dale L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Jackson Laboratory; University of Massachusetts System; University of Massachusetts Worcester	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	michelle.kelliher@umassmed.edu; bernstein.bradley@mgh.harvard.edu	Kung, Andrew L/AEU-0826-2022; ravegnini, gloria/K-1330-2016; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; ravegnini, gloria/0000-0002-7774-402X; Williamson, Kaylyn/0000-0002-3252-5050; Gillespie, Shawn/0000-0003-1913-0860; Brehm, Michael/0000-0001-6813-3262	US National Institutes of Health (NIH) Training [5-T32-GM007748-33]; Doris Duke Charitable Foundation [2006087]; Fulbright Diabetes UK Fellowship [BDA 11/0004348]; Broad Institute; NIH/NIDDK [5U01DK085526]; DK088389; National Human Genome Research Institute (NHGRI) [U54HG003067]; NIH [U01 DK085501, U01 DK085524, U01 DK085545, U01 DK085584]; Swedish Research Council [Dnr 521-2010-3490, Dnr 349-2006-237]; European Research Council (ERC) [GENETARGET T2D, GA269045]; ENGAGE [2007-201413]; CEED3 [2008-223211]; Sigrid Juselius Foundation and the Folkh lsan Research Foundation; ERC [AdG 293574]; Research Council of Norway [197064/V50]; KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck Foundation; Wellcome Trust [WT098017, WT064890, WT090532]; Uppsala University; Uppsala University Hospital; Swedish Research Council; Swedish Heart- Lung Foundation; Academy of Finland [124243]; Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes [1510/31/06]; Commission of the European Community; Commission of the European Community [HEALTH-F2-2007-201681]; Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project (EXGENESIS) [LSHM-CT-2004-005272]; City of Kuopio and Social Insurance Institution of Finland; The Academy of Finland [139635]; Finnish Foundation for Cardiovascular Disease; Wellcome Trust grants [WT098017, WT064890, WT090532, WT090367, WT098381]; National Heart, Lung, and Blood Institute; National Institute on Minority Health and Health Disparities [N01 HC-95170N01, HC-95171N01, HC-95172]; European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation; US National Institutes of Health (NIH) [HL007574- 30]; St. Baldrick's fellowship; US NIH T32 training [CA130807, HL007627]; American Cancer Society [125087-PF-13247-01-LIB]; National Human Genome Research Institute [ENCODE U54 HG004570]; NIH Common Fund for Epigenomics [U01 ES017155]; NIH/NCI [CA096899, 5P01 CA109901-10]; Howard Hughes Medical Institute; Starr Cancer Consortium; The Leukemia & Lymphoma Society Specialized Center of Research Program;  [R01DK062370];  [R01DK072193];  [Z01HG000024];  [102318];  [123885];  [U01-DK085545]; NATIONAL CANCER INSTITUTE [P01CA109901, R01CA096899, P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG006991] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Fulbright Diabetes UK Fellowship(Diabetes UK); Broad Institute; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DK088389; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); ENGAGE; CEED3; Sigrid Juselius Foundation and the Folkh lsan Research Foundation; ERC(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck Foundation(Lundbeckfonden); Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University; Uppsala University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart- Lung Foundation(Swedish Heart-Lung Foundation); Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes; Commission of the European Community(European Commission); Commission of the European Community(European Commission); Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project (EXGENESIS); City of Kuopio and Social Insurance Institution of Finland; The Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Disease; Wellcome Trust grants(Wellcome Trust); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's fellowship; US NIH T32 training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Common Fund for Epigenomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Starr Cancer Consortium; The Leukemia & Lymphoma Society Specialized Center of Research Program; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to T. Look, M. Harris, L. Silverman and S. Sallan for providing the pediatric T- ALL samples. We thank the Flow Cytometry Core of the Harvard Stem Cell Institute and the Center for Regenerative Medicine and Technology for excellent flow sorting. We thank E. Rheinbay, M. Suva, R. Ryan, N. Riggi, A. Goren, O. Ram, J. Wu, L. Pan, W. Pear and M. Rivera for helpful discussions; V. Mootha for critical comments on the manuscript; S. Muller- Knapp and the Structural Genomics Consortium (Oxford, UK) for their assistance with inhibitor experiments; L. Hamm and the Broad RNAi Platform for help with the shRNA screen; R. Issner, X. Zhang, C. Epstein, N. Shoresh, T. Durham and the Broad Genome Sequencing Platform for technical assistance; A. Christie for help with mouse experiments; L. Gaffney for help with illustrations; and O. Weigert for providing the BCL2 ORF. B. K. was supported by a US National Institutes of Health (NIH) T32 training grant (HL007574- 30) and by a St. Baldrick's fellowship. J. E. R. was supported by a US NIH T32 training grant (CA130807) and by a postdoctoral fellowship from the American Cancer Society (125087-PF-13247-01-LIB). H. W. is supported by a US NIH T32 training grant (HL007627). This work was supported by the National Human Genome Research Institute (ENCODE U54 HG004570 to B. E. B.), the NIH Common Fund for Epigenomics (U01 ES017155 to B. E. B.), the NIH/NCI (CA096899 to M. A. K. and 5P01 CA109901- 10 to J. E. B.), the Howard Hughes Medical Institute (B. E. B.) and the Starr Cancer Consortium (B. E. B.). The Leukemia & Lymphoma Society Specialized Center of Research Program supports B. E. B., J. C. A., J. E. B., K. S. and A. L. K.	Blobel GA, 2011, CANCER CELL, V20, P287, DOI 10.1016/j.ccr.2011.08.019; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kluk MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067306; Kluk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033813; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Palomero T, 2009, CLIN LYMPHOMA MYELOM, V9, pS205, DOI 10.3816/CLM.2009.s.013; Pear Warren S., 1997, P41; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Voigt P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-133; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	43	250	259	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					364	+		10.1038/ng.2913	http://dx.doi.org/10.1038/ng.2913			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24584072	Green Accepted			2022-12-25	WOS:000334510100012
J	Kuipers, F; Groen, AK				Kuipers, Folkert; Groen, Albert K.			FXR: the key to benefits in bariatric surgery?	NATURE MEDICINE			English	Editorial Material							Y GASTRIC BYPASS; BILE-ACIDS; WEIGHT-LOSS; OBESITY; MICE; HOMEOSTASIS; GLUCOSE		[Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9700 AB Groningen, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9700 AB Groningen, Netherlands.	f.kuipers@umcg.nl		Kuipers, Folkert/0000-0003-2518-737X				Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cariou B, 2007, FEBS LETT, V581, P5191, DOI 10.1016/j.febslet.2007.09.064; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ryan K.K., 2014, NATURE          0326, DOI [10.1038/nature13135, DOI 10.1038/NATURE13135]; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157	16	28	28	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					337	338		10.1038/nm.3525	http://dx.doi.org/10.1038/nm.3525			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710375				2022-12-25	WOS:000334361500011
J	Schain, AJ; Hill, RA; Grutzendler, J				Schain, Aaron J.; Hill, Robert A.; Grutzendler, Jaime			Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENERATION MICROSCOPY; FLUORESCENT PROTEINS; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; CEREBRAL-CORTEX; BRAIN; MOUSE; DEMYELINATION; EXPRESSION	We report a newly developed technique for high-resolution in vivo imaging of myelinated axons in the brain, spinal cord and peripheral nerve that requires no fluorescent labeling. This method, based on spectral confocal reflectance microscopy (SCoRe), uses a conventional laser-scanning confocal system to generate images by merging the simultaneously reflected signals from multiple lasers of different wavelengths. Striking color patterns unique to individual myelinated fibers are generated that facilitate their tracing in dense axonal areas. These patterns highlight nodes of Ranvier and Schmidt-Lanterman incisures and can be used to detect various myelin pathologies. Using SCoRe we carried out chronic brain imaging up to 400 mu m deep, capturing de novo myelination of mouse cortical axons in vivo. We also established the feasibility of imaging myelinated axons in the human cerebral cortex. SCoRe adds a powerful component to the evolving toolbox for imaging myelination in living animals and potentially in humans.	[Schain, Aaron J.; Hill, Robert A.; Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Grutzendler, J (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	jaime.grutzendler@yale.edu		Hill, Robert/0000-0001-6080-8712	Cognitive Neurology and Alzheimer's disease Center (CNADC) at Northwestern University [AG13854];  [R01AG027855];  [R01HL106815]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027855] Funding Source: NIH RePORTER	Cognitive Neurology and Alzheimer's disease Center (CNADC) at Northwestern University; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the following grants: R01AG027855 and R01HL106815 (J.G.). We would like to thank J. Bewersdorf and D. Toomre for helpful discussions and P. Yuan for critical reading of the manuscript. We thank A. Nishiyama (University of Connecticut) and F. Kirchhoff (University of Saarland) for providing PLPDsRed mice. Postmortem human specimen was obtained from the brain bank in the Cognitive Neurology and Alzheimer's disease Center (CNADC) at Northwestern University (grant AG13854).	Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Ben Arous J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3650770; Binding J, 2011, OPT EXPRESS, V19, P4833, DOI 10.1364/OE.19.004833; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Farrar MJ, 2011, BIOPHYS J, V100, P1362, DOI 10.1016/j.bpj.2011.01.031; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fenrich KK, 2012, J PHYSIOL-LONDON, V590, P3665, DOI 10.1113/jphysiol.2012.230532; Filler TJ, 2000, J PATHOL, V190, P635; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fu Y, 2008, OPT EXPRESS, V16, P19396, DOI 10.1364/OE.16.019396; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; GOULD RM, 1995, J NEUROCYTOL, V24, P85, DOI 10.1007/BF01181552; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; HA H, 1970, J COMP NEUROL, V140, P227, DOI 10.1002/cne.901400206; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Imitola J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533312; JACOBSON S, 1963, J COMP NEUROL, V121, P5, DOI 10.1002/cne.901210103; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaya F, 2012, J NEUROSCI, V32, P12885, DOI 10.1523/JNEUROSCI.2252-12.2012; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Macleod HA, 2001, THIN FILM OPTICAL FI; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WAXMAN SG, 1975, NEUROSCI LETT, V1, P251, DOI 10.1016/0304-3940(75)90039-7; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Witte S, 2011, P NATL ACAD SCI USA, V108, P5970, DOI 10.1073/pnas.1018743108; Xiao J, 2006, BRAIN RES, V1077, P81, DOI 10.1016/j.brainres.2006.01.021; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	41	110	111	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					443	+		10.1038/nm.3495	http://dx.doi.org/10.1038/nm.3495			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24681598	Green Accepted			2022-12-25	WOS:000334361500027
J	Burton, JN; Adey, A; Patwardhan, RP; Qiu, RL; Kitzman, JO; Shendure, J				Burton, Joshua N.; Adey, Andrew; Patwardhan, Rupali P.; Qiu, Ruolan; Kitzman, Jacob O.; Shendure, Jay			Chromosome-scale scaffolding of de novo genome assemblies based on chromatin interactions	NATURE BIOTECHNOLOGY			English	Article							MAMMALIAN GENOMES; PRINCIPLES; ALIGNMENT; MODEL; MAPS	Genomes assembled de novo from short reads are highly fragmented relative to the finished chromosomes of Homo sapiens and key model organisms generated by the Human Genome Project. To address this problem, we need scalable, cost-effective methods to obtain assemblies with chromosome-scale contiguity. Here we show that genome-wide chromatin interaction data sets, such as those generated by Hi-C, are a rich source of long-range information for assigning, ordering and orienting genomic sequences to chromosomes, including across centromeres. To exploit this finding, we developed an algorithm that uses Hi-C data for ultra-long-range scaffolding of de novo genome assemblies. We demonstrate the approach by combining shotgun fragment and short jump mate-pair sequences with Hi-C data to generate chromosome-scale de novo assemblies of the human, mouse and Drosophila genomes, achieving-for the human genome-98% accuracy in assigning scaffolds to chromosome groups and 99% accuracy in ordering and orienting scaffolds within chromosome groups. Hi-C data can also be used to validate chromosomal translocations in cancer genomes.	[Burton, Joshua N.; Adey, Andrew; Patwardhan, Rupali P.; Qiu, Ruolan; Kitzman, Jacob O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jnburton@uw.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Kitzman, Jacob/0000-0002-6145-882X; Shendure, Jay/0000-0002-1516-1865; Burton, Joshua/0000-0003-2817-7353	National Human Genome Research Institute (NHGRI) [HG006283]; National Science Foundation [DGE-0718124]; NHGRI [T32HG000035]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006283, T32HG000035] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank F. Ay, E. Eichler, J. Felsenstein, P. Green, L. Hillier, M. van Min, W. Noble, R. Waterston and members of the Shendure lab for helpful discussions. Some of the sequencing data used in this research were derived from a HeLa cell line. Henrietta Lacks, and the HeLa cell line that was established from her tumor cells without her knowledge or consent in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. Our work was supported by grant HG006283 from the National Human Genome Research Institute (NHGRI; to J.S.); a graduate research fellowship DGE-0718124 from the National Science Foundation (to A.A. and J.O.K.); and grant T32HG000035 from the NHGRI (to J.N.B.).	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jung J, 2003, J GLOBAL OPTIM, V25, P91; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Macville M, 1999, CANCER RES, V59, P141; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290	33	673	702	24	176	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1119	+		10.1038/nbt.2727	http://dx.doi.org/10.1038/nbt.2727			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24185095	Green Accepted			2022-12-25	WOS:000328251900025
J	Paffett-Lugassy, N; Singh, R; Nevis, KR; Guner-Ataman, B; O'Loughlin, E; Jahangiri, L; Harvey, RP; Burns, CG; Burns, CE				Paffett-Lugassy, Noelle; Singh, Reena; Nevis, Kathleen R.; Guner-Ataman, Burcu; O'Loughlin, Evan; Jahangiri, Leila; Harvey, Richard P.; Burns, C. Geoffrey; Burns, Caroline E.			Heart field origin of great vessel precursors relies on nkx2.5-mediated vasculogenesis	NATURE CELL BIOLOGY			English	Article							PROGENITOR SPECIFICATION; ZEBRAFISH; CELLS; PROTEIN; GENE; SURVIVAL; REPORTER; FATE	The pharyngeal arch arteries (PAAs) are transient embryonic blood vessels that make indispensable contributions to the carotid arteries and great vessels of the heart, including the aorta and pulmonary arteries(1,2). During embryogenesis, the PAAs appear in a craniocaudal sequence to connect pre-existing segments of the primitive circulation after de novo vasculogenic assembly from angioblast precursors(3,4). Despite the unique spatiotemporal characteristics of PAA development, the embryonic origins of PM angioblasts and the genetic factors regulating their emergence remain unknown. Here, we identify the embryonic source of PAA endothelium as nlo(2.5(+) progenitors in lateral plate mesoderm long considered to adopt cell fates within the heart exclusively(5,6). Further, we report that PAA endothelial differentiation relies on Nkx2.5, a canonical cardiac transcription factor not previously implicated in blood vessel formation. Together, these studies reveal the heart field origin of PAA endothelium and attribute a new vasculogenic function to the cardiac transcription factor Nkx2.5 during great vessel precursor development.	[Paffett-Lugassy, Noelle; Nevis, Kathleen R.; Guner-Ataman, Burcu; O'Loughlin, Evan; Jahangiri, Leila; Burns, C. Geoffrey; Burns, Caroline E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Paffett-Lugassy, Noelle; Nevis, Kathleen R.; Guner-Ataman, Burcu; O'Loughlin, Evan; Jahangiri, Leila; Burns, C. Geoffrey; Burns, Caroline E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Paffett-Lugassy, Noelle; Burns, C. Geoffrey; Burns, Caroline E.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Singh, Reena; Harvey, Richard P.] Victor Chang Res Inst, Darlinghurst, NSW 2010, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Victor Chang Cardiac Research Institute	Burns, CG (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	gburns@cvrc.mgh.harvard.edu; cburns6@partners.org	Jahangiri, Leila/AAA-9786-2022	Jahangiri, Leila/0000-0003-0235-8447; O'Loughlin, Evan/0000-0001-5940-6150; Harvey, Richard/0000-0002-9950-9792; SINGH, REENA/0000-0001-8860-8800	Harvard Stem Cell Institute Training Grant [5HL087735]; National Research Service Award [1F32HL 112579, 5F32HL110627]; National Heart, Lung and Blood Institute (NHLBI); American Heart Association (AHA) Post-Doctoral Fellowship [10P05T4170037]; American Heart Association [10GRNT4270021]; Harvard Stem Cell Institute (Seed Grant); March of Dimes Foundation [FY12-467]; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111179, R01HL068885, F32HL110627, F32HL112579, R01HL096816, T32HL087735] Funding Source: NIH RePORTER	Harvard Stem Cell Institute Training Grant; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA) Post-Doctoral Fellowship(American Heart Association); American Heart Association(American Heart Association); Harvard Stem Cell Institute (Seed Grant); March of Dimes Foundation(March of Dimes); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to S. Paskaradevan and I. Scott (University of Toronto, USA) for their training in blastula transplantation. We thank C. Kinney for creating Supplementary Fig. 1; P. Obregon and T. Cashman for technical assistance in generating the Tg(nkx2.5:kaede) and Tg(nkx2.5:nZsYellow) transgenic lines, respectively; W. Goessling (Harvard Medical School, USA) for providing Tg(sox17:GFP) fish; T. North, and L. Zon (Harvard Medical School, USA) for providing Tg(kdrl:GFP) fish; I. Drummond (Massachusetts General Hospital, USA) for providing bon"425 fish; B. Barut (Harvard Medical School, USA) and L. Zon for providing bacterial artificial chromosomes; T. Evans (Weill Cornell Medical College, USA) for providing nkx2.5 plasmid for probe generation; G. Wilkinson (Medical College of Wisconsin, USA) and S. Sumanas (Cincinnati Children's Hospital Medical Center, USA) for providing etsrp71 plasmid for probe generation; and the MGH Nephrology Division for access to their confocal microscopy facilities. We thank A. Vasilyev for assistance with confocal microscopy. N.P.L was supported by the Harvard Stem Cell Institute Training Grant (5HL087735) and a National Research Service Award (1F32HL 112579) from the National Heart, Lung and Blood Institute (NHLBI). B.G-A. was financially supported by an American Heart Association (AHA) Post-Doctoral Fellowship (10P05T4170037). K.R.N. is financially supported by a National Research Service Award (5F32HL110627) from the National Heart, Lung and Blood Institute (NHLBI). R.P.H. is supported by grants from the National Health and Medical Research Council of Australia (NHMRC; 573732, 573703), Atlantic Philanthropies (19131) and National Heart Foundation of Australia (G0853718). R.P.H. holds an NHMRC Australia Fellowship (573705). This wo rk was financially supported by awards from the National Heart Lung and Blood Institute (5R01HL096816), American Heart Association (Grant in Aid no. 10GRNT4270021), and Harvard Stem Cell Institute (Seed Grant) to C.G.B. and the National Heart Lung and Blood Institute (5R01HL111179), the March of Dimes Foundation (FY12-467), and the Harvard Stem Cell Institute (Seed Grant and Young Investigator Award) to C.E.B. R.P.H. dedicates this work to Irene Myrtle Harvey, 1923-2013, from whom scholarship and inspiration were drawn.	Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Brand M, 2002, KEEPING RAISING ZEBR; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Chapnik E, 2012, DEV BIOL, V362, P50, DOI 10.1016/j.ydbio.2011.11.008; Congdon ED, 1922, CONTRIB EMBRYOL, V14, P49; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Guner-Ataman B, 2013, DEVELOPMENT, V140, P1353, DOI 10.1242/dev.088351; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Harris IS, 2010, PEDIATR CARDIOL, V31, P391, DOI 10.1007/s00246-010-9642-8; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Kikuchi Y, 2000, GENE DEV, V14, P1279; Li P, 2012, DEV BIOL, V361, P116, DOI 10.1016/j.ydbio.2011.10.018; Long S, 2002, BIOTECHNIQUES, V32, P494, DOI 10.2144/02323bm04; Lorandeau CG, 2011, ANAT REC, V294, P93, DOI 10.1002/ar.21301; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Moore KL, 1993, DEV HUMAN CLIN ORIEN DEV HUMAN CLIN ORIEN, V7th; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Serbedzija GN, 1998, DEVELOPMENT, V125, P1095; Simoes FC, 2011, DEVELOPMENT, V138, P3235, DOI 10.1242/dev.059634; Srinivas S., 2001, BMC DEV BIOL, V1, P1478; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Targoff KL, 2008, DEV BIOL, V322, P314, DOI 10.1016/j.ydbio.2008.07.037; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	44	44	46	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1362	U225		10.1038/ncb2862	http://dx.doi.org/10.1038/ncb2862			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24161929	Green Accepted, Green Submitted			2022-12-25	WOS:000326680700012
J	Udagawa, T; Farny, NG; Jakovcevski, M; Kaphzan, H; Alarcon, JM; Anilkumar, S; Ivshina, M; Hurt, JA; Nagaoka, K; Nalavadi, VC; Lorenz, LJ; Bassell, GJ; Akbarian, S; Chattarji, S; Klann, E; Richter, JD				Udagawa, Tsuyoshi; Farny, Natalie G.; Jakovcevski, Mira; Kaphzan, Hanoch; Alarcon, Juan Marcos; Anilkumar, Shobha; Ivshina, Maria; Hurt, Jessica A.; Nagaoka, Kentaro; Nalavadi, Vijayalaxmi C.; Lorenz, Lori J.; Bassell, Gary J.; Akbarian, Schahram; Chattarji, Sumantra; Klann, Eric; Richter, Joel D.			Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology	NATURE MEDICINE			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; CAMKII MESSENGER-RNA; T-MAZE ALTERNATION; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; WORKING-MEMORY; MOUSE MODEL; TRANSLATION; HIPPOCAMPUS	Fragile X syndrome (FXS), the most common cause of inherited mental retardation and autism, is caused by transcriptional silencing of FMR1, which encodes the translational repressor fragile X mental retardation protein (FMRP). FMRP and cytoplasmic polyadenylation element-binding protein (CPEB), an activator of translation, are present in neuronal dendrites, are predicted to bind many of the same mRNAs and may mediate a translational homeostasis that, when imbalanced, results in FXS. Consistent with this possibility, Fmr1(-/y); Cpeb1(-/-) double-knockout mice displayed amelioration of biochemical, morphological, electrophysiological and behavioral phenotypes associated with FXS. Acute depletion of CPEB1 in the hippocampus of adult Fmr1(-/y) mice rescued working memory deficits, demonstrating reversal of this FXS phenotype. Finally, we find that FMRP and CPEB1 balance translation at the level of polypeptide elongation. Our results suggest that disruption of translational homeostasis is causal for FXS and that the maintenance of this homeostasis by FMRP and CPEB1 is necessary for normal neurologic function.	[Udagawa, Tsuyoshi; Farny, Natalie G.; Ivshina, Maria; Nagaoka, Kentaro; Lorenz, Lori J.; Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Jakovcevski, Mira; Akbarian, Schahram] Univ Massachusetts, Sch Med, Brudnik Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA USA; [Kaphzan, Hanoch; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Alarcon, Juan Marcos] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Anilkumar, Shobha; Chattarji, Sumantra] Inst Stem Cell Biol & Regenerat Med, Ctr Brain Dev & Repair, Bangalore, Karnataka, India; [Anilkumar, Shobha; Chattarji, Sumantra] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Hurt, Jessica A.] MIT, Dept Biol, Cambridge, MA USA; [Nalavadi, Vijayalaxmi C.; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Massachusetts Institute of Technology (MIT); Emory University	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu	Jakovcevski, Mira/M-1930-2018; Nagaoka, Kentaro/C-2019-2013; Farny, Natalie/ABD-4468-2020; Jakovcevski, Mira/N-2430-2019	Jakovcevski, Mira/0000-0003-2262-823X; Nagaoka, Kentaro/0000-0003-1038-1380; Farny, Natalie/0000-0003-1143-4560; Jakovcevski, Mira/0000-0003-2262-823X; Ivshina, Maria/0000-0002-0999-3470	FRAXA Research Foundation; US National Institutes of Health NRSA [F32GM095060]; NIH [GM46779, NS079415, MH086509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095060, R01GM046779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079415] Funding Source: NIH RePORTER	FRAXA Research Foundation; US National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Dawra for technical assistance, P. Lombroso (Yale University) and C. Proud (University of Southampton) for kind gifts of antibodies (STEP and eEF2, respectively), J. Pelletier (McGill University) for the kind gift of hippuristanol and members of the Richter lab for helpful discussions. T.U. and N.G.F. gratefully acknowledge fellowships from the FRAXA Research Foundation. J.A.H. was supported by US National Institutes of Health NRSA Postdoctoral Fellowship F32GM095060. This work was supported by NIH grants GM46779 and NS079415 to J.D.R. and MH086509 to S. Akbarian.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Avgustinovich DF, 2000, BEHAV GENET, V30, P101, DOI 10.1023/A:1001999020138; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; BRITO LSO, 1987, BRAZ J MED BIOL RES, V20, P125; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; Morellini F, 2006, EUR J NEUROSCI, V23, P1255, DOI 10.1111/j.1460-9568.2006.04657.x; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Raju R.T., 2004, BRAIN BEHAV; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; RICHTER JD, 1982, DEV BIOL, V89, P159, DOI 10.1016/0012-1606(82)90304-9; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Svitkin YV, 2007, METHOD ENZYMOL, V429, P53, DOI 10.1016/S0076-6879(07)29004-4; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	44	88	90	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1473	+		10.1038/nm.3353	http://dx.doi.org/10.1038/nm.3353			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24141422	Green Accepted			2022-12-25	WOS:000326920300024
J	Tannour-Louet, M; Han, S; Louet, JF; Zhang, B; Romero, K; Addai, J; Sahin, A; Cheung, SW; Lamb, DJ				Tannour-Louet, Mounia; Han, Shuo; Louet, Jean-Francois; Zhang, Bin; Romero, Karina; Addai, Josephine; Sahin, Aysegul; Cheung, Sau Wai; Lamb, Dolores J.			Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action	NATURE MEDICINE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; ANDROGEN RECEPTOR TRANSACTIVATION; GUBERNACULAR DEVELOPMENT; MOLECULAR-BASIS; SNARE VAMP7; IN-UTERO; EXPRESSION; PROTEASOME; EXPOSURE; ALPHA	Despite the fact that genitourinary defects are among the most common birth defects in newborns, little is known about their etiology. Here we analyzed children born with congenital genitourinary tract masculinization disorders by array-comparative genomic hybridization, which revealed in 1.35% of cases the presence of de novo copy number gains at Xq28 encompassing the VAMP7 gene, which encodes a vesicle-trafficking protein that is part of the SNARE complex. Transgenic mice carrying a bacterial artificial chromosome encoding human VAMP7 mimicked the defective urogenital traits observed in boys with masculinization disorders such as cryptorchidism, urethral defects and hypospadias. Transgenic mice also exhibited reduced penile length, focal spermatogenic anomalies, diminished sperm motility and subfertility. VAMP7 colocalized with estrogen receptor alpha (ESR1) in the presence of its cognate ligand, 17 beta-estradiol. Elevated levels of VAMP7 markedly intensified ESR1-potentiated transcriptional activity by increasing ESR1 protein cellular content upon ligand stimulation and upregulated the expression of estrogen-responsive genes including ATF3, CYR61 and CTGF, all of which have been implicated in human hypospadias. Hence, increased gene dosage of VAMP7, and thus higher expression levels of its protein product, enhances estrogen receptor action in male genitourinary tissues, affects the virilization of the reproductive tract and results in genitourinary birth defects in humans.	[Tannour-Louet, Mounia; Romero, Karina; Addai, Josephine; Sahin, Aysegul; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Tannour-Louet, Mounia] CNRS, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; [Han, Shuo; Louet, Jean-Francois; Zhang, Bin; Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Louet, Jean-Francois] Fac Med Nice, INSERM, Ctr Mediterraneen Med Mol, U1065, F-06034 Nice, France; [Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lamb, Dolores J.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA	Baylor College of Medicine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Baylor College of Medicine; Baylor College of Medicine	Tannour-Louet, M (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.	mounia.louet@gmail.com; dlamb@bcm.edu	Mounia, TANNOUR LOUET/T-2622-2019; TANNOUR LOUET, Mounia/G-5413-2017	Mounia, TANNOUR LOUET/0000-0003-0614-063X; TANNOUR LOUET, Mounia/0000-0003-0614-063X; Louet, Jean-Francois/0000-0002-1626-7098	US National Institutes of Health [K12 DK0083014]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK078121]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078121, K12DK083014] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank all the referring physicians and especially E.T. Gonzales, L. Cisek, N. Janzen, D.R. Roth, and E. Jones, the affected individuals and their family members who participated in this study. We thank M Marcelli (Baylor College of Medicine) for providing the foreskin fibroblasts for analysis. We thank L. White, C. Shaw and F. De Mayo for their assistance. This study was supported in part by US National Institutes of Health grant K12 DK0083014 (KURe to D.J.L.) and R01DK078121 from the National Institute of Diabetes and Digestive and Kidney Diseases (to D.J.L.).	Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Beleza-Meireles A, 2008, EUR J ENDOCRINOL, V158, P729, DOI 10.1530/EJE-07-0793; Cederroth CR, 2007, ENDOCRINOLOGY, V148, P5507, DOI 10.1210/en.2007-0689; Chen HY, 2010, J BIOL CHEM, V285, P27776, DOI 10.1074/jbc.M110.156091; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Ferlin A, 2008, JAMA-J AM MED ASSOC, V300, P2271, DOI 10.1001/jama.2008.668; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Goyal HO, 2007, REPRODUCTION, V133, P1057, DOI 10.1530/REP-06-0326; Goyal HO, 2009, BIOL REPROD, V81, P507, DOI 10.1095/biolreprod.108.071951; Gurbuz C, 2010, KOREAN J UROL, V51, P561, DOI 10.4111/kju.2010.51.8.561; Hadziselimovic F, 2011, SEX DEV, V5, P49, DOI 10.1159/000323955; Hadziselimovic F, 2009, SEX DEV, V3, P253, DOI 10.1159/000249147; HAZARY S, 1960, ANAT REC, V136, P437, DOI 10.1002/ar.1091360402; Jasavala R, 2007, MOL CELL PROTEOMICS, V6, P252, DOI 10.1074/mcp.M600169-MCP200; Jiang XW, 2004, ASIAN J ANDROL, V6, P325; Kalfa N, 2008, J UROLOGY, V180, P2183, DOI 10.1016/j.juro.2008.07.066; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lambard S, 2005, J STEROID BIOCHEM, V95, P63, DOI 10.1016/j.jsbmb.2005.04.020; Li XD, 2001, ENDOCRINOLOGY, V142, P2435, DOI 10.1210/en.142.6.2435; Li XD, 2008, GEN COMP ENDOCR, V159, P1, DOI 10.1016/j.ygcen.2008.07.025; Liu BC, 2005, PEDIATR RES, V58, P1280, DOI 10.1203/01.pdr.0000187796.28007.2d; Liu B, 2007, PEDIATR DEVEL PATHOL, V10, P446, DOI 10.2350/06-04-0079.1; Liu BC, 2006, HORM RES, V65, P217, DOI 10.1159/000092402; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; MCLACHLAN JA, 1975, SCIENCE, V190, P991, DOI 10.1126/science.242076; Mills IG, 2005, J CELL BIOL, V170, P191, DOI 10.1083/jcb.200503106; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785; Nishida Hisayo, 2008, Congenital Anomalies, V48, P63, DOI 10.1111/j.1741-4520.2008.00180.x; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Ray MR, 2006, INT J CANCER, V118, P1108, DOI 10.1002/ijc.21469; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Rivas A, 2002, ENDOCRINOLOGY, V143, P4797, DOI 10.1210/en.2002-220531; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Shono T, 1996, INT J ANDROL, V19, P263, DOI 10.1111/j.1365-2605.1996.tb00474.x; Simon L, 2012, INT J ANDROL, V35, P364, DOI 10.1111/j.1365-2605.2011.01232.x; Song WC, 1997, ENDOCRINOLOGY, V138, P5006, DOI 10.1210/en.138.11.5006; Storgaard L, 2006, REPROD TOXICOL, V21, P4, DOI 10.1016/j.reprotox.2005.05.006; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Thenot S, 1999, MOL CELL ENDOCRINOL, V156, P85, DOI 10.1016/S0303-7207(99)00139-2; Vidaeff AC, 2005, REPROD TOXICOL, V20, P5, DOI 10.1016/j.reprotox.2004.12.015; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang Z, 2007, J UROLOGY, V177, P1939, DOI 10.1016/j.juro.2007.01.014; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200	58	41	41	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					715	724		10.1038/nm.3580	http://dx.doi.org/10.1038/nm.3580			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24880616	Green Accepted			2022-12-25	WOS:000338689500013
J	Sun, HY; Qian, Q; Wu, K; Luo, JJ; Wang, SS; Zhang, CW; Ma, YF; Liu, Q; Huang, XZ; Yuan, QB; Han, RX; Zhao, M; Dong, GJ; Guo, LB; Zhu, XD; Gou, ZH; Wang, W; Wu, YJ; Lin, HX; Fu, XD				Sun, Hongying; Qian, Qian; Wu, Kun; Luo, Jijing; Wang, Shuansuo; Zhang, Chengwei; Ma, Yanfei; Liu, Qian; Huang, Xianzhong; Yuan, Qingbo; Han, Ruixi; Zhao, Meng; Dong, Guojun; Guo, Longbiao; Zhu, Xudong; Gou, Zhiheng; Wang, Wen; Wu, Yuejin; Lin, Hongxuan; Fu, Xiangdong			Heterotrimeric G proteins regulate nitrogen-use efficiency in rice	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; NATURAL VARIATION; GREEN-REVOLUTION; GAMMA-SUBUNITS; GRAIN-SIZE; GENE; ASSIMILATION; SUPPRESSION; DWARFISM; NUMBER	The drive toward more sustainable agriculture has raised the profile of crop plant nutrient-use efficiency. Here we show that a major rice nitrogen-use efficiency quantitative trait locus (qNGR9) is synonymous with the previously identified gene DEP1 (DENSE AND ERECT PANICLES 1). The different DEP1 alleles confer different nitrogen responses, and genetic diversity analysis suggests that DEP1 has been subjected to artificial selection during Oryza sativa spp. japonica rice domestication. The plants carrying the dominant dep1-1 allele exhibit nitrogen-insensitive vegetative growth coupled with increased nitrogen uptake and assimilation, resulting in improved harvest index and grain yield at moderate levels of nitrogen fertilization. The DEP1 protein interacts in vivo with both the Gel (RGA1) and G beta (RGB1) subunits, and reduced RGA1 or enhanced RGB1 activity inhibits nitrogen responses. We conclude that the plant G protein complex regulates nitrogen signaling and modulation of heterotrimeric G protein activity provides a strategy for environmentally sustainable increases in rice grain yield.	[Sun, Hongying; Wu, Kun; Wang, Shuansuo; Zhang, Chengwei; Ma, Yanfei; Liu, Qian; Huang, Xianzhong; Yuan, Qingbo; Han, Ruixi; Zhao, Meng; Fu, Xiangdong] Chinese Acad Sci, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China; [Qian, Qian; Dong, Guojun; Guo, Longbiao; Zhu, Xudong] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Luo, Jijing; Lin, Hongxuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, State Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Zhao, Meng; Wu, Yuejin] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Tech Biol & Agr Engn, Hefei, Peoples R China; [Gou, Zhiheng; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Fu, XD (corresponding author), Chinese Acad Sci, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China.	xdfu@genetics.ac.cn	Luo, Jijing/Q-3687-2018; Qian, Liu/GPS-5502-2022; Lin, Hong-Xuan/AEQ-6607-2022; Wang, Wen/AAP-9873-2020; qian, qian/AAH-8708-2021	Lin, Hong-Xuan/0000-0002-2818-023X; QIAN, LIU/0000-0003-0560-4287	973 Program from National Basic Research Program of China [2011CB915403, 2011CB100302, 2012AA10A301]; National Natural Science Foundation [31130070, 91335207]	973 Program from National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank N.P. Harberd for the critical comments on the manuscript and P. Schulze-Lefert, H. Liao and Y. Tong for advice. This research was supported by grants from the 973 Program from National Basic Research Program of China (2011CB915403, 2011CB100302 and 2012AA10A301) and the National Natural Science Foundation (31130070 and 91335207) to X.F.	Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fujisawa Y, 1999, P NATL ACAD SCI USA, V96, P7575, DOI 10.1073/pnas.96.13.7575; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jones JC, 2011, CHEM ENG PROG, V107, P4; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Li SJ, 2012, NEW PHYTOL, V194, P690, DOI 10.1111/j.1469-8137.2012.04083.x; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; New DC, 1998, BIOL SIGNAL RECEPT, V7, P98; Obara M, 2004, THEOR APPL GENET, V110, P1, DOI 10.1007/s00122-004-1828-0; Obara M, 2010, THEOR APPL GENET, V121, P535, DOI 10.1007/s00122-010-1328-3; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; Taguchi-Shiobara F, 2011, BREEDING SCI, V61, P17, DOI 10.1270/jsbbs.61.17; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Utsunomiya Y, 2011, PLANT J, V67, P907, DOI 10.1111/j.1365-313X.2011.04643.x; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	30	237	297	22	285	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					652	656		10.1038/ng.2958	http://dx.doi.org/10.1038/ng.2958			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24777451				2022-12-25	WOS:000336870700026
J	Tsai, SQ; Wyvekens, N; Khayter, C; Foden, JA; Thapar, V; Reyon, D; Goodwin, MJ; Aryee, MJ; Joung, JK				Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith			Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing	NATURE BIOTECHNOLOGY			English	Article							CAS9; ACTIVATION; ENDONUCLEASE; TALENS	Monomeric CRISPR-Cas9 nucleases are widely used for targeted genome editing but can induce unwanted off-target mutations with high frequencies. Here we describe dimeric RNA-guided FokI nucleases (RFNs) that can recognize extended sequences and edit endogenous genes with high efficiencies in human cells. RFN cleavage activity depends strictly on the binding of two guide RNAs (gRNAs) to DNA with a defined spacing and orientation substantially reducing the likelihood that a suitable target site will occur more than once in the genome and therefore improving specificities relative to wild-type Cas9 monomers. RFNs guided by a single gRNA generally induce lower levels of unwanted mutations than matched monomeric Cas9 nickases. In addition, we describe a simple method for expressing multiple gRNAs bearing any 5' end nucleotide, which gives dimeric RFNs a broad targeting range. RFNs combine the ease of RNA-based targeting with the specificity enhancement inherent to dimerization and are likely to be useful in applications that require highly precise genome editing.	[Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Reyon, Deepak; Goodwin, Mathew J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Tsai, Shengdar Q.; Reyon, Deepak; Aryee, Martin J.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012; Reyon, Deepak/HCH-3183-2022; Aryee, Martin/AAC-8113-2020; Wilson, Matthew H/K-3193-2013	Tsai, Shengdar Q./0000-0001-9161-3993; 	National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378, NIH R01 GM088040, NIH P50 HG005550, NIH R01 AR063070]; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; NIH [F32 GM105189]; US Army Research Laboratory and the US Army Research Office [W911NF-11-2-0056]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105189, DP1GM105378, R01GM088040] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Research Laboratory and the US Army Research Office; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Fu and M. Maeder for helpful discussions and Y. Fu, J. Angstman and B. Kleinstiver for comments on the manuscript. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM088040, NIH P50 HG005550, NIH R01 AR063070, and the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award. S.Q.T. was supported by NIH F32 GM105189. This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under grant number W911NF-11-2-0056. Plasmids described in this work will be deposited with and made available through the nonprofit plasmid distribution service Addgene (http://www. addgene. org/crispr-cas).	Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	31	671	932	7	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					569	+		10.1038/nbt.2908	http://dx.doi.org/10.1038/nbt.2908			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24770325	Green Accepted, Green Submitted			2022-12-25	WOS:000337233800020
J	Birmingham, WR; Starbird, CA; Panosian, TD; Nannemann, DP; Iverson, TM; Bachmann, BO				Birmingham, William R.; Starbird, Chrystal A.; Panosian, Timothy D.; Nannemann, David P.; Iverson, T. M.; Bachmann, Brian O.			Bioretrosynthetic construction of a didanosine biosynthetic pathway	NATURE CHEMICAL BIOLOGY			English	Article							DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; XANTHINE-OXIDASE; KINASE; RIBOKINASE; REVEALS; ENZYME; PHOSPHOPENTOMUTASE; ACTIVATION	Concatenation of engineered biocatalysts into multistep pathways markedly increases their utility, but the development of generalizable assembly methods remains a major challenge. Herein we evaluate ' bioretrosynthesis', which is an application of the retrograde evolution hypothesis, for biosynthetic pathway construction. To test bioretrosynthesis, we engineered a pathway for synthesis of the antiretroviral nucleoside analog didanosine (2 ',3 ' -dideoxyinosine). Applying both directed evolution-and structure-based approaches, we began pathway construction with a retro-extension from an engineered purine nucleoside phosphorylase and evolved 1,5-phosphopentomutase to accept the substrate 2,3-dideoxyribose 5-phosphate with a 700-fold change in substrate selectivity and threefold increased turnover in cell lysate. A subsequent retrograde pathway extension, via ribokinase engineering, resulted in a didanosine pathway with a 9,500-fold change in nucleoside production selectivity and 50-fold increase in didanosine production. Unexpectedly, the result of this bioretrosynthetic step was not a retro-extension from phosphopentomutase but rather the discovery of a fortuitous pathway-shortening bypass via the engineered ribokinase.	[Birmingham, William R.; Iverson, T. M.; Bachmann, Brian O.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37235 USA; [Starbird, Chrystal A.] Vanderbilt Univ, Med Ctr, Chem & Phys Biol Program, Nashville, TN 37235 USA; [Panosian, Timothy D.; Iverson, T. M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Nannemann, David P.; Bachmann, Brian O.] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Birmingham, WR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37235 USA.	tina.iverson@vanderbilt.edu; brian.bachmann@vanderbilt.edu	Birmingham, William/J-4864-2017	Birmingham, William/0000-0002-8880-5502; Bachmann, Brian/0000-0001-5815-1176; Nannemann, David/0000-0002-4946-3263	US National Institutes of Health (NIH) [T32 GM065086]; NIH training [5T32GM008320, T90 DA022873]; US National Science Foundation [DGE: 0909667]; NIH [GM079419, GM077189, S10 RR026915]; Vanderbilt Institute of Chemical Biology; US DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R01GM061606, R01GM079419, R01GM077189, T32GM065086, R25GM062459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute of Chemical Biology; US DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Phelan, K. McCulloch and C. Goodwin for assistance with data acquisition. We also thank J. Zang (Chinese Academy of Sciences), A. Joachimiak (Argonne National Laboratory and University of Chicago), J. Deutscher (Centre national de la recherche scientifique) and S. Ealick (Cornell University) for expression plasmids used in this study. This work was supported by the US National Institutes of Health (NIH) grant T32 GM065086 and the D. Stanley and Ann T. Tarbell Endowment fund (W.R.B.), NIH training grant 5T32GM008320, a US National Science Foundation individual graduate fellowship DGE: 0909667 (C.A.S.), NIH training grants T32NS07491 and 5T32GM008320 (T.D.P.), NIH training grant T90 DA022873 (D.P.N.), NIH grants GM079419 (to T.M.I.) and GM077189 (B.O.B.) and the Vanderbilt Institute of Chemical Biology. The use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under contract no. DE-AC02-06CH11357. The use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). The use of the Vanderbilt robotic crystallization facility was supported by NIH grant S10 RR026915.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; Bachmann BO, 2010, NAT CHEM BIOL, V6, P390, DOI 10.1038/nchembio.377; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball EG, 1939, J BIOL CHEM, V128, P51; Bezy V, 2005, J CHROMATOGR B, V821, P132, DOI 10.1016/j.jchromb.2005.04.003; Bhabha G, 2013, NAT STRUCT MOL BIOL, V20, P1243, DOI 10.1038/nsmb.2676; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cabrera R, 2011, J BIOL CHEM, V286, P5774, DOI 10.1074/jbc.M110.163162; Campobasso N, 2000, BIOCHEMISTRY-US, V39, P7868, DOI 10.1021/bi0000061; Charrier V, 1997, J BIOL CHEM, V272, P14166, DOI 10.1074/jbc.272.22.14166; COREY EJ, 1991, ANGEW CHEM INT EDIT, V30, P455, DOI 10.1002/anie.199104553; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Datta R, 2006, BIOCHEM J, V394, P35, DOI 10.1042/BJ20051513; DEGROOT H, 1985, BIOCHEM J, V230, P255, DOI 10.1042/bj2300255; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksen DT, 2014, J STRUCT BIOL, V185, P234, DOI 10.1016/j.jsb.2013.03.011; Gao X, 2009, CHEM BIOL, V16, P1064, DOI 10.1016/j.chembiol.2009.09.017; Hamamoto T, 1998, BIOSCI BIOTECH BIOCH, V62, P1103, DOI 10.1271/bbb.62.1103; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Ito T, 2009, CHEMBIOCHEM, V10, P2253, DOI 10.1002/cbic.200900339; Iverson T.M., 2012, BIOCHEMISTRY-US, V51, P1964; Li J, 2012, J STRUCT BIOL, V177, P578, DOI 10.1016/j.jsb.2011.12.010; Liang J, 2010, ORG PROCESS RES DEV, V14, P193, DOI 10.1021/op900272d; Ma SK, 2010, GREEN CHEM, V12, P81, DOI 10.1039/b919115c; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nannemann DP, 2010, PROTEIN ENG DES SEL, V23, P607, DOI 10.1093/protein/gzq033; Niu W, 2003, J AM CHEM SOC, V125, P12998, DOI 10.1021/ja036391+; Nocek B, 2011, J MOL BIOL, V406, P325, DOI 10.1016/j.jmb.2010.12.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Panosian TD, 2011, J BIOL CHEM, V286, P8043, DOI 10.1074/jbc.M110.201350; Panosian TD, 2010, ACTA CRYSTALLOGR F, V66, P811, DOI 10.1107/S1744309110017549; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Scism RA, 2010, CHEMBIOCHEM, V11, P67, DOI 10.1002/cbic.200900620; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; SUTHERLAND JD, 1993, BIOORG MED CHEM LETT, V3, P1185, DOI 10.1016/S0960-894X(00)80311-X; Trinh CH, 2009, ACTA CRYSTALLOGR D, V65, P201, DOI 10.1107/S0907444908041115; Turner NJ, 2013, NAT CHEM BIOL, V9, P285, DOI 10.1038/nchembio.1235; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zhang MQ, 2008, J MED CHEM, V51, P5494, DOI 10.1021/jm8006068; Zhang Y, 2004, STRUCTURE, V12, P1809, DOI 10.1016/j.str.2004.07.020	52	42	45	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					392	U111		10.1038/nchembio.1494	http://dx.doi.org/10.1038/nchembio.1494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24657930	Green Accepted			2022-12-25	WOS:000334672700014
J	Newman, AM; Bratman, SV; To, J; Wynne, JF; Eclov, NCW; Modlin, LA; Liu, CL; Neal, JW; Wakelee, HA; Merritt, RE; Shrager, JB; Loo, BW; Alizadeh, AA; Diehn, M				Newman, Aaron M.; Bratman, Scott V.; To, Jacqueline; Wynne, Jacob F.; Eclov, Neville C. W.; Modlin, Leslie A.; Liu, Chih Long; Neal, Joel W.; Wakelee, Heather A.; Merritt, Robert E.; Shrager, Joseph B.; Loo, Billy W., Jr.; Alizadeh, Ash A.; Diehn, Maximilian			An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; SOMATIC MUTATIONS; PLASMA; REARRANGEMENTS; RESISTANCE; THERAPY; GENE	Circulating tumor DNA (ctDNA) is a promising biomarker for noninvasive assessment of cancer burden, but existing ctDNA detection methods have insufficient sensitivity or patient coverage for broad clinical applicability. Here we introduce cancer personalized profiling by deep sequencing (CAPP-Seq), an economical and ultrasensitive method for quantifying ctDNA. We implemented CAPP-Seq for non-small-cell lung cancer (NSCLC) with a design covering multiple classes of somatic alterations that identified mutations in >95% of tumors. We detected ctDNA in 100% of patients with stage II-IV NSCLC and in 50% of patients with stage I, with 96% specificity for mutant allele fractions down to similar to 0.02%. Levels of ctDNA were highly correlated with tumor volume and distinguished between residual disease and treatment-related imaging changes, and measurement of ctDNA levels allowed for earlier response assessment than radiographic approaches. Finally, we evaluated biopsy-free tumor screening and genotyping with CAPP-Seq. We envision that CAPP-Seq could be routinely applied clinically to detect and monitor diverse malignancies, thus facilitating personalized cancer therapy.	[Newman, Aaron M.; Bratman, Scott V.; Liu, Chih Long; Alizadeh, Ash A.; Diehn, Maximilian] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Newman, Aaron M.; Liu, Chih Long; Neal, Joel W.; Wakelee, Heather A.; Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst, Stanford, CA 94305 USA; [Bratman, Scott V.; To, Jacqueline; Wynne, Jacob F.; Eclov, Neville C. W.; Modlin, Leslie A.; Loo, Billy W., Jr.; Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Merritt, Robert E.; Shrager, Joseph B.] Stanford Univ, Div Thorac Surg, Dept Cardiothorac Surg, Stanford Sch Med, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Hematol, Stanford Canc Inst, Stanford, CA 94305 USA; [Diehn, Maximilian] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University	Diehn, M (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	arasha@stanford.edu; diehn@stanford.edu	Newman, Aaron M/ABE-1620-2021; Wakelee, Heather/P-2623-2019; Alizadeh, Ash A/C-5594-2009; wang, edwin/G-5372-2010; Eclov, Neville/AAG-1502-2020	Newman, Aaron M/0000-0002-1857-8172; Alizadeh, Ash A/0000-0002-5153-5625; Eclov, Neville/0000-0003-1454-006X; Bratman, Scott/0000-0001-8610-4908	US Department of Defense; US National Institutes of Health Director's New Innovator Award Program [1-DP2-CA186569]; Ludwig Institute for Cancer Research; Radiological Society of North America [RR1221]; Association of American Cancer Institutes Translational Cancer Research Fellowship; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE [T32CA009302, DP2CA186569] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); US National Institutes of Health Director's New Innovator Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Radiological Society of North America; Association of American Cancer Institutes Translational Cancer Research Fellowship; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Quake and members of his lab for suggestions and N. Neff for technical assistance. This work was supported by the US Department of Defense (M.D., A.A.A., A.M.N.), the US National Institutes of Health Director's New Innovator Award Program (M.D.; 1-DP2-CA186569), the Ludwig Institute for Cancer Research (M.D., A.A.A.), the Radiological Society of North America (S.V.B.; #RR1221), an Association of American Cancer Institutes Translational Cancer Research Fellowship (S.V.B.) and a grant from both the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation (A.M.N.). A.A.A. and M.D. are supported by Doris Duke Clinical Scientist Development Awards.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gautschi O, 2007, CANCER LETT, V254, P265, DOI 10.1016/j.canlet.2007.03.008; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; He J, 2011, ONCOTARGET, V2, P178; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyengar P, 2012, J NATL COMPR CANC NE, V10, P1514, DOI 10.6004/jnccn.2012.0157; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Narayan A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	35	1335	1492	6	406	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					552	558		10.1038/nm.3519	http://dx.doi.org/10.1038/nm.3519			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24705333	Green Accepted			2022-12-25	WOS:000335710700028
J	Khalifeh-Soltani, A; McKleroy, W; Sakuma, S; Cheung, YY; Tharp, K; Qiu, YF; Turner, SM; Chawla, A; Stahl, A; Atabai, K				Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Cheung, Yuk Yin; Tharp, Kevin; Qiu, Yifu; Turner, Scott M.; Chawla, Ajay; Stahl, Andreas; Atabai, Kamran			Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids	NATURE MEDICINE			English	Article							ALPHA(V)BETA(3) INTEGRIN; INSULIN; CD36; ADIPOCYTES; IDENTIFICATION; TRANSLOCATION; PHAGOCYTOSIS; LACTADHERIN; EXPRESSION; TRANSPORT	Fatty acids are integral mediators of energy storage, membrane formation and cell signaling. The pathways that orchestrate uptake of fatty acids remain incompletely understood. Expression of the integrin ligand Mfge8 is increased in human obesity and in mice on a high-fat diet, but its role in obesity is unknown. We show here that Mfge8 promotes the absorption of dietary triglycerides and the cellular uptake of fatty acid and that Mfge8-deficient (Mfge8(-/-)) mice are protected from diet-induced obesity, steatohepatitis and insulin resistance. Mechanistically, we found that Mfge8 coordinates fatty acid uptake through alpha(v)beta(3) integrin- and alpha(v)beta(5) integrin-dependent phosphorylation of Akt by phosphatidylinositide-3 kinase and mTOR complex 2, leading to translocation of Cd36 and Fatp1 from cytoplasmic vesicles to the cell surface. Collectively, our results imply a role for Mfge8 in regulating the absorption and storage of dietary fats, as well as in the development of obesity and its complications.	[Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Cheung, Yuk Yin; Qiu, Yifu; Chawla, Ajay; Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Atabai, Kamran] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Cheung, Yuk Yin; Chawla, Ajay; Atabai, Kamran] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Tharp, Kevin; Stahl, Andreas] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Tharp, Kevin; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Turner, Scott M.] KineMed Inc, Emeryville, CA USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Atabai, K (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	kamran.atabai@ucsf.edu	Sakuma, Stephen/AAH-1880-2020	Sakuma, Stephen/0000-0002-0779-5139; tharp, kevin/0000-0002-3543-3266; Qiu, Yifu/0000-0001-5645-3189	US National Institutes of Health [P30 DK 063-7202]; University of California, San Francisco (UCSF) Diabetes and Endocrinology Research Center; UCSF Cardiovascular Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, T32DK007202, T32DK061918, P30DK063720, R01DK066336] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco (UCSF) Diabetes and Endocrinology Research Center; UCSF Cardiovascular Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health grant P30 DK 063-7202 and the University of California, San Francisco (UCSF) Diabetes and Endocrinology Research Center and UCSF Cardiovascular Research Institute startup funds (K.A.). We would like to thank K. Nguyen for help with flow cytometry studies, A. Atakilit and D. Sheppard (UCSF Lung Biology Center) for providing integrin-blocking antibodies, R. Silverstein for providing Cd36<SUP>-/-</SUP> mice (Cleveland Clinic Research Institute) and K. Ashrafi for thoughtful review of the manuscript.	Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Berk PD, 1999, J BIOL CHEM, V274, P28626, DOI 10.1074/jbc.274.40.28626; Berk PD, 1997, J BIOL CHEM, V272, P8830, DOI 10.1074/jbc.272.13.8830; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Chabowski A, 2004, AM J PHYSIOL-ENDOC M, V287, pE781, DOI 10.1152/ajpendo.00573.2003; Cheng M, 2012, DIABETES RES CLIN PR, V95, P125, DOI 10.1016/j.diabres.2011.09.030; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Kudo M, 2013, P NATL ACAD SCI USA, V110, P660, DOI 10.1073/pnas.1216673110; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu YY, 2010, ANTICANCER RES, V30, P369; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; POEHLMAN ET, 1994, ANN INTERN MED, V121, P860, DOI 10.7326/0003-4819-121-11-199412010-00006; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rolland Y, 2011, CURR OPIN CLIN NUTR, V14, P15, DOI 10.1097/MCO.0b013e328340c2c2; Ryeom SW, 1996, J CELL SCI, V109, P387; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Stump DD, 2001, J LIPID RES, V42, P509; Tanaka T, 2001, J LIPID RES, V42, P751; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Twito T, 2011, ANIM GENET, V42, P642, DOI 10.1111/j.1365-2052.2011.02191.x; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052541; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499; Zheng DQ, 1999, CANCER RES, V59, P1655	49	63	65	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					175	183		10.1038/nm.3450	http://dx.doi.org/10.1038/nm.3450			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24441829	Green Accepted			2022-12-25	WOS:000330915000019
J	Qiao, H; Rao, HBDP; Yang, Y; Fong, JH; Cloutier, JM; Deacon, DC; Nagel, KE; Swartz, RK; Strong, E; Holloway, JK; Cohen, PE; Schimenti, J; Ward, J; Hunter, N				Qiao, Huanyu; Rao, H. B. D. Prasada; Yang, Ye; Fong, Jared H.; Cloutier, Jeffrey M.; Deacon, Dekker C.; Nagel, Kathryn E.; Swartz, Rebecca K.; Strong, Edward; Holloway, J. Kim; Cohen, Paula E.; Schimenti, John; Ward, Jeremy; Hunter, Neil			Antagonistic roles of ubiquitin ligase HEI10 and SUMO ligase RNF212 regulate meiotic recombination	NATURE GENETICS			English	Article							SYNAPTONEMAL COMPLEX; CHROMOSOME SYNAPSIS; MAMMALIAN MEIOSIS; MALE-MOUSE; PROGRESSION; SPO11; SYCP1; GENE; MICE	Crossover recombination facilitates the accurate segregation of homologous chromosomes during meiosis1,2. In mammals, poorly characterized regulatory processes ensure that every pair of chromosomes obtains at least one crossover, even though most recombination sites yield non-crossovers(3). Designation of crossovers involves selective localization of the SUMO ligase RNF212 to a minority of recombination sites, where it stabilizes pertinent factors such as MutSg (ref. 4). Here we show that the ubiquitin ligase HEI10 (also called CCNB1IP1) 5,6 is essential for this crossover/non-crossover differentiation process. In HEI10-deficient mice, RNF212 localizes to most recombination sites, and dissociation of both RNF212 and MutS. from chromosomes is blocked. Consequently, recombination is impeded, and crossing over fails. In wild-type mice, HEI10 accumulates at designated crossover sites, suggesting that it also has a late role in implementing crossing over. As with RNF212, dosage sensitivity for HEI10 indicates that it is a limiting factor for crossing over. We suggest that SUMO and ubiquitin have antagonistic roles during meiotic recombination that are balanced to effect differential stabilization of recombination factors at crossover and non-crossover sites.	[Qiao, Huanyu; Rao, H. B. D. Prasada; Yang, Ye; Fong, Jared H.; Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Qiao, Huanyu; Rao, H. B. D. Prasada; Yang, Ye; Fong, Jared H.; Hunter, Neil] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Cloutier, Jeffrey M.; Deacon, Dekker C.; Nagel, Kathryn E.; Swartz, Rebecca K.; Ward, Jeremy] Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA; [Strong, Edward] Cornell Univ, Coll Vet Med, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Holloway, J. Kim; Cohen, Paula E.] Cornell Univ, Dept Biomed Sci, Ctr Reprod Gen, Ithaca, NY USA; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; Cornell University; Cornell University; University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA.	nhunter@ucdavis.edu	Yang, Ye/C-8397-2011	Deacon, Dekker/0000-0002-4160-5730; Cloutier, Jeffrey/0000-0002-8630-8609; Qiao, Huanyu/0000-0003-0966-8077	US National Institutes of Health (NIH) [R01GM084955, R01GM45415, HD041012]; National Science Foundation grant CAREER [0844941]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041012, R00HD065870] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD041012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045415, T32GM007309, R01GM084955] Funding Source: NIH RePORTER; Direct For Biological Sciences [0844941] Funding Source: National Science Foundation	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation grant CAREER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Kong for communicating unpublished results. This work was supported by US National Institutes of Health (NIH) grants R01GM084955 to N. H., R01GM45415 to J. S. and HD041012 to P. E. C. and by National Science Foundation grant CAREER 0844941 to J. W. N. H. is an investigator of the Howard Hughes Medical Institute.	Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chicheportiche A, 2007, J CELL SCI, V120, P1733, DOI 10.1242/jcs.004945; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Cobb J, 1999, DEV BIOL, V205, P49, DOI 10.1006/dbio.1998.9101; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Hirose Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001329; Holloway JK, 2010, J CELL BIOL, V188, P779, DOI 10.1083/jcb.200909048; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Qiao HY, 2011, CHROMOSOME RES, V19, P193, DOI 10.1007/s10577-010-9184-1; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sakuno T, 2011, DEV CELL, V21, P534, DOI 10.1016/j.devcel.2011.08.012; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Strong ER, 2010, GENES-BASEL, V1, P440, DOI 10.3390/genes1030440; Toby GG, 2003, MOL CELL BIOL, V23, P2109, DOI 10.1128/MCB.23.6.2109-2122.2003; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139	28	110	114	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					194	+		10.1038/ng.2858	http://dx.doi.org/10.1038/ng.2858			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24390283	Green Submitted, Green Accepted			2022-12-25	WOS:000331208300018
J	Bard-Chapeau, EA; Nguyen, AT; Rust, AG; Sayadi, A; Lee, P; Chua, BQ; New, LS; de Jong, J; Ward, JM; Chin, CKY; Chew, V; Toh, C; Abastado, JP; Benoukraf, T; Soong, R; Bard, FA; Dupuy, AJ; Johnson, RL; Radda, GK; Chan, ECY; Wessels, LFA; Adams, DJ; Jenkins, NA; Copeland, NG				Bard-Chapeau, Emilie A.; Nguyen, Anh-Tuan; Rust, Alistair G.; Sayadi, Ahmed; Lee, Philip; Chua, Belinda Q.; New, Lee-Sun; de Jong, Johann; Ward, Jerrold M.; Chin, Christopher K. Y.; Chew, Valerie; Han Chong Toh; Abastado, Jean-Pierre; Benoukraf, Touati; Soong, Richie; Bard, Frederic A.; Dupuy, Adam J.; Johnson, Randy L.; Radda, George K.; Chan, Eric Chun Yong; Wessels, Lodewyk F. A.; Adams, David J.; Jenkins, Nancy A.; Copeland, Neal G.			Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model	NATURE GENETICS			English	Article							FINGER PROTEIN ZBTB20; REAL-TIME PCR; ADENOSINE KINASE; INTRATUMOR HETEROGENEITY; CANCER METABOLISM; PYRUVATE-KINASE; DOWN-REGULATION; LIVER; CELL; EXPRESSION	The most common risk factor for developing hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV). To better understand the evolutionary forces driving HCC, we performed a near-saturating transposon mutagenesis screen in a mouse HBV model of HCC. This screen identified 21 candidate early stage drivers and a very large number (2,860) of candidate later stage drivers that were enriched for genes that are mutated, deregulated or functioning in signaling pathways important for human HCC, with a striking 1,199 genes being linked to cellular metabolic processes. Our study provides a comprehensive overview of the genetic landscape of HCC.	[Bard-Chapeau, Emilie A.; Nguyen, Anh-Tuan; Sayadi, Ahmed; Chua, Belinda Q.; Ward, Jerrold M.; Chin, Christopher K. Y.; Bard, Frederic A.; Jenkins, Nancy A.; Copeland, Neal G.] ASTAR, Inst Mol & Cell Biol, Biopolis, Singapore, Singapore; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge, England; [Lee, Philip; Radda, George K.] Natl Univ Singapore, Singapore Bioimaging Consortium, Ctr Translat Med, Clin Imaging Res Ctr, Singapore 117548, Singapore; [New, Lee-Sun; Chan, Eric Chun Yong] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [de Jong, Johann; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [Chew, Valerie; Abastado, Jean-Pierre] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore; [Han Chong Toh] Natl Canc Ctr, Singapore, Singapore; [Benoukraf, Touati; Soong, Richie] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Dupuy, Adam J.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Wellcome Trust Sanger Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; Netherlands Cancer Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National Cancer Centre Singapore (NCCS); National University of Singapore; University of Iowa; University of Texas System; UTMD Anderson Cancer Center	Copeland, NG (corresponding author), Methodist Hosp, Res Inst, 6535 Fannin, Houston, TX 77030 USA.	ncopeland@tmhs.org	Benoukraf, Touati/K-9978-2019; Chan, Eric Chun Yong/E-7101-2013; Toh, Chee-Keong/AAC-9610-2020; Bard, Frederic Andre Jean/G-9914-2011	Benoukraf, Touati/0000-0002-4789-8028; Rust, Alistair/0000-0001-7287-192X; Soong, Richie/0000-0002-0152-1225; Adams, David/0000-0001-9490-0306; Chan, Eric Chun Yong/0000-0001-6107-9072; de Jong, Johann/0000-0002-2097-0915; Dupuy, Adam/0000-0002-8561-4911; Bard, Frederic Andre Jean/0000-0002-3783-4805	Biomedical Research Council; Agency for Science, Technology and Research, Singapore; Cancer Prevention Research Institute of Texas (CPRIT); Wellcome Trust; Cancer Research UK; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Prevention Research Institute of Texas (CPRIT); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge K. Reifenberg at Johannes Gutenberg University, Germany, for giving us the HBsAg mouse strain (originated from F. Chisari). We also thank K. Rogers and S. Rogers at the Institute of Molecular and Cell Biology Histopathology core for their necropsy and histotechnology assistance. We thank P. Cheok, N. Lim and D. Chen for their help with mouse breeding and monitoring. This work was supported by the Biomedical Research Council, Agency for Science, Technology and Research, Singapore and the Cancer Prevention Research Institute of Texas (CPRIT). A. G. R. and D.J.A. are supported by the Wellcome Trust and Cancer Research UK. N.A.J. and N. G. C. are both CPRIT Scholars in Cancer Research.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bernard F, 2009, LEUKEMIA, V23, P583, DOI 10.1038/leu.2008.228; Berquam-Vrieze KE, 2011, BLOOD, V118, P4646, DOI 10.1182/blood-2011-03-343947; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004; Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cheng F, 2011, ONCOGENE, V30, P3599, DOI 10.1038/onc.2011.71; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eppig Janan T, 2007, Toxicol Pathol, V35, P456, DOI 10.1080/01926230701310536; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; JACKSON RC, 1978, BRIT J CANCER, V37, P701, DOI 10.1038/bjc.1978.107; Jee J, 2011, BIOINFORMATICS, V27, P1152, DOI 10.1093/bioinformatics/btr092; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Lee P, 2013, HEPATOLOGY, V57, P515, DOI 10.1002/hep.26028; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Morrow M, 2007, ONCOGENE, V26, P4404, DOI 10.1038/sj.onc.1210227; Nii A, 2009, HEPATOL RES, V39, P274, DOI 10.1111/j.1872-034X.2008.00457.x; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; QUEENER SF, 1971, CANCER RES, V31, P1004; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder MA, 2010, CARDIOVASC RES, V86, P82, DOI 10.1093/cvr/cvp396; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Sutherland APR, 2009, MOL CELL BIOL, V29, P2804, DOI 10.1128/MCB.01667-08; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Watt AJ, 2001, MECH DEVELOP, V100, P205, DOI 10.1016/S0925-4773(00)00530-X; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Zhang GW, 2012, J INVEST SURG, V25, P93, DOI 10.3109/08941939.2011.606875; Zheng TS, 2011, CANCER LETT, V302, P91, DOI 10.1016/j.canlet.2010.12.008	87	90	92	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					24	+		10.1038/ng.2847	http://dx.doi.org/10.1038/ng.2847			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316982	Green Accepted			2022-12-25	WOS:000329113500008
J	Parkinson, K; Baines, AE; Keller, T; Gruenheit, N; Bragg, L; North, RA; Thompson, CRL				Parkinson, Katie; Baines, Abigail E.; Keller, Thomas; Gruenheit, Nicole; Bragg, Laricia; North, R. Alan; Thompson, Christopher R. L.			Calcium-dependent regulation of Rab activation and vesicle fusion by an intracellular P2X ion channel	NATURE CELL BIOLOGY			English	Article							CONTRACTILE VACUOLE SYSTEM; EXCHANGE FACTOR; ENDOPLASMIC-RETICULUM; SECRETORY VESICLES; DICTYOSTELIUM; PROTEIN; GTPASE; RECEPTORS; CALMODULIN; CHELATORS	Rab GTPases play key roles in the delivery, docking and fusion of intracellular vesicles. However, the mechanism by which spatial and temporal regulation of Rab GTPase activity is controlled is poorly understood. Here we describe a mechanism by which localized calcium release through a vesicular ion channel controls Rab GTPase activity. We show that activation of P2XA, an intracellular ion channel localized to the Dictyostelium discoideum contractile vacuole system, results in calcium efflux required for downregulation of Rab11a activity and efficient vacuole fusion. Vacuole fusion and Rab11a downregulation require the activity of CnrF, an EF-hand-containing Rab GAP found in a complex with Rab11a and P2XA. CnrF Rab GAP activity for Rab11a is enhanced by the presence of calcium and the EF-hand domain. These findings suggest that P2XA activation results in vacuolar calcium release, which triggers activation of CnrF Rab GAP activity and subsequent downregulation of Rab11a to allow vacuole fusion.	[Parkinson, Katie; Baines, Abigail E.; Keller, Thomas; Gruenheit, Nicole; North, R. Alan; Thompson, Christopher R. L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Bragg, Laricia; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Thompson, CRL (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	christopher.thompson@manchester.ac.uk	Gruenheit, Nicole/E-8718-2011; Gruenheit, Nicole/Q-5214-2016; North, Richard/GQA-6156-2022	Gruenheit, Nicole/0000-0003-3046-9347; 	Medical Research Council [G0900069]; Wellcome Trust [WT095643]; MRC [G0900069] Funding Source: UKRI; Wellcome Trust [095643/A/11/Z] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Medical Research Council grant (G0900069) to R.A.N. and C.R.L.T. and a Wellcome Trust Investigator Award (WT095643) to C.R.L.T.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Allan CY, 2009, METHODS MOL BIOL, V571, P291, DOI 10.1007/978-1-60761-198-1_20; Allen RD, 2000, BIOESSAYS, V22, P1035; Baines A, 2013, J BIOL CHEM, V288, P20992, DOI 10.1074/jbc.M112.445346; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Bush J, 1996, MOL BIOL CELL, V7, P1623, DOI 10.1091/mbc.7.10.1623; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Du F, 2008, EMBO J, V27, P2064, DOI 10.1038/emboj.2008.131; Essid M, 2012, MOL BIOL CELL, V23, P1267, DOI 10.1091/mbc.E11-06-0576; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Harris E, 2001, J CELL SCI, V114, P3035; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Ludlow MJ, 2009, J BIOL CHEM, V284, P35227, DOI 10.1074/jbc.M109.045674; Medkova M, 2006, MOL BIOL CELL, V17, P2757, DOI 10.1091/mbc.E05-10-0917; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Moreno SNJ, 2009, J EUKARYOT MICROBIOL, V56, P208, DOI 10.1111/j.1550-7408.2009.00404.x; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sivaramakrishnan V, 2012, J BIOL CHEM, V287, P28315, DOI 10.1074/jbc.M112.372565; Starai VJ, 2005, J BIOL CHEM, V280, P16754, DOI 10.1074/jbc.M500421200; STAROVASNIK MA, 1992, PROTEIN SCI, V1, P245; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Temesvari LA, 1996, J CELL SCI, V109, P1479; Wu WI, 2004, TRAFFIC, V5, P346, DOI 10.1111/j.1600-0854.2004.00177.x; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135	49	37	39	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					87	+		10.1038/ncb2887	http://dx.doi.org/10.1038/ncb2887			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24335649	Green Accepted, Green Submitted			2022-12-25	WOS:000329042000014
J	Chen, W; Gao, YQ; Xie, WB; Gong, L; Lu, K; Wang, WS; Li, Y; Liu, XQ; Zhang, HY; Dong, HX; Zhang, W; Zhang, LJ; Yu, SB; Wang, GW; Lian, XM; Luo, J				Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Liu, Xianqing; Zhang, Hongyan; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie			Genome-wide association analyses provide genetic and biochemical insights into natural variation in rice metabolism	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; COMPLEX TRAITS; CULTIVATED RICE; EXPRESSION; IDENTIFICATION; SEQUENCE; PLANTS; HEALTH; BIOSYNTHESIS; ACCUMULATION	Plant metabolites are important to world food security in terms of maintaining sustainable yield and providing food with enriched phytonutrients. Here we report comprehensive profiling of 840 metabolites and a further metabolic genome-wide association study based on similar to 6.4 million SNPs obtained from 529 diverse accessions of Oryza sativa. We identified hundreds of common variants influencing numerous secondary metabolites with large effects at high resolution. We observed substantial heterogeneity in the natural variation of metabolites and their underlying genetic architectures among different subspecies of rice. Data mining identified 36 candidate genes modulating levels of metabolites that are of potential physiological and nutritional importance. As a proof of concept, we functionally identified or annotated five candidate genes influencing metabolic traits. Our study provides insights into the genetic and biochemical bases of rice metabolome variation and can be used as a powerful complementary tool to classical phenotypic trait mapping for rice improvement.	[Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China; [Liu, Xianqing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Zhang, Hongyan] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Luo, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	xmlian@mail.hzau.edu.cn; jie.luo@mail.hzau.edu.cn	Gong, Liang/CAG-5950-2022; Xie, Weibo/B-3771-2008; Xie, Weibo/AAI-2412-2021	Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; Lian, Xingming/0000-0002-5307-2839; , sibin/0000-0003-0458-7526	Major State Basic Research Development Program of China (973 Program) [2013CB127001]; National High Technology R&D Program of China (863 Program) [2012AA10A303, 2012AA10A304]; National Natural Science Foundation of China [31070267, 31100962]; Program for New Century Excellent Talents in University of Ministry of Education in China [NCET-09-0401]; Ministry of Science and Technology [2010CB125901, 2011CB100304]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education in China(Program for New Century Excellent Talents in University (NCET)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We appreciate the critical reading and helpful comments on the manuscript made by C. Martin from John Innes Centre, UK and Q. Zhang from Huazhong Agricultural University, China. We thank W Yan for kindly providing 148 varieties from a mini-core subset of the US Department of Agriculture rice gene bank. This work was supported by the Major State Basic Research Development Program of China (973 Program) (number 2013CB127001), the National High Technology R&D Program of China (863 Program) (numbers 2012AA10A303 and 2012AA10A304), the National Natural Science Foundation of China (numbers 31070267 and 31100962) and the Program for New Century Excellent Talents in University of Ministry of Education in China (NCET-09-0401). We are also thankful for support from the Ministry of Science and Technology (numbers 2010CB125901 and 2011CB100304).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Hellmann H, 2010, MOLECULES, V15, P442, DOI 10.3390/molecules15010442; Herrero S, 2011, PLANT MOL BIOL, V76, P157, DOI 10.1007/s11103-011-9777-x; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Joseph B, 2013, ELIFE, V2, DOI 10.7554/eLife.00776; Jung KH, 2013, RICE, V6, DOI 10.1186/1939-8433-6-19; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kawaura K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-271; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Keurentjes JJB, 2009, CURR OPIN PLANT BIOL, V12, P223, DOI 10.1016/j.pbi.2008.12.003; Kliebenstein DJ, 2001, GENETICS, V159, P359; Ko JH, 2008, J PLANT PHYSIOL, V165, P435, DOI 10.1016/j.jplph.2007.01.006; Kusano M, 2012, MOL PLANT, V5, P442, DOI 10.1093/mp/ssr101; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Minorsky PV, 2002, PLANT PHYSIOL, V128, P1167, DOI 10.1104/pp.900030; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Redestig H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-176; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Shimizu T, 2012, J BIOL CHEM, V287, P19315, DOI 10.1074/jbc.M112.351270; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Traka MH, 2011, PLANT CELL, V23, P2483, DOI 10.1105/tpc.111.087916; Weng JK, 2012, SCIENCE, V337, P960, DOI 10.1126/science.1221614; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	53	398	449	22	418	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					714	721		10.1038/ng.3007	http://dx.doi.org/10.1038/ng.3007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24908251				2022-12-25	WOS:000338093800012
J	Perry, RJ; Zhang, XM; Zhang, DY; Kumashiro, N; Camporez, JPG; Cline, GW; Rothman, DL; Shulman, GI				Perry, Rachel J.; Zhang, Xian-Man; Zhang, Dongyan; Kumashiro, Naoki; Camporez, Joao-Paulo G.; Cline, Gary W.; Rothman, Douglas L.; Shulman, Gerald I.			Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis	NATURE MEDICINE			English	Article							LIVER PYRUVATE-CARBOXYLASE; RAT-LIVER; INSULIN; GLUCOSE; MECHANISMS; INFUSION; THERAPY; ABSENCE; CNS	Leptin treatment reverses hyperglycemia in animal models of poorly controlled type 1 diabetes (T1D)1-6, spurring great interest in the possibility of treating patients with this hormone. The antidiabetic effect of leptin has been postulated to occur through suppression of glucagon production, suppression of glucagon responsiveness or both; however, there does not appear to be a direct effect of leptin on the pancreatic alpha ce117. Thus, the mechanisms responsible for the antidiabetic effect of leptin remain poorly understood. We quantified liver-specific rates of hepatic gluconeogenesis and substrate oxidation in conjunction with rates of whole-body acetate, glycerol and fatty acid turnover in three rat models of poorly controlled diabetes, including a model of diabetic ketoacidosis8. We show that the higher rates of hepatic gluconeogenesis in all these models could be attributed to hypoleptinemia-induced activity of the hypothalamic-pituitaryadrenal (HPA) axis, resulting in higher rates of adipocyte lipolysis, hepatic conversion of glycerol to glucose through a substrate push mechanism and conversion of pyruvate to glucose through greater hepatic acetyl-CoA allosteric activation of pyruvate carboxylase flux. Notably, these effects could be dissociated from changes in plasma insulin and glucagon concentrations and hepatic gluconeogenic protein expression. All the altered systemic and hepatic metabolic fluxes could be mimicked by infusing rats with Intralipid or corticosterone and were corrected by leptin replacement. These data demonstrate a critical role for lipolysis and substrate delivery to the liver, secondary to hypoleptinemia and HPA axis activity, in promoting higher hepatic gluconeogenesis and hyperglycemia in poorly controlled diabetes.	[Perry, Rachel J.; Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Perry, Rachel J.; Zhang, Xian-Man; Kumashiro, Naoki; Camporez, Joao-Paulo G.; Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Rothman, Douglas L.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Rothman, Douglas L.] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Novo Nordisk Foundation; University of Copenhagen	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Camporez, Joao Paulo G/B-9122-2015; Shulman, Gerald I./P-7176-2019; Kumashiro, Naoki/AAI-4857-2020	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064; Camporez, Joao Paulo/0000-0003-3486-4301	US National Institutes of Health [R01 DK-4y936, R24 DK-085638, U24 DK-059635, P30 DK-45735]; American Diabetes Association-Merck Clinical/Translational Science Postdoctoral Fellowship Award from the American Diabetes Association; Novo Nordisk Boundatim\for Basic Metabolic Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R24DK085638, T32DK101019, R01DK040936, U24DK059635] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association-Merck Clinical/Translational Science Postdoctoral Fellowship Award from the American Diabetes Association; Novo Nordisk Boundatim\for Basic Metabolic Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank r Samuel, D. Befroy and K. Petersen for helpful discussions and J. Dong, Y. IcosoYer, M. Kahn, B. Perler, J. Stack and M. Batsu for expert technical support. This study was funded by grants from the US National Institutes of Health (R01 DK-4y936, R24 DK-085638, U24 DK-059635 and P30 DK-45735), an American Diabetes Association-Merck Clinical/Translational Science Postdoctoral Fellowship Award from the American Diabetes Association and the Novo Nordisk Boundatim\for Basic Metabolic Research.	BODEN G, 1995, DIABETES, V44, P1239, DOI 10.2337/diabetes.44.10.1239; Chen LJ, 2011, ENDOCR PRACT, V17, P819, DOI 10.4158/EP11101.OR; Chinookoswong N, 1999, DIABETES, V48, P1487, DOI 10.2337/diabetes.48.7.1487; COLEMAN DL, 1977, DIABETOLOGIA, V13, P25, DOI 10.1007/BF00996323; Craighead J E, 1980, Monogr Pathol, V21, P166; da Silva AA, 2006, AM J PHYSIOL-REG I, V291, pR1275, DOI 10.1152/ajpregu.00187.2006; DUBUC PU, 1977, HORM METAB RES, V9, P95, DOI 10.1055/s-0028-1095550; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; Hathout EH, 1999, J CLIN ENDOCR METAB, V84, P4545, DOI 10.1210/jc.84.12.4545; Kitabchi AE, 2003, J CLIN ENDOCR METAB, V88, P2593, DOI 10.1210/jc.2002-021975; KITABCHI AE, 1995, MED CLIN N AM, V79, P9, DOI 10.1016/S0025-7125(16)30082-7; Kratzsch J, 2006, EUR J ENDOCRINOL, V155, P609, DOI 10.1530/eje.1.02261; Laker RC, 2011, AM J PHYSIOL-REG I, V300, pR511, DOI 10.1152/ajpregu.00079.2010; Lin CY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1084, DOI 10.1152/ajpendo.00489.2001; LOOSE DS, 1983, J CLIN INVEST, V72, P404, DOI 10.1172/JCI110982; MCCLURE WR, 1971, J BIOL CHEM, V246, P3569; Meek TH, 2013, ENDOCRINOLOGY, V154, P3067, DOI 10.1210/en.2013-1328; Minokoshi Yasuhiko, 2012, Indian J Endocrinol Metab, V16, pS562, DOI 10.4103/2230-8210.105573; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Previs SF, 1999, AM J PHYSIOL-ENDOC M, V277, pE154, DOI 10.1152/ajpendo.1999.277.1.E154; SCRUTTON MC, 1972, BIOCHEM BIOPH RES CO, V48, P85, DOI 10.1016/0006-291X(72)90347-6; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Szucs N, 2001, Pituitary, V4, P71, DOI 10.1023/A:1012990928218; Toda C, 2013, DIABETES, V62, P2295, DOI 10.2337/db12-1629; UTTER MF, 1960, J BIOL CHEM, V235, pPC17; Wang JP, 2008, J ENDOCRINOL, V198, P541, DOI 10.1677/JOE-08-0135; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; WARREN GB, 1974, BIOCHEM J, V139, P311, DOI 10.1042/bj1390311	29	136	141	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					759	763		10.1038/nm.3579	http://dx.doi.org/10.1038/nm.3579			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24929951	Green Accepted			2022-12-25	WOS:000338689500019
J	Elliott, TS; Townsley, FM; Bianco, A; Ernst, RJ; Sachdeva, A; Elsasser, SJ; Davis, L; Lang, K; Pisa, R; Greiss, S; Lilley, KS; Chin, JW				Elliott, Thomas S.; Townsley, Fiona M.; Bianco, Ambra; Ernst, Russell J.; Sachdeva, Amit; Elsaesser, Simon J.; Davis, Lloyd; Lang, Kathrin; Pisa, Rudolf; Greiss, Sebastian; Lilley, Kathryn S.; Chin, Jason W.			Proteome labeling and protein identification in specific tissues and at specific developmental stages in an animal	NATURE BIOTECHNOLOGY			English	Article							NONCANONICAL AMINO-ACIDS; TRANSFER-RNA SYNTHETASE; DIELS-ALDER REACTIONS; MAMMALIAN-CELLS; GENETIC-CODE; TETRAZINE CYCLOADDITIONS; DROSOPHILA-MELANOGASTER; RECOMBINANT PROTEINS; TRANS-CYCLOOCTENES; LIVING CELLS	Identifying the proteins synthesized at specific times in cells of interest in an animal will facilitate the study of cellular functions and dynamic processes. Here we introduce stochastic orthogonal recoding of translation with chemoselective modification (SORT-M) to address this challenge. SORT-M involves modifying cells to express an orthogonal aminoacyl-tRNA synthetase/tRNA pair to enable the incorporation of chemically modifiable analogs of amino acids at diverse sense codons in cells in rich media. We apply SORT-M to Drosophila melanogaster fed standard food to label and image proteins in specific tissues at precise developmental stages with diverse chemistries, including cyclopropene-tetrazine inverse electron demand Diels-Alder cycloaddition reactions. We also use SORT-M to identify proteins synthesized in germ cells of the fly ovary without dissection. SORT-M will facilitate the definition of proteins synthesized in specific sets of cells to study development, and learning and memory in flies, and may be extended to animals.	[Elliott, Thomas S.; Townsley, Fiona M.; Bianco, Ambra; Ernst, Russell J.; Sachdeva, Amit; Elsaesser, Simon J.; Davis, Lloyd; Lang, Kathrin; Pisa, Rudolf; Greiss, Sebastian; Chin, Jason W.] Med Res Council Lab Mol Biol, Cambridge, England; [Pisa, Rudolf; Chin, Jason W.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Chin, JW (corresponding author), Med Res Council Lab Mol Biol, Cambridge, England.	chin@mrc-lmb.cam.ac.uk	Elsässer, Simon/AAM-3986-2020; Pisa, Rudolf/AAT-2951-2020; Lang, Kathrin/AAD-2559-2020; Lilley, Kathryn/ABF-5787-2020; Greiss, Sebastian/B-2395-2015; Singh, Pramod K./F-1379-2016; Lang, Kathrin/M-6472-2015	Elsässer, Simon/0000-0001-8724-4849; Pisa, Rudolf/0000-0001-7571-7135; Lilley, Kathryn/0000-0003-0594-6543; Singh, Pramod K./0000-0002-3155-6621; Greiss, Sebastian/0000-0001-9130-0831; Lang, Kathrin/0000-0002-1318-6567	Herchel Smith Fund; Cambridge University Department of Chemistry the Medical Research Council [U105181009, UD99999908]; European Research Council for funding; MRC [MC_UP_A024_1008, MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009, MC_UP_A024_1008] Funding Source: researchfish	Herchel Smith Fund; Cambridge University Department of Chemistry the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council for funding; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are exceptionally grateful to M. Skehl and S. Maslen of the LMB Mass Spectrometry service for mass spectrometry, R. Feret of the Cambridge Centre for Proteomics for assistance with DIGE, and S. Bullock (LMB) for advice and comments. We are grateful to the Herchel Smith Fund (S.J.E., administered through Cambridge University Department of Chemistry) the Medical Research Council (U105181009, UD99999908) and the European Research Council for funding.	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Borrmann A, 2012, CHEMBIOCHEM, V13, P2094, DOI 10.1002/cbic.201200407; BOWNES M, 1986, ANNU REV ENTOMOL, V31, P507, DOI 10.1146/annurev.en.31.010186.002451; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2012, SCIENCE, V336, P428, DOI 10.1126/science.1221761; Cole CM, 2013, CHEMBIOCHEM, V14, P205, DOI 10.1002/cbic.201200719; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Dubnau J, 2012, SCIENCE, V335, P664, DOI 10.1126/science.1218171; Feret R., 2014, CURR PROTOC PROTEIN, V75, P222; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Harper S., 2001, CURR PROTOC PROTEIN, V11, P104, DOI DOI 10.4; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Howden AJM, 2013, NAT METHODS, V10, P343, DOI [10.1038/NMETH.2401, 10.1038/nmeth.2401]; Karp NA, 2004, PROTEOMICS, V4, P1421, DOI 10.1002/pmic.200300681; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; LIANG L, 1994, DEVELOPMENT, V120, P1201; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Ngo JT, 2013, P NATL ACAD SCI USA, V110, P4992, DOI 10.1073/pnas.1216375110; Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Patterson DM, 2012, J AM CHEM SOC, V134, P18638, DOI 10.1021/ja3060436; Plass T, 2012, ANGEW CHEM INT EDIT, V51, P4166, DOI 10.1002/anie.201108231; Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745; Sopko R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009050; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Truong F, 2012, J AM CHEM SOC, V134, P8551, DOI 10.1021/ja3004667; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Von Stetina JR, 2011, G3-GENES GENOM GENET, V1, P607, DOI 10.1534/g3.111.001438; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yang J, 2012, ANGEW CHEM INT EDIT, V51, P7476, DOI 10.1002/anie.201202122; Yu ZP, 2012, ANGEW CHEM INT EDIT, V51, P10600, DOI 10.1002/anie.201205352	49	133	135	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					465	U186		10.1038/nbt.2860	http://dx.doi.org/10.1038/nbt.2860			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24727715	Green Accepted			2022-12-25	WOS:000336036100022
J	Ma, HS; Xu, H; O'Farrell, PH				Ma, Hansong; Xu, Hong; O'Farrell, Patrick H.			Transmission of mitochondrial mutations and action of purifying selection in Drosophila melanogaster	NATURE GENETICS			English	Article							RAPID SEGREGATION; DNA HETEROPLASMY; INHERITANCE; MORPHOGENESIS; REDUCTION; EXPLAINS; GENETICS; DRIFT	It is not known how selection affects mutations in the multiple copies of the mitochondrial genome(1-11). We transferred cytoplasm between D. melanogaster embryos carrying mitochondrial mutations to create heteroplasmic lines transmitting two mitochondrial genotypes. Increased temperature imposed selection against a temperature-sensitive mutation affecting cytochrome oxidase, driving decreases in the abundance of the mutant genome over successive generations. Selection did not influence the health or fertility of the flies but acted during midoogenesis to influence competition between the genomes. Mitochondria might incur an advantage through selective localization, survival or proliferation, yet timing and insensitivity to park mutation suggest that preferential proliferation underlies selection. Selection drove complete replacement of the temperature-sensitive mitochondrial genome by a wild-type genome but also stabilized the multigenerational transmission of two genomes carrying complementing detrimental mutations. While they are so balanced, these stably transmitted mutations have no detrimental phenotype, but their segregation could contribute to disease phenotypes and somatic aging.	[Ma, Hansong; Xu, Hong; O'Farrell, Patrick H.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	O'Farrell, PH (corresponding author), Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA.	ofarrell@cgl.ucsf.edu	Ma, Hansong/A-7794-2012; Xu, Hong/H-9997-2016; Ma, Hansong/O-7736-2019	Ma, Hansong/0000-0002-2705-1970; Xu, Hong/0000-0003-1049-1184; Ma, Hansong/0000-0002-2705-1970; O'Farrell, Patrick/0000-0003-0011-2734	US National Institutes of Health [GM086854, ES020725]; United Mitochondrial Disease Foundation; Human Frontiers Science Program [LT000138/2010-l]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120005, R01GM086854] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Martinez for helping perform the park RNAi experiment and G. Mardon (Baylor College of Medicine) for kindly providing the dpk<SUP>Delta 21</SUP> strain. This research was supported by the US National Institutes of Health (GM086854 and ES020725) and by United Mitochondrial Disease Foundation funding to P.H.O. H.M. was supported by the Human Frontiers Science Program (LT000138/2010-l).	Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; King R. C., 1970, OVARIAN DEV DROSOPHI; MATSUURA ET, 1989, GENETICS, V122, P663; Ogienko AA, 2007, RUSS J GENET+, V43, P1120, DOI 10.1134/S1022795407100055; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; SOLIGNAC M, 1987, GENETICS, V117, P687; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; VOLZLINGENHOHL A, 1992, P NATL ACAD SCI USA, V89, P11528, DOI 10.1073/pnas.89.23.11528; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wright S., 1984, EVOLUTION GENETICS P, V2; Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226	24	71	71	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					393	+		10.1038/ng.2919	http://dx.doi.org/10.1038/ng.2919			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24614071	Green Accepted			2022-12-25	WOS:000334510100018
J	Yoo, HY; Sung, MK; Lee, SH; Kim, S; Lee, H; Park, S; Kim, SC; Lee, B; Rho, K; Lee, JE; Cho, KH; Kim, W; Ju, H; Kim, J; Kim, SJ; Kim, WS; Lee, S; Ko, YH				Yoo, Hae Yong; Sung, Min Kyung; Lee, Seung Ho; Kim, Sangok; Lee, Haeseung; Park, Seongjin; Kim, Sang Cheol; Lee, Byungwook; Rho, Kyoohyoung; Lee, Jong-Eun; Cho, Kwang-Hwi; Kim, Wankyu; Ju, Hyunjung; Kim, Jaesang; Kim, Seok Jin; Kim, Won Seog; Lee, Sanghyuk; Ko, Young Hyeh			A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma	NATURE GENETICS			English	Article							THERAPEUTIC TARGETS; SOMATIC MUTATIONS; SEQUENCING DATA; READ ALIGNMENT; RNA-SEQ; GENE; GENOME; CANCER; EXOME; TET2	The molecular mechanisms underlying angioimmunoblastic T cell lymphoma (AITL), a common type of mature T cell lymphoma of poor prognosis, are largely unknown. Here we report a frequent somatic mutation in RHOA (encoding p. Gly17Val) using exome and transcriptome sequencing of samples from individuals with AITL. Further examination of the RHOA mutation encoding p. Gly17Val in 239 lymphoma samples showed that the mutation was specific to T cell lymphoma and was absent from B cell lymphoma. We demonstrate that the RHOA mutation encoding p.Gly17Val, which was found in 53.3% (24 of 45) of the AITL cases examined, is oncogenic in nature using multiple molecular assays. Molecular modeling and docking simulations provided a structural basis for the loss of GTPase activity in the RHOA Gly17Val mutant. Our experimental data and modeling results suggest that the RHOA mutation encoding p. Gly17Val is a driver mutation in AITL. On the basis of these data and through integrated pathway analysis, we build a comprehensive signaling network for AITL oncogenesis.	[Yoo, Hae Yong; Lee, Seung Ho] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Yoo, Hae Yong; Ju, Hyunjung; Kim, Seok Jin; Kim, Won Seog; Ko, Young Hyeh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Res Inst Future Med,Samsung Biomed Res Inst, Seoul, South Korea; [Sung, Min Kyung; Park, Seongjin; Kim, Sang Cheol; Lee, Byungwook] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr KOBIC, Taejon, South Korea; [Kim, Sangok; Lee, Haeseung; Kim, Wankyu; Kim, Jaesang; Lee, Sanghyuk] Ewha Womans Univ, ERCSB, Seoul, South Korea; [Kim, Sangok; Lee, Haeseung; Kim, Wankyu; Kim, Jaesang; Lee, Sanghyuk] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Rho, Kyoohyoung; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea; [Cho, Kwang-Hwi] Soongsil Univ, Sch Syst Biomed Sci, Seoul, South Korea; [Kim, Seok Jin; Kim, Won Seog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol & Oncol, Seoul, South Korea; [Ko, Young Hyeh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Ewha Womans University; DNA Link, Inc.; Soongsil University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, S (corresponding author), Ewha Womans Univ, ERCSB, Seoul, South Korea.	sanghyuk@ewha.ac.kr; yhko310@skku.edu		kim, wankyu/0000-0003-3181-0594; Sung, Minkyung/0000-0001-6573-2622; ko, young hyeh/0000-0002-4383-0579	Samsung Biomedical Research Institute [SP2-B2-04, GE1-B2-071]; Samsung Cancer Research Institute [SCRI-12-02]; National Research Foundation of Korea [NRF-2012M3A9D1054744, NRF-2012M3A9B9036673, NRF-2011-0019745]; GIST; ERCSB; Ewha Global Top5 Grant of Ewha Womans University	Samsung Biomedical Research Institute(Samsung); Samsung Cancer Research Institute(Samsung); National Research Foundation of Korea(National Research Foundation of Korea); GIST; ERCSB; Ewha Global Top5 Grant of Ewha Womans University	We appreciate helpful discussion and comments from P.J. Park (Harvard Medical School). This work was supported by grants from the Samsung Biomedical Research Institute (SP2-B2-04 to Y.H.K., W.S.K. and H.Y.Y. and GE1-B2-071 to H.Y.Y.), the Samsung Cancer Research Institute (cancer genomics project SCRI-12-02), the National Research Foundation of Korea (NRF-2012M3A9D1054744 and NRF-2012M3A9B9036673 to S.L. and NRF-2011-0019745), the GIST (Gwangju Institute of Science and Technology) Systems Biology Infrastructure Establishment Grant through ERCSB (S.L. and J.K.) and the Ewha Global Top5 Grant of Ewha Womans University.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cleverley SC, 2000, ONCOGENE, V19, P13, DOI 10.1038/sj.onc.1203259; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Jaganathan BG, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-66; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morin P, 2009, EUR J CELL BIOL, V88, P495, DOI 10.1016/j.ejcb.2009.04.005; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	38	235	238	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					371	+		10.1038/ng.2916	http://dx.doi.org/10.1038/ng.2916			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24584070				2022-12-25	WOS:000334510100013
J	Koike-Yusa, H; Li, YL; Tan, EP; Velasco-Herrera, MD; Yusa, K				Koike-Yusa, Hiroko; Li, Yilong; Tan, E-Pien; Velasco-Herrera, Martin Del Castillo; Yusa, Kosuke			Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; CAS9; MOUSE; SPECIFICITY; GENERATION; NUCLEASES; DESIGN; MICE; ART; INTERFERENCE	Identification of genes influencing a phenotype of interest is frequently achieved through genetic screening by RNA interference (RNAi) or knockouts. However, RNAi may only achieve partial depletion of gene activity, and knockout-based screens are difficult in diploid mammalian cells. Here we took advantage of the efficiency and high throughput of genome editing based on type II, clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Gas) systems to introduce genome-wide targeted mutations in mouse embryonic stem cells (ESCs). We designed 87,897 guide RNAs (gRNAs) targeting 19,150 mouse protein-coding genes and used a lentiviral vector to express these gRNAs in ESCs that constitutively express Cas9. Screening the resulting ESC mutant libraries for resistance to either Clostridium septicum alpha-toxin or 6-thioguanine identified 27 known and 4 previously unknown genes implicated in these phenotypes. Our results demonstrate the potential for efficient loss-of-function screening using the CRISPR-Cas9 system.	[Koike-Yusa, Hiroko; Li, Yilong; Tan, E-Pien; Velasco-Herrera, Martin Del Castillo; Yusa, Kosuke] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Yusa, K (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	ky1@sanger.ac.uk		Del Castillo Velasco Herrera, Martin/0000-0001-5956-0211	Wellcome Trust PhD program; Cancer Research UK; Wellcome Trust [WT077187]; Cancer Research UK [14356] Funding Source: researchfish	Wellcome Trust PhD program(Wellcome Trust); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	We thank A. Bradley for comments on the manuscript, B. Ng and W Cheng for the flow cytometry analyses, and the Sanger Institute DNA pipeline for the sequence analyses. We also thank J. Takeda and T. Kinoshita for providing us alpha-toxin and the cDNA expression vectors, respectively. Y.L. is supported by the Wellcome Trust PhD program. M.D.C.V.-H. is supported by the Cancer Research UK and Wellcome Trust PhD program. This work was supported by Wellcome Trust (WT077187). The mouse CRISPR library is available through Addgene. The plasmid DNAs are available at the Wellcome Trust Sanger Institute Archives (http://www.sangetac.ulthechnology/clonerequests/).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002	35	679	783	4	206	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					267	273		10.1038/nbt.2800	http://dx.doi.org/10.1038/nbt.2800			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24535568				2022-12-25	WOS:000332819800025
J	Levinson, NM; Boxer, SG				Levinson, Nicholas M.; Boxer, Steven G.			A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity	NATURE CHEMICAL BIOLOGY			English	Article							TYROSINE KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; INHIBITION; COMPLEX; BINDING; DESIGN; MOLECULES; HYDRATION	Kinase inhibitors are important cancer drugs, but they tend to display limited target specificity, and their target profiles are often challenging to rationalize in terms of molecular mechanism. Here we report that the clinical kinase inhibitor bosutinib recognizes its kinase targets by engaging a pair of conserved structured water molecules in the active site and that many other kinase inhibitors share a similar recognition mechanism. Using the nitrile group of bosutinib as an infrared probe, we show that the gatekeeper residue and one other position in the ATP-binding site control access of the drug to the structured water molecules and that the amino acids found at these positions account for the kinome-wide target spectrum of the drug. Our work highlights the importance of structured water molecules for inhibitor recognition, reveals a new role for the kinase gatekeeper and showcases an effective approach for elucidating the molecular origins of selectivity patterns.	[Levinson, Nicholas M.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Levinson, NM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	nickl@stanford.edu		Levinson, Nicholas/0000-0003-4338-8087; Boxer, Steven/0000-0001-9167-4286	Independence Award [K99/R00, 1K99GM102288-01]; US National Institutes of Health [GM27738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027738, K99GM102288, R01GM027738] Funding Source: NIH RePORTER	Independence Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank N. Jura and P. Littlefield (University of California-San Francisco) for providing purified Her3 and J. Kuriyan and K. Engel (University of CaliforniaBerkeley) for providing purified EGFR. We also thank N. Jura and K. Shokat for critical reading of the manuscript and A. Cohen for help with X-ray crystallography. This work is supported by a K99/R00 Pathway to Independence Award (1K99GM102288-01) to N.M.L. and a long-standing grant from the US National Institutes of Health (GM27738) to S.G.B.	Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Campone M, 2012, ANN ONCOL, V23, P610, DOI 10.1093/annonc/mdr261; Choi JH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2844787; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cortes JE, 2010, J CLIN ONCOL, V28, P487; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davies TG, 2002, NAT STRUCT BIOL, V9, P745, DOI 10.1038/nsb842; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fried SD, 2013, J AM CHEM SOC, V135, P11181, DOI 10.1021/ja403917z; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Liddle J, 2011, BIOORG MED CHEM LETT, V21, P6188, DOI 10.1016/j.bmcl.2011.07.082; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuoka D, 2009, J PHYS CHEM B, V113, P11274, DOI 10.1021/jp902459n; Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6; Park JH, 2012, BIOCHEM J, V448, P417, DOI 10.1042/BJ20121513; Poornima CS, 1995, J COMPUT AID MOL DES, V9, P500, DOI 10.1007/BF00124321; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Reimers JR, 1999, J AM CHEM SOC, V121, P3730, DOI 10.1021/ja983878n; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101	43	107	109	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					127	132		10.1038/NCHEMBIO.1404	http://dx.doi.org/10.1038/NCHEMBIO.1404			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24292070	Green Accepted			2022-12-25	WOS:000330751600011
J	Vitner, EB; Salomon, R; Farfel-Becker, T; Meshcheriakova, A; Ali, M; Klein, AD; Platt, FM; Cox, TM; Futerman, AH				Vitner, Einat B.; Salomon, Ran; Farfel-Becker, Tamar; Meshcheriakova, Anna; Ali, Mohammad; Klein, Andres D.; Platt, Frances M.; Cox, Timothy M.; Futerman, Anthony H.			RIPK3 as a potential therapeutic target for Gaucher's disease	NATURE MEDICINE			English	Article							DOMAIN KINASE RIP; CELL-DEATH; INDUCED INFLAMMATION; NEURONOPATHIC FORMS; MOUSE MODEL; NECROSIS; NECROPTOSIS; APOPTOSIS; RIPOPTOSOME; INHIBITION	Gaucher's disease (GD), an inherited metabolic disorder caused by mutations in the glucocerebrosidase gene (GBA), is the most common lysosomal storage disease(1). Heterozygous mutations in GBA are a major risk factor for Parkinson's disease(2). GD is divided into three clinical subtypes based on the absence (type 1) or presence (types 2 and 3) of neurological signs. Type 1 GD was the first lysosomal storage disease (LSD) for which enzyme therapy became available, and although infusions of recombinant glucocerebrosidase (GCase) ameliorate the systemic effects of GD, the lack of efficacy for the neurological manifestations, along with the considerable expense(3) and inconvenience of enzyme therapy for patients, renders the search for alternative or complementary therapies paramount. Glucosylceramide and glucosylsphingosine accumulation in the brain leads to massive neuronal loss in patients with neuronopathic GD (nGD)(4) and in nGD mouse models(5-7). However, the mode of neuronal death is not known. Here, we show that modulating the receptor-interacting protein kinase-3 (Ripk3) pathway markedly improves neurological and systemic disease in a mouse model of GD. Notably, Ripk3 deficiency substantially improved the clinical course of GD mice, with increased survival and motor coordination and salutary effects on cerebral as well as hepatic injury.	[Vitner, Einat B.; Salomon, Ran; Farfel-Becker, Tamar; Meshcheriakova, Anna; Ali, Mohammad; Klein, Andres D.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Cox, Timothy M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Weizmann Institute of Science; University of Oxford; University of Cambridge	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Bleiberg Vitner, Einat/0000-0001-8578-8551; Futerman, Anthony/0000-0003-0013-0115; KLEIN, ANDRES/0000-0002-9951-2174; Platt, Frances/0000-0001-7614-0403	Children's Gaucher Research Fund; Joseph Meyerhoff family; Royal Society; Medical Research Council [MR/K025570/1, MR/K015338/1] Funding Source: researchfish; MRC [MR/K025570/1, MR/K015338/1] Funding Source: UKRI	Children's Gaucher Research Fund; Joseph Meyerhoff family; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Cachon-Gonzalez (University of Cambridge) for providing twitcher mouse tissue, D. Wallach (Weizmann Institute of Science, Israel) for providing Tnf and Ripk3 knockout mice, R. Schiffmann (Baylor Research Institute) for postmortem human brain tissue, V. Kiss (Weizmann Institute of Science) for help with fluorescence microscopy and N. Platt (University of Oxford) for helpful comments. This work was supported by the Children's Gaucher Research Fund. A.H.F. is the incumbent of an endowed professorial chair supported by the Joseph Meyerhoff family. F.M.P. is a Royal Society Wolfson Research Merit Award holder.	Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cox TM, 2013, AM J HEMATOL, V88, P163, DOI 10.1002/ajh.23399; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farfel-Becker T, 2011, DIS MODEL MECH, V4, P746, DOI 10.1242/dmm.008185; Farfel-Becker T, 2011, HUM MOL GENET, V20, P1375, DOI 10.1093/hmg/ddr019; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Jagtap PG, 2007, J MED CHEM, V50, P1886, DOI 10.1021/jm061016o; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; KANFER JN, 1975, BIOCHEM BIOPH RES CO, V67, P85, DOI 10.1016/0006-291X(75)90286-7; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Silke J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003845; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; SUZUKI K, 1995, MICROSC RES TECHNIQ, V32, P204, DOI 10.1002/jemt.1070320304; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.94	40	122	137	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					204	208		10.1038/nm.3449	http://dx.doi.org/10.1038/nm.3449			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24441827				2022-12-25	WOS:000330915000022
J	Aggarwal, SR				Aggarwal, Saurabh Rob			What's fueling the biotech engine-2012 to 2013	NATURE BIOTECHNOLOGY			English	Article							TRIAL; PRICE	Biologics sales grew at an incredible rate during the past 18 months, especially when compared with pharmaceuticals. But with pressure on pricing and biosimilars looming, how long will it be until biologics' last hurrah?	[Aggarwal, Saurabh Rob] Novel Hlth Strategies LLC, Bethesda, MD 20814 USA; [Aggarwal, Saurabh Rob] Inst Global Policy Res, Washington, DC USA		Aggarwal, SR (corresponding author), Novel Hlth Strategies LLC, Bethesda, MD 20814 USA.	sa2@novelhealthstrategies.com	Plakhotnik, Xenia/L-2185-2016		Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology; American Association of Liver Diseases; American Heart Association; American Society of Hematology; Biotechnology Industry Association	Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology(General Electric); American Association of Liver Diseases; American Heart Association(American Heart Association); American Society of Hematology; Biotechnology Industry Association	The author thanks Novel Health Strategies, the Institute for Global Policy Research, the American Society of Clinical Oncology, the American College of Rheumatology, the American Association of Liver Diseases, American Heart Association, the American Society of Hematology and the Biotechnology Industry Association for providing support for this article.	Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Aggarwal S, 2011, NAT BIOTECHNOL, V29, P1083, DOI 10.1038/nbt.2060; Aggarwal S, 2010, NAT BIOTECHNOL, V28, P1165, DOI 10.1038/nbt1110-1165; Aggarwal S, 2009, NAT BIOTECHNOL, V27, P987, DOI 10.1038/nbt1109-987; Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437; [Anonymous], 2013, NAT BIOTECHNOL, V31, P264; [Anonymous], 2013, NAT BIOTECHNOL, V31, P947; [Anonymous], 2013, ASCO DAILY NEWS 0604; [Anonymous], 2013, NAT BIOTECHNOL, V31, P1; Bach P, 2012, NY TIMES; Fellner Chris, 2012, P T, V37, P503; Fox JL, 2013, NAT BIOTECHNOL, V31, P8, DOI 10.1038/nbt0113-8; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Volovat C., 2013, CLIN BREAST IN PRESS	19	205	216	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					32	39		10.1038/nbt.2794	http://dx.doi.org/10.1038/nbt.2794			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406926				2022-12-25	WOS:000329513000012
J	Mohseni, M; Sun, JL; Lau, A; Curtis, S; Goldsmith, J; Fox, VL; Wei, CJ; Frazier, M; Samson, O; Wong, KK; Kim, C; Camargo, FD				Mohseni, Morvarid; Sun, Jianlong; Lau, Allison; Curtis, Stephen; Goldsmith, Jeffrey; Fox, Victor L.; Wei, Chongjuan; Frazier, Marsha; Samson, Owen; Wong, Kwok-Kim; Kim, Carla; Camargo, Fernando D.			A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PROTEIN; REGULATE CELL-PROLIFERATION; CONTACT INHIBITION; GROWTH-CONTROL; CANCER CELLS; LUNG-CANCER; LKB1; KINASE; POLARITY; INACTIVATION	The Hippo-YAP pathway is an emerging signalling cascade involved in the regulation of stem cell activity and organ size. To identify components of this pathway, we performed an RNAi-based kinome screen in human cells. Our screen identified several kinases not previously associated with Hippo signalling that control multiple cellular processes. One of the hits, LKB1, is a common tumour suppressor whose mechanism of action is only partially understood. We demonstrate that LKB1 acts through its substrates of the microtubule affinity-regulating kinase family to regulate the localization of the polarity determinant Scribble and the activity of the core Hippo kinases. Our data also indicate that YAP is functionally important for the tumour suppressive effects of LKB1. Our results identify a signalling axis that links YAP activation with LKB1 mutations, and have implications for the treatment of LKB1-mutant human malignancies. In addition, our findings provide insight into upstream signals of the Hippo-YAP signalling cascade.	[Mohseni, Morvarid; Sun, Jianlong; Lau, Allison; Curtis, Stephen; Kim, Carla; Camargo, Fernando D.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Mohseni, Morvarid; Sun, Jianlong; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mohseni, Morvarid; Sun, Jianlong; Lau, Allison; Curtis, Stephen; Kim, Carla; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Curtis, Stephen; Kim, Carla] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Goldsmith, Jeffrey] Boston Childrens Hosp, Ctr Pediat Polyposis, Boston, MA 02115 USA; [Fox, Victor L.] Boston Childrens Hosp, Div Gastroenterol & Nutr, Boston, MA 02115 USA; [Wei, Chongjuan; Frazier, Marsha] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Samson, Owen] Canc Res UK, Beatson Inst Canc Res, Wnl Signaling & Colorectal Canc Grp, Glasgow G61 1BD, Lanark, Scotland; [Wong, Kwok-Kim] Harvard Univ, Sch Med, Brigham & Womens Hosp, Genet Div,Dept Med, Boston, MA 02115 USA; [Wong, Kwok-Kim] Dana Farber Harvard Can Ctr, Ludwig Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Texas System; UTMD Anderson Cancer Center; Beatson Institute; Cancer Research UK; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	Fernando.camargo@childrens.harvard.edu		wong, kwok kin/0000-0001-6323-235X; Lau, Allison/0000-0003-4250-7355; camargo, fernando/0000-0002-5630-5909; Sansom, Owen J./0000-0001-9540-3010	Stand Up to Cancer-AACR initiative, NIH [R01 CA131426]; DOD [81XWH-10-1-0724]; NATIONAL CANCER INSTITUTE [R01CA131426, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099559] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for stimulating and insightful discussions by members of the Camargo laboratory. Special thanks to R. Bronson of the Harvard Rodent Facility and R. Mathieu of she Stem Cell Program FACS facility. We are grateful to N. Bardeesy for Lkb1 conditional mice. This study was supported by awards from Stand Up to Cancer-AACR initiative (F.D.C.), NIH grant R01 CA131426 (F.D.C.) and DOD 81XWH-10-1-0724. M.M. is a DOD-CDMRP Postdoctoral Fellow. F.D.C. is a Pew Scholar in the Biomedical Sciences.	Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Doles J, 2010, CANCER RES, V70, P1033, DOI 10.1158/0008-5472.CAN-09-2113; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Nguyen HB, 2013, ONCOGENE, V32, P4100, DOI 10.1038/onc.2012.431; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Parsons LM, 2010, FLY, V4, P288, DOI 10.4161/fly.4.4.13116; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182; Zaric J, 2012, ONCOGENE, V31, P48, DOI 10.1038/onc.2011.218; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou W, 2013, CHIN J CANCER, V32, P427, DOI 10.5732/cjc.013.10086	45	211	219	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					108	+		10.1038/ncb2884	http://dx.doi.org/10.1038/ncb2884			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24362629	Green Accepted			2022-12-25	WOS:000329042000016
J	Campinho, P; Behrndt, M; Ranft, J; Risler, T; Minc, N; Heisenberg, CP				Campinho, Pedro; Behrndt, Martin; Ranft, Jonas; Risler, Thomas; Minc, Nicolas; Heisenberg, Carl-Philipp			Tension-oriented cell divisions limit anisotropic tissue tension in epithelial spreading during zebrafish epiboly	NATURE CELL BIOLOGY			English	Article							EMBRYONIC-TISSUES; ENVELOPING LAYER; MECHANICS; PLANE; SHAPE; ORGANIZATION; STRESS	Epithelial spreading is a common and fundamental aspect of various developmental and disease-related processes such as epithelial closure and wound healing. A key challenge for epithelial tissues undergoing spreading is to increase their surface area without disrupting epithelial integrity. Here we show that orienting cell divisions by tension constitutes an efficient mechanism by which the enveloping cell layer (EVL) releases anisotropic tension while undergoing spreading during zebrafish epiboly. The control of EVL cell-division orientation by tension involves cell elongation and requires myosin II activity to align the mitotic spindle with the main tension axis. We also found that in the absence of tension-oriented cell divisions and in the presence of increased tissue tension, EVL cells undergo ectopic fusions, suggesting that the reduction of tension anisotropy by oriented cell divisions is required to prevent EVL cells from fusing. We conclude that cell-division orientation by tension constitutes a key mechanism for limiting tension anisotropy and thus promoting tissue spreading during EVL epiboly.	[Campinho, Pedro; Behrndt, Martin; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria; [Ranft, Jonas; Risler, Thomas] Inst Curie, Ctr Rech, F-75005 Paris, France; [Ranft, Jonas; Risler, Thomas] Univ Paris 06, UMR 168, F-75005 Paris, France; [Ranft, Jonas; Risler, Thomas] CNRS, UMR 168, F-75005 Paris, France; [Ranft, Jonas] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Minc, Nicolas] CNRS, UMR 7592, Inst Jacques Monod, F-75205 Paris, France	Institute of Science & Technology - Austria; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Heisenberg, CP (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	heisenberg@ist.ac.at	Risler, Thomas/E-6943-2011	Risler, Thomas/0000-0003-1677-4636; Minc, Nicolas/0000-0002-5543-7950; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Ranft, Jonas/0000-0002-7843-7443; Campinho, Pedro/0000-0002-8526-5416	IST Austria; MPI-CBG; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [I930-B20]; Austrian Science Fund (FWF) [I 930] Funding Source: researchfish	IST Austria; MPI-CBG; Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to B. Aiguy, S. Eaton, S. Grill, R. Hauschild and M. Sixt for advice, and the imaging and zebrafish facilities of the IST Austria and MPI-CBG for continuous help. We are particularly grateful to J-F. Joanny for discussions regarding the theory part of this work, and B. Baum for sharing data before publication. This work was supported by the IST Austria, MPI-CBG and a grant from the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) (I930-B20) to C-P.H.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bittig T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063001; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Foty RA, 1996, DEVELOPMENT, V122, P1611; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; KAGEYAMA T, 1982, J EXP ZOOL, V219, P241, DOI 10.1002/jez.1402190213; Kane D, 2002, RES PRO CEL, V40, P117; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; KELLER RE, 1987, DEV BIOL, V120, P12, DOI 10.1016/0012-1606(87)90099-6; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Minc N, 2012, TRENDS CELL BIOL, V22, P193, DOI 10.1016/j.tcb.2012.01.003; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009; Ranft J, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12046-5; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Risler T, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/065011; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; TRINKAUS JP, 1951, J EXP ZOOL, V118, P269, DOI 10.1002/jez.1401180204; TRINKAUS JP, 1984, AM ZOOL, V24, P673; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn	46	163	164	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1405	+		10.1038/ncb2869	http://dx.doi.org/10.1038/ncb2869			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24212092	Green Submitted			2022-12-25	WOS:000327944200005
J	Jain, N; Miu, B; Jiang, JK; McKinstry, KK; Prince, A; Swain, SL; Greiner, DL; Thomas, CJ; Sanderson, MJ; Berg, LJ; Kang, J				Jain, Nitya; Miu, Bing; Jiang, Jian-kang; McKinstry, Kai K.; Prince, Amanda; Swain, Susan L.; Greiner, Dale L.; Thomas, Craig J.; Sanderson, Michael J.; Berg, Leslie J.; Kang, Joonsoo			CD28 and ITK signals regulate autoreactive T cell trafficking	NATURE MEDICINE			English	Article							COSTIMULATORY MOLECULES; B7/CD28 COSTIMULATION; CTLA-4; ACTIVATION; ANTIGEN; MICE; MOUSE; STIMULATION; REQUIREMENT; LYMPHOCYTES	Activation of self-reactive T cells and their trafficking to target tissues leads to autoimmune organ destruction. Mice lacking the co-inhibitory receptor cytotoxic T lymphocyte antigen-4 (CTLA-4) develop fatal autoimmunity characterized by lymphocytic infiltration into nonlymphoid tissues. Here, we demonstrate that the CD28 co-stimulatory pathway regulates the trafficking of self-reactive Ctla4(-/-) T cells to tissues. Concurrent ablation of the CD28-activated Tec family kinase Ilk does not block spontaneous T cell activation but instead causes self-reactive Ctla4(-/-) T cells to accumulate in secondary lymphoid organs. Despite excessive spontaneous T cell activation and proliferation in lymphoid organs, Itk(-/-); Ctla4(-/-) mice are otherwise healthy, mount antiviral immune responses and exhibit a long lifespan. We propose that ITK specifically licenses autoreactive T cells to enter tissues to mount destructive immune responses. Notably, ITK inhibitors mimic the null mutant phenotype and also prevent pancreatic islet infiltration by diabetogenic T cells in mouse models of type 1 diabetes, highlighting their potential utility for the treatment of human autoimmune disorders.	[Jain, Nitya; Miu, Bing; McKinstry, Kai K.; Prince, Amanda; Swain, Susan L.; Berg, Leslie J.; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Jiang, Jian-kang; Thomas, Craig J.] NIH, Chem Genom Ctr, Rockville, MD USA; [Greiner, Dale L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sanderson, Michael J.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kang, J (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	joonsoo.kang@umassmed.edu		Thomas, Craig/0000-0001-9386-9001; kang, joonsoo/0000-0001-8419-7995	US National Institutes of Health (NIH) [AI46629, AI050864, AI046530, AI083505, RC1 DK086474]; Molecular Libraries Initiative; Intramural Research Program of the NIH National Human Genome Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629, R01AI083505, P01AI046530, U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086474, P30DK032520] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Initiative; Intramural Research Program of the NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Huseby, B. Seed and R. Friedline for discussion, S. Turley for advice with stromal cells, T. Hunig (University of Wurzburg) for the SACD28 antibody, M. Coles for assistance with microscopy, M. Krummel for advice on imaging, D. Serreze for studies with diabetogenic CD8<SUP>+</SUP> T cells, E. Huseby (University of Massachusetts Medical School) for MHC class II-deficient Rag1<SUP>-/-</SUP> mice and R. Welsh for the LCMV infection protocol. Core resources supported by the University of Massachusetts Medical School Diabetes Endocrinology Research Center grant DK32520 were used. This work was supported by US National Institutes of Health (NIH) grants to D.L.G. (AI46629, AI050864), S.L.S. (AI046530), L.J.B. (AI083505) and J.K. (RC1 DK086474 and AI083505). US NIH Chemical Genomics Center was supported by the Molecular Libraries Initiative and the Intramural Research Program of the NIH National Human Genome Research Institute.	Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Bachmann MF, 1998, J IMMUNOL, V160, P95; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Goverman J, 1997, CRIT REV IMMUNOL, V17, P469; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Guo WC, 2012, MOL PHARMACOL, V82, P938, DOI 10.1124/mol.112.079889; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Kondo S, 1996, J IMMUNOL, V157, P4822; Kreisel D, 2002, J IMMUNOL, V169, P6154, DOI 10.4049/jimmunol.169.11.6154; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Liu LP, 2005, CURR TOP DEV BIOL, V68, P149, DOI 10.1016/S0070-2153(05)68006-4; Lozanoska-Ochser B, 2008, J IMMUNOL, V181, P6109, DOI 10.4049/jimmunol.181.9.6109; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Marelli-Berg FM, 2007, TRENDS IMMUNOL, V28, P267, DOI 10.1016/j.it.2007.04.008; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Perez VL, 1998, CELL IMMUNOL, V189, P31, DOI 10.1006/cimm.1998.1362; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Riether D, 2009, BIOORG MED CHEM LETT, V19, P1588, DOI 10.1016/j.bmcl.2009.02.012; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanderson MJ, 2011, PULM PHARMACOL THER, V24, P452, DOI 10.1016/j.pupt.2011.05.001; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHIMIZU Y, 1992, J EXP MED, V175, P577, DOI 10.1084/jem.175.2.577; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006	58	31	32	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1632	1637		10.1038/nm.3393	http://dx.doi.org/10.1038/nm.3393			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24270545	Green Accepted			2022-12-25	WOS:000328181400032
J	Pan, X; Liu, J; Nguyen, T; Liu, CY; Sun, JH; Teng, YJ; Fergusson, MM; Rovira, II; Allen, M; Springer, DA; Aponte, AM; Gucek, M; Balaban, RS; Murphy, E; Finkel, T				Pan, Xin; Liu, Jie; Nguyen, Tiffany; Liu, Chengyu; Sun, Junhui; Teng, Yanjie; Fergusson, Maria M.; Rovira, Ilsa I.; Allen, Michele; Springer, Danielle A.; Aponte, Angel M.; Gucek, Marjan; Balaban, Robert S.; Murphy, Elizabeth; Finkel, Toren			The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter	NATURE CELL BIOLOGY			English	Article							PERMEABILITY TRANSITION PORE; RAT KIDNEY MITOCHONDRIA; ESSENTIAL COMPONENT; S-NITROSYLATION; CYCLOSPORINE-A; CA2+ UPTAKE; CELL-DEATH; TRANSPORT; PHOSPHORYLATION; ENERGETICS	Mitochondrial calcium has been postulated to regulate a wide range of processes from bioenergetics to cell death. Here, we characterize a mouse model that lacks expression of the recently discovered mitochondrial calcium uniporter (MCU). Mitochondria derived from MCU-/- mice have no apparent capacity to rapidly uptake calcium. Whereas basal metabolism seems unaffected, the skeletal muscle of MCU-/- mice exhibited alterations in the phosphorylation and activity of pyruvate dehydrogenase. In addition, MCU-/- mice exhibited marked impairment in their ability to perform strenuous work. We further show that mitochondria from MCU-/- mice lacked evidence for calcium-induced permeability transition pore (PIP) opening. The lack of PIP opening does not seem to protect MCU-/- cells and tissues from cell death, although MCU-/- hearts fail to respond to the PIP inhibitor cyclosporin A. Taken together, these results clarify how acute alterations in mitochondrial matrix calcium can regulate mammalian physiology.	[Pan, Xin; Liu, Jie; Teng, Yanjie; Fergusson, Maria M.; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Pan, Xin] Natl Ctr Biomed Anal, Beijing 100850, Peoples R China; [Nguyen, Tiffany; Sun, Junhui; Balaban, Robert S.; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, IPSC, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Genome Engn Core, NIH, Bethesda, MD 20892 USA; [Allen, Michele; Springer, Danielle A.] NHLBI, Murine Phenotyping Core, NIH, Bethesda, MD 20892 USA; [Aponte, Angel M.; Gucek, Marjan] NHLBI, Prote Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Murphy, E (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	murphy1@nih.gov; finkelt@nih.gov	Nguyen, Tiffany/HGD-2431-2022	Pan, Xin/0000-0002-1982-2261	NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZICHL005907, ZIGHL006020, ZIAHL004601, ZIAHL006185, ZICHL006019, ZIAHL002066, ZIGHL006190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to C. Brantner, P. S. Connelly and M. P. Daniels of the NHLBI Electron Microscopy Core Facility for assistance with electron microscopy, C. Petucci of the Metabolomics Core Facility Sanford-Burnham Medical Research Institute for aiding in the metabolomic profiling, C. Combs and the NHLBI Microscopy Core for help with the Rhod-2 fluorescent measurements and A. Wiederkehr for the original mito-aequorin adenovirus. This work was supported by NIH Intramural funds.	Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Blattner JR, 2001, ANAL BIOCHEM, V295, P220, DOI 10.1006/abio.2001.5219; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; CHANCE B, 1965, J BIOL CHEM, V240, P2729; Curry MC, 2013, BIOCHEM BIOPH RES CO, V434, P695, DOI 10.1016/j.bbrc.2013.04.015; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Griffiths EJ, 2000, CELL CALCIUM, V27, P87, DOI 10.1054/ceca.1999.0094; Griffiths EJ, 2009, J MOL CELL CARDIOL, V46, P789, DOI 10.1016/j.yjmcc.2009.03.001; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hochachka PW, 1997, J EXP BIOL, V200, P381; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Lygate CA, 2013, CIRC RES, V112, P945, DOI 10.1161/CIRCRESAHA.112.300725; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wei AC, 2012, J GEN PHYSIOL, V139, P465, DOI 10.1085/jgp.201210784; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015	48	450	457	5	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1464	+		10.1038/ncb2868	http://dx.doi.org/10.1038/ncb2868			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24212091	Green Accepted			2022-12-25	WOS:000327944200011
J	Robinson, DR; Wu, YM; Vats, P; Su, FY; Lonigro, RJ; Cao, XH; Kalyana-Sundaram, S; Wang, R; Ning, Y; Hodges, L; Gursky, A; Siddiqui, J; Tomlins, SA; Roychowdhury, S; Pienta, KJ; Kim, SY; Roberts, JS; Rae, JM; Van Poznak, CH; Hayes, DF; Chugh, R; Kunju, LP; Talpaz, M; Schott, AF; Chinnaiyan, AM				Robinson, Dan R.; Wu, Yi-Mi; Vats, Pankaj; Su, Fengyun; Lonigro, Robert J.; Cao, Xuhong; Kalyana-Sundaram, Shanker; Wang, Rui; Ning, Yu; Hodges, Lynda; Gursky, Amy; Siddiqui, Javed; Tomlins, Scott A.; Roychowdhury, Sameek; Pienta, Kenneth J.; Kim, Scott Y.; Roberts, J. Scott; Rae, James M.; Van Poznak, Catherine H.; Hayes, Daniel F.; Chugh, Rashmi; Kunju, Lakshmi P.; Talpaz, Moshe; Schott, Anne F.; Chinnaiyan, Arul M.			Activating ESR1 mutations in hormone-resistant metastatic breast cancer	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; LIGAND-BINDING; AROMATASE INHIBITION; SOMATIC MUTATION; THERAPY; TAMOXIFEN; GENE; IDENTIFICATION; CONFORMATION; EXPRESSION	Breast cancer is the most prevalent cancer in women, and over two-thirds of cases express estrogen receptor-alpha (ER-alpha, encoded by ESR1). Through a prospective clinical sequencing program for advanced cancers, we enrolled 11 patients with ER-positive metastatic breast cancer. Whole-exome and transcriptome analysis showed that six cases harbored mutations of ESR1 affecting its ligand-binding domain (LBD), all of whom had been treated with anti-estrogens and estrogen deprivation therapies. A survey of The Cancer Genome Atlas (TCGA) identified four endometrial cancers with similar mutations of ESR1. The five new LBD-localized ESR1 mutations identified here (encoding p.Leu536Gln, p.Tyr537Ser, p.Tyr537Cys, p.Tyr537Asn and p.Asp538Gly) were shown to result in constitutive activity and continued responsiveness to antiestrogen therapies in vitro. Taken together, these studies suggest that activating mutations in ESR1 are a key mechanism in acquired endocrine resistance in breast cancer therapy.	[Robinson, Dan R.; Wu, Yi-Mi; Vats, Pankaj; Su, Fengyun; Lonigro, Robert J.; Cao, Xuhong; Kalyana-Sundaram, Shanker; Wang, Rui; Ning, Yu; Hodges, Lynda; Gursky, Amy; Siddiqui, Javed; Tomlins, Scott A.; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Wu, Yi-Mi; Vats, Pankaj; Su, Fengyun; Kalyana-Sundaram, Shanker; Wang, Rui; Ning, Yu; Gursky, Amy; Siddiqui, Javed; Tomlins, Scott A.; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Lonigro, Robert J.; Rae, James M.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Roychowdhury, Sameek] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Baltimore, MD USA; [Kim, Scott Y.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Roberts, J. Scott] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Rae, James M.; Van Poznak, Catherine H.; Hayes, Daniel F.; Chugh, Rashmi; Talpaz, Moshe; Schott, Anne F.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Vats, Pankaj/AAL-1443-2020; Hayes, Daniel/ABE-1129-2020; Schott, Anne/AAD-1902-2019	Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Talpaz, Moshe/0000-0003-3361-3981; Vats, Pankaj/0000-0001-8441-7732	Prostate Cancer Foundation; National Cancer Institute Early Detection Research Network [U01 CA111275]; National Human Genome Research Institute Clinical Sequencing Exploratory Research (CSER) Consortium [1UM1HG006508]; US Department of Defense [W81XWH-12-1-0080]; Department of Defense; Alfred A. Taubman Institute; American Cancer Society; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [U01CA111275] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006508] Funding Source: NIH RePORTER	Prostate Cancer Foundation; National Cancer Institute Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute Clinical Sequencing Exploratory Research (CSER) Consortium; US Department of Defense(United States Department of Defense); Department of Defense(United States Department of Defense); Alfred A. Taubman Institute; American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank D. Miller, T. Barrette and D. Gibbs for hardware and database management, K. Giles for assistance with manuscript preparation, physicians M. Wicha, L. Pierce, D. Smith, K. Levin and F. Feng for referring patients, and C. Betts and J. Athanikar for assistance with tumor boards. We also thank the larger MI-ONCOSEQ team, including clinical research coordinator E. Williams, pathologist R. Mehra, genetic counselors J. Everett, S. Gustafson and V. Raymond, and radiologists E. Higgins, E. Caoili and R. Dunnick. This project is supported in part by the Prostate Cancer Foundation with funding for our sequencing infrastructure, the National Cancer Institute Early Detection Research Network (U01 CA111275), National Human Genome Research Institute Clinical Sequencing Exploratory Research (CSER) Consortium (1UM1HG006508), US Department of Defense contract W81XWH-12-1-0080 and a Department of Defense Era of Hope Scholar Award. A. M. C. is also supported by the Alfred A. Taubman Institute, the American Cancer Society, the Howard Hughes Medical Institute and a Doris Duke Charitable Foundation Clinical Scientist Award.	Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huang HJ, 2002, MOL ENDOCRINOL, V16, P1778, DOI 10.1210/me.2002-0089; Ingle JN, 2006, J CLIN ONCOL, V24, P1052, DOI 10.1200/JCO.2005.04.1053; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Lonning PE, 2013, ENDOCR-RELAT CANCER, V20, pR183, DOI 10.1530/ERC-13-0099; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pearce ST, 2003, J BIOL CHEM, V278, P7630, DOI 10.1074/jbc.M211129200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Skafar DF, 2000, CELL BIOCHEM BIOPHYS, V33, P53, DOI 10.1385/CBB:33:1:53; Sokolosky ML, 2011, ONCOTARGET, V2, P538, DOI 10.18632/oncotarget.302; Swaby RF, 2008, CLIN BREAST CANCER, V8, P124, DOI 10.3816/CBC.2008.n.012; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zhao CQ, 2003, J BIOL CHEM, V278, P27278, DOI 10.1074/jbc.M303840200	40	733	771	6	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1446	U197		10.1038/ng.2823	http://dx.doi.org/10.1038/ng.2823			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24185510	Green Accepted			2022-12-25	WOS:000327715800009
J	Agarwal, V; El Gamal, AA; Yamanaka, K; Poth, D; Kersten, RD; Schorn, M; Allen, EE; Moore, BS				Agarwal, Vinayak; El Gamal, Abrahim A.; Yamanaka, Kazuya; Poth, Dennis; Kersten, Roland D.; Schorn, Michelle; Allen, Eric E.; Moore, Bradley S.			Biosynthesis of polybrominated aromatic organic compounds by marine bacteria	NATURE CHEMICAL BIOLOGY			English	Article							CANDIDA-PARAPSILOSIS CBS604; DIPHENYL ETHERS; ANTIBIOTIC PENTABROMOPSEUDILIN; DEPENDENT MONOOXYGENASE; MASS-SPECTROMETRY; NATURAL-PRODUCTS; IN-VITRO; SP-NOV; IDENTIFICATION; 4-HYDROXYBENZOATE	Polybrominated diphenyl ethers (PBDEs) and polybrominated bipyrroles are natural products that bioaccumulate in the marine food chain. PBDEs have attracted widespread attention because of their persistence in the environment and potential toxicity to humans. However, the natural origins of PBDE biosynthesis are not known. Here we report marine bacteria as producers of PBDEs and establish a genetic and molecular foundation for their production that unifies paradigms for the elaboration of bromophenols and bromopyrroles abundant in marine biota. We provide biochemical evidence of marine brominases revealing decarboxylative-halogenation enzymology previously unknown among halogenating enzymes. Biosynthetic motifs discovered in our study were used to mine sequence databases to discover unrealized marine bacterial producers of organobromine compounds.	[Agarwal, Vinayak; El Gamal, Abrahim A.; Allen, Eric E.; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Oceans & Human Hlth, La Jolla, CA 92093 USA; [Yamanaka, Kazuya; Poth, Dennis; Kersten, Roland D.; Schorn, Michelle; Allen, Eric E.; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Oceans & Human Hlth, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu	schorn, michelle/AAD-6284-2020; Yamanaka, Kazuya/AFQ-2728-2022; Agarwal, Vinayak/L-5688-2017	Yamanaka, Kazuya/0000-0002-6141-697X; Moore, Bradley/0000-0002-4652-1253	US National Science Foundation [OCE-1313747]; US National Institute of Environmental Health Sciences through the Oceans and Human Health program [P01-ES021921]; Gordon and Betty Moore Foundation Marine Microbial Sequencing Project; Helen Hay Whitney Foundation postdoctoral fellowship; US National Institutes of Health (NIH) Marine Biotechnology Training Grant predoctoral fellowship [T32-GM067550]; NIH [S10-RR031562]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550] Funding Source: NIH RePORTER; Division Of Ocean Sciences [1313747] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US National Institute of Environmental Health Sciences through the Oceans and Human Health program; Gordon and Betty Moore Foundation Marine Microbial Sequencing Project; Helen Hay Whitney Foundation postdoctoral fellowship; US National Institutes of Health (NIH) Marine Biotechnology Training Grant predoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank our colleagues E. Frick for preliminary in vitro studies with Bmp6, B.M. Duggan for assistance in NMR data collection, P.A. Jordan for NMR data analysis, Y. Su for MS data collection and L.I. Aluwihare for useful discussions. This work was jointly supported by the US National Science Foundation (OCE-1313747) and the US National Institute of Environmental Health Sciences (P01-ES021921) through the Oceans and Human Health program, the Gordon and Betty Moore Foundation Marine Microbial Sequencing Project, the Helen Hay Whitney Foundation postdoctoral fellowship to V.A., the US National Institutes of Health (NIH) Marine Biotechnology Training Grant predoctoral fellowship to A.A.E. (T32-GM067550) and an NIH instrument grant (S10-RR031562).	Al-Mourabit A, 2011, NAT PROD REP, V28, P1229, DOI 10.1039/c0np00013b; ANDERSEN RJ, 1974, MAR BIOL, V27, P281, DOI 10.1007/BF00394363; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BEISSNER RS, 1981, BIOCHEMISTRY-US, V20, P3724, DOI 10.1021/bi00516a009; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; Brochardt SA, 2001, APPL ENVIRON MICROB, V67, P3174, DOI 10.1128/AEM.67.7.3174-3179.2001; Buedenbender S, 2009, J MOL BIOL, V385, P520, DOI 10.1016/j.jmb.2008.10.057; BURKHOLDER PR, 1966, APPL MICROBIOL, V14, P649, DOI 10.1128/AEM.14.4.649-653.1966; Calcul L, 2009, J NAT PROD, V72, P443, DOI 10.1021/np800737z; Donia MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017897; Dorrestein PC, 2005, P NATL ACAD SCI USA, V102, P13843, DOI 10.1073/pnas.0506964102; Dorrestein PC, 2006, NAT PROD REP, V23, P893, DOI 10.1039/b511400b; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Eppink MHM, 2000, EUR J BIOCHEM, V267, P6832, DOI 10.1046/j.1432-1033.2000.01783.x; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; Feher D, 2010, J NAT PROD, V73, P1963, DOI 10.1021/np100506z; Gaul S, 2011, MAR POLLUT BULL, V62, P2463, DOI 10.1016/j.marpolbul.2011.08.022; Gribble G. W., 2010, NATURALLY OCCURRING, V91; Gribble GJ, 2000, ENVIRON SCI POLLUT R, V7, P37, DOI 10.1065/espr199910.002; Gribble GW, 2012, ALKALOIDS-CHEM BIOL, V71, P1, DOI 10.1016/B978-0-12-398282-7.00001-1; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HANEFELD U, 1994, J ORG CHEM, V59, P3604, DOI 10.1021/jo00092a020; HEWSON WD, 1980, J PHYCOL, V16, P340; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Isnansetyo A, 2003, ANTIMICROB AGENTS CH, V47, P480, DOI 10.1128/AAC.47.2.480-488.2003; John EA, 2004, J NAT PROD, V67, P1929, DOI 10.1021/np0498399; KING GM, 1995, MAR BIOL, V123, P369, DOI 10.1007/BF00353628; Kitamura M, 2005, CHEM LETT, V34, P1272, DOI 10.1246/cl.2005.1272; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; KUNIYOSHI M, 1985, EXPERIENTIA, V41, P523, DOI 10.1007/BF01966182; Li DB, 2009, METHOD ENZYMOL, V458, P487, DOI 10.1016/S0076-6879(09)04819-8; Liu YN, 2013, J GEOPHYS RES-OCEANS, V118, P3950, DOI 10.1002/jgrc.20299; Lofstrand K, 2010, ENVIRON SCI POLLUT R, V17, P1460, DOI 10.1007/s11356-010-0331-1; Lucas-Elio P, 2012, STAND GENOMIC SCI, V6, P63, DOI 10.4056/sigs.2545743; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Malmvarn A, 2008, CHEMOSPHERE, V72, P910, DOI 10.1016/j.chemosphere.2008.03.036; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Marsh G, 2005, ENVIRON SCI TECHNOL, V39, P8684, DOI 10.1021/es051153v; Mas S, 2007, J MASS SPECTROM, V42, P890, DOI 10.1002/jms.1224; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Peschke JD, 2005, BIOSCI BIOTECH BIOCH, V69, P628, DOI 10.1271/bbb.69.628; Ren XM, 2013, ENVIRON SCI-PROC IMP, V15, P702, DOI 10.1039/c3em00023k; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Teuten EL, 2005, SCIENCE, V307, P917, DOI 10.1126/science.1106882; Ucan-Marin F, 2010, ENVIRON SCI TECHNOL, V44, P497, DOI 10.1021/es902691u; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; van Pee KH, 2012, METHOD ENZYMOL, V516, P237, DOI 10.1016/B978-0-12-394291-3.00004-6; Vetter W, 2001, ARCH ENVIRON CON TOX, V41, P221; Vetter W, 2012, ALKALOIDS-CHEM BIOL, V71, P211, DOI 10.1016/B978-0-12-398282-7.00003-5; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wan Y, 2009, ENVIRON SCI TECHNOL, V43, P7536, DOI 10.1021/es901357u; Wiseman SB, 2011, MAR POLLUT BULL, V63, P179, DOI 10.1016/j.marpolbul.2011.02.008	55	190	193	12	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					640	U182		10.1038/nchembio.1564	http://dx.doi.org/10.1038/nchembio.1564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24974229	Green Accepted, Green Submitted			2022-12-25	WOS:000339380100010
J	Lin, DC; Meng, X; Hazawa, M; Nagata, Y; Varela, AM; Xu, L; Sato, Y; Liu, LZ; Ding, LW; Sharma, A; Goh, BC; Lee, SC; Petersson, BF; Yus, FG; Macary, P; Oo, MZ; Ha, CS; Yang, H; Ogawa, S; Loh, KS; Koeffler, HP				Lin, De-Chen; Meng, Xuan; Hazawa, Masaharu; Nagata, Yasunobu; Varela, Ana Maria; Xu, Liang; Sato, Yusuke; Liu, Li-Zhen; Ding, Ling-Wen; Sharma, Arjun; Goh, Boon Cher; Lee, Soo Chin; Petersson, Bengt Fredrik; Yu, Feng Gang; Macary, Paul; Oo, Min Zin; Ha, Chan Soh; Yang, Henry; Ogawa, Seishi; Loh, Kwok Seng; Koeffler, H. Phillip			The genomic landscape of nasopharyngeal carcinoma	NATURE GENETICS			English	Article							HIGH-THROUGHPUT ANNOTATION; INACTIVATING MUTATIONS; TARGETING AUTOPHAGY; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; ARID1A MUTATIONS; P53 GENE; CANCER; REVEALS; MUTAGENESIS	Nasopharyngeal carcinoma (NPC) has extremely skewed ethnic and geographic distributions, is poorly understood at the genetic level and is in need of effective therapeutic approaches. Here we determined the mutational landscape of 128 cases with NPC using whole-exome and targeted deep sequencing, as well as SNP array analysis. These approaches revealed a distinct mutational signature and nine significantly mutated genes, many of which have not been implicated previously in NPC. Notably, integrated analysis showed enrichment of genetic lesions affecting several important cellular processes and pathways, including chromatin modification, ERBB-PI3K signaling and autophagy machinery. Further functional studies suggested the biological relevance of these lesions to the NPC malignant phenotype. In addition, we uncovered a number of new druggable candidates because of their genomic alterations. Together our study provides a molecular basis for a comprehensive understanding of, and exploring new therapies for, NPC.	[Lin, De-Chen; Meng, Xuan; Hazawa, Masaharu; Varela, Ana Maria; Xu, Liang; Liu, Li-Zhen; Ding, Ling-Wen; Sharma, Arjun; Goh, Boon Cher; Lee, Soo Chin; Yang, Henry; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Lin, De-Chen; Koeffler, H. Phillip] Univ Calif Los Angeles, Los Angeles Sch Med, Div Hematol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA USA; [Meng, Xuan] Natl Univ Singapore, Sch Med, Dept Med, Singapore 117548, Singapore; [Nagata, Yasunobu; Sato, Yusuke; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan; [Nagata, Yasunobu; Sato, Yusuke; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Goh, Boon Cher; Lee, Soo Chin] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore; [Petersson, Bengt Fredrik] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Yu, Feng Gang; Loh, Kwok Seng] Natl Univ Singapore Hosp, Dept Otolaryngol, Singapore 117548, Singapore; [Macary, Paul; Oo, Min Zin] Natl Univ Singapore, Dept Immunol, Singapore 117548, Singapore; [Ha, Chan Soh] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Singapore 117548, Singapore	National University of Singapore; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; National University of Singapore; University of Tokyo; Kyoto University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lin, DC (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	dchlin11@gmail.com	HAZAWA, Masaharu/A-6520-2016; Xu, Liang/I-9877-2014; LIN, DECHEN/K-9457-2014; Ding, Ling-Wen/H-6916-2019; SHARMA, ARJUN/U-5920-2019; Lee, Soo Chin/S-9111-2016; Loh, Thomas/GYU-2298-2022; Hazawa, M/AAA-2712-2021; Ogawa, Seishi/AAE-7088-2019	Xu, Liang/0000-0002-2700-4840; Ding, Ling-Wen/0000-0003-0022-1551; Lee, Soo Chin/0000-0002-5835-6419; Sharma, ARJUN/0000-0002-5705-5470; MacAry, Paul/0000-0002-1139-8996	US National Institutes of Health [R01CA026038-35]; National Research Foundation Singapore; Singapore Ministry of Education under the Research Centres of Excellence initiative; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; Terry Fox Foundation International Run Program through Terry Fox Singapore Run; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under the Research Centres of Excellence initiative(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Terry Fox Foundation International Run Program through Terry Fox Singapore Run; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M.-S. Zeng (Sun Yat-sen University Cancer Center), T. Chan (Memorial Sloan-Kettering Cancer Center), Z.J. Zang (National Cancer Centre Singapore) and P. Tan for generously sharing materials as well as relevant facilities. This work is supported by US National Institutes of Health grant R01CA026038-35 (H.P.K.), the National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centres of Excellence initiative (H.P.K.) and the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award to H.P.K. This work is also supported by The Terry Fox Foundation International Run Program through funds raised by the Terry Fox Singapore Run to the National University Cancer Institute, Singapore (NCIS).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; ANDERSSONANVRET M, 1977, INT J CANCER, V20, P486, DOI 10.1002/ijc.2910200403; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carter H, 2010, CANCER BIOL THER, V10, P582, DOI 10.4161/cbt.10.6.12537; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; CHAKRANI F, 1995, INT J CANCER, V61, P316, DOI 10.1002/ijc.2910610307; Chan ASC, 2000, CANCER RES, V60, P5365; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chou CC, 2009, MED ONCOL, V26, P322, DOI 10.1007/s12032-008-9124-5; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Dikshit B, 2013, ONCOGENE, V32, P3798, DOI 10.1038/onc.2012.393; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932; Garber K, 2011, J NATL CANCER I, V103, P708, DOI 10.1093/jnci/djr168; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041055; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Or YYY, 2006, INT J CANCER, V118, P1065, DOI 10.1002/ijc.21444; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Sheu JJC, 2009, CANCER EPIDEM BIOMAR, V18, P2709, DOI 10.1158/1055-9965.EPI-09-0349; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; SUN Y, 1992, P NATL ACAD SCI USA, V89, P6516, DOI 10.1073/pnas.89.14.6516; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wong WC, 2011, BIOINFORMATICS, V27, P2147, DOI 10.1093/bioinformatics/btr357; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1988, CANCER RES, V48, P1954; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	50	234	246	2	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					866	871		10.1038/ng.3006	http://dx.doi.org/10.1038/ng.3006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24952746				2022-12-25	WOS:000339704400015
J	Jex, AR; Nejsum, P; Schwarz, EM; Hu, L; Young, ND; Hall, RS; Korhonen, PK; Liao, SG; Thamsborg, S; Xia, JQ; Xu, PW; Wang, SW; Scheerlinck, JPY; Hofmann, A; Sternberg, PW; Wang, J; Gasser, RB				Jex, Aaron R.; Nejsum, Peter; Schwarz, Erich M.; Hu, Li; Young, Neil D.; Hall, Ross S.; Korhonen, Pasi K.; Liao, Shengguang; Thamsborg, Stig; Xia, Jinquan; Xu, Pengwei; Wang, Shaowei; Scheerlinck, Jean-Pierre Y.; Hofmann, Andreas; Sternberg, Paul W.; Wang, Jun; Gasser, Robin B.			Genome and transcriptome of the porcine whipworm Trichuris suis	NATURE GENETICS			English	Article							NEMATODE STEINERNEMA-CARPOCAPSAE; INFLAMMATORY-BOWEL-DISEASE; DRAFT GENOME; ALLERGIC DISEASES; C-ELEGANS; MURIS; PARASITE; INFECTIONS; AUTOIMMUNE; REACTIVITY	Trichuris (whipworm) infects 1 billion people worldwide and causes a disease (trichuriasis) that results in major socioeconomic losses in both humans and pigs. Trichuriasis relates to an inflammation of the large intestine manifested in bloody diarrhea, and chronic disease can cause malnourishment and stunting in children. Paradoxically, Trichuris of pigs has shown substantial promise as a treatment for human autoimmune disorders, including inflammatory bowel disease (IBD) and multiple sclerosis. Here we report whole-genome sequencing at similar to 140-fold coverage of adult male and female T. suis and similar to 80-Mb draft assemblies. We explore stage-, sex- and tissue-specific transcription of mRNAs and small noncoding RNAs.	[Jex, Aaron R.; Schwarz, Erich M.; Young, Neil D.; Hall, Ross S.; Korhonen, Pasi K.; Scheerlinck, Jean-Pierre Y.; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Nejsum, Peter; Thamsborg, Stig] Univ Copenhagen, Copenhagen, Denmark; [Schwarz, Erich M.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Hu, Li; Liao, Shengguang; Xia, Jinquan; Xu, Pengwei; Wang, Shaowei; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Sternberg, Paul W.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Jawhara Albrahim Ctr Excellence Res Here, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Melbourne; University of Copenhagen; Cornell University; Beijing Genomics Institute (BGI); Griffith University; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong	Jex, AR (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.	ajex@unimelb.edu.au; wangjun@genomics.org.cn; robinbg@unimelb.edu.au	Gasser, Robin/ABH-6185-2020; Jex, Aaron/AGZ-7897-2022; Young, Neil David/AAU-4572-2020; Hofmann, Andreas/B-9515-2008; Hofmann, Andreas/M-9870-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Xu, PengWei/I-5711-2018	Gasser, Robin/0000-0002-4423-1690; Jex, Aaron/0000-0002-1285-7947; Young, Neil David/0000-0001-8756-229X; Hofmann, Andreas/0000-0003-4408-5467; Hofmann, Andreas/0000-0003-4408-5467; Schwarz, Erich/0000-0003-3151-4381; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Korhonen, Pasi/0000-0002-9957-4674; Xu, PengWei/0000-0001-6686-8716; Nejsum, Peter/0000-0002-6673-8505; Scheerlinck, Jean-Pierre/0000-0002-8385-353X; Thamsborg, Stig Milan/0000-0003-3304-7422	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) of Australia; BGI-Shenzhen; Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government [VR0007]; Alexander von Humboldt Foundation; Australian Academy of Science; Australian-American Fulbright Commission; Danish Agency for Science, Technology and Innovation; Cornell University; Howard Hughes Medical Institute (HHMI); US National Institutes of Health (NIH); Melbourne Water Corporation; IBM Research Collaboratory for Life Sciences Melbourne; NHMRC Early Career Research Fellowship	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); BGI-Shenzhen; Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Australian Academy of Science; Australian-American Fulbright Commission; Danish Agency for Science, Technology and Innovation; Cornell University; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melbourne Water Corporation; IBM Research Collaboratory for Life Sciences Melbourne(International Business Machines (IBM)); NHMRC Early Career Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We are indebted to the staff of the BGI-Shenzhen who assisted this study but whose names are not included in the authorship. We also acknowledge the continued contributions of staff at WormBase. This project was funded by the Australian Research Council (ARC), the National Health and Medical Research Council (NHMRC) of Australia and BGI-Shenzhen. This research was supported by a Victorian Life Sciences Computation Initiative (VLSCI) grant number VR0007 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government (A.R.J. and R.B.G.). Other support to R.B.G. from the Alexander von Humboldt Foundation, Australian Academy of Science, the Australian-American Fulbright Commission, Melbourne Water Corporation and the IBM Research Collaboratory for Life Sciences - Melbourne is gratefully acknowledged. RN. was supported by Danish Agency for Science, Technology and Innovation. N.D.Y. holds an NHMRC Early Career Research Fellowship. E.M.S. was supported by startup funds from Cornell University. P.W.S. is an investigator with the Howard Hughes Medical Institute (HHMI) and acknowledges support from the US National Institutes of Health (NIH).	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Balasubramanian N, 2010, PARASITE IMMUNOL, V32, P165, DOI 10.1111/j.1365-3024.2009.01172.x; BEER RJS, 1973, PARASITOLOGY, V67, P253, DOI 10.1017/S0031182000046497; BURROWS RB, 1964, J PARASITOL, V50, P675, DOI 10.2307/3276127; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; COOPER ES, 1992, PARASITOLOGY, V104, pS91, DOI 10.1017/S0031182000075272; Da'dara A, 2011, BLOOD REV, V25, P175, DOI 10.1016/j.blre.2011.04.002; DRAKE L, 1994, P ROY SOC B-BIOL SCI, V257, P255, DOI 10.1098/rspb.1994.0123; DRAKE LJ, 1994, PARASITOLOGY, V109, P623, DOI 10.1017/S0031182000076502; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Golias Ch, 2007, Hippokratia, V11, P124; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hoover-Plow J, 2010, VASC HEALTH RISK MAN, V6, P199; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; Lu ZJ, 2011, GENOME RES, V21, P276, DOI 10.1101/gr.110189.110; MACDONALD TT, 1991, J CLIN PATHOL, V44, P194, DOI 10.1136/jcp.44.3.194; Marceau F, 2008, BRIT J PHARMACOL, V154, P1163, DOI 10.1038/bjp.2008.233; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SHEFFIELD HG, 1963, J PARASITOL, V49, P998, DOI 10.2307/3275740; SPAKULOVA M, 1994, J HELMINTHOL, V68, P67, DOI 10.1017/S0022149X0001350X; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Tilney LG, 2005, J EXP ZOOL PART A, V303A, P927, DOI 10.1002/jez.a.214; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Zigmond E, 2007, GUT, V56, P82, DOI 10.1136/gut.2006.095497; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	44	69	72	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					701	706		10.1038/ng.3012	http://dx.doi.org/10.1038/ng.3012			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24929829	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000338093800010
J	Olson, EJ; Tabor, JJ				Olson, Evan J.; Tabor, Jeffrey J.			Optogenetic characterization methods overcome key challenges in synthetic and systems biology	NATURE CHEMICAL BIOLOGY			English	Article							GENETIC LOGIC GATES; MAP KINASE PATHWAY; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATORS; SIGNALING DYNAMICS; PATTERN-FORMATION; TOGGLE SWITCH; LIVING CELLS; CANCER-CELLS; EXPRESSION	Systems biologists aim to understand how organism-level processes, such as differentiation and multicellular development, are encoded in DNA. Conversely, synthetic biologists aim to program systems-level biological processes, such as engineered tissue growth, by writing artificial DNA sequences. To achieve their goals, these groups have adapted a hierarchical electrical engineering framework that can be applied in the forward direction to design complex biological systems or in the reverse direction to analyze evolved networks. Despite much progress, this framework has been limited by an inability to directly and dynamically characterize biological components in the varied contexts of living cells. Recently, two optogenetic methods for programming custom gene expression and protein localization signals have been developed and used to reveal fundamentally new information about biological components that respond to those signals. This basic dynamic characterization approach will be a major enabling technology in synthetic and systems biology.	[Olson, Evan J.] Rice Univ, Grad Program Appl Phys, Houston, TX USA; [Tabor, Jeffrey J.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Tabor, Jeffrey J.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University; Rice University; Rice University	Tabor, JJ (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	jeff.tabor@rice.edu	Tabor, Jeffrey/A-7022-2008	Tabor, Jeffrey/0000-0001-7316-0361	US National Science Foundation Biotechnology, Biochemical and Biomass Engineering (BBBE) program [EFRI-1137266]; Office of Naval Research (ONR) Multidisciplinary University Research Initiative (MURI) program [N000141310074]; Defense Advanced Research Projects Agency Living Foundries Advanced Tools and Capabilities for Generalizable Platforms (ATCG); ONR Young Investigator Programs	US National Science Foundation Biotechnology, Biochemical and Biomass Engineering (BBBE) program; Office of Naval Research (ONR) Multidisciplinary University Research Initiative (MURI) program; Defense Advanced Research Projects Agency Living Foundries Advanced Tools and Capabilities for Generalizable Platforms (ATCG); ONR Young Investigator Programs	We thank L.A. Hartsough for his comments on the manuscript. E.J.O. and J.J.T. are supported by the US National Science Foundation Biotechnology, Biochemical and Biomass Engineering (BBBE) program (EFRI-1137266) and the Office of Naval Research (ONR) Multidisciplinary University Research Initiative (MURI) program (N000141310074). J.J.T. is supported by the Defense Advanced Research Projects Agency Living Foundries Advanced Tools and Capabilities for Generalizable Platforms (ATCG) and ONR Young Investigator Programs.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, INTRO SYSTEMS BIOL D; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Ang J, 2011, METHOD ENZYMOL, P279, DOI [10.1016/B978-0-12-381270-4.00010-X, 10.1016/S0076-6879(11)87010-2]; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bacchus W, 2012, CURR OPIN BIOTECH, V23, P695, DOI 10.1016/j.copbio.2011.12.004; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bleris L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.49; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cardinale S, 2013, CELL REP, V4, P231, DOI 10.1016/j.celrep.2013.06.023; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gefen O, 2014, P NATL ACAD SCI USA, V111, P556, DOI 10.1073/pnas.1314114111; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Horowitz P., 2015, ART ELECT; Huh JH, 2013, ACS SYNTH BIOL, V2, P418, DOI 10.1021/sb300107h; Hussain F, 2014, P NATL ACAD SCI USA, V111, P972, DOI 10.1073/pnas.1316298111; Jayanthi S, 2013, ACS SYNTH BIOL, V2, P431, DOI 10.1021/sb300098w; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/nmeth.2969, 10.1038/NMETH.2969]; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Moser F, 2012, ACS SYNTH BIOL, V1, P555, DOI 10.1021/sb3000832; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/nmeth.2404, 10.1038/NMETH.2404]; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Pantazes RJ, 2011, CURR OPIN STRUC BIOL, V21, P467, DOI 10.1016/j.sbi.2011.04.005; Pathak GP, 2013, BIOL CELL, V105, P59, DOI 10.1111/boc.201200056; Payne S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.55; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Sasson V, 2012, MOL CELL, V46, P399, DOI 10.1016/j.molcel.2012.04.032; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Smith R, 2014, P NATL ACAD SCI USA, V111, P1969, DOI 10.1073/pnas.1315954111; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tabor JJ, 2008, MOL BIOSYST, V4, P754, DOI 10.1039/b801245h; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Torella JP, 2014, NUCLEIC ACIDS RES, V42, P681, DOI 10.1093/nar/gkt860; Uhlendorf J, 2012, P NATL ACAD SCI USA, V109, P14271, DOI 10.1073/pnas.1206810109; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Weiss R., 2002, NSC 1 1 WORKSH NONS, P54; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Xie Z, 2010, NUCLEIC ACIDS RES, V38, P2692, DOI 10.1093/nar/gkq117; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Zhang HQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4102	95	50	50	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					502	511		10.1038/NCHEMBIO.1559	http://dx.doi.org/10.1038/NCHEMBIO.1559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24937068				2022-12-25	WOS:000337871200007
J	Goo, L; Chohan, V; Nduati, R; Overbaugh, J				Goo, Leslie; Chohan, Vrasha; Nduati, Ruth; Overbaugh, Julie			Early development of broadly neutralizing antibodies in HIV-1-infected infants	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCLONAL-ANTIBODIES; DISEASE PROGRESSION; ENVELOPE VARIANTS; HIV-1; INFECTION; POTENT; SENSITIVITY; SUBTYPE; BREADTH	Eliciting protective neutralizing antibodies (NAbs) against HIV-1 is daunting because of the extensive genetic and antigenic diversity of HIV-1. Moreover, broad and potent responses are uncommon even during persistent infection, with only a subset of adults developing broadly neutralizing antibodies (bNAbs) that recognize viral variants from different HIV-1 clades(1-8). It is not known whether bNAbs can also arise in HIV-1-infected infants, who typically progress to disease faster than adults(9), presumably in part due to an immature immune system(10). Here, we show that bNAbs develop at least as commonly in infants as in adults. Cross-clade NAb responses were detected in 20/28 infected infants, in some cases within 1 year of infection. Among infants with breadth of responses within the top quartile, neutralization of tier 2 or 3 variants from multiple clades was detected at 20 months after infection. These findings suggest that, even in early life, there is sufficient B cell functionality to mount bNAbs against HIV-1. Additionally, the relatively early appearance of bNAbs in infants. may provide a unique setting for understanding the pathways of B cell maturation leading to bNAbs.	[Goo, Leslie; Chohan, Vrasha; Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Goo, Leslie] Univ Washington, Dept Global Hlth, Grad Program Pathobiol, Seattle, WA 98195 USA; [Nduati, Ruth] Univ Nairobi, Dept Pediat, Nairobi, Kenya; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Nairobi; Fred Hutchinson Cancer Center	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	joverbau@fhcrc.org			US National Institutes of Health [AI076105, AI103981]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103981, R01AI076105] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to the participants and staff of the Nairobi Breastfeeding Trial; P. Poignard (International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute) for providing envelope plasmids used for viruses in Supplementary Figure 2; P. Moore (Centre for HIV and Sexually Transmitted Infections, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa) and G. Shaw (Perelman School of Medicine, University of Pennsylvania) for providing 7312-A and 7312-C1 plasmids; X. Wu and J. Mascola (Vaccine Research Center, US National Institutes of Health) for providing RSC3 and RSC3d371I plasmids; N. Doria-Rose, S. O'Dell and J. Mascola (Vaccine Research Center, US National Institutes of Health) for providing JRCSF N160K and N332A plasmids; S. Rainwater and B. Wang for assistance in obtaining viral clade information; V. Cortez for assistance in RSC3 protein purification; C. Milligan for sample database management; G. John-Stewart, I. Georgiev, V. Cortez, D. Lehman, C Milligan and K. Ronen for helpful discussions; and B. Richardson for advice on statistical analyses. This work was supported by US National Institutes of Health grants AI076105 and AI103981.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Blish CA, 2007, AIDS, V21, P693, DOI 10.1097/QAD.0b013e32805e8727; Blish CA, 2009, J VIROL, V83, P7783, DOI 10.1128/JVI.00673-09; CAVACINI LA, 1995, J IMMUNOL, V155, P3638; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Lynch JB, 2011, J VIROL, V85, P5252, DOI 10.1128/JVI.02216-10; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	34	118	122	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					655	658		10.1038/nm.3565	http://dx.doi.org/10.1038/nm.3565			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24859529	Green Accepted			2022-12-25	WOS:000337071000028
J	Guilinger, JP; Thompson, DB; Liu, DR				Guilinger, John P.; Thompson, David B.; Liu, David R.			Fusion of catalytically inactive Cas9 to Fokl nuclease improves the specificity of genome modification	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; DNA-CLEAVAGE; HUMAN-CELLS; TARGET DNA; RNA; CRISPR; NICKASES; PROTEINS; IMMUNITY; REVEALS	Genome editing by Cas9, which cleaves double-stranded DNA at a sequence programmed by a short single-guide RNA (sgRNA), can result in off-target DNA modification that may be detrimental in some applications. To improve DNA cleavage specificity, we generated fusions of catalytically inactive Cas9 and Fokl nuclease (fCas9). DNA cleavage by fCas9 requires association of two fCas9 monomers that simultaneously bind target sites similar to 15 or 25 base pairs apart. In human cells, fCas9 modified target DNA sites with > 140-fold higher specificity than wild-type Cas9 and with an efficiency similar to that of paired Cas9 'nickases', recently engineered variants that cleave only one DNA strand per monomer. The specificity of fCas9 was at least fourfold higher than that of paired nickases at loci with highly similar off-target sites. Target sites that conform to the substrate requirements of fCas9 occur on average every 34 bp in the human genome, suggesting the versatility of this approach for highly specific genome-wide editing.	[Guilinger, John P.; Thompson, David B.; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Guilinger, John P.; Thompson, David B.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022; Wilson, Matthew H/K-3193-2013		Defense Advanced Research Projects Agency [HR0011-11-2-0003, N66001-12-C-4207]; US National Institutes of Health [NIGMS R01 GM095501]; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095501] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.P.G., D.B.T. and D.R.L. were supported by Defense Advanced Research Projects Agency HR0011-11-2-0003 and N66001-12-C-4207, US National Institutes of Health NIGMS R01 GM095501 (D.R.L.) and the Howard Hughes Medical Institute (HHMI). D.R.L. was supported as a HHMI Investigator. We thank R. McDonald for technical assistance and V. Pattanayak for helpful comments.	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	32	582	805	7	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					577	+		10.1038/nbt.2909	http://dx.doi.org/10.1038/nbt.2909			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24770324	Green Accepted			2022-12-25	WOS:000337233800021
J	Pollak, M				Pollak, Michael			Repurposing biguanides to target energy metabolism for cancer treatment	NATURE MEDICINE			English	Editorial Material							METFORMIN		[Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Pollak, Michael] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University	Pollak, M (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	michael.pollak@mcgill.ca		Pollak, Michael/0000-0003-3047-0604				Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483; BIRSOY, NATURE; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Madiraju A. K., 2014, NATURE          0521, DOI [10.1038/nature13270, DOI 10.1038/NATURE13270]; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Pollak M, 2013, CANCER CELL, V23, P263, DOI 10.1016/j.ccr.2013.02.015; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	17	75	77	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					591	593		10.1038/nm.3596	http://dx.doi.org/10.1038/nm.3596			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24901568				2022-12-25	WOS:000337071000019
J	Wang, RX; Yu, CR; Dambuza, IM; Mahdi, RM; Dolinska, MB; Sergeev, YV; Wingfield, PT; Kim, SH; Egwuagu, CE				Wang, Ren-Xi; Yu, Cheng-Rong; Dambuza, Ivy M.; Mahdi, Rashid M.; Dolinska, Monika B.; Sergeev, Yuri V.; Wingfield, Paul T.; Kim, Sung-Hye; Egwuagu, Charles E.			Interleukin-35 induces regulatory B cells that suppress autoimmune disease	NATURE MEDICINE			English	Article							T-CELLS; MICE; EXPRESSION; RESPONSES; CYTOKINE; UVEITIS; IL-35; INFLAMMATION; CONTRIBUTES; POPULATION	Interleukin-10 (IL-10)-producing regulatory B (Bred cells suppress autoimmune disease, and increased numbers of B-reg cells prevent host defense to infection and promote tumor growth and metastasis by converting resting CD4(+) T cells to regulatory T (T-reg) cells. The mechanisms mediating the induction and development of B-reg cells remain unclear. Here we show that IL-35 induces B-reg cells and promotes their conversion to a B-reg subset that produces IL-35 as well as IL-10. Treatment of mice with IL-35 conferred protection from experimental autoimmune uveitis (EAU), and mice lacking IL-35 (p35 knockout (KO) mice) or defective in IL-35 signaling (IL-12R beta 2 KO mice) produced less B-reg cells endogenously or after treatment with IL-35 and developed severe uveitis. Adoptive transfer of B-reg cells induced by recombinant IL-35 suppressed EAU when transferred to mice with established disease, inhibiting pathogenic T helper type 17 (T(H)17) and T(H)1 cells while promoting T-reg cell expansion. In B cells, IL-35 activates STAT1 and STAT3 through the IL-35 receptor comprising the IL-12R beta 2 and IL-27R alpha subunits. As IL-35 also induced the conversion of human B cells into B-reg cells, these findings suggest that IL-35 may be used to induce autologous B-reg and IL-35(+) B-reg cells and treat autoimmune and inflammatory disease.	[Wang, Ren-Xi; Yu, Cheng-Rong; Dambuza, Ivy M.; Mahdi, Rashid M.; Kim, Sung-Hye; Egwuagu, Charles E.] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Dolinska, Monika B.; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Wingfield, Paul T.] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov	Dambuza, Ivy/M-2484-2019; Wang, Renxi/AAM-1326-2020	Yu, Cheng-Rong/0000-0001-7246-0362; Wang, Renxi/0000-0003-4130-3334; Wingfield, Paul/0000-0002-9515-4752	NEI; NIH; NATIONAL EYE INSTITUTE [ZIAEY000476, ZIAEY000262, ZIAEY000372, ZIAEY000350] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Intramural Research Programs of the NEI and NIH provided funding for this research. We thank H. Young (National Cancer Institute, NIH) and R.R. Caspi and C.-C. Chan (NEI, NIH) for critical reading of the manuscript. We also thank C.-C. Chan for expert analyses of Fundus images and histology sections. In addition, we thank A. O'Hara and C.A. Hunter (University of Pennsylvania) for providing IL-27R alpha KO B cells and R. Villasmil (NEI/NIH FLOW Cytometry Core facility) for cell sorting and FACS analysis.	Berthelot JM, 2013, JOINT BONE SPINE, V80, P18, DOI 10.1016/j.jbspin.2012.04.010; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; CASPI RR, 1988, J IMMUNOL, V140, P1490; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Hamaguchi Yasuhito, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P29; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Nussenblatt Robert B, 2002, Int Rev Immunol, V21, P273, DOI 10.1080/08830180212067; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pers JO, 2008, CLIN REV ALLERG IMMU, V34, P50, DOI 10.1007/s12016-007-8015-4; Rafei M, 2009, NAT MED, V15, P1038, DOI 10.1038/nm.2003; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Tarrant TK, 1998, J IMMUNOL, V161, P122; Vasconcellos R, 2011, J IMMUNOL, V187, P3402, DOI 10.4049/jimmunol.1100224; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	36	498	531	7	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					633	641		10.1038/nm.3554	http://dx.doi.org/10.1038/nm.3554			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24743305	Green Accepted			2022-12-25	WOS:000337071000025
J	Haynes, CA; Gonzalez, R				Haynes, Chad A.; Gonzalez, Ramon			Rethinking biologocal activation of methane and conversion to liquid fuels	NATURE CHEMICAL BIOLOGY			English	Article							RIBULOSE MONOPHOSPHATE PATHWAY; ANAEROBIC DEGRADATION; HIGHER ALCOHOLS; MASS-TRANSFER; ETHYLBENZENE; OXIDATION; BIODEGRADATION; METHANOGENESIS; METABOLISM; KINETICS		[Haynes, Chad A.] Booz Allen Hamilton, Washington, DC USA; [Gonzalez, Ramon] United States Dept Energy, Adv Res Projects Agency Energy, Washington, DC USA	Booz Allen Hamilton Holding Corporation	Haynes, CA (corresponding author), Booz Allen Hamilton, Washington, DC USA.	ramon.gonzalez@hq.doe.gov	Gonzalez, Ramon/B-1961-2010					[Anonymous], 2012, ADV TECHN AM TRANSP; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Austin RN, 2011, METALLOMICS, V3, P775, DOI 10.1039/c1mt00048a; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Boden R, 2011, J BACTERIOL, V193, P7001, DOI 10.1128/JB.06267-11; Bogorad IW, 2013, NATURE, V502, P693, DOI 10.1038/nature12575; Boll M., 2010, HDB HYDROCARBON LIPI, P1011, DOI [10.1007/978-3-540-77587-4_71, DOI 10.1007/978-3-540-77587-4_71]; Callaghan AV, 2008, BIOCHEM BIOPH RES CO, V366, P142, DOI 10.1016/j.bbrc.2007.11.094; Callaghan AV, 2010, ENVIRON SCI TECHNOL, V44, P7287, DOI 10.1021/es1002023; Canadian Association of Petroleum Producers, 2013, CRUD OIL FOR MARK TR; Conrado RJ, 2014, SCIENCE, V343, P621, DOI 10.1126/science.1246929; Crowther GJ, 2008, J BACTERIOL, V190, P5057, DOI 10.1128/JB.00228-08; DAVICO GE, 1995, J AM CHEM SOC, V117, P2590, DOI 10.1021/ja00114a023; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Duncan KE, 2009, ENVIRON SCI TECHNOL, V43, P7977, DOI 10.1021/es9013932; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Gaddis ES, 1999, CHEM ENG PROCESS, V38, P503, DOI 10.1016/S0255-2701(99)00046-X; Gieg LM, 2010, ENVIRON MICROBIOL, V12, P3074, DOI 10.1111/j.1462-2920.2010.02282.x; Global Gas Flaring Reduction Partnership, 2012, GGFR PARTN MARK 10 A; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Jang YS, 2013, BIOTECHNOL BIOENG, V110, P1646, DOI 10.1002/bit.24843; Johnson HA, 2001, J BACTERIOL, V183, P4536, DOI 10.1128/JB.183.15.4536-4542.2001; Johnson HA, 1999, J BACTERIOL, V181, P5662, DOI 10.1128/JB.181.18.5662-5668.1999; Kalyuzhnaya MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3785; Kato N, 2006, BIOSCI BIOTECH BIOCH, V70, P10, DOI 10.1271/bbb.70.10; Keil FJ, 2013, NAT CHEM, V5, P91, DOI 10.1038/nchem.1557; Keller MW, 2013, P NATL ACAD SCI USA, V110, P5840, DOI 10.1073/pnas.1222607110; Kniemeyer O, 2003, APPL ENVIRON MICROB, V69, P760, DOI 10.1128/AEM.69.2.760-768.2003; Krishnan MS, 1999, APPL BIOCHEM BIOTECH, V77-9, P373, DOI 10.1385/ABAB:78:1-3:373; Kunapuli U, 2008, ENVIRON MICROBIOL, V10, P1703, DOI 10.1111/j.1462-2920.2008.01588.x; Kung Y, 2009, BIOCHEMISTRY-US, V48, P7432, DOI 10.1021/bi900574h; Lan EI, 2013, BIORESOURCE TECHNOL, V135, P339, DOI 10.1016/j.biortech.2012.09.104; Lee SJ, 2013, NATURE, V494, P380, DOI 10.1038/nature11880; Li J, 2011, BIOCHEM BIOPH RES CO, V406, P621, DOI 10.1016/j.bbrc.2011.02.107; Lin TY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.374918; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Musat F, 2009, ENVIRON MICROBIOL, V11, P209, DOI 10.1111/j.1462-2920.2008.01756.x; National Research Council, 2009, AM EN FUT TECHN TRAN, P211; Oelgeschlager E, 2008, ARCH MICROBIOL, V190, P257, DOI 10.1007/s00203-008-0382-6; Orgill JJ, 2013, BIORESOURCE TECHNOL, V133, P340, DOI 10.1016/j.biortech.2013.01.124; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Schmit TM, 2009, BIOMASS BIOENERG, V33, P1442, DOI 10.1016/j.biombioe.2009.06.010; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SENIOR PJ, 1980, BIOTECHNOL LETT, V2, P205, DOI 10.1007/BF01209434; Shima S, 2012, NATURE, V481, P98, DOI 10.1038/nature10663; Smith SM, 2011, BIOCHEMISTRY-US, V50, P10231, DOI 10.1021/bi200801z; Suenaga H, 2006, BIOSCI BIOTECH BIOCH, V70, P1021, DOI 10.1271/bbb.70.1021; Szaleniec M, 2007, BIOCHEMISTRY-US, V46, P7637, DOI 10.1021/bi700633c; Tijm P. J. A., 2010, GAS LIQUIDS FISCHER; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Ulrich AC, 2005, ENVIRON SCI TECHNOL, V39, P6681, DOI 10.1021/es050294u; United States Energy Information Agency, 2012, ANN EN REV; United States Energy Information Agency, 2013, TECHN REC SHAL OIL S; United States Energy Information Agency, 2012, SHORT TERM EN OUTL; US Environmental Protection Agency, 2012, SUMM REP GLOB ANTHR; Valdes C., 2011, BRAZILS EHANOL IND L, P4; Ye R.W, 2012, METHOD MOL BIOL, V2012, P85	63	194	202	9	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					331	339		10.1038/nchembio.1509	http://dx.doi.org/10.1038/nchembio.1509			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24743257				2022-12-25	WOS:000334672700005
J	Lohr, JG; Adalsteinsson, VA; Cibulskis, K; Choudhury, AD; Rosenberg, M; Cruz-Gordillo, P; Francis, JM; Zhang, CZ; Shalek, AK; Satija, R; Trombetta, JJ; Lu, D; Tallapragada, N; Tahirova, N; Kim, S; Blumenstiel, B; Sougnez, C; Lowe, A; Wong, B; Auclair, D; Van Allen-, EM; Nakabayashi, M; Lis, RT; Lee, GSM; Li, T; Chabot, MS; Taplin, ME; Taplin, ME; Clancy, TE; Loda, M; Regev, A; Meyerson, M; Hahn, WC; Kantoff, PW; Golub, TR; Getz, G; Boehm, JS; Love, JC				Lohr, Jens G.; Adalsteinsson, Viktor A.; Cibulskis, Kristian; Choudhury, Atish D.; Rosenberg, Mara; Cruz-Gordillo, Peter; Francis, Joshua M.; Zhang, Cheng-Zhong; Shalek, Alex K.; Satija, Rahul; Trombetta, John J.; Lu, Diana; Tallapragada, Naren; Tahirova, Narmin; Kim, Sora; Blumenstiel, Brendan; Sougnez, Carrie; Lowe, Alarice; Wong, Bang; Auclair, Daniel; Van Allen-, Eliezer M.; Nakabayashi, Mari; Lis, Rosina T.; Lee, Gwo-Shu M.; Li, Tiantian; Chabot, Matthew S.; Ly, Amy; Taplin, Mary-Ellen; Clancy, Thomas E.; Loda, Massimo; Regev, Aviv; Meyerson, Matthew; Hahn, William C.; Kantoff, Philip W.; Golub, Todd R.; Getz, Gad; Boehm, Jesse S.; Love, J. Christopher			Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer	NATURE BIOTECHNOLOGY			English	Article							COPY-NUMBER; MUTATIONAL LANDSCAPE; RNA-SEQ; HETEROGENEITY; PROGRESSION; EVOLUTION; FRAMEWORK; GENOMICS; SURVIVAL; REVEALS	Comprehensive analyses of cancer genomes promise to inform prognoses and precise cancer treatments. A major barrier, however, is inaccessibility of metastatic tissue. A potential solution is to characterize circulating tumor cells (CTCs), but this requires overcoming the challenges of isolating rare cells and sequencing low-input material. Here we report an integrated process to isolate, qualify and sequence whole exomes of CTCs with high fidelity using a census-based sequencing strategy. Power calculations suggest that mapping of > 99.995% of the standard exome is possible in CTCs. We validated our process in two patients with prostate cancer, including one for whom we sequenced CTCs, a lymph node metastasis and nine cores of the primary tumor. Fifty-one of 73 CTC mutations (70%) were present in matched tissue. Moreover, we identified 10 early trunk and 56 metastatic trunk mutations in the non-CTC tumor samples and found 90% and 73% of these mutations, respectively, in CTC exomes. This study establishes a foundation for CTC genomics in the clinic.	[Lohr, Jens G.; Adalsteinsson, Viktor A.; Cibulskis, Kristian; Choudhury, Atish D.; Rosenberg, Mara; Cruz-Gordillo, Peter; Francis, Joshua M.; Zhang, Cheng-Zhong; Satija, Rahul; Trombetta, John J.; Lu, Diana; Kim, Sora; Blumenstiel, Brendan; Sougnez, Carrie; Wong, Bang; Auclair, Daniel; Van Allen-, Eliezer M.; Loda, Massimo; Regev, Aviv; Meyerson, Matthew; Hahn, William C.; Golub, Todd R.; Getz, Gad; Boehm, Jesse S.; Love, J. Christopher] Eli & Edythe L Broad Inst & Harvard, Cambridge, MA 02142 USA; [Lohr, Jens G.; Choudhury, Atish D.; Francis, Joshua M.; Zhang, Cheng-Zhong; Satija, Rahul; Trombetta, John J.; Lu, Diana; Van Allen-, Eliezer M.; Nakabayashi, Mari; Lis, Rosina T.; Lee, Gwo-Shu M.; Li, Tiantian; Chabot, Matthew S.; Meyerson, Matthew; Hahn, William C.; Kantoff, Philip W.; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lohr, Jens G.; Choudhury, Atish D.; Van Allen-, Eliezer M.; Clancy, Thomas E.; Loda, Massimo; Meyerson, Matthew; Hahn, William C.; Kantoff, Philip W.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Adalsteinsson, Viktor A.; Tallapragada, Naren; Tahirova, Narmin; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Shalek, Alex K.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Lowe, Alarice; Hahn, William C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ly, Amy] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Love, J. Christopher] Ragon Inst MGH & Harvard, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Love, JC (corresponding author), Eli & Edythe L Broad Inst & Harvard, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org; boehm@broadinstitute.org; clove@mit.edu	Cibulskis, Kristian/AAC-7380-2019; Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019; Kim, Sora/D-7707-2015	Shalek, Alex/0000-0001-5670-8778; Kim, Sora/0000-0002-9856-9574; Cruz-Gordillo, Peter/0000-0002-0264-7348; Choudhury, Atish/0000-0001-9344-6631; Boehm, Jesse/0000-0002-6795-6336; Lowe, Alarice/0000-0002-3235-9013; Meyerson, Matthew/0000-0002-9133-8108; Kantoff, Philip/0000-0001-7275-0597; Rosenberg, Mara/0000-0001-6400-3161; Cibulskis, Kristian/0000-0003-1343-1582	Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (DF/HCC SPORE) [5P50CA100707-10]; Wong Family Award; National Science Foundation; Prostate Cancer Foundation Young Investigator Award; Department of Defense Physician Scientist Training Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, P50CA100707, T32CA009172] Funding Source: NIH RePORTER	Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (DF/HCC SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wong Family Award; National Science Foundation(National Science Foundation (NSF)); Prostate Cancer Foundation Young Investigator Award; Department of Defense Physician Scientist Training Award(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	G. L. was supported by a Conquer Cancer Foundation Young Investigator Award, US National Institutes of Health grant 5P50CA100707-10 (DF/HCC SPORE) and the Wong Family Award. V. A. A. was supported in part by a graduate fellowship from the National Science Foundation. A. D. C. is supported by the Prostate Cancer Foundation Young Investigator Award and the Department of Defense Physician Scientist Training Award. J. C. L. is a Camille Dreyfus Teacher-Scholar. We acknowledge the Arthur and Linda Gelb Center for Translational Research for the acquisition and annotation of clinical samples and A. Abbott and A. Van Den Abbeele from the Dana-Farber Cancer Institute (DFCI) Department of Imaging for positron-emission tomography (PET) images. We also acknowledge P. K. Brastianos (Department of Medical Oncology, DFCI) and I. Dunn (Department of Neurosurgery, Brigham and Women's Hospital) for contributing samples for CTC analysis, D. Peck for help with technology development, O. Voznesensky and S. Balk for purification of DNA from the metastatic tumor for sequencing, C. Whittaker and S. S. Levine for advice on sequencing and analysis and the Broad Genomics Platform for the development of new sequencing approaches used here. This work was also supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, and we thank the Koch Institute Swanson Biotechnology Center for technical support, specifically the BioMicroCenter. This work was also supported in part by Janssen Pharmaceuticals, Inc. and the Klarman Family Foundation. We would like to thank Illumina for providing the MagSweeper. The authors dedicate this paper to the memory of Officer Sean Collier, for his caring service to the MIT community and for his sacrifice.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2013, CLIN CANCER RES, V19, P517, DOI 10.1158/1078-0432.CCR-12-1452; Cann GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049144; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El Gammal AT, 2010, CLIN CANCER RES, V16, P56, DOI 10.1158/1078-0432.CCR-09-1423; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Nickerson ML, 2013, HUM MUTAT, V34, P1231, DOI 10.1002/humu.22346; Oh WK, 2006, CLIN GENITOURIN CANC, V5, P61, DOI 10.3816/CGC.2006.n.019; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Ross RW, 2005, CLIN CANCER RES, V11, P8109, DOI 10.1158/1078-0432.CCR-05-1250; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Swennenhuis JF, 2013, GENOME MED, V5, DOI 10.1186/gm510; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	41	407	426	7	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					479	U202		10.1038/nbt.2892	http://dx.doi.org/10.1038/nbt.2892			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752078	Green Accepted, Green Submitted			2022-12-25	WOS:000336036100024
J	Witkowski, L; Carrot-Zhang, J; Albrecht, S; Fahiminiya, S; Hamel, N; Tomiak, E; Grynspan, D; Saloustros, E; Nadaf', J; Rivera, B; Gilpin, C; Castellsague, E; Silva-Smith, R; Plourde, F; Wu, M; Saskin, A; Arseneault, M; Karabakhtsian, RG; Reilly, EA; Ueland, FR; Margiolaki, A; Pavlakis, K; Castellino, SM; Lamovec, J; Mackay, HJ; Roth, LM; Ulbright, TM; Bender, TA; Georgoulias, V; Longy, M; Berchuck, A; Tischkowitz, M; Nage, I; Siebert, R; Stewart, CJR; Arseneau, J; McCluggage, WG; Clarke, BA; Riazalhosseini', Y; Hasselblatt, M; Majewski, J; Foulkes, WD				Witkowski, Leora; Carrot-Zhang, Jian; Albrecht, Steffen; Fahiminiya, Somayyeh; Hamel, Nancy; Tomiak, Eva; Grynspan, David; Saloustros, Emmanouil; Nadaf', Javad; Rivera, Barbara; Gilpin, Catherine; Castellsague, Ester; Silva-Smith, Rachel; Plourde, Francois; Wu, Mona; Saskin, Avi; Arseneault, Madeleine; Karabakhtsian, Rouzan G.; Reilly, Elizabeth A.; Ueland, Frederick R.; Margiolaki, Anna; Pavlakis, Kitty; Castellino, Sharon M.; Lamovec, Janez; Mackay, Helen J.; Roth, Lawrence M.; Ulbright, Thomas M.; Bender, Tracey A.; Georgoulias, Vassilis; Longy, Michel; Berchuck, Andrew; Tischkowitz, Marc; Nage, Inga; Siebert, Reiner; Stewart, Colin J. R.; Arseneau, Jocelyne; McCluggage, W. Glenn; Clarke, Blaise A.; Riazalhosseini, Yasser; Hasselblatt, Martin; Majewski, Jacek; Foulkes, William D.			Germ line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type	NATURE GENETICS			English	Article							BRG1; EXPRESSION; CANCERS; COMPLEXES; NEOPLASMS; GENOME; TUMORS; EXOME; GENE	Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is the most common undifferentiated ovarian malignancy in women under 40 years of age(1). We sequenced the exomes of six individuals from three families with SCCOHT. After discovering segregating deleterious germline mutations in SMARCA4 in all three families, we tested DNA from a fourth affected family, which also carried a segregating SMARCA4 germline mutation. All the familial tumors sequenced harbored either a somatic mutation or loss of the wild-type allele. Immunohistochemical analysis of these cases and additional familial and non-familial cases showed loss of SMARCA4 (BRG1) protein in 38 of 40 tumors overall. Sequencing of cases with available DNA identified at least one germline or somatic deleterious SMARCA4 mutation in 30 01 32 cases. Additionally, the SCCOHT cell line BIN-67 had biallelic deleterious mutations in SMARCA4. Our findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches.	[Witkowski, Leora; Hamel, Nancy; Gilpin, Catherine; Castellsague, Ester; Silva-Smith, Rachel; Plourde, Francois; Wu, Mona; Foulkes, William D.] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Witkowski, Leora; Silva-Smith, Rachel; Plourde, Francois; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Dept Med Genet, Montreal, PQ, Canada; [Witkowski, Leora; Silva-Smith, Rachel; Plourde, Francois; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada; [Witkowski, Leora; Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Rivera, Barbara; Castellsague, Ester; Wu, Mona; Saskin, Avi; Arseneault, Madeleine; Majewski, Jacek; Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Nadaf', Javad; Arseneault, Madeleine; Riazalhosseini, Yasser; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Nadaf', Javad; Arseneault, Madeleine; Riazalhosseini, Yasser; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Dept Med Genet, Montreal, PQ H3H 1P3, Canada; [Tomiak, Eva; Gilpin, Catherine] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON, Canada; [Grynspan, David] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Saloustros, Emmanouil; Margiolaki, Anna; Georgoulias, Vassilis] Univ Hosp Heraklion, Dept Med Oncol, Hereditary Canc Clin, Iraklion, Greece; [Karabakhtsian, Rouzan G.; Reilly, Elizabeth A.; Ueland, Frederick R.] Univ Kentucky, Markey Canc Ctr, Dept Pathol & Lab Med, Lexington, KY USA; [Pavlakis, Kitty] Univ Athens, Dept Pathol, Athens 11528, Greece; [Castellino, Sharon M.] Wake Forest Sch Med, Dept Pediat Hematol Oncol, Winston Salem, NC USA; [Lamovec, Janez] Inst Oncol, Dept Pathol, Ljubljana, Slovenia; [Mackay, Helen J.] Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada; [Roth, Lawrence M.; Ulbright, Thomas M.; Bender, Tracey A.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Longy, Michel] Inst Bergonie, Unite Oncogenet, Bordeaux, France; [Berchuck, Andrew] Duke Univ, Med Ctr, Div Gynecol Oncol, Durham, NC USA; [Tischkowitz, Marc] Univ Cambridge, Dept Med Genet, Cambridge, England; [Nage, Inga; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Nage, Inga; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Stewart, Colin J. R.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Arseneau, Jocelyne] McGill Univ, Royal Victoria Hosp, McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ H3A 1A1, Canada; [McCluggage, W. Glenn] Royal Grp Hosp Trust, Dept Pathol, Belfast, Antrim, North Ireland; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol Lab Med Program, Toronto, ON, Canada; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, Munster, Germany	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University Hospital of Heraklion; University of Kentucky; National & Kapodistrian University of Athens; Wake Forest University; Institute of Oncology - Slovenia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Indiana University System; Indiana University-Purdue University Indianapolis; UNICANCER; Institut Bergonie; Duke University; University of Cambridge; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Western Australia; McGill University; Royal Victoria Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Munster	Foulkes, WD (corresponding author), McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada.	william.foulkes@mcgill.ca	Siebert, Reiner/A-8049-2010; Rivera, Barbara/AFM-6892-2022; Castellsagué, Ester/R-1676-2016; Carrot-Zhang, Jian/K-8618-2019; Rivera, Barbara/AAI-8047-2020; Hamel, Nancy/L-5122-2016; Saloustros, Emmanouil/AAC-8235-2020; Tischkowitz, Marc/O-4452-2018; Foulkes, William D./AAR-9586-2021	Rivera, Barbara/0000-0001-9434-6288; Castellsagué, Ester/0000-0003-1298-9971; Rivera, Barbara/0000-0001-9434-6288; Hamel, Nancy/0000-0001-8971-0428; Saloustros, Emmanouil/0000-0002-0485-0120; Tischkowitz, Marc/0000-0002-7880-0628; Foulkes, William D./0000-0001-7427-4651; Hasselblatt, Martin/0000-0003-2707-8484; Clarke, Blaise/0000-0002-2585-8391	Jewish General Hospital Foundation; Jodi Taiger Lazarus Fund; Fonds de Recherche du Quebec-Sante; KinderKrebsInitiative Buchholz/Holm-Seppensen; Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster [Ha3/016/11]	Jewish General Hospital Foundation; Jodi Taiger Lazarus Fund; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); KinderKrebsInitiative Buchholz/Holm-Seppensen; Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster	This work is dedicated to the memory of Georgia Enter and Latosha Durham. We thank K. Hill and the Small Cell Ovarian Cancer Foundation for help in recruitment to this study, B. Vanderhyden (University of Ottawa) for providing the BIN-67 cells, S. Croce and CS. Choong for aiding in the collection of pathological samples, P.-O. Fiset for help with immunohistochemistry and N. Benlimame, R. Zuhlke-Jenisch, C. Kemming, M. LeiBe, S. Peetz-Dienhart, L. Raestrup, K. Schmidt and C. Theile for technical assistance. N. Jabado, I. Bah and members of the Foulkes laboratory provided helpful discussions. We also thank the McGill University and Genome Quebec Innovation Centre for their cooperation, H. Pierce for her help with contacting family 1 and D. Samelak for her help with family 3. Equipment for immunohistochemistry analysis was made available through Sonderforschungsbereich Transregio (SFB TR) 128 (grant to T. Kuhlmann (Z1)). We received funding from the Jewish General Hospital Foundation and the Jodi Taiger Lazarus Fund (W.D.F.), the Fonds de Recherche du Quebec-Sante (LW), KinderKrebsInitiative Buchholz/Holm-Seppensen (R.S.) and Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster (Ha3/016/11) (M.H.).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brennan B, 2013, LANCET ONCOL, V14, pE329, DOI 10.1016/S1470-2045(13)70088-3; Clement PB, 2005, MODERN PATHOL, V18, pS113, DOI 10.1038/modpathol.3800313; Distelmaier F, 2006, CANCER, V107, P2298, DOI 10.1002/cncr.22213; EICHHORN JH, 1992, AM J SURG PATHOL, V16, P926, DOI 10.1097/00000478-199210000-00002; Estel R, 2011, ARCH GYNECOL OBSTET, V284, P1277, DOI 10.1007/s00404-011-1846-5; Gunduz E, 2005, INT J ONCOL, V26, P201; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; Holley T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050586; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kosho T, 2013, AM J MED GENET A, V161A, P1221, DOI 10.1002/ajmg.a.35933; Kupryjanczyk J, 2013, POL J PATHOL, V64, P238, DOI 10.5114/PJP.2013.39331; LAMOVEC J, 1995, ARCH PATHOL LAB MED, V119, P523; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Longy M, 1996, J MED GENET, V33, P333, DOI 10.1136/jmg.33.4.333; Martinez-Borges AR, 2009, PEDIATR BLOOD CANCER, V53, P1334, DOI 10.1002/pbc.22184; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; McCluggage WG, 2004, ADV ANAT PATHOL, V11, P288, DOI 10.1097/01.pap.0000138146.357376.1e; McCluggage WG, 2004, INT J GYNECOL PATHOL, V23, P330, DOI 10.1097/01.pgp.0000139644.38835.9d; McDonald JM, 2012, J PEDIATR SURG, V47, P588, DOI 10.1016/j.jpedsurg.2011.12.004; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; PECCATORI F, 1993, GYNECOL ONCOL, V49, P95, DOI 10.1006/gyno.1993.1093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; SCULLY RE, 1987, ENVIRON HEALTH PERSP, V73, P15, DOI 10.2307/3430594; Scully RE, 1979, ATLAS TUMOR PATHOLOG; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Smith MJ, 2013, NAT GENET, V45, P295, DOI 10.1038/ng.2552; Smith MJ, 2012, NEUROGENETICS, V13, P141, DOI 10.1007/s10048-012-0319-8; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; ULBRIGHT TM, 1987, HUM PATHOL, V18, P175, DOI 10.1016/S0046-8177(87)80336-2; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Witkowski L, 2013, J PATHOL, V231, P35, DOI 10.1002/path.4225; Wong AKC, 2000, CANCER RES, V60, P6171; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004	38	291	304	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					438	443		10.1038/ng.2931	http://dx.doi.org/10.1038/ng.2931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24658002				2022-12-25	WOS:000335422900008
J	Helsmoortel, C; Vulto-van Silfhout, AT; Coe, BP; Vandeweyer, G; Rooms, L; van den Ende, J; Schuurs-Hoeijmakers, JHM; Marcelis, CL; Willemsen, MH; Vissers, LELM; Yntema, HG; Bakshi, M; Wilson, M; Witherspoon, KT; Malmgren, H; Nordgren, A; Anneren, G; Fichera, M; Bosco, P; Romano, C; de Vries, BBA; Kleefstra, T; Kooy, RF; Eichler, EE; Van der Aa, N				Helsmoortel, Celine; Vulto-van Silfhout, Anneke T.; Coe, Bradley P.; Vandeweyer, Geert; Rooms, Liesbeth; van den Ende, Jenneke; Schuurs-Hoeijmakers, Janneke H. M.; Marcelis, Carlo L.; Willemsen, Marjolein H.; Vissers, Lisenka E. L. M.; Yntema, Helger G.; Bakshi, Madhura; Wilson, Meredith; Witherspoon, Kali T.; Malmgren, Helena; Nordgren, Ann; Anneren, Goran; Fichera, Marco; Bosco, Paolo; Romano, Corrado; de Vries, Bert B. A.; Kleefstra, Tjitske; Kooy, R. Frank; Eichler, Evan E.; Van der Aa, Nathalie			A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP	NATURE GENETICS			English	Article							DEPENDENT NEUROPROTECTIVE PROTEIN; CHROMATIN-REMODELING COMPLEX; GENES; HAPLOINSUFFICIENCY; COMPONENTS; PHENOTYPE; GALAXY; ROLES; NAP	Despite the high heritability of autism spectrum disorders (ASD), characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests or activities(1), a genetic diagnosis can be established in only a minority of patients. Known genetic causes include chromosomal aberrations, such as the duplication of the 15q11-13 region, and monogenic causes, as in Rett and fragile- X syndromes. The genetic heterogeneity within ASD is striking, with even the most frequent causes responsible for only 1% of cases at the most. Even with the recent developments in nextgeneration sequencing, for the large majority of cases no molecular diagnosis can be established(2-7). Here, we report ten patients with ASD and other shared clinical characteristics, including intellectual disability and facial dysmorphisms caused by a mutation in ADNP, a transcription factor involved in the SWI/ SNF remodeling complex. We estimate this gene to be mutated in at least 0.17% of ASD cases, making it one of the most frequent ASD- associated genes known to date.	[Helsmoortel, Celine; Vandeweyer, Geert; Rooms, Liesbeth; Kooy, R. Frank; Van der Aa, Nathalie] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H. M.; Marcelis, Carlo L.; Willemsen, Marjolein H.; Vissers, Lisenka E. L. M.; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Nijmegen Ctr Mol Life Sci,Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Coe, Bradley P.; Witherspoon, Kali T.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Coe, Bradley P.; Witherspoon, Kali T.; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Vandeweyer, Geert] Univ Antwerp, Dept Math & Comp Sci, Biomed Informat Res Ctr Antwerpen Biomina, Edegem, Belgium; [van den Ende, Jenneke; Van der Aa, Nathalie] Univ Antwerp Hosp, Antwerp, Belgium; [Bakshi, Madhura] Westmead Hosp, Dept Med Genet, Sydney, NSW, Australia; [Wilson, Meredith] Childrens Hosp, Dept Clin Genet, Westmead, NSW, Australia; [Malmgren, Helena; Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, Clin Genet Unit, Stockholm, Sweden; [Anneren, Goran] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Fichera, Marco] IRCCS, Assoc Oasi Maria Santissima, Neurol Unit, Troina, Italy; [Fichera, Marco] Univ Catania, Catania, Italy; [Bosco, Paolo] IRCCS, Assoc Oasi Maria Santissima, Lab Cytogenet, Troina, Italy; [Romano, Corrado] IRCCS, Assoc Oasi Maria Santissima, Unit Pediat & Med Genet, Troina, Italy; [de Vries, Bert B. A.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Antwerp; Radboud University Nijmegen; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Antwerp; University of Sydney; University of Sydney; Karolinska Institutet; Uppsala University; IRCCS Oasi Maria SS; University of Catania; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; Radboud University Nijmegen	Van der Aa, N (corresponding author), Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium.	frank.kooy@uantwerpen.be; nathalie.vanderaa@uza.be	Willemsen, Marjolein/R-5958-2019; Kleefstra, Tjitske/G-2619-2012; Yntema, H.G./L-4771-2015; AT, Vulto-van Silfhout/H-4199-2015; Nordgren, Ann C/N-4057-2013; Marcelis, C.L.M./L-4504-2015; Fichera, Marco/K-9220-2016; Kooy, Frank/F-5276-2014; Vissers, Lisenka ELM/A-2598-2015; Nordgren, Ann/AAQ-9142-2021; Coe, Bradley/A-2878-2009; Romano, Corrado/B-9695-2008	Nordgren, Ann C/0000-0003-3285-4281; Marcelis, C.L.M./0000-0001-7095-4641; Fichera, Marco/0000-0002-8225-6880; Kooy, Frank/0000-0003-2024-0485; Vissers, Lisenka ELM/0000-0001-6470-5497; Nordgren, Ann/0000-0003-3285-4281; Romano, Corrado/0000-0003-1049-0683; Helsmoortel, Celine/0000-0001-7180-7707; Coe, Bradley/0000-0001-8471-4016; Vandeweyer, Geert/0000-0002-6262-6522	Belgian National Fund for Scientific Research-Flanders (FWO); University of Antwerp; Dutch Organization for Health Research and Development [917-86-319, 40-00812-98-12109, 907-00-365]; EU-funded GENCODYS project [EU-7th-2010-241995]; Simons Foundation Autism Research Initiative award [SFARI191889EE]; NIH [MH101221]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	Belgian National Fund for Scientific Research-Flanders (FWO)(Fonds de la Recherche Scientifique - FNRSFWO); University of Antwerp; Dutch Organization for Health Research and Development; EU-funded GENCODYS project; Simons Foundation Autism Research Initiative award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the Belgian National Fund for Scientific Research-Flanders (FWO) to G.V. and R.F.K., the Special Research Fund of the University of Antwerp (Bijzonder Onderzoeksfonds (BOF- IWT)) to C.H., by grants from the Dutch Organization for Health Research and Development (917-86-319 and 40-00812-98-12109 to B.B.A. d.V. and 907-00-365 to T.K.), the EU-funded GENCODYS project (EU-7th-2010-241995 to A.T.V.-v.S., B.B.A.d.V. and T.K.), Simons Foundation Autism Research Initiative award (SFARI191889EE to E.E.E.) and NIH (MH101221 to E.E.E.). We acknowledge R. Pettinato and M. Elia for the first enrolling of patients 8 and 9, respectively, and J. Shendure and B. O'Roak for details regarding ADNP molecular inversion probe design. E.E.E. is an investigator of the Howard Hughes Medical Institute.	Aboonq MS, 2012, J MOL NEUROSCI, V46, P33, DOI 10.1007/s12031-011-9562-y; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Choi EY, 2001, EXP CELL RES, V271, P180, DOI 10.1006/excr.2001.5355; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dresner E, 2011, EUR NEUROPSYCHOPHARM, V21, P355, DOI 10.1016/j.euroneuro.2010.06.004; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gozes I, 1997, J NEUROBIOL, V33, P329, DOI 10.1002/(SICI)1097-4695(199709)33:3<329::AID-NEU10>3.0.CO;2-A; Gozes I, 2005, CNS DRUG REV, V11, P353; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kosho T, 2013, AM J MED GENET A, V161A, P1221, DOI 10.1002/ajmg.a.35933; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Mosch K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015894; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandeweyer G, 2012, AM J HUM GENET, V90, P1071, DOI 10.1016/j.ajhg.2012.04.020; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Yang MCW, 2005, AM J RESP CELL MOL, V32, P35, DOI 10.1165/rcmb.2003-0422OC; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	200	205	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					380	+		10.1038/ng.2899	http://dx.doi.org/10.1038/ng.2899			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24531329	Green Accepted			2022-12-25	WOS:000334510100015
J	Karginov, AV; Tsygankov, D; Berginski, M; Chu, PH; Trudeau, ED; Yi, JJ; Gomez, S; Elston, TC; Hahn, KM				Karginov, Andrei V.; Tsygankov, Denis; Berginski, Matthew; Chu, Pei-Hsuan; Trudeau, Evan D.; Yi, Jason J.; Gomez, Shawn; Elston, Timothy C.; Hahn, Klaus M.			Dissecting motility signaling through activation of specific Src-effector complexes	NATURE CHEMICAL BIOLOGY			English	Article							FOCAL ADHESION KINASE; ROUS-SARCOMA-VIRUS; TYROSINE PHOSPHORYLATION; CELL-MIGRATION; MEDIAL AXIS; MEMBRANE; TRANSFORMATION; PP60C-SRC; BINDING; PROTEIN	We describe an approach to selectively activate a kinase in a specific protein complex or at a specific subcellular location within living cells and within minutes. This reveals the effects of specific kinase pathways without time for genetic compensation. The new technique, dubbed rapamycin-regulated targeted activation of pathways (RapRTAP), was used to dissect the role of Src kinase interactions with FAK and p130Cas in cell motility and morphodynamics. The overall effects of Src activation on cell morphology and adhesion dynamics were first quantified, without restricting effector access. Subsets of Src-induced behaviors were then attributed to specific interactions between Src and the two downstream proteins. Activation of Src in the cytoplasm versus at the cell membrane also produced distinct phenotypes. The conserved nature of the kinase site modified for RapRTAP indicates that the technique can be applied to many kinases.	[Karginov, Andrei V.; Tsygankov, Denis; Chu, Pei-Hsuan; Trudeau, Evan D.; Yi, Jason J.; Elston, Timothy C.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Berginski, Matthew] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Gomez, Shawn; Hahn, Klaus M.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Karginov, AV (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60680 USA.	khahn@med.unc.edu	Ramos, Joe W./L-6189-2013; Tsygankov, Denis/L-4672-2019	Ramos, Joe W./0000-0002-9708-2115; Hahn, Klaus/0000-0002-1970-7562; Gomez, Shawn/0000-0002-8251-4552; Yi, Jason/0000-0001-9648-9899; Tsygankov, Denis/0000-0002-1180-3584	US National Institutes of Health [R21CA159179, GM102924, GM094663, GM079271]; NATIONAL CANCER INSTITUTE [R21CA159179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271, R01GM102924, U01GM094663] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Clarke for help with figures and are grateful to the US National Institutes of Health for funding (R21CA159179 to A.V.K., GM102924 and GM094663 to K.M.H. and GM079271 to T.C.E.).	Aichholzer O, 2009, COMPUT AIDED DESIGN, V41, P339, DOI 10.1016/j.cad.2008.08.008; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blum H., 1967, MODELS PERCEPTION SP, P362, DOI DOI 10.1142/S0218654308001154; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; CALOTHY G, 1987, J VIROL, V61, P1678, DOI 10.1128/JVI.61.5.1678-1681.1987; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chin F, 1999, DISCRETE COMPUT GEOM, V21, P405, DOI 10.1007/PL00009429; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; DHAR A, 1991, J BIOL CHEM, V266, P18797; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gustavsson A, 2004, J BIOL CHEM, V279, P22893, DOI 10.1074/jbc.M309693200; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Karginov A. V., 2011, CURR PROT CELL BIOL, V53, P14; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LEE DT, 1982, IEEE T PATTERN ANAL, V4, P363, DOI 10.1109/TPAMI.1982.4767267; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PELLMAN D, 1985, P NATL ACAD SCI USA, V82, P1623, DOI 10.1073/pnas.82.6.1623; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; RESH MD, 1985, J CELL BIOL, V100, P409, DOI 10.1083/jcb.100.2.409; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tsygankov D, 2014, J CELL BIOL, V204, P443, DOI 10.1083/jcb.201306067; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WEERNINK PAO, 1995, J BIOL CHEM, V270, P2264, DOI 10.1074/jbc.270.5.2264; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	34	40	40	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					286	290		10.1038/NCHEMBIO.1477	http://dx.doi.org/10.1038/NCHEMBIO.1477			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24609359	Green Accepted			2022-12-25	WOS:000333172900011
J	Paulson, RF				Paulson, Robert F.			Targeting a new regulator of erythropoiesis to alleviate anemia	NATURE MEDICINE			English	Editorial Material							INEFFECTIVE ERYTHROPOIESIS		Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Paulson, RF (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.	rfp5@psu.edu			NIDDK NIH HHS [R01 DK080040] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dicato M, 2010, CURR OPIN ONCOL, V22, P307, DOI 10.1097/CCO.0b013e32833aa9de; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Shander A, 2011, BRIT J ANAESTH, V107, P41, DOI 10.1093/bja/aer350; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Tanno Toshihiko, 2010, Adv Hematol, V2010, P358283, DOI 10.1155/2010/358283	12	23	26	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					334	335		10.1038/nm.3524	http://dx.doi.org/10.1038/nm.3524			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710373				2022-12-25	WOS:000334361500009
J	Ramkhelawon, B; Hennessy, EJ; Menager, M; Ray, TD; Sheedy, FJ; Hutchison, S; Wanschel, A; Oldebeken, S; Geoffrion, M; Spiro, W; Miller, G; McPherson, R; Rayner, KJ; Moore, KJ				Ramkhelawon, Bhama; Hennessy, Elizabeth J.; Menager, Mickael; Ray, Tathagat Dutta; Sheedy, Frederick J.; Hutchison, Susan; Wanschel, Amarylis; Oldebeken, Scott; Geoffrion, Michele; Spiro, Westley; Miller, George; McPherson, Ruth; Rayner, Katey J.; Moore, Kathryn J.			Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity	NATURE MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; ISCHEMIA-REPERFUSION INJURY; FREE FATTY-ACIDS; WEIGHT-LOSS; ATHEROSCLEROSIS REGRESSION; INFLAMMATORY RESPONSE; PROTECTS KIDNEY; T-CELLS; MICE	During obesity, macrophage accumulation in adipose tissue propagates the chronic inflammation and insulin resistance associated with type 2 diabetes. The factors, however, that regulate the accrual of macrophages in adipose tissue are not well understood. Here we show that the neuroimmune guidance cue netrin-1 is highly expressed in obese but not lean adipose tissue of humans and mice, where it directs the retention of macrophages. Netrin-1, whose expression is induced in macrophages by the saturated fatty acid palmitate, acts via its receptor Unc5b to block their migration. In a mouse model of diet-induced obesity, we show that adipose tissue macrophages exhibit reduced migratory capacity, which can be restored by blocking netrin-1. Furthermore, hematopoietic deletion of Ntn1 facilitates adipose tissue macrophage emigration, reduces inflammation and improves insulin sensitivity. Collectively, these findings identify netrin-1 as a macrophage retention signal in adipose tissue during obesity that promotes chronic inflammation and insulin resistance.	[Ramkhelawon, Bhama; Hennessy, Elizabeth J.; Ray, Tathagat Dutta; Sheedy, Frederick J.; Hutchison, Susan; Wanschel, Amarylis; Oldebeken, Scott; Spiro, Westley; Moore, Kathryn J.] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med,Marc & Ruti Bell Program Vasc Biol & Dis, New York, NY 10003 USA; [Menager, Mickael] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY USA; [Geoffrion, Michele] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Miller, George; McPherson, Ruth; Rayner, Katey J.] NYU, Sch Med, Dept Surg, New York, NY USA	New York University; New York University; University of Ottawa; University of Ottawa Heart Institute; New York University	Moore, KJ (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med,Marc & Ruti Bell Program Vasc Biol & Dis, New York, NY 10003 USA.	kathryn.moore@nyumc.org	Ménager, Mickaël M/L-2334-2017; Wanschel, Amarylis/A-8452-2013; Wanschel, Amarylis/B-3591-2019; Hennessy, Elizabeth/AAJ-4800-2021; Moore, Kathryn/ABE-6416-2020	Wanschel, Amarylis/0000-0001-7307-915X; Wanschel, Amarylis/0000-0002-5603-7983; Hennessy, Elizabeth/0000-0002-1231-5777; Moore, Kathryn/0000-0003-2505-2547; Sheedy, Frederick/0000-0003-2645-8493; Rayner, Katey/0000-0001-6230-426X; Sheedy, Frederick/0000-0002-4722-3135	US National Institutes of Health [RC1HL100815, T32HL098129]; American Heart Association [13POST14490016]; Canadian Institutes of Health Research [MOP-2390941]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098129, RC1HL100815] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this work came from the US National Institutes of Health (RC1HL100815 to K.J.M. and T32HL098129 to E.J.H.), the American Heart Association (13POST14490016 to B.R.) and the Canadian Institutes of Health Research (MOP-2390941 to R.M.).	Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Boden G, 2002, CURR OPIN CLIN NUTR, V5, P545, DOI 10.1097/00075197-200209000-00014; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jung DY, 2013, AM J PHYSIOL-ENDOC M, V304, pE964, DOI 10.1152/ajpendo.00462.2012; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Koppaka S, 2013, DIABETES, V62, P1843, DOI 10.2337/db12-0868; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Salminen M, 2000, DEVELOPMENT, V127, P13; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	61	168	176	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					377	+		10.1038/nm.3467	http://dx.doi.org/10.1038/nm.3467			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24584118	Green Accepted			2022-12-25	WOS:000334361500018
J	Bernet, JD; Doles, JD; Hall, JK; Tanaka, KK; Carter, TA; Olwin, BB				Bernet, Jennifer D.; Doles, Jason D.; Hall, John K.; Tanaka, Kathleen Kelly; Carter, Thomas A.; Olwin, Bradley B.			p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice	NATURE MEDICINE			English	Article							FIBROBLAST GROWTH-FACTORS; SATELLITE CELLS; HEPARAN-SULFATE; MYOBLAST PROLIFERATION; PROGENITOR CELLS; GENE-EXPRESSION; SARCOPENIA; YOUNG; REGENERATION; REQUIREMENT	Skeletal muscle aging results in a gradual loss of skeletal muscle mass, skeletal muscle function and regenerative capacity, which can lead to sarcopenia and increased mortality. Although the mechanisms underlying sarcopenia remain unclear, the skeletal muscle stem cell, or satellite cell, is required for muscle regeneration. Therefore, identification of signaling pathways affecting satellite cell function during aging may provide insights into therapeutic targets for combating sarcopenia. Here, we show that a cell-autonomous loss in self-renewal occurs via alterations in fibroblast growth factor receptor-1, p38 alpha and p38 beta mitogen-activated protein kinase signaling in satellite cells from aged mice. We further demonstrate that pharmacological manipulation of these pathways can ameliorate age-associated self-renewal defects. Thus, our data highlight an age-associated deregulation of a satellite cell homeostatic network and reveal potential therapeutic opportunities for the treatment of progressive muscle wasting.	[Bernet, Jennifer D.; Doles, Jason D.; Hall, John K.; Tanaka, Kathleen Kelly; Carter, Thomas A.; Olwin, Bradley B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Olwin, BB (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	bradley.olwin@colorado.edu	Olwin, Bradley B/A-1333-2014	Carter, Thomas/0000-0001-7081-3259; Doles, Jason/0000-0002-6830-708X; Kelly, Kathleen/0000-0002-1102-6279	US National Institutes of Health [AR49446, AG040074]; Ellison Medical Foundation; National Institutes of Health [T32GM007135]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040074] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Olwin lab members, especially B. Pawlikowski, M. Hall and A. Cadwallader, for revising the manuscript and helpful discussions. We thank T. Vogler, T. McClure and M. Palmer for technical assistance. N. Dalla Betta helped with mouse maintenance. C. English and the University of Colorado Boulder Molecular, Cellular and Developmental Biology Light Microscopy Core provided facilities and assistance. D.M. Spencer developed the inducible FGFR1 construct available from Addgene. This work was supported by grants from the US National Institutes of Health (AR49446 and AG040074) and The Ellison Medical Foundation to B.B.O. and from the National Institutes of Health (T32GM007135) to J.D.B.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brien P, 2013, STEM CELLS, V31, P1597, DOI 10.1002/stem.1399; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Carlson BM, 1996, J GERONTOL A-BIOL, V51, pB43, DOI 10.1093/gerona/51A.1.B43; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Hannon K, 1996, J CELL BIOL, V132, P1151, DOI 10.1083/jcb.132.6.1151; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; Kudla AJ, 1998, J CELL BIOL, V142, P241, DOI 10.1083/jcb.142.1.241; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Marsh DR, 1997, J APPL PHYSIOL, V83, P1270, DOI 10.1152/jappl.1997.83.4.1270; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1995, CELL TISSUE RES, V280, P277; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Roubenoff R, 2000, J Nutr Health Aging, V4, P140; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; SADEH M, 1988, J NEUROL SCI, V87, P67, DOI 10.1016/0022-510X(88)90055-X; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Whitney ML, 2001, J BIOL CHEM, V276, P41191, DOI 10.1074/jbc.M103191200; Williamson KA, 2013, AGING CELL, V12, P139, DOI 10.1111/acel.12031; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	45	343	352	6	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					265	271		10.1038/nm.3465	http://dx.doi.org/10.1038/nm.3465			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24531379	Green Accepted			2022-12-25	WOS:000332595600021
J	Liu, YW; Carlsson, R; Comabella, M; Wang, JY; Kosicki, M; Carrion, B; Hasan, M; Wu, XD; Montalban, X; Dziegiel, MH; Sellebjerg, F; Sorensen, PS; Helin, K; Issazadeh-Navikas, S				Liu, Yawei; Carlsson, Robert; Comabella, Manuel; Wang, JunYang; Kosicki, Michael; Carrion, Belinda; Hasan, Maruf; Wu, Xudong; Montalban, Xavier; Dziegiel, Morten Hanefeld; Sellebjerg, Finn; Sorensen, Per Soelberg; Helin, Kristian; Issazadeh-Navikas, Shohreh			FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REMITTING MULTIPLE-SCLEROSIS; ANTIGEN-PRESENTING CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL SIGNATURE; PD-L1 EXPRESSION; INTERFERON-BETA; IN-VIVO; ACTIVATION; INDUCTION	The defective generation or function of regulatory T (T-reg) cells in autoimmune disease contributes to chronic inflammation and tissue injury. We report the identification of FoxA1 as a transcription factor in T cells that, after ectopic expression, confers suppressive properties in a newly identified T-reg cell population, herein called FoxA1(+) T-reg cells. FoxA1 bound to the Pdl1 promoter, inducing programmed cell death ligand 1 (Pd-I1) expression, which was essential for the FoxA1(+) T-reg cells to kill activated T cells. FoxA1(+) T-reg cells develop primarily in the central nervous system in response to autoimmune inflammation, have a distinct transcriptional profile and are CD4(+)FoxA1(+)CD47(+)CD69(+)PD-L1(h1)FoxP3(-). Adoptive transfer of stable FoxA1(+) T-reg cells inhibited experimental autoimmune encephalomyelitis in a FoxA1-and Pd-I1-dependent manner. The development of FoxA1(+) T-reg cells is induced by interferon-beta (IFN-beta) and requires T cell-intrinsic IFN-alpha/beta receptor (Ifnar) signaling, as the frequency of FoxA1(+) T-reg cells was reduced in Ifnb(-/-) and Ifnar(-/-) mice. In individuals with relapsing-remitting multiple sclerosis, clinical response to treatment with IFN-beta was associated with an increased frequency of suppressive FoxA1(+) T-reg cells in the blood. These findings suggest that FoxA1 is a lineage-specification factor that is induced by IFN-beta and supports the differentiation and suppressive function of FoxA1(+) T-reg cells.	[Liu, Yawei; Carlsson, Robert; Wang, JunYang; Kosicki, Michael; Carrion, Belinda; Hasan, Maruf; Wu, Xudong; Helin, Kristian; Issazadeh-Navikas, Shohreh] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Comabella, Manuel; Montalban, Xavier] Univ Autonoma Barcelona, HUVH, Unitat Neuroimmunol Clin, Ctr Esclerosi Multiple Catalunya CEM Cat, E-08193 Barcelona, Spain; [Dziegiel, Morten Hanefeld] Copenhagen Univ Hosp, Blood Bank, Copenhagen, Denmark; [Sellebjerg, Finn; Sorensen, Per Soelberg] Univ Copenhagen, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Sellebjerg, Finn; Sorensen, Per Soelberg] Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark	University of Copenhagen; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Issazadeh-Navikas, S (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	shohreh.issazadeh@bric.ku.dk	Helin, Kristian/HDM-8306-2022; Wu, Xudong/ABG-3732-2020; Issazadeh-Navikas, Shohreh/AAI-7900-2021; Helin, Kristian/K-2526-2019; Montalban, Xavier/J-5938-2016	Helin, Kristian/0000-0003-1975-6097; Wu, Xudong/0000-0001-9594-479X; Montalban, Xavier/0000-0002-0098-9918; Comabella Lopez, Manuel/0000-0002-2373-6657; Carrion, Belinda/0000-0002-4245-1139; Sorensen, Per Soelberg/0000-0002-2818-3780; Hasan, Maruf/0000-0001-9169-5423; Sellebjerg, Finn/0000-0002-1333-9623; Kosicki, Michael/0000-0001-7173-8852; Dziegiel, Morten Hanefeld/0000-0001-8034-1523; Carlsson, Robert/0000-0001-5955-2916	Lundbeck Foundation in Denmark; Danish Multiple Sclerosis Society; Danish Council for Independent Research-Medical Sciences; Danish Cancer Society; Swedish Research Council-Medicine; Bibi and Nils Jensen Foundation; Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish	Lundbeck Foundation in Denmark; Danish Multiple Sclerosis Society; Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Danish Cancer Society(Danish Cancer Society); Swedish Research Council-Medicine(Swedish Research Council); Bibi and Nils Jensen Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from The Lundbeck Foundation in Denmark, The Danish Multiple Sclerosis Society, The Danish Council for Independent Research-Medical Sciences, The Danish Cancer Society, The Swedish Research Council-Medicine and the Bibi and Nils Jensen Foundation to S.I.-N. We thank H. Wekerle, U. Grohmann and M. Prinz for valuable discussion and suggestions.	Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bach JF, 2003, ANN NY ACAD SCI, V998, P161, DOI 10.1196/annals.1254.017; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kumar V, 1996, J EXP MED, V184, P1609, DOI 10.1084/jem.184.5.1609; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Liu YW, 2013, J NEUROSCI, V33, P14231, DOI 10.1523/JNEUROSCI.5812-12.2013; Liu YW, 2010, IMMUNOL CELL BIOL, V88, P468, DOI 10.1038/icb.2009.111; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Motallebipour M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r129; Nakshatri H, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001008; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Porrini AM, 1998, J NEUROIMMUNOL, V81, P109, DOI 10.1016/S0165-5728(97)00165-3; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; QIAN XB, 1995, MOL CELL BIOL, V15, P1364; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Sundrud MS, 2010, CURR OPIN IMMUNOL, V22, P286, DOI 10.1016/j.coi.2010.03.006; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	53	111	116	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					272	282		10.1038/nm.3485	http://dx.doi.org/10.1038/nm.3485			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24531377				2022-12-25	WOS:000332595600022
J	Motta-Mena, LB; Reade, A; Mallory, MJ; Glantz, S; Weiner, OD; Lynch, KW; Gardner, KH				Motta-Mena, Laura B.; Reade, Anna; Mallory, Michael J.; Glantz, Spencer; Weiner, Orion D.; Lynch, Kristen W.; Gardner, Kevin H.			An optogenetic gene expression system with rapid activation and deactivation kinetics	NATURE CHEMICAL BIOLOGY			English	Article							DNA-BINDING PROTEIN; T-CELLS; SPATIOTEMPORAL CONTROL; STRUCTURAL BASIS; MESSENGER-RNA; LIGHT; TRANSCRIPTION; DOMAIN; IDENTIFICATION; SPECTROSCOPY	Optogenetic gene expression systems can control transcription with spatial and temporal detail unequaled with traditional inducible promoter systems. However, current eukaryotic light-gated transcription systems are limited by toxicity, dynamic range or slow activation and deactivation. Here we present an optogenetic gene expression system that addresses these shortcomings and demonstrate its broad utility. Our approach uses an engineered version of EL222, a bacterial light-oxygen-voltage protein that binds DNA when illuminated with blue light. The system has a large (>100-fold) dynamic range of protein expression, rapid activation (<10 s) and deactivation kinetics (<50 s) and a highly linear response to light. With this system, we achieve light-gated transcription in several mammalian cell lines and intact zebrafish embryos with minimal basal gene activation and toxicity. Our approach provides a powerful new tool for optogenetic control of gene expression in space and time.	[Motta-Mena, Laura B.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Motta-Mena, Laura B.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Reade, Anna; Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Reade, Anna; Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Mallory, Michael J.; Lynch, Kristen W.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Glantz, Spencer] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Gardner, Kevin H.] CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10021 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; City University of New York (CUNY) System	Gardner, KH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	Kevin.Gardner@asrc.cuny.edu	Weiner, Orion D/F-2576-2011; Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Weiner, Orion D/0000-0002-1778-6543; Gardner, Kevin H./0000-0002-8671-2556; Reade, Anna/0000-0002-9989-5486	US National Institutes of Health [R01 GM081875, GM106239, R01 GM103383, R01 GM096164]; Cancer Prevention and Research Institute of Texas [RP130312]; Defense Advanced Research Projects Agency (Living Foundries) [HR0011-12-C-0068]; Robert A. Welch Foundation [I-1424]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106239, R01GM103383, R01GM084040, R01GM096164] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Defense Advanced Research Projects Agency (Living Foundries); Robert A. Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the US National Institutes of Health (R01 GM081875 and GM106239 to K. H. G.; R01 GM103383 to K. W. L.; R01 GM096164 to O.D.W.), Cancer Prevention and Research Institute of Texas (RP130312), Defense Advanced Research Projects Agency (Living Foundries HR0011-12-C-0068 to B. Chow (University of Pennsylvania), supporting S. G.) and the Robert A. Welch Foundation (I-1424 to K. H. G.). K. H. G. is the Virginia Lazenby O'Hara Chair in Biochemistry and W. W. Caruth Scholar in Biomedical Research. A. R. was supported by a National Science Foundation Graduate Research Fellowship. We thank S. L. McKnight and P. R. Potts (both at UT Southwestern Medical Center) for generously providing constructs.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Chen EF, 2007, BIOCHEMISTRY-US, V46, P4619, DOI 10.1021/bi602544n; Christie JM, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P277, DOI 10.1002/352760510X.ch13; Dembowski JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000595; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Krueger M, 2007, GENE, V404, P93, DOI 10.1016/j.gene.2007.09.002; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050738; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Maizel A, 2011, PLANT J, V68, P377, DOI 10.1111/j.1365-313X.2011.04692.x; Mallory MJ, 2011, MOL CELL BIOL, V31, P2184, DOI 10.1128/MCB.05170-11; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Qian XS, 2011, J IMMUNOL, V186, P6454, DOI 10.4049/jimmunol.1002672; Rivera-Cancel G, 2012, BIOCHEMISTRY-US, V51, P10024, DOI 10.1021/bi301306t; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/nchembio.1185, 10.1038/NCHEMBIO.1185]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Swanson B., 2007, PROMEGA CORPORATION, V17, P3; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Weber W, 2007, CURR OPIN BIOTECH, V18, P399, DOI 10.1016/j.copbio.2007.09.002; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a	47	225	233	8	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					196	+		10.1038/NCHEMBIO.1430	http://dx.doi.org/10.1038/NCHEMBIO.1430			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24413462	Green Accepted, Green Submitted			2022-12-25	WOS:000331616900010
J	Zimdahl, B; Ito, T; Blevins, A; Bajaj, J; Konuma, T; Weeks, J; Koechlein, CS; Kwon, HY; Arami, O; Rizzieri, D; Broome, HE; Chuah, C; Oehler, VG; Sasik, R; Hardiman, G; Reya, T				Zimdahl, Bryan; Ito, Takahiro; Blevins, Allen; Bajaj, Jeevisha; Konuma, Takaaki; Weeks, Joi; Koechlein, Claire S.; Kwon, Hyog Young; Arami, Omead; Rizzieri, David; Broome, H. Elizabeth; Chuah, Charles; Oehler, Vivian G.; Sasik, Roman; Hardiman, Gary; Reya, Tannishtha			Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia	NATURE GENETICS			English	Article							DRIVE TRANSGENE EXPRESSION; SELF-RENEWAL; SPINDLE ORIENTATION; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; MURINE MODEL; CANCER; DIFFERENTIATION; PROLIFERATION; SEGREGATION	Cell fate can be controlled through asymmetric division and segregation of protein determinants, but the regulation of this process in the hematopoietic system is poorly understood. Here we show that the dynein-binding protein Lis1 is critically required for hematopoietic stem cell function and leukemogenesis. Conditional deletion of Lis1 (also known as Pafah1b1) in the hematopoietic system led to a severe bloodless phenotype, depletion of the stem cell pool and embryonic lethality. Further, real-time imaging revealed that loss of Lis1 caused defects in spindle positioning and inheritance of cell fate determinants, triggering accelerated differentiation. Finally, deletion of Lis1 blocked the propagation of myeloid leukemia and led to a marked improvement in survival, suggesting that Lis1 is also required for oncogenic growth. These data identify a key role for Lis1 in hematopoietic stem cells and mark its directed control of asymmetric division as a critical regulator of normal and malignant hematopoietic development.	[Zimdahl, Bryan; Ito, Takahiro; Blevins, Allen; Bajaj, Jeevisha; Konuma, Takaaki; Weeks, Joi; Koechlein, Claire S.; Kwon, Hyog Young; Arami, Omead; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Zimdahl, Bryan; Ito, Takahiro; Blevins, Allen; Bajaj, Jeevisha; Konuma, Takaaki; Weeks, Joi; Koechlein, Claire S.; Kwon, Hyog Young; Arami, Omead; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA USA; [Zimdahl, Bryan; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Rizzieri, David] Duke Univ, Med Ctr, Dept Med, Div Cell Therapy, Durham, NC 27710 USA; [Broome, H. Elizabeth] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Broome, H. Elizabeth; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Chuah, Charles] Singapore Gen Hosp, Dept Hematol, Singapore, Singapore; [Chuah, Charles] Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Oehler, Vivian G.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA	University of California System; University of California San Diego; Duke University; Duke University; University of California System; University of California San Diego; University of California System; University of California San Diego; Singapore General Hospital; National University of Singapore; Fred Hutchinson Cancer Center; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University	Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	treya@ucsd.edu	Kwon, Hyog/T-7915-2019; Ito, Takahiro/F-5006-2011	Kwon, Hyog/0000-0003-1663-5118; Ito, Takahiro/0000-0001-7165-0412; Konuma, Takaaki/0000-0002-1953-8463; Hardiman, Gary/0000-0003-4558-0400	US National Institutes of Health (NIH) Cancer Biology Training Grant [T32 CA 59365-18]; NIH Pharmacological Sciences Training Program [T32 GM007752]; California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship; Japanese Society for the Promotion of Science; Leukemia and Lymphoma Society Scholar Award; University of California San Diego Moores Cancer Center National Cancer Institute Core Grant [P30CA23100]; NIH [DK63031, HL097767, DP1 CA174422]; NATIONAL CANCER INSTITUTE [DP1CA174422, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006430] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Cancer Biology Training Grant; NIH Pharmacological Sciences Training Program; California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); University of California San Diego Moores Cancer Center National Cancer Institute Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to B. Hogan, J. Chang, A. Desai, J. Gleeson, J.E. Lee, M.F. Wu, M. Sander and J. Koop for experimental advice and reagents. We would also like to thank M. Kritzik for advice and comments on the manuscript; M. Nakamura for experimental help; M. Cook, L. Matinek, B. Harvat, E. O'Conner and K. Marquez for cell sorting; and W. Pear (University of Pennsylvania) and A.M. Pendergast (Duke University) for the BCR-ABL construct, D.G. Gilliland (University of Pennsylvania) for the NUP98-HOXA9 construct, S. Armstrong (Memorial Sloan-Kettering Cancer Center) for the MLL-AF9 construct, C. Counter (Duke University) for NRAS<SUP>G12V</SUP>, S. Russell (Peter MacCallum Cancer Centre) for the mCherry-alpha-tubulin construct, G. Wahl (Salk Institute) for the H2B-GFP (pEGFPN1) vector and D. Kioussis (Medical Research Council National Institute for Medical Research) for the Vav1-cre transgenic line. B.Z. and C.S.K. received support from US National Institutes of Health (NIH) Cancer Biology Training Grant (T32 CA 59365-18) and NIH Pharmacological Sciences Training Program (T32 GM007752), respectively. T.I. is a recipient of a California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship, and T.K. is supported by a postdoctoral fellowship from the Japanese Society for the Promotion of Science. This work was also supported by a Leukemia and Lymphoma Society Scholar Award, the University of California San Diego Moores Cancer Center National Cancer Institute Core Grant, P30CA23100, as well as by NIH grants DK63031, HL097767 and DP1 CA174422 awarded to T.R.	Almarza E, 2004, EXP HEMATOL, V32, P360, DOI 10.1016/j.exphem.2004.01.005; Arnold B.C., 1992, 1 COURSE ORDER STAT; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Ogilvy S, 1999, BLOOD, V94, P1855; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	55	72	76	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					245	+		10.1038/ng.2889	http://dx.doi.org/10.1038/ng.2889			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24487275	Green Accepted			2022-12-25	WOS:000332036700008
J	Beug, ST; Tang, VA; LaCasse, EC; Cheung, HH; Beauregard, CE; Brun, J; Nuyens, JP; Earl, N; St-Jean, M; Holbrook, J; Dastidar, H; Mahoney, DJ; Ilkow, C; Le Boeuf, F; Bell, JC; Korneluk, RG				Beug, Shawn T.; Tang, Vera A.; LaCasse, Eric C.; Cheung, Herman H.; Beauregard, Caroline E.; Brun, Jan; Nuyens, Jeffrey P.; Earl, Nathalie; St-Jean, Martine; Holbrook, Janelle; Dastidar, Himika; Mahoney, Douglas J.; Ilkow, Carolina; Le Boeuf, Fabrice; Bell, John C.; Korneluk, Robert G.			Smac mimetics and innate immune stimuli synergize to promote tumor death	NATURE BIOTECHNOLOGY			English	Article							NF-KAPPA-B; APOPTOSIS PROTEINS; ONCOLYTIC VIRUSES; VACCINIA VIRUS; IAP ANTAGONIST; CANCER-CELL; ALPHA; RECOGNITION; INTERFERON; INHIBITORS	Smac mimetic compounds (SMC), a class of drugs that sensitize cells to apoptosis by counteracting the activity of inhibitor of apoptosis (IAP) proteins, have proven safe in phase 1 clinical trials in cancer patients. However, because SMCs act by enabling transduction of pro-apoptotic signals, SMC monotherapy may be efficacious only in the subset of patients whose tumors produce large quantities of death-inducing proteins such as inflammatory cytokines. Therefore, we reasoned that SMCs would synergize with agents that stimulate a potent yet safe "cytokine storm." Here we show that oncolytic viruses and adjuvants such as poly(I: C) and CpG induce bystander death of cancer cells treated with SMCs that is mediated by interferon beta (IFN-beta), tumor necrosis factor alpha (TNF-alpha) and/or TNF-related apoptosis-inducing ligand (TRAIL). This combinatorial treatment resulted in tumor regression and extended survival in two mouse models of cancer. As these and other adjuvants have been proven safe in clinical trials, it may be worthwhile to explore their clinical efficacy in combination with SMCs.	[Beug, Shawn T.; Tang, Vera A.; LaCasse, Eric C.; Cheung, Herman H.; Beauregard, Caroline E.; Brun, Jan; Nuyens, Jeffrey P.; Earl, Nathalie; St-Jean, Martine; Holbrook, Janelle; Korneluk, Robert G.] Eastern Ontario Res Inst, Childrens Hosp, Apoptosis Res Ctr, Solange Gauthier Karsh Mol Genet Lab, Ottawa, ON, Canada; [Dastidar, Himika; Mahoney, Douglas J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Ilkow, Carolina; Le Boeuf, Fabrice; Bell, John C.] Ottawa Hosp Res Inst, Ctr Innovat Canc Therapeut, Ottawa, ON, Canada; [Bell, John C.; Korneluk, Robert G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Calgary; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Korneluk, RG (corresponding author), Eastern Ontario Res Inst, Childrens Hosp, Apoptosis Res Ctr, Solange Gauthier Karsh Mol Genet Lab, Ottawa, ON, Canada.	bob@arc.cheo.ca		Ilkow, Carolina/0000-0003-3488-4062	Canadian Institutes of Health Research (CIHR, MOP) [86627]; Ottawa Regional Cancer Foundation (ORCF); Ottawa Kiwanis Medical Foundation; Children's Hospital of Eastern Ontario (CHEO) Foundation; The Lotte & John Hecht Memorial Foundation Innovation Grant of the Canadian Cancer Society; OICR; The Terry Fox Foundation; Alliance for Cancer Gene Therapy (USA); CIHR; Alberta Innovates [201201214] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR, MOP)(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation (ORCF); Ottawa Kiwanis Medical Foundation; Children's Hospital of Eastern Ontario (CHEO) Foundation; The Lotte & John Hecht Memorial Foundation Innovation Grant of the Canadian Cancer Society; OICR; The Terry Fox Foundation; Alliance for Cancer Gene Therapy (USA); CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	We thank D. Porter, B. Firestone, L. Zawel and J.S. Cameron of Novartis for providing LCL161. We thank S. Wang (University of Michigan) for providing SM-122 and SM-164. We thank R. Al-awar and her medicinal chemistry team at the Ontario Institute for Cancer Research (OICR) for providing OICR720. We thank S. Pichette for her assistance with the creation of VSV Delta 51-TNF-alpha. This work is supported by grants awarded to R.G.K. by the Canadian Institutes of Health Research (CIHR, MOP #86627), the Ottawa Regional Cancer Foundation (ORCF), the Ottawa Kiwanis Medical Foundation, the Children's Hospital of Eastern Ontario (CHEO) Foundation, and The Lotte & John Hecht Memorial Foundation Innovation Grant of the Canadian Cancer Society. J.C.B. is supported by OICR and The Terry Fox Foundation. F. L.B. was supported by an industrial fellowship from CIHR. D.J.M. is the recipient of a New Investigator Award from the Alliance for Cancer Gene Therapy (USA). R.G.K. is a Fellow of the Royal Society of Canada and a distinguished professor of the University of Ottawa. We thank D. Stojdl (Children's Hospital of Eastern Ontario Research Institute) for SNB75.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Brun J, 2010, MOL THER, V18, P1440, DOI 10.1038/mt.2010.103; Butowski N, 2009, J NEURO-ONCOL, V91, P175, DOI 10.1007/s11060-008-9693-3; Butowski N, 2009, J NEURO-ONCOL, V91, P183, DOI 10.1007/s11060-008-9705-3; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen KF, 2012, BIOCHEM PHARMACOL, V84, P268, DOI 10.1016/j.bcp.2012.04.023; Cheung HH, 2010, J BIOL CHEM, V285, P40612, DOI 10.1074/jbc.M110.183616; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Dhuria S, 2013, J CLIN PHARMACOL, V53, P642, DOI 10.1002/jcph.79; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Erickson RI, 2013, TOXICOL SCI, V131, P247, DOI 10.1093/toxsci/kfs265; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; LaCasse EC, 2013, CANCER LETT, V332, P215, DOI 10.1016/j.canlet.2012.06.015; Le Boeuf F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2974; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2011, MOL CANCER THER, V10, P902, DOI 10.1158/1535-7163.MCT-10-0864; Lun XQ, 2010, MOL THER, V18, P1927, DOI 10.1038/mt.2010.183; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rosenfeld MR, 2010, NEURO-ONCOLOGY, V12, P1071, DOI 10.1093/neuonc/noq071; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; Vaha-Koskela MJV, 2013, J VIROL, V87, P2363, DOI 10.1128/JVI.01609-12; Vandenabeele P, 2012, NAT REV IMMUNOL, V12, P833, DOI 10.1038/nri3325; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wong H, 2012, TOXICOL SCI, V130, P205, DOI 10.1093/toxsci/kfs235; Yarilina A, 2010, CURR DIR AUTOIMMUN, V11, P94, DOI 10.1159/000289199	47	92	99	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					182	+		10.1038/nbt.2806	http://dx.doi.org/10.1038/nbt.2806			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24463573	Green Accepted			2022-12-25	WOS:000331074000024
J	Chen, WQ; Wang, RW; Chen, BY; Zhong, XW; Kong, HH; Bai, YL; Zhou, Q; Xie, CH; Zhang, JQ; Guo, A; Tian, XX; Jones, PP; O'Mara, ML; Liu, YJ; Mi, T; Zhang, L; Bolstad, J; Semeniuk, L; Cheng, HQ; Zhang, JL; Chen, J; Tieleman, DP; Gillis, AM; Duff, HJ; Fill, M; Song, LS; Chen, SRW				Chen, Wenqian; Wang, Ruiwu; Chen, Biyi; Zhong, Xiaowei; Kong, Huihui; Bai, Yunlong; Zhou, Qiang; Xie, Cuihong; Zhang, Jingqun; Guo, Ang; Tian, Xixi; Jones, Peter P.; O'Mara, Megan L.; Liu, Yingjie; Mi, Tao; Zhang, Lin; Bolstad, Jeff; Semeniuk, Lisa; Cheng, Hongqiang; Zhang, Jianlin; Chen, Ju; Tieleman, D. Peter; Gillis, Anne M.; Duff, Henry J.; Fill, Michael; Song, Long-Sheng; Chen, S. R. Wayne			The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias	NATURE MEDICINE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; RETICULUM CA2+-RELEASE CHANNEL; SPONTANEOUS CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; LUMINAL CA2+; CARDIAC-MUSCLE; SUDDEN-DEATH; CRYSTAL-STRUCTURE; PURKINJE-FIBERS; MOLECULAR-BASIS	Spontaneous Ca2+ release from intracellular stores is important for various physiological and pathological processes. In cardiac muscle cells, spontaneous store overload induced Ca2+ release (SOICR) can result in Ca2+ waves, a major cause of ventricular tachyarrhythmias (VTs) and sudden death. The molecular mechanism underlying SOICR has been a mystery for decades. Here we show that a point mutation, E4872A, in the helix bundle crossing region (the proposed gate) of the cardiac ryanodine receptor (RyR2) completely abolishes luminal, but not cytosolic, Ca2+ activation of RyR2. The introduction of metal-binding histidines at this site converts RyR2 into a lumina! Ni2+-gated channel. Mouse hearts harboring a heterozygous RyR2 mutation at this site (E4872Q) are resistant to SOICR and are completely protected against Ca2+-triggered VTs. These data show that the RyR2 gate directly senses lumina! (store) Ca2+, explaining the regulation of RyR2 by luminal Ca2+, the initiation of Ca2+ waves and Ca2+-triggered arrhythmias. This newly identified store-sensing gate structure is conserved in all RyR and inositol 1,4,5-trisphosphate receptor isoforms.	[Chen, Wenqian; Wang, Ruiwu; Zhong, Xiaowei; Kong, Huihui; Bai, Yunlong; Zhou, Qiang; Xie, Cuihong; Tian, Xixi; Jones, Peter P.; Liu, Yingjie; Mi, Tao; Zhang, Lin; Bolstad, Jeff; Semeniuk, Lisa; Gillis, Anne M.; Duff, Henry J.; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Chen, Biyi; Guo, Ang; Song, Long-Sheng] Univ Iowa, Dept Internal Med, Carver Coll Med, Di Cardiovasc Med, Iowa City, IA 52242 USA; [Zhang, Jingqun; Fill, Michael; Chen, S. R. Wayne] Rush Univ, Dept Mol Biophys & Physiol, Med Ctr, Chicago, IL 60612 USA; [O'Mara, Megan L.; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [O'Mara, Megan L.; Tieleman, D. Peter] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Cheng, Hongqiang; Zhang, Jianlin; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Iowa; Rush University; University of Calgary; University of Calgary; University of California System; University of California San Diego	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	swchen@ucalgary.ca	Chen, Ju/E-5579-2011; Tieleman, D. Peter/A-4790-2011; O'Mara, Megan/ABF-8913-2020; Jones, Peter P/G-2618-2013; Chen, Biyi/AAF-3077-2021; O'Mara, Megan/AAY-5934-2021; O'Mara, Megan L/A-4962-2011; Guo, Ang/M-3549-2013	Tieleman, D. Peter/0000-0001-5507-0688; O'Mara, Megan/0000-0002-8764-1585; O'Mara, Megan L/0000-0002-8764-1585; Song, Long-Sheng/0000-0002-6035-8106; Jones, Pete/0000-0001-7977-1737; Guo, Ang/0000-0002-5551-2279; Cheng, Hongqiang/0000-0001-9662-1570	Canadian Institutes of Health Research (CIHR); US National Institutes of Health; Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; AIHS; Heart and Stroke Foundation; CIHR; AIHS Scientist Awards; Alberta Innovates [201400104, 201001238] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905, R01HL066100, R01HL082902, R01HL106968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111397] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; AIHS; Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS Scientist Awards; Alberta Innovates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR) to H.J.D., D.P.T. and S.R.W.C., the US National Institutes of Health to J.C., L.-S.S., M.F. and S.R.W.C., the Heart and Stroke Foundation of Alberta to A.M.G., H.J.D. and S.R.W.C. and the Canada Foundation for Innovation (S.R.W.C.) and by the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (S.R.W.C.). We are grateful for generous donations from the King family, the Howarth family and the Libin Cardiovascular Institute of Alberta. We are also grateful to W.C. Claycomb from the Louisiana State University Health Sciences Center for kindly providing the HL-1 cardiac cell line and to J. Lytton from the University of Calgary for the gift of the beta-actin-specific antibody. W.C., X.Z. and X.T. are recipients of the Alberta Innovates-Health Solutions (AIHS) Studentship Award; P.P.J. is a recipient of AIHS and Heart and Stroke Foundation Fellowship Awards; M.L.O. is the recipient of a CIHR Fellowship Award; and H.J.D., D.P.T. and S.R.W.C. are recipients of AIHS Scientist Awards.	BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Dabertrand F, 2008, CELL CALCIUM, V44, P180, DOI 10.1016/j.ceca.2007.11.009; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eisner DA, 2009, CIRC J, V73, P1561, DOI 10.1253/circj.CJ-09-0478; FABIATO A, 1992, ADV EXP MED BIOL, V311, P245; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; KASS RS, 1982, BIOPHYS J, V38, P259, DOI 10.1016/S0006-3495(82)84557-8; Keller M, 2007, CARDIOVASC RES, V74, P39, DOI 10.1016/j.cardiores.2007.02.006; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Liu YW, 2010, J GEN PHYSIOL, V135, P15, DOI 10.1085/jgp.200910273; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MITCHELL RD, 1984, J BIOL CHEM, V259, P1073; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NUNN DL, 1992, MOL PHARMACOL, V41, P115; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Sedej S, 2010, CARDIOVASC RES, V87, P50, DOI 10.1093/cvr/cvq007; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; SITSAPESAN R, 1995, J MEMBRANE BIOL, V146, P133, DOI 10.1007/BF00238004; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; STERN MD, 1983, J GEN PHYSIOL, V82, P119, DOI 10.1085/jgp.82.1.119; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; WIER WG, 1983, P NATL ACAD SCI-BIOL, V80, P7367, DOI 10.1073/pnas.80.23.7367; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 1998, BIOPHYS J, V75, P2302, DOI 10.1016/S0006-3495(98)77674-X; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou JS, 2004, J GEN PHYSIOL, V124, P409, DOI 10.1085/jgp.200409105; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	58	130	132	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					184	192		10.1038/nm.3440	http://dx.doi.org/10.1038/nm.3440			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24441828	Green Accepted			2022-12-25	WOS:000330915000020
J	Kim, HJ; Raphael, AR; LaDow, ES; McGurk, L; Weber, RA; Trojanowski, JQ; Lee, VMY; Finkbeiner, S; Gitler, AD; Bonini, NM				Kim, Hyung-Jun; Raphael, Alya R.; LaDow, Eva S.; McGurk, Leeanne; Weber, Ross A.; Trojanowski, John Q.; Lee, Virginia M-Y; Finkbeiner, Steven; Gitler, Aaron D.; Bonini, Nancy M.			Therapeutic modulation of eIF2 alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models	NATURE GENETICS			English	Article							TARGETED GENE-EXPRESSION; STRESS GRANULE FORMATION; DNA-BINDING PROTEIN; PRION-LIKE DOMAINS; ALPHA-SYNUCLEIN; MOLECULAR DETERMINANTS; ENDOGENOUS TDP-43; DROSOPHILA MODEL; 43 KDA; RNA	Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset neurodegenerative disease primarily affecting motor neurons. A unifying feature of many proteins associated with ALS, including TDP-43 and ataxin-2, is that they localize to stress granules. Unexpectedly, we found that genes that modulate stress granules are strong modifiers of TDP-43 toxicity in Saccharomyces cerevisiae and Drosophila melanogaster. eIF2 alpha phosphorylation is upregulated by TDP-43 toxicity in flies, and TDP-43 interacts with a central stress granule component, polyA-binding protein (PABP). In human ALS spinal cord neurons, PABP accumulates abnormally, suggesting that prolonged stress granule dysfunction may contribute to pathogenesis. We investigated the efficacy of a small molecule inhibitor of eIF2 alpha phosphorylation in ALS models. Treatment with this inhibitor mitigated TDP-43 toxicity in flies and mammalian neurons. These findings indicate that the dysfunction induced by prolonged stress granule formation might contribute directly to ALS and that compounds that mitigate this process may represent a novel therapeutic approach.	[Kim, Hyung-Jun; McGurk, Leeanne; Weber, Ross A.; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Raphael, Alya R.; Gitler, Aaron D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [LaDow, Eva S.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Trojanowski, John Q.; Lee, Virginia M-Y] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	University of Pennsylvania; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Pennsylvania; Pennsylvania Medicine	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu	McGurk, Leeanne/L-6734-2019	McGurk, Leeanne/0000-0002-6493-6751; Gitler, Aaron/0000-0001-8603-1526	Howard Hughes Medical Institute; US National Institutes of Health [R01NS073660]; NIH Director's New Innovator [DP2OD004417]; US NIH grant [R01NS065317, AG10124, AG32953, AG17586, NS53488]; Robert Packard Center for ALS and the Williams H. Adams Foundation; Target ALS; BrightFocus Alzheimer's disease research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488, R01NS039074, R01NS073660, R01NS065317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032953, P30AG010124, P01AG017586] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS and the Williams H. Adams Foundation; Target ALS; BrightFocus Alzheimer's disease research grant(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Teng and Y. Zhu for technical assistance and W. Motley, A. Berson and other laboratory members for insightful comments. This work was funded by grants from the Howard Hughes Medical Institute (N.M.B.), grant R01NS073660 from the US National Institutes of Health (NIH; A.D.G. and N.M.B.), NIH Director's New Innovator Award DP2OD004417 (A.D.G.) and US NIH grant R01NS065317 (A.D.G.), the Robert Packard Center for ALS and the Williams H. Adams Foundation (S.F.), and US NIH grants AG10124, AG32953, AG17586 and NS53488 (J. Q. T. and V.M.-Y. L.). A.D.G. and S.F. are supported by a grant from Target ALS. A.R.R. is supported by a BrightFocus Alzheimer's disease research grant.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Armakola M, 2011, METHODS, V53, P238, DOI 10.1016/j.ymeth.2010.11.006; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND S, 1993, NUCLEIC ACIDS RES, V21, P3699, DOI 10.1093/nar/21.16.3699; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chowdhury A, 2012, RNA, V18, P936, DOI 10.1261/rna.029876.111; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Dalton LE, 2012, PROG MOL BIOL TRANSL, V106, P189, DOI 10.1016/B978-0-12-396456-4.00003-1; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hart MP, 2012, J NEUROSCI, V32, P9133, DOI 10.1523/JNEUROSCI.0996-12.2012; Hekmat-Scafe DS, 2005, GENETICS, V169, P1477, DOI 10.1534/genetics.104.036558; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Khong A, 2011, J VIROL, V85, P1439, DOI 10.1128/JVI.02220-10; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tazen S., 2013, JAMA NEUROL     0819, DOI [10.1001/jamaneurol.2013.443, DOI 10.1001/JAMANEUR0L.2013.443]; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	63	255	262	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					152	+		10.1038/ng.2853	http://dx.doi.org/10.1038/ng.2853			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24336168	Green Submitted, Green Accepted			2022-12-25	WOS:000331208300011
J	Bonnelykke, K; Sleiman, P; Nielsen, K; Kreiner-Moller, E; Mercader, JM; Belgrave, D; den Dekker, HT; Husby, A; Sevelsted, A; Faura-Tellez, G; Mortensen, LJ; Paternoster, L; Flaaten, R; Molgaard, A; Smart, DE; Thomsen, PF; Rasmussen, MA; Bonas-Guarch, S; Holst, C; Nohr, EA; Yadav, R; March, ME; Blicher, T; Lackie, PM; Jaddoe, VWV; Simpson, A; Holloway, JW; Duijts, L; Custovic, A; Davies, DE; Torrents, D; Gupta, R; Hollegaard, MV; Hougaard, DM; Hakonarson, H; Bisgaard, H				Bonnelykke, Klaus; Sleiman, Patrick; Nielsen, Kasper; Kreiner-Moller, Eskil; Mercader, Josep M.; Belgrave, Danielle; den Dekker, Herman T.; Husby, Anders; Sevelsted, Astrid; Faura-Tellez, Grissel; Mortensen, Li Juel; Paternoster, Lavinia; Flaaten, Richard; Molgaard, Anne; Smart, David E.; Thomsen, Philip F.; Rasmussen, Morten A.; Bonas-Guarch, Silvia; Holst, Claus; Nohr, Ellen A.; Yadav, Rachita; March, Michael E.; Blicher, Thomas; Lackie, Peter M.; Jaddoe, Vincent W. V.; Simpson, Angela; Holloway, John W.; Duijts, Liesbeth; Custovic, Adnan; Davies, Donna E.; Torrents, David; Gupta, Ramneek; Hollegaard, Mads V.; Hougaard, David M.; Hakonarson, Hakon; Bisgaard, Hans			A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations	NATURE GENETICS			English	Article							BLOOD SPOT SAMPLES; GENOTYPE IMPUTATION; SEQUENCE VARIANTS; BIRTH COHORT; CHILDREN; AIRWAY; EXPRESSION; RESOURCE; GENETICS; BIOBANK	Asthma exacerbations are among the most frequent causes of hospitalization during childhood, but the underlying mechanisms are poorly understood. We performed a genome-wide association study of a specific asthma phenotype characterized by recurrent, severe exacerbations occurring between 2 and 6 years of age in a total of 1,173 cases and 2,522 controls. Cases were identified from national health registries of hospitalization, and DNA was obtained from the Danish Neonatal Screening Biobank. We identified five loci with genome-wide significant association. Four of these, GSDMB, IL33, RAD50 and IL1RL1, were previously reported as asthma susceptibility loci, but the effect sizes for these loci in our cohort were considerably larger than in the previous genome-wide association studies of asthma. We also obtained strong evidence for a new susceptibility gene, CDHR3 (encoding cadherin-related family member 3), which is highly expressed in airway epithelium. These results demonstrate the strength of applying specific phenotyping in the search for asthma susceptibility genes.	[Bonnelykke, Klaus; Kreiner-Moller, Eskil; Husby, Anders; Sevelsted, Astrid; Mortensen, Li Juel; Flaaten, Richard; Molgaard, Anne] Univ Copenhagen, Gentofte, Denmark; [Bonnelykke, Klaus; Kreiner-Moller, Eskil; Husby, Anders; Sevelsted, Astrid; Mortensen, Li Juel; Flaaten, Richard; Molgaard, Anne] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark; [Sleiman, Patrick; March, Michael E.] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Nielsen, Kasper; Yadav, Rachita; Gupta, Ramneek] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Mercader, Josep M.; Bonas-Guarch, Silvia; Torrents, David] Joint Inst Res Biomed, Barcelona, Spain; [Mercader, Josep M.; Bonas-Guarch, Silvia; Torrents, David] IRB BSC, Barcelona Supercomputing Ctr, Program Computat Biol, Barcelona, Spain; [Belgrave, Danielle; Simpson, Angela; Custovic, Adnan] Univ Manchester, Ctr Resp Med & Allergy, Inst Inflammat & Repair, Manchester, Lancs, England; [Belgrave, Danielle; Simpson, Angela; Custovic, Adnan] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England; [Belgrave, Danielle] Univ Manchester, Ctr Hlth Informat, Inst Populat Hlth, Manchester, Lancs, England; [den Dekker, Herman T.; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [den Dekker, Herman T.; Duijts, Liesbeth] Erasmus MC, Dept Pediat, Div Resp Med, Rotterdam, Netherlands; [den Dekker, Herman T.; Jaddoe, Vincent W. V.; Duijts, Liesbeth] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Husby, Anders; Davies, Donna E.] Univ Southampton, Southampton Univ Hosp, Fac Med, Brooke Lab Clin & Expt Sci, Southampton, Hants, England; [Faura-Tellez, Grissel; Holloway, John W.] Univ Southampton, Southampton Gen Hosp, Fac Med, Southampton, Hants, England; [Faura-Tellez, Grissel] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Paternoster, Lavinia] Univ Bristol, Sch Social & Community Med, Integrat Epidemiol Unit, Bristol, Avon, England; [Thomsen, Philip F.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Rasmussen, Morten A.] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark; [Holst, Claus] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Nohr, Ellen A.] Univ Southern Denmark, Inst Clin Res, Aarhus, Denmark; [Nohr, Ellen A.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Blicher, Thomas] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth Sci, Ctr Prot Res, Copenhagen, Denmark; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Duijts, Liesbeth] Erasmus MC, Dept Pediat, Div Neonatol, Rotterdam, Netherlands; [Torrents, David] ICREA, Barcelona, Spain; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Danish Ctr Neonatal Screening, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Technical University of Denmark; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southampton; University of Southampton; University of Groningen; University of Bristol; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark; Aarhus University; Novo Nordisk Foundation; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; ICREA; Statens Serum Institut	Bonnelykke, K (corresponding author), Univ Copenhagen, Gentofte, Denmark.	kb@copsac.com	Gupta, Ramneek/G-7278-2012; Davies, Donna E/H-2993-2012; Bisgaard, Hans/N-4761-2016; March, Michael/AAB-6502-2019; Bonàs-Guarch, Sílvia/K-2863-2017; Arendt, Morten/S-8843-2017; Holloway, John W/B-5424-2009; Rasmussen, Morten/AAE-9517-2020; Custovic, Adnan/A-2435-2012; Hougaard, David/AAD-6368-2019; Thomsen, Philip Francis/AAE-9354-2019; Paternoster, Lavinia/C-1292-2015; Torrents, David/G-5785-2015	Gupta, Ramneek/0000-0001-6841-6676; Bisgaard, Hans/0000-0003-4131-7592; March, Michael/0000-0001-9173-6862; Bonàs-Guarch, Sílvia/0000-0002-2085-7488; Arendt, Morten/0000-0001-7431-5206; Holloway, John W/0000-0001-9998-0464; Rasmussen, Morten/0000-0001-7431-5206; Custovic, Adnan/0000-0001-5218-7071; Thomsen, Philip Francis/0000-0002-9867-4366; Bonnelykke, Klaus/0000-0003-2003-1018; Nielsen, Kasper/0000-0002-5510-7767; Husby, Anders/0000-0002-7634-8455; Kreiner, Eskil/0000-0003-1204-2438; Davies, Donna/0000-0002-5117-2991; Simpson, Angela/0000-0003-2733-6666; Paternoster, Lavinia/0000-0003-2514-0889; smart, David/0000-0002-1411-723X; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Mercader, Josep M/0000-0001-8494-3660; Torrents, David/0000-0002-6086-9037	ICREA Funding Source: Custom; MRC [G0501506, G0900453, MR/K002449/1, G0601361] Funding Source: UKRI; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [11/010] Funding Source: researchfish; Medical Research Council [G0501506, G0900453, MR/K002449/1, G0601361] Funding Source: Medline; NHGRI NIH HHS [U01 HG006830] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830] Funding Source: NIH RePORTER	ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hollegaard MV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-58; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Iskandar A, 2012, THORAX, V67, P252, DOI 10.1136/thoraxjnl-2011-200324; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Lowe L, 2002, LANCET, V359, P1904, DOI 10.1016/S0140-6736(02)08781-0; Lozano P, 1999, J ALLERGY CLIN IMMUN, V104, P957, DOI 10.1016/S0091-6749(99)70075-8; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matterne U, 2011, QUAL LIFE RES, V20, P1295, DOI 10.1007/s11136-011-9868-9; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Thomsen SF, 2010, J ALLERGY CLIN IMMUN, V126, P626, DOI 10.1016/j.jaci.2010.06.017; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	54	370	383	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					51	+		10.1038/ng.2830	http://dx.doi.org/10.1038/ng.2830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24241537				2022-12-25	WOS:000329113500012
J	Hudak, JE; Canham, SM; Bertozzi, CR				Hudak, Jason E.; Canham, Stephen M.; Bertozzi, Carolyn R.			Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-KILLER-CELLS; BREAST-CANCER CELLS; SIALIC-ACID; MEDIATED CYTOTOXICITY; INHIBITORY RECEPTOR; IDENTIFICATION; EXPRESSION; LIGANDS; GLYCOSPHINGOLIPIDS; SPECIFICITY	The increase of cell surface sialic acid is a characteristic shared by many tumor types. A correlation between hypersialylation and immunoprotection has been observed, but few hypotheses have provided a mechanistic understanding of this immunosuppressive phenomenon. Here, we show that increasing sialylated glycans on cancer cells inhibits human natural killer (NK) cell activation through the recruitment of sialic acid-binding immunoglobulin-like lectin 7 (Siglec-7). Key to these findings was the use of glycopolymers end-functionalized with phospholipids, which enable the introduction of synthetically defined glycans onto cancer cell surfaces. Remodeling the sialylation status of cancer cells affected the susceptibility to NK cell cytotoxicity via Siglec-7 engagement in a variety of tumor types. These results support a model in which hypersialylation offers a selective advantage to tumor cells under pressure from NK immunosurveillance by increasing Siglec ligands. We also exploited this finding to protect allogeneic and xenogeneic primary cells from NK-mediated killing, suggesting the potential of Siglecs as therapeutic targets in cell transplant therapy.	[Hudak, Jason E.; Canham, Stephen M.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Hudak, JE (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu		Canham, Stephen/0000-0003-4750-8066	US National Institutes of Health [R01 GM59907, F32DK095521]; US National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059907, T32GM066698] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Paulson (Scripps Research Institute) for the gift of plasmids encoding Siglec-7 and Siglec-9; M. Boyce (Duke University) for the gift of pMSCV retroviral plasmids and advice; D. Raulet, M. Ardolino, A. Iannello, P. Drake and C. Hudak for advice and expertise; and B. Belardi and D. Rabuka for helpful discussion and manuscript critique. This work was funded by a grant from the US National Institutes of Health (R01 GM59907). J.E.H. was supported by a predoctoral fellowship from the US National Science Foundation. S.M.C. was supported by a postdoctoral fellowship from the US National Institutes of Health (F32DK095521).	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Avril T, 2006, J LEUKOCYTE BIOL, V80, P787, DOI 10.1189/jlb.1005559; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cohen M, 2010, J IMMUNOL, V185, P5869, DOI 10.4049/jimmunol.1001635; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Courtney AH, 2009, P NATL ACAD SCI USA, V106, P2500, DOI 10.1073/pnas.0807207106; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Forte P, 2005, J IMMUNOL, V175, P5463, DOI 10.4049/jimmunol.175.8.5463; Fukuda M, 1996, CANCER RES, V56, P2237; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Godal R, 2006, BLOOD, V107, P3205, DOI 10.1182/blood-2005-07-2880; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hudak JE, 2011, J AM CHEM SOC, V133, P16127, DOI 10.1021/ja206023e; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Leivonen M, 2001, ONCOLOGY-BASEL, V61, P299, DOI 10.1159/000055337; Leonard JP, 2004, CLIN CANCER RES, V10, P5327, DOI 10.1158/1078-0432.CCR-04-0294; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Liang YJ, 2013, P NATL ACAD SCI USA, V110, P4968, DOI 10.1073/pnas.1302825110; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; Murphy WJ, 2001, IMMUNOL REV, V181, P279, DOI 10.1034/j.1600-065X.2001.1810124.x; Nath D, 1999, IMMUNOLOGY, V98, P213; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; OGATA S, 1992, CANCER RES, V52, P4741; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Rabuka D, 2008, J AM CHEM SOC, V130, P5947, DOI 10.1021/ja710644g; Rabuka D, 2007, J AM CHEM SOC, V129, P5462, DOI 10.1021/ja067819i; Sommaggio Roberta, 2012, Methods Mol Biol, V885, P91, DOI 10.1007/978-1-61779-845-0_7; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Triulzi C, 2010, CANCER RES, V70, P7431, DOI 10.1158/0008-5472.CAN-10-0493; van der Touw W, 2010, AM J TRANSPLANT, V10, P1354, DOI 10.1111/j.1600-6143.2010.03086.x; VANRINSUM J, 1986, INT J CANCER, V38, P915, DOI 10.1002/ijc.2910380620; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; YOGEESWARAN G, 1981, INT J CANCER, V28, P517, DOI 10.1002/ijc.2910280419; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	59	252	258	8	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					69	U111		10.1038/NCHEMBIO.1388	http://dx.doi.org/10.1038/NCHEMBIO.1388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24292068	Green Accepted			2022-12-25	WOS:000328854900013
J	Lin, PL; Ford, CB; Coleman, MT; Myers, AJ; Gawande, R; Ioerger, T; Sacchettini, J; Fortune, SM; Flynn, JL				Lin, Philana Ling; Ford, Christopher B.; Coleman, M. Teresa; Myers, Amy J.; Gawande, Richa; Ioerger, Thomas; Sacchettini, James; Fortune, Sarah M.; Flynn, JoAnne L.			Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing	NATURE MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CYNOMOLGUS MACAQUES; INFECTION; BIOMARKERS; DYNAMICS; MODEL	Over 30% of the world's population is infected with Mycobacterium tuberculosis (Mtb), yet only similar to 5-10% will develop clinical disease(1). Despite considerable effort, researchers understand little about what distinguishes individuals whose infection progresses to active tuberculosis (TB) from those whose infection remains latent for decades. The variable course of disease is recapitulated in cynomolgus macaques infected with Mtb(2). Active disease occurs in similar to 45% of infected macaques and is defined by clinical, microbiologic and immunologic signs, whereas the remaining infected animals are clinically asymptomatic(2,3). Here, we use individually marked Mtb isolates and quantitative measures of culturable and cumulative bacterial burden to show that most lung lesions are probably founded by a single bacterium and reach similar maximum burdens. Despite this observation, the fate of individual lesions varies substantially within the same host. Notably, in active disease, the host sterilizes some lesions even while others progress. Our data suggest that lesional heterogeneity arises, in part, through differential killing of bacteria after the onset of adaptive immunity. Thus, individual lesions follow diverse and overlapping trajectories, suggesting that critical responses occur at a lesional level to ultimately determine the clinical outcome of infection. Defining the local factors that dictate outcome will be useful in developing effective interventions to prevent active TB.	[Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [Ford, Christopher B.; Gawande, Richa; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Ford, Christopher B.; Fortune, Sarah M.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Coleman, M. Teresa] Univ Pittsburgh, Sch Med, Dept Radiol, Positron Emiss Tomog Res Ctr, Pittsburgh, PA USA; [Myers, Amy J.; Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Ioerger, Thomas] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX USA; [Sacchettini, James] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Fortune, Sarah M.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu; joanne@pitt.edu	Flynn, JoAnne/ABC-7371-2020	, Richa/0000-0002-1831-0977; Fortune, Sarah/0000-0001-7565-9975	Bill & Melinda Gates Foundation; Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation; US National Institutes of Health, National Institute of Allergy and Infectious Diseases DAIT; US National Institutes of Health [HL106804, AI094745, HL110811, DP2 0D001378, AI076217]; Howard Hughes Medical Institute, the Physician Scientist Early Career Award; Harvard Merit Fellowship; Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship; Robert A. Welch Foundation; Melvin J. and Geraldine L. Glimcher Associate Professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110811, R01HL106804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094745, T32AI007638, U19AI076217] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation; US National Institutes of Health, National Institute of Allergy and Infectious Diseases DAIT; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute, the Physician Scientist Early Career Award; Harvard Merit Fellowship; Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship; Robert A. Welch Foundation(The Welch Foundation); Melvin J. and Geraldine L. Glimcher Associate Professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were funded by the Bill & Melinda Gates Foundation (grants to J.L.F. and P.L.L.), the Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation (P.L.L.), US National Institutes of Health, National Institute of Allergy and Infectious Diseases DAIT BAA-05-10 (J.L.F.), US National Institutes of Health grants HL106804 (J.L.F.), AI094745 (J.L.F.), HL110811 (J.L.F.), DP2 0D001378 (S.M.F.) and AI076217 (S.M.F.), the Howard Hughes Medical Institute, the Physician Scientist Early Career Award (S.M.F.), the Harvard Merit Fellowship (C.B.F.), the Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship (S.M.F.), the Robert A. Welch Foundation (J.S.) and the Melvin J. and Geraldine L. Glimcher Associate Professorship (S.M.F.). We are grateful to E. Klein and C. Janssen for conducting necropsies, C. Scanga for coordination of studies, M. Rodgers, C. Cochran and C. Bigbee for excellent technical assistance, M. O'Malley, P. Johnston, J. Tomko, D. Fillmore and J. Frye for outstanding veterinary technical assistance, the members of the Flynn and Fortune labs for helpful discussions and B. Bloom, D. Young and E. Rubin for helpful comments on the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Canetti G., 1955, TUBERCLE BACILLUS; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KENNEDY HE, 1958, AM REV TUBERC PULM, V77, P802; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; VANDIVIERE H M, 1956, Am J Med Sci, V232, P30, DOI 10.1097/00000441-195607000-00006; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	20	310	320	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					75	+		10.1038/nm.3412	http://dx.doi.org/10.1038/nm.3412			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24336248	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000329349400022
J	Takasato, M; Er, PX; Becroft, M; Vanslambrouck, JM; Stanley, EG; Elefanty, AG; Little, MH				Takasato, M.; Er, P. X.; Becroft, M.; Vanslambrouck, J. M.; Stanley, E. G.; Elefanty, A. G.; Little, M. H.			Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney	NATURE CELL BIOLOGY			English	Article							INTERMEDIATE MESODERM; MOUSE EMBRYO; 3-DIMENSIONAL CULTURE; NEPHRON PROGENITORS; METANEPHRIC KIDNEY; SIGNALING PATHWAYS; GENE; EXPRESSION; MESENCHYME; PROTEIN	With the prevalence of end-stage renal disease rising 8% per annum globally(1), there is an urgent need for renal regenerative strategies. The kidney is a mesodermal organ that differentiates from the intermediate mesoderm (IM) through the formation of a ureteric bud (UB) and the interaction between this bud and the adjacent IM-derived metanephric mesenchyme(2) (MM). The nephrons arise from a nephron progenitor population derived from the MM (ref. 3). The IM itself is derived from the posterior primitive streak(4). Although the developmental origin of the kidney is well understood(2), nephron formation in the human kidney is completed before birth(5). Hence, there is no postnatal stem cell able to replace lost nephrons. In this study, we have successfully directed the differentiation of human embryonic stem cells (hESCs) through posterior primitive streak and IM under fully chemically defined monolayer culture conditions using growth factors used during normal embryogenesis. This differentiation protocol results in the synchronous induction of UB and MM that forms a self-organizing structure, including nephron formation, in vitro. Such hESC-derived components show broad renal potential ex vivo, illustrating the potential for pluripotent-stem-cell-based renal regeneration.	[Takasato, M.; Er, P. X.; Becroft, M.; Vanslambrouck, J. M.; Little, M. H.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Stanley, E. G.; Elefanty, A. G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Stanley, E. G.; Elefanty, A. G.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University	Little, MH (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	M.Little@imb.uq.edu.au	Elefanty, Andrew G/A-6066-2008; Little, Melissa H/A-6170-2010; Takasato, Minoru/K-2035-2014; Stanley, Ed G/A-2985-2013	Little, Melissa H/0000-0003-0380-2263; Takasato, Minoru/0000-0002-0458-7414; Stanley, Ed G/0000-0002-6389-3665; Elefanty, Andrew/0000-0001-6448-8314	Queensland State Government through a National/International Research Alliance Project; Australian Research Council of the Stem Cells Australia Strategic Research Initiative [SRI110001002]; National Health and Medical Research Council of Australia [APP1041277]	Queensland State Government through a National/International Research Alliance Project; Australian Research Council of the Stem Cells Australia Strategic Research Initiative(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We are grateful to E. Wolvetang for providing an iPSC line and D. Titmarsh, A. Hidalgo-Gonzalez and J. Cooper-White for supportive comments. This work was supported by the Queensland State Government through a National/International Research Alliance Project, the Australian Research Council as part of the Stem Cells Australia Strategic Research Initiative (SRI110001002) and the National Health and Medical Research Council of Australia (APP1041277). M.H.L. is a Senior Principal Research Fellow of the NHMRC.	Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Colvin JS, 1999, DEV DYNAM, V216, P72; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Davies Jamie A, 2012, Methods Mol Biol, V886, P135, DOI 10.1007/978-1-61779-851-1_12; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Guillaume R, 2009, DEV BIOL, V329, P169, DOI 10.1016/j.ydbio.2009.02.034; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Little MH, 2012, COLD SPRING HARB PER, V4; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Mugford JW, 2008, DEV BIOL, V319, P396, DOI 10.1016/j.ydbio.2008.03.044; Narayanan K, 2013, KIDNEY INT, V83, P593, DOI 10.1038/ki.2012.442; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Rumballe BA, 2011, DEV BIOL, V360, P110, DOI 10.1016/j.ydbio.2011.09.011; Soares ML, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-28; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Srinivas S, 1999, DEV GENET, V24, P241; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takasato M, 2014, PEDIATR NEPHROL, V29, P543, DOI 10.1007/s00467-013-2592-7; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Torres M, 1995, DEVELOPMENT, V121, P4057; TRINKAUS JP, 1955, P NATL ACAD SCI USA, V41, P787, DOI 10.1073/pnas.41.10.787; Tsang TE, 2000, DEV BIOL, V223, P77, DOI 10.1006/dbio.2000.9733; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107	39	438	464	5	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					118	+		10.1038/ncb2894	http://dx.doi.org/10.1038/ncb2894			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24335651				2022-12-25	WOS:000329042000017
J	Fierro-Gonzalez, JC; White, MD; Silva, JC; Plachta, N				Fierro-Gonzalez, Juan Carlos; White, Melanie D.; Silva, Juan Carlos; Plachta, Nicolas			Cadherin-dependent filopodia control preimplantation embryo compaction	NATURE CELL BIOLOGY			English	Article							MOUSE 8-CELL BLASTOMERES; MAMMALIAN EMBRYO; MYOSIN-X; DYNAMIC ACTIN; CELL-ADHESION; ORGANIZATION; SPECIFICITY; POLARITY; SURFACE; FATE	Compaction of the preimplantation embryo is the earliest morphogenetic process essential for mammalian development, yet it remains unclear how round cells elongate to form a compacted embryo. Here, using live mouse embryo imaging, we demonstrate that cells extend long E-cadherin-dependent filopodia on to neighbouring cells, which control the cell shape changes necessary for compaction. We found that filopodia extension is tightly coordinated with cell elongation, whereas retraction occurs before cells become round again before dividing. Laser-based ablations revealed that filopodia are required to maintain elongated cell shapes. Moreover, molecular disruption of the filopodia components E-cadherin, alpha- and beta-catenin, F-actin and myosin-X prevents cells from elongating and compacting the embryo. Finally, we show that early filopodia formation triggered by overexpressing myosin-X is sufficient to induce premature compaction. Our findings establish a role for filopodia during preimplantation embryonic development and provide an in vivo context to investigate the biological functions of filopodia in mammals.	[Fierro-Gonzalez, Juan Carlos; White, Melanie D.; Silva, Juan Carlos; Plachta, Nicolas] Monash Univ, European Mol Biol Lab, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University	Plachta, N (corresponding author), Monash Univ, European Mol Biol Lab, Australian Regenerat Med Inst, Level 1 Bldg 75, Clayton, Vic 3800, Australia.	nicolas.plachta@emblaustralia.org	White, Melanie/J-5565-2019; Fierro-González, Juan Carlos/F-8430-2010	White, Melanie/0000-0002-7399-8348; Fierro-González, Juan Carlos/0000-0003-4871-1621	ARC [DP120104594, DE120100794]; NHMRC [APP1052171]; Monash University; Wenner-Gren Foundations; Swedish Society for Medical Research	ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Wenner-Gren Foundations; Swedish Society for Medical Research	We thank A. Yap, E. Jesudason, A. Fouras and J. Polo for comments on the manuscript; T. Bell for advice on laser ablations; S. Firth and I. Harper for help with imaging experiments; and R. Cheney, A. Yap and B. Henderson for sharing DNA constructs. N.P. is supported by ARC DP120104594 and DE120100794, NHMRC APP1052171 and Monash University Strategic and Interdisciplinary grants, and J.C.F-G. by Wenner-Gren Foundations and Swedish Society for Medical Research Postdoctoral Fellowships.	Berg JS, 2000, J CELL SCI, V113, P3439; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; CALARCO PG, 1973, DEV BIOL, V32, P208, DOI 10.1016/0012-1606(73)90233-9; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; DUCIBELLA T, 1977, J CELL BIOL, V74, P153, DOI 10.1083/jcb.74.1.153; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; JOHNSON MH, 1986, J EMBRYOL EXP MORPH, V93, P239; JOHNSON MH, 1984, J EMBRYOL EXP MORPH, V82, P97; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kaur G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2657; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Kobayashi N, 2006, J PHARMACOL EXP THER, V317, P309, DOI 10.1124/jpet.105.097535; Landry DW, 2006, REGEN MED, V1, P367, DOI 10.2217/17460751.1.3.367; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Le Cruguel S, 2013, J ASSIST REPROD GEN, V30, P683, DOI 10.1007/s10815-013-9983-3; MARO B, 1984, J EMBRYOL EXP MORPH, V84, P217; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Michael M, 2013, SEMIN CELL DEV BIOL, V24, P298, DOI 10.1016/j.semcdb.2012.12.004; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Skiadas CC, 2006, FERTIL STERIL, V86, P1386, DOI 10.1016/j.fertnstert.2006.03.051; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; SUTHERLAND AE, 1983, DEV BIOL, V100, P328, DOI 10.1016/0012-1606(83)90227-0; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	33	138	144	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1424	+		10.1038/ncb2875	http://dx.doi.org/10.1038/ncb2875			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24270889				2022-12-25	WOS:000327944200007
J	Hung, RJ; Spaeth, CS; Yesilyurt, HG; Terman, JR				Hung, Ruei-Jiun; Spaeth, Christopher S.; Yesilyurt, Hunkar Gizem; Terman, Jonathan R.			SeIR reverses Mical-mediated oxidation of actin to regulate F-actin dynamics	NATURE CELL BIOLOGY			English	Article							METHIONINE SULFOXIDE REDUCTASES; REDOX REGULATION; DROSOPHILA BRISTLES; GENE-EXPRESSION; AXON GUIDANCE; PLEXIN; PROTEIN; THIOREDOXIN; BUNDLES; CYTOSKELETON	Actin's polymerization properties are markedly altered by oxidation of its conserved Met 44 residue. Mediating this effect is a specific oxidation-reduction (redox) enzyme, Mica!, that works with Semaphorin repulsive guidance cues and selectively oxidizes Met 44. We now find that this actin-regulatory process is reversible. Employing a genetic approach, we identified a specific methionine sulfoxide reductase (MsrB) enzyme SeIR that opposes Mical redox activity and Semaphorin-Plexin repulsion to direct multiple actin-dependent cellular behaviours in vivo. SeIR specifically catalyses the reduction of the R isomer of methionine sulfoxide (methionine-R-sulfoxide) to methionine, and we found that SeIR directly reduced Mical-oxidized actin, restoring its normal polymerization properties. These results indicate that Mical oxidizes actin stereospecifically to generate actin Met-44-R-sulfoxide (actin(Met(R)O-44)) and also implicate the interconversion of specific Met/Met(R)O residues as a precise means to modulate protein function. Our results therefore uncover a specific reversible redox actin regulatory system that controls cell and developmental biology.	[Hung, Ruei-Jiun; Spaeth, Christopher S.; Yesilyurt, Hunkar Gizem; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Spaeth, Christopher S.; Yesilyurt, Hunkar Gizem; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Spaeth, Christopher S.; Yesilyurt, Hunkar Gizem; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Grad Program Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Terman, JR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	jonathan.terman@utsouthwestern.edu			Cancer Prevention Research Institute of Texas (CPRIT); NIDA [T-32-DA7290]; NIH [NS073968, MH085923]; Welch Foundation [I-1749]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073968] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas (CPRIT); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Cowan, E. Kavalali, H. Kramer, C. Pak, E. Reisler and M. Rosen for comments and FlyBase, J. Yoon (UT Southwestern, USA), H. Aberle (University of Munster, Germany), Kyoto Stock Center, Vienna Drosophila RNAi Center and the Bloomington Stock Center for reagents. Mass spectrometry was performed by Y. Li (UT Southwestern Protein Chemistry Technology Center). Supported by Cancer Prevention Research Institute of Texas (CPRIT) predoctoral (R-J.H.), NIDA T-32-DA7290 postdoctoral (C.S.S.) and NIH (NS073968; MH085923) and Welch Foundation (I-1749) (J.R.T.) grants.	Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Bergen HR, 2003, RAPID COMMUN MASS SP, V17, P1467, DOI 10.1002/rcm.1075; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; Caplan S., 2013, ANTIOXID REDOX SIGNA; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Cooper J. A., 1992, PRATICAL APPROACH SE, P47; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Guild GM, 2003, J CELL BIOL, V162, P1069, DOI 10.1083/jcb.200305143; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Hopmann R, 2003, MOL BIOL CELL, V14, P118, DOI 10.1091/mbc.E02-05-0300; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2011, CYTOSKELETON, V68, P415, DOI 10.1002/cm.20527; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2012, ACTA BIOCH BIOPH SIN, V44, P623, DOI 10.1093/abbs/gms038; Kisiel M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-65; Knowles-Barley S, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq005; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lundblad R. L., 2005, CHEM REAGENTS PROTEI, P205; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Sheterline P, 1998, ACTIN; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; Tilney LG, 2004, MOL BIOL CELL, V15, P5481, DOI 10.1091/mbc.E04-06-0472; Tilney LG, 2003, MOL BIOL CELL, V14, P3953, DOI 10.1091/mbc.E03-03-0158; Tilney LG, 1996, J CELL BIOL, V135, P1291, DOI 10.1083/jcb.135.5.1291; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vanoni MA, 2013, INT J MOL SCI, V14, P6920, DOI 10.3390/ijms14046920; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Walsh C., 2006, POSTTRANSLATIONAL MO; Wang XG, 2010, ANTIOXID REDOX SIGN, V13, P565, DOI 10.1089/ars.2009.2833; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yang TH, 2012, NEURON, V74, P108, DOI 10.1016/j.neuron.2011.12.034; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zhou YP, 2011, CELL MOL LIFE SCI, V68, P4033, DOI 10.1007/s00018-011-0787-2	68	99	101	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1445	+		10.1038/ncb2871	http://dx.doi.org/10.1038/ncb2871			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24212093	Green Accepted			2022-12-25	WOS:000327944200009
J	Perez-Andreu, V; Roberts, KG; Harvey, RC; Yang, WJ; Cheng, C; Pei, DQ; Xu, H; Gastier-Foster, J; E, SY; Lim, JYS; Chen, IM; Fan, YP; Devidas, M; Borowitz, MJ; Smith, C; Neale, G; Burchard, EG; Torgerson, DG; Klussmann, FA; Villagran, CRN; Winick, NJ; Camitta, BM; Raetz, E; Wood, B; Yue, F; Carroll, WL; Larsen, E; Bowman, WP; Loh, ML; Dean, M; Bhojwani, D; Pui, CH; Evans, WE; Relling, MV; Hunger, SP; Willman, CL; Mullighan, CG; Yang, JJ				Perez-Andreu, Virginia; Roberts, Kathryn G.; Harvey, Richard C.; Yang, Wenjian; Cheng, Cheng; Pei, Deqing; Xu, Heng; Gastier-Foster, Julie; E, Shuyu; Lim, Joshua Yew-Suang; Chen, I-Ming; Fan, Yiping; Devidas, Meenakshi; Borowitz, Michael J.; Smith, Colton; Neale, Geoffrey; Burchard, Esteban G.; Torgerson, Dara G.; Antillon Klussmann, Federico; Najera Villagran, Cesar Rolando; Winick, Naomi J.; Camitta, Bruce M.; Raetz, Elizabeth; Wood, Brent; Yue, Feng; Carroll, William L.; Larsen, Eric; Bowman, W. Paul; Loh, Mignon L.; Dean, Michael; Bhojwani, Deepa; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.; Hunger, Stephen P.; Willman, Cheryl L.; Mullighan, Charles G.; Yang, Jun J.			Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse	NATURE GENETICS			English	Article							CHILDRENS ONCOLOGY GROUP; MINIMAL RESIDUAL DISEASE; GENOME-WIDE ASSOCIATION; ACUTE MYELOID-LEUKEMIA; MYELOPROLIFERATIVE NEOPLASMS; GENE-EXPRESSION; JAK2 HAPLOTYPE; CELL-TYPES; SUSCEPTIBILITY; POPULATIONS	Recent genomic profiling of childhood acute lymphoblastic leukemia (ALL) identified a high-risk subtype with an expression signature resembling that of Philadelphia chromosome-positive ALL and poor prognosis (Ph-like ALL). However, the role of inherited genetic variation in Ph-like ALL pathogenesis remains unknown. In a genome-wide association study (GWAS) of 511 ALL cases and 6,661 non-ALL controls, we identified a susceptibility locus for Ph-like ALL (GATA3, rs3824662; P = 2.17 x 10(-14), odds ratio (OR) = 3.85 for Ph-like ALL versus non-ALL; P = 1.05 x 10(-8), OR = 3.25 for Ph-like ALL versus non-Ph-like ALL), with independent validation. The rs3824662 risk allele was associated with somatic lesions underlying Ph-like ALL (CRLF2 rearrangement, JAK gene mutation and IKZF1 deletion) and with variation in GATA3 expression. Finally, genotype at the GATA3 SNP was also associated with early treatment response and risk of ALL relapse. Our results provide insights into interactions between inherited and somatic variants and their role in ALL pathogenesis and prognosis.	[Perez-Andreu, Virginia; Yang, Wenjian; Xu, Heng; E, Shuyu; Lim, Joshua Yew-Suang; Smith, Colton; Evans, William E.; Relling, Mary V.; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Roberts, Kathryn G.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Harvey, Richard C.; Chen, I-Ming; Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Cheng, Cheng; Pei, Deqing] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Gastier-Foster, Julie] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA; [Gastier-Foster, Julie] Ohio State Univ, Sch Med, Dept Pediat, Columbus, OH 43210 USA; [Lim, Joshua Yew-Suang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Devidas, Meenakshi] Univ Florida, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Burchard, Esteban G.; Torgerson, Dara G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci & Med, San Francisco, CA 94143 USA; [Antillon Klussmann, Federico; Najera Villagran, Cesar Rolando] Unidad Nacl Oncol Pediat, Guatemala City, Guatemala; [Winick, Naomi J.] Univ Texas SW Med Ctr Dallas, Dept Pediat Hematol Oncol, Dallas, TX 75390 USA; [Camitta, Bruce M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Raetz, Elizabeth; Carroll, William L.] NYU, Inst Canc, New York, NY USA; [Wood, Brent] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Yue, Feng] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Larsen, Eric] Maine Childrens Canc Program, Scarborough, ME USA; [Bowman, W. Paul] Cook Childrens Med Ctr, Dept Hematol & Oncol, Ft Worth, TX USA; [Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Dean, Michael] NCI, Expt Immunol Lab, Frederick, MD 21701 USA; [Bhojwani, Deepa; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Hunger, Stephen P.] Univ Colorado, Childrens Hosp Colorado, Dept Hematol & Oncol, Aurora, CO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of New Mexico; St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; National University of Singapore; St Jude Children's Research Hospital; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Medicine; St Jude Children's Research Hospital; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; New York University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cook Children's Medical Center; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	jun.yang@stjude.org	Xu, Heng/AAS-3465-2021; Pui, Ching-Hon/N-8076-2018; Dean, Michael/R-7501-2019; Yang, Jun J./ABG-5646-2020; Evans, William E./C-2069-2012; Dean, Michael C/G-8172-2012; Relling, Mary/N-5032-2018; Devidas, Meenakshi/H-1170-2019; e, s/GWU-7511-2022; Cheng, Cheng/N-8075-2018; Mullighan, Charles/H-3253-2011	Xu, Heng/0000-0002-7748-2621; Pui, Ching-Hon/0000-0003-0303-5658; Yang, Jun J./0000-0002-0770-9659; Evans, William E./0000-0002-9333-5322; Dean, Michael C/0000-0003-2234-0631; Devidas, Meenakshi/0000-0002-1099-3478; Mullighan, Charles/0000-0002-1871-1850; Bhojwani, Deepa/0000-0002-7559-7927; Harvey, Richard/0000-0002-4904-9767; Loh, Mignon/0000-0003-4099-4700	Jeffrey Pride Foundation; National Childhood Cancer Foundation; Spanish Ministry of Education; St. Jude Children's Research Hospital Academic Programs Special Fellowship; American Society of Hematology Scholar Award; Alex Lemonade Stand Foundation for Childhood Cancer Young Investigator Grant; Order of St. Francis Foundation; National Health and Medical Research Council (Australia); Haematology Society of Australia; New Zealand Novartis New Investigator Scholarship; US National Institutes of Health [CA156449, CA21765, CA36401, CA98543, CA114766, CA98413, CA140729, GM92666]; National Cancer Institute; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, U01CA157937, ZIABC011300, U10CA098413, R01CA036401, U24CA114766, R01CA140729, U10CA098543, R37CA036401, RC4CA156449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	Jeffrey Pride Foundation; National Childhood Cancer Foundation; Spanish Ministry of Education(Spanish Government); St. Jude Children's Research Hospital Academic Programs Special Fellowship; American Society of Hematology Scholar Award; Alex Lemonade Stand Foundation for Childhood Cancer Young Investigator Grant; Order of St. Francis Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Haematology Society of Australia; New Zealand Novartis New Investigator Scholarship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients and parents who participated in the COG protocols included in this study, the clinicians and research staff at COG institutions and J. Pullen (University of Mississippi at Jackson) for assistance in the classification of patients with ALL. Genome-wide genotyping of COG P9905 samples was performed by the Center for Molecular Medicine with generous financial support from the Jeffrey Pride Foundation and the National Childhood Cancer Foundation. V. P.-A. is supported by a Spanish Ministry of Education Fellowship Grant and by a St. Jude Children's Research Hospital Academic Programs Special Fellowship. J.J.Y. is supported by an American Society of Hematology Scholar Award, an Alex Lemonade Stand Foundation for Childhood Cancer Young Investigator Grant and by the Order of St. Francis Foundation. K. G. R. is supported by a National Health and Medical Research Council (Australia) Overseas Training Fellowship and by a Haematology Society of Australia and New Zealand Novartis New Investigator Scholarship. C. G. M. is a Pew Scholar in the Biomedical Sciences and a St. Baldrick's Scholar. We thank M. Shriver (Pennsylvania State University) for sharing SNP genotype data for the Native American references, J. Pritchard and J. Degner (University of Chicago) for sharing DNase I hypersensitivity data for HapMap YRI cell lines, R. C. Ribeiro (St. Jude Children's Research Hospital) and P. De Alarcon (University of Illinois College of Medicine at Peoria) for coordinating collaborations in Guatemala and S. Naron for her editorial assistance. This work was supported by the US National Institutes of Health (grant numbers CA156449, CA21765, CA36401, CA98543, CA114766, CA98413, CA140729 and GM92666), in part by the intramural Program of the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC). Study sponsors were not directly involved in the design of the study, the collection, analysis and interpretation of data, the writing of the manuscript or the decision to submit the manuscript. Detailed acknowledgments for the dbGaP data sets are provided in the Supplementary Note.	Andersen PK, 2010, STAT METHODS MED RES, V19, P71, DOI 10.1177/0962280209105020; Biondi A, 2012, LANCET ONCOL, V13, P936, DOI 10.1016/S1470-2045(12)70377-7; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Chen IM, 2012, BLOOD, V119, P3512, DOI 10.1182/blood-2011-11-394221; Davies SM, 2008, BLOOD, V111, P2984, DOI 10.1182/blood-2007-09-114082; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Loh ML, 2013, BLOOD, V121, P485, DOI 10.1182/blood-2012-04-422691; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Paulsson K, 2010, P NATL ACAD SCI USA, V107, P21719, DOI 10.1073/pnas.1006981107; Pritchard JK, 2000, GENETICS, V155, P945; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stanulla M, 2007, BLOOD CELL MOL DIS, V39, P160, DOI 10.1016/j.bcmd.2007.04.005; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Troyer JL, 2011, J INFECT DIS, V203, P1491, DOI 10.1093/infdis/jir046; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Xu H, 2012, J CLIN ONCOL, V30, P751, DOI 10.1200/JCO.2011.38.0345; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	48	200	209	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1494	U127		10.1038/ng.2803	http://dx.doi.org/10.1038/ng.2803			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24141364	Green Accepted			2022-12-25	WOS:000327715800018
J	Frampton, GM; Fichtenholtz, A; Otto, GA; Wang, K; Downing, SR; He, J; Schnall-Levin, M; White, J; Sanford, EM; An, P; Sun, J; Juhn, F; Brennan, K; Iwanik, K; Maillet, A; Buell, J; White, E; Zhao, M; Balasubramanian, S; Terzic, S; Richards, T; Banning, V; Garcia, L; Mahoney, K; Zwirko, Z; Donahue, A; Beltran, H; Mosquera, JM; Rubin, MA; Dogan, S; Hedvat, CV; Berger, MF; Pusztai, L; Lechner, M; Boshoff, C; Jarosz, M; Vietz, C; Parker, A; Miller, VA; Ross, JS; Curran, J; Cronin, MT; Stephens, PJ; Lipson, D; Yelensky, R				Frampton, Garrett M.; Fichtenholtz, Alex; Otto, Geoff A.; Wang, Kai; Downing, Sean R.; He, Jie; Schnall-Levin, Michael; White, Jared; Sanford, Eric M.; An, Peter; Sun, James; Juhn, Frank; Brennan, Kristina; Iwanik, Kiel; Maillet, Ashley; Buell, Jamie; White, Emily; Zhao, Mandy; Balasubramanian, Sohail; Terzic, Selmira; Richards, Tina; Banning, Vera; Garcia, Lazaro; Mahoney, Kristen; Zwirko, Zac; Donahue, Amy; Beltran, Himisha; Mosquera, Juan Miguel; Rubin, Mark A.; Dogan, Snjezana; Hedvat, Cyrus V.; Berger, Michael F.; Pusztai, Lajos; Lechner, Matthias; Boshoff, Chris; Jarosz, Mirna; Vietz, Christine; Parker, Alex; Miller, Vincent A.; Ross, Jeffrey S.; Curran, John; Cronin, Maureen T.; Stephens, Philip J.; Lipson, Doron; Yelensky, Roman			Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing	NATURE BIOTECHNOLOGY			English	Article							NEGATIVE BREAST-CANCER; TUMOR SAMPLES; MUTATIONAL PROCESSES; DRUG-SENSITIVITY; LUNG-CANCER; GENES; IMMUNOHISTOCHEMISTRY; IDENTIFICATION; AMPLIFICATION; LANDSCAPE	As more clinically relevant cancer genes are identified, comprehensive diagnostic approaches are needed to match patients to therapies, raising the challenge of optimization and analytical validation of assays that interrogate millions of bases of cancer genomes altered by multiple mechanisms. Here we describe a test based on massively parallel DNA sequencing to characterize base substitutions, short insertions and deletions (indels), copy number alterations and selected fusions across 287 cancer-related genes from routine formalin-fixed and paraffin-embedded (FFPE) clinical specimens. We implemented a practical validation strategy with reference samples of pooled cell lines that model key determinants of accuracy, including mutant allele frequency, indel length and amplitude of copy change. Test sensitivity achieved was 95-99% across alteration types, with high specificity (positive predictive value >99%). We confirmed accuracy using 249 FFPE cancer specimens characterized by established assays. Application of the test to 2,221 clinical cases revealed clinically actionable alterations in 76% of tumors, three times the number of actionable alterations detected by current diagnostic tests.	[Frampton, Garrett M.; Fichtenholtz, Alex; Otto, Geoff A.; Wang, Kai; Downing, Sean R.; He, Jie; Schnall-Levin, Michael; White, Jared; Sanford, Eric M.; An, Peter; Sun, James; Juhn, Frank; Brennan, Kristina; Iwanik, Kiel; Maillet, Ashley; Buell, Jamie; White, Emily; Zhao, Mandy; Balasubramanian, Sohail; Terzic, Selmira; Richards, Tina; Banning, Vera; Garcia, Lazaro; Mahoney, Kristen; Zwirko, Zac; Donahue, Amy; Jarosz, Mirna; Vietz, Christine; Parker, Alex; Miller, Vincent A.; Ross, Jeffrey S.; Curran, John; Cronin, Maureen T.; Stephens, Philip J.; Lipson, Doron; Yelensky, Roman] Fdn Med, Cambridge, MA USA; [Beltran, Himisha] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10021 USA; [Beltran, Himisha; Mosquera, Juan Miguel; Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY USA; [Beltran, Himisha; Mosquera, Juan Miguel; Rubin, Mark A.] New York Presbyterian Hosp, New York, NY USA; [Mosquera, Juan Miguel; Rubin, Mark A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Dogan, Snjezana; Hedvat, Cyrus V.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Pusztai, Lajos] Yale Univ, Sch Med, Yale Canc Ctr, Genet & Genom Program, New Haven, CT USA; [Lechner, Matthias; Boshoff, Chris] UCL, UCL Canc Inst, London, England; [Ross, Jeffrey S.] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA	Foundation Medicine; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; Yale University; University of London; University College London; Albany Medical College	Lipson, D (corresponding author), Fdn Med, Cambridge, MA USA.	dlipson@foundationmedicine.com; ryelensky@foundationmedicine.com	Pusztai, Lajos/AAB-2901-2019	Rubin, Mark/0000-0002-8321-9950; Sanford, Eric/0000-0002-9232-9334; Frampton, Garrett/0000-0002-2361-2750; HEDVAT, CYRUS/0000-0003-0045-3491	Damon Runyon Cancer Research Foundation [CI-67-13]; Wellcome Trust Fellowship [WT093855MA]; Austrian Science Fund [J2856]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Wellcome Trust Fellowship(Wellcome Trust); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge L. Gay for advice and assistance with manuscript preparation. H. B. is the Damon Runyon-Gordon Family Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-67-13). M. L. was supported by a Wellcome Trust Fellowship (WT093855MA) and by the Austrian Science Fund (J2856).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lovly CM, 2013, J CLIN ONCOL S, V31; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Mardis ER, 2012, CURR OPIN GENET DEV, V22, P245, DOI 10.1016/j.gde.2012.03.005; McCourt CM, 2013, J CLIN PATHOL, V66, P58, DOI 10.1136/jclinpath-2012-201140; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pao W., P AM THORAC SOC; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Ross JS, 2011, BIOMARK MED, V5, P307, DOI [10.2217/BMM.11.31, 10.2217/bmm.11.31]; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Stegmeier F, 2010, CLIN PHARMACOL THER, V87, P543, DOI 10.1038/clpt.2009.297; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Swanton C, 2012, LANCET ONCOL, V13, P668, DOI 10.1016/S1470-2045(12)70312-1; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92	53	1356	1438	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1023	+		10.1038/nbt.2696	http://dx.doi.org/10.1038/nbt.2696			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24142049	Green Accepted			2022-12-25	WOS:000326921200025
J	Gombos, L; Neuner, A; Berynskyy, M; Fava, LL; Wade, RC; Sachse, C; Schiebel, E				Gombos, Linda; Neuner, Annett; Berynskyy, Mykhaylo; Fava, Luca L.; Wade, Rebecca C.; Sachse, Carsten; Schiebel, Elmar			GTP regulates the microtubule nucleation activity of gamma-tubulin	NATURE CELL BIOLOGY			English	Article							SPINDLE POLE BODY; ALPHA-BETA-TUBULIN; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; BUDDING YEAST; SWISS-MODEL; PROTEIN; COMPLEX; MUTATIONS; BINDING	Both subunits of ap-tubulin that comprise the core components of microtubules bind GTP. GTP binding to alpha-tubulin has a structural role, whereas beta-tubulin binds and hydrolyses GTP to regulate microtubule dynamics. gamma-tubulin, another member of the tubulin superfamily that seeds microtubule nucleation at microtubule-organizing centres, also binds GTP; however, the importance of this association remains elusive. To address the role of GTP binding to gamma-tubulin, we systematically mutagenized the GTP contact residues in the yeast gamma-tubulin Tub4. Tub4'-mutant proteins that exhibited greatly reduced GTP affinity still assembled into the small y-tubulin complex. However, tub4GTP mutants were no longer viable, and had defects in interaction between y-tubulin and alpha beta-tubulin, decreased microtubule nucleation and defects in microtubule organization. In vitro and in vivo data show that only gamma-tubulin loaded with GTP nucleates microtubules. Our results suggest that GTP recruitment to gamma-tubulin enhances its interaction with alpha beta-tubulin similarly to GTP recruitment to p-tubulin.	[Gombos, Linda; Neuner, Annett; Fava, Luca L.; Wade, Rebecca C.; Schiebel, Elmar] Univ Heidelberg ZMBH, Zentrum Mol Biol, ZMBH DKFZ Alliance, D-69120 Heidelberg, Germany; [Berynskyy, Mykhaylo; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, D-69118 Heidelberg, Germany; [Sachse, Carsten] EMBL Heidelberg, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Heidelberg Institute for Theoretical Studies; European Molecular Biology Laboratory (EMBL)	Schiebel, E (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, ZMBH DKFZ Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de	Wade, Rebecca/L-1489-2019; Sachse, Carsten/H-2727-2012; Sachse, Carsten/AAY-9384-2020; Fava, Luca/E-2876-2017	Wade, Rebecca/0000-0001-5951-8670; Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; Fava, Luca/0000-0002-6741-1723	DFG [Schi 295/4-1/2]	DFG(German Research Foundation (DFG))	This work was supported by the grant DFG Schi 295/4-1/2. We acknowledge D. Botstein (Princeton University, USA) and M. Knop (ZMBH, Heidelberg University, Germany) for plasmids and J. Kilmartin (MRC, Cambridge, UK) for antibodies. We thank I. Hagan for critical reading of the manuscript and U. Hide for technical assistance. We thank the EMBL EM facility for assistance and helpful discussions.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Anders KR, 2001, MOL BIOL CELL, V12, P3973, DOI 10.1091/mbc.12.12.3973; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cuschieri L, 2006, MOL BIOL CELL, V17, P4420, DOI 10.1091/mbc.E06-03-0245; Dougherty CA, 2001, BIOCHEMISTRY-US, V40, P15725, DOI 10.1021/bi010070y; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Erlemann S, 2012, J CELL BIOL, V197, P59, DOI 10.1083/jcb.201111123; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Guthrie C., 1991, METHOD ENZYMOL, V194, P429; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jung MK, 2001, MOL BIOL CELL, V12, P2119, DOI 10.1091/mbc.12.7.2119; Kitamura E, 2010, DEV CELL, V18, P248, DOI 10.1016/j.devcel.2009.12.018; Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Kupke T, 2011, EMBO J, V30, P3337, DOI 10.1038/emboj.2011.242; Lin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019700; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MACHIN NA, 1995, MOL BIOL CELL, V6, P1241, DOI 10.1091/mbc.6.9.1241; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Nguyen T, 1998, MOL BIOL CELL, V9, P2201, DOI 10.1091/mbc.9.8.2201; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1999, CELL MOL LIFE SCI, V56, P133, DOI 10.1007/s000180050012; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Ortiz J, 2009, GENE DEV, V23, P2778, DOI 10.1101/gad.541309; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Pereira G, 1997, J CELL SCI, V110, P295; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209; Shang YH, 2005, J CELL BIOL, V171, P1035, DOI 10.1083/jcb.200508184; Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tange Y, 2004, GENETICS, V167, P1095, DOI 10.1534/genetics.104.027946; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; Zabala JC, 1996, J CELL SCI, V109, P1471; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	52	19	19	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1317	U129		10.1038/ncb2863	http://dx.doi.org/10.1038/ncb2863			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24161932				2022-12-25	WOS:000326680700008
J	Han, A; Glanville, J; Hansmann, L; Davis, MM				Han, Arnold; Glanville, Jacob; Hansmann, Leo; Davis, Mark M.			Linking T-cell receptor sequence to functional phenotype at the single-cell level	NATURE BIOTECHNOLOGY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; TRANSCRIPTION FACTORS; ALLELIC EXCLUSION; BETA-CHAINS; TCR-ALPHA; CYTOMETRY; EXPRESSION; DIVERSITY; ANTIBODY	Although each T lymphocyte expresses a T-cell receptor (TCR) that recognizes cognate antigen and controls T-cell activation, different T cells bearing the same TCR can be functionally distinct. Each TCR is a heterodimer, and both alpha- and beta-chains contribute to determining TCR antigen specificity. Here we present a methodology enabling integration of information about TCR specificity with information about T cell function. This method involves sequencing of TCR alpha and TCR beta genes, and amplifying functional genes characteristic of different T cell subsets, in single T cells. Because this approach retains information about individual TCR alpha-TCRb beta pairs, TCRs of interest can be expressed and used in functional studies, for antigen discovery, or in therapeutic applications. We apply this approach to study the clonal ancestry and differentiation of T lymphocytes infiltrating a human colorectal carcinoma.	[Han, Arnold] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol, Stanford, CA 94305 USA; [Han, Arnold; Hansmann, Leo; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Glanville, Jacob; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Program Computat & Syst Immunol, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Hansmann, Leo/V-3748-2019	Hansmann, Leo/0000-0003-3790-0128; Davis, Mark/0000-0001-6868-657X	Simons Foundation; German Research Foundation (D.F.G.); US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100739, T32DK007056] Funding Source: NIH RePORTER	Simons Foundation; German Research Foundation (D.F.G.)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Davis laboratory and the Y.-H. Chien laboratory for helpful discussions. We thank E. Newell for critical reading of the manuscript and helpful suggestions. We thank C. Bolen for assistance with data analysis. We thank X. Ji for deep sequencing. Tissue was obtained through the Stanford University Tissue Bank. The Stanford Shared FACS Facility provided use of equipment and the Stanford Functional Genomics Facility provided deep sequencing services. A. H. is supported by a grant from the Simons Foundation. L. H. is supported by a fellowship from the German Research Foundation (D.F.G.). M. M. D. is funded by the US National Institutes of Health and is an investigator of the Howard Hughes Medical Institute.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Assenmacher M., 2002, CURR PROTOC IMMUNOL, V46; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gascoigne NRJ, 1999, SEMIN IMMUNOL, V11, P337, DOI 10.1006/smim.1999.0190; Gerlinger M, 2013, J PATHOL, V231, P424, DOI 10.1002/path.4284; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hinrichs CS, 2013, NAT BIOTECHNOL, V31, P999, DOI 10.1038/nbt.2725; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037338; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Sasada T, 2011, IMMUNOTHERAPY-UK, V3, P1235, DOI [10.2217/imt.11.106, 10.2217/IMT.11.106]; Scurr M, 2012, CELL IMMUNOL, V279, P21, DOI 10.1016/j.cellimm.2012.08.004; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vahedi G, 2013, IMMUNOLOGY, V139, P294, DOI 10.1111/imm.12113; Wills QF, 2013, NAT BIOTECHNOL, V31, P748, DOI 10.1038/nbt.2642; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; YANAGI Y, 1985, P NATL ACAD SCI USA, V82, P3430, DOI 10.1073/pnas.82.10.3430; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	45	332	388	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					684	+		10.1038/nbt.2938	http://dx.doi.org/10.1038/nbt.2938			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24952902	Green Accepted			2022-12-25	WOS:000338705900035
J	Paladino, S; Lebreton, S; Tivodar, S; Formiggini, F; Ossato, G; Gratton, E; Tramier, M; Coppey-Moisan, M; Zurzolo, C				Paladino, Simona; Lebreton, Stephanie; Tivodar, Simona; Formiggini, Fabio; Ossato, Giulia; Gratton, Enrico; Tramier, Marc; Coppey-Moisan, Maite; Zurzolo, Chiara			Golgi sorting regulates organization and activity of GPI proteins at apical membranes	NATURE CHEMICAL BIOLOGY			English	Article							POLARIZED EPITHELIAL-CELLS; ANCHORED PROTEINS; PLASMA-MEMBRANE; LIVING CELLS; MDCK CELLS; SIGNAL-TRANSDUCTION; OLIGOMERIZATION; CHOLESTEROL; SURFACE; MICRODOMAINS	Here we combined classical biochemistry with new biophysical approaches to study the organization of glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-APs) with high spatial and temporal resolution at the plasma membrane of polarized epithelial cells. We show that in polarized MDCK cells, after sorting in the Golgi, each GPI-AP reaches the apical surface in homoclusters. Golgi-derived homoclusters are required for their subsequent plasma membrane organization into cholesterol-dependent heteroclusters. By contrast, in nonpolarized MDCK cells, GPI-APs are delivered to the surface as monomers in an unpolarized manner and are not able to form heteroclusters. We further demonstrate that this GPI-AP organization is regulated by the content of cholesterol in the Golgi apparatus and is required to maintain the functional state of the protein at the apical membrane. Thus, in contrast to fibroblasts, in polarized epithelial cells, a selective cholesterol-dependent sorting mechanism in the Golgi regulates both the organization and function of GPI-APs at the apical surface.	[Paladino, Simona; Tivodar, Simona; Zurzolo, Chiara] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Paladino, Simona; Formiggini, Fabio] CEINGE Biotecnol Avanzate, Naples, Italy; [Lebreton, Stephanie; Zurzolo, Chiara] Inst Pasteur, Unite Traf Membranaire & Pathogenese, Paris, France; [Formiggini, Fabio; Ossato, Giulia] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA; [Tramier, Marc] Univ Rennes 1, CNRS, Inst Genet & Dev Rennes, UMR 6290, Rennes, France; [Coppey-Moisan, Maite] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, Paris, France	University of Naples Federico II; CEINGE Biotecnologie Avanzate; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Paladino, S (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.	zurzolo@pasteur.fr	Zurzolo, Chiara/AAH-5225-2019; Paladino, Simona/J-5383-2018; Paladino, Simona/ABH-7826-2020	Paladino, Simona/0000-0001-5332-6774; ZURZOLO, Chiara/0000-0001-6048-6602; Coppey-Moisan, Maite/0000-0002-6246-4973; Tramier, Marc/0000-0001-8200-6446; Lebreton, Stephanie/0000-0002-9879-0404; Formiggini, Fabio/0000-0002-3547-4500	Agence Nationale de la Recherche (ANR) [05-BLAN 296-01, ANR-09-BLAN-0122]; European Union FP7 [222887]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [2007-2009]; Fondation pour la Recherche Medicale (FRM) 'Grands Equipements' [NIH-P41 P41-RRO3155, NIH-P50-GM076516]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Union FP7(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondation pour la Recherche Medicale (FRM) 'Grands Equipements'; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Casanova (Institut Pasteur) for his technical support, N. Auduge (Institut Jacques Monod, ImagoSeine) for his help in FLIM analysis, P. Riccio (University of Naples Federico II) for her help in statistical analysis and the imaging facility at Pasteur Institute (PFID) and at CEINGE Institute (DIM). We thank A. Le Bivic (Institut de Biologie du Developpement de Marseille Luminy (IBDML), Marseille, France), S. Mayor (National Centre for Biological Sciences (NCBS), Bangalore, India) and N. Sidenius (Fondazione Italiana Ricerca sul Cancro Institute of Molecular Oncology (IFOM), Milan, Italy) for cDNA encoding p75-GFP, CHO cells expressing GFP-FR, and cDNAs encoding mGFP-GPI and mGFP-mGFP GPI (uPAR), respectively. This work was supported by the Agence Nationale de la Recherche (ANR) (05-BLAN 296-01 and ANR-09-BLAN-0122) and the European Union FP7 (Priority, grant 222887) to C. Z.; an Associazione Italiana per la Ricerca sul Cancro (AIRC) grant (MFAG 2007-2009) to S. P.; ANR PFTV2007 and Fondation pour la Recherche Medicale (FRM) 'Grands Equipements' to M.C.- M.; and grants NIH-P41 P41-RRO3155 and NIH-P50-GM076516 from the US National Institutes of Health to E. G.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; BRIDGMAN PC, 1981, P NATL ACAD SCI-BIOL, V78, P1278, DOI 10.1073/pnas.78.2.1278; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Catino MA, 2008, TRAFFIC, V9, P2141, DOI 10.1111/j.1600-0854.2008.00826.x; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; HANNAN LA, 1993, J CELL BIOL, V120, P353, DOI 10.1083/jcb.120.2.353; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Hellriegel C, 2011, FASEB J, V25, P2883, DOI 10.1096/fj.11-181537; Hillesheim LN, 2006, BIOPHYS J, V91, P4273, DOI 10.1529/biophysj.106.085845; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Imjeti NS, 2011, MOL BIOL CELL, V22, P4621, DOI 10.1091/mbc.E11-04-0320; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lebreton S, 2008, J BIOL CHEM, V283, P29545, DOI 10.1074/jbc.M803819200; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Mallengo G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940570; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Padilla-Parra S, 2008, BIOPHYS J, V95, P2976, DOI 10.1529/biophysj.108.131276; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Tivodar S, 2006, FEBS LETT, V580, P5705, DOI 10.1016/j.febslet.2006.09.022; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	52	35	35	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					350	U55		10.1038/NCHEMBIO.1495	http://dx.doi.org/10.1038/NCHEMBIO.1495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24681536	Green Accepted, Green Submitted			2022-12-25	WOS:000334672700008
J	Petkovic, M; Jemaiel, A; Daste, F; Specht, CG; Izeddin, I; Vorkel, D; Verbavatz, JM; Darzacq, X; Triller, A; Pfenninger, KH; Tareste, D; Jackson, CL; Galli, T				Petkovic, Maja; Jemaiel, Aymen; Daste, Frederic; Specht, Christian G.; Izeddin, Ignacio; Vorkel, Daniela; Verbavatz, Jean-Marc; Darzacq, Xavier; Triller, Antoine; Pfenninger, Karl H.; Tareste, David; Jackson, Catherine L.; Galli, Thierry			The SNARE Sec22b has a non-fusogenic function in plasma membrane expansion	NATURE CELL BIOLOGY			English	Article							NERVE GROWTH CONES; FETAL-RAT-BRAIN; ENDOPLASMIC-RETICULUM; NEURITE OUTGROWTH; MEDIATED TRANSPORT; LIPID-BILAYERS; CONTACT SITES; TI-VAMP; PROTEIN; FUSION	Development of the nervous system requires extensive axonal and dendritic growth during which neurons massively increase their surface area. Here we report that the endoplasmic reticulum (ER)-resident SNARE Sec22b has a conserved non-fusogenic function in plasma membrane expansion. Sec22b is closely apposed to the plasma membrane SNARE syntaxin1. Sec22b forms a trans-SNARE complex with syntaxin1 that does not include SNAP23/25/29, and does not mediate fusion. Insertion of a long rigid linker between the SNARE and transmembrane domains of Sec22b extends the distance between the ER and plasma membrane, and impairs neurite growth but not the secretion of VSV-G. In yeast, Sec22 interacts with lipid transfer proteins, and inhibition of Sec22 leads to defects in lipid metabolism at contact sites between the ER and plasma membrane. These results suggest that close apposition of the ER and plasma membrane mediated by Sec22 and plasma membrane syntaxins generates a non-fusogenic SNARE bridge contributing to plasma membrane expansion, probably through non-vesicular lipid transfer.	[Petkovic, Maja; Daste, Frederic; Tareste, David; Galli, Thierry] Univ Paris 06, INSERM, U950, F-75013 Paris, France; [Petkovic, Maja; Daste, Frederic; Tareste, David; Galli, Thierry] Univ Paris Diderot, Sorbonne Paris Cite, ERL U950, F-75013 Paris, France; [Petkovic, Maja; Jemaiel, Aymen; Daste, Frederic; Verbavatz, Jean-Marc; Tareste, David; Jackson, Catherine L.; Galli, Thierry] CNRS, UMR 7592, Inst Jacques Monod, F-75013 Paris, France; [Petkovic, Maja] Ecole Neurosci Paris, F-75006 Paris, France; [Jemaiel, Aymen; Jackson, Catherine L.] Inst Jacques Monod, F-75013 Paris, France; [Daste, Frederic] Univ Paris 05, Sorbonne Paris Cite, Ecole Doctorale Frontieres Vivant FdV, Programme Bettencourt, F-75004 Paris, France; [Specht, Christian G.; Izeddin, Ignacio; Darzacq, Xavier; Triller, Antoine] Ecole Normale Super IBENS, Inst Biol, INSERM U1024, CNRS UMR8197, F-75005 Paris, France; [Vorkel, Daniela; Verbavatz, Jean-Marc] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Pfenninger, Karl H.] Univ Colorado, Sch Med, Linda Crnic Inst Syndrome, Aurora, CO 80045 USA; [Pfenninger, Karl H.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Max Planck Society; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jackson, CL (corresponding author), CNRS, UMR 7592, Inst Jacques Monod, F-75013 Paris, France.	jackson@ijm.univ-paris-diderot.fr; thierry.galli@inserm.fr	Tareste, David/L-2639-2017; Jackson, Catherine/T-5688-2019; Izeddin, Ignacio/H-2628-2013; Galli, Thierry/Q-2249-2019; Tareste, David/P-9249-2019; Galli, Thierry/G-8842-2011	Tareste, David/0000-0002-8744-7598; Izeddin, Ignacio/0000-0002-8476-3915; Galli, Thierry/0000-0001-8514-7455; Tareste, David/0000-0002-8744-7598; Galli, Thierry/0000-0001-8514-7455; Specht, Christian G/0000-0001-6038-7735; Verbavatz, Jean-Marc/0000-0002-4654-1174; TRILLER, Antoine/0000-0002-7530-1233; Darzacq, Xavier/0000-0003-2537-8395; Jackson, Catherine/0000-0002-0843-145X	French National Research Agency [ANR-10-INSB-04]; INSERM; CNRS; Association Francaise contre les Myopathies (AFM); Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM); Ecole desNeurosciences de Paris (ENP); Fondation des Treilles; Paris Descartes University; Ecole Doctorale Frontieres du Vivant (FdV)	French National Research Agency(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Ecole desNeurosciences de Paris (ENP); Fondation des Treilles; Paris Descartes University; Ecole Doctorale Frontieres du Vivant (FdV)	We are grateful to F. Polleux, V. Medvedeva and A. Assali for advice on in utero electroporation, N. Rouach for calcium imaging and F. Perez for the gift of RUSH reagents. We are grateful to Y. N. Jan for support to M. P. in revising the manuscript, and L. Bosanac for support with software. We are grateful to A. Pierani and members of the Galli laboratory for discussions. We acknowledge France-BioImaging infrastructure supported by the French National Research Agency (ANR-10-INSB-04, 'Investments for the future'). Work in our group was financially supported in part by grants from INSERM, CNRS, the Association Francaise contre les Myopathies (AFM), the Association pour la Recherche sur le Cancer (ARC), the Mairie de Paris Medical Research and Health Program, the Fondation pour la Recherche Medicale (FRM), the Ecole desNeurosciences de Paris (ENP), and awards of the Association Robert Debre pour la Recherche Medicale to T. G., ANR JC grant to D. T. and the Ecole des Neurosciences de Paris (ENP) and award of the Fondation des Treilles to M. P. F. D. is supported by a PhD fellowship from Paris Descartes University and funds by the PhD Program Ecole Doctorale Frontieres du Vivant (FdV)-Programme Bettencourt.	Alberts P, 2003, MOL BIOL CELL, V14, P4207, DOI 10.1091/mbc.e03-03-0147; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Becher A, 1999, EUR J CELL BIOL, V78, P650, DOI 10.1016/S0171-9335(99)80050-8; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Boss WF, 2012, ANNU REV PLANT BIOL, V63, P409, DOI 10.1146/annurev-arplant-042110-103840; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Domanska MK, 2010, BIOPHYS J, V99, P2936, DOI 10.1016/j.bpj.2010.09.011; El Beheiry M, 2013, NAT METHODS, V10, P689, DOI 10.1038/nmeth.2566; ELLIS L, 1985, J NEUROSCI, V5, P1393; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; LOCKERBIE RO, 1991, J CELL BIOL, V112, P1215, DOI 10.1083/jcb.112.6.1215; Lohse K, 1996, DEV BRAIN RES, V96, P83, DOI 10.1016/0165-3806(96)00076-4; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miao Y, 2013, ELIFE, V2, DOI 10.7554/eLife.00802; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Pfenninger K H, 1981, Neurosci Res Program Bull, V20, P73; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schulte C, 2010, TRAFFIC, V11, P1304, DOI 10.1111/j.1600-0854.2010.01095.x; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; SWIFT LL, 1995, J LIPID RES, V36, P395; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200; Zhang D, 2012, CURR BIOL, V22, P2048, DOI 10.1016/j.cub.2012.08.047; Zylbersztejn K, 2012, J CELL BIOL, V196, P37, DOI 10.1083/jcb.201106113	75	91	92	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					434	U121		10.1038/ncb2937	http://dx.doi.org/10.1038/ncb2937			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24705552				2022-12-25	WOS:000335438400008
J	Kircher, M; Witten, DM; Jain, P; O'Roak, BJ; Cooper, GM; Shendure, J				Kircher, Martin; Witten, Daniela M.; Jain, Preti; O'Roak, Brian J.; Cooper, Gregory M.; Shendure, Jay			A general framework for estimating the relative pathogenicity of human genetic variants	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDERS; INTELLECTUAL DISABILITY; HUMAN EXOMES; HUMAN GENOME; IN-VIVO; DATABASE; DISEASE; UPDATE; ELEMENTS	Current methods for annotating and interpreting human genetic variation tend to exploit a single information type (for example, conservation) and/or are restricted in scope (for example, to missense changes). Here we describe Combined Annotation-Dependent Depletion (CADD), a method for objectively integrating many diverse annotations into a single measure (C score) for each variant. We implement CADD as a support vector machine trained to differentiate 14.7 million high-frequency human-derived alleles from 14.7 million simulated variants. We precompute C scores for all 8.6 billion possible human single-nucleotide variants and enable scoring of short insertions-deletions. C scores correlate with allelic diversity, annotations of functionality, pathogenicity, disease severity, experimentally measured regulatory effects and complex trait associations, and they highly rank known pathogenic variants within individual genomes. The ability of CADD to prioritize functional, deleterious and pathogenic variants across many functional categories, effect sizes and genetic architectures is unmatched by any current single-annotation method.	[O'Roak, Brian J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Witten, Daniela M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Jain, Preti; Cooper, Gregory M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	gcooper@hudsonalpha.org; shendure@uw.edu	Shendure, Jay/AAU-3684-2021; Kircher, Martin/H-6909-2019; Ganesh, Dunna Sai/AGX-5170-2022; Kircher, Martin/HDL-9392-2022; wang, edwin/G-5372-2010; Cooper, Gregory/D-6914-2011	Kircher, Martin/0000-0001-9278-5471; O'Roak, Brian/0000-0002-4141-0095; Cooper, Gregory/0000-0001-5509-9923; Shendure, Jay/0000-0002-1516-1865	US NIH [U54HG006493, DP5OD009145, DP1HG007811]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, DP1HG007811, UM1HG006493] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009145] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Green and members of the Shendure laboratory for helpful discussions and suggestions. Our work was supported by US NIH grants U54HG006493 (to J.S. and G.M.C.), DP5OD009145 (to D.M.W.) and DP1HG007811 (to J.S.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; Baker M, 2012, NATURE, V491, P171, DOI 10.1038/491171a; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Franc V, 2009, J MACH LEARN RES, V10, P2157; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giardine B, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9479; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Kimura MA, 1985, NEUTRAL THEORY MOL E; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Makrythanasis P, 2013, CLIN GENET, V84, P539, DOI 10.1111/cge.12081; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826	59	3602	3640	11	328	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					310	+		10.1038/ng.2892	http://dx.doi.org/10.1038/ng.2892			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24487276	Green Published, Green Accepted			2022-12-25	WOS:000332036700017
J	Gole, J; Gore, A; Richards, A; Chiu, YJ; Fung, HL; Bushman, D; Chiang, HI; Chun, J; Lo, YH; Zhang, K				Gole, Jeff; Gore, Athurva; Richards, Andrew; Chiu, Yu-Jui; Fung, Ho-Lim; Bushman, Diane; Chiang, Hsin-I; Chun, Jerold; Lo, Yu-Hwa; Zhang, Kun			Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells	NATURE BIOTECHNOLOGY			English	Article							SPERM CELLS; ANEUPLOIDY; RECOMBINATION; AMPLIFICATION; NUCLEOTIDE; MOSAICISM; EVOLUTION; RARE	Genome sequencing of single cells has a variety of applications, including characterizing difficult-to-culture microorganisms and identifying somatic mutations in single cells from mammalian tissues. A major hurdle in this process is the bias in amplifying the genetic material from a single cell, a procedure known as polymerase cloning. Here we describe the microwell displacement amplification system (MIDAS), a massively parallel polymerase cloning method in which single cells are randomly distributed into hundreds to thousands of nanoliter wells and their genetic material is simultaneously amplified for shotgun sequencing. MIDAS reduces amplification bias because polymerase cloning occurs in physically separated, nanoliter-scale reactors, facilitating the de novo assembly of near-complete microbial genomes from single Escherichia coli cells. In addition, MIDAS allowed us to detect single-copy number changes in primary human adult neurons at 1- to 2-Mb resolution. MIDAS can potentially further the characterization of genomic diversity in many heterogeneous cell populations.	[Gole, Jeff; Gore, Athurva; Richards, Andrew; Fung, Ho-Lim; Chiang, Hsin-I; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, Inst Genom Med, La Jolla, CA 92093 USA; [Gole, Jeff; Gore, Athurva; Richards, Andrew; Fung, Ho-Lim; Chiang, Hsin-I; Zhang, Kun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Chiu, Yu-Jui] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Bushman, Diane; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Lo, Yu-Hwa] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, Inst Genom Med, La Jolla, CA 92093 USA.	kzhang@bioeng.ucsd.edu	t, lf/AAJ-4924-2020; Chun, Jerold/Y-4670-2019; Chiang, Hsin-I/AAF-6578-2020; Zhang, Kun/ABE-6349-2020	Chiang, Hsin-I/0000-0002-2815-4314; Zhang, Kun/0000-0002-7596-5224; CHIU, YU-JUI/0000-0002-5382-106X	US National Institutes of Health [R01HG004876, R01GM097253, U01MH098977, P50HG005550]; National Science Foundation [OCE-1046368]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550, R01HG004876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM097253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH098977] Funding Source: NIH RePORTER; Directorate For Geosciences [1046368] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Chen, H. Choi and the UCSD Nano3 facility for initial help with microwell fabrication, E Liang for initial technical assistance and P. Pevzner for advice on de novo genome assembly. This project was funded by US National Institutes of Health grants R01HG004876, R01GM097253, U01MH098977 and P50HG005550, and National Science Foundation grant OCE-1046368.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Inoue J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl350; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Westra JW, 2008, J COMP NEUROL, V507, P1944, DOI 10.1002/cne.21648; Westra JW, 2010, J COMP NEUROL, V518, P3981, DOI 10.1002/cne.22436; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yang AH, 2003, J NEUROSCI, V23, P10454; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	39	163	178	5	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1126	+		10.1038/nbt.2720	http://dx.doi.org/10.1038/nbt.2720			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24213699	Green Accepted			2022-12-25	WOS:000328251900026
J	Henderson, NC; Arnold, TD; Katamura, Y; Giacomini, MM; Rodriguez, JD; McCarty, JH; Pellicoro, A; Raschperger, E; Betsholtz, C; Ruminski, PG; Griggs, DW; Prinsen, MJ; Maher, JJ; Iredale, JP; Lacy-Hulbert, A; Adams, RH; Sheppard, D				Henderson, Neil C.; Arnold, Thomas D.; Katamura, Yoshio; Giacomini, Marilyn M.; Rodriguez, Juan D.; McCarty, Joseph H.; Pellicoro, Antonella; Raschperger, Elisabeth; Betsholtz, Christer; Ruminski, Peter G.; Griggs, David W.; Prinsen, Michael J.; Maher, Jacquelyn J.; Iredale, John P.; Lacy-Hulbert, Adam; Adams, Ralf H.; Sheppard, Dean			Targeting of alpha(v) integrin identifies a core molecular pathway that regulates fibrosis in several organs	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; ACTIVATES LATENT TGF-BETA-1; RAT HEPATIC LIPOCYTES; INCREASED EXPRESSION; FACTOR RECEPTOR; IN-VIVO; LIVER; INDUCTION; COLLAGEN; CELLS	Myofibroblasts are the major source of extracellular matrix components that accumulate during tissue fibrosis, and hepatic stellate cells (HSCs) are believed to be the major source of myofibroblasts in the liver. To date, robust systems to genetically manipulate these cells have not been developed. We report that Cre under control of the promoter of Pdgfrb (Pdgfrb-Cre) inactivates loxP-flanked genes in mouse HSCs with high efficiency. We used this system to delete the gene encoding alpha(v) integrin subunit because various alpha(v)-containing integrins have been suggested as central mediators of fibrosis in multiple organs. Such depletion protected mice from carbon tetrachloride-induced hepatic fibrosis, whereas global loss of beta(3), beta(5) or beta(6) integrins or conditional loss of beta(8) integrins in HSCs did not. We also found that Pdgfrb-Cre effectively targeted myofibroblasts in multiple organs, and depletion of the alpha(v) integrin subunit using this system was protective in other models of organ fibrosis, including pulmonary and renal fibrosis. Pharmacological blockade of alpha(v)-containing integrins by a small molecule (CWHM 12) attenuated both liver and lung fibrosis, including in a therapeutic manner. These data identify a core pathway that regulates fibrosis and suggest that pharmacological targeting of all alpha(v) integrins may have clinical utility in the treatment of patients with a broad range of fibrotic diseases.	[Henderson, Neil C.; Katamura, Yoshio; Giacomini, Marilyn M.; Rodriguez, Juan D.; Sheppard, Dean] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Henderson, Neil C.; Pellicoro, Antonella; Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Arnold, Thomas D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Raschperger, Elisabeth; Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Raschperger, Elisabeth; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Ruminski, Peter G.; Griggs, David W.; Prinsen, Michael J.] St Louis Univ, Edward A Doisy Res Ctr, Ctr World Hlth & Med, St Louis, MO 63103 USA; [Maher, Jacquelyn J.] Univ Calif San Francisco, Ctr Liver, Dept Med, San Francisco, CA 94143 USA; [Lacy-Hulbert, Adam] Massachusetts Gen Hosp, Dept Pediat, Program Dev Immunol, Boston, MA 02114 USA; [Lacy-Hulbert, Adam] Harvard Univ, Sch Med, Boston, MA USA; [Adams, Ralf H.] Univ Munster, Fac Med, Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany	University of California System; University of California San Francisco; University of Edinburgh; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; Uppsala University; Karolinska Institutet; Saint Louis University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Max Planck Society; University of Munster	Henderson, NC (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA.	neil.henderson@ed.ac.uk; dean.sheppard@ucsf.edu	Adams, Ralf H/AAE-9274-2019; Prinsen, Michael/AAB-3228-2020	Iredale, John/0000-0003-2174-5127; Lacy-Hulbert, Adam/0000-0003-2162-0156	Wellcome Trust Intermediate Clinical Fellowship [085187]; National Institutes of Health [HL102292, HL53949, AI077439]; University of California, San Francisco (UCSF) Liver Center Tool and Technology grant; UCSF Liver Center [P30 DK026743]; Medical Research Council [MR/J010766/1, G0901697] Funding Source: researchfish; MRC [G0901697, G0600033, MR/J010766/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053949, R37HL053949, P01HL108794, R01HL102292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK093695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078402] Funding Source: NIH RePORTER	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco (UCSF) Liver Center Tool and Technology grant; UCSF Liver Center; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Wellcome Trust Intermediate Clinical Fellowship (ref. 085187) to N.C.H., National Institutes of Health grants HL102292, HL53949 and AI077439 (to D.S.), a University of California, San Francisco (UCSF) Liver Center Tool and Technology grant (to N.C.H) and P30 DK026743 (UCSF Liver Center). We thank K. Thorn at the UCSF Nikon Imaging Center for assistance with image analysis. We also thank C. Her, N. Wu, S. Huling, D. Rodrigues and R. Aucott for expert technical assistance. We also acknowledge the contribution of M. Singh (chemical synthesis of compounds CWHM 12 and CWHM 96), D. Tajfirouz, S. Freeman and M. Yates at Saint Louis University for technical assistance in conducting integrin functional assays to characterize compound activities. L. Reichardt (UCSF) provided Itgb8<SUP>flox/flox</SUP> mice and R. Hynes (Massachusetts Institute of Technology) provided Itgb3<SUP>-1-</SUP> mice on 129/svJae background. S. Violette (Biogen Idee) provided antibody to alpha<INF>v</INF>beta<INF>6</INF> (human/mouse chimeric 2A1), W. Stallcup (Sanford-Burnham Medical Research Institute) provided antibody to PDGFR-beta and H. Yagita (Juntendo University) provided antibody to a, integrin (clone RMV-7).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abraham S, 2008, CIRC RES, V102, P562, DOI 10.1161/CIRCRESAHA.107.167908; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; BREUSS JM, 1995, J CELL SCI, V108, P2241; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Coin PG, 1996, J IMMUNOL, V156, P4797; DELEEUW AM, 1984, HEPATOLOGY, V4, P392; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ikura Y, 1997, J GASTROENTEROL, V32, P496, DOI 10.1007/BF02934089; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 1996, AM J PATHOL, V148, P785; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Zhu JW, 2002, DEVELOPMENT, V129, P2891	41	524	558	9	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1617	1624		10.1038/nm.3282	http://dx.doi.org/10.1038/nm.3282			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24216753	Green Accepted, Green Submitted			2022-12-25	WOS:000328181400030
J	Li, MZ; Tian, SL; Jin, L; Zhou, GY; Li, Y; Zhang, Y; Wang, T; Yeung, CKL; Chen, L; Ma, JD; Zhang, JB; Jiang, AA; Li, J; Zhou, CW; Zhang, J; Liu, YK; Sun, XQ; Zhao, HW; Niu, ZX; Lou, PE; Xian, LJ; Shen, XY; Liu, SQ; Zhang, SH; Zhang, MW; Zhu, L; Shuai, SR; Bai, L; Tang, GQ; Liu, HF; Jiang, YZ; Mai, MM; Xiao, J; Wang, X; Zhou, Q; Wang, ZQ; Stothard, P; Xue, M; Gao, XL; Luo, ZG; Gu, YR; Zhu, HM; Hu, XX; Zhao, YF; Plastow, GS; Wang, JY; Jiang, Z; Li, K; Li, N; Li, XW; Li, RQ				Li, Mingzhou; Tian, Shilin; Jin, Long; Zhou, Guangyu; Li, Ying; Zhang, Yuan; Wang, Tao; Yeung, Carol K. L.; Chen, Lei; Ma, Jideng; Zhang, Jinbo; Jiang, Anan; Li, Ji; Zhou, Chaowei; Zhang, Jie; Liu, Yingkai; Sun, Xiaoqing; Zhao, Hongwei; Niu, Zexiong; Lou, Pinger; Xian, Lingjin; Shen, Xiaoyong; Liu, Shaoqing; Zhang, Shunhua; Zhang, Mingwang; Zhu, Li; Shuai, Surong; Bai, Lin; Tang, Guoqing; Liu, Haifeng; Jiang, Yanzhi; Mai, Miaomiao; Xiao, Jian; Wang, Xun; Zhou, Qi; Wang, Zhiquan; Stothard, Paul; Xue, Ming; Gao, Xiaolian; Luo, Zonggang; Gu, Yiren; Zhu, Hongmei; Hu, Xiaoxiang; Zhao, Yaofeng; Plastow, Graham S.; Wang, Jinyong; Jiang, Zhi; Li, Kui; Li, Ning; Li, Xuewei; Li, Ruiqiang			Genomic analyses identify distinct patterns of selection in domesticated pigs and Tibetan wild boars	NATURE GENETICS			English	Article							HIGH-FIBER DIETS; HIGH-ALTITUDE; HUMAN-POPULATIONS; BEHAVIOR; HYPOXIA; ADAPTATION; EVOLUTION; SOWS; PHYLOGEOGRAPHY; HYPERTENSION	We report the sequencing at 131x coverage, de novo assembly and analyses of the genome of a female Tibetan wild boar. We also resequenced the whole genomes of 30 Tibetan wild boars from six major distributed locations and 18 geographically related pigs in China. We characterized genetic diversity, population structure and patterns of evolution. We searched for genomic regions under selection, which includes genes that are involved in hypoxia, olfaction, energy metabolism and drug response. Comparing the genome of Tibetan wild boar with those of neighboring Chinese domestic pigs further showed the impact of thousands of years of artificial selection and different signatures of selection in wild boar and domestic pig. We also report genetic adaptations in Tibetan wild boar that are associated with high altitudes and characterize the genetic basis of increased salivation in domestic pig.	[Li, Mingzhou; Jin, Long; Li, Ying; Wang, Tao; Ma, Jideng; Jiang, Anan; Zhou, Chaowei; Zhang, Jie; Liu, Yingkai; Lou, Pinger; Xian, Lingjin; Zhang, Shunhua; Zhang, Mingwang; Zhu, Li; Shuai, Surong; Bai, Lin; Tang, Guoqing; Liu, Haifeng; Jiang, Yanzhi; Mai, Miaomiao; Xiao, Jian; Wang, Xun; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China; [Li, Mingzhou; Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Li, Mingzhou; Li, Ruiqiang] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Tian, Shilin; Zhou, Guangyu; Zhang, Yuan; Yeung, Carol K. L.; Zhang, Jinbo; Li, Ji; Sun, Xiaoqing; Zhao, Hongwei; Niu, Zexiong; Shen, Xiaoyong; Liu, Shaoqing; Zhu, Hongmei; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Zhou, Qi] Yaan Vocat Coll, Yaan, Peoples R China; [Wang, Zhiquan; Stothard, Paul; Plastow, Graham S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Xue, Ming] Minist Agr China, Natl Anim Husb Serv, Beijing, Peoples R China; [Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Luo, Zonggang] Southwest Univ Rongchang, Dept Anim Sci, Chongqing, Peoples R China; [Gu, Yiren] Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China; [Hu, Xiaoxiang; Zhao, Yaofeng; Li, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Sichuan Agricultural University; Peking University; Peking University; University of Alberta; Ministry of Agriculture & Rural Affairs; University of Houston System; University of Houston; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Li, XW (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China.	xuewei.li@sicau.edu.cn; lirq@pku.edu.cn	zhang, jin/GXV-9154-2022; Tian, Shilin/AAP-9998-2020	Plastow, Graham/0000-0002-3774-3110; Tian, Shilin/0000-0001-8958-1806; Li, Mingzhou/0000-0001-8681-7684	National Special Foundation for Transgenic Species of China [2014ZX0800950B, 2009ZX08009-155B, 2011ZX08006-003]; Foundation for Discipline Construction of Sichuan Agricultural University; Ministry of Agriculture of China [NYCYTX-009]; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province [2011YZGG15]; National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences; China Postdoctoral Science Foundation [2012M520123]; Chongqing Fund for Distinguished Young Scientists [CSTC2010BA1007]; Peking University; Peking-Tsinghua Center for Life Sciences; National Basic Research Program of China [2011CB809201]	National Special Foundation for Transgenic Species of China; Foundation for Discipline Construction of Sichuan Agricultural University; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Fund for Distinguished Young Scientists; Peking University(Peking University); Peking-Tsinghua Center for Life Sciences; National Basic Research Program of China(National Basic Research Program of China)	We thank J. Guan, Y. Liu, Y. Xie, H. Wang and L. Bai for help in preparing the pig tissues. We thank Q. Quan, F. Wang, Y. Tan, Y. Guo and G. Yu for the optimizing chart. We thank S. Zhao and L. Huang for critical review of the manuscript. This work was supported by grants from the National Special Foundation for Transgenic Species of China (2014ZX0800950B, 2009ZX08009-155B and 2011ZX08006-003), the Foundation for Discipline Construction of Sichuan Agricultural University, the Specialized Research Fund of Ministry of Agriculture of China (NYCYTX-009), the Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province (2011YZGG15), the National High Technology Research and Development Program of China (863 Program) (2013AA102502), the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences and the China Postdoctoral Science Foundation (2012M520123) to X. L. and M. L., the Chongqing Fund for Distinguished Young Scientists (CSTC2010BA1007) to J. W. and the Fund of Peking University to the Biodynamic Optical Imaging Center (BIOPIC), the Fund of Peking-Tsinghua Center for Life Sciences and the Fund of National Basic Research Program of China (2011CB809201) to R.L.	Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beall CM, 2004, P NATL ACAD SCI USA, V101, P14300, DOI 10.1073/pnas.0405949101; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Chen JM, 2008, MOL PHYLOGENET EVOL, V48, P168, DOI 10.1016/j.ympev.2008.03.008; Chen KF, 2007, INT J BIOL SCI, V3, P153; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Gerstein HC, 2006, CAN MED ASSOC J, V174, P25, DOI 10.1503/cmaj.050649; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Kanis E, 2004, ANIM SCI, V78, P315, DOI 10.1017/S1357729800054102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kuehn M, 2008, EUR ARCH OTO-RHINO-L, V265, P299, DOI 10.1007/s00405-007-0446-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li Y, 2012, J SYST EVOL, V50, P362, DOI 10.1111/j.1759-6831.2012.00209.x; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Meyer UA, 2013, ANNU REV PHARMACOL, V53, P475, DOI 10.1146/annurev-pharmtox-010510-100502; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramonet Y, 1999, J ANIM SCI, V77, P591; Ramonet Y, 2000, BRIT J NUTR, V84, P85; Romanenko V, 2006, J BIOL CHEM, V281, P27964, DOI 10.1074/jbc.M603871200; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Taylor BJ, 2013, J CARD FAIL, V19, P50, DOI 10.1016/j.cardfail.2012.11.005; Whittaker X, 1999, APPL ANIM BEHAV SCI, V63, P25, DOI 10.1016/S0168-1591(98)00243-3; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhu L, 2009, HIGH ALT MED BIOL, V10, P45, DOI 10.1089/ham.2008.1042	56	329	368	15	283	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1431	U180		10.1038/ng.2811	http://dx.doi.org/10.1038/ng.2811			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24162736				2022-12-25	WOS:000327715800007
J	Kolodziej, M; Klein, I; Reisman, L				Kolodziej, Michael; Klein, Ira; Reisman, Lonny			A new value proposition	NATURE MEDICINE			English	Editorial Material									[Kolodziej, Michael; Klein, Ira; Reisman, Lonny] Aetna, Hartford, CT USA		Kolodziej, M (corresponding author), Aetna, Hartford, CT USA.								0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1365	1365		10.1038/nm1113-1365	http://dx.doi.org/10.1038/nm1113-1365			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202379				2022-12-25	WOS:000326920300009
J	Schiffels, S; Durbin, R				Schiffels, Stephan; Durbin, Richard			Inferring human population size and separation history from multiple genome sequences	NATURE GENETICS			English	Article							CONDITIONAL SAMPLING DISTRIBUTION; ALLELE FREQUENCY-SPECTRUM; MUTATION-RATE; DEMOGRAPHIC HISTORY; GENETIC DIVERSITY; SOUTHERN; COALESCENT; EXPANSION; REVEALS; MITOCHONDRIAL	The availability of complete human genome sequences from populations across the world has given rise to new population genetic inference methods that explicitly model ancestral relationships under recombination and mutation. So far,. application of these methods to evolutionary history more recent than 20,000-30,000 years ago and to population separations has been limited. Here we present a new method that overcomes these shortcomings. The multiple sequentially Markovian coalescent (MSMC) analyzes the observed pattern of mutations in multiple individuals, focusing on the first coalescence between any two individuals. Results from applying MSMC to genome sequences from nine populations across the world suggest that the genetic separation of non-African ancestors from African Yoruban ancestors started long before 50,000 years ago and give information about human population history as recent as 2,000 years ago, including the bottleneck in the peopling of the Americas and separations within Africa, East Asia and Europe.	[Schiffels, Stephan; Durbin, Richard] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	Wellcome Trust Sanger Institute	Schiffels, S (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	stephan.schiffels@sanger.ac.uk	Durbin, Richard/AAE-7178-2019; Schiffels, Stephan/D-5675-2018	Durbin, Richard/0000-0002-9130-1006; Schiffels, Stephan/0000-0002-1017-9150	EMBO (European Molecular Biology Organization); Wellcome Trust [098051]	EMBO (European Molecular Biology Organization)(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Scally for useful comments and discussion, in particular on interpreting population divergence estimates, and the Durbin group for general discussion. S.S. thanks A. Fischer for helpful support with HMM implementation details. We thank J. Kidd, S. Gravel and C. Bustamante for making ancestry tracts for the MXL individuals available to us. S.S. acknowledges grant support from an EMBO (European Molecular Biology Organization) long-term fellowship. This work was funded by Wellcome Trust grant 098051.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032473; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Marjoram P, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-16; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mathieson I., 2014, DEMOGRAPHY AGE RARE; Matsumura S, 2008, P ROY SOC B-BIOL SCI, V275, P1501, DOI 10.1098/rspb.2007.1724; McVean GAT, 2005, PHILOS T R SOC B, V360, P1387, DOI 10.1098/rstb.2005.1673; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Nachman MW, 2000, GENETICS, V156, P297; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Paul JS, 2011, GENETICS, V187, P1115, DOI 10.1534/genetics.110.125534; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Steinrucken M, 2013, THEOR POPUL BIOL, V87, P51, DOI 10.1016/j.tpb.2012.08.004; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811	46	516	523	6	209	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					919	925		10.1038/ng.3015	http://dx.doi.org/10.1038/ng.3015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24952747	Green Submitted, Green Accepted			2022-12-25	WOS:000339704400025
J	Terasaka, N; Hayashi, G; Katoh, T; Suga, H				Terasaka, Naohiro; Hayashi, Gosuke; Katoh, Takayuki; Suga, Hiroaki			An orthogonal ribosome-tRNA pair via engineering of the peptidyl transferase center	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; BOND FORMATION; AMINOACYLATION; END; SYNTHETASES; SITE	The Watson-Crick base pairs between the 3'-terminal end of tRNAs and ribosomal RNA in the peptidyl transferase center are universally conserved. Here, we report that the introduction of compensatory mutations to Escherichia coli RNAs in this site leads to an orthogonal system independent of the wild-type counterpart, as demonstrated via the production of two peptide sequences from a single mRNA. This work thus identifies a new way to reprogram the genetic code.	[Terasaka, Naohiro; Hayashi, Gosuke; Katoh, Takayuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 113, Japan; [Suga, Hiroaki] Univ Tokyo, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Tokyo 113, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Suga, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 113, Japan.	hsuga@chem.s.u-tokyo.ac.jp	Terasaka, Naohiro/I-2537-2018	Terasaka, Naohiro/0000-0002-4988-6899; Katoh, Takayuki/0000-0001-6550-6203	Japan Society for the Promotion of Science (JSPS) [21000005]; Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technology [24-8188, 21-9361]; JSPS [24681047]; JST Rising Star Award of Molecular Technology	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technology; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST Rising Star Award of Molecular Technology	We thank R. Green for the gift of a ribosome construct linked to the MS2 tag. This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Specially Promoted Research (21000005) and the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technology to H.S. N.T. (24-8188) and G.H. (21-9361) are supported by Grants-in-Aid for JSPS Fellows. T.K. is supported by a JSPS Grant-in-Aid for Young Scientists (A) (24681047) and a JST Rising Star Award of Molecular Technology.	Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; CAVARELLI J, 1993, FASEB J, V7, P79, DOI 10.1096/fasebj.7.1.8422978; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Green R, 1998, SCIENCE, V280, P286, DOI 10.1126/science.280.5361.286; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; LIU MS, 1994, P NATL ACAD SCI USA, V91, P10389, DOI 10.1073/pnas.91.22.10389; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ohta A, 2007, CHEM BIOL, V14, P1315, DOI 10.1016/j.chembiol.2007.10.015; Ohuchi M, 2007, CURR OPIN CHEM BIOL, V11, P537, DOI 10.1016/j.cbpa.2007.08.011; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Sako Y, 2008, J AM CHEM SOC, V130, P7232, DOI 10.1021/ja800953c; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; SCHULMAN LH, 1977, BIOCHEMISTRY-US, V16, P4256, DOI 10.1021/bi00638a020; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Xiao H, 2008, NATURE, V454, P358, DOI 10.1038/nature07033; Youngman EM, 2005, METHODS, V36, P305, DOI 10.1016/j.ymeth.2005.04.007; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595	23	45	48	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					555	557		10.1038/NCHEMBIO.1549	http://dx.doi.org/10.1038/NCHEMBIO.1549			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24907900				2022-12-25	WOS:000337871200013
J	Alcolea, MP; Greulich, P; Wabik, A; Frede, J; Simons, BD; Jones, PH				Alcolea, Maria P.; Greulich, Philip; Wabik, Agnieszka; Frede, Julia; Simons, Benjamin D.; Jones, Philip H.			Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change	NATURE CELL BIOLOGY			English	Article							EPIDERMAL-KERATINOCYTES; NOTCH RECEPTORS; HAIR FOLLICLE; STEM-CELLS; CARCINOMA; MUTATIONS; SKIN; CANCERIZATION; INFLAMMATION; EXPRESSION	Multiple cancers may arise from within a clonal region of preneoplastic epithelium, a phenomenon termed 'field change'(1,2). However, it is not known how field change develops. Here we investigate this question using lineage tracing to track the behaviour of scattered single oesophageal epithelial progenitor cells expressing a mutation that inhibits the Notch signalling pathway. Notch is frequently subject to inactivating mutation in squamous cancers(3-6). Quantitative analysis reveals that cell divisions that produce two differentiated daughters are absent from mutant progenitors. As a result, mutant clones are no longer lost by differentiation and become functionally immortal. Furthermore, mutant cells promote the differentiation of neighbouring wild-type cells, which are then lost from the tissue. These effects lead to clonal expansion, with mutant cells eventually replacing the entire epithelium. Notch inhibition in progenitors carrying p53 stabilizing mutations creates large confluent regions of doubly mutant epithelium. Field change is thus a consequence of imbalanced differentiation in individual progenitor cells.	[Alcolea, Maria P.; Wabik, Agnieszka; Frede, Julia; Jones, Philip H.] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge CB2 0XZ, England; [Greulich, Philip; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Jones, PH (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Box 197,Cambridge Biomedical Campus, Cambridge CB2 0XZ, England.	phj20@MRC-CU.cam.ac.uk	Jones, Philip/D-2464-2009; Simons, Benjamin/AAY-8920-2020	Jones, Philip/0000-0002-5904-795X; Simons, Benjamin/0000-0002-3875-7071; Frede, Julia/0000-0002-4380-9673; Greulich, Philip/0000-0001-5247-6738; Alcolea, Maria P./0000-0002-8396-6454	MRC; NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research); Wellcome Trust [WT090334MA, 098357/Z/12/Z]; Deutsche Forschungsgemeinschaft Research Fellowship; European Union Marie Curie Fellowship [PIEF-LIF-2007-220016]; MRC [MC_UU_12022/3, MC_U105370181] Funding Source: UKRI; Cancer Research UK [17257] Funding Source: researchfish; Medical Research Council [MC_UU_12022/3, MC_U105370181] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft Research Fellowship(German Research Foundation (DFG)); European Union Marie Curie Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Warren Pear (University of Pennsylvania) for the DNMaml mouse strain, E. Choolun, K. Murai, J. Fowler and the staff at ARES (Cambridge) for support and technical assistance and R. Kopan for informative discussions. We acknowledge the support of the MRC, the NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research), the Wellcome Trust (grant numbers WT090334MA, P.H.J., and 098357/Z/12/Z, B.D.S.),a Deutsche Forschungsgemeinschaft Research Fellowship (P.G.) and European Union Marie Curie Fellowship PIEF-LIF-2007-220016 (M.P.A.).	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Antal T., 2010, J STAT MECH-THEORY E, V2010; BENNETT WP, 1991, ONCOGENE, V6, P1779; Box GE, 1992, BAYESIAN INFERENCE S; Braakhuis BJM, 2003, CANCER RES, V63, P1727; BURNS ER, 1976, ANAT REC, V184, P265, DOI 10.1002/ar.1091840302; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Demehri S, 2009, DEVELOPMENT, V136, P891, DOI 10.1242/dev.030700; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Haccou P., 2005, BRANCHING PROCESSES; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Naganuma S, 2012, AM J CANCER RES, V2, P459; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ohashi S., 2010, GASTROENTEROLOGY; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Rubio C A, 1987, In Vivo, V1, P35; Sakamoto K, 2012, LAB INVEST, V92, P688, DOI 10.1038/labinvest.2012.9; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198	38	100	100	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2014	16	6					612	+		10.1038/ncb2963	http://dx.doi.org/10.1038/ncb2963			36	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AI2EB	24814514	Green Accepted			2022-12-25	WOS:000336669100017
J	Wang, G; McCain, ML; Yang, LH; He, AB; Pasqualini, FS; Agarwal, A; Yuan, HY; Jiang, DW; Zhang, DH; Zangi, L; Geva, J; Roberts, AE; Ma, Q; Ding, J; Chen, JH; Wang, DZ; Li, K; Wang, JW; Wanders, RJA; Kulik, W; Vaz, FM; Laflamme, MA; Murry, CE; Chien, KR; Kelley, RI; Church, GM; Parker, KK; Pu, WT				Wang, Gang; McCain, Megan L.; Yang, Luhan; He, Aibin; Pasqualini, Francesco Silvio; Agarwal, Ashutosh; Yuan, Hongyan; Jiang, Dawei; Zhang, Donghui; Zangi, Lior; Geva, Judith; Roberts, Amy E.; Ma, Qing; Ding, Jian; Chen, Jinghai; Wang, Da-Zhi; Li, Kai; Wang, Jiwu; Wanders, Ronald J. A.; Kulik, Wim; Vaz, Frederic M.; Laflamme, Michael A.; Murry, Charles E.; Chien, Kenneth R.; Kelley, Richard I.; Church, George M.; Parker, Kevin Kit; Pu, William T.			Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies	NATURE MEDICINE			English	Article							RNA; FIBROBLASTS	Study of monogenic mitochondrial cardiomyopathies may yield insights into mitochondrial roles in cardiac development and disease. Here, we combined patient-derived and genetically engineered induced pluripotent stem cells (iPSCs) with tissue engineering to elucidate the pathophysiology underlying the cardiomyopathy of Barth syndrome (BTHS), a mitochondrial disorder caused by mutation of the gene encoding tafazzin (TAZ). Using BTHS iPSC-derived cardiomyocytes (iPSC-CMs), we defined metabolic, structural and functional abnormalities associated with TAZ mutation. BTHS iPSC-CMs assembled sparse and irregular sarcomeres, and engineered BTHS 'heart-on-chip' tissues contracted weakly. Gene replacement and genome editing demonstrated that TAZ mutation is necessary and sufficient for these phenotypes. Sarcomere assembly and myocardial contraction abnormalities occurred in the context of normal whole-cell ATP levels. Excess levels of reactive oxygen species mechanistically linked TAZ mutation to impaired cardiomyocyte function. Our study provides new insights into the pathogenesis of Barth syndrome, suggests new treatment strategies and advances iPSC-based in vitro modeling of cardiomyopathy.	[Wang, Gang; He, Aibin; Jiang, Dawei; Zhang, Donghui; Zangi, Lior; Geva, Judith; Roberts, Amy E.; Ma, Qing; Ding, Jian; Chen, Jinghai; Wang, Da-Zhi; Li, Kai; Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [McCain, Megan L.; Yang, Luhan; Pasqualini, Francesco Silvio; Agarwal, Ashutosh; Yuan, Hongyan; Church, George M.; Parker, Kevin Kit] Harvard Univ, Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Yang, Luhan; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Roberts, Amy E.] Boston Childrens Hosp, Div Genet, Dept Med, Boston, MA USA; [Wang, Jiwu] Allele Biotechnol & Pharmaceut Inc, San Diego, CA USA; [Wang, Jiwu] Scintillon Inst, Dept Photobiol & Bioengn, San Diego, CA USA; [Wanders, Ronald J. A.; Kulik, Wim; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Clin Chem & Pediat, NL-1105 AZ Amsterdam, Netherlands; [Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Laflamme, Michael A.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Bioengn, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Med & Cardiol, Seattle, WA 98195 USA; [Chien, Kenneth R.] Karolinska Inst, Dept Cell & Mol Biol & Med, Stockholm, Sweden; [Kelley, Richard I.] Kennedy Krieger Inst, Div Metab, Baltimore, MD USA; [Parker, Kevin Kit; Pu, William T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet; Kennedy Krieger Institute; Harvard University	Pu, WT (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	kkparker@seas.harvard.edu; wpu@enders.tch.harvard.edu	He, Aibin/AAI-1639-2019; zhang, donghui/I-5130-2013; Laflamme, Michael/AAV-6791-2021; Yuan, Hongyan/C-3816-2011; zhang, donghui/AAY-4690-2021; Pasqualini, Francesco/AAQ-5928-2021; Pu, William/AAJ-8301-2020; Ding, Jian/F-6996-2015	He, Aibin/0000-0002-3489-2305; Laflamme, Michael/0000-0001-5908-880X; Yuan, Hongyan/0000-0001-8225-0211; zhang, donghui/0000-0001-7258-8577; Pasqualini, Francesco/0000-0001-7038-3121; Pu, William/0000-0002-4551-8079; Ding, Jian/0000-0002-5578-5410; church, george/0000-0001-6232-9969; Vaz, Frederic/0000-0002-9048-1041	Barth Syndrome Foundation; Boston Children's Hospital Translational Investigator Service; US National Institutes of Health (NIH) NHLBI Progenitor Cell Biology Consortium [NIH U01 HL100401, U01 HL100408]; NIH [RC1 HL099618, UH2 TR000522]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000522, UH2TR000522] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099618, U01HL100401, U01HL100408, T32HL007572] Funding Source: NIH RePORTER	Barth Syndrome Foundation; Boston Children's Hospital Translational Investigator Service; US National Institutes of Health (NIH) NHLBI Progenitor Cell Biology Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work supported by the Barth Syndrome Foundation, the Boston Children's Hospital Translational Investigator Service, the US National Institutes of Health (NIH) NHLBI Progenitor Cell Biology Consortium (NIH U01 HL100401 and U01 HL100408), NIH RC1 HL099618, NIH UH2 TR000522 and charitable donations from E. Marram, K. Carpenter and G.F. Smith.	Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j; Alford PW, 2010, BIOMATERIALS, V31, P3613, DOI 10.1016/j.biomaterials.2010.01.079; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Parker KK, 2008, CIRC RES, V103, P340, DOI 10.1161/CIRCRESAHA.108.182469; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Rigaud C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-70; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Steinberg SF, 2013, CIRC RES, V112, P393, DOI 10.1161/CIRCRESAHA.111.300496; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Valianpour F, 2003, J LIPID RES, V44, P560, DOI 10.1194/jlr.M200217-JLR200; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682	30	562	578	7	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					616	623		10.1038/nm.3545	http://dx.doi.org/10.1038/nm.3545			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24813252	Green Accepted, Green Submitted			2022-12-25	WOS:000337071000023
J	Nath, S; Dancourt, J; Shteyn, V; Puente, G; Fong, WM; Nag, S; Bewersdorf, J; Yamamoto, A; Antonny, B; Melia, TJ				Nath, Sangeeta; Dancourt, Julia; Shteyn, Vladimir; Puente, Gabriella; Fong, Wendy M.; Nag, Shanta; Bewersdorf, Joerg; Yamamoto, Ai; Antonny, Bruno; Melia, Thomas J.			Lipidation of the LC3/GABARAP family of autophagy proteins relies on a membrane-curvature-sensing domain in Atg3	NATURE CELL BIOLOGY			English	Article							IN-VITRO RECONSTITUTION; ATG12-ATG5 CONJUGATE; LC3; REVEALS; PHOSPHATIDYLETHANOLAMINE; BILAYERS; SCAFFOLD; DEFECTS; GABARAP; COMPLEX	The components supporting autophagosome growth on the cup-like isolation membrane are likely to be different from those found on closed and maturing autophagosomes. The highly curved rim of the cup may serve as a functionally required surface for transiently associated components of the early acting autophagic machinery. Here we demonstrate that the E2-like enzyme, Atg3, facilitates LC3/GABARAP lipidation only on membranes exhibiting local lipid-packing defects. This activity requires an amino-terminal amphipathic helix similar to motifs found on proteins targeting highly curved intracellular membranes. By tuning the hydrophobicity of this motif, we can promote or inhibit lipidation in vitro and in rescue experiments in Atg3-knockout cells, implying a physiologic role for this stress detection. The need for extensive lipid-packing defects suggests that Atg3 is designed to work at highly curved membranes, perhaps including the limiting edge of the growing phagophore.	[Nath, Sangeeta; Dancourt, Julia; Shteyn, Vladimir; Puente, Gabriella; Nag, Shanta; Bewersdorf, Joerg; Melia, Thomas J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Fong, Wendy M.; Yamamoto, Ai] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Fong, Wendy M.; Yamamoto, Ai] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Fong, Wendy M.; Yamamoto, Ai] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Antonny, Bruno] CNRS, Inst Pharmacol Mol & Cellulaire, F-06103 Paris, France; [Antonny, Bruno] Univ Nice, F-06103 Nice, France	Yale University; Columbia University; Columbia University; Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Melia, TJ (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	thomas.melia@yale.edu	Dancourt, Julia/U-1533-2017; Antonny, Bruno/ABH-7434-2020	Dancourt, Julia/0000-0002-6237-1566; Antonny, Bruno/0000-0002-9166-8668; Bewersdorf, Joerg/0000-0002-4085-7020; Puente, Gabriella/0000-0001-7738-9710	NIH [GM100930, NS063973]; ERC [268888-B.A.]; Yale fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077111, R01NS063973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Yale fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Atg3- knockout MEFs were a gift from M. Komatsu, (Tokyo Metropolitan Organization for Medical Research, Japan) and Atg5 knockout MEFs from N. Mizushima (Tokyo University). This work was financially supported by grants from the NIH (GM100930-T.J.M.) and (NS063973-T.J.M.andA.Y.)and the ERC (advanced grant 268888-B.A.)and by Yale fellowships to G.P.(BioSTEP) and T.J.M. (Anderson). We also thank A. Jotwani and B. Mugo for help with electrophoresis experiments, E. Karatekin for help with dynamic lights cattering and F. Pincet for helpful comments.	Antonny B., 2010, ANN REV BIOCH; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2009, FEBS LETT, V583, P1078, DOI 10.1016/j.febslet.2009.03.009; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hayashi-Nishino M, 2010, AUTOPHAGY, V6, P301, DOI 10.4161/auto.6.2.11134; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jotwani A, 2012, METHOD CELL BIOL, V108, P93, DOI 10.1016/B978-0-12-386487-1.00005-5; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Oh-Oka K, 2008, J BIOL CHEM, V283, P21847, DOI 10.1074/jbc.M801836200; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Proikas-Cezanne T, 2011, J CELL MOL MED, V15, P2007, DOI 10.1111/j.1582-4934.2011.01339.x; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Vamparys L, 2013, BIOPHYS J, V104, P585, DOI 10.1016/j.bpj.2012.11.3836; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	51	163	165	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					415	U80		10.1038/ncb2940	http://dx.doi.org/10.1038/ncb2940			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24747438	Green Accepted			2022-12-25	WOS:000335438400006
J	Kim, DK; Jeong, JH; Lee, JM; Kim, KS; Park, SH; Kim, YD; Koh, M; Shin, M; Jung, YS; Kim, HS; Lee, TH; Oh, BC; Kim, JI; Park, HT; Jeong, WI; Lee, CH; Park, SB; Min, JJ; Jung, SI; Choi, SY; Choy, HE; Choi, HS				Kim, Don-Kyu; Jeong, Jae-Ho; Lee, Ji-Min; Kim, Kwang Soo; Park, Seung-Hwan; Kim, Yong Deuk; Koh, Minseob; Shin, Minsang; Jung, Yoon Seok; Kim, Hyung-Seok; Lee, Tae-Hoon; Oh, Byung-Chul; Kim, Jae Il; Park, Hwan Tae; Jeong, Won-Il; Lee, Chul-Ho; Park, Seung Bum; Min, Jung-Joon; Jung, Sook-In; Choi, Seok-Yong; Choy, Hyon E.; Choi, Hueng-Sik			Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis	NATURE MEDICINE			English	Article							ERR-GAMMA; HEPATIC GLUCONEOGENESIS; KEY REGULATOR; LIVER-INJURY; MACROPHAGES; HEPCIDIN; GROWTH; FERROPORTIN; METABOLISM; EXPRESSION	In response to microbial infection, expression of the defensin-like peptide hepcidin (encoded by Hamp) is induced in hepatocytes to decrease iron release from macrophages(1). To elucidate the mechanism by which Salmonella enterica var. Typhimurium (S. typhimurium), an intramacrophage bacterium, alters host iron metabolism for its own survival, we examined the role of nuclear receptor family members belonging to the NR3B subfamily in mouse hepatocytes. Here, we report that estrogen-related receptor gamma (ERR gamma, encoded by Esrrg) modulates the intramacrophage proliferation of S. typhimurium by altering host iron homeostasis, and we demonstrate an antimicrobial effect of an ERR gamma inverse agonist. Hepatic ERR gamma expression was induced by S. typhimurium-stimulated interleukin-6 signaling, resulting in an induction of hepcidin and eventual hypoferremia in mice. Conversely, ablation of ERR gamma mRNA expression in liver attenuated the S. typhimurium-mediated induction of hepcidin and normalized the hypoferremia caused by S. typhimurium infection. An inverse agonist of ERR gamma ameliorated S. typhimurium-mediated hypoferremia through reduction of ERR gamma-mediated hepcidin mRNA expression and exerted a potent antimicrobial effect on the S. typhimurium infection, thereby improving host survival. Taken together, these findings suggest an alternative approach to control multidrug-resistant intracellular bacteria by modulating host iron homeostasis.	[Kim, Don-Kyu; Lee, Ji-Min; Kim, Yong Deuk; Shin, Minsang; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Natl Creat Res Initiat, Ctr Nucl Receptor Signals, Kwangju, South Korea; [Kim, Don-Kyu; Lee, Ji-Min; Kim, Yong Deuk; Shin, Minsang; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Jeong, Jae-Ho; Kim, Kwang Soo; Choy, Hyon E.] Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea; [Jeong, Jae-Ho; Kim, Kwang Soo; Lee, Tae-Hoon; Min, Jung-Joon; Jung, Sook-In; Choy, Hyon E.] Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Kwangju, South Korea; [Park, Seung-Hwan; Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Kwangju, South Korea; [Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea; [Kim, Hyung-Seok] Chonnam Natl Univ, Sch Med, Dept Forens Med, Kwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Dent Sci Res Inst, Dept Oral Biochem, Kwangju, South Korea; [Oh, Byung-Chul] Gachon Univ, Grad Sch Med, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Jae Il] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Kim, Jae Il] AnyGen, Jeonnam NanoBioRes Ctr, Jangseong Gun, South Korea; [Park, Hwan Tae] Dong A Univ, Coll Med, Mitochondria Hub Regulat Ctr, Dept Physiol, Pusan, South Korea; [Jeong, Won-Il] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Choi, Seok-Yong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU); Chonnam National University; Chonnam National University; Gachon University; Gwangju Institute of Science & Technology (GIST); Dong A University; Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Chonnam National University; Chonnam National University	Choy, HE (corresponding author), Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea.	hyonchoy@jnu.ac.kr; hsc@chonnam.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Park, Seung Bum/N-1901-2014; JEONG, WON IL/B-6615-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Park, Seung Bum/0000-0003-1753-1433; Jeong, Jae-Ho/0000-0002-5544-9572; Park, Seung-Hwan/0000-0003-4613-4680; Koh, Minseob/0000-0003-1935-4776; Shin, Minsang/0000-0001-8679-446X; Oh, Byung-Chul/0000-0002-4277-7083; Choi, Seok-Yong/0000-0001-7193-292X	National Research Foundation of Korea [20110018305, 20100019512, 2012-0006073]; Korean government (Ministry of Science, ICT & Future Planning)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (Ministry of Science, ICT & Future Planning)(Korean Government)	We would like to thank D. Moore, S. Adhya and E.-K. Jo for critical reading of the manuscript, K.A. Cho for technical assistance and M. Shong (Chungnam National University) for providing the TEL-JAK2 construct. This work was supported by a National Creative Research Initiatives Grant (20110018305) and the Future-based Technology Development Program (BIO Fields) (20100019512) through the National Research Foundation of Korea (funded by the Korean government (Ministry of Science, ICT & Future Planning)) (H.-S.C.) and by the National Research Foundation of Korea (no. 2012-0006073) (H.E.C.).	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Byun JS, 2013, J HEPATOL, V58, P342, DOI 10.1016/j.jhep.2012.09.016; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Collins HL, 2008, EUR J IMMUNOL, V38, P1803, DOI 10.1002/eji.200838505; Fritsche G, 2012, J LEUKOCYTE BIOL, V92, P353, DOI 10.1189/jlb.1111554; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Kim DK, 2013, DIABETES, V62, P3093, DOI 10.2337/db12-0946; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939	25	106	109	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					419	+		10.1038/nm.3483	http://dx.doi.org/10.1038/nm.3483			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658075				2022-12-25	WOS:000334361500023
J	Gerlinger, M; Horswell, S; Larkin, J; Rowan, AJ; Salm, MP; Varela, I; Fisher, R; McGranahan, N; Matthews, N; Santos, CR; Martinez, P; Phillimore, B; Begum, S; Rabinowitz, A; Spencer-Dene, B; Gulati, S; Bates, PA; Stamp, G; Pickering, L; Gore, M; Nicol, DL; Hazell, S; Futreal, PA; Stewart, A; Swanton, C				Gerlinger, Marco; Horswell, Stuart; Larkin, James; Rowan, Andrew J.; Salm, Max P.; Varela, Ignacio; Fisher, Rosalie; McGranahan, Nicholas; Matthews, Nicholas; Santos, Claudio R.; Martinez, Pierre; Phillimore, Benjamin; Begum, Sharmin; Rabinowitz, Adam; Spencer-Dene, Bradley; Gulati, Sakshi; Bates, Paul A.; Stamp, Gordon; Pickering, Lisa; Gore, Martin; Nicol, David L.; Hazell, Steven; Futreal, P. Andrew; Stewart, Aengus; Swanton, Charles			Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; INTRATUMOR HETEROGENEITY; SOMATIC MUTATIONS; CANCER; PATTERNS; DIVERSITY; DELETIONS; PBRM1	Clear cell renal carcinomas (ccRCCs) can display intratumor heterogeneity (ITH). We applied multiregion exome sequencing (M-seq) to resolve the genetic architecture and evolutionary histories of ten ccRCCs. Ultra-deep sequencing identified ITH in all cases. We found that 73-75% of identified ccRCC driver aberrations were subclonal, confounding estimates of driver mutation prevalence. ITH increased with the number of biopsies analyzed, without evidence of saturation in most tumors. Chromosome 3p loss and VHL aberrations were the only ubiquitous events. The proportion of C>T transitions at CpG sites increased during tumor progression. M-seq permits the temporal resolution of ccRCC evolution and refines mutational signatures occurring during tumor development.	[Gerlinger, Marco; Rowan, Andrew J.; McGranahan, Nicholas; Santos, Claudio R.; Martinez, Pierre; Swanton, Charles] Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London WC2A 3PX, England; [Horswell, Stuart; Salm, Max P.; Spencer-Dene, Bradley; Gulati, Sakshi; Bates, Paul A.; Stamp, Gordon; Stewart, Aengus] Canc Res UK London Res Inst, London WC2A 3PX, England; [Larkin, James; Fisher, Rosalie; Pickering, Lisa; Gore, Martin] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England; [Varela, Ignacio] Univ Cantabria, Dept Biol Mol, CSIC UC Sodercan, Inst Biomed & Biotecnol Cantabria, E-39005 Santander, Spain; [Matthews, Nicholas; Phillimore, Benjamin; Begum, Sharmin; Rabinowitz, Adam] Canc Res UK London Res Inst, Adv Sequencing Facil, London WC2A 3PX, England; [Nicol, David L.] Royal Marsden Hosp, Dept Urol, London SW3 6JJ, England; [Hazell, Steven] Royal Marsden Hosp, Dept Pathol, London SW3 6JJ, England; [Futreal, P. Andrew] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Swanton, Charles] UCL, Inst Canc, London, England	Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Cancer Research UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of London; University College London	Swanton, C (corresponding author), Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London WC2A 3PX, England.	charles.swanton@cancer.org.uk	Varela, Ignacio/AAA-7680-2021; Varela, Ignacio/G-1699-2016; Bates, Paul A/AAF-8561-2020; McGranahan, Nicholas/ABD-6561-2021; wang, edwin/G-5372-2010; Nicol, David L/M-6809-2016	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Bates, Paul A/0000-0003-0621-0925; McGranahan, Nicholas/0000-0001-9537-4045; Nicol, David L/0000-0002-5623-7467; Swanton, Charles/0000-0002-4299-3018; Martinez, Pierre/0000-0001-7069-4413; Santos, Claudio/0000-0002-8766-2247; Salm, Max/0000-0002-5742-3376; Gerlinger, Marco/0000-0003-2719-299X; Nicol, David/0000-0003-0107-6990; Larkin, James/0000-0001-5569-9523; Horswell, Stuart/0000-0003-2787-1933	Cancer Research UK Biomarkers and Imaging Discovery and Development Committee (BIDD); Medical Research Council; Seventh European Union Framework Programme; Breast Cancer Research Foundation; Rosetrees Trust; Ramon y Cajal program of the Ministerio de Economia y Competitividad, Spain; Novartis; National Institute for Health Research Biomedical Research Centres at University College London Hospitals; Royal Marsden Hospital; Cancer Research UK [10748] Funding Source: researchfish; Medical Research Council [G0902275] Funding Source: researchfish; MRC [G0902275] Funding Source: UKRI	Cancer Research UK Biomarkers and Imaging Discovery and Development Committee (BIDD); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Seventh European Union Framework Programme; Breast Cancer Research Foundation; Rosetrees Trust(Rosetrees Trust); Ramon y Cajal program of the Ministerio de Economia y Competitividad, Spain; Novartis(Novartis); National Institute for Health Research Biomedical Research Centres at University College London Hospitals; Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients, the research nurses at the Royal Marsden Hospital, and Lifetech and Westminster Genomic Services at the University of Westminster, London, for their assistance with validation. C.S. and M. Gerlinger are supported by grants from Cancer Research UK Biomarkers and Imaging Discovery and Development Committee (BIDD), the Medical Research Council and the Seventh European Union Framework Programme, and C.S. is supported by the Breast Cancer Research Foundation and the Rosetrees Trust. We acknowledge the Ramon y Cajal program of the Ministerio de Economia y Competitividad, Spain, and Novartis for funding support for E-PREDICT clinical trials. This study was supported by researchers at the National Institute for Health Research Biomedical Research Centres at University College London Hospitals and at the Royal Marsden Hospital.	Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Purdom PW, 2000, BIOINFORMATICS, V16, P140, DOI 10.1093/bioinformatics/16.2.140; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	43	851	868	1	101	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					225	+		10.1038/ng.2891	http://dx.doi.org/10.1038/ng.2891			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24487277	Green Accepted, Green Submitted			2022-12-25	WOS:000332036700006
J	Sakata-Yanagimoto, M; Enami, T; Yoshida, K; Shiraishi, Y; Ishii, R; Miyake, Y; Muto, H; Tsuyama, N; Sato-Otsubo, A; Okuno, Y; Sakata, S; Kamada, Y; Nakamoto-Matsubara, R; Tran, NB; Izutsu, K; Sato, Y; Ohta, Y; Furuta, J; Shimizu, S; Komeno, T; Sato, Y; Ito, T; Noguchi, M; Noguchi, E; Sanada, M; Chiba, K; Tanaka, H; Suzukawa, K; Nanmoku, T; Hasegawa, Y; Nureki, O; Miyano, S; Nakamura, N; Takeuchi, K; Ogawa, S; Chiba, S				Sakata-Yanagimoto, Mamiko; Enami, Terukazu; Yoshida, Kenichi; Shiraishi, Yuichi; Ishii, Ryohei; Miyake, Yasuyuki; Muto, Hideharu; Tsuyama, Naoko; Sato-Otsubo, Aiko; Okuno, Yusuke; Sakata, Seiji; Kamada, Yuhei; Nakamoto-Matsubara, Rie; Nguyen Bich Tran; Izutsu, Koji; Sato, Yusuke; Ohta, Yasunori; Furuta, Junichi; Shimizu, Seiichi; Komeno, Takuya; Sato, Yuji; Ito, Takayoshi; Noguchi, Masayuki; Noguchi, Emiko; Sanada, Masashi; Chiba, Kenichi; Tanaka, Hiroko; Suzukawa, Kazumi; Nanmoku, Toru; Hasegawa, Yuichi; Nureki, Osamu; Miyano, Satoru; Nakamura, Naoya; Takeuchi, Kengo; Ogawa, Seishi; Chiba, Shigeru			Somatic RHOA mutation in angioimmunoblastic T cell lymphoma	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; TET2; FREQUENT; PHOSPHORYLATION; ALIGNMENT; GTPASES; FAMILY; GENES; FORM	Angioimmunoblastic T cell lymphoma (AITL) is a distinct subtype of peripheral T cell lymphoma characterized by generalized lymphadenopathy and frequent autoimmune-like manifestations(1,2). Although frequent mutations in TET2, IDH2 and DNMT3A, which are common to various hematologic malignancies3,4, have been identified in AITL(5-8), the molecular pathogenesis specific to this lymphoma subtype is unknown. Here we report somatic RHOA mutations encoding a p. Gly17Val alteration in 68% of AITL samples. Remarkably, all cases with the mutation encoding p. Gly17Val also had TET2 mutations. The RHOA mutation encoding p. Gly17Val was specifically identified in tumor cells, whereas TET2 mutations were found in both tumor cells and non-tumor hematopoietic cells. RHOA encodes a small GTPase that regulates diverse biological processes. We demonstrated that the Gly17Val RHOA mutant did not bind GTP and also inhibited wild-type RHOA function. Our findings suggest that impaired RHOA function in cooperation with preceding loss of TET2 function contributes to AITL-specific pathogenesis.	[Sakata-Yanagimoto, Mamiko; Enami, Terukazu; Miyake, Yasuyuki; Muto, Hideharu; Kamada, Yuhei; Nakamoto-Matsubara, Rie; Nguyen Bich Tran; Suzukawa, Kazumi; Hasegawa, Yuichi; Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Yoshida, Kenichi; Sato-Otsubo, Aiko; Okuno, Yusuke; Sato, Yusuke; Sanada, Masashi; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Cancer Genom Project, Tokyo, Japan; [Yoshida, Kenichi; Sato-Otsubo, Aiko; Sato, Yusuke; Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Ishii, Ryohei; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Tsuyama, Naoko; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Sakata, Seiji; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Izutsu, Koji] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Izutsu, Koji] Okinaka Mem Inst Med Res, Tokyo, Japan; [Ohta, Yasunori] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Furuta, Junichi] Univ Tsukuba, Dept Dermatol, Fac Med, Tsukuba, Ibaraki, Japan; [Shimizu, Seiichi] Tsuchiura Kyodo Gen Hosp, Dept Hematol, Tsuchiura, Ibaraki, Japan; [Komeno, Takuya] Natl Hosp Org, Mito Med Ctr, Dept Hematol, Mito, Ibaraki, Japan; [Sato, Yuji] Tsukuba Mem Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan; [Ito, Takayoshi] JA Toride Med Ctr, Dept Hematol, Toride, Japan; [Noguchi, Masayuki] Univ Tsukuba, Dept Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Tsukuba, Ibaraki, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Suzukawa, Kazumi; Nanmoku, Toru] Univ Tsukuba Hosp, Dept Clin Lab, Tsukuba, Ibaraki, Japan; [Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 25911, Japan; [Chiba, Shigeru] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tokyo; Kyoto University; University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Toranomon Hospital; Toranomon Hospital; University of Tsukuba; Tsuchiura Kyodo Hospital; University of Tsukuba; University of Tsukuba; University of Tokyo; University of Tsukuba; Tokai University; University of Tsukuba	Chiba, S (corresponding author), Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan.	sogawa-tky@umin.ac.jp; schiba-t@md.tsukuba.ac.jp	NUREKI, OSAMU/G-4960-2014; Mamiko, Sakata-yanagimoto/AAP-3298-2020; Nguyen, Tran/AAH-8493-2019; Izutsu, Koji/AAI-1125-2019; Ogawa, Seishi/AAE-7088-2019; Okuno, Yusuke/C-9082-2009; Takeuchi, Kengo/C-3614-2008	Okuno, Yusuke/0000-0003-3139-9272; Takeuchi, Kengo/0000-0002-1599-5800; Suzukawa, Kazumi/0000-0001-9904-3905; Miyano, Satoru/0000-0002-1753-6616; Ishii, Ryohei/0000-0003-2486-1393; Yoshida, Kenichi/0000-0003-4612-2778; Tsuyama, Naoko/0000-0002-8718-4599; Izutsu, Koji/0000-0001-9129-8057; Muto, Hideharu/0000-0002-9146-012X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22134006, 22130002, 24390241, 25112703, 25670444, 25461407]; Sagawa Foundation for Promotion of Cancer Research; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [25670444, 24390241] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Foundation for Promotion of Cancer Research; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Okoshi, N. Obara, Y. Yokoyama, H. Nishikii, N. Kurita and M. Seki for contributing to sample collection and banking. We also thank Y. Sakashita and T. Takahashi for technical assistance, and S. Narumiya and I. Kitabayashi for efficient discussion. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22134006 to S. O.; 22130002, 24390241, 25112703 and 25670444 to S. C.; 25461407 to M. S.-Y.) and was supported by the Sagawa Foundation for Promotion of Cancer Research, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (M. S.-Y.).	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Cleverley SC, 2000, ONCOGENE, V19, P13, DOI 10.1038/sj.onc.1203259; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleige A, 2007, J BIOL CHEM, V282, P24320, DOI 10.1074/jbc.M703119200; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Rodriguez-Pinilla SM, 2008, AM J SURG PATHOL, V32, P1787, DOI 10.1097/PAS.0b013e31817f123e; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mylona A, 2011, MOL CELL BIOL, V31, P267, DOI 10.1128/MCB.01058-10; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow S.H., 2008, WHO CLASSIFICATION T, P306; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041007; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	34	382	392	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					171	+		10.1038/ng.2872	http://dx.doi.org/10.1038/ng.2872			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413737				2022-12-25	WOS:000331208300014
J	Wong, CC; Martincorena, I; Rust, AG; Rashid, M; Alifrangis, C; Alexandrov, LB; Tiffen, JC; Kober, C; Green, AR; Massie, CE; Nangalia, J; Lempidaki, S; Dohner, H; Dhner, K; Bray, SJ; McDermott, U; Papaemmanuil, E; Campbell, PJ; Adams, DJ				Wong, Chi C.; Martincorena, Inigo; Rust, Alistair G.; Rashid, Mamunur; Alifrangis, Constantine; Alexandrov, Ludmil B.; Tiffen, Jessamy C.; Kober, Christina; Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti; Lempidaki, Stella; Doehner, Hartmut; Dhner, Konstanze; Bray, Sarah J.; McDermott, Ultan; Papaemmanuil, Elli; Campbell, Peter J.; Adams, David J.		Chronic Myeloid Disorders Working	Inactivating CUX1 mutations promote tumorigenesis	NATURE GENETICS			English	Article							RECURRENT SOMATIC MUTATIONS; CCAAT DISPLACEMENT PROTEIN; DNA-BINDING; FREQUENT MUTATIONS; GENOMIC COMPLEXITY; GENETIC LANDSCAPE; DRIVER MUTATIONS; CELL CARCINOMA; CUT REPEATS; EXOME	A major challenge in cancer genetics is to determine which low-frequency somatic mutations are drivers of tumorigenesis. Here we interrogate the genomes of 7,651 diverse human cancers and find inactivating mutations in the homeodomain transcription factor gene CUX1 (cut-like homeobox 1) in similar to 1-5% of various tumors. Meta-analysis of CUX1 mutational status in 2,519 cases of myeloid malignancies reveals disruptive mutations associated with poor survival, highlighting the clinical significance of CUX1 loss. In parallel, we validate CUX1 as a bona fide tumor suppressor using mouse transposon-mediated insertional mutagenesis and Drosophila cancer models. We demonstrate that CUX1 deficiency activates phosphoinositide 3-kinase (PI3K) signaling through direct transcriptional downregulation of the PI3K inhibitor PIK3IP1 (phosphoinositide-3-kinase interacting protein 1), leading to increased tumor growth and susceptibility to PI3K-AKT inhibition. Thus, our complementary approaches identify CUX1 as a pan-driver of tumorigenesis and uncover a potential strategy for treating CUX1-mutant tumors.	[Wong, Chi C.; Rust, Alistair G.; Rashid, Mamunur; Tiffen, Jessamy C.; Kober, Christina; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Cambridge, England; [Wong, Chi C.; Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Martincorena, Inigo; Alifrangis, Constantine; Alexandrov, Ludmil B.; Papaemmanuil, Elli; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge, England; [Lempidaki, Stella; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Doehner, Hartmut; Dhner, Konstanze] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; Ulm University	Adams, DJ (corresponding author), Wellcome Trust Sanger Inst, Expt Canc Genet, Cambridge, England.	da1@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Döhner, Hartmut/C-8933-2016	Alexandrov, Ludmil/0000-0003-3596-4515; Döhner, Hartmut/0000-0003-2116-5536; Green, Anthony/0000-0002-9795-0218; Massie, Charlie/0000-0003-2314-4843; Martincorena, Inigo/0000-0003-1122-4416; Adams, David/0000-0001-9490-0306; Rust, Alistair/0000-0001-7287-192X; McDermott, Ultan/0000-0001-9032-4700; Bray, Sarah/0000-0002-1642-599X	Cancer Research UK; Wellcome Trust; European Research Council; Medical Research Council; Leukemia and Lymphoma Research; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America; EMBO; Kay Kendall Leukaemia Fund Clinical Fellowship; MRC [G0800034, MR/L007177/1] Funding Source: UKRI; Cancer Research UK [13031, 16629] Funding Source: researchfish; Medical Research Council [MR/L007177/1, G0800034] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukemia and Lymphoma Research; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); EMBO(European Molecular Biology Organization (EMBO)); Kay Kendall Leukaemia Fund Clinical Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PLKO.pig vector was a kind gift from I. Lemischka (Mount Sinai School of Medicine). Plasmids pXJ42 and pXJ myc-CUX1<SUP>p110</SUP>-HA were kindly provided by A. Nepveu (McGill University). We thank D. Pask, J. Carter, T. Hamilton and staff of the Sanger RSF for animal husbandry. C. C. W. and D. J. A. are supported by Cancer Research UK, The Wellcome Trust and the European Research Council. S. J. B. and S. L. are supported by the Medical Research Council. Work in the A. R. G. laboratory is supported by Leukemia and Lymphoma Research, Cancer Research UK, the Kay Kendall Leukaemia Fund, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, and the Leukemia & Lymphoma Society of America. I. M. is supported by an EMBO Long-Term Fellowship. J.N. is supported by a Kay Kendall Leukaemia Fund Clinical Fellowship. U. M. is supported by a Cancer Research UK Clinician Scientist Fellowship.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goulet B, 2002, CANCER RES, V62, P6625; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulea L, 2012, GENE, V497, P18, DOI 10.1016/j.gene.2012.01.039; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schlenk RF, 2010, J CLIN ONCOL, V28, P4642, DOI 10.1200/JCO.2010.28.6856; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Terriente-Felix A, 2013, DEVELOPMENT, V140, P926, DOI 10.1242/dev.086785; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhai ZZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002582; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	72	86	87	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					33	+		10.1038/ng.2846	http://dx.doi.org/10.1038/ng.2846			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316979	Green Accepted			2022-12-25	WOS:000329113500009
J	Flower, DR				Flower, Darren R.			Designing immunogenic peptides	NATURE CHEMICAL BIOLOGY			English	Article							IN-VITRO ANALYSIS; BIOINFORMATIC APPROACH; PREDICTION; BINDING; SUPERTYPES; SILICO	Peptides fulfill many roles in immunology, yet none are more important than their role as immunogenic epitopes driving the adaptive immune response, our ultimate bulwark against infectious disease. Peptide epitopes are mediated primarily by their interaction with major histocompatibility complexes (T-cell epitopes) and antibodies (B-cell epitopes). As pathogen genomes continue to be revealed, both experimental and computational epitope mapping are becoming crucial tools in vaccine discovery(1,2). Immunoinformatics offers many tools, techniques and approaches for in silico epitope characterization, which is capable of greatly accelerating epitope design.	Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Flower, DR (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	d.r.flower@aston.ac.uk	Flower, Darren/F-1263-2010	Flower, Darren/0000-0002-8542-7067				Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Deavin AJ, 1996, MOL IMMUNOL, V33, P145, DOI 10.1016/0161-5890(95)00120-4; Donnes P, 2005, PROTEIN SCI, V14, P2132, DOI 10.1110/ps.051352405; Doytchinova IA, 2006, J MED CHEM, V49, P2193, DOI 10.1021/jm050876m; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Doytchinova IA, 2004, J IMMUNOL, V172, P7495, DOI 10.4049/jimmunol.172.12.7495; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS4, DOI 10.1186/1745-7580-6-S2-S4; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Macdonald IK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001149; Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Walshe VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008095	18	25	29	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					748	752		10.1038/nchembio.1383	http://dx.doi.org/10.1038/nchembio.1383			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231606				2022-12-25	WOS:000327130000002
J	Hartwell, KA; Miller, PG; Mukherjee, S; Kahn, AR; Stewart, AL; Logan, DJ; Negri, JM; Duvet, M; Jaras, M; Puram, R; Dancik, V; Al-Shahrour, F; Kindler, T; Tothova, Z; Chattopadhyay, S; Hasaka, T; Narayan, R; Dai, MJ; Huang, C; Shterental, S; Chu, LP; Haydu, JE; Shieh, JH; Steensma, DP; Munoz, B; Bittker, JA; Shamji, AF; Clemons, PA; Tolliday, NJ; Carpenter, AE; Gilliland, DG; Stern, AM; Moore, MAS; Scadden, DT; Schreiber, SL; Ebert, BL; Golub, TR				Hartwell, Kimberly A.; Miller, Peter G.; Mukherjee, Siddhartha; Kahn, Alissa R.; Stewart, Alison L.; Logan, David J.; Negri, Joseph M.; Duvet, Mildred; Jaeras, Marcus; Puram, Rishi; Dancik, Vlado; Al-Shahrour, Fatima; Kindler, Thomas; Tothova, Zuzana; Chattopadhyay, Shrikanta; Hasaka, Thomas; Narayan, Rajiv; Dai, Mingji; Huang, Christina; Shterental, Sebastian; Chu, Lisa P.; Haydu, J. Erika; Shieh, Jae Hung; Steensma, David P.; Munoz, Benito; Bittker, Joshua A.; Shamji, Alykhan F.; Clemons, Paul A.; Tolliday, Nicola J.; Carpenter, Anne E.; Gilliland, D. Gary; Stern, Andrew M.; Moore, Malcolm A. S.; Scadden, David T.; Schreiber, Stuart L.; Ebert, Benjamin L.; Golub, Todd R.			Niche-based screening identifies small-molecule inhibitors of leukemia stem cells	NATURE CHEMICAL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; PROGENITOR CELLS; STROMAL CELLS; PROTEIN TRANSFERASE; FREQUENCY-ANALYSIS; INDUCED APOPTOSIS; IN-VIVO; CANCER; GENES; MICE	Efforts to develop more effective therapies for acute leukemia may benefit from high-throughput screening systems that reflect the complex physiology of the disease, including leukemia stem cells (LSCs) and supportive interactions with the bone marrow microenvironment. The therapeutic targeting of LSCs is challenging because LSCs are highly similar to normal hematopoietic stem and progenitor cells (HSPCs) and are protected by stromal cells in vivo. We screened 14,718 compounds in a leukemia-stroma co-culture system for inhibition of cobblestone formation, a cellular behavior associated with stem-cell function. Among those compounds that inhibited malignant cells but spared HSPCs was the cholesterol-lowering drug lovastatin. Lovastatin showed anti-LSC activity in vitro and in an in vivo bone marrow transplantation model. Mechanistic studies demonstrated that the effect was on target, via inhibition of HMG-CoA reductase. These results illustrate the power of merging physiologically relevant models with high-throughput screening.	[Hartwell, Kimberly A.; Stewart, Alison L.; Logan, David J.; Negri, Joseph M.; Duvet, Mildred; Dancik, Vlado; Al-Shahrour, Fatima; Chattopadhyay, Shrikanta; Hasaka, Thomas; Narayan, Rajiv; Dai, Mingji; Huang, Christina; Munoz, Benito; Bittker, Joshua A.; Shamji, Alykhan F.; Clemons, Paul A.; Tolliday, Nicola J.; Carpenter, Anne E.; Gilliland, D. Gary; Stern, Andrew M.; Scadden, David T.; Schreiber, Stuart L.; Ebert, Benjamin L.; Golub, Todd R.] Broad Inst, Cambridge, MA 02142 USA; [Hartwell, Kimberly A.; Miller, Peter G.; Jaeras, Marcus; Puram, Rishi; Al-Shahrour, Fatima; Kindler, Thomas; Tothova, Zuzana; Shterental, Sebastian; Chu, Lisa P.; Haydu, J. Erika; Gilliland, D. Gary; Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Hartwell, Kimberly A.; Miller, Peter G.; Jaeras, Marcus; Puram, Rishi; Al-Shahrour, Fatima; Kindler, Thomas; Tothova, Zuzana; Shterental, Sebastian; Chu, Lisa P.; Haydu, J. Erika; Steensma, David P.; Gilliland, D. Gary; Ebert, Benjamin L.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Mukherjee, Siddhartha; Duvet, Mildred; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Mukherjee, Siddhartha; Duvet, Mildred; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Kahn, Alissa R.; Shieh, Jae Hung] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Chattopadhyay, Shrikanta; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Dai, Mingji; Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Steensma, David P.; Gilliland, D. Gary; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gilliland, D. Gary; Schreiber, Stuart L.; Golub, Todd R.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Chevy Chase, MD USA; [Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Golub, TR (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	m-moore@ski.mskcc.org; dscadden@mgh.harvard.edu; stuart_schreiber@harvard.edu; bebert@partners.org; golub@broadinstitute.org	DAI, M/GPS-8291-2022; Kindler, Thomas/K-5995-2013; Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; Kahn, Alissa/0000-0003-2248-8505; Miller, Peter/0000-0002-6797-9335; Stern, Andrew/0000-0002-8437-2957; Jaras, Marcus/0000-0003-4080-7055; Steensma, David/0000-0001-5130-9284	Starr Cancer Consortium (SCC) [l1 A50]; US National Institutes of Health [U54CA112962, U01HL1004402, T32 HL007623, T32 GM007753, N01-CO-12400, R01 GM089652, RL1CA133834, 20XS139, RL1HG004671, RL1GM084437, UL1RR024924]; US National Science Foundation [DBI 1148823]; NATIONAL CANCER INSTITUTE [RL1CA133834, U54CA112962, P30CA008748, K08CA158149, T32CA009172] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, F32HL010044] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437, T32GM007753, R01GM089652] Funding Source: NIH RePORTER	Starr Cancer Consortium (SCC); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank L. VerPlank, V. Raksakulthai, A. Liberzon, M. Palmer, G. Cowley, J. Burbank, P. Aspesi Jr., M. Bliss-Moreau, D. Barker, B. Wagner, A. Krivtsov, S. A. Armstrong, R. Karmacharya, J. Perez, R. Onofrio, D. Thomas, R. Busanelli, D. Auclair, K. Masson, J. Du, C. Moore, M. Kharas, Y. Hoshida, D. Bachovchin, A. Mullally, J. Grabarek, A. Fraser, A. Basu, J. Cheah, N. Bodycombe, C. Mulrooney, S. Johnston, G. Walzer, D. Wilpitz, A. Bracha, A. Fabian, C. Hon, J. McGrath, C. Hartland, M. Hickey, T. R. Jones, M. Bray, K. Sokolnicki, R. Okabe, M. Paktinat, M. McConkey, L. Gaffney, L. Solomon, K. Rose and Broad Compound Management. We also thank the Golub, Gilliland and Ebert laboratories for scientific discussions and technical expertise. This work was funded by grants from the Starr Cancer Consortium (SCC Award l1 A50), the US National Institutes of Health (U54CA112962, U01HL1004402, T32 HL007623, T32 GM007753, N01-CO-12400, R01 GM089652, RL1CA133834, 20XS139, RL1HG004671, RL1CA133834, RL1GM084437 and UL1RR024924) and the US National Science Foundation (DBI 1148823). The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. T. R. G., D. G. G. and S. L. S. are investigators at the Howard Hughes Medical Institute.	Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Costello RT, 2000, CANCER RES, V60, P4403; Despeaux M, 2011, LEUKEMIA, V25, P1789, DOI 10.1038/leu.2011.145; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Escuin D, 2009, CELL CYCLE, V8, P3914, DOI 10.4161/cc.8.23.10105; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Konstantinopoulos PA, 2007, TRENDS PHARMACOL SCI, V28, P6, DOI 10.1016/j.tips.2006.11.005; Kornblau SM, 2007, BLOOD, V109, P2999, DOI 10.1182/blood-2006-08-044446; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Langdon Wallace Y., 2012, Critical Reviews in Oncogenesis, V17, P199; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Lobell RB, 2001, CANCER RES, V61, P8758; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Osmak M, 2012, CANCER LETT, V324, P1, DOI 10.1016/j.canlet.2012.04.011; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; PLOEMACHER RE, 1991, BLOOD, V78, P2527; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; STENTOFT J, 1990, DRUG SAFETY, V5, P7, DOI 10.2165/00002018-199005010-00003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terpstra W, 1996, BLOOD, V87, P2187, DOI 10.1182/blood.V87.6.2187.bloodjournal8762187; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147	52	85	87	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					840	+		10.1038/NCHEMBIO.1367	http://dx.doi.org/10.1038/NCHEMBIO.1367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24161946	Green Accepted			2022-12-25	WOS:000327130000017
J	Selvaraj, S; Dixon, JR; Bansal, V; Ren, B				Selvaraj, Siddarth; Dixon, Jesse R.; Bansal, Vikas; Ren, Bing			Whole-genome haplotype reconstruction using proximity-ligation and shotgun sequencing	NATURE BIOTECHNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE ASSOCIATIONS; DNA METHYLATION; VARIANTS; MAP; EXPRESSION; FRAMEWORK; ORIGIN; CELLS; LOCI	Rapid advances in high-throughput sequencing facilitate variant discovery and genotyping, but linking variants into a single haplotype remains challenging. Here we demonstrate HaploSeq, an approach for assembling chromosome-scale haplotypes by exploiting the existence of 'chromosome territories'. We use proximity ligation and sequencing to show that alleles on homologous chromosomes occupy distinct territories, and therefore this experimental protocol preferentially recovers physically linked DNA variants on a homolog. Computational analysis of such data sets allows for accurate (similar to 99.5%) reconstruction of chromosome-spanning haplotypes for similar to 95% of alleles in hybrid mouse cells with 30x sequencing coverage. To resolve haplotypes for a human genome, which has a low density of variants, we coupled HaploSeq with local conditional phasing to obtain haplotypes for similar to 81% of alleles with similar to 98% accuracy from just 17x sequencing. Whereas methods based on proximity ligation were originally designed to investigate spatial organization of genomes, our results lend support for their use as a general tool for haplotyping.	[Selvaraj, Siddarth; Dixon, Jesse R.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA USA; [Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Bansal, Vikas] Scripps Translat Sci Inst, La Jolla, CA USA; [Bansal, Vikas] Scripps Hlth, La Jolla, CA USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181	Ludwig Institute for Cancer Research; Roadmap Epigenome Project [U01 ES017166]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; Roadmap Epigenome Project; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Heard for providing the CASTxJ129 hybrid mouse ES cell line for this study. We thank V. Bafna for providing valuable suggestions in the course of the work. We are also grateful for the comments on this manuscript by K. Zhang. Funding for this study is provided by the Ludwig Institute for Cancer Research and the Roadmap Epigenome Project (U01 ES017166).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Krueger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038983; Levy S., PLOS BIOL; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108; Zeng D, 2005, GENET EPIDEMIOL, V28, P70, DOI 10.1002/gepi.20040; Zschocke J, 2008, J INHERIT METAB DIS, V31, P599, DOI 10.1007/s10545-008-1016-5	46	167	183	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1111	+		10.1038/nbt.2728	http://dx.doi.org/10.1038/nbt.2728			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24185094	Green Accepted			2022-12-25	WOS:000328251900024
J	Cheloha, RW; Maeda, A; Dean, T; Gardella, TJ; Gellman, SH				Cheloha, Ross W.; Maeda, Akira; Dean, Thomas; Gardella, Thomas J.; Gellman, Samuel H.			Backbone modification of a polypeptide drug alters duration of action in vivo	NATURE BIOTECHNOLOGY			English	Article							ALPHA-HELIX MIMICRY; AMINO-ACID RESIDUES; PARATHYROID-HORMONE; RECEPTOR CONFORMATION; PROTEIN; PEPTIDES; ANALOGS; RECOGNITION; MECHANISM; CAMP	Systematic modification of the backbone of bioactive polypeptides through beta-amino acid residue incorporation could provide a strategy for generating molecules with improved drug properties, but such alterations can result in lower receptor affinity and potency. Using an agonist of parathyroid hormone receptor-1 (PTHR1), a G protein-coupled receptor in the B-family, we present an approach for alpha ->beta residue replacement that enables both high activity and improved pharmacokinetic properties in vivo.	[Cheloha, Ross W.; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Maeda, Akira; Dean, Thomas; Gardella, Thomas J.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Maeda, Akira; Dean, Thomas; Gardella, Thomas J.] Harvard Univ, Sch Med, Boston, MA USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gardella, TJ (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	gardella@helix.mgh.harvard.edu; gellman@chem.wisc.edu			US National Institutes of Health [GM056414, NIDDK-11794]; National Institutes of Health Biotechnology Training grant [T32 GM008349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349, R01GM056414] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biotechnology Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (GM056414 (to S. H. G.) and NIDDK-11794 (to T.J.G.)). R. W. C. was supported in part by a National Institutes of Health Biotechnology Training grant (T32 GM008349).	Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Boersma MD, 2012, J AM CHEM SOC, V134, P315, DOI 10.1021/ja207148m; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Denton EV, 2013, ORG LETT, V15, P5318, DOI 10.1021/ol402568j; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Hoare SRJ, 2001, J BIOL CHEM, V276, P7741, DOI 10.1074/jbc.M009395200; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Johnson LM, 2013, METHOD ENZYMOL, V523, P407, DOI 10.1016/B978-0-12-394292-0.00019-9; Kostenuik PJ, 2007, J BONE MINER RES, V22, P1534, DOI 10.1359/JBMR.070616; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Peggion E, 2002, BIOCHEMISTRY-US, V41, P8162, DOI 10.1021/bi0200155; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Schievano E, 2003, BIOPOLYMERS, V70, P534, DOI 10.1002/bip.10508; Serada M, 2012, XENOBIOTICA, V42, P398, DOI 10.3109/00498254.2011.622811; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UZAWA T, 1995, BONE, V16, P477; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Winer KK, 2008, J CLIN ENDOCR METAB, V93, P3389, DOI 10.1210/jc.2007-2552	20	86	88	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					653	+		10.1038/nbt.2920	http://dx.doi.org/10.1038/nbt.2920			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24929976	Green Accepted			2022-12-25	WOS:000338705900030
J	Qin, H; Lerman, B; Sakamaki, I; Wei, GW; Cha, SCC; Rao, SS; Qian, JF; Hailemichael, Y; Nurieva, R; Dwyer, KC; Roth, J; Yi, Q; Overwijk, WW; Kwak, LW				Qin, Hong; Lerman, Beatrisa; Sakamaki, Ippei; Wei, Guowei; Cha, Soungchul C.; Rao, Sheetal S.; Qian, Jianfei; Hailemichael, Yared; Nurieva, Roza; Dwyer, Karen C.; Roth, Johannes; Yi, Qing; Overwijk, Willem W.; Kwak, Larry W.			Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice	NATURE MEDICINE			English	Article							ACCUMULATION; CANCER; S100A9	Immune evasion is an emerging hallmark of cancer progression. However, functional studies to understand the role of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment are limited by the lack of available specific cell surface markers. We adapted a competitive peptide phage display platform to identify candidate peptides binding MDSCs specifically and generated peptide-Fc fusion proteins (peptibodies). In multiple tumor models, intravenous peptibody injection completely depleted blood, splenic and intratumoral MDSCs in tumor-bearing mice without affecting proinflammatory immune cell types, such as dendritic cells. Whereas control Gr-1-specific antibody primarily depleted granulocytic MDSCs, peptibodies depleted both granulocytic and monocytic MDSC subsets. Peptibody treatment was associated with inhibition of tumor growth in vivo, which was superior to that achieved with Gr-1-specific antibody. Immunoprecipitation of MDSC membrane proteins identified S100 family proteins as candidate targets. Our strategy may be useful to identify new diagnostic and therapeutic surface targets on rare cell subtypes, including human MDSCs.	[Qin, Hong; Lerman, Beatrisa; Sakamaki, Ippei; Wei, Guowei; Cha, Soungchul C.; Rao, Sheetal S.; Qian, Jianfei; Yi, Qing; Kwak, Larry W.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Qin, Hong; Lerman, Beatrisa; Sakamaki, Ippei; Wei, Guowei; Cha, Soungchul C.; Rao, Sheetal S.; Qian, Jianfei; Hailemichael, Yared; Nurieva, Roza; Dwyer, Karen C.; Yi, Qing; Overwijk, Willem W.; Kwak, Larry W.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Lerman, Beatrisa; Kwak, Larry W.] Univ Texas Grad Sch Biomed Sci, Houston, TX USA; [Hailemichael, Yared; Overwijk, Willem W.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Nurieva, Roza] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Dwyer, Karen C.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Munster	Kwak, LW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.	lkwak@mdanderson.org		Kwak, Larry/0000-0002-1884-5349	Developmental Research Program award from the US National Cancer Institute Specialized Programs of Research Excellence in Lymphoma [P50 CA136411]; NATIONAL CANCER INSTITUTE [P50CA136411, P30CA016672] Funding Source: NIH RePORTER	Developmental Research Program award from the US National Cancer Institute Specialized Programs of Research Excellence in Lymphoma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Developmental Research Program award to H.Q. from the US National Cancer Institute Specialized Programs of Research Excellence in Lymphoma (P50 CA136411). We thank D. Hawke for performing proteomic sequencing and analyzing results, D. Kusewitt (M.D. Anderson Cancer Center) for providing S100A9-deficient mice and D. Gwak for editing assistance.	Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Kallberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034207; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Ugel S, 2009, CURR OPIN PHARMACOL, V9, P470, DOI 10.1016/j.coph.2009.06.014; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x	16	148	160	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					676	681		10.1038/nm.3560	http://dx.doi.org/10.1038/nm.3560			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24859530	Green Accepted			2022-12-25	WOS:000337071000032
J	Bejarano, E; Yuste, A; Patel, B; Stout, RF; Spray, DC; Cuervo, AM				Bejarano, Eloy; Yuste, Andrea; Patel, Bindi; Stout, Randy F., Jr.; Spray, David C.; Cuervo, Ana Maria			Connexins modulate autophagosome biogenesis	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PLASMA-MEMBRANE; GAP-JUNCTIONS; RAT-LIVER; PATHWAY; PHOSPHORYLATION; CONTRIBUTES; ENDOCYTOSIS; INHIBITION; MATURATION	The plasma membrane contributes to the formation of autophagosomes, the double-membrane vesicles that sequester cytosolic cargo and deliver it to lysosomes for degradation during autophagy. In this study, we have identified a regulatory role for connexins (Cx), the main components of plasma membrane gap junctions, in autophagosome formation. We have found that plasma-membrane-localized Cx proteins constitutively downregulate autophagy through a direct interaction with several autophagy-related proteins involved in the initial steps of autophagosome formation, such as Atg 16 and components of the PI(3) K autophagy initiation complex (Vps34, Beclin-1 and Vps15). On nutrient starvation, this inhibitory effect is released by the arrival of Atg 14 to the Cx-Atg complex. This promotes the internalization of Cx-Atg along with Atg9, which is also recruited to the plasma membrane in response to starvation. Maturation of the Cx-containing pre-autophagosomes into autophagosomes leads to degradation of these endogenous inhibitors, allowing for sustained activation of autophagy.	[Bejarano, Eloy; Yuste, Andrea; Patel, Bindi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Bejarano, Eloy; Yuste, Andrea; Patel, Bindi; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Stout, Randy F., Jr.; Spray, David C.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	ana-maria.cuervo@einstein.yu.edu	Bejarano, Eloy/AAJ-4708-2021	Bejarano, Eloy/0000-0001-8390-1581; Cuervo, Ana Maria/0000-0002-0771-700X; Stout, Randy/0000-0003-2725-306X; Spray, David/0000-0001-8368-5073	NIH/NIA [AG031782, AG038072, 5T32NS007439, DK041018]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021860, P30DK041296, R01DK098408, P01DK041918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, P30AG038072, R01AG021904, P01AG031782] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Mizushima for providing the Atg 5<SUP>-/-</SUP> MEFs, M. M. Thi for the immortalized WT and Cx43<SUP>-/-</SUP> osteoblast celllines, A. Diaz-Carretero for technical assistance on DNA preparations and cell culture and S. Kaushik and S. Hutten for critically reviewing this manuscript. This work was supported by grants NIH/NIA AG031782, AG038072, 5T32NS007439 and DK041018 and the generous support of Robert and Renee Belfer.	AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; Dahm L, 2010, CELL BIOL TOXICOL, V26, P579, DOI 10.1007/s10565-010-9165-3; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Guan XJ, 1996, CARCINOGENESIS, V17, P1791, DOI 10.1093/carcin/17.9.1791; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Johnstone SR, 2012, J MEMBRANE BIOL, V245, P319, DOI 10.1007/s00232-012-9453-3; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mureli S, 2013, AM J PHYSIOL-HEART C, V304, pH600, DOI 10.1152/ajpheart.00533.2012; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Reggiori F, 2012, J CELL BIOL, V198, P151, DOI 10.1083/jcb.201206119; Rowland AM, 2006, J NEUROSCI, V26, P1711, DOI 10.1523/JNEUROSCI.2279-05.2006; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shah US, 2001, J ENDOCRINOL, V171, P199, DOI 10.1677/joe.0.1710199; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; SLUSAREWICZ P, 1994, J CELL BIOL, V124, P405, DOI 10.1083/jcb.124.4.405; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thi MM, 2010, AM J PHYSIOL-CELL PH, V299, pC994, DOI 10.1152/ajpcell.00544.2009; Turner MS, 2004, CIRC RES, V95, P726, DOI 10.1161/01.RES.0000144805.11519.1e; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	53	95	98	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					401	U55		10.1038/ncb2934	http://dx.doi.org/10.1038/ncb2934			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24705551	Green Accepted			2022-12-25	WOS:000335438400005
J	Bullen, CK; Laird, GM; Durand, CM; Siliciano, JD; Siliciano, RF				Bullen, C. Korin; Laird, Gregory M.; Durand, Christine M.; Siliciano, Janet D.; Siliciano, Robert F.			New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE INHIBITORS; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; ACTIVATION; REACTIVATION; EXPRESSION; RESERVOIR; PROSTRATIN; REPLICATION; STABILITY	HIV-1 persists in a latent reservoir despite antiretroviral therapy (ART)(1-5). This reservoir is the major barrier to HIV-1 eradication(6,7). Current approaches to purging the latent reservoir involve pharmacologic induction of HIV-1 transcription and subsequent killing of infected cells by cytolytic T lymphocytes (CTLs) or viral cytopathic effects(8-10). Agents that reverse latency without activating T cells have been identified using in vitro models of latency. However, their effects on latently infected cells from infected individuals remain largely unknown. Using a new ex vivo assay, we demonstrate that none of the latency-reversing agents (LRAs) tested induced outgrowth of HIV-1 from the latent reservoir of patients on ART. Using a quantitative reverse transcription PCR assay specific for all HIV-1 mRNAs, we demonstrate that LRAs that do not cause T cell activation do not induce substantial increases in intracellular HIV-1 mRNA in patient cells; only the protein kinase C agonist bryostatin-1 caused significant increases. These findings demonstrate that current in vitro models do not fully recapitulate mechanisms governing HIV-1 latency in vivo. Further, our data indicate that non-activating LRAs are unlikely to drive the elimination of the latent reservoir in vivo when administered individually.	[Bullen, C. Korin; Laird, Gregory M.; Durand, Christine M.; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu		Devadason, Caroline/0000-0002-2204-8174; Durand, Christine M./0000-0003-2605-9257	Martin Delaney Collaboratory of AIDS Researchers for Eradication; Delaney AIDS Research Enterprise (US National Institutes of Health) [AI096113, AI096109]; Foundation for AIDS Research [108165-50-RGRL, 108707-54-RKRL]; Johns Hopkins Center for AIDS Research; US National Institutes of Health [43222]; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, U19AI096113, U19AI096109, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	Martin Delaney Collaboratory of AIDS Researchers for Eradication; Delaney AIDS Research Enterprise (US National Institutes of Health); Foundation for AIDS Research; Johns Hopkins Center for AIDS Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. McHugh and A. Devadason for assistance with study participants. Funding was provided by the Martin Delaney Collaboratory of AIDS Researchers for Eradication and the Delaney AIDS Research Enterprise (US National Institutes of Health grants AI096113 and AI096109 (R.F.S.)), the Foundation for AIDS Research grants 108165-50-RGRL (R.F.S.) and 108707-54-RKRL (C.M.D.), the Johns Hopkins Center for AIDS Research (J.D.S.), US National Institutes of Health grant 43222 (R.F.S.) and the Howard Hughes Medical Institute (R.F.S.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Baba M, 2000, AIDS RES HUM RETROV, V16, P935, DOI 10.1089/08892220050058344; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Choudhary SK, 2011, ANNU REV PHARMACOL, V51, P397, DOI 10.1146/annurev-pharmtox-010510-100237; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/nchem.1395, 10.1038/NCHEM.1395]; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Doyon G, 2013, AIDS, V27, pF7, DOI 10.1097/QAD.0b013e3283570620; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hakre S, 2012, FEMS MICROBIOL REV, V36, P706, DOI 10.1111/j.1574-6976.2012.00335.x; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Moriuchi H, 1999, J IMMUNOL, V162, P7543; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P790, DOI 10.4161/hv.23202; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shan L, 2013, J VIROL, V87, P6521, DOI 10.1128/JVI.00006-13; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Spivak AM, 2014, CLIN INFECT DIS, V58, P883, DOI 10.1093/cid/cit813; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	37	366	381	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					425	+		10.1038/nm.3489	http://dx.doi.org/10.1038/nm.3489			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658076	Green Accepted			2022-12-25	WOS:000334361500024
J	Flannick, J; Thorleifsson, G; Beer, NL; Jacobs, SBR; Grarup, N; Burtt, NP; Mahajan, A; Fuchsberger, C; Atzmon, G; Benediktsson, R; Blangero, J; Bowden, DW; Brandslund, I; Brosnan, J; Burslem, F; Chambers, J; Cho, YS; Cho, YS; Douglas, DA; Duggirala, R; Dymek, Z; Farjoun, Y; Fennell, T; Fontanillas, P; Forsen, T; Gabriel, S; Glaser, B; Gudbjartsson, DF; Hanis, C; Hansen, T; Hreidarsson, AB; Hveem, K; Ingelsson, E; Isomaa, B; Johansson, S; Jorgensen, T; Jorgensen, ME; Kathiresan, S; Kong, A; Kooner, J; Kravic, J; Laakso, M; Lee, JY; Lind, L; Lindgren, CM; Linneberg, A; Masson, G; Meitinger, T; Mohlke, KL; Molven, A; Morris, AP; Potluri, S; Rauramaa, R; Ribel-Madsen, R; Richard, AM; Rolph, T; Saloemaa, V; Segre, AV; Skarstrand, H; Steinthorsdottir, V; Stringham, HM; Sulem, P; Tai, ES; Teo, YY; Teslovich, T; Thorsteinsdottir, U; Trimmer, JK; Tuomi, T; Tuomilehto, J; Vaziri-Sani, F; Voight, BF; Voight, BF; Boehnke, M; McCarthy, MI; Njolstad, PR; Pedersen, O; Groop, L; Cox, DR; Stefansson, K; Altshuler, D				Flannick, Jason; Thorleifsson, Gudmar; Beer, Nicola L.; Jacobs, Suzanne B. R.; Grarup, Niels; Burtt, Noel P.; Mahajan, Anubha; Fuchsberger, Christian; Atzmon, Gil; Benediktsson, Rafn; Blangero, John; Bowden, Don W.; Brandslund, Ivan; Brosnan, Julia; Burslem, Frank; Chambers, John; Cho, Yoon Shin; Christensen, Cramer; Douglas, Desiree A.; Duggirala, Ravindranath; Dymek, Zachary; Farjoun, Yossi; Fennell, Timothy; Fontanillas, Pierre; Forsen, Tom; Gabriel, Stacey; Glaser, Benjamin; Gudbjartsson, Daniel F.; Hanis, Craig; Hansen, Torben; Hreidarsson, Astradur B.; Hveem, Kristian; Ingelsson, Erik; Isomaa, Bo; Johansson, Stefan; Jorgensen, Torben; Jorgensen, Marit Eika; Kathiresan, Sekar; Kong, Augustine; Kooner, Jaspal; Kravic, Jasmina; Laakso, Markku; Lee, Jong-Young; Lind, Lars; Lindgren, Cecilia M.; Linneberg, Allan; Masson, Gisli; Meitinger, Thomas; Mohlke, Karen L.; Molven, Anders; Morris, Andrew P.; Potluri, Shobha; Rauramaa, Rainer; Ribel-Madsen, Rasmus; Richard, Ann-Marie; Rolph, Tim; Salomaa, Veikko; Segre, Ayellet V.; Skaerstrand, Hanna; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Sulem, Patrick; Tai, E. Shyong; Teo, Yik Ying; Teslovich, Tanya; Thorsteinsdottir, Unnur; Trimmer, Jeff K.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Vaziri-Sani, Fariba; Voight, Benjamin F.; Wilson, James G.; Boehnke, Michael; McCarthy, Mark I.; Njolstad, Pal R.; Pedersen, Oluf; Groop, Leif; Cox, David R.; Stefansson, Kari; Altshuler, David		Go-T2D Consortium; T2D-Genes Consortium	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes	NATURE GENETICS			English	Article							ZINC TRANSPORTER ZNT8; GENOME-WIDE ASSOCIATION; GLUCOSE-HOMEOSTASIS; COMMON VARIANTS; BETA-CELL; INSULIN; RARE; PATHOPHYSIOLOGY; EXPRESSION; RESPONSES	Loss-of-function mutations protective against human disease provide in vivo validation of therapeutic targets1-3, but none have yet been described for type 2 diabetes (T2D). Through sequencing or genotyping of -150,000 individuals across 5 ancestry groups, we identified 12 rare protein-truncating variants in SLC30A8, which encodes an islet zinc transporter (ZnT8) 4 and harbors a common variant (p. Trp325Arg) associated with T2D risk and glucose and proinsulin levels5-7. Collectively, carriers of protein-truncating variants had 65% reduced T2D risk (P = 1.7 x 10(-6)), and non-diabetic Icelandic carriers of a frameshift variant (p. Lys34Serfs* 50) demonstrated reduced glucose levels (-0.17 s. d., P = 4.6 x 10(-4)). The two most common proteintruncating variants (p. Arg138* and p. Lys34Serfs* 50) individually associate with T2D protection and encode unstable ZnT8 proteins. Previous functional study of SLC30A8 suggested that reduced zinc transport increases T2D risk(8,9), and phenotypic heterogeneity was observed in mouse Slc30a8 knockouts(10-15). In contrast, loss-of-function mutations in humans provide strong evidence that SLC30A8 haploinsufficiency protects against T2D, suggesting ZnT8 inhibition as a therapeutic strategy in T2D prevention.	[Flannick, Jason; Beer, Nicola L.; Jacobs, Suzanne B. R.; Burtt, Noel P.; Dymek, Zachary; Farjoun, Yossi; Fennell, Timothy; Fontanillas, Pierre; Gabriel, Stacey; Kathiresan, Sekar; Lindgren, Cecilia M.; Segre, Ayellet V.; Voight, Benjamin F.; Njolstad, Pal R.; Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Flannick, Jason; Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Kong, Augustine; Masson, Gisli; Steinthorsdottir, Valgerdur; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Beer, Nicola L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Grarup, Niels; Hansen, Torben; Ribel-Madsen, Rasmus; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Mahajan, Anubha; Ingelsson, Erik; Lindgren, Cecilia M.; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Fuchsberger, Christian; Stringham, Heather M.; Teslovich, Tanya; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Benediktsson, Rafn; Hreidarsson, Astradur B.] Landspitali Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Blangero, John; Duggirala, Ravindranath] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC USA; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Brosnan, Julia; Richard, Ann-Marie; Rolph, Tim; Trimmer, Jeff K.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Burslem, Frank] Prescient Life Sci, Cardiovasc & Metab Dis Practice, London, England; [Chambers, John] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Chambers, John; Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Healthcare Natl Hlth Serv NHS Trust, London, England; [Chambers, John; Kooner, Jaspal] Ealing Hosp NHS Trust, Southall, Middx, England; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Christensen, Cramer] Vejle Hosp, Dept Internal Med & Endocrinol, Vejle, Denmark; [Douglas, Desiree A.; Skaerstrand, Hanna; Vaziri-Sani, Fariba] Lund Univ, Dept Clin Sci, Unit Diabet & Celiac Dis, Malmo, Sweden; [Forsen, Tom; Tuomi, Tiinamaija] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Forsen, Tom] Vaasa Hlth Care Ctr, Diabetes Care Unit, Vaasa, Finland; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel; [Glaser, Benjamin] IDRG, Holon, Israel; [Hanis, Craig] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Hveem, Kristian] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Levanger, Norway; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Johansson, Stefan; Molven, Anders; Njolstad, Pal R.] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med, Copenhagen, Denmark; [Jorgensen, Torben; Linneberg, Allan] Aalborg Univ, Fac Med, Aalborg, Denmark; [Jorgensen, Marit Eika] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, NHLI, London, England; [Kravic, Jasmina; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lee, Jong-Young] Korea Natl Inst Hlth, Osong Hlth Technol, Ctr Genome Sci, Seoul, Chungcheongbuk, South Korea; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Potluri, Shobha; Cox, David R.] Pfizer Inc, Appl Quantitat Genotherapeut, San Francisco, CA USA; [Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Tai, E. Shyong; Teo, Yik Ying] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Dept Med, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Teo, Yik Ying] Genome Inst Singapore, Agcy Sci Technol & Res, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabetes Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Phys & Biophys, Jackson, MS 39216 USA; [McCarthy, Mark I.] Churchill Hosp, Hlth Res NIHR Biomed Res Ctr, Oxford Natl Inst, Oxford, England; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Groop, Leif] Univ Helsinki, Finnish Inst Mol Med FIMM, Helsinki, Finland; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Oxford; Novo Nordisk Foundation; University of Copenhagen; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Landspitali National University Hospital; Texas Biomedical Research Institute; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Pfizer; Imperial College London; Imperial College London; Hallym University; University of Southern Denmark; Lillebaelt Hospital; Lund University; University of Helsinki; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Southern Denmark; Norwegian University of Science & Technology (NTNU); Uppsala University; Folkhalsan Research Center; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Copenhagen; Aalborg University; Steno Diabetes Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Imperial College London; Lund University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Uppsala University; University of Copenhagen; Technical University of Munich; University of North Carolina; University of North Carolina Chapel Hill; University of Bergen; University of Bergen; Haukeland University Hospital; University of Liverpool; Pfizer; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; University of Iceland; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Mississippi; University of Mississippi Medical Center; University of Bergen; Haukeland University Hospital; University of Helsinki; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Altshuler, D (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA.	kstefans@decode.is; altshuler@molbio.mgh.harvard.edu	Pedersen, Oluf/Z-1731-2019; Benediktsson, Rafn/R-2457-2018; Altshuler, David M/A-4476-2009; Pedersen, Oluf/AAG-8015-2020; Lee, Jong-Young/M-6319-2013; Blangero, John/ABA-7175-2021; Vaziri-Sani, Fariba/J-6390-2014; Chen, Peng/E-5546-2015; Hveem, Kristian/AFV-4683-2022; Fuchsberger, Christian/ABD-7127-2021; Stefansson, Kari/AAE-7187-2019; Jørgensen, Torben/Z-1335-2018; Glaser, Benjamin/F-8411-2017; Meitinger, Thomas/O-1318-2015; Grarup, Niels/K-2807-2015; Johansson, Stefan/C-4394-2011; McCarthy, Mark/M-3763-2015	Pedersen, Oluf/0000-0002-3321-3972; Benediktsson, Rafn/0000-0002-2954-9801; Altshuler, David M/0000-0002-7250-4107; Lee, Jong-Young/0000-0002-0092-9958; Vaziri-Sani, Fariba/0000-0002-9953-2829; Chen, Peng/0000-0002-1422-4641; Fuchsberger, Christian/0000-0002-5918-8947; Glaser, Benjamin/0000-0003-4711-5000; Grarup, Niels/0000-0001-5526-1070; Johansson, Stefan/0000-0002-2298-7008; Mahajan, Anubha/0000-0001-5585-3420; Yoon, Joon/0000-0002-9509-119X; McCarthy, Mark/0000-0002-4393-0510; Tuomi, Tiinamaija/0000-0002-8306-6202; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Hansen, Torben/0000-0001-8748-3831; Voight, Benjamin/0000-0002-6205-9994; Jacobs, Suzanne/0000-0002-8103-1700; Brandslund, Ivan/0000-0002-4203-5442; Jorgensen, Marit Eika/0000-0001-8356-5565; Lindgren, Cecilia/0000-0002-4903-9374; Jorgensen, Torben/0000-0001-9453-2830; Linneberg, Allan/0000-0002-0994-0184; Meitinger, Thomas/0000-0002-8838-8403; Kong, Augustine/0000-0001-8193-5438; Tai, E Shyong/0000-0003-2929-8966	US National Institutes of Health (NIH) Training [5-T32-GM007748-33]; Doris Duke Charitable Foundation [2006087]; Fulbright Diabetes UK Fellowship [BDA 11/0004348]; Broad Institute from Pfizer, Inc.; NIH [U01 DK085501, U01 DK085524, U01 DK085545, U01 DK085584]; Swedish Research Council [Dnr 521-2010-3490, Dnr 349-2006-237]; European Research Council (ERC) [GENETARGET T2D, GA269045]; ENGAGE [2007-201413]; CEED3 [2008-223211]; Sigrid Juselius Foundation; Folkh lsan Research Foundation; ERC [AdG 293574]; Research Council of Norway [197064/V50]; KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck Foundation; Novo Nordisk Foundation; Wellcome Trust [WT098017, WT064890, WT090532, WT090367, WT098381]; Uppsala University; Swedish Research Council and the Swedish Heart- Lung Foundation; Academy of Finland [124243, 102318, 123885, 139635]; Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes [1510/31/06]; Commission of the European Community [HEALTH-F2-2007-201681]; Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project [LSHM-CT-2004-005272]; City of Kuopio and Social Insurance Institution of Finland; Finnish Foundation for Cardiovascular Disease; NIH/NIDDK [U01-DK085545]; National Heart, Lung, and Blood Institute (NHLBI); National Institute on Minority Health and Health Disparities [N01 HC-95170, N01 HC-95171, N01 HC-95172]; European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation (Barndiabetesfonden);  [5U01DK085526];  [DK088389];  [U54HG003067];  [R01DK072193];  [R01DK062370];  [Z01HG000024]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005637] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095170, N01HC095172, N01HC095171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R13CA124293] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, Z01HG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK088389, R01DK093757, U01DK085526, R01DK062370, U01DK085501, U01DK062370, R01DK072193, U01DK085545, U01DK085584, U01DK085524, R01DK098032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Fulbright Diabetes UK Fellowship(Diabetes UK); Broad Institute from Pfizer, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); ENGAGE; CEED3; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkh lsan Research Foundation; ERC(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University; Swedish Research Council and the Swedish Heart- Lung Foundation; Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes; Commission of the European Community(European Commission); Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project; City of Kuopio and Social Insurance Institution of Finland; Finnish Foundation for Cardiovascular Disease; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation (Barndiabetesfonden); ; ; ; ; ; ; National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This manuscript is dedicated to the memory of David R. Cox, our dear friend and colleague, who was relentlessly supportive of this work-and more generally, of the use of human genetics to improve human health. He is missed, but his legacy goes on. We gratefully acknowledge the contribution of all similar to 150,000 participants from the various population studies that contributed to this work. J.F. was supported in part by US National Institutes of Health (NIH) Training Grant 5-T32-GM007748-33. D. A. was supported by funding from the Doris Duke Charitable Foundation (2006087). N. L. B. was supported by a Fulbright Diabetes UK Fellowship (BDA 11/0004348). This work was supported in part by funding to the Broad Institute (principal investigator D. A.) from Pfizer, Inc. Funding for the GoT2D and T2D-GENES studies was provided by grants 5U01DK085526 (NIH/NIDDK; Multiethnic Study of Type 2 Diabetes Genes), DK088389 (NIH/NIDDK; Low-Pass Sequencing and High-Density SNP Genotyping for Type 2 Diabetes) and U54HG003067 (National Human Genome Research Institute (NHGRI); Large-Scale Sequencing and Analysis of Genomes), as well as by NIH grants U01 DK085501, U01 DK085524, U01 DK085545 and U01 DK085584. The Malm Preventive Project and the Scania Diabetes Registry were supported by grants from the Swedish Research Council (Dnr 521-2010-3490 to L. G. and Dnr 349-2006-237 to the Lund University Diabetes Centre), as well as by a European Research Council (ERC) grant (GENETARGET T2D, GA269045) and two European Union grants (ENGAGE (2007-201413) and CEED3 (2008-223211)) to L. G. The Botnia study was supported by funding from the Sigrid Juselius Foundation and the Folkh lsan Research Foundation. P. R. N. was funded by the ERC (AdG 293574), the Research Council of Norway (197064/V50), the KG Jebsen Foundation, the University of Bergen, the Western Norway Health Authority, the European Association for the Study of Diabetes Sabbatical Leave Programme and Innovest. The Danish studies were supported by the Lundbeck Foundation (Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp); http://www.lucamp.org/) and the Danish Council for Independent Research. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk/). The PIVUS/ ULSAM cohort was supported by Wellcome Trust grants WT098017, WT064890 and WT090532, Uppsala University, the Uppsala University Hospital, the Swedish Research Council and the Swedish Heart- Lung Foundation. The METSIM study was supported by the Academy of Finland (contract 124243), the Finnish Heart Foundation, the Finnish Diabetes Foundation, Tekes (contract 1510/31/06), the Commission of the European Community (HEALTH-F2-2007-201681) and grants R01DK062370 and R01DK072193 (NIH/NIDDK) and grant (NHGRI). The FUSION study was supported by grants R01DK062370 and R01DK072193 (NIH/NIDDK) and grant Z01HG000024 (NHGRI). The DR's EXTRA Study was supported by the Ministry of Education and Culture of Finland (627; 2004-2011), the Academy of Finland (102318; 123885), Kuopio University Hospital, the Finnish Diabetes Association, the Finnish Heart Association and the P ivikki and Sakari Sohlberg Foundation and by grants from the European Commission Framework Programme 6 Integrated Project (EXGENESIS); LSHM-CT-2004-005272, City of Kuopio and Social Insurance Institution of Finland (4/26/2010). V.; Salomaa is funded by the Academy of Finland, grant 139635, and by the Finnish Foundation for Cardiovascular Disease. Sequencing and genotyping of British individuals was supported by Wellcome Trust grants WT090367, WT090532 and WT098381 and by NIH/NIDDK grant U01-DK085545. Funding for the Jackson Heart Study (JHS) was provided by the National Heart, Lung, and Blood Institute (NHLBI) and by the National Institute on Minority Health and Health Disparities (N01 HC-95170, N01 HC-95171 and N01 HC-95172). A. P. M. acknowledges support from Wellcome Trust grants WT098017, WT090532 and WT064890. F.V.-S. and H. S. were supported by the European Union Seventh Framework Programme, DIAPREPP (Diabetes Type 1 Prediction, Early Pathogenesis and Prevention, grant agreement 202013), and by the Swedish Child Diabetes Foundation (Barndiabetesfonden).	Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xavier GD, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/906590	28	329	336	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					357	+		10.1038/ng.2915	http://dx.doi.org/10.1038/ng.2915			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24584071	Green Accepted			2022-12-25	WOS:000334510100011
J	Webber, P				Webber, Philip			Does CRISPR-Cas open new possibilities for patents or present a moral maze?	NATURE BIOTECHNOLOGY			English	Editorial Material							ENDONUCLEASE	CRISPR-Cas systems, which enable the production of new artificial genes, synthetic proteins and new transgenic organisms, will challenge patent practices worldwide.	Dehns Patent & Trade Mark Attorneys, Oxford, England		Webber, P (corresponding author), Dehns Patent & Trade Mark Attorneys, Oxford, England.	pwebber@dehns.com						[Anonymous], 1843, T 0019/90 Onco-Mouse/Harvard, Patent No. 3; [Anonymous], 1998, OFFICIAL J L; [Anonymous], 1998, Official Journal, VL213, P0013, Patent No. [0242236, 0 242 236]; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	8	14	14	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					331	334		10.1038/nbt.2843	http://dx.doi.org/10.1038/nbt.2843			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714479				2022-12-25	WOS:000334340800014
J	Cosgrove, BD; Gilbert, PM; Porpiglia, E; Mourkioti, F; Lee, SP; Corbel, SY; Llewellyn, ME; Delp, SL; Blau, HM				Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Llewellyn, Michael E.; Delp, Scott L.; Blau, Helen M.			Rejuvenation of the muscle stem cell population restores strength to injured aged muscles	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; SATELLITE-CELL; SELF-RENEWAL; LIFE-SPAN; P38 MAPK; INHIBITORS; EXPRESSION; PROLIFERATION; EXPANSION; MODEL	The elderly often suffer from progressive muscle weakness and regenerative failure. We demonstrate that muscle regeneration is impaired with aging owing in part to a cell-autonomous functional decline in skeletal muscle stem cells (MuSCs). Two-thirds of MuSCs from aged mice are intrinsically defective relative to MuSCs from young mice, with reduced capacity to repair myofibers and repopulate the stem cell reservoir in vivo following transplantation. This deficiency is correlated with a higher incidence of cells that express senescence markers and is due to elevated activity of the p38 alpha and p38 beta mitogen-activated kinase pathway. We show that these limitations cannot be overcome by transplantation into the microenvironment of young recipient muscles. In contrast, subjecting the MuSC population from aged mice to transient inhibition of p38 alpha and p38 beta in conjunction with culture on soft hydrogel substrates rapidly expands the residual functional MuSC population from aged mice, rejuvenating its potential for regeneration and serial transplantation as well as strengthening of damaged muscles of aged mice. These findings reveal a synergy between biophysical and biochemical cues that provides a paradigm for a localized autologous muscle stem cell therapy for the elderly.	[Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Blau, Helen M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Gilbert, Penney M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Gilbert, Penney M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Llewellyn, Michael E.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Toronto; University of Toronto; Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	penney.gilbert@utoronto.ca; hblau@stanford.edu	Cosgrove, Benjamin/A-9810-2016	Cosgrove, Benjamin/0000-0003-2164-350X; Delp, Scott/0000-0002-9643-7551; Gilbert, Penney/0000-0001-5509-9616; Mourkioti, Foteini/0000-0002-7119-6640; Porpiglia, Ermelinda/0000-0003-2652-899X	US National Institutes of Health (NIH) [R25CA118681, K99AG042491]; NIH [T32CA009151, K99AR061465, U01HL100397, U01HL099997, R01AG020961, R01HL096113, R01AG009521]; California Institute for Regenerative Medicine [TG2-01159, RT1-01001, TR3-05501]; IBM Faculty Award; Baxter Foundation; NATIONAL CANCER INSTITUTE [T32CA009151, R25CA118681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL099997, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR061465, R01AR063963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG042491, R01AG009521, R21AG044815, R01AG020961] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); IBM Faculty Award(International Business Machines (IBM)); Baxter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Koleckar, P. Kraft, N. Nguyen, A. Thayer, C. Marceau, K. Magnusson and A. Ho for technical assistance; K. Havenstrite and R. Haynes for polymer synthesis; and the Stanford Center for Innovation in In-Vivo Imaging (SCI<SUP>3</SUP>), the Stanford Shared FAGS Facility (SSFF) and IBM Almaden for technical support. This work was funded by US National Institutes of Health (NIH) training grant R25CA118681 and grant K99AG042491 (B.D.C.); NIH training grant T32CA009151 and grant K99AR061465 and California Institute for Regenerative Medicine training grant TG2-01159 (P.M.G.); and NIH grants U01HL100397, U01HL099997, R01AG020961, R01HL096113 and R01AG009521, an IBM Faculty Award, California Institute for Regenerative Medicine grants RT1-01001 and TR3-05501 and the Baxter Foundation (H.M.B.).	Arpke RW, 2013, STEM CELLS, V31, P1611, DOI 10.1002/stem.1402; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brien P, 2013, STEM CELLS, V31, P1597, DOI 10.1002/stem.1399; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lefkovits I., 1999, LIMITING DILUTION AN; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; Page TH, 2010, ARTHRITIS RHEUM-US, V62, P3221, DOI 10.1002/art.27631; Parham DM, 2006, ARCH PATHOL LAB MED, V130, P1454; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; THOMPSON LV, 1994, PHYS THER, V74, P71, DOI 10.1093/ptj/74.1.71; Tivey HSE, 2013, J GERONTOL A-BIOL, V68, P1001, DOI 10.1093/gerona/gls336; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Wong ESM, 2009, DEV CELL, V17, P142, DOI 10.1016/j.devcel.2009.05.009; Zou J, 2012, ANN HEMATOL, V91, P813, DOI 10.1007/s00277-011-1397-7	55	393	406	6	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					255	264		10.1038/nm.3464	http://dx.doi.org/10.1038/nm.3464			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24531378	Green Accepted			2022-12-25	WOS:000332595600020
J	Dembele, L; Franetich, JF; Lorthiois, A; Gego, A; Zeeman, AM; Kocken, CHM; Le Grand, R; Dereuddre-Bosquet, N; van Gemert, GJ; Sauerwein, R; Vaillant, JC; Hannoun, L; Fuchter, MJ; Diagana, TT; Malmquist, NA; Scherf, A; Snounou, G; Mazier, D				Dembele, Laurent; Franetich, Jean-Francois; Lorthiois, Audrey; Gego, Audrey; Zeeman, Anne-Marie; Kocken, Clemens H. M.; Le Grand, Roger; Dereuddre-Bosquet, Nathalie; van Gemert, Geert-Jan; Sauerwein, Robert; Vaillant, Jean-Christophe; Hannoun, Laurent; Fuchter, Matthew J.; Diagana, Thierry T.; Malmquist, Nicholas A.; Scherf, Artur; Snounou, Georges; Mazier, Dominique			Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures	NATURE MEDICINE			English	Article							PLASMODIUM-VIVAX; EXOERYTHROCYTIC PARASITES; 2 POPULATIONS; CYNOMOLGI; FORMS; DISCOVERY; RELAPSE; MATRIX; GEL	Malaria relapses, resulting from the activation of quiescent hepatic hypnozoites of Plasmodium vivax and Plasmodium ovale, hinder global efforts to control and eliminate malaria. As primaquine, the only drug capable of eliminating hypnozoites, is unsuitable for mass administration, an alternative drug is needed urgently. Currently, analyses of hypnozoites, including screening of compounds that would eliminate them, can only be made using common macaque models, principally Macaca rhesus and Macaca fascicularis, experimentally infected with the relapsing Plasmodium cynomolgi. Here, we present a protocol for long-term in vitro cultivation of P cynomolgi-infected M. fascicularis primary hepatocytes during which hypnozoites persist and activate to resume normal development. In a proof-of-concept experiment, we obtained evidence that exposure to an inhibitor of histone modification enzymes implicated in epigenetic control of gene expression induces an accelerated rate of hypnozoite activation. The protocol presented may further enable investigations of hypnozoite biology and the search for compounds that kill hypnozoites or disrupt their quiescence.	[Dembele, Laurent; Franetich, Jean-Francois; Lorthiois, Audrey; Gego, Audrey; Snounou, Georges; Mazier, Dominique] Univ Paris 06, Sorbonne Univ, UMR S945, Paris, France; [Dembele, Laurent; Franetich, Jean-Francois; Lorthiois, Audrey; Gego, Audrey; Snounou, Georges; Mazier, Dominique] INSERM, U945, Paris, France; [Zeeman, Anne-Marie; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] Commissariat Energie Atom & Energies Alternat, Inst Emerging Dis & Innovat Therapies, Div Immunovirol, Fontenay Aux Roses, France; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] Univ Paris 11, UMRE01, Orsay, France; [van Gemert, Geert-Jan; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Vaillant, Jean-Christophe; Hannoun, Laurent] Hop La Pitie Salpetriere, Serv Chirurg Digest Hepatobiliopancreat & Transpl, Paris, France; [Fuchter, Matthew J.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore, Singapore; [Malmquist, Nicholas A.; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Paras, Paris, France; [Malmquist, Nicholas A.; Scherf, Artur] CNRS, Unite Rech Associee 2581, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Novartis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Snounou, G (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S945, Paris, France.	georges.snounou@upmc.fr	Franetich, Jean-François/GZA-9674-2022; Sauerwein, Robert/C-8519-2013; Snounou, Georges/F-3352-2011	DEMBELE, LAURENT/0000-0001-9087-8439; Kocken, Clemens/0000-0002-4784-1734; Malmquist, Nicholas/0000-0003-2822-8245; Zeeman, Anne-Marie/0000-0002-0157-4669; Snounou, Georges/0000-0002-6133-6398; Fuchter, Matthew/0000-0002-1767-7072; Scherf, Artur/0000-0003-2411-3328	Wellcome Trust [WT078285]; Medicines for Malaria Venture; Biomedical Primate Research Centre (the Netherlands); Universite Pierre et Marie Curie-Paris 6 (France); Seventh Framework Programme EU European Research Council Executive Agency Advanced Grant [250320]; Laboratoires d'Excellence (LABEX) grant from the Agence Nationale de la Recherche (France) [ANR-11-LABX0024]	Wellcome Trust(Wellcome TrustEuropean Commission); Medicines for Malaria Venture; Biomedical Primate Research Centre (the Netherlands)(Netherlands Government); Universite Pierre et Marie Curie-Paris 6 (France); Seventh Framework Programme EU European Research Council Executive Agency Advanced Grant; Laboratoires d'Excellence (LABEX) grant from the Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	This work was supported in part by a translational research grant (WT078285) from the Wellcome Trust, a grant from the Medicines for Malaria Venture to the Novartis Institute for Tropical Diseases (Singapore), the Biomedical Primate Research Centre (the Netherlands), the Universite Pierre et Marie Curie-Paris 6 (France), a Seventh Framework Programme EU European Research Council Executive Agency Advanced Grant (Plasmoescape 250320) to A.S. and a Laboratoires d'Excellence (LABEX) grant (ANR-11-LABX0024) from the Agence Nationale de la Recherche (France). We are grateful to T.A. Moss (Imperial College London) for the chemical synthesis of TM2-115. HepaRG cells were provided by C. Guguen-Guillouzo (Biopredic International). pTRIP-CMV-GFP Delta U3 vector was provided by P. Ravassard (le Centre de Recherche de I'Institut du Cerveau et de la Moelle Epiniere). We thank the staff of the Flow Cytometry Core CyPS at the Universite Pierre et Marie Curie (Pitie-Salpetriere Hospital, Paris, France) for their help and assistance. Finally, we thank A.C. Gruner for her excellent critical comments on the manuscript.	ATKINSON CT, 1989, AM J TROP MED HYG, V40, P131, DOI 10.4269/ajtmh.1989.40.131; Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Bray R. S., 1957, STUDIES EXOERYTHROCY; Chattopadhyay R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014275; CLEMENT B, 1984, HEPATOLOGY, V4, P373, DOI 10.1002/hep.1840040305; COATNEY GR, 1971, PRIMATE MALARIAS; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26, DOI 10.1128/CMR.5.1.26-35.1992; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Garnham PCC, 1966, MALARIA PARASITES OT; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOLLINGDALE MR, 1986, AM J TROP MED HYG, V35, P275, DOI 10.4269/ajtmh.1986.35.275; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; Kocken CHM, 2009, ANTIMICROB AGENTS CH, V53, P421, DOI 10.1128/AAC.00576-08; Kono Y, 1997, IN VITRO CELL DEV-AN, V33, P467; KROTOSKI WA, 1980, BMJ-BRIT MED J, V280, P153, DOI 10.1136/bmj.280.6208.153-a; KROTOSKI WA, 1982, AM J TROP MED HYG, V31, P24, DOI 10.4269/ajtmh.1982.31.24; Liu Duo, 1995, Chinese Journal of Parasitology & Parasitic Diseases, V13, P86; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Malmquist NA, 2012, P NATL ACAD SCI USA, V109, P16708, DOI 10.1073/pnas.1205414109; MAZIER D, 1984, NATURE, V307, P367, DOI 10.1038/307367a0; Mazier D, 2009, NAT REV DRUG DISCOV, V8, P854, DOI 10.1038/nrd2960; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P609, DOI 10.4269/ajtmh.1982.31.609; SHORTT HE, 1948, BRIT MED J, V1, P1225, DOI 10.1136/bmj.1.4564.1225; Shu H, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P185; SHUTE PG, 1976, T ROY SOC TROP MED H, V70, P474, DOI 10.1016/0035-9203(76)90132-2; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Voorberg-van der Wel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054888; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	35	132	134	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					307	312		10.1038/nm.3461	http://dx.doi.org/10.1038/nm.3461			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24509527				2022-12-25	WOS:000332595600027
J	Iyer, SM; Montgomery, KL; Towne, C; Lee, SY; Ramakrishnan, C; Deisseroth, K; Delp, SL				Iyer, Shrivats Mohan; Montgomery, Kate L.; Towne, Chris; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl; Delp, Scott L.			Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice	NATURE BIOTECHNOLOGY			English	Article							OPTICAL CONTROL; NOCICEPTIVE NEURONS; ACTIVATION; DELIVERY	Primary nociceptors are the first neurons involved in the complex processing system that regulates normal and pathological pain(1). Because of constraints on pharmacological and electrical stimulation, noninvasive excitation and inhibition of these neurons in freely moving nontransgenic animals has not been possible. Here we use an optogenetic(2) strategy to bidirectionally control nociceptors of nontransgenic mice. Intrasciatic nerve injection of adeno-associated viruses,encoding an excitatory opsin enabled light-inducible stimulation of acute pain, place aversion and optogenetically mediated reductions in withdrawal thresholds to mechanical and thermal stimuli. In contrast, viral delivery of an inhibitory opsin enabled light-inducible inhibition of acute pain perception, and reversed mechanical allodynia and thermal hyperalgesia in a model of neuropathic pain. Light was delivered transdermally, allowing these behaviors to be induced in freely moving animals. This approach may have utility in basic and translational pain research, and enable rapid drug screening and testing of newly engineered opsins.	[Iyer, Shrivats Mohan; Montgomery, Kate L.; Towne, Chris; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Delp, SL (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	delp@stanford.edu	Core, Vector/CAF-4832-2022	Delp, Scott/0000-0002-9643-7551; Ramakrishnan, Charu/0000-0002-3474-6332; Iyer, Shrivats/0000-0003-4648-3637	US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [R01-NS080954]; Stanford Bio-X NeuroVentures program; Stanford Bio-X Interdisciplinary Initiatives program; Office of Technology Licensing Stanford Graduate Fellowship; Howard Hughes Medical Institute International Student Research Fellowship; Bio-X Bioengineering Graduate Fellowship; Stanford Interdisciplinary Graduate Fellowship; Swiss National Science Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080954] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford Bio-X NeuroVentures program; Stanford Bio-X Interdisciplinary Initiatives program; Office of Technology Licensing Stanford Graduate Fellowship; Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); Bio-X Bioengineering Graduate Fellowship; Stanford Interdisciplinary Graduate Fellowship; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Liske, X. Qian, S. Mackey, A. Weitz, D.J. Clark, D.C. Yeomans, P. Sabhaie, C. Gorini, S. Young and H. Scutt for useful discussions and assistance with experiments. This study was supported by the US National Institutes of Health (National Institute of Neurological Disorders and Stroke grant R01-NS080954), the Stanford Bio-X NeuroVentures program and the Stanford Bio-X Interdisciplinary Initiatives program. S.M.I. was supported by an Office of Technology Licensing Stanford Graduate Fellowship and by a Howard Hughes Medical Institute International Student Research Fellowship. K.L.M. was supported by a Bio-X Bioengineering Graduate Fellowship and by a Stanford Interdisciplinary Graduate Fellowship. C.T. was supported by a Swiss National Science Foundation Fellowship.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P849, DOI 10.1038/nbt.2016; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Chow BY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003101; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Ji ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032699; Kokel D, 2013, NAT CHEM BIOL, V9, P257, DOI [10.1038/NCHEMBIO.1183, 10.1038/nchembio.1183]; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liske H, 2013, MUSCLE NERVE, V47, P916, DOI 10.1002/mus.23696; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Williams JC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003100; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	28	140	174	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					274	278		10.1038/nbt.2834	http://dx.doi.org/10.1038/nbt.2834			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24531797	Green Accepted			2022-12-25	WOS:000332819800026
J	Brastianos, PK; Taylor-Weiner, A; Manley, PE; Jones, RT; Dias-Santagata, D; Thorner, AR; Lawrence, MS; Rodriguez, FJ; Bernardo, LA; Schubert, L; Sunkavalli, A; Shillingford, N; Calicchio, ML; Lidov, HGW; Taha, H; Martinez-Lage, M; Santi, M; Storm, PB; Lee, JYK; Palmer, JN; Adappa, ND; Scott, RM; Dunn, IF; Laws, ER; Stewart, C; Ligon, KL; Hoang, MP; Van Hummelen, P; Hahn, WC; Louis, DN; Resnick, AC; Kieran, MW; Getz, G; Santagata, S				Brastianos, Priscilla K.; Taylor-Weiner, Amaro; Manley, Peter E.; Jones, Robert T.; Dias-Santagata, Dora; Thorner, Aaron R.; Lawrence, Michael S.; Rodriguez, Fausto J.; Bernardo, Lindsay A.; Schubert, Laura; Sunkavalli, Ashwini; Shillingford, Nick; Calicchio, Monica L.; Lidov, Hart G. W.; Taha, Hala; Martinez-Lage, Maria; Santi, Mariarita; Storm, Phillip B.; Lee, John Y. K.; Palmer, James N.; Adappa, Nithin D.; Scott, R. Michael; Dunn, Ian F.; Laws, Edward R., Jr.; Stewart, Chip; Ligon, Keith L.; Hoang, Mai P.; Van Hummelen, Paul; Hahn, William C.; Louis, David N.; Resnick, Adam C.; Kieran, Mark W.; Getz, Gad; Santagata, Sandro			Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas	NATURE GENETICS			English	Article							ADAMANTINOMATOUS CRANIOPHARYNGIOMAS; BETA-CATENIN; CANCER; TUMORS; INHIBITION; RESISTANCE; DISCOVERY; FRAMEWORK; MELANOMA; SURVIVAL	Craniopharyngiomas are epithelial tumors that typically arise in the suprasellar region of the brain(1). Patients experience substantial clinical sequelae from both extension of the tumors and therapeutic interventions that damage the optic chiasm, the pituitary stalk and the hypothalamic area(2-4). Using whole-exome sequencing, we identified mutations in CTNNB1 (beta-catenin) in nearly all adamantinomatous craniopharyngiomas examined (11/12, 92%) and recurrent mutations in BRAF (resulting in p. Val600Glu) in all papillary craniopharyngiomas (3/3, 100%). Targeted genotyping revealed BRAF p. Val600Glu in 95% of papillary craniopharyngiomas (36 of 39 tumors) and mutation of CTNNB1 in 96% of adamantinomatous craniopharyngiomas (51 of 53 tumors). The CTNNB1 and BRAF mutations were clonal in each tumor subtype, and we detected no other recurrent mutations or genomic aberrations in either subtype. Adamantinomatous and papillary craniopharyngiomas harbor mutations that are mutually exclusive and clonal. These findings have important implications for the diagnosis and treatment of these neoplasms.	[Brastianos, Priscilla K.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.] Massachusetts Gen Hosp, Div Neurooncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.; Dias-Santagata, Dora; Lidov, Hart G. W.; Scott, R. Michael; Dunn, Ian F.; Laws, Edward R., Jr.; Ligon, Keith L.; Hoang, Mai P.; Hahn, William C.; Louis, David N.; Kieran, Mark W.; Getz, Gad; Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA USA; [Brastianos, Priscilla K.; Jones, Robert T.; Thorner, Aaron R.; Ligon, Keith L.; Van Hummelen, Paul] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Brastianos, Priscilla K.; Taylor-Weiner, Amaro; Lawrence, Michael S.; Stewart, Chip; Hahn, William C.; Getz, Gad] Broad Inst MIT & Harvard, Boston, MA USA; [Manley, Peter E.; Kieran, Mark W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Jones, Robert T.; Thorner, Aaron R.; Schubert, Laura; Sunkavalli, Ashwini; Van Hummelen, Paul; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Dias-Santagata, Dora; Bernardo, Lindsay A.; Hoang, Mai P.; Louis, David N.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Rodriguez, Fausto J.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Shillingford, Nick; Calicchio, Monica L.; Lidov, Hart G. W.; Ligon, Keith L.; Santagata, Sandro] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Lidov, Hart G. W.; Ligon, Keith L.; Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Taha, Hala] Childrens Canc Hosp Egypt, Cairo, Egypt; [Martinez-Lage, Maria] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Santi, Mariarita] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Storm, Phillip B.; Lee, John Y. K.; Palmer, James N.; Resnick, Adam C.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Storm, Phillip B.; Resnick, Adam C.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Palmer, James N.; Adappa, Nithin D.] Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Scott, R. Michael] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Dunn, Ian F.; Laws, Edward R., Jr.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Kieran, Mark W.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Santagata, Sandro] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Children's Cancer Hospital 57357; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Brastianos, PK (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.	pbrast@broadinstitute.org; gadgetz@broadinstitute.org; ssantagata@partners.org	Lawrence, Michael/AAC-8202-2020; Martinez-Lage, Maria/S-6665-2019	van hummelen, paul/0000-0002-4801-8600; Kieran, Mark/0000-0003-2184-7692; Jones, Robert/0000-0001-8007-4023; Hoang, Mai/0000-0002-1406-7981; Sunkavalli, Ashwini/0000-0002-5561-3694; Shillingford, Nick/0000-0001-9636-9977; Brastianos, Priscilla/0000-0003-4470-8425; Santagata, Sandro/0000-0002-7528-9668; Martinez-Lage, Maria/0000-0002-5859-7562	Brain Science Foundation [K12 CA090354-11, K08 NS064168]; Terri Brodeur Breast Cancer Foundation; Conquer Cancer Foundation; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [K12CA090354, P01CA142536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Brain Science Foundation; Terri Brodeur Breast Cancer Foundation; Conquer Cancer Foundation; American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ducar for his assistance with genomic analyses; S. Chauvin for project management; L. Brown and H. Malkin for assisting with sample collection; T. Woo, B. Rich, R. Machaidze and D. Feldman for technical assistance; N. Stransky for the design of Figure 2a; and H. Taylor-Weiner and C. H. Brastianos for critical review of the manuscript. This work was supported by the Jared Branfman Sunflowers for Life Fund for Pediatric Brain and Spinal Cancer Research, the Pediatric Low-Grade Astrocytoma (PLGA) Program (S. S., W. C. H. and Charles D. Stiles), Pedals for Pediatrics and the Clark Family (P. E. M. and M. W. K.), the Stahl Family Charitable Foundation (P. E. M.), the Stop & Shop Pediatric Brain Tumor Program (P. E. M. and M. W. K.), the Pediatric Brain Tumor Clinical and Research Fund (P. E. M. and M. W. K.), the Children's Brain Tumor Foundation and the V Foundation (S. S.). S. S. is supported by grant K08 NS064168, and P. K. B. is supported by grant K12 CA090354-11, the Brain Science Foundation, Susan G. Komen for the Cure, the Terri Brodeur Breast Cancer Foundation, the Conquer Cancer Foundation and the American Brain Tumor Association.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ascierto PA, 2013, J CLIN ONCOL, V31, P3205, DOI 10.1200/JCO.2013.49.8691; Barkhoudarian G, 2013, PITUITARY, V16, P1, DOI 10.1007/s11102-012-0402-z; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chamberlain MC, 2013, J NEURO-ONCOL, V114, P237, DOI 10.1007/s11060-013-1176-5; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; CROTTY TB, 1995, J NEUROSURG, V83, P206, DOI 10.3171/jns.1995.83.2.0206; Cushing H., 1932, JAMA-J AM MED ASSOC, V100, P284; Demichelis F, 2008, NUCLEIC ACIDS RES, V36, P2446, DOI 10.1093/nar/gkn089; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Duff JM, 2000, NEUROSURGERY, V46, P291, DOI 10.1097/00006123-200002000-00007; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Kato K, 2004, J PATHOL, V203, P814, DOI 10.1002/path.1562; Laczmanska I, 2011, ACTA BIOCHIM POL, V58, P467; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liubinas SV, 2011, J CLIN NEUROSCI, V18, P451, DOI 10.1016/j.jocn.2010.10.004; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Louis DN, 2007, WHO CLASSIFICATION T, P238; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Manley PE, 2012, J NEURO-ONCOL, V108, P543, DOI 10.1007/s11060-012-0859-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; Rickert CH, 2003, J NEUROL NEUROSUR PS, V74, P260, DOI 10.1136/jnnp.74.2.260; Rush S, 2013, J CLIN ONCOL, V31, pE159, DOI 10.1200/JCO.2012.44.1568; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Sekine S, 2002, AM J PATHOL, V161, P1997, DOI 10.1016/S0002-9440(10)64477-X; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stanley FKT, 2013, MUTAT RES-FUND MOL M, V750, P31, DOI 10.1016/j.mrfmmm.2013.07.008; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tian YJ, 2011, J MOL DIAGN, V13, P669, DOI 10.1016/j.jmoldx.2011.07.002; WEINER HL, 1994, NEUROSURGERY, V35, P1001, DOI 10.1227/00006123-199412000-00001; Yoshimoto M, 2004, J NEUROSURG, V101, P85, DOI 10.3171/ped.2004.101.2.0085	50	270	291	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					161	U100		10.1038/ng.2868	http://dx.doi.org/10.1038/ng.2868			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413733	Green Accepted, Green Submitted			2022-12-25	WOS:000331208300012
J	Rosen, CB; Rodriguez-Larrea, D; Bayley, H				Rosen, Christian B.; Rodriguez-Larrea, David; Bayley, Hagan			Single-molecule site-specific detection of protein phosphorylation with a nanopore	NATURE BIOTECHNOLOGY			English	Article							DNA; TRANSLOCATION; PEPTIDE	We demonstrate single-molecule, site-specific detection of protein phosphorylation with protein nanopore technology. A model protein, thioredoxin, was phosphorylated at two adjacent sites. Analysis of the ionic current amplitude and noise, as the protein unfolds and moves through an a-hemolysin pore, enables the distinction between unphosphorylated, monophosphorylated and diphosphorylated variants. Our results provide a step toward nanopore proteomics.	[Rosen, Christian B.; Rodriguez-Larrea, David; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England; [Rosen, Christian B.] Aarhus Univ, Dept Chem, Ctr DNA Nanotechnol, DK-8000 Aarhus, Denmark; [Rosen, Christian B.] Aarhus Univ, iNANO, Aarhus, Denmark	University of Oxford; Aarhus University; Aarhus University	Rodriguez-Larrea, D (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3QZ, England.	david.rodriguez-larrea@chem.ox.ac.uk; hagan.bayley@chem.ox.ac.uk	Rodriguez-Larrea, David/ABH-3171-2020	Rodriguez-Larrea, David/0000-0002-5580-7413; Bayley, Hagan/0000-0003-2499-6116	National Institutes of Health; Oxford Nanopore Technologies; European Research Council; Danish National Research Foundation [DNRF78]; Aarhus University, Faculty of Science and Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford Nanopore Technologies; European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Aarhus University, Faculty of Science and Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank E. Mikhailova for the preparation of alpha-hemolysin pores. We thank L. Harrington for the PKA-CAT plasmid and the purification protocol for the catalytic subunit of PKA. This work has been supported by the National Institutes of Health, Oxford Nanopore Technologies and an European Research Council Advanced Grant. C.B.R. is funded by the Danish National Research Foundation (grant number DNRF78) and Aarhus University, Faculty of Science and Technology.	Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Nivala J, 2013, NAT BIOTECHNOL, V31, P247, DOI 10.1038/nbt.2503; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Rodriguez-Larrea D, 2013, NAT NANOTECHNOL, V8, P288, DOI [10.1038/nnano.2013.22, 10.1038/NNANO.2013.22]; Tam JP, 1999, BIOPOLYMERS, V51, P311, DOI 10.1002/(SICI)1097-0282(1999)51:5<311::AID-BIP2>3.0.CO;2-A; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Witus LS, 2010, J AM CHEM SOC, V132, P16812, DOI 10.1021/ja105429n	14	169	175	3	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					179	181		10.1038/nbt.2799	http://dx.doi.org/10.1038/nbt.2799			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24441471	Green Accepted			2022-12-25	WOS:000331074000023
J	Tahara, N; Mukherjee, J; de Haas, HJ; Petrov, AD; Tawakol, A; Haider, N; Tahara, A; Constantinescu, CC; Zhou, J; Boersma, HH; Imaizumi, T; Nakano, M; Finn, A; Fayad, Z; Virmani, R; Fuster, V; Bosca, L; Narula, J				Tahara, Nobuhiro; Mukherjee, Jogeshwar; de Haas, Hans J.; Petrov, Artiom D.; Tawakol, Ahmed; Haider, Nezam; Tahara, Atsuko; Constantinescu, Cristian C.; Zhou, Jun; Boersma, Hendrikus H.; Imaizumi, Tsutomu; Nakano, Masataka; Finn, Aloke; Fayad, Zahi; Virmani, Renu; Fuster, Valentin; Bosca, Lisardo; Narula, Jagat			2-deoxy-2[F-18]fluoro-D-mannose positron emission tomography imaging in atherosclerosis	NATURE MEDICINE			English	Article							NONINVASIVE DETECTION; GLUCOSE TRANSPORTERS; PLAQUE INFLAMMATION; DISEASE; FLUORODEOXYGLUCOSE; MACROPHAGES; MECHANISMS	Progressive inflammation in atherosclerotic plaques is associated with increasing risk of plaque rupture. Molecular imaging of activated macrophages with 2-deoxy-2[F-18]fluoro-D-glucose ([F-18]FDG) has been proposed for identification of patients at higher risk for acute vascular events. Because mannose is an isomer of glucose that is taken up by macrophages through glucose transporters and because mannose receptors are expressed on a subset of the macrophage population in high-risk plaques, we applied F-18-labeled mannose (2-deoxy-2[F-18]fluoro-D-mannose, [F-18]FDM) for targeting of plaque inflammation. Here, we describe comparable uptake of [F-18]FDM and [F-18]FDG in atherosclerotic lesions in a rabbit model; [F-18]FDM uptake was proportional to the plaque macrophage population. Our FDM competition studies in cultured cells with 2-deoxy-2-[C-14]carbon-D-glucose ([C-14]2DG) support at least 35% higher [F-18]FDM uptake by macrophages in cell experiments. We also demonstrate that FDM restricts binding of anti mannose receptor antibody to macrophages by approximately 35% and that mannose receptor targeting may provide an additional avenue for imaging of plaque inflammation.	[Tahara, Nobuhiro; Tahara, Atsuko; Imaizumi, Tsutomu] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; [Mukherjee, Jogeshwar; Constantinescu, Cristian C.; Zhou, Jun] Univ Calif Irvine, Irvine, CA USA; [de Haas, Hans J.; Petrov, Artiom D.; Haider, Nezam; Fayad, Zahi; Fuster, Valentin; Narula, Jagat] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [de Haas, Hans J.; Boersma, Hendrikus H.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Tawakol, Ahmed] Harvard Univ, Sch Med, Boston, MA USA; [Tawakol, Ahmed] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nakano, Masataka; Virmani, Renu] CVPath Inst, Gaithersburg, MD USA; [Finn, Aloke] Emory Univ, Sch Med, Atlanta, GA USA; [Fuster, Valentin] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Bosca, Lisardo] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Ctr Mixto, Consejo Super Invest Cient, Madrid, Spain	Kurume University; University of California System; University of California Irvine; Icahn School of Medicine at Mount Sinai; University of Groningen; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; CVPath Institute; Emory University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Narula, J (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	narula@mountsinai.org	Fayad, Zahi/Z-3272-2019; Bosca, Lisardo/A-2059-2008; Mukherjee, Jogeshwar/O-1320-2013; Fuster, Valentin/H-4319-2015; Boersma, Hendrikus/AAF-8139-2020	Fayad, Zahi/0000-0002-3439-7347; Bosca, Lisardo/0000-0002-0253-5469; Mukherjee, Jogeshwar/0000-0003-1009-877X; Fuster, Valentin/0000-0002-9043-9986; Boersma, Hendrikus/0000-0003-1892-9830	International Research Fund for Subsidy of Kyusyu University School of Medicine Alumni; Banyu Fellowship Program; Banyu Life Science Foundation International; foundation De Drie Lichten; Dutch Heart Association; Spanish Government [BFU2011-24760, RD12/0042/0019]; US National Institutes of Health from the US National Center for Research Resources [S10RR019269]; US National Institute of Biomedical Imaging and Bioengineering [R01 EB006110]; US National Institutes of Health [1RO1-HL68657]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019269] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006110] Funding Source: NIH RePORTER	International Research Fund for Subsidy of Kyusyu University School of Medicine Alumni; Banyu Fellowship Program; Banyu Life Science Foundation International(Banyu Life Science Foundation International); foundation De Drie Lichten; Dutch Heart Association; Spanish Government(Spanish GovernmentEuropean Commission); US National Institutes of Health from the US National Center for Research Resources; US National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank E. Lopez-Collazo for help in the preparation of human macrophages. Additionally, we thank T. Yamald, D.S. Mohar, S. Pandey, M. Pan, R. Kant and R. Coleman for their help in development of tracer labeling and [<SUP>18</SUP>F]FDM imaging. Finally, we thank C. Minh and J. Song for their valuable help with analyzing PET images. This research was supported by a research grant from the International Research Fund for Subsidy of Kyusyu University School of Medicine Alumni and the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International to N.T., research grants from the foundation De Drie Lichten and the Dutch Heart Association (Dr. E. Dekker student grant) to H.J.d.H., grants BFU2011-24760 and RD12/0042/0019 from the Spanish Government to L.B., US National Institutes of Health grant S10RR019269 from the US National Center for Research Resources and grant R01 EB006110 from the US National Institute of Biomedical Imaging and Bioengineering to J.M. and US National Institutes of Health grant 1RO1-HL68657 to J.N.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartung D, 2007, J NUCL MED, V48, P1816, DOI 10.2967/jnumed.107.043463; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kietselaer BLJH, 2004, NEW ENGL J MED, V350, P1472, DOI 10.1056/NEJM200404013501425; Kolodgie FD, 2003, CIRCULATION, V108, P3134, DOI 10.1161/01.CIR.0000105761.00573.50; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Narula J, 2007, NAT MED, V13, P532, DOI 10.1038/nm0507-532; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Otsuka F, 2012, MT SINAI J MED, V79, P641, DOI 10.1002/msj.21353; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Rudd JHF, 2010, J AM COLL CARDIOL, V55, P2527, DOI 10.1016/j.jacc.2009.12.061; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069; Tsimikas S, 2002, AM J CARDIOL, V90, p22L, DOI 10.1016/S0002-9149(02)02958-2; Villanueva FS, 1998, CIRCULATION, V98, P1, DOI 10.1161/01.CIR.98.1.1	20	127	130	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					215	219		10.1038/nm.3437	http://dx.doi.org/10.1038/nm.3437			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412923				2022-12-25	WOS:000330915000024
J	Gump, JM; Staskiewicz, L; Morgan, MJ; Bamberg, A; Riches, DWH; Thorburn, A				Gump, Jacob M.; Staskiewicz, Leah; Morgan, Michael J.; Bamberg, Alison; Riches, David W. H.; Thorburn, Andrew			Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1	NATURE CELL BIOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FAS-ASSOCIATED PHOSPHATASE-1; CANCER DEVELOPMENT; MEDIATED CLEAVAGE; FLOW-CYTOMETRY; APOPTOSIS; DEATH; ACTIVATION; CASPASE-8; CD95	Autophagy regulates cell death both positively and negatively, but the molecular basis for this paradox remains inadequately characterized. We demonstrate here that transient cell-to-cell variations in autophagy can promote either cell death or survival depending on the stimulus and cell type. By separating cells with high and low basal autophagy using flow cytometry, we demonstrate that autophagy determines which cells live or die in response to death receptor activation. We have determined that selective autophagic degradation of the phosphatase Fap-1 promotes Fas apoptosis in Type I cells, which do not require mitochondrial permeabilization for efficient apoptosis. Conversely, autophagy inhibits apoptosis in Type II cells (which require mitochondrial involvement) or on treatment with TRAIL in either Type I or II cells. These data illustrate that differences in autophagy in a cell population determine cell fate in a stimulus- and cell-type-specific manner. This example of selective autophagy of an apoptosis regulator may represent a general mechanism for context-specific regulation of cell fate by autophagy.	[Gump, Jacob M.; Staskiewicz, Leah; Morgan, Michael J.; Thorburn, Andrew] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Bamberg, Alison; Riches, David W. H.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Thorburn, A (corresponding author), Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA.	Andrew.Thorburn@ucdenver.edu			National Institutes of Health [R01 CA111421, CA150925, HL68628]; American Cancer Society [5T32CA82086-10];  [P30 CA46934]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA111421, R01CA150925, T32CA082086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114754, R01HL068628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all members of the A.T. laboratory for thoughtful discussions and critical comments. We are grateful to K. Helm, L. Acosta and C. Childs of the University of Colorado Cancer Center Flow Cytometry Core for their guidance and assistance. We also thank D. Dill and the University of Colorado Anschutz Medical Campus (UCAMC) Electron Microscopy Core for electron micrographs and technical assistance, and R. Moldovan at the UCAMC Advanced Light Microscopy Core for assistance with confocal imaging. This work was supported by National Institutes of Health grants R01 CA111421 and CA150925 (A.T.), HL68628 (D.W.H.R.), and Shared Resources supported by P30 CA46934. J.M.G. was previously supported by 5T32CA82086-10 (UCAMC Department of Pediatrics) and is now an American Cancer Society Postdoctoral Fellow.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Ivanov VN, 2006, J BIOL CHEM, V281, P1840, DOI 10.1074/jbc.M509866200; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaminskyy VO, 2012, AUTOPHAGY, V8, P1032, DOI 10.4161/auto.20123; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li Y, 2000, INT J CANCER, V87, P473, DOI 10.1002/1097-0215(20000815)87:4<473::AID-IJC3>3.0.CO;2-1; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Meinhold-Heerlein I, 2001, AM J PATHOL, V158, P1335, DOI 10.1016/S0002-9440(10)64084-9; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schmitz I, 1999, CELL DEATH DIFFER, V6, P821, DOI 10.1038/sj.cdd.4400569; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; White EJ, 2011, AM J CANCER RES, V1, P362; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	52	152	160	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					47	+		10.1038/ncb2886	http://dx.doi.org/10.1038/ncb2886			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24316673	Green Accepted			2022-12-25	WOS:000329042000010
J	White, AC; Khuu, JK; Dang, CY; Hu, J; Tran, KV; Liu, A; Gomez, S; Zhang, Z; Yi, R; Scumpia, P; Grigorian, M; Lowry, WE				White, A. C.; Khuu, J. K.; Dang, C. Y.; Hu, J.; Tran, K. V.; Liu, A.; Gomez, S.; Zhang, Z.; Yi, R.; Scumpia, P.; Grigorian, M.; Lowry, W. E.			Stem cell quiescence acts as a tumour suppressor in squamous tumours	NATURE CELL BIOLOGY			English	Article							HAIR FOLLICLE; TGF-BETA; INACTIVATING MUTATIONS; MOUSE SKIN; MIR-21; CYCLE; PTEN; EXPRESSION; ORIGIN; DIFFERENTIATION	In some organs, adult stem cells are uniquely poised to serve as cancer cells of origin. It is unclear, however, whether tumorigenesis is influenced by the activation state of the adult stem cell. Hair follicle stem cells (HFSCs) act as cancer cells of origin for cutaneous squamous cell carcinoma and undergo defined cycles of quiescence and activation. The data presented here show that HFSCs are unable to initiate tumours during the quiescent phase of the hair cycle, indicating that the mechanisms that keep HFSCs dormant are dominant over the gain of oncogenes (such as Ras) or the loss of tumour suppressors (such as p53). Furthermore, Pten activity is necessary for quiescence-based tumour suppression, as its deletion alleviates tumour suppression without affecting proliferation. These data demonstrate that stem cell quiescence is a form of tumour suppression in HFSCs, and that Pten plays a role in maintaining quiescence in the presence of tumorigenic stimuli.	[White, A. C.; Khuu, J. K.; Dang, C. Y.; Hu, J.; Tran, K. V.; Liu, A.; Gomez, S.; Grigorian, M.; Lowry, W. E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [White, A. C.; Khuu, J. K.; Dang, C. Y.; Hu, J.; Tran, K. V.; Liu, A.; Gomez, S.; Grigorian, M.; Lowry, W. E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med, Los Angeles, CA 90095 USA; [Zhang, Z.; Yi, R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Scumpia, P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Lowry, W. E.] Univ Calif Los Angeles, Jonsson Canc Res Ctr, Los Angeles, CA 90095 USA; [Lowry, W. E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lowry, WE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	blowry@ucla.edu	Zhang, Zhaojie/H-9614-2014	Zhang, Zhaojie/0000-0002-2321-2538; YI, RUI/0000-0002-6934-7091; White, Andrew/0000-0002-5436-5377; , Kathy/0000-0001-5118-782X	CIRM [TG2-01169]; CRCC; JCCF; NIH [T32 CA009056, 5R01AR057409-03]; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059697, R01AR057409] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); CRCC; JCCF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to acknowledge the technical support of W. Kim; the management of animal facilities (DLAM); the FACS core (EEBSCRC); the TPCL (Department of Pathology, UCLA); the gene expression core (Department of Pathology, UCLA) and X. Gaeta for a critical reading of the manuscript. This work was supported by grants from CIRM (TG2-01169), CRCC, The JCCF, and NIH (UCLA Tumour Biology Program, Ruth L. Kirschstein Institutional National Research Service Award # T32 CA009056, UCLA; and 5R01AR057409-03). WEL holds the Maria Rowena Ross Term Chair in Cell Biology.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahmed MI, 2011, J CELL SCI, V124, P3399, DOI 10.1242/jcs.086710; Al-Zaid T, 2012, J CUTAN PATHOL, V39, P493, DOI 10.1111/j.1600-0560.2012.01888.x; ANDREASEN E, 1956, Acta Pathol Microbiol Scand Suppl, V39, P76; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BROWNSTEIN MH, 1977, JAMA-J AM MED ASSOC, V238, P26; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Finch JS, 1996, CARCINOGENESIS, V17, P2551, DOI 10.1093/carcin/17.12.2551; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gu TT, 2011, CANCER RES, V71, P2821, DOI 10.1158/0008-5472.CAN-10-3399; Horenstein MG, 2013, AM J DERMATOPATH, V35, P818, DOI 10.1097/DAD.0b013e3182827fc7; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kimura-Ueki M, 2012, J INVEST DERMATOL, V132, P1338, DOI 10.1038/jid.2011.490; KLINKEN-RASMUSSEN L, 1956, Acta Pathol Microbiol Scand Suppl, V39, P78; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kubo Y, 1999, J DERMATOL SCI, V19, P199, DOI 10.1016/S0923-1811(98)00058-9; Kurose K, 2000, GENE CHROMOSOME CANC, V29, P166, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1025>3.3.CO;2-D; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; LAVKER RM, 1993, J INVEST DERMATOL, V101, pS16, DOI 10.1111/1523-1747.ep12362556; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Li SL, 2013, MOL CARCINOGEN, V52, P751, DOI 10.1002/mc.21896; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lowry WE, 2007, FRONT BIOSCI-LANDMRK, V12, P3911, DOI 10.2741/2360; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Mancuso M, 2006, CANCER RES, V66, P6606, DOI 10.1158/0008-5472.CAN-05-3690; MILLER SJ, 1993, J INVEST DERMATOL, V101, P591, DOI 10.1111/1523-1747.ep12366045; Narducci MG, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.32; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Paus R, 1999, J INVEST DERM SYMP P, V4, P338, DOI 10.1038/sj.jidsp.5640241; Plikus MV, 2012, J INVEST DERMATOL, V132, P1321, DOI 10.1038/jid.2012.38; Rozenberg J, 2009, MOL CANCER RES, V7, P654, DOI 10.1158/1541-7786.MCR-08-0011; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sugawara K, 2010, J DERMATOL SCI, V57, P155, DOI 10.1016/j.jdermsci.2009.12.004; Tran LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031053; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zhu HL, 2012, J CLIN IMMUNOL, V32, P514, DOI 10.1007/s10875-011-9647-y	54	56	56	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					99	+		10.1038/ncb2889	http://dx.doi.org/10.1038/ncb2889			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24335650	Green Accepted			2022-12-25	WOS:000329042000015
J	Francis, JM; Kiezun, A; Ramos, AH; Serra, S; Pedamallu, CS; Qian, ZR; Banck, MS; Kanwar, R; Kulkarni, AA; Karpathakis, A; Manzo, V; Contractor, T; Philips, J; Nickerson, E; Pho, N; Hooshmand, SM; Brais, LK; Lawrence, MS; Pugh, T; McKenna, A; Sivachenko, A; Cibulskis, K; Carter, SL; Ojesina, AI; Freeman, S; Jones, RT; Voet, D; Saksena, G; Auclair, D; Onofrio, R; Shefler, E; Sougnez, C; Grimsby, J; Green, L; Lennon, N; Meyer, T; Caplin, M; Chung, DC; Beutler, AS; Ogino, S; Thirlwell, C; Shivdasani, R; Asa, SL; Harris, CR; Getz, G; Kulke, M; Meyerson, M				Francis, Joshua M.; Kiezun, Adam; Ramos, Alex H.; Serra, Stefano; Pedamallu, Chandra Sekhar; Qian, Zhi Rong; Banck, Michaela S.; Kanwar, Rahul; Kulkarni, Amit A.; Karpathakis, Anna; Manzo, Veronica; Contractor, Tanupriya; Philips, Juliet; Nickerson, Elizabeth; Nam Pho; Hooshmand, Susanne M.; Brais, Lauren K.; Lawrence, Michael S.; Pugh, Trevor; McKenna, Aaron; Sivachenko, Andrey; Cibulskis, Kristian; Carter, Scott L.; Ojesina, Akinyemi I.; Freeman, Samuel; Jones, Robert T.; Voet, Douglas; Saksena, Gordon; Auclair, Daniel; Onofrio, Robert; Shefler, Erica; Sougnez, Carrie; Grimsby, Jonna; Green, Lisa; Lennon, Niall; Meyer, Tim; Caplin, Martyn; Chung, Daniel C.; Beutler, Andreas S.; Ogino, Shuji; Thirlwell, Christina; Shivdasani, Ramesh; Asa, Sylvia L.; Harris, Chris R.; Getz, Gad; Kulke, Matthew; Meyerson, Matthew			Somatic mutation of CDKN1B in small intestine neuroendocrine tumors	NATURE GENETICS			English	Article							DEPENDENT KINASE INHIBITOR; P27(KIP1) GENE; BREAST-CANCER; FREQUENT LOSS; MICE LACKING; SUPPRESSOR; GROWTH; HAPLOINSUFFICIENCY; HETEROZYGOSITY; ADENOCARCINOMA	The diagnosed incidence of small intestine neuroendocrine tumors (SI-NETs) is increasing, and the underlying genomic mechanisms have not yet been defined. Using exome- and genome-sequence analysis of SI-NETs, we identified recurrent somatic mutations and deletions in CDKN1B, the cyclin-dependent kinase inhibitor gene, which encodes p27. We observed frameshift mutations of CDKN1B in 14 of 180 SI-NETs, and we detected hemizygous deletions encompassing CDKN1B in 7 out of 50 SI-NETs, nominating p27 as a tumor suppressor and implicating cell cycle dysregulation in the etiology of SI-NETs.	[Francis, Joshua M.; Kiezun, Adam; Ramos, Alex H.; Pedamallu, Chandra Sekhar; Nickerson, Elizabeth; Nam Pho; Lawrence, Michael S.; Pugh, Trevor; McKenna, Aaron; Sivachenko, Andrey; Cibulskis, Kristian; Carter, Scott L.; Ojesina, Akinyemi I.; Voet, Douglas; Saksena, Gordon; Auclair, Daniel; Onofrio, Robert; Shefler, Erica; Sougnez, Carrie; Grimsby, Jonna; Green, Lisa; Lennon, Niall; Getz, Gad; Meyerson, Matthew] Broad Inst, Cambridge, MA USA; [Francis, Joshua M.; Ramos, Alex H.; Pedamallu, Chandra Sekhar; Qian, Zhi Rong; Manzo, Veronica; Philips, Juliet; Hooshmand, Susanne M.; Brais, Lauren K.; Ojesina, Akinyemi I.; Freeman, Samuel; Ogino, Shuji; Shivdasani, Ramesh; Kulke, Matthew; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Serra, Stefano; Asa, Sylvia L.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Banck, Michaela S.; Kanwar, Rahul; Kulkarni, Amit A.; Beutler, Andreas S.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Banck, Michaela S.; Beutler, Andreas S.] Mayo Clin, Ctr Canc, Rochester, MN USA; [Karpathakis, Anna; Meyer, Tim; Thirlwell, Christina] UCL, Inst Canc, London, England; [Karpathakis, Anna; Meyer, Tim; Caplin, Martyn; Thirlwell, Christina] Royal Free Hosp, NET Unit, London NW3 2QG, England; [Contractor, Tanupriya; Harris, Chris R.] Raymond & Beverly Sackler Fdn, New Brunswick, NJ USA; [Jones, Robert T.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Chung, Daniel C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Chung, Daniel C.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Asa, Sylvia L.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada; [Harris, Chris R.] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA; [Harris, Chris R.] Univ Med & Dent New Jersey, Dept Pediat, New Brunswick, NJ USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; Mayo Clinic; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kulke, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_kulke@dfci.harvard.edu; matthew_meyerson@dfci.harvard.edu	Pedamallu, Chandra Sekhar/AAV-6745-2020; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Pugh, Trevor/Y-2535-2019; Kanwar, Rahul/K-1954-2015; Pedamallu, Chandra Sekhar/AAV-6723-2020	Pugh, Trevor/0000-0002-8073-5888; Kanwar, Rahul/0000-0002-4575-8654; Jones, Robert/0000-0001-8007-4023; Ojesina, Akinyemi/0000-0003-0755-3639; Freeman, Samuel/0000-0001-8285-0057; Cibulskis, Kristian/0000-0003-1343-1582; serra, stefano/0000-0002-3258-2637; Ogino, Shuji/0000-0002-3909-2323; Meyerson, Matthew/0000-0002-9133-8108; Asa, Sylvia/0000-0001-8418-5054	Caring for Carcinoid Foundation; Raymond and Beverly Sackler Foundation for the Arts and Sciences; Cancer Research UK; Cancer Research UK [12183] Funding Source: researchfish; National Institute for Health Research [CL-2007-18-006] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA015083] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; Raymond and Beverly Sackler Foundation for the Arts and Sciences; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Caring for Carcinoid Foundation (S. L. A. and M. M.), the Raymond and Beverly Sackler Foundation for the Arts and Sciences (C. T., A. Karpathakis, S. L. A. and M. M.) and Cancer Research UK (C. T. and A. Karpathakis).	Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cunningham JL, 2011, GENE CHROMOSOME CANC, V50, P82, DOI 10.1002/gcc.20834; Curtit E, 2013, ONCOLOGIST, V18, P667, DOI 10.1634/theoncologist.2012-0350; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Habbe N, 2013, SURG TODAY, V43, P1168, DOI 10.1007/s00595-012-0408-1; Hatta Y, 1997, BRIT J CANCER, V75, P1256, DOI 10.1038/bjc.1997.214; Hetet G, 2000, Hematol J, V1, P42, DOI 10.1038/sj.thj.6200008; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kibel AS, 1999, GENE CHROMOSOME CANC, V25, P270, DOI 10.1002/(SICI)1098-2264(199907)25:3<270::AID-GCC9>3.3.CO;2-Q; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kulke MH, 2008, GENE CHROMOSOME CANC, V47, P591, DOI 10.1002/gcc.20561; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le Toriellec E, 2008, BLOOD, V111, P2321, DOI 10.1182/blood-2007-06-095570; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; PIETENPOL JA, 1995, CANCER RES, V55, P1206; Polish A, 2011, J NATL COMPR CANC NE, V9, P1397, DOI 10.6004/jnccn.2011.0118; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Takeuchi S, 1996, CANCER RES, V56, P738; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vinik AI, 2010, PANCREAS, V39, P713, DOI 10.1097/MPA.0b013e3181ebaffd; Ying HQ, 2011, CANCER DISCOV, V1, P158, DOI 10.1158/2159-8290.CD-11-0031; Zimmer SN, 2011, BLOOD, V118, P69, DOI 10.1182/blood-2010-09-307942	51	219	227	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1483	U110		10.1038/ng.2821	http://dx.doi.org/10.1038/ng.2821			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24185511	Green Accepted			2022-12-25	WOS:000327715800016
J	Bajou, K; Herkenne, S; Thijssen, VL; D'Amico, S; Nguyen, NQN; Bouche, A; Tabruyn, S; Srahna, M; Carabin, JY; Nivelles, O; Paques, C; Cornelissen, I; Lion, M; Noel, A; Gils, A; Vinckier, S; Declerck, PJ; Griffioen, AW; Dewerchin, M; Martial, JA; Carmeliet, P; Struman, I				Bajou, Khalid; Herkenne, Stephanie; Thijssen, Victor L.; D'Amico, Salvino; Ngoc-Quynh-Nhu Nguyen; Bouche, Ann; Tabruyn, Sebastien; Srahna, Mohammed; Carabin, Jean-Yves; Nivelles, Olivier; Paques, Cecile; Cornelissen, Ivo; Lion, Michelle; Noel, Agnes; Gils, Ann; Vinckier, Stefan; Declerck, Paul J.; Griffioen, Arjan W.; Dewerchin, Mieke; Martial, Joseph A.; Carmeliet, Peter; Struman, Ingrid			PAT-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin	NATURE MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CAPILLARY ENDOTHELIAL-CELLS; FACTOR-KAPPA-B; TUMOR-GROWTH; UROKINASE RECEPTOR; GENE-TRANSFER; ANGIOGENESIS; PROTEIN; CANCER; PAI-1	The N-terminal fragment of prolactin (16K PRL) inhibits tumor growth by impairing angiogenesis, but the underlying mechanisms are unknown. Here, we found that 16K PRL binds the fibrinolytic inhibitor plasminogen activator inhibitor-1 (PAI-1), which is known to contextually promote tumor angiogenesis and growth. Loss of PAI-1 abrogated the antitumoral and antiangiogenic effects of 16K PRL. PAI-1 bound the ternary complex PAI-1-urokinase-type plasminogen activator (uPA)-uPA receptor (uPAR), thereby exerting antiangiogenic effects. By inhibiting the antifibrinolytic activity of PAI-1, 16K PRL also protected mice against thromboembolism and promoted arterial clot lysis. Thus, by signaling through the PAI-1-uPA-uPAR complex, 16K PRL impairs tumor vascularization and growth and, by inhibiting the antifibrinolytic activity of PAI-1, promotes thrombolysis.	[Bajou, Khalid; Herkenne, Stephanie; D'Amico, Salvino; Ngoc-Quynh-Nhu Nguyen; Tabruyn, Sebastien; Srahna, Mohammed; Carabin, Jean-Yves; Nivelles, Olivier; Paques, Cecile; Lion, Michelle; Martial, Joseph A.; Struman, Ingrid] Univ Liege, Mol Angiogenesis Lab, Interdisciplinary Cluster Appl Genoprote GIGA Res, Liege, Belgium; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Angiogenesis Lab, Amsterdam, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Dept Radiotherapy, Amsterdam, Netherlands; [Bouche, Ann; Cornelissen, Ivo; Vinckier, Stefan; Dewerchin, Mieke; Carmeliet, Peter] VIB, Vesalius Res Ctr VRC, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium; [Bouche, Ann; Cornelissen, Ivo; Vinckier, Stefan; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium; [Noel, Agnes] Univ Liege, GIGA Res Ctr, Unit Biol Tumor & Dev, Liege, Belgium; [Gils, Ann; Declerck, Paul J.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium	University of Liege; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Liege; KU Leuven	Struman, I (corresponding author), Univ Liege, Mol Angiogenesis Lab, Interdisciplinary Cluster Appl Genoprote GIGA Res, Liege, Belgium.	i.struman@ulg.ac.be	Thijssen, Victor LJL/B-2792-2009; Carmeliet, Peter/AAQ-5140-2020; Declerck, Paul J/A-2330-2017	Thijssen, Victor LJL/0000-0002-6146-1842; Carmeliet, Peter/0000-0001-7961-1821; Declerck, Paul J/0000-0003-1259-9105; Noel, Agnes/0000-0002-7670-6179; Herkenne, stephanie/0000-0002-2106-9360; struman, ingrid/0000-0003-2550-3707; Bajou, Khalid/0000-0002-5529-9228	University of Liege; Fonds pour la Recherche Industrielle et Agricole (FRIA), Belgium; Fonds National de la Recherche Scientifique (FNRS), Belgium; Belgian Federal Science Policy Office [IUAP06/30]; Neoangio program from the 'Service Public de Wallonie' [616476]; Belgian Foundation against Cancer, Televie; Leon Fredericq Fund; Centre Anticancereux (Liege, Belgium); Dutch Cancer Society [UM2008-4101, VU2009-4358]; Belgian Science Policy (IAP) [P7/03]; Leducq Network of Excellence; Flanders Research Foundation (FWO); Foundation against Cancer, European Research Council Advanced Research [EU-ERC269073]; long-term structural Methusalem - Flemish Government	University of Liege(University of Liege); Fonds pour la Recherche Industrielle et Agricole (FRIA), Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Neoangio program from the 'Service Public de Wallonie'; Belgian Foundation against Cancer, Televie; Leon Fredericq Fund; Centre Anticancereux (Liege, Belgium); Dutch Cancer Society(KWF Kankerbestrijding); Belgian Science Policy (IAP)(Belgian Federal Science Policy Office); Leducq Network of Excellence; Flanders Research Foundation (FWO)(FWO); Foundation against Cancer, European Research Council Advanced Research; long-term structural Methusalem - Flemish Government	We thank J.-M. Foidart for helpful discussions. We also thank A. Igout, O. Jacquin and M. Galleni for assisting with SPR, E. Rozet for helping with statistical analysis, R. Lijnen (Center for Molecular and Vascular Biology) for providing the PAT-1 ELISA and N. Fusenig (German Cancer Research) for providing BD VII cells. We thank the technology platforms support staff at the GIGA Research Center and P. Drion of the mouse facility (GIGA). This study was supported by the University of Liege, the Fonds pour la Recherche Industrielle et Agricole (FRIA), Belgium, the Fonds National de la Recherche Scientifique (FNRS), Belgium, the Belgian Federal Science Policy Office grant IUAP06/30 (to I.S., A.N. and P.C.), Neoangio program grant no. 616476 from the 'Service Public de Wallonie' (to I.S.. and A.N.), the Belgian Foundation against Cancer, Televie, the Leon Fredericq Fund and the Centre Anticancereux (Liege, Belgium) and Dutch Cancer Society grants UM2008-4101 and VU2009-4358 (to V.L.T. and A.W.G.). The work of P.C. is supported by the Belgian Science Policy (IAP no. P7/03), the Leducq Network of Excellence, the Flanders Research Foundation (FWO), the Foundation against Cancer, European Research Council Advanced Research Grant EU-ERC269073 and long-term structural Methusalem funding by the Flemish Government.	Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bentzien F, 2001, CANCER RES, V61, P7356; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; Carmeliet P, 1997, CIRCULATION, V96, P3180, DOI 10.1161/01.CIR.96.9.3180; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; CLAPP C, 1992, ENDOCRINOLOGY, V130, P1380, DOI 10.1210/en.130.3.1380; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P301, DOI 10.1016/j.tem.2006.08.002; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Eitzman DT, 1996, BLOOD, V87, P4718; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gonzalez C, 2007, LAB INVEST, V87, P1009, DOI 10.1038/labinvest.3700662; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Kim J, 2003, CANCER RES, V63, P386; Kinet V, 2009, CANCER LETT, V284, P222, DOI 10.1016/j.canlet.2009.04.030; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Martini JF, 2000, MOL ENDOCRINOL, V14, P1536, DOI 10.1210/me.14.10.1536; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Mutch NJ, 2007, J THROMB HAEMOST, V5, P812, DOI 10.1111/j.1538-7836.2007.02430.x; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Nguyen NQN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027318; Nguyen NQN, 2007, MOL THER, V15, P2094, DOI 10.1038/sj.mt.6300294; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; RIJKEN DC, 1981, J LAB CLIN MED, V97, P477; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; SEIFFERT D, 1991, J BIOL CHEM, V266, P2824; Shu E, 2003, PATHOPHYSIOL HAEMO T, V33, P206, DOI 10.1159/000081510; Smith LH, 2006, BLOOD, V107, P132, DOI 10.1182/blood-2005-07-2681; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Tabruyn SP, 2007, MOL ENDOCRINOL, V21, P1422, DOI 10.1210/me.2007-0021; Tabruyn SP, 2005, MOL ENDOCRINOL, V19, P1932, DOI 10.1210/me.2004-0515; Tabruyn SP, 2003, MOL ENDOCRINOL, V17, P1815, DOI 10.1210/me.2003-0132; Tsantes AE, 2008, THROMB RES, V122, P736, DOI 10.1016/j.thromres.2007.09.005; Zangari M, 2009, J CLIN ONCOL, V27, P4865, DOI 10.1200/JCO.2009.22.3875; Zhu YH, 1999, CIRCULATION, V99, P3050, DOI 10.1161/01.CIR.99.23.3050	44	71	74	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					741	747		10.1038/nm.3552	http://dx.doi.org/10.1038/nm.3552			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24929950				2022-12-25	WOS:000338689500016
J	Hu, YC; Dietrich, D; Xu, W; Patel, A; Thuss, JAJ; Wang, JJ; Yin, WB; Qiao, KJ; Houk, KN; Vederas, JC; Tang, Y				Hu, Youcai; Dietrich, David; Xu, Wei; Patel, Ashay; Thuss, Justin A. J.; Wang, Jingjing; Yin, Wen-Bing; Qiao, Kangjian; Houk, K. N.; Vederas, John C.; Tang, Yi			A carbonate-forming Baeyer-Villiger monooxygenase	NATURE CHEMICAL BIOLOGY			English	Article							BIOSYNTHESIS; REARRANGEMENT; DERIVATIVES; CHEMISTRY; OXIDATION; DOMAIN	Despite the remarkable versatility displayed by flavin-dependent monooxygenases (FMOs) in natural product biosynthesis, one notably missing activity is the oxidative generation of carbonate functional groups. We describe a multifunctional Baeyer-Villiger monooxygenase, CcsB, which catalyzes the formation of an in-line carbonate in the macrocyclic portion of cytochalasin E. This study expands the repertoire of activities of FMOs and provides a possible synthetic strategy for transformation of ketones into carbonates.	[Hu, Youcai; Xu, Wei; Wang, Jingjing; Yin, Wen-Bing; Qiao, Kangjian; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Dietrich, David; Thuss, Justin A. J.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Patel, Ashay; Houk, K. N.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of Alberta; University of California System; University of California Los Angeles	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB, Canada.	john.vederas@ualberta.ca; yitang@ucla.edu	wang, jing/GRS-7509-2022; Yin, Wen-Bing/AAF-4825-2021; Hu, Youcai/I-9668-2014; WANG, JINGYI/GSJ-1241-2022; Patel, Ashay/ABF-3880-2020	Patel, Ashay/0000-0002-7571-3406; Vederas, John/0000-0002-2996-0326	US National Institutes of Health [1R01GM085128, 1DP1GM106413]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; US National Science Foundation (NSF) [CHE-1059084]; Chemistry Biology Interface program [T32GM008496]; NSF [CHE-1048804]; Extreme Science and Engineering Design Environment program [TG-CHE040013N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106413, T32GM008496, R01GM085128] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); US National Science Foundation (NSF)(National Science Foundation (NSF)); Chemistry Biology Interface program; NSF(National Science Foundation (NSF)); Extreme Science and Engineering Design Environment program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (1R01GM085128 and 1DP1GM106413) to YT., the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair in Bioorganic and Medicinal Chemistry to J.C.V. and the US National Science Foundation (NSF) CHE-1059084 to K.N.H. A.P. thanks the Chemistry Biology Interface program (T32GM008496) for support. NMR instrumentation was supported by the NSF equipment grant CHE-1048804. We thank Y.-H. Chooi and N.K. Garg for helpful discussions. We thank S.I. Khan at the University of California-Los Angeles Department of Chemistry and Biochemistry crystallography facility for solving the X-ray structures. We thank D. Li at Chinese Ocean University for providing the standards for 5, 9 and 10. We acknowledge the Extreme Science and Engineering Design Environment program (TG-CHE040013N) for providing high-performance computing resources.	de Gonzalo G, 2010, CHEMBIOCHEM, V11, P2208, DOI 10.1002/cbic.201000395; Francisco WA, 1996, J BIOL CHEM, V271, P104, DOI 10.1074/jbc.271.1.104; Frank B, 2007, J MOL BIOL, V374, P24, DOI 10.1016/j.jmb.2007.09.015; Hong XC, 2006, TETRAHEDRON LETT, V47, P8387, DOI 10.1016/j.tetlet.2006.09.071; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Ishiuchi K, 2013, J AM CHEM SOC, V135, P7371, DOI 10.1021/ja402828w; KIMURA Y, 1989, AGR BIOL CHEM TOKYO, V53, P1699, DOI 10.1080/00021369.1989.10869501; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Lin ZJ, 2009, HELV CHIM ACTA, V92, P1538, DOI 10.1002/hlca.200800455; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mejia-Oneto JM, 2008, HELV CHIM ACTA, V91, P285, DOI 10.1002/hlca.200890034; Minato H, 1970, J Chem Soc Perkin 1, V1, P38; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Pongcharoen W, 2006, J NAT PROD, V69, P856, DOI 10.1021/np0600649; Qiao KJ, 2011, METAB ENG, V13, P723, DOI 10.1016/j.ymben.2011.09.008; ROBERT JL, 1975, HELV CHIM ACTA, V58, P2501, DOI 10.1002/hlca.19750580830; RUBIN MB, 1988, J ORG CHEM, V53, P3355, DOI 10.1021/jo00249a043; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; Tang MC, 2013, ACS CATAL, V3, P444, DOI 10.1021/cs300819e; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; Tomoda H, 1999, J ANTIBIOT, V52, P851, DOI 10.7164/antibiotics.52.851; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/NCHEMBIO.1366, 10.1038/nchembio.1366]; VEDERAS JC, 1980, J AM CHEM SOC, V102, P374, DOI 10.1021/ja00521a063; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Zhang H, 2014, CHEM REV, V114, P883, DOI 10.1021/cr300430e	25	57	58	8	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					552	554		10.1038/NCHEMBIO.1527	http://dx.doi.org/10.1038/NCHEMBIO.1527			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24838010	Green Accepted, Green Submitted			2022-12-25	WOS:000337871200012
J	Assie, G; Letouze, E; Fassnacht, M; Jouinot, A; Luscap, W; Barreau, O; Omeiri, H; Rodriguez, S; Perlemoine, K; Rene-Corail, F; Elarouci, N; Sbiera, S; Kroiss, M; Allolio, B; Waldmann, J; Quinkler, M; Mannelli, M; Mantero, F; Papathomas, T; De Krijger, R; Tabarin, A; Kerlan, V; Baudin, E; Tissier, F; Dousset, B; Groussin, L; Amar, L; Clauser, E; Bertagna, X; Ragazzon, B; Beuschlein, F; Libe, R; de Reynies, A; Bertherat, J				Assie, Guillaume; Letouze, Eric; Fassnacht, Martin; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Elarouci, Nabila; Sbiera, Silviu; Kroiss, Matthias; Allolio, Bruno; Waldmann, Jens; Quinkler, Marcus; Mannelli, Massimo; Mantero, Franco; Papathomas, Thomas; De Krijger, Ronald; Tabarin, Antoine; Kerlan, Veronique; Baudin, Eric; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Amar, Laurence; Clauser, Eric; Bertagna, Xavier; Ragazzon, Bruno; Beuschlein, Felix; Libe, Rossella; de Reynies, Aurelien; Bertherat, Jerome			Integrated genomic characterization of adrenocortical carcinoma	NATURE GENETICS			English	Article							LONG NONCODING RNAS; COPY-NUMBER CHANGES; HUMAN CANCER; MOLECULAR CLASSIFICATION; TUMOR-SUPPRESSOR; MUTATIONS; GENE; EXPRESSION; MANAGEMENT; MICRORNA	Adrenocortical carcinomas (ACCs) are aggressive cancers originating in the cortex of the adrenal gland(1). Despite overall poor prognosis, ACC outcome is heterogeneous(2,3). We performed exome sequencing and SNP array analysis of 45 ACCs and identified recurrent alterations in known driver genes(4,5) (CTNNB1, TP53, CDKN2A, RB1 and MEN1) and in genes not previously reported in ACC (ZNRF3, DAXX, TERT and MED12), which we validated in an independent cohort of 77 ACCs. ZNRF3, encoding a cell surface E3 ubiquitin ligase(6), was the most frequently altered gene (21%) and is a potential new tumor suppressor gene related to the beta-catenin pathway. Our integrated genomic analyses further identified two distinct molecular subgroups with opposite outcome. The C1A group of ACCs with poor outcome displayed numerous mutations and DNA methylation alterations, whereas the C1B group of ACCs with good prognosis displayed specific deregulation of two microRNA clusters. Thus, aggressive and indolent ACCs correspond to two distinct molecular entities driven by different oncogenic alterations.	[Assie, Guillaume; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Libe, Rossella; Bertherat, Jerome] INSERM, Inst Cochin, U1016, Paris, France; [Assie, Guillaume; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Libe, Rossella; Bertherat, Jerome] CNRS, UMR 8104, Paris, France; [Assie, Guillaume; Jouinot, Anne; Luscap, Windy; Barreau, Olivia; Omeiri, Hanin; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Tissier, Frederique; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Libe, Rossella; Bertherat, Jerome] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Assie, Guillaume; Barreau, Olivia; Dousset, Bertrand; Groussin, Lionel; Bertagna, Xavier; Libe, Rossella; Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, Ctr Rare Adrenal Dis, F-75674 Paris, France; [Letouze, Eric; Elarouci, Nabila; de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs CIT, Paris, France; [Fassnacht, Martin; Sbiera, Silviu; Beuschlein, Felix] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Sbiera, Silviu; Allolio, Bruno] Univ Hosp Wurzburg, Dept Internal Med 1, Endocrine & Diabet Unit, Wurzburg, Germany; [Fassnacht, Martin; Kroiss, Matthias] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Waldmann, Jens] Univ Hosp Giessen & Marburg, Marburg, Germany; [Quinkler, Marcus] Charite, Charite Campus Mitte, Dept Clin Epidemiol, D-13353 Berlin, Germany; [Mannelli, Massimo] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Mantero, Franco] Univ Padua, Dept Med, Endocrinol Unit, Padua, Italy; [Papathomas, Thomas; De Krijger, Ronald] Erasmus MC Univ Med Ctr, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Tabarin, Antoine] Univ Hosp Bordeaux, Dept Endocrinol Diabet & Metab Dis, Bordeaux, France; [Tabarin, Antoine; Kerlan, Veronique; Baudin, Eric; Bertagna, Xavier; Libe, Rossella; Bertherat, Jerome] Rare Adrenal Canc Network COMETE, Paris, France; [Kerlan, Veronique] Univ Hosp Brest, Dept Endocrinol Diabet & Metab Dis, Brest, France; [Baudin, Eric] Univ Paris 11, Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France; [Tissier, Frederique] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Pathol, Paris, France; [Dousset, Bertrand] Hop Cochin, AP HP, Dept Digest & Endocrine Surg, F-75674 Paris, France; [Amar, Laurence] Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, Paris, France; [Clauser, Eric] Hop Cochin, AP HP, Oncogenet Lab, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; University of Wurzburg; University of Wurzburg; University Hospital of Giessen & Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Florence; University of Padua; Erasmus University Rotterdam; Erasmus MC; CHU Bordeaux; CHU Brest; Universite de Bretagne Occidentale; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Bertherat, J (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.	jerome.bertherat@cch.aphp.fr	Amar, Laurence/P-5278-2017; KERLAN, Veronique/AAF-3901-2020; Letouzé, Eric/AAP-9924-2020; Kroiss, Matthias/AAF-1624-2019; Fassnacht, Martin/N-9614-2019; Sbiera, Silviu/E-8128-2019; de Krijger, Ronald/J-2564-2019; Kroiss, Matthias/B-4785-2014; jouinot, anne/AAA-9297-2022; de Reyniès, Aurélien/Q-8640-2017; Ragazzon, Bruno/E-6541-2017	Amar, Laurence/0000-0003-3942-4276; Letouzé, Eric/0000-0002-6369-2839; Kroiss, Matthias/0000-0002-7628-3161; Fassnacht, Martin/0000-0001-6170-6398; Sbiera, Silviu/0000-0002-6271-5533; Kroiss, Matthias/0000-0002-7628-3161; jouinot, anne/0000-0002-7922-2065; de Reyniès, Aurélien/0000-0002-1328-5290; Ragazzon, Bruno/0000-0001-9476-4973; BERTHERAT, Jerome/0000-0003-2551-3008; Groussin, Lionel/0000-0003-1476-475X; Dousset, Bertrand/0000-0003-2526-7345; RONDOF, Windy/0000-0002-8160-4900; libe, rossella/0000-0003-2881-6362; kerlan, veronique/0000-0001-8105-6628; Quinkler, Marcus/0000-0003-4028-1671; Rodriguez, Stephanie/0000-0003-4520-144X; Assie, Guillaume/0000-0001-9590-0906; Mannelli, Massimo/0000-0002-8001-9857	Programme Hospitaller de Recherche Clinique [AOM95201]; Seventh Framework Programme [259735]; Institut National du Cancer Recherche Translationelle [2009-RT-02]; Institut National du Cancer; INSEAM; Conny-Maeva Charitable Foundation	Programme Hospitaller de Recherche Clinique; Seventh Framework Programme(European Commission); Institut National du Cancer Recherche Translationelle(Institut National du Cancer (INCA) France); Institut National du Cancer(Institut National du Cancer (INCA) France); INSEAM; Conny-Maeva Charitable Foundation	We thank E Letourneur, R. Pelletier and S. Jacques from the Genomic platform of the Cochin Institute and P. Nietscke from the Paris Descartes University Bioinformatics platform for their technical support, J. Metal and J. Godet from the Ligue Nationale Contre le Cancer for organization of the Cartes d'Identite des Tumeurs (CIT) program, P.F. Plouin for organization of the COMETE network, the tumor bank of Cochin Hospital (B. Terris and M. Sibony) for help in sample collection, the Oncogenetic Department of Cochin Hospital (V Duchossoy), A. Steel for management of the ENSAT database, the members of our laboratories and the COMETE and ENSAT networks for support and discussions, and all the staffs of the clinical and pathology departments who were involved in patient care. This study is part of the CIT Program from La Ligue Nationale Contre le Cancer. It was supported by funding from the Programme Hospitaller de Recherche Clinique to the COMETE network (grant AOM95201), the Seventh Framework Programme (FP7/2007-2013) under grant agreement 259735, Institut National du Cancer Recherche Translationelle 2009-RT-02, the Institut National du Cancer (to the Rare Adrenal Cancer Network COMETE), INSEAM (G.A. receives a Contrat d'Interface) and the Conny-Maeva Charitable Foundation (to the laboratory of J.B.).	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barreau O, 2013, J CLIN ENDOCR METAB, V98, pE174, DOI 10.1210/jc.2012-2993; Barreau O, 2012, J CLIN ENDOCR METAB, V97, pE301, DOI 10.1210/jc.2011-1588; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Cheunsuchon P, 2011, AM J PATHOL, V179, P2120, DOI 10.1016/j.ajpath.2011.07.002; De Martino MC, 2013, J CLIN ENDOCR METAB, V98, P4080, DOI 10.1210/jc.2013-2165; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Fonseca AL, 2012, GENE CHROMOSOME CANC, V51, P949, DOI 10.1002/gcc.21978; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x; Kerkhofs TMA, 2013, EUR J CANCER, V49, P2579, DOI 10.1016/j.ejca.2013.02.034; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Laurell C, 2009, EUR J ENDOCRINOL, V161, P141, DOI 10.1530/EJE-09-0068; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; LUTON JP, 1990, NEW ENGL J MED, V322, P1195, DOI 10.1056/NEJM199004263221705; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Rechache NS, 2012, J CLIN ENDOCR METAB, V97, pE1004, DOI 10.1210/jc.2011-3298; Ronchi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073959; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Schteingart DE, 2005, ENDOCR-RELAT CANCER, V12, P667, DOI 10.1677/erc.1.01029; Soon PSH, 2009, MINERVA ENDOCRINOL, V34, P137; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Stephan EA, 2008, MOL CANCER THER, V7, P425, DOI 10.1158/1535-7163.MCT-07-0267; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Tombol Z, 2009, ENDOCR-RELAT CANCER, V16, P895, DOI 10.1677/ERC-09-0096; Wandoloski M, 2009, SURG CLIN N AM, V89, P1255, DOI 10.1016/j.suc.2009.06.019; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	53	420	424	7	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					607	612		10.1038/ng.2953	http://dx.doi.org/10.1038/ng.2953			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747642				2022-12-25	WOS:000336870700018
J	Boroviak, T; Loos, R; Bertone, P; Smith, A; Nichols, J				Boroviak, Thorsten; Loos, Remco; Bertone, Paul; Smith, Austin; Nichols, Jennifer			The ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification	NATURE CELL BIOLOGY			English	Article							PRIMITIVE ENDODERM; GENE-EXPRESSION; GROUND-STATE; BASEMENT-MEMBRANES; VISCERAL ENDODERM; IN-VIVO; DIFFERENTIATION; LINES; PLURIPOTENCY; DERIVATION	The precise relationship of embryonic stem cells (ESCs) to cells in the mouse embryo remains controversial. We present transcriptional and functional data to identify the embryonic counterpart of ESCs. Marker profiling shows that ESCs are distinct from early inner cell mass (ICM) and closely resemble pre-implantation epiblast. A characteristic feature of mouse ESCs is propagation without ERK signalling. Single-cell culture reveals that cell-autonomous capacity to thrive when the ERK pathway is inhibited arises late during blastocyst development and is lost after implantation. The frequency of deriving clonal ESC lines suggests that all E4.5 epiblast cells can become ESCs. We further show that ICM cells from early blastocysts can progress to ERK independence if provided with a specific laminin substrate. These findings suggest that formation of the epiblast coincides with competence for ERK-independent self-renewal in vitro and consequent propagation as ESC lines.	[Boroviak, Thorsten; Bertone, Paul; Smith, Austin; Nichols, Jennifer] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Loos, Remco; Bertone, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Bertone, Paul] European Mol Biol Lab, Genome Biol & Dev Biol Units, D-69117 Heidelberg, Germany; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of Cambridge; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Cambridge; University of Cambridge	Nichols, J (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Tennis Court Rd, Cambridge CB2 1QR, England.	jn270@cam.ac.uk	Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682; Loos, Remco/0000-0002-9850-6821; Boroviak, Thorsten Edwin/0000-0001-8703-8949	Wellcome Trust; Medical Research Council; BBSRC; Louis Jeantet Foundation; EMBL; University of Cambridge; BBSRC [BB/G015678/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G015678/1] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G1100526] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Louis Jeantet Foundation; EMBL; University of Cambridge(University of Cambridge); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C-E Dumeau and W. Mansfield for chimaera production, P. Humphreys for assistance with imaging, S. Jameson and staff for animal husbandry, the EMBL Genomics Core Facility for sequencing, and G. Martello for helpful discussion on the manuscript. This work was financially supported by the Wellcome Trust, Medical Research Council, BBSRC, the Louis Jeantet Foundation, EMBL and the University of Cambridge. A.S. is a Medical Research Council Professor.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Delhaise F, 1996, EUR J MORPHOL, V34, P237, DOI 10.1076/ejom.34.4.237.13046; Domogatskaya A, 2008, STEM CELLS, V26, P2800, DOI 10.1634/stemcells.2007-0389; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Grabarek JB, 2012, DEVELOPMENT, V139, P129, DOI 10.1242/dev.067702; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Haapa-Paananen S, 2012, ONCOGENE, V31, P1299, DOI 10.1038/onc.2011.316; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pelton TA, 2002, J CELL SCI, V115, P329; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith A, 2013, CELL STEM CELL, V13, P6, DOI 10.1016/j.stem.2013.06.016; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	82	307	313	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2014	16	6					513	+		10.1038/ncb2965	http://dx.doi.org/10.1038/ncb2965			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AI2EB	24859004	Green Accepted, Green Submitted			2022-12-25	WOS:000336669100008
J	O'Brien, AJ; Fullerton, JN; Massey, KA; Auld, G; Sewell, G; James, S; Newson, J; Karra, E; Winstanley, A; Alazawi, W; Garcia-Martinez, R; Cordoba, J; Nicolaou, A; Gilroy, DW				O'Brien, Alastair J.; Fullerton, James N.; Massey, Karen A.; Auld, Grace; Sewell, Gavin; James, Sarah; Newson, Justine; Karra, Effie; Winstanley, Alison; Alazawi, William; Garcia-Martinez, Rita; Cordoba, Joan; Nicolaou, Anna; Gilroy, Derek W.			Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E-2	NATURE MEDICINE			English	Article							CHRONIC LIVER-FAILURE; INFECTIONS; MACROPHAGE; PHAGOCYTOSIS; DYSFUNCTION; PREVALENCE; SUPPRESSES; MANAGEMENT; ASCITES	Liver disease is one of the leading causes of death worldwide(1). Patients with cirrhosis display an increased predisposition to and mortality from infection due to multimodal defects in the innate immune system(2-4); however, the causative mechanism has remained elusive. We present evidence that the cyclooxygenase (COX)-derived eicosanoid prostaglandin E-2 (PGE(2)) drives cirrhosis-associated immunosuppression. We observed elevated circulating concentrations (more than seven times as high as in healthy volunteers) of PGE(2) in patients with acute decompensation of cirrhosis. Plasma from these and patients with end-stage liver disease (ESLD) suppressed macrophage proinflammatory cytokine secretion and bacterial killing in vitro in a PGE(2)-dependent manner via the prostanoid type E receptor-2 (EP2), effects not seen with plasma from patients with stable cirrhosis (Child-Pugh score grade A). Albumin, which reduces PGE(2) bioavailability, was decreased in the serum of patients with acute decompensation or ESLD (<30 mg/dl) and appears to have a role in modulating PGE(2)-mediated immune dysfunction. In vivo administration of human albumin solution to these patients significantly improved the plasma-induced impairment of macrophage proinflammatory cytokine production in vitro. Two mouse models of liver injury (bile duct ligation and carbon tetrachloride) also exhibited elevated PGE(2), reduced circulating albumin concentrations and EP2-mediated immunosuppression. Treatment with COX inhibitors or albumin restored immune competence and survival following infection with group B Streptococcus. Taken together, human albumin solution infusions may be used to reduce circulating PGE(2) levels, attenuating immune suppression and reducing the risk of infection in patients with acutely decompensated cirrhosis or ESLD.	[O'Brien, Alastair J.; Fullerton, James N.; Auld, Grace; James, Sarah; Newson, Justine; Karra, Effie; Gilroy, Derek W.] UCL, Ctr Clin Pharmacol & Therapeut, Div Med, London, England; [Massey, Karen A.; Nicolaou, Anna] Univ Manchester, Manchester Pharm Sch, Fac Med & Human Sci, Manchester, Lancs, England; [Sewell, Gavin] UCL, Div Med, London, England; [Winstanley, Alison] Univ Coll London Hosp, Dept Histopathol, London, England; [Alazawi, William] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Ctr Digest Dis, Liver Unit, London, England; [Garcia-Martinez, Rita] Univ Autonoma Barcelona, Hosp Clin Barcelona, Serv Hepatol, Hosp Univ Vall dHebron, E-08193 Barcelona, Spain; [Cordoba, Joan] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain	University of London; University College London; University of Manchester; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Gilroy, DW (corresponding author), UCL, Ctr Clin Pharmacol & Therapeut, Div Med, London, England.	d.gilroy@ucl.ac.uk	Gilroy, Derek/AAP-7227-2020; Nicolaou, Anna/D-4025-2018; Gilroy, Derek W/C-2588-2009	Gilroy, Derek/0000-0003-3476-0844; Nicolaou, Anna/0000-0002-1314-413X; Fullerton, James/0000-0002-4855-9255; Alazawi, William/0000-0002-3891-5914; O'Brien, Alastair/0000-0002-9168-7009; Garcia Martinez, Rita/0000-0003-2159-2757; Sewell, Gavin/0000-0002-3002-9248	National Institute of Health Research University College London Hospitals Biomedical Research Centre; Wellcome Trust; Academy of Medical Sciences (AMS) [AMS-SGCL5-Alazawi] Funding Source: researchfish; National Institute for Health Research [ACF-2010-18-029, CL-2010-19-004] Funding Source: researchfish	National Institute of Health Research University College London Hospitals Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank R. Mookerjee (Royal Free Hospital) for allowing use of samples from the DASIMAR study, N. Shah for collecting these samples and N. Davies for technical assistance. We also thank A. Healey for technical support and H. Antoniades for facilitating sample acquisition. E. coli and GBS clinical isolates were provided by V. Gant, University College London Hospitals. D.W.G. is a Wellcome Trust senior research fellow and support for work presented here was provided by the Wellcome Trust. Support was also provided by a grant from the National Institute of Health Research University College London Hospitals Biomedical Research Centre (A.J.O.).	Alves de Mattos Angelo, 2011, Ann Hepatol, V10 Suppl 1, pS15; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bourdonnay E, 2012, J LEUKOCYTE BIOL, V92, P219, DOI 10.1189/jlb.1211590; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Fagiuoli S, 2014, DIGEST LIVER DIS, V46, P204, DOI 10.1016/j.dld.2013.07.015; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; FIERER J, 1979, J CLIN INVEST, V63, P912, DOI 10.1172/JCI109391; Fullerton JN, 2014, TRENDS IMMUNOL, V35, P12, DOI 10.1016/j.it.2013.10.008; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; GOSS JA, 1992, ANN SURG, V215, P553, DOI 10.1097/00000658-199206000-00001; HASSNER A, 1981, BRIT MED J, V282, P1262, DOI 10.1136/bmj.282.6272.1262; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; McAnulty RJ, 1997, BIOCHEM J, V321, P639, DOI 10.1042/bj3210639; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mookerjee RP, 2007, HEPATOLOGY, V46, P831, DOI 10.1002/hep.21737; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; O'Brien AJ, 2012, INTENS CARE MED, V38, P991, DOI 10.1007/s00134-012-2523-2; RAJKOVIC IA, 1986, HEPATOLOGY, V6, P252, DOI 10.1002/hep.1840060217; Romanelli RG, 2006, WORLD J GASTROENTERO, V12, P1403, DOI 10.3748/wjg.v12.i9.1403; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Yang JS, 2002, PROTEIN SCI, V11, P538, DOI 10.1110/ps.28702	28	186	192	0	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					522	527		10.1038/nm.3516	http://dx.doi.org/10.1038/nm.3516			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24728410	Green Accepted, Green Submitted			2022-12-25	WOS:000335710700023
J	Schober, A; Nazari-Jahantigh, M; Wei, YY; Bidzhekov, K; Gremse, F; Grommes, J; Megens, RTA; Heyll, K; Noels, H; Hristov, M; Wang, SS; Kiessling, F; Olson, EN; Weber, C				Schober, Andreas; Nazari-Jahantigh, Maliheh; Wei, Yuanyuan; Bidzhekov, Kiril; Gremse, Felix; Grommes, Jochen; Megens, Remco T. A.; Heyll, Kathrin; Noels, Heidi; Hristov, Michael; Wang, Shusheng; Kiessling, Fabian; Olson, Eric N.; Weber, Christian			MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1	NATURE MEDICINE			English	Article							ARTERIAL ENDOTHELIUM; CELL REPAIR; IN-VIVO; APOPTOSIS; MIR-126; ACTIVATION; INJURY; FLOW; REPLICATION; DYSFUNCTION	Atherosclerosis, a hyperlipidemia-induced chronic inflammatory process of the arterial wall, develops preferentially at sites where disturbed laminar flow compromises endothelial cell (EC) function. Here we show that endothelial miR-126-5p maintains a proliferative reserve in ECs through suppression of the Notch1 inhibitor delta-like 1 homolog (Dlk1) and thereby prevents atherosclerotic lesion formation. Endothelial recovery after denudation was impaired in Mir126(-/-) mice because lack of miR-126-5p, but not miR-126-3p, reduced EC proliferation by derepressing Dlk1. At nonpredilection sites, high miR-126-5p levels in endothelial cells confer a proliferative reserve that compensates for the antiproliferative effects of hyperlipidemia, such that atherosclerosis was exacerbated in Mir126(-/-) mice. In contrast, downregulation of miR-126-5p by disturbed flow abrogated EC proliferation at predilection sites in response to hyperlipidemic stress through upregulation of Dlk1 expression. Administration of miR-126-5p rescued EC proliferation at predilection sites and limited atherosclerosis, introducing a potential therapeutic approach.	[Schober, Andreas; Nazari-Jahantigh, Maliheh; Wei, Yuanyuan; Bidzhekov, Kiril; Megens, Remco T. A.; Heyll, Kathrin; Hristov, Michael; Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Schober, Andreas; Nazari-Jahantigh, Maliheh; Wei, Yuanyuan; Heyll, Kathrin; Noels, Heidi; Weber, Christian] Rheinisch Westfal Tech Hsch RWTH Aachen Univ, Inst Mol Cardiovasc Res, Aachen, Germany; [Schober, Andreas; Weber, Christian] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Gremse, Felix; Kiessling, Fabian] Rhein Westfal TH Aachen, Dept Expt Mol Imaging, Aachen, Germany; [Grommes, Jochen] Rhein Westfal TH Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany; [Grommes, Jochen] Med Univ Maastricht, Maastricht, Netherlands; [Wang, Shusheng] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Weber, Christian] Univ Maastricht, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	University of Munich; RWTH Aachen University; German Centre for Cardiovascular Research; Munich Heart Alliance; RWTH Aachen University; Maastricht University; RWTH Aachen University; Maastricht University; Maastricht University Medical Centre (MUMC); Tulane University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Maastricht University	Schober, A (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	aschober@med.lmu.de; chweber@med.lmu.de	Wei, Yuanyuan/H-7963-2014; Jahantigh, Maliheh Nazari/B-4304-2013; Noels, Heidi/AAQ-2622-2020; Weber, Christian/AAW-2153-2020; Kiessling, Fabian/Y-2417-2019; Schober, Andreas/B-2866-2013	Wei, Yuanyuan/0000-0003-0635-6879; Jahantigh, Maliheh Nazari/0000-0002-1094-107X; Weber, Christian/0000-0003-4610-8714; Kiessling, Fabian/0000-0002-7341-0399; Schober, Andreas/0000-0001-7798-136X; Grommes, Jochen/0000-0002-6419-6802; megens, remco/0000-0001-9871-6696	Deutsche Forschungsgemeinschaft, Germany [FOR809, WE1913/11-2, SCHO1056/3-2]; German Federal Ministry of Education and Research [01KU1213A]; German Centre for Cardiovascular Research [MHA VD1.2]; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany; NATIONAL EYE INSTITUTE [R01EY021862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, R01HL077439, R01HL111665, U01HL100401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Centre for Cardiovascular Research; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.S., F.K. and C.W. are funded by the Deutsche Forschungsgemeinschaft, Germany (FOR809, WE1913/11-2 and SCHO1056/3-2). A.S. and C.W. are funded by the German Federal Ministry of Education and Research (01KU1213A) and by the German Centre for Cardiovascular Research (MHA VD1.2). M.N.-J. was funded by the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany. We thank J. Schmidt (University of Illinois) and R. H. Adams (Max-Planck-Institute for Molecular Biomedicine) for providing Dlk1<SUP>flox</SUP> and Bmx-Cre<SUP>ERT2</SUP> mice, respectively. We thank L. Natarelli, L. Pawig, J. Corbalan Campos, R. Soltan, M. Garbe, C. Geissler, P. Hartmann and S. Elbin for technical assistance.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Akhtar S, 2013, ARTERIOSCL THROM VAS, V33, P679, DOI 10.1161/ATVBAHA.112.301162; Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361; Appelbe OK, 2013, MECH DEVELOP, V130, P143, DOI 10.1016/j.mod.2012.09.010; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bidzhekov K, 2007, J CELL MOL MED, V11, P1395, DOI 10.1111/j.1582-4934.2007.00123.x; Chen CH, 2000, CIRCULATION, V101, P171, DOI 10.1161/01.CIR.101.2.171; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Colles SM, 2001, TRENDS CARDIOVAS MED, V11, P131, DOI 10.1016/S1050-1738(01)00106-2; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Foteinos G, 2008, CIRCULATION, V117, P1856, DOI 10.1161/CIRCULATIONAHA.107.746008; Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069; HANSSON GK, 1985, AM J PATHOL, V121, P123; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Itoh Y, 2010, ARTERIOSCL THROM VAS, V30, P1725, DOI 10.1161/ATVBAHA.110.207365; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Kaiser D, 1997, BIOCHEM BIOPH RES CO, V231, P586, DOI 10.1006/bbrc.1997.6146; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Mortensen SB, 2012, DIABETES, V61, P2814, DOI 10.2337/db12-0176; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Neth P, 2013, CARDIOVASC RES, V99, P294, DOI 10.1093/cvr/cvt096; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; Nuovo GJ, 2009, BIOTECHNIQUES, V46, P115, DOI 10.2144/000113068; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Schmitt MMN, 2014, CIRCULATION, V129, P66, DOI 10.1161/CIRCULATIONAHA.113.004149; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; SCHWARTZ SM, 1977, CIRC RES, V41, P248, DOI 10.1161/01.RES.41.2.248; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; WRIGHT HP, 1968, NATURE, V220, P78, DOI 10.1038/220078a0; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	47	456	476	7	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					368	+		10.1038/nm.3487	http://dx.doi.org/10.1038/nm.3487			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24584117	Green Accepted			2022-12-25	WOS:000334361500017
J	Tang, YT; Gao, X; Rosa, BA; Abubucker, S; Hallsworth-Pepin, K; Martin, J; Tyagi, R; Heizer, E; Zhang, X; Bhonagiri-Palsikar, V; Minx, P; Warren, WC; Wang, Q; Zhan, B; Hotez, PJ; Sternberg, PW; Dougall, A; Gaze, ST; Mulvenna, J; Sotillo, J; Ranganathan, S; Rabelo, EM; Wilson, RK; Felgner, PL; Bethony, J; Hawdon, JM; Gasser, RB; Loukas, A; Mitreva, M				Tang, Yat T.; Gao, Xin; Rosa, Bruce A.; Abubucker, Sahar; Hallsworth-Pepin, Kymberlie; Martin, John; Tyagi, Rahul; Heizer, Esley; Zhang, Xu; Bhonagiri-Palsikar, Veena; Minx, Patrick; Warren, Wesley C.; Wang, Qi; Zhan, Bin; Hotez, Peter J.; Sternberg, Paul W.; Dougall, Annette; Gaze, Soraya Torres; Mulvenna, Jason; Sotillo, Javier; Ranganathan, Shoba; Rabelo, Elida M.; Wilson, Richard K.; Felgner, Philip L.; Bethony, Jeffrey; Hawdon, John M.; Gasser, Robin B.; Loukas, Alex; Mitreva, Makedonka			Genome of the human hookworm Necator americanus	NATURE GENETICS			English	Article							TRANSMITTED HELMINTH INFECTIONS; HAMSTERS MESOCRICETUS-AURATUS; MULTIPLE SEQUENCE ALIGNMENT; ANTHELMINTIC EMODEPSIDE; GENE ONTOLOGY; IN-VITRO; PROTEIN; ANNOTATION; IDENTIFICATION; IVERMECTIN	The hookworm Necator americanus is the predominant soil-transmitted human parasite. Adult worms feed on blood in the small intestine, causing iron-deficiency anemia, malnutrition, growth and development stunting in children, and severe morbidity and mortality during pregnancy in women. We report sequencing and assembly of the N. americanus genome (244 Mb, 19,151 genes). Characterization of this first hookworm genome sequence identified genes orchestrating the hookworm's invasion of the human host, genes involved in blood feeding and development, and genes encoding proteins that represent new potential drug targets against hookworms. N. americanus has undergone a considerable and unique expansion of immunomodulator proteins, some of which we highlight as potential treatments against inflammatory diseases. We also used a protein microarray to demonstrate a postgenomic application of the hookworm genome sequence. This genome provides an invaluable resource to boost ongoing efforts toward fundamental and applied postgenomic research, including the development of new methods to control hookworm and human immunological diseases.	[Tang, Yat T.; Gao, Xin; Rosa, Bruce A.; Abubucker, Sahar; Hallsworth-Pepin, Kymberlie; Martin, John; Tyagi, Rahul; Heizer, Esley; Zhang, Xu; Bhonagiri-Palsikar, Veena; Minx, Patrick; Warren, Wesley C.; Wang, Qi; Wilson, Richard K.; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Warren, Wesley C.; Wilson, Richard K.; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA; [Zhan, Bin; Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Houston, TX 77030 USA; [Zhan, Bin; Hotez, Peter J.] Sabin Vaccine Inst, Houston, TX USA; [Zhan, Bin; Hotez, Peter J.] Texas Childrens Hosp Ctr Vaccine Dev, Houston, TX USA; [Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sternberg, Paul W.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dougall, Annette; Gaze, Soraya Torres; Sotillo, Javier; Loukas, Alex] James Cook Univ, Queensland Trop Hlth Alliance, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia; [Mulvenna, Jason] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Rabelo, Elida M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Bethony, Jeffrey; Hawdon, John M.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; California Institute of Technology; Howard Hughes Medical Institute; James Cook University; QIMR Berghofer Medical Research Institute; Macquarie University; National University of Singapore; Universidade Federal de Minas Gerais; University of California System; University of California Irvine; George Washington University; University of Melbourne; Washington University (WUSTL)	Mitreva, M (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	mmitreva@genome.wustl.edu	Mulvenna, Jason/H-7110-2014; Gaze, Soraya/B-9419-2013; Hawdon, John/I-1201-2019; Pacific-Southwest, RCE/B-6155-2009; Rabelo, Elida ML/C-2401-2015; Wilson, Richard K./AAF-4139-2019; Sotillo, Javier/B-7354-2014; Gao, Cyan/O-9316-2014; Gasser, Robin/ABH-6185-2020; Loukas, Alex/B-7355-2014	Mulvenna, Jason/0000-0003-3521-8061; Gaze, Soraya/0000-0001-8600-2389; Hawdon, John/0000-0002-6164-1413; Rabelo, Elida ML/0000-0002-2566-5012; Wilson, Richard K./0000-0002-1992-1358; Sotillo, Javier/0000-0002-1443-7233; Gasser, Robin/0000-0002-4423-1690; Mitreva, Makedonka/0000-0001-9572-3436; Ranganathan, Shoba/0000-0002-8290-813X; Loukas, Alex/0000-0002-0896-8441; Hotez, Peter/0000-0001-8770-1042; Wolf, Nathaniel/0000-0001-6567-2447; Tyagi, Rahul/0000-0002-6680-8972	US National Institutes of Health (NIH)-National Human Genome Research Institute [U54HG003079]; NIH-National Institute of Allergy and Infectious Diseases [AI081803]; NIH-National Institute of General Medical Sciences [GM097435]; Australian Research Council and Australia's National Health and Medical Research Council; Protein Microarray Laboratory at the University of California-Irvine [U54AI065359]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081803, U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097435] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-National Human Genome Research Institute; NIH-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Research Council and Australia's National Health and Medical Research Council(Australian Research Council); Protein Microarray Laboratory at the University of California-Irvine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the faculty and staff of the Genome Institute at Washington University and the Protein Microarray Laboratory at the University of California-Irvine (U54AI065359) who contributed to this study. The genome sequencing and annotation work was funded by US National Institutes of Health (NIH)-National Human Genome Research Institute grant U54HG003079 to R.K.W. Comparative genome analysis was funded by grants NIH-National Institute of Allergy and Infectious Diseases AI081803 and NIH-National Institute of General Medical Sciences GM097435 to M.M. Funds from the Australian Research Council and Australia's National Health and Medical Research Council to R.B.G. are gratefully acknowledged. P.W.S. is an investigator with the Howard Hughes Medical Institute. We thank the faculty and staff of The Genome Institute at Washington University who contributed to this study.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bull K, 2007, INT J PARASITOL, V37, P627, DOI 10.1016/j.ijpara.2006.10.013; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Cantacessi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031164; Cantacessi C, 2012, MOL CELL PROBE, V26, P54, DOI 10.1016/j.mcp.2011.10.001; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chu D, 2004, INFECT IMMUN, V72, P2214, DOI 10.1128/IAI.72.4.2214-2221.2004; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Culley FJ, 2000, J IMMUNOL, V165, P6447, DOI 10.4049/jimmunol.165.11.6447; Daveson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017366; Diemert DJ, 2008, CLIN INFECT DIS, V46, P282, DOI 10.1086/524070; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; GEARY TG, 1993, EXP PARASITOL, V77, P88, DOI 10.1006/expr.1993.1064; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HANCOCK JM, 1994, COMPUT APPL BIOSCI, V10, P67; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Humphries DL, 1997, T ROY SOC TROP MED H, V91, P518, DOI 10.1016/S0035-9203(97)90007-9; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Jian X, 2003, EXP PARASITOL, V104, P62, DOI 10.1016/S0014-4894(03)00094-8; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kaminsky R, 2008, PARASITOL RES, V103, P931, DOI 10.1007/s00436-008-1080-7; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kotze AC, 2012, VET PARASITOL, V186, P118, DOI 10.1016/j.vetpar.2011.11.052; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; KUMAR S, 1992, J PARASITOL, V78, P917, DOI 10.2307/3283331; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIONEL NDW, 1969, BMJ-BRIT MED J, V4, P340, DOI 10.1136/bmj.4.5679.340; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McSorley HJ, 2010, PARASITE IMMUNOL, V32, P549, DOI 10.1111/j.1365-3024.2010.01224.x; Miller T. A., 1971, Adv Parasitology, V9, P153, DOI 10.1016/S0065-308X(08)60161-X; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Navarro S, 2013, INT J PARASITOL, V43, P225, DOI 10.1016/j.ijpara.2012.11.005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Page AP, 2003, ADV PARASIT, V53, P85, DOI 10.1016/S0065-308X(03)53003-2; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Quinnell RJ, 2010, J INFECT DIS, V202, P954, DOI 10.1086/655813; Ranjit N, 2009, J INFECT DIS, V199, P904, DOI 10.1086/597048; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RICHARDS JC, 1995, INT J PARASITOL, V25, P1185, DOI 10.1016/0020-7519(95)00036-2; Robertson Hugh M, 2006, WormBook, P1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider B, 2011, HUM VACCINES, V7, P1234, DOI 10.4161/hv.7.11.18443; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Sundaresh S, 2006, BIOINFORMATICS, V22, P1760, DOI 10.1093/bioinformatics/btl162; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003505; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003149; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Viney ME, 2005, INT J PARASITOL, V35, P1473, DOI 10.1016/j.ijpara.2005.07.006; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Willson J, 2003, PARASITOLOGY, V126, P79, DOI 10.1017/S0031182002002639; Xiao S, 2008, EXP PARASITOL, V118, P32, DOI 10.1016/j.exppara.2007.05.010; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109	103	141	145	0	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					261	+		10.1038/ng.2875	http://dx.doi.org/10.1038/ng.2875			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24441737	hybrid, Green Accepted			2022-12-25	WOS:000332036700010
J	Huang, H; Ceccarelli, DF; Orlicky, S; St-Cyr, DJ; Ziemba, A; Garg, P; Plamondon, S; Auer, M; Sidhu, S; Marinier, A; Kleiger, G; Tyers, M; Sicheri, F				Huang, Hao; Ceccarelli, Derek F.; Orlicky, Stephen; St-Cyr, Daniel J.; Ziemba, Amy; Garg, Pankaj; Plamondon, Serge; Auer, Manfred; Sidhu, Sachdev; Marinier, Anne; Kleiger, Gary; Tyers, Mike; Sicheri, Frank			E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin	NATURE CHEMICAL BIOLOGY			English	Article							RING E3 LIGASE; COMPLEX; ACTIVATION; MECHANISM; REVEALS; DOMAIN; CDC34; SCF; TURNOVER; SUBUNIT	Weak protein interactions between ubiquitin and the ubiquitin-proteasome system (UPS) enzymes that mediate its covalent attachment to substrates serve to position ubiquitin for optimal catalytic transfer. We show that a small-molecule inhibitor of the E2 ubiquitin-conjugating enzyme Cdc34A, called CC0651, acts by trapping a weak interaction between ubiquitin and the E2 donor ubiquitin-binding site. A structure of the ternary CC0651-Cdc34A-ubiquitin complex reveals that the inhibitor engages a composite binding pocket formed from Cdc34A and ubiquitin. CC0651 also suppresses the spontaneous hydrolysis rate of the Cdc34A-ubiquitin thioester without decreasing the interaction between Cdc34A and the RING domain subunit of the E3 enzyme. Stabilization of the numerous other weak interactions between ubiquitin and UPS enzymes by small molecules may be a feasible strategy to selectively inhibit different UPS activities.	[Huang, Hao; Ceccarelli, Derek F.; Orlicky, Stephen; Sicheri, Frank] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [St-Cyr, Daniel J.; Plamondon, Serge; Marinier, Anne; Tyers, Mike] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Ziemba, Amy; Kleiger, Gary] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA; [Garg, Pankaj; Sidhu, Sachdev; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Garg, Pankaj; Sidhu, Sachdev] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Auer, Manfred] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Auer, Manfred] Univ Edinburgh, Sch Biomed Sci, Edinburgh, Midlothian, Scotland; [Marinier, Anne] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Tyers, Mike] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Toronto; University of Toronto; University of Edinburgh; University of Edinburgh; Universite de Montreal; Universite de Montreal	Tyers, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	md.tyers@umontreal.ca; sicheri@lunenfeld.ca	Sicheri, Frank/F-8856-2013; St-Cyr, Daniel J/B-3558-2008; Tyers, Michael/ABE-3194-2021	St-Cyr, Daniel J/0000-0003-2432-6585; Auer, Manfred/0000-0001-8920-3522; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	National Center for Research Resources at the US National Institutes of Health (NIH) [RR-15301]; US Department of Energy [ACO2-06CH11357]; National Center for Research Resources [5P2ORR016464-11]; National Institute of General Medical Sciences from the NIH [8 P20 GM103440-11]; Canadian Institutes of Health Research [MOP-126129, MOP-57795]; Ministere de renseignement superieur, de la recherche, de la science et de la technologie du Quebec through Genome Quebec; Canadian Institutes of Health Research Postdoctoral Fellowship; Canada Research Chair in structural biology; Canada Research Chair in systems and synthetic biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER; Medical Research Council [MC_G0802522] Funding Source: researchfish; MRC [MC_G0802522] Funding Source: UKRI	National Center for Research Resources at the US National Institutes of Health (NIH); US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the NIH; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de renseignement superieur, de la recherche, de la science et de la technologie du Quebec through Genome Quebec; Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in structural biology; Canada Research Chair in systems and synthetic biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Ernst, R. Deshaies, A. van der Sloot, R. Grunberg, J.-F. Lavallee, C. James, K. Chan and E Mercurio for helpful discussions. We also thank I. Kourinov and staff at the Argonne National Laboratory for assistance with microdiffraction experiments at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, as supported by award RR-15301 from the National Center for Research Resources at the US National Institutes of Health (NIH) and contract DE-ACO2-06CH11357 from the US Department of Energy. G.K. and A.Z. are funded by grants. from the National Center for Research Resources (5P2ORR016464-11) and the National Institute of General Medical Sciences (8 P20 GM103440-11) from the NIH. This work was supported by grants to P.S. and M.T. from the Canadian Institutes of Health Research (MOP-126129, MOP-57795); by an award from the Ministere de renseignement superieur, de la recherche, de la science et de la technologie du Quebec through Genome Quebec to MT.; by a Canadian Institutes of Health Research Postdoctoral Fellowship to D.J.S.-C.; by a Canada Research Chair in structural biology to ES.; and by a Canada Research Chair in systems and synthetic biology to M.T.	Bracher PJ, 2011, ORIGINS LIFE EVOL B, V41, P399, DOI 10.1007/s11084-011-9243-4; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Liao H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009183; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Song J, 2009, PROTEIN SCI, V18, P2492, DOI 10.1002/pro.254; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	40	54	55	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					156	163		10.1038/NCHEMBIO.1412	http://dx.doi.org/10.1038/NCHEMBIO.1412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316736	Green Accepted			2022-12-25	WOS:000330751600015
J	Lewis, SM; Wu, X; Pustilnik, A; Sereno, A; Huang, F; Rick, HL; Guntas, G; Leaver-Fay, A; Smith, EM; Ho, C; Hansen-Estruch, C; Chamberlain, AK; Truhlar, SM; Conner, EM; Atwell, S; Kuhlman, B; Demarest, SJ				Lewis, Steven M.; Wu, Xiufeng; Pustilnik, Anna; Sereno, Arlene; Huang, Flora; Rick, Heather L.; Guntas, Gurkan; Leaver-Fay, Andrew; Smith, Eric M.; Ho, Carolyn; Hansen-Estruch, Christophe; Chamberlain, Aaron K.; Truhlar, Stephanie M.; Conner, Elaine M.; Atwell, Shane; Kuhlman, Brian; Demarest, Stephen J.			Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface	NATURE BIOTECHNOLOGY			English	Article							CANCER-THERAPY; TUMOR-GROWTH; SPECIFICITY; BINDING; STABILITY; DOMAIN; HETERODIMERIZATION; TRASTUZUMAB; SURVIVAL; INHIBIT	Robust generation of IgG bispecific antibodies has been a long-standing challenge. Existing methods require extensive engineering of each individual antibody, discovery of common light chains, or complex and laborious biochemical processing. Here we combine computational and rational design approaches with experimental structural validation to generate antibody heavy and light chains with orthogonal Fab interfaces. Parental monoclonal antibodies incorporating these interfaces, when simultaneously co-expressed, assemble into bispecific IgG with improved heavy chain-light chain pairing. Bispecific IgGs generated with this approach exhibit pharmacokinetic and other desirable properties of native IgG, but bind target antigens monovalently. As such, these bispecific reagents may be useful in many biotechnological applications.	[Lewis, Steven M.; Guntas, Gurkan; Leaver-Fay, Andrew; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Wu, Xiufeng; Pustilnik, Anna; Sereno, Arlene; Huang, Flora; Smith, Eric M.; Ho, Carolyn; Hansen-Estruch, Christophe; Chamberlain, Aaron K.; Truhlar, Stephanie M.; Atwell, Shane; Demarest, Stephen J.] Eli Lilly Biotechnol Ctr, San Diego, CA USA; [Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Eli Lilly; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	bkuhlman@email.unc.edu; demarestsj@lilly.com			Lilly Research Laboratories; Lilly Research Award Program (LRAP); US DOE [DE-AC02-06CH11357]	Lilly Research Laboratories(Eli Lilly); Lilly Research Award Program (LRAP); US DOE(United States Department of Energy (DOE))	This work was supported by the Lilly Research Laboratories and the Lilly Research Award Program (LRAP). We thank J. Hannah and B. Gutierrez for their help with transient transfection, R. Yuan and D. He for assistance with protein purification, M. Batt and J. Fitchett for their training and up keep of the mass spectrometry facility at Lilly. B. Stranges provided suggestions for the computational docking protocol. Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. We thank S. Wasserman, S. Sojitra, J. Koss for data collection and operation of the beamline.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Casimiro DR, 1997, STRUCTURE, V5, P1407, DOI 10.1016/S0969-2126(97)00291-8; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Doern A, 2009, J BIOL CHEM, V284, P10254, DOI 10.1074/jbc.M809709200; Dong JY, 2011, J BIOL CHEM, V286, P4703, DOI 10.1074/jbc.M110.184317; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P667, DOI 10.1093/protein/gzq034; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020937; Lewis SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020872; Li BH, 2013, CANCER RES, V73, P6471, DOI 10.1158/0008-5472.CAN-13-0657; Lum LG, 2011, BIODRUGS, V25, P365, DOI 10.2165/11595950-000000000-00000; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scheer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051817; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Tan PH, 1998, BIOPHYS J, V75, P1473, DOI 10.1016/S0006-3495(98)74066-4; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268	44	161	230	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					191	+		10.1038/nbt.2797	http://dx.doi.org/10.1038/nbt.2797			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24463572				2022-12-25	WOS:000331074000025
J	Lien, WH; Polak, L; Lin, MY; Lay, K; Zhang, DY; Fuchs, E				Lien, Wen-Hui; Polak, Lisa; Lin, Mingyan; Lay, Kenneth; Zhang, Deyou; Fuchs, Elaine			In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; SELF-RENEWAL; TCF3 REPRESSION; DIFFERENTIATION; PHOSPHORYLATION; ACTIVATION; PROTEINS; PROLIFERATION; PLURIPOTENCY	Hair follicle stem cells (HFSCs) regenerate hair in response to Wnt signalling. Here, we unfold genome-wide transcriptional and chromatin landscapes of beta-catenin-TCF3/4-TLE circuitry, and genetically dissect their biological roles within the native HFSC niche. We show that during HFSC quiescence, TCF3, TCF4 and TLE (Groucho) bind coordinately and transcriptionally repress Wnt target genes. We also show that beta-catenin is dispensable for HFSC viability, and that if TCF3/4 levels are sufficiently reduced, it is dispensable for proliferation. However, beta-catenin is essential to activate genes that launch hair follicle fate and suppress sebocyte fate determination. TCF3/4 deficiency mimics Wnt-beta-catenin-dependent activation of these hair follicle fate targets; TCF3 overexpression parallels their TLE4-dependent suppression. Our studies unveil TCF3/4-TLE histone deacetylases as a repressive rheostat, whose action can be relieved by Wnt-beta-catenin signalling. When TCF3/4 and TLE levels are high, HFSCs can maintain sternness, but remain quiescent. When these levels drop or when Wnt-beta-catenin levels rise, this balance is shifted and hair regeneration initiates.	[Lien, Wen-Hui; Polak, Lisa; Lay, Kenneth; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA; [Lin, Mingyan; Zhang, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zhang, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zhang, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; lin, mingyan/HDL-9420-2022	Zheng, Deyou/0000-0003-4354-5337; Lien, Wen-Hui/0000-0002-2282-3169	Harvey L. Karp Postdoctoral Fellowship; Jane Coffin Child Fellowship; NIH/NIAMS [R01AR31737]; NIH/NIMH [R21MH099452, R01MH073164]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073164, R21MH099452] Funding Source: NIH RePORTER	Harvey L. Karp Postdoctoral Fellowship; Jane Coffin Child Fellowship; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Dewell for assistance in high-throughput sequencing (RU Genomics Resource Center), X. Guo for help in ChIP-seq analysis (Zheng laboratory), and S. Mazel, L. Li, S. Semova and S. Tadesse for FACS sorting (RU FAGS facility). We also thank Fuchs' laboratory members N. Stokes, D. Oristian and A. Aldeguer for assistance in mouse research (Fuchs laboratory); A. Rodriguez-Folgueras for assistance in confocal microscopy; and T. Chen, A. Rodriguez-Folgueras, S. Luo and B. Keyes for discussions and comments. W-H.L. was supported by a Harvey L. Karp Postdoctoral Fellowship and a Jane Coffin Child Fellowship. E.F. is an HHMI Investigator. This work was supported by a grant (to E.F.) from the NIH/NIAMS (R01AR31737) and partially by NIH/NIMH (R21MH099452, R01MH073164, D.Z.).	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hoffman JA, 2013, DEVELOPMENT, V140, P1665, DOI 10.1242/dev.087387; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Park MH, 2012, BIOCHEM BIOPH RES CO, V419, P543, DOI 10.1016/j.bbrc.2012.02.056; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Shy BR, 2013, CELL REP, V4, P1, DOI 10.1016/j.celrep.2013.06.001; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	52	141	151	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2014	16	2					179	190		10.1038/ncb2903	http://dx.doi.org/10.1038/ncb2903			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA5TB	24463605	Green Accepted			2022-12-25	WOS:000331161400007
J	Palomero, T; Couronne, L; Khiabanian, H; Kim, MY; Ambesi-Impiombato, A; Perez-Garcia, A; Carpenter, Z; Abate, F; Allegretta, M; Haydu, JE; Jiang, XY; Lossos, IS; Nicolas, C; Balbin, M; Bastard, C; Bhagat, G; Piris, MA; Campo, E; Bernard, OA; Rabadan, R; Ferrando, AA				Palomero, Teresa; Couronne, Lucile; Khiabanian, Hossein; Kim, Mi-Yeon; Ambesi-Impiombato, Alberto; Perez-Garcia, Arianne; Carpenter, Zachary; Abate, Francesco; Allegretta, Maddalena; Haydu, J. Erika; Jiang, Xiaoyu; Lossos, Izidore S.; Nicolas, Concha; Balbin, Milagros; Bastard, Christian; Bhagat, Govind; Piris, Miguel A.; Campo, Elias; Bernard, Olivier A.; Rabadan, Raul; Ferrando, Adolfo A.			Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas	NATURE GENETICS			English	Article							READ ALIGNMENT; FAMILY GTPASES; PROTEIN; ACTIVATION; APOPTOSIS; SENSITIVITY; INHIBITION; LEUKEMIA; TET2; GEFS	Peripheral T cell lymphomas (PTCLs) are a heterogeneous and poorly understood group of non-Hodgkin lymphomas1,2. Here we combined whole-exome sequencing of 12 tumor-normal DNA pairs, RNA sequencing analysis and targeted deep sequencing to identify new genetic alterations in PTCL transformation. These analyses identified highly recurrent epigenetic factor mutations in TET2, DNMT3A and IDH2 as well as a new highly prevalent RHOA mutation encoding a p. Gly17Val alteration present in 22 of 35 (67%) angioimmunoblastic T cell lymphoma (AITL) samples and in 8 of 44 (18%) PTCL, not otherwise specified (PTCL-NOS) samples. Mechanistically, the RHOA Gly17Val protein interferes with RHOA signaling in biochemical and cellular assays, an effect potentially mediated by the sequestration of activated guanine-exchange factor (GEF) proteins. In addition, we describe new and recurrent, albeit less frequent, genetic defects including mutations in FYN, ATM, B2M and CD58 implicating SRC signaling, impaired DNA damage response and escape from immune surveillance mechanisms in the pathogenesis of PTCL.	[Palomero, Teresa; Couronne, Lucile; Kim, Mi-Yeon; Ambesi-Impiombato, Alberto; Perez-Garcia, Arianne; Allegretta, Maddalena; Haydu, J. Erika; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Couronne, Lucile; Bhagat, Govind; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Khiabanian, Hossein; Carpenter, Zachary; Abate, Francesco] Columbia Univ, Dept Syst Biol, New York, NY USA; [Abate, Francesco] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Jiang, Xiaoyu; Lossos, Izidore S.] Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL USA; [Lossos, Izidore S.] Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL USA; [Nicolas, Concha] Univ Oviedo, Hosp Cent Asturias, Hematol Serv, E-33080 Oviedo, Spain; [Balbin, Milagros] Hosp Univ Cent Asturias, Inst Univ Oncol Principado Asturias, Mol Oncol Lab, Oviedo, Spain; [Bastard, Christian] Univ Rouen, Ctr Henri Becquerel, INSERM U918, Rouen, France; [Piris, Miguel A.] Hosp Univ Marques Valdecilla, Dept Pathol, Santander, Spain; [Piris, Miguel A.] Inst Formac & Invest Marques Valdecilla IFIMAV, Santander, Spain; [Campo, Elias] Hosp Clin Barcelona, Dept Pathol, Hematopathol Sect, Barcelona, Spain; [Campo, Elias] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain; [Bernard, Olivier A.] INSERM U985, Villejuif, France; [Bernard, Olivier A.] Univ Paris 11, Orsay, France; [Bernard, Olivier A.] Inst Gustave Roussy, Villejuif, France; [Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Polytechnic University of Turin; University of Miami; Central University Hospital Asturias; University of Oviedo; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Columbia University; Columbia University	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	tp2151@columbia.edu; rabadan@dbmi.columbia.edu; af2196@columbia.edu	Bhagat, Govind/AAE-9493-2021; Piris, Miguel A/AAP-1445-2020; Khiabanian, Hossein/N-7207-2019; Piris, Miguel A/B-7067-2008; Campo, Elias/AAC-5593-2019; Bernard, Olivier A./E-5721-2016; Rabadan, Raul/AAZ-7367-2020; Campo, elias/O-7192-2016; Balbín, Milagros/I-4206-2015	Bhagat, Govind/0000-0001-6250-048X; Piris, Miguel A/0000-0001-5839-3634; Khiabanian, Hossein/0000-0003-1446-4394; Piris, Miguel A/0000-0001-5839-3634; Campo, Elias/0000-0001-9850-9793; Campo, elias/0000-0001-9850-9793; Balbín, Milagros/0000-0001-5325-0407; Bernard, Olivier/0000-0002-0463-9747; Rabadan, Raul/0000-0001-7946-9255; Couronne, Lucile/0000-0002-1357-5482	Leukemia and Lymphoma Society Translational Research Grant; Herbert Irving Comprehensive Cancer Center interprogrammatic pilot project grant; US National Institutes of Health Ruth L. Kirschstein National Research Service Award [1F30CA174099]; Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa)-Direction de l'Hospitalisation et de l'Organisation des soins (DHOS) translational research grant; ITMO (Institut Multi-Organismes Cancer); INCa; Leukemia and Lymphoma Society; Spanish Ministry of Science and Innovation [SAF2012-38432]; Institucio Catalana de Recerca i Estudis Avancats; NATIONAL CANCER INSTITUTE [P30CA013696, K12CA090354] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Translational Research Grant(Leukemia and Lymphoma Society); Herbert Irving Comprehensive Cancer Center interprogrammatic pilot project grant; US National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)-Direction de l'Hospitalisation et de l'Organisation des soins (DHOS) translational research grant; ITMO (Institut Multi-Organismes Cancer); INCa(Institut National du Cancer (INCA) France); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institucio Catalana de Recerca i Estudis Avancats(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank V. Ribrag (Institut Gustave Roussy) for providing a PTCL sample and R. Parsons (Mount Sinai School of Medicine) for assistance in the setup of RHOA GTP-loading assays. This work was supported by a Leukemia and Lymphoma Society Translational Research Grant (A. A. F.), a Herbert Irving Comprehensive Cancer Center interprogrammatic pilot project grant (A. A. F. and R. R.), a US National Institutes of Health Ruth L. Kirschstein National Research Service Award (1F30CA174099 to J. E. H.), a grant from the Ligue Nationale Contre le Cancer (O. A. B.) and an Institut National du Cancer (INCa)-Direction de l'Hospitalisation et de l'Organisation des soins (DHOS) translational research grant (O. A. B.). L. C. is funded by ITMO (Institut Multi-Organismes Cancer) and INCa. M.-Y. K. is funded by the Leukemia and Lymphoma Society. E. C. is supported by the Spanish Ministry of Science and Innovation (SAF2012-38432) and Institucio Catalana de Recerca i Estudis Avancats.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armitage JO, 2012, AM J HEMATOL, V87, P512, DOI 10.1002/ajh.23144; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Ghosh PM, 1999, ONCOGENE, V18, P4120, DOI 10.1038/sj.onc.1202792; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Harr MW, 2010, CELL DEATH DIFFER, V17, P1381, DOI 10.1038/cdd.2010.25; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Longenecker K, 2003, ACTA CRYSTALLOGR D, V59, P876, DOI 10.1107/S0907444903005390; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mayer T, 1999, ONCOGENE, V18, P2117, DOI 10.1038/sj.onc.1202537; McCormack PL, 2011, DRUGS, V71, P1771, DOI 10.2165/11207580-000000000-00000; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pan ZXK, 1998, J IMMUNOL, V160, P3038; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	36	390	399	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					166	+		10.1038/ng.2873	http://dx.doi.org/10.1038/ng.2873			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413734	Green Accepted			2022-12-25	WOS:000331208300013
J	Kim, HY; Lee, HJ; Chang, YJ; Pichavant, M; Shore, SA; Fitzgerald, KA; Iwakura, Y; Israel, E; Bolger, K; Faul, J; DeKruyff, RH; Umetsu, DT				Kim, Hye Young; Lee, Hyun Jun; Chang, Ya-Jen; Pichavant, Muriel; Shore, Stephanie A.; Fitzgerald, Katherine A.; Iwakura, Yoichiro; Israel, Elliot; Bolger, Kenneth; Faul, John; DeKruyff, Rosemarie H.; Umetsu, Dale T.			Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity	NATURE MEDICINE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; ROR-GAMMA-T; ALLERGIC-ASTHMA; INSULIN-RESISTANCE; ADAPTIVE IMMUNITY; ADIPOSE-TISSUE; ALUMINUM ADJUVANT; TH17 CELLS; MICE	Obesity is associated with the development of asthma, which is often difficult to control. To understand the immunological pathways that lead to obesity-associated asthma, we fed mice a high-fat diet for 12 weeks, which resulted in obesity and the development of airway hyperreactivity (AHR), a cardinal feature of asthma. This AHR was independent of adaptive immunity, as it occurred in obese Rag1(-/-) mice, which lack B and T cells, and was dependent on interleukin-17A (IL-17A) and the NLRP3 inflammasome, as it did not develop in obese Il17a(-/-) or Nlrp3(-/-) mice. AHR was also associated with the expansion of CCR6(+) type 3 innate lymphoid cells (ILCs) producing IL-17A (ILC3 cells) in the lung, which could by themselves mediate AHR when adoptively transferred into Rag2(-/-) ; Il2rg(-/-) mice treated with recombinant IL-1 beta. Macrophage-derived IL-1 beta production was induced by HFD and expanded the number of lung ILC3 cells. Blockade of IL-1 beta with an IL-1 receptor antagonist abolished obesity-induced AHR and reduced the number of ILC3 cells. As we found ILC3-like cells in the bronchoalveolar lavage fluid of individuals with asthma, we suggest that obesity-associated asthma is facilitated by inflammation mediated by NLRP3, IL-1 beta and ILC3 cells.	[Kim, Hye Young; Lee, Hyun Jun; Chang, Ya-Jen; Pichavant, Muriel; DeKruyff, Rosemarie H.; Umetsu, Dale T.] Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo, Japan; [Israel, Elliot] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care, Sch Med,Dept Med, Boston, MA 02115 USA; [Bolger, Kenneth; Faul, John] Connolly Hosp Blanchardstown, Resp Dept, Dublin, Ireland	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Umetsu, DT (corresponding author), Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA.	umetsud@gene.com	Pichavant, Muriel/B-9036-2018; Kim, Hye Young/AAF-7609-2020; Fitzgerald, Katherine/ABE-6317-2020; Chang, Ya-Jen/O-1584-2018; Iwakura, Yoichiro/E-5457-2011	Pichavant, Muriel/0000-0002-1315-4397; Kim, Hye Young/0000-0001-5978-512X; Chang, Ya-Jen/0000-0003-1377-6142; Iwakura, Yoichiro/0000-0002-9934-5775; Fitzgerald, Kate/0000-0003-3175-609X	US National Institutes of Health [RO1AI068085, RO1HL62348, ES013307]; D. and D. Bunning Food Allergy Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI068085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013307] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D. and D. Bunning Food Allergy Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the National Institutes of Health Tetramer Facility, Emory University, Atlanta, Georgia, for providing CD1d tetramers. This work was supported by grants RO1AI068085, RO1HL62348 and ES013307 from the US National Institutes of Health and with funds from The D. and D. Bunning Food Allergy Project.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Allen IC, 2012, J IMMUNOL, V188, P2884, DOI 10.4049/jimmunol.1102488; Arteaga-Solis E, 2013, CELL METAB, V17, P35, DOI 10.1016/j.cmet.2012.12.004; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen Y, 2006, CHEST, V130, P890, DOI 10.1378/chest.130.3.890; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farah CS, 2012, RESPIROLOGY, V17, P412, DOI 10.1111/j.1440-1843.2011.02080.x; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lu FL, 2006, AM J PHYSIOL-LUNG C, V290, pL856, DOI 10.1152/ajplung.00386.2005; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Williams AS, 2013, PULM PHARMACOL THER, V26, P444, DOI 10.1016/j.pupt.2012.05.001; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018	64	410	429	4	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					54	+		10.1038/nm.3423	http://dx.doi.org/10.1038/nm.3423			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24336249	Green Accepted, Green Submitted			2022-12-25	WOS:000329349400019
J	Kleinman, CL; Gerges, N; Papillon-Cavanagh, S; Sin-Chan, P; Pramatarova, A; Quang, DAK; Adoue, V; Busche, S; Caron, M; Djambazian, H; Bemmo, A; Fontebasso, AM; Spence, T; Schwartzentruber, J; Albrecht, S; Hauser, P; Garami, M; Klekner, A; Bognar, L; Montes, JL; Staffa, A; Montpetit, A; Berube, P; Zakrzewska, M; Zakrzewski, K; Liberski, PP; Dong, ZF; Siegel, PM; Duchaine, T; Perotti, C; Fleming, A; Faury, D; Remke, M; Gallo, M; Dirks, P; Taylor, MD; Sladek, R; Pastinen, T; Chan, JA; Huang, A; Majewski, J; Jabado, N				Kleinman, Claudia L.; Gerges, Noha; Papillon-Cavanagh, Simon; Sin-Chan, Patrick; Pramatarova, Albena; Quang, Dong-Anh Khuong; Adoue, Veronique; Busche, Stephan; Caron, Maxime; Djambazian, Haig; Bemmo, Amandine; Fontebasso, Adam M.; Spence, Tara; Schwartzentruber, Jeremy; Albrecht, Steffen; Hauser, Peter; Garami, Miklos; Klekner, Almos; Bognar, Laszlo; Montes, Jose-Luis; Staffa, Alfredo; Montpetit, Alexandre; Berube, Pierre; Zakrzewska, Magdalena; Zakrzewski, Krzysztof; Liberski, Pawel P.; Dong, Zhifeng; Siegel, Peter M.; Duchaine, Thomas; Perotti, Christian; Fleming, Adam; Faury, Damien; Remke, Marc; Gallo, Marco; Dirks, Peter; Taylor, Michael D.; Sladek, Robert; Pastinen, Tomi; Chan, Jennifer A.; Huang, Annie; Majewski, Jacek; Jabado, Nada			Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASES DNMT3A; RNA-SEQ; CANCER-CELLS; HUMAN GENOME; METHYLATION; GENES; IDENTIFICATION; MUTATIONS; ULTRAFAST; ALIGNMENT	Embryonal tumors with multilayered rosettes (ETMRs) are rare, deadly pediatric brain tumors characterized by high-level amplification of the microRNA cluster C19MC(1,2). We performed integrated genetic and epigenetic analyses of 12 ETMR samples and identified, in all cases, C19MC fusions to TTYH1 driving expression of the microRNAs. ETMR tumors, cell lines and xenografts showed a specific DNA methylation pattern distinct from those of other tumors and normal tissues. We detected extreme overexpression of a previously uncharacterized isoform of DNMT3B originating at an alternative promoter(3) that is active only in the first weeks of neural tube development. Transcriptional and immunohistochemical analyses suggest that C19MC-dependent DNMT3B deregulation is mediated by RBL2, a known repressor of DNMT3B(4,5). Transfection with individual C19MC microRNAs resulted in DNMT3B upregulation and RBL2 downregulation in cultured cells. Our data suggest a potential oncogenic re-engagement of an early developmental program in ETMR via epigenetic alteration mediated by an embryonic, brain-specific DNMT3B isoform.	[Kleinman, Claudia L.; Papillon-Cavanagh, Simon; Pramatarova, Albena; Adoue, Veronique; Busche, Stephan; Caron, Maxime; Djambazian, Haig; Bemmo, Amandine; Schwartzentruber, Jeremy; Staffa, Alfredo; Montpetit, Alexandre; Berube, Pierre; Sladek, Robert; Pastinen, Tomi] McGill Univ, Montreal, PQ, Canada; [Kleinman, Claudia L.; Papillon-Cavanagh, Simon; Pramatarova, Albena; Adoue, Veronique; Busche, Stephan; Caron, Maxime; Djambazian, Haig; Bemmo, Amandine; Schwartzentruber, Jeremy; Staffa, Alfredo; Montpetit, Alexandre; Berube, Pierre; Sladek, Robert; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Kleinman, Claudia L.; Gerges, Noha; Quang, Dong-Anh Khuong; Sladek, Robert; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sin-Chan, Patrick; Spence, Tara; Huang, Annie] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Ctr Hlth, Montreal, PQ, Canada; [Hauser, Peter; Garami, Miklos] Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, H-4012 Debrecen, Hungary; [Montes, Jose-Luis] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Neurosurg,,Dept Surg, Montreal, PQ, Canada; [Zakrzewska, Magdalena; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland; [Zakrzewski, Krzysztof] Polish Mothers Mem Hosp, Res Inst, Dept Neurosurg, Lodz, Poland; [Dong, Zhifeng; Siegel, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Duchaine, Thomas] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Perotti, Christian; Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Fleming, Adam; Faury, Damien] McGill Univ, Dept Pediat, Div Pediat Hematol Oncol, Montreal, PQ, Canada; [Fleming, Adam; Faury, Damien] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Remke, Marc; Gallo, Marco; Dirks, Peter; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Huang, Annie] Univ Toronto, Hosp Sick Children, Dept Pediat, Arthur & Sonia Labatt Brain Tumour Res Ctr,Progra, Toronto, ON M5G 1X8, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; Semmelweis University; University of Debrecen; McGill University; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; McGill University; McGill University; University of Calgary; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Jabado, N (corresponding author), McGill Univ, Montreal, PQ, Canada.	annie.huang@sickkids.ca; jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca	Papillon-Cavanagh, Simon/AAS-8749-2020; Zakrzewska, Magdalena/S-9308-2016; Sladek, Robert/R-2391-2019; Zakrzewski, Krzysztof/M-5985-2014; Khuong Quang, Dong Anh/GPT-2523-2022; Garami, Miklós/AAK-5680-2021; Jabado, Nada/AAN-4026-2020; Fleming, Adam J/ABB-2202-2021; Duchaine, Thomas/U-2399-2019	Papillon-Cavanagh, Simon/0000-0002-0372-2266; Zakrzewska, Magdalena/0000-0001-5826-7726; Sladek, Robert/0000-0002-2730-1204; Fleming, Adam J/0000-0002-7194-3220; Remke, Marc/0000-0002-9404-9993; Adoue, Veronique/0000-0003-3548-7456; Taylor, Michael/0000-0001-7009-3466; Zakrzewski, Krzysztof/0000-0001-5454-1783; Kleinman, Claudia/0000-0002-5158-7126; Berube, Pierre/0000-0002-1008-192X; Duchaine, Thomas/0000-0002-3454-1839; Gallo, Marco/0000-0002-8451-8207; Schwartzentruber, Jeremy/0000-0002-6183-2092	Cancer Research Society; National Research and Development Fund (NKFP) [1A/002/2004, TAMOP-4.2.2A-11/1/KONV-2012-0025]; Canadian Institutes of Health Research [102684]; Chercheur Clinicien Senior Award; RMGA (Reseau Medical de Genetique Apliquee; Network of Applied Genetic Medicine) fellowship; Fonds de Recherche du Quebec-Sante; Cedars; Canadian Institutes of Health Research; McGill-Canadian Institutes of Health Research Training Program in Systems Biology; Hungarian Scientific Research Fund (OTKA) [T-04639]	Cancer Research Society; National Research and Development Fund (NKFP); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Chercheur Clinicien Senior Award; RMGA (Reseau Medical de Genetique Apliquee; Network of Applied Genetic Medicine) fellowship; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Cedars; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill-Canadian Institutes of Health Research Training Program in Systems Biology; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Cancer Research Society and was funded in part by Hungarian Scientific Research Fund (OTKA) contract T-04639, by National Research and Development Fund (NKFP) contracts 1A/002/2004 (P. H., M. Garami and L. B.) and TAMOP-4.2.2A-11/1/KONV-2012-0025 (A. K. and L. B.), and by Canadian Institutes of Health Research grant 102684 (A. H.). N.J. is a member of the Penny Cole laboratory and is the recipient of a Chercheur Clinicien Senior Award. S. B. is supported by an RMGA (Reseau Medical de Genetique Apliquee; Network of Applied Genetic Medicine) fellowship. T. P. and J.M. hold Canada Research Chairs (tier 2). C. L. K. is the recipient of a fellowship award from the Fonds de Recherche du Quebec-Sante, N.G. is the recipient of a studentship award from Cedars, and A. M. F. is the recipient of a studentship from the Canadian Institutes of Health Research and the McGill-Canadian Institutes of Health Research Training Program in Systems Biology. R. S. is supported by the Canadian Institutes of Health Research.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flor I, 2012, J PATHOL, V227, P270, DOI 10.1002/path.4014; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Gessi M, 2009, AM J SURG PATHOL, V33, P211, DOI 10.1097/PAS.0b013e318186235b; Hayette S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051527; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Korshunov A, 2012, ACTA NEUROPATHOL, V124, P875, DOI 10.1007/s00401-012-1068-3; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Pfister S, 2009, ACTA NEUROPATHOL, V117, P457, DOI 10.1007/s00401-008-0467-y; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Tan MH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.65; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Yanagisawa Y, 2002, BBA-GENE STRUCT EXPR, V1577, P457, DOI 10.1016/S0167-4781(02)00482-7; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008	43	122	125	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					39	+		10.1038/ng.2849	http://dx.doi.org/10.1038/ng.2849			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316981				2022-12-25	WOS:000329113500010
J	Denny, JC; Bastarache, L; Ritchie, MD; Carroll, RJ; Zink, R; Mosley, JD; Field, JR; Pulley, JM; Ramirez, AH; Bowton, E; Basford, MA; Carrell, DS; Peissig, PL; Kho, AN; Pacheco, JA; Rasmussen, LV; Crosslin, DR; Crane, PK; Pathak, J; Bielinski, SJ; Pendergrass, SA; Xu, H; Hindorff, LA; Li, RL; Manolio, TA; Chute, CG; Chisholm, RL; Larson, EB; Jarvik, GP; Brilliant, MH; McCarty, CA; Kullo, IJ; Haines, JL; Crawford, DC; Masys, DR; Roden, DM				Denny, Joshua C.; Bastarache, Lisa; Ritchie, Marylyn D.; Carroll, Robert J.; Zink, Raquel; Mosley, Jonathan D.; Field, Julie R.; Pulley, Jill M.; Ramirez, Andrea H.; Bowton, Erica; Basford, Melissa A.; Carrell, David S.; Peissig, Peggy L.; Kho, Abel N.; Pacheco, Jennifer A.; Rasmussen, Luke V.; Crosslin, David R.; Crane, Paul K.; Pathak, Jyotishman; Bielinski, Suzette J.; Pendergrass, Sarah A.; Xu, Hua; Hindorff, Lucia A.; Li, Rongling; Manolio, Teri A.; Chute, Christopher G.; Chisholm, Rex L.; Larson, Eric B.; Jarvik, Gail P.; Brilliant, Murray H.; McCarty, Catherine A.; Kullo, Iftikhar J.; Haines, Jonathan L.; Crawford, Dana C.; Masys, Daniel R.; Roden, Dan M.			Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data	NATURE BIOTECHNOLOGY			English	Article							RISK; VARIANTS; DISEASES; BIOBANK; TRAITS; TOOL; METAANALYSIS; PHENOTYPES; MELANOMA	Candidate gene and genome-wide association studies (GWAS) have identified genetic variants that modulate risk for a human disease; many of these associations require further study to replicate the results. Here we report the first c large-scale application of the phenome-wide association "study (PheWAS) paradigm within electronic medical records E (EMRs), an unbiased approach to replication and discovery. v that interrogates relationships between targeted genotypes 1s and multiple phenotypes. We scanned for associations z between 3,144 single-nucleotide polymorphisms (previously N implicated by GWAS as mediators of human traits) and 1,358 EMR-derived phenotypes in 13,835 individuals of European ancestry. This PheWAS replicated 66% (51/77) of sufficiently powered prior GWAS associations and revealed 63 potentially pleiotropic associations with P < 4.6 x 10(-6) (false discovery rate < 0.1); the strongest of these novel associations were replicated in an independent cohort (n = 7,406). These findings validate PheWAS as a tool to allow unbiased interrogation across multiple phenotypes in EMR-based cohorts and to enhance analysis of the genomic basis of human disease.	[Denny, Joshua C.; Mosley, Jonathan D.; Ramirez, Andrea H.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Denny, Joshua C.; Bastarache, Lisa; Carroll, Robert J.; Zink, Raquel] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Pendergrass, Sarah A.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Syst Genom, University Pk, PA 16802 USA; [Field, Julie R.; Pulley, Jill M.; Bowton, Erica; Basford, Melissa A.] Vanderbilt Univ, Sch Med, Res Off, Nashville, TN 37212 USA; [Pulley, Jill M.] Vanderbilt Univ, Sch Med, Dept Med Adm, Nashville, TN 37212 USA; [Carrell, David S.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Peissig, Peggy L.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Kho, Abel N.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Pacheco, Jennifer A.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Rasmussen, Luke V.] Northwestern Univ, Dept Preventat Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Crane, Paul K.; Jarvik, Gail P.] Univ Washington, Dept Med, Seattle, WA USA; [Pathak, Jyotishman; Chute, Christopher G.] Mayo Clin, Div Biomed Informat, Rochester, MN USA; [Pathak, Jyotishman; Jarvik, Gail P.] Mayo Clin, Div Stat, Rochester, MN USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Xu, Hua] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Li, Rongling; Manolio, Teri A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Chisholm, Rex L.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Brilliant, Murray H.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Haines, Jonathan L.; Crawford, Dana C.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA; [Masys, Daniel R.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Northwestern University; Feinberg School of Medicine; Mayo Clinic; Vanderbilt University; University of Washington; University of Washington Seattle; Vanderbilt University	Denny, JC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	josh.denny@vanderbilt.edu	Chute, Christopher/AAT-8540-2021; Jarvik, Gail P/N-6476-2014; Crawford, Dana/O-5578-2019; Denny, Josh/AAL-3359-2021; Bielinski, Suzette/A-2238-2009; Austin, Eric Douglas/A-6070-2013; Roden, Dan/ABD-5412-2021; Haines, Jonathan/C-3374-2012; Chisholm, Rex/B-3418-2009	Jarvik, Gail P/0000-0002-6710-8708; Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Bielinski, Suzette/0000-0002-2905-5430; Austin, Eric Douglas/0000-0002-1709-9022; Haines, Jonathan/0000-0002-4351-4728; McCarty, Catherine/0000-0003-1089-0142; Pendergrass, Rion/0000-0002-0565-6522; Chisholm, Rex/0000-0002-5638-3990; Crane, Paul/0000-0003-4278-7465; Pacheco, Jennifer/0000-0001-8021-5818; Mosley, Jonathan/0000-0001-6421-2887; Rasmussen, Luke/0000-0002-4497-8049	eMERGE Network; National Human Genome Research Institute (NHGRI); National Institute of General Medical Sciences (NIGMS) (Group Health Cooperative/University of Washington) [U01-HG004610, U01-HG006375]; Marshfield Clinic [U01-HG004608]; Mayo Clinic [U01-HG004599, U01-HG006379]; Northwestern University [U01-HG004609, U01-HG006388]; Essentia Institute of Rural Health/Marshfield Clinic [U01-HG006389]; Vanderbilt University [U01-HG004603, U01-HG006378]; Vanderbilt University serving as the Coordinating Center [U01-HG006385]; NHGRI [U01-HG004424]; Johns Hopkins University, Center for Inherited Disease Research [U01-HG004438]; NIGMS [RC2-GM092318]; National Library of Medicine [R01-LM010685]; National Center for Advancing Translational Sciences [UL1TR000427, UL1 RR024975, 2 UL1 TR000445]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, UL1TR000150, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006379, U01HG004608, U01HG004609, U01HG004610, U01HG006388, U01HG006389, U01HG004424, U01HG004438, U01HG006378, U01HG006385, U01HG004603, U01HG006375, U01HG004599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007569, R01GM105688] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685, T15LM007450] Funding Source: NIH RePORTER	eMERGE Network; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences (NIGMS) (Group Health Cooperative/University of Washington); Marshfield Clinic; Mayo Clinic; Northwestern University; Essentia Institute of Rural Health/Marshfield Clinic; Vanderbilt University; Vanderbilt University serving as the Coordinating Center; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Johns Hopkins University, Center for Inherited Disease Research; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the eMERGE Network, initiated and funded by the National Human Genome Research Institute (NHGRI), with additional funding from the National Institute of General Medical Sciences (NIGMS), through the following grants: U01-HG004610 and U01-HG006375 (Group Health Cooperative/University of Washington); U01-HG004608 (Marshfield Clinic); U01-HG004599 and U01-HG006379 (Mayo Clinic); U01-HG004609 and U01-HG006388 (Northwestern University); U01-HG006389 (Essentia Institute of Rural Health/Marshfield Clinic); U01-HG004603 and U01-HG006378 (Vanderbilt University); and U01-HG006385 (Vanderbilt University serving as the Coordinating Center). Funding support for eMERGE genotyping was provided by NHGRI through the grants: U01-HG004424 (The Broad Institute) and U01-HG004438 (Johns Hopkins University, Center for Inherited Disease Research). Replication genotypes were derived from a pharmacogenomics resource supported by NIGMS RC2-GM092318. Development of the PheWAS method is also supported by R01-LM010685 from the National Library of Medicine. BioVU received and continues to receive support through the National Center for Research Resources UL1 RR024975, which is now the National Center for Advancing Translational Sciences, 2 UL1 TR000445. Additional support for this work at the University of Washington was partially provided by the National Center for Advancing Translational Sciences grant UL1TR000427.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; Denny JC, 2008, AM J MED, V121, P239, DOI 10.1016/j.amjmed.2007.09.014; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2011, CANCER RES, V71, P1533, DOI 10.1158/0008-5472.CAN-10-1818; Hanauer DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005203; He C, 2009, DIABETES OBES METAB, V11, P53, DOI 10.1111/j.1463-1326.2008.01003.x; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Klompas M., 2012, DIABETES CARE, DOI [10.2337/dc12-0964, DOI 10.2337/DCL2-0964]; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McDavid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063481; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Turner S., 2011, CURR PROTOC HUM GENE, V68, P19; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	48	534	540	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1102	+		10.1038/nbt.2749	http://dx.doi.org/10.1038/nbt.2749			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24270849	Green Accepted, Bronze			2022-12-25	WOS:000328251900023
J	Hackl, MJ; Burford, JL; Villanueva, K; Lam, L; Susztak, K; Schermer, B; Benzing, T; Peti-Peterdi, J				Hackl, Matthias J.; Burford, James L.; Villanueva, Katie; Lam, Lisa; Susztak, Katalin; Schermer, Bernhard; Benzing, Thomas; Peti-Peterdi, Janos			Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags	NATURE MEDICINE			English	Article							URETERAL OBSTRUCTION; ATUBULAR GLOMERULI; NEPHROTIC SYNDROME; PODOCYTES; INJURY; MICE; RECOMBINASE; RECRUITMENT; PROTEINURIA; REVEALS	Podocytes are critical in the maintenance of a healthy glomerular filter; however, they have been difficult to study in the intact kidney because of technical limitations. Here we report the development of serial multiphoton microscopy (MPM) of the same glomeruli over several days to visualize the motility of podocytes and parietal epithelial cells (PECs) in vivo. In podocin-GFP mice, podocytes formed sporadic multicellular clusters after unilateral ureteral ligation and migrated into the parietal Bowman's capsule. The tracking of single cells in podocin-confetti mice featuring cell-specific expression of CFP, GFP, YFP or RFP revealed the simultaneous migration of multiple podocytes. In phosphoenolpyruvate carboxykinase (PEPCK)-GFP mice, serial MPM found PEC-to-podocyte migration and nanotubule connections. Our data support a highly dynamic rather than a static nature of the glomerular environment and cellular composition. Future application of this new approach should advance our understanding of the mechanisms of glomerular injury and regeneration.	[Hackl, Matthias J.; Burford, James L.; Villanueva, Katie; Lam, Lisa; Peti-Peterdi, Janos] Univ So Calif, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Hackl, Matthias J.; Burford, James L.; Villanueva, Katie; Lam, Lisa; Peti-Peterdi, Janos] Univ So Calif, Dept Med, Los Angeles, CA USA; [Hackl, Matthias J.; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Hackl, Matthias J.; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	University of Southern California; University of Southern California; University of Cologne; University of Cologne; University of Pennsylvania	Peti-Peterdi, J (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.	petipete@usc.edu	Susztak, Katalin/ABE-7474-2021; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014	Susztak, Katalin/0000-0002-1005-3726; Schermer, Bernhard/0000-0002-5194-9000; Burford, James/0000-0001-9714-8578; Hackl, Matthias/0000-0002-4199-3374; Peti-Peterdi, Janos/0000-0003-4092-6185	US National Institutes of Health [DK64324, DK076077]; American Diabetes Association [1-11-BS-121]; University Kidney Research Organization; Deutsche Forschungsgemeinschaft [SFB635, HA-6212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076077, R01DK064324] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); University Kidney Research Organization; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US National Institutes of Health grant DK64324, American Diabetes Association grant 1-11-BS-121 and the University Kidney Research Organization to J.P.-P., Deutsche Forschungsgemeinschaft grant SFB635 to T.B. and US National Institutes of Health grant DK076077 to K.S. M.J.H. was supported by Deutsche Forschungsgemeinschaft grant HA-6212. We thank M. Hammerschmidt and H.-M. Pogoda (Institute of Developmental Biology, University of Cologne) for granting access to their imaging facility. We thank ER. Danesh (Baylor College of Medicine) and V. Haase (Vanderbilt University) for providing podocin-iCreER<SUP>T2</SUP> and PEPCK-Cre mice, respectively.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Benigni A, 2011, AM J PATHOL, V179, P628, DOI 10.1016/j.ajpath.2011.04.003; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Forbes MS, 2011, AM J PHYSIOL-RENAL, V301, pF110, DOI 10.1152/ajprenal.00022.2011; Gibson IW, 1996, J PATHOL, V179, P421; Grgic I, 2012, J AM SOC NEPHROL, V23, P785, DOI 10.1681/ASN.2011100988; Hohne M, 2013, AM J PATHOL, V182, P332, DOI 10.1016/j.ajpath.2012.11.002; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, pF495, DOI 10.1152/ajprenal.00521.2005; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoury CC, 2012, BIOCHEM BIOPH RES CO, V427, P525, DOI 10.1016/j.bbrc.2012.09.089; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Peti-Peterdi J, 2012, AM J PHYSIOL-RENAL, V302, pF227, DOI 10.1152/ajprenal.00561.2011; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Salmon AHJ, 2012, J AM SOC NEPHROL, V23, P1339, DOI 10.1681/ASN.2012010017; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schiessl IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052499; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Wang JR, 2010, GENESIS, V48, P446, DOI 10.1002/dvg.20635; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	40	123	123	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1661	1666		10.1038/nm.3405	http://dx.doi.org/10.1038/nm.3405			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24270544	Green Accepted			2022-12-25	WOS:000328181400037
J	Nelson, JW; Sudarsan, N; Furukawa, K; Weinberg, Z; Wang, JX; Breaker, RR				Nelson, James W.; Sudarsan, Narasimhan; Furukawa, Kazuhiro; Weinberg, Zasha; Wang, Joy X.; Breaker, Ronald R.			Riboswitches in eubacteria sense the second messenger c-di-AMP	NATURE CHEMICAL BIOLOGY			English	Article							RESUSCITATION-PROMOTING FACTORS; LIGAND-BINDING; S-ADENOSYLHOMOCYSTEINE; STRUCTURAL BASIS; GENE-EXPRESSION; BACTERIA; IDENTIFICATION; TRANSCRIPTION; SPORULATION; RESISTANCE	Cyclic di-adenosine monophosphate (c-di-AMP) is a recently discovered bacterial second messenger implicated in the control of cell wall metabolism, osmotic stress responses and sporulation. However, the mechanisms by which c-di-AMP triggers these physiological responses have remained largely unknown. Notably, a candidate riboswitch class called ydaO associates with numerous genes involved in these same processes. Although a representative ydaO motif RNA recently was reported to weakly bind ATP, we report that numerous members of this noncoding RNA class selectively respond to c-di-AMP with subnanomolar affinity. Our findings resolve the mystery regarding the primary ligand for this extremely common riboswitch class and expose a major portion of the super-regulon of genes that are controlled by the widespread bacterial second messenger c-di-AMP.	[Nelson, James W.] Yale Univ, Dept Chem, New Haven, CT USA; [Sudarsan, Narasimhan; Weinberg, Zasha; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Sudarsan, Narasimhan; Furukawa, Kazuhiro; Weinberg, Zasha; Wang, Joy X.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Wang, Joy Xin/D-2482-2010	Breaker, Ronald/0000-0002-2165-536X; Nelson, James/0000-0001-5033-6766; Weinberg, Zasha/0000-0002-6681-3624	NIH [RR19895-02]; Japan Society for the Promotion of Science fellowship for research abroad; US National Institutes of Health [GM022778, DE022340]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science fellowship for research abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Roth and other members of the Breaker laboratory for helpful discussions. We also thank N. Carriero and R. Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02). K. F. was supported by a Japan Society for the Promotion of Science fellowship for research abroad. This project was supported by US National Institutes of Health grants (GM022778 and DE022340) to R. R. B. Research in the Breaker laboratory is also supported by the Howard Hughes Medical Institute.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Haller A, 2011, ACCOUNTS CHEM RES, V44, P1339, DOI 10.1021/ar200035g; Hofacker IL, 2009, CURR PROTOC BIOINFOR, V12, P2; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Marchais A, 2011, RNA BIOL, V8, P358, DOI 10.4161/rna.8.3.14998; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer MM, 2011, RNA BIOL, V8, P5, DOI 10.4161/rna.8.1.13865; Moriyama R, 1999, J BACTERIOL, V181, P2373, DOI 10.1128/JB.181.8.2373-2378.1999; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Roth A., NAT CHEM BI IN PRESS; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Shanahan CA, 2013, BIOCHEMISTRY-US, V52, P365, DOI 10.1021/bi301510v; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Watson PY, 2012, NAT CHEM BIOL, V8, P963, DOI [10.1038/nchembio.1095, 10.1038/NCHEMBIO.1095]; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	63	191	201	2	73	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					834	+		10.1038/NCHEMBIO.1363	http://dx.doi.org/10.1038/NCHEMBIO.1363			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24141192	Green Accepted			2022-12-25	WOS:000327130000016
J	Van Allen, EM; Wagle, N; Stojanov, P; Perrin, DL; Cibulskis, K; Marlow, S; Jane-Valbuena, J; Friedrich, DC; Kryukov, G; Carter, SL; McKenna, A; Sivachenko, A; Rosenberg, M; Kiezun, A; Voet, D; Lawrence, M; Lichtenstein, LT; Gentry, JG; Huang, FW; Fostel, J; Farlow, D; Barbie, D; Gandhi, L; Lander, ES; Gray, SW; Joffe, S; Janne, P; Garber, J; MacConaill, L; Lindeman, N; Rollins, B; Kantoff, P; Fisher, SA; Gabriel, S; Getz, G; Garraway, LA				Van Allen, Eliezer M.; Wagle, Nikhil; Stojanov, Petar; Perrin, Danielle L.; Cibulskis, Kristian; Marlow, Sara; Jane-Valbuena, Judit; Friedrich, Dennis C.; Kryukov, Gregory; Carter, Scott L.; McKenna, Aaron; Sivachenko, Andrey; Rosenberg, Mara; Kiezun, Adam; Voet, Douglas; Lawrence, Michael; Lichtenstein, Lee T.; Gentry, Jeff G.; Huang, Franklin W.; Fostel, Jennifer; Farlow, Deborah; Barbie, David; Gandhi, Leena; Lander, Eric S.; Gray, Stacy W.; Joffe, Steven; Janne, Pasi; Garber, Judy; MacConaill, Laura; Lindeman, Neal; Rollins, Barrett; Kantoff, Philip; Fisher, Sheila A.; Gabriel, Stacey; Getz, Gad; Garraway, Levi A.			Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; LUNG-CANCER; LANDSCAPE; PLATFORM; CATALOG; GENOME; ERA	Translating whole-exome sequencing (WES) for prospective clinical use may have an impact on the care of patients with cancer; however, multiple innovations are necessary for clinical implementation. These include rapid and robust WES of DNA derived from formalin-fixed, paraffin-embedded tumor tissue, analytical output similar to data from frozen samples and clinical interpretation of WES data for prospective use. Here, we describe a prospective clinical WES platform for archival formalin-fixed, paraffin-embedded tumor samples. The platform employs computational methods for effective clinical analysis and interpretation of WES data. When applied retrospectively to 511 exomes, the interpretative framework revealed a 'long tail' of somatic alterations in clinically important genes. Prospective application of this approach identified clinically relevant alterations in 15 out of 16 patients. In one patient, previously undetected findings guided clinical trial enrollment, leading to an objective clinical response. Overall, this methodology may inform the widespread implementation of precision cancer medicine.	[Van Allen, Eliezer M.; Wagle, Nikhil; Stojanov, Petar; Marlow, Sara; Jane-Valbuena, Judit; Huang, Franklin W.; Barbie, David; Gandhi, Leena; Gray, Stacy W.; Joffe, Steven; Janne, Pasi; Garber, Judy; MacConaill, Laura; Lindeman, Neal; Rollins, Barrett; Kantoff, Philip; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Wagle, Nikhil; Stojanov, Petar; Perrin, Danielle L.; Cibulskis, Kristian; Marlow, Sara; Jane-Valbuena, Judit; Friedrich, Dennis C.; Kryukov, Gregory; Carter, Scott L.; McKenna, Aaron; Sivachenko, Andrey; Rosenberg, Mara; Kiezun, Adam; Voet, Douglas; Lawrence, Michael; Lichtenstein, Lee T.; Gentry, Jeff G.; Huang, Franklin W.; Fostel, Jennifer; Farlow, Deborah; Lander, Eric S.; Fisher, Sheila A.; Gabriel, Stacey; Getz, Gad; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [McKenna, Aaron] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Joffe, Steven] Childrens Hosp Boston, Boston, MA USA; [MacConaill, Laura; Lindeman, Neal] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	gadgetz@broadinstitute.org; levi_garraway@dfci.harvard.edu	Stojanov, Petar/GQI-4462-2022; Gray, Stacy/GRF-6833-2022; Cibulskis, Kristian/AAC-7380-2019; Wagle, Nikhil/Q-7428-2019; Gray, Stacy/AAJ-2956-2020; Joffe, Steven/H-3941-2019; Lawrence, Michael/AAC-8202-2020; Kryukov, Gregory V/A-9592-2008	Stojanov, Petar/0000-0001-7815-776X; Gray, Stacy/0000-0001-6948-0143; Joffe, Steven/0000-0002-0667-7384; Kryukov, Gregory/0000-0002-6131-9483; Kantoff, Philip/0000-0001-7275-0597; Rosenberg, Mara/0000-0001-6400-3161; Cibulskis, Kristian/0000-0003-1343-1582; Gandhi, Leena/0000-0002-2398-9179	Chair in Oncology at Massachusetts General Hospital; Starr Cancer Foundation; Prostate Cancer Foundation; US National Institutes of Health (NIH) NHGRI Clinical Sequencing Exploratory Research grant [1U01HG006492]; NIH National Cancer Institute [1U24CA126546]; US Department of Defense; NIH [U24CA143845]; Dana-Farber Leadership Council; NATIONAL CANCER INSTITUTE [U24CA126546, R33CA155554, T32CA009172, P30CA014051, U24CA143845] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006492, U54HG003067] Funding Source: NIH RePORTER	Chair in Oncology at Massachusetts General Hospital; Starr Cancer Foundation; Prostate Cancer Foundation; US National Institutes of Health (NIH) NHGRI Clinical Sequencing Exploratory Research grant; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Leadership Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the patients and clinicians for their participation in this project. We thank the Broad Genomics Platform (specifically K. Anderka, A. Cheney, E. Wheeler, T. Mason and C. Crawford). We thank C. Sougnez for facilitating data deposition. We also thank A. Lane and A. Yoda (Dana-Farber Cancer Institute), for their contributions to the JAK3 experimental work: A. Lane provided Ba/F3 cells, and A. Yoda provided murine stem cell virus puromycin vector. G.G. is partially funded by a Paul C. Zamecnik, MD, Chair in Oncology at Massachusetts General Hospital. This work was supported by the Starr Cancer Foundation (L.A.G.), the Prostate Cancer Foundation (E.M.V.A. and L.A.G.), US National Institutes of Health (NIH) NHGRI Clinical Sequencing Exploratory Research grant 1U01HG006492 (L.A.G.), the NIH National Cancer Institute grant 1U24CA126546 (L.A.G. and E.S.L.), the US Department of Defense (L.A.G.), NIH U24CA143845 grant (G.G.) and the Dana-Farber Leadership Council (E.M.V.A.).	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goetz L, 2013, JAMA-J AM MED ASSOC, V309, P37, DOI 10.1001/jama.2012.70832; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Levine RL, 2012, CURR TOP MICROBIOL, V355, P119, DOI 10.1007/82_2011_170; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Natsume H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-97; Pao W, 2005, NEW ENGL J MED, V353, P1740; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Yeh P, 2013, CLIN CANCER RES, V19, P1894, DOI 10.1158/1078-0432.CCR-12-1894	39	386	389	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					682	688		10.1038/nm.3559	http://dx.doi.org/10.1038/nm.3559			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24836576	Green Submitted, Green Accepted			2022-12-25	WOS:000337071000033
J	Rice, GI; Duany, YD; Jenkinson, EM; Forte, GMA; Anderson, BH; Ariaudo, G; Bader-Meunier, B; Baildam, EM; Battini, R; Beresford, MW; Casarano, M; Chouchane, M; Cimaz, R; Collins, AE; Cordeiro, NJV; Dale, RC; Davidson, JE; De Waele, L; Desguerre, I; Faivre, L; Fazzi, E; Isidor, B; Lagae, L; Latchman, AR; Lebon, P; Li, CM; Livingston, JH; Lourenco, CM; Mancardi, MM; Masurel-Paulet, A; McInnes, LB; Menezes, MP; Mignot, C; O'Sullivan, J; Orcesi, S; Picco, PP; Riva, E; Robinson, RA; Rodriguez, D; Salvatici, E; Scott, C; Szybowska, M; Tolmie, JL; Vanderver, A; Vanhulle, C; Vieira, JP; Webb, K; Whitney, RN; Williams, SG; Wolfe, LA; Zuberi, SM; Hur, S; Crow, YJ				Rice, Gillian I.; Duany, Yoandris del Toro; Jenkinson, Emma M.; Forte, Gabriella M. A.; Anderson, Beverley H.; Ariaudo, Giada; Bader-Meunier, Brigitte; Baildam, Eileen M.; Battini, Roberta; Beresford, Michael W.; Casarano, Manuela; Chouchane, Mondher; Cimaz, Rolando; Collins, Abigail E.; Cordeiro, Nuno J. V.; Dale, Russell C.; Davidson, Joyce E.; De Waele, Liesbeth; Desguerre, Isabelle; Faivre, Laurence; Fazzi, Elisa; Isidor, Bertrand; Lagae, Lieven; Latchman, Andrew R.; Lebon, Pierre; Li, Chumei; Livingston, John H.; Lourenco, Charles M.; Mancardi, Maria Margherita; Masurel-Paulet, Alice; McInnes, Lain B.; Menezes, Manoj P.; Mignot, Cyril; O'Sullivan, James; Orcesi, Simona; Picco, Paolo P.; Riva, Enrica; Robinson, Robert A.; Rodriguez, Diana; Salvatici, Elisabetta; Scott, Christiaan; Szybowska, Marta; Tolmie, John L.; Vanderver, Adeline; Vanhulle, Catherine; Vieira, Jose Pedro; Webb, Kate; Whitney, Robyn N.; Williams, Simon G.; Wolfe, Lynne A.; Zuberi, Sameer M.; Hur, Sun; Crow, Yanick J.			Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling	NATURE GENETICS			English	Article							AICARDI-GOUTIERES-SYNDROME; DYSCHROMATOSIS SYMMETRICA HEREDITARIA; EXPRESSION SIGNATURE; DSRNA RECOGNITION; MDA5 FILAMENTS; AUTOIMMUNITY; LUPUS; TREX1; MICE; DISORDERS	The type I interferon system is integral to human antiviral immunity. However, inappropriate stimulation or defective negative regulation of this system can lead to inflammatory disease. We sought to determine the molecular basis of genetically uncharacterized cases of the type I interferonopathy Aicardi-Goutieres syndrome and of other undefined neurological and immunological phenotypes also demonstrating an upregulated type I interferon response. We found that heterozygous mutations in the cytosolic double-stranded RNA receptor gene IFIH1 (also called MDA5) cause a spectrum of neuroimmunological features consistently associated with an enhanced interferon state. Cellular and biochemical assays indicate that these mutations confer gain of function such that mutant IFIH1 binds RNA more avidly, leading to increased baseline and ligand-induced interferon signaling. Our results demonstrate that aberrant sensing of nucleic acids can cause immune upregulation.	[Rice, Gillian I.; Jenkinson, Emma M.; Forte, Gabriella M. A.; Anderson, Beverley H.; O'Sullivan, James; Williams, Simon G.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Duany, Yoandris del Toro; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Duany, Yoandris del Toro; Hur, Sun] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Ariaudo, Giada; Orcesi, Simona] C Mondino Natl Neurol Inst, Child Neurol & Psychiat Unit, Pavia, Italy; [Ariaudo, Giada] Univ Pavia, Dept Brain & Behav Sci, Unit Child Neurol & Psychiat, I-27100 Pavia, Italy; [Bader-Meunier, Brigitte] Hop Necker Enfants Malad, AP HP, Imagine Fdn, Dept Pediat Immunol & Rheumatol,INSERM U76, Paris, France; [Baildam, Eileen M.; Beresford, Michael W.] Alder Hey Childrens Natl Hlth Serv NHS Fdn Trus, Dept Paediat Rheumatol, Liverpool, Merseyside, England; [Battini, Roberta; Casarano, Manuela] IRCCS Stella Mans, Dept Dev Neurosci, Pisa, Italy; [Beresford, Michael W.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Chouchane, Mondher] CHU Dijon, Serv Pediat 1, Dijon, France; [Cimaz, Rolando] AOU Meyer, Dept Pediat, Florence, Italy; [Cimaz, Rolando] Univ Florence, Florence, Italy; [Collins, Abigail E.] Univ Colorado, Sch Med, Dept Pediat, Div Pediat Neurol, Denver, CO USA; [Cordeiro, Nuno J. V.] Rainbow House NHS Ayrshire & Arran, Dept Paediat, Irvine, CA USA; [Dale, Russell C.] Univ Sydney, Childrens Hosp Westmead, Neuroimmunol Grp, Sydney, NSW 2006, Australia; [Davidson, Joyce E.] Royal Hosp Sick Children, Dept Paediat Rheumatol, Glasgow G3 8SJ, Lanark, Scotland; [De Waele, Liesbeth; Lagae, Lieven] Katholieke Univ Leuven Hosp, Dept Paediat Neurol, Louvain, Belgium; [Desguerre, Isabelle] Hop Necker Enfants Malad, AP HP, INSERM U768, Dept Pediat Neurol, Paris, France; [Faivre, Laurence; Masurel-Paulet, Alice] CHU Dijon, Hop Enfants, Ctr Genet, Dijon, France; [Faivre, Laurence; Masurel-Paulet, Alice] Univ Bourgogne, Dijon, France; [Fazzi, Elisa] Univ Brescia, Dept Clin & Expt Sci, Civil Hosp, Child Neurol & Psychiat Unit, Brescia, Italy; [Isidor, Bertrand] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Isidor, Bertrand] INSERM, UMRS 957, Nantes, France; [Latchman, Andrew R.] McMaster Univ, Dept Pediat, Div Gen Pediat, McMaster Childrens Hosp, Hamilton, ON, Canada; [Lebon, Pierre] Univ & Fac Med Paris Descartes, Paris, France; [Li, Chumei; Szybowska, Marta] McMaster Univ, McMaster Childrens Hosp, Clin Genet Program, Dept Pediat, Hamilton, ON, Canada; [Livingston, John H.] Leeds Teaching Hosp NHS Trust, Dept Paediat Neurol, Leeds, W Yorkshire, England; [Lourenco, Charles M.] Univ Sao Paulo, Clin Hosp Ribeirao Preto, Sao Paulo, Brazil; [Mancardi, Maria Margherita] Giannina Gaslim Inst, Dept Neurosci, Operat Unit Child Neuropsychiat, Genoa, Italy; [McInnes, Lain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Menezes, Manoj P.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2006, Australia; [Mignot, Cyril] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Picco, Paolo P.] Giannina Gaslini Inst, Genoa, Italy; [Salvatici, Elisabetta] Univ Milan, San Paolo Hosp, Clin Dept Pediat, Milan, Italy; [Robinson, Robert A.] Great Ormond St Hosp Sick Children, Dept Neurol, London WC1N 3JH, England; [Rodriguez, Diana] HUEP, AP HP, Hop A Trousseau, Serv Neuropediat,Ctr Reference Neurogenet, Paris, France; [Rodriguez, Diana] Univ Paris 06, Paris, France; [Rodriguez, Diana] INSERM U676, Paris, France; [Scott, Christiaan; Webb, Kate] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat Rheumatol, ZA-79250 Cape Town, South Africa; [Tolmie, John L.] So Gen Hosp, Dept Clin Genet, Glasgow G51 4TF, Lanark, Scotland; [Vanderver, Adeline] Childrens Natl Med Ctr, Dept Pediat Neurol, Washington, DC 20010 USA; [Vanhulle, Catherine] CHU Rouen, Hop Charles Nicolle, Serv Neonatal & Reanimat, Rouen, France; [Vieira, Jose Pedro] Hosp Dona Estefania, Ctr Hosp Lisboa Cent, Dept Neurol, Lisbon, Portugal; [Whitney, Robyn N.] McMaster Univ, McMaster Childrens Hosp, Dept Pediat, Div Pediat Neurol, Hamilton, ON, Canada; [Wolfe, Lynne A.] US Natl Inst Hlth Undiagnosed Dis Program, Bethesda, MD USA; [Zuberi, Sameer M.] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Paediat Neurosci Res Grp, Glasgow G3 8SJ, Lanark, Scotland; [Zuberi, Sameer M.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland	University of Manchester; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; IRCCS Fondazione Casimiro Mondino; University of Pavia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Alder Hey Children's NHS Foundation Trust; IRCCS Fondazione Stella Maris; University of Liverpool; CHU Dijon Bourgogne; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Sydney; University of Glasgow; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Universite de Bourgogne; University of Brescia; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); McMaster University; UDICE-French Research Universities; Universite Paris Cite; McMaster University; University of Leeds; Universidade de Sao Paulo; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Glasgow; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; San Paolo-Polo Universitaria Hospital; University of Milan; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Cape Town; University of Glasgow; Children's National Health System; CHU de Rouen; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; McMaster University; National Institutes of Health (NIH) - USA; University of Glasgow; University of Glasgow	Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	sun.hur@childrens.harvard.edu; yanickcrow@mac.com	Crow, Yanick J/N-6120-2014; Latchman, Andrew/AAW-2493-2021; Beresford, Michael William/AAB-5261-2021; orcesi, simona/J-6030-2016; Whitney, Robyn/AAS-2867-2021; Isidor, Bertrand/L-2435-2015; Isidor, Bertrand/AAJ-3456-2021; Rodriguez, Diana/GVR-7668-2022; vieira, jose pedro/AAT-4370-2020; CIMAZ, Rolando/AAA-9058-2019; Fazzi, Elisa/J-6076-2016; Vanderver, Adeline/CAG-5072-2022; battini, roberta/P-9095-2017; Scott, Chris/I-4442-2019; Rice, Gillian I/G-3128-2015	Crow, Yanick J/0000-0001-7211-7564; Latchman, Andrew/0000-0001-6946-8611; Beresford, Michael William/0000-0002-5400-9911; orcesi, simona/0000-0001-8947-9342; Whitney, Robyn/0000-0001-6851-0646; Isidor, Bertrand/0000-0001-6480-126X; Isidor, Bertrand/0000-0001-6480-126X; vieira, jose pedro/0000-0002-2270-5314; CIMAZ, Rolando/0000-0002-3260-4226; Fazzi, Elisa/0000-0003-4805-7906; battini, roberta/0000-0002-7889-1355; Scott, Chris/0000-0003-3874-1704; Rice, Gillian I/0000-0002-4223-0571; Menezes, Manoj/0000-0003-3160-6112; McInnes, Iain/0000-0002-6462-4280; bader-meunier, brigitte/0000-0001-8476-8196; Webb, Kate/0000-0003-1087-5946; Picco, Paolo/0000-0003-0686-0725; Vanderver, Adeline/0000-0002-6290-6751; Faivre, Laurence/0000-0001-9770-444X; Williams, Simon/0000-0001-7396-4108	Novartis Foundation; Boston Children's Hospital; Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre; Greater Manchester Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; European Union's Seventh Framework Programme [241779]; European Research Council [GA 309449]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Great Ormond Street Hospital Childrens Charity [V1212] Funding Source: researchfish	Novartis Foundation(Novartis); Boston Children's Hospital; Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre; Greater Manchester Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; European Union's Seventh Framework Programme(European Commission); European Research Council(European Research Council (ERC)European Commission); Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Great Ormond Street Hospital Childrens Charity	We sincerely thank the participating families for the use of genetic samples and clinical information and all clinicians who contributed samples and data not included in this manuscript. We thank D. Chase for proofreading the manuscript. We thank G. Notarangelo for helpful discussion. Y.d.T.D. holds a Novartis Foundation postdoctoral fellowship. S.H. holds a Pew scholarship and Career Development award from Boston Children's Hospital. Y.J.C. acknowledges the Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre, the Greater Manchester Comprehensive Local Research Network, the Great Ormond Street Hospital Children's Charity, the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 241779 and the European Research Council (GA 309449). The authors would like to thank the NHLBI GO ESP and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Cen H, 2013, AUTOIMMUNITY, V46, P455, DOI 10.3109/08916934.2013.796937; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow YJ, 2014, CLIN EXP IMMUNOL, V175, P1, DOI 10.1111/cei.12115; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gresser I, 1980, Ann N Y Acad Sci, V350, P12, DOI 10.1111/j.1749-6632.1980.tb20602.x; GRESSER I, 1975, NATURE, V258, P76, DOI 10.1038/258076a0; GRESSER I, 1976, NATURE, V263, P420, DOI 10.1038/263420a0; Herries D.G., 1985, ENZYME STRUCTURE MEC; Kondo T, 2008, J DERMATOL, V35, P662, DOI 10.1111/j.1346-8138.2008.00540.x; Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Stetson DB, 2012, CURR OPIN IMMUNOL, V24, P692, DOI 10.1016/j.coi.2012.09.007; Tojo K, 2006, MOVEMENT DISORD, V21, P1510, DOI 10.1002/mds.21011; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048	29	380	393	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					503	509		10.1038/ng.2933	http://dx.doi.org/10.1038/ng.2933			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686847	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000335422900020
J	Ciceri, P; Muller, S; O'Mahony, A; Fedorov, O; Filippakopoulos, P; Hunt, JP; Lasater, EA; Pallares, G; Picaud, S; Wells, C; Martin, S; Wodicka, LM; Shah, NP; Treiber, DK; Knapp, S				Ciceri, Pietro; Mueller, Susanne; O'Mahony, Alison; Fedorov, Oleg; Filippakopoulos, Panagis; Hunt, Jeremy P.; Lasater, Elisabeth A.; Pallares, Gabriel; Picaud, Sarah; Wells, Christopher; Martin, Sarah; Wodicka, Lisa M.; Shah, Neil P.; Treiber, Daniel K.; Knapp, Stefan			Dual kinase-bromodomain inhibitors for rationally designed polypharmacology	NATURE CHEMICAL BIOLOGY			English	Article							SELECTIVE INHIBITOR; THERAPEUTIC TARGET; MULTIPLE-MYELOMA; IN-VITRO; CANCER; RECOGNITION; DEPENDENCE; DISCOVERY; CYTOKINE; REVEALS	Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clinical responses to targeted therapies. The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clinical development challenges. Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy. Here we report that several clinical kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors. Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clinical PLK1 and JAK2-FLT3 kinase inhibitors, respectively, is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacological targeting. Furthermore, structureactivity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.	[Ciceri, Pietro; Hunt, Jeremy P.; Pallares, Gabriel; Wodicka, Lisa M.; Treiber, Daniel K.] DiscoveRx Corp, KINOMEscan Div, San Diego, CA USA; [Mueller, Susanne; Filippakopoulos, Panagis; Picaud, Sarah; Wells, Christopher; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Mueller, Susanne; Fedorov, Oleg; Wells, Christopher; Martin, Sarah; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, TDI, Oxford, England; [O'Mahony, Alison] DiscoveRx Corp, BioSeek Div, San Francisco, CA USA; [Filippakopoulos, Panagis; Picaud, Sarah] Univ Oxford, Nuffield Dept Clin Med, LICR, Oxford, England; [Lasater, Elisabeth A.; Shah, Neil P.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA	University of Oxford; University of Oxford; University of Oxford; University of California System; University of California San Francisco	Ciceri, P (corresponding author), DiscoveRx Corp, KINOMEscan Div, San Diego, CA USA.	dtreiber@discoverx.com; stefan.knapp@sgc.ox.ac.uk	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Muller-Knapp, Susanne/0000-0003-2402-4157; Filippakopoulos, Panagis/0000-0002-1515-1317; OMahony, Alison/0000-0001-8403-0351	National Cancer Institute [1R01 CA166616-01]; US National Institutes of Health National Cancer Institute [T32CA108462-07]; Leukemia and Lymphoma scholar in Clinical Research; Structural Genomics Consortium [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research, Genome Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer, Takeda and the Wellcome Trust [092809/Z/10/Z]; NATIONAL CANCER INSTITUTE [R01CA166616, T32CA108462] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma scholar in Clinical Research; Structural Genomics Consortium(University of Toronto); AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research, Genome Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer, Takeda and the Wellcome Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S.M., S.P., P.F., C.W., O.F., S.M. and S.K. are grateful for support by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z). This work was supported in part by a grant from the National Cancer Institute (1R01 CA166616-01) to N.P.S. and by a US National Institutes of Health National Cancer Institute grant (T32CA108462-07) to E.A.L. N.P.S. is a Leukemia and Lymphoma scholar in Clinical Research. We thank P. Gallant, T. Wehrman, E.L. Berg and P. Khanna for critically reading the manuscript and for valuable discussions, the KINOMEscan team for measuring inhibitor K<INF>d</INF> values, the BioSeek team for performing BioMAP screens and A. Rooks, R. Nepomuceno and B. Belli for performing MV4-11 proliferation assays.	[Anonymous], 2007, SCALA SCAL TOG MULT; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Cai ZW, 2008, J MED CHEM, V51, P1976, DOI 10.1021/jm7013309; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2000, METH MOL B, V99, P161; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dittmann A, 2014, ACS CHEM BIOL, V9, P495, DOI 10.1021/cb400789e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gunawardane RN, 2013, MOL CANCER THER, V12, P438, DOI 10.1158/1535-7163.MCT-12-0305; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Kyttaris VC, 2012, DRUG DES DEV THER, V6, P245, DOI 10.2147/DDDT.S25426; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Martin MP, 2013, ACS CHEM BIOL, V8, P2360, DOI 10.1021/cb4003283; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Philpott M, 2011, MOL BIOSYST, V7, P2899, DOI 10.1039/c1mb05099k; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Ramakrishnan V, 2010, AM J HEMATOL, V85, P675, DOI 10.1002/ajh.21785; Rodriguez M., 2014, 55 AM SOC HEM ANN M; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; Siu M, 2013, BIOORG MED CHEM LETT, V23, P5014, DOI 10.1016/j.bmcl.2013.06.008; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Tong YS, 2008, BIOORG MED CHEM LETT, V18, P5206, DOI 10.1016/j.bmcl.2008.08.079; Trusolino L, 2012, CANCER DISCOV, V2, P876, DOI 10.1158/2159-8290.CD-12-0400; Vidler LR, 2013, J MED CHEM, V56, P8073, DOI 10.1021/jm4011302; Weigelt B, 2013, CLIN CANCER RES, V19, P3533, DOI 10.1158/1078-0432.CCR-12-3815; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	61	243	251	5	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					305	+		10.1038/nchembio.1471	http://dx.doi.org/10.1038/nchembio.1471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24584101	Green Submitted, Green Accepted			2022-12-25	WOS:000333172900014
J	Xu, YM; Cai, C; Chandarajoti, K; Hsieh, PH; Li, LY; Pham, TQ; Sparkenbaugh, EM; Sheng, JZ; Key, NS; Pawlinski, R; Harris, EN; Linhardt, RJ; Liu, J				Xu, Yongmei; Cai, Chao; Chandarajoti, Kasemsiri; Hsieh, Po-Hung; Li, Lingyun; Pham, Truong Q.; Sparkenbaugh, Erica M.; Sheng, Juzheng; Key, Nigel S.; Pawlinski, Rafal; Harris, Edward N.; Linhardt, Robert J.; Liu, Jian			Homogeneous low-molecular-weight heparins with reversible anticoagulant activity	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL SELECTIVITY; HYALURONAN RECEPTOR; SYNTHETIC HEPARIN; ANTITHROMBIN-III; SULFATE; BINDING; BIOSYNTHESIS; 3-O-SULFOTRANSFERASE; WARFARIN; ANTIDOTE	Low-molecular-weight heparins (LMWHs) are carbohydrate-based anticoagulants clinically used to treat thrombotic disorders, but impurities, structural heterogeneity or functional irreversibility can limit treatment options. We report a series of synthetic LMWHs prepared by cost-effective chemoenzymatic methods. The high activity of one defined synthetic LMWH against human factor Xa (FXa) was reversible in vitro and in vivo using protamine, demonstrating that synthetically accessible constructs can have a critical role in the next generation of LMWHs.	[Xu, Yongmei; Chandarajoti, Kasemsiri; Hsieh, Po-Hung; Pham, Truong Q.; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Cai, Chao; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY USA; [Sparkenbaugh, Erica M.; Key, Nigel S.; Pawlinski, Rafal] Univ N Carolina, Dept Med, McAllister Heart Inst, Div Hematol Oncol, Chapel Hill, NC USA; [Sheng, Juzheng] Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drug, Jinan 250100, Peoples R China; [Harris, Edward N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	University of North Carolina; University of North Carolina Chapel Hill; Rensselaer Polytechnic Institute; University of North Carolina; University of North Carolina Chapel Hill; Shandong University; University of Nebraska System; University of Nebraska Lincoln	Xu, YM (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA.	linhar@rpi.edu; jian_liu@unc.edu	PAwlinski, Rafal/AAD-6090-2022; /AAX-1685-2020; Chandarajoti, Kasemsiri/GZL-9477-2022; Sheng, Juzheng/G-2693-2013	Sheng, Juzheng/0000-0003-2856-9162; Cai, Chao/0000-0003-4377-3989	US National Institutes of Health [HL094463, GM102137, HL62244, HL096972, GM38060, HL096679, HL117659]; US National Institutes of Health Research Training Grant [T32-HL007149]; Royal Thai Government fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463, U01HL117659, T32HL007149, R01HL062244, R01HL096972, R01HL096679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137, R01GM038060] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Research Training Grant; Royal Thai Government fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.E. Rogers for helpful discussions. This work is supported in part by US National Institutes of Health grants HL094463 (to J.L.), GM102137 (to J.L.), HL62244 (to R.J.L.), HL096972 (to R.J.L.), GM38060 (to R.J.L.) HL096679 (to R.P.) and HL117659 (to N.S.K. and R.P.). E.M.S. is supported by a US National Institutes of Health Research Training Grant (T32-HL007149). K.C. is a recipient of a Royal Thai Government fellowship.	Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Bianchini EP, 2011, BLOOD, V117, P2054, DOI 10.1182/blood-2010-06-288522; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Duncan MB, 2004, BBA-GEN SUBJECTS, V1671, P34, DOI 10.1016/j.bbagen.2003.12.010; Harder S, 2012, J CLIN PHARMACOL, V52, P964, DOI 10.1177/0091270011409231; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hirsh J, 2007, CIRCULATION, V116, P552, DOI 10.1161/CIRCULATIONAHA.106.685974; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Lee S, 2013, NAT BIOTECHNOL, V31, P220, DOI 10.1038/nbt.2528; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Martinez-Gonzalez J, 2010, EXPERT REV CARDIOVAS, V8, P625, DOI [10.1586/erc.10.35, 10.1586/ERC.10.35]; Melnikova I, 2009, NAT REV DRUG DISCOV, V8, P353, DOI 10.1038/nrd2851; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; Pempe EH, 2012, J BIOL CHEM, V287, P20774, DOI 10.1074/jbc.M111.320069; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Petitou M., 1989, U.S. Patent, Patent No. [4,818,816, 4818816]; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Sundaram M, 2003, P NATL ACAD SCI USA, V100, P651, DOI 10.1073/pnas.252643299; Turnbull JE, 2011, SCIENCE, V334, P462, DOI 10.1126/science.1211605; Weitz JI, 2007, EXPERT OPIN INV DRUG, V16, P271, DOI 10.1517/13543784.16.3.271; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345; Zhang ZQ, 2008, J MED CHEM, V51, P5498, DOI 10.1021/jm800785t	31	142	149	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					248	+		10.1038/NCHEMBIO.1459	http://dx.doi.org/10.1038/NCHEMBIO.1459			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24561662	Green Accepted, Green Published			2022-12-25	WOS:000333172900005
J	Goodman, C				Goodman, Catherine			Making sense of nonsense	NATURE CHEMICAL BIOLOGY			English	Editorial Material													Goodman, Catherine/AAO-6148-2020	Goodman, Catherine/0000-0003-3415-8554					0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					167	167		10.1038/nchembio.1473	http://dx.doi.org/10.1038/nchembio.1473			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24531061				2022-12-25	WOS:000331616900002
J	Krieg, M; Dunn, AR; Goodman, MB				Krieg, Michael; Dunn, Alexander R.; Goodman, Miriam B.			Mechanical control of the sense of touch by beta-spectrin	NATURE CELL BIOLOGY			English	Article							LIVING CELLS; ALPHA-SPECTRIN; MEMBRANE; CHANNEL; MICROTUBULES; CYTOSKELETAL; MUTATIONS; TRANSDUCTION; ORGANIZATION; PROTEINS	The ability to sense and respond to mechanical stimuli emanates from sensory neurons and is shared by most, if not all, animals. Exactly how such neurons receive and distribute mechanical signals during touch sensation remains mysterious. Here, we show that sensation of mechanical forces depends on a continuous, pre-stressed spectrin cytoskeleton inside neurons. Mutations in the tetramerization domain of Caenorhabditis elegans beta-spectrin (UNC-70), an actin-membrane crosslinker, cause defects in sensory neuron morphology under compressive stress in moving animals. Through atomic force spectroscopy experiments on isolated neurons, in vivo laser axotomy and fluorescence resonance energy transfer imaging to measure force across single cells and molecules, we show that spectrin is held under constitutive tension in living animals, which contributes to elevated pre-stress in touch receptor neurons. Genetic manipulations that decrease such spectrin-dependent tension also selectively impair touch sensation, suggesting that such pre-tension is essential for efficient responses to external mechanical stimuli.	[Krieg, Michael; Goodman, Miriam B.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Krieg, Michael; Dunn, Alexander R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodman, MB (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272; Krieg, Michael/0000-0003-0501-5036	NIH Office of Research Infrastructure Programs; Stanford Bio-XIIP award; National Institutes of Health [DP2OD007078, RO1NS047715, RO1EB006745]; National Science Foundation [1136790]; Stanford Cardiovascular Institute Seed Grant; Burroughs-Wellcome Career Award at the Scientific Interface; Long-term fellowship from HFSP;  [NS06973];  [S10RR05574]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007078] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Bio-XIIP award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Stanford Cardiovascular Institute Seed Grant; Burroughs-Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Long-term fellowship from HFSP; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Shaw, A. Slade and S. Minne of Bruker Instruments for generous loan of AFM; Z. Liao for worm injections; D. Ramallo, C. Buckley, A. Olson, J. Mulholland for assistance with microscopy; K. Shen for loan of equipment for worm injection and strain integration; C.P. Heisenberg, K.C. Huang and W.J. Nelson for comments. Confocal microscopy and laser axotomy conducted in the Neuroscience Microscopy Service (NMS, partially supported by NS06973) and the Cell Science Imaging Facility (CSIF) at Stanford. Some strains provided by M. Chalfie, E. Jorgensen, W. Schaefer and the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (partially supported by S10RR05574). Work supported by a Stanford Bio-XIIP award (A.R.D., M.B.G.), the National Institutes of Health (DP2OD007078 to A.R.D., RO1NS047715 and RO1EB006745 to M.B.G.), the National Science Foundation (No. 1136790, A.R.D.), Stanford Cardiovascular Institute Seed Grant (A.R.D.), Burroughs-Wellcome Career Award at the Scientific Interface (A.R.D.) and a Long-term fellowship from HFSP (M.K.).	Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bignone PA, 2003, BIOCHEM J, V374, P613, DOI 10.1042/BJ20030507; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; Cueva JG, 2007, J NEUROSCI, V27, P14089, DOI 10.1523/JNEUROSCI.4179-07.2007; Das M., 2008, EPL, V84; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guo YX, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.198103; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hardie RC, 2012, SCIENCE, V338, P260, DOI 10.1126/science.1222376; Hart A. C., 2006, WORMBOOK; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HUTTER JL, 1993, REV SCI INSTRUM, V64, P3342, DOI 10.1063/1.1144449; Hwang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035343; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Jiang HQ, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2966216; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; KUIKEN GDC, 1984, J FLUID MECH, V141, P289, DOI 10.1017/S0022112084000859; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; Landau L. D., 1986, COURSE THEORETICAL P, V7; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Li DH, 2010, J BIOL CHEM, V285, P29535, DOI 10.1074/jbc.M110.145573; LIU SC, 1980, NATURE, V285, P586, DOI 10.1038/285586a0; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043164; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sleep J, 1999, BIOPHYS J, V77, P3085, DOI 10.1016/S0006-3495(99)77139-0; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tolomeo JA, 1997, BIOPHYS J, V73, P2241, DOI 10.1016/S0006-3495(97)78255-9; Topalidou I., 2012, CURR BIOL, P1; Vogel BE, 2001, DEVELOPMENT, V128, P883; WAUGH RE, 1988, J CLIN INVEST, V81, P133, DOI 10.1172/JCI113284; Xiao J, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085708; Xiao J, 2008, J APPL PHYS, V104, DOI 10.1063/1.2968228; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zar JH., 2010, BIOSTAT ANAL	66	124	127	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					224	+		10.1038/ncb2915	http://dx.doi.org/10.1038/ncb2915			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24561618	Green Accepted			2022-12-25	WOS:000332124000008
J	Sherwood, RI; Hashimoto, T; O'Donnell, CW; Lewis, S; Barkal, AA; van Hoff, JP; Karun, V; Jaakkola, T; Gifford, DK				Sherwood, Richard I.; Hashimoto, Tatsunori; O'Donnell, Charles W.; Lewis, Sophia; Barkal, Amira A.; van Hoff, John Peter; Karun, Vivek; Jaakkola, Tommi; Gifford, David K.			Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; IN-VIVO; COMPACTED CHROMATIN; HUMAN GENOME; BINDING; NETWORK; GENES; PLURIPOTENCY; REPRESSION; RESOLUTION	We describe protein interaction quantitation (PIQ), a computational method for modeling the magnitude and shape of genome-wide DNase I hypersensitivity profiles to identify transcription factor (TF) binding sites. Through the use of machine-learning techniques, PIQ identified binding sites for >700 TFs from one DNase I hypersensitivity analysis followed by sequencing (DNase-seq) experiment with accuracy comparable to that of chromatin immunoprecipitation followed by sequencing (ChIP-seq). We applied PIQ to analyze DNase-seq data from mouse embryonic stem cells differentiating into prepancreatic and intestinal endoderm. We identified 120 and experimentally validated eight 'pioneer' TF families that dynamically open chromatin. Four pioneer TF families only opened chromatin in one direction from their motifs. Furthermore, we identified 'settler' TFs whose genomic binding is principally governed by proximity to open chromatin. Our results support a model of hierarchical TF binding in which directional and nondirectional pioneer activity shapes the chromatin landscape for population by settler TFs.	[Sherwood, Richard I.; Lewis, Sophia; Barkal, Amira A.; van Hoff, John Peter; Karun, Vivek] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sherwood, Richard I.; Lewis, Sophia; Barkal, Amira A.; van Hoff, John Peter; Karun, Vivek] Harvard Univ, Sch Med, Boston, MA USA; [Hashimoto, Tatsunori; O'Donnell, Charles W.; Jaakkola, Tommi; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [O'Donnell, Charles W.; Gifford, David K.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [O'Donnell, Charles W.; Gifford, David K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University	Gifford, DK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rsherwood@partners.org; gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; O'donnell, Colm/0000-0002-8004-450X	US National Institutes of Health Common Fund [5UL1DE019581, RL1DE019021, 5TL1EB008540]; Harvard Stem Cell Institute's Sternlicht Director's Fund; NIH [1U01HG007037, 5P01NS055923]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [TL1EB008540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019581, RL1DE019021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	US National Institutes of Health Common Fund; Harvard Stem Cell Institute's Sternlicht Director's Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Losyev, J. Huynh and members of the Massachusetts Institute of Technology BioMicro Center for technical assistance, K. Kawakami (National Institute of Genetics) for Tol2 plasmids, H. Wichterle (Columbia University) for mESCs, and R. Maas for help with the manuscript. We acknowledge funding from the US National Institutes of Health Common Fund 5UL1DE019581, RL1DE019021 and 5TL1EB008540; the Harvard Stem Cell Institute's Sternlicht Director's Fund award to R.I.S., and NIH grants 1U01HG007037 and 5P01NS055923 to D.K.G.	Bhattacharya A, 2003, CANCER RES, V63, P8167; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen XY, 2010, BIOINFORMATICS, V26, pi334, DOI 10.1093/bioinformatics/btq175; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; He H.H., 2013, NAT METHODS, DOI [10.1038/nmeth.2762, DOI 10.1038/NMETH.2762]; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Koohy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069853; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Minka T. P., 2001, PROC 17 C UNCERTAINT, P362; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Song L, 2010, COLD SPRING HARB PRO, V2010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	49	284	287	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					171	+		10.1038/nbt.2798	http://dx.doi.org/10.1038/nbt.2798			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24441470	Bronze, Green Submitted, Green Accepted			2022-12-25	WOS:000331074000022
J	Carbone, F; De Rosa, V; Carrieri, PB; Montella, S; Bruzzese, D; Porcellini, A; Procaccini, C; La Cava, A; Matarese, G				Carbone, Fortunata; De Rosa, Veronica; Carrieri, Pietro B.; Montella, Silvana; Bruzzese, Dario; Porcellini, Antonio; Procaccini, Claudio; La Cava, Antonio; Matarese, Giuseppe			Regulatory T cell proliferative potential is impaired in human autoimmune disease	NATURE MEDICINE			English	Article							2 FOXP3 ISOFORMS; SUPPRESSIVE FUNCTION; SPLICE VARIANTS; EXPRESSION; LEPTIN; TOLERANCE; IL2RA; REG	Human CD4(+)CD25(high)CD127(-)FoxP3(+) regulatory T (Treg) cells suppress immune responses in vitro and in vivo(1). Reduced suppressive function and/or number of peripheral T-reg cells has been previously reported in autoimmune disorders(2,3). T-reg cells represent the most actively replicating compartment within the CD4(+) cells in vivo, but they are hyporesponsive to classical T cell receptor (TCR) stimulation in vitro, a condition that is secondary to their overactive metabolic state(4,5). Here we report that proliferation of T-reg cells after TCR stimulation is impaired in subjects with relapsing-remitting multiple sclerosis (RRMS) because of altered interleukin-2 (IL-2) secretion and IL-2 receptor (IL-2R)-signal transducer and activator of transcription 5 (STAT5) signaling. This is associated with decreased expression of the forkhead box P3 (FoxP3) 44- and 47-kDa splicing forms, overactivation of S6 ribosomal protein (a downstream target of the mammalian target of rapamycin, mTOR) and altered activity of the cyclin-dependent kinase inhibitor p27 (p27(kip1)) and extracellular signal-related kinases 1 and 2 (ERK1/2). The impaired capacity of T-reg cells to proliferate in RRMS correlates with the clinical state of the subject, where increasing disease severity is associated with a decline in T-reg cell expansion. These results suggest a previously unrecognized mechanism that may account for the progressive loss of T-reg cells in autoimmune disease.	[Carbone, Fortunata; De Rosa, Veronica; Procaccini, Claudio] Consiglio Nazl Ric IEOS CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Carbone, Fortunata; Procaccini, Claudio; Matarese, Giuseppe] Univ Salerno, Dipartimento Med & Chirurg, I-84100 Salerno, Italy; [De Rosa, Veronica] Ist Ricovero & Cura Carattere Sci IRCCS Fdn Santa, Unita NeuroImmunol, Rome, Italy; [Carrieri, Pietro B.; Montella, Silvana] Univ Naples Federico II, Dipartimento Neurosci, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dipartimento Sci Med Prevent, Naples, Italy; [Porcellini, Antonio] Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, Naples, Italy; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Matarese, Giuseppe] IRCCS MultiMed, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Salerno; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; IRCCS Multimedica	Matarese, G (corresponding author), Univ Salerno, Dipartimento Med & Chirurg, Baronissi Campus, I-84100 Salerno, Italy.	gmatarese@unisa.it	Carbone, Fortunata/K-3176-2016; Porcellini, Antonio/AAC-6097-2019; /AAG-9576-2020; Procaccini, Claudio/AAB-3696-2019; Matarese, Giuseppe/AAO-4077-2021; Porcellini, Antonio/E-1900-2011	Carbone, Fortunata/0000-0003-4299-6515; /0000-0002-8839-0933; Matarese, Giuseppe/0000-0001-9429-0616; Porcellini, Antonio/0000-0001-6882-9518; Bruzzese, Dario/0000-0001-9911-4646; PROCACCINI, CLAUDIO/0000-0002-2184-0442	Fondazione Italiana Sclerosi Multipla (FISM) [2012/R/11]; European Union IDEAS Programme European Research Council Starting Grant [310496]; Ministero della Salute [GR-2010-2315414]; Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBFR12I3UB_004]; US National Institutes of Health [AI95921]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095921] Funding Source: NIH RePORTER	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); European Union IDEAS Programme European Research Council Starting Grant; Ministero della Salute(Ministry of Health, Italy); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from Fondazione Italiana Sclerosi Multipla (FISM) 2012/R/11, the European Union IDEAS Programme European Research Council Starting Grant "menTORingTregs" 310496, the Ministero della Salute Grant GR-2010-2315414 and the Fondo per gli Investimenti della Ricerca di Base (FIRB) grant RBFR12I3UB_004; A.L.C. is supported by the US National Institutes of Health grant AI95921. The authors thank S. De Simone and M. Galgani from the MoFlo Cell Sorting Facility and C. La Rocca for assistance in the T<INF>reg</INF> cell isolations. This work is dedicated to the memory of E. Papa and S. Zappacosta.	Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Batocchi AP, 2003, J NEUROIMMUNOL, V139, P150, DOI 10.1016/S0165-5728(03)00154-1; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Cavanillas ML, 2010, EUR J HUM GENET, V18, P794, DOI 10.1038/ejhg.2010.15; Cheng GY, 2013, J IMMUNOL, V190, P1567, DOI 10.4049/jimmunol.1201218; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Guo WG, 2009, BIOMETRIKA, V96, P1012, DOI 10.1093/biomet/asp048; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; James MJ, 2003, BLOOD, V102, P2173, DOI 10.1182/blood-2003-02-0637; Kaur G, 2010, MOL IMMUNOL, V48, P321, DOI 10.1016/j.molimm.2010.07.008; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Lechler R, 2001, IMMUNOLOGY, V103, P262, DOI 10.1046/j.1365-2567.2001.01250.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lord JD, 2012, DIGEST DIS SCI, V57, P2846, DOI 10.1007/s10620-012-2292-3; Mailer RKW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006104; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Murdoch DJ, 1996, AM STAT, V50, P178, DOI 10.2307/2684435; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Procaccini C, 2012, TRENDS IMMUNOL, V33, P1, DOI 10.1016/j.it.2011.09.002; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Suzuki K, 2011, INT J IMMUNOPATH PH, V24, P7, DOI 10.1177/039463201102400102; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941	35	155	156	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					69	+		10.1038/nm.3411	http://dx.doi.org/10.1038/nm.3411			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317118				2022-12-25	WOS:000329349400021
J	Kreso, A; van Galen, P; Pedley, NM; Lima-Fernandes, E; Frelin, C; Davis, T; Cao, LX; Baiazitov, R; Du, W; Sydorenko, N; Moon, YC; Gibson, L; Wang, YD; Leung, C; Iscove, NN; Arrowsmith, CH; Szentgyorgyi, E; Gallinger, S; Dick, JE; O'Brien, CA				Kreso, Antonija; van Galen, Peter; Pedley, Nicholas M.; Lima-Fernandes, Evelyne; Frelin, Catherine; Davis, Thomas; Cao, Liangxian; Baiazitov, Ramil; Du, Wu; Sydorenko, Nadiya; Moon, Young-Choon; Gibson, Lianne; Wang, Yadong; Leung, Cherry; Iscove, Norman N.; Arrowsmith, Cheryl H.; Szentgyorgyi, Eva; Gallinger, Steven; Dick, John E.; O'Brien, Catherine A.			Self-renewal as a therapeutic target in human colorectal cancer	NATURE MEDICINE			English	Article							STEM-CELLS; INITIATING CELLS; BMI1; CHEMOTHERAPY; IDENTIFICATION; MAINTENANCE; POPULATION; PROTEINS; CAPACITY	Tumor recurrence following treatment remains a major clinical challenge. Evidence from xenograft models and human trials indicates selective enrichment of cancer-initiating cells (CICs) in tumors that survive therapy. Together with recent reports showing that CIC gene signatures influence patient survival, these studies predict that targeting self-renewal, the key 'stemness' property unique to CICs, may represent a new paradigm in cancer therapy. Here we demonstrate that tumor formation and, more specifically, human colorectal CIC function are dependent on the canonical self-renewal regulator BMI-1. Downregulation of BMI-1 inhibits the ability of colorectal CICs to self-renew, resulting in the abrogation of their tumorigenic potential. Treatment of primary colorectal cancer xenografts with a small-molecule BMI-1 inhibitor resulted in colorectal CIC loss with long-term and irreversible impairment of tumor growth. Targeting the BMI-1-related self-renewal machinery provides the basis for a new therapeutic approach in the treatment of colorectal cancer.	[Kreso, Antonija; van Galen, Peter; Pedley, Nicholas M.; Frelin, Catherine; Gibson, Lianne; Wang, Yadong; Leung, Cherry; Iscove, Norman N.; Arrowsmith, Cheryl H.; Dick, John E.; O'Brien, Catherine A.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kreso, Antonija; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Pedley, Nicholas M.; Gibson, Lianne; Wang, Yadong; Leung, Cherry; O'Brien, Catherine A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lima-Fernandes, Evelyne; Arrowsmith, Cheryl H.] Struct Genom Consortium, Toronto, ON, Canada; [Frelin, Catherine; Iscove, Norman N.; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Davis, Thomas; Cao, Liangxian; Baiazitov, Ramil; Du, Wu; Sydorenko, Nadiya; Moon, Young-Choon] PTC Therapeut, South Plainfield, NJ USA; [Iscove, Norman N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Szentgyorgyi, Eva] Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Gallinger, Steven; O'Brien, Catherine A.] Toronto Gen Hosp, Dept Surg, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	jdick@uhnres.utoronto.ca	Gallinger, Steven/E-4575-2013	Dick, John/0000-0002-9527-8317; Lima Fernandes, Evelyne/0000-0002-3628-9745; O'Brien, Catherine/0000-0003-0682-3879; Arrowsmith, Cheryl/0000-0002-4971-3250; van Galen, Peter/0000-0002-0735-1570	Wellcome Trust; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research; Canada Research Chair; Princess Margaret Hospital Foundation; Fonds National de la Recherche, Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND) [PDR 2012-2 4735314]; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Wellcome Trust(Wellcome TrustEuropean Commission); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Princess Margaret Hospital Foundation; Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank R. Lopez and P. Lo from the Animal Research Centre, University Health Network and A. Khandani, P. Penttila, and S. Zhao from the Sickkids Flow Cytometry facility for their skillful assistance. We are grateful to all members of the Dick lab, especially M. Anders, E. Laurenti, N. Mbong, S. Doulatov, M. Milyavsky and F. Notta, as well as C. Gedye and J. Wang for their advice and critical comments. We thank E. Lechman (University Health Network, Toronto), J. Moffat (University of Toronto) and T. Chiba (Chiba University) for lentiviral vectors expressing shRNAs to BMI1. We also thank members from the Department of Pathology (Toronto General Hospital), including F. Meng, M. Sukhram, V. Son, H. Begley and P. Shaw, for providing colon cancer samples. This work was supported by funds to PTC Therapeutics from the Wellcome Trust and to J.E.D. from Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research and a Summit Award with funds from the province of Ontario, the Canadian Institutes for Health Research, a Canada Research Chair, the Princess Margaret Hospital Foundation and funds to E.L.-F. by Fonds National de la Recherche, Luxembourg and the Marie Curie Actions of the European Commission (FP7-COFUND, PDR 2012-2 4735314). This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Du JJ, 2010, MED ONCOL, V27, P1273, DOI 10.1007/s12032-009-9373-y; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kreso A., 2008, CURR PROTOC STEM CEL, V7; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kvinlaug BT, 2007, EXPERT OPIN THER TAR, V11, P915, DOI 10.1517/14728222.11.7.915; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005	42	353	373	2	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					29	+		10.1038/nm.3418	http://dx.doi.org/10.1038/nm.3418			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24292392				2022-12-25	WOS:000329349400016
J	Behjati, S; Tarpey, PS; Presneau, N; Scheipl, S; Pillay, N; Van Loo, P; Wedge, DC; Cooke, SL; Gundem, G; Davies, H; Nik-Zainal, S; Martin, S; McLaren, S; Goodie, V; Robinson, B; Butler, A; Teague, JW; Halai, D; Khatri, B; Myklebost, O; Baumhoer, D; Jundt, G; Hamoudi, R; Tirabosco, R; Amary, MF; Futreal, PA; Stratton, MR; Campbell, PJ; Flanagan, AM				Behjati, Sam; Tarpey, Patrick S.; Presneau, Nadege; Scheipl, Susanne; Pillay, Nischalan; Van Loo, Peter; Wedge, David C.; Cooke, Susanna L.; Gundem, Gunes; Davies, Helen; Nik-Zainal, Serena; Martin, Sancha; McLaren, Stuart; Goodie, Victoria; Robinson, Ben; Butler, Adam; Teague, Jon W.; Halai, Dina; Khatri, Bhavisha; Myklebost, Ola; Baumhoer, Daniel; Jundt, Gernot; Hamoudi, Rifat; Tirabosco, Roberto; Amary, M. Fernanda; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.; Flanagan, Adrienne M.			Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone	NATURE GENETICS			English	Article							PEDIATRIC GLIOBLASTOMA; HISTONE H3.3; HUMAN REPLACEMENT; K27M MUTATION; EXPRESSION; BREAST; GENES; CANCERS; GLIOMAS	It is recognized that some mutated cancer genes contribute to the development of many cancer types, whereas others are cancer type specific. For genes that are mutated in multiple cancer classes, mutations are usually similar in the different affected cancer types. Here, however, we report exquisite tumor type specificity for different histone H3.3 driver alterations. In 73 of 77 cases of chondroblastoma (95%), we found p.Lys36Met alterations predominantly encoded in H3F3B, which is one of two genes for histone H3.3. In contrast, in 92% (49/53) of giant cell tumors of bone, we found histone H3.3 alterations exclusively in H3F3A, leading to p.Gly34Trp or, in one case, p.Gly34Leu alterations. The mutations were restricted to the stromal cell population and were not detected in osteoclasts or their precursors. In the context of previously reported H3F3A mutations encoding p.Lys27Met and p.Gly34Arg or p.Gly34Val alterations in childhood brain tumors, a remarkable picture of tumor type specificity for histone H3.3 driver alterations emerges, indicating that histone H3.3 residues, mutations and genes have distinct functions.	[Behjati, Sam; Tarpey, Patrick S.; Van Loo, Peter; Wedge, David C.; Cooke, Susanna L.; Gundem, Gunes; Davies, Helen; Nik-Zainal, Serena; Martin, Sancha; McLaren, Stuart; Goodie, Victoria; Robinson, Ben; Butler, Adam; Teague, Jon W.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge, England; [Presneau, Nadege; Scheipl, Susanne; Pillay, Nischalan; Hamoudi, Rifat; Flanagan, Adrienne M.] Univ Coll London Canc Inst, London, England; [Presneau, Nadege; Hamoudi, Rifat; Flanagan, Adrienne M.] Sarah Cannon Univ Coll London Adv Diagnost Mol Pr, London, England; [Scheipl, Susanne] Med Univ, Univ Klin Orthopadie & Orthopad Chirurg, Graz, Austria; [Pillay, Nischalan; Halai, Dina; Khatri, Bhavisha; Tirabosco, Roberto; Amary, M. Fernanda; Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp Natl Hlth Serv NHS Trus, Stanmore, Middx, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Louvain, Belgium; [Myklebost, Ola] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Tumour Biol, Oslo, Norway; [Baumhoer, Daniel; Jundt, Gernot] Univ Basel Hosp, Inst Pathol, Bone Tumour Reference Ctr, CH-4031 Basel, Switzerland; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of London; University College London; University of London; University College London; Medical University of Graz; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Oslo; University of Basel; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Flanagan, AM (corresponding author), Univ Coll London Canc Inst, London, England.	a.flanagan@ucl.ac.uk	Myklebost, Ola/E-9335-2010; Nik-Zainal, Serena/ABD-4437-2020; Wedge, David/AAC-4977-2021; Amary, Fernanda/AAI-7339-2020	Myklebost, Ola/0000-0002-2866-3223; Hamoudi, Rifat/0000-0002-1402-0868; Martin, Sancha/0000-0001-6213-5259; Pillay, Nischalan/0000-0003-0579-4105; Behjati, Sam/0000-0002-6600-7665; Presneau, Nadege/0000-0002-2107-6691; Van Loo, Peter/0000-0003-0292-1949; Wedge, David/0000-0002-7572-3196; Flanagan, Adrienne/0000-0002-2832-1303	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Skeletal Cancer Action Trust (SCAT), UK; Rosetrees Trust UK; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Centre; Norwegian Research Council [218241/H10]; Research Foundation-Flanders (FWO); Wellcome Trust; Rosetrees Trust [M23-F1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Skeletal Cancer Action Trust (SCAT), UK; Rosetrees Trust UK(Rosetrees Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Centre; Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Foundation-Flanders (FWO)(FWO); Wellcome Trust(Wellcome TrustEuropean Commission); Rosetrees Trust(Rosetrees Trust)	We are grateful to the patients for participating in the research and to the clinicians and support staff involved in their care. This work was supported by funding from the Wellcome Trust (grant 077012/Z/05/Z), the Skeletal Cancer Action Trust (SCAT), UK, and the Rosetrees Trust UK. Material was obtained from the Royal National Orthopaedic Hospital Musculoskeletal Research Programme and Biobank, all of which was coordinated by D. Brooking and R. Grinnell, Biobank staff at the Royal National Orthopaedic Hospital. Support was provided to A. M. F. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Centre. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant WT088340MA). O.M. is funded by the Norwegian Research Council (grant 218241/H10).; P.V.L. is a postdoctoral researcher of the Research Foundation-Flanders (FWO). S. B. is funded through the Wellcome Trust PhD Programme for Clinicians.	ALBIG W, 1995, GENOMICS, V30, P264, DOI 10.1006/geno.1995.9878; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fletcher C.D.M., 2013, PATHOLOGY GENETICS T, P427; Frank D, 2003, GENE, V312, P135, DOI 10.1016/S0378-1119(03)00609-7; Gessi M, 2013, J NEURO-ONCOL, V112, P67, DOI 10.1007/s11060-012-1040-z; Gielen GH, 2013, AM J CLIN PATHOL, V139, P345, DOI 10.1309/AJCPABOHBC33FVMO; HORTON MA, 1985, CANCER RES, V45, P5663; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; Lasky T, 1996, ENVIRON HEALTH PERSP, V104, P1324, DOI 10.2307/3432969; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LopezFernandez LA, 1997, INT J DEV BIOL, V41, P699; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Taylor RM, 2012, LAB INVEST, V92, P600, DOI 10.1038/labinvest.2012.5; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wulling M, 2001, J CANCER RES CLIN, V127, P467, DOI 10.1007/s004320100234; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	27	461	472	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1479	U105		10.1038/ng.2814	http://dx.doi.org/10.1038/ng.2814			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24162739	Green Accepted			2022-12-25	WOS:000327715800015
J	Park, SH; Veerapu, NS; Shin, EC; Biancotto, A; McCoy, JP; Capone, S; Folgori, A; Rehermann, B				Park, Su-Hyung; Veerapu, Naga Suresh; Shin, Eui-Cheol; Biancotto, Angelique; McCoy, J. Philip; Capone, Stefania; Folgori, Antonella; Rehermann, Barbara			Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection	NATURE MEDICINE			English	Article							INJECTION-DRUG USERS; IMMUNE-RESPONSES; REGULATORY CELLS; PERSISTENCE; GENERATION; PROTECTION; CLEARANCE; INDUCTION; EFFECTOR; KINETICS	Hepatitis C virus (HCV) is endemic in many countries due to its high propensity for establishing persistence(1). The presence of HCV-specific T cells in subjects repeatedly exposed to HCV who test negative for HCV RNA and antibodies and who do not have any history of HCV infection has been interpreted as T cell-mediated protection(2-5). Here, we show in nonhuman primates that repeated exposure to human plasma with trace amounts of HCV induced HCV-specific T cells without seroconversion and systemic viremia but did not protect upon subsequent HCV challenge. Rather, HCV-specific recall and de novo T cell responses, as well as intrahepatic T cell recruitment and interferon-gamma (IFN-gamma) production, were suppressed upon HCV challenge, concomitant with quantitative and qualitative changes in regulatory T cells (T-reg cells) that occurred after subinfectious HCV exposure and increased after HCV challenge. In vitro T-reg cell depletion restored HCV-specific T cell responses. Thus, T cells primed by trace amounts of HCV do not generate effective recall responses upon subsequent HCV infection. Subinfectious HCV exposure predisposes to T-reg cell expansion, which suppresses effector T cells during subsequent infection. Strategies to reverse this exposure-induced immune suppression should be examined to aid in the development of T cell-based vaccines against HCV and other endemic pathogens.	[Park, Su-Hyung; Veerapu, Naga Suresh; Shin, Eui-Cheol; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Biancotto, Angelique; McCoy, J. Philip] NHLBI, Flow Cytometry Core Facil, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Capone, Stefania; Folgori, Antonella] Okairos, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rehermann, B (corresponding author), NIDDK, Immunol Sect, Liver Dis Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	rehermann@nih.gov	biancotto, angelique/C-4632-2011; mccoy, john philip/ABD-9348-2021; Park, Su-Hyung/N-3514-2014; Shin, Eui-Cheol/C-1690-2011	biancotto, angelique/0000-0003-2271-009X; Park, Su-Hyung/0000-0001-6363-7736; Shin, Eui-Cheol/0000-0002-6308-9503; Rehermann, Barbara/0000-0001-6832-9951; Capone, Stefania/0000-0002-2272-120X	intramural research program of the NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054508] Funding Source: NIH RePORTER	intramural research program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T.J. Rowell, J. Fontenot and the staff at New Iberia Research Center for the care of the chimpanzees and technical support and L. Holz (NIDDK) and W. Kastenmuller (NIAID) for discussion and reading of the manuscript. This work was supported by the intramural research program of the NIDDK.	Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Biancotto A, 2012, CYTOM PART A, V81A, P15, DOI 10.1002/cyto.a.21158; Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; de Herve MGD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1992; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Freeman AJ, 2004, J INFECT DIS, V190, P1093, DOI 10.1086/422605; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Heller T, 2013, J INFECT DIS, V208, P1020, DOI 10.1093/infdis/jit270; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000707; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Mizukoshi E, 2008, J INFECT DIS, V198, P203, DOI 10.1086/589510; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scognamiglio P, 1999, J IMMUNOL, V162, P6681; Shin EC, 2008, J VIROL, V82, P9782, DOI 10.1128/JVI.00475-08; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Surls J, 2010, VACCINE, V28, P7319, DOI 10.1016/j.vaccine.2010.08.074; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; Veerapu NS, 2011, GASTROENTEROLOGY, V140, P676, DOI 10.1053/j.gastro.2010.10.048; Zeremski M, 2009, J VIRAL HEPATITIS, V16, P10, DOI 10.1111/j.1365-2893.2008.01016.x	40	36	42	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1638	1642		10.1038/nm.3408	http://dx.doi.org/10.1038/nm.3408			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24270546	Green Accepted			2022-12-25	WOS:000328181400033
J	Thrane, VR; Thrane, AS; Wang, FS; Cotrina, ML; Smith, NA; Chen, M; Xu, QW; Kang, N; Fujita, T; Nagelhus, EA; Nedergaard, M				Thrane, Vinita Rangroo; Thrane, Alexander S.; Wang, Fushun; Cotrina, Maria L.; Smith, Nathan A.; Chen, Michael; Xu, Qiwu; Kang, Ning; Fujita, Takumi; Nagelhus, Erlend A.; Nedergaard, Maiken			Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering	NATURE MEDICINE			English	Article							CAT MOTOR CORTEX; NA-K-2CL COTRANSPORTER; HYPERAMMONEMIA; BRAIN; MICE; HOMEOSTASIS; REVEALS; SODIUM; CELLS; NKCC1	Ammonia is a ubiquitous waste product of protein metabolism that can accumulate in numerous metabolic disorders, causing neurological dysfunction ranging from cognitive impairment to tremor, ataxia, seizures, coma and death(1). The brain is especially vulnerable to ammonia as it readily crosses the blood-brain barrier in its gaseous form, NH3, and rapidly saturates its principal removal pathway located in astrocytes(2). Thus, we wanted to determine how astrocytes contribute to the initial deterioration of neurological functions characteristic of hyperammonemia in vivo. Using a combination of two-photon imaging and electrophysiology in awake head-restrained mice, we show that ammonia rapidly compromises astrocyte potassium buffering, increasing extracellular potassium concentration and overactivating the Na+-K+-2Cl(-) cotransporter isoform 1 (NKCC1) in neurons. The consequent depolarization of the neuronal GABA reversal potential (E-GABA) selectively impairs cortical inhibitory networks. Genetic deletion of NKCC1 or inhibition of it with the clinically used diuretic bumetanide potently suppresses ammonia-induced neurological dysfunction. We did not observe astrocyte swelling or brain edema in the acute phase, calling into question current concepts regarding the neurotoxic effects of ammonia(3.4). Instead, our findings identify failure of potassium buffering in astrocytes as a crucial mechanism in ammonia neurotoxicity and demonstrate the therapeutic potential of blocking this pathway by inhibiting NKCC1.	[Thrane, Vinita Rangroo; Thrane, Alexander S.; Wang, Fushun; Cotrina, Maria L.; Smith, Nathan A.; Chen, Michael; Xu, Qiwu; Kang, Ning; Fujita, Takumi; Nagelhus, Erlend A.; Nedergaard, Maiken] Univ Rochester, Ctr Translat Neuromed, Div Glial Dis & Therapeut, Rochester, NY 14627 USA; [Thrane, Vinita Rangroo; Thrane, Alexander S.; Nagelhus, Erlend A.] Univ Oslo, Inst Basic Med Sci, Letten Ctr, Oslo, Norway; [Thrane, Vinita Rangroo; Thrane, Alexander S.] Univ Oslo, Ctr Mol Med Norway, Oslo, Norway; [Thrane, Vinita Rangroo; Thrane, Alexander S.] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Smith, Nathan A.] Univ Utah, Inst Brain, Lab Glial Neuronal Interact Epilepsy, Salt Lake City, UT USA; [Nagelhus, Erlend A.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway	University of Rochester; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; Utah System of Higher Education; University of Utah; University of Oslo	Thrane, AS (corresponding author), Univ Rochester, Ctr Translat Neuromed, Div Glial Dis & Therapeut, Rochester, NY 14627 USA.	alexander.thrane@gmail.com	Smith, Nathan Anthony/AAF-8573-2020; Thrane, Alexander S/G-4124-2011	Smith, Nathan Anthony/0000-0002-9254-5360; Thrane, Alexander S/0000-0001-5646-1111	US National Institutes of Health [NS078304, NS078167, F31NS073390]; Research Council of Norway (NevroNor FRIMEDBIO grants); European Commission [FP7-ICT-9-601055]; Molecular Life Science program at the University of Oslo; Letten Foundation; Fulbright Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078167, F31NS073390, R01NS056188, R01NS075177, R01NS078304, P01NS050315] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway (NevroNor FRIMEDBIO grants)(Research Council of Norway); European Commission(European CommissionEuropean Commission Joint Research Centre); Molecular Life Science program at the University of Oslo; Letten Foundation; Fulbright Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.J. Cooper for discussion of the study, S. Kennedy for help with <SUP>1</SUP>H-NMR experiments, L.K. Bekar for help with electrophysiology, J. Chang for designing MatLab software, D. Wang for advice regarding electroencephalogram analysis, J.M. Wilson (University of Pennsylvania) for providing the Otc<SUP>spf-ash</SUP> mice, J.D. Rothstein (Johns Hopkins University) for providing Glt1-eGFP BAC transgenic mice and C. Nicholson and S. Hrabetova for advice on fabrication and use of ion-sensitive electrodes. This work was supported by the US National Institutes of Health (grants NS078304 and NS078167 to M.N. and F31NS073390 to N.A.S.), Research Council of Norway (NevroNor FRIMEDBIO grants to E.A.N.), European Commission FP7-ICT-9-601055 to E.A.N., the Molecular Life Science program at the University of Oslo, the Letten Foundation and the Fulbright Foundation.	BENJAMIN AM, 1978, J NEUROCHEM, V30, P131, DOI 10.1111/j.1471-4159.1978.tb07044.x; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535; Cagnon L, 2007, BRAIN RES REV, V56, P183, DOI 10.1016/j.brainresrev.2007.06.026; Cooper AJL, 2011, NEUROCHEM INT, V59, P456, DOI 10.1016/j.neuint.2010.11.011; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; JAVAHERI S, 1993, J NEUROCHEM, V61, P1525, DOI 10.1111/j.1471-4159.1993.tb13648.x; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Lichter-Konecki U, 2008, GLIA, V56, P365, DOI 10.1002/glia.20624; LUX HD, 1971, SCIENCE, V173, P555, DOI 10.1126/science.173.3996.555; Marcaggi P, 2004, EUR J NEUROSCI, V19, P966, DOI 10.1111/j.0953-816X.2004.03165.x; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; RAABE W, 1975, J NEUROPHYSIOL, V38, P347, DOI 10.1152/jn.1975.38.2.347; RAABE WA, 1981, BRAIN RES, V210, P311, DOI 10.1016/0006-8993(81)90904-5; RATNAKUMARI L, 1992, BIOCHEM BIOPH RES CO, V184, P746, DOI 10.1016/0006-291X(92)90653-3; RATNAKUMARI L, 1995, NEUROSCI LETT, V197, P89, DOI 10.1016/0304-3940(95)11906-D; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Stephan J, 2012, GLIA, V60, P965, DOI 10.1002/glia.22328; SZERB JC, 1992, PROG NEUROBIOL, V39, P135, DOI 10.1016/0301-0082(92)90008-3; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Thrane VR, 2012, NEUROSCIENCE, V220, P247, DOI 10.1016/j.neuroscience.2012.06.022; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; WANIEWSKI RA, 1992, J NEUROCHEM, V58, P167, DOI 10.1111/j.1471-4159.1992.tb09292.x; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P1443, DOI 10.1152/jn.2000.83.3.1443; Yamamoto Y, 2013, EPILEPSIA, V54, P983, DOI 10.1111/epi.12125; Ye XH, 1997, PEDIATR RES, V41, P527, DOI 10.1203/00006450-199704000-00012	39	162	168	4	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1643	1648		10.1038/nm.3400	http://dx.doi.org/10.1038/nm.3400			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24240184	Green Accepted			2022-12-25	WOS:000328181400034
J	Barmada, SJ; Serio, A; Arjun, A; Bilican, B; Daub, A; Ando, DM; Tsvetkov, A; Pleiss, M; Li, XL; Peisach, D; Shaw, C; Chandran, S; Finkbeiner, S				Barmada, Sami J.; Serio, Andrea; Arjun, Arpana; Bilican, Bilada; Daub, Aaron; Ando, D. Michael; Tsvetkov, Andrey; Pleiss, Michael; Li, Xingli; Peisach, Daniel; Shaw, Christopher; Chandran, Siddharthan; Finkbeiner, Steven			Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models	NATURE CHEMICAL BIOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INCLUSION-BODY FORMATION; SPINAL MOTOR-NEURONS; MOUSE MODEL; MUTANT HUNTINGTIN; TDP-43; DISEASE; DEATH; PROTEINOPATHIES; DEGRADATION	Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have distinct clinical features but a common pathology-cytoplasmic inclusions rich in transactive response element DNA-binding protein of 43 kDa (TDP43). Rare TDP43 mutations cause ALS or FTD, but abnormal TDP43 levels and localization may cause disease even if TDP43 lacks a mutation. Here we show that individual neurons vary in their ability to clear TDP43 and are exquisitely sensitive to TDP43 levels. To measure TDP43 clearance, we developed and validated a single-cell optical method that overcomes the confounding effects of aggregation and toxicity and discovered that pathogenic mutations shorten TDP43 half-life. New compounds that stimulate autophagy improved TDP43 clearance and localization and enhanced survival in primary murine neurons and in human stem cell-derived neurons and astrocytes harboring mutant TDP43. These findings indicate that the levels and localization of TDP43 critically determine neurotoxicity and show that autophagy induction mitigates neurodegeneration by acting directly on TDP43 clearance.	[Barmada, Sami J.; Arjun, Arpana; Daub, Aaron; Ando, D. Michael; Tsvetkov, Andrey; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; [Barmada, Sami J.; Finkbeiner, Steven] Univ Calif San Francisco, Med Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Barmada, Sami J.; Li, Xingli; Peisach, Daniel] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Serio, Andrea; Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Serio, Andrea; Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, Ctr Regenerat Med, MRC, Edinburgh, Midlothian, Scotland; [Serio, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Serio, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Serio, Andrea] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England; [Ando, D. Michael; Finkbeiner, Steven] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Tsvetkov, Andrey] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Pleiss, Michael; Finkbeiner, Steven] Gladstone Inst, Keck Program Brain Cell Engn, San Francisco, CA USA; [Shaw, Christopher] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA USA; [Finkbeiner, Steven] Hellman Family Fdn Alzheimers Dis Res Program, San Francisco, CA USA; [Finkbeiner, Steven] Roddenberry Stem Cell Program, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Edinburgh; University of Edinburgh; Imperial College London; Imperial College London; Imperial College London; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of London; King's College London; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.	sfinkbeiner@gladstone.ucsf.edu	Serio, Andrea/AAJ-9478-2020	Serio, Andrea/0000-0002-7271-1878; Ando, Michael/0000-0001-9022-8444; Barmada, Sami/0000-0002-9604-968X; Chandran, Siddharthan/0000-0001-6827-1593; Shaw, Christopher/0000-0003-0251-0146	National Institutes of Neurological Disorders and Stroke [K08 NS072233, 3R01 NS039074, R01 NS083390, R43 NS081844, U24 NS078370]; ALS Association; Robert Packard Center for ALS Research and the William H. Adams Foundation; Target ALS; Roddenberry Stem Cell Program; Taube-Koret Center for Neurodegenerative Disease; Hellman Family Foundation Alzheimer's Disease Research Program; Protein Folding Diseases Initiative at the University of Michigan; California Institute of Regenerative Medicine [TR4-06693, U01 MH1050135]; US National Institutes of Health Extramural Research Facilities Improvement Program Project [C06 RR018928]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105035, F30MH010501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083390, K08NS072233, U24NS078370, R43NS081844, R01NS039074] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; Robert Packard Center for ALS Research and the William H. Adams Foundation; Target ALS; Roddenberry Stem Cell Program; Taube-Koret Center for Neurodegenerative Disease; Hellman Family Foundation Alzheimer's Disease Research Program; Protein Folding Diseases Initiative at the University of Michigan; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health Extramural Research Facilities Improvement Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank B. Miller, B. Seeley, C. Lomen-Hoerth and the members of the Finkbeiner lab for their generous support and advice. H. Zahed and J. Margulis deserve special acknowledgment for their assistance. We thank G. Howard for editorial assistance and K. Nelson for administrative assistance. We also thank G. Yu and J. Herz (University of Texas, Southwestern) for anti-TDP43 antibodies. This work was supported by National Institutes of Neurological Disorders and Stroke grants K08 NS072233 (to S. J. B.), 3R01 NS039074, R01 NS083390, R43 NS081844 and U24 NS078370 (to S. F.); the ALS Association (S. F.); the Robert Packard Center for ALS Research and the William H. Adams Foundation (S. F.); and Target ALS (S. F.). Additional support was provided by the Roddenberry Stem Cell Program (to S. F.), the Taube-Koret Center for Neurodegenerative Disease (S. F.), the Hellman Family Foundation Alzheimer's Disease Research Program (S. F.), the Protein Folding Diseases Initiative at the University of Michigan (S. J. B.) and the California Institute of Regenerative Medicine TR4-06693 (S. F.) and U01 MH1050135 (S. F.). The animal care facility was partly supported by an US National Institutes of Health Extramural Research Facilities Improvement Program Project (C06 RR018928).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Davidson YS, 2011, ACTA NEUROPATHOL, V122, P703, DOI 10.1007/s00401-011-0879-y; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Finkbeiner S, 2010, NAT MED, V16, P1227, DOI 10.1038/nm.2222; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Jacquier A, 2009, HUM MOL GENET, V18, P2127, DOI 10.1093/hmg/ddp136; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Krauss S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2514; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roberson ED, 2012, ANN NEUROL, V72, P837, DOI 10.1002/ana.23722; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Stavrovskaya IG, 2004, J EXP MED, V200, P211, DOI 10.1084/jem.20032053; Szczudlik A, 1998, Neurol Neurochir Pol, V32, P821; Tsao W, 2012, BRAIN RES, V1462, P26, DOI 10.1016/j.brainres.2012.04.031; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/NCHEMBIO.1308, 10.1038/nchembio.1308]; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069864; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541	50	289	289	15	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					677	U119		10.1038/nchembio.1563	http://dx.doi.org/10.1038/nchembio.1563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24974230	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000339380100015
J	Ichida, JK; Julia, TCW; Williams, LA; Carter, AC; Shi, YX; Moura, MT; Ziller, M; Singh, S; Amabile, G; Bock, C; Umezawa, A; Rubin, LL; Bradner, JE; Akutsu, H; Meissner, A; Eggan, K				Ichida, Justin K.; Julia, T. C. W.; Williams, Luis A.; Carter, Ava C.; Shi, Yingxiao; Moura, Marcelo T.; Ziller, Michael; Singh, Sean; Amabile, Giovanni; Bock, Christoph; Umezawa, Akihiro; Rubin, Lee L.; Bradner, James E.; Akutsu, Hidenori; Meissner, Alexander; Eggan, Kevin			Notch inhibition allows oncogene-independent generation of iPS cells	NATURE CHEMICAL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; MOUSE; SKIN; DIFFERENTIATION; SUPPRESSOR; MUTATIONS; INDUCTION; EFFICIENT; PATHWAY	The reprogramming of somatic cells to pluripotency using defined transcription factors holds great promise for biomedicine. However, human reprogramming remains inefficient and relies either on the use of the potentially dangerous oncogenes KLF4 and CMYC or the genetic inhibition of the tumor suppressor gene p53. We hypothesized that inhibition of signal transduction pathways that promote differentiation of the target somatic cells during development might relieve the requirement for non-core pluripotency factors during induced pluripotent stem cell (iPSC) reprogramming. Here, we show that inhibition of Notch greatly improves the efficiency of iPSC generation from mouse and human keratinocytes by suppressing p21 in a p53-independent manner and thereby enriching for undifferentiated cells capable of long-term self-renewal. Pharmacological inhibition of Notch enabled routine production of human iPSCs without KLF4 and CMYC while leaving p53 activity intact. Thus, restricting the development of somatic cells by altering intercellular communication enables the production of safer human iPSCs.	[Ichida, Justin K.; Julia, T. C. W.; Williams, Luis A.; Carter, Ava C.; Moura, Marcelo T.; Ziller, Michael; Singh, Sean; Bock, Christoph; Rubin, Lee L.; Meissner, Alexander; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ichida, Justin K.; Julia, T. C. W.; Williams, Luis A.; Carter, Ava C.; Moura, Marcelo T.; Singh, Sean; Eggan, Kevin] Stanley Ctr Psychiat Res, Howard Hughes Med Inst, Cambridge, MA USA; [Julia, T. C. W.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ziller, Michael; Bock, Christoph; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA USA; [Amabile, Giovanni] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA; [Umezawa, Akihiro; Akutsu, Hidenori] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ichida, Justin K.; Shi, Yingxiao] Univ So Calif, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; National Center for Child Health & Development - Japan; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Southern California	Akutsu, H (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan.	akutsu-h@ncchd.go.go.jp; alexander_meissner@harvard.edu; keggan@scrb.harvard.edu	Moura, M. T./G-8561-2014; Bock, Christoph/AAE-7618-2019; Eggan, Kevin/P-7119-2018; Moura, Marcelo T./AAF-3132-2019	Moura, M. T./0000-0003-3808-6607; Bock, Christoph/0000-0001-6091-3088; Moura, Marcelo T./0000-0003-3808-6607; Carter, Ava/0000-0002-1892-8742; Rubin, Lee/0000-0002-8658-841X	US National Institutes of Health (NIH) [5R01GM096067]; NIH [5P01GM099117, 1K99NS077435-01A, 4R00NS077435-03]; Howard Hughes Medical Institute; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21390456, 22659304]; JST-CREST; Stan and Fiona Druckenmiller-New York Stem Cell Foundation postdoctoral fellowship; Novartis Institutes for BioMedical Research; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096067, P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS077435, K99NS077435] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Stan and Fiona Druckenmiller-New York Stem Cell Foundation postdoctoral fellowship; Novartis Institutes for BioMedical Research; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank E. Son for assistance with microarray data analysis, S. Sato for assistance with chimera experiments, E. Kiskinis for assistance with nanostring analysis and K. Koszka and M. Yamaki for assistance with teratoma experiments. The authors are grateful for the financial support that made this work possible. K.E. was supported by US National Institutes of Health (NIH) R01 grant 5R01GM096067, NIH P01 grant 5P01GM099117 and the Howard Hughes Medical Institute. A.M. was supported by NIH P01 grant 5P01GM099117. H.A. was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grant-in-aid for Scientific Research (21390456) and Grant-in-Aid for challenging Exploratory Research (22659304) and a grant from JST-CREST. J.K.I. was supported by a Stan and Fiona Druckenmiller-New York Stem Cell Foundation postdoctoral fellowship, NIH K99 grant 1K99NS077435-01A1, NIH R00 grant 4R00NS077435-03 and the Novartis Institutes for BioMedical Research. C.B. was supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brosh R, 2013, CELL DEATH DIFFER, V20, P312, DOI 10.1038/cdd.2012.125; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Federation AJ, 2014, TRENDS CELL BIOL, V24, P179, DOI 10.1016/j.tcb.2013.09.011; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kavian N, 2010, ARTHRITIS RHEUM-US, V62, P3477, DOI 10.1002/art.27626; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lake BB, 2012, STEM CELLS, V30, P888, DOI 10.1002/stem.1054; Lee YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045633; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li YX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3174; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Son MJ, 2013, STEM CELLS, V31, P1121, DOI 10.1002/stem.1368; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang JX, 2012, STEM CELLS, V30, P1405, DOI 10.1002/stem.1121; Ye D, 2012, STEM CELLS, V30, P1645, DOI 10.1002/stem.1149; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	45	46	47	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					632	U171		10.1038/nchembio.1552	http://dx.doi.org/10.1038/nchembio.1552			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24952596	Green Accepted, Green Submitted			2022-12-25	WOS:000339380100009
J	Guenther, CA; Tasic, B; Luo, LQ; Bedell, MA; Kingsley, DM				Guenther, Catherine A.; Tasic, Bosiljka; Luo, Liqun; Bedell, Mary A.; Kingsley, David M.			A molecular basis for classic blond hair color in Europeans	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN PIGMENTATION; GENETIC-DETERMINANTS; FOLLICLE DEVELOPMENT; ALPHA-ENHANCER; HMG DOMAIN; DNA; MICE; EXPRESSION; RECEPTOR	Hair color differences are among the most obvious examples of phenotypic variation in humans. Although genome-wide association studies (GWAS) have implicated multiple loci in human pigment variation, the causative base-pair changes are still largely unknown(1). Here we dissect a regulatory region of the KITLG gene (encoding KIT ligand) that is significantly associated with common blond hair color in northern Europeans2. Functional tests demonstrate that the region contains a regulatory enhancer that drives expression in developing hair follicles. This enhancer contains a common SNP (rs12821256) that alters a binding site for the lymphoid enhancer-binding factor 1 (LEF1) transcription factor, reducing LEF1 responsiveness and enhancer activity in cultured human keratinocytes. Mice carrying ancestral or derived variants of the human KITLG enhancer exhibit significant differences in hair pigmentation, confirming that altered regulation of an essential growth factor contributes to the classic blond hair phenotype found in northern Europeans.	[Guenther, Catherine A.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Guenther, Catherine A.; Tasic, Bosiljka; Luo, Liqun; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Tasic, Bosiljka; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Bedell, Mary A.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Georgia; University of Georgia	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	kingsley@stanford.edu		Luo, Liqun/0000-0001-5467-9264	University of Georgia Research Foundation; US National Institutes of Health [GM65393, R01-NS050835]; Center of Excellence in Genomic Science [5P50HG2568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	University of Georgia Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Genomic Science; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Moon (University of Washington) for the XE237 LEF1 expression plasmid, R. Nusse (Stanford University) for the SuperTOPFlash plasmid, C. Lowe (Stanford University) for help with statistical and 1000 Genomes Project analysis and members of the Kingsley laboratory for useful comments on the manuscript. This work was supported in part by the University of Georgia Research Foundation (M.A.B.) and by US National Institutes of Health grants GM65393 (M.A.B.), R01-NS050835 (L.L.) and a Center of Excellence in Genomic Science award 5P50HG2568 (D.M.K.). L.L. and D.M.K. are investigators of the Howard Hughes Medical Institute.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Bedell MA, 1996, GENETICS, V142, P927; Beechey C.V., 1986, MOUSE NEWS LETT, V74, P92; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cruz-Inigo AE, 2011, DERMATOL CLIN, V29, P79, DOI 10.1016/j.det.2010.08.015; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Homer, 2011, ILIAD HOMER; Jash A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040828; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MORRISONGRAHAM K, 1993, BIOESSAYS, V15, P77, DOI 10.1002/bies.950150202; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; PITMAN J, 2003, BLONDES; Praetorius C, 2013, CELL, V155, P1022, DOI 10.1016/j.cell.2013.10.022; Rajeevan H, 2003, NUCLEIC ACIDS RES, V31, P270, DOI 10.1093/nar/gkg043; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744; Zhang MF, 2013, HUM MOL GENET, V22, P2948, DOI 10.1093/hmg/ddt142; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	43	111	115	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					748	752		10.1038/ng.2991	http://dx.doi.org/10.1038/ng.2991			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24880339	Green Accepted			2022-12-25	WOS:000338093800018
J	Wang, XK; Bledsoe, KL; Graham, RP; Asmann, YW; Viswanatha, DS; Lewis, JE; Lewis, JT; Chou, MM; Yaszemski, MJ; Jen, J; Westendorf, JJ; Oliveira, AM				Wang, Xiaoke; Bledsoe, Krista L.; Graham, Rondell P.; Asmann, Yan W.; Viswanatha, David S.; Lewis, Jean E.; Lewis, Jason T.; Chou, Margaret M.; Yaszemski, Michael J.; Jen, Jin; Westendorf, Jennifer J.; Oliveira, Andre M.			Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma	NATURE GENETICS			English	Article							WAARDENBURG SYNDROME; PAX3 FUNCTIONS; PAIRED DOMAIN; GENE; MUTATION; MOUSE; MELANOMA; TUMOR	Biphenotypic sinonasal sarcoma (SNS) is a newly described tumor of the nasal and paranasal areas. Here we report a recurrent chromosomal translocation in SNS, t(2;4)(q35;q31.1), resulting in a PAX3-MAML3 fusion protein that is a potent transcriptional activator of PAX3 response elements. The SNS phenotype is characterized by aberrant expression of genes involved in neuroectodermal and myogenic differentiation, closely simulating the developmental roles of PAX3.	[Wang, Xiaoke; Graham, Rondell P.; Viswanatha, David S.; Lewis, Jean E.; Lewis, Jason T.; Oliveira, Andre M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Bledsoe, Krista L.] Mayo Grad Sch, Dept Biochem & Mol Biol, Rochester, MN USA; [Asmann, Yan W.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Chou, Margaret M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chou, Margaret M.] Perelman Sch Med, Philadelphia, PA USA; [Yaszemski, Michael J.; Westendorf, Jennifer J.; Oliveira, Andre M.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Jen, Jin] Mayo Clin, Ctr Individualized Med, Med Genome Facil, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Mayo Clinic	Oliveira, AM (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	oliveira.andre@mayo.edu		Graham, Rondell/0000-0002-8686-4867	US National Institutes of Health [T32 CA148073]; Mayo Clinic DLMP [2012/13]; NATIONAL CANCER INSTITUTE [P30CA015083, T32CA148073] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic DLMP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank A. Maran, K.L. Shogren, S.L. Segovis, J.L. Herrick and X. Li for logistical support in the performance of several of these experiments. We also express gratitude to L. Jin, M.R. Erickson-Johnson, B.R. Evers, C.W. Roth, R.N. Wehrs, A.R. Seys and M.L. Lonzo for technical support in the Molecular Anatomic Pathology Laboratory and Cytogenetics Laboratory, to T.J. Flotte and L.A. Gross in the Pathology Resource Core Laboratory, to K.C. Hailing and M.E. Brown for administration support, to T.L. Schmidt for secretarial assistance and to T.A. Bennett for editorial assistance. We also thank C.P. Kolbert and B.W. Eckloff at the Gene Expression Core and the Sequencing Core at the Mayo Medical Genome Facility for providing transcriptome sequencing and gene expression profiling services. This work was supported by Mayo Clinic DLMP 2012/13 Research Grants and by US National Institutes of Health grant T32 CA148073.	Asher JH, 1996, HUM MUTAT, V7, P30, DOI 10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; Chen Z, 2014, ONCOGENE, V33, P3869, DOI 10.1038/onc.2013.348; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gil Z, 2003, CANCER GENET CYTOGEN, V145, P139, DOI 10.1016/S0165-4608(03)00036-0; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lewis JT, 2012, AM J SURG PATHOL, V36, P517, DOI 10.1097/PAS.0b013e3182426886; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Medic S, 2011, BIOCHEM BIOPH RES CO, V411, P832, DOI 10.1016/j.bbrc.2011.07.053; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Nakazaki H, 2008, DEV BIOL, V316, P510, DOI 10.1016/j.ydbio.2008.01.008; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; TASSABEHJI M, 1994, HUM MOL GENET, V3, P1069, DOI 10.1093/hmg/3.7.1069; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Wang QY, 2008, J CELL MOL MED, V12, P2281, DOI 10.1111/j.1582-4934.2008.00427.x; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2	20	87	93	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					666	668		10.1038/ng.2989	http://dx.doi.org/10.1038/ng.2989			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24859338	Green Accepted			2022-12-25	WOS:000338093800005
J	Stowell, SR; Arthur, CM; McBride, R; Berger, O; Razi, N; Heimburg-Molinaro, J; Rodrigues, LC; Gourdine, JP; Noll, AJ; von Gunten, S; Smith, DF; Knirel, YA; Paulson, JC; Cummings, RD				Stowell, Sean R.; Arthur, Connie M.; McBride, Ryan; Berger, Oren; Razi, Nahid; Heimburg-Molinaro, Jamie; Rodrigues, Lilian C.; Gourdine, Jean-Philippe; Noll, Alexander J.; von Gunten, Stephan; Smith, David F.; Knirel, Yuriy A.; Paulson, James C.; Cummings, Richard D.			Microbial glycan microarrays define key features of host-microbial interactions	NATURE CHEMICAL BIOLOGY			English	Article							BURKHOLDERIA-PSEUDOMALLEI; ANTIGEN MICROARRAYS; BACILLUS-ANTHRACIS; O-POLYSACCHARIDE; INNATE; GALECTIN-3; RECOGNITION; TECHNOLOGY; PNEUMONIAE; INFECTION	Genomic approaches continue to provide unprecedented insight into the microbiome, yet host immune interactions with diverse microbiota can be difficult to study. We therefore generated a microbial microarray containing defined antigens isolated from a broad range of microbial flora to examine adaptive and innate immunity. Serological studies with this microarray show that immunoglobulins from multiple mammalian species have unique patterns of reactivity, whereas exposure of animals to distinct microbes induces specific serological recognition. Although adaptive immunity exhibited plasticity toward microbial antigens, immunological tolerance limits reactivity toward self. We discovered that several innate immune galectins show specific recognition of microbes that express self-like antigens, leading to direct killing of a broad range of Gram-negative and Gram-positive microbes. Thus, host protection against microbes seems to represent a balance between adaptive and innate immunity to defend against evolving antigenic determinants while protecting against molecular mimicry.	[Stowell, Sean R.; Arthur, Connie M.; Heimburg-Molinaro, Jamie; Rodrigues, Lilian C.; Gourdine, Jean-Philippe; Noll, Alexander J.; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Stowell, Sean R.; Arthur, Connie M.; Heimburg-Molinaro, Jamie; Rodrigues, Lilian C.; Gourdine, Jean-Philippe; Noll, Alexander J.; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Glyc Ctr, Atlanta, GA 30322 USA; [McBride, Ryan; Berger, Oren; Razi, Nahid; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [McBride, Ryan; Berger, Oren; Razi, Nahid; Paulson, James C.] Scripps Res Inst, Dept & Chem Physiol, La Jolla, CA 92037 USA; [von Gunten, Stephan] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia	Emory University; Emory University; Scripps Research Institute; Scripps Research Institute; University of Bern; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry	Stowell, SR (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	jpaulson@scripps.edu; rdcummi@emory.edu	Knirel, Yuriy A/E-2058-2014; Gourdine, Jean-Philippe/P-4323-2018; McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019; Terra, Lilian Cataldi Rodrigues/GYV-2597-2022	Gourdine, Jean-Philippe/0000-0001-9969-8610; Terra, Lilian Cataldi Rodrigues/0000-0002-2014-2263; von Gunten, Stephan/0000-0002-2753-8738	US National Blood Foundation; NIH; Swiss National Science Foundation [310030_135734]; CSL Behring AG, Bern, Switzerland; CAPES Foundation, Ministry of Education, Brazil [BEX 9320/13-0];  [R01AI050143];  [P01HL107151NIH];  [HL085607];  [P41GM103694];  [R24GM098791];  [U54GM62116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151, T32HL069769, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103694, U54GM062116, R24GM098791] Funding Source: NIH RePORTER	US National Blood Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CSL Behring AG, Bern, Switzerland; CAPES Foundation, Ministry of Education, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Blood Foundation and NIH Loan Repayment Grants to S.R.S.; by R01AI050143 and P01HL107151NIH to J.C.P.; by HL085607, P41GM103694 and R24GM098791 to R.D.C.; and by U54GM62116 to the Consortium for Functional Glycomics. S.V.G. was supported by grants from the Swiss National Science Foundation (no. 310030_135734) and from CSL Behring AG, Bern, Switzerland. L.C.R. was supported by grant no. BEX 9320/13-0 from the CAPES Foundation, Ministry of Education, Brazil. We thank T. Ju, X. Song, Y. Wang and S. Cummings for helpful discussion. We also thank L. Robison and J. Rangarajan for help printing the various versions of the MGM. Consortium for Functional Glycomics array data can be accessed at http://www.functionalglycomics.org/.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arthur CM, 2014, CURR OPIN CHEM BIOL, V18, P55, DOI 10.1016/j.cbpa.2013.12.017; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baader J, 2011, BIOSENS BIOELECTRON, V26, P1839, DOI 10.1016/j.bios.2010.01.021; Blixt O, 2008, GLYCOCONJUGATE J, V25, P27, DOI 10.1007/s10719-007-9045-0; COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; John CM, 2002, CELL MICROBIOL, V4, P649, DOI 10.1046/j.1462-5822.2002.00219.x; Kamena F, 2008, NAT CHEM BIOL, V4, P238, DOI 10.1038/nchembio.75; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; Knirel YA, 2014, GLYCOCONJUGATE J, V31, P7, DOI 10.1007/s10719-013-9497-3; Kocharova NA, 2004, CARBOHYD RES, V339, P415, DOI 10.1016/j.carres.2003.10.023; Kocharova NA, 2004, CARBOHYD RES, V339, P195, DOI 10.1016/j.carres.2003.10.017; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Parthasarathy N, 2008, CARBOHYD RES, V343, P2783, DOI 10.1016/j.carres.2008.05.021; Parthasarathy N, 2006, DIAGN MICR INFEC DIS, V56, P329, DOI 10.1016/j.diagmicrobio.2006.04.018; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; PETERSON PK, 1981, ANNU REV MED, V32, P29, DOI 10.1146/annurev.me.32.020181.000333; Quattroni P, 2012, CELL MICROBIOL, V14, P1657, DOI 10.1111/j.1462-5822.2012.01838.x; Shanahan F, 2011, CURR OPIN GASTROEN, V27, P61, DOI 10.1097/MOG.0b013e328340076f; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; SPRINGER GF, 1959, ANN NY ACAD SCI, V78, P272, DOI 10.1111/j.1749-6632.1959.tb53110.x; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Thirumalapura NR, 2005, J IMMUNOL METHODS, V298, P73, DOI 10.1016/j.jim.2005.01.004; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wang DN, 2007, PROTEOMICS, V7, P180, DOI 10.1002/pmic.200600478; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	42	137	138	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					470	476		10.1038/NCHEMBIO.1525	http://dx.doi.org/10.1038/NCHEMBIO.1525			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24814672	Green Accepted			2022-12-25	WOS:000336238200015
J	Strittmatter, SM				Strittmatter, Stephen M.			Old drugs learn new tricks	NATURE MEDICINE			English	Editorial Material							ESTROGEN; RATES		[Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurobiol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	NCATS NIH HHS [UH3 TR000967] Funding Source: Medline; NIA NIH HHS [R01 AG034924] Funding Source: Medline; NINDS NIH HHS [R01 NS080388] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hilbish KG, 2013, BIRTH DEFECTS RES B, V98, P400, DOI 10.1002/bdrb.21083; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Kulkarni J, 2001, SCHIZOPHR RES, V48, P137, DOI 10.1016/S0920-9964(00)00088-8; LIN TS, 1978, J MED CHEM, V21, P109, DOI 10.1021/jm00199a020; Nair P, 2013, P NATL ACAD SCI USA, V110, P2430, DOI 10.1073/pnas.201300188; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Wang XX, 2009, J NEUROTRAUM, V26, P81, DOI 10.1089/neu.2007.0464; YARCHOAN R, 1987, NEW ENGL J MED, V316, P557, DOI 10.1056/NEJM198702263160925; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	15	119	121	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					590	591		10.1038/nm.3595	http://dx.doi.org/10.1038/nm.3595			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24901567	Green Accepted			2022-12-25	WOS:000337071000018
J	Fan, Y; Potdar, AA; Gong, YQ; Eswarappa, SM; Donnola, S; Lathia, JD; Hambardzumyan, D; Rich, JN; Fox, PL				Fan, Yi; Potdar, Alka A.; Gong, Yanqing; Eswarappa, Sandeepa M.; Donnola, Shannon; Lathia, Justin D.; Hambardzumyan, Dolores; Rich, Jeremy N.; Fox, Paul L.			Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1 alpha accumulation	NATURE CELL BIOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; HER-2/NEU OVEREXPRESSION; HYPOXIA; CANCER; GLIOMA; CELLS; OXYGEN; MICROENVIRONMENT; TEMOZOLOMIDE	The tumour vascular microenvironment supports tumorigenesis not only by supplying oxygen and diffusible nutrients but also by secreting soluble factors that promote tumorigenesis. Here we identify a feedforward mechanism in which endothelial cells (ECs), in response to tumour-derived mediators, release angiocrines driving aberrant vascularization and glioblastoma multiforme (GBM) progression through a hypoxia-independent induction of hypoxia-inducible factor (HIF)-1 alpha. Phosphorylation of profilin-1 (Pfn-1) at Tyr 129 in ECs induces binding to the tumour suppressor protein von Hippel-Lindau (VHL), and prevents VHL-mediated degradation of prolyl-hydroxylated HIF-1 alpha, culminating in HIF-1 alpha accumulation even in normoxia. Elevated HIF-1 alpha induces expression of multiple angiogenic factors, leading to vascular abnormality and tumour progression. In a genetic model of GBM, mice with an EC-specific defect in Pfn-1 phosphorylation exhibit reduced tumour angiogenesis, normalized vasculature and improved survival. Moreover, EC-specific Pfn-1 phosphorylation is associated with tumour aggressiveness in human glioma. These findings suggest that targeting Pfn-1 phosphorylation may offer a selective strategy for therapeutic intervention of malignant solid tumours.	[Fan, Yi; Potdar, Alka A.; Eswarappa, Sandeepa M.; Lathia, Justin D.; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Fan, Yi] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Potdar, Alka A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Gong, Yanqing] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Gong, Yanqing] Univ Penn, Perelman Sch Med, Dept Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Donnola, Shannon; Hambardzumyan, Dolores; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Hambardzumyan, Dolores] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; University of Pennsylvania; Pennsylvania Medicine; Case Western Reserve University; Cleveland Clinic Foundation; University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Eswarappa, Sandeep/AFG-1997-2022; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022		National Institutes of Health [K99HL103792, P01HL029582, P01HL076491, R21HL094841]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to A. Horowitz for helpful suggestions, E. Ritchie for technical assistance, and J. Drazba for image analysis. This work was supported in part by National Institutes of Health grants K99HL103792 (to Y.F.),and P01HL029582, P01HL076491 and R21HL094841 (to P.L.F.).	Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862; Fan Y, 2009, DEV CELL, V16, P661, DOI 10.1016/j.devcel.2009.03.009; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Galban S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035857; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haynik DM, 2007, APPL IMMUNOHISTO M M, V15, P56, DOI 10.1097/01.pai.0000213133.09160.da; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Koka V, 2003, AM J CLIN ONCOL-CANC, V26, P332, DOI 10.1097/00000421-200308000-00004; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Park JH, 2003, CLIN CANCER RES, V9, P433; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Potti A, 2004, CANCER INVEST, V22, P537, DOI 10.1081/CNV-200026523; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; VAUPEL P, 1989, CANCER RES, V49, P6449; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003	55	53	57	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					445	U144		10.1038/ncb2954	http://dx.doi.org/10.1038/ncb2954			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24747440	Green Accepted			2022-12-25	WOS:000335438400009
J	Patro, R; Mount, SM; Kingsford, C				Patro, Rob; Mount, Stephen M.; Kingsford, Carl			Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL EXPRESSION; SEQUENCES	We introduce Sailfish, a computational method for quantifying the abundance of previously annotated RNA isoforms from RNA-seq data. Because Sailfish entirely avoids mapping reads, a time-consuming step in all current methods, it provides quantification estimates much faster than do existing approaches (typically 20 times faster) without loss of accuracy. By facilitating frequent reanalysis of data and reducing the need to optimize parameters, Sailfish exemplifies the potential of lightweight algorithms for efficiently processing sequencing reads.	[Patro, Rob; Kingsford, Carl] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Mount, Stephen M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Mount, Stephen M.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Carnegie Mellon University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Kingsford, C (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	carlk@cs.cmu.edu		Mount, Steve/0000-0003-2748-8205	US National Science Foundation [CCF-1256087, CCF-1053918, EF-0849899]; US National Institutes of Health [R21AI085376, R21HG006913, R01HG007104]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006913, R01HG007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085376] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1319998] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been partially funded by the US National Science Foundation (CCF-1256087, CCF-1053918, and EF-0849899) and US National Institutes of Health (R21AI085376, R21HG006913 and R01HG007104). C. K. received support as an Alfred P. Sloan Research Fellow. We would like to thank A. Roberts for helping to diagnose and resolve an artifact in an earlier version of this manuscript pertaining to the synthetic data generated by the Flux Simulator.	Botelho F.C., 2007, P 10 INT WORKSH ALG, P139; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mortazavi A, NAT METHODS; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Philippe N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r30; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roychowdhury S., 2011, SCI TRANS MED; Sacomoto GAT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S5; Salzman J, 2011, STAT SCI, V26, P62, DOI 10.1214/10-STS343; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varadhan R, 2008, SCAND J STAT, V35, P335, DOI 10.1111/j.1467-9469.2007.00585.x; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	21	353	359	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					462	U174		10.1038/nbt.2862	http://dx.doi.org/10.1038/nbt.2862			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752080	Green Submitted, Green Accepted			2022-12-25	WOS:000336036100021
J	Huang, QL; Whitington, T; Gao, P; Lindberg, JF; Yang, YH; Sun, JL; Vaisanen, MR; Szulkin, R; Annala, M; Yan, J; Egevad, LA; Zhang, K; Lin, RZ; Jolma, A; Nykter, M; Manninen, A; Wiklund, F; Vaarala, MH; Visakorpi, T; Xu, JF; Taipale, J; Wei, GH				Huang, Qilai; Whitington, Thomas; Gao, Ping; Lindberg, Johan F.; Yang, Yuehong; Sun, Jielin; Vaisanen, Marja-Riitta; Szulkin, Robert; Annala, Matti; Yan, Jian; Egevad, Lars A.; Zhang, Kai; Lin, Ruizhu; Jolma, Arttu; Nykter, Matti; Manninen, Aki; Wiklund, Fredrik; Vaarala, Markku H.; Visakorpi, Tapio; Xu, Jianfeng; Taipale, Jussi; Wei, Gong-Hong			A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; G84E MUTATION; RISK; GENE; LOCI; ENHANCERS; REPLICATION; CONSORTIUM; SIGNATURES; LANDSCAPE	Genome-wide association studies have identified thousands of SNPs associated with predisposition to various diseases, including prostate cancer. However, the mechanistic roles of these SNPs remain poorly defined, particularly for noncoding polymorphisms. Here we find that the prostate cancer risk-associated SNP rs339331 at 6q22 lies within a functional HOXB13-binding site. The risk-associated T allele at rs339331 increases binding of HOXB13 to a transcriptional enhancer, conferring allele-specific upregulation of the rs339331-associated gene RFX6. Suppression of RFX6 diminishes prostate cancer cell proliferation, migration and invasion. Clinical data indicate that RFX6 upregulation in human prostate cancers correlates with tumor progression, metastasis and risk of biochemical relapse. Finally, we observe a significant association between the risk-associated T allele at rs339331 and increased RFX6 mRNA levels in human prostate tumors. Together, our results suggest that rs339331 affects prostate cancer risk by altering RFX6 expression through a functional interaction with the prostate cancer susceptibility gene HOXB13.	[Huang, Qilai; Gao, Ping; Yang, Yuehong; Zhang, Kai; Lin, Ruizhu; Manninen, Aki; Wei, Gong-Hong] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Huang, Qilai; Gao, Ping; Yang, Yuehong; Zhang, Kai; Lin, Ruizhu; Manninen, Aki; Wei, Gong-Hong] Univ Oulu, Inst Biomed, Dept Med Biochem & Mol Biol, Oulu, Finland; [Whitington, Thomas; Yan, Jian; Jolma, Arttu; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Sun, Jielin; Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Vaisanen, Marja-Riitta; Vaarala, Markku H.] Oulu Univ Hosp, Dept Pathol, Oulu, Finland; [Annala, Matti; Nykter, Matti; Visakorpi, Tapio] Univ Tampere, Inst Biomed Technol & BioMediTech, Prostate Canc Res Ctr, FIN-33101 Tampere, Finland; [Annala, Matti; Nykter, Matti; Visakorpi, Tapio] Tampere Univ Hosp, Tampere, Finland; [Egevad, Lars A.] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Jolma, Arttu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland; [Vaarala, Markku H.] Univ Oulu, Med Res Ctr, Oulu, Finland	University of Oulu; University of Oulu; Karolinska Institutet; Fudan University; University of Oulu; Tampere University; Tampere University; Tampere University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Oulu	Wei, GH (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.	jussi.taipale@ki.se; gonghong.wei@oulu.fi	Wei, Gonghong/C-6263-2014; Yan, Jian/B-2631-2018; Zhang, Kai/M-9831-2017; Manninen, Aki/AAC-8067-2019; Huang, Qilai/B-4725-2015; Vaarala, Markku/B-4116-2013; Jolma, Arttu/AAK-9649-2021	Yan, Jian/0000-0002-1267-2870; Zhang, Kai/0000-0003-2962-3976; Manninen, Aki/0000-0002-6263-8101; Huang, Qilai/0000-0002-4252-3980; Vaarala, Markku/0000-0003-4735-815X; Nykter, Matti/0000-0001-6956-2843; Wei, Gong-Hong/0000-0001-6546-9334; gao, ping/0000-0003-1383-3290; Jolma, Arttu/0000-0002-2543-7490; Visakorpi, Tapio/0000-0002-5004-0364; Lindberg, Johan/0000-0003-3610-6774	Academy of Finland [135560, 251314]; Chinese National Key Basic Research Program Grant 973 [2012CB518301]; Biocenter Oulu; University of Oulu; Biocenter Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; China Scholarship Council fellowship via Northwest Agriculture and Forestry University [201206300074]; Cancer Foundation Finland sr [130133] Funding Source: researchfish	Academy of Finland(Academy of Finland); Chinese National Key Basic Research Program Grant 973(National Basic Research Program of China); Biocenter Oulu; University of Oulu; Biocenter Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; China Scholarship Council fellowship via Northwest Agriculture and Forestry University; Cancer Foundation Finland sr	We thank P. Vuokila, S. Lahdesmaki, J. Traskelin and A. Viklund for technical service, M. Mannikko for DNA sequencing, M. Taipale and L. Hu for massively parallel sequencing, P. Karppinen for critically reading the manuscript and A. Juffer for providing the Linux High-Performance Computing server. We also thank the TCGA Research Network for generating the TCGA data sets for prostate adenocarcinoma. A.M. and K.Z. are funded by the Academy of Finland (135560 and 251314). J.X. is funded by Chinese National Key Basic Research Program Grant 973 (2012CB518301). This work was supported by Strategic Funds from Biocenter Oulu and the University of Oulu, Biocenter Finland, the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation and a China Scholarship Council fellowship, 201206300074, via Northwest Agriculture and Forestry University.	Akbari MR, 2012, J NATL CANCER I, V104, P1260, DOI 10.1093/jnci/djs288; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kim Y.R., 2013, ONCOGENE, DOI [10.1038/onc.2013.404, DOI 10.1038/0NC.2013.404]; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Laitinen VH, 2013, CANCER EPIDEM BIOMAR, V22, P452, DOI 10.1158/1055-9965.EPI-12-1000-T; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P212, DOI 10.1158/1055-9965.EPI-11-0870-T; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Long QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037866; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Szulkin R, 2012, PROSTATE, V72, P30, DOI 10.1002/pros.21403; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang ML, 2012, CARCINOGENESIS, V33, P356, DOI 10.1093/carcin/bgr279; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu JF, 2013, HUM GENET, V132, P5, DOI 10.1007/s00439-012-1229-4; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	146	149	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					126	+		10.1038/ng.2862	http://dx.doi.org/10.1038/ng.2862			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24390282				2022-12-25	WOS:000331208300008
J	Masureel, M; Martens, C; Stein, RA; Mishra, S; Ruysschaert, JM; Mchaourab, HS; Govaerts, C				Masureel, Matthieu; Martens, Chloe; Stein, Richard A.; Mishra, Smriti; Ruysschaert, Jean-Marie; Mchaourab, Hassane S.; Govaerts, Cedric			Protonation drives the conformational switch in the multidrug transporter LmrP	NATURE CHEMICAL BIOLOGY			English	Article							MAJOR FACILITATOR SUPERFAMILY; ESCHERICHIA-COLI; LACTOSE PERMEASE; LACTOCOCCUS-LACTIS; SUGAR BINDING; GLYCEROL-3-PHOSPHATE TRANSPORTER; DISTANCE MEASUREMENTS; ACTIVE-TRANSPORT; STRUCTURAL BASIS; DRUG EXTRUSION	Multidrug antiporters of the major facilitator superfamily couple proton translocation to the extrusion of cytotoxic molecules. The conformational changes that underlie the transport cycle and the structural basis of coupling of these transporters have not been elucidated. Here we used extensive double electron-electron resonance measurements to uncover the conformational equilibrium of LmrP, a multidrug transporter from Lactococcus lactis, and to investigate how protons and ligands shift this equilibrium to enable transport. We find that the transporter switches between outward-open and outward-closed conformations, depending on the protonation states of specific acidic residues forming a transmembrane protonation relay. Our data can be framed in a model of transport wherein substrate binding initiates the transport cycle by opening the extracellular side. Subsequent protonation of membrane-embedded acidic residues induces substrate release to the extracellular side and triggers a cascade of conformational changes that concludes in proton release to the intracellular side.	[Masureel, Matthieu; Martens, Chloe; Ruysschaert, Jean-Marie; Govaerts, Cedric] Univ Libre Brussels, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium; [Stein, Richard A.; Mishra, Smriti; Mchaourab, Hassane S.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37203 USA	Universite Libre de Bruxelles; Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37203 USA.	hassane.mchaourab@vanderbilt.edu; cedric.govaerts@ulb.ac.be	Mishra, Smriti/D-4034-2009; martens, chloe/AAI-3398-2020	Mishra, Smriti/0000-0002-6765-5007; martens, chloe/0000-0002-1617-4238	Mandat d'Impulsion Scientifique from the Fonds de is Recherche Scientifique (FRS-FNRS), Belgium [F.4523.12]; National Institute for General Medical Sciences-US National Institutes of Health [GM-077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	Mandat d'Impulsion Scientifique from the Fonds de is Recherche Scientifique (FRS-FNRS), Belgium; National Institute for General Medical Sciences-US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Remaut for insightful discussions and H. Koteiche and R. Steed for critically reading the manuscript. This work was supported by a Mandat d'Impulsion Scientifique (no. F.4523.12) from the Fonds de is Recherche Scientifique (FRS-FNRS), Belgium, to C.G. and by the National Institute for General Medical Sciences-US National Institutes of Health (GM-077659) to H.S.M. M.M. was a research fellow of the Fonds pour Is Formation a is Recherche dans l'Industrie et dans l'Agriculture (FRIA), Belgium, and the FRS-FNRS. C.M. is a research fellow of the FRIA. C.G. is a research associate of the FRS-FNRS.	Andersen AZ, 2009, COMPUT BIOL CHEM, V33, P71, DOI 10.1016/j.compbiolchem.2008.08.001; Baker J, 2012, PROTEINS, V80, P1620, DOI 10.1002/prot.24056; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Enkavi G, 2010, BIOCHEMISTRY-US, V49, P1105, DOI 10.1021/bi901412a; Fluman N, 2012, MOL CELL, V47, P777, DOI 10.1016/j.molcel.2012.06.018; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Frillingos S, 1997, PROTEIN SCI, V6, P438; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Gbaguidi B, 2004, CELL MOL LIFE SCI, V61, P2646, DOI 10.1007/s00018-004-4298-2; Guan L, 2004, P NATL ACAD SCI USA, V101, P12148, DOI 10.1073/pnas.0404936101; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Hirai T, 2004, BIOPHYS J, V87, P3600, DOI 10.1529/biophysj.104.049320; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Liu ZY, 2010, J MOL BIOL, V396, P617, DOI 10.1016/j.jmb.2009.12.044; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Madej MG, 2012, P NATL ACAD SCI USA, V109, pE2970, DOI 10.1073/pnas.1211183109; Mazurkiewicz P, 2004, BBA-BIOENERGETICS, V1658, P252, DOI 10.1016/j.bbabio.2004.06.004; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; Mazurkiewicz P, 2002, J BIOL CHEM, V277, P26081, DOI 10.1074/jbc.M203141200; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Ocaktan A, 1997, J BIOL CHEM, V272, P21964, DOI 10.1074/jbc.272.35.21964; Pazdernik NJ, 2000, J MEMBRANE BIOL, V174, P31, DOI 10.1007/s002320001029; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; SEOL W, 1992, BIOCHEMISTRY-US, V31, P3550, DOI 10.1021/bi00128a032; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2012, P NATL ACAD SCI USA, V109, P16835, DOI 10.1073/pnas.1214890109; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; TANFORD C, 1983, ANNU REV BIOCHEM, V52, P379, DOI 10.1146/annurev.bi.52.070183.002115; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Yin Y, 2006, BIOPHYS J, V91, P3972, DOI 10.1529/biophysj.106.085993; Zhou YG, 2011, J BIOL CHEM, V286, P30415, DOI 10.1074/jbc.M111.268433; Zou P, 2010, BIOPHYS J, V98, pL18, DOI 10.1016/j.bpj.2009.12.4193	50	48	49	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					149	155		10.1038/nchembio.1408	http://dx.doi.org/10.1038/nchembio.1408			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316739	Green Accepted			2022-12-25	WOS:000330751600014
J	Wu, SK; Gomez, GA; Michael, M; Verma, S; Cox, HL; Lefevre, JG; Parton, RG; Hamilton, NA; Neufeld, Z; Yap, AS				Wu, Selwin K.; Gomez, Guillermo A.; Michael, Magdalene; Verma, Suzie; Cox, Hayley L.; Lefevre, James G.; Parton, Robert G.; Hamilton, Nicholas A.; Neufeld, Zoltan; Yap, Alpha S.			Cortical F-actin stabilization generates apical-lateral patterns of junctional contractility that integrate cells into epithelia	NATURE CELL BIOLOGY			English	Article							E-CADHERIN; MYOSIN-II; ADHERENS JUNCTIONS; ALPHA-CATENIN; TENSION; FORCE; DYNAMICS; NETWORK; ORGANIZATION; ARCHITECTURE	E-cadherin cell-cell junctions couple the contractile cortices of epithelial cells together, generating tension within junctions that influences tissue organization. Although junctional tension is commonly studied at the apical zonula adherens, we now report that E-cadherin adhesions induce the contractile actomyosin cortex throughout the apical lateral axis of junctions. However, cells establish distinct regions of contractile activity even within individual contacts, producing high tension at the zonula adherens but substantially lower tension elsewhere. We demonstrate that N-WASP (also known as WASL) enhances apical junctional tension by stabilizing local F-actin networks, which otherwise undergo stress-induced turnover. Further, we find that cells are extruded from monolayers when this pattern of intra-junctional contractility is disturbed, either when N-WASP redistributes into lateral junctions in H-Ras(V12)-expressing cells or on mosaic redistribution of active N-WASP itself. We propose that local control of actin filament stability regulates the landscape of intra-junctional contractility to determine whether or not cells integrate into epithelial populations.	[Wu, Selwin K.; Gomez, Guillermo A.; Michael, Magdalene; Verma, Suzie; Cox, Hayley L.; Parton, Robert G.; Hamilton, Nicholas A.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Div Mol Cell Biol, Brisbane, Qld 4072, Australia; [Lefevre, James G.; Hamilton, Nicholas A.] Univ Queensland, Inst Mol Biosci, Div Genom & Computat Biol, Brisbane, Qld 4072, Australia; [Neufeld, Zoltan] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Gomez, GA (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Cell Biol, Brisbane, Qld 4072, Australia.	g.gomez@uq.edu.au; a.yap@uq.edu.au	Lefevre, James/J-1794-2014; Neufeld, Zoltan/C-3008-2011; Yap, Alpha S./J-1554-2014; Gomez, Guillermo/J-2993-2014; Hamilton, Nicholas A/A-6033-2010; Wu, Selwin/V-3464-2019; Michael, Magdalene/K-1526-2014; Michael, Magdalene/AAR-8700-2020; Parton, Robert/C-5673-2009	Lefevre, James/0000-0002-5945-9575; Yap, Alpha S./0000-0002-1038-8956; Gomez, Guillermo/0000-0002-0494-2404; Hamilton, Nicholas A/0000-0003-0331-3427; Wu, Selwin/0000-0002-5185-8467; Michael, Magdalene/0000-0003-2577-729X; Parton, Robert/0000-0002-7494-5248; Neufeld, Zoltan/0000-0003-3236-9278	National Health and Medical Research Council of Australia [631383, APP1010489, APP1037320, 1044041, 511055, 569542]; Australian Research Council [DP120104667]; Kids Cancer Project of The Oncology Children's Foundation; University of Queensland Research Scholarship; Australian Cancer Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Kids Cancer Project of The Oncology Children's Foundation; University of Queensland Research Scholarship(University of Queensland); Australian Cancer Research Foundation	We thank our laboratory colleagues for their unstinting support and advice; A. Langendijk and B. Hogan for exploratory experiments; and our many other colleagues who generously provided reagents and helpful suggestions. This work was supported by the National Health and Medical Research Council of Australia, through grants and research fellowships to A.S.Y. (631383, APP1010489, APP1037320, 1044041) and R.G.P. (511055, 569542, APP1037320), the Australian Research Council (DP120104667) and the Kids Cancer Project of The Oncology Children's Foundation. S.W. was supported by a University of Queensland Research Scholarship. Confocal and optical microscopy was performed at the ACRF Cancer Biology Imaging Facility, established with the generous support of the Australian Cancer Research Foundation.	Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gomez GA, 2011, TRENDS CELL BIOL, V21, P499, DOI 10.1016/j.tcb.2011.05.006; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Hong SJ, 2011, J CELL BIOL, V192, P1073, DOI 10.1083/jcb.201006113; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kovacs EM, 2011, CELL ADHES MIGR, V5, P344, DOI 10.4161/cam.5.4.16717; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; Larsson LI, 2006, HISTOCHEM CELL BIOL, V126, P575, DOI 10.1007/s00418-006-0193-2; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Levayer R, 2013, DEV CELL, V26, P162, DOI 10.1016/j.devcel.2013.06.020; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mangold S, 2011, CURR BIOL, V21, P503, DOI 10.1016/j.cub.2011.02.018; Marshall TW, 2011, MOL BIOL CELL, V22, P3962, DOI 10.1091/mbc.E11-05-0469; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; McLachlan RW, 2011, CYTOSKELETON, V68, P32, DOI 10.1002/cm.20492; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Slattum G, 2009, J CELL BIOL, V186, P693, DOI 10.1083/jcb.200903079; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Stachowiak MR, 2012, BIOPHYS J, V103, P1265, DOI [10.1016/j.bpj.2012.08.025, 10.1016/j.bpj.2012.08.028]; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Thoresen T, 2011, BIOPHYS J, V100, P2698, DOI 10.1016/j.bpj.2011.04.031; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Vogel SK, 2013, ELIFE, V2, DOI 10.7554/eLife.00116; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Wu SK, 2013, CELL COMMUN ADHES, V20, P201, DOI 10.3109/15419061.2013.856889; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	60	154	156	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2014	16	2					167	178		10.1038/ncb2900	http://dx.doi.org/10.1038/ncb2900			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA5TB	24413434				2022-12-25	WOS:000331161400006
J	Gao, XX; Hannoush, RN				Gao, Xinxin; Hannoush, Rami N.			Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine	NATURE CHEMICAL BIOLOGY			English	Article							FATTY ACYLATION; PROTEINS; INHIBITION; PORCN; GENE; GLYCOSYLATION; RECOGNITION; BIOGENESIS; LIPIDATION; MUTATIONS	Wnts are secreted palmitoylated glycoproteins that are important in embryonic development and human cancers. Here we report a method for imaging the palmitoylated form of Wnt proteins with subcellular resolution using clickable bioorthogonal fatty acids and in situ proximity ligation. Palmitoylated Wnt3a is visualized throughout the secretory pathway and trafficks to multivesicular bodies that act as export sites in secretory cells. We establish that glycosylation is not required for Wnt3a palmitoylation, which is necessary but not sufficient for Wnt3a secretion. Wnt3a is palmitoylated by fatty acids 13-16 carbons in length at Ser209 but not at Cys77, consistent with a slow turnover rate. We find that porcupine (PORCN) itself is palmitoylated, demonstrating what is to our knowledge the first example of palmitoylation of an MBOAT protein, and this modification partially regulates Wnt palmitoylation and signaling. Our data reveal the role of O-palmitoylation in Wnt signaling and suggest another layer of cellular control over PORCN function and Wnt secretion.	[Gao, Xinxin; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, XX (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	hannoush.rami@gene.com						Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bornholdt D, 2009, HUM MUTAT, V30, pE618, DOI 10.1002/humu.20992; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; OMARY MB, 1981, J BIOL CHEM, V256, P2888; PATTERSON SI, 1995, METHOD ENZYMOL, V250, P284; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STAUFENBIEL M, 1987, MOL CELL BIOL, V7, P2981, DOI 10.1128/MCB.7.8.2981; Steinhauer J, 2009, CURR OPIN GENET DEV, V19, P308, DOI 10.1016/j.gde.2009.04.006; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yang PT, 2012, EMBO MOL MED, V4, P1294, DOI 10.1002/emmm.201201486; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	52	116	120	1	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					61	U102		10.1038/NCHEMBIO.1392	http://dx.doi.org/10.1038/NCHEMBIO.1392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24292069				2022-12-25	WOS:000328854900012
J	Hao, ZY; Lou, HB; Zhu, RF; Zhu, JH; Zhang, DM; Zhao, BXS; Zeng, SZ; Chen, X; Chan, J; He, C; Chen, PR				Hao, Ziyang; Lou, Hubing; Zhu, Rongfeng; Zhu, Jiuhe; Zhang, Dianmu; Zhao, Boxuan Simen; Zeng, Shizhe; Chen, Xing; Chan, Jefferson; He, Chuan; Chen, Peng R.			The multiple antibiotic resistance regulator MarR is a copper sensor in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							DNA-BINDING MECHANISM; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; HYDROPEROXIDE; DAMAGE; STRESS; OPERON; DEATH; SALMONELLA; METABOLISM	The widely conserved multiple antibiotic resistance regulator (MarR) family of transcription factors modulates bacterial detoxification in response to diverse antibiotics, toxic chemicals or both. The natural inducer for Escherichia coli MarR, the prototypical transcription repressor within this family, remains unknown. Here we show that copper signaling potentiates MarR derepression in E. coli. Copper(II) oxidizes a cysteine residue (Cys80) on MarR to generate disulfide bonds between two MarR dimers, thereby inducing tetramer formation and the dissociation of MarR from its cognate promoter DNA. We further discovered that salicylate, a putative MarR inducer, and the clinically important bactericidal antibiotics norfloxacin and ampicillin all stimulate intracellular copper elevation, most likely through oxidative impairment of copper-dependent envelope proteins, including NADH dehydrogenase-2. This membrane-associated copper oxidation and liberation process derepresses MarR, causing increased bacterial antibiotic resistance. Our study reveals that this bacterial transcription regulator senses copper(II) as a natural signal to cope with stress caused by antibiotics or the environment.	[Hao, Ziyang; Lou, Hubing; Zhang, Dianmu; Zhao, Boxuan Simen; Chen, Xing; He, Chuan; Chen, Peng R.] Peking Univ, Synthet & Funct Biomol Ctr, Beijing Natl Lab Mol Sci, Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhu, Rongfeng; Chen, Peng R.] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Zhu, Jiuhe] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhao, Boxuan Simen; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhao, Boxuan Simen; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Zeng, Shizhe] Renmin Univ, Int Curriculum Ctr, High Sch, Beijing, Peoples R China; [Chan, Jefferson] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [He, Chuan; Chen, Peng R.] Shanghai Univ, E Inst Chem Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Peking University; China Agricultural University; University of Chicago; University of Chicago; Renmin University of China; University of California System; University of California Berkeley; Shanghai University	Hao, ZY (corresponding author), Peking Univ, Synthet & Funct Biomol Ctr, Beijing Natl Lab Mol Sci, Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	chuanhe@uchicago.edu; pengchen@pku.edu.cn	Zhao, Boxuan/Q-2159-2019; Lou, Hubing/D-3507-2014	Zhao, Boxuan/0000-0002-3729-4511; Chan, Jefferson/0000-0003-4139-4379	National Basic Research Foundation of China [2010CB912302, 2012CB917301, 2011CB809103]; National Natural Science Foundation of China [21225206, 91013005, 21001010]; US National Science Foundation [CHE-1213598]; E-Institutes of Shanghai Municipal Education Commission [E09013]	National Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF)); E-Institutes of Shanghai Municipal Education Commission	We thank J. Rosner (National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health) for providing the strains of M2073 (WT E. coli) and M2076 (marRAB mutant strains) bearing the marR::lacZ reporter, J.J. Collins (Department of Biomedical Engineering, Boston University) for providing the pL(lexO)GFP reporter, C.J. Chang (College of Chemistry, University of California-Berkeley) for providing the Cu(I)-specific fluorescent probe CS-1 and S.F. Reichard for editing. The E. coli WT (K12) strain (BW25113) and all of the single-gene deletion mutants were obtained from the National BioResource Project (National Institute of Genetics, Japan). We also thank the staff members of the Shanghai Synchrotron Radiation Facility and the Beijing Synchrotron Radiation Facility. This work was supported by research grants from the National Basic Research Foundation of China (2010CB912302 and 2012CB917301 to P.R.C.; 2011CB809103 to C.H.), the National Natural Science Foundation of China (21225206, 91013005 and 21001010 to P.R.C.), the US National Science Foundation (CHE-1213598 to C.H.) and the E-Institutes of Shanghai Municipal Education Commission (project number E09013 to C.H. and P.R.C.).	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Ding XQ, 2011, J NUTR BIOCHEM, V22, P301, DOI 10.1016/j.jnutbio.2010.06.010; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Domain F, 2007, MOL MICROBIOL, V66, P383, DOI 10.1111/j.1365-2958.2007.05928.x; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; MARTIN RG, 1995, J BACTERIOL, V177, P4176, DOI 10.1128/jb.177.14.4176-4178.1995; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Patikarnmonthon N, 2010, FEMS MICROBIOL LETT, V313, P75, DOI 10.1111/j.1574-6968.2010.02124.x; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodriguez-Montelongo L, 2006, ARCH BIOCHEM BIOPHYS, V451, P1, DOI 10.1016/j.abb.2006.04.019; RODRIGUEZMONTELONGO L, 1993, BIOCHIM BIOPHYS ACTA, V1144, P77, DOI 10.1016/0005-2728(93)90033-C; RODRIGUEZMONTELONGO L, 1995, ARCH BIOCHEM BIOPHYS, V323, P19, DOI 10.1006/abbi.1995.0004; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Uversky VN, 1998, BBA-PROTEIN STRUCT M, V1388, P133, DOI 10.1016/S0167-4838(98)00173-3; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhao BS, 2010, J AM CHEM SOC, V132, P17065, DOI 10.1021/ja1071114	55	103	107	5	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					21	U48		10.1038/NCHEMBIO.1380	http://dx.doi.org/10.1038/NCHEMBIO.1380			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24185215				2022-12-25	WOS:000328854900006
J	Meijon, M; Satbhai, SB; Tsuchimatsu, T; Busch, W				Meijon, Monica; Satbhai, Santosh B.; Tsuchimatsu, Takashi; Busch, Wolfgang			Genome-wide association study using cellular traits identifies a new regulator of root development in Arabidopsis	NATURE GENETICS			English	Article							GENETIC-VARIATION; SELECTION; PLATFORM; LOCI; MAP	With the increased availability of high-resolution sequence information, genome-wide association (GWA) studies have become feasible in a number of species(1-8). The vast majority of these studies are conducted in human populations, where it is difficult to provide strong evidence for the functional involvement of unknown genes that are identified using GWA. Here we used the model organism Arabidopsis thaliana to combine high-throughput confocal microscopy imaging of traits at the cellular level, GWA and expression analyses to identify genomic regions that are associated with developmental cell-type traits. We identify and characterize a new F-box gene, KUK, that regulates meristem and cell length. We further show that polymorphisms in the coding sequence are the major causes of KUK allele-dependent natural variation in root development. This work demonstrates the feasibility of GWA using cellular traits to identify causal genes for basic biological processes such as development.	[Meijon, Monica; Satbhai, Santosh B.; Tsuchimatsu, Takashi; Busch, Wolfgang] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Busch, W (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria.	wolfgang.busch@gmi.oeaw.ac.at	Busch, Wolfgang/B-8593-2008; Tsuchimatsu, Takashi/T-7402-2019; Satbhai, Santosh/A-5499-2016; Meijón, Mónica/G-7366-2016; Meijón, Mónica/N-6285-2014; Tsuchimatsu, Takashi/A-9218-2017	Busch, Wolfgang/0000-0003-2042-7290; Tsuchimatsu, Takashi/0000-0003-1241-9338; Satbhai, Santosh/0000-0002-2770-656X; Meijón, Mónica/0000-0003-1563-5554; Meijón, Mónica/0000-0003-1563-5554; Tsuchimatsu, Takashi/0000-0003-1241-9338	Austrian Academy of Science through the Gregor Mendel Institute; European Molecular Biology Organization (EMBO)	Austrian Academy of Science through the Gregor Mendel Institute; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	We are grateful for assistance in the GWA analysis and access to software from A. Korte, U. Seren, B. Vilhjalmsson and M. Nordborg and for technical assistance from B. Wohlrab and C. Goschl. We thank P. Benfey, T. Greb, M. Nordborg, L. Valledor, A. Korte, D. Filiault and members of the Busch laboratory for valuable discussions and critical reading of the manuscript. We thank V. Nizhynska, P. Korte and M. Nordborg (Gregor Mendel Institute, Vienna, Austria) for donating seeds for natural accession, S. Waidmann, P. Sanchez and J. Agusti (Gregor Mendel Institute, Vienna, Austria) for materials and advice on vectors and cloning and T. Friese for manuscript editing. This research was supported by funds from the Austrian Academy of Science through the Gregor Mendel Institute and a European Molecular Biology Organization (EMBO) long-term fellowship to T.T.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Busch W, 2012, NAT METHODS, V9, P1101, DOI [10.1038/NMETH.2185, 10.1038/nmeth.2185]; Chao DY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002923; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; Gunther Torsten, 2011, BMC Res Notes, V4, P232, DOI 10.1186/1756-0500-4-232; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Parker CC, 2012, BEHAV GENET, V42, P437, DOI 10.1007/s10519-011-9524-8; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weigel D., 2006, CSH PROTOC, V2006; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	35	103	107	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					77	+		10.1038/ng.2824	http://dx.doi.org/10.1038/ng.2824			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24212884				2022-12-25	WOS:000329113500017
J	Polak, P; Lawrence, MS; Haugen, E; Stoletzki, N; Stojanov, P; Thurman, RE; Garraway, LA; Mirkin, S; Getz, G; Stamatoyannopoulos, JA; Sunyaev, SR				Polak, Paz; Lawrence, Michael S.; Haugen, Eric; Stoletzki, Nina; Stojanov, Petar; Thurman, Robert E.; Garraway, Levi A.; Mirkin, Sergei; Getz, Gad; Stamatoyannopoulos, John A.; Sunyaev, Shamil R.			Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair	NATURE BIOTECHNOLOGY			English	Article							NUCLEOTIDE EXCISION-REPAIR; NUCLEASE-HYPERSENSITIVE SITES; SOMATIC MUTATIONS; DAMAGE; NUCLEOSOMES; EVOLUTION; YEAST	Carcinogenesis and neoplastic progression are mediated by the accumulation of somatic mutations. Here we report that the local density of somatic mutations in cancer genomes is highly reduced specifically in accessible regulatory DNA defined by DNase I hypersensitive sites. This reduction is independent of any known factors influencing somatic mutation density and is observed in diverse cancer types, suggesting a general mechanism. By analyzing individual cancer genomes(1), we show that the reduced local mutation density within regulatory DNA is linked to intact global genome repair machinery, with nearly complete abrogation of the hypomutation phenomenon in individual cancers that possess mutations in components of the nucleotide excision repair system. Together, our results connect chromatin structure, gene regulation and cancer-associated somatic mutation.	[Polak, Paz; Stoletzki, Nina; Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Polak, Paz; Stoletzki, Nina; Garraway, Levi A.; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA USA; [Polak, Paz; Lawrence, Michael S.; Stoletzki, Nina; Stojanov, Petar; Garraway, Levi A.; Getz, Gad; Sunyaev, Shamil R.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Haugen, Eric; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Haugen, Eric; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Med Oncol, Seattle, WA 98195 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mirkin, Sergei] Tufts Univ, Dept Biol, Medford, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Tufts University	Sunyaev, SR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	jstam@u.washington.edu; ssunyaev@rics.bwh.harvard.edu	Polak, Paz/AAH-9380-2020; Mirkin, Sergei/A-7310-2010; Stojanov, Petar/GQI-4462-2022; Mirkin, Sergei/AAR-7226-2020; Lawrence, Michael/AAC-8202-2020	Stojanov, Petar/0000-0001-7815-776X; Mirkin, Sergei/0000-0003-4576-7582; Haugen, Eric/0000-0001-7444-8981	US National Institutes of Health (NIH) [U54CA143874, RO1MH101244, U54HG004592, HG007010]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institutes of Health (NIH) grants U54CA143874 and RO1MH101244 to S. R. S. and U54HG004592 and HG007010 to J.A.S. We thank D. Gordenin for his valuable feedback.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; CHENG KC, 1992, J BIOL CHEM, V267, P166; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fei J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001183; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Girard PM, 1997, BIOCHIMIE, V79, P559, DOI 10.1016/S0300-9084(97)82004-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Haruta N, 2012, NUCLEIC ACIDS RES, V40, P8406, DOI 10.1093/nar/gks580; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legault J, 1997, MOL CELL BIOL, V17, P5437, DOI 10.1128/MCB.17.9.5437; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Parker SCJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002871; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Sugasawa K, 2008, CARCINOGENESIS, V29, P455, DOI 10.1093/carcin/bgm282; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008	48	83	83	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					71	+		10.1038/nbt.2778	http://dx.doi.org/10.1038/nbt.2778			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24336318	Green Submitted, Bronze, Green Accepted			2022-12-25	WOS:000329513000020
J	Yang, N; Wernig, M				Yang, Nan; Wernig, Marius			A case for neural stem cell therapy	NATURE MEDICINE			English	Editorial Material							OLIGODENDROCYTE PROGENITOR CELLS		[Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University	Yang, N (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wernig@stanford.edu	Yang, Nan/H-3174-2012	Yang, Nan/0000-0003-3663-1288				Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Potts Matthew B, 2013, Surg Neurol Int, V4, pS22, DOI 10.4103/2152-7806.109190; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564	10	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1580	1581		10.1038/nm.3425	http://dx.doi.org/10.1038/nm.3425			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309657				2022-12-25	WOS:000328181400026
J	Huang, H; Suslov, NB; Li, NS; Shelke, SA; Evans, ME; Koldobskaya, Y; Rice, PA; Piccirilli, JA				Huang, Hao; Suslov, Nikolai B.; Li, Nan-Sheng; Shelke, Sandip A.; Evans, Molly E.; Koldobskaya, Yelena; Rice, Phoebe A.; Piccirilli, Joseph A.			A G-quadruplex-containing RNA activates fluorescence in a GFP-like fluorophore	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; DNA; RECOGNITION; APTAMER; CRYSTALLOGRAPHY; IDENTIFICATION; METABOLITES; SCATTERING; PROTEINS; SEQUENCE	Spinach is an in vitro-selected RNA aptamer that binds a GFP-like ligand and activates its green fluorescence. Spinach is thus an RNA analog of GFP and has potentially widespread applications for in vivo labeling and imaging. We used antibody-assisted crystallography to determine the structures of Spinach both with and without bound fluorophore at 2.2-angstrom and 2.4-angstrom resolution, respectively. Spinach RNA has an elongated structure containing two helical domains separated by an internal bulge that folds into a G-quadruplex motif of unusual topology. The G-quadruplex motif and adjacent nucleotides comprise a partially preformed binding site for the fluorophore. The fluorophore binds in a planar conformation and makes extensive aromatic stacking and hydrogen bond interactions with the RNA. Our findings provide a foundation for structure-based engineering of new fluorophore-binding RNA aptamers.	[Huang, Hao; Koldobskaya, Yelena; Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Suslov, Nikolai B.; Li, Nan-Sheng; Shelke, Sandip A.; Evans, Molly E.; Rice, Phoebe A.; Piccirilli, Joseph A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	price@uchicago.edu; jpicciri@uchicago.edu	Shelke, Sandip/I-6022-2019; Shelke, Sandip/B-4691-2014	Shelke, Sandip/0000-0002-6119-123X; Shelke, Sandip/0000-0002-6119-123X; Evans, Molly/0000-0002-7239-1667	US National Institutes of Health (NIH) [R01-AI081987]; NIH [T32GM007183]; US National Institute of General Medical Sciences Medical Scientist National Research Service [5 T32GM07281]; USA Department of Energy; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281, T32GM008720, T32GM007183, R01GM102489] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of General Medical Sciences Medical Scientist National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USA Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to I. M. Steele for assistance in determining the structure of unbound DFHBI. We thank L. Zhang for the advice on structure and model building. We thank J. R. Fuller for refinement software support. We also thank F. C. Chou and R. Das for their aid with ERRASER software and K. N. Dyer, T. R. Sosnick and J. R. Hinshaw for the help with SAXS experiments. We thank members of the Piccirilli group, J. P. Staley and D. M. J. Lilley for helpful discussions and comments on the manuscript. The work is supported by US National Institutes of Health (NIH) grants R01-AI081987, NIH training grant T32GM008720 (to M. E. E.) and R01-GM102489 (to J. A. P.), NIH training grant T32GM007183 (to N. B. S.) and US National Institute of General Medical Sciences Medical Scientist National Research Service Award no. 5 T32GM07281 (to Y. K.). This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamline 24-ID-C& E, GM/CA beamline 23-ID-D and Advanced Light Source beamline 12.3.1 SIBYLS, all supported by USA Department of Energy.	Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; Afonine P. V., 2005, CCP4 NEWSLETT; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chayen NE, 2009, J APPL CRYSTALLOGR, V42, P743, DOI 10.1107/S0021889809021700; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Han KY, 2013, J AM CHEM SOC, V135, P19033, DOI 10.1021/ja411060p; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hud NV, 1999, J MOL BIOL, V285, P233, DOI 10.1006/jmbi.1998.2327; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kao C, 2001, METHODS, V23, P201, DOI 10.1006/meth.2000.1131; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Kellenberger CA, 2013, J AM CHEM SOC, V135, P4906, DOI 10.1021/ja311960g; Kim I, 2007, RNA, V13, P289, DOI 10.1261/rna.342607; Koldobskaya Y, 2011, NAT STRUCT MOL BIOL, V18, P100, DOI 10.1038/nsmb.1945; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liberman JA, 2012, WIRES RNA, V3, P369, DOI 10.1002/wrna.114; Lim KW, 2013, ANGEW CHEM INT EDIT, V52, P8566, DOI 10.1002/anie.201302995; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Mashima T, 2009, NUCLEIC ACIDS RES, V37, P6249, DOI 10.1093/nar/gkp647; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mullen MA, 2012, J AM CHEM SOC, V134, P812, DOI 10.1021/ja2096255; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pothoulakis G, 2014, ACS SYNTH BIOL, V3, P182, DOI 10.1021/sb400089c; Royant A, 2011, J STRUCT BIOL, V174, P385, DOI 10.1016/j.jsb.2011.02.004; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song WJ, 2014, J AM CHEM SOC, V136, P1198, DOI 10.1021/ja410819x; Stahley MR, 2007, J MOL BIOL, V372, P89, DOI 10.1016/j.jmb.2007.06.026; Strack RL, 2013, NAT METHODS, V10, P1219, DOI [10.1038/NMETH.2701, 10.1038/nmeth.2701]; Strack RL, 2013, CURR OPIN CHEM BIOL, V17, P651, DOI 10.1016/j.cbpa.2013.05.014; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wadley LM, 2004, NUCLEIC ACIDS RES, V32, P6650, DOI 10.1093/nar/gkh1002; Wang PC, 2013, CHEM SCI, V4, P2865, DOI 10.1039/c3sc50729g; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yang P, 2009, ANGEW CHEM INT EDIT, V48, P2188, DOI 10.1002/anie.200805613; Ye JD, 2008, P NATL ACAD SCI USA, V105, P82, DOI 10.1073/pnas.0709082105; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang XB, 2011, ANNU REV ANAL CHEM, V4, P105, DOI 10.1146/annurev.anchem.111808.073617; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	216	226	9	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					686	U128		10.1038/NCHEMBIO.1561	http://dx.doi.org/10.1038/NCHEMBIO.1561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24952597	Green Accepted			2022-12-25	WOS:000339380100016
J	Laszlo, AH; Derrington, IM; Ross, BC; Brinkerhoff, H; Adey, A; Nova, IC; Craig, JM; Langford, KW; Samson, JM; Daza, R; Doering, K; Shendure, J; Gundlach, JH				Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Adey, Andrew; Nova, Ian C.; Craig, Jonathan M.; Langford, Kyle W.; Samson, Jenny Mae; Daza, Riza; Doering, Kenji; Shendure, Jay; Gundlach, Jens H.			Decoding long nanopore sequencing reads of natural DNA	NATURE BIOTECHNOLOGY			English	Article							SINGLE; MEMBRANE; RESOLUTION; FLUID	Nanopore sequencing of DNA is a single-molecule technique that may achieve long reads, low cost and high speed with minimal sample preparation and instrumentation. Here, we build on recent progress with respect to nanopore resolution and DNA control to interpret the procession of ion current levels observed during the translocation of DNA through the pore MspA. As approximately four nucleotides affect the ion current of each level, we measured the ion current corresponding to all 256 four-nucleotide combinations (quadromers). This quadromer map is highly predictive of ion current levels of previously unmeasured sequences derived from the bacteriophage phi X 174 genome. Furthermore, we show nanopore sequencing reads of phi X 174 up to 4,500 bases in length, which can be unambiguously aligned to the phi X 174 reference genome, and demonstrate proof-of-concept utility with respect to hybrid genome assembly and polymorphism detection. This work provides a foundation for nanopore sequencing of long, natural DNA strands.	[Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Craig, Jonathan M.; Langford, Kyle W.; Samson, Jenny Mae; Doering, Kenji; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Adey, Andrew; Daza, Riza; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	gundlach@uw.edu	Daza, Riza M./HCH-4047-2022; Shendure, Jay/AAU-3684-2021	Ross, Brian/0000-0003-2432-4678; Brinkerhoff, Henry/0000-0003-2735-8048; Craig, Jonathan M/0000-0003-4791-5112; Gundlach, Jens Horst/0000-0002-0773-8038; Shendure, Jay/0000-0002-1516-1865; Laszlo, Andrew/0000-0002-7853-0533	National Institutes of Health, National Human Genome Research Institutes (NHGRI) Genome Program [R01HG005115, R01HG006321, R01HG006283]; National Science Foundation [DGE-0718124]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321, R01HG006283, R01HG005115] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institutes (NHGRI) Genome Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Thanks to J.J. Bartlett and B. Tickman for their help in data acquisition. This work was supported by the National Institutes of Health, National Human Genome Research Institutes (NHGRI) $1,000 Genome Program Grants R01HG005115, R01HG006321 and R01HG006283 and graduate research fellowship DGE-0718124 from the National Science Foundation (to A.A.).	Baaken G, 2008, LAB CHIP, V8, P938, DOI 10.1039/b800431e; Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Durbin R., 2006, BIOL SEQUENCE ANAL; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Heitz BA, 2011, LANGMUIR, V27, P1882, DOI 10.1021/la1025944; Heitz BA, 2010, J AM CHEM SOC, V132, P7086, DOI 10.1021/ja100245d; Jain T, 2013, ANAL CHEM, V85, P3871, DOI 10.1021/ac302972c; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Schibel AEP, 2010, ANAL CHEM, V82, P7259, DOI 10.1021/ac101183j; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12	32	272	285	11	234	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					829	833		10.1038/nbt.2950	http://dx.doi.org/10.1038/nbt.2950			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24964173	Green Accepted			2022-12-25	WOS:000346455900044
J	Kutscheidt, S; Zhu, RJ; Antoku, S; Luxton, GWG; Stagljar, I; Fackler, OT; Gundersen, GG				Kutscheidt, Stefan; Zhu, Ruijun; Antoku, Susumu; Luxton, G. W. Gant; Stagljar, Igor; Fackler, Oliver T.; Gundersen, Gregg G.			FHOD1 interaction with nesprin-2G mediates TAN line formation and nuclear movement	NATURE CELL BIOLOGY			English	Article							ACTIN STRESS FIBERS; FORMIN FHOD1; CENTROSOME ORIENTATION; F-ACTIN; MIGRATION; MICROTUBULES; ACTIVATION; FLOW; STABILIZATION; REORIENTATION	Active positioning of the nucleus is integral to division, migration and differentiation of mammalian cells(1). Fibroblasts polarizing for migration orient their centrosomes by actin-dependent nuclear movement(2). This nuclear movement depends on nesprin-2 giant (N2G), a large, actin-binding outer nuclear membrane component of transmembrane actin-associated (TAN) lines that couple nuclei to moving actin cables(3). Here, we identify the diaphanous formin FHOD1 as an interaction partner of N2G. Silencing FHOD1 expression or expression of fragments containing binding sites for N2G or FHOD1 disrupted nuclear movement and centrosome orientation in polarizing fibroblasts. Unexpectedly, silencing of FHOD1 expression did not affect the formation or rearward flow of dorsal actin cables required for nuclear positioning. Rather, N2G-FHOD1 interaction provided a second connection to actin cables essential for TAN line formation and thus nuclear movement. These results reveal a unique function for a formin in coupling an organelle to actin filaments for translocation, and suggest that TAN lines require multi-point attachments to actin cables to resist the large forces necessary to move the nucleus.	[Kutscheidt, Stefan; Fackler, Oliver T.] Univ Heidelberg Hosp, Dept Infect Dis, D-69120 Heidelberg, Germany; [Zhu, Ruijun; Antoku, Susumu; Luxton, G. W. Gant; Gundersen, Gregg G.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Ruprecht Karls University Heidelberg; Columbia University; University of Toronto	Fackler, OT (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, D-69120 Heidelberg, Germany.	liver.fackler@med.uni-heidelberg.de; ggg1@columbia.edu	Luxton, GW Gant/A-7212-2017	Luxton, GW Gant/0000-0002-6180-8906; Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [GRK1188, FA 378/6-2]; NIH [GM099481]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099481] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Discher and M. Geyer for helpful discussion. This work was financially supported in part by the Deutsche Forschungsgemeinschaft (GRK1188 to S.K., grant FA 378/6-2 to O.T.F.) and NIH (grant GM099481 to G.G.G.). O.T.F. is a member of the CellNetworks Cluster of Excellence EXC81.	Alvarez DE, 2013, J CELL BIOL, V202, P1075, DOI 10.1083/jcb.201303055; Autore F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063633; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Chang W, 2013, MOL BIOL CELL, V24, P3869, DOI 10.1091/mbc.E13-06-0307; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Gomes ER, 2006, METHOD ENZYMOL, V406, P579, DOI 10.1016/S0076-6879(06)06045-9; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; IYER K, 2005, SCI STKE, V2005; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Luxton GWG, 2011, NUCLEUS-PHILA, V2, P173, DOI [10.4161/nucl.2.3.16243, 10.1073/pnas.1000824108]; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Madrid R, 2005, FEBS LETT, V579, P441, DOI 10.1016/j.febslet.2004.12.009; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Schonichen A, 2013, J CELL SCI, V126, P1891, DOI 10.1242/jcs.126706; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Truong D, 2013, CELL MICROBIOL, V15, P2051, DOI 10.1111/cmi.12173	31	80	80	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					708	+		10.1038/ncb2981	http://dx.doi.org/10.1038/ncb2981			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24880667	Green Accepted			2022-12-25	WOS:000338187900011
J	Keys, TG; Fuchs, HLS; Ehrit, J; Alves, J; Freiberger, F; Gerardy-Schahn, R				Keys, Timothy G.; Fuchs, Hazel L. S.; Ehrit, Joerg; Alves, Juergen; Freiberger, Friedrich; Gerardy-Schahn, Rita			Engineering the product profile of a polysialyltransferase	NATURE CHEMICAL BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; ESCHERICHIA-COLI K1; POLYSIALIC ACID; CHEMOENZYMATIC SYNTHESIS; DIRECTED EVOLUTION; LENGTH CONTROL; GROUP-C; POLYSIALYLATION; BIOSYNTHESIS; PROCESSIVITY	Oligo- and polysaccharides have myriad applications as therapeutic reagents from glycoconjugate vaccines to matrices for tissue engineering. Polysaccharide length may vary over several orders of magnitude and is a critical determinant of both their physical properties and biological activities. Therefore, the tailored synthesis of oligo- and polysaccharides of defined size is a major goal for glycoengineering. By mutagenesis and screening of a bacterial polysialyltransferase (polyST), we identified a single-residue switch that controls the size distribution of polymeric products. Specific substitutions at this site yielded distributive enzymes that synthesize polysaccharides with narrow size distribution ideal for glycoengineering applications. Mechanistic investigation revealed that the wild-type enzyme has an extended binding site that accommodates at least 20 residues of the growing polymer; changes in affinity along this binding site allow fine-tuning of the enzyme's product distribution.	[Keys, Timothy G.; Fuchs, Hazel L. S.; Ehrit, Joerg; Freiberger, Friedrich; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, Hannover, Germany; [Alves, Juergen] Hannover Med Sch, Inst Biophys Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School	Keys, TG (corresponding author), Hannover Med Sch, Inst Cellular Chem, Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de		Keys, Timothy Gerard/0000-0003-2921-0362	Deutsche Forschungsgemeinschaft (DFG) [GE 801/6-2, Ge801/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank M. Berger and A. Bethe for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of DFG Research Unit 548 to R.G.-S. (grant no. GE 801/6-2 and Ge801/10-1).	Aharoni A, 2006, NAT METHODS, V3, P609, DOI 10.1038/NMETH899; BERG OG, 1982, TRENDS BIOCHEM SCI, V7, P52, DOI 10.1016/0968-0004(82)90075-5; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bloom JD, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-29; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Constantinou A, 2008, BIOCONJUGATE CHEM, V19, P643, DOI 10.1021/bc700319r; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; El Maarouf A, 2012, J BIOL CHEM, V287, P32770, DOI 10.1074/jbc.M112.377614; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Freiberger F, 2013, CHEMBIOCHEM, V14, P1949, DOI 10.1002/cbic.201300367; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; Hildebrandt H, 2015, TOP CURR CHEM, V366, P55, DOI 10.1007/128_2013_446; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Keys TG, 2012, ANAL BIOCHEM, V427, P60, DOI 10.1016/j.ab.2012.04.033; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Lindhout T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069888; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; May JF, 2009, P NATL ACAD SCI USA, V106, P11851, DOI 10.1073/pnas.0901407106; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; McCarthy PC, 2013, GLYCOCONJUGATE J, V30, P857, DOI 10.1007/s10719-013-9490-x; Miyake K, 2004, ADV BIOCHEM ENG BIOT, V90, P89; Otto NJ, 2012, J BIOL CHEM, V287, P7203, DOI 10.1074/jbc.M111.311704; Peterson DC, 2011, J BACTERIOL, V193, P1576, DOI 10.1128/JB.00924-10; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Steenbergen SM, 2003, J BIOL CHEM, V278, P15349, DOI 10.1074/jbc.M208837200; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Stepto RFT, 2010, POLYM INT, V59, P23, DOI 10.1002/pi.2748; Stubbe J, 2005, ANNU REV BIOCHEM, V74, P433, DOI 10.1146/annurev.biochem.74.082803.133013; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	45	27	27	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					437	442		10.1038/nchembio.1501	http://dx.doi.org/10.1038/nchembio.1501			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24727899				2022-12-25	WOS:000336238200010
J	Sturgeon, CM; Ditadi, A; Awong, G; Kennedy, M; Keller, G				Sturgeon, Christopher M.; Ditadi, Andrea; Awong, Geneve; Kennedy, Marion; Keller, Gordon			Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION CULTURES; YOLK-SAC; HAEMOGENIC ENDOTHELIUM; WNT/BETA-CATENIN; IN-VITRO; PROGENITORS; BLOOD; PATHWAY; EMBRYO; INDUCTION	Efforts to derive hematopoietic stem cells (HSCs) from human pluripotent stem cells (hPSCs) are complicated by the fact that embryonic hematopoiesis consists of two programs, primitive and definitive, that differ in developmental potential. As only definitive hematopoiesis generates HSCs, understanding how this program develops is essential for being able to produce this cell population in vitro. Here we show that both hematopoietic programs transition through hemogenic endothelial intermediates and develop from KDR(+)CD34(-)CD144(-) progenitors that are distinguished by CD235a expression. Generation of primitive progenitors (KDR(+)CD235a(+)) depends on stage-specific activin-nodal signaling and inhibition of the Wnt-beta-catenin pathway, whereas specification of definitive progenitors (KDR(+)CD235a(-)) requires Wnt-beta-catenin signaling during this same time frame. Together, these findings establish simple selective differentiation strategies for the generation of primitive or definitive hematopoietic progenitors by Wnt-beta-catenin manipulation, and in doing so provide access to enriched populations for future studies on hPSC-derived hematopoietic development.	[Sturgeon, Christopher M.; Ditadi, Andrea; Awong, Geneve; Kennedy, Marion; Keller, Gordon] McEwen Ctr Regenerat Med, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Keller, G (corresponding author), McEwen Ctr Regenerat Med, Univ Hlth Network, Toronto, ON, Canada.	gkeller@uhnresearch.ca	; Ditadi, Andrea/K-3461-2016	Keller, Gordon/0000-0001-9309-9297; Ditadi, Andrea/0000-0003-3283-8943; , Christopher/0000-0003-1508-4414	National Institutes of Health [U01 HL100395]; CIHR [MOP93569, HOP83070, MOP12927]; McMurrich Post-Doctoral Fellowship; Magna-Golftown Post-Doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); McMurrich Post-Doctoral Fellowship; Magna-Golftown Post-Doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank the SickKids-UHN Flow Cytometry Facility for their expert assistance with cell sorting, in particular A. Khandani. This work was supported by National Institutes of Health grants U01 HL100395 and CIHR MOP93569, HOP83070 and MOP12927. C. M. S. and A. D. were supported by the McMurrich Post-Doctoral Fellowship and the Magna-Golftown Post-Doctoral Fellowship, respectively.	Antas VI, 2013, INT J BIOCHEM CELL B, V45, P692, DOI 10.1016/j.biocel.2012.12.013; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi K, 1998, DEVELOPMENT, V125, P725; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Fraser Stuart T, 2013, ISRN Hematol, V2013, P568928, DOI 10.1155/2013/568928; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang W, 2013, STEM CELL REP, V1, P46, DOI 10.1016/j.stemcr.2013.03.003; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Paluru P, 2014, STEM CELL RES, V12, P441, DOI 10.1016/j.scr.2013.12.003; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; PESCHLE C, 1984, P NATL ACAD SCI-BIOL, V81, P2416, DOI 10.1073/pnas.81.8.2416; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Slukvin II, 2013, CELL CYCLE, V12, P720, DOI 10.4161/cc.23823; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sturgeon CM, 2012, DEV CELL, V23, P45, DOI 10.1016/j.devcel.2012.05.021; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489	44	242	254	4	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					554	+		10.1038/nbt.2915	http://dx.doi.org/10.1038/nbt.2915			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24837661	Green Accepted			2022-12-25	WOS:000337233800018
J	Jeck, WR; Sharpless, NE				Jeck, William R.; Sharpless, Norman E.			Detecting and characterizing circular RNAs	NATURE BIOTECHNOLOGY			English	Review							EXON REPETITION; MESSENGER-RNAS; GENE; TRANSCRIPTS; EXPRESSION; MOLECULES; DELETION; ABUNDANT; CIRCLES; SPONGES	Circular RNA transcripts were first identified in the early 1990s but knowledge of these species has remained limited, as their study through traditional methods of RNA analysis has been difficult. Now, novel bioinformatic approaches coupled with biochemical enrichment strategies and deep sequencing have allowed comprehensive studies of circular RNA species. Recent studies have revealed thousands of endogenous circular RNAs in mammalian cells, some of which are highly abundant and evolutionarily conserved. Evidence is emerging that some circRNAs might regulate microRNA (miRNA) function, and roles in transcriptional control have also been suggested. Therefore, study of this class of noncoding RNAs has potential implications for therapeutic and research applications. We believe the key future challenge for the field will be to understand the regulation and function of these unusual molecules.	[Jeck, William R.; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Sharpless, Norman E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA.	nes@med.unc.edu		Sharpless, Norman/0000-0001-7078-9455; Jeck, William/0000-0003-0257-4529	National Institute on Aging [F30 AG041567-3, RO1 AG024379-11]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379, F30AG041567] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to acknowledge W. Marzluff for his assistance in preparing this manuscript, as well as funding from the National Institute on Aging, grants F30 AG041567-3 and RO1 AG024379-11.	ARNBERG AC, 1980, CELL, V19, P313, DOI 10.1016/0092-8674(80)90505-X; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Chao CW, 1998, MOL MED, V4, P614, DOI 10.1007/BF03401761; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; COCQUERELLE C, 1992, EMBO J, V11, P1095, DOI 10.1002/j.1460-2075.1992.tb05148.x; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fonseca NA, 2012, BIOINFORMATICS, V28, P3169, DOI 10.1093/bioinformatics/bts605; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frantz SA, 1999, P NATL ACAD SCI USA, V96, P5400, DOI 10.1073/pnas.96.10.5400; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gualandi F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e100; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Haupenthal J, 2006, BIOCHEM PHARMACOL, V71, P702, DOI 10.1016/j.bcp.2005.11.015; Hurowitz EH, 2004, GENOME BIOL, V5; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; KOS A, 1986, NATURE, V323, P558, DOI 10.1038/323558a0; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; Liu YC, 2013, INT J BIOCHEM CELL B, V45, P2643, DOI 10.1016/j.biocel.2013.09.003; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Pasman Z, 1996, RNA, V2, P603; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rigatti R, 2004, NUCLEIC ACIDS RES, V32, P441, DOI 10.1093/nar/gkh197; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; SCHINDLER CW, 1982, PLASMID, V7, P263, DOI 10.1016/0147-619X(82)90007-5; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Surono A, 1999, HUM MOL GENET, V8, P493, DOI 10.1093/hmg/8.3.493; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; TABAK HF, 1988, NUCLEIC ACIDS RES, V16, P6597, DOI 10.1093/nar/16.14.6597; Umekage S., 2012, INNOVATIONS BIOTECHN, P75; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; ZAPHIROPOULOS PG, 1993, BIOCHEM BIOPH RES CO, V192, P778, DOI 10.1006/bbrc.1993.1482; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017	52	1671	1791	23	418	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					453	461		10.1038/nbt.2890	http://dx.doi.org/10.1038/nbt.2890			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811520	Green Accepted, Green Submitted			2022-12-25	WOS:000336036100020
J	Rajagopalan, S; Wang, C; Yu, K; Kuzin, AP; Richter, F; Lew, S; Miklos, AE; Matthews, ML; Seetharaman, J; Su, M; Hunt, JF; Cravatt, BF; Baker, D				Rajagopalan, Sridharan; Wang, Chu; Yu, Kai; Kuzin, Alexandre P.; Richter, Florian; Lew, Scott; Miklos, Aleksandr E.; Matthews, Megan L.; Seetharaman, Jayaraman; Su, Min; Hunt, John F.; Cravatt, Benjamin F.; Baker, David			Design of activated serine-containing catalytic triads with atomic-level accuracy	NATURE CHEMICAL BIOLOGY			English	Article							COMPUTATIONAL DESIGN; ENZYMES; HYDROLYSIS	A challenge in the computational design of enzymes is that multiple properties, including substrate binding, transition state stabilization and product release, must be simultaneously optimized, and this has limited the absolute activity of successful designs. Here, we focus on a single critical property of many enzymes: the nucleophilicity of an active site residue that initiates catalysis. We design proteins with idealized serine-containing catalytic triads and assess their nucleophilicity directly in native biological systems using activity-based organophosphate probes. Crystal structures of the most successful designs show unprecedented agreement with computational models, including extensive hydrogen bonding networks between the catalytic triad (or quartet) residues, and mutagenesis experiments demonstrate that these networks are critical for serine activation and organophosphate reactivity. Following optimization by yeast display, the designs react with organophosphate probes at rates comparable to natural serine hydrolases. Co-crystal structures with diisopropyl fluorophosphate bound to the serine nucleophile suggest that the designs could provide the basis for a new class of organophosphate capture agents.	[Rajagopalan, Sridharan; Yu, Kai; Richter, Florian; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wang, Chu; Matthews, Megan L.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA USA; [Wang, Chu; Matthews, Megan L.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA USA; [Kuzin, Alexandre P.; Lew, Scott; Seetharaman, Jayaraman; Su, Min; Hunt, John F.] Columbia Univ, Dept Biol Sci, Northeast Struct Genom Consortium, New York, NY USA; [Richter, Florian; Baker, David] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Kuzin, Alexandre P.] EXCET Inc, Springfield, VA USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; Columbia University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rajagopalan, S (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@uw.edu	Wang, Chu/AAE-8759-2021; Matthews, Megan/W-2217-2017; Baker, David/K-8941-2012; wang, chu/GYJ-2191-2022; Wang, Chu/C-4442-2015	Wang, Chu/0000-0002-6925-1268; Matthews, Megan/0000-0003-1178-4616; Baker, David/0000-0001-7896-6217; Wang, Chu/0000-0002-6925-1268; Miklos, Aleksandr/0000-0001-6375-2304	Defense Threat Reduction Agency (DTRA); National Institute on Drug Abuse [DA033670]; National Institute of General Medical Sciences Protein Structure Initiative (PSI) [U54-GM094597]; NIH-National Institute of Environmental Health Sciences [K99/R00]; Independence Postdoctoral [1K99ES020851-01]; Helen Hay Whitney Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES020851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033670, R01DA033760] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of General Medical Sciences Protein Structure Initiative (PSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Independence Postdoctoral; Helen Hay Whitney Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Masuda and D. Milliken for helping with ABPP screening, R. Xiao and G. Kornhaber for experimental support with sample preparation and structure determination and the Rosen Lab for sharing instrumentation for performing fluopol experiments. This work was supported in part by the Defense Threat Reduction Agency (DTRA) (D.B.), the National Institute on Drug Abuse grant DA033670 (B.F.C.) and by a grant from the National Institute of General Medical Sciences Protein Structure Initiative (PSI), U54-GM094597 (J.F.H.). Fellowship support from the Sir Henry Wellcome Postdoctoral Fellowship (S.R.), NIH-National Institute of Environmental Health Sciences K99/R00 Pathways to Independence Postdoctoral Award 1K99ES020851-01 (C.W.) and Helen Hay Whitney Fellowship (M.L.M.) are gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Botos I, 2007, CURR OPIN STRUC BIOL, V17, P683, DOI 10.1016/j.sbi.2007.08.003; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; COREY DR, 1992, J AM CHEM SOC, V114, P4905, DOI 10.1021/ja00038a067; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Ditargiani RC, 2010, CHEM-BIOL INTERACT, V187, P349, DOI 10.1016/j.cbi.2010.02.021; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fischer S, 2005, ARCH BIOCHEM BIOPHYS, V434, P108, DOI 10.1016/j.abb.2004.10.029; Fleishman SJ, 2011, PROTEIN SCI, V20, P753, DOI 10.1002/pro.604; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kim K, 2011, CHEM REV, V111, P5345, DOI 10.1021/cr100193y; Kwasnieski O, 2009, J PHYS CHEM B, V113, P10001, DOI 10.1021/jp903843s; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lenz DE, 2007, TOXICOLOGY, V233, P31, DOI 10.1016/j.tox.2006.11.066; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacsial-Ong Eden Joy, 2013, Front Biosci (Schol Ed), V5, P516; Raushel FM, 2011, NATURE, V469, P310, DOI 10.1038/469310a; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schwans JP, 2011, J AM CHEM SOC, V133, P20052, DOI 10.1021/ja208050t; Shieh HS, 1996, NATURE, V383, P279, DOI 10.1038/383279a0; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Tsai PC, 2012, BIOCHEMISTRY-US, V51, P6463, DOI 10.1021/bi300811t; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	41	55	55	6	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					386	U100		10.1038/nchembio.1498	http://dx.doi.org/10.1038/nchembio.1498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24705591	Green Accepted			2022-12-25	WOS:000334672700013
J	Sawa-Makarska, J; Abert, C; Romanov, J; Zens, B; Ibiricu, I; Martens, S				Sawa-Makarska, Justyna; Abert, Christine; Romanov, Julia; Zens, Bettina; Ibiricu, Iosune; Martens, Sascha			Cargo binding to Atg19 unmasks additional Atg8 binding sites to mediate membrane-cargo apposition during selective autophagy	NATURE CELL BIOLOGY			English	Article							VACUOLE TARGETING PATHWAY; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; ALPHA-MANNOSIDASE; LIR MOTIF; MECHANISM; CYTOPLASM; PROTEINS; COMPLEX; RECOGNITION	Autophagy protects cells from harmful substances such as protein aggregates, damaged mitochondria and intracellular pathogens, and has been implicated in a variety of diseases. Selectivity of autophagic processes is mediated by cargo receptors that link cargo to Atg8 family proteins on the developing autophagosomal membrane. To avoid collateral degradation during constitutive autophagic pathways, the autophagic machinery must not only select cargo but also exclude non-cargo material. Here we show that cargo directly activates the cargo receptor Atg19 by exposing multiple Atg8 binding sites. Furthermore, Atg19 mediates tight apposition of the cargo and Atg8-coated membranes in a fully reconstituted system. These properties are essential for the function of Atg19 during selective autophagy in vivo. Our results suggest that cargo receptors contribute to tight membrane bending of the isolation membrane around the cargo.	[Sawa-Makarska, Justyna; Abert, Christine; Romanov, Julia; Zens, Bettina; Ibiricu, Iosune; Martens, Sascha] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Martens, S (corresponding author), Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	sascha.martens@univie.ac.at	Martens, Sascha/C-3693-2011	Sawa-Makarska, Justyna/0000-0002-9321-976X; Martens, Sascha/0000-0003-3786-8199	University of Vienna; European Research Council; FWF Austrian Science Fund [P25546-B20]; VIPS Program of the Austrian Federal Ministry of Science and Research; Austrian FFG; ERC [260304]; Austrian Science Fund (FWF) [P 25546] Funding Source: researchfish	University of Vienna; European Research Council(European Research Council (ERC)European Commission); FWF Austrian Science Fund(Austrian Science Fund (FWF)); VIPS Program of the Austrian Federal Ministry of Science and Research; Austrian FFG; ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank C. Kraft and T. Brach for providing reagents and G. Warren for critical comments on the manuscript. Funding by the University of Vienna is gratefully acknowledged. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007- 2013)/ERC grant agreement number 260304, from the FWF Austrian Science Fund (grant number P25546-B20) and by the EMBO Young Investigator Program to S. M. We also acknowledge funding by the VIPS Program of the Austrian Federal Ministry of Science and Research and the City of Vienna to J. S-M. and by the Austrian FFG to C. A.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Geng JF, 2008, J CELL BIOL, V182, P129, DOI 10.1083/jcb.200711112; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Leber R, 2001, J BIOL CHEM, V276, P29210, DOI 10.1074/jbc.M101438200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Orsi A, 2010, CURR OPIN CELL BIOL, V22, P150, DOI 10.1016/j.ceb.2009.11.013; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906	36	84	84	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					425	U100		10.1038/ncb2935	http://dx.doi.org/10.1038/ncb2935			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24705553	Green Accepted			2022-12-25	WOS:000335438400007
J	Bentley, K; Franco, CA; Philippides, A; Blanco, R; Dierkes, M; Gebala, V; Stanchi, F; Jones, M; Aspalter, IM; Cagna, G; Westrom, S; Claesson-Welsh, L; Vestweber, D; Gerhardt, H				Bentley, Katie; Franco, Claudio Areias; Philippides, Andrew; Blanco, Raquel; Dierkes, Martina; Gebala, Veronique; Stanchi, Fabio; Jones, Martin; Aspalter, Irene M.; Cagna, Guiseppe; Westrom, Simone; Claesson-Welsh, Lena; Vestweber, Dietmar; Gerhardt, Holger			The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis	NATURE CELL BIOLOGY			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; ADHESION HYPOTHESIS; REGULATES FORMATION; ADAPTER PROTEIN; IN-VIVO; MORPHOGENESIS; PERMEABILITY; PTP; ENDOCYTOSIS; SIMULATION	Endothelial cells show surprising cell rearrangement behaviour during angiogenic sprouting; however, the underlying mechanisms and functional importance remain unclear. By combining computational modelling with experimentation, we identify that Notch/VEGFR-regulated differential dynamics of VE-cadherin junctions drive functional endothelial cell rearrangements during sprouting. We propose that continual flux in Notch signalling levels in individual cells results in differential VE-cadherin turnover and junctional-cortex protrusions, which powers differential cell movement. In cultured endothelial cells, Notch signalling quantitatively reduced junctional VE-cadherin mobility. In simulations, only differential adhesion dynamics generated long-range position changes, required for tip cell competition and stalk cell intercalation. Simulation and quantitative image analysis on VE-cadherin junctional patterning in vivo identified that differential VE-cadherin mobility is lost under pathological high VEGF conditions, in retinopathy and tumour vessels. Our results provide a mechanistic concept for how cells rearrange during normal sprouting and how rearrangement switches to generate abnormal vessels in pathologies.	[Bentley, Katie; Franco, Claudio Areias; Blanco, Raquel; Gebala, Veronique; Jones, Martin; Aspalter, Irene M.; Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London WC2A 3LY, England; [Philippides, Andrew] Univ Sussex, Dept Informat, Ctr Computat Neurosci & Robot, Brighton BN1 9QJ, E Sussex, England; [Dierkes, Martina; Cagna, Guiseppe; Vestweber, Dietmar] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Stanchi, Fabio; Gerhardt, Holger] VIB3 Vesalius Res Ctr, Vasc Patterning Lab, B-3000 Louvain, Belgium; [Stanchi, Fabio; Gerhardt, Holger] CMVB, Dept Oncol, B-3000 Louvain, Belgium; [Westrom, Simone; Claesson-Welsh, Lena] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden	Cancer Research UK; University of Sussex; Max Planck Society; Uppsala University	Bentley, K (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Computat Biol Lab,Ctr Vasc Biol Res, Boston, MA 02215 USA.	kbentley@bidmc.harvard.edu; holger.gerhardt@cancer.org.uk	Jones, Martin/C-9936-2010; Philippides, Andrew/E-7240-2010; Franco, Claudio A/D-8117-2015; Gerhardt, Holger/G-4610-2011; Jones, Martin/AAE-8458-2019; Franco, Claudio A/B-1060-2013	Jones, Martin/0000-0003-0994-5652; Philippides, Andrew/0000-0001-5503-0467; Franco, Claudio A/0000-0002-2861-3883; Gerhardt, Holger/0000-0002-3030-0384; Jones, Martin/0000-0003-0994-5652; Franco, Claudio A/0000-0002-2861-3883; Vestweber, Dietmar/0000-0002-3517-732X; Stanchi, Fabio/0000-0003-3393-2472; Aspalter, Irene Maria/0000-0002-6155-9006; Bentley, Katie/0000-0002-9391-659X	Marie Curie FP7 people initiative Fellowship; HFSP fellowship; EPSRC [EP/I031758/1]; Deutsche Forschungsgemeinschaft [SFB629]; Max-Planck-Society; Knut and Alice Wallenberg Foundation; Association for International Cancer Research; Cancer Research UK; Lister Institute of Preventive Medicine; Leducq transatlantic Network ARTEMIS; ERC [311719]; Engineering and Physical Sciences Research Council [EP/I031758/1] Funding Source: researchfish	Marie Curie FP7 people initiative Fellowship; HFSP fellowship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; Leducq transatlantic Network ARTEMIS(Leducq Foundation); ERC(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Cancer Research UK, the Lister Institute of Preventive Medicine, the Leducq transatlantic Network ARTEMIS and the ERC starting grant REshape (311719). C.F. is supported by a Marie Curie FP7 people initiative Fellowship. R.B. is supported by a HFSP fellowship. AP was financially supported by EPSRC grant EP/I031758/1. G.C. and D.V. were supported by funds from the Deutsche Forschungsgemeinschaft (SFB629) and the Max-Planck-Society. L.C.W. and S.W. are supported by grants from the Knut and Alice Wallenberg Foundation and from the Association for International Cancer Research. We thank B. Cruys (KU Leuven) and C. Lewis (MIT) for comments on the manuscript. We thank R. Chaleil for his support and maintenance of the high-performance computing system.	Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; Bauer AL, 2010, J THEOR BIOL, V264, P838, DOI 10.1016/j.jtbi.2010.03.025; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Franco CA, 2013, DEVELOPMENT, V140, P2321, DOI 10.1242/dev.091074; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; GOODWIN BC, 1993, J THEOR BIOL, V163, P135, DOI 10.1006/jtbi.1993.1112; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kouklis P, 2003, J BIOL CHEM, V278, P16230, DOI 10.1074/jbc.M212591200; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745; Neumann M, 2006, EMBO REP, V7, P36, DOI 10.1038/sj.embor.7400597; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Podgorski GJ, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-43; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Saharinen P, 2011, J CLIN INVEST, V121, P2157, DOI 10.1172/JCI58196; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; SEYFRIED TN, 1992, MOL CHEM NEUROPATHOL, V17, P147, DOI 10.1007/BF03159989; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sun ZY, 2012, J EXP MED, V209, P1363, DOI 10.1084/jem.20111343; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; vanOss C, 1996, J THEOR BIOL, V181, P203, DOI 10.1006/jtbi.1996.0126; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005	63	232	236	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					309	+		10.1038/ncb2926	http://dx.doi.org/10.1038/ncb2926			41	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24658686				2022-12-25	WOS:000333556900005
J	Penkov, S; Ogawa, A; Schmidt, U; Tate, D; Zagoriy, V; Boland, S; Gruner, M; Vorkel, D; Verbavatz, JM; Sommer, RJ; Knolker, HJ; Kurzchalia, TV				Penkov, Sider; Ogawa, Akira; Schmidt, Ulrike; Tate, Dhananjay; Zagoriy, Vyacheslav; Boland, Sebastian; Gruner, Margit; Vorkel, Daniela; Verbavatz, Jean-Marc; Sommer, Ralf J.; Knoelker, Hans-Joachim; Kurzchalia, Teymuras V.			A wax ester promotes collective host finding in the nematode Pristionchus pacificus	NATURE CHEMICAL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; BEHAVIOR; DAUERLARVA; LARVAE	Survival of nematode species depends on how successfully they disperse in the habitat and find a new host. As a new strategy for collective host finding in the nematode Pristionchus pacificus, dauer larvae synthesize an extremely long-chain polyunsaturated wax ester (nematoil) that covers the surface of the animal. The oily coat promotes congregation of up to one thousand individuals into stable 'dauer towers' that can reach a beetle host more easily.	[Penkov, Sider; Zagoriy, Vyacheslav; Boland, Sebastian; Vorkel, Daniela; Verbavatz, Jean-Marc; Kurzchalia, Teymuras V.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Ogawa, Akira; Tate, Dhananjay; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany; [Ogawa, Akira] RIKEN Quantitat Biol Ctr, Lab Dev Dynam, Kobe, Hyogo, Japan; [Schmidt, Ulrike; Gruner, Margit; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, Dresden, Germany	Max Planck Society; Max Planck Society; RIKEN; Technische Universitat Dresden	Penkov, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	hans-joachim.knoelker@tu-dresden.de; kurzchalia@mpi-cbg.de	Boland, Sebastian/AAL-4065-2020; Knölker, Hans-Joachim/I-4954-2019; Boland, Sebastian/AAJ-3560-2020	Knölker, Hans-Joachim/0000-0002-9631-5239; Boland, Sebastian/0000-0002-6694-2039; Verbavatz, Jean-Marc/0000-0002-4654-1174; Tate, Dhananjay/0000-0002-3761-4167	European Science Foundation EuroMembrane Network (DFG) [KN 240/13-1]	European Science Foundation EuroMembrane Network (DFG)	We thank all members of the Kurzchalia, Sommer and Knolker labs for helpful discussions. We are grateful to J. Saenz for proofreading the manuscript. We thank the Caenorhabditis Genetics Center for providing C. elegans strains. Work in the Knolker laboratory was supported by the European Science Foundation EuroMembrane Network (DFG grant KN 240/13-1). We thank R. Czerwonka for her experimental support in the synthesis of nematoil and J. Sampaio and O. Lavrynenko for their assistance in MS.	ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRENNER S, 1974, GENETICS, V77, P71; Brown FD, 2011, P ROY SOC B-BIOL SCI, V278, P3260, DOI 10.1098/rspb.2011.0129; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Croll NA., 1977, BIOL NEMATODES, P152; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fuchs G., 1914, VERHANDLUNG GESELLSC, V2, P688; Gems D, 1998, GENETICS, V150, P129; Lee H, 2012, NAT NEUROSCI, V15, P107, DOI 10.1038/nn.2975; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Ogawa A, 2009, SCIENCE, V326, P944, DOI 10.1126/science.1183272; Okumura E, 2013, J EXP BIOL, V216, P1470, DOI 10.1242/jeb.075739; POPHAM JD, 1978, CAN J ZOOL, V56, P1556, DOI 10.1139/z78-217; Riddle D. L., 1988, COLD SPRING HARBOR M, V17; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Wharton DA, 2008, J EXP BIOL, V211, P2901, DOI 10.1242/jeb.020743; Wolfmeier U., 2000, ULLMANNS ENCY IND CH	18	19	19	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					281	+		10.1038/NCHEMBIO.1460	http://dx.doi.org/10.1038/NCHEMBIO.1460			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24584102				2022-12-25	WOS:000333172900010
J	Casali, N; Nikolayevskyy, V; Balabanova, Y; Harris, SR; Ignatyeva, O; Kontsevaya, I; Corander, J; Bryant, J; Parkhill, J; Nejentsev, S; Horstmann, RD; Brown, T; Drobniewski, F				Casali, Nicola; Nikolayevskyy, Vladyslav; Balabanova, Yanina; Harris, Simon R.; Ignatyeva, Olga; Kontsevaya, Irina; Corander, Jukka; Bryant, Josephine; Parkhill, Julian; Nejentsev, Sergey; Horstmann, Rolf D.; Brown, Timothy; Drobniewski, Francis			Evolution and transmission of drug-resistant tuberculosis in a Russian population	NATURE GENETICS			English	Article							MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; NUCLEOTIDE POLYMORPHISMS; COMPENSATORY MUTATIONS; BEIJING STRAIN; GENE; ETHIONAMIDE; FITNESS; STRATEGIES; KANAMYCIN	The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.	[Casali, Nicola; Nikolayevskyy, Vladyslav; Balabanova, Yanina; Brown, Timothy; Drobniewski, Francis] Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England; [Harris, Simon R.; Bryant, Josephine; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Ignatyeva, Olga; Kontsevaya, Irina] Samara Oblast TB Dispensary, Samara, Russia; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Drobniewski, Francis] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England	University of London; Queen Mary University London; Wellcome Trust Sanger Institute; University of Helsinki; University of Cambridge; Bernhard Nocht Institut fur Tropenmedizin; Imperial College London	Drobniewski, F (corresponding author), Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England.	f.drobniewski@qmul.ac.uk	Parkhill, Julian/G-4703-2011; Bryant, Josephine/ABC-8288-2021; Kontsevaya, Irina/AAJ-8173-2020; Nikolayevskyy, Vladyslav/HFZ-7738-2022; Harris, Simon R/K-1318-2013	Parkhill, Julian/0000-0002-7069-5958; Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Harris, Simon R/0000-0003-1512-6194; Kontsevaya, Irina/0000-0003-3421-7550; Ignatyeva, Olga/0000-0003-2020-4206; Drobniewski, Francis/0000-0002-5661-2490	European Union Framework Programme 7 (TB-EUROGEN) [201483]; Wellcome Trust [098051]; EUROGEN; Wellcome Trust Senior Research Fellow in Basic Biomedical Science [095198/Z/10/Z]; European Research Council Starting Grant [260477]; Medical Research Council [974668] Funding Source: researchfish	European Union Framework Programme 7 (TB-EUROGEN); Wellcome Trust(Wellcome TrustEuropean Commission); EUROGEN; Wellcome Trust Senior Research Fellow in Basic Biomedical Science(Wellcome Trust); European Research Council Starting Grant(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to members of the Public Health England National Mycobacterium Reference Laboratory and the Samara Regional Tuberculosis Laboratory for bacteriological work, particularly M. Stone, X. Gonzalo and A. Broda. We would also like to thank the Samara Tuberculosis Service, particularly I. Fedorin, as well as V. Kulichenko. We thank R. Hooper for expert statistical advice, S. Hoffner for bacteriological advice and S. Bentley for sequencing advice. This study was supported by European Union Framework Programme 7 (grant 201483; TB-EUROGEN), with sequencing funded by the Wellcome Trust (grant 098051) and EUROGEN. S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science (095198/Z/10/Z) and is also supported by European Research Council Starting Grant 260477.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Balabanova Y, 2005, EUR J CLIN MICROBIOL, V24, P136, DOI 10.1007/s10096-004-1268-4; Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-0003511, 10.1136/bmjopen-2011-000351]; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020531; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Cai JJ, 2008, J HERED, V99, P438, DOI 10.1093/jhered/esm127; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Hall AR, 2010, P ROY SOC B-BIOL SCI, V277, P643, DOI 10.1098/rspb.2009.1630; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Health Protection Agency, 2012, TUB UK 2012 REP; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nei M., 1987, MOL EVOLUTIONARY GEN; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reynolds MG, 2000, GENETICS, V156, P1471; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shen X, 2007, ANTIMICROB AGENTS CH, V51, P2618, DOI 10.1128/AAC.01516-06; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000455; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; Wu SP, 2009, MICROBIOL-SGM, V155, P1272, DOI 10.1099/mic.0.024638-0; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	64	317	331	1	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					279	+		10.1038/ng.2878	http://dx.doi.org/10.1038/ng.2878			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24464101	Green Accepted, Green Submitted			2022-12-25	WOS:000332036700012
J	Kuleshov, V; Xie, D; Chen, R; Pushkarev, D; Ma, ZH; Blauwkamp, T; Kertesz, M; Snyder, M				Kuleshov, Volodymyr; Xie, Dan; Chen, Rui; Pushkarev, Dmitry; Ma, Zhihai; Blauwkamp, Tim; Kertesz, Michael; Snyder, Michael			Whole-genome haplotyping using long reads and statistical methods	NATURE BIOTECHNOLOGY			English	Article							IMPRINTED GENES; SEQUENCE; AMPLIFICATION; POLYMORPHISM	The rapid growth of sequencing technologies has greatly contributed to our understanding of human genetics. Yet, despite this growth, mainstream technologies have not been fully able to resolve the diploid nature of the human genome. Here we describe statistically aided, long-read haplotyping (SLRH), a rapid, accurate method that uses a statistical algorithm to take advantage of the partially phased information contained in long genomic fragments analyzed by short-read sequencing. For a human sample, as little as 30 Gbp of additional sequencing data are needed to phase genotypes identified by 50x coverage whole-genome sequencing. Using SLRH, we phase 99% of single-nucleotide variants in three human genomes into long haplotype blocks 0.2-1 Mbp in length. We apply our method to determine allele-specific methylation patterns in a human genome and identify hundreds of differentially methylated regions that were previously unknown. SLRH should facilitate population-scale haplotyping of human genomes.	[Kuleshov, Volodymyr] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kuleshov, Volodymyr; Pushkarev, Dmitry; Blauwkamp, Tim; Kertesz, Michael] Illumina Inc, San Diego, CA USA; [Kuleshov, Volodymyr; Xie, Dan; Chen, Rui; Ma, Zhihai; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Illumina; Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Ma, Zhihai/E-7130-2015	Snyder, Michael/0000-0003-0784-7987	US National Institutes of Health [HL107393-02, HG004558-05]; Genetics Department of Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102556] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Department of Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Pan for assistance in coordinating contacts and discussions. This work is funded by US National Institutes of Health grants HL107393-02, HG004558-05, and the Genetics Department of Stanford University.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fong CY, 2010, DEV MED CHILD NEUROL, V52, P489, DOI 10.1111/j.1469-8749.2010.03618.x; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li N, 2003, GENETICS, V165, P2213; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; RUANO G, 1990, P NATL ACAD SCI USA, V87, P6296, DOI 10.1073/pnas.87.16.6296; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shimizu H, 1999, J AM ACAD DERMATOL, V41, P950, DOI 10.1016/S0190-9622(99)70252-5; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Welch KO, 2007, AM J MED GENET A, V143A, P1567, DOI 10.1002/ajmg.a.31701; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108	31	125	132	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					261	266		10.1038/nbt.2833	http://dx.doi.org/10.1038/nbt.2833			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24561555	Green Accepted			2022-12-25	WOS:000332819800024
J	Taur, Y; Pamer, EG				Taur, Ying; Pamer, Eric G.			Fixing the microbiota to treat Clostridium difficile infections	NATURE MEDICINE			English	Editorial Material							SPORE GERMINATION; BILE-SALTS; EPIDEMIOLOGY		[Taur, Ying; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Taur, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA.	taury@mskcc.org		Taur, Ying/0000-0002-6601-8284	NIAID NIH HHS [R01 AI095706, K23 AI095398] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095398, R01AI095706] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Emanuelsson F, 2014, SCAND J INFECT DIS, V46, P89, DOI 10.3109/00365548.2013.858181; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Kassam Z, 2013, AM J GASTROENTEROL, V108, P1538, DOI 10.1038/ajg.2013.214; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	18	34	63	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					246	247		10.1038/nm.3492	http://dx.doi.org/10.1038/nm.3492			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24603796	Green Accepted			2022-12-25	WOS:000332595600017
J	Fushinobu, S				Fushinobu, Shinya			A new face for biomass breakdown	NATURE CHEMICAL BIOLOGY			English	News Item							DEGRADATION; INSIGHTS; ENZYMES		Univ Tokyo, Dept Biotechnol, Tokyo, Japan	University of Tokyo	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011	Fushinobu, Shinya/0000-0003-1346-6435				ERIKSSON KE, 1974, FEBS LETT, V49, P282, DOI 10.1016/0014-5793(74)80531-4; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807	10	19	19	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					88	89		10.1038/nchembio.1434	http://dx.doi.org/10.1038/nchembio.1434			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24362704				2022-12-25	WOS:000330751600002
J	Haris, M; Singh, A; Cai, KJ; Kogan, F; McGarvey, J; DeBrosse, C; Zsido, GA; Witschey, WRT; Koomalsingh, K; Pilla, JJ; Chirinos, JA; Ferrari, VA; Gorman, JH; Hariharan, H; Gorman, RC; Reddy, R				Haris, Mohammad; Singh, Anup; Cai, Kejia; Kogan, Feliks; McGarvey, Jeremy; DeBrosse, Catherine; Zsido, Gerald A.; Witschey, Walter R. T.; Koomalsingh, Kevin; Pilla, James J.; Chirinos, Julio A.; Ferrari, Victor A.; Gorman, Joseph H.; Hariharan, Hari; Gorman, Robert C.; Reddy, Ravinder			A technique for in vivo mapping of myocardial creatine kinase metabolism	NATURE MEDICINE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; ENERGY PHOSPHATE METABOLITES; FAILING HUMAN MYOCARDIUM; CONTRAST; VIABILITY; EXCHANGE; MRI; SPECTROSCOPY; INFARCTION; QUANTIFICATION	ATP derived from the conversion of phosphocreatine to creatine by creatine kinase provides an essential chemical energy source that governs myocardial contraction. Here, we demonstrate that the exchange of amine protons from creatine with protons in bulk water can be exploited to image creatine through chemical exchange saturation transfer (CrEST) in myocardial tissue. We show that CrEST provides about two orders of magnitude higher sensitivity compared to H-1 magnetic resonance spectroscopy. Results of CrEST studies from ex vivo myocardial tissue strongly correlate with results from 1H and P-31 magnetic resonance spectroscopy and biochemical analysis. We demonstrate the feasibility of CrEST measurement in healthy and infarcted myocardium in animal models in vivo on a 3-T clinical scanner. As proof of principle, we show the conversion of phosphocreatine to creatine by spatiotemporal mapping of creatine changes in the exercised human calf muscle. We also discuss the potential utility of CrEST in studying myocardial disorders.	[Haris, Mohammad; Singh, Anup; Cai, Kejia; Kogan, Feliks; DeBrosse, Catherine; Witschey, Walter R. T.; Hariharan, Hari; Reddy, Ravinder] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA; [McGarvey, Jeremy; Zsido, Gerald A.; Witschey, Walter R. T.; Koomalsingh, Kevin; Pilla, James J.; Gorman, Joseph H.; Gorman, Robert C.] Univ Penn, Dept Surg, Gorman Cardiovasc Res Grp, Philadelphia, PA 19104 USA; [Chirinos, Julio A.] Philadelphia Vet Affairs Med Ctr, Dept Med, Philadelphia, PA USA; [Chirinos, Julio A.; Ferrari, Victor A.] Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Reddy, R (corresponding author), Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA.	krr@mail.med.upenn.edu	Kogan, Feliks/AAH-5814-2019	Haris, Mohammad/0000-0002-4945-2935; Reddy, Ravinder/0000-0003-4580-2392; Hariharan, Hari/0000-0002-7032-6968; Kogan, Feliks/0000-0003-0580-7308; Singh, Anup/0000-0001-6744-8326; Ferrari, Victor/0000-0001-8696-3243	National Institutes of Health [P41 EB015893, P41 E5015893S1, R21DA032256-01]; Translational Biomedical Imaging Center of the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL108157, R00HL108157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Biomedical Imaging Center of the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P41 EB015893, P41 E5015893S1 and R21DA032256-01 and a pilot grant from the Translational Biomedical Imaging Center of the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania. The authors acknowledge W Liu and S. Pickup for technical assistance in using the 9.4-T NMR spectrometer, K. Nath for assistance with biochemical analysis and D. Reddy for help with regulatory protocol.	ARUS C, 1984, FEBS LETT, V165, P231, DOI 10.1016/0014-5793(84)80175-1; BALABAN RS, 1991, RADIOLOGY, V180, P671, DOI 10.1148/radiology.180.3.1871277; Bax J.J, 1997, INT J CARD IMAGING, V13, P157; Bax JJ, 1997, INT J CARDIAC IMAG, V13, P145, DOI 10.1023/A:1005744810876; Bax JJ, 2000, EUR HEART J, V21, P961, DOI 10.1053/euhj.2000.2110; Bax JJ, 1999, JMRI-J MAGN RESON IM, V10, P418; Beek AM, 2003, J AM COLL CARDIOL, V42, P895, DOI 10.1016/S0735-1097(03)00835-0; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; BONOW RO, 1991, SEMIN NUCL MED, V21, P230, DOI 10.1016/S0001-2998(05)80043-1; Bottomley PA, 1998, LANCET, V351, P714, DOI 10.1016/S0140-6736(97)06402-7; Bottomley PA, 1997, RADIOLOGY, V204, P403, DOI 10.1148/radiology.204.2.9240527; Bottomley PA, 1996, MAGNET RESON MED, V35, P664, DOI 10.1002/mrm.1910350507; Bottomley PA, 2001, RADIOLOGY, V219, P411, DOI 10.1148/radiology.219.2.r01ma39411; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; CRANE P, 1993, EUR J NUCL MED, V20, P20, DOI 10.1007/BF02261241; Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9; Francescato MP, 2008, J APPL PHYSIOL, V105, P158, DOI 10.1152/japplphysiol.00007.2008; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Hans M., 2011, NEUROIMAGE, V54, P2079; Haris M, 2012, NMR BIOMED, V25, P1305, DOI 10.1002/nbm.2792; Hu QS, 2006, AM J PHYSIOL-HEART C, V291, pH648, DOI 10.1152/ajpheart.01387.2005; Kim HW, 2009, J AM COLL CARDIOL, V55, P1, DOI 10.1016/j.jacc.2009.06.059; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kitagawa K, 2003, RADIOLOGY, V226, P138, DOI 10.1148/radiol.2261012108; Lamb HJ, 1997, CIRCULATION, V96, P2969, DOI 10.1161/01.CIR.96.9.2969; Laser A, 1996, J MOL CELL CARDIOL, V28, P1531, DOI 10.1006/jmcc.1996.0143; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Liu GS, 2010, CONTRAST MEDIA MOL I, V5, P162, DOI 10.1002/cmmi.383; Metzler B, 2002, J CARDIOVASC MAGN R, V4, P493, DOI 10.1081/JCMR-120016387; Nakae I, 2003, J AM COLL CARDIOL, V42, P1587, DOI 10.1016/j.jacc.2003.05.005; Neubauer S, 2000, MAGN RESON MATER PHY, V11, P73; REIJENGA JC, 1986, J CHROMATOGR, V374, P162, DOI 10.1016/S0378-4347(00)83266-1; REIMER KA, 1983, AM J CARDIOL, V52, pA72; Schroeder MA, 2011, CIRCULATION, V124, P1580, DOI 10.1161/CIRCULATIONAHA.111.024919; Schwitter J, 2011, EUR HEART J, V32, P799, DOI 10.1093/eurheartj/ehq481; Song HK, 2000, MAGNET RESON MED, V44, P825, DOI 10.1002/1522-2594(200012)44:6<825::AID-MRM2>3.0.CO;2-D; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Woo DC, 2010, APPL MAGN RESON, V38, P65, DOI 10.1007/s00723-009-0055-x; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	40	130	133	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					209	214		10.1038/nm.3436	http://dx.doi.org/10.1038/nm.3436			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412924	Green Accepted			2022-12-25	WOS:000330915000023
J	Lee, RE; Hurdle, JG; Liu, JY; Bruhn, DF; Matt, T; Scherman, MS; Vaddady, PK; Zheng, Z; Qi, JJ; Akbergenov, R; Das, S; Madhura, DB; Rathit, C; Trivedi, A; Villellas, C; Lee, RB; Rakesh; Waidyarachchi, SL; Sun, DQ; McNeil, MR; Ainsa, JA; Boshoff, HI; Gonzalez-Juarrero, M; Meibohm, B; Bottger, EC; Lenaerts, AJ				Lee, Richard E.; Hurdle, Julian G.; Liu, Jiuyu; Bruhn, David F.; Matt, Tanja; Scherman, Michael S.; Vaddady, Pavan K.; Zheng, Zhong; Qi, Jianjun; Akbergenov, Rashid; Das, Sourav; Madhura, Dora B.; Rathit, Chetan; Trivedi, Ashit; Villellas, Cristina; Lee, Robin B.; Rakesh; Waidyarachchi, Samanthi L.; Sun, Dianqing; McNeil, Michael R.; Ainsa, Jose A.; Boshoff, Helena I.; Gonzalez-Juarrero, Mercedes; Meibohm, Bernd; Boettger, Erik C.; Lenaerts, Anne J.			Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux	NATURE MEDICINE			English	Article							MEDICINAL CHEMISTS GUIDE; 16S RIBOSOMAL-RNA; MYCOBACTERIUM-TUBERCULOSIS; SPECTINOMYCIN MODIFICATION; RESISTANCE; GLYCYLCYCLINE; ANTIBIOTICS; SELECTIVITY; INHIBITION; PUMP	Although the classical antibiotic spectinomycin is a potent bacterial protein synthesis inhibitor, poor antimycobacterial activity limits its clinical application for treating tuberculosis. Using structure-based design, we generated a new semisynthetic series of spectinomycin analogs with selective ribosomal inhibition and excellent narrow-spectrum antitubercular activity. In multiple murine infection models, these spectinamides were well tolerated, significantly reduced lung mycobacterial burden and increased survival. In vitro studies demonstrated a lack of cross resistance with existing tuberculosis therapeutics, activity against multidrug-resistant (MDR) and extensively drug-resistant tuberculosis and an excellent pharmacological profile. Key to their potent antitubercular properties was their structural modification to evade the Rv1258c efflux pump, which is upregulated in MDR strains and is implicated in macrophage-induced drug tolerance. The antitubercular efficacy of spectinamides demonstrates that synthetic modifications to classical antibiotics can overcome the challenge of intrinsic efflux pump-mediated resistance and expands opportunities for target-based tuberculosis drug discovery.	[Lee, Richard E.; Hurdle, Julian G.; Liu, Jiuyu; Bruhn, David F.; Zheng, Zhong; Qi, Jianjun; Das, Sourav; Lee, Robin B.; Rakesh; Waidyarachchi, Samanthi L.; Sun, Dianqing] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Matt, Tanja; Akbergenov, Rashid; Boettger, Erik C.] Univ Zurich, Inst Med Mikrobiol, Natl Zentrum Mykobakterien, Zurich, Switzerland; [Scherman, Michael S.; McNeil, Michael R.; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol, Mycobacterial Res Labs, Ft Collins, CO 80523 USA; [Vaddady, Pavan K.; Madhura, Dora B.; Rathit, Chetan; Trivedi, Ashit; Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Villellas, Cristina; Ainsa, Jose A.] Univ Zaragoza, Dept Microbiol Med Prevent & Salud Publ, Zaragoza, Spain; [Ainsa, Jose A.] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Boshoff, Helena I.] NIAID, TB Res Stn, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	St Jude Children's Research Hospital; University of Zurich; Colorado State University; University of Tennessee System; University of Tennessee Health Science Center; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lee, RE (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.lee@stjude.org	McNeil, Michael/G-3325-2019; Lee, Richard/AAX-3996-2021; Böttger, Erik C./F-6175-2011; Ainsa, Jose A/G-5635-2010; Lenaerts, Anne/F-1353-2017; Lee, Richard/J-4997-2013	Lee, Richard/0000-0002-2397-0443; Ainsa, Jose A/0000-0003-2076-844X; Lee, Richard/0000-0002-2397-0443; Trivedi, Ashit/0000-0002-5040-5722; Meibohm, Bernd/0000-0003-3923-3648; hurdle, julian/0000-0003-2214-8105; gonzalez-juarrero, mercedes/0000-0002-4045-2365; Vaddady, Pavan/0000-0002-7369-6649; Das, Sourav/0000-0003-1759-0345	US National Institutes of Health (NIH) [AI090810]; National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery Indefinite Quantity (IDIQ); Contract Task Order [HHSN272201000009I/01]; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital (SJCRH); Intramural Research Program of the NIAID, NIH; Spanish Government [BIO-2009-09405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090810, ZIAAI000734, ZIAAI000693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery Indefinite Quantity (IDIQ); Contract Task Order; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital (SJCRH); Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Spanish Government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (NIH) grant AI090810 (R.E.L., E.C.B., A.J.L. and B.M.), the National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery Indefinite Quantity (IDIQ) (R.E.L. and M.G.) Contract Task Order HHSN272201000009I/01, the American Lebanese Syrian Associated Charities (ALSAC) and St. Jude Children's Research Hospital (SJCRH) (R.E.L.) and in part by the Intramural Research Program of the NIAID, NIH (H.I.B.) and the Spanish Government (grant BIO-2009-09405) (J.A.A.). We thank L. Yang and J. Scarborough from SJCRH for their help with analysis of the final compounds, M. Maddox from SJCRH for technical assistance in determining MIC values, J. Ryman from the University of Tennessee Health Science Center for technical assistance in the performance of pharmacokinetic studies in mice, M. Butler from Microbiotix for coordination of the MDR tuberculosis testing and E. Tuomanen from SJCRH for critical evaluation of this manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Akbergenov R, 2011, ANTIMICROB AGENTS CH, V55, P4712, DOI 10.1128/AAC.00628-11; Akiyoshi M, 1976, Jpn J Antibiot, V29, P771; Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Barnhill AE, 2012, ANTIMICROB AGENTS CH, V56, P4046, DOI 10.1128/AAC.00678-12; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Dartois V, 2013, BIOORG MED CHEM LETT, V23, P4741, DOI 10.1016/j.bmcl.2013.07.006; Drusano GL, 2004, NAT REV MICROBIOL, V2, P289, DOI 10.1038/nrmicro862; FOLEY L, 1979, J ANTIBIOT, V32, P418, DOI 10.7164/antibiotics.32.418; FOLEY L, 1978, J ANTIBIOT, V31, P979, DOI 10.7164/antibiotics.31.979; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Galimand M, 2000, ANTIMICROB AGENTS CH, V44, P1365, DOI 10.1128/AAC.44.5.1365-1366.2000; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hobbie SN, 2007, NUCLEIC ACIDS RES, V35, P6086, DOI 10.1093/nar/gkm658; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; Lee RE, 1996, CURR TOP MICROBIOL, V215, P1; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Madhura DB, 2013, PHARMAZIE, V68, P675, DOI 10.1691/ph.2013.3501; MAIER R, 1981, J ANTIBIOT, V34, P16, DOI 10.7164/antibiotics.34.16; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; NOVAK E, 1974, J CLIN PHARMACOL, V14, P442, DOI 10.1002/j.1552-4604.1974.tb02326.x; Projan SJ, 2000, PHARMACOTHERAPY, V20, p219S, DOI 10.1592/phco.20.14.219S.35046; Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11; ROSENBROOK W, 1975, J ANTIBIOT, V28, P953, DOI 10.7164/antibiotics.28.953; Shcherbakov D, 2010, MOL MICROBIOL, V77, P830, DOI 10.1111/j.1365-2958.2010.07218.x; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; THOMAS RC, 1985, J ANTIBIOT, V38, P208, DOI 10.7164/antibiotics.38.208; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; WILEY PF, 1963, J AM CHEM SOC, V85, P2652, DOI 10.1021/ja00900a028; WOITUN E, 1981, J ANTIBIOT, V34, P22, DOI 10.7164/antibiotics.34.22; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; ZURENKO GE, 1988, ANTIMICROB AGENTS CH, V32, P216, DOI 10.1128/AAC.32.2.216	44	124	126	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					152	158		10.1038/nm.3458	http://dx.doi.org/10.1038/nm.3458			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24464186	Green Accepted			2022-12-25	WOS:000330915000016
J	Thompson, BA; Spurdle, AB; Plazzer, JP; Greenblatt, MS; Akagi, K; Al-Mulla, F; Bapat, B; Bernstein, I; Capella, G; den Dunnen, JT; du Sart, D; Fabre, A; Farrell, MP; Farrington, SM; Frayling, IM; Frebourg, T; Goldgar, DE; Heinen, CD; Holinski-Feder, E; Kohonen-Corish, M; Robinson, KL; Leung, SY; Martins, A; Moller, P; Morak, M; Nystrom, M; Peltomaki, P; Pineda, M; Qi, M; Ramesar, R; Rasmussen, LJ; Royer-Pokora, B; Scott, RJ; Sijmons, R; Tavtigian, SV; Tops, CM; Weber, T; Wijnen, J; Woods, MO; Macrae, F; Genuardi, M				Thompson, Bryony A.; Spurdle, Amanda B.; Plazzer, John-Paul; Greenblatt, Marc S.; Akagi, Kiwamu; Al-Mulla, Fahd; Bapat, Bharati; Bernstein, Inge; Capella, Gabriel; den Dunnen, Johan T.; du Sart, Desiree; Fabre, Aurelie; Farrell, Michael P.; Farrington, Susan M.; Frayling, Ian M.; Frebourg, Thierry; Goldgar, David E.; Heinen, Christopher D.; Holinski-Feder, Elke; Kohonen-Corish, Maija; Robinson, Kristina Lagerstedt; Leung, Suet Yi; Martins, Alexandra; Moller, Pal; Morak, Monika; Nystrom, Minna; Peltomaki, Paivi; Pineda, Marta; Qi, Ming; Ramesar, Rajkumar; Rasmussen, Lene Juel; Royer-Pokora, Brigitte; Scott, Rodney J.; Sijmons, Rolf; Tavtigian, Sean V.; Tops, Carli M.; Weber, Thomas; Wijnen, Juul; Woods, Michael O.; Macrae, Finlay; Genuardi, Maurizio		InSiGHT	Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; UNKNOWN CLINICAL-SIGNIFICANCE; MSH6 GERMLINE MUTATIONS; HUMAN GENOME VARIATION; LYNCH-SYNDROME; SEQUENCE VARIANTS; MICROSATELLITE INSTABILITY; COLON-CANCER; MISSENSE SUBSTITUTIONS; TUMOR CHARACTERISTICS	The clinical classification of hereditary sequence variants identified in disease-related genes directly affects clinical management of patients and their relatives. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) undertook a collaborative effort to develop, test and apply a standardized classification scheme to constitutional variants in the Lynch syndrome-associated genes MLH1, MSH2, MSH6 and PMS2. Unpublished data submission was encouraged to assist in variant classification and was recognized through microattribution. The scheme was refined by multidisciplinary expert committee review of the clinical and functional data available for variants, applied to 2,360 sequence alterations, and disseminated online. Assessment using validated criteria altered classifications for 66% of 12,006 database entries. Clinical recommendations based on transparent evaluation are now possible for 1,370 variants that were not obviously protein truncating from nomenclature. This large-scale endeavor will facilitate the consistent management of families suspected to have Lynch syndrome and demonstrates the value of multidisciplinary collaboration in the curation and classification of variants in public locus-specific databases.	[Thompson, Bryony A.; Spurdle, Amanda B.] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Thompson, Bryony A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Plazzer, John-Paul; Macrae, Finlay] Royal Melbourne Hosp, Dept Colorectal Med & Genet, Melbourne, Vic, Australia; [Greenblatt, Marc S.] Univ Vermont, Coll Med, Vermont Canc Ctr, Burlington, VT USA; [Akagi, Kiwamu] Saitama Canc Ctr, Div Mol Diag & Canc Prevent, Saitama, Japan; [Al-Mulla, Fahd] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Pathol, Safat, Kuwait; [Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Bernstein, Inge] Danish Hereditary Nonpolyposis Colorectal Canc Re, Copenhagen, Denmark; [Bernstein, Inge] Aalborg Univ Hosp, Dept Surg Gastroenterol, Aalborg, Denmark; [Capella, Gabriel; Pineda, Marta] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain; [den Dunnen, Johan T.; Tops, Carli M.; Wijnen, Juul] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [du Sart, Desiree] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Mol Genet Lab, Melbourne, Vic, Australia; [Fabre, Aurelie] INSERM, Dept Med Genet & Funct Genom, UMR S910, F-13258 Marseille, France; [Farrell, Michael P.] Mater Private Hosp, Dept Canc Genet, Dublin, Ireland; [Farrington, Susan M.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Frayling, Ian M.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Frebourg, Thierry; Martins, Alexandra] Univ Rouen, Inst Res & Innovat Biomed, INSERM, U1079, Rouen, France; [Frebourg, Thierry] Rouen Univ Hosp, Dept Genet, Rouen, France; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Goldgar, David E.; Tavtigian, Sean V.] Huntsman Canc Inst, Salt Lake City, UT USA; [Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT USA; [Holinski-Feder, Elke; Morak, Monika] Med Genet Zentrum, Munich, Germany; [Holinski-Feder, Elke; Morak, Monika] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Kohonen-Corish, Maija] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Kohonen-Corish, Maija] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Kohonen-Corish, Maija] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Robinson, Kristina Lagerstedt] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Genet Diag Lab, Pokfulam, Hong Kong, Peoples R China; [Moller, Pal] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Genet, Res Grp Inherited Canc, Oslo, Norway; [Nystrom, Minna] Univ Helsinki, Dept Biosci, Div Genet, Helsinki, Finland; [Peltomaki, Paivi] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Qi, Ming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, James Watson Inst Genom Sci,Beijing Genome Inst,C, Beijing, Peoples R China; [Qi, Ming] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA; [Ramesar, Rajkumar] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Human Genet,MRC,Human Genet Res Unit, ZA-7925 Cape Town, South Africa; [Rasmussen, Lene Juel] Univ Copenhagen, Ctr Healthy Aging, Copenhagen, Denmark; [Royer-Pokora, Brigitte] Univ Dusseldorf, Inst Human Genet, Dusseldorf, Germany; [Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, Fac Hlth, Discipline Med Genet, Newcastle, NSW 2300, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Div Mol Med, Newcastle, NSW, Australia; [Sijmons, Rolf] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Weber, Thomas] State Univ New York Downstate, Dept Surg, Brooklyn, NY USA; [Woods, Michael O.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Genuardi, Maurizio] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Genuardi, Maurizio] Fiorgen Fdn Pharmacogen, Florence, Italy	QIMR Berghofer Medical Research Institute; University of Queensland; Royal Melbourne Hospital; University of Vermont; Kuwait University; University of Toronto; Aalborg University; Aalborg University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Murdoch Children's Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Mater Private Hospital; University of Edinburgh; Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; University of Connecticut; University of Connecticut; University of Munich; Garvan Institute of Medical Research; Western Sydney University; University of New South Wales Sydney; Karolinska Institutet; Karolinska University Hospital; University of Hong Kong; University of Oslo; University of Helsinki; University of Helsinki; Beijing Genomics Institute (BGI); Zhejiang University; University of Rochester; University of Cape Town; University of Copenhagen; Heinrich Heine University Dusseldorf; Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; University of Groningen; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Memorial University Newfoundland; University of Florence	Genuardi, M (corresponding author), Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy.	maurizio.genuardi@unifi.it	Martins, Alexandra/J-9592-2013; Ward, Robyn L/I-2313-2013; Genuardi, Maurizio/K-3049-2018; Ligtenberg, Marjolijn/N-9666-2013; Capella, Gabriel/I-1879-2015; Mensenkamp, Arjen/L-4520-2015; Farrington, Susan M/Q-2710-2019; Leung, Suet Yi/C-4340-2009; Silva, Felipe/B-2943-2011; Fabre, Aurelie/M-1660-2016; Castillo, Adela Castillejo/AAD-3477-2020; Ramesar, Raj S/I-6941-2015; dunnen, johan den/ABH-4228-2020; Farrington, Susan M/C-7319-2013; Bapat, Bharati/B-5839-2014; Bernstein, Inge/AAD-8159-2020; Blanco, Ignacio/AAN-5426-2021; martinez, joaquin/AAN-6939-2020; Viel, Alessandra/J-7116-2018; Riu, Marta Pineda/I-1497-2015; Kohonen-Corish, Maija/Q-9763-2019; Spurdle, Amanda B/A-4978-2011; Al-Mulla, Fahd/E-2068-2015; Frebourg, Thierry/AAK-8390-2020; Zahary, Mohd Nizam/K-7280-2015; Jenkins, Mark/P-7803-2015; Dunlop, Malcolm/F-1973-2011; Leung, Suet Yi/T-9620-2019; Pedroni, Monica/C-9384-2015; Scott, Rodney/B-2827-2013	Martins, Alexandra/0000-0003-4322-8497; Ward, Robyn L/0000-0002-6877-8906; Genuardi, Maurizio/0000-0002-7410-8351; Ligtenberg, Marjolijn/0000-0003-1290-1474; Capella, Gabriel/0000-0002-4669-7320; Mensenkamp, Arjen/0000-0003-3805-877X; Farrington, Susan M/0000-0001-5955-7389; Silva, Felipe/0000-0002-4241-3036; Fabre, Aurelie/0000-0002-6748-0147; Castillo, Adela Castillejo/0000-0002-9581-6285; Ramesar, Raj S/0000-0001-5688-1634; dunnen, johan den/0000-0002-6304-1710; Bernstein, Inge/0000-0003-4095-432X; Blanco, Ignacio/0000-0002-7414-7481; martinez, joaquin/0000-0001-7908-0063; Viel, Alessandra/0000-0003-2804-0840; Riu, Marta Pineda/0000-0002-5403-5845; Kohonen-Corish, Maija/0000-0002-4073-1479; Spurdle, Amanda B/0000-0003-1337-7897; Al-Mulla, Fahd/0000-0001-5409-3829; Glaser, Elizabeth/0000-0002-1918-057X; Thompson, Bryony/0000-0001-8655-1839; Peltomaki, Paivi/0000-0001-8819-2980; Frebourg, Thierry/0000-0003-0399-4007; Soto, Jose Luis/0000-0003-0234-9188; Garcia-Planells, Javier/0000-0002-3224-2966; Jenkins, Mark/0000-0002-8964-6160; Hofstra, Robert/0000-0001-7498-3829; Frayling, Ian/0000-0002-3420-0794; Sarin, Rajiv/0000-0002-6405-8282; Dunlop, Malcolm/0000-0002-3033-5851; Engel, Christoph/0000-0002-7247-282X; Nystrom, Minna/0000-0003-0827-0243; Leung, Suet Yi/0000-0001-8614-4619; Lagerstedt Robinson, Kristina/0000-0001-9848-0468; Barbera, Victor-Manuel/0000-0002-4012-6973; Pedroni, Monica/0000-0001-5374-5362; Sexton, Adrienne/0000-0001-8749-1639; Alenda, Cristina/0000-0002-0560-1759; TRICARICO, ROSSELLA/0000-0001-7055-7208; Rasmussen, Lene Juel/0000-0001-6864-963X; Valenzuela, Cristian/0000-0002-8694-9174; Chialina, Sergio/0000-0001-5320-454X; Parsons, Michael/0000-0003-3242-8477; Potter, John/0000-0001-5439-1500; Zahary, Mohd Nizam/0000-0001-7449-2501; Gille, Johan/0000-0003-4526-298X; Scott, Rodney/0000-0001-7724-3404; Buchanan, Daniel/0000-0003-2225-6675; Shia, Jinru/0000-0002-4351-2511; tops, funnel/0000-0003-3116-4203	Cancer Council of Victoria; Cancer Council of Queensland PhD scholarship; Queensland Institute of Medical Research PhD Top-Up award; National Health and Medical Research Council Senior Research Fellow [1010859]; Cancer Australia; Tuscan Tumor Institute (ITT); Royal Melbourne Hospital Foundation; National Cancer Institute/US National Institutes of Health (NCI/US NIH) [1R01CA164944]; Ministerio de Ciencia e Innovacion [SAF 12-33636]; Fundacion Cient fica de la Asociacion Espanola Contra el Cancer; French National Cancer Institute; Institut National du Cancer (INCa) French MMR Committee; Association of International Cancer Research [12-1087]; Medical Research Council UK [MR/K018647/1]; NHS Wales National Institute for Health and Social Care (NIHSCR); Mayo Specialized Programs of Research Excellence (SPORE) grant [P50CA11620106]; US NIH [R01 CA115783-02/CA/NCI]; German Cancer Aid (Deutsche Krebshilfe); Wilhelm Sander Foundation; Cancer Institute NSW; Hong Kong Cancer Fund; Direction Generale de l'Offre des Soins (INCa/DGOS); European Research Council [FP7-ERC-232635]; Nordea-Fonden; German Cancer Aid; Canadian Cancer Society Research Institute [18223]; MRC [MR/K018647/1, MC_PC_U127527198, MC_U127527198] Funding Source: UKRI; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127527198, MC_PC_U127527198, MR/K018647/1] Funding Source: researchfish; Worldwide Cancer Research [12-1087] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U24CA074799, U24CA097735, U01CA097735, U01CA074794, R01CA164944, U24CA074800, U01CA074800, U01CA074799, UM1CA167551, P50CA116201, U01CA074783, U24CA074783, U24CA074794, R01CA115783] Funding Source: NIH RePORTER	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Queensland PhD scholarship(Cancer Council Queensland); Queensland Institute of Medical Research PhD Top-Up award; National Health and Medical Research Council Senior Research Fellow(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Tuscan Tumor Institute (ITT); Royal Melbourne Hospital Foundation; National Cancer Institute/US National Institutes of Health (NCI/US NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Cient fica de la Asociacion Espanola Contra el Cancer; French National Cancer Institute(Institut National du Cancer (INCA) France); Institut National du Cancer (INCa) French MMR Committee; Association of International Cancer Research; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS Wales National Institute for Health and Social Care (NIHSCR); Mayo Specialized Programs of Research Excellence (SPORE) grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Wilhelm Sander Foundation; Cancer Institute NSW; Hong Kong Cancer Fund; Direction Generale de l'Offre des Soins (INCa/DGOS); European Research Council(European Research Council (ERC)European Commission); Nordea-Fonden; German Cancer Aid(Deutsche Krebshilfe); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all submitters of data to the InSiGHT database (retrospective and prospective), the Colon Cancer Family Registry and the German Hereditary Non-polyposis Colorectal Cancer Consortium for their contributions of unpublished data, acknowledged formally through microattribution. We would also like to acknowledge L. Marquart for providing statistical advice and T. O'Mara for providing advice and assistance with the statistical package R. We are extremely grateful to the Hicks Foundation (Australia) for inaugural support of InSiGHT database curator J.-P.P. Funding for VIC teleconferences was provided by the Cancer Council of Victoria. B.A.T. is supported by a Cancer Council of Queensland PhD scholarship and by a Queensland Institute of Medical Research PhD Top-Up award. A.B.S. is a National Health and Medical Research Council Senior Research Fellow. The work performed by A.B.S. and B.A.T. was additionally supported by Cancer Australia (1010859). M.G. is supported by a grant from the Tuscan Tumor Institute (ITT). J.-P.P. is currently supported by the Royal Melbourne Hospital Foundation. S.V.T., M.S.G., A.B.S., L.J.R. and R.S. are supported by grant 1R01CA164944 from the National Cancer Institute/US National Institutes of Health (NCI/US NIH). G.C. and M.P. were supported by the Ministerio de Ciencia e Innovacion (SAF 12-33636) and by the Fundacion Cient fica de la Asociacion Espanola Contra el Cancer. A.F. is supported by the French National Cancer Institute and by the Institut National du Cancer (INCa) French MMR Committee. S.M.F. is supported by grants from the Association of International Cancer Research (12-1087) and by the Medical Research Council UK (MR/K018647/1). NHS Wales National Institute for Health and Social Care (NIHSCR) funding was provided to I.M.F. via the Cardiff & Vale University Health Board. D.E.G. is supported by funding from Mayo Specialized Programs of Research Excellence (SPORE) grant P50CA11620106 (principal investigator J. Ingle). C.D.H. is funded by US NIH grant R01 CA115783-02/CA/NCI. E. H.-F. and M. M. are supported by German Cancer Aid (Deutsche Krebshilfe) and by the Wilhelm Sander Foundation. M.K.-C. is funded by Cancer Institute NSW. S.Y.L. is supported by the Hong Kong Cancer Fund. A. M. is supported by the French National Cancer Institute and by the Direction Generale de l'Offre des Soins (INCa/DGOS). The Sigrid Juselius Foundation funds M. N. Funding for P. P. is provided by the European Research Council (FP7-ERC-232635). L.J.R. is funded by Nordea-Fonden. B.R.-P. is supported by German Cancer Aid. M.O.W. was supported by the Canadian Cancer Society Research Institute (grant 18223).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnold S, 2009, HUM MUTAT, V30, P757, DOI 10.1002/humu.20936; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Buerki N, 2012, GENE CHROMOSOME CANC, V51, P83, DOI 10.1002/gcc.20935; Couch FJ, 2008, HUM MUTAT, V29, P1314, DOI 10.1002/humu.20899; Drost M, 2012, HUM MUTAT, V33, P488, DOI 10.1002/humu.22000; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Fox BI, 2013, J BIOMED INFORM, V46, P795, DOI 10.1016/j.jbi.2013.05.006; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Greenblatt MS, 2008, HUM MUTAT, V29, P1273, DOI 10.1002/humu.20889; Grindedal EM, 2009, CANCER EPIDEM BIOMAR, V18, P2460, DOI 10.1158/1055-9965.EPI-09-0058; Heinen CD, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-9; Hinrichsen I, 2013, CLIN CANCER RES, V19, P2432, DOI 10.1158/1078-0432.CCR-12-3299; Jarvinen HJ, 2009, J CLIN ONCOL, V27, P4793, DOI 10.1200/JCO.2009.23.7784; Kohonen-Corish MRJ, 2011, HUM MUTAT, V32, P491, DOI 10.1002/humu.21450; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Leenen CHM, 2011, CLIN GENET, V80, P558, DOI 10.1111/j.1399-0004.2010.01608.x; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Mead LJ, 2007, CLIN CANCER RES, V13, P2865, DOI 10.1158/1078-0432.CCR-06-2174; Ou J, 2007, HUM MUTAT, V28, P1047, DOI 10.1002/humu.20580; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Rasmussen LJ, 2012, HUM MUTAT, V33, P1617, DOI 10.1002/humu.22168; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Spurdle AB, 2010, CURR OPIN GENET DEV, V20, P315, DOI 10.1016/j.gde.2010.03.009; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; Tavtigian SV, 2008, HUM MUTAT, V29, P1261, DOI 10.1002/humu.20903; Thompson BA, 2013, HUM MUTAT, V34, P255, DOI 10.1002/humu.22214; Thompson BA, 2013, HUM MUTAT, V34, P200, DOI 10.1002/humu.22213; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vallee MP, 2012, HUM MUTAT, V33, P22, DOI 10.1002/humu.21629; van Oers JMM, 2010, P NATL ACAD SCI USA, V107, P13384, DOI 10.1073/pnas.1008589107; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Wimmer K, 2008, HUM GENET, V124, P105, DOI 10.1007/s00439-008-0542-4; Win AK, 2012, JNCI-J NATL CANCER I, V104, P1363, DOI 10.1093/jnci/djs351; Win AK, 2012, J CLIN ONCOL, V30, P958, DOI 10.1200/JCO.2011.39.5590; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612; Xie J, 2010, CANCER PREV RES, V3, P1409, DOI 10.1158/1940-6207.CAPR-10-0118; You JF, 2010, BRIT J CANCER, V103, P1840, DOI 10.1038/sj.bjc.6605988	55	321	325	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					107	+		10.1038/ng.2854	http://dx.doi.org/10.1038/ng.2854			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24362816	Green Accepted			2022-12-25	WOS:000331208300006
J	Counago, RM; Ween, MP; Begg, SL; Bajaj, M; Zuegg, J; O'Mara, ML; Cooper, MA; McEwan, AG; Paton, JC; Kobe, B; McDevitt, CA				Counago, Rafael M.; Ween, Miranda P.; Begg, Stephanie L.; Bajaj, Megha; Zuegg, Johannes; O'Mara, Megan L.; Cooper, Matthew A.; McEwan, Alastair G.; Paton, James C.; Kobe, Bostjan; McDevitt, Christopher A.			Imperfect coordination chemistry facilitates metal ion release in the Psa permease	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; OXIDATIVE STRESS RESISTANCE; TREPONEMA-PALLIDUM TROA; ZINC TRANSPORT PROTEIN; X-RAY-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING-PROTEIN; SUPEROXIDE-DISMUTASE	The relative stability of divalent first-row transition metal ion complexes, as defined by the Irving-Williams series, poses a fundamental chemical challenge for selectivity in bacterial metal ion acquisition. Here we show that although the substratebinding protein of Streptococcus pneumoniae, PsaA, is finely attuned to bind its physiological substrate manganese, it can also bind a broad range of other divalent transition metal cations. By combining high-resolution structural data, metal-binding assays and mutational analyses, we show that the inability of open-state PsaA to satisfy the preferred coordination chemistry of manganese enables the protein to undergo the conformational changes required for cargo release to the Psa permease. This is specific for manganese ions, whereas zinc ions remain bound to PsaA. Collectively, these findings suggest a new ligand binding and release mechanism for PsaA and related substrate-binding proteins that facilitate specificity for divalent cations during competition from zinc ions, which are more abundant in biological systems.	[Counago, Rafael M.; O'Mara, Megan L.; McEwan, Alastair G.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Counago, Rafael M.; Bajaj, Megha; O'Mara, Megan L.; McEwan, Alastair G.; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Counago, Rafael M.; Bajaj, Megha; Zuegg, Johannes; Cooper, Matthew A.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ween, Miranda P.; Begg, Stephanie L.; Paton, James C.; McDevitt, Christopher A.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [O'Mara, Megan L.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Adelaide; University of Queensland	Counago, RM (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	b.kobe@uq.edu.au; christopher.mcdevitt@adelaide.edu.au	O'Mara, Megan/ABF-8913-2020; Cooper, Matthew A./C-7988-2009; Zuegg, Johannes/C-1347-2014; Counago, Rafael/F-4418-2016; O'Mara, Megan L/A-4962-2011; Neville (née Begg), Stephanie/AAZ-1380-2021; O'Mara, Megan/AAY-5934-2021; McDevitt, Christopher A./A-4940-2009; Couñago, Rafael/AAX-1577-2020; Kobe, Bostjan/D-1292-2009	Cooper, Matthew A./0000-0003-3147-3460; Zuegg, Johannes/0000-0001-6240-6020; Counago, Rafael/0000-0003-1847-5090; O'Mara, Megan L/0000-0002-8764-1585; Neville (née Begg), Stephanie/0000-0002-7298-9335; O'Mara, Megan/0000-0002-8764-1585; McDevitt, Christopher A./0000-0003-1596-4841; Couñago, Rafael/0000-0003-1847-5090; Kobe, Bostjan/0000-0001-9413-9166; ween, miranda/0000-0002-0600-4585; McEwan, Alastair/0000-0002-2419-1003	Australian Research Council (ARC) [DP0986578, DP120103957]; National Health and Medical Research Council (NHMRC) [1022240, 565526]; ARC Discovery Early Career Researcher Award	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by the Australian Research Council (ARC) grants DP0986578 to A.G.M. and DP120103957 to C.A.M. and the National Health and Medical Research Council (NHMRC) project grant 1022240 to C.A.M. and program grant 565526 to J. C. P., A.G.M. and B.K. M.L.O. holds an ARC Discovery Early Career Researcher Award. B.K. is a NHMRC Senior Research Fellow. J.C.P. is a NHMRC Senior Principal Research Fellow. We thank A.E. Mark for discussions.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Counago RM, 2012, CURR DRUG TARGETS, V13, P1400; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Felder CB, 1999, AAPS PHARMSCI, V1; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; MAO B, 1982, J BIOL CHEM, V257, P1131; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pennella MA, 2003, P NATL ACAD SCI USA, V100, P3713, DOI 10.1073/pnas.0636943100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000	59	104	105	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					35	U66		10.1038/NCHEMBIO.1382	http://dx.doi.org/10.1038/NCHEMBIO.1382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24212134				2022-12-25	WOS:000328854900008
J	Kurzrock, R; Kantarjian, H; Stewart, DJ				Kurzrock, Razelle; Kantarjian, Hagop; Stewart, David J.			A cancer trial scandal and its regulatory backlash	NATURE BIOTECHNOLOGY			English	Article							CELL LUNG-CANCER; CLINICAL-TRIALS; PHASE-III; GEMCITABINE; CHEMOTHERAPY; METAANALYSIS; CISPLATIN	Regulatory fallout from a scandal surrounding the fabrication of data used to support a molecular test in a Duke University cancer trial is exacting an unjustifiable toll not only on health economics but also on patient lives.	[Kurzrock, Razelle] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Stewart, David J.] Univ Ottawa, Div Med Oncol, Ottawa, ON, Canada	University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of Ottawa	Kurzrock, R (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	rkurzrock@ucsd.edu	Kurzrock, Razelle/AAU-9782-2020		NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTI W, 1995, BRIT MED J, V311, P899; [Anonymous], NONSM CELL LUNG CANC; Beckloff Associates Inc, REG PAR LAB DEV TEST; Behazin N. S., MEDSCAPE; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; D'Addario G, 2005, J CLIN ONCOL, V23, P2926, DOI 10.1200/JCO.2005.03.045; F. Hoffman-La Roche Ltd, 2010, ROCH PROV UPD FDA AP; Hart P.K., 2012, HOUSTON CHRONICLE; Institute of Medicine, 2012, EV TRANSL OM LESS LE; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Laack E, 2004, J CLIN ONCOL, V22, P2348, DOI 10.1200/JCO.2004.10.576; Monnerat C, 2006, ANN ONCOL, V17, pV86, DOI 10.1093/annonc/mdj958; Most clinical trials done abroad, 2009, WALL STREET J; Pujol JL, 2006, LUNG CANCER-J IASLC, V51, P335, DOI 10.1016/j.lungcan.2005.11.001; Rajeswaran A, 2008, LUNG CANCER, V59, P1, DOI 10.1016/j.lungcan.2007.07.012; Schulman K. A., 2010, J INVEST MED, V58, P31; Spigel DR, 2010, J THORAC ONCOL, V5, P841, DOI 10.1097/JTO.0b013e3181d737e3; Stewart DJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-193; Stewart DJ, 2010, J CLIN ONCOL, V28, P2925, DOI 10.1200/JCO.2009.27.5404; Stewart DJ, 2009, J CLIN ONCOL, V27, P328, DOI 10.1200/JCO.2008.18.9621; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; U.S. Food and Drug Administration, FDA APPR NEW TREATM; US Food and Drug Administration, DEV ADV INV DEV EX I; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Westin JR, 2012, MOL CANCER THER, V11, P2549, DOI 10.1158/1535-7163.MCT-12-0473	27	12	12	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					27	31		10.1038/nbt.2792	http://dx.doi.org/10.1038/nbt.2792			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406925				2022-12-25	WOS:000329513000011
J	Liehl, P; Zuzarte-Luis, V; Chan, JN; Zillinger, T; Baptista, F; Carapau, D; Konert, M; Hanson, KK; Carret, C; Lassnig, C; Muller, M; Kalinke, U; Saeed, M; Chora, AF; Golenbock, DT; Strobl, B; Prudencio, M; Coelho, LP; Kappe, SH; Superti-Furga, G; Pichlmair, A; Vigario, AM; Rice, CM; Fitzgerald, KA; Barchet, W; Mota, MM				Liehl, Peter; Zuzarte-Luis, Vanessa; Chan, Jennie; Zillinger, Thomas; Baptista, Fernanda; Carapau, Daniel; Konert, Madlen; Hanson, Kirsten K.; Carret, Celine; Lassnig, Caroline; Mueller, Mathias; Kalinke, Ulrich; Saeed, Mohsan; Chora, Angelo Ferreira; Golenbock, Douglas T.; Strobl, Birgit; Prudencio, Miguel; Coelho, Luis P.; Kappe, Stefan H.; Superti-Furga, Giulio; Pichlmair, Andreas; Vigario, Ana M.; Rice, Charles M.; Fitzgerald, Katherine A.; Barchet, Winfried; Mota, Maria M.			Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection	NATURE MEDICINE			English	Article							DOUBLE-STRANDED-RNA; RIG-I; HEPATITIS-C; ADAPTER PROTEIN; RECOGNITION; INTERFERON; MALARIA; BERGHEI; HEPATOCYTES; RECEPTORS	Before they infect red blood cells and cause malaria, Plasmodium parasites undergo an obligate and clinically silent expansion phase in the liver that is supposedly undetected by the host. Here, we demonstrate the engagement of a type I interferon (IFN) response during Plasmodium replication in the liver. We identified Plasmodium RNA as a previously unrecognized pathogen-associated molecular pattern (PAMP) capable of activating a type I IFN response via the cytosolic pattern recognition receptor Mda5. This response, initiated by liver-resident cells through the adaptor molecule for cytosolic RNA sensors, Mavs, and the transcription factors Irf3 and Irf7, is propagated by hepatocytes in an interferon-alpha/beta receptor-dependent manner. This signaling pathway is critical for immune cell-mediated host resistance to liver-stage Plasmodium infection, which we find can be primed with other PAMPs, including hepatitis C virus RNA. Together, our results show that the liver has sensor mechanisms for Plasmodium that mediate a functional antiparasite response driven by type I IFN.	[Liehl, Peter; Zuzarte-Luis, Vanessa; Baptista, Fernanda; Carapau, Daniel; Konert, Madlen; Hanson, Kirsten K.; Carret, Celine; Chora, Angelo Ferreira; Prudencio, Miguel; Coelho, Luis P.; Vigario, Ana M.; Mota, Maria M.] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal; [Chan, Jennie; Golenbock, Douglas T.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Zillinger, Thomas; Barchet, Winfried] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Lassnig, Caroline; Mueller, Mathias; Strobl, Birgit] Austria Univ Vet Med Vienna, Inst Anim Breeding & Genet & Biomodels, Vienna, Austria; [Kalinke, Ulrich] Hannover Med Sch, Inst Expt Infect Res, TWINCORE, Ctr Expt & Clin Infect Res, Hannover, Germany; [Kalinke, Ulrich] Helmholtz Ctr Infect Res, Hannover, Germany; [Saeed, Mohsan; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10021 USA; [Kappe, Stefan H.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Superti-Furga, Giulio; Pichlmair, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Vigario, Ana M.] Univ Madeira, Unidade Ciencias Med, Ctr Compentencia Ciencias Vida, Funchal, Portugal	Universidade de Lisboa; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Rockefeller University; Center for Infectious Disease Research; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Universidade da Madeira	Mota, MM (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.	mmota@fm.ul.pt	Mota, Maria/AAF-2048-2019; Carapau, Daniel/J-3966-2012; Superti-Furga, Giulio/F-4755-2015; Prudêncio, Miguel/ABD-9282-2021; Ferreira Chora, Angelo/AAZ-6503-2021; Zuzarte-Luis, Vanessa/M-9105-2013; Fitzgerald, Katherine/ABE-6317-2020; Zillinger, Thomas/AAD-7320-2020; Coelho, Luis Pedro/D-1260-2009; Superti-Furga, Giulio/AAE-5681-2019; Saeed, Mohsan/AAM-8375-2021	Carapau, Daniel/0000-0001-8888-6333; Superti-Furga, Giulio/0000-0002-0570-1768; Prudêncio, Miguel/0000-0003-1746-6029; Ferreira Chora, Angelo/0000-0002-7941-7196; Zuzarte-Luis, Vanessa/0000-0003-0023-5953; Zillinger, Thomas/0000-0002-0866-4835; Coelho, Luis Pedro/0000-0002-9280-7885; Fitzgerald, Kate/0000-0003-3175-609X; Kalinke, Ulrich/0000-0003-0503-9564; Barchet, Winfried/0000-0002-6745-6606; Mota, Maria Manuel/0000-0002-2858-1041; LASSNIG, Caroline/0000-0001-7905-3620; Vigario, Ana Margarida/0000-0001-5679-1196; Hanson, Kirsten/0000-0002-0154-0979; Muller, Mathias/0000-0002-7879-3552; Strobl, Birgit/0000-0001-5716-3212	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/SAU-GMG/100313/2008, PTDC/SAU-GMG/104392/2008, PTDC/SAU-MIC/113697/2009]; European Research Council [ERC-2012-StG_20111109]; European Community's Seventh Framework Programme [242095]; US National Institutes of Health [AI079293]; Austrian Science Fund [SFB F28]; Deutsche Forschungs Gesellschaft [BA3544/1-1, SFB704]; Starr Foundation; Greenberg Medical Research Institute; Bill & Melinda Gates Foundation [OPP1021571, R10291, M11R11017]; Fondation pour la Recherche Medicale; FCT [SFRH/BPD/41547/2007, SFRH/BPD/64626/2009, SFRH/BPD/40965/2007]; European Molecular Biology Organization [ALTF357-2009]; Digestive System at The Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079293, T32AI095213, R56AI067497] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); European Research Council(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Deutsche Forschungs Gesellschaft(German Research Foundation (DFG)); Starr Foundation; Greenberg Medical Research Institute; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Digestive System at The Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Mavs<SUP>-/-</SUP> mice were from Z.J. Chen (South Western Medical School). Mda5<SUP>-/-</SUP> mice were from M. Colonna (Washington University). Rig-I<SUP>-/-</SUP>, Tlr3<SUP>-/-</SUP>, Tlr4<SUP>-/-</SUP>, Trif<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice were a gift from S. Akira (Osaka University). Trif<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice were used for generating Trif<SUP>-/-</SUP>; Myd88<SUP>-/-</SUP> mice. Irf7<SUP>-/-</SUP> and Irf3<SUP>-/-</SUP> mice were kindly provided by T. Taniguchi (University of Tokyo). We would like to thank A. Parreira for Anopheles stephensi production and infection, M. Rebelo for help with P. falciparum in vitro cultures, J. Ribot for help with chimeric mice and A. Zaidman-Remy for critical reading of the manuscript. We are grateful to M. Seabra (CEDOC, Faculdade de Ciencias Medicas) and A. Holder (UK Medical Research Council National Institute for Medical Research) for providing antisera. This work was supported by Fundacao para a Ciencia e Tecnologia (FCT, Portugal) grants (PTDC/SAU-GMG/100313/2008 to M.M.M., PTDC/SAU-GMG/104392/2008 to C.C. and PTDC/SAU-MIC/113697/2009 to V.Z.-L., and also by the European Research Council grant ERC-2012-StG_20111109 to M.M.M., the European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement 242095 to M.M.M., US National Institutes of Health grant AI079293 to K.A.F. and D.T.G., Austrian Science Fund grant SFB F28 to M.M. and B. S., Deutsche Forschungs Gesellschaft grants BA3544/1-1 and SFB704 (to W.B.), the Starr Foundation, the Greenberg Medical Research Institute and Bill & Melinda Gates Foundation grant OPP1021571 (subcontract R10291, M11R11017, all to C.M.R.). P.L. was supported by Fondation pour la Recherche Medicale and FCT (fellowship SFRH/BPD/41547/2007). V.Z.-L. was supported by European Molecular Biology Organization fellowship ALTF357-2009. D.C. and C.C. were supported by FCT fellowships (SFRH/BPD/64626/2009 and SFRH/BPD/40965/2007, respectively). M.S. was supported in part by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University.	Andrade BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019841; [Anonymous], PLOS MED; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; da Silva ML, 2012, TRAFFIC, V13, P1351, DOI 10.1111/j.1600-0854.2012.01398.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KHAN ZM, 1992, INFECT IMMUN, V60, P264, DOI 10.1128/IAI.60.1.264-270.1992; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037103	52	176	184	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					47	+		10.1038/nm.3424	http://dx.doi.org/10.1038/nm.3424			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24362933	Green Accepted, Bronze			2022-12-25	WOS:000329349400018
J	Yim, HS; Cho, YS; Guang, XM; Kang, SG; Jeong, JY; Cha, SS; Oh, HM; Lee, JH; Yang, EC; Kwon, KK; Kim, YJ; Kim, TW; Kim, W; Jeon, JH; Kim, SJ; Choi, DH; Jho, S; Kim, HM; Ko, J; Kim, H; Shin, YA; Jung, HJ; Zheng, Y; Wang, Z; Chen, Y; Chen, M; Jiang, AW; Li, EL; Zhang, S; Hou, HL; Kim, TH; Yu, LL; Liu, S; Ahn, K; Cooper, J; Park, SG; Hong, CP; Jin, W; Kim, HS; Park, C; Lee, K; Chun, S; Morin, PA; O'Brien, SJ; Lee, H; Kimura, J; Moon, DY; Manica, A; Edwards, J; Kim, BC; Kim, S; Wang, J; Bhak, J; Lee, HS; Lee, JH				Yim, Hyung-Soon; Cho, Yun Sung; Guang, Xuanmin; Kang, Sung Gyun; Jeong, Jae-Yeon; Cha, Sun-Shin; Oh, Hyun-Myung; Lee, Jae-Hak; Yang, Eun Chan; Kwon, Kae Kyoung; Kim, Yun Jae; Kim, Tae Wan; Kim, Wonduck; Jeon, Jeong Ho; Kim, Sang-Jin; Choi, Dong Han; Jho, Sungwoong; Kim, Hak-Min; Ko, Junsu; Kim, Hyunmin; Shin, Young-Ah; Jung, Hyun-Ju; Zheng, Yuan; Wang, Zhuo; Chen, Yan; Chen, Ming; Jiang, Awei; Li, Erli; Zhang, Shu; Hou, Haolong; Kim, Tae Hyung; Yu, Lili; Liu, Sha; Ahn, Kung; Cooper, Jesse; Park, Sin-Gi; Hong, Chang Pyo; Jin, Wook; Kim, Heui-Soo; Park, Chankyu; Lee, Kyooyeol; Chun, Sung; Morin, Phillip A.; O'Brien, Stephen J.; Lee, Hang; Kimura, Jumpei; Moon, Dae Yeon; Manica, Andrea; Edwards, Jeremy; Kim, Byung Chul; Kim, Sangsoo; Wang, Jun; Bhak, Jong; Lee, Hyun Sook; Lee, Jung-Hyun			Minke whale genome and aquatic adaptation in cetaceans	NATURE GENETICS			English	Article							PROTEIN; ALIGNMENT; SEQUENCE; DATABASE; GENES; IDENTIFICATION; FAMILIES; STRESS; GLUTATHIONE; PERFORMANCE	The shift from terrestrial to aquatic life by whales was a substantial evolutionary event. Here we report the whole-genome sequencing and de novo assembly of the minke whale genome, as well as the whole-genome sequences of three minke whales, a fin whale, a bottlenose dolphin and a finless porpoise. Our comparative genomic analysis identified an expansion in the whale lineage of gene families associated with stress-responsive proteins and anaerobic metabolism, whereas gene families related to body hair and sensory receptors were contracted. Our analysis also identified whale-specific mutations in genes encoding antioxidants and enzymes controlling blood pressure and salt concentration. Overall the whale-genome sequences exhibited distinct features that are associated with the physiological and morphological changes needed for life in an aquatic environment, marked by resistance to physiological stresses caused by a lack of oxygen, increased amounts of reactive oxygen species and high salt levels.	[Yim, Hyung-Soon; Kang, Sung Gyun; Jeong, Jae-Yeon; Cha, Sun-Shin; Oh, Hyun-Myung; Lee, Jae-Hak; Yang, Eun Chan; Kwon, Kae Kyoung; Kim, Yun Jae; Kim, Tae Wan; Kim, Wonduck; Jeon, Jeong Ho; Kim, Sang-Jin; Choi, Dong Han; Lee, Hyun Sook; Lee, Jung-Hyun] Korea Inst Ocean Sci & Technol, Ansan, South Korea; [Cho, Yun Sung; Jho, Sungwoong; Kim, Hak-Min; Shin, Young-Ah; Kim, Byung Chul; Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Suwon, South Korea; [Guang, Xuanmin; Zheng, Yuan; Wang, Zhuo; Chen, Yan; Chen, Ming; Jiang, Awei; Li, Erli; Zhang, Shu; Yu, Lili; Liu, Sha; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Kang, Sung Gyun; Jeong, Jae-Yeon; Cha, Sun-Shin; Kim, Sang-Jin; Lee, Hyun Sook; Lee, Jung-Hyun] Univ Sci & Technol, Dept Marine Biotechnol, Taejon, South Korea; [Cha, Sun-Shin] Korea Maritime Univ, Ocean Sci & Technol Sch, Pusan, South Korea; [Ko, Junsu; Kim, Hyunmin; Jung, Hyun-Ju; Kim, Tae Hyung; Ahn, Kung; Cooper, Jesse; Park, Sin-Gi; Hong, Chang Pyo; Bhak, Jong] TheragenEtex, Theragen BiO Inst, Suwon, South Korea; [Hou, Haolong] Shaanxi Yulin Energy Grp Co Ltd, Yulin, Shaanxi, Peoples R China; [Jin, Wook] Gachon Univ, Sch Med, Dept Mol Med, Inchon, South Korea; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, Pusan, South Korea; [Park, Chankyu; Lee, Kyooyeol] Konkuk Univ, Dept Anim Biotechnol, Lab Genome Biol, Seoul, South Korea; [Chun, Sung] Brigham & Womens Hosp, Dept Med, Div Genet, La Jolla, CA USA; [Chun, Sung] Harvard Univ, Sch Med, Boston, MA USA; [Morin, Phillip A.] Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Southwest Fisheries Sci Ctr, Marine Mammal & Turtle Div, La Jolla, CA 92038 USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [Lee, Hang] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Kimura, Jumpei] Seoul Natl Univ, Coll Vet Med, Dept Anat & Cell Biol, Seoul, South Korea; [Moon, Dae Yeon] Minist Ocean & Fisheries, Marine Biodivers Inst Korea MABIK, Sejong, South Korea; [Manica, Andrea] Univ Cambridge, Dept Zool, Evolutionary Ecol Grp, Cambridge, England; [Edwards, Jeremy] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Kim, Sangsoo] Soongsil Univ, Sch Syst Biomed Sci, Seoul, South Korea; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Bhak, Jong] Seoul Natl Univ, Dept Transdisciplinary Studies, Program Nano Sci & Technol, Suwon, South Korea; [Bhak, Jong] Adv Inst Convergence Technol Nano Sci & Technol, Suwon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Beijing Genomics Institute (BGI); Korea Maritime & Ocean University; Gachon University; Pusan National University; Konkuk University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Oceanic Atmospheric Admin (NOAA) - USA; Saint Petersburg State University; Seoul National University (SNU); Seoul National University (SNU); University of Cambridge; University of New Mexico; University of New Mexico's Health Sciences Center; Soongsil University; University of Copenhagen; King Abdulaziz University; Seoul National University (SNU)	Lee, HS (corresponding author), Korea Inst Ocean Sci & Technol, Ansan, South Korea.	jongbhak@genomics.org; jlee@kiost.ac	yan, chen/AAS-4603-2021; Manica, Andrea/B-5497-2008; Park, Chankyu/D-8775-2011; Kim, Hak-Min/G-6012-2016; Hong, Chang Pyo/I-6813-2019; Kim, Heui-Soo/ABF-3773-2021; Hong, Chang Pyo/AGR-6554-2022; OBRIEN, STEPHEN/ABD-1346-2020; Morin, Phillip A/E-9515-2010; Wang, Jun/A-7261-2013; Hou, Haolong/AGZ-0160-2022; Chun, Sung/I-2212-2015; Manica, Andrea/N-9013-2019; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Manica, Andrea/0000-0003-1895-450X; Kim, Hak-Min/0000-0001-6066-2469; Kim, Heui-Soo/0000-0002-5226-6594; Hou, Haolong/0000-0002-3870-7226; Chun, Sung/0000-0003-3440-1913; Manica, Andrea/0000-0003-1895-450X; Wang, Zhuo/0000-0002-4069-9501; Cha, Sun-Shin/0000-0002-0913-8706; Morin, Phillip/0000-0002-3279-1519; Yang, Eun Chan/0000-0001-8211-8130; Wang, Jun/0000-0002-8540-8931; Kim, Hyunmin/0000-0002-6435-2553; O'Brien, Stephen J./0000-0001-7353-8301; Cho, Yun Sung/0000-0003-4490-8769; yu, lili/0000-0003-0435-0385; OBRIEN, STEPHEN/0000-0001-7857-0757; Park, Chankyu/0000-0003-4855-2210; Wang, Jun/0000-0002-2113-5874	Korea Institute of Ocean Science and Technology (KIOST) in-house program, the Marine and Extreme Genome Research Center program of the Ministry of Oceans and Fisheries, Korea [PE98993]; Industrial Strategic Technology Development Program, Bioinformatics Platform Development for Next-Generation Bioinformation Analysis [10040231]; Russian Ministry of Science [11.G34.31.0068]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006876, R01HG005852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104973] Funding Source: NIH RePORTER	Korea Institute of Ocean Science and Technology (KIOST) in-house program, the Marine and Extreme Genome Research Center program of the Ministry of Oceans and Fisheries, Korea; Industrial Strategic Technology Development Program, Bioinformatics Platform Development for Next-Generation Bioinformation Analysis; Russian Ministry of Science; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	No animals were killed or captured as a result of these studies. Samples of four minke whales and a finless porpoise for sequencing were acquired from the east coast of Korea after they were accidently killed and investigated by the maritime police. The sample from a bottlenose dolphin was obtained from Marine Park in Jeju Island, Korea. The fin whale sample was collected from a dead stranded fin whale by the Southwest Fisheries Science Center (SWFSC 134239) under US Marine Mammal Permit 14097-01, and the sample was transported internationally under a Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) permit. We thank C.-W. Kim (Marine Park Co., Ltd.) and Y.-R. An (Cetacean Research Institute) for the bottlenose dolphin and minke whale samples, respectively. We also thank M. Bhak for editing. We thank many people not listed as authors who provided feedback, samples and encouragement, especially the Cetacean Research Institute in Ulsan, Korea. This work was supported by the Korea Institute of Ocean Science and Technology (KIOST) in-house program (PE98993), the Marine and Extreme Genome Research Center program of the Ministry of Oceans and Fisheries, Korea. This work was also supported by the Industrial Strategic Technology Development Program 10040231, Bioinformatics Platform Development for Next-Generation Bioinformation Analysis. The Russian Ministry of Science supported S.J.O. (mega-grant 11.G34.31.0068).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; ARNASON U, 1993, J MOL EVOL, V37, P312; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATTWOOD TK, 1994, NUCLEIC ACIDS RES, V22, P3590; ATTWOOD TK, 1994, PROTEIN ENG, V7, P841, DOI 10.1093/protein/7.7.841; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Caballero S, 2010, ZOO BIOL, V29, P647, DOI 10.1002/zoo.20299; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dawkins R., 2004, ANCESTORS TALE PILGR; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; FOYER CH, 1995, PLANT PHYSIOL, V109, P1047, DOI 10.1104/pp.109.3.1047; Gonchar O., 2010, J BIOL SCI, V10, P545, DOI [DOI 10.3923/JBS.2010.545.554, 10.3923/jbs.2010.545.554]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Herzing Denise L., 2003, Aquatic Mammals, V29, P335, DOI 10.1578/01675420360736505; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065944; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; McGowen MR, 2012, P ROY SOC B-BIOL SCI, V279, P3643, DOI 10.1098/rspb.2012.0869; Meredith RW, 2011, P ROY SOC B-BIOL SCI, V278, P993, DOI 10.1098/rspb.2010.1280; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; O'Brien S.J., 2006, ATLAS MAMMALIAN GENO; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Palumbi SR, 1998, J HERED, V89, P459; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Reeves R. R., 2002, NATL AUDUBON SOC GUI; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Shaffer SA, 1997, J EXP BIOL, V200, P3091; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Taylor BL, 2007, GENERATION LENGTH PE, P24; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Williams TM, 1999, J EXP BIOL, V202, P2739; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V1; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	72	181	187	11	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					88	+		10.1038/ng.2835	http://dx.doi.org/10.1038/ng.2835			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24270359	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000329113500019
J	Reiling, JH; Olive, AJ; Sanyal, S; Carette, JE; Brummelkamp, TR; Ploegh, HL; Starnbach, MN; Sabatini, DM				Reiling, Jan H.; Olive, Andrew J.; Sanyal, Sumana; Carette, Jan E.; Brummelkamp, Thijn R.; Ploegh, Hidde L.; Starnbach, Michael N.; Sabatini, David M.			A CREB3-ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; UNFOLDED PROTEIN RESPONSE; RETICULUM ER STRESS; BREFELDIN-A; ENDOPLASMIC-RETICULUM; LUMINAL DOMAIN; ARF PROTEINS; HUMAN-CELLS; COMPLEX; FRAGMENTATION	Treatment of cells with brefeldin A (BFA) blocks secretory vesicle transport and causes a collapse of the Golgi apparatus. To gain more insight into the cellular mechanisms mediating BFA toxicity, we conducted a genome-wide haploid genetic screen that led to the identification of the small G protein ADP-ribosylation factor 4 (ARF4). ARF4 depletion preserves viability, Golgi integrity and cargo trafficking in the presence of BFA, and these effects depend on the guanine nucleotide exchange factor GBF1 and other ARF isoforms including ARF1 and ARF5. ARF4 knockdown cells show increased resistance to several human pathogens including Chlamydia trachomatis and Shigella flexneri. Furthermore, ARF4 expression is induced when cells are exposed to several Golgi-disturbing agents and requires the CREB3 (also known as Luman or LZIP) transcription factor, whose downregulation mimics ARF4 loss. Thus, we have uncovered a CREB3-ARF4 signalling cascade that may be part of a Golgi stress response set in motion by stimuli compromising Golgi capacity.	[Reiling, Jan H.; Sanyal, Sumana; Carette, Jan E.; Brummelkamp, Thijn R.; Ploegh, Hidde L.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reiling, Jan H.; Sanyal, Sumana; Ploegh, Hidde L.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Reiling, Jan H.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Olive, Andrew J.; Starnbach, Michael N.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Reiling, JH (corresponding author), BioMed X GmbH, Neuenheimer Feld 583, D-69120 Heidelberg, Germany.	reiling@bio.mx; sabatini@wi.mit.edu	Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013	Olive, Andrew/0000-0003-3441-3113; /0000-0002-1446-7256; Sanyal, Sumana/0000-0002-6230-5366; Carette, Jan/0000-0002-5187-8070	US National Institutes of Health (NIH) [CA103866]; D. H. Koch Institute for Integrative Cancer Research; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D. H. Koch Institute for Integrative Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. G. Donaldson for providing the pGEX-VHS-GAT construct, R. A. Weinberg for the Calu-1 cell line and D. Kim for help with confocal microscopy. This work was supported by grants from the US National Institutes of Health (NIH; CA103866) and the D. H. Koch Institute for Integrative Cancer Research to D.M.S. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Barzilay E, 2005, TRAFFIC, V6, P794, DOI 10.1111/j.1600-0854.2005.00317.x; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Coers J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001346; Cohen L. A., 2010, CURR PROTOC CELL BIO, V48, P11; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DenBoer LM, 2013, BBA-GENE REGUL MECH, V1829, P921, DOI 10.1016/j.bbagrm.2013.04.001; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Elwell C. A., 2011, PLOS PATHOG, V7; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Huynh DP, 2003, HUM MOL GENET, V12, P1485, DOI 10.1093/hmg/ddg175; Jang SY, 2012, CANCER LETT, V314, P185, DOI 10.1016/j.canlet.2011.09.028; Jehl SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002809; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Kondo Y, 2012, CELL STRUCT FUNCT, V37, P141, DOI 10.1247/csf.12015; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; Nickel W, 1996, J BIOL CHEM, V271, P15870, DOI 10.1074/jbc.271.27.15870; Nojiri H, 1999, FEBS LETT, V453, P140, DOI 10.1016/S0014-5793(99)00709-7; Oku M, 2011, CELL STRUCT FUNCT, V36, P1, DOI 10.1247/csf.10014; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Shao RG, 1996, EXP CELL RES, V227, P190, DOI 10.1006/excr.1996.0266; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; SINGLETON VL, 1958, NATURE, V181, P1072, DOI 10.1038/1811072a0; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; TEAL SB, 1994, J BIOL CHEM, V269, P3135; van der Velden AWM, 2008, J IMMUNOL, V180, P5569, DOI 10.4049/jimmunol.180.8.5569; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; ZHANG GF, 1993, J CELL SCI, V104, P819; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	70	96	97	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1473	+		10.1038/ncb2865	http://dx.doi.org/10.1038/ncb2865			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24185178	Green Submitted, Green Accepted			2022-12-25	WOS:000327944200012
J	Palczewska, G; Dong, ZQ; Golczak, M; Hunter, JJ; Williams, DR; Alexander, NS; Palczewski, K				Palczewska, Grazyna; Dong, Zhiqian; Golczak, Marcin; Hunter, Jennifer J.; Williams, David R.; Alexander, Nathan S.; Palczewski, Krzysztof			Noninvasive two-photon microscopy imaging of mouse retina and retinal pigment epithelium through the pupil of the eye	NATURE MEDICINE			English	Article							FLUORESCENCE; CHEMISTRY; MODELS	Two-photon excitation microscopy can image retinal molecular processes in vivo. Intrinsically fluorescent retinyl esters in subcellular structures called retinosomes are an integral part of the visual chromophore regeneration pathway. Fluorescent condensation products of all-trans-retinal accumulate in the eye with age and are also associated with age-related macular degeneration (AMD). Here, we report repetitive, dynamic imaging of these compounds in live mice through the pupil of the eye. By leveraging advanced adaptive optics, we developed a data acquisition algorithm that permitted the identification of retinosomes and condensation products in the retinal pigment epithelium by their characteristic localization, spectral properties and absence in genetically modified or drug-treated mice. This imaging approach has the potential to detect early molecular changes in retinoid metabolism that trigger light- and AMD-induced retinal defects and to assess the effectiveness of treatments for these conditions.	[Palczewska, Grazyna; Dong, Zhiqian; Palczewski, Krzysztof] Polgenix, Cleveland, OH 44106 USA; [Golczak, Marcin; Alexander, Nathan S.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hunter, Jennifer J.; Williams, David R.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Hunter, Jennifer J.] Univ Rochester, Flaum Eye Inst, Rochester, NY USA; [Hunter, Jennifer J.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Williams, David R.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA	Case Western Reserve University; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Palczewski, K (corresponding author), Polgenix, Cleveland, OH 44106 USA.	kxp65@case.edu		Hunter, Jennifer/0000-0001-5801-4737; DONG, ZHIQIAN/0000-0002-8748-4532	National Eye Institute of the NIH [R01EY008061, R01EY009339, R24EY021126, P3OEY11373]; National Institute on Aging of the NIH [R44AG043645]; NIH institutional training [5T32EY007157, 5T32DK007319]; NATIONAL EYE INSTITUTE [R01EY008061, T32EY007157, P30EY011373, R01EY009339, R24EY021126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG043645] Funding Source: NIH RePORTER	National Eye Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Aging of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH institutional training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Redmond (National Eye Institute of the US National Institutes of Health (NIH)) for Rpe65-1- mice and J. Wilson (Baylor College of Medicine) for GFP-rhodopsin mice. We also thank the team at Bioptigen for advice on preparation of mice for live animal imaging, D. Piston for stimulating discussion and L.T. Webster Jr. and members of K.E's laboratory and Polgenix's team for critical comments on the manuscript. Research reported in this publication was supported by the National Eye Institute of the NIH under award numbers R01EY008061, R01EY009339, R24EY021126 and P3OEY11373 and by the National Institute on Aging of the NIH under award number R44AG043645. N.S.A. was supported by NIH institutional training grants 5T32EY007157 and 5T32DK007319.	BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Bueno JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505018; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Delori F. o. C., 2007, J OPT SOC AM A, V24, P1250; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Drabent R, 1997, J PHOTOCH PHOTOBIO B, V37, P254, DOI 10.1016/S1011-1344(96)07400-3; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Godara P, 2010, OPTOMETRY VISION SCI, V87, P930, DOI 10.1097/OPX.0b013e3181ff9a8b; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Hunter JJ, 2011, BIOMED OPT EXPRESS, V2, P139, DOI 10.1364/BOE.2.000139; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kocaoglu OP, 2011, BIOMED OPT EXPRESS, V2, P748, DOI 10.1364/BOE.2.000748; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda T, 2013, INVEST OPHTH VIS SCI, V54, P455, DOI 10.1167/iovs.12-11152; Moroni L, 2000, J PHYS CHEM A, V104, P11063, DOI [10.1021/jp002098+, 10.1021/jp002098]; Padayatti P, 2012, BIOCHEMISTRY-US, V51, P1625, DOI 10.1021/bi201682q; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Sharma R, 2013, BIOMED OPT EXPRESS, V4, P1285, DOI 10.1364/BOE.4.001285; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Spiess E, 2005, J MICROSC-OXFORD, V217, P200, DOI 10.1111/j.1365-2818.2005.01437.x; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Xi P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059629; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	40	78	78	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					785	789		10.1038/nm.3590	http://dx.doi.org/10.1038/nm.3590			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24952647	Green Accepted			2022-12-25	WOS:000338689500023
J	Tang, YJ; Gholamin, S; Schubert, S; Willardson, MI; Lee, A; Bandopadhayay, P; Bergthold, L; Masoud, S; Nguyen, B; Vue, N; Balansay, B; Yu, FR; Oh, S; Woo, P; Chen, S; Ponnuswami, A; Monje, M; Atwood, SX; Whitson, RJ; Mitra, S; Cheshier, SH; Qi, J; Beroukhim, R; Tang, JY; Wechsler-Reya, R; Oro, AE; Link, BA; Bradner, JE; Cho, YJ				Tang, Yujie; Gholamin, Sharareh; Schubert, Simone; Willardson, Minde I.; Lee, Alex; Bandopadhayay, Pratiti; Bergthold, Guillame; Masoud, Sabran; Nguyen, Brian; Vue, Nujsaubnusi; Balansay, Brianna; Yu, Furong; Oh, Sekyung; Woo, Pamelyn; Chen, Spenser; Ponnuswami, Anitha; Monje, Michelle; Atwood, Scott X.; Whitson, Ramon J.; Mitra, Siddhartha; Cheshier, Samuel H.; Qi, Jun; Beroukhim, Rameen; Tang, Jean Y.; Wechsler-Reya, Rob; Oro, Anthony E.; Link, Brian A.; Bradner, James E.; Cho, Yoon-Jae			Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition	NATURE MEDICINE			English	Article							BASAL-CELL CARCINOMA; SONIC-HEDGEHOG; PATCHED GENE; PROTEIN BRD4; SELECTIVE-INHIBITION; NEURONAL PRECURSORS; SUPER-ENHANCERS; HUMAN GLI2; P-TEFB; MEDULLOBLASTOMA	Hedgehog signaling drives oncogenesis in several cancers, and strategies targeting this pathway have been developed, most notably through inhibition of Smoothened (SMO). However, resistance to Smoothened inhibitors occurs by genetic changes of Smoothened or other downstream Hedgehog components. Here we overcome these resistance mechanisms by modulating GLI transcription through inhibition of bromo and extra C-terminal (BET) bromodomain proteins. We show that BRD4 and other BET bromodomain proteins regulate GLI transcription downstream of SMO and suppressor of fused (SUFU), and chromatin immunoprecipitation studies reveal that BRD4 directly occupies GM and GLI2 promoters, with a substantial decrease in engagement of these sites after treatment with JQ1, a small-molecule inhibitor targeting BRD4. Globally, genes associated with medulloblastoma-specific GLI1 binding sites are downregulated in response to JQ1 treatment, supporting direct regulation of GLI activity by BRD4. Notably, patient- and GEMM (genetically engineered mouse model)-derived Hedgehog-driven tumors (basal cell carcinoma, medulloblastoma and atypical teratoid rhabdoid tumor) respond to JQ1 even when harboring genetic lesions rendering them resistant to Smoothened antagonists. Altogether, our results reveal BET proteins as critical regulators of Hedgehog pathway transcriptional output and nominate BET bromodomain inhibitors as a strategy for treating Hedgehog-driven tumors with emerged or a priori resistance to Smoothened antagonists.	[Tang, Yujie; Schubert, Simone; Masoud, Sabran; Nguyen, Brian; Vue, Nujsaubnusi; Balansay, Brianna; Yu, Furong; Oh, Sekyung; Woo, Pamelyn; Chen, Spenser; Ponnuswami, Anitha; Monje, Michelle; Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Tang, Yujie; Gholamin, Sharareh; Schubert, Simone; Yu, Furong; Oh, Sekyung; Mitra, Siddhartha; Cheshier, Samuel H.; Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Willardson, Minde I.; Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Lee, Alex; Atwood, Scott X.; Whitson, Ramon J.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Bandopadhayay, Pratiti; Bergthold, Guillame; Beroukhim, Rameen; Bradner, James E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bandopadhayay, Pratiti; Bergthold, Guillame] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bandopadhayay, Pratiti; Bergthold, Guillame] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Bandopadhayay, Pratiti; Beroukhim, Rameen; Bradner, James E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Qi, Jun; Beroukhim, Rameen; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wechsler-Reya, Rob] Sanford Burnham Med Res, La Jolla, CA USA; [Cho, Yoon-Jae] Stanford Univ, Med Ctr, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Medical College of Wisconsin; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute; Stanford Cancer Institute; Stanford University	Cho, YJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	yjcho1@stanford.edu	Oh, Sekyung/J-9331-2017	Oh, Sekyung/0000-0002-6880-5281; Masoud, Sabran/0000-0002-7758-3545; Atwood, Scott/0000-0001-7407-9792; Gholamin, Sharareh/0000-0001-7425-6074; Tang, Jean/0000-0002-5510-6502; Oro, Anthony/0000-0002-6261-138X; Chen, Spenser/0000-0003-2741-9058; Lee, Alexander/0000-0002-4583-0740	St. Baldrick's Foundation Scholar Award; Beirne Faculty Scholar Endowment; US National Institutes of Health (NIH) [U01-CA176287]; Alex's Lemonade Stand Foundation Young Investigator Award; Damon-Runyon Cancer Research Foundation; NIH [R01-CA159859]; pilot project grant from the Medical College of Wisconsin Cancer Center-Advancing a Healthier Wisconsin; California Institute of Regenerative Medicine [LA1-01747]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA157895, U01CA176287, R01CA159859] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001931, R01EY016060, R01EY014167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054780, R01AR046786] Funding Source: NIH RePORTER	St. Baldrick's Foundation Scholar Award; Beirne Faculty Scholar Endowment; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation Young Investigator Award; Damon-Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project grant from the Medical College of Wisconsin Cancer Center-Advancing a Healthier Wisconsin; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported the St. Baldrick's Foundation Scholar Award (Y.-J.C.), a Beirne Faculty Scholar Endowment (Y.-J.C.), US National Institutes of Health (NIH) grant U01-CA176287 (Y.-J.C.), an Alex's Lemonade Stand Foundation Young Investigator Award (Y.T.), the Damon-Runyon Cancer Research Foundation (J.Q. and J.E.B.), NIH R01-CA159859 (R.W.-R.) and a pilot project grant from the Medical College of Wisconsin Cancer Center-Advancing a Healthier Wisconsin (B.A.L.). R.W.-R. is the recipient of a Leadership Award (LA1-01747) from the California Institute of Regenerative Medicine. We thank the Stanford Functional Genomics Facility (SFGF) and the Protein and Nucleic Acid (PAN) facility for their assistance in generating gene expression microarray data and reagents. We thank M. Scott (Stanford), C. Rudin (Memorial Sloan-Kettering Cancer Center), P. Beachy (Stanford), A. Sweet-Cordero (Stanford), P.-T. Chang (University of California, San Francisco), R. Karlstrom (University of Massachusetts, Amherst) and J.K. Chen (Stanford) for reagents, helpful suggestions and/or critical reading of the manuscript.	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; BINNS W, 1965, J AM VET MED ASSOC, V147, P839; Buczkowicz P, 2011, J NEUROPATH EXP NEUR, V70, P430, DOI 10.1097/NEN.0b013e31821b94db; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1965, CANCER-AM CANCER SOC, V18, P89, DOI 10.1002/1097-0142(196501)18:1<89::AID-CNCR2820180114>3.0.CO;2-9; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lee J, 2012, INVEST OPHTH VIS SCI, V53, P8214, DOI 10.1167/iovs.12-11061; Lee MJ, 2012, P NATL ACAD SCI USA, V109, P7859, DOI 10.1073/pnas.1114718109; Lewis KE, 1999, DEV BIOL, V208, P14, DOI 10.1006/dbio.1998.9169; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Shen MC, 2013, DEV DYNAM, V242, P539, DOI 10.1002/dvdy.23955; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie JW, 1997, CANCER RES, V57, P2369; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang YM, 2009, NEOPLASIA, V11, P96, DOI 10.1593/neo.81264; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	60	218	226	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					732	740		10.1038/nm.3613	http://dx.doi.org/10.1038/nm.3613			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24973920	Green Submitted, Green Accepted			2022-12-25	WOS:000338689500015
J	Huo, YL; Macara, IG				Huo, Yongliang; Macara, Ian G.			The Par3-like polarity protein Par3L is essential for mammary stem cell maintenance	NATURE CELL BIOLOGY			English	Article							LKB1; GENE; EXPRESSION; GLAND	The Par polarity proteins play key roles in asymmetric division of Drosophila melanogaster stem cells; however, whether the same mechanisms control stem cells in mammals is controversial. Although necessary for mammary gland morphogenesis, Par3 is not essential for mammary stem cell function. We discovered that, instead, a previously uncharacterized protein, Par3-like ( Par3L), is vital for mammary gland stem cell maintenance. Par3L function has been mysterious because, unlike Par3, it does not interact with atypical protein kinase C or the Par6 polarity protein. We found that Par3L is expressed by multipotent stem cells in the terminal end buds of murine mammary glands. Ablation of Par3L resulted in rapid and profound stem cell loss. Unexpectedly, Par3L, but not Par3, binds to the tumour suppressor protein Lkb1 and inhibits its kinase activity. This interaction is key for the function of Par3L in mammary stem cell maintenance. Our data reveal insights into a link between cell polarity proteins and stem cell survival, and uncover a biological function for Par3L.	[Huo, Yongliang; Macara, Ian G.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Macara, IG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	ian.g.macara@vanderbilt.edu			NIH grant [GM070902]; DoD postdoctoral fellowship [W81XWH-11-1-0083]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grant GM070902 (I.G.M.) and DoD postdoctoral fellowship W81XWH-11-1-0083 (Y.H.).	Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Brill B, 2008, LAB ANIM-UK, V42, P104, DOI 10.1258/la.2007.06003e; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gao L, 2002, GENE, V294, P99, DOI 10.1016/S0378-1119(02)00681-9; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Rohrschneider LR, 2005, DEV BIOL, V283, P503, DOI 10.1016/j.ydbio.2005.04.032; Sengupta A, 2011, P NATL ACAD SCI USA, V108, P9957, DOI 10.1073/pnas.1103132108; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003	22	36	36	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2014	16	6					526	+		10.1038/ncb2969	http://dx.doi.org/10.1038/ncb2969			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AI2EB	24859006	Green Accepted			2022-12-25	WOS:000336669100009
J	Jimenez-Oses, G; Osuna, S; Gao, X; Sawaya, MR; Gilson, L; Collier, SJ; Huisman, GW; Yeates, TO; Tang, Y; Houk, KN				Jimenez-Oses, Gonzalo; Osuna, Silvia; Gao, Xue; Sawaya, Michael R.; Gilson, Lynne; Collier, Steven J.; Huisman, Gjalt W.; Yeates, Todd O.; Tang, Yi; Houk, K. N.			The role of distant mutations and allosteric regulation on LovD active site dynamics	NATURE CHEMICAL BIOLOGY			English	Article							FATTY-ACID SYNTHASE; DIHYDROFOLATE-REDUCTASE; DIRECTED EVOLUTION; ENZYME CATALYSIS; PROTEINS; SIMVASTATIN; REVEALS; MOTIONS; FOLD	Natural enzymes have evolved to perform their cellular functions under complex selective pressures, which often require their catalytic activities to be regulated by other proteins. We contrasted a natural enzyme, LovD, which acts on a protein-bound (LovF) acyl substrate, with a laboratory-generated variant that was transformed by directed evolution to accept instead a small free acyl thioester and no longer requires the acyl carrier protein. The resulting 29-mutant variant is 1,000-fold more efficient in the synthesis of the drug simvastatin than the wild-type LovD. This is to our knowledge the first nonpatent report of the enzyme currently used for the manufacture of simvastatin as well as the intermediate evolved variants. Crystal structures and microsecond-scale molecular dynamics simulations revealed the mechanism by which the laboratory-generated mutations free LovD from dependence on protein-protein interactions. Mutations markedly altered conformational dynamics of the catalytic residues, obviating the need for allosteric modulation by the acyl carrier LovF.	[Jimenez-Oses, Gonzalo; Osuna, Silvia; Tang, Yi; Houk, K. N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Gao, Xue; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Gilson, Lynne; Collier, Steven J.; Huisman, Gjalt W.] Codexis Inc, Redwood City, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jimenez-Oses, G (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	gjalt.huisman@codexis.com; yeates@mbi.ucla.edu; yitang@ucla.edu; houk@chem.ucla.edu	Jiménez-Osés, Gonzalo/B-8057-2014; Osuna, Sílvia/B-6191-2009; gao, xue/J-7037-2016	Jiménez-Osés, Gonzalo/0000-0003-0105-4337; Osuna, Sílvia/0000-0003-3657-6469; Huisman, Gjalt/0000-0003-1955-1120; Sawaya, Michael/0000-0003-0874-9043; Yeates, Todd/0000-0001-5709-9839; gao, xue/0000-0003-3213-9704	National Institutes of Health [1R01GM097200, GM075962]; Ministerio de Economia y Competitividad [EX2012-1063]; European Union Marie Curie [PIOE-GA-2009-252856]; National Institute of General Medical Sciences [RC2GM093307]; National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307, R01GM097200, R01GM075962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government); European Union Marie Curie(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health through grant 1R01GM097200 (to Y.T., TOY. and K.N.H.) and GM075962 (to K.N.H.). G.J.-O. and S.O. were supported by Ministerio de Economia y Competitividad (EX2012-1063) and European Union Marie Curie (PIOE-GA-2009-252856) postdoctoral fellowships, respectively. We thank the LovD evolution team at Codexis, Inc. for generating the variants used for this work. ANTON simulations were performed on the National Resource for Biomedical Supercomputing at the Pittsburgh Supercomputing Centre with funding from the National Institute of General Medical Sciences under grant RC2GM093307. Additional calculations were performed on the MinoTauro cluster at the Barcelona Supercomputing Center and Hoffman2 and Dawson2 graphics processing unit clusters at the University of California-Los Angeles and the Extreme Science and Engineering Discovery Environment, which is supported by the National Science Foundation (OCI-1053575).	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Collier S.J., 2011, World Intellectual Patent Organization patent, Patent No. [WO2011/041233, 2011041233, WO 2011041233 A1]; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Gao X, 2009, CHEM BIOL, V16, P1064, DOI 10.1016/j.chembiol.2009.09.017; Gilson L., 2011, World Intellectual Property Organization patent, Patent No. [WO2011/041231, 2011041231]; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Schulenburg C, 2013, TOP CURR CHEM, V337, P41, DOI 10.1007/128_2012_411; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Wagner UG, 2002, PROTEIN SCI, V11, P467, DOI 10.1110/ps.33002; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; Xie XK, 2007, APPL ENVIRON MICROB, V73, P2054, DOI 10.1128/AEM.02820-06; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g	24	126	131	0	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					431	436		10.1038/nchembio.1503	http://dx.doi.org/10.1038/nchembio.1503			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24727900	Green Accepted, Green Submitted			2022-12-25	WOS:000336238200009
J	Anderson, TM; Clay, MC; Cioffi, AG; Diaz, KA; Hisao, GS; Tuttle, MD; Nieuwkoop, AJ; Comellas, G; Maryum, N; Wang, S; Uno, BE; Wildeman, EL; Gonen, T; Rienstra, CM; Burke, MD				Anderson, Thomas M.; Clay, Mary C.; Cioffi, Alexander G.; Diaz, Katrina A.; Hisao, Grant S.; Tuttle, Marcus D.; Nieuwkoop, Andrew J.; Comellas, Gemma; Maryum, Nashrah; Wang, Shu; Uno, Brice E.; Wildeman, Erin L.; Gonen, Tamir; Rienstra, Chad M.; Burke, Martin D.			Amphotericin forms an extramembranous and fungicidal sterol sponge	NATURE CHEMICAL BIOLOGY			English	Article							SOLID-STATE NMR; ACHOLEPLASMA-LAIDLAWII CELLS; POLYENE ANTIBIOTICS; CORRELATION SPECTROSCOPY; ION-CHANNEL; ERGOSTEROL; MEMBRANES; YEAST; RESISTANCE; CONSTRAINTS	For over 50 years, amphotericin has remained the powerful but highly toxic last line of defense in treating life-threatening fungal infections in humans with minimal development of microbial resistance. Understanding how this small molecule kills yeast is thus critical for guiding development of derivatives with an improved therapeutic index and other resistance-refractory antimicrobial agents. In the widely accepted ion channel model for its mechanism of cytocidal action, amphotericin forms aggregates inside lipid bilayers that permeabilize and kill cells. In contrast, we report that amphotericin exists primarily in the form of large, extramembranous aggregates that kill yeast by extracting ergosterol from lipid bilayers. These findings reveal that extraction of a polyfunctional lipid underlies the resistance-refractory antimicrobial action of amphotericin and suggests a roadmap for separating its cytocidal and membrane-permeabilizing activities. This new mechanistic understanding is also guiding development of what are to our knowledge the first derivatives of amphotericin that kill yeast but not human cells.	[Anderson, Thomas M.; Clay, Mary C.; Hisao, Grant S.; Tuttle, Marcus D.; Nieuwkoop, Andrew J.; Maryum, Nashrah; Wang, Shu; Uno, Brice E.; Rienstra, Chad M.; Burke, Martin D.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Cioffi, Alexander G.; Diaz, Katrina A.; Wildeman, Erin L.; Burke, Martin D.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Comellas, Gemma; Rienstra, Chad M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Wang, Shu; Burke, Martin D.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Anderson, TM (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	rienstra@illinois.edu; burke@scs.illinois.edu	Nieuwkoop, Andrew/AAV-7657-2021	Nieuwkoop, Andrew/0000-0003-4557-1416; Muraglia, Katrina/0000-0002-4162-4667	US National Institutes of Health (NIH) [R01GM080436, F30DK081272]; University of Illinois at Urbana-Champaign; American Heart Association Predoctoral Fellow; NIH National Research Service Award Predoctoral Fellow; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK081272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080436] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Urbana-Champaign; American Heart Association Predoctoral Fellow(American Heart Association); NIH National Research Service Award Predoctoral Fellow; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge P.J. Hergenrother and E. Oldfield for helpful discussions, and we thank J.J. Lopez for preliminary spin diffusion SSNMR experiments. Portions of this work were supported by the US National Institutes of Health (NIH) (R01GM080436 and F30DK081272) and the University of Illinois at Urbana-Champaign (Centennial Scholar Award to C.M.R.). M.D.B. is a Howard Hughes Medical Institute Early Career Scientist. M.C.C. is an American Heart Association Predoctoral Fellow. T.M.A. is a Ruth L. Kirchstein NIH National Research Service Award Predoctoral Fellow. The Gonen lab is funded by the Howard Hughes Medical Institute.	ANDREOLI TE, 1968, J GEN PHYSIOL, V52, P300, DOI 10.1085/jgp.52.2.300; ANDREOLI TE, 1974, ANN NY ACAD SCI, V235, P448, DOI 10.1111/j.1749-6632.1974.tb43283.x; Baginski M, 2002, BBA-BIOMEMBRANES, V1567, P63, DOI 10.1016/S0005-2736(02)00581-3; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; CASS A, 1970, J GEN PHYSIOL, V56, P100, DOI 10.1085/jgp.56.1.100; Cereghetti DM, 2006, SYNTHESIS-STUTTGART, P914, DOI 10.1055/s-2006-926368; Chen LL, 2006, J AM CHEM SOC, V128, P9992, DOI 10.1021/ja062347t; CHERON M, 1988, BIOCHEM PHARMACOL, V37, P827, DOI 10.1016/0006-2952(88)90168-2; Comellas G, 2011, J MAGN RESON, V209, P131, DOI 10.1016/j.jmr.2010.12.011; Croatt MP, 2011, ORG LETT, V13, P1390, DOI 10.1021/ol2000765; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; ERMISHKIN LN, 1976, NATURE, V262, P698, DOI 10.1038/262698a0; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Finkelstein A, 1973, Membranes, V2, P377; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hohwy M, 2000, J AM CHEM SOC, V122, P3218, DOI 10.1021/ja9913737; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hsueh YW, 2007, BIOPHYS J, V92, P1606, DOI 10.1529/biophysj.106.097345; Huster D, 2002, J AM CHEM SOC, V124, P874, DOI 10.1021/ja017001r; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Kang CK, 2013, MICROBIOL-SGM, V159, P939, DOI 10.1099/mic.0.065714-0; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Katzung B.G., 2012, PHARMACOL TOXICOL; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Matsumori N, 2006, J AM CHEM SOC, V128, P11977, DOI 10.1021/ja063433w; Matsuoka S, 2006, BIOORGAN MED CHEM, V14, P6608, DOI 10.1016/j.bmc.2006.06.001; Milhaud J, 2002, BBA-BIOMEMBRANES, V1558, P95, DOI 10.1016/S0005-2736(01)00416-3; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Mouri R, 2008, BIOCHEMISTRY-US, V47, P7807, DOI 10.1021/bi800334p; Murata M, 2009, PURE APPL CHEM, V81, P1123, DOI 10.1351/PAC-CON-08-08-37; Nadaud PS, 2007, J AM CHEM SOC, V129, P7502, DOI 10.1021/ja072349t; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Palacios DS, 2007, J AM CHEM SOC, V129, P13804, DOI 10.1021/ja075739o; Palacios DS, 2011, P NATL ACAD SCI USA, V108, P6733, DOI 10.1073/pnas.1015023108; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Rienstra CM, 2002, J AM CHEM SOC, V124, P11908, DOI 10.1021/ja020802p; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; SANKARAM MB, 1991, P NATL ACAD SCI USA, V88, P8686, DOI 10.1073/pnas.88.19.8686; SEO S, 1988, J CHEM SOC PERK T 1, P2407, DOI 10.1039/p19880002407; Shervani Z, 1996, COLLOID SURFACE B, V7, P31, DOI 10.1016/0927-7765(96)01283-0; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tang M, 2005, J AM CHEM SOC, V127, P13919, DOI 10.1021/ja0526665; te Welscher YM, 2012, P NATL ACAD SCI USA, V109, P11156, DOI 10.1073/pnas.1203375109; Umegawa Y, 2012, BIOCHEMISTRY-US, V51, P83, DOI 10.1021/bi2012542; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V291, P577, DOI 10.1016/0005-2736(73)90509-9; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Volmer AA, 2010, NAT PROD REP, V27, P1329, DOI 10.1039/b820743g; WATSON K, 1975, BIOCHEM J, V146, P401, DOI 10.1042/bj1460401; Wilcock BC, 2013, J AM CHEM SOC, V135, P8488, DOI 10.1021/ja403255s; Winkler JK, 2007, J AGR FOOD CHEM, V55, P6482, DOI 10.1021/jf070594q; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	58	271	282	7	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					400	U121		10.1038/nchembio.1496	http://dx.doi.org/10.1038/nchembio.1496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24681535	Green Submitted, Green Accepted			2022-12-25	WOS:000334672700015
J	Mouw, JK; Yui, Y; Damiano, L; Bainer, RO; Lakins, JN; Acerbi, I; Ou, GQ; Wijekoon, AC; Levental, KR; Gilbert, PM; Hwang, ES; Chen, YY; Weaver, VM				Mouw, Janna K.; Yui, Yoshihiro; Damiano, Laura; Bainer, Russell O.; Lakins, Johnathon N.; Acerbi, Irene; Ou, Guanqing; Wijekoon, Amanda C.; Levental, Kandice R.; Gilbert, Penney M.; Hwang, E. Shelley; Chen, Yunn-Yi; Weaver, Valerie M.			Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression	NATURE MEDICINE			English	Article							BREAST; TARGETS; INTERFERENCE; PHENOTYPE; MIR-17-92; PATHWAYS; SUBTYPES; DENSITY; GROWTH; FORCE	Tissue mechanics regulate development and homeostasis and are consistently modified in tumor progression. Nevertheless, the fundamental molecular mechanisms through which altered mechanics regulate tissue behavior and the clinical relevance of these changes remain unclear. We demonstrate that increased matrix stiffness modulates microRNA expression to drive tumor progression through integrin activation of beta-catenin and MYC. Specifically, in human and mouse tissue, increased matrix stiffness induced miR-18a to reduce levels of the tumor suppressor phosphatase and tensin homolog ( PTEN), both directly and indirectly by decreasing levels of homeobox A9 (HOXA9). Clinically, extracellular matrix stiffness correlated directly and significantly with miR-18a expression in human breast tumor biopsies. miR-18a expression was highest in basal-like breast cancers in which PTEN and HOXA9 levels were lowest, and high miR-18a expression predicted poor prognosis in patients with luminal breast cancers. Our findings identify a mechanically regulated microRNA circuit that can promote malignancy and suggest potential prognostic roles for HOXA9 and miR-18a levels in stratifying patients with luminal breast cancers.	[Mouw, Janna K.; Yui, Yoshihiro; Damiano, Laura; Bainer, Russell O.; Lakins, Johnathon N.; Acerbi, Irene; Ou, Guanqing; Wijekoon, Amanda C.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Levental, Kandice R.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Gilbert, Penney M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Hwang, E. Shelley] Duke Univ, Ctr Comprehens Canc, Dept Surg, Durham, NC USA; [Chen, Yunn-Yi] UCSF, Dept Pathol, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, Dept Anat, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, UCSF Helen Diller Comprehens Canc Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA.	valerie.weaver@ucsfmedctr.org	Acerbi, Irene/AAA-3120-2019	Gilbert, Penney/0000-0001-5509-9616; Yui, Yoshihiro/0000-0002-5806-7801; Levental, Kandice/0000-0002-2234-3683; Mouw, Janna K/0000-0002-9846-8466; Weaver, Valerie marie/0000-0003-4786-6752	US Department of Defense Breast Cancer Research Program (DOD BCRP) [W81XWH-07-1-0538]; Susan G. Komen Postdoctoral Fellowship [PDF12230246]; US National Science Foundation; DOD BCRP [W81XWH-05-1-0330, W81XWH-13-1-0216]; US National Institutes of Health NCI [R01 CA138818, U54 CA143836, R01 CA085492, U01 ES019458]; Susan G. Komen grant [KG110560PP]; NATIONAL CANCER INSTITUTE [R01CA085492, R01CA138818, U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER	US Department of Defense Breast Cancer Research Program (DOD BCRP)(United States Department of Defense); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); US National Science Foundation(National Science Foundation (NSF)); DOD BCRP(United States Department of Defense); US National Institutes of Health NCI; Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the members of the Weaver and N. Boudreau labs for helpful discussions. Atomic force microscopy analysis of the PyMT samples was performed by H. Yu. Animal handling was supported by L. Korets. miRNA and antagomir constructs were provided by M. Scherr at the Medical School Hannover. PTEN proximal promoter constructs were provided by C. Eng at the Genomic Medical Institute. LOX inhibitory antibodies were provided by A. Giaccia at the Stanford University School of Medicine. HOXA9 was provided by T. Nakamura at the Japanese Foundation for Cancer Research. This work was supported by US Department of Defense Breast Cancer Research Program (DOD BCRP) grant W81XWH-07-1-0538 (J.K.M.), Susan G. Komen Postdoctoral Fellowship PDF12230246 (I.A.), US National Science Foundation Graduate Research Fellowship (G.O.), DOD BCRP grants W81XWH-05-1-0330 and W81XWH-13-1-0216 (V.M.W.), US National Institutes of Health NCI grants R01 CA138818, U54 CA143836, R01 CA085492 and U01 ES019458 (V.M.W.) and Susan G. Komen grant KG110560PP (V.M.W. and E.S.W.).	Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Chang JM, 2013, EUR RADIOL, V23, P2450, DOI 10.1007/s00330-013-2866-2; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Enright AJ, 2004, GENOME BIOL, V5; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Fasching PA, 2006, EUR J RADIOL, V60, P398, DOI 10.1016/j.ejrad.2006.08.002; Gan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025809; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Jin Yi, 2013, Methods Mol Biol, V936, P117; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lakins Johnathon N, 2012, Methods Mol Biol, V916, P317, DOI 10.1007/978-1-61779-980-8_24; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YM, 2012, BLOOD, V119, P4486, DOI 10.1182/blood-2011-09-378687; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Neth P, 2013, CARDIOVASC RES, V99, P294, DOI 10.1093/cvr/cvt096; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; von Minckwitz G, 2013, J CLIN ONCOL, V31, P3623, DOI 10.1200/JCO.2012.45.0940; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang ZG, 2013, COMPR PHYSIOL, V3, P599, DOI 10.1002/cphy.c110002; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yehya N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-154; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	53	275	281	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					360	+		10.1038/nm.3497	http://dx.doi.org/10.1038/nm.3497			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24633304	Green Accepted			2022-12-25	WOS:000334361500016
J	Shuhendler, AJ; Pu, KY; Cui, L; Uetrecht, JP; Rao, JH				Shuhendler, Adam J.; Pu, Kanyi; Cui, Lina; Uetrecht, Jack P.; Rao, Jianghong			Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing	NATURE BIOTECHNOLOGY			English	Article							REACTIVE OXYGEN; NITRIC-OXIDE; HEPATOTOXICITY; MICE; BIOACTIVATION; PEROXYNITRITE; MITOCHONDRIAL; MECHANISMS; METABOLITES; TOXICOLOGY	Current drug-safety assays for hepatotoxicity rely on biomarkers with low predictive power. The production of radical species, specifically reactive oxygen species (ROS) and reactive nitrogen species (RNS), has been proposed as an early unifying event linking the bioactivation of drugs to hepatotoxicity and as a more direct and mechanistic indicator of hepatotoxic potential. Here we present a nanosensor for rapid, real-time in vivo imaging of drug-induced ROS and RNS for direct evaluation of acute hepatotoxicity. By combining fluorescence resonance energy transfer (FRET) and chemiluminescence resonance energy transfer (CRET), our semiconducting polymer-based nanosensor simultaneously and differentially detects RNS and ROS using two optically independent channels. We imaged drug-induced hepatotoxicity and its remediation longitudinally in mice after systemic challenge with acetaminophen or isoniazid. We detected dose-dependent ROS and RNS activity in the liver within minutes of drug challenge, which preceded histological changes, protein nitration and DNA double-strand-break induction.	[Shuhendler, Adam J.; Pu, Kanyi; Cui, Lina; Rao, Jianghong] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Uetrecht, Jack P.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	Stanford University; University of Toronto	Rao, JH (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	jrao@stanford.edu	Pu, Kanyi/F-2957-2010; Shuhendler, Adam/B-6333-2014	Pu, Kanyi/0000-0002-8064-6009; Shuhendler, Adam/0000-0001-6952-5217	US National Institutes of Health National Cancer Institute (NCI) [R01CA135294, R01DK099800-06A1, R21CA138353A2]; Stanford University NCI CCNE-T [U54CA151459]; In Vivo Cellular and Molecular Imaging Centers [P50CA114747]; Susan G. Komen For The Cure for fellowship; NATIONAL CANCER INSTITUTE [R21CA138353, P50CA114747, R01CA135294, U54CA151459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099800] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute (NCI); Stanford University NCI CCNE-T; In Vivo Cellular and Molecular Imaging Centers; Susan G. Komen For The Cure for fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health National Cancer Institute (NCI) grants R01CA135294, R01DK099800-06A1, R21CA138353A2, the Stanford University NCI CCNE-T grant (U54CA151459) and In Vivo Cellular and Molecular Imaging Centers grant (P50CA114747). A.J.S. acknowledges Susan G. Komen For The Cure for fellowship support. We acknowledge the use of the SCi<SUP>3</SUP> Core Facility and the Neuroscience Microscopy Service Facility at Stanford University, P. Chu for her expertise in preparation of histology samples, E.J. McWalter for assistance with MatLab script, and S. Machtaler for assistance with tissue preparation and imaging by confocal microscopy.	Antoine DJ, 2008, EXPERT OPIN DRUG MET, V4, P1415, DOI [10.1517/17425255.4.11.1415, 10.1517/17425255.4.11.1415 ]; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Guimard NKE, 2009, MACROMOLECULES, V42, P502, DOI 10.1021/ma8019859; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Herd RM, 1997, DERMATOL CLIN, V15, P355, DOI 10.1016/S0733-8635(05)70446-0; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Holt Michael, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00663-0_1; Hu YX, 2013, ACS NANO, V7, P5376, DOI 10.1021/nn4012384; Jackson TE, 2000, TOXICOL SCI, V55, P266, DOI 10.1093/toxsci/55.2.266; James LP, 2003, TOXICOL SCI, V75, P458, DOI 10.1093/toxsci/kfg181; Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; LAUTERBURG BH, 1985, J PHARMACOL EXP THER, V235, P566; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Li F, 2013, NAT MED, V19, P418, DOI 10.1038/nm.3104; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029; Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372; McGill MR, 2013, PHARM RES-DORDR, V30, P2174, DOI 10.1007/s11095-013-1007-6; McGill MR, 2013, TOXICOL APPL PHARM, V269, P240, DOI 10.1016/j.taap.2013.03.026; Metushi IG, 2011, CLIN PHARMACOL THER, V89, P911, DOI 10.1038/clpt.2010.355; Metushi IG, 2012, CHEM RES TOXICOL, V25, P2567, DOI 10.1021/tx300341r; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Nasr A, 2011, ADV THER, V28, P842, DOI 10.1007/s12325-011-0059-4; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Oushiki D, 2010, J AM CHEM SOC, V132, P2795, DOI 10.1021/ja910090v; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Pessayre Dominique, 2010, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-00663-0_11; Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/NNANO.2013.302, 10.1038/nnano.2013.302]; Pu KY, 2013, ANGEW CHEM INT EDIT, V52, P10325, DOI 10.1002/anie.201303420; Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Sakatis MZ, 2012, CHEM RES TOXICOL, V25, P2067, DOI [10.1021/tx300075J, 10.1021/tx300075j]; Saukkonen JJ, 2012, AM J RESP CRIT CARE, V185, P598, DOI 10.1164/rccm.201112-2174ED; Shuhendler AJ, 2011, ACS NANO, V5, P1958, DOI 10.1021/nn103024b; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Sokolov AN, 2012, ACCOUNTS CHEM RES, V45, P361, DOI 10.1021/ar2001233; Srivastava A, 2010, Handb Exp Pharmacol, P165, DOI 10.1007/978-3-642-00663-0_7; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tang W, 2010, DRUG METAB REV, V42, P225, DOI 10.3109/03602530903401658; Tengowski MW, 2005, PROG DRUG RES, V62, P257; Walsh JS, 2011, ANNU REV PHARMACOL, V51, P145, DOI 10.1146/annurev-pharmtox-010510-100514; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wu CF, 2013, ANGEW CHEM INT EDIT, V52, P3086, DOI 10.1002/anie.201205133; Xiong LQ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2197; Zhang N, 2013, NAT MED, V19, P500, DOI 10.1038/nm.3110	55	420	427	25	483	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					373	U240		10.1038/nbt.2838	http://dx.doi.org/10.1038/nbt.2838			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24658645	Green Accepted			2022-12-25	WOS:000334340800022
J	Torres-Rosas, R; Yehia, G; Pena, G; Mishra, P; Thompson-Bonilla, MD; Moreno-Eutimio, MA; Arriaga-Pizano, LA; Isibasi, A; Ulloa, L				Torres-Rosas, Rafael; Yehia, Ghassan; Pena, Geber; Mishra, Priya; del Rocio Thompson-Bonilla, Maria; Adan Moreno-Eutimio, Mario; Andrea Arriaga-Pizano, Lourdes; Isibasi, Armando; Ulloa, Luis			Dopamine mediates vagal modulation of the immune system by electroacupuncture	NATURE MEDICINE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TUMOR-NECROSIS-FACTOR; VAGUS NERVE; REGULATORY LYMPHOCYTES; SEVERE SEPSIS; SEPTIC SHOCK; DOUBLE-BLIND; ACUPUNCTURE; STIMULATION; FENOLDOPAM	Previous anti-inflammatory strategies against sepsis, a leading cause of death in hospitals, had limited efficacy in clinical trials, in part because they targeted single cytokines and the experimental models failed to mimic clinical settings(1-3). Neuronal networks represent physiological mechanisms, selected by evolution to control inflammation, that can be exploited for the treatment of inflammatory and infectious disorders(3). Here, we report that sciatic nerve activation with electroacupuncture controls systemic inflammation and rescues mice from polymicrobial peritonitis. Electroacupuncture at the sciatic nerve controls systemic inflammation by inducing vagal activation of aromatic L-amino acid decarboxylase, leading to the production of dopamine in the adrenal medulla. Experimental models with adrenolectomized mice mimic clinical adrenal insufficiency(4), increase the susceptibility to sepsis and prevent the anti-inflammatory effects of electroacupuncture. Dopamine inhibits cytokine production via dopamine type 1 (D1) receptors. D1 receptor agonists suppress systemic inflammation and rescue mice with adrenal insufficiency from polymicrobial peritonitis. Our results suggest a new anti-inflammatory mechanism mediated by the sciatic and vagus nerves that modulates the production of catecholamines in the adrenal glands. From a pharmacological perspective, the effects of selective dopamine agonists mimic the anti-inflammatory effects of electroacupuncture and can provide therapeutic advantages to control inflammation in infectious and inflammatory disorders.	[Torres-Rosas, Rafael; Yehia, Ghassan; Pena, Geber; Mishra, Priya; del Rocio Thompson-Bonilla, Maria; Ulloa, Luis] Rutgers State Univ, New Jersey Med Sch, Dept Surg, Lab Antiinflammatory Signaling, Newark, NJ 07102 USA; [Torres-Rosas, Rafael; Andrea Arriaga-Pizano, Lourdes; Isibasi, Armando] Natl Med Ctr Siglo XXI, Med Res Unit Immunochem, Mexico City, DF, Mexico; [del Rocio Thompson-Bonilla, Maria] Inst Social Secur & Serv States Employees Res Ins, Mexico City, DF, Mexico; [Adan Moreno-Eutimio, Mario] Hosp Juarez Mexico, Lab Immunobiol, Mexico City, DF, Mexico; [Ulloa, Luis] Rutgers State Univ, New Jersey Med Sch, Ctr Immunol & Inflammat, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ulloa, L (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Surg, Lab Antiinflammatory Signaling, Newark, NJ 07102 USA.	mail@luisulloa.com	pena, Geber/AAD-5890-2019; Arriaga-Pizano, Lourdes/AAI-9628-2021; Torres-Rosas, Rafael/G-6936-2019; Ulloa, Luis/AAE-8751-2019; Moreno-Eutimio, Mario Adán/E-6899-2019	Arriaga-Pizano, Lourdes/0000-0003-4433-2106; Torres-Rosas, Rafael/0000-0002-5934-003X; Ulloa, Luis/0000-0002-7702-7549; Moreno-Eutimio, Mario Adán/0000-0002-9955-8498	Mexican National Council for Science and Technology; Department of Surgery of the New Jersey Medical School; Foundation of University of Medicine and Dentistry of New Jersey; US National Institutes of Health [RO1-GM084125]; University Autonoma Benito Juarez de Oaxaca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084125] Funding Source: NIH RePORTER	Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Department of Surgery of the New Jersey Medical School; Foundation of University of Medicine and Dentistry of New Jersey; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Autonoma Benito Juarez de Oaxaca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Morcillo, J.M. Inclan-Rico and J.R. Berlin for their comments and suggestions and M. Marks (University of Colorado) and B. Kobilka (Stanford University) for the alpha<INF>7</INF>nAChR and beta<INF>2</INF>AR knockout mice. R.T.-R. was supported by the University Autonoma Benito Juarez de Oaxaca. M.d.R.T.-B. was supported by the Mexican National Council for Science and Technology. L.U. is supported by the faculty program of the Department of Surgery of the New Jersey Medical School, the Foundation of University of Medicine and Dentistry of New Jersey and US National Institutes of Health grant RO1-GM084125.	Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Annane D, 2008, CURR PHARM DESIGN, V14, P1882, DOI 10.2174/138161208784980626; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cal B., 2009, J CELL MOL MED, V13, P3774; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; COUPLAND RE, 1989, J ANAT, V163, P173; DENEF C, 1980, NATURE, V285, P243, DOI 10.1038/285243a0; Ernst E, 2011, PAIN, V152, P755, DOI 10.1016/j.pain.2010.11.004; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; GORISSEN H, 1979, NATURE, V279, P72, DOI 10.1038/279072a0; GRENADER A, 1991, J PHARMACOL EXP THER, V258, P193; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; LEE A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003281.PUB2; Morelli A, 2005, CRIT CARE MED, V33, P2451, DOI 10.1097/01.CCM.0000186413.04875.EF; Napadow V, 2004, J ALTERN COMPLEM MED, V10, P565, DOI 10.1089/1075553041323849; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WEBER RR, 1988, BRIT J CLIN PHARMACO, V25, P17, DOI 10.1111/j.1365-2125.1988.tb03276.x; Wu HM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004131.pub2	33	329	368	12	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					291	295		10.1038/nm.3479	http://dx.doi.org/10.1038/nm.3479			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24562381	Green Accepted			2022-12-25	WOS:000332595600024
J	von Figura, G; Fukuda, A; Roy, N; Liku, ME; Morris, JP; Kim, GE; Russ, HA; Firpo, MA; Mulvihill, SJ; Dawson, DW; Ferrer, J; Mueller, WF; Busch, A; Hertel, KJ; Hebrok, M				von Figura, Guido; Fukuda, Akihisa; Roy, Nilotpal; Liku, Muluye E.; Morris, John P.; Kim, Grace E.; Russ, Holger A.; Firpo, Matthew A.; Mulvihill, Sean J.; Dawson, David W.; Ferrer, Jorge; Mueller, William F.; Busch, Anke; Hertel, Klemens J.; Hebrok, Matthias			The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma	NATURE CELL BIOLOGY			English	Article							INTRAEPITHELIAL NEOPLASIA; INVASIVE ADENOCARCINOMA; TUMOR-SUPPRESSOR; CANCER; MUTATIONS; KRAS; EXPRESSION; HAPLOINSUFFICIENCY; PROGRESSION; ARID1A	Pancreatic ductal adenocarcinoma (PDA) develops through distinct precursor lesions, including pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasia (IPMN). However, genetic features resulting in IPMN-associated PDA (IPMN-PDA) versus PanIN-associated PDA (PanIN-PDA) are largely unknown. Here we find that loss of Brg1, a core subunit of SWI/SNF chromatin remodelling complexes, cooperates with oncogenic Kras to form cystic neoplastic lesions that resemble human IPMN and progress to PDA. Although Brg1-null IPMN-PDA develops rapidly, it possesses a distinct transcriptional profile compared with PanIN-PDA driven by mutant Kras and hemizygous p53 deletion. IPMN-PDA also is less lethal, mirroring prognostic trends in PDA patients. In addition, Brg1 deletion inhibits Kras-dependent PanIN development from adult acinar cells, but promotes Kras-driven preneoplastic transformation in adult duct cells. Therefore, this study implicates Brg1 as a determinant of context-dependent Kras-driven pancreatic tumorigenesis and suggests that chromatin remodelling may underlie the development of distinct PDA subsets.	[von Figura, Guido; Fukuda, Akihisa; Roy, Nilotpal; Liku, Muluye E.; Morris, John P.; Russ, Holger A.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [von Figura, Guido] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, D-81675 Munich, Germany; [Fukuda, Akihisa] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; [Kim, Grace E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Firpo, Matthew A.; Mulvihill, Sean J.] Univ Utah, Dept Surg, Salt Lake City, UT 84115 USA; [Firpo, Matthew A.; Mulvihill, Sean J.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84115 USA; [Dawson, David W.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; [Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 ONN, England; [Mueller, William F.; Busch, Anke; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California San Francisco; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Kyoto University; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; Imperial College London; University of California System; University of California Irvine	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, 513 Parnassus Ave,HSW 1116,Box 0540, San Francisco, CA 94143 USA.	mhebrok@diabetes.ucsf.edu	Dawson, David/I-5917-2014; Ferrer, Jorge/A-3176-2012	Ferrer, Jorge/0000-0002-5959-5729; Kim, Grace/0000-0003-4603-9448; Hertel, Klemens/0000-0002-7560-9529	NIH [CA112537, CA149548]; Deutsche Forschungsgemeinschaft (DFG) [FI 1719/1-1]; Klein Family Foundation; Japan Society for the Promotion of Science; US National Pancreas Foundation; Kato Memorial Biosciences Foundation; CIRM [TG 201153]; UCSF Diabetes and Endocrinology Research Center (DERC) NIH [P30DK63720]; NATIONAL CANCER INSTITUTE [P30CA062203, R01CA112537, R21CA149548, P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Klein Family Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Pancreas Foundation; Kato Memorial Biosciences Foundation; CIRM(California Institute for Regenerative Medicine); UCSF Diabetes and Endocrinology Research Center (DERC) NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Wright for sharing Ptf1a-Cre and Ptf1a-Cre<SUP>ER</SUP> mice, D. Tuveson for Kras<SUP>G12D</SUP> mice, and P. Chambon and D. Reisman for Brg1<SUP>flox</SUP> mice, respectively. We thank C. Austin and D. Ngow for tissue processing and excellent technical assistance and all M.H. laboratory members for helpful discussion. Work in M.H.'s laboratory was supported by a grant from the NIH (CA112537). G.v.F. was supported by a postdoctoral Research Fellowship from the Deutsche Forschungsgemeinschaft (DFG, FI 1719/1-1) and a Klein Family Foundation Fellowship. A.F. was supported by a post-doctoral Research Fellowship from the Japan Society for the Promotion of Science, a Fellowship from the US National Pancreas Foundation, and a Fellowship from the Kato Memorial Biosciences Foundation. M.E.L. was supported by CIRM training grant TG 201153. W.F.M., A.B. and K.J.H. were supported by a grant from the NIH (CA149548). Image acquisition was supported by the imaging core of the UCSF Diabetes and Endocrinology Research Center (DERC) NIH grant P30DK63720.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Dal Molin M, 2012, HUM PATHOL, V43, P585, DOI 10.1016/j.humpath.2011.06.009; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Masui T, 2001, CLIN CANCER RES, V7, P3437; Matthaei H, 2012, ANN SURG, V255, P326, DOI 10.1097/SLA.0b013e3182378a18; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Poultsides GA, 2010, ANN SURG, V251, P470, DOI 10.1097/SLA.0b013e3181cf8a19; Ray KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016786; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shi CJ, 2012, HUM PATHOL, V43, P1, DOI 10.1016/j.humpath.2011.04.003; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Tanaka T, 2013, PANCREAS, V42, P488, DOI 10.1097/MPA.0b013e318269d281; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	61	128	131	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					255	+		10.1038/ncb2916	http://dx.doi.org/10.1038/ncb2916			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24561622	Green Accepted			2022-12-25	WOS:000332124000012
J	Dominguez, E; Galmozzi, A; Chang, JW; Hsu, KL; Pawlak, J; Li, WW; Godio, C; Thomas, J; Partida, D; Niessen, S; O'Brien, PE; Russell, AP; Watt, MJ; Nomura, DK; Cravatt, BF; Saez, E				Dominguez, Eduardo; Galmozzi, Andrea; Chang, Jae Won; Hsu, Ku-Lung; Pawlak, Joanna; Li, Weiwei; Godio, Cristina; Thomas, Jason; Partida, David; Niessen, Sherry; O'Brien, Paul E.; Russell, Aaron P.; Watt, Matthew J.; Nomura, Daniel K.; Cravatt, Benjamin F.; Saez, Enrique			integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes	NATURE CHEMICAL BIOLOGY			English	Article							DECREASES BLOOD-LIPIDS; PPAR-GAMMA EXPRESSION; SERINE HYDROLASES; COMPLEX PROTEOMES; TRIACYLGLYCEROL; LIPASE; METABOLISM; INHIBITORS; PROTEINS; TARGET	Phenotypic screening is making a comeback in drug discovery as the maturation of chemical proteomics methods has facilitated target identification for bioactive small molecules. A limitation of these approaches is that time-consuming genetic methods or other means are often required to determine the biologically relevant target (or targets) from among multiple protein-compound interactions that are typically detected. Here, we have combined phenotypic screening of a directed small-molecule library with competitive activity-based protein profiling to map and functionally characterize the targets of screening hits. Using this approach, we identify carboxylesterase 3 (Ces3, also known as Cesld) as a primary molecular target of bioactive compounds that promote lipid storage in adipocytes. We further show that Ces3 activity is markedly elevated during adipocyte differentiation. Treatment of two mouse models of obesity-diabetes with a Ces3 inhibitor ameliorates multiple features of metabolic syndrome, illustrating the power of the described strategy to accelerate the identification and pharmacologic validation of new therapeutic targets.	[Dominguez, Eduardo; Galmozzi, Andrea; Chang, Jae Won; Hsu, Ku-Lung; Pawlak, Joanna; Li, Weiwei; Godio, Cristina; Thomas, Jason; Partida, David; Niessen, Sherry; Nomura, Daniel K.; Cravatt, Benjamin F.; Saez, Enrique] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Dominguez, Eduardo; Galmozzi, Andrea; Chang, Jae Won; Hsu, Ku-Lung; Pawlak, Joanna; Li, Weiwei; Godio, Cristina; Thomas, Jason; Partida, David; Niessen, Sherry; Nomura, Daniel K.; Cravatt, Benjamin F.; Saez, Enrique] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [O'Brien, Paul E.] Monash Univ, Alfred Hosp, Ctr Obes Res & Educ, Prahran, Vic, Australia; [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, NSW, Australia; [Watt, Matthew J.] Monash Univ, Dept Physiol, Biol Lipid Metab Lab, Clayton, Vic 3168, Australia	Scripps Research Institute; Scripps Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Deakin University; Monash University	Saez, E (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	cravatt@scripps.edu; esaez@scripps.edu	Chang, Jae Won/AAN-4139-2020; Hsu, Ku-Lung/L-6256-2019; Watt, Matthew J/B-2089-2014; Dominguez, Eduardo/AAD-6578-2020; Hsu, Ku-Lung/J-2885-2014	Hsu, Ku-Lung/0000-0001-5620-3972; Dominguez, Eduardo/0000-0003-3359-5867; Hsu, Ku-Lung/0000-0001-5620-3972; Russell, Aaron/0000-0002-7323-9501; Godio, Cristina/0000-0003-2639-6368	American Diabetes Association; McDonald's Center for Type 2 Diabetes and Obesity; US National Institutes of Health [DK081003, DK099810]; NIH [DK099810]; National Health and Medical Research Council of Australia; Xunta de,Galicia, Spain; Hewitt Foundation; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099810, R01DK081003] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); McDonald's Center for Type 2 Diabetes and Obesity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Xunta de,Galicia, Spain(Xunta de Galicia); Hewitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Kralli and P. Tontonoz for valuable discussions. E.S. is supported by a Career Development Award from the American Diabetes Association, the McDonald's Center for Type 2 Diabetes and Obesity and US National Institutes of Health grants DK081003 and DK099810. B.F.C. is supported by NIH grant DK099810. M.J.W. is supported by grants and a Senior Research Fellowship from the National Health and Medical Research Council of Australia. A.P.R. is supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia. ED. was supported by an Anxeles Alvarino fellowship from the Xunta de,Galicia, Spain. K.-L.H. was supported by a Hewitt Foundation postdoctoral fellowship.	Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P4649, DOI 10.1210/jc.2004-0224; Birner-Gruenberger R, 2012, INSECT BIOCHEM MOLEC, V42, P220, DOI 10.1016/j.ibmb.2011.12.004; Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; FULCHER GR, 1992, DIABETES, V41, P1400, DOI 10.2337/diabetes.41.11.1400; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Girousse A, 2012, INT J OBESITY, V36, P581, DOI 10.1038/ijo.2011.113; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4; Jernas M, 2009, BIOCHEM BIOPH RES CO, V383, P63, DOI 10.1016/j.bbrc.2009.03.120; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Kodadek T, 2010, NAT CHEM BIOL, V6, P162, DOI 10.1038/nchembio.303; Laggner C, 2012, NAT CHEM BIOL, V8, P144, DOI 10.1038/nchembio.732; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Lian JH, 2012, HEPATOLOGY, V56, P2154, DOI 10.1002/hep.25881; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Marrades MP, 2010, OBESITY FACTS, V3, P312, DOI 10.1159/000321451; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Moellering RE, 2012, CHEM BIOL, V19, P11, DOI 10.1016/j.chembiol.2012.01.001; Morak M, 2009, J LIPID RES, V50, P1281, DOI 10.1194/jlr.M800566-JLR200; Nagashima S, 2011, J ATHEROSCLER THROMB, V18, P190, DOI 10.5551/jat.6478; Okazaki H, 2006, DIABETES, V55, P2091, DOI 10.2337/db05-0585; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Schicher M, 2010, J PROTEOME RES, V9, P6334, DOI 10.1021/pr1005795; Schmidinger H, 2006, AMINO ACIDS, V30, P333, DOI 10.1007/s00726-006-0305-2; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wani JH, 2008, CARDIOL CLIN, V26, P639, DOI 10.1016/j.ccl.2008.06.008; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	50	93	93	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					113	121		10.1038/nchembio.1429	http://dx.doi.org/10.1038/nchembio.1429			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24362705	Green Submitted, Green Accepted			2022-12-25	WOS:000330751600009
J	Dowling, DP; Bruender, NA; Young, AP; McCarty, RM; Bandarian, V; Drennan, CL				Dowling, Daniel P.; Bruender, Nathan A.; Young, Anthony P.; McCarty, Reid M.; Bandarian, Vahe; Drennan, Catherine L.			Radical SAM enzyme QueE defines a new minimal core fold and metal-dependent mechanism	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; BIOSYNTHESIS; LYASE; RESIDUES; REVEALS; COMPLEX; ION; TIM	7-carboxy-7-deazaguanine synthase (QueE) catalyzes a key S-adenosyl-L-methionine (AdoMet)- and Mg2+-dependent radical-mediated ring contraction step, which is common to the biosynthetic pathways of all deazapurine-containing compounds. QueE is a member of the Ado Met radical superfamily, which employs the 5'-deoxyadenosyl radical from reductive cleavage of Ado Met to initiate chemistry. To provide a mechanistic rationale for this elaborate transformation, we present the crystal structure of a QueE along with structures of pre- and post-turnover states. We find that substrate binds perpendicular to the [4Fe-45]-bound Ado Met, exposing its C6 hydrogen atom for abstraction and generating the binding site for Mg2+, which coordinates directly to the substrate. The Burkholderia multivorans structure reported here varies from all other previously characterized members of the Ado Met radical superfamily in that it contains a hypermodified (beta(6)/alpha(3)) protein core and an expanded cluster-binding motif, CX14CX2C.	[Dowling, Daniel P.; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Dowling, Daniel P.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bruender, Nathan A.; Young, Anthony P.; McCarty, Reid M.; Bandarian, Vahe] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Arizona; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	cdrennan@mit.edu		Bruender, Nathan/0000-0002-6129-8897; Young, Anthony/0000-0003-2273-346X; Dowling, Daniel/0000-0002-2536-0905	US National Institutes of Health [GM72623, GM72623 SO1]; Burroughs Wellcome Fund; Biological Chemistry Training Grant [GM008804]; National Synchrotron Light Source (NSLS); Advanced Photon Source (APS) on the Northeastern Collaborative Access Team (NE-CAT) beamlines; NSLS comes from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy (DOE); National Center for Research Resources [P41RR012408, 5P41RR015301-10]; National Institute of General Medical Sciences at the National Institutes of Health [P41GM103473, 8 P41 GM103403-10]; US DOE [DE-ACO2-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008804, R01GM072623, P41GM111244, P41GM103403, P41GM103473] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Biological Chemistry Training Grant; National Synchrotron Light Source (NSLS); Advanced Photon Source (APS) on the Northeastern Collaborative Access Team (NE-CAT) beamlines; NSLS comes from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grant GM72623 (V.B.) with Administrative Supplement GM72623 SO1 to V.B. for the collaboration between V.B. and C.L.D.; a Career Award in Biomedical Sciences from the Burroughs Wellcome Fund (V.B.); and a Biological Chemistry Training Grant (GM008804) (R.M.M.). Additionally, C.L.D. is a Howard Hughes Medical Investigator. This work is based on research conducted at beamline X25 of the National Synchrotron Light Source (NSLS) and at the Advanced Photon Source (APS) on the Northeastern Collaborative Access Team (NE-CAT) beamlines. Financial support from NSLS comes from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy (DOE) and from the National Center for Research Resources (P41RR012408) and the National Institute of General Medical Sciences at the National Institutes of Health (P41GM103473). NE-CAT at APS is supported by grants from the National Center for Research Resources (5P41RR015301-10) and the National Institute of General Medical Sciences at the National Institutes of Health (8 P41 GM103403-10). APS is an Office of Science User Facility operated for the US DOE Office of Science by Argonne National Laboratory and is also supported by the US DOE under contract number DE-ACO2-06CH11357. We thank G.L. Holliday and P. Babbitt (University of California San Francisco) and the Enzyme Function Initiative for their analysis of sequences in the AdoMet radical enzyme superfamily, which are available from the Structure Function Linkage Database (http://sfid.rbvi.ucsf.edu/django/superfamily/29/).	Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; Farrar CE, 2009, BIOCHEMISTRY-US, V48, P2448, DOI 10.1021/bi8022569; FREY PA, 1993, FASEB J, V7, P662, DOI 10.1096/fasebj.7.8.8500691; Frey PA, 2011, BBA-PROTEINS PROTEOM, V1814, P1548, DOI 10.1016/j.bbapap.2011.03.005; GOLDMAN A, 1987, J MOL BIOL, V194, P143, DOI 10.1016/0022-2836(87)90723-6; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; Kamachi T, 2011, INORG CHEM, V50, P2944, DOI 10.1021/ic102352b; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Marsh ENG, 2012, BBA-PROTEINS PROTEOM, V1824, P1154, DOI 10.1016/j.bbapap.2012.03.012; McCarty RM, 2013, BIOCHEMISTRY-US, V52, P188, DOI 10.1021/bi301156w; McCarty RM, 2012, BIOORG CHEM, V43, P15, DOI 10.1016/j.bioorg.2012.01.001; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; NEIDHART DJ, 1991, BIOCHEMISTRY-US, V30, P9264, DOI 10.1021/bi00102a019; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Romier C, 1996, EMBO J, V15, P2850, DOI 10.1002/j.1460-2075.1996.tb00646.x; Shibata N, 2010, J BIOL CHEM, V285, P26484, DOI 10.1074/jbc.M110.125112; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Takagi H, 2004, BIOCHEM BIOPH RES CO, V319, P787, DOI 10.1016/j.bbrc.2004.05.055; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Toraya T, 2010, BIOCHEMISTRY-US, V49, P7210, DOI 10.1021/bi100561m; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	37	47	48	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					106	112		10.1038/nchembio.1426	http://dx.doi.org/10.1038/nchembio.1426			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24362703	Green Submitted, Green Accepted			2022-12-25	WOS:000330751600008
J	Stanton, BC; Nielsen, AAK; Tamsir, A; Clancy, K; Peterson, T; Voigt, CA				Stanton, Brynne C.; Nielsen, Alec A. K.; Tamsir, Alvin; Clancy, Kevin; Peterson, Todd; Voigt, Christopher A.			Genomic mining of prokaryotic repressors for orthogonal logic gates	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; ESCHERICHIA-COLI; TAL EFFECTORS; OPERATOR; TRANSCRIPTION; DNA; CONSTRUCTION; SPECIFICITY; SELECTION	Genetic circuits perform computational operations based on interactions between freely diffusing molecules within a cell. When transcription factors are combined to build a circuit, unintended interactions can disrupt its function. Here, we apply 'part mining' to build a library of 73 TetR-family repressors gleaned from prokaryotic genomes. The operators of a subset were determined using an in vitro method, and this information was used to build synthetic promoters. The promoters and repressors were screened for cross-reactions. Of these, 16 were identified that both strongly repress their cognate promoter (5- to 207-fold) and exhibit minimal interactions with other promoters. Each repressor-promoter pair was converted to a NOT gate and characterized. Used as a set of 16 NOT/NOR gates, there are >10(54) circuits that could be built by changing the pattern of input and output promoters. This represents a large set of compatible gates that can be used to construct user-defined circuits.	[Stanton, Brynne C.; Nielsen, Alec A. K.; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Tamsir, Alvin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Clancy, Kevin; Peterson, Todd] Life Technol, Synthet Biol R&D Unit, Carlsbad, CA USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; Thermo Fisher Scientific	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com			Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a [FA9550-11-C-0028]; Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO) [N66001-12-C-4016]; Office of Naval Research [N00014-13-1-0074]; US National Institutes of Health [GM095765]; US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a; Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank C. Warren of Illumavista Biosciences for aid with array design, array experiments, data analysis and Peel scripts that were used for array data extraction. Research for this publication was conducted with government support under FA9550-11-C-0028 and was awarded by the Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a to A.A.K.N. C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO) (N66001-12-C-4016), Office of Naval Research (N00014-13-1-0074), US National Institutes of Health (GM095765) and the US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC, SA5284-11210).	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brown S., 2008, FUNDAMENTALS DIGITAL, V3rd; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; DINGERMANN T, 1992, EMBO J, V11, P1487, DOI 10.1002/j.1460-2075.1992.tb05193.x; Durai S, 2006, COMB CHEM HIGH T SCR, V9, P301, DOI 10.2174/138620706776843147; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; GATZ C, 1988, P NATL ACAD SCI USA, V85, P1394, DOI 10.1073/pnas.85.5.1394; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; Helbl V, 1998, J MOL BIOL, V276, P319, DOI 10.1006/jmbi.1997.1539; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Krueger M, 2007, GENE, V404, P93, DOI 10.1016/j.gene.2007.09.002; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lycett GJ, 2004, GENETICS, V167, P1781, DOI 10.1534/genetics.104.028175; Moser F, 2012, ACS SYNTH BIOL, V1, P555, DOI 10.1021/sb3000832; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Politz MC, 2013, CHEM COMMUN, V49, P4325, DOI 10.1039/c2cc37107c; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rudell R. L., 1986, MUTIPLE VALUED LOGIC; Saez E, 1997, CURR OPIN BIOTECH, V8, P608, DOI 10.1016/S0958-1669(97)80037-7; Sleight SC, 2013, ACS SYNTH BIOL, V2, P519, DOI 10.1021/sb400055h; Stanton BC, 2009, MOL MICROBIOL, V72, P1334, DOI 10.1111/j.1365-2958.2009.06719.x; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Thompson KE, 2012, ACS SYNTH BIOL, V1, P118, DOI 10.1021/sb200015u; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2011, CURR OPIN CHEM BIOL, V15, P414, DOI 10.1016/j.cbpa.2011.03.003; Weiss R., 2001, DNA Computing. 6th International Workshop on DNA-Based Computers, DNA 2000. Revised Papers (Lecture Notes in Computer Science Vol.2054), P1; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	50	230	243	4	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					99	105		10.1038/nchembio.1411	http://dx.doi.org/10.1038/nchembio.1411			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316737	Green Accepted, Green Submitted			2022-12-25	WOS:000330751600007
J	Ellefson, JW; Meyer, AJ; Hughes, RA; Cannon, JR; Brodbelt, JS; Ellington, AD				Ellefson, Jared W.; Meyer, Adam J.; Hughes, Randall A.; Cannon, Joe R.; Brodbelt, Jennifer S.; Ellington, Andrew D.			Directed evolution of genetic parts and circuits by compartmentalized partnered replication	NATURE BIOTECHNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; POLYMERASE-CHAIN-REACTION; TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; SELF-REPLICATION; DNA FRAGMENTS; SELECTION; SPECIFICITY; MUTAGENESIS; MUTATIONS	Most existing directed evolution methods, both in vivo(1-3) and in vitro(4-6), suffer from inadvertent selective pressures (i.e., altering organism fitness), resulting in the evolution of products with unintended or suboptimal function. To overcome these barriers, here we present compartmentalized partnered replication (CPR). In this approach, synthetic circuits are linked to the production of Taq DNA polymerase so that evolved circuits that most efficiently drive Taq DNA polymerase production are enriched by exponential amplification during a subsequent emulsion PCR step. We apply CPR to evolve a T7 RNA polymerase variant that recognizes an orthogonal promoter and to reengineer the tryptophanyl tRNA-synthetase: suppressor tRNA pair from Saccharomyces cerevisiae(7) to efficiently and site-specifically incorporate an unnatural amino acid into proteins. In both cases, the CPR-evolved parts were more orthogonal and/or more active than variants evolved using other methods. CPR should be useful for evolving any genetic part or circuit that can be linked to Taq DNA polymerase expression.	[Ellefson, Jared W.; Meyer, Adam J.; Hughes, Randall A.; Ellington, Andrew D.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hughes, Randall A.; Ellington, Andrew D.] Univ Texas Austin, Appl Res Labs, Austin, TX 78713 USA; [Cannon, Joe R.; Brodbelt, Jennifer S.; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ellington, AD (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	andy.ellington@mail.utexas.edu		Cannnon, Joe/0000-0002-3010-0964; Meyer, Adam/0000-0001-5455-3418	National Security Science and Engineering Faculty [FA9550-10-1-0169]; Welch Foundation [F-1654, F-1155]; National Science Foundation [CHE1012622]; Defense Advanced Research Projects Agency [HR-0011-12-C-0066]	National Security Science and Engineering Faculty; Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the National Security Science and Engineering Faculty (FA9550-10-1-0169) the Welch Foundation (F-1654 to A. D. E. and F-1155 to J.S.B.), the National Science Foundation (CHE1012622 to J.S.B.), and the Defense Advanced Research Projects Agency (HR-0011-12-C-0066). J.S.B. thanks Thermo Fisher Scientific with helping on the modifications to the Orbitrap Elite mass spectrometer to allow UVPD.	BREAKER RR, 1994, P NATL ACAD SCI USA, V91, P6093, DOI 10.1073/pnas.91.13.6093; Bull JJ, 1995, J MOL EVOL, V41, P1160, DOI 10.1007/BF00173197; Chatterjee A, 2013, ANGEW CHEM INT EDIT, V52, P5106, DOI 10.1002/anie.201301094; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chelliserrykattil J, 2001, BMC Biotechnol, V1, P13, DOI 10.1186/1472-6750-1-13; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davidson EA, 2012, ACS SYNTH BIOL, V1, P190, DOI 10.1021/sb3000113; Dickinson BC, 2013, P NATL ACAD SCI USA, V110, P9007, DOI 10.1073/pnas.1220670110; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Ghadessy FJ, 2007, METH MOL B, V352, P237; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Goldsmith M, 2009, P NATL ACAD SCI USA, V106, P6197, DOI 10.1073/pnas.0809506106; Han SW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2157; Hughes RA, 2011, METHOD ENZYMOL, V498, P277, DOI 10.1016/B978-0-12-385120-8.00012-7; Hughes RA, 2010, NUCLEIC ACIDS RES, V38, P6813, DOI 10.1093/nar/gkq521; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Levy M, 2005, RNA, V11, P1555, DOI 10.1261/rna.2121705; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; Shaw JB, 2013, J AM CHEM SOC, V135, P12646, DOI 10.1021/ja4029654; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	35	93	97	1	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					97	+		10.1038/nbt.2714	http://dx.doi.org/10.1038/nbt.2714			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24185096				2022-12-25	WOS:000329513000024
J	Huang, SXL; Islam, MN; O'Neill, J; Hu, Z; Yang, YG; Chen, YW; Mumau, M; Green, MD; Vunjak-Novakovic, G; Bhattacharya, J; Snoeck, HW				Huang, Sarah X. L.; Islam, Mohammad Naimul; O'Neill, John; Hu, Zheng; Yang, Yong-Guang; Chen, Ya-Wen; Mumau, Melanie; Green, Michael D.; Vunjak-Novakovic, Gordana; Bhattacharya, Jahar; Snoeck, Hans-Willem			Efficient generation of lung and airway epithelial cells from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR; DIRECTED DIFFERENTIATION; NODAL ANTAGONISTS; II CELLS; HUMAN ES; ENDODERM; PROGENITORS; RECEPTOR; IDENTITY; FOREGUT	The ability to generate lung and airway epithelial cells from human pluripotent stem cells (hPSCs) would have applications in regenerative medicine, modeling of lung disease, drug screening and studies of human lung development. We have established, based on developmental paradigms, a highly efficient method for directed differentiation of hPSCs into lung and airway epithelial cells. Long-term differentiation of hPSCs in vivo and in vitro yielded basal, goblet, Clara, ciliated, type I and type II alveolar epithelial cells. The type II alveolar epithelial cells were capable of surfactant protein-B uptake and stimulated surfactant release, providing evidence of specific function. Inhibiting or removing retinoic acid, Wnt and BMP-agonists to signaling pathways critical for early lung development in the mouse-recapitulated defects in corresponding genetic mouse knockouts. As this protocol generates most cell types of the respiratory system, it may be useful for deriving patient-specific therapeutic cells.	[Huang, Sarah X. L.; Hu, Zheng; Yang, Yong-Guang; Chen, Ya-Wen; Mumau, Melanie; Green, Michael D.; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Huang, Sarah X. L.; Islam, Mohammad Naimul; Yang, Yong-Guang; Chen, Ya-Wen; Mumau, Melanie; Vunjak-Novakovic, Gordana; Bhattacharya, Jahar; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [O'Neill, John; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Bhattacharya, Jahar] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY USA; [Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Snoeck, HW (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA.	hs2680@columbia.edu		Islam, Mohammad Naimul/0000-0001-7929-9444; Yang, Yong-Guang/0000-0003-4985-1247; Green, Michael/0000-0003-4951-7118; Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Chen, Ya-Wen/0000-0003-2382-8444	NHLBI NIH HHS [R01 HL120046] Funding Source: Medline; NIAID NIH HHS [R01 AI064569, T32 AI106711] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106711, R01AI064569] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barrantes ID, 2003, GENE DEV, V17, P2239, DOI 10.1101/gad.269103; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Green MD, 2013, BIOESSAYS, V35, P261, DOI 10.1002/bies.201200090; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Malpel S, 2000, DEVELOPMENT, V127, P3057; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Post M, 1996, DEVELOPMENT, V122, P3107; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weaver M, 1999, DEVELOPMENT, V126, P4005; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Wongtrakool C, 2003, J BIOL CHEM, V278, P46911, DOI 10.1074/jbc.M307977200; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	48	352	369	6	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					84	+		10.1038/nbt.2754	http://dx.doi.org/10.1038/nbt.2754			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24291815	Green Accepted			2022-12-25	WOS:000329513000022
J	Li, PS; Fu, ZY; Zhang, YY; Zhang, JH; Xu, CQ; Ma, YT; Li, BL; Song, BL				Li, Pei-Shan; Fu, Zhen-Yan; Zhang, Ying-Yu; Zhang, Jin-Hui; Xu, Chen-Qi; Ma, Yi-Tong; Li, Bo-Liang; Song, Bao-Liang			The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1	NATURE MEDICINE			English	Article							FATE DETERMINANT NUMB; N-TERMINAL DOMAIN; UBIQUITIN LIGASE; EZETIMIBE BLOCKS; MAMMALIAN NUMB; PROTEIN; BINDING; INTERNALIZATION; PHOSPHORYLATION; IDENTIFICATION	Hypercholesterolemia, typically due to excessive cholesterol uptake, is a major risk factor for cardiovascular disease, which is responsible for similar to 50% of all deaths in developed societies. Although it has been shown that intestinal cholesterol absorption is mediated by vesicular endocytosis of the Niemann-Pick C1-like 1 (NPC1L1) protein(1,2), the mechanism of sterol-stimulated NPC1L1 internalization is still mysterious. Here, we identified an endocytic peptide signal, YVNXXF (where X stands for any amino acid), in the cytoplasmic C-terminal tail of NPC1L1. Cholesterol binding on the N-terminal domain of NPC1L1 released the YVNXXF-containing region of NPC1L1 from association with the plasma membrane and enabled Numb binding. We also found that Numb, a clathrin adaptor, specifically recognized this motif and recruited clathrin for internalization. Disrupting the NPC1L1-Numb interaction decreased cholesterol uptake. Ablation of Numb in mouse intestine significantly reduced dietary cholesterol absorption and plasma cholesterol level. Together, these data show that Numb is a pivotal protein for intestinal cholesterol absorption and may provide a therapeutic target for hypercholesterolemia.	[Li, Pei-Shan; Fu, Zhen-Yan; Zhang, Ying-Yu; Zhang, Jin-Hui; Xu, Chen-Qi; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Fu, Zhen-Yan; Ma, Yi-Tong] Xinjiang Med Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Urumqi, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Xinjiang Medical University	Song, BL (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	blsong@sibcb.ac.cn	zhang, jin/GXV-9154-2022; zhang, jinhui/GXF-6528-2022	Song, Bao-Liang/0000-0002-6397-5935; Xu, Chenqi/0000-0002-4968-6782; Li, Peishan/0000-0002-6881-396X	Ministry of Science and Technology of China [2009CB919000, 2011CB910900, 2012CB524900]; National Natural Science Foundation of China [30925012, 31230020, 81260041, 81270155, 91213306]; Shanghai Science and Technology Committee [11JC1414100]; Xinjiang Science and Technology Department [2013911111]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Xinjiang Science and Technology Department	We thank Y.-X. Qu, J. Xu and J. Qin for technical assistance. We thank W. Qi for helpful discussion and revision of the paper. We thank S. Robine (Institut Curie) for the gift of transgenic mice (heterozygous for villin-Cre-ERT2). We thank S. Kathiresan, X. Lin and X.-F. Lu for discussions. This work was supported by grants from the Ministry of Science and Technology of China (2009CB919000, 2011CB910900 and 2012CB524900), National Natural Science Foundation of China (30925012, 31230020, 81260041, 81270155 and 91213306), Shanghai Science and Technology Committee (11JC1414100) and Xinjiang Science and Technology Department (2013911111).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Kwon HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018722; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; SALISBURY BG, 1995, ATHEROSCLEROSIS, V115, P45, DOI 10.1016/0021-9150(94)05499-9; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Tong X, 2010, MOL BIOL CELL, V21, P802, DOI 10.1091/mbc.E09-09-0831; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Xie C, 2012, J LIPID RES, V53, P2092, DOI 10.1194/jlr.M027359; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yogosawa S, 2003, BIOCHEM BIOPH RES CO, V302, P869, DOI 10.1016/S0006-291X(03)00282-1; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	39	59	70	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					80	+		10.1038/nm.3417	http://dx.doi.org/10.1038/nm.3417			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24336247				2022-12-25	WOS:000329349400023
J	Mehnert, M; Sommer, T; Jarosch, E				Mehnert, Martin; Sommer, Thomas; Jarosch, Ernst			Der1 promotes movement of misfolded proteins through the endoplasmic reticulum membrane	NATURE CELL BIOLOGY			English	Article							ER-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-LIGASE; QUALITY-CONTROL; SUBSTRATE RETROTRANSLOCATION; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; DISLOCATION; COMPLEX; PROTEASOME	Misfolded proteins of the secretory pathway are extracted from the endoplasmic reticulum (ER), polyubiquitylated by a protein complex termed the Hmg-CoA reductase degradation ligase (HRD ligase) and degraded by cytosolic 26S proteasomes. The movement of these proteins through the lipid bilayer is assumed to occur via a protein-conducting channel of unknown nature. We show that the integral membrane protein Der1 oligomerizes, which relies on its interaction with the scaffolding protein Usa1. Mutations in the transmembrane domains of Der1 block the passage of soluble proteins across the ER membrane. As determined by site-specific photocrosslinking, the ER-luminal exposed parts of Den l are in spatial proximity to the substrate receptor Hrd3, whereas the membrane-embedded domains reside adjacent to the ubiquitin ligase Hrd1. Intriguingly, both regions also form crosslinks to client proteins. Our data imply that Der1 initiates the export of aberrant polypeptides from the ER lumen by threading such molecules into the ER membrane and routing them to Hrd1 for ubiquitylation.	[Mehnert, Martin; Sommer, Thomas; Jarosch, Ernst] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Sommer, T (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	tsommer@mdc-berlin.de; ejarosch@mdc-berlin.de		Jarosch, Ernst/0000-0002-5897-3492; Mehnert, Martin/0000-0001-7753-1596	Deutsche Forschungsgemeinschaft [JA 1830/1-2, SFB 740, 1365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors wish to thank the members of the laboratory for helpful and stimulating discussions, unpublished data and materials. We thank C. Volkwein for excellent technical assistance. We would like to thank P. G. Schultz (Scripps Research Institute, USA) for materials needed for the in vivo crosslinking experiments. T.A. Rapoport (Harvard Medical School, USA), D.H. Wolf (University of Stuttgart, Germany) and R. Y. Hampton (University of California, USA) are acknowledged for providing antibodies and plasmids. The Deutsche Forschungsgemeinschaft generously supports T.S. and E.J. (JA 1830/1-2, SFB 740, Priority Program 1365, the German-Israel Project Cooperation DIP).	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gelman Marina S, 2003, Methods Mol Biol, V232, P27; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Maeda T, 2009, FEBS J, V276, P5832, DOI 10.1111/j.1742-4658.2009.07264.x; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Stanley AM, 2011, FEBS LETT, V585, P1281, DOI 10.1016/j.febslet.2011.04.009; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	53	98	100	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					77	+		10.1038/ncb2882	http://dx.doi.org/10.1038/ncb2882			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24292014	Green Accepted			2022-12-25	WOS:000329042000013
J	Dirkx, E; Gladka, MM; Philippen, LE; Armand, AS; Kinet, V; Leptidis, S; el Azzouzi, H; Salic, K; Bourajjaj, M; da Silva, GJJ; Olieslagers, S; van der Nagel, R; de Weger, R; Bitsch, N; Kisters, N; Seyen, S; Morikawa, Y; Chanoine, C; Heymans, S; Volders, PGA; Thum, T; Dimmeler, S; Cserjesi, P; Eschenhagen, T; Martins, PAD; De Windt, LJ				Dirkx, Ellen; Gladka, Monika M.; Philippen, Leonne E.; Armand, Anne-Sophie; Kinet, Virginie; Leptidis, Stefanos; el Azzouzi, Hamid; Salic, Kanita; Bourajjaj, Meriem; da Silva, Gustavo J. J.; Olieslagers, Serve; van der Nagel, Roel; de Weger, Roel; Bitsch, Nicole; Kisters, Natasja; Seyen, Sandrine; Morikawa, Yuka; Chanoine, Christophe; Heymans, Stephane; Volders, Paul G. A.; Thum, Thomas; Dimmeler, Stefanie; Cserjesi, Peter; Eschenhagen, Thomas; Martins, Paula A. da Costa; De Windt, Leon J.			Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure	NATURE CELL BIOLOGY			English	Article							CARDIAC NEURAL CREST; HYPERTROPHY IN-VIVO; T-CELLS; CARDIOMYOCYTE HYPERTROPHY; VENTRICULAR HYPERTROPHY; SIGNALING PATHWAYS; MOUSE DEVELOPMENT; NUCLEAR-FACTOR; KAPPA-B; EXPRESSION	Although aberrant reactivation of embryonic gene programs is intricately linked to pathological heart disease, the transcription factors driving these gene programs remain ill-defined. Here we report that increased calcineurin/Nfat signalling and decreased miR-25 expression integrate to re-express the basic helix-loop-helix (bHLH) transcription factor dHAND (also known as Hand2) in the diseased human and mouse myocardium. In line, mutant mice overexpressing Hand2 in otherwise healthy heart muscle cells developed a phenotype of pathological hypertrophy. Conversely, conditional gene-targeted Hand2 mice demonstrated a marked resistance to pressure-overload-induced hypertrophy, fibrosis, ventricular dysfunction and induction of a fetal gene program. Furthermore, in vivo inhibition of miR-25 by a specific antagomir evoked spontaneous cardiac dysfunction and sensitized the murine myocardium to heart failure in a Hand2-dependent manner. Our results reveal that signalling cascades integrate with microRNAs to induce the expression of the bHLH transcription factor Hand2 in the postnatal mammalian myocardium with impact on embryonic gene programs in heart failure.	[Dirkx, Ellen; Gladka, Monika M.; Philippen, Leonne E.; Kinet, Virginie; Leptidis, Stefanos; el Azzouzi, Hamid; Salic, Kanita; Olieslagers, Serve; Bitsch, Nicole; Kisters, Natasja; Seyen, Sandrine; Heymans, Stephane; Volders, Paul G. A.; Martins, Paula A. da Costa; De Windt, Leon J.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Cardiol, NL-6229 ER Maastricht, Netherlands; [Armand, Anne-Sophie; Chanoine, Christophe] Univ Paris 05, UMR CNRS 8194, Ctr Etud Sensori Motricite, F-75006 Paris, France; [Leptidis, Stefanos; el Azzouzi, Hamid; Salic, Kanita; Bourajjaj, Meriem] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, NL-3511 GC Utrecht, Netherlands; [da Silva, Gustavo J. J.] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, NO-7491 Trondheim, Norway; [van der Nagel, Roel] Univ Med Ctr Utrecht, Dept Med Physiol, NL-3584 CX Utrecht, Netherlands; [de Weger, Roel] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Morikawa, Yuka] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Thum, Thomas] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, D-30625 Hannover, Germany; [Thum, Thomas] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Cserjesi, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, D-20246 Hamburg, Germany	Maastricht University; UDICE-French Research Universities; Universite Paris Cite; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Norwegian University of Science & Technology (NTNU); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Saint Lukes Episcopal Hospital; Texas Heart Institute; Hannover Medical School; Imperial College London; Goethe University Frankfurt; Columbia University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Martins, PAD (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Cardiol, NL-6229 ER Maastricht, Netherlands.	p.dacostamartins@maastrichtuniversity.nl; l.dewindt@maastrichtuniversity.nl	de Windt, Leon/AAO-6395-2020; da Silva, Gustavo J Justo/H-5222-2011; Morikawa, Yuka/ABH-6969-2020; Morikawa, Yuka/E-3092-2010; Leptidis, Stefanos/D-1455-2016; Morikawa, Yuka/AAP-8917-2021	de Windt, Leon/0000-0002-7793-2856; da Silva, Gustavo J Justo/0000-0002-1651-7966; Morikawa, Yuka/0000-0002-4571-8409; Leptidis, Stefanos/0000-0003-0172-4193; Morikawa, Yuka/0000-0002-4571-8409; chanoine, christophe/0000-0001-8155-2357; Gladka, Monika/0000-0002-4094-4335; Thum, Thomas/0000-0003-4360-1511; el Azzouzi, Hamid/0000-0003-1242-9691; Dimmeler, Stefanie/0000-0002-1045-2436; Armand, Anne-Sophie/0000-0002-0291-6421; Heymans, Stephane/0000-0001-9477-7803	German Research Foundation [TH903/11-1, E588/12-1]; REBIRTH Exellence Cluster; German Centre for Cardiovascular Research; German Ministry of Research and Education (BMBF); Leducq Career Development Award; Dutch Heart Foundation [NH52010B261]; Netherlands CardioVascular Research Initiative	German Research Foundation(German Research Foundation (DFG)); REBIRTH Exellence Cluster; German Centre for Cardiovascular Research; German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Leducq Career Development Award; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands CardioVascular Research Initiative	We gratefully acknowledge G. Summer for bioinformatics help and G. van Hout for technical support. T.T. was supported by the German Research Foundation (TH903/11-1) and the REBIRTH Exellence Cluster. T.E. was supported by the German Research Foundation (E588/12-1) and the DZHK, the German Centre for Cardiovascular Research funded by the German Ministry of Research and Education (BMBF). P.A.d.C.M. was supported by a Leducq Career Development Award and the Dutch Heart Foundation grant NH52010B261. L.J.D.W. acknowledges support from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development (ZonMW) and the Royal Netherlands Academy of Sciences. L.J.D.W. was further supported by a VIDI award 917-863-72 from the ZonMW; the Dutch Heart Foundation program grant NH52007B167; the Fondation Leducq Transatlantic Network of Excellence program 08-CVD-03 and grant 311549 from the European Research Council (ERC).	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Baker RK, 2001, MECH DEVELOP, V104, P129, DOI 10.1016/S0925-4773(01)00363-X; Bar H, 2003, BASIC RES CARDIOL, V98, P285, DOI 10.1007/s00395-003-0410-2; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Dai YS, 2002, J BIOL CHEM, V277, P12604, DOI 10.1074/jbc.M200283200; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Katz AM, 1995, EUR HEART J, V16, P110, DOI 10.1093/eurheartj/16.suppl_O.110; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Luo C, 1996, MOL CELL BIOL, V16, P3955; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Meijs MFL, 2007, CURR MED CHEM, V14, P157, DOI 10.2174/092986707779313354; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morikawa Y, 2007, DEV BIOL, V307, P114, DOI 10.1016/j.ydbio.2007.04.027; Morikawa Y, 2008, CIRC RES, V103, P1422, DOI 10.1161/CIRCRESAHA.108.180083; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Saadane N, 2000, AM J PHYSIOL-HEART C, V278, pH796, DOI 10.1152/ajpheart.2000.278.3.H796; SAVAGE DD, 1990, AM J CARDIOL, V65, P371, DOI 10.1016/0002-9149(90)90304-J; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Snider P, 2007, THESCIENTIFICWORLDJO, V7, P1090, DOI 10.1100/tsw.2007.189; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Zhang Z, 2011, DEV BIOL, V351, P254, DOI 10.1016/j.ydbio.2011.01.005; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	64	103	108	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1282	U62		10.1038/ncb2866	http://dx.doi.org/10.1038/ncb2866			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24161931				2022-12-25	WOS:000326680700005
J	Huang, CH; Tang, M; Shi, CJ; Iglesias, PA; Devreotes, PN				Huang, Chuan-Hsiang; Tang, Ming; Shi, Changji; Iglesias, Pablo A.; Devreotes, Peter N.			An excitable signal integrator couples to an idling cytoskeletal oscillator to drive cell migration	NATURE CELL BIOLOGY			English	Article							REACTION-DIFFUSION WAVES; POSITIVE-FEEDBACK LOOP; DICTYOSTELIUM CELLS; LEADING-EDGE; RAC1 GTPASES; ACTIN WAVES; RHO GTPASES; MOTILITY; ACTIVATION; DYNAMICS	It is generally believed that cytoskeletal activities drive random cell migration, whereas signal transduction events initiated by receptors regulate the cytoskeleton to guide cells. However, we find that the cytoskeletal network, involving SCAR/WAVE, Arp 2/3 and actin-binding proteins, is capable of generating only rapid oscillations and undulations of the cell boundary. The signal transduction network, comprising multiple pathways that include Ras GTPases, P1(3)K and Rac GTPases, is required to generate the sustained protrusions of migrating cells. The signal transduction network is excitable, exhibiting wave propagation, refractoriness and maximal response to suprathreshold stimuli, even in the absence of the cytoskeleton. We suggest that cell motility results from coupling of 'pacemaker' signal transduction and 'idling motor' cytoskeletal networks, and various guidance cues that modulate the threshold for triggering signal transduction events are integrated to control the mode and direction of migration.	[Huang, Chuan-Hsiang; Tang, Ming; Devreotes, Peter N.] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Shi, Changji; Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Devreotes, PN (corresponding author), Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	pnd@jhmi.edu		Huang, Chuan-Hsiang/0000-0001-9993-8004; Iglesias, Pablo/0000-0002-0840-155X	National Institutes of Health [GM28007, GM34933, GM71920]; Damon Runyon Cancer Research Foundation [DRG2019-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071920, R01GM028007, R37GM028007, R01GM086704, R01GM034933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank M. Amzel, D. Montell, M. Iijima, T. Inoue and members of the Devreotes and Iglesias laboratories for helpful suggestions, B. Diplas for generating cell centroid tracks, P. Van Haastert for the RBD-GFP construct, R. Insall (The Beatson Institute, UK) for the HSPC300-GFP construct, G. Gerisch (Max Planck Institute for Biochemistry, Germany) for the LimE-RFP construct, and D. Robinson (Johns Hopkins University, USA) for coronin-GFP and the original video of dynacortin-expressing cells. We are grateful to V. Filic and I. Weber (Ruder Boskovic Institute, Croatia) for sharing the PAK(GBD)-YFP biosensor for Rac activity. This work was supported in part by grants from the National Institutes of Health, GM28007 (to P.N.D.), GM34933 (to P.N.D.) and GM71920 (to P.A.I.), and a H. L. Plotnick Fellowship from the Damon Runyon Cancer Research Foundation, DRG2019-09 (to C.H.H.).	Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Asano Y, 2008, CELL MOTIL CYTOSKEL, V65, P923, DOI 10.1002/cm.20314; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cal H., 2010, J CELL BIOL, V190, P233; Case LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026631; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; Dumontier M, 2000, J CELL SCI, V113, P2253; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Filic V, 2012, J CELL SCI, V125, P387, DOI 10.1242/jcs.089680; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2009, CELL ADHES MIGR, V3, P373, DOI 10.4161/cam.3.4.9708; Gerisch Gunther, 2010, PMC Biophys, V3, P7, DOI 10.1186/1757-5036-3-7; Hall A., BIOCH SOC T, V33; Hecht I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002044; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kabacoff C, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-53; Kae H, 2004, EMBO REP, V5, P602, DOI 10.1038/sj.embor.7400151; Kim J, 2007, PLOS COMPUT BIOL, V3, P2190, DOI 10.1371/journal.pcbi.0030218; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Meinhardt H, 1999, J CELL SCI, V112, P2867; Mitchell IM, 2008, J SCI COMPUT, V35, P300, DOI 10.1007/s10915-007-9174-4; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Poirier CC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002467; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Veltman DM, 2012, J CELL BIOL, V198, P501, DOI 10.1083/jcb.201205058; Vicker MG, 2002, FEBS LETT, V510, P5, DOI 10.1016/S0014-5793(01)03207-0; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Vicker MG, 2000, BIOPHYS CHEM, V84, P87, DOI 10.1016/S0301-4622(99)00146-5; Vilar JMG, 1999, PHYS REV E, V59, P5920, DOI 10.1103/PhysRevE.59.5920; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yang L, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-68; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhang S, 2008, CURR BIOL, V18, P1587, DOI 10.1016/j.cub.2008.08.069; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	69	134	135	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1307	U108		10.1038/ncb2859	http://dx.doi.org/10.1038/ncb2859			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24142103	Green Accepted			2022-12-25	WOS:000326680700007
J	Motz, GT; Santoro, SP; Wang, LP; Garrabrant, T; Lastra, RR; Hagemann, IS; Lal, P; Feldman, MD; Benencia, F; Coukos, G				Motz, Gregory T.; Santoro, Stephen P.; Wang, Li-Ping; Garrabrant, Tom; Lastra, Ricardo R.; Hagemann, Ian S.; Lal, Priti; Feldman, Michael D.; Benencia, Fabian; Coukos, George			Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors	NATURE MEDICINE			English	Article							EPITHELIAL OVARIAN-CANCER; T-CELLS; GROWTH-FACTOR; LIGAND EXPRESSION; INFILTRATION; MELANOMA; ANGIOGENESIS; IMMUNOTHERAPY; LYMPHOCYTES; CARCINOMA	We describe a new mechanism regulating the tumor endothelial barrier and T cell infiltration into tumors. We detected selective expression of the death mediator Fas ligand (FasL, also called CD95L) in the vasculature of human and mouse solid tumors but not in normal vasculature. In these tumors, FasL expression was associated with scarce CD8(+) infiltration and a predominance of FoxP3(+) T regulatory (T-reg) cells. Tumor-derived vascular endothelial growth factor A (VEGF-A), interleukin 10 (IL-10) and prostaglandin E-2 (PGE(2)) cooperatively induced FasL expression in endothelial cells, which acquired the ability to kill effector CD8(+) T cells but not T-reg cells because of higher levels of c-FLIP expression in T-reg cells. In mice, genetic or pharmacologic suppression of FasL produced a substantial increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells. Pharmacologic inhibition of VEGF and PGE(2) produced a marked increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells that was dependent on attenuation of FasL expression and led to CD8-dependent tumor growth suppression. Thus, tumor paracrine mechanisms establish a tumor endothelial death barrier, which has a critical role in establishing immune tolerance and determining the fate of tumors.	[Motz, Gregory T.; Santoro, Stephen P.; Garrabrant, Tom; Benencia, Fabian; Coukos, George] Univ Penn, Sch Med, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Wang, Li-Ping; Lastra, Ricardo R.; Hagemann, Ian S.; Lal, Priti; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Coukos, G (corresponding author), Univ Hosp Lausanne CHUV, Ludwig Canc Res Ctr, Dept Oncol, Lausanne, Switzerland.	george.coukos@chuv.ch	Hagemann, Ian/ABB-2854-2021; Benencia, Fabian/AAH-1613-2020; Coukos, George/ABG-7389-2020	Hagemann, Ian/0000-0002-3855-9745; Benencia, Fabian/0000-0003-3049-6150; Coukos, George/0000-0001-8813-7367	US National Institutes of Health Transformative [R01 CA156695]; US National Cancer Institute (NCI) [T32 CA009140]; Ovarian Cancer Research Fund; NCI [R25 CA101871]; NATIONAL CANCER INSTITUTE [R25CA101871, R01CA156695, T32CA009140] Funding Source: NIH RePORTER	US National Institutes of Health Transformative; US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by US National Institutes of Health Transformative R01 CA156695 (G.C.), US National Cancer Institute (NCI) training grant T32 CA009140 (G.T.M.), a grant by the Ovarian Cancer Research Fund (G.T.M.) and NCI training grant R25 CA101871 (S.P.S.). We thank S. Nagata (Kyoto University) for the FasL expression plasmids and C. June (University of Pennsylvania) for the lentivirus expression vector. We also thank D. Powell and A. Facciabene for thoughtful discussion.	Abrahams VM, 2003, CANCER RES, V63, P5573; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bouma-ter-Steege JCA, 2004, CLIN CANCER RES, V10, P7171; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Chappell DB, 1999, CANCER RES, V59, P59; Cipponi A, 2011, CANCER IMMUNOL IMMUN, V60, P1153, DOI 10.1007/s00262-011-1026-2; D Basu G, 2006, J IMMUNOL, V177, P2391, DOI 10.4049/jimmunol.177.4.2391; Donskov F, 2004, CLIN CANCER RES, V10, P7911, DOI 10.1158/1078-0432.CCR-04-1111; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Favre-Felix N, 2000, J IMMUNOL, V164, P5023, DOI 10.4049/jimmunol.164.10.5023; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Griffioen AW, 1996, CANCER RES, V56, P1111; Griffioen AW, 1996, BLOOD, V88, P667, DOI 10.1182/blood.V88.2.667.bloodjournal882667; Gupta RA, 2003, CANCER RES, V63, P906; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Herrero R, 2011, J CLIN INVEST, V121, P1174, DOI 10.1172/JCI43004; Huang XY, 2010, J EXP MED, V207, P505, DOI 10.1084/jem.20090397; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; Lam CT, 2011, CLIN CANCER RES, V17, P3123, DOI 10.1158/1078-0432.CCR-10-2802; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Manning EA, 2007, CLIN CANCER RES, V13, P3951, DOI 10.1158/1078-0432.CCR-07-0374; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Sata M, 2001, J IMMUNOL, V166, P6964, DOI 10.4049/jimmunol.166.11.6964; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tei K, 2002, CANCER RES, V62, P6289; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Yang J, 2003, J BIOL CHEM, V278, P15185, DOI 10.1074/jbc.M211707200; Yu JS, 2003, J NEURO-ONCOL, V64, P55, DOI 10.1023/A:1024933925645; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1	45	547	581	4	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					607	615		10.1038/nm.3541	http://dx.doi.org/10.1038/nm.3541			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24793239	Green Accepted			2022-12-25	WOS:000337071000022
J	Nam, HJ; van Deursen, JM				Nam, Hyun-Ja; van Deursen, Jan M.			Cyclin B2 and p53 control proper timing of centrosome separation	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC RETENTION SIGNAL; BIPOLAR SPINDLE FORMATION; POLO-LIKE KINASE-1; CELL LUNG-CANCER; KINETOCHORE-MICROTUBULE ATTACHMENTS; CHROMOSOMAL INSTABILITY; GOLGI-APPARATUS; XENOPUS OOCYTES; B1; EXPRESSION	Cyclins B1 and B2 are frequently elevated in human cancers and are associated with tumour aggressiveness and poor clinical outcome; however, whether and how B-type cyclins drive tumorigenesis is unknown. Here we show that cyclin B1 and B2 transgenic mice are highly prone to tumours, including tumour types where B-type cyclins serve as prognosticators. Cyclins B1 and B2 both induce aneuploidy when overexpressed but through distinct mechanisms, with cyclin B1 inhibiting separase activation, leading to anaphase bridges, and cyclin B2 triggering aurora-A-mediated Plk1 hyperactivation, resulting in accelerated centrosome separation and lagging chromosomes. Complementary experiments revealed that cyclin B2 and p53 act antagonistically to control aurora-A-mediated centrosome splitting and accurate chromosome segregation in normal cells. These data demonstrate a causative link between B-type cyclin overexpression and tumour pathophysiology, and uncover previously unknown functions of cyclin B2 and p53 in centrosome separation that may be perturbed in many human cancers.	[Nam, Hyun-Ja; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X	NATIONAL CANCER INSTITUTE [R01CA126828] Funding Source: NIH RePORTER; NCI NIH HHS [CA126828, R01 CA126828] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; BAILLY E, 1992, J CELL SCI, V101, P529; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; CHAPMAN DL, 1993, DEVELOPMENT, V118, P229; Chen Y, 2012, ONCOL REP, V27, P487, DOI 10.3892/or.2011.1519; Cooper WA, 2009, HISTOPATHOLOGY, V55, P28, DOI 10.1111/j.1365-2559.2009.03331.x; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Dove WF, 1998, PHILOS T ROY SOC B, V353, P915, DOI 10.1098/rstb.1998.0256; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kabeche L, 2012, CURR BIOL, V22, P638, DOI 10.1016/j.cub.2012.02.030; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Kotani T, 2001, MOL REPROD DEV, V59, P199, DOI 10.1002/mrd.1023; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Moser MJ, 2000, CANCER RES, V60, P2492; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Park SH, 2007, CLIN CANCER RES, V13, P858, DOI 10.1158/1078-0432.CCR-06-1461; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, CELL GROWTH DIFFER, V2, P305; Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Silkworth WT, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-19; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Soria JC, 2000, CANCER RES, V60, P4000; Spalluto C, 2013, CELL CYCLE, V12, P1802, DOI 10.4161/cc.24840; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Stirling PC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002057; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wu CC, 2012, CELL CYCLE, V11, P3433, DOI 10.4161/cc.21732; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073; Yoshitome S, 1998, BIOL CELL, V90, P509, DOI 10.1016/S0248-4900(99)80009-4; Yoshitome S, 2003, MOL CANCER RES, V1, P589; Zhang Y, 2012, J CLIN INVEST, V122, P4362, DOI 10.1172/JCI63084	65	125	131	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2014	16	6					535	+		10.1038/ncb2952	http://dx.doi.org/10.1038/ncb2952			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AI2EB	24776885	Green Accepted			2022-12-25	WOS:000336669100010
J	Gaudry, KS; Cummings, DE				Gaudry, Kate S.; Cummings, Daniel E.			Patent office backlog adds billions to national drug expenditure	NATURE BIOTECHNOLOGY			English	Editorial Material									[Gaudry, Kate S.] Kilpatrick Townsend & Stockton LLP, Washington, DC 20005 USA; [Cummings, Daniel E.] Creighton Univ, Sch Law, Omaha, NE 68178 USA	Creighton University	Gaudry, KS (corresponding author), Kilpatrick Townsend & Stockton LLP, Washington, DC 20005 USA.	kgaudry@kilpatricktownsend.com						Alazraki M., 2011, DAILYFINANCE    0227; Centers for Medicare & Medicaid Services, 2013, NAT HLTH EXP; Dicken J.E., 2012, DRUG PRICING RES SAV; Gaudry K. S., 2014, LOOK RESULTS USPTOS; Gaudry KS, 2011, NAT BIOTECHNOL, V29, P876, DOI 10.1038/nbt.1993; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Morgan S., 2010, COMMONWEALTH FUND PU, V89, P1408; Office of the Inspector General, 2006, GEN DRUG UT STAT MED; US Department of Health and Human Services, 2013, 1227 ADA HHS; US Patent and Trademark Office, 2012, US DEP COMM MAN PAT; US Patent and Trademark Office, 2013, PRES BUDG SUBM FISC; US Patent and Trademark Office, 2012, PERF ACC REP FISC YE	13	2	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					436	439		10.1038/nbt.2894	http://dx.doi.org/10.1038/nbt.2894			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811513				2022-12-25	WOS:000336036100015
J	Im, H; Shao, HL; Park, YI; Peterson, VM; Castro, CM; Weissleder, R; Lee, H				Im, Hyungsoon; Shao, Huilin; Park, Yong Il; Peterson, Vanessa M.; Castro, Cesar M.; Weissleder, Ralph; Lee, Hakho			Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor	NATURE BIOTECHNOLOGY			English	Article							OVARIAN-CANCER; PROTEIN; MARKER; MICROARRAYS; EXPRESSION; KNOWLEDGE; ASCITES; GROWTH; ARRAYS; CD24	Exosomes show potential for cancer diagnostics because they transport molecular contents of the cells from which they originate. Detection and molecular profiling of exosomes is technically challenging and often requires extensive sample purification and labeling. Here we describe a label-free, high-throughput approach for quantitative analysis of exosomes. Our nano-plasmonic exosome (nPLEX) assay is based on transmission surface plasmon resonance through periodic nanohole arrays. Each array is functionalized with antibodies to enable profiling of exosome surface proteins and proteins present in exosome lysates. We show that this approach offers improved sensitivity over previous methods, enables portable operation when integrated with miniaturized optics and allows retrieval of exosomes for further study. Using nPLEX to analyze ascites samples from ovarian cancer patients, we find that exosomes derived from ovarian cancer cells can be identified by their expression of CD24 and EpCAM, suggesting the potential of exosomes for diagnostics.	[Im, Hyungsoon; Shao, Huilin; Park, Yong Il; Peterson, Vanessa M.; Castro, Cesar M.; Weissleder, Ralph; Lee, Hakho] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Weissleder, R (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; hlee@mgh.harvard.edu	Park, Yong Il/AAI-1187-2019; Im, Hyungsoon/A-3178-2009	Park, Yong Il/0000-0003-3167-4908; Im, Hyungsoon/0000-0002-0626-1346; /0000-0003-0828-4143	US National Institutes of Health (NIH) [R01-HL113156, R01-EB010011, R01-EB00462605A1, T32CA79443, K12CA087723-11A1]; National Heart, Lung, and Blood Institute [HHSN268201000044C]; Center for Nanoscale Systems (CNS) at Harvard University (National Science Foundation award) [ECS-0335765]; NATIONAL CANCER INSTITUTE [K12CA087723, P01CA069246, R01CA204019, T32CA079443] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011, R01EB000462, R01EB004626] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Nanoscale Systems (CNS) at Harvard University (National Science Foundation award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank S. Skates (Massachusetts General Hospital) for helpful discussion on statistical analyses; M. Birrer for facilitating sample collection; K. Joyes for reviewing the manuscript. This work was supported in part by US National Institutes of Health (NIH) grants R01-HL113156 (H.L.), R01-EB010011 (R.W.), R01-EB00462605A1 (R.W.), T32CA79443 (R.W.), K12CA087723-11A1 (C.M.C) and National Heart, Lung, and Blood Institute contract HHSN268201000044C (R.W.). The device was fabricated using the facilities at the Center for Nanoscale Systems (CNS) at Harvard University (National Science Foundation award ECS-0335765).	Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Brolo AG, 2012, NAT PHOTONICS, V6, P709, DOI 10.1038/nphoton.2012.266; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; CANNEY PA, 1985, BRIT J CANCER, V52, P131, DOI 10.1038/bjc.1985.161; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Chu AY, 2005, MODERN PATHOL, V18, P105, DOI 10.1038/modpathol.3800259; Escobedo C, 2013, LAB CHIP, V13, P2445, DOI 10.1039/c3lc50107h; Gordon R, 2008, ACCOUNTS CHEM RES, V41, P1049, DOI 10.1021/ar800074d; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Im H, 2010, CHEM SCI, V1, P688, DOI 10.1039/c0sc00365d; Im H, 2009, ANAL CHEM, V81, P2854, DOI 10.1021/ac802276x; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Lee HJ, 2006, ANAL CHEM, V78, P6504, DOI 10.1021/ac060881d; Li JH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-244; MacBeath G, 2000, SCIENCE, V289, P1760; Meden H, 1997, EUR J OBSTET GYN R B, V71, P173, DOI 10.1016/S0301-2115(96)02630-9; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Palik E.D, 1998, HDB OPTICAL CONSTANT; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Psyrri A, 2005, CLIN CANCER RES, V11, P8637, DOI 10.1158/1078-0432.CCR-05-1436; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tassa C, 2010, BIOCONJUGATE CHEM, V21, P14, DOI 10.1021/bc900438a; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yanik AA, 2011, P NATL ACAD SCI USA, V108, P11784, DOI 10.1073/pnas.1101910108; Yuan HK, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075102	36	831	847	37	761	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					490	U219		10.1038/nbt.2886	http://dx.doi.org/10.1038/nbt.2886			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752081	Green Accepted			2022-12-25	WOS:000336036100026
J	Chau, YY; Bandiera, R; Serrels, A; Martinez-Estrada, OM; Qing, W; Lee, M; Slight, J; Thornburn, A; Berry, R; McHaffie, S; Stimson, RH; Walker, BR; Chapuli, RM; Schedl, A; Hastie, N				Chau, You-Ying; Bandiera, Roberto; Serrels, Alan; Martinez-Estrada, Ofelia M.; Qing, Wei; Lee, Martin; Slight, Joan; Thornburn, Anna; Berry, Rachel; McHaffie, Sophie; Stimson, Roland H.; Walker, Brian R.; Munoz Chapuli, Ramon; Schedl, Andreas; Hastie, Nick			Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source	NATURE CELL BIOLOGY			English	Article							SMOOTH-MUSCLE-CELLS; PERICARDIAL FAT; ADIPOSE-TISSUE; IN-VIVO; WHITE; IDENTIFICATION; VASCULATURE; LINEAGE; HEART; WT1	Fuelled by the obesity epidemic, there is considerable interest in the developmental origins of white adipose tissue (WAT) and the stem and progenitor cells from which it arises. Whereas increased visceral fat mass is associated with metabolic dysfunction, increased subcutaneous WAT is protective. There are six visceral fat depots: perirenal, gonadal, epicardial, retroperitoneal, omental and mesenteric, and it is a subject of much debate whether these have a common developmental origin and whether this differs from that for subcutaneous WAT. Here we show that all six visceral WAT depots receive a significant contribution from cells expressing Wt1 late in gestation. Conversely, no subcutaneous WAT or brown adipose tissue arises from Wt1-expressing cells. Postnatally, a subset of visceral WAT continues to arise from Wt1-expressing cells, consistent with the finding that Wt1 marks a proportion of cell populations enriched in WAT progenitors. We show that all visceral fat depots have a mesothelial layer like the visceral organs with which they are associated, and provide several lines of evidence that Wt1-expressing mesothelium can produce adipocytes. These results reveal a major ontogenetic difference between visceral and subcutaneous WAT, and pinpoint the lateral plate mesoderm as a major source of visceral WAT. They also support the notion that visceral WAT progenitors are heterogeneous, and suggest that mesothelium is a source of adipocytes.	[Chau, You-Ying; Qing, Wei; Slight, Joan; Thornburn, Anna; Berry, Rachel; McHaffie, Sophie; Hastie, Nick] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Bandiera, Roberto; Schedl, Andreas] Univ Nice Sophia Antipolis, INSERM, Ctr Biochim, IBV,U1091, F-06100 Nice 2, France; [Serrels, Alan; Lee, Martin] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Martinez-Estrada, Ofelia M.] Univ Barcelona, Fac Biol, Dept Cell Biol, E-08028 Barcelona, Spain; [Stimson, Roland H.; Walker, Brian R.] Univ Edinburgh, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Munoz Chapuli, Ramon] Univ Malaga, Dept Anim Biol, E-29071 Malaga, Spain	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Edinburgh; University of Barcelona; University of Edinburgh; Universidad de Malaga	Chau, YY (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	You-Ying.Chau@igmm.ed.ac.uk; nicholas.hastie@igmm.ed.ac.uk	Martinez-Estrada, Ofelia M/V-4733-2017; Lee, Martin/K-8682-2015; Schedl, Andreas/GOP-3427-2022; Schedl, Andreas/F-8823-2015; Munoz-Chapuli, Ramon/K-7306-2014	Martinez-Estrada, Ofelia M/0000-0002-1814-1974; Lee, Martin/0000-0001-6529-5784; Schedl, Andreas/0000-0001-9380-7396; Munoz-Chapuli, Ramon/0000-0001-6392-6802; McHaffie, Sophie/0000-0002-9088-2646	EUFP7 programme; British Heart Foundation and the Medical Research Council; Medical Research Council; MINECO, Spain [BFU2011-25304, BFU2012-25304]; Wellcome Trust [091374/z/10/z]; ARC [SL 120120304626]; ANR (ADSTEM); FRM [DEQ20090515425]; MRC [MR/K010271/1, MC_U127527180, MC_PC_U127527180] Funding Source: UKRI; British Heart Foundation [RG/11/4/28734] Funding Source: researchfish; Medical Research Council [MC_PC_U127527180, MR/K010271/1, MC_U127527180] Funding Source: researchfish	EUFP7 programme(European Commission); British Heart Foundation and the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MINECO, Spain(Spanish Government); Wellcome Trust(Wellcome Trust); ARC(Australian Research Council); ANR (ADSTEM)(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Perry and M. Pearson (MRC HGU, IGMM, Edinburgh) for assistance with image capturing and time-lapse videoing, C. Nicol and L.Lettice for assistance with graphic design and publication (MRC HGU, IGMM, Edinburgh), L. Ramage (University/BHF Centre for Cardio vascular Science, Edinburgh) for technical assistance with human adipose tissues, R. Carmona and E.Cano (University of Malaga, Malaga) for assistance with immuno staining, E. Freyer (MRCHGU, IGMM, Edinburgh) and M. Waterfall (School of Biological Sciences, Edinburgh University, Edinburgh) for assistance in running the FACS facility. Human sample collection was funded by the EUFP7 programme, the British Heart Foundation and the Medical Research Council. This work has been supported by a Medical Research Council core grant to the Human Genetics Unit (Edinburgh), grant BFU2011-25304 (MINECO, Spain), grant BFU2012-25304, and the Wellcome Trust (091374/z/10/z). A. Schedl was supported by grants from ARC (SL 120120304626), ANR (ADSTEM) and FRM (DEQ20090515425)	Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Billon N, 2012, STEM CELL REV REP, V8, P55, DOI 10.1007/s12015-011-9242-x; Cano E, 2013, AM J PHYSIOL-LUNG C, V305, pL322, DOI 10.1152/ajplung.00424.2012; Carmona R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055890; Chau YY, 2012, TRENDS GENET, V28, P515, DOI 10.1016/j.tig.2012.04.004; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Kanamori-Katayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025391; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512	29	339	344	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					367	+		10.1038/ncb2922	http://dx.doi.org/10.1038/ncb2922			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24609269	Green Accepted			2022-12-25	WOS:000333556900010
J	Rajagopala, SV; Sikorski, P; Kumar, A; Mosca, R; Vlasblom, J; Arnold, R; Franca-Koh, J; Pakala, SB; Phanse, S; Ceol, A; Hauser, R; Siszler, G; Wuchty, S; Emili, A; Babu, M; Aloy, P; Pieper, R; Uetz, P				Rajagopala, Seesandra V.; Sikorski, Patricia; Kumar, Ashwani; Mosca, Roberto; Vlasblom, James; Arnold, Roland; Franca-Koh, Jonathan; Pakala, Suman B.; Phanse, Sadhna; Ceol, Arnaud; Haeuser, Roman; Siszler, Gabriella; Wuchty, Stefan; Emili, Andrew; Babu, Mohan; Aloy, Patrick; Pieper, Rembert; Uetz, Peter			The binary protein-protein interaction landscape of Escherichia coli	NATURE BIOTECHNOLOGY			English	Article							COLI; COMPLEXES; NETWORKS; IDENTIFICATION; MAP	Efforts to map the Escherichia coli interactome have identified several hundred macromolecular complexes, but direct binary protein-protein interactions (PPIs) have not been surveyed on a large scale. Here we performed yeast two-hybrid screens of 3,305 baits against 3,606 preys (similar to 70% of the E. coli proteome) in duplicate to generate a map of 2,234 interactions, which approximately doubles the number of known binary PPIs in E. coli. Integration of binary PPI and genetic-interaction data revealed functional dependencies among components involved in cellular processes, including envelope integrity, flagellum assembly and protein quality control. Many of the binary interactions that we could map in multiprotein complexes were informative regarding internal topology of complexes and indicated that interactions in complexes are substantially more conserved than those interactions connecting different complexes. This resource will be useful for inferring bacterial gene function and provides a draft reference of the basic physical wiring network of this evolutionarily important model microbe.	[Rajagopala, Seesandra V.; Sikorski, Patricia; Franca-Koh, Jonathan; Pakala, Suman B.; Pieper, Rembert] J Craig Venter Inst, Rockville, MD USA; [Kumar, Ashwani; Vlasblom, James; Phanse, Sadhna; Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Mosca, Roberto; Ceol, Arnaud; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Arnold, Roland; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr, Toronto, ON, Canada; [Haeuser, Roman; Siszler, Gabriella] German Canc Res Ctr, Heidelberg, Germany; [Wuchty, Stefan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Aloy, Patrick] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	J. Craig Venter Institute; University of Regina; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; ICREA; Virginia Commonwealth University	Rajagopala, SV (corresponding author), J Craig Venter Inst, Rockville, MD USA.	raja@jcvi.org; mohan.babu@uregina.ca	Arnold, Roland/AAC-5256-2022; Mohan, Babu P./I-7362-2019; Uetz, Peter/A-7119-2012; Aloy, Patrick/AAB-3538-2019; Ceol, Arnaud/H-3386-2012	Arnold, Roland/0000-0002-7496-7578; Uetz, Peter/0000-0001-6194-4927; Ceol, Arnaud/0000-0001-9533-4246; Pakala, Suman/0000-0001-5156-0823; Sikorski, Patricia/0000-0003-4609-1174; Aloy, Patrick/0000-0002-3557-0236; Rajagopala, Seesandra/0000-0001-7176-5770; Mosca, Roberto/0000-0002-3244-1885; Phanse, Sadhna/0000-0001-6306-0551	US National Institutes of Health [GM079710]; Seventh Research Framework Programme of the European Union (AntiPathoGN; EU) [HEALTH-F3-2009-223101]; Natural Sciences and Engineering Research Council [DG-20234]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079710] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seventh Research Framework Programme of the European Union (AntiPathoGN; EU); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); ICREA(ICREA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.V.R. and P.U. were supported by US National Institutes of Health grant GM079710. P.U., R.H. and P.A. were supported by the Seventh Research Framework Programme of the European Union (AntiPathoGN; EU grant HEALTH-F3-2009-223101). M.B. was supported by the Discovery Grant from the Natural Sciences and Engineering Research Council (DG-20234). We thank X. De Bolle (University of Namur, Belgium) for providing pRH016 and pRH018 vectors.	Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Babu M., PLOS GENET; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Goll J, 2008, BIOINFORMATICS, V24, P1743, DOI 10.1093/bioinformatics/btn285; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Lasker K, 2010, MOL CELL PROTEOMICS, V9, P1689, DOI 10.1074/mcp.R110.000067; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166; Rajagopala SV, 2012, METHODS, V58, P392, DOI 10.1016/j.ymeth.2012.07.015; Rajagopala SV, 2011, METHODS MOL BIOL, V781, P1, DOI 10.1007/978-1-61779-276-2_1; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Rajagopala SV, 2008, BIOINFORMATICS, V24, P2622, DOI 10.1093/bioinformatics/btn481; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	40	137	141	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					285	290		10.1038/nbt.2831	http://dx.doi.org/10.1038/nbt.2831			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24561554	Green Accepted			2022-12-25	WOS:000332819800028
J	Wang, WJ; Wang, Y; Chen, HZ; Xing, YZ; Li, FW; Zhang, Q; Zhou, B; Zhang, HK; Zhang, J; Bian, XL; Li, L; Liu, Y; Zhao, BX; Chen, Y; Wu, R; Li, AZ; Yao, LM; Chen, P; Zhang, Y; Tian, XY; Beermann, F; Wu, M; Han, JH; Huang, PQ; Lin, TW; Wu, Q				Wang, Wei-jia; Wang, Yuan; Chen, Hang-zi; Xing, Yong-zhen; Li, Feng-wei; Zhang, Qian; Zhou, Bo; Zhang, Hong-kui; Zhang, Jie; Bian, Xue-li; Li, Li; Liu, Yuan; Zhao, Bi-xing; Chen, Yan; Wu, Rong; Li, An-zhong; Yao, Lu-ming; Chen, Ping; Zhang, Yi; Tian, Xu-yang; Beermann, Friedrich; Wu, Mian; Han, Jiahuai; Huang, Pei-qiang; Lin, Tianwei; Wu, Qiao			Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway	NATURE CHEMICAL BIOLOGY			English	Article							APOPTOSIS; MITOPHAGY; SURVIVAL; NUR77; P53; VEMURAFENIB; ACTIVATION; MECHANISMS; CROSSTALK; INDUCTION	Autophagy is linked to cell death, yet the associated mechanisms are largely undercharacterized. We discovered that melanoma, which is generally resistant to drug-induced apoptosis, can undergo autophagic cell death with the participation of orphan nuclear receptor TR3. A sequence of molecular events leading to cellular demise is launched by a specific chemical compound, 1-(3,4,5-trihydroxyphenyl)nonan-1-one, newly acquired from screening a library of TR3-targeting compounds. The autophagic cascade comprises TR3 translocation to mitochondria through interaction with the mitochondrial outer membrane protein Nix, crossing into the mitochondrial inner membrane through Tom40 and Tom70 channel proteins, dissipation of mitochondrial membrane potential by the permeability transition pore complex ANT1-VDAC1 and induction of autophagy. This process leads to excessive mitochondria clearance and irreversible cell death. It implicates a new approach to melanoma therapy through activation of a mitochondrial signaling pathway that integrates a nuclear receptor with autophagy for cell death.	[Wang, Wei-jia; Wang, Yuan; Chen, Hang-zi; Xing, Yong-zhen; Li, Feng-wei; Zhang, Qian; Zhou, Bo; Bian, Xue-li; Li, Li; Liu, Yuan; Zhao, Bi-xing; Chen, Yan; Wu, Rong; Li, An-zhong; Yao, Lu-ming; Chen, Ping; Zhang, Yi; Tian, Xu-yang; Han, Jiahuai; Lin, Tianwei; Wu, Qiao] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Fujian Province, Peoples R China; [Zhang, Hong-kui; Zhang, Jie; Huang, Pei-qiang] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Fujian Province, Peoples R China; [Beermann, Friedrich] SV EPFL, Swiss Inst Expt Canc Res, ISREC, Lausanne, Switzerland; [Wu, Mian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Xiamen University; Xiamen University; Swiss Institute Experimental Cancer Research; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Lin, TW (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Fujian Province, Peoples R China.	twlin@xmu.edu.cn; qiaow@xmu.edu.cn	Han, J/G-4671-2010	Li, Li/0000-0002-7720-6731; Bian, Xueli/0000-0001-9940-8396; Huang, Pei-Qiang/0000-0003-3230-0457; Luming, Yao/0000-0002-9417-4356; Wu, Mian/0000-0002-2714-0500	National Natural Science Fund of China; '973' Project of the Ministry of Science and Technology [31230019, 2014CB910602, 31370724, 31221065, 30971525]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF002]; 111 Project of Education of China [B06016]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); '973' Project of the Ministry of Science and Technology(National Basic Research Program of China); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University; 111 Project of Education of China(Ministry of Education, China - 111 Project)	We thank L. Yu from Tsinghua University; S.C. Lin from Xiamen University; and Q. Chen from the Institute of Zoology, Chinese Academy of Science, China for their critical suggestions. We would like to thank G.Q. Wang from the Zhongshan Hospital of Xiamen University for providing MeWo melanoma cells. This work was supported by grants from the National Natural Science Fund of China and the '973' Project of the Ministry of Science and Technology (31230019, 2014CB910602, 31370724, 31221065 and 30971525); the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2012KF002); and the 111 Project of Education of China (no. B06016). The crystallographic data collection at Beamline BL17U1 at Shanghai Synchrotron Radiation Facility is gratefully acknowledged.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Chen HZ, 2012, ONCOGENE, V31, P2876, DOI 10.1038/onc.2011.463; Chen HZ, 2008, CARCINOGENESIS, V29, P2078, DOI 10.1093/carcin/bgn197; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vogelzang NJ, 2012, J CLIN ONCOL, V30, P88, DOI 10.1200/JCO.2011.40.1919; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang RH, 2013, EMBO MOL MED, V5, P137, DOI 10.1002/emmm.201201369; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu H, 2007, CANCER BIOL THER, V6, P405, DOI 10.4161/cbt.6.3.3755; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhan Yan-Yan, 2004, Ai Zheng, V23, P1593; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhao BX, 2011, MOL ENDOCRINOL, V25, P1337, DOI 10.1210/me.2011-0081	44	103	111	1	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					133	140		10.1038/NCHEMBIO.1406	http://dx.doi.org/10.1038/NCHEMBIO.1406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316735				2022-12-25	WOS:000330751600012
J	Dahl, RH; Zhang, F; Alonso-Gutierrez, J; Baidoo, E; Batth, TS; Redding-Johanson, AM; Petzold, CJ; Mukhopadhyay, A; Lee, TS; Adams, PD; Keasling, JD				Dahl, Robert H.; Zhang, Fuzhong; Alonso-Gutierrez, Jorge; Baidoo, Edward; Batth, Tanveer S.; Redding-Johanson, Alyssa M.; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Lee, Taek Soon; Adams, Paul D.; Keasling, Jay D.			Engineering dynamic pathway regulation using stress-response promoters	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MICROBIAL-PRODUCTION; MEVALONATE PATHWAY; ISOPRENOID PATHWAY; ACID; OPTIMIZATION; DESIGN; SYSTEM; IDENTIFICATION	Heterologous pathways used in metabolic engineering may produce intermediates toxic to the cell. Dynamic control of pathway enzymes could prevent the accumulation of these metabolites, but such a strategy requires sensors, which are largely unknown, that can detect and respond to the metabolite. Here we applied whole-genome transcript arrays to identify promoters that respond to the accumulation of toxic intermediates, and then used these promoters to control accumulation of the intermediate and improve the final titers of a desired product. We apply this approach to regulate farnesyl pyrophosphate (FPP) production in the isoprenoid biosynthetic pathway in Escherichia coli. This strategy improved production of amorphadiene, the final product, by twofold over that from inducible or constitutive promoters, eliminated the need for expensive inducers, reduced acetate accumulation and improved growth. We extended this approach to another toxic intermediate to demonstrate the broad utility of identifying novel sensor-regulator systems for dynamic regulation.	[Dahl, Robert H.; Zhang, Fuzhong; Alonso-Gutierrez, Jorge; Baidoo, Edward; Batth, Tanveer S.; Redding-Johanson, Alyssa M.; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Lee, Taek Soon; Adams, Paul D.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Dahl, Robert H.; Zhang, Fuzhong; Alonso-Gutierrez, Jorge; Baidoo, Edward; Batth, Tanveer S.; Redding-Johanson, Alyssa M.; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Lee, Taek Soon; Adams, Paul D.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Dahl, Robert H.; Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Adams, Paul D.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012; Mukhopadhyay, Aindrila/AAW-7257-2021; Adams, Paul David/A-1977-2013	Keasling, Jay D/0000-0003-4170-6088; Adams, Paul David/0000-0001-9333-8219; Batth, Tanveer Singh/0000-0001-5346-4544; Zhang, Fuzhong/0000-0001-6979-7909; Petzold, Christopher/0000-0002-8270-5228	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	The authors thank D.Pitera for the pADSmut plasmid and W.Holtz for the BglBrick plasmids with the lacUV5 promoter and LacI<SUP>Q</SUP> removed. J.A.-G. thanks Fundacion Ramon Areces for his PostDoc fellowship. This work was part of the Department of Energy Joint BioEnergy Institute (http://www.jbei.org/) supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; CHEN AJ, 1994, PROTEIN SCI, V3, P600; Chen CY, 2000, PLANT PHYSIOL, V123, P853, DOI 10.1104/pp.123.3.853; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; De Mey M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-26; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dietrich JA, 2013, ACS SYNTH BIOL, V2, P47, DOI 10.1021/sb300091d; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop Mary J, 2010, Syst Synth Biol, V4, P95, DOI 10.1007/s11693-010-9052-5; Fazelinia H, 2007, BIOPHYS J, V92, P2120, DOI 10.1529/biophysj.106.096016; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hinson DD, 1997, J LIPID RES, V38, P2216; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Kang Z, 2008, APPL MICROBIOL BIOT, V79, P203, DOI 10.1007/s00253-008-1428-z; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Krings U, 1998, APPL MICROBIOL BIOT, V49, P1, DOI 10.1007/s002530051129; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Miksch G, 2005, J BIOTECHNOL, V120, P25, DOI 10.1016/j.jbiotec.2005.04.027; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Smolke CD, 2001, METAB ENG, V3, P313, DOI 10.1006/mben.2001.0194; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	54	314	346	21	261	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1039	+		10.1038/nbt.2689	http://dx.doi.org/10.1038/nbt.2689			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24142050				2022-12-25	WOS:000326921200027
J	Costello, JC; Heiser, LM; Georgii, E; Gonen, M; Menden, MP; Wang, NJ; Bansal, M; Ammad-ud-din, M; Hintsanen, P; Khan, SA; Mpindi, JP; Kallioniemi, O; Honkela, A; Aittokallio, T; Wennerberg, K; Collins, JJ; Gallahan, D; Singer, D; Saez-Rodriguez, J; Kaski, S; Gray, JW; Stolovitzky, G				Costello, James C.; Heiser, Laura M.; Georgii, Elisabeth; Gonen, Mehmet; Menden, Michael P.; Wang, Nicholas J.; Bansal, Mukesh; Ammad-ud-din, Muhammad; Hintsanen, Petteri; Khan, Suleiman A.; Mpindi, John-Patrick; Kallioniemi, Olli; Honkela, Antti; Aittokallio, Tero; Wennerberg, Krister; Collins, James J.; Gallahan, Dan; Singer, Dinah; Saez-Rodriguez, Julio; Kaski, Samuel; Gray, Joe W.; Stolovitzky, Gustavo		NCI DREAM Community	A community effort to assess and improve drug sensitivity prediction algorithms	NATURE BIOTECHNOLOGY			English	Article							CANCER CELL-LINES; HUMAN BREAST; GENES; ARRAY; IDENTIFICATION; ENCYCLOPEDIA; SIGNATURES; RESPONSES; RESOURCE; WISDOM	Predicting the best treatment strategy from genomic information is a core goal of precision medicine. Here we focus on predicting drug response based on a cohort of genomic, epigenomic and proteomic profiling data sets measured in human breast cancer cell lines. Through a collaborative effort between the National Cancer Institute (NCI) and the Dialogue on Reverse Engineering Assessment and Methods (DREAM) project, we analyzed a total of 44 drug sensitivity prediction algorithms. The top-performing approaches modeled nonlinear relationships and incorporated biological pathway information. We found that gene expression microarrays consistently provided the best predictive power of the individual profiling data sets; however, performance was increased by including multiple, independent data sets. We discuss the innovations underlying the top-performing methodology, Bayesian multitask MKL, and we provide detailed descriptions of all methods. This study establishes benchmarks for drug sensitivity prediction and identifies approaches that can be leveraged for the development of new methods.	[Costello, James C.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Costello, James C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Heiser, Laura M.; Wang, Nicholas J.; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Georgii, Elisabeth; Gonen, Mehmet; Ammad-ud-din, Muhammad; Khan, Suleiman A.; Kaski, Samuel] Aalto Univ, Helsinki Inst Informat Technol HIIT, Dept Informat & Comp Sci, Espoo, Finland; [Menden, Michael P.; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Bansal, Mukesh] Columbia Univ, Dept Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY USA; [Hintsanen, Petteri; Mpindi, John-Patrick; Kallioniemi, Olli; Aittokallio, Tero; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Honkela, Antti; Kaski, Samuel] Univ Helsinki, Dept Comp Sci, Helsinki Inst Informat Technol HIIT, SF-00510 Helsinki, Finland; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Gallahan, Dan; Singer, Dinah] NCI, NIH, Bethesda, MD 20892 USA; [Stolovitzky, Gustavo] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Boston University; Howard Hughes Medical Institute; Boston University; Oregon Health & Science University; Aalto University; University of Helsinki; European Molecular Biology Laboratory (EMBL); Columbia University; University of Helsinki; Aalto University; University of Helsinki; Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); International Business Machines (IBM)	Kaski, S (corresponding author), Aalto Univ, Helsinki Inst Informat Technol HIIT, Dept Informat & Comp Sci, Espoo, Finland.	samuel.kaski@aalto.fi; grayjo@ohsu.edu; gustavo@us.ibm.com	Li, Jun/O-9911-2014; B, Krithika/H-7099-2019; Gönen, Mehmet/O-7322-2015; Coelho, Luis Pedro/D-1260-2009; Wennerberg, Krister/AFM-0539-2022; van Westen, Gerard JP/D-7432-2011; Kaski, Samuel/B-6684-2008; Bhattacharjee, Madhuchhanda/ABI-3732-2020; Wang, Difei/E-7066-2010; wang, edwin/G-5372-2010; Bender, Andreas/C-6942-2009; Song, Lei/F-6946-2018; Kallioniemi, Olli P/H-5111-2011; Zhao, Junfei/J-1425-2018; Di Camillo, Barbara/L-3202-2013; Wang, Wen/E-6320-2012; Wennerberg, Krister/AAH-2919-2022; Cokelaer, Thomas/AAN-8240-2020; Aittokallio, Tero/B-6583-2009; Hwang, Woochang/AAU-8398-2020; Saez-Rodriguez, Julio/H-7114-2019; Gray, Joe/AAX-9549-2020; Li, Jun/AAE-4393-2022; Yuan, Yuan/H-4007-2013; Duren, Zhana/A-6425-2018; Khan, Suleiman/F-3472-2017; Rajwa, Bartek/B-3169-2009; Ma, Jian/A-9838-2008; Overington, John P/G-8607-2015; De Baets, Bernard/E-8877-2010; Walter, Thomas/B-9079-2015	Li, Jun/0000-0002-1171-7141; B, Krithika/0000-0003-4015-7056; Gönen, Mehmet/0000-0002-2483-075X; Coelho, Luis Pedro/0000-0002-9280-7885; Wennerberg, Krister/0000-0002-1352-4220; van Westen, Gerard JP/0000-0003-0717-1817; Kaski, Samuel/0000-0003-1925-9154; Bhattacharjee, Madhuchhanda/0000-0002-8700-376X; Bender, Andreas/0000-0002-6683-7546; Kallioniemi, Olli P/0000-0002-3231-0332; Di Camillo, Barbara/0000-0001-8415-4688; Wang, Wen/0000-0002-5812-6744; Wennerberg, Krister/0000-0002-1352-4220; Cokelaer, Thomas/0000-0001-6286-1138; Aittokallio, Tero/0000-0002-0886-9769; Hwang, Woochang/0000-0003-0876-7305; Saez-Rodriguez, Julio/0000-0002-8552-8976; Li, Jun/0000-0002-1171-7141; Yuan, Yuan/0000-0003-4706-7897; Duren, Zhana/0000-0003-4685-811X; Khan, Suleiman/0000-0002-0823-4042; Rajwa, Bartek/0000-0001-7540-8236; Ma, Jian/0000-0002-4202-5834; Overington, John P/0000-0002-5859-1064; Lee, Junehawk/0000-0001-8908-0884; Vert, Jean-Philippe/0000-0001-9510-8441; Gusev, Yuriy/0000-0001-7371-4715; Abbuehl, Jean-Paul/0000-0003-3135-6969; Han, Leng/0000-0002-7380-2640; Pal, Ranadip/0000-0002-9311-5901; Bansal, Mukesh/0000-0003-1481-6767; IJzerman, Ad/0000-0002-1182-2259; MOONEY, SEAN D/0000-0003-2654-0833; Ha, Min Jin/0000-0002-5165-1642; Boehm, Frederick/0000-0002-1644-5931; Costello, James/0000-0003-3158-9682; Wegner, Jorg Kurt/0000-0002-1852-9434; Peng, Jian/0000-0002-1736-2978; De Baets, Bernard/0000-0002-3876-620X; Walter, Thomas/0000-0001-7419-7879; varoquaux, Nelle/0000-0002-8748-6546; Dundar, Murat/0000-0001-5752-468X; Altman, Russ/0000-0003-3859-2905; Grau, Michael/0000-0003-1909-0133; Califano, Andrea/0000-0003-4742-3679; Homicsko, Krisztian/0000-0003-0912-6198; Sadanandam, Anguraj/0000-0001-8485-5150	MaGNeT grant [5U54CA121852-08]; National Institutes of Health, National Cancer Institute [U54 CA 112970]; Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research [SU2C-AACR-DT0409]; Prospect Creek Foundation; Howard Hughes Medical Institute (HHMI); Academy of Finland (Finnish Center of Excellence in Computational Inference Research COIN) [251170, 140057]; NATIONAL CANCER INSTITUTE [U54CA121852, P50CA058207, P30CA016672, U54CA112970] Funding Source: NIH RePORTER	MaGNeT grant; National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research; Prospect Creek Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Academy of Finland (Finnish Center of Excellence in Computational Inference Research COIN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The data were kindly provided before publication for this challenge by J.W.G. We acknowledge the contributions of all participants in the co-organized NCI and DREAM Summit held on April 23, 2012, for the development of the challenge (http://www.the-dream-project.org/sites/the-dream-project.org/files/documents/dream7/dream_participant_list.docx). This work is supported in part by the following: MaGNeT grant (5U54CA121852-08); National Institutes of Health, National Cancer Institute grant U54 CA 112970; Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research grant SU2C-AACR-DT0409; Prospect Creek Foundation; Howard Hughes Medical Institute (HHMI); and The Academy of Finland (Finnish Center of Excellence in Computational Inference Research COIN, grant nos. 251170 and 140057).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Costello JC, 2013, CLIN PHARMACOL THER, V93, P396, DOI 10.1038/clpt.2013.36; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrell FE, 2001, REGRESSION MODELING; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Howlander N, 2013, SEER CANC STAT REV, P1975; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo WL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-77; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Masica DL, 2013, CANCER RES, V73, P1699, DOI 10.1158/0008-5472.CAN-12-3122; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rantala L. M., 2013, MICROARRAYS, V2, P97; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Scholkopf B, 2001, LEARNING KERNELS SUP; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	49	431	433	4	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1202	U57		10.1038/nbt.2877	http://dx.doi.org/10.1038/nbt.2877			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	24880487	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-25	WOS:000346156800022
J	Cang, CL; Bekele, B; Ren, DJ				Cang, Chunlei; Bekele, Biruk; Ren, Dejian			The voltage-gated sodium channel TPC1 confers endolysosomal excitability	NATURE CHEMICAL BIOLOGY			English	Article							LEAK CHANNELS; ION-CHANNEL; PATCH-CLAMP; K+ CHANNEL; CALCIUM; NAADP; CA2+; PROTEINS; ACIDIFICATION; EXPRESSION	The physiological function and molecular regulation of plasma membrane potential have been extensively studied, but how intracellular organelles sense and control membrane potential is not well understood. Using whole-organelle patch clamp recording, we show that endosomes and lysosomes are electrically excitable organelles. In a subpopulation of endolysosomes, a brief electrical stimulus elicits a prolonged membrane potential depolarization spike. The organelles have a previously uncharacterized, depolarization-activated, noninactivating Na+ channel (lysoNa(v)). The channel is formed by a two-repeat six-transmembrane-spanning (2x6TM) protein, TPC1, which represents the evolutionary transition between 6TM and 4x6TM voltage-gated channels. Luminal alkalization also opens lysoNav by markedly shifting the channel's voltage dependence of activation toward hyperpolarization. Thus, TPC1 is a member of a new family of voltage-gated Isle channels that senses pH changes and confers electrical excitability to organelles.	[Cang, Chunlei; Bekele, Biruk; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Cang, CL (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	ccang@sas.upenn.edu; dren@sas.upenn.edu	Cang, Chunlei/D-9185-2019	Cang, Chunlei/0000-0002-3302-0927	American Heart Association; US National Institutes of Health [2R01NS055293, 5R01NS074257]; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055293, R01NS074257] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ren lab for discussion and support and D. Clapham for suggestions. This work was funded, in part, by the American Heart Association, the US National Institutes of Health (grants 2R01NS055293 and 5R01NS074257 to D.R.) and the University of Pennsylvania Research Foundation.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Beam KG, 1997, METHOD CELL BIOL, V52, P283, DOI 10.1016/S0091-679X(08)60384-2; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Haggie PM, 2009, AM J PHYSIOL-LUNG C, V296, pL859, DOI 10.1152/ajplung.00018.2009; HARIKUMAR P, 1983, J BIOL CHEM, V258, P403; Hilgemann D.W., 2001, SCI STKE, V2011, pre19; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Jan LY, 2012, J PHYSIOL-LONDON, V590, P2591, DOI 10.1113/jphysiol.2011.224212; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rybalchenko V, 2012, J BIOL CHEM, V287, P20407, DOI 10.1074/jbc.M112.359612; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Schieder M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3151pl3; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Yu F.H, 2004, SCI STKE, pre15; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	50	114	116	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					463	469		10.1038/nchembio.1522	http://dx.doi.org/10.1038/nchembio.1522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24776928				2022-12-25	WOS:000336238200014
J	Dhandapany, PS; Razzaque, MA; Muthusami, U; Kunnoth, S; Edwards, JJ; Mulero-Navarro, S; Riess, I; Pardo, S; Sheng, JP; Rani, DS; Rani, B; Govindaraj, P; Flex, E; Yokota, T; Furutani, M; Nishizawa, T; Nakanishi, T; Robbins, J; Limongelli, G; Hajjar, RJ; Lebeche, D; Bahl, A; Khullar, M; Rathinavel, A; Sadler, KC; Tartaglia, M; Matsuoka, R; Thangaraj, K; Gelb, BD				Dhandapany, Perundurai S.; Razzaque, Md Abdur; Muthusami, Uthiralingam; Kunnoth, Sreejith; Edwards, Jonathan J.; Mulero-Navarro, Sonia; Riess, Ilan; Pardo, Sherly; Sheng, Jipo; Rani, Deepa Selvi; Rani, Bindu; Govindaraj, Periyasamy; Flex, Elisabetta; Yokota, Tomohiro; Furutani, Michiko; Nishizawa, Tsutomu; Nakanishi, Toshio; Robbins, Jeffrey; Limongelli, Giuseppe; Hajjar, Roger J.; Lebeche, Djamel; Bahl, Ajay; Khullar, Madhu; Rathinavel, Andiappan; Sadler, Kirsten C.; Tartaglia, Marco; Matsuoka, Rumiko; Thangaraj, Kumarasamy; Gelb, Bruce D.			RAF1 mutations in childhood-onset dilated cardiomyopathy	NATURE GENETICS			English	Article							CAUSE NOONAN; PATHWAY	Dilated cardiomyopathy (DCM) is a highly heterogeneous trait with sarcomeric gene mutations predominating. The cause of a substantial percentage of DCMs remains unknown, and no gene-specific therapy is available. On the basis of resequencing of 513 DCM cases and 1,150 matched controls from various cohorts of distinct ancestry, we discovered rare, functional RAF1 mutations in 3 of the cohorts (South Indian, North Indian and Japanese). The prevalence of RAF1 mutations was similar to 9% in childhood-onset DCM cases in these three cohorts. Biochemical studies showed that DCM-associated RAF1 mutants had altered kinase activity, resulting in largely unaltered ERK activation but in AKT that was hyperactivated in a BRAF-dependent manner. Constitutive expression of these mutants in zebrafish embryos resulted in a heart failure phenotype with AKT hyperactivation that was rescued by treatment with rapamycin. These findings provide new mechanistic insights and potential therapeutic targets for RAH-associated DCM and further expand the clinical spectrum of RAH-related human disorders.	[Dhandapany, Perundurai S.; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Dhandapany, Perundurai S.; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Dhandapany, Perundurai S.; Edwards, Jonathan J.; Mulero-Navarro, Sonia; Riess, Ilan; Gelb, Bruce D.] Hess Ctr Sci & Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Razzaque, Md Abdur; Robbins, Jeffrey] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA; [Razzaque, Md Abdur] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Muthusami, Uthiralingam; Kunnoth, Sreejith] Loyola Coll, Dept Adv Zool & Biotechnol, Madras, Tamil Nadu, India; [Muthusami, Uthiralingam] Manonmaniam Sundaranar Univ, Dept Biotechnol, Tirunelveli, India; [Pardo, Sherly] Univ Puerto Rico, San Juan, PR 00936 USA; [Sheng, Jipo; Hajjar, Roger J.; Lebeche, Djamel] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY USA; [Rani, Deepa Selvi; Govindaraj, Periyasamy; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Rani, Bindu; Bahl, Ajay; Khullar, Madhu] Postgrad Inst Med Educ & Res PGIMER, Chandigarh, India; [Govindaraj, Periyasamy] Bharathidasan Univ, Sch Basic Med Sci, Dept Biomed Sci, Tiruchirappalli, Tamil Nadu, India; [Flex, Elisabetta; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Yokota, Tomohiro; Furutani, Michiko; Nishizawa, Tsutomu; Nakanishi, Toshio; Matsuoka, Rumiko] Tokyo Womens Med Univ, Int Res & Educ Inst Integrated Med Sci, Tokyo, Japan; [Furutani, Michiko; Nakanishi, Toshio; Matsuoka, Rumiko] Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo, Japan; [Limongelli, Giuseppe] Univ Naples 2, Monaldi Hosp, Naples, Italy; [Rathinavel, Andiappan] Thanjavur Med Coll, Dept Cardiothorac Surg, Thanjavur, India; [Sadler, Kirsten C.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY USA; [Sadler, Kirsten C.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA; [Sadler, Kirsten C.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; University of Wisconsin System; University of Wisconsin Madison; Loyola College - Chennai; Manonmaniam Sundaranar University; University of Puerto Rico; Icahn School of Medicine at Mount Sinai; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Bharathidasan University; Istituto Superiore di Sanita (ISS); Tokyo Women's Medical University; Tokyo Women's Medical University; Universita della Campania Vanvitelli; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Gelb, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.	bruce.gelb@mssm.edu	Nair, AS/F-1155-2010; Flex, Elisabetta/A-5958-2017; Tartaglia, Marco/K-2955-2018; LImongelli, Giuseppe/K-4885-2018	Nair, AS/0000-0001-9258-8566; Flex, Elisabetta/0000-0002-6802-1356; Tartaglia, Marco/0000-0001-7736-9672; Edwards, Jonathan/0000-0002-8153-7066; Khullar, Madhu/0000-0003-4461-2466; Razzaque, Md Abdur/0000-0002-5932-3432; Yokota, Tomohiro/0000-0003-2540-3810; Perundurai, Dhandapany/0000-0001-7831-9570; Sadler Edepli, Kirsten/0000-0002-1100-4125; LImongelli, Giuseppe/0000-0002-8291-9517; Thangaraj, Kumarasamy/0000-0002-0075-0106; Mulero Navarro, Sonia/0000-0001-5739-8062	National Heart, Lung, and Blood Institute [HL071207, HL097357]; Telethon-Italy [GGP10020, GGP13107]; Sarnoff Cardiovascular Research Foundation; American Heart Association; Network project grant from the Council of Scientific and Industrial Research (CSIR) of the government of India [CARDIOMED-BSC0122]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097357, R01HL071207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080789] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon-Italy(Fondazione Telethon); Sarnoff Cardiovascular Research Foundation; American Heart Association(American Heart Association); Network project grant from the Council of Scientific and Industrial Research (CSIR) of the government of India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank A. Mir and C.Evan for their technical support in the zebrafish studies, P.Poulikakos (Icahn School of Medicine at Mount Sinai) and M. Baccarini (Max F.Perutz Laboratories, University of Vienna) for the Braf and Rafl knockout MEFs, and P.Vaideeswar for the initial collection of samples from cardiomyopathy cases. This work was supported in part by grants from the National Heart, Lung, and Blood Institute to B.D.G. (HL071207) and D.L. (HL097357) and by grants from Telethon-Italy to M.T. (GGP10020 and GGP13107). J.J.E. was a research fellow supported by the Sarnoff Cardiovascular Research Foundation. M.A.R. is a postdoctoral fellow of the American Heart Association (Great Rivers Affiliate). K.T. was supported by a Network project grant (CARDIOMED-BSC0122) from the Council of Scientific and Industrial Research (CSIR) of the government of India.	Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Kaski JP, 2012, CIRC-CARDIOVASC GENE, V5, P317, DOI 10.1161/CIRCGENETICS.111.960468; Lin AE, 2011, AM J MED GENET A, V155A, P486, DOI 10.1002/ajmg.a.33857; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Sala V, 2012, MOL MED, V18, P938, DOI 10.2119/molmed.2011.00512; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Watkins H, 2003, CIRCULATION, V107, P1344, DOI 10.1161/01.CIR.0000057860.52586.9C; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929	16	51	52	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					635	639		10.1038/ng.2963	http://dx.doi.org/10.1038/ng.2963			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24777450	Green Accepted			2022-12-25	WOS:000336870700023
J	Buczkowicz, P; Hoeman, C; Rakopoulos, P; Pajovic, S; Letourneau, L; Dzamba, M; Morrison, A; Lewis, P; Bouffet, E; Bartels, U; Zuccaro, J; Agnihotri, S; Rya, S; Barszczyk, M; Chornenkyy, Y; Bourgey, M; Bourque, G; Montpetit, A; Cordero, F; Castelo-Branco, P; Mangere, J; Tabori, U; Ching, K; Huang, A; Taylor, KR; Mackay, A; Bendell, AE; Nazarian, J; Fangusaro, JR; Karajannis, MA; Zagzag, D; Foreman, NK; Donson, A; Hegert, JV; Smith, A; Chan, J; Lafay-Cousin, L; Dunn, S; Hukin, J; Dunham, C; Scheinemann, K; Michaud, J; Zelcer, S; Ramsay, D; Cain, J; Brennan, C; Souweidane, MM; Jones, C; Allis, CD; Brudno, M; Becher, O; Hawkins, C				Buczkowicz, Pawel; Hoeman, Christine; Rakopoulos, Patricia; Pajovic, Sanja; Letourneau, Louis; Dzamba, Misko; Morrison, Andrew; Lewis, Peter; Bouffet, Eric; Bartels, Ute; Zuccaro, Jennifer; Agnihotri, Sameer; Rya, Scott; Barszczyk, Mark; Chornenkyy, Yevgen; Bourgey, Mathieu; Bourque, Guillaume; Montpetit, Alexandre; Cordero, Francisco; Castelo-Branco, Pedro; Mangere, Joshua; Tabori, Uri; Ching, King; Huang, Annie; Taylor, Kathryn R.; Mackay, Alan; Bendell, Anne E.; Nazarian, Javad; Fangusaro, Jason R.; Karajannis, Matthias A.; Zagzag, David; Foreman, Nicholas K.; Donson, Andrew; Hegert, Julia V.; Smith, Amy; Chan, Jennifer; Lafay-Cousin, Lucy; Dunn, Sandra; Hukin, Juliette; Dunham, Chris; Scheinemann, Katrin; Michaud, Jean; Zelcer, Shayna; Ramsay, David; Cain, Jason; Brennan, Cameron; Souweidane, Mark M.; Jones, Chris; Allis, C. David; Brudno, Michael; Becher, Oren; Hawkins, Cynthia			Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; BONE MORPHOGENETIC PROTEIN; BRAIN-STEM GLIOMAS; CELL-PROLIFERATION; ID2 EXPRESSION; HISTONE H3.3; CANCER; GENES; DIFFERENTIATION; FEATURES	Diffuse intrinsic pontine glioma (DIPG) is a fatal brain cancer that arises in the brainstem of children, with no effective treatment and near 100% fatality. The failure of most therapies can be attributed to the delicate location of these tumors and to the selection of therapies on the basis of assumptions that DIPGs are molecularly similar to adult disease. Recent studies have unraveled the unique genetic makeup of this brain cancer, with nearly 80% found to harbor a p.Lys27Met histone H3.3 or p.Lys27Met histone H3.1 alteration. However, DIPGs are still thought of as one disease, with limited understanding of the genetic drivers of these tumors. To understand what drives DIPGs, we integrated whole-genome sequencing with methylation, expression and copy number profiling, discovering that DIPGs comprise three molecularly distinct subgroups (H3-K27M, silent and MYCN) and uncovering a new recurrent activating mutation affecting the activin receptor gene ACVR1 in 20% of DIPGs. Mutations in ACVR1 were constitutively activating, leading to SMAD phosphorylation and increased expression of the downstream activin signaling targets ID1 and ID2. Our results highlight distinct molecular subgroups and novel therapeutic targets for this incurable pediatric cancer.	[Buczkowicz, Pawel; Hawkins, Cynthia] Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Buczkowicz, Pawel; Rakopoulos, Patricia; Pajovic, Sanja; Morrison, Andrew; Zuccaro, Jennifer; Agnihotri, Sameer; Barszczyk, Mark; Chornenkyy, Yevgen; Castelo-Branco, Pedro; Mangere, Joshua; Tabori, Uri; Ching, King; Huang, Annie; Hawkins, Cynthia] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Buczkowicz, Pawel; Rakopoulos, Patricia; Barszczyk, Mark; Chornenkyy, Yevgen; Hawkins, Cynthia] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hoeman, Christine; Cordero, Francisco] Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC USA; [Letourneau, Louis; Bourgey, Mathieu; Bourque, Guillaume; Montpetit, Alexandre] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Dzamba, Misko; Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Lewis, Peter; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Bouffet, Eric; Bartels, Ute; Tabori, Uri; Huang, Annie] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Taylor, Kathryn R.; Mackay, Alan; Jones, Chris] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Bendell, Anne E.] Childrens Hosp & Clin Minnesota, Dept Pediat Hematol Oncol, Minneapolis, MN USA; [Nazarian, Javad] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA; [Fangusaro, Jason R.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat Hematol, Chicago, IL USA; [Karajannis, Matthias A.] NYU, Langone Med Ctr, Inst Canc, Div Pediat Hematol Oncol & Neuropathol, New York, NY USA; [Foreman, Nicholas K.; Donson, Andrew] Childrens Hosp Colorado, Dept Pediat, Denver, CO USA; [Hegert, Julia V.; Smith, Amy] Arnold Palmer Hosp Children, Dept Pathol, Orlando, FL USA; [Chan, Jennifer; Lafay-Cousin, Lucy] Univ Calgary, Fac Med, Clark H Smith Brain Tumour Ctr, Calgary, AB, Canada; [Dunn, Sandra; Hukin, Juliette; Dunham, Chris] BC Childrens Hosp, Dept Pediat Neurol & Neurooncol, Vancouver, BC, Canada; [Scheinemann, Katrin] McMaster Childrens Hosp, Div Hematol Oncol, Hamilton, ON, Canada; [Michaud, Jean] Childrens Hosp Eastern Ontario, Dept Pathol & Lab Med, Ottawa, ON K1H 8L1, Canada; [Zelcer, Shayna; Ramsay, David] Childrens Hosp London, Hlth Sci Ctr, Dept Hematol Oncol, London, ON, Canada; [Cain, Jason] Monash Inst Med Res, Monash Med Ctr, Clayton, Vic, Australia; [Brennan, Cameron; Souweidane, Mark M.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Brennan, Cameron; Souweidane, Mark M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Brudno, Michael] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Duke University; McGill University; University of Toronto; Rockefeller University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Children's Hospitals & Clinics of Minnesota; Children's National Health System; Ann & Robert H. Lurie Children's Hospital of Chicago; New York University; NYU Langone Medical Center; Children's Hospital Colorado; University of Calgary; BC Childrens Hospital; University of British Columbia; McMaster University; University of Ottawa; Children's Hospital of Eastern Ontario; London Health Sciences Centre; University of Manitoba; Children's Hospital Research Institute of Manitoba; Western University (University of Western Ontario); Monash University; Cornell University; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hawkins, C (corresponding author), Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada.	oren.becher@duke.edu; cynthia.hawkins@sickkids.ca	Bouffet, Eric/AAB-8999-2020; Becher, Oren/AAI-7495-2020; Brennan, Cameron/R-7082-2019; Karajannis, Matthias A/H-8845-2019; Jones, Chris/ABE-6059-2021; AGNIHOTRI, SAMEER/HHS-2255-2022; Bourque, Guillaume/AFR-2927-2022	Brennan, Cameron/0000-0003-4064-8891; Karajannis, Matthias A/0000-0002-7151-6528; Jones, Chris/0000-0001-8118-2296; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Bourque, Guillaume/0000-0002-3933-9656; Tabori, Uri/0000-0002-5019-2683; Lewis, Peter/0000-0002-9816-7823; Foreman, Nicholas/0000-0003-4848-4801; Hukin, Juliette/0000-0002-8727-8456; Dunham, Christopher/0000-0002-6244-0584; Nazarian, Javad/0000-0002-1951-9828; Becher, Oren/0000-0003-4016-8492; Bourgey, Mathieu/0000-0002-8432-834X	Canadian Institutes of Health Research (CIHR) [MOP 115004]; Genome Canada/CIHR; Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research); US Department of Defense; Pediatric Brain Tumor Foundation; National Health Service (NHS); Stavros Niarchos Foundation; National Center for Research Resources [UL1TR000038]; US National Institutes of Health; National Cancer Institute [5P30CA016087-32]; Genome Canada/CIHR joint ATID Competition; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014236, P30CA060553, P30CA008748, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada/CIHR; Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research)(Canadian Institutes of Health Research (CIHR)); US Department of Defense(United States Department of Defense); Pediatric Brain Tumor Foundation; National Health Service (NHS); Stavros Niarchos Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genome Canada/CIHR joint ATID Competition; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank all of the patients and families for donating tissue for this research. This work was supported by the Canadian Institutes of Health Research (CIHR, MOP 115004) and was funded in part by a Genome Canada/CIHR grant (cofunding from Genome BC, Genome Quebec, CIHR-ICR (Institute for Cancer Research) and C17, through the Genome Canada/CIHR joint ATID Competition (project title: The Canadian Paediatric Cancer Genome Consortium (CPCGC): Translating Next-Generation Sequencing Technologies into Improved Therapies for High-Risk Childhood Cancer)). P.B. is a recipient of a CIHR Doctoral Frederick Banting and Charles Best Canada Graduate Scholarships award. O.B. is a Damon Runyon Clinical Investigator and is supported by the US Department of Defense and the Pediatric Brain Tumor Foundation. C.J., A. Mackay and K.R.T. acknowledge National Health Service (NHS) funding to the Biomedical Research Centre and support from the Stavros Niarchos Foundation. Sample collection for M.A.K. and D.Z. was supported in part by grant UL1TR000038 from the National Center for Research Resources, US National Institutes of Health and by grant 5P30CA016087-32 from the National Cancer Institute.	Buczkowicz P, 2013, BRAIN PATHOL, V23, P244, DOI 10.1111/j.1750-3639.2012.00633.x; Chen XS, 2012, J NEUROSCI RES, V90, P925, DOI 10.1002/jnr.22826; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Freeman CR, 1999, CHILD NERV SYST, V15, P545, DOI 10.1007/s003810050542; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herbert Brittney-Shea, 2003, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1806s20; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurooka H, 2012, BIOCHEM BIOPH RES CO, V420, P281, DOI 10.1016/j.bbrc.2012.02.150; Liu Z, 2012, ACTA BIOCH BIOPH SIN, V44, P503, DOI 10.1093/abbs/gms030; MARIA BL, 1993, J CHILD NEUROL, V8, P112, DOI 10.1177/088307389300800203; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Petrie KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005005; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shin M, 2013, J BONE MINER METAB, V31, P34, DOI 10.1007/s00774-012-0381-1; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; STILLER CA, 1994, BRIT MED J, V309, P1612, DOI 10.1136/bmj.309.6969.1612; Wazir U, 2013, ANTICANCER RES, V33, P2179; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	24	392	404	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					451	456		10.1038/ng.2936	http://dx.doi.org/10.1038/ng.2936			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705254	Green Accepted, Green Submitted			2022-12-25	WOS:000335422900010
J	Marchant, DJ; Bellac, CL; Moraes, TJ; Wadsworth, SJ; Dufour, A; Butler, GS; Bilawchuk, LM; Hendry, RG; Robertson, AG; Cheung, CT; Ng, J; Ang, L; Luo, ZS; Heilbron, K; Norris, MJ; Duan, WM; Bucyk, T; Karpov, A; Devel, L; Georgiadis, D; Hegele, RG; Luo, HL; Granville, DJ; Dive, V; McManus, BM; Overall, CM				Marchant, David J.; Bellac, Caroline L.; Moraes, Theo J.; Wadsworth, Samuel J.; Dufour, Antoine; Butler, Georgina S.; Bilawchuk, Leanne M.; Hendry, Reid G.; Robertson, A. Gordon; Cheung, Caroline T.; Ng, Julie; Ang, Lisa; Luo, Zongshu; Heilbron, Karl; Norris, Michael J.; Duan, Wenming; Bucyk, Taylor; Karpov, Andrei; Devel, Laurent; Georgiadis, Dimitris; Hegele, Richard G.; Luo, Honglin; Granville, David J.; Dive, Vincent; McManus, Bruce M.; Overall, Christopher M.			A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity	NATURE MEDICINE			English	Article							MACROPHAGE; INFLAMMATION; INHIBITORS; CLEAVAGE; OPINION; VIRUSES; ALPHA	Interferon-alpha (IFN-alpha) is essential for antiviral immunity, but in the absence of matrix metalloproteinase-12 (MMP-12) or I kappa B alpha (encoded by NFKBIA) we show that IFN-alpha is retained in the cytosol of virus-infected cells and is not secreted. Our findings suggest that activated I kappa B alpha mediates the export of IFN-alpha from virus-infected cells and that the inability of cells in Mmp12(-/-) but not wild-type mice to express I kappa B alpha and thus export IFN-alpha makes coxsackievirus type B3 infection lethal and renders respiratory syncytial virus more pathogenic. We show here that after macrophage secretion, MMP-12 is transported into virus-infected cells. In He La cells MMP-12 is also translocated to the nucleus, where it binds to the NFKBIA promoter, driving transcription. We also identified dual-regulated substrates that are repressed both by MMP-12 binding to the substrate's gene exons and by MMP-12-mediated cleavage of the substrate protein itself. Whereas intracellular MMP-12 mediates NFKBIA transcription, leading to IFN-alpha secretion and host protection, extracellular MMP-12 cleaves off the IFN-alpha receptor 2 binding site of systemic IFN-alpha, preventing an unchecked immune response. Consistent with an unexpected role for MMP-12 in clearing systemic IFN-alpha, treatment of coxsackievirus type B3-infected wild-type mice with a membrane-impermeable MMP-12 inhibitor elevates systemic IFN-alpha levels and reduces viral replication in pancreas while sparing intracellular MMP-12. These findings suggest that inhibiting extracellular MMP-12 could be a new avenue for the development of antiviral treatments.	[Marchant, David J.; Wadsworth, Samuel J.; Cheung, Caroline T.; Ng, Julie; Ang, Lisa; Luo, Zongshu; Heilbron, Karl; Karpov, Andrei; Luo, Honglin; Granville, David J.; McManus, Bruce M.] Univ British Columbia, Dept Pathol & Lab Med, UBC James Hogg Res Ctr, Inst Heart Lung Hlth,St Pauls Hosp Providence Hlt, Vancouver, BC V5Z 1M9, Canada; [Marchant, David J.; Bilawchuk, Leanne M.; Hendry, Reid G.; Bucyk, Taylor] Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Bellac, Caroline L.; Dufour, Antoine; Butler, Georgina S.; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Bellac, Caroline L.; Dufour, Antoine; Butler, Georgina S.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Bellac, Caroline L.; Dufour, Antoine; Butler, Georgina S.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Inst Life Sci, Fac Dent, Vancouver, BC V5Z 1M9, Canada; [Moraes, Theo J.; Norris, Michael J.; Duan, Wenming; Hegele, Richard G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Robertson, A. Gordon] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Devel, Laurent; Georgiadis, Dimitris; Dive, Vincent] Commissariat Energie Atom, Labex LERMIT, Serv Ingn Mol Prot, Gif Sur Yvette, France	St. Paul's Hospital; University of British Columbia; University of Alberta; University of British Columbia; University of British Columbia; University of British Columbia; University of Toronto; British Columbia Cancer Agency; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	McManus, BM (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, UBC James Hogg Res Ctr, Inst Heart Lung Hlth,St Pauls Hosp Providence Hlt, Vancouver, BC V5Z 1M9, Canada.	bruce.mcmanus@hli.ubc.ca; chris.overall@ubc.ca	Dufour, Antoine/AAB-7886-2019; Georgiadis, Dimitris/AAB-1550-2020; Butler, Georgina/GQP-7553-2022; Moraes, Theo/CAJ-3254-2022	Butler, Georgina/0000-0003-1172-1578; Moraes, Theo/0000-0001-9968-6601; Hegele, Richard/0000-0003-1073-8044; Ng, Julie/0000-0003-0490-208X	Canadian Institutes of Health Research [08-0369, MOP-37937, MOP-111055]; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Canada Research Chair in Viral Pathogenesis; US Myocarditis Foundation; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Canada Research Chair in Metalloproteinase Proteomics and Systems Biology; Genome Canada/British Columbia; Networks of Centres of Excellence-CECR Centre of Excellence for Prevention of Organ Failure	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Canada Research Chair in Viral Pathogenesis; US Myocarditis Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Canada Research Chair in Metalloproteinase Proteomics and Systems Biology(Canada Research Chairs); Genome Canada/British Columbia(Genome Canada); Networks of Centres of Excellence-CECR Centre of Excellence for Prevention of Organ Failure	We thank C. Smits at St. Paul's Hospital for technical assistance and expert advice regarding the humane care of animal models used in this study. We thank T. Buroker at Seattle Children's Hospital for I kappa B alpha plasmid promoter constructs and A. Hoffmann at the University of California-San Diego for Nfkbia<SUP>-/-</SUP> cells and advice. HL1 cardiomyocytes were a gift from W. Claycomb (Louisiana State University). This work was supported by Canadian Institutes of Health Research grants on MMPs during viral infection (no. 08-0369 (B.M.M., D.J.M.)) and on MMPs in inflammation (nos. MOP-37937 and MOP-111055 (C.M.O.)) and an Infrastructure Grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research) and by the British Columbia Proteomics Network (C.M.O.); salary support for D.J.M. is provided by a Canada Research Chair in Viral Pathogenesis and is supported by research fellowships from the US Myocarditis Foundation and the Heart and Stroke Foundation of Canada; H.L. is funded by the Heart and Stroke Foundation of British Columbia and Yukon; salary support for C.M.O. is provided by a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology B.M.M. is funded by the Heart and Stroke Foundation of British Columbia and Yukon, Genome Canada/British Columbia and the Networks of Centres of Excellence-CECR Centre of Excellence for Prevention of Organ Failure.	Belvisi MG, 2003, INFLAMM RES, V52, P95, DOI 10.1007/s000110300020; BRUNNER KT, 1960, J IMMUNOL, V85, P99; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Garmaroudi FS, 2010, P NATL ACAD SCI USA, V107, P17053, DOI 10.1073/pnas.1006478107; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Koyanagi S, 1997, J PHARMACOL EXP THER, V283, P259; Lambert AL, 2003, TOXICOL SCI, V72, P339, DOI 10.1093/toxsci/kfg032; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shimizu-Hirota R, 2012, GENE DEV, V26, P395, DOI 10.1101/gad.178749.111; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488	28	175	180	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					497	506		10.1038/nm.3508	http://dx.doi.org/10.1038/nm.3508			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24784232				2022-12-25	WOS:000335710700020
J	Behjati, S; Tarpey, PS; Sheldon, H; Martincorena, I; Van Loo, P; Gundem, G; Wedge, DC; Ramakrishna, M; Cooke, SL; Pillay, N; Vollan, HKM; Papaemmanuil, E; Koss, H; Bunney, TD; Hardy, C; Joseph, OR; Martin, S; Mudie, L; Butler, A; Teague, JW; Patil, M; Steers, G; Cao, Y; Gumbs, C; Ingram, D; Lazar, AJ; Little, L; Mahadeshwar, H; Protopopov, A; Al Sannaa, GA; Seth, S; Song, XZ; Tang, JB; Zhang, JH; Ravi, V; Torres, KE; Khatri, B; Halai, D; Roxanis, I; Baumhoer, D; Tirabosco, R; Amary, MF; Boshoff, C; McDermott, U; Katan, M; Stratton, MR; Futreal, PA; Flanagan, AM; Harris, A; Campbell, PJ				Behjati, Sam; Tarpey, Patrick S.; Sheldon, Helen; Martincorena, Inigo; Van Loo, Peter; Gundem, Gunes; Wedge, David C.; Ramakrishna, Manasa; Cooke, Susanna L.; Pillay, Nischalan; Vollan, Hans Kristian M.; Papaemmanuil, Elli; Koss, Hans; Bunney, Tom D.; Hardy, Claire; Joseph, Olivia R.; Martin, Sancha; Mudie, Laura; Butler, Adam; Teague, Jon W.; Patil, Meena; Steers, Graham; Cao, Yu; Gumbs, Curtis; Ingram, Davis; Lazar, Alexander J.; Little, Latasha; Mahadeshwar, Harshad; Protopopov, Alexei; Al Sannaa, Ghadah A.; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zhang, Jianhua; Ravi, Vinod; Torres, Keila E.; Khatri, Bhavisha; Halai, Dina; Roxanis, Ioannis; Baumhoer, Daniel; Tirabosco, Roberto; Amary, M. Fernanda; Boshoff, Chris; McDermott, Ultan; Katan, Matilda; Stratton, Michael R.; Futreal, P. Andrew; Flanagan, Adrienne M.; Harris, Adrian; Campbell, Peter J.			Recurrent PTPRB and PLCG1 mutations in angiosarcoma	NATURE GENETICS			English	Article							PHOSPHATASE VE-PTP; TYROSINE PHOSPHATASE; SOMATIC MUTATIONS; CELL TUMOR; CADHERIN; REVEALS; VASCULOGENESIS	Angiosarcoma is an aggressive malignancy that arises spontaneously or secondarily to ionizing radiation or chronic lymphoedema(1). Previous work has identified aberrant angiogenesis, including occasional somatic mutations in angiogenesis signaling genes, as a key driver of angiosarcoma(1). Here we employed whole-genome, whole-exome and targeted sequencing to study the somatic changes underpinning primary and secondary angiosarcoma. We identified recurrent mutations in two genes, PTPRB and PLCG1, which are intimately linked to angiogenesis. The endothelial phosphatase PTPRB, a negative regulator of vascular growth factor tyrosine kinases, harbored predominantly truncating mutations in 10 of 39 tumors (26%). PLCG1, a signal transducer of tyrosine kinases, encoded a recurrent, likely activating p. Arg707Gln missense variant in 3 of 34 cases (9%). Overall, 15 of 39 tumors (38%) harbored at least one driver mutation in angiogenesis signaling genes. Our findings inform and reinforce current therapeutic efforts to target angiogenesis signaling in angiosarcoma.	[Behjati, Sam; Tarpey, Patrick S.; Martincorena, Inigo; Van Loo, Peter; Gundem, Gunes; Wedge, David C.; Ramakrishna, Manasa; Cooke, Susanna L.; Vollan, Hans Kristian M.; Papaemmanuil, Elli; Hardy, Claire; Joseph, Olivia R.; Martin, Sancha; Mudie, Laura; Butler, Adam; Teague, Jon W.; McDermott, Ultan; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge, England; [Sheldon, Helen; Harris, Adrian] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Louvain, Belgium; [Pillay, Nischalan; Khatri, Bhavisha; Halai, Dina; Tirabosco, Roberto; Amary, M. Fernanda; Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, NHS Trust, Stanmore HA7 4LP, Middx, England; [Pillay, Nischalan; Boshoff, Chris; Flanagan, Adrienne M.] UCL, Inst Canc, London, England; [Vollan, Hans Kristian M.] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Vollan, Hans Kristian M.] Univ Oslo, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Koss, Hans; Bunney, Tom D.; Katan, Matilda] UCL, Div Biosci, Inst Struct & Mol Biol, London, England; [Koss, Hans] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Patil, Meena; Steers, Graham; Roxanis, Ioannis; Harris, Adrian] John Radcliffe Hosp, Dept Pathol, Oxford OX3 9DU, England; [Cao, Yu; Gumbs, Curtis; Ingram, Davis; Lazar, Alexander J.; Little, Latasha; Mahadeshwar, Harshad; Protopopov, Alexei; Al Sannaa, Ghadah A.; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zhang, Jianhua; Ravi, Vinod; Torres, Keila E.; Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Baumhoer, Daniel] Univ Basel Hosp, Inst Pathol, Inst Appl Canc Sci, Bone Tumour Reference Ctr, CH-4031 Basel, Switzerland; [Boshoff, Chris] Pfizer Oncol, La Jolla, CA USA; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Oxford; Flanders Institute for Biotechnology (VIB); KU Leuven; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Oslo; University of Oslo; University of London; Birkbeck University London; University College London; MRC National Institute for Medical Research; University of Oxford; University of Texas System; UTMD Anderson Cancer Center; University of Basel; Pfizer; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton, England.	pc8@sanger.ac.uk	Amary, Fernanda/AAI-7339-2020; Seth, Sahil/I-5809-2019; Koss, Hans/AAN-2816-2021; Harris, Adrian L/ABA-3343-2020; Wedge, David/AAC-4977-2021; Lazar, Alexander J/A-3416-2008	Seth, Sahil/0000-0003-4579-3959; Harris, Adrian L/0000-0003-1376-8409; Lazar, Alexander J/0000-0002-6395-4499; Flanagan, Adrienne/0000-0002-2832-1303; Martin, Sancha/0000-0001-6213-5259; Wedge, David/0000-0002-7572-3196; Joseph, Olivia/0000-0002-5751-2002; Martincorena, Inigo/0000-0003-1122-4416; Bunney, Tom/0000-0002-0281-8813; Pillay, Nischalan/0000-0003-0579-4105; Behjati, Sam/0000-0002-6600-7665; Koss, Hans/0000-0003-0493-169X; Torres, Keila E/0000-0002-1855-0989; McDermott, Ultan/0000-0001-9032-4700; Sheldon, Helen/0000-0002-0945-5496; Van Loo, Peter/0000-0003-0292-1949	Wellcome Trust [077012/Z/05/Z]; National Institute for Health Research; University College London Hospital Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre; Cancer Research UK; Oxford Biomedical Research Centre; Breast Cancer Research Foundation; Wellcome Trust Senior Clinical Research Fellowship [WT088340MA]; Norwegian Radium Hospital's Foundation; Wellcome Trust PhD Programme for Clinicians; Cancer Prevention Research Institute of Texas and the Welch Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, K08CA160443] Funding Source: NIH RePORTER; Cancer Research UK [11359, 16567] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospital Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); Oxford Biomedical Research Centre; Breast Cancer Research Foundation; Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); Norwegian Radium Hospital's Foundation; Wellcome Trust PhD Programme for Clinicians(Wellcome Trust); Cancer Prevention Research Institute of Texas and the Welch Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank M. Taylor and R. Leek for sample preparation. We are grateful to the patients for participating in the research and to the clinicians and support staff involved in their care from the Oxford University Hospitals NHS Trust, the University of Texas MD Anderson Cancer Center Sarcoma Program and the London Sarcoma Service. This work was supported by funding from the Wellcome Trust (grant reference 077012/Z/05/Z). The material was obtained from the Royal National Orthopaedic Hospital Musculoskeletal Research Program and Biobank and from the Oxford Radcliffe Biobank. Support was provided to A. M. F. by the National Institute for Health Research, the University College London Hospital Biomedical Research Centre and the Cancer Research UK University College London Experimental Cancer Medicine Centre. Support was provided to A. H. by Cancer Research UK, the Oxford Biomedical Research Centre and the Breast Cancer Research Foundation. P. J. C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). P. V. L. is a postdoctoral researcher of the Research Foundation-Flanders (FWO). H. K. M. V. is supported by the Norwegian Radium Hospital's Foundation. S. B. is funded through the Wellcome Trust PhD Programme for Clinicians. P. A. F. is supported by the Cancer Prevention Research Institute of Texas and the Welch Foundation.	Antonescu CR, 2009, CANCER RES, V69, P7175, DOI 10.1158/0008-5472.CAN-09-2068; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Carra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051245; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Everett KL, 2009, J BIOL CHEM, V284, P23083, DOI 10.1074/jbc.M109.019265; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Guo TH, 2011, GENE CHROMOSOME CANC, V50, P25, DOI 10.1002/gcc.20827; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Z, 2009, P NATL ACAD SCI USA, V106, P22399, DOI 10.1073/pnas.0911189106; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	31	176	183	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					376	+		10.1038/ng.2921	http://dx.doi.org/10.1038/ng.2921			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24633157	Green Submitted, Green Accepted			2022-12-25	WOS:000334510100014
J	Liang, Q; Dexheimer, TS; Zhang, P; Rosenthal, AS; Villamil, MA; You, CJ; Zhang, QT; Chen, JJ; Ott, CA; Sun, HM; Luci, DK; Yuan, BF; Simeonov, A; Jadhav, A; Xiao, H; Wang, YS; Maloney, DJ; Zhuang, ZH				Liang, Qin; Dexheimer, Thomas S.; Zhang, Ping; Rosenthal, Andrew S.; Villamil, Mark A.; You, Changjun; Zhang, Qiuting; Chen, Junjun; Ott, Christine A.; Sun, Hongmao; Luci, Diane K.; Yuan, Bifeng; Simeonov, Anton; Jadhav, Ajit; Xiao, Hui; Wang, Yinsheng; Maloney, David J.; Zhuang, Zhihao			A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEAR ANTIGEN PCNA; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; UBIQUITIN CONJUGATION; TRANSLESION SYNTHESIS; CISPLATIN RESISTANCE; MAMMALIAN-CELLS; POL-ETA; REPAIR; CANCER	Protein ubiquitination and deubiquitination are central to the control of a large number of cellular pathways and signaling networks in eukaryotes. Although the essential roles of ubiquitination have been established in the eukaryotic DNA damage response, the deubiquitination process remains poorly defined. Chemical probes that perturb the activity of deubiquitinases (DUBs) are needed to characterize the cellular function of deubiquitination. Here we report ML323 (2), a highly potent inhibitor of the USP1-UAF1 deubiquitinase complex with excellent selectivity against human DUBs, deSUMOylase, deneddylase and unrelated proteases. Using ML323, we interrogated deubiquitination in the cellular response to UV-and cisplatin-induced DNA damage and revealed new insights into the requirement of deubiquitination in the DNA translesion synthesis and Fanconi anemia pathways. Moreover, ML323 potentiates cisplatin cytotoxicity in non-small cell lung cancer and osteosarcoma cells. Our findings point to USP1-UAF1 as a key regulator of the DNA damage response and a target for overcoming resistance to the platinum-based anticancer drugs.	[Liang, Qin; Zhang, Ping; Villamil, Mark A.; Chen, Junjun; Ott, Christine A.; Zhuang, Zhihao] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Dexheimer, Thomas S.; Rosenthal, Andrew S.; Sun, Hongmao; Luci, Diane K.; Simeonov, Anton; Jadhav, Ajit; Maloney, David J.] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [You, Changjun; Yuan, Bifeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Zhang, Qiuting] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Xiao, Hui] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10467 USA	University of Delaware; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of California System; University of California Riverside; Nanchang University; Yeshiva University; Albert Einstein College of Medicine	Zhuang, ZH (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	maloneyd@mail.nih.gov; zzhuang@udel.edu	Yuan, Bi-Feng/K-5803-2013; liang, qin/C-8284-2016; 高, 雨莉/HGU-8187-2022	Yuan, Bi-Feng/0000-0001-5223-4659; Jadhav, Ajit/0000-0001-7955-1451; You, Changjun/0000-0003-4301-2098	US National Institutes of Health (NIH) [R03DA030552]; National Center for Advancing Translational Sciences; NIH [R01GM097468, R01DK082779, T32GM008550]; Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research [U54MH084681]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000067, ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097468, T32GM008550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA030552] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Cordeiro-Stone (University of North Carolina at Chapel Hill) for xeroderma pigmentosum variant (XPV) human fibroblasts GM02359-hTERT (XP115LO) and Pol eta-complemented GM02359-hTERT (XPV + Pol eta) and M. Jasin ( Memorial Sloan-Kettering Cancer Center) for DR-GFP U2OS cells. We also thank C. Arrowsmith (University of Toronto and Ontario Cancer Institute) for the USP21 plasmid; A. Tencer for assistance with protein purification; S. Michael and R. Jones for automation support; P. Shinn and D. van Leer for assistance with compound management; and W. Leister, H. Baker, C. Leclair and E. Fernandez for analytical chemistry and compound purification support. This work was supported by US National Institutes of Health (NIH) grant R03DA030552 and in part by NIH grant R01GM097468 to Z.Z. C.A.O. was supported by NIH training grant T32GM008550. Work in the laboratory of Y.W. was supported by NIH grant R01DK082779. T.S.D., A.S.R., D.K.L., A.S., A.J. and D.J.M. were supported by the intramural research program of the National Center for Advancing Translational Sciences and the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research (U54MH084681).	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bell DW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002245; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brabec V, 2002, DRUG RESIST UPDATE, V5, P147, DOI 10.1016/S1368-7646(02)00047-X; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Guervilly JH, 2011, HUM MOL GENET, V20, P2171, DOI 10.1093/hmg/ddr103; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Khrapunovich-Baine M, 2009, BIOCHEMISTRY-US, V48, P11664, DOI 10.1021/bi901351q; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park E, 2013, MOL CELL, V50, P908, DOI 10.1016/j.molcel.2013.05.017; POST RM, 1980, PSYCHOPHARMACOLOGY, V67, P297, DOI 10.1007/BF00431272; Prage EB, 2011, BIOCHEMISTRY-US, V50, P7684, DOI 10.1021/bi2010448; Renaud E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053693; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Takata M, 2009, MUTAT RES-FUND MOL M, V668, P92, DOI 10.1016/j.mrfmmm.2008.12.012; Taylor ER, 2003, VIROLOGY, V315, P103, DOI 10.1016/S0042-6822(03)00588-9; Villamil MA, 2012, BIOCHEMISTRY-US, V51, P9112, DOI 10.1021/bi300845s; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Zhuang ZH, 2008, P NATL ACAD SCI USA, V105, P5361, DOI 10.1073/pnas.0801310105	59	158	162	3	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					298	+		10.1038/NCHEMBIO.1455	http://dx.doi.org/10.1038/NCHEMBIO.1455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24531842	Green Accepted			2022-12-25	WOS:000333172900013
J	Rongvaux, A; Willinger, T; Martinek, J; Strowig, T; Gearty, SV; Teichmann, LL; Saito, Y; Marches, F; Halene, S; Palucka, AK; Manz, MG; Flavell, RA				Rongvaux, Anthony; Willinger, Tim; Martinek, Jan; Strowig, Till; Gearty, Sofia V.; Teichmann, Lino L.; Saito, Yasuyuki; Marches, Florentina; Halene, Stephanie; Palucka, A. Karolina; Manz, Markus G.; Flavell, Richard A.			Development and function of human innate immune cells in a humanized mouse model	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; TUMOR-ASSOCIATED MACROPHAGES; REGULATORY PROTEIN ALPHA; LYMPHOID-SYSTEM MICE; NATURAL-KILLER-CELLS; IN-VIVO; TRANSGENIC EXPRESSION; RECONSTITUTION; ENGRAFTMENT; HOMEOSTASIS	Mice repopulated with human hematopoietic cells are a powerful tool for the study of human hematopoiesis and immune function in vivo. However, existing humanized mouse models cannot support development of human innate immune cells, including myeloid cells and natural killer (NK) cells. Here we describe two mouse strains called MITRG and MISTRG, in which human versions of four genes encoding cytokines important for innate immune cell development are knocked into their respective mouse loci. The human cytokines support the development and function of monocytes, macrophages and NK cells derived from human fetal liver or adult CD34(+) progenitor cells injected into the mice. Human macrophages infiltrated a human tumor xenograft in MITRG and MISTRG mice in a manner resembling that observed in tumors obtained from human patients. This humanized mouse model may be used to model the human immune system in scenarios of health and pathology, and may enable evaluation of therapeutic candidates in an in vivo setting relevant to human physiology.	[Rongvaux, Anthony; Willinger, Tim; Strowig, Till; Gearty, Sofia V.; Flavell, Richard A.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Martinek, Jan; Marches, Florentina; Palucka, A. Karolina] Baylor Inst Immunol Res, Dallas, TX USA; [Martinek, Jan] Baylor Univ, Biomed Studies Program, Waco, TX 76798 USA; [Teichmann, Lino L.] Yale Univ, Dept Lab Med, New Haven, CT USA; [Teichmann, Lino L.] Univ Hosp Bonn, Dept Med 3, Bonn, Germany; [Saito, Yasuyuki] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Halene, Stephanie] Yale Univ, Dept Internal Med, Sect Hematol, New Haven, CT USA; [Halene, Stephanie] Yale Univ, Yale Comprehens Canc Ctr, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Baylor Scott & White Health; Baylor University; Yale University; University of Bonn; University of Zurich; University Zurich Hospital; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA.	markus.manz@usz.ch; richard.flavell@yale.edu	Saito, Yasuyuki/AAD-1436-2019; Saito, Yasuyuki/C-2541-2015; Teichmann, Lino/GQA-4636-2022	Saito, Yasuyuki/0000-0002-9291-1383; Saito, Yasuyuki/0000-0002-9291-1383; Strowig, Till/0000-0003-0185-1459; Willinger, TIM/0000-0002-8720-7199; Manz, Markus/0000-0002-4676-7931; Teichmann, Lino/0000-0001-9489-7282; Gearty, Sofia/0000-0001-8633-3663	Bill and Melinda Gates Foundation; US National Institutes of Health [CA156689, CA129350, CA84512, CA140602]; University of Zurich Clinical Research Program; Juvenile Diabetes Research Foundation; Connecticut Stem Cell Research Grants Program; Baylor Health Care System Foundation; American Cancer Society [58-012-54]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA140602, R01CA129350, R01CA156689, P01CA084512] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Zurich Clinical Research Program; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Connecticut Stem Cell Research Grants Program; Baylor Health Care System Foundation; American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Yancopoulos, D. Valenzuela, A. Murphy and W. Auerbach at Regeneron Pharmaceuticals who generated, in collaboration with our groups, the individual knock-in alleles combined in MISTRG, J. Alderman for managerial support, A.M. Franco, P. Ranney, C. Weibel, S. Patel and M. Santhanakrishnan for technical assistance, G. Lyon for cell sorting and C. Lieber for manuscript submission. This work was supported by the Bill and Melinda Gates Foundation and US National Institutes of Health CA156689 (to R. A. F. and M.G.M.), CA129350, CA84512, CA140602 (to A.K.P.); the University of Zurich Clinical Research Program (to M.G.M.); the Juvenile Diabetes Research Foundation and the Connecticut Stem Cell Research Grants Program (to R.A.F.); the Baylor Health Care System Foundation (to A.K.P.); and an Institutional Research Grant 58-012-54 from the American Cancer Society (to S.H.). T.S. was supported by the Leukemia and Lymphoma Society. The Me290 cell line was established at the Ludwig Cancer Institute in Lausanne.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Drake AC, 2012, CELL MOL IMMUNOL, V9, P215, DOI 10.1038/cmi.2012.6; Gille C, 2012, HUM IMMUNOL, V73, P346, DOI 10.1016/j.humimm.2012.01.006; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ito R, 2013, J IMMUNOL, V191, P2890, DOI 10.4049/jimmunol.1203543; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kandalaft LE, 2011, CURR TOP MICROBIOL, V344, P129, DOI 10.1007/82_2010_95; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Li Y, 2013, J IMMUNOL, V191, P3192, DOI 10.4049/jimmunol.1300742; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rathinam C, 2011, BLOOD, V118, P3119, DOI 10.1182/blood-2010-12-326926; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Strowig T, 2010, BLOOD, V116, P4158, DOI 10.1182/blood-2010-02-270678; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Valmori D, 1998, J IMMUNOL, V160, P1750; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang XL, 2012, J CLIN INVEST, V122, P3888, DOI 10.1172/JCI64397; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3	50	452	472	8	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					364	U230		10.1038/nbt.2858	http://dx.doi.org/10.1038/nbt.2858			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633240	Green Accepted			2022-12-25	WOS:000334340800021
J	Fu, YF; Sander, JD; Reyon, D; Cascio, VM; Joung, JK				Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith			Improving CRISPR-Cas nuclease specificity using truncated guide RNAs	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER TARGETER; HUMAN-CELLS; TRANSCRIPTION FACTORS; HUMAN GENOME; TOOL; NICKASES; SYSTEMS; NICKING; GENES; ZIFIT	Clustered, regularly interspaced, short palindromic repeat (CRISPR) RNA-guided nucleases (RGNs) are highly efficient genome editing tools(1-3). CRISPR-associated 9 (Cas9) RGNs are directed to genomic loci by guide RNAs (gRNAs) containing 20 nucleotides that are complementary to a target DNA sequence. However, RGNs can induce mutations at sites that differ by as many as five nucleotides from the intended target(4-6). Here we report that truncated gRNAs, with shorter regions of target complementarity <20 nucleotides in length, can decrease undesired mutagenesis at some off-target sites by 5,000-fold or more without sacrificing on-target genome editing efficiencies. In addition, use of truncated gRNAs can further reduce off-target effects induced by pairs of Cas9 variants that nick DNA (paired nickases). Our results delineate a simple, effective strategy to improve the specificities of Cas9 nucleases or paired nickases.	[Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jsander@alumni.iastate.edu; jjoung@mgh.harvard.edu	Reyon, Deepak/HCH-3183-2022		National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R01 GM088040, NIH P50 HG005550]; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory; US Army-Research Office [W911NF-11-2-0056]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army-Research Office; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Maeder, S. Tsai and J. Angstman for helpful discussions and comments on the manuscript and J. Foden for technical assistance. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM088040, NIH P50 HG005550, and the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award. This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army-Research Office under grant number W911NF-11-2-0056.	Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	28	1270	1549	14	468	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					279	284		10.1038/nbt.2808	http://dx.doi.org/10.1038/nbt.2808			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24463574	Green Submitted, Green Accepted			2022-12-25	WOS:000332819800027
J	Bonning, BC; Pal, N; Liu, SJ; Wang, ZH; Sivakumar, S; Dixon, PM; King, GF; Miller, WA				Bonning, Bryony C.; Pal, Narinder; Liu, Sijun; Wang, Zhaohui; Sivakumar, S.; Dixon, Philip M.; King, Glenn F.; Miller, W. Allen			Toxin delivery by the coat protein of an aphid-vectored plant virus provides plant resistance to aphids	NATURE BIOTECHNOLOGY			English	Article							INSECTICIDAL NEUROTOXIN; BACILLUS-THURINGIENSIS; BT COTTON; TRANSMISSION; LUTEOVIRUSES; BACULOVIRUS; EXPRESSION; PARTICLES; VENOM; GENE	The sap-sucking insects (order Hemiptera), including aphids, planthoppers, whiteflies and stink bugs, present one of the greatest challenges for pest management in global agriculture. Insect neurotoxins offer an alternative to chemical insecticides for controlling these pests, but require delivery into the insect hemocoel. Here we use the coat protein of a luteovirus, an aphid-vectored plant virus, to deliver a spider-derived, insect-specific toxin that acts within the hemocoel. The luteovirid coat protein is sufficient for delivery of fused proteins into the hemocoel of pea aphids, Acyrthosiphon pisum, without virion assembly. We show that when four aphid pest species-A. pisum, Rhopalosiphum padi, Aphis glycines and Myzus persicae-feed on a recombinant coat protein-toxin fusion, either in an experimental membrane sachet or in transgenic Arabidopsis plants, they experience significant mortality. Aphids fed on these fusion proteins showed signs of neurotoxin-induced paralysis. Luteovirid coat protein-insect neurotoxin fusions represent a promising strategy for transgenic control of aphids and potentially other hemipteran pests.	[Bonning, Bryony C.; Pal, Narinder; Liu, Sijun; Sivakumar, S.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Wang, Zhaohui; Miller, W. Allen] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Dixon, Philip M.] Iowa State Univ, Dept Stat, Ames, IA USA; [King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Iowa State University; Iowa State University; Iowa State University; University of Queensland	Bonning, BC (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	bbonning@iastate.edu; wamiller@iastate.edu	King, Glenn F/J-5059-2012; Dixon, Philip Michael/I-4843-2019	King, Glenn F/0000-0002-2308-2200; Dixon, Philip Michael/0000-0002-1778-0686; Swaminathan, Sivakumar/0000-0003-3931-275X	USDA North Central Biotechnology Initiative [97-34340-3987]; USDA National Research Initiative [02-01280]; Australian Research Council [DP0774245]; Bayer Crop Science; Syngenta; DuPont Pioneer; Grow Iowa Values Funds; Iowa State University Plant Sciences Institute; Hatch Act; State of Iowa	USDA North Central Biotechnology Initiative; USDA National Research Initiative(United States Department of Agriculture (USDA)); Australian Research Council(Australian Research Council); Bayer Crop Science(Bayer AG); Syngenta(Syngenta); DuPont Pioneer; Grow Iowa Values Funds; Iowa State University Plant Sciences Institute; Hatch Act(United States Department of Agriculture (USDA)); State of Iowa	We thank R. Harrison, US Department of Agriculture (USDA), Beltsville, Maryland, for construction of the baculovirus expressing CP-GFP and for production of the PEMV coat protein antiserum. This work was supported by the USDA North Central Biotechnology Initiative grant number 97-34340-3987, USDA National Research Initiative grant number 02-01280, Australian Research Council Discovery Grant DP0774245, Bayer Crop Science, Syngenta, DuPont Pioneer, Grow Iowa Values Funds, Iowa State University Plant Sciences Institute, and by Hatch Act and State of Iowa funds. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture.	[Anonymous], 2013, Science, V341, P730, DOI 10.1126/science.341.6147.730; Bonning B.C., 2013, TRENDS BIOT IN PRESS; Chougule NP, 2012, TOXINS, V4, P405, DOI 10.3390/toxins4060405; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Crossley A.C., 1985, P487; Demler SA, 1997, J GEN VIROL, V78, P511, DOI 10.1099/0022-1317-78-3-511; FEBVAY G, 1988, CAN J ZOOL, V66, P2449, DOI 10.1139/z88-362; Fitches EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039389; Fitches EC, 2010, PEST MANAG SCI, V66, P74, DOI 10.1002/ps.1833; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; HUGHES PR, 1986, J INVERTEBR PATHOL, V48, P187, DOI 10.1016/0022-2011(86)90122-9; Jeffers LA, 2008, J INSECT PHYSIOL, V54, P319, DOI 10.1016/j.jinsphys.2007.10.009; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Lamb JW, 1996, J GEN VIROL, V77, P1349, DOI 10.1099/0022-1317-77-7-1349; *LEORA SOFTW POLO, 1987, US GUID PROB LOG AN; Li GP, 2010, ENVIRON ENTOMOL, V39, P1378, DOI 10.1603/EN09223; Li HR, 2011, J INVERTEBR PATHOL, V107, P69, DOI 10.1016/j.jip.2011.02.001; Liu SJ, 2009, ARCH VIROL, V154, P469, DOI 10.1007/s00705-009-0327-7; Liu SJ, 2006, J VIROL METHODS, V132, P174, DOI 10.1016/j.jviromet.2005.10.015; Locke M, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P687; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; Pal N, 2013, TOXICON, V70, P114, DOI 10.1016/j.toxicon.2013.04.015; Pennacchio F, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P269, DOI 10.1016/B978-0-12-384858-1.00022-9; Reavy B, 2002, ADV BOT RES, V36, P21, DOI 10.1016/S0065-2296(02)36057-9; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; SAS Institute, 2013, SAS STAT R 9 3 US GU; Schmidt N.R., 2010, MOL BIOL GENETICS LE, P307; Sivakumar S, 2009, VIRUS RES, V139, P54, DOI 10.1016/j.virusres.2008.10.002; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Tortiglione C, 2002, MOL BREEDING, V9, P159, DOI 10.1023/A:1019785914424; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x	37	48	49	0	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					102	+		10.1038/nbt.2753	http://dx.doi.org/10.1038/nbt.2753			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24316580				2022-12-25	WOS:000329513000025
J	Kim, DG; Lee, JY; Kwon, NH; Fang, PF; Zhang, Q; Wang, J; Young, NL; Guo, M; Cho, HY; Mushtaq, AU; Jeon, YH; Choi, JW; Han, JM; Kang, HW; Joo, JE; Hur, Y; Kang, W; Yang, H; Nam, DH; Lee, MS; Lee, JW; Kim, ES; Moon, A; Kim, K; Kim, D; Kang, EJ; Moon, Y; Rhee, KH; Han, BW; Yang, JS; Han, G; Yang, WS; Lee, C; Wang, MW; Kim, S				Kim, Dae Gyu; Lee, Jin Young; Kwon, Nam Hoon; Fang, Pengfei; Zhang, Qian; Wang, Jing; Young, Nicolas L.; Guo, Min; Cho, Hye Young; Mushtaq, Ameeq Ul; Jeon, Young Ho; Choi, Jin Woo; Han, Jung Min; Kang, Ho Woong; Joo, Jae Eun; Hur, Youn; Kang, Wonyoung; Yang, Heekyoung; Nam, Do-Hyun; Lee, Mi-Sook; Lee, Jung Weon; Kim, Eun-Sook; Moon, Aree; Kim, Kibom; Kim, Doyeun; Kang, Eun Joo; Moon, Youngji; Rhee, Kyung Hee; Han, Byung Woo; Yang, Jee Sun; Han, Gyoonhee; Yang, Won Suk; Lee, Cheolju; Wang, Ming-Wei; Kim, Sunghoon			Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction	NATURE CHEMICAL BIOLOGY			English	Article							ION-CYCLOTRON RESONANCE; MASS-SPECTROMETRY; SCATTERING SAXS; GENE-EXPRESSION; CELL INVASION; SYSTEM; CANCER; METASTASIS; CARCINOMA; PROTEINS	Lysyl-tRNA synthetase (KRS), a protein synthesis enzyme in the cytosol, relocates to the plasma membrane after a laminin signal and stabilizes a 67-kDa laminin receptor (67LR) that is implicated in cancer metastasis; however, its potential as an antimetastatic therapeutic target has not been explored. We found that the small compound BC-K-YH16899, which binds KRS, impinged on the interaction of KRS with 67LR and suppressed metastasis in three different mouse models. The compound inhibited the KRS-67LR interaction in two ways. First, it directly blocked the association between KRS and 67LR. Second, it suppressed the dynamic movement of the N-terminal extension of KRS and reduced membrane localization of KRS. However, it did not affect the catalytic activity of KRS. Our results suggest that specific modulation of a cancer-related KRS-67LR interaction may offer a way to control metastasis while avoiding the toxicities associated with inhibition of the normal functions of KRS.	[Kim, Dae Gyu; Lee, Jin Young; Kwon, Nam Hoon; Han, Jung Min; Kim, Kibom; Kim, Doyeun; Kang, Eun Joo; Moon, Youngji; Yang, Won Suk; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Kim, Dae Gyu; Lee, Jin Young; Kwon, Nam Hoon; Han, Jung Min; Lee, Mi-Sook; Lee, Jung Weon; Kim, Kibom; Kim, Doyeun; Rhee, Kyung Hee; Han, Byung Woo; Yang, Won Suk; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul, South Korea; [Fang, Pengfei; Wang, Jing; Guo, Min] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Zhang, Qian] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Young, Nicolas L.] Florida State Univ, Ion Cyclotron Resonance Program, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cho, Hye Young; Mushtaq, Ameeq Ul; Jeon, Young Ho] Korea Univ, Coll Pharm, Sejong, South Korea; [Choi, Jin Woo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Kang, Ho Woong; Joo, Jae Eun; Hur, Youn] Yuhan Res Inst, Yongin, South Korea; [Kang, Wonyoung; Yang, Heekyoung; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Kim, Eun-Sook; Moon, Aree] Duksung Womens Univ, Coll Pharm, Seoul, South Korea; [Han, Gyoonhee] Yonsei Univ, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea; [Lee, Cheolju] Korea Inst Sci & Technol, BRI, Seoul, South Korea; [Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [Kim, Sunghoon] Seoul Natl Univ, World Class Univ, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Scripps Research Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Korea University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Duksung Women's University; Yonsei University; Korea Institute of Science & Technology (KIST); Chinese Academy of Sciences; Seoul National University (SNU)	Kim, DG (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea.	sungkim@snu.ac.kr	Young, Nicolas/AAI-5242-2020; Kim, Sunghoon/AAE-8314-2020; Fang, Pengfei/O-3696-2015; Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Young, Nicolas/0000-0002-3323-2815; Fang, Pengfei/0000-0002-3448-5494; Lee, Jung Weon/0000-0003-2722-8200; Han, Jung Min/0000-0003-3372-7575; Mushtaq, Ameeq Ul/0000-0002-5636-2567; Wang, Jing/0000-0002-7566-1212; kim, sunghoon/0000-0002-1570-3230	Global Frontier Project [M1AXA002-20100029785, NRF-M1AXA002-2010-0029765, NRF-2012M3A6A4054271, NRF-2012-054237]; World Class University [R31-2008000- 10086-0]; Proteogenomic Research Program [2012M3A9B9036679]; National Research Foundation; Ministry of Education, Science and Technology of Korea [ROA-2012-0006262]; Ministry for Health and Welfare Affairs of Korea [A092255]; Gyeonggi Research Development Program; US National Institutes of Health [GM100136]; US National Science Foundation Division of Materials Research [DMR-11-57490]; Kimmel Scholar Award for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106134, R01GM100136] Funding Source: NIH RePORTER	Global Frontier Project; World Class University; Proteogenomic Research Program; National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare Affairs of Korea; Gyeonggi Research Development Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Division of Materials Research(National Science Foundation (NSF)); Kimmel Scholar Award for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Global Frontier Project (grants NRF-M1AXA002-20100029785 (S. K.), NRF-M1AXA002-2010-0029765 (Y. H. J.), NRF-2012M3A6A4054271 (J. W. L.) and NRF-2012-054237 (B. W. H.)), the World Class University (grant R31-2008000- 10086-0 (G. H.)), the Proteogenomic Research Program (2012M3A9B9036679 (C. L.)) and by the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea (grant ROA-2012-0006262 (A. M.)). This study was also funded by the Ministry for Health and Welfare Affairs of Korea through the Korea Healthcare Technology Research and Development Project (A092255 (D.-H. N.)) and by a grant from Gyeonggi Research Development Program (S. K.). This work was supported in part by grants from the US National Institutes of Health (GM100136 (M. G.)); the US National Science Foundation Division of Materials Research through DMR-11-57490 (A. G. Marshall, Florida State University); by the state of Florida (M. G.) and by a Kimmel Scholar Award for Cancer Research (M. G.). We appreciate A. G. Marshall for supporting the HDX-MS program and facility, M.-S. Seok (Korea University) for the preparation of the nanodisc and S. W. Lee (Sungkyunkwan University) for X-ray analysis.	Allen Bibb Jr, 2009, J Am Coll Radiol, V6, P606, DOI 10.1016/j.jacr.2009.06.007; ARGUELLO F, 1992, CANCER RES, V52, P2304; Batissoco AC, 2009, BRAZ J MED BIOL RES, V42, P168, DOI 10.1590/S0100-879X2009000200004; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; Cardin V, 2011, CEREB CORTEX, V21, P550, DOI 10.1093/cercor/bhq122; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fontanini G, 1997, CLIN CANCER RES, V3, P227; Ford CL, 1999, CANCER RES, V59, P704; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Hippo Y, 2002, CANCER RES, V62, P233; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kawamata H, 2008, J BIOL CHEM, V283, P28321, DOI 10.1074/jbc.M805599200; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim KA, 2004, FEBS LETT, V565, P181, DOI 10.1016/j.febslet.2004.03.062; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Li D, 2009, EUR SURG RES, V42, P168, DOI 10.1159/000198234; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Nyberg P, 2003, J BIOL CHEM, V278, P22404, DOI 10.1074/jbc.M210325200; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Schmidlin K, 2010, CLIN ORAL IMPLAN RES, V21, P550, DOI 10.1111/j.1600-0501.2009.01907.x; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Shenkarev ZO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P756, DOI 10.1134/S0006297909070086; Soares Mônica Regina Pereira Senra, 2010, Braz. Dent. J., V21, P550, DOI 10.1590/S0103-64402010000600012; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VandenBrule FA, 1996, HUM PATHOL, V27, P1185, DOI 10.1016/S0046-8177(96)90313-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Young IS, 2010, CURR OPIN LIPIDOL, V21, P550, DOI 10.1097/MOL.0b013e328340b4d9; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang HM, 2009, J AM SOC MASS SPECTR, V20, P520, DOI 10.1016/j.jasms.2008.11.010; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	54	44	49	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					29	U57		10.1038/NCHEMBIO.1381	http://dx.doi.org/10.1038/NCHEMBIO.1381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24212136	Green Accepted			2022-12-25	WOS:000328854900007
J	Smurnyy, Y; Cai, M; Wu, H; McWhinnie, E; Tallarico, JA; Yang, Y; Feng, Y				Smurnyy, Yegor; Cai, Mi; Wu, Hua; McWhinnie, Elizabeth; Tallarico, John A.; Yang, Yi; Feng, Yan			DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells	NATURE CHEMICAL BIOLOGY			English	Article							TRIPTOLIDE; GENERATION; REPAIR; TFIIH; RESISTANCE; INHIBITOR; MUTATIONS; NUCLEASES; FRAMEWORK; SYSTEM	Identification and validation of drug-resistant mutations can provide important insights into the mechanism of action of a compound. Here we demonstrate the feasibility of such an approach in mammalian cells using next-generation sequencing of drug-resistant clones and CRISPR-Cas9-mediated gene editing on two drug-target pairs, 6-thioguanine-HPRT1 and triptolide-ERCC3. We showed that disrupting functional HPRT1 allele or introducing ERCC3 point mutations by gene editing can confer drug resistance in cells.	[Smurnyy, Yegor; Cai, Mi; Wu, Hua; McWhinnie, Elizabeth; Tallarico, John A.; Yang, Yi; Feng, Yan] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Feng, Y (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	yan.feng@novartis.com	Cai, Mi/O-5355-2014; Cai, Mi/A-3380-2015					Andersson BS, 1995, LEUKEMIA, V9, P2100; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Corson TW, 2011, CHEMBIOCHEM, V12, P1767, DOI 10.1002/cbic.201100007; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Glaab WE, 1998, CARCINOGENESIS, V19, P1931, DOI 10.1093/carcin/19.11.1931; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Jawhari A, 2002, J BIOL CHEM, V277, P31761, DOI 10.1074/jbc.M203792200; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Leuenroth SJ, 2007, P NATL ACAD SCI USA, V104, P4389, DOI 10.1073/pnas.0700499104; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu Y, 2014, CHEM BIOL, V21, P246, DOI 10.1016/j.chembiol.2013.12.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soundararajan R, 2009, CANCER BIOL THER, V8, P2054, DOI 10.4161/cbt.8.21.9803; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Van der Auwera G.A., 2013, CURR PROT BIOINFORMA, V43; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	29	59	65	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					623	U152		10.1038/nchembio.1550	http://dx.doi.org/10.1038/nchembio.1550			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24929529				2022-12-25	WOS:000339380100006
J	He, M; Subramanian, R; Bangs, F; Omelchenko, T; Liem, KF; Kapoor, TM; Anderson, KV				He, Mu; Subramanian, Radhika; Bangs, Fiona; Omelchenko, Tatiana; Liem, Karel F., Jr.; Kapoor, Tarun M.; Anderson, Kathryn V.			The kinesin-4 protein Kif7 regulates mammalian Hedgehog signalling by organizing the cilium tip compartment	NATURE CELL BIOLOGY			English	Article							INTRAFLAGELLAR TRANSPORT; LENGTH; CHLAMYDOMONAS; GROWTH; IFT; IDENTIFICATION; LOCALIZATION; MICROTUBULES; TRANSDUCTION; MECHANISMS	Mammalian Hedgehog (Hh) signal transduction requires a primary cilium, a microtubule-based organelle, and the Gli-Sufu complexes that mediate Hh signalling, which are enriched at cilia tips. Kif7, a kinesin-4 family protein, is a conserved regulator of the Hh signalling pathway and a human ciliopathy protein. Here we show that Kif7 localizes to the cilium tip, the site of microtubule plus ends, where it limits cilium length and controls cilium structure. Purified recombinant Kif7 binds the plus ends of growing microtubules in vitro, where it reduces the rate of microtubule growth and increases the frequency of microtubule catastrophe. Kif7 is not required for normal intraflagellar transport or for trafficking of Hh pathway proteins into cilia. Instead, a central function of Kif7 in the mammalian Hh pathway is to control cilium architecture and to create a single cilium tip compartment, where Gli-Sufu activity can be correctly regulated.	[He, Mu; Bangs, Fiona; Liem, Karel F., Jr.; Anderson, Kathryn V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [He, Mu] Cornell Univ, Weill Cornell Grad Sch Med Sci, Program Biochem & Struct Biol Cell & Dev Biol & M, New York, NY 10065 USA; [Subramanian, Radhika; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Omelchenko, Tatiana] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Rockefeller University; Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	k-anderson@ski.mskcc.org		Anderson, Kathryn/0000-0003-1657-2161; He, Mu/0000-0002-3812-6165	National Institutes of Health [NS044385, GM65933]; MSKCC Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Gunther-Cummins, P. Satir (Albert Einstein College of Medicine, Bronx, NY), K. Uryu (Rockefeller University) for assistance with TEM, and Alan Hall for use of a microscope for TIRF imaging. We thank H. Bazzi, A. Parrish and T. Bestor for helpful comments on the manuscript. We thank B. Tsou and W-J. Wang for technical support and helpful discussion. We thank C.C. Hui (Sick Children's Hospital) for providing Kif7<SUP>-/-</SUP> mice. We thank J. Eggenschwiler (University of Georgia) and A. Salic (Harvard University) for antibodies. We thank N. Lampen for help with scanning electron microscopy and the Memorial Sloan-Kettering Cancer Center core facilities and the Rockefeller University Bio-Imaging Resource Center for help with imaging. We thank R. Hendrickson and H. Erdjument-Bromage for help with mass spectrometry. This work was supported by National Institutes of Health grants NS044385 to K.V. Anderson and GM65933 to T.M. Kapoor and the MSKCC Cancer Center Support Grant P30 CA008748.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Cole DG, 1999, J CELL BIOL, V147, P463, DOI 10.1083/jcb.147.3.463; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; HYMAN AA, 1991, J CELL SCI, P125; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2009, CURR BIOL, V19, pR729, DOI 10.1016/j.cub.2009.07.060; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Klejnot M, 2012, ACTA CRYSTALLOGR D, V68, P154, DOI 10.1107/S0907444911053042; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Matise MP, 1998, DEVELOPMENT, V125, P2759; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Morsci NS, 2011, CURR BIOL, V21, P1239, DOI 10.1016/j.cub.2011.06.027; Niwa S., 2012, DEV CELL; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; SCHOLEY JM, 1985, NATURE, V318, P483, DOI 10.1038/318483a0; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Stumpff J, 2012, DEV CELL, V22, P1017, DOI 10.1016/j.devcel.2012.02.013; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	54	185	191	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					663	+		10.1038/ncb2988	http://dx.doi.org/10.1038/ncb2988			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24952464	Green Accepted			2022-12-25	WOS:000338187900007
J	Mauri, C; Nistala, K				Mauri, Claudia; Nistala, Kiran			Interleukin-35 takes the 'B' line	NATURE MEDICINE			English	Editorial Material							CELLS; AUTOIMMUNITY; CONTRIBUTES; IMMUNITY	Regulatory B cells exert an immunosuppressive role by secreting the cytokine interleukin-10 (IL-10). Two studies have now identified B cell derived IL-35 as both an inducer and a mediator of regulatory B cell function. IL-35 switched off inflammation in mouse models of autoimmunity, whereas its absence in B cells in mice enhanced survival after Salmonella enterica serovar Typhimurium infection. IL-35 could therefore be targeted for treating human autoimmune and infectious disease.	[Mauri, Claudia; Nistala, Kiran] UCL, Div Med, Ctr Rheumatol, London, England	University of London; University College London	Mauri, C (corresponding author), UCL, Div Med, Ctr Rheumatol, London, England.	c.mauri@ucl.ac.uk; k.nistala@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022	Mauri, Claudia/0000-0001-9761-2625	Arthritis Research UK [19314, 17707] Funding Source: Medline; Versus Arthritis [17707, 19314] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Vasconcellos R, 2011, J IMMUNOL, V187, P3402, DOI 10.4049/jimmunol.1100224; WANG, NATURE; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	16	19	21	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					580	581		10.1038/nm.3594	http://dx.doi.org/10.1038/nm.3594			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24901562				2022-12-25	WOS:000337071000013
J	Mecozzi, VJ; Berman, DE; Simoes, S; Vetanovetz, C; Awal, MR; Patel, VM; Schneider, RT; Petsko, GA; Ringe, D; Small, SA				Mecozzi, Vincent J.; Berman, Diego E.; Simoes, Sabrina; Vetanovetz, Chris; Awal, Mehraj R.; Patel, Vivek M.; Schneider, Remy T.; Petsko, Gregory A.; Ringe, Dagmar; Small, Scott A.			Pharmacological chaperones stabilize retromer to limit APP processing	NATURE CHEMICAL BIOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; MAMMALIAN RETROMER; BINDING-SITES; COMPLEX; RECEPTOR; MICE; DYSFUNCTION; INHIBITION; EXPRESSION	Retromer is a multiprotein complex that trafficks cargo out of endosomes. The neuronal retromer traffics the amyloid-precursor protein (APP) away from endosomes, a site where APP is cleaved into pathogenic fragments in Alzheimer's disease. Here we determined whether pharmacological chaperones can enhance retromer stability and function. First, we relied on the crystal structures of retromer proteins to help identify the 'weak link' of the complex and to complete an in silico screen of small molecules predicted to enhance retromer stability. Among the hits, an in vitro assay identified one molecule that stabilized retromer against thermal denaturation. Second, we turned to cultured hippocampal neurons, showing that this small molecule increases the levels of retromer proteins, shifts APP away from the endosome, and decreases the pathogenic processing of APP. These findings show that pharmacological chaperones can enhance the function of a multiprotein complex and may have potential therapeutic implications for neurodegenerative diseases.	[Mecozzi, Vincent J.; Awal, Mehraj R.; Petsko, Gregory A.; Ringe, Dagmar] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02254 USA; [Mecozzi, Vincent J.; Awal, Mehraj R.; Petsko, Gregory A.; Ringe, Dagmar] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Chem, Waltham, MA 02254 USA; [Berman, Diego E.; Simoes, Sabrina; Vetanovetz, Chris; Patel, Vivek M.; Schneider, Remy T.; Small, Scott A.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Neurol & Pathol, New York, NY USA; [Petsko, Gregory A.] Weill Cornell Med Coll, Helen & Robert Appel Alzheimers Dis Res Inst, New York, NY USA; [Petsko, Gregory A.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Petsko, Gregory A.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA	Brandeis University; Brandeis University; Columbia University; Cornell University; Cornell University; Cornell University	Mecozzi, VJ (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02254 USA.	gpetsko@med.cornell.edu; ringe@brandeis.edu; sas68@columbia.edu	Petsko, Gregory/AAO-7962-2020	Patel, Vivek/0000-0002-8949-139X	US National Institute on Aging/US National Institutes of Health (NIH) [AG025161, AG08702]; NATIONAL INSTITUTE ON AGING [R01AG025161, P50AG008702] Funding Source: NIH RePORTER	US National Institute on Aging/US National Institutes of Health (NIH); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the US National Institute on Aging/US National Institutes of Health (NIH) grants AG025161 and AG08702, The Alzheimer's Association, Developmental Therapeutics Program of the National Cancer Institute, Medkoo Biosciences, The Fidelity Biosciences Research Initiative and give special thanks to S. Weninger for advice and encouragement. We also thank The McKnight Endowment for Neuroscience, the Ellison Medical Foundation, and the Gottlieb Family Foundation.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bhalla A, 2012, NEUROBIOL DIS, V47, P126, DOI 10.1016/j.nbd.2012.03.030; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mattos C, 1996, NAT BIOTECHNOL, V14, P595, DOI 10.1038/nbt0596-595; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Norwood SJ, 2011, TRAFFIC, V12, P56, DOI 10.1111/j.1600-0854.2010.01124.x; Ringe Dagmar, 2009, J Biol, V8, P80, DOI 10.1186/jbiol186; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Swarbrick JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020420; Vardarajan BN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.020; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40	36	152	156	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					443	449		10.1038/NCHEMBIO.1508	http://dx.doi.org/10.1038/NCHEMBIO.1508			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24747528	Green Accepted			2022-12-25	WOS:000336238200011
J	Yin, H; Xue, W; Chen, S; Bogorad, RL; Benedetti, E; Grompe, M; Koteliansky, V; Sharp, PA; Jacks, T; Anderson, DG				Yin, Hao; Xue, Wen; Chen, Sidi; Bogorad, Roman L.; Benedetti, Eric; Grompe, Markus; Koteliansky, Victor; Sharp, Phillip A.; Jacks, Tyler; Anderson, Daniel G.			Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype	NATURE BIOTECHNOLOGY			English	Article							MOUSE MODEL; HUMAN-CELLS; IN-VIVO; SPECIFICITY; NUCLEASES; REPAIR; GENE; DNA	We demonstrate CRISPR-Cas9-mediated correction of a Fah mutation in hepatocytes in a mouse model of the human disease hereditary tyrosinemia. Delivery of components of the CRISPR-Cas9 system by hydrodynamic injection resulted in initial expression of the wild-type Fah protein in similar to 1/250 liver cells. Expansion of Fah-positive hepatocytes rescued the body weight loss phenotype. Our study indicates that CRISPR-Cas9-mediated genome editing is possible in adult animals and has potential for correction of human genetic diseases.	[Yin, Hao; Xue, Wen; Chen, Sidi; Bogorad, Roman L.; Sharp, Phillip A.; Jacks, Tyler; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Benedetti, Eric; Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Oregon Stem Cell Ctr, Portland, OR 97201 USA; [Koteliansky, Victor] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Anderson, Daniel G.] Harvard MIT, Div Hlth Sci & Technol, Cambridge, MA USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Oregon Health & Science University; Skolkovo Institute of Science & Technology; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	CHEN, SIDI/D-8284-2016	CHEN, SIDI/0000-0002-3819-5005; Grompe, Markus/0000-0002-6616-4345	National Cancer Institute [2-PO1-CA42063, P30-CA14051]; National Institutes of Health (NIH) [R01-CA133404]; Howard Hughes Investigator; NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence [5-U51-CA151884-04]; Damon Runyon Fellow [DRG2117- 12];  [1K99CA169512]; NATIONAL CANCER INSTITUTE [U54CA151884, P01CA042063, R00CA169512, P30CA014051, K99CA169512, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048252] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Investigator(Howard Hughes Medical Institute); NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Fellow; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank I. Zhuang and W.Cai for technical assistance, F.Zhang for sharing pX330 CRISPR vectors, and D.Crowley and K. Cormier for histology. This work was supported in part by grants 2-PO1-CA42063 to P.A.S. and T.J. and core grant P30-CA14051 from the National Cancer Institute. This work was supported in part by National Institutes of Health (NIH) Grant R01-CA133404 and the Marie-D. & Pierre Casimir-Lambert Fund to P.A.S.T.J. is a Howard Hughes Investigator, the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. H.Y. and S.C. are supported by 5-U51-CA151884-04 NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence. W.X. is supported by grant 1K99CA169512. S.C. is a Damon Runyon Fellow (DRG2117- 12). The authors acknowledge the service of the late Sean Collier to the MIT community. We thank the Swanson Biotechnology Center for technical support.	Aponte JL, 2001, P NATL ACAD SCI USA, V98, P641, DOI 10.1073/pnas.98.2.641; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016	15	641	763	11	415	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					551	553		10.1038/nbt.2884	http://dx.doi.org/10.1038/nbt.2884			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24681508	Green Accepted, Green Published			2022-12-25	WOS:000337233800017
J	Ramos, P; Karnezis, AN; Craig, DW; Sekulic, A; Russell, ML; Hendricks, WPD; Corneveaux, JJ; Barrett, MT; Shumanskys, K; Yang, YD; Shah, SP; Prentice, LM; Marra, MA; Kiefer, J; Zismann, VL; McEachron, TA; McEachron, TA; Prat, J; D'Angelo, E; Clarke, BA; Pressey, JG; Farley, JH; Anthony, SP; Roden, RBS; Cunliffe, HE; Huntsman, DG; Trent, JM				Ramos, Pilar; Karnezis, Anthony N.; Craig, David W.; Sekulic, Aleksandar; Russell, Megan L.; Hendricks, William P. D.; Corneveaux, Jason J.; Barrett, Michael T.; Shumanskys, Karey; Yang, Yidong; Shah, Sohrab P.; Prentice, Leah M.; Marra, Marco A.; Kiefer, Jeffrey; Zismann, Victoria L.; McEachron, Troy A.; Salhia, Bodour; Prat, Jaime; D'Angelo, Emanuela; Clarke, Blaise A.; Pressey, Joseph G.; Farley, John H.; Anthony, Stephen P.; Roden, Richard B. S.; Cunliffe, Heather E.; Huntsman, David G.; Trent, Jeffrey M.			Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4	NATURE GENETICS			English	Article							CANCERS; BRG1	Small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is an extremely rare, aggressive cancer affecting children and young women. We identified germline and somatic inactivating mutations in the SWI/SNF chromatin-remodeling gene SMARCA4 in 75% (9/12) of SCCOHT cases in addition to SMARCA4 protein loss in 82% (14/17) of SCCOHT tumors but in only 0.4% (2/485) of other primary ovarian tumors. These data implicate SMARCA4 in SCCOHT oncogenesis.	[Ramos, Pilar; Craig, David W.; Sekulic, Aleksandar; Russell, Megan L.; Hendricks, William P. D.; Corneveaux, Jason J.; Barrett, Michael T.; Kiefer, Jeffrey; Zismann, Victoria L.; McEachron, Troy A.; Salhia, Bodour; Cunliffe, Heather E.; Trent, Jeffrey M.] Translat Genom Res Inst TGen, Div Integrated Canc Genom, Phoenix, AZ USA; [Karnezis, Anthony N.; Shah, Sohrab P.; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Karnezis, Anthony N.; Prentice, Leah M.; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Sekulic, Aleksandar] Mayo Clin, Dept Dermatol, Scottsdale, AZ USA; [Shumanskys, Karey; Yang, Yidong; Shah, Sohrab P.] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 4E6, Canada; [Marra, Marco A.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Prat, Jaime; D'Angelo, Emanuela] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Pathol, Barcelona, Spain; [Clarke, Blaise A.] Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Pressey, Joseph G.] Univ Alabama Birmingham, Childrens Hosp Alabama, Dept Pediat Hematol Oncol, Birmingham, AL USA; [Farley, John H.] Creighton Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol, Phoenix, AZ USA; [Farley, John H.] St Josephs Hosp, Phoenix, AZ USA; [Anthony, Stephen P.] Evergreen Hematol & Oncol, Spokane, WA USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Cunliffe, Heather E.] Univ Otago, Dept Pathol, Dunedin, New Zealand	Translational Genomics Research Institute; University of British Columbia; British Columbia Cancer Agency; Mayo Clinic; Mayo Clinic Phoenix; British Columbia Cancer Agency; British Columbia Cancer Agency; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alabama System; University of Alabama Birmingham; Creighton University; St. Joseph's Hospital and Medical Center; Johns Hopkins University; University of Otago	Huntsman, DG (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	dhuntsma@bccancer.bc.ca; jtrent@tgen.org	D'Angelo, Emanuela/J-3417-2012; Marra, Marco A/B-5987-2008; Huntsman, David/ABE-6082-2020; Pressey, Joseph G/AAP-2782-2020; Prat, Jaime/G-4679-2011; Jeff/ABB-2636-2021; Craig, David Wesley/K-6961-2019	Marra, Marco A/0000-0001-7146-7175; Pressey, Joseph G/0000-0003-1816-3281; Jeff/0000-0002-1238-3120; Craig, David Wesley/0000-0003-2040-1955; Clarke, Blaise/0000-0002-2585-8391; D'ANGELO, Emanuela/0000-0002-6173-1806; , William/0000-0001-7192-8699	Marsha Rivkin Center for Ovarian Cancer Research; Anne Rita Monahan Foundation; Ovarian Cancer Alliance of Arizona; Small Cell Ovarian Cancer Foundation; Terry Fox Research Initiative New Frontiers Program in Cancer; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Marsha Rivkin Center for Ovarian Cancer Research; Anne Rita Monahan Foundation; Ovarian Cancer Alliance of Arizona; Small Cell Ovarian Cancer Foundation; Terry Fox Research Initiative New Frontiers Program in Cancer; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We particularly thank the families and patients who joined this institutional review board (IRB)-approved study for their critical contributions. We also thank the faculty and staff at TGen from the Macromolecular Analysis & Processing Center (G. Hostetter and J. LoBello) and the Office of Research Compliance & Quality Management (L. Nordstrom, S. Althoff and S. Buchholtz); the Children's Oncology Group for their samples; and B. Vanderhyden (University of Ottawa and Ottawa Hospital Research Institute) for BIN-67 cells. This study was supported by grants from the Marsha Rivkin Center for Ovarian Cancer Research, the Anne Rita Monahan Foundation, the Ovarian Cancer Alliance of Arizona, the Small Cell Ovarian Cancer Foundation and philanthropic support to the TGen Foundation. Further support was provided to A.N.K. and D.G.H. by the Terry Fox Research Initiative New Frontiers Program in Cancer and to A.N.K. by the Molecular Oncologic Pathology Fellowship of the Canadian Institutes of Health Research.	Eaton KW, 2011, PEDIATR BLOOD CANCER, V56, P7, DOI 10.1002/pbc.22831; Estel R, 2011, ARCH GYNECOL OBSTET, V284, P1277, DOI 10.1007/s00404-011-1846-5; Florell SR, 1999, MED PEDIATR ONCOL, V32, P304, DOI 10.1002/(SICI)1096-911X(199904)32:4<304::AID-MPO13>3.0.CO;2-M; Gamwell LF, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-33; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Kupryjanczyk J, 2013, POL J PATHOL, V64, P238, DOI 10.5114/PJP.2013.39331; Martinez-Borges AR, 2009, PEDIATR BLOOD CANCER, V53, P1334, DOI 10.1002/pbc.22184; McCluggage WG, 2004, INT J GYNECOL PATHOL, V23, P330, DOI 10.1097/01.pgp.0000139644.38835.9d; McDonald JM, 2012, J PEDIATR SURG, V47, P588, DOI 10.1016/j.jpedsurg.2011.12.004; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Serber DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031346; Shrimali RK, 2011, MED ONCOL, V28, P766, DOI 10.1007/s12032-010-9509-0; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004	14	220	230	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					427	429		10.1038/ng.2928	http://dx.doi.org/10.1038/ng.2928			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24658001	Green Accepted			2022-12-25	WOS:000335422900006
J	Seguin, L; Kato, S; Franovic, A; Camargo, MF; Lesperance, J; Elliott, KC; Yebra, M; Mielgo, A; Lowy, AM; Husain, H; Cascone, T; Diao, LX; Wang, J; Wistuba, II; Heymach, JV; Lippman, SM; Desgrosellier, JS; Anand, S; Weis, SM; Cheresh, DA				Seguin, Laetitia; Kato, Shumei; Franovic, Aleksandra; Camargo, M. Fernanda; Lesperance, Jacqueline; Elliott, Kathryn C.; Yebra, Mayra; Mielgo, Ainhoa; Lowy, Andrew M.; Husain, Hatim; Cascone, Tina; Diao, Lixia; Wang, Jing; Wistuba, Ignacio I.; Heymach, John V.; Lippman, Scott M.; Desgrosellier, Jay S.; Anand, Sudarshan; Weis, Sara M.; Cheresh, David A.			An integrin beta(3)-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition	NATURE CELL BIOLOGY			English	Article							HUMAN BREAST-CANCER; ACQUIRED-RESISTANCE; ENDOTHELIAL-CELLS; TARGETED THERAPY; EXPRESSION; ALPHA-V-BETA-3; METASTASIS; GROWTH; OVEREXPRESSION; ANGIOGENESIS	Tumour cells, with stem-like properties, are highly aggressive and often show drug resistance. Here, we reveal that integrin alpha(v)beta(3) serves as a marker of breast, lung and pancreatic carcinomas with stem-like properties that are highly resistant to receptor tyrosine kinase inhibitors such as erlotinib. This was observed in vitro and in mice bearing patient-derived tumour xenografts or in clinical specimens from lung cancer patients who had progressed on erlotinib. Mechanistically, alpha(v)beta(3,) in the unliganded state, recruits KRAS and RalB to the tumour cell plasma membrane, leading to the activation of TBK1 and NF-kB. In fact, alpha(v)beta(3) expression and the resulting KRAS-RalB-NF-kB pathway were both necessary and sufficient for tumour initiation, anchorage independence, self-renewal and erlotinib resistance. Pharmacological targeting of this pathway with bortezomib reversed both tumour stemness and erlotinib resistance. These findings not only identify alpha(v)beta(3) as a marker/driver of carcinoma stemness but also reveal a therapeutic strategy to sensitize such tumours to RTK inhibition.	[Seguin, Laetitia; Franovic, Aleksandra; Camargo, M. Fernanda; Lesperance, Jacqueline; Elliott, Kathryn C.; Yebra, Mayra; Mielgo, Ainhoa; Desgrosellier, Jay S.; Anand, Sudarshan; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Seguin, Laetitia; Franovic, Aleksandra; Camargo, M. Fernanda; Lesperance, Jacqueline; Elliott, Kathryn C.; Yebra, Mayra; Mielgo, Ainhoa; Lippman, Scott M.; Desgrosellier, Jay S.; Anand, Sudarshan; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Kato, Shumei; Husain, Hatim] Univ Calif San Diego, Sch Med, Div Hematol Oncol, La Jolla, CA 92093 USA; [Lowy, Andrew M.] Univ Calif San Diego, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA; [Cascone, Tina; Diao, Lixia; Wang, Jing; Wistuba, Ignacio I.; Heymach, John V.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Cascone, Tina; Diao, Lixia; Wang, Jing; Wistuba, Ignacio I.; Heymach, John V.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	Desgrosellier, Jay S/A-8756-2008; Heymach, John/AAG-2361-2019; ANAND, SUDARSHAN/I-5316-2019	Heymach, John/0000-0001-9068-8942; ANAND, SUDARSHAN/0000-0002-4969-6884; Seguin, Laetitia/0000-0002-9610-7093; SEGUIN, Laetitia/0000-0003-2950-4766	US National Institutes of Health [CA45726, CA168692, HL57900, R3750286, CA155620]; National Cancer Institute of National Institutes of Health [T32CA121938]; Association pour la Recherchesurle Cancer (ARC); La Fondation Philippe; NATIONAL CANCER INSTITUTE [R01CA168692, R37CA050286, R01CA045726, P30CA016672, T32CA121938, R01CA155620, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, R00HL112962] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of National Institutes of Health; Association pour la Recherchesurle Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); La Fondation Philippe; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Shields, E. Murphy, L. Acevedo, S. Advani, M. Huang, I. Tancioni, B. Walshand A. Larange for helpful discussions. We thank D. Young for his advice and the technical support with the FACS sorter. We thank the Moores Cancer Center Biore pository and H. Howard for their help with the PDXs. We thank J. Camonis for providing RalB constructs. We also thank C. Mirsaidi from Molecular Response LLC for providing the PDX act human lung cancer patient-derived xenograft models used here. D.A.C. was supported by US National Institutes of Health grants CA45726, CA168692, HL57900 and R3750286. A.M.L. was supported by NIH CA155620 .S.K. was supported by the National Cancer Institute of the National Institutes of Health under award number T32CA121938. L.S. was supported by the Association pour la Recherchesurle Cancer (ARC) and La Fondation Philippe.	Adhikari AS, 2011, FRONT BIOSCI-LANDMRK, V16, P1927, DOI 10.2741/3831; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bhat K. P., 2013, CANC CELL; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Evellin S, 2013, MOL CELL BIOL, V33, P1198, DOI 10.1128/MCB.01054-12; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Hamada J, 2001, INT J CANCER, V93, P516, DOI 10.1002/ijc.1357; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hieken TJ, 1996, J SURG RES, V63, P169, DOI 10.1006/jsre.1996.0242; Jin Y, 1998, BLOOD, V92, P2777, DOI 10.1182/blood.V92.8.2777.420k27_2777_2790; Jinushi M, 2012, CANCER RES, V72, P56, DOI 10.1158/0008-5472.CAN-11-2028; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Knowles LM, 2013, CANCER RES, V73, P6175, DOI 10.1158/0008-5472.CAN-13-0602; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Miller PG, 2013, CANCER CELL, V24, P45, DOI 10.1016/j.ccr.2013.05.004; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Patel Purvi, 2012, Front Endocrinol (Lausanne), V3, P125, DOI 10.3389/fendo.2012.00125; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Takayama S, 2005, ANTICANCER RES, V25, P79; Teicher BA, 2011, CLIN CANCER RES, V17, P6389, DOI 10.1158/1078-0432.CCR-11-1417; Umemoto T, 2008, BIOCHEM BIOPH RES CO, V365, P176, DOI 10.1016/j.bbrc.2007.10.168; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Workman P, 2011, CANCER CELL, V19, P437, DOI 10.1016/j.ccr.2011.03.020; Xu L, 2013, FRONT BIOSCI-LANDMRK, V18, P795, DOI 10.2741/4143; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021	59	257	269	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					457	U172		10.1038/ncb2953	http://dx.doi.org/10.1038/ncb2953			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24747441	Green Accepted			2022-12-25	WOS:000335438400010
J	Shin, K; Lim, A; Odegaard, JI; Honeycutt, JD; Kawano, S; Hsieh, MH; Beachy, PA				Shin, Kunyoo; Lim, Agnes; Odegaard, Justin I.; Honeycutt, Jared D.; Kawano, Sally; Hsieh, Michael H.; Beachy, Philip A.			Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma	NATURE CELL BIOLOGY			English	Article							EPITHELIAL STEM-CELLS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; UROTHELIAL CARCINOMAS; PANCREATIC-CANCER; CIGARETTE-SMOKING; MONOCLONAL ORIGIN; CLONAL ANALYSIS; URINARY-TRACT; OF-ORIGIN; TUMOR	Understanding how malignancies arise within normal tissues requires identification of the cancer cell of origin and knowledge of the cellular and tissue dynamics of tumour progression. Here we examine bladder cancer in a chemical carcinogenesis model that mimics muscle-invasive human bladder cancer. With no prior bias regarding genetic pathways or cell types, we prospectively mark or ablate cells to show that muscle-invasive bladder carcinomas arise exclusively from Sonic hedgehog (Shh)-expressing stem cells in basal urothelium. These carcinomas arise clonally from a single cell whose progeny aggressively colonize a major portion of the urothelium to generate a lesion with histological features identical to human carcinoma in situ. Shh-expressing basal cells within this precursor lesion become tumour-initiating cells, although Shh expression is lost in subsequent carcinomas. We thus find that invasive carcinoma is initiated from basal urothelial stem cells but that tumour cell phenotype can diverge significantly from that of the cancer cell of origin.	[Shin, Kunyoo; Kawano, Sally; Beachy, Philip A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lim, Agnes; Beachy, Philip A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Odegaard, Justin I.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Honeycutt, Jared D.] Stanford Univ, Sch Med, Stanford Immunol, Stanford, CA 94305 USA; [Hsieh, Michael H.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Beachy, Philip A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Beachy, Philip A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Shin, K (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	shink@ohsu.edu; pbeachy@stanford.edu	Hsieh, Michael/E-8274-2010	Hsieh, Michael/0000-0002-9650-2691; Shin, Kunyoo/0000-0002-1519-9839; Lim, Agnes/0000-0002-6618-2500	National Institutes of Health; Pathway to Independence Award [K99/R00]; NATIONAL CANCER INSTITUTE [R01CA157877, R00CA166232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Weissman and Y. Rinkevich for their generous provision of the Rainbow mouse, T. Desai, A. Oro and J. Sage for their critical reading of the manuscript, and the Stanford Neuroscience Microscopy Service for help with confocal microscopy. This research was supported in part by grants from the National Institutes of Health (P.A.B.) and a Pathway to Independence Award (K99/R00) to K.S. P.A.B. is an investigator of the Howard Hughes Medical Institute.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allred D. Craig, 2010, Journal of the National Cancer Institute Monographs, P134, DOI 10.1093/jncimonographs/lgq035; Ayala AG, 2007, ARCH PATHOL LAB MED, V131, P1257; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BRYAN GT, 1983, ENVIRON HEALTH PERSP, V49, P201, DOI 10.2307/3429598; BRYAN GT, 1977, CANCER RES, V37, P2813; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P104, DOI 10.1002/cncr.10151; Dahse R, 2003, ONCOL REP, V10, P2033; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Duggan BJ, 2004, J UROLOGY, V171, P419, DOI 10.1097/01.ju.0000100105.27708.6c; Fadl-Elmula I, 1999, BRIT J CANCER, V81, P6, DOI 10.1038/sj.bjc.6690643; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Forsti A, 2001, EUR J CANCER, V37, P1372, DOI 10.1016/S0959-8049(01)00118-6; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Hafner C, 2001, ONCOGENE, V20, P4910, DOI 10.1038/sj.onc.1204671; He XB, 2009, STEM CELLS, V27, P1487, DOI 10.1002/stem.92; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Hisha H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03224; Hoglund M, 2007, SEMIN CANCER BIOL, V17, P225, DOI 10.1016/j.semcancer.2006.02.002; JOST SP, 1989, VIRCHOWS ARCH B, V57, P27, DOI 10.1007/BF02899062; Kimura F, 2003, INT J CANCER, V104, P568, DOI 10.1002/ijc.10988; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Montironi R, 2007, NAT CLIN PRACT UROL, V4, P321, DOI 10.1038/ncpuro0815; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; NAGAO M, 1977, CANCER RES, V37, P399; Paiss T, 2002, J UROLOGY, V167, P718, DOI 10.1016/S0022-5347(01)69133-X; Prevo LJ, 1999, CANCER RES, V59, P4784; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Scarlett CJ, 2011, PATHOLOGY, V43, P183, DOI 10.1097/PAT.0b013e3283445e3a; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; SIDRANSKY D, 1992, NEW ENGL J MED, V326, P737, DOI 10.1056/NEJM199203123261104; Simon R, 2001, CANCER RES, V61, P355; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; SPRUCK CH, 1994, CANCER RES, V54, P784; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thievessen I, 2005, J CELL PHYSIOL, V203, P372, DOI 10.1002/jcp.20248; Trkova M, 2006, CANCER LETT, V242, P68, DOI 10.1016/j.canlet.2005.10.036; Vriesema JLJ, 2001, INT J CANCER, V93, P699, DOI 10.1002/ijc.1402; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Yamamoto S, 1998, CARCINOGENESIS, V19, P855, DOI 10.1093/carcin/19.5.855; Yanai H, 2013, J GASTROENTEROL, V48, P423, DOI 10.1007/s00535-012-0736-3; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q	57	135	136	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2014	16	5					469	U194		10.1038/ncb2956	http://dx.doi.org/10.1038/ncb2956			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AG5DC	24747439	Green Accepted			2022-12-25	WOS:000335438400011
J	Siliciano, RF				Siliciano, Robert F.			Targeting reservoirs to clear and cure	NATURE MEDICINE			English	Editorial Material							HIGHLY PATHOGENIC SIV; CD4(+) T-CELLS; VIRAL RESERVOIRS; HIV-1		[Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	rsiliciano@jhmi.edu						Buckheit RW, 2013, CELL MOL LIFE SCI, V70, P1009, DOI 10.1007/s00018-012-1101-7; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218	15	15	15	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					484	485		10.1038/nm.3550	http://dx.doi.org/10.1038/nm.3550			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24804757				2022-12-25	WOS:000335710700018
J	Gray, LT; Vallur, AC; Eddy, J; Maizels, N				Gray, Lucas T.; Vallur, Aarthy C.; Eddy, Johanna; Maizels, Nancy			G quadruplexes are genomewide targets of transcriptional helicases XPB and XPD	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; FACTOR TFIIH; HUMAN GENES; MOTIFS; FANCJ; REPLICATION; MUTATIONS; STABILITY; SEQUENCES	G4 motifs are greatly enriched near promoters, suggesting that quadruplex structures may be targets of transcriptional regulation. Here we show, by ChIP-Seq analysis of human cells, that 40% of the binding sites of the transcription-associated helicases, XPB and XPD, overlap with G4 motifs. The highly significant overlap of XPB and XPD binding sites with G4 motifs cannot be explained by GC richness or parameters of the genomewide analysis, but instead suggests that these proteins are recruited to quadruplex structures that form in genomic DNA (G4 DNA). Biochemical analysis demonstrates that XPD is a robust G4 DNA helicase and that XPB binds G4 DNA. XPB and XPD are enriched near the transcription start site at 20% of genes, especially highly transcribed genes. XPB and XPD enrichment at G4 motifs characterizes specific signaling pathways and regulatory pathways associated with specific cancers. These results identify new candidate pathways for therapies targeted to quadruplexes.	[Gray, Lucas T.; Vallur, Aarthy C.; Maizels, Nancy] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Eddy, Johanna; Maizels, Nancy] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gray, LT (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	maizels@uw.edu		Graybuck, Lucas/0000-0002-8814-6818	US National Institutes of Health-National Cancer Institute grant [P01 CA077852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065988] Funding Source: NIH RePORTER	US National Institutes of Health-National Cancer Institute grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this manuscript was supported by US National Institutes of Health-National Cancer Institute grant P01 CA077852. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank our Program Project colleagues for active discussions, M. White (St. Andrews University, Scotland) for the XPD expression construct; J. Tainer (Scripps Research Institute) for the XPB expression construct; A. Bailey for help with sequencing library preparation and C. Lee and J. Shendure for sequencing of ChIP-Seq libraries on an Illumina Hi-Seq 2000 (University of Washington).	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bauer NN, 2007, EXP CELL RES, V313, P3832, DOI 10.1016/j.yexcr.2007.08.017; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; de la Faverie AR, 2011, BIOCHIMIE, V93, P1357, DOI 10.1016/j.biochi.2011.05.022; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Eddy J, 2009, MOL CARCINOGEN, V48, P319, DOI 10.1002/mc.20496; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gray LT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002972; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Hashimoto S, 2009, HUM MOL GENET, V18, pR224, DOI 10.1093/hmg/ddp390; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Kamileri I, 2012, TRENDS GENET, V28, P566, DOI 10.1016/j.tig.2012.06.004; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Oksenych V, 2010, CELL CYCLE, V9, P90, DOI 10.4161/cc.9.1.10267; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tornaletti S, 2008, J BIOL CHEM, V283, P12756, DOI 10.1074/jbc.M705003200; Uringa EJ, 2011, NUCLEIC ACIDS RES, V39, P1647, DOI 10.1093/nar/gkq1045; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	148	151	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					313	+		10.1038/NCHEMBIO.1475	http://dx.doi.org/10.1038/NCHEMBIO.1475			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24609361	Green Accepted			2022-12-25	WOS:000333172900015
J	Seewaldt, V				Seewaldt, Victoria			ECM stiffness paves the way for tumor cells	NATURE MEDICINE			English	Editorial Material							BREAST-CANCER; MAMMOGRAPHIC DENSITY; PROGRESSION; CARCINOMA; COLLAGEN; RISK		Duke Univ, Dept Med, Durham, NC 27706 USA	Duke University	Seewaldt, V (corresponding author), Duke Univ, Dept Med, Durham, NC 27706 USA.	seewa001@mc.duke.edu						Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cecchini RS, 2012, CANCER PREV RES, V5, P1321, DOI 10.1158/1940-6207.CAPR-12-0273; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gierach GL, 2012, J NATL CANCER I, V104, P1218, DOI 10.1093/jnci/djs327; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Grady D, 2012, NY TIMES; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513	14	81	85	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					332	333		10.1038/nm.3523	http://dx.doi.org/10.1038/nm.3523			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710372				2022-12-25	WOS:000334361500008
J	Sorrentino, G; Ruggeri, N; Specchia, V; Cordenonsi, M; Mano, M; Dupont, S; Manfrin, A; Ingallina, E; Sommaggio, R; Piazza, S; Rosato, A; Piccolo, S; Del Sal, G				Sorrentino, Giovanni; Ruggeri, Naomi; Specchia, Valeria; Cordenonsi, Michelangelo; Mano, Miguel; Dupont, Sirio; Manfrin, Andrea; Ingallina, Eleonora; Sommaggio, Roberta; Piazza, Silvano; Rosato, Antonio; Piccolo, Stefano; Del Sal, Giannino			Metabolic control of YAP and TAZ by the mevalonate pathway	NATURE CELL BIOLOGY			English	Article							HIPPO PATHWAY; ORGAN GROWTH; TRANSCRIPTION; CHOLESTEROL; STATINS; YAP/TAZ	The YAP and TAZ mediators of the Hippo pathway ( hereafter called YAP/TAZ) promote tissue proliferation and organ growth. However, how their biological properties intersect with cellular metabolism remains unexplained. Here, we show that YAP/TAZ activity is controlled by the SREBP/mevalonate pathway. Inhibition of the rate-limiting enzyme of this pathway ( HMG-CoA reductase) by statins opposes YAP/TAZ nuclear localization and transcriptional responses. Mechanistically, the geranylgeranyl pyrophosphate produced by the mevalonate cascade is required for activation of Rho GTPases that, in turn, activate YAP/TAZ by inhibiting their phosphorylation and promoting their nuclear accumulation. The mevalonate-YAP/TAZ axis is required for proliferation and self-renewal of breast cancer cells. In Drosophila melanogaster, inhibition of mevalonate biosynthesis and geranylgeranylation blunts the eye overgrowth induced by Yorkie, the YAP/TAZ orthologue. In tumour cells, YAP/TAZ activation is promoted by increased levels of mevalonic acid produced by SREBP transcriptional activity, which is induced by its oncogenic cofactor mutant p53. These findings reveal an additional layer of YAP/TAZ regulation by metabolic cues.	[Sorrentino, Giovanni; Ruggeri, Naomi; Ingallina, Eleonora; Piazza, Silvano; Del Sal, Giannino] LNCIB, I-34149 Trieste, Italy; [Sorrentino, Giovanni; Ruggeri, Naomi; Ingallina, Eleonora; Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Specchia, Valeria] Univ Salento, DiSTeBA, I-73100 Lecce, Italy; [Cordenonsi, Michelangelo; Dupont, Sirio; Manfrin, Andrea; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35126 Padua, Italy; [Mano, Miguel] ICGEB, I-34149 Trieste, Italy; [Sommaggio, Roberta; Rosato, Antonio] Univ Padua, Dipartimento Sci Oncol & Chirurg, I-35128 Padua, Italy; [Sommaggio, Roberta; Rosato, Antonio] Ist Oncol Veneto IRCCS, I-35128 Padua, Italy	University of Trieste; University of Salento; University of Padua; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Padua; IRCCS Istituto Oncologico Veneto (IOV)	Del Sal, G (corresponding author), LNCIB, Area Sci Pk, I-34149 Trieste, Italy.	delsal@lncib.it	Sommaggio, Roberta/Q-6119-2016; Dupont, Sirio/AAP-8133-2021; Mano, Miguel/A-4462-2013; Rosato, Antonio/E-8626-2010; Specchia, Valeria/AAS-8179-2020; Manfrin, Andrea/AAC-1066-2020; Cordenonsi, Michelangelo/K-7692-2016	Sommaggio, Roberta/0000-0002-5682-5867; Mano, Miguel/0000-0003-1922-4824; Rosato, Antonio/0000-0002-5263-8386; Specchia, Valeria/0000-0002-1051-6014; Manfrin, Andrea/0000-0002-1519-6582; Cordenonsi, Michelangelo/0000-0002-8253-5724; DEL SAL, GIANNINO/0000-0003-2185-6003; Dupont, Sirio/0000-0002-6869-1966; Sorrentino, Giovanni/0000-0001-8628-8778; Piazza, Silvano/0000-0002-7156-5434; PICCOLO, STEFANO/0000-0002-2037-0004	Associazione Italiana per la Ricerca sul Cancro (AIRC); AIRC Special Program Molecular Clinical Oncology; Italian Ministry of Education, University and Research (COFIN, FIRB-accordi di programma 2010) [RBAP10XKNC_003]; Italian Ministry of Education, University and Research [FIRB RBAP11Z4Z9, RBFR10V8K6]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and Research (COFIN, FIRB-accordi di programma 2010)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	We thank A.Comel, F. Mantovani, A. Rustighiand D. Walerich for helpful discussion and reading the manuscript and A. Testa for discussions and proofreading the manuscript. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and AIRC Special Program Molecular Clinical Oncology '5 per mille' to S.P., A.R. and G.D.S. and the Italian Ministry of Education, University and Research (COFIN, FIRB-accordi di programma 2010 cod. RBAP10XKNC_003) to G.D.S. M.M. is supported by the FIRB RBAP11Z4Z9 project from the Italian Ministry of Education, University and Research. V.S. is supported by grant FIRB no. RBFR10V8K6 from the Italian Ministry of Education, University and Research. G. S. is a fellow of the Fondazione Italiana perla Ricercasul Cancro (FIRC). We acknowledge G. Pastore for technical support and F. Vita for technical support with electron microscopy. The results published here are in part based on data generated by The Cancer TCGA Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Keller PJ, 2005, METHODS, V37, P131, DOI 10.1016/j.ymeth.2005.05.023; Larsson O, 1996, CRIT REV ONCOL HEMAT, V22, P197, DOI 10.1016/1040-8428(96)00193-X; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Nielsen SF, 2013, NEW ENGL J MED, V368, P576, DOI 10.1056/NEJMc1214827; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Stanger BZ, 2008, CELL CYCLE, V7, P318, DOI 10.4161/cc.7.3.5348; Sudol Marius, 2010, Genes Cancer, V1, P1115, DOI 10.1177/1947601911401911; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	34	512	524	3	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					357	+		10.1038/ncb2936	http://dx.doi.org/10.1038/ncb2936			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24658687				2022-12-25	WOS:000333556900009
J	Tatton-Brown, K; Seal, S; Ruark, E; Harmer, J; Ramsay, E; Duarte, SD; Zachariou, A; Hanks, S; O'Brien, E; Aksglaede, L; Baralle, D; Dabir, T; Gener, B; Goudie, D; Homfray, T; Kumar, A; Pilz, DT; Selicorni, A; Temple, IK; Van Maldergem, L; Yachelevich, N; van Montfort, R; Rahman, N				Tatton-Brown, Katrina; Seal, Sheila; Ruark, Elise; Harmer, Jenny; Ramsay, Emma; Duarte, Silvana del Vecchio; Zachariou, Anna; Hanks, Sandra; O'Brien, Eleanor; Aksglaede, Lise; Baralle, Diana; Dabir, Tabib; Gener, Blanca; Goudie, David; Homfray, Tessa; Kumar, Ajith; Pilz, Daniela T.; Selicorni, Angelo; Temple, I. Karen; Van Maldergem, Lionel; Yachelevich, Naomi; van Montfort, Robert; Rahman, Nazneen		Childhood Overgrowth Consortium	Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; DE-NOVO METHYLATION; NSD1; EZH2; RECOGNITION; HEIGHT; DOMAIN	Overgrowth disorders are a heterogeneous group of conditions characterized by increased growth parameters and other variable clinical features such as intellectual disability and facial dysmorphism(1). To identify new causes of human overgrowth, we performed exome sequencing in ten proband-parent trios and detected two de novo DNMT3A mutations. We identified 11 additional de novo mutations by sequencing DNMT3A in a further 142 individuals with overgrowth. The mutations alter residues in functional DNMT3A domains, and protein modeling suggests that they interfere with domain-domain interactions and histone binding. Similar mutations were not present in 1,000 UK population controls (13/152 cases versus 0/1,000 controls; P < 0.0001). Mutation carriers had a distinctive facial appearance, intellectual disability and greater height. DNMT3A encodes a DNA methyltransferase essential for establishing methylation during embryogenesis and is commonly somatically mutated in acute myeloid leukemia(2-4). Thus, DNMT3A joins an emerging group of epigenetic DNA- and histone-modifying genes associated with both developmental growth disorders and hematological malignancies(5).	[Tatton-Brown, Katrina; Seal, Sheila; Ruark, Elise; Ramsay, Emma; Duarte, Silvana del Vecchio; Zachariou, Anna; Hanks, Sandra; O'Brien, Eleanor; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Tatton-Brown, Katrina; Rahman, Nazneen] Royal Marsden Hosp, Canc Genet Unit, London SW3 6JJ, England; [Tatton-Brown, Katrina; Homfray, Tessa] St Georges Univ London, London, England; [Harmer, Jenny] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Aksglaede, Lise] Copenhagen Univ Hosp, Dept Clin Genet, Copenhagen, Denmark; [Baralle, Diana] Univ Southampton, Fac Med, Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Dabir, Tabib] Belfast City Hosp, Clin Genet Serv, Northern Ireland Reg Genet Ctr, Belfast BT9 7AD, Antrim, North Ireland; [Gener, Blanca] Hosp Univ Cruces, BioCruces Hlth Res Inst, Serv Genet, Bizkaia, Spain; [Goudie, David] Univ Dundee, Ninewells Hosp & Med Sch, Dept Human Genet, Dundee DD1 9SY, Scotland; [Kumar, Ajith] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff, S Glam, Wales; [Selicorni, Angelo] Univ Milano Bicocca, Fdn Monza Brianza Bambino Sua Mamma MBBM, Ambulatorio Genet Clin Pediat, Clin Pediat,AO, Monza, Italy; [Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, F-25030 Besancon, France; [Yachelevich, Naomi] NYU, New York Univ Hosp Ctr, Clin Genet Serv, New York, NY USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; St Georges University London; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Copenhagen; University of Southampton; Belfast City Hospital; Hospital Universitario Cruces; University of Dundee; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cardiff University; University of Milano-Bicocca; Universite de Franche-Comte	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England.	kate.tatton-brown@icr.ac.uk; rahmanlab@icr.ac.uk	Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019; Aksglaede, Lise/AAI-7163-2020; temple, isabel K/K-2391-2015; Rahman, Nazneen/D-2802-2013	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Rahman, Nazneen/0000-0003-4376-0440; Temple, Isabel Karen/0000-0002-6045-1781; Aksglaede, Lise/0000-0001-7885-7467; O'Brien, Eleanor/0000-0002-5375-459X; Baralle, Diana/0000-0003-3217-4833	Royal Marsden/Institute of Cancer Research National Institute for Health Research (NIHR) Biomedical Research Centre; Wellcome Trust [100210/Z/12/Z]; Institute of Cancer Research, London.; Cancer Research UK [11566] Funding Source: researchfish; Medical Research Council [G0400188] Funding Source: researchfish; MRC [G0400188] Funding Source: UKRI	Royal Marsden/Institute of Cancer Research National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Cancer Research, London.; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the families for their participation in our research and the physicians and nurses who recruited them. Samples were collected through the Childhood Overgrowth Collaboration; a full list of collaborators is presented in the Supplementary Note. We are grateful to M. Warren-Perry, D. Dudakia and J. Bull for assistance in recruitment and to E. Moran (New York University Hospital for Joint Diseases) and A. Murray (University Hospital of Wales) for their clinical input for COG1770 and COG0109, respectively. We thank A. Strydom for assistance in preparing the manuscript. We are grateful to G. Lunter and M. Munz (Wellcome Trust Centre for Human Genetics, Oxford University) for their contributions to the development of the custom annotation tool SAVANT. We acknowledge use of services provided by the Institute of Cancer Research Genetics Core Facility, which is managed by S. H. and N. R. We acknowledge National Health Service (NHS) funding to the Royal Marsden/Institute of Cancer Research National Institute for Health Research (NIHR) Biomedical Research Centre. We also thank Mariani Foundation Milan for supporting the clinical activity of Genetica Clinica Pediatrica, Fondazione MBBM, AO San Gerardo Monza. This research was supported by the Wellcome Trust (100210/Z/12/Z) and by the Institute of Cancer Research, London.	Abdel-Wahab O, 2013, BLOOD, V121, P3563, DOI 10.1182/blood-2013-01-451781; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cerveira N, 2003, LEUKEMIA, V17, P2244, DOI 10.1038/sj.leu.2403104; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Durand C, 2013, NAT REV ENDOCRINOL, V9, P171, DOI 10.1038/nrendo.2012.251; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Hata K, 2002, DEVELOPMENT, V129, P1983; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lund K, 2014, LEUKEMIA, V28, P44, DOI 10.1038/leu.2013.288; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Morishita M, 2011, BIOCHEM BIOPH RES CO, V412, P214, DOI 10.1016/j.bbrc.2011.07.061; Nikoloski G, 2012, INT J HEMATOL, V95, P8, DOI 10.1007/s12185-011-0996-3; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Rimmer A, 2012, PLATYPUS INTEGRATED; Rush Margaret, 2009, Epigenetics, V4, P404; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Tatton-Brown K, 2013, AM J MED GENET C, V163C, P71, DOI 10.1002/ajmg.c.31362; Tatton-Brown K, 2013, AM J MED GENET C, V163C, P86, DOI 10.1002/ajmg.c.31359; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	28	189	191	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					385	+		10.1038/ng.2917	http://dx.doi.org/10.1038/ng.2917			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24614070	Green Accepted, Green Submitted			2022-12-25	WOS:000334510100016
J	Ravikumar, A; Arrieta, A; Liu, CC				Ravikumar, Arjun; Arrieta, Adrian; Liu, Chang C.			An orthogonal DNA replication system in yeast	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; SPONTANEOUS MUTATION; KILLER PLASMID; DECARBOXYLASE; EVOLUTION; MICROBES; FUSION; PGKL1	An extranuclear replication system, consisting of an orthogonal DNA plasmid-DNA polymerase pair, was developed in Saccharomyces cerevisiae. Engineered error-prone DNA polymerases showed complete mutational targeting in vivo: per-base mutation rates on the plasmid were increased substantially and remained stable with no increase in genomic rates. Orthogonal replication serves as a platform for in vivo continuous evolution and as a system whose replicative properties can be manipulated independently of the host's.	[Ravikumar, Arjun; Arrieta, Adrian; Liu, Chang C.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Liu, Chang C.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Liu, Chang C.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Liu, CC (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	ccl@uci.edu		Arrieta, Adrian/0000-0002-1875-5714; Liu, Chang/0000-0002-3290-2880	University of California-Irvine; US National Science Foundation	University of California-Irvine(University of California System); US National Science Foundation(National Science Foundation (NSF))	This research was funded by generous startup funds from the University of California-Irvine to C. C. L. and a US National Science Foundation Graduate Research Fellowship to A. R. We are greatly indebted to A. P. Arkin and members of the Miller Institute of the University of California-Berkeley for early encouragement of this idea. We thank R. Rezvani, K. F. Kearns and K. H. Spencer for experimental assistance. We thank J.E. Dueber (University of California-Berkeley) for helpful discussions and the gift of certain yeast expression plasmids. We thank P. G. Schultz, J.A. Wells and G. A. Weiss for valuable comments on our work.	An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Burker D.J., 2005, METHODS YEAST GENETI; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Finney-Manchester SP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt150; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Frishman F., 1975, P NATO ADV STUDY I, P401; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GUNGE N, 1981, J BACTERIOL, V147, P155, DOI 10.1128/JB.147.1.155-160.1981; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; JUNG GH, 1987, NUCLEIC ACIDS RES, V15, P9088, DOI 10.1093/nar/15.21.9088; KAMPER J, 1991, CURR GENET, V19, P109, DOI 10.1007/BF00326291; Klassen Roland, 2007, V7, P187, DOI 10.1007/7171_2007_095; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Miller BG, 2002, ANNU REV BIOCHEM, V71, P847, DOI 10.1146/annurev.biochem.71.110601.135446; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; ROSE MD, 1991, ANNU REV MICROBIOL, V45, P539; SMILEY JA, 1992, BIOCHEMISTRY-US, V31, P12162, DOI 10.1021/bi00163a027; Uil TG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1258	23	59	66	14	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					175	+		10.1038/NCHEMBIO.1439	http://dx.doi.org/10.1038/NCHEMBIO.1439			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24487693				2022-12-25	WOS:000331616900006
J	Vriens, J; Held, K; Janssens, A; Toth, BI; Kerselaers, S; Nilius, B; Vennekens, R; Voets, T				Vriens, Joris; Held, Katharina; Janssens, Annelies; Toth, Balazs Istvan; Kerselaers, Sara; Nilius, Bernd; Vennekens, Rudi; Voets, Thomas			Opening of an alternative ion permeation pathway in a nociceptor TRP channel	NATURE CHEMICAL BIOLOGY			English	Article							PREGNENOLONE SULFATE; POTASSIUM CHANNEL; SODIUM-CHANNELS; PORE DILATION; DOUBLE-BLIND; GATING PORE; IN-VITRO; CLOTRIMAZOLE; RECEPTOR; COLD	Sensory neurons detect chemical stimuli through projections in the skin and mucosa, where several transient receptor potential (TRP) channels act as primary chemosensors. TRP channels are tetramers, and it is generally accepted that binding of ligands causes the opening of a single central cation-conducting pore. Contrary to this view, we here provide evidence for a second permeation pathway in the TRP channel TRPM3, which can be gated by combined application of endogenous neurosteroids and exogenous chemicals such as clotrimazole or several structurally related drugs. This alternative pathway is preserved following desensitization, blockade, mutagenesis and chemical modification of the central pore and enables massive Na+ influx at negative voltages. Opening of this alternative pathway can enhance excitation of sensory neurons and thereby exacerbate TRPM3-dependent pain. Our findings indicate that a single sensory TRP channel can encompass two distinct ionotropic chemoreceptors, which may have important ramifications for TRP channel function and pharmacology.	[Vriens, Joris; Held, Katharina; Janssens, Annelies; Toth, Balazs Istvan; Kerselaers, Sara; Nilius, Bernd; Vennekens, Rudi; Voets, Thomas] Katholieke Univ Leuven, Lab Ion Channel Res, Louvain, Belgium; [Vriens, Joris; Held, Katharina; Janssens, Annelies; Toth, Balazs Istvan; Kerselaers, Sara; Nilius, Bernd; Vennekens, Rudi; Voets, Thomas] Katholieke Univ Leuven, TRP Res Platform Leuven TRPLe, Louvain, Belgium; [Vriens, Joris; Held, Katharina] Katholieke Univ Leuven, Lab Obstet & Expt Gynaecol, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven	Voets, T (corresponding author), Katholieke Univ Leuven, Lab Ion Channel Res, Louvain, Belgium.	joris.vriens@med.kuleuven.be; thomas.voets@med.kuleuven.be	Held, Katharina/AAR-4020-2021; Voets, Thomas/AAD-4389-2019; Tóth, Balázs István/K-1214-2013; Held, Katharina/AAU-4515-2020; Vennekens, Rudi/AAQ-1664-2020; Vriens, Joris/G-9966-2018	Voets, Thomas/0000-0001-5526-5821; Tóth, Balázs István/0000-0002-4103-4333; Vennekens, Rudi/0000-0002-2564-5150; Vriens, Joris/0000-0002-2502-0409; Janssens, Annelies/0000-0002-6735-8248; Held, Katharina/0000-0002-1727-9517	Belgian Federal Government [IUAP P7/13]; Research Foundation-Flanders [G.0565.07, G.0825.11]; Research Council of the KU Leuven [GOA 2009/07]; Planckaert-De Waele fund; Marie Curie Intra-European Fellowship within the Seventh European Community Framework Programme	Belgian Federal Government; Research Foundation-Flanders(FWO); Research Council of the KU Leuven(KU Leuven); Planckaert-De Waele fund; Marie Curie Intra-European Fellowship within the Seventh European Community Framework Programme	We thank all members of the Laboratory of Ion Channel Research for helpful discussions. We thank the Cell Banking Facility of the Physiology Department at the Institute of Functional Genomics (Montpellier, France) for the F11 cell line. This work was supported by grants from the Belgian Federal Government (IUAP P7/13 to T. V.), the Research Foundation-Flanders (G.0565.07 and G.0825.11 to T. V. and J.V.), the Research Council of the KU Leuven (GOA 2009/07 and PF-TRPLe to T. V. and R. V.), the Planckaert-De Waele fund (to J.V.) and by a Marie Curie Intra-European Fellowship within the Seventh European Community Framework Programme (to B.I.T.).	Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; BINET O, 1994, MYCOSES, V37, P455, DOI 10.1111/j.1439-0507.1994.tb00400.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Ciurtin C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-111; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Czerninski R, 2010, CLIN ORAL INVEST, V14, P71, DOI 10.1007/s00784-009-0275-3; del Palacio A, 2001, MYCOSES, V44, P173, DOI 10.1046/j.1439-0507.2001.00632.x; ERLIJ D, 1994, J PHYSIOL-LONDON, V481, P533, DOI 10.1113/jphysiol.1994.sp020461; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Havlikova H, 2002, J CLIN ENDOCR METAB, V87, P2225, DOI 10.1210/jc.87.5.2225; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNaughton-Smith GA, 2008, J MED CHEM, V51, P976, DOI 10.1021/jm070663s; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Morley JE, 1997, P NATL ACAD SCI USA, V94, P7537, DOI 10.1073/pnas.94.14.7537; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Tai KK, 1998, NATURE, V391, P605, DOI 10.1038/35416; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Torres-Rodriguez JM, 1999, ANTIMICROB AGENTS CH, V43, P1258, DOI 10.1128/AAC.43.5.1258; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	44	61	62	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					188	+		10.1038/NCHEMBIO.1428	http://dx.doi.org/10.1038/NCHEMBIO.1428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24390427				2022-12-25	WOS:000331616900009
J	Pasquali, L; Gaulton, KJ; Rodriguez-Segui, SA; Mularoni, L; Miguel-Escalada, I; Akerman, I; Tena, JJ; Moran, I; Gomez-Marin, C; van de Bunt, M; Ponsa-Cobas, J; Castro, N; Nammo, T; Cebola, I; Garcia-Hurtado, J; Maestro, MA; Pattou, F; Piemonti, L; Berney, T; Gloyn, AL; Ravassard, P; Gomez-Skarmeta, JL; Muller, F; McCarthy, MI; Ferrer, J				Pasquali, Lorenzo; Gaulton, Kyle J.; Rodriguez-Segui, Santiago A.; Mularoni, Loris; Miguel-Escalada, Irene; Akerman, Ildem; Tena, Juan J.; Moran, Ignasi; Gomez-Marin, Carlos; van de Bunt, Martijn; Ponsa-Cobas, Joan; Castro, Natalia; Nammo, Takao; Cebola, Ines; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Pattou, Francois; Piemonti, Lorenzo; Berney, Thierry; Gloyn, Anna L.; Ravassard, Philippe; Luis Gomez-Skarmeta, Jose; Mueller, Ferenc; McCarthy, Mark I.; Ferrer, Jorge			Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants	NATURE GENETICS			English	Article							BETA-CELL; TRANSCRIPTION FACTORS; HISTONE MODIFICATIONS; PROVIDES INSIGHTS; GENE; CHROMATIN; GENOME; EXPRESSION; GLUCOSE; LIVER	Type 2 diabetes affects over 300 million people, causing severe complications and premature death, yet the underlying molecular mechanisms are largely unknown. Pancreatic islet dysfunction is central in type 2 diabetes pathogenesis, and understanding islet genome regulation could therefore provide valuable mechanistic insights. We have now mapped and examined the function of human islet cis-regulatory networks. We identify genomic sequences that are targeted by islet transcription factors to drive islet-specific gene activity and show that most such sequences reside in clusters of enhancers that form physical three-dimensional chromatin domains. We find that sequence variants associated with type 2 diabetes and fasting glycemia are enriched in these clustered islet enhancers and identify trait-associated variants that disrupt DNA binding and islet enhancer activity. Our studies illustrate how islet transcription factors interact functionally with the epigenome and provide systematic evidence that the dysregulation of islet enhancers is relevant to the mechanisms underlying type 2 diabetes.	[Pasquali, Lorenzo; Rodriguez-Segui, Santiago A.; Mularoni, Loris; Akerman, Ildem; Castro, Natalia; Nammo, Takao; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain; [Pasquali, Lorenzo; Mularoni, Loris; Akerman, Ildem; Castro, Natalia; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Ferrer, Jorge] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Gaulton, Kyle J.; van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford OX3 7LJ, England; [Miguel-Escalada, Irene; Mueller, Ferenc] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Tena, Juan J.; Gomez-Marin, Carlos; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide Junta Andalucia, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Moran, Ignasi; Ponsa-Cobas, Joan; Cebola, Ines; Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Pattou, Francois] Univ Lille 2, INSERM Biotherapies Diabet U859, Lille, France; [Piemonti, Lorenzo] Ist Sci San Raffaele, Diabet Res Inst, I-20132 Milan, Italy; [Berney, Thierry] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Berney, Thierry] Univ Geneva, Geneva, Switzerland; [Ravassard, Philippe] Univ Paris 06, INSERM U975, CNRS UMR 7225, Biotechnol & Biotherapy Team,Ctr Rech,Inst Cervea, Paris, France	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Birmingham; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ferrer, J (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain.	j.ferrer@imperial.ac.uk	Berney, Thierry/ABE-9450-2021; Pasquali, Lorenzo/B-6239-2008; Pattou, Francois/O-6151-2017; Tena, Juan J./Q-5995-2019; Piemonti, Lorenzo/P-7605-2017; Ferrer, Jorge/A-3176-2012; Gómez-Marín, Carlos/AAX-2173-2021; Moran, Ignasi/AAA-6417-2020; Miguel-Escalada, Irene/J-6535-2014; Gomez-Skarmeta, Jose Luis/B-5268-2014; Tena, Juan J/M-2265-2014; Mularoni, Loris/B-3777-2017; Cebola, Inês/AAG-9652-2020; McCarthy, Mark/M-3763-2015	Berney, Thierry/0000-0002-4230-9378; Pasquali, Lorenzo/0000-0003-2423-1826; Pattou, Francois/0000-0001-8388-3766; Tena, Juan J./0000-0001-8165-7984; Piemonti, Lorenzo/0000-0002-2172-2198; Ferrer, Jorge/0000-0002-5959-5729; Moran, Ignasi/0000-0002-3307-7106; Miguel-Escalada, Irene/0000-0003-3461-6404; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Tena, Juan J/0000-0001-8165-7984; Mularoni, Loris/0000-0001-7053-7717; Cebola, Inês/0000-0003-3528-4982; Garcia-Hurtado, Javier/0000-0001-5271-3107; van de Bunt, Martijn/0000-0002-6744-6125; McCarthy, Mark/0000-0002-4393-0510; Gloyn, Anna/0000-0003-1205-1844; Gaulton, Kyle/0000-0003-1318-7161; Rodriguez-Segui, Santiago A./0000-0003-2952-8485; Akerman, Ildem/0000-0002-9875-1421; Gomez-Marin, Carlos/0000-0001-9724-2919; ravassard, philippe/0000-0002-0393-9262; mueller, ferenc/0000-0002-0996-774X	National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes; Biomedical Research Council of Singapore; National Research Foundation (NRF); European Foundation for the Study of Diabetes Lilly fellowship; Ministerio de Econom a y Competitividad [SAF2011-27086, BFU2010-14839, CSD2007-00008]; Innovative Medicines Initiative; Andalusian Government [CVI-3488]; Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network; Wellcome Trust [090532, 098381, 090367, 095101, 101033]; Juvenile Diabetes Research Foundation [31-2012-783]; Framework Programme 7 [HEALTH-F4-2007-201413]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF); European Foundation for the Study of Diabetes Lilly fellowship; Ministerio de Econom a y Competitividad(Spanish Government); Innovative Medicines Initiative; Andalusian Government; Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network; Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Framework Programme 7; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J.Rios (IDIBAPS) for expert statistical advice, M. Parsons (Johns Hopkins University) for Tg(ins: mCherry)jh2 transgenics and R. Stein (Vanderbilt University), J. Habener (Harvard University) and G. Gradwohl (Institute of Genetics and Molecular and Cellular Biology) for MAFA, IDX1, and NGN3 DNA constructs.We thank the DIAGRAM and MAGIC consortia, the Singapore Prospective Study Program, the Singapore Consortium of Cohort Studies, the Singapore Indian Eye Study, the Singapore Malay Eye Study and Y.Y.Teo, E.S.Tai, T.Y. Wong, W.Y. Lim and X.Wang (National University of Singapore; funded by the National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes, the Biomedical Research Council of Singapore and the National Research Foundation (NRF) Fellowship scheme).This work was carried out in part at the Centre Esther Koplowitz. This work was funded by grants from a European Foundation for the Study of Diabetes Lilly fellowship (L.Pasquali), the Ministerio de Econom a y Competitividad (SAF2011-27086 to J.F., BFU2010-14839 and CSD2007-00008 to J.L.G.S.), the Innovative Medicines Initiative (DIRECT to M.I.M. and J.F.), the Andalusian Government (CVI-3488 to J.L.G.S.), the Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network (F.M.and J.F.), the Wellcome Trust (090532, 098381 and 090367 to M.I.M., 095101 to A.L.G., 101033 to J.F.), Juvenile Diabetes Research Foundation (31-2012-783 to T.B., F.P. and L. Piemonti) and Framework Programme 7 (HEALTH-F4-2007-201413 to M.I.M.).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hindorff LA, CATALOG PUBLISHED GE; Hu LP, 2005, AM J PHYSIOL-ENDOC M, V289, pE1085, DOI 10.1152/ajpendo.00210.2005; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rozen S, 2000, Methods Mol Biol, V132, P365; Sander M, 2000, DEVELOPMENT, V127, P5533; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Tennant BR, 2013, DIABETOLOGIA, V56, P542, DOI 10.1007/s00125-012-2797-5; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	71	342	346	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					136	+		10.1038/ng.2870	http://dx.doi.org/10.1038/ng.2870			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413736	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000331208300009
J	Dolgin, E				Dolgin, Elie			ENCAPSULATE THIS	NATURE MEDICINE			English	News Item																		Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110; Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744; Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1	4	41	44	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					9	11		10.1038/nm0114-9	http://dx.doi.org/10.1038/nm0114-9			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398953				2022-12-25	WOS:000329349400007
J	Komatsu, N; Okamoto, K; Sawa, S; Nakashima, T; Oh-hora, M; Kodama, T; Tanaka, S; Bluestone, JA; Takayanagi, H				Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Nakashima, Tomoki; Oh-hora, Masatsugu; Kodama, Tatsuhiko; Tanaka, Sakae; Bluestone, Jeffrey A.; Takayanagi, Hiroshi			Pathogenic conversion of Foxp3(+) T cells into T(H)17 cells in autoimmune arthritis	NATURE MEDICINE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; RHEUMATOID-ARTHRITIS; TNF-ALPHA; INDUCTION; PLASTICITY; IMMUNE; DIFFERENTIATION; POPULATION; ACTIVATION; EXPRESSION	Autoimmune diseases often result from an imbalance between regulatory T (T-reg) cells and interleukin-17 (IL-17)-producing T helper (T(H)17) cells; the origin of the latter cells remains largely unknown. Foxp3 is indispensable for the suppressive function of Treg cells, but the stability of Foxp3 has been under debate. Here we show that T(H)17 cells originating from Foxp3(+) T cells have a key role in the pathogenesis of autoimmune arthritis. Under arthritic conditions, CD25(lo)Foxp3(+)CD4(+) T cells lose Foxp3 expression (herein called exFoxp3 cells) and undergo transdifferentiation into T(H)17 cells. Fate mapping analysis showed that IL-17-expressing exFoxp3 T (exFoxp3 T(H)17) cells accumulated in inflamed joints. The conversion of Foxp3(+)CD4(+) T cells to T(H)17 cells was mediated by synovial fibroblast-derived IL-6. These exFoxp3 T(H)17 cells were more potent osteoclastogenic T cells than were naive CD4(+) T cell-derived T(H)17 cells. Notably, exFoxp3 T(H)17 cells were characterized by the expression of Sox4, chemokine (C-C motif) receptor 6 (CCR6), chemokine (C-C motif) ligand 20 (CCL20), IL-23 receptor (IL-23R) and receptor activator of NF-kappa B ligand (RANKL, also called TNFSF11). Adoptive transfer of autoreactive, antigen-experienced CD25(lo)Foxp3(+)CD4(+) T cells into mice followed by secondary immunization with collagen accelerated the onset and increased the severity of arthritis and was associated with the loss of Foxp3 expression in the majority of transferred T cells. We observed IL-17(+)Foxp3(+) T cells in the synovium of subjects with active rheumatoid arthritis (RA), which suggests that plastic Foxp3(+) T cells contribute to the pathogenesis of RA. These findings establish the pathological importance of Foxp3 instability in the generation of pathogenic T(H)17 cells in autoimmunity.	[Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Takayanagi, Hiroshi] Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan; [Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Nakashima, Tomoki; Takayanagi, Hiroshi] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Oh-hora, Masatsugu] Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Oh-hora, Masatsugu] JST, Precursory Res Embryon Sci & Technol Program, Bunkyo Ku, Tokyo, Japan; [Oh-hora, Masatsugu] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Takayanagi, Hiroshi] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; University of California System; University of California San Francisco; University of Western Australia	Takayanagi, H (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	takayana@m.u-tokyo.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	JST; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046643] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24117725] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to S. Hori (RIKEN Center for Integrative Medical Sciences) and Y. Iwakura (Tokyo University of Science) for providing B6.Foxp3<SUP>hCD2</SUP> knock-in mice and Il17a<SUP>-/-</SUP> mice, respectively. We also thank T. Negishi-Koga, M. Shinohara, A. Terashima, M. Guerrini, L. Danks, M. Hayashi, T. Ando, Y. Ogiwara, N. Otsuka, T. Kato, C. Tsuda, T. Suda, A. Suematsu, S. Fukuse, Y. Wada, A. Izumi and K. Kaneki for discussion and assistance. This work was supported in part by a grant for the ERATO Takayanagi Osteonetwork Project from JST; a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for JSPS Fellows; and a grant for the GCOE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan. N. K. was supported by JSPS Research Fellowships for Young Scientists.	Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ramezani-Rad P, 2013, BLOOD, V121, P148, DOI 10.1182/blood-2012-05-428938; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wehrens EJ, 2013, NAT REV RHEUMATOL, V9, P34, DOI 10.1038/nrrheum.2012.149; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	42	677	715	7	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					62	+		10.1038/nm.3432	http://dx.doi.org/10.1038/nm.3432			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24362934	Green Published			2022-12-25	WOS:000329349400020
J	Huang, HT; Kathrein, KL; Barton, A; Gitlin, Z; Huang, YH; Ward, TP; Hofmann, O; Dibiase, A; Song, AH; Tyekucheva, S; Hide, W; Zhou, Y; Zon, LI				Huang, Hsuan-Ting; Kathrein, Katie L.; Barton, Abby; Gitlin, Zachary; Huang, Yue-Hua; Ward, Thomas P.; Hofmann, Oliver; Dibiase, Anthony; Song, Anhua; Tyekucheva, Svitlana; Hide, Winston; Zhou, Yi; Zon, Leonard I.			A network of epigenetic regulators guides developmental haematopoiesis in vivo	NATURE CELL BIOLOGY			English	Article							EMBRYONIC-DEVELOPMENT; CHROMATIN; TRANSCRIPTION; GENE; IDENTIFICATION; PROTEIN; P300; EXPRESSION; REPRESSION; DEFECTS	The initiation of cellular programs is orchestrated by key transcription factors and chromatin regulators that activate or inhibit target gene expression. To generate a compendium of chromatin factors that establish the epigenetic code during developmental haematopoiesis, a large-scale reverse genetic screen was conducted targeting orthologues of 425 human chromatin factors in zebrafish. A set of chromatin regulators was identified that target different stages of primitive and definitive blood formation, including factors not previously implicated in haematopoiesis. We identified 15 factors that regulate development of primitive erythroid progenitors and 29 factors that regulate development of definitive haematopoietic stem and progenitor cells. These chromatin factors are associated with SWI/SNF and ISWI chromatin remodelling, SET1 methyltransferase, CBP-p300-HBO1-NuA4 acetyltransferase, HDAC-NuRD deacetylase, and Polycomb repressive complexes. Our work provides a comprehensive view of how specific chromatin factors and their associated complexes play a major role in the establishment of haematopoietic cells in vivo.	[Huang, Hsuan-Ting; Zon, Leonard I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Huang, Hsuan-Ting; Kathrein, Katie L.; Barton, Abby; Gitlin, Zachary; Huang, Yue-Hua; Ward, Thomas P.; Dibiase, Anthony; Song, Anhua; Zhou, Yi; Zon, Leonard I.] Childrens Hosp Boston, Stem Cell Program, Boston, MA 02115 USA; [Huang, Hsuan-Ting; Kathrein, Katie L.; Barton, Abby; Gitlin, Zachary; Huang, Yue-Hua; Ward, Thomas P.; Dibiase, Anthony; Song, Anhua; Zhou, Yi; Zon, Leonard I.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Huang, Hsuan-Ting; Kathrein, Katie L.; Barton, Abby; Gitlin, Zachary; Huang, Yue-Hua; Ward, Thomas P.; Dibiase, Anthony; Song, Anhua; Zhou, Yi; Zon, Leonard I.] Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Hofmann, Oliver; Hide, Winston; Zon, Leonard I.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Tyekucheva, Svitlana; Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Tyekucheva, Svitlana] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Zon, LI (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017; Hide, Winston/R-3815-2019; Hofmann, Oliver/F-1800-2013	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hofmann, Oliver/0000-0002-7738-1513	NIH NIDDK [5R01DK053298-15, 5P30 DK49216-19, DK53298-15, R24 DK092760-02, 1F32DK089876-01]; NIH NHLBI [5R01HL048801-21, T32 HL066987-09]; HHMI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, R24DK092760, P30DK056465, F32DK089876, R01DK053298] Funding Source: NIH RePORTER	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); HHMI(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank O. Tamplin, T. V. Bowman, P. Cahan and C. K. Kaufman for helpful discussions. The work was supported by NIH NIDDK 5R01DK053298-15, NIH NHLBI 5R01HL048801-21, NIH NIDDK 5P30 DK49216-19, NIH NIDDK DK53298-15, NIH NIDDK R24 DK092760-02, HHMI (to L.I.Z.), NIH NHLBI T32 HL066987-09 and NIH NIDDK 1F32DK089876-01 (to K.L.K).	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; Duhoux FP, 2012, BRIT J HAEMATOL, V156, P76, DOI 10.1111/j.1365-2141.2011.08918.x; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Gregg RG, 2003, P NATL ACAD SCI USA, V100, P6535, DOI 10.1073/pnas.0631813100; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lawrence C, 2012, LAB ANIMAL, V41, P158, DOI 10.1038/laban0612-158; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peter B. B., 2011, PLOS BIOL, V9; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rivera CG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S61; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Takihara Y, 2008, INT J HEMATOL, V87, P25, DOI 10.1007/s12185-007-0006-y; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; van der Velden YU, 2012, DEVELOPMENT, V139, P2210, DOI 10.1242/dev.077156; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; WANG W, 1998, P NATL ACAD SCI USA, V195, P95; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	48	64	66	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1516	+		10.1038/ncb2870	http://dx.doi.org/10.1038/ncb2870			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24240475	Green Submitted, Green Accepted			2022-12-25	WOS:000327944200016
J	Xia, Y; Nivet, E; Sancho-Martinez, I; Gallegos, T; Suzuki, K; Okamura, D; Wu, MZ; Dubova, I; Esteban, CR; Montserrat, N; Campistol, JM; Belmonte, JCI				Xia, Yun; Nivet, Emmanuel; Sancho-Martinez, Ignacio; Gallegos, Thomas; Suzuki, Keiichiro; Okamura, Daiji; Wu, Min-Zu; Dubova, Ilir; Esteban, Concepcion Rodriguez; Montserrat, Nuria; Campistol, Josep M.; Izpisua Belmonte, Juan Carlos			Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; BRANCHING MORPHOGENESIS; IN-VITRO; EPITHELIA; SPECIFICATION; EXPRESSION; DISEASE; LINEAGE; MODELS; FATE	Diseases affecting the kidney constitute a major health issue worldwide. Their incidence and poor prognosis affirm the urgent need for the development of new therapeutic strategies. Recently, differentiation of pluripotent cells to somatic lineages has emerged as a promising approach for disease modelling and cell transplantation. Unfortunately, differentiation of pluripotent cells into renal lineages has demonstrated limited success. Here we report on the differentiation of human pluripotent cells into ureteric-bud-committed renal progenitor-like cells. The generated cells demonstrated rapid and specific expression of renal progenitor markers on 4-day exposure to defined media conditions. Further maturation into ureteric bud structures was accomplished on establishment of a three-dimensional culture system in which differentiated human cells assembled and integrated alongside murine cells for the formation of chimeric ureteric buds. Altogether, our results provide a new platform for the study of kidney diseases and lineage commitment, and open new avenues for the future application of regenerative strategies in the clinic.	[Xia, Yun; Nivet, Emmanuel; Sancho-Martinez, Ignacio; Gallegos, Thomas; Suzuki, Keiichiro; Okamura, Daiji; Wu, Min-Zu; Dubova, Ilir; Esteban, Concepcion Rodriguez; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Sancho-Martinez, Ignacio; Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Montserrat, Nuria] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 50018, Spain; [Campistol, Josep M.] Univ Barcelona, Div Renal, Hosp Clin, E-08036 Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Xia, Yun/K-4128-2015; Montserrat, Nuria/F-3136-2016; Nivet, Emmanuel/C-2729-2014	Xia, Yun/0000-0003-2184-4870; Montserrat, Nuria/0000-0002-1603-1755; Nivet, Emmanuel/0000-0001-7903-4059; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Josep M, Campistol/0000-0001-6244-0253; Suzuki, Keiichiro/0000-0001-5603-9105	California Institute for Regenerative Medicine; Nomis Foundation; Fundacion Cellex; G. Harold and L. Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; IPSEN Foundation; Fundacio La Marato de TV3 [121330]; CIBER BBN; ISCIII-TERCEL-MINECO	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Nomis Foundation; Fundacion Cellex(Foundation CELLEX); G. Harold and L. Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; IPSEN Foundation(Ipsen); Fundacio La Marato de TV3; CIBER BBN; ISCIII-TERCEL-MINECO	We thank M. Schwarz for administrative support. We thank J. Kasuboski from Waitt Advanced Biophotonics Core at Salk for help with imaging processing. We thank B. C. Lu for his suggestions regarding kidney dissection and organ culture. Y.X. and K.S. were partially supported by the California Institute for Regenerative Medicine. I.S-M. was partially supported by a Nomis Foundation postdoctoral fellowship. Work in the laboratory of J.C.I.B. was supported by grants from Fundacion Cellex, the G. Harold and L. Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, IPSEN Foundation, Fundacio La Marato de TV3 (121330), CIBER BBN and ISCIII-TERCEL-MINECO.	Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Bruce SJ, 2007, DIFFERENTIATION, V75, P337, DOI 10.1111/j.1432-0436.2006.00149.x; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Davies Jamie A, 2012, Methods Mol Biol, V886, P135, DOI 10.1007/978-1-61779-851-1_12; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuure S, 2005, MECH DEVELOP, V122, P765, DOI 10.1016/j.mod.2005.03.006; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Little MH, 2012, COLD SPRING HARB PER, V4; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Nagao S, 2010, AM J PHYSIOL-RENAL, V299, pF1078, DOI 10.1152/ajprenal.00504.2009; Narayanan K, 2013, KIDNEY INT, V83, P593, DOI 10.1038/ki.2012.442; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Ren XH, 2010, ACTA BIOCH BIOPH SIN, V42, P464, DOI 10.1093/abbs/gmq046; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Song B., 2012, PLOS ONE, V7; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328	33	220	229	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1507	+		10.1038/ncb2872	http://dx.doi.org/10.1038/ncb2872			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24240476				2022-12-25	WOS:000327944200015
J	Heinrich, S; Geissen, EM; Kamenz, J; Trautmann, S; Widmer, C; Drewe, P; Knop, M; Radde, N; Hasenauer, J; Hauf, S				Heinrich, Stephanie; Geissen, Eva-Maria; Kamenz, Julia; Trautmann, Susanne; Widmer, Christian; Drewe, Philipp; Knop, Michael; Radde, Nicole; Hasenauer, Jan; Hauf, Silke			Determinants of robustness in spindle assembly checkpoint signalling	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; CYCLE-REGULATED GENES; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; MITOTIC CHECKPOINT; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; CHROMOSOME INSTABILITY; BIOLOGICAL NOISE	The spindle assembly checkpoint is a conserved signalling pathway that protects genome integrity. Given its central importance, this checkpoint should withstand stochastic fluctuations and environmental perturbations, but the extent of and mechanisms underlying its robustness remain unknown. We probed spindle assembly checkpoint signalling by modulating checkpoint protein abundance and nutrient conditions in fission yeast. For core checkpoint proteins, a mere 20% reduction can suffice to impair signalling, revealing a surprising fragility. Quantification of protein abundance in single cells showed little variability (noise) of critical proteins, explaining why the checkpoint normally functions reliably. Checkpoint-mediated stoichiometric inhibition of the anaphase activator Cdc20 (Slpl in Schizosaccharomyces pombe) can account for the tolerance towards small fluctuations in protein abundance and explains our observation that some perturbations lead to non-genetic variation in the checkpoint response. Our work highlights low gene expression noise as an important determinant of reliable checkpoint signalling.	[Heinrich, Stephanie; Kamenz, Julia; Widmer, Christian; Drewe, Philipp; Hauf, Silke] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Geissen, Eva-Maria; Radde, Nicole] Univ Stuttgart, Inst Syst Theory & Automat Control, D-70550 Stuttgart, Germany; [Trautmann, Susanne; Knop, Michael] EMBL, D-69117 Heidelberg, Germany; [Widmer, Christian; Drewe, Philipp] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Knop, Michael] Heidelberg Univ, DKFZ ZMBH Allianz, Deutsch Krebsforschungszentrum, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Hasenauer, Jan] Helmholtz Zentrum Munchen, Inst Computat Biol, D-85764 Neuherberg, Germany; [Hasenauer, Jan] Tech Univ Munich, Dept Math, D-85748 Garching, Germany	Eberhard Karls University of Tubingen; Max Planck Society; University of Stuttgart; European Molecular Biology Laboratory (EMBL); Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hauf, S (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany.	silke.hauf@tuebingen.mpg.de	Heinrich, Stephanie/AAL-1508-2020; Geissen, Eva-Maria/AAZ-7040-2020; Hauf, Silke/H-7321-2012; Hasenauer, Jan/B-8853-2013	Heinrich, Stephanie/0000-0003-1607-4525; Hauf, Silke/0000-0001-5938-721X; Hasenauer, Jan/0000-0002-4935-3312; Kamenz, Julia/0000-0001-9673-5404; Boss, Philipp/0000-0002-5459-9771	Max Planck Society; Ernst Schering Foundation; Boehringer Ingelheim Fonds; Memorial Sloan-Kettering Cancer Center; Cluster of Excellence in Simulation Technology (EXC 310) of the German Research Foundation (DFG); Human Frontier Science Program (HFSP); Ministry of Science, Research and Arts of Baden-Wurttemberg; Federal Ministry of Education and Research (BMBF) within the Virtual Liver project [0315766]	Max Planck Society(Max Planck Society); Ernst Schering Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Memorial Sloan-Kettering Cancer Center; Cluster of Excellence in Simulation Technology (EXC 310) of the German Research Foundation (DFG); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Ministry of Science, Research and Arts of Baden-Wurttemberg; Federal Ministry of Education and Research (BMBF) within the Virtual Liver project	We thank S. Umrania and G. Raetsch for help with developing image analysis software, M. Wachsmuth for FCS analysis software, D. Zenklusen and S-R. Imrazene for sharing their FISH protocol, B. Schwalb and A. Tresch for providing mRNA half-life measurements, N. Hustedt and J. Sauerwald for experiments, E. Illgen, E. Schwoerzer, J. Binder, F. Bolukbasi and W. Hauf for excellent technical help, T. Holder for data processing scripts, C. Liebig for advice on image processing, and F. Theis for support in developing the multi-experiment modelling. We are grateful to K. Gull and T. Matsumoto for antibodies, and to F. Bono, F. Herzog, M. Hothorn, S. Legewie and Y. Watanabe for comments on the manuscript. This work was supported by the Max Planck Society (S. Hauf, S. Heinrich, J.K., C.W. and P.D.), the Ernst Schering Foundation (fellowship to S. Heinrich), the Boehringer Ingelheim Fonds (fellowship to J.K.), the Memorial Sloan-Kettering Cancer Center (C.W. and P.D.), the Cluster of Excellence in Simulation Technology (EXC 310) of the German Research Foundation (DFG; N.R.), the Human Frontier Science Program (HFSP; postdoctoral fellowship to ST.), the funding program for junior professors of the Ministry of Science, Research and Arts of Baden-Wurttemberg (E-M.G. and N.R.), and the Federal Ministry of Education and Research (BMBF) within the Virtual Liver project (Grant No. 0315766; J.H.).	Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Barnhart EL, 2011, MOL BIOL CELL, V22, P2448, DOI 10.1091/mbc.E09-01-0029; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Doncic A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100070; Emre D, 2011, J CELL SCI, V124, P1664, DOI 10.1242/jcs.081216; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; He XW, 1998, J CELL SCI, V111, P1635; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Heinrich S, 2012, J CELL SCI, V125, P4720, DOI 10.1242/jcs.110387; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Johnston K, 2010, J CELL BIOL, V189, P937, DOI 10.1083/jcb.200912022; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Krien MJE, 1998, J CELL SCI, V111, P967; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Matsumura T, 2003, GENES CELLS, V8, P341, DOI 10.1046/j.1365-2443.2003.00637.x; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mueller F, 2013, NAT METHODS, V10, P277, DOI 10.1038/nmeth.2406; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Perkins W., 2011, PREPRINT; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Ryan SD, 2012, P NATL ACAD SCI USA, V109, pE2205, DOI 10.1073/pnas.1201911109; Schmidt U, 2009, RNA, V15, P862, DOI 10.1261/rna.1387009; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Tange Y, 2007, GENETICS, V175, P1571, DOI 10.1534/genetics.106.061309; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Widmer C., 2013, PREPRINT; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Wu YJ, 2006, BIOMETRICS, V62, P877, DOI 10.1111/j.1541-0420.2006.00533.x; Yamada HY, 2000, J CELL SCI, V113, P3989; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zich J, 2012, CURR BIOL, V22, P296, DOI 10.1016/j.cub.2011.12.049	85	64	66	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1328	U155		10.1038/ncb2864	http://dx.doi.org/10.1038/ncb2864			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24161933				2022-12-25	WOS:000326680700009
J	Ertych, N; Stolz, A; Stenzinger, A; Weichert, W; Kaulfuss, S; Burfeind, P; Aigner, A; Wordeman, L; Bastians, H				Ertych, Norman; Stolz, Ailine; Stenzinger, Albrecht; Weichert, Wilko; Kaulfuss, Silke; Burfeind, Peter; Aigner, Achim; Wordeman, Linda; Bastians, Holger			Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells	NATURE CELL BIOLOGY			English	Article							MEROTELIC KINETOCHORE ORIENTATION; SMALL-MOLECULE INHIBITOR; MAMMALIAN TISSUE-CELLS; HUMAN SOMATIC-CELLS; MITOTIC SPINDLES; AURORA KINASE; CENTROSOME AMPLIFICATION; TUMOR-SUPPRESSOR; ANEUPLOIDY; DYNAMICS	Chromosomal instability (CIN) is defined as the perpetual missegregation of whole chromosomes during mitosis and represents a hallmark of human cancer. However, the mechanisms influencing CIN and its consequences on tumour growth are largely unknown. We identified an increase in microtubule plus-end assembly rates as a mechanism influencing CIN in colorectal cancer cells. This phenotype is induced by overexpression of the oncogene AURKA or by loss of the tumour suppressor gene CHK2, a genetic constitution found in 73% of human colorectal cancers. Increased microtubule assembly rates are associated with transient abnormalities in mitotic spindle geometry promoting the generation of lagging chromosomes and influencing CIN. Reconstitution of proper microtubule assembly rates by chemical or genetic means suppresses CIN and thereby, unexpectedly, accelerates tumour growth in vitro and in vivo. Thus, we identify a fundamental mechanism influencing CIN in cancer cells and reveal its adverse consequence on tumour growth.	[Ertych, Norman; Stolz, Ailine; Bastians, Holger] Goettingen Ctr Mol Biosci GZMB, Sect Cellular Oncol, Inst Mol Oncol, D-37077 Gottingen, Germany; [Ertych, Norman; Stolz, Ailine; Bastians, Holger] Univ Gottingen, Univ Med Ctr, D-37077 Gottingen, Germany; [Stenzinger, Albrecht; Weichert, Wilko] Heidelberg Univ, Univ Med Ctr, Inst Pathol, D-69120 Heidelberg, Germany; [Weichert, Wilko] German Consortium Translat Canc Res, D-69120 Heidelberg, Germany; [Kaulfuss, Silke; Burfeind, Peter] Univ Gottingen, Univ Med Ctr, Inst Human Genet, D-37073 Gottingen, Germany; [Aigner, Achim] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Wordeman, Linda] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Gottingen; Ruprecht Karls University Heidelberg; University of Gottingen; Leipzig University; University of Washington; University of Washington Seattle	Bastians, H (corresponding author), Goettingen Ctr Mol Biosci GZMB, Sect Cellular Oncol, Inst Mol Oncol, D-37077 Gottingen, Germany.	holger.bastians@uni-goettingen.de	Aigner, Achim/R-4429-2017	Aigner, Achim/0000-0002-2778-6256; Kaulfuss, Silke/0000-0003-2577-9711; Wordeman, Linda/0000-0002-9444-0650	Molecular Diagnostic Program of the German Consortium for Translational Cancer Research - Germany Ministry of Education and Research; National Institutes of Health [GM069429]; DFG;  [KFO179]; NATIONAL CANCER INSTITUTE [R21CA174527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069429] Funding Source: NIH RePORTER	Molecular Diagnostic Program of the German Consortium for Translational Cancer Research - Germany Ministry of Education and Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Vogelstein, M. Grade, M. Eilers, S. Duensing, I. Hoffmann, J. Chung, O. Sibon and M. Brandeis for cell lines and plasmids. We thank F. Alves and J. Napp for providing nude mice, R. Kampe and B. Obst for excellent technical assistance and T. Beissbarth for the help with statistical analyses. We are grateful to H. Krebber, Z. Storchova and all members of the Bastians laboratory for critically reading the manuscript. This work was supported by the Molecular Diagnostic Program of the German Consortium for Translational Cancer Research funded by the Germany Ministry of Education and Research (W. W.), the grant GM069429 from the National Institutes of Health (L. W.) and the DFG, the KFO179 and by a Heisenberg professorship awarded by the DFG to H. B.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Derry WB, 1998, CANCER RES, V58, P1177; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1992, J CELL SCI, V102, P401; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lin CH, 2010, J CELL BIOL, V189, P1097, DOI 10.1083/jcb.200911120; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Muller C, 2007, CANCER CHEMOTH PHARM, V59, P157, DOI 10.1007/s00280-006-0254-1; Orr B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00164; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sironi L, 2011, CYTOSKELETON, V68, P266, DOI 10.1002/cm.20510; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Thakur HC, 2013, BIOL CHEM, V394, P1411, DOI 10.1515/hsz-2013-0184; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	58	122	123	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					779	U274		10.1038/ncb2994	http://dx.doi.org/10.1038/ncb2994			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	24976383	Green Accepted			2022-12-25	WOS:000339904900010
J	Duhr, F; Deleris, P; Raynaud, F; Seveno, M; Lopez, SM; la Cour, CM; Millan, MJ; Bockaert, J; Marin, P; Chaumont-Dubel, S				Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Lopez, Severine Morisset; la Cour, Clotilde Mannoury; Millan, Mark J.; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine			Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth	NATURE CHEMICAL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; METABOTROPIC GLUTAMATE RECEPTORS; ACTIN POLYMERIZATION; NEURONAL MORPHOLOGY; CALCIUM CHANNELS; PHOSPHORYLATION; SEROTONIN; EXPRESSION; CDC42; DIFFERENTIATION	The serotonin(6) receptor (5-HT6R) is a promising target for treating cognitive deficits of schizophrenia often linked to alterations of neuronal development. This receptor controls neurodevelopmental processes, but the signaling mechanisms involved remain poorly understood. Using a proteomic strategy, we show that 5-HT(6)Rs constitutively interact with cyclin-dependent kinase 5 (Cdk5). Expression of 5-HT(6)Rs in NG108-15 cells induced neurite growth and expression of voltage-gated Ca2+ channels, two hallmarks of neuronal differentiation. 5-HT6R-elicited neurite growth was agonist independent and prevented by the 5-HT6R antagonist SB258585, which behaved as an inverse agonist. Moreover, it required receptor phosphorylation at Ser350 by Cdk5 and Cdc42 activity. Supporting a role of native 5-HT(6)Rs in neuronal differentiation, neurite growth of primary neurons was reduced by SB258585, by silencing 5-HT6R expression or by mutating Ser350 into alanine. These results reveal a functional interplay between Cdk5 and a G protein-coupled receptor to control neuronal differentiation.	[Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine] CNRS, Inst Genom Fonct, UMR 5203, F-34000 Montpellier, France; [Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine] INSERM, U661, Montpellier, France; [Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine] Univ Montpellier I, UMR 5203, Montpellier, France; [Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine] Univ Montpellier 2, UMR 5203, Montpellier, France; [Lopez, Severine Morisset] CNRS, Ctr Biophys Mol, UPR 4301, Orleans, France; [la Cour, Clotilde Mannoury; Millan, Mark J.] Inst Rech Servier, Croissy Sur Seine, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Servier; Institut de Recherches Internationales Servier	Marin, P (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, F-34000 Montpellier, France.	philippe.marin@igf.cnrs.fr; severine.chaumont-dubel@igf.cnrs.fr	MORISSET, Séverine/S-7450-2017	MORISSET, Séverine/0000-0002-9930-7824; Raynaud, Fabrice/0000-0003-3055-0524; Chaumont-Dubel, Severine/0000-0001-6860-6891; SEVENO, Martial/0000-0002-5000-8735	Fondation pour la Recherche Medicale [Equipe FRM2009]; Fondation FondaMental (fondation de cooperation scientifique); ANR [ANR-11-BSV4-0008]; CNRS; INSERM; University Montpellier 1; la Region Languedoc-Roussillon; Fonds National de la Recherche (Luxembourg)	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation FondaMental (fondation de cooperation scientifique); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Montpellier 1; la Region Languedoc-Roussillon(Region Occitanie); Fonds National de la Recherche (Luxembourg)(Luxembourg National Research Fund)	This work was supported by grants from the Fondation pour la Recherche Medicale (Contract Equipe FRM2009), Fondation FondaMental (fondation de cooperation scientifique), ANR (contract no. ANR-11-BSV4-0008), CNRS, INSERM, University Montpellier 1 and la Region Languedoc-Roussillon. F.D. was a recipient of a fellowship from Fonds National de la Recherche (Luxembourg). MS analyses were performed using the facilities of the Functional Proteomic Platform of Montpellier Languedoc-Roussillon, and confocal microscopy was performed using the facilities of Montpellier RIO Imaging Platform. The BRET and 96-well FRET experiments were performed using the ARPEGE Pharmacology Screening Interactome platform facility (Institut de Genomique Fonctionnelle de Montpellier).	Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Chemin J, 2002, J NEUROSCI, V22, P6856; Chen C, 2012, INT J BIOCHEM CELL B, V44, P447, DOI 10.1016/j.biocel.2011.11.022; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Delcourt N, 2007, EMBO J, V26, P1542, DOI 10.1038/sj.emboj.7601608; Dolezal V, 2001, BRAIN RES, V910, P134, DOI 10.1016/S0006-8993(01)02701-9; Engmann O, 2011, BRAIN, V134, P2408, DOI 10.1093/brain/awr155; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Hamon M, 1999, NEUROPSYCHOPHARMACOL, V21, pS68, DOI 10.1038/sj.npp.1395368; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Ko J, 2001, J NEUROSCI, V21, P6758; Kvachnina E, 2005, J NEUROSCI, V25, P7821, DOI 10.1523/JNEUROSCI.1790-05.2005; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Marcos B, 2010, INT J NEUROPSYCHOPH, V13, P775, DOI 10.1017/S146114570999054X; Meffre J, 2012, EMBO MOL MED, V4, P1043, DOI 10.1002/emmm.201201410; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Mitchell ES, 2005, PHARMACOL THERAPEUT, V108, P320, DOI 10.1016/j.pharmthera.2005.05.001; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Orlando LR, 2009, J NEUROCHEM, V110, P557, DOI 10.1111/j.1471-4159.2009.06139.x; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; Upton N, 2008, NEUROTHERAPEUTICS, V5, P458, DOI 10.1016/j.nurt.2008.05.008; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Zhang JP, 2006, EUR J PHARMACOL, V534, P77, DOI 10.1016/j.ejphar.2006.01.049	37	76	78	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					590	597		10.1038/NCHEMBIO.1547	http://dx.doi.org/10.1038/NCHEMBIO.1547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24880860				2022-12-25	WOS:000337871200018
J	Landgraf, KE; Steffek, M; Quan, C; Tom, J; Yu, C; Santell, L; Maun, HR; Eigenbrot, C; Lazarus, RA				Landgraf, Kyle E.; Steffek, Micah; Quan, Clifford; Tom, Jeffrey; Yu, Christine; Santell, Lydia; Maun, Henry R.; Eigenbrot, Charles; Lazarus, Robert A.			An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides	NATURE CHEMICAL BIOLOGY			English	Article							HEPATOCYTE GROWTH-FACTOR; SERINE-PROTEASE; MET RECEPTOR; PULMONARY-FIBROSIS; STRUCTURAL BASIS; LIVER-CIRRHOSIS; LIGAND-BINDING; LUNG FIBROSIS; BETA-CHAIN; IN-VIVO	Stimulation of hepatocyte growth factor (HGF) signaling through the Met receptor is an attractive approach for promoting tissue repair and preventing fibrosis. Using structure-guided peptide phage display combined with an activity-based sorting strategy, we engineered allosteric activators of zymogen-like pro-HGF to bypass proteolytic activation and reversibly stimulate pro-HGF signaling through Met. Biochemical, structural and biological data showed that zymogen activator peptides (ZAPtides) potently and selectively bind the activation pocket within the serine protease-like beta-chain of pro-HGF and display titratable activation of pro-HGF-dependent Met signaling, leading to cell survival and migration. To further demonstrate the versatility of our ZAPtide platform, we identified allosteric activators for pro-macrophage stimulating protein and a zymogen serine protease, Protein C, which also provides evidence for target selectivity. These studies reveal that ZAPtides use molecular mimicry of the trypsin-like N-terminal insertion mechanism and establish a new paradigm for selective pharmacological activation of plasminogen-related growth factors and zymogen serine proteases.	[Landgraf, Kyle E.; Quan, Clifford; Tom, Jeffrey; Santell, Lydia; Maun, Henry R.; Lazarus, Robert A.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Steffek, Micah; Yu, Christine; Eigenbrot, Charles] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	kyle@avidbiotics.com; laz@gene.com			Department of Energy Office of Science; Genentech	Department of Energy Office of Science(United States Department of Energy (DOE)); Genentech(Roche HoldingGenentech)	We thank gCell, Oligonucleotide Synthesis, DNA Sequencing and the Protein Expression facilities at Genentech for their support. We thank T. Lipari and D. Kirchhofer for providing full-length HGF proteins and helpful discussions. We also thank M. Sagolla and the Center for Advanced Light Microscopy at Genentech for help with migration assays. We acknowledge the use of synchrotron X-ray sources at Advanced Photon Source, Argonne National Laboratory and Stanford Synchrotron Radiation Lightsource, supported by the Department of Energy Office of Science.	Benight NM, 2012, EXPERT OPIN THER TAR, V16, P921, DOI 10.1517/14728222.2012.710200; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Botkjaer KA, 2009, BIOCHEMISTRY-US, V48, P9606, DOI 10.1021/bi900510f; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chakraborty S, 2013, EXPERT OPIN INV DRUG, V22, P499, DOI 10.1517/13543784.2013.778972; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hartmann G, 1998, CURR BIOL, V8, pR739; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Huntington JA, 2012, BBA-PROTEINS PROTEOM, V1824, P246, DOI 10.1016/j.bbapap.2011.07.005; Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108; Kaibori M, 2002, J SURG RES, V106, P108, DOI 10.1006/jsre.2002.6438; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Khan AR, 1998, PROTEIN SCI, V7, P815; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; Landgraf KE, 2010, J BIOL CHEM, V285, P40362, DOI 10.1074/jbc.M110.179721; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; LOKKER NA, 1994, PROTEIN ENG, V7, P895, DOI 10.1093/protein/7.7.895; LYON M, 1994, J BIOL CHEM, V269, P11216; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Miyazawa K, 2010, FEBS J, V277, P2208, DOI 10.1111/j.1742-4658.2010.07637.x; NAKA D, 1992, J BIOL CHEM, V267, P20114; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Phin S, 2010, AM J RESP CELL MOL, V42, P286, DOI 10.1165/rcmb.2008-0305OC; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Tolbert WD, 2010, P NATL ACAD SCI USA, V107, P13264, DOI 10.1073/pnas.1005183107; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545	48	21	21	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					567	573		10.1038/NCHEMBIO.1533	http://dx.doi.org/10.1038/NCHEMBIO.1533			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24859116				2022-12-25	WOS:000337871200015
J	Goh, G; Scholl, UI; Healy, JM; Choi, M; Prasad, ML; Nelson-Williams, C; Kuntsman, JW; Korah, R; Suttorp, AC; Dietrich, D; Haase, M; Willenberg, HS; Stalberg, P; Hellman, P; Akerstrom, G; Bjorklund, P; Carling, T; Lifton, RP				Goh, Gerald; Scholl, Ute I.; Healy, James M.; Choi, Murim; Prasad, Manju L.; Nelson-Williams, Carol; Kuntsman, John W.; Korah, Reju; Suttorp, Anna-Carinna; Dietrich, Dimo; Haase, Matthias; Willenberg, Holger S.; Stalberg, Peter; Hellman, Per; Akerstrom, Goran; Bjorklund, Peyman; Carling, Tobias; Lifton, Richard P.			Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors	NATURE GENETICS			English	Article							DEPENDENT PROTEIN-KINASE; ALDOSTERONE-PRODUCING ADENOMAS; WNT-SIGNALING PATHWAY; CUSHINGS-SYNDROME; ADRENOCORTICAL TUMORS; BETA-CATENIN; CARNEY COMPLEX; GENOMIC CHARACTERIZATION; GENETIC-HETEROGENEITY; CATALYTIC SUBUNIT	Adrenal tumors autonomously producing cortisol cause Cushing's syndrome(1-4). We performed exome sequencing of 25 tumor-normal pairs and identified 2 subgroups. Eight tumors (including three carcinomas) had many somatic copy number variants (CNVs) with frequent deletion of CDC42 and CDKN2A, amplification of 5q31.2 and protein-altering mutations in TP53 and RB1. Seventeen tumors (all adenomas) had no somatic CNVs or TP53 or RB1 mutations. Six of these had known gain-of-function mutations in CTNNB1 (beta-catenin)(5,6) or GNAS (G alpha(s))(7,8). Six others had somatic mutations in PRKACA (protein kinase A (PKA) catalytic subunit) resulting in a p.Leu206Arg substitution. Further sequencing identified this mutation in 13 of 63 tumors (35% of adenomas with overt Cushing's syndrome). PRKACA, GNAS and CTNNB1 mutations were mutually exclusive. Leu206 directly interacts with the regulatory subunit of PKA, PRKAR1A(9,10). Leu206Arg PRKACA loses PRKAR1A binding, increasing the phosphorylation of downstream targets. PKA activity induces cortisol production and cell proliferation(11-15), providing a mechanism for tumor development. These findings define distinct mechanisms underlying adrenal cortisol-producing tumors.	[Goh, Gerald; Scholl, Ute I.; Choi, Murim; Nelson-Williams, Carol; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Goh, Gerald; Scholl, Ute I.; Choi, Murim; Nelson-Williams, Carol; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Scholl, Ute I.] Univ Hosp Dusseldorf, Div Nephrol, Dusseldorf, Germany; [Healy, James M.; Kuntsman, John W.; Korah, Reju; Carling, Tobias] Yale Univ, Sch Med, Dept Surg, Yale Endocrine Neoplasia Lab, New Haven, CT 06510 USA; [Choi, Murim; Lifton, Richard P.] Yale Ctr Mendelian Genom, New Haven, CT USA; [Prasad, Manju L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Suttorp, Anna-Carinna] Univ Hosp Dusseldorf, Dept Pathol, Dusseldorf, Germany; [Dietrich, Dimo] Univ Bonn, Inst Pathol, Bonn, Germany; [Haase, Matthias; Willenberg, Holger S.] Univ Hosp Dusseldorf, Div Endocrinol & Diabetol, Dusseldorf, Germany; [Stalberg, Peter; Hellman, Per; Akerstrom, Goran; Bjorklund, Peyman] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Carling, Tobias] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Yale University; Yale University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Bonn; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Uppsala University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Goh, Gerald/N-1684-2015; Choi, Murim/AAP-9120-2021; Goh, Gerald/E-9158-2014; Hellman, Per/AAL-9817-2021	Goh, Gerald/0000-0002-3832-6466; Goh, Gerald/0000-0002-3832-6466; Hellman, Per/0000-0002-5322-5073; Stalberg, Peter/0000-0002-9625-1394; Scholl, Ute/0000-0002-0309-8045; Healy, James/0000-0002-1941-4452; Kunstman, John/0000-0002-2618-4173	US National Institutes of Health (NIH) Centers for Mendelian Genomics [5U54HG006504]; Agency for Science, Technology and Research of Singapore; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the US National Institutes of Health (NIH) Centers for Mendelian Genomics (5U54HG006504). G.G. is supported by the Agency for Science, Technology and Research of Singapore. T.C. is a Damon Runyon Clinical Investigator supported in part by the Damon Runyon Cancer Research Foundation. R.P.L. is an investigator of the Howard Hughes Medical Institute,	Almeida MQ, 2011, J CLIN ENDOCR METAB, V96, pE728, DOI 10.1210/jc.2010-2420; Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Almeida MQ, 2010, BEST PRACT RES CL EN, V24, P907, DOI 10.1016/j.beem.2010.10.006; Almeida MQ, 2010, HUM MOL GENET, V19, P1387, DOI 10.1093/hmg/ddq014; Bertherat J, 2003, CANCER RES, V63, P5308; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Bonnet S, 2011, J CLIN ENDOCR METAB, V96, pE419, DOI 10.1210/jc.2010-1885; Brauckhoff M, 2012, EXP CLIN ENDOCR DIAB, V120, P472, DOI 10.1055/s-0032-1321807; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Cazabat Laure, 2006, Pituitary, V9, P211, DOI 10.1007/s11102-006-0266-1; Chiodini I, 2011, J CLIN ENDOCR METAB, V96, P1223, DOI 10.1210/jc.2010-2722; ChoChung YS, 1995, CRIT REV ONCOL HEMAT, V21, P33, DOI 10.1016/1040-8428(94)00166-9; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; de Joussineau C, 2012, MOL CELL ENDOCRINOL, V351, P28, DOI 10.1016/j.mce.2011.10.006; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; El Wakil A, 2011, MOL CELL ENDOCRINOL, V332, P32, DOI 10.1016/j.mce.2010.11.014; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Gaujoux S, 2008, J CLIN ENDOCR METAB, V93, P4135, DOI 10.1210/jc.2008-0631; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GILLIES GE, 1982, NATURE, V299, P355, DOI 10.1038/299355a0; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hatipoglu BA, 2012, J SURG ONCOL, V106, P565, DOI 10.1002/jso.23197; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Horvath A, 2006, CANCER RES, V66, P11571, DOI 10.1158/0008-5472.CAN-06-2914; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lania AG, 2006, NAT CLIN PRACT ENDOC, V2, P681, DOI 10.1038/ncpendmet0324; Meoli E, 2008, CANCER RES, V68, P3133, DOI 10.1158/0008-5472.CAN-08-0064; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newell-Price J, 1998, ENDOCR REV, V19, P647, DOI 10.1210/er.19.5.647; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; RAMACHANDRAN J, 1987, ANN NY ACAD SCI, V512, P415, DOI 10.1111/j.1749-6632.1987.tb24977.x; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Roger PP, 1995, VITAM HORM, V51, P59, DOI 10.1016/S0083-6729(08)61038-9; Ronchi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073959; Rosenberg D, 2002, ANN NY ACAD SCI, V968, P65, DOI 10.1111/j.1749-6632.2002.tb04327.x; SAFFRAN M, 1962, BRIT MED BULL, V18, P122, DOI 10.1093/oxfordjournals.bmb.a069952; Schinner S, 2007, INT J OBESITY, V31, P864, DOI 10.1038/sj.ijo.0803508; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Scholl UI, 2012, P NATL ACAD SCI USA, V109, P2533, DOI 10.1073/pnas.1121407109; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Tombol Z, 2009, ENDOCR-RELAT CANCER, V16, P895, DOI 10.1677/ERC-09-0096; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Zenkert S, 2000, EUR J ENDOCRINOL, V142, P294, DOI 10.1530/eje.0.1420294; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	59	159	161	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					613	617		10.1038/ng.2956	http://dx.doi.org/10.1038/ng.2956			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747643	Green Accepted			2022-12-25	WOS:000336870700019
J	Lokken, KL; Tsolis, RM; Baumler, AJ				Lokken, Kristen L.; Tsolis, Renee M.; Baeumler, Andreas J.			Hypoferremia of infection: a double-edged sword?	NATURE MEDICINE			English	Editorial Material							MACROPHAGE IRON HOMEOSTASIS; SALMONELLA-TYPHIMURIUM; FERROPORTIN; HEPCIDIN; GAMMA; AVAILABILITY; REGULATOR; ENTERICA; PROTEIN; EFFLUX		[Lokken, Kristen L.; Tsolis, Renee M.; Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Lokken, KL (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Baumler, Andreas J/H-2301-2011	Baumler, Andreas J/0000-0001-9152-7809; Tsolis, Renee/0000-0001-9131-6657				Abdullah Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037349; BAUMLER AJ, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P115; CARTWRIGHT GE, 1946, J CLIN INVEST, V25, P65, DOI 10.1172/JCI101690; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; Kim DK, 2014, NAT MED, V20, P419, DOI 10.1038/nm.3483; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Mair SM, 2011, J INFECT DIS, V204, P685, DOI 10.1093/infdis/jir395; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009	17	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					335	337		10.1038/nm.3526	http://dx.doi.org/10.1038/nm.3526			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710374				2022-12-25	WOS:000334361500010
J	Alabert, C; Bukowski-Wills, JC; Lee, SB; Kustatscher, G; Nakamura, K; Alves, FD; Menard, P; Mejlvang, J; Rappsilber, J; Groth, A				Alabert, Constance; Bukowski-Wills, Jimi-Carlo; Lee, Sung-Bau; Kustatscher, Georg; Nakamura, Kyosuke; Alves, Flavia de Lima; Menard, Patrice; Mejlvang, Jakob; Rappsilber, Juri; Groth, Anja			Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE; PROTEINS; SITES; PCNA; INHERITANCE; COMPLEX; MODEL; ORGANIZATION; CHROMOSOMES; PROPAGATION	To maintain genome function and stability, DNA sequence and its organization into chromatin must be duplicated during cell division. Understanding how entire chromosomes are copied remains a major challenge. Here, we use nascent chromatin capture (NCC) to profile chromatin proteome dynamics during replication in human cells. NCC relies on biotin-dUTP labelling of replicating DNA, affinity purification and quantitative proteomics. Comparing nascent chromatin with mature post-replicative chromatin, we provide association dynamics for 3,995 proteins. The replication machinery and 485 chromatin factors such as CAF-1, DNMT1 and SUV39h1 are enriched in nascent chromatin, whereas 170 factors including histone H1, DNMT3, MBD1-3 and PRC1 show delayed association. This correlates with H4K5K12diAc removal and H3K9me1 accumulation, whereas H3K27me3 and H3K9me3 remain unchanged. Finally, we combine NCC enrichment with experimentally derived chromatin probabilities to predict a function in nascent chromatin for 93 uncharacterized proteins, and identify FAM111A as a replication factor required for PCNA loading. Together, this provides an extensive resource to understand genome and epigenome maintenance.	[Alabert, Constance; Lee, Sung-Bau; Nakamura, Kyosuke; Menard, Patrice; Mejlvang, Jakob; Groth, Anja] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Alabert, Constance; Lee, Sung-Bau; Nakamura, Kyosuke; Menard, Patrice; Mejlvang, Jakob; Groth, Anja] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Bukowski-Wills, Jimi-Carlo; Kustatscher, Georg; Alves, Flavia de Lima; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Rappsilber, Juri] Tech Univ Berlin, Dept Biotechnol, D-13353 Berlin, Germany	University of Copenhagen; University of Copenhagen; University of Edinburgh; Technical University of Berlin	Rappsilber, J (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	juri.rappsilber@ed.ac.uk; anja.groth@bric.ku.dk	Rappsilber, Juri/ABF-3328-2020; Groth, Anja/AAH-5386-2019; Rappsilber, Juri/B-7265-2015; Lee, Sung-Bau/AAJ-5176-2021	Groth, Anja/0000-0003-0577-1771; Rappsilber, Juri/0000-0001-5999-1310; Lee, Sung-Bau/0000-0002-8628-8687; Kustatscher, Georg/0000-0001-8955-0866; Wills, Jimi/0000-0003-1669-007X; Menard, Patrice/0000-0001-8844-3727; Nakamura, Kyosuke/0000-0003-1809-639X	European Research Council [281,765]; Lundbeck Foundation; Danish Cancer Society; Danish National Research Foundation [DNRF82]; Medical Research Council; Novo Nordisk Foundation; FP7 Marie Curie Actions ITN Nucleosome4D; Wellcome Trust [084229, 077707, 092076, 091020]; HFSP; Danish Medical Research Council; FEBS; Lundbeck Foundation [R22-2007-1245] Funding Source: researchfish; Wellcome Trust [103139/Z/13/Z] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); FP7 Marie Curie Actions ITN Nucleosome4D; Wellcome Trust(Wellcome Trust); HFSP(Human Frontier Science Program); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FEBS; Lundbeck Foundation(Lundbeckfonden); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank J. Dejardin for fruitful discussions, K. Helin for reagents (Biotech Research and Innovation Centre and Centre for Epigenetics, University of Copenhagen, Denmark), Ib J. Christensen for support on statistics, and C. Wu, W. C. Earnshaw and Z. Jasencakova for critical reading of this manuscript. The A.G. laboratory is supported by a European Research Council Starting Grant (ERC2011StG, no. 281,765), the Lundbeck Foundation, the Danish Cancer Society, the Danish National Research Foundation (DNRF82) and Medical Research Council, the Novo Nordisk Foundation and FP7 Marie Curie Actions ITN Nucleosome4D. The Wellcome Trust generously supported this work through a Senior Research Fellowship to J. R. (084229), two Wellcome Trust Centre Core Grants (077707, 092076) and an instrument grant (091020). C. A. was supported by fellowships from HFSP and the Danish Medical Research Council. G. K. was supported by a FEBS Long-Term fellowship.	Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Annunziato AT, 2012, BBA-GENE REGUL MECH, V1819, P196, DOI 10.1016/j.bbagrm.2011.07.005; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Boyarchuk E, 2011, CURR OPIN CELL BIOL, V23, P266, DOI 10.1016/j.ceb.2011.03.006; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Fine DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002949; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kliszczak AE, 2011, SCI REP-UK, V1, DOI 10.1038/srep00095; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; Kustatscher G, 2014, EMBO J, V33, P648, DOI 10.1002/embj.201387614; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Masata M, 2011, FOLIA BIOL-PRAGUE, V57, P3; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maya-Mendoza A, 2012, METHODS, V57, P140, DOI 10.1016/j.ymeth.2012.05.006; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nekrasov M, 2012, NAT STRUCT MOL BIOL, V19, P1076, DOI 10.1038/nsmb.2424; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PERRY CA, 1991, EXP CELL RES, V196, P337, DOI 10.1016/0014-4827(91)90269-Z; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SARIBAN E, 1985, MOL CELL BIOL, V5, P1279, DOI 10.1128/MCB.5.6.1279; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; Xu M, 2012, EMBO REP, V13, P60, DOI 10.1038/embor.2011.206; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106	57	213	219	6	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					281	+		10.1038/ncb2918	http://dx.doi.org/10.1038/ncb2918			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24561620	Green Accepted			2022-12-25	WOS:000332124000015
J	Balazs, AB; Ouyang, Y; Hong, CM; Chen, J; Nguyen, SM; Rao, DS; An, DS; Baltimore, D				Balazs, Alejandro B.; Ouyang, Yong; Hong, Christin M.; Chen, Joyce; Nguyen, Steven M.; Rao, Dinesh S.; An, Dong Sung; Baltimore, David			Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission	NATURE MEDICINE			English	Article							PREEXPOSURE PROPHYLAXIS; NEUTRALIZING ANTIBODIES; INFECTION; BROAD	The vast majority of new HIV infections result from relatively inefficient transmission(1,2) of the virus across mucosal surfaces during sexual intercourse(3). A consequence of this inefficiency is that small numbers of transmitted founder viruses initiate most heterosexual infections(4). This natural bottleneck to transmission has stimulated efforts to develop interventions that are aimed at blocking this step of the infection process(5). Despite the promise of this strategy, clinical trials of preexposure prophylaxis have had limited degrees of success in humans, in part because of lack of adherence to the recommended preexposure treatment regimens(6,7). In contrast, a number of existing vaccines elicit systemic immunity that protects against mucosal infections, such as the vaccines for influenza(8) and human papilloma virus(8). We recently demonstrated the ability of vectored immunoprophylaxis (VIP) to prevent intravenous transmission of HIV in humanized mice using broadly neutralizing antibodies(10). Here we demonstrate that VIP is capable of protecting humanized mice from intravenous as well as vaginal challenge with diverse HIV strains despite repeated exposures. Moreover, animals receiving VIP that expresses a modified VRC07 antibody were completely resistant to repetitive intravaginal challenge by a heterosexually transmitted founder HIV strain(11), suggesting that VI. may be effective in preventing vaginal transmission of HIV between humans.	[Balazs, Alejandro B.; Ouyang, Yong; Hong, Christin M.; Chen, Joyce; Nguyen, Steven M.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [An, Dong Sung] Univ Calif Los Angeles, Sch Nursing, UCLA AIDS Inst, Dept Translat Sci, Los Angeles, CA 90024 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337; Balazs, Alejandro/0000-0002-1767-3944; Hong, Christin/0000-0003-1826-9246; Chen, Joyce/0000-0001-7851-8457	UCLA Center for AIDS Research (CFAR) [AI028697]; NIAID [1K22AI102769, 1R01AI100652-01A1]; Sidney Kimmel Foundation for Cancer Research [SKF-11-013]; NIH [1K08CA133521]; NIH through NIAID [HHSN266200500035C]; Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [K08CA133521, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100652, P30AI028697, K22AI102769] Funding Source: NIH RePORTER	UCLA Center for AIDS Research (CFAR); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sidney Kimmel Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge G. Nabel (Sanofi-Pasteur) and J. Mascola (US National Institutes of Health (NIH) Vaccine Research Center) for VRC01, VRC-PG04, VRC07 and VRC07G54W expression plasmids and proteins, D. Burton (Scripps) for b12, PG9, PGT121 and PGT128 expression plasmids, M. Nussenzweig (Rockefeller) for 3BNC117 and 12A12 expression plasmids and P. Bjorkman (California Institute of Technology) for the NIH45-46W expression plasmid. We also thank the Caltech Protein Expression Center for providing purified antibodies. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), NIH: pYK-JRCSF from I.S.Y. Chen and Y. Koyanagi, pREJO.c/2864 from J. Kappes and C. Ochsenbauer and TZM-bl cells from J. Kappes and X. Wu. We thank J. Kim, D. Majumdar, M. Mann and A. So for their helpful comments and other members of the Baltimore lab, as well as R. Cortado and S. Shimizu in the An lab, for their assistance in carrying out this work. Preparation of human CD34<SUP>+</SUP> cells, tissue procurement and BLT mice were supported by the UCLA Center for AIDS Research (CFAR) AI028697. A.B.B. is supported by the NIAID Career Transition Award 1K22AI102769. D.S.R. was a Sidney Kimmel Scholar supported by the Sidney Kimmel Foundation for Cancer Research (Translational Award SKF-11-013) and is supported by career development award 1K08CA133521 from the NIH. D.S.A. is supported by NIAID grant 1R01AI100652-01A1. This project was supported by the NIH (HHSN266200500035C) through a contract from the NIAID and by the Joint Center for Translational Medicine.	Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwon Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O34; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Marrazzo M.J., 2013, 20 C RETR OPP INF; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	26	177	189	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					296	300		10.1038/nm.3471	http://dx.doi.org/10.1038/nm.3471			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24509526	Green Submitted, Green Accepted			2022-12-25	WOS:000332595600025
J	Hernandez, FJ; Huang, LY; Olson, ME; Powers, KM; Hernandez, LI; Meyerholz, DK; Thedens, DR; Behlke, MA; Horswill, AR; McNamara, JO				Hernandez, Frank J.; Huang, Lingyan; Olson, Michael E.; Powers, Kristy M.; Hernandez, Luiza I.; Meyerholz, David K.; Thedens, Daniel R.; Behlke, Mark A.; Horswill, Alexander R.; McNamara, James O., II			Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe	NATURE MEDICINE			English	Article							NEAR-INFRARED FLUORESCENCE; IN-VIVO; EXTRACELLULAR NUCLEASE; BACTERIAL-INFECTION; REAL-TIME; MICE; OLIGONUCLEOTIDES; IDENTIFICATION; OSTEOMYELITIS; STREPTOCOCCI	Technologies that enable the rapid detection and localization of bacterial infections in living animals could address an unmet need for infectious disease diagnostics. We describe a molecular imaging approach for the specific, noninvasive detection of S. aureus based on the activity of the S. aureus secreted nuclease, micrococcal nuclease (MN). Several short synthetic oligonucleotides, rendered resistant to mammalian serum nucleases by various chemical modifications and flanked with a fluorophore and quencher, were activated upon degradation by purified MN and in S. aureus culture supernatants. A probe consisting of a pair of deoxythymidines flanked by several 2'-o-methyl-modified nucleotides was activated in culture supernatants of S. aureus but not in culture supernatants of several other pathogenic bacteria. Systemic administration of this probe to mice bearing S. aureus muscle infections resulted in probe activation at the infection sites in an MN-dependent manner. This new bacterial imaging approach has potential clinical applicability for infections with S. aureus and several other medically important pathogens.	[Hernandez, Frank J.; Hernandez, Luiza I.; McNamara, James O., II] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Huang, Lingyan; Powers, Kristy M.; Behlke, Mark A.] Integrated DNA Technol IDT, Coralville, IA USA; [Olson, Michael E.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Dept Radiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	McNamara, JO (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	james-mcnamara@uiowa.edu	Hernandez, Frank J./G-5583-2017; Meyerholz, David/J-8131-2019; Hernandez, Frank J./AAR-9031-2021	Hernandez, Frank J./0000-0001-6308-8087; Meyerholz, David/0000-0003-1552-3253; Hernandez, Frank J./0000-0001-6308-8087; Behlke, Mark/0000-0002-4218-857X; McNamara, James/0000-0003-4091-618X	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [AI083211, AI101391]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106738, P01AI083211, R21AI101391] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health under award numbers AI083211 (A.R.H.) and AI101391 (J.O.M. II). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. F.J.H. was supported by a postdoctoral fellowship from the American Heart Association. The authors thank J. Kavanaugh for technical assistance with bacterial cultures and R. Schmidt and J. Widness for sharing a Sysmex XT-200i Automated Hematology Analyzer.	Agarwal V, 2011, NEUROIMAG CLIN N AM, V21, P975, DOI 10.1016/j.nic.2011.07.011; ARNONE A, 1969, P NATL ACAD SCI USA, V64, P420, DOI 10.1073/pnas.64.2.420; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Boerlin P, 2003, J CLIN MICROBIOL, V41, P767, DOI 10.1128/JCM.41.2.767-771.2003; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; Clerc O, 2011, J ANTIMICROB CHEMOTH, V66, P1168, DOI 10.1093/jac/dkr047; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; CUNNINGHAM L, 1956, J AM CHEM SOC, V78, P4642, DOI 10.1021/ja01599a031; DEMARIE S, 1990, INTENS CARE MED, V16, pS239, DOI 10.1007/BF01709708; Elias DR, 2008, CANCER BIOMARK, V4, P287, DOI 10.3233/CBM-2008-4602; FERREIRA BT, 1992, ZBL BAKT-INT J MED M, V277, P493; FERRIERI P, 1980, J EXP MED, V151, P56, DOI 10.1084/jem.151.1.56; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Hope-Roberts M, 2011, BIOTECH HISTOCHEM, V86, P104, DOI 10.3109/10520295.2010.498295; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kobayashi H, 2011, CHEM SOC REV, V40, P4626, DOI 10.1039/c1cs15077d; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; Leevy WM, 2008, BIOCONJUGATE CHEM, V19, P686, DOI 10.1021/bc700376v; Leevy WM, 2006, J AM CHEM SOC, V128, P16476, DOI 10.1021/ja0665592; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Matsui A, 2010, SURGERY, V148, P78, DOI 10.1016/j.surg.2009.12.003; Moon AF, 2011, NUCLEIC ACIDS RES, V39, P2943, DOI 10.1093/nar/gkq1152; Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; POCHON F, 1960, B SOC CHIM BIOL, V42, P795; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; White AG, 2010, BIOCONJUGATE CHEM, V21, P1297, DOI 10.1021/bc1000998; Wu PIK, 2008, J BIOMECH, V41, P2884, DOI 10.1016/j.jbiomech.2008.06.025; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	39	78	83	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					301	306		10.1038/nm.3460	http://dx.doi.org/10.1038/nm.3460			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24487433	Green Accepted			2022-12-25	WOS:000332595600026
J	Sakamaki, JI; Fu, A; Reeks, C; Baird, S; Depatie, C; Al Azzabi, M; Bardeesy, N; Gingras, AC; Yee, SP; Screaton, RA				Sakamaki, Jun-Ichi; Fu, Accalia; Reeks, Courtney; Baird, Stephen; Depatie, Chantal; Al Azzabi, Mufida; Bardeesy, Nabeel; Gingras, Anne-Claude; Yee, Siu-Pok; Screaton, Robert A.			Role of the SIK2-p35-PJA2 complex in pancreatic beta-cell functional compensation	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; SALT-INDUCIBLE KINASE; INSULIN-SECRETION; SIGNAL-TRANSDUCTION; DIABETES-MELLITUS; COACTIVATOR TORC2; GLUCOSE-TOLERANCE; RESISTANCE; SIK2; PHOSPHORYLATION	Energy sensing by the AMP-activated protein kinase (AMPK) is of fundamental importance in cell biology. In the pancreatic beta-cell, AMPK is a central regulator of insulin secretion. The capacity of the beta-cell to increase insulin output is a critical compensatory mechanism in prediabetes, yet its molecular underpinnings are unclear. Here we delineate a complex consisting of the AMPK-related kinase SIK2, the CDK5 activator CDK5R1 (also known as p35) and the E3 ligase PJA2 essential for beta-cell functional compensation. Following glucose stimulation, SIK2 phosphorylates p35 at Ser 91, to trigger its ubiquitylation by PJA2 and promote insulin secretion. Furthermore, SIK2 accumulates in beta-cells in models of metabolic syndrome to permit compensatory secretion; in contrast, beta-cell knockout of SIK2 leads to accumulation of p35 and impaired secretion. This work demonstrates that the SIK2-p35-PJA2 complex is essential for glucose homeostasis and provides a link between p35-CDK5 and the AMPK family in excitable cells.	[Sakamaki, Jun-Ichi; Fu, Accalia; Reeks, Courtney; Baird, Stephen; Depatie, Chantal; Al Azzabi, Mufida; Screaton, Robert A.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Fu, Accalia; Screaton, Robert A.] Univ Ottawa, Dept Cellular & Mol Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada; [Bardeesy, Nabeel] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Gingras, Anne-Claude] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Yee, Siu-Pok] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Screaton, Robert A.] Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Connecticut; University of Ottawa	Screaton, RA (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.	rob@arc.cheo.ca	Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Fu, Accalia/0000-0002-1110-8039; Sakamaki, Jun-ichi/0000-0003-3361-6314	Canadian Diabetes Association [OG-3-11-3328-RS]; Canadian Institutes of Health Research (CIHR) [MOP-97772]; Canadian Foundation for Innovation (CFI); CIHR [MOP-84314]; Japan Society for the Promotion of Science [10J00366]; Canadian Diabetes Studentship; NATIONAL CANCER INSTITUTE [U01CA141576] Funding Source: NIH RePORTER	Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Diabetes Studentship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank members of the R.A.S. laboratory and M. Wheeler for helpful comments and Z-Y. Lin for proteomic analysis. We acknowledge the Department of Laboratory Medicine and Pathology Core Facility at the University of Ottawa and K. Yates at the University of Ottawa Animal Care for technical assistance. This work was supported by grants from the Canadian Diabetes Association (number OG-3-11-3328-RS), the Canadian Institutes of Health Research (CIHR) MOP-97772 and the Canadian Foundation for Innovation (CFI) to R.A.S., operating grant from CIHR (MOP-84314) to A-C.G., by a Japan Society for the Promotion of Science Fellows to J.S. (10J00366), and a Canadian Diabetes Studentship to A.F. A-C.G. holds the Canada Research Chair in Functional Proteomics and the Lea Reichmann Chair in Cancer Proteomics. R.A.S. holds the Canada Research Chair in Apoptotic Signalling.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Byrne MM, 1996, AM J PHYSIOL-ENDOC M, V270, pE572, DOI 10.1152/ajpendo.1996.270.4.E572; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi S, 2011, J BIOL CHEM, V286, P2658, DOI 10.1074/jbc.C110.119222; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Eberhard CE, 2013, ENDOCRINOLOGY, V154, P2308, DOI 10.1210/en.2012-2088; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lignitto L, 2011, NAT CELL BIOL, V13, P412, DOI 10.1038/ncb2209; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Nagel S, 2010, LEUKEMIA LYMPHOMA, V51, P881, DOI 10.3109/10428191003699878; NAKAYAMA M, 1995, J NEUROSCI, V15, P5238; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Nie J, 2013, P NATL ACAD SCI USA, V110, P13857, DOI 10.1073/pnas.1307698110; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Nolan CJ, 2010, J GASTROEN HEPATOL, V25, P1594, DOI 10.1111/j.1440-1746.2010.06473.x; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	53	57	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					234	+		10.1038/ncb2919	http://dx.doi.org/10.1038/ncb2919			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24561619	Green Accepted			2022-12-25	WOS:000332124000009
J	Okosun, J; Bodor, C; Wang, J; Araf, S; Yang, CY; Pan, CY; Boller, S; Cittaro, D; Bozek, M; Iqbal, S; Matthews, J; Wrench, D; Marzec, J; Tawana, K; Popov, N; O'Riain, C; O'Shea, D; Carlotti, E; Davies, A; Lawrie, CH; Matolcsy, A; Calaminici, M; Norton, A; Byers, RJ; Mein, C; Stupka, E; Lister, TA; Lenz, G; Montoto, S; Gribben, JG; Fan, YH; Grosschedl, R; Chelala, C; Fitzgibbon, J				Okosun, Jessica; Boedoer, Csaba; Wang, Jun; Araf, Shamzah; Yang, Cheng-Yuan; Pan, Chenyi; Boller, Soeren; Cittaro, Davide; Bozek, Monika; Iqbal, Sameena; Matthews, Janet; Wrench, David; Marzec, Jacek; Tawana, Kiran; Popov, Nikolay; O'Riain, Ciaran; O'Shea, Derville; Carlotti, Emanuela; Davies, Andrew; Lawrie, Charles H.; Matolcsy, Andras; Calaminici, Maria; Norton, Andrew; Byers, Richard J.; Mein, Charles; Stupka, Elia; Lister, T. Andrew; Lenz, Georg; Montoto, Silvia; Gribben, John G.; Fan, Yuhong; Grosschedl, Rudolf; Chelala, Claude; Fitzgibbon, Jude			Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma	NATURE GENETICS			English	Article							SOMATIC HYPERMUTATION; HODGKIN LYMPHOMA; GLOBULAR DOMAIN; READ ALIGNMENT; PAIRED-END; CELL; DNA; TRANSFORMATION; EXPRESSION; DISCOVERY	Follicular lymphoma is an incurable malignancy(1), with transformation to an aggressive subtype representing a critical event during disease progression. Here we performed whole-genome or whole-exome sequencing on 10 follicular lymphoma-transformed follicular lymphoma pairs followed by deep sequencing of 28 genes in an extension cohort, and we report the key events and evolutionary processes governing tumor initiation and transformation. Tumor evolution occurred through either a 'rich' or 'sparse' ancestral common progenitor clone (CPC). We identified recurrent mutations in linker histone, JAK-STAT signaling, NF-kappa B signaling and B cell developmental genes. Longitudinal analyses identified early driver mutations in chromatin regulator genes (CREBBP, EZH2 and KMT2D (MLL2)), whereas mutations in EBF1 and regulators of NF-.B signaling (MYD88 and TNFAIP3) were gained at transformation. Collectively, this study provides new insights into the genetic basis of follicular lymphoma and the clonal dynamics of transformation and suggests that personalizing therapies to target key genetic alterations in the CPC represents an attractive therapeutic strategy.	[Okosun, Jessica; Boedoer, Csaba; Araf, Shamzah; Iqbal, Sameena; Matthews, Janet; Wrench, David; Tawana, Kiran; Popov, Nikolay; O'Riain, Ciaran; O'Shea, Derville; Carlotti, Emanuela; Calaminici, Maria; Lister, T. Andrew; Montoto, Silvia; Gribben, John G.; Fitzgibbon, Jude] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England; [Boedoer, Csaba; Matolcsy, Andras] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Wang, Jun; Marzec, Jacek; Chelala, Claude] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Yang, Cheng-Yuan; Boller, Soeren; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, Freiburg, Germany; [Pan, Chenyi; Fan, Yuhong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Pan, Chenyi; Fan, Yuhong] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Cittaro, Davide; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Bozek, Monika; Mein, Charles] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, London, England; [Davies, Andrew] Univ Southampton, Canc Sci Div, Southampton, Hants, England; [Lawrie, Charles H.] Biodonostia Res Inst, Dept Oncol, San Sebastian, Spain; [Norton, Andrew] Christie Natl Hlth Serv NHS Fdn Trust, Dept Histopathol, Manchester, Lancs, England; [Byers, Richard J.] Manchester Royal Infirm, Dept Histopathol, Manchester M13 9WL, Lancs, England; [Lenz, Georg] Charite, Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany	University of London; Queen Mary University London; Semmelweis University; University of London; Queen Mary University London; Max Planck Society; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; Queen Mary University London; University of Southampton; Christie NHS Foundation Trust; University of Manchester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Okosun, J (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England.	j.e.okosun@qmul.ac.uk; bodor.csaba1@med.semmelweis-univ.hu	Montoto, Silvia/M-6812-2019; Cittaro, Davide/K-2405-2018; Lenz, Georg/I-6844-2012; Bodor, Csaba/O-4524-2017	Montoto, Silvia/0000-0002-3006-9725; Cittaro, Davide/0000-0003-0384-3700; Okosun, Jessica/0000-0001-6021-5044; chelala, claude/0000-0002-2488-0669; Mein, Charles/0000-0003-0811-9658; Lawrie, Charles/0000-0002-8882-1131; Fitzgibbon, Jude/0000-0002-9069-1866; Pan, Chenyi/0000-0002-0089-7482; O'Shea, Derville/0000-0002-5244-5023; Wang, Jun/0000-0003-2509-9599; Stupka, Elia/0000-0003-3154-4011; Bodor, Csaba/0000-0002-0729-692X; Marzec, Jacek/0000-0001-6577-8866; Byers, Richard/0000-0003-0796-0365	Cancer Research UK through the Genomic Initiative and Programme grant [15968]; Leukemia and Lymphoma Research; Hungarian Scientific Research Fund [K-76204]; Georgia Cancer Coalition Distinguished Scholar Award; US National Institutes of Health [GM085261]; European Hematology Association (EHA) Partner fellowship [2009/1]; European Union and the State of Hungary; European Social Fund in the framework [TAMOP 4.2.4. A/1-11-1-2012-0001]; Kay Kendall Leukaemia Fund (KKLF) Junior Clinical Research Fellowship [KKL 557]; Cancer Research UK [15968] Funding Source: researchfish; National Institute for Health Research [ACF-2011-19-002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085261] Funding Source: NIH RePORTER	Cancer Research UK through the Genomic Initiative and Programme grant; Leukemia and Lymphoma Research; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Georgia Cancer Coalition Distinguished Scholar Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Hematology Association (EHA) Partner fellowship; European Union and the State of Hungary; European Social Fund in the framework; Kay Kendall Leukaemia Fund (KKLF) Junior Clinical Research Fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the patients for donating tumor specimens as part of this study. We would like to thank T. Chaplin-Perkins and B. Young for performing the SNP 6.0 array experiments as part of the Affymetrix Array Core Facility and G. Clark at the London Research Institute for automated DNA sequencing. This study was predominantly funded by Cancer Research UK through the Genomic Initiative and Programme grant (15968) to J. F. and was also supported by Leukemia and Lymphoma Research (grant to J. F.) and Hungarian Scientific Research Fund (Orszogos Tudomonyos Kutatosi Alapprogramok, OTKA) grant K-76204 (to A. M.). Y. F. is a recipient of the Georgia Cancer Coalition Distinguished Scholar Award, and C. P. and Y. F. are, in part, supported by US National Institutes of Health grant GM085261 (to Y. F.). C. B. is a recipient of the European Hematology Association (EHA) Partner fellowship (2009/1) and was supported by the European Union and the State of Hungary, cofinanced by the European Social Fund in the framework of TAMOP 4.2.4. A/1-11-1-2012-0001 National Excellence Program. J. O. is a recipient of the Kay Kendall Leukaemia Fund (KKLF) Junior Clinical Research Fellowship (KKL 557).	Al-Tourah AJ, 2008, J CLIN ONCOL, V26, P5165, DOI 10.1200/JCO.2008.16.0283; Baus D, 2009, LEUKEMIA, V23, P1885, DOI 10.1038/leu.2009.103; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bodor C, 2011, LEUKEMIA, V25, P726, DOI 10.1038/leu.2010.311; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eide MB, 2010, BLOOD, V116, P1489, DOI 10.1182/blood-2010-03-272278; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2004, METHOD ENZYMOL, V377, P85; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Khodabakhshi AH, 2012, ONCOTARGET, V3, P1308; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Ladetto M, 2001, EXP HEMATOL, V29, P183, DOI 10.1016/S0301-472X(00)00651-2; Landau DA, 2013, GENOME MED, V5, DOI 10.1186/gm451; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Medrzycki M, 2012, JOVE-J VIS EXP, DOI 10.3791/3577; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Montoto S, 2011, J CLIN ONCOL, V29, P1827, DOI 10.1200/JCO.2010.32.7577; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mottok A, 2007, BLOOD, V110, P3387, DOI 10.1182/blood-2007-03-082511; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Ritz O, 2009, BLOOD, V114, P1236, DOI 10.1182/blood-2009-03-209759; Ruminy P, 2008, BLOOD, V112, P1951, DOI 10.1182/blood-2007-11-124560; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vyas P, 2012, J BIOL CHEM, V287, P11778, DOI 10.1074/jbc.M111.312819; Weigert O, 2012, CANCER DISCOV, V2, P47, DOI 10.1158/2159-8290.CD-11-0208; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	57	463	474	4	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					176	+		10.1038/ng.2856	http://dx.doi.org/10.1038/ng.2856			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24362818	Green Accepted			2022-12-25	WOS:000331208300015
J	Trompette, A; Gollwitzer, ES; Yadava, K; Sichelstiel, AK; Sprenger, N; Ngom-Bru, C; Blanchard, C; Junt, T; Nicod, LP; Harris, NL; Marsland, BJ				Trompette, Aurelien; Gollwitzer, Eva S.; Yadava, Koshika; Sichelstiel, Anke K.; Sprenger, Norbert; Ngom-Bru, Catherine; Blanchard, Carine; Junt, Tobias; Nicod, Laurent P.; Harris, Nicola L.; Marsland, Benjamin J.			Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis	NATURE MEDICINE			English	Article							CHAIN FATTY-ACIDS; DENDRITIC CELLS; FUNGAL MICROBIOTA; LARGE-INTESTINE; EARLY-LIFE; BACTERIA; INFLAMMATION; PROTEIN; ABSORPTION; INCREASE	Metabolites from intestinal microbiota are key determinants of host-microbe mutualism and, consequently, the health or disease of the intestinal tract. However, whether such host-microbe crosstalk influences inflammation in peripheral tissues, such as the lung, is poorly understood. We found that dietary fermentable fiber content changed the composition of the gut and lung microbiota, in particular by altering the ratio of Firmicutes to Bacteroidetes. The gut microbiota metabolized the fiber, consequently increasing the concentration of circulating short-chain fatty acids (SCFAs). Mice fed a high-fiber diet had increased circulating levels of SCFAs and were protected against allergic inflammation in the lung, whereas a low-fiber diet decreased levels of SCFAs and increased allergic airway disease. Treatment of mice with the SCFA propionate led to alterations in bone marrow hematopoiesis that were characterized by enhanced generation of macrophage and dendritic cell (DC) precursors and subsequent seeding of the lungs by DCs with high phagocytic capacity but an impaired ability to promote T helper type 2 (T(H)2) cell effector function. The effects of propionate on allergic inflammation were dependent on G protein-coupled receptor 41 (GPR41, also called free fatty acid receptor 3 or FFAR3), but not GPR43 (also called free fatty acid receptor 2 or FFAR2). Our results show that dietary fermentable fiber and SCFAs can shape the immunological environment in the lung and influence the severity of allergic inflammation.	[Trompette, Aurelien; Gollwitzer, Eva S.; Yadava, Koshika; Sichelstiel, Anke K.; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, Fac Biol & Med, Serv Pneumol, Ctr Hosp Univ Vaudois CHUV BH19 206, Lausanne, Switzerland; [Sprenger, Norbert; Ngom-Bru, Catherine; Blanchard, Carine] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Junt, Tobias] Novartis Pharma AG, Basel, Switzerland; [Harris, Nicola L.] Ecole Polytech Fed Lausanne, Global Hlth Inst, SV Global Hlth Inst GHI Stn 19, CH-1015 Lausanne, Switzerland	University of Lausanne; Nestle SA; Novartis; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Marsland, BJ (corresponding author), Univ Lausanne, Fac Biol & Med, Serv Pneumol, Ctr Hosp Univ Vaudois CHUV BH19 206, Lausanne, Switzerland.	bemamin.marsland@chuv.ch	Junt, Tobias/AAE-4389-2021; Nicod, Laurent/ABD-3360-2020; harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210; Nicod, Laurent P/0000-0002-0905-916X; yadava, koshika/0000-0002-5827-9177	Swiss National Science Foundation [310030.130029]; Fondation Placide Nicod	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Placide Nicod	This work has been supported by the Swiss National Science Foundation grant 310030.130029 awarded to B.J.M. We thank R. Driscoll and the Fondation Placide Nicod for support and A. Genevaz, B. Berger and E. Rezzonico for scientific assistance related to microbiota analysis. B.J.M. is a Cloetta Medical Research Fellow.	Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; BINDER HJ, 1989, GASTROENTEROLOGY, V96, P989, DOI 10.1016/0016-5085(89)91614-4; Blainey P.C., 2012, SCI TRANSL MED, V4; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Greger J.L., 1999, J NUTR, V129, p1434S; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101; KANEKO T, 1994, J DAIRY SCI, V77, P393, DOI 10.3168/jds.S0022-0302(94)76965-4; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakaji S, 2002, EUR J NUTR, V41, P222, DOI 10.1007/s00394-002-0379-x; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Plantinga M., 2013, IMMUNITY, V38, P322; Riedl J, 1999, J NUTR, V129, P2170, DOI 10.1093/jn/129.12.2170; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Scholz-Ahrens K.E., 2007, J NUTR, V137, p2513S; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0	43	1525	1606	26	506	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					159	166		10.1038/nm.3444	http://dx.doi.org/10.1038/nm.3444			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24390308				2022-12-25	WOS:000330915000017
J	Loose, M; Mitchison, TJ				Loose, Martin; Mitchison, Timothy J.			The bacterial cell division proteins FtsA and FtsZ self-organize into dynamic cytoskeletal patterns	NATURE CELL BIOLOGY			English	Article							GENETIC-ANALYSIS; Z-RING; ZIPA; FILAMENTS; ACTIN; CONFORMATIONS; MEMBRANE; MOVEMENT	Bacterial cytokinesis is commonly initiated by the Z-ring, a cytoskeletal structure that assembles at the site of division. Its primary component is FtsZ, a tubulin superfamily GTPase, which is recruited to the membrane by the actin-related protein FtsA. Both proteins are required for the formation of the Z-ring, but if and how they influence each other's assembly dynamics is not known. Here, we reconstituted FtsA-dependent recruitment of FtsZ polymers to supported membranes, where both proteins self-organize into complex patterns, such as fast-moving filament bundles and chirally rotating rings. Using fluorescence microscopy and biochemical perturbations, we found that these large-scale rearrangements of FtsZ emerge from its polymerization dynamics and a dual, antagonistic role of FtsA: recruitment of FtsZ filaments to the membrane and negative regulation of FtsZ organization. Our findings provide a model for the initial steps of bacterial cell division and illustrate how dynamic polymers can self-organize into large-scale structures.	[Loose, Martin; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Loose, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	martin_loose@hms.harvard.edu		Loose, Martin/0000-0001-7309-9724	EMBO [ALTF 394-2011]; HFSP [LT000466/2012];  [NIH-GM39565]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039565, R37GM039565] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the laboratories of T.J.M., T. Bernhardt and T. Rapoport for discussions and support; J. Werbin (Harvard Medical School, USA) for the plasmid for sortase expression; H. Erickson (Duke University, USA) for the plasmid for FtsZ-YFP-mts expression; J. Brugues for valuable discussions and advice; and E. Garner, K. Kruse and S. Grill for discussions and comments on the manuscript. We would also like to thank the Nikon Imaging Center at Harvard Medical School for their excellent service. M.L. is supported by fellowships from EMBO (ALTF 394-2011) and HFSP (LT000466/2012). Cytoskeleton dynamics research in the T.J.M. group is supported by NIH-GM39565.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arumugam S, 2012, ANGEW CHEM INT EDIT, V51, P11858, DOI 10.1002/anie.201204332; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Erickson HP, 2010, MOL MICROBIOL, V78, P267, DOI 10.1111/j.1365-2958.2010.07321.x; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Henley CL, 2012, J STAT PHYS, V148, P740, DOI 10.1007/s10955-012-0520-z; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; HITT AL, 1990, J BIOL CHEM, V265, P1639; Hsin J, 2012, P NATL ACAD SCI USA, V109, P9432, DOI 10.1073/pnas.1120761109; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Kas J, 1996, BIOPHYS J, V70, P609, DOI 10.1016/S0006-3495(96)79630-3; Kirkpatrick CL, 2011, CURR OPIN MICROBIOL, V14, P691, DOI 10.1016/j.mib.2011.09.011; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; LANGE G, 1988, EUR J BIOCHEM, V178, P61, DOI 10.1111/j.1432-1033.1988.tb14429.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Martos A, 2010, BIOCHEMISTRY-US, V49, P10780, DOI 10.1021/bi101495x; Mateos-Gil P, 2012, P NATL ACAD SCI USA, V109, P8133, DOI 10.1073/pnas.1204844109; Mateos-Gil P, 2012, BBA-BIOMEMBRANES, V1818, P806, DOI 10.1016/j.bbamem.2011.12.012; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Needleman DJ, 2010, MOL BIOL CELL, V21, P323, DOI 10.1091/mbc.E09-09-0816; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2013, P NATL ACAD SCI USA, V110, P11000, DOI 10.1073/pnas.1222254110; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; Popp M. W-L., 2009, CURR PROTOC PROTEIN, V56; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Sumino Y, 2012, NATURE, V483, P448, DOI 10.1038/nature10874; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Wang S, 2012, P NATL ACAD SCI USA, V109, pE595, DOI 10.1073/pnas.1117132109	61	240	245	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					38	+		10.1038/ncb2885	http://dx.doi.org/10.1038/ncb2885			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24316672	Green Accepted			2022-12-25	WOS:000329042000009
J	Rahal, R; Frick, M; Romero, R; Korn, JM; Kridel, R; Chan, FC; Meissner, B; Bhang, HE; Ruddy, D; Kauffmann, A; Farsidjani, A; Derti, A; Rakiec, D; Naylor, T; Pfister, E; Kovats, S; Kim, S; Dietze, K; Dorken, B; Steidl, C; Tzankov, A; Hummel, M; Monahan, J; Morrissey, MP; Fritsch, C; Sellers, WR; Cooke, VG; Gascoyne, RD; Lenz, G; Stegmeier, F				Rahal, Rami; Frick, Mareike; Romero, Rodrigo; Korn, Joshua M.; Kridel, Robert; Chan, Fong Chun; Meissner, Barbara; Bhang, Hyo-eun; Ruddy, Dave; Kauffmann, Audrey; Farsidjani, Ali; Derti, Adnan; Rakiec, Daniel; Naylor, Tara; Pfister, Estelle; Kovats, Steve; Kim, Sunkyu; Dietze, Kerstin; Doerken, Bernd; Steidl, Christian; Tzankov, Alexandar; Hummel, Michael; Monahan, John; Morrissey, Michael P.; Fritsch, Christine; Sellers, William R.; Cooke, Vesselina G.; Gascoyne, Randy D.; Lenz, Georg; Stegmeier, Frank			Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma	NATURE MEDICINE			English	Article							GENE-EXPRESSION; IKK-ALPHA; ACTIVATION; KINASE; PATHWAYS; CANCER; NIK; PHOSPHORYLATION; MUTATIONS; DISCOVERY	Mantle cell lymphoma (MCL) is an aggressive malignancy that is characterized by poor prognosis(1). Large-scale pharmacological profiling across more than 100 hematological cell line models identified a subset of MCL cell lines that are highly sensitive to the B cell receptor (BCR) signaling inhibitors ibrutinib and sotrastaurin. Sensitive MCL models exhibited chronic activation of the BCR-driven classical nuclear factor-kappa B (NF-kappa B) pathway, whereas insensitive cell lines displayed activation of the alternative NF-kappa B pathway. Transcriptome sequencing revealed genetic lesions in alternative NF-kappa B pathway signaling components in ibrutinib-insensitive cell lines, and sequencing of 165 samples from patients with MCL identified recurrent mutations in TRAF2 or BIRC3 in 15% of these individuals. Although they are associated with insensitivity to ibrutinib, lesions in the alternative NF-kappa B pathway conferred dependence on the protein kinase NIK (also called mitogen-activated protein 3 kinase 14 or MAP3K14) both in vitro and in vivo. Thus, NIK is a new therapeutic target for MCL treatment, particularly for lymphomas that are refractory to BCR pathway inhibitors. Our findings reveal a pattern of mutually exclusive activation of the BCR-NF-kappa B or NIK-NF-kappa B pathways in MCL and provide critical insights into patient stratification strategies for NF-kappa B pathway-targeted agents.	[Rahal, Rami; Romero, Rodrigo; Korn, Joshua M.; Bhang, Hyo-eun; Ruddy, Dave; Farsidjani, Ali; Derti, Adnan; Rakiec, Daniel; Naylor, Tara; Kovats, Steve; Kim, Sunkyu; Monahan, John; Morrissey, Michael P.; Sellers, William R.; Cooke, Vesselina G.; Stegmeier, Frank] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Frick, Mareike; Dietze, Kerstin; Doerken, Bernd; Lenz, Georg] Charite, Dept Hematol Oncol & Tumor Immunol, Mol Canc Res Ctr, D-13353 Berlin, Germany; [Kridel, Robert; Chan, Fong Chun; Meissner, Barbara; Steidl, Christian; Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol & Expt Therapeut, Vancouver, BC, Canada; [Kridel, Robert; Chan, Fong Chun; Meissner, Barbara; Steidl, Christian; Gascoyne, Randy D.] BC Canc Res Ctr, Vancouver, BC, Canada; [Kauffmann, Audrey; Pfister, Estelle; Fritsch, Christine] Novartis Inst Biomed Res, Basel, Switzerland; [Tzankov, Alexandar] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Hummel, Michael] Charite, Dept Pathol, D-13353 Berlin, Germany	Novartis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; British Columbia Cancer Agency; British Columbia Cancer Agency; Novartis; University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stegmeier, F (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	georg.lenz@charite.de; frank.stegmeier@novartis.com	Lenz, Georg/I-6844-2012; Kridel, Robert/V-8739-2019; Gascoyne, Randy D/A-6009-2013; Tzankov, Alexandar/H-5656-2019	Gascoyne, Randy D/0000-0002-2610-5690; Tzankov, Alexandar/0000-0002-1100-3819; Kridel, Robert/0000-0003-0287-7124; Hummel, Michael/0000-0001-6717-605X; Romero, Rodrigo/0000-0002-9388-8306; /0000-0001-5216-0565; Monahan, John/0000-0002-3125-8704; Romero, Rodrigo/0000-0003-1689-0784	Else Kroner-Fresenius-Stiftung; German Research Foundation; Deutsche Krebshilfe; New Frontiers in Cancer Terry Fox program project grant [19001]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; University of British Columbia	Else Kroner-Fresenius-Stiftung; German Research Foundation(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); New Frontiers in Cancer Terry Fox program project grant; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia	We thank T. Haferlach and W. Kern from the Munich Leukemia Laboratory (MLL) for providing MCL samples. We thank N. Clipstone (Loyola University) for the pMSCV-IRES-GFP vector. We also thank M. Wartmann, M. Stump, T. Hood and S. Zhu for sharing technical advice. We are grateful to D. Weinstock, R. Pagliarini, D. Porter, S. Sharma, N. Wilson and N. Keen for their critical reading of this manuscript. All authors except M.F., R.K., F.C.C., B.M., K.D., B D., C. S., A.T., M.H., R.D.G. and G.L. are employees of Novartis Institutes for Biomedical Research. This work was supported by research grants to G.L. from the Else Kroner-Fresenius-Stiftung, the German Research Foundation and the Deutsche Krebshilfe. Additionally, this work was supported by a New Frontiers in Cancer Terry Fox program project grant (19001) to R.D.G. and a Career Investigator award by the Michael Smith Foundation for Health Research to C.S. R.K. is a recipient of fellowships from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the University of British Columbia (Four Year Fellowship).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Ghielmini M, 2009, BLOOD, V114, P1469, DOI 10.1182/blood-2009-02-179739; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Jabbour E, 2012, AM J HEMATOL, V87, P1038, DOI 10.1002/ajh.23282; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Ranuncolo SM, 2012, BLOOD, V120, P3756, DOI 10.1182/blood-2012-01-405951; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wagner J, 2011, J MED CHEM, V54, P6028, DOI 10.1021/jm200469u; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	46	242	250	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					87	+		10.1038/nm.3435	http://dx.doi.org/10.1038/nm.3435			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24362935				2022-12-25	WOS:000329349400024
J	Edelstein, LC; Simon, LM; Montoya, RT; Holinstat, M; Chen, ES; Bergeron, A; Kong, XG; Nagalla, S; Mohandas, N; Cohen, DE; Dong, JF; Shaw, C; Bray, PF				Edelstein, Leonard C.; Simon, Lukas M.; Montoya, Raul Teruel; Holinstat, Michael; Chen, Edward S.; Bergeron, Angela; Kong, Xianguo; Nagalla, Srikanth; Mohandas, Narla; Cohen, David E.; Dong, Jing-fei; Shaw, Chad; Bray, Paul F.			Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c	NATURE MEDICINE			English	Article							PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; GENETIC-STRUCTURE; SECONDARY PREVENTION; ACTIVATED RECEPTORS; TRANSCRIPTION; VORAPAXAR; MICRORNAS; DISEASE; AGGREGATION; MECHANISM	Racial differences in the pathophysiology of atherothrombosis are poorly understood. We explored the function and transcriptome of platelets in healthy black (n = 70) and white (n = 84) subjects. Platelet aggregation and calcium mobilization induced by the PAR4 thrombin receptor were significantly greater in black subjects. Numerous differentially expressed RNAs were associated with both race and PAR4 reactivity, including PCTP (encoding phosphatidylcholine transfer protein), and platelets from black subjects expressed higher levels of PC-TP protein. PC-TP inhibition or depletion blocked PAR4- but not PAR1-mediated activation of platelets and megakaryocytic cell lines. miR-376c levels were differentially expressed by race and PAR4 reactivity and were inversely correlated with PCTP mRNA levels, PC-TP protein levels and PAR4 reactivity. miR-376c regulated the expression of PC-TP in human megakaryocytes. A disproportionately high number of microRNAs that were differentially expressed by race and PAR4 reactivity, including miR-376c, are encoded in the DLK1-DIO3 locus and were expressed at lower levels in platelets from black subjects. These results suggest that PC-TP contributes to the racial difference in PAR4-mediated platelet activation, indicate a genomic contribution to platelet function that differs by race and emphasize a need to consider the effects of race when developing anti-thrombotic drugs.	[Edelstein, Leonard C.; Montoya, Raul Teruel; Holinstat, Michael; Kong, Xianguo; Nagalla, Srikanth; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Edelstein, Leonard C.; Montoya, Raul Teruel; Holinstat, Michael; Kong, Xianguo; Nagalla, Srikanth; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Simon, Lukas M.; Chen, Edward S.; Shaw, Chad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bergeron, Angela] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA; [Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Dong, Jing-fei] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Shaw, Chad] Rice Univ, Dept Stat, Houston, TX 77251 USA	Jefferson University; Jefferson University; Baylor College of Medicine; Baylor College of Medicine; New York Blood Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Puget Sound Blood Center; Rice University	Bray, PF (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA.	cashaw@bcm.tmc.edu; paul.bray@jefferson.edu	Teruel-Montoya, Raúl/H-9012-2017	Teruel-Montoya, Raúl/0000-0002-6741-9725; Shaw, Chad/0000-0001-7267-5398; Simon, Lukas/0000-0001-6148-8861; Edelstein, Leonard/0000-0002-8976-6410	US National Institutes of Health (NIH) [HL102482]; Cardeza Foundation for Hematologic Research; NIH [DK48873, DK56626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048873, R01DK048873, R29DK048873, R01DK056626] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007880] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardeza Foundation for Hematologic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank S. McKenzie for helpful discussions, S. Kunapuli (Temple University) for the PAR1 inhibitor, J. ltaliano (Harvard Medical School) for the antibody to tubulin, L. Ma for technical support, R. Baserga (Thomas Jefferson University) for the HCT116-Dicer knockout 2 cells and P. Yu for normalizing Affymetrix data. This work was supported by US National Institutes of Health (NIH) grant HL102482 (to P.F.B.) and the Cardeza Foundation for Hematologic Research. Compound A1 was developed with the support of NIH grants DK48873 and DK56626 (to D.E.C.).	Abrams C.S., 2006, HEMOSTASIS THROMBOSI, P617; Baez JM, 2005, BIOCHEM J, V388, P57, DOI 10.1042/BJ20041899; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; CHO JH, 1995, HYPERTENSION, V25, P377, DOI 10.1161/01.HYP.25.3.377; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Geijtenbeek TBH, 1996, BIOCHEM J, V316, P49; Goodall AH, 2010, BLOOD, V116, P4646, DOI 10.1182/blood-2010-04-280925; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henriksen RA, 2002, ARTERIOSCL THROM VAS, V22, P861, DOI 10.1161/01.ATV.0000014742.56572.25; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lova P, 2004, J BIOL CHEM, V279, P25299, DOI 10.1074/jbc.M313199200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MAHADEVAPPA VG, 1984, J BIOL CHEM, V259, P9369; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; OZAKI Y, 1992, BIOCHEM BIOPH RES CO, V183, P864, DOI 10.1016/0006-291X(92)90563-Z; Phimister EG, 2003, NEW ENGL J MED, V348, P1081, DOI 10.1056/NEJMp030028; Ple H, 2012, THROMB HAEMOSTASIS, V108, P605, DOI 10.1160/TH12-03-0153; Quinton TM, 2004, J BIOL CHEM, V279, P18434, DOI 10.1074/jbc.M401431200; Risch N, 2002, GENOME BIOL, V3, pcomment2007; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Shishova EY, 2011, HEPATOLOGY, V54, P664, DOI 10.1002/hep.24393; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wagle N, 2008, ANAL BIOCHEM, V383, P85, DOI 10.1016/j.ab.2008.07.039; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Xu QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026905; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	52	146	152	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1609	1616		10.1038/nm.3385	http://dx.doi.org/10.1038/nm.3385			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24216752	Green Accepted, Green Submitted			2022-12-25	WOS:000328181400029
J	Bernard, SC; Simpson, N; Join-Lambert, O; Federici, C; Laran-Chich, MP; Maissa, N; Bouzinba-Segard, H; Morand, PC; Chretien, F; Taouji, S; Chevet, E; Janel, S; Lafont, F; Coureuil, M; Segura, A; Niedergang, F; Marullo, S; Couraud, PO; Nassif, X; Bourdoulous, S				Bernard, Sandra C.; Simpson, Nandi; Join-Lambert, Olivier; Federici, Christian; Laran-Chich, Marie-Pierre; Maissa, Nawal; Bouzinba-Segard, Haniaa; Morand, Philippe C.; Chretien, Fabrice; Taouji, Said; Chevet, Eric; Janel, Sebastien; Lafont, Frank; Coureuil, Mathieu; Segura, Audrey; Niedergang, Florence; Marullo, Stefano; Couraud, Pierre-Olivier; Nassif, Xavier; Bourdoulous, Sandrine			Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization	NATURE MEDICINE			English	Article							ENDOTHELIAL-CELLS; IV PILI; ADHESIVE PROPERTIES; BRAIN; HAB18G/CD147; INVASION; MENINGOCOCCEMIA; MODULATION; ATTACHMENT; EXPRESSION	Neisseria meningitidis is a cause of meningitis epidemics worldwide and of rapidly progressing fatal septic shock. A crucial step in the pathogenesis of invasive meningococcal infections is the adhesion of bloodborne meningococci to both peripheral and brain endothelia, leading to major vascular dysfunction. Initial adhesion of pathogenic strains to endothelial cells relies on meningococcal type IV pili, but the endothelial receptor for bacterial adhesion remains unknown. Here, we report that the immunoglobulin superfamily member CD147 (also called extracellular matrix metalloproteinase inducer (EMMPRIN) or Basigin) is a critical host receptor for the meningococcal pilus components PiIE and PiIV. Interfering with this interaction potently inhibited the primary attachment of meningococci to human endothelial cells in vitro and prevented colonization of vessels in human brain tissue explants ex vivo and in humanized mice in vivo. These findings establish the molecular events by which meningococci target human endothelia, and they open new perspectives for treatment and prevention of meningococcus-induced vascular dysfunctions.	[Bernard, Sandra C.; Simpson, Nandi; Federici, Christian; Laran-Chich, Marie-Pierre; Maissa, Nawal; Bouzinba-Segard, Haniaa; Morand, Philippe C.; Niedergang, Florence; Marullo, Stefano; Couraud, Pierre-Olivier; Bourdoulous, Sandrine] Inst Cochin, U1016, INSERM, Paris, France; [Bernard, Sandra C.; Simpson, Nandi; Federici, Christian; Laran-Chich, Marie-Pierre; Maissa, Nawal; Bouzinba-Segard, Haniaa; Morand, Philippe C.; Niedergang, Florence; Marullo, Stefano; Couraud, Pierre-Olivier; Bourdoulous, Sandrine] CNRS, UMR8104, Paris, France; [Bernard, Sandra C.; Simpson, Nandi; Federici, Christian; Laran-Chich, Marie-Pierre; Maissa, Nawal; Bouzinba-Segard, Haniaa; Niedergang, Florence; Marullo, Stefano; Couraud, Pierre-Olivier; Bourdoulous, Sandrine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bernard, Sandra C.] Univ Paris Diderot, Paris, France; [Join-Lambert, Olivier; Coureuil, Mathieu; Segura, Audrey; Nassif, Xavier] Inst Necker Enfants Malades, U1151, INSERM, Paris, France; [Join-Lambert, Olivier; Coureuil, Mathieu; Segura, Audrey; Nassif, Xavier] CNRS, UMR8253, Paris, France; [Join-Lambert, Olivier; Morand, Philippe C.; Coureuil, Mathieu; Segura, Audrey; Nassif, Xavier] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Join-Lambert, Olivier; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, Paris, France; [Chretien, Fabrice] Inst Pasteur, Unite Histopathol Humaine & Modeles Anim, Paris, France; [Chretien, Fabrice] Univ Versailles St Quentinen en Yvelines, Fac Med, Versailles, France; [Chretien, Fabrice] Hop Raymond Poincare, AP HP, Paris, France; [Taouji, Said; Chevet, Eric] Univ Bordeaux, INSERM, U1053, BMYscreen, Bordeaux, France; [Janel, Sebastien; Lafont, Frank] Inst Pasteur de Lille, Ctr Infect & Immun Lille, Lille, France; [Janel, Sebastien; Lafont, Frank] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UM8204, F-59019 Lille, France; [Janel, Sebastien; Lafont, Frank] INSERM, U1019, F-59045 Lille, France; [Janel, Sebastien; Lafont, Frank] Univ Lille Nord France, BioImaging Ctr Lille BICeL, Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Bourdoulous, S (corresponding author), Inst Cochin, U1016, INSERM, Paris, France.	sandrine.bourdoulous@inserm.fr	TAOUJI, Saïd/K-5734-2014; Morand, Philippe/C-1213-2016; Coureuil, Mathieu/D-4793-2017; Join-Lambert, Olivier/AAE-5205-2019; Marullo, Stefano/C-6142-2008; Janel, Sébastien/B-4242-2015; chevet, eric/E-4992-2016; Chretien, fabrice B/D-4035-2018	Morand, Philippe/0000-0003-0306-8759; Coureuil, Mathieu/0000-0001-7655-9685; Marullo, Stefano/0000-0001-9604-9973; Janel, Sébastien/0000-0001-6736-3162; chevet, eric/0000-0001-5855-4522; Chretien, fabrice B/0000-0002-2794-1383; Lafont, frank/0000-0001-8668-2580; Nassif, Xavier/0000-0003-2855-3240; Niedergang, Florence/0000-0002-7064-830X; TAOUJI, Said/0000-0001-6736-9716	Universite Paris Diderot; La Ville de Paris; Agence Nationale de la Recherche of France [ANR-06-MIME-029, ANR-09-BLAN-0137-03]; Universite Paris Descartes [AAP-2011]; Fondation pour la Recherche Medicale of France; ANR [ANR-10-EQPX-04-01]; Association pour la Recherche sur le Cancer	Universite Paris Diderot; La Ville de Paris; Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Universite Paris Descartes; Fondation pour la Recherche Medicale of France; ANR(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank B.B. Weksler (Weill Cornell Medical College), J. Nelson (Oregon Health and Science University), M. Bukrinslcy (George Washington University Medical Center) and P. Mangeat (Centre de Recherche en Biochimie Macromoleculaire) for providing HBMECs, BB19' cells, CD147 constructs and anti-ezrin antibody, respectively; P. Pelissier (Hopital Saint Joseph) for providing human tissue samples for the human skin graft model; P. Bourdoncle, B. Durel, L. Stouvenel, M. Favier and C. Lessaffre for their technical help; J.M. Bruneau and F. Moreau for their technical help on surface plasmon resonance experiments; M. Popoff for his help on AFM analysis; Hamamatsu Photonics for providing access to their Nanozoomer scanning microscopy; and A. Fouet and J. Gavard for critical reading of the manuscript. S.C.B. was supported by a doctoral fellowship from Universite Paris Diderot and Association pour la Recherche sur le Cancer. This work was supported by collaborative research grants from La Ville de Paris to S.B. and EN., from the Agence Nationale de la Recherche of France (ANR-06-MIME-029; ANR-09-BLAN-0137-03) and the Universite Paris Descartes (AAP-2011) to S.B., X.N. and S.M., from the Fondation pour la Recherche Medicale of France to X.N. and S.M. and from the ANR (ANR-10-EQPX-04-01) to F.L.	Bertossi M, 2002, ANAT EMBRYOL, V205, P229, DOI 10.1007/s00429-002-0245-x; Brandtzaeg P, 2012, METHODS MOL BIOL, V799, P21, DOI 10.1007/978-1-61779-346-2_2; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Chen YK, 2009, CANCER LETT, V278, P113, DOI 10.1016/j.canlet.2009.01.004; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128; Dupin N, 2012, CLIN INFECT DIS, V54, P1162, DOI 10.1093/cid/cis120; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; GRAY F, 2002, GREENFIELDS NEUROPAT, P151; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helm RA, 2010, J BACTERIOL, V192, P3822, DOI 10.1128/JB.00280-10; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Join-Lambert O, 2013, J INFECT DIS, V208, P1590, DOI 10.1093/infdis/jit301; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Lancellotti M, 2006, MICROBES INFECT, V8, P191, DOI 10.1016/j.micinf.2005.06.012; Lecuyer H, 2012, INFECT IMMUN, V80, P175, DOI 10.1128/IAI.05837-11; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Melican K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003139; Melican K, 2012, CURR OPIN MICROBIOL, V15, P50, DOI 10.1016/j.mib.2011.10.008; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; PINNER RW, 1991, INFECT IMMUN, V59, P3169, DOI 10.1128/IAI.59.9.3169-3175.1991; Sameshima T, 2000, INT J CANCER, V88, P21, DOI 10.1002/1097-0215(20001001)88:1<21::AID-IJC4>3.0.CO;2-S; Schweitzer KM, 1997, LAB INVEST, V76, P25; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1985, J EXP MED, V161, P1539, DOI 10.1084/jem.161.6.1539; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; TRUST TJ, 1983, INFECT IMMUN, V41, P106, DOI 10.1128/IAI.41.1.106-113.1983; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Watanabe A, 2010, J VIROL, V84, P4183, DOI 10.1128/JVI.02168-09; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x	42	109	113	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					725	731		10.1038/nm.3563	http://dx.doi.org/10.1038/nm.3563			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24880614	Bronze, Green Published			2022-12-25	WOS:000338689500014
J	Peglion, F; Llense, F; Etienne-Manneville, S				Peglion, Florent; Llense, Flora; Etienne-Manneville, Sandrine			Adherens junction treadmilling during collective migration	NATURE CELL BIOLOGY			English	Article							E-CADHERIN ENDOCYTOSIS; ADENOMATOUS POLYPOSIS-COLI; CELL-CELL ADHESION; N-CADHERIN; P120 CATENIN; ACTIN CYTOSKELETON; BETA-CATENIN; ASTROCYTE MIGRATION; CLASSICAL CADHERINS; VE-CADHERIN	Collective cell migration is essential for both physiological and pathological processes. Adherens junctions (AJs) maintain the integrity of the migrating cell group and promote cell coordination while allowing cellular rearrangements. Here, we show that AJs undergo a continuous treadmilling along the lateral sides of adjacent leading cells. The treadmilling is driven by an actin-dependent rearward movement of AJs and is supported by the polarized recycling of N-cadherin. N-cadherin is mainly internalized at the cell rear and then recycled to the leading edge where it accumulates before being incorporated into forming AJs at the front of lateral cell-cell contacts. The polarized dynamics of AJs is controlled by a front-to-rear gradient of p120-catenin phosphorylation, which regulates polarized trafficking of N-cadherin. Perturbation of the GSK3-dependent phosphorylation of p120-catenin impacts on the stability of AJs, and the polarity and speed of leading cells during collective migration.	[Peglion, Florent; Llense, Flora; Etienne-Manneville, Sandrine] Inst Pasteur, CNRS URA 2582, Cell Polar Migrat & Canc Unit, F-75724 Paris 15, France; [Peglion, Florent] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Etienne-Manneville, S (corresponding author), Inst Pasteur, CNRS URA 2582, Cell Polar Migrat & Canc Unit, 25 Rue Dr Roux, F-75724 Paris 15, France.	sandrine.etienne-manneville@pasteur.fr	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675; PEGLION, Florent/0000-0002-9364-9444	University Paris VI and VII; Association pour la Recherche contre le Cancer; Fondation pour la Recherche Medicale; Institut National du Cancer; l'Association pour la Recherche contre le Cancer; La Ligue contre le Cancer	University Paris VI and VII; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); l'Association pour la Recherche contre le Cancer; La Ligue contre le Cancer(Ligue nationale contre le cancer)	We are particularly grateful to M. Piel (Institut Curie, France), A. B. Reynolds (Vanderbilt University, USA), A. Ridley (King's College, UK), C. Gauthier-Rouviere (CRBM, France), B. Goud (Institut Curie, France), M. Cohen-Salmon (College de France, France), D. Riveline (IGBMC, France) and L. Looger (Janelia Farm, USA) for plasmids and reagents. We thank J-Y. Tinevez and E. Perret from the Plate-Forme d'Imagerie Dynamique/IMAGOPOLE, of Institut Pasteur, and J-B. Manneville for critical reading of the manuscript. F. P. is financially supported by the University Paris VI and VII, the Association pour la Recherche contre le Cancer and the Fondation pour la Recherche Medicale; and F. L. by the Institut National du Cancer. This work was supported by the Institut National du Cancer, l'Association pour la Recherche contre le Cancer, and La Ligue contre le Cancer. We also would like to thank D. Porquet and G. Porquet for contributing to the funding of this study.	Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Angst BD, 2001, J CELL SCI, V114, P629; Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Camand E, 2012, J CELL SCI, V125, P844, DOI 10.1242/jcs.087668; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dupin I, 2011, J CELL SCI, V124, P865, DOI 10.1242/jcs.076356; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville Sandrine, 2012, Subcell Biochem, V60, P225, DOI 10.1007/978-94-007-4186-7_10; Etienne-Manneville S, 2011, SEMIN CELL DEV BIOL, V22, P850, DOI 10.1016/j.semcdb.2011.07.023; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ewald AJ, 2012, J CELL SCI, V125, P2638, DOI 10.1242/jcs.096875; FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; Gnanaguru G, 2013, DEVELOPMENT, V140, P2050, DOI 10.1242/dev.087817; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lohia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051130; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sabatini PJB, 2011, J CELL SCI, V124, P2013, DOI 10.1242/jcs.076901; Sharma M, 2007, J BIOL CHEM, V282, P8545, DOI 10.1074/jbc.M610272200; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Smutny M, 2010, J CELL BIOL, V189, P1075, DOI 10.1083/jcb.201005151; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Ulrich Florian, 2008, V440, P371, DOI 10.1007/978-1-59745-178-9_27; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	69	104	105	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					639	+		10.1038/ncb2985	http://dx.doi.org/10.1038/ncb2985			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24929360				2022-12-25	WOS:000338187900005
J	Frielingsdorf, S; Fritsch, J; Schmidt, A; Hammer, M; Lowenstein, J; Siebert, E; Pelmenschikov, V; Jaenicke, T; Kalms, J; Rippers, Y; Lendzian, F; Zebger, I; Teutloff, C; Kaupp, M; Bittl, R; Hildebrandt, P; Friedrich, B; Lenz, O; Scheerer, P				Frielingsdorf, Stefan; Fritsch, Johannes; Schmidt, Andrea; Hammer, Mathias; Loewenstein, Julia; Siebert, Elisabeth; Pelmenschikov, Vladimir; Jaenicke, Tina; Kalms, Jacqueline; Rippers, Yvonne; Lendzian, Friedhelm; Zebger, Ingo; Teutloff, Christian; Kaupp, Martin; Bittl, Robert; Hildebrandt, Peter; Friedrich, Baerbel; Lenz, Oliver; Scheerer, Patrick			Reversible [4Fe-3S] cluster morphing in an O2-tolerant [NiFe] hydrogenase	NATURE CHEMICAL BIOLOGY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; MEMBRANE-BOUND HYDROGENASE; IRON-SULFUR PROTEIN; OXYGEN-TOLERANT; RALSTONIA-EUTROPHA; CRYSTAL-STRUCTURE; ACTIVE-SITE; O-2-TOLERANT; ELECTRON; H-2	Hydrogenases catalyze the reversible oxidation of H-2 into protons and electrons and are usually readily inactivated by O-2. However, a subgroup of the [NiFe] hydrogenases, including the membrane-bound [NiFe] hydrogenase from Ralstonia eutropha, has evolved remarkable tolerance toward O-2 that enables their host organisms to utilize H-2 as an energy source at high O-2. This feature is crucially based on a unique six cysteine-coordinated [4Fe-3S] cluster located close to the catalytic center, whose properties were investigated in this study using a multidisciplinary approach. The [4Fe-3S] cluster undergoes redox-dependent reversible transformations, namely iron swapping between a sulfide and a peptide amide N. Moreover, our investigations unraveled the redox-dependent and reversible occurence of an oxygen ligand located at a different iron. This ligand is hydrogen bonded to a conserved histidine that is essential for H-2 oxidation at high O-2. We propose that these transformations, reminiscent of those of the P-cluster of nitrogenase, enable the consecutive transfer of two electrons within a physiological potential range.	[Frielingsdorf, Stefan; Fritsch, Johannes; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, Berlin, Germany; [Frielingsdorf, Stefan; Siebert, Elisabeth; Rippers, Yvonne; Lendzian, Friedhelm; Zebger, Ingo; Hildebrandt, Peter; Lenz, Oliver] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Schmidt, Andrea; Hammer, Mathias; Kalms, Jacqueline; Scheerer, Patrick] Charite, AG Proteinstrukturanal, Inst Med Phys & Biophys ChariteCrossOver, Berlin, Germany; [Loewenstein, Julia; Teutloff, Christian; Bittl, Robert] Free Univ Berlin, Fachbereich Phys, Berlin, Germany; [Pelmenschikov, Vladimir; Kaupp, Martin] Tech Univ Berlin, Inst Chem, Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin; Free University of Berlin; Technical University of Berlin	Frielingsdorf, S (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Berlin, Germany.	oliver.lenz@tu-berlin.de; patrick.scheerer@charite.de	Lenz, Oliver/C-1582-2019; Hildebrandt, Peter/J-5658-2014; Frielingsdorf, Stefan/AAD-8065-2019; Kaupp, Martin Prof. Dr./K-9569-2016; Bittl, Robert/I-8149-2013; Lenz, Oliver/N-5130-2019; Pelmenschikov, Vladimir/O-7640-2019	Lenz, Oliver/0000-0003-4550-5128; Hildebrandt, Peter/0000-0003-1030-5900; Frielingsdorf, Stefan/0000-0002-4141-7836; Kaupp, Martin Prof. Dr./0000-0003-1582-2819; Bittl, Robert/0000-0003-4103-3768; Lenz, Oliver/0000-0003-4550-5128; Pelmenschikov, Vladimir/0000-0002-0523-4418; Scheerer, Patrick/0000-0001-5028-2075	German Research Foundation (DFG) Cluster of Excellence 'Unifying Concepts in Catalysis'; European Research Council [ERC-2009/249910-TUDOR]	German Research Foundation (DFG) Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We are grateful to D. von Stetten and A. Royant of the ID29S-Cryobench (European Synchrotron Radiation Facility (ESRF), Grenoble) and the scientific staff of the ESRF at beamlines ID14-1, ID 14-4, ID29, ID 23-1 and ID23-2 and to U. Muller, M. Weiss and the scientific staff of the BESSY-MX/Helmholtz-Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1, BL 14.2 and BL 14.3 operated by the Joint Berlin MX-Laboratory at the BESSY II electron storage ring (Berlin-Adlershof, Germany), where the data were collected, for continuous support. We thank C. Muller-Dieckmann for helpful advice in collecting anomalous data at the ID29 (ESRF, Grenoble). J. Hamann is acknowledged for excellent technical support in molecular biology. J. Newie, S. Wohlfahrt and T. Goris are acknowledged for their help in constructing MBH variants. This work was supported by the German Research Foundation (DFG) Cluster of Excellence 'Unifying Concepts in Catalysis' (to P.S., O.L., P.H., V.P. and R.B.). P.S. acknowledges K.P. Hofmann and his advanced investigator European Research Council grant (ERC-2009/249910-TUDOR) for support.	Abou Hamdan A, 2013, NAT CHEM BIOL, V9, P15, DOI [10.1038/nchembio.1110, 10.1038/NCHEMBIO.1110]; Abou Hamdan A, 2012, J AM CHEM SOC, V134, P8368, DOI 10.1021/ja301802r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball EG, 1937, J BIOL CHEM, V118, P219; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bruska MK, 2013, DALTON T, V42, P8729, DOI 10.1039/c3dt50763g; CAMMACK R, 1973, BIOCHEM BIOPH RES CO, V54, P548, DOI 10.1016/0006-291X(73)91457-5; Cammack R, 2010, BIOL MAGN RESON, V29, P11, DOI 10.1007/978-1-4419-1139-1_2; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; Cross M, 2002, J BIOL INORG CHEM, V7, P781, DOI 10.1007/s00775-002-0355-1; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dikanov S. A., 1992, ELECT SPIN ECHO ENVE; EDMONDS DT, 1973, J MAGN RESON, V12, P134, DOI 10.1016/0022-2364(73)90136-4; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Frielingsdorf S, 2011, BIOCHEMISTRY-US, V50, P10836, DOI 10.1021/bi201594m; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Fritscher J, 2004, PHYS CHEM CHEM PHYS, V6, P4950, DOI 10.1039/b408764j; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Green MT, 2006, J AM CHEM SOC, V128, P1902, DOI 10.1021/ja054074s; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; Ishikita H, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0518; JOHNSON RE, 1983, J AM CHEM SOC, V105, P7280, DOI 10.1021/ja00363a013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Lanzilotta WN, 1998, BIOCHEMISTRY-US, V37, P11376, DOI 10.1021/bi980048d; Lauterbach L, 2013, J AM CHEM SOC, V135, P17897, DOI 10.1021/ja408420d; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Maly T, 2004, J MAGN RESON, V170, P88, DOI 10.1016/j.jmr.2004.06.003; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Noveron JC, 1998, INORG CHEM, V37, P1138, DOI 10.1021/ic971388a; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2013, P NATL ACAD SCI USA, V110, P483, DOI 10.1073/pnas.1202575110; Pandelia ME, 2012, CHEM COMMUN, V48, P823, DOI 10.1039/c1cc16109a; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Pelmenschikov V, 2013, J AM CHEM SOC, V135, P11809, DOI 10.1021/ja402159u; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Rippers Y, 2012, CHEMPHYSCHEM, V13, P3852, DOI 10.1002/cphc.201200562; Roessler MM, 2012, J AM CHEM SOC, V134, P15581, DOI 10.1021/ja307117y; Saggu M, 2010, PHYS CHEM CHEM PHYS, V12, P2139, DOI 10.1039/b922236g; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SANDERSLOEHR J, 1988, ACS SYM SER, V372, P49; Schafer C, 2013, APPL ENVIRON MICROB, V79, P5137, DOI 10.1128/AEM.01576-13; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E., 2013, PROKARYOTES PROKARYO, P119, DOI [DOI 10.1007/978-3-642-30141-4_65, 10.1007/978-3-642-30141-4_65]; SHERGILL JK, 1994, BBA-BIOENERGETICS, V1185, P35, DOI 10.1016/0005-2728(94)90190-2; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; Siebert E, 2013, ANGEW CHEM INT EDIT, V52, P5162, DOI 10.1002/anie.201209732; SLOLL S, 2006, J MAGN RESON, V178, P42; Vignais PM, 2005, COORDIN CHEM REV, V249, P1677, DOI 10.1016/j.ccr.2005.01.026; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; WALLBANK B, 1974, J ELECTRON SPECTROSC, V4, P263, DOI 10.1016/0368-2048(74)80057-5	60	64	64	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					378	U92		10.1038/nchembio.1500	http://dx.doi.org/10.1038/nchembio.1500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24705592				2022-12-25	WOS:000334672700012
J	Gruell, H; Klein, F				Gruell, Henning; Klein, Florian			Tracking the development of broadly neutralizing antibodies	NATURE MEDICINE			English	Editorial Material							VACCINE DEVELOPMENT; HIV-1; VIRUS		[Gruell, Henning; Klein, Florian] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA	Rockefeller University	Gruell, H (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	fklein@rockefeller.edu		Grull, Henning/0000-0002-0725-7138				Dona-Rose N.A., 2014, NATURE, DOI [10.1038/nature13036, DOI 10.1038/NATURE13036]; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Larimore K, 2012, J IMMUNOL, V189, P3221, DOI 10.4049/jimmunol.1201303; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949	14	6	6	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					482	483		10.1038/nm.3567	http://dx.doi.org/10.1038/nm.3567			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24804756				2022-12-25	WOS:000335710700017
J	Murat, P; Zhong, J; Lekieffre, L; Cowieson, NP; Clancy, JL; Preiss, T; Balasubramanian, S; Khanna, R; Tellam, J				Murat, Pierre; Zhong, Jie; Lekieffre, Lea; Cowieson, Nathan P.; Clancy, Jennifer L.; Preiss, Thomas; Balasubramanian, Shankar; Khanna, Rajiv; Tellam, Judy			G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN TELOMERIC DNA; T-CELL RECOGNITION; SMALL-MOLECULE; ENDOGENOUS PRESENTATION; VIRAL PROTEIN; CD8(+); INHIBITION; EXPRESSION; EVASION; MAINTENANCE	Viruses that establish latent infections have evolved unique mechanisms to avoid host immune recognition. Maintenance proteins of these viruses regulate their synthesis to levels sufficient for maintaining persistent infection but below threshold levels for host immune detection. The mechanisms governing this finely tuned regulation of viral latency are unknown. Here we show that mRNAs encoding gammaherpesviral maintenance proteins contain within their open reading frames clusters of unusual structural elements, G-quadruplexes, which are responsible for the cis-acting regulation of viral mRNA translation. By studying the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1) mRNA, we demonstrate that destabilization of G-quadruplexes using antisense oligonucleotides increases EBNA1 mRNA translation. In contrast, pretreatment with a G-quadruplex- stabilizing small molecule, pyridostatin, decreases EBNA1 synthesis, highlighting the importance of G-quadruplexes within virally encoded transcripts as unique regulatory signals for translational control and immune evasion. Furthermore, these findings suggest alternative therapeutic strategies focused on targeting RNA structure within viral ORFs.	[Murat, Pierre; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge, England; [Zhong, Jie; Lekieffre, Lea; Khanna, Rajiv; Tellam, Judy] QIMR Berghofer Med Res Inst, Clive Berghofer Canc Res Ctr, Dept Immunol, Brisbane, Qld, Australia; [Zhong, Jie; Lekieffre, Lea; Khanna, Rajiv; Tellam, Judy] QIMR Berghofer Med Res Inst, QIMR Ctr Immunotherapy & Vaccine Dev, Brisbane, Qld, Australia; [Lekieffre, Lea] Monash Univ, Ctr Synchrotron Sci, Melbourne, Vic 3004, Australia; [Clancy, Jennifer L.; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Genom Biol Dept, Canberra, ACT 2601, Australia; [Balasubramanian, Shankar] Canc Res UK, Li Ka Shing Ctr, Cambridge Inst, Cambridge, England; [Balasubramanian, Shankar] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England	University of Cambridge; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Monash University; Australian National University; John Curtin School of Medical Research; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Murat, P (corresponding author), Univ Cambridge, Dept Chem, Cambridge, England.	judy.tellam@qimr.edu.au	Preiss, Thomas/F-7355-2010; Balasubramanian, Shankar/C-1671-2009; Murat, Pierre/L-9304-2019; Khanna, Rajiv/A-7691-2008	Preiss, Thomas/0000-0001-6273-784X; Khanna, Rajiv/0000-0003-2241-0353; Balasubramanian, Shankar/0000-0002-0281-5815	National Health and Medical Research Council (NHMRC) of Australia [496684, APP1005091]; NHMRC Career Development Award Fellowship [496712]; NHMRC Senior Principal Research Fellowship [APP1002476]; Cancer Research UK; Cancer Research UK [11961] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Award Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank J. Shine and R. Tellam for valuable discussions, D. Hoang-Le and G. Wei for technical assistance and M. Di Antonio for providing PDS. Project grants (496684 and APP1005091) from the National Health and Medical Research Council (NHMRC) of Australia supported this research. J. T. was supported with a NHMRC Career Development Award Fellowship (no. 496712). R. K. is supported with a NHMRC Senior Principal Research Fellowship (APP1002476). The Balasubramanian group is supported by a program grant funded by Cancer Research UK.	Apcher S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001151; Apcher S, 2009, J VIROL, V83, P1289, DOI 10.1128/JVI.01369-08; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; Blake N, 2010, J GEN VIROL, V91, P829, DOI 10.1099/vir.0.018242-0; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Bugaut A, 2010, ORG BIOMOL CHEM, V8, P2771, DOI 10.1039/c002418j; Cardinaud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008692; Clancy JL, 2011, RNA, V17, P1025, DOI 10.1261/rna.2567611; Cristillo AD, 2001, J THEOR BIOL, V208, P475, DOI 10.1006/jtbi.2000.2233; Endoh T, 2013, ANGEW CHEM INT EDIT, V52, P5522, DOI 10.1002/anie.201300058; Everly D, 2012, CURR CANCER RES, P133, DOI 10.1007/978-1-4614-0016-5_7; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lee SP, 2004, J EXP MED, V199, P1409, DOI 10.1084/jem.20040121; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; MATHEWS MB, 2007, ORIGINS PRINCIPLES T; Mergny JL, 2001, P NATL ACAD SCI USA, V98, P3062, DOI 10.1073/pnas.051620698; Mukherjee S, 1998, J EXP MED, V187, P445, DOI 10.1084/jem.187.3.445; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Ossevoort M, 2007, MOL IMMUNOL, V44, P3588, DOI 10.1016/j.molimm.2007.03.005; Ostankovitch M, 2005, J IMMUNOL, V174, P2544, DOI 10.4049/jimmunol.174.5.2544; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; Ressing ME, 2008, SEMIN CANCER BIOL, V18, P397, DOI 10.1016/j.semcancer.2008.10.008; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Tellam J, 2008, P NATL ACAD SCI USA, V105, P9319, DOI 10.1073/pnas.0801968105; Tellam J, 2007, J EXP MED, V204, P525, DOI 10.1084/jem.20062508; Tellam JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003112; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Zaldumbide A, 2007, MOL IMMUNOL, V44, P1352, DOI 10.1016/j.molimm.2006.05.012; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	50	170	175	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					358	U64		10.1038/NCHEMBIO.1479	http://dx.doi.org/10.1038/NCHEMBIO.1479			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24633353	Bronze, Green Accepted			2022-12-25	WOS:000334672700009
J	Angelo, M; Bendall, SC; Finck, R; Hale, MB; Hitzman, C; Borowsky, AD; Levenson, RM; Lowe, JB; Liu, SD; Zhao, SC; Natkunam, Y; Nolan, GP				Angelo, Michael; Bendall, Sean C.; Finck, Rachel; Hale, Matthew B.; Hitzman, Chuck; Borowsky, Alexander D.; Levenson, Richard M.; Lowe, John B.; Liu, Scot D.; Zhao, Shuchun; Natkunam, Yasodha; Nolan, Garry P.			Multiplexed ion beam imaging of human breast tumors	NATURE MEDICINE			English	Article							MASS-SPECTROMETRY; PROTEIN EXPRESSION; CYTOMETRY; ANTIBODY; IMMUNOHISTOCHEMISTRY; QUANTIFICATION; CLUSTERS; TISSUES	Immunohistochemistry (IHC) is a tool for visualizing protein expression that is employed as part of the diagnostic workup for the majority of solid tissue malignancies. Existing IHC methods use antibodies tagged with fluorophores or enzyme reporters that generate colored pigments. Because these reporters exhibit spectral and spatial overlap when used simultaneously, multiplexed IHC is not routinely used in clinical settings. We have developed a method that uses secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. Multiplexed ion beam imaging (MIBI) is capable of analyzing up to 100 targets simultaneously over a five-log dynamic range. Here, we used MIBI to analyze formalin-fixed, paraffin-embedded human breast tumor tissue sections stained with ten labels simultaneously. The resulting data suggest that MIBI can provide new insights into disease pathogenesis that will be valuable for basic research, drug discovery and clinical diagnostics.	[Angelo, Michael; Bendall, Sean C.; Finck, Rachel; Hale, Matthew B.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Angelo, Michael] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hitzman, Chuck] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Borowsky, Alexander D.; Levenson, Richard M.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Lowe, John B.; Liu, Scot D.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Zhao, Shuchun; Natkunam, Yasodha] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University; University of California System; University of California Davis; Roche Holding; Genentech; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019; Natkunam, Yasodha/L-5454-2015; Borowsky, Alexander D/S-5404-2017	Natkunam, Yasodha/0000-0002-9816-1018; Angelo, Michael/0000-0003-1531-5067; Bendall, Sean/0000-0003-1341-2453; Nolan, Garry/0000-0002-8862-9043	Stanford Molecular Imaging Scholars Program through the US National Institutes of Health (NIH) [5R25CA11868107]; Damon Runyon Cancer Research Foundation [DRG-2017-09]; NIH [1K99 GM104148-01, 0158 G KB065, 1R01CA130826, 5U54CA143907, HHSN272200700038C, N01-HV-00242, 41000411217, 5-24927, P01 CA034233-22A1, PN2EY018228, RFA CA 09-009, RFA CA 09-011, U19 AI057229, U54CA149145]; Northrop-Grumman Corporation [7500108142 BISC]; US National Science Foundation [0922648]; California Institute for Regenerative Medicine [DR1-01477, RB2-01592]; European Commission [HEALTH.2010.1.2-1]; US FDA [HHSF223201210194C: BAA-12-00118]; US Department of Defense [W81XWH-12-1-0591 OCRP-TIA NWC]; Entertainment Industry Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA093373, U54CA149145, U54CA119367, F32CA009009, P50CA114747, F32CA009011, R25CA118681, R01CA130826, P01CA034233, U54CA143907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027582, S10RR027431] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, U19AI057229, R01AI073724, P01AI036535, R01AI035304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM104148, K99GM104148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016318] Funding Source: NIH RePORTER	Stanford Molecular Imaging Scholars Program through the US National Institutes of Health (NIH); Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northrop-Grumman Corporation; US National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); European Commission(European CommissionEuropean Commission Joint Research Centre); US FDA(United States Department of Health & Human Services); US Department of Defense(United States Department of Defense); Entertainment Industry Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Hubbard, C. Espiritu, S. Rost, L. Rangell and the Genentech Human Tissue Lab for assistance in preparing and processing tissue sections. We also thank A. Jager for technical support with CyTOF and antibody labeling. M.A. is supported by the Stanford Molecular Imaging Scholars Program through the US National Institutes of Health (NIH, 5R25CA11868107). S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09) and NIH (1K99 GM104148-01). R.F. is supported by Northrop-Grumman Corporation (7500108142 BISC). This work was supported by a US National Science Foundation equipment grant (0922648) to the Stanford Nano Center for the NanoSIMS 50L analytical system used in the work here. This work was also supported by grants (to the Nolan lab) from the NIH (0158 G KB065, 1R01CA130826, 5U54CA143907, HHSN272200700038C, N01-HV-00242, 41000411217, 5-24927, P01 CA034233-22A1, P01 CA034233-22A1, PN2EY018228, RFA CA 09-009, RFA CA 09-011, U19 AI057229 and U54CA149145), the California Institute for Regenerative Medicine (DR1-01477 and RB2-01592), the European Commission (HEALTH.2010.1.2-1), the US FDA (HHSF223201210194C: BAA-12-00118), the US Department of Defense (W81XWH-12-1-0591 OCRP-TIA NWC) and the Entertainment Industry Foundation.	Aerni HR, 2009, ANAL CHEM, V81, P7490, DOI 10.1021/ac900974j; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Bodo J, 2009, J HISTOCHEM CYTOCHEM, V57, P701, DOI 10.1369/jhc.2009.953547; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Caprioli RM, 2008, PROTEOMICS, V8, P3679, DOI 10.1002/pmic.200890064; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coons AH, 1942, J IMMUNOL, V45, P159; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Giesen C, 2011, ANAL CHEM, V83, P8177, DOI 10.1021/ac2016823; Glass G, 2009, J HISTOCHEM CYTOCHEM, V57, P899, DOI 10.1369/jhc.2009.953612; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Hasui K, 2003, J HISTOCHEM CYTOCHEM, V51, P1169, DOI 10.1177/002215540305100907; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Ornatsky OI, 2008, J ANAL ATOM SPECTROM, V23, P463, DOI 10.1039/b710510j; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Rimm DL, 2006, NAT BIOTECHNOL, V24, P914, DOI 10.1038/nbt0806-914; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schubert W, 2009, J PROTEOME RES, V8, P2696, DOI 10.1021/pr800944f; Seeley EH, 2008, PROTEOM CLIN APPL, V2, P1435, DOI 10.1002/prca.200800013; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smith NS, 2008, APPL SURF SCI, V255, P1606, DOI 10.1016/j.apsusc.2008.05.141; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Wahlby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026; Williams Peter, 2006, J Biol, V5, P18, DOI 10.1186/jbiol49; Wu B, 2011, INT J MASS SPECTROM, V307, P112, DOI 10.1016/j.ijms.2011.01.019	34	553	567	13	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					436	+		10.1038/nm.3488	http://dx.doi.org/10.1038/nm.3488			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24584119	Green Accepted			2022-12-25	WOS:000334361500026
J	Guilluy, C; Osborne, LD; Van Landeghem, L; Sharek, L; Superfine, R; Garcia-Mata, R; Burridge, K				Guilluy, Christophe; Osborne, Lukas D.; Van Landeghem, Laurianne; Sharek, Lisa; Superfine, Richard; Garcia-Mata, Rafael; Burridge, Keith			Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus	NATURE CELL BIOLOGY			English	Article							EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; LAMIN-A/C; ACTIN; RHO; INTEGRINS; MECHANICS; ADHESION; BINDING; STRESS	Mechanical forces influence many aspects of cell behaviour. Forces are detected and transduced into biochemical signals by force-bearing molecular elements located at the cell surface, in adhesion complexes or in cytoskeletal structures. The nucleus is physically connected to the cell surface through the cytoskeleton and the linker of nucleoskeleton and cytoskeleton (LINC) complex, allowing rapid mechanical stress transmission from adhesions to the nucleus. Although it has been demonstrated that nuclei experience force, the direct effect of force on the nucleus is not known. Here we show that isolated nuclei are able to respond to force by adjusting their stiffness to resist the applied tension. Using magnetic tweezers, we found that applying force on nesprin-1 triggers nuclear stiffening that does not involve chromatin or nuclear actin, but requires an intact nuclear lamina and emerin, a protein of the inner nuclear membrane. Emerin becomes tyrosine phosphorylated in response to force and mediates the nuclear mechanical response to tension. Our results demonstrate that mechanotransduction is not restricted to cell surface receptors and adhesions but can occur in the nucleus.	[Guilluy, Christophe; Van Landeghem, Laurianne; Sharek, Lisa; Garcia-Mata, Rafael; Burridge, Keith] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Osborne, Lukas D.; Superfine, Richard] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Guilluy, C (corresponding author), Inst Thorax, INSERM, UMR1087, F-44000 Nantes, France.	christophe.guilluy@inserm.fr; Keith_Burridge@med.unc.edu	Van Landeghem, Laurianne/K-2430-2015; guilluy, christophe/C-6002-2014; Guilluy, Christophe/Z-1015-2019; Van+Landeghem, Laurianne/AAG-7334-2019; Superfine, Richard/A-1968-2012	guilluy, christophe/0000-0003-1141-0809; Guilluy, Christophe/0000-0003-1141-0809; Van+Landeghem, Laurianne/0000-0001-7408-3521; Superfine, Richard/0000-0002-2569-071X	National Institutes of Health [GM029860, P41-EB002025-23A1, R01-HL077546-03A2]; University Cancer Research Fund from the Lineberger Comprehensive Cancer Center; European Union [254747]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund from the Lineberger Comprehensive Cancer Center; European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health Grants numbers GM029860 (to K.B.), P41-EB002025-23A1 (R.S.) and R01-HL077546-03A2 (R.S.), and a grant from the University Cancer Research Fund from the Lineberger Comprehensive Cancer Center. C.G. is supported by a Marie Curie Outgoing International Fellowship from the European Union Seventh Frame work Programme (FP7/2007-2013) under grant agreement no. 254747.	Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Dahl KN, 2011, J CELL SCI, V124, P675, DOI 10.1242/jcs.069096; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Fisher JK, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2166509; Folker ES, 2011, P NATL ACAD SCI USA, V108, P131, DOI 10.1073/pnas.1000824108; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Khatau S. B., 2012, SCI REP, V2, P1; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Philip JT, 2008, J BIOMECH, V41, P3164, DOI 10.1016/j.jbiomech.2008.08.024; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rowat AC, 2006, BIOPHYS J, V91, P4649, DOI 10.1529/biophysj.106.086454; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tifft KE, 2009, J CELL SCI, V122, P3780, DOI 10.1242/jcs.048397; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594	33	360	364	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					376	+		10.1038/ncb2927	http://dx.doi.org/10.1038/ncb2927			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24609268	Green Submitted, Green Accepted			2022-12-25	WOS:000333556900011
J	Hill, JH; Chen, Z; Xu, H				Hill, Jahda H.; Chen, Zhe; Xu, Hong			Selective propagation of functional mitochondrial DNA during oogenesis restricts the transmission of a deleterious mitochondrial variant	NATURE GENETICS			English	Article							BALBIANI BODY; DROSOPHILA; HETEROPLASMY; INHERITANCE; FUSOME	Although mitochondrial DNA (mtDNA) is prone to mutation and few mtDNA repair mechanisms exist(1), crippling mitochondrial mutations are exceedingly rare(2). Recent studies have demonstrated strong purifying selection in the mouse female germline(3,4). However, the mechanisms underlying positive selection of healthy mitochondria remain to be elucidated. We visualized mtDNA replication during Drosophila melanogaster oogenesis, finding that mtDNA replication commenced before oocyte determination during the late germarium stage and was dependent on mitochondrial fitness. We isolated a temperature- sensitive lethal mtDNA allele, mt:CoIT300I, which resulted in reduced mtDNA replication in the germarium at the restrictive temperature. Additionally, the frequency of the mt:CoIT300I allele in heteroplasmic flies was decreased, both during oogenesis and over multiple generations, at the restrictive temperature. Furthermore, we determined that selection against mt:CoIT300I overlaps with the timing of selective replication of mtDNA in the germarium. These findings establish a previously uncharacterized developmental mechanism for the selective amplification of wild-type mtDNA, which may be evolutionarily conserved to limit the transmission of deleterious mutations.	[Hill, Jahda H.; Chen, Zhe; Xu, Hong] NHLBI, Mol Genet Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Xu, H (corresponding author), NHLBI, Mol Genet Lab, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.	xuh5@nhlbi.nih.gov	Chen, Zhe/E-4278-2015; Xu, Hong/H-9997-2016; Chen, Zhe/H-1417-2016	Chen, Zhe/0000-0002-8209-0999; Xu, Hong/0000-0003-1049-1184; 	National, Heart, Lung, and Blood Institute (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006153] Funding Source: NIH RePORTER	National, Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are indebted to P. O'Farrell, in whose laboratory the mt:CoI<SUP>T300I</SUP> fly was isolated. We thank R. Balaban, T. Finkel, A. Michelson, H. Parthasarathy, N. Rusan and R. Youle for comments on the manuscript; P. O'Farrell and A. Spradling for their insightful discussions; P. Hwang for technical assistance; the Spradling laboratory (Carnegie Institute) and the Bloomington and Vienna stock centers for Drosophila stocks; Genetic Services, Inc., for embryo injection; and the Developmental Studies Hybridoma Bank for antibodies. This work was supported by the National, Heart, Lung, and Blood Institute (NHLBI) Intramural Program.	CALLEJA M, 1993, J BIOL CHEM, V268, P18891; CHANCE B, 1955, J BIOL CHEM, V217, P409; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427; HORWITZ HB, 1971, J CELL BIOL, V49, P546, DOI 10.1083/jcb.49.2.546; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; KOCH EA, 1983, CELL TISSUE RES, V228, P21; LIN HF, 1994, DEVELOPMENT, V120, P947; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919; NIKI Y, 1989, NATURE, V341, P551, DOI 10.1038/341551a0; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Rand DM, 2008, PLOS BIOL, V6, P229, DOI 10.1371/journal.pbio.0060035; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; Spradling Allan C., 1993, P1; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226; Yoneda M, 1996, Methods Enzymol, V264, P432, DOI 10.1016/S0076-6879(96)64039-7; Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5	26	105	106	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					389	+		10.1038/ng.2920	http://dx.doi.org/10.1038/ng.2920			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24614072	Green Accepted			2022-12-25	WOS:000334510100017
J	Mavrakis, M; Azou-Gros, Y; Tsai, FC; Alvarado, J; Bertin, A; Iv, F; Kress, A; Brasselet, S; Koenderink, GH; Lecuit, T				Mavrakis, Manos; Azou-Gros, Yannick; Tsai, Feng-Ching; Alvarado, Jose; Bertin, Aurelie; Iv, Francois; Kress, Alla; Brasselet, Sophie; Koenderink, Gijsje H.; Lecuit, Thomas			Septins promote F-actin ring formation by crosslinking actin filaments into curved bundles	NATURE CELL BIOLOGY			English	Article							NONMUSCLE MYOSIN-II; MAMMALIAN SEPTIN; DROSOPHILA EMBRYO; CONTRACTILE RING; CLEAVAGE FURROW; CYTOKINESIS; ANILLIN; CELLULARIZATION; ORGANIZATION; MEMBRANE	Animal cell cytokinesis requires a contractile ring of crosslinked actin filaments and myosin motors. How contractile rings form and are stabilized in dividing cells remains unclear. We address this problem by focusing on septins, highly conserved proteins in eukaryotes whose precise contribution to cytokinesis remains elusive. We use the cleavage of the Drosophila melanogaster embryo as a model system, where contractile actin rings drive constriction of invaginating membranes to produce an epithelium in a manner akin to cell division. In vivo functional studies show that septins are required for generating curved and tightly packed actin filament networks. In vitro reconstitution assays show that septins alone bundle actin filaments into rings, accounting for the defects in actin ring formation in septin mutants. The bundling and bending activities are conserved for human septins, and highlight unique functions of septins in the organization of contractile actomyosin rings.	[Mavrakis, Manos; Azou-Gros, Yannick; Iv, Francois; Lecuit, Thomas] Aix Marseille Univ, Inst Biol Dev Marseille, CNRS, UMR 7288, F-13288 Marseille, France; [Tsai, Feng-Ching; Alvarado, Jose; Koenderink, Gijsje H.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Bertin, Aurelie] Inst Curie, CNRS, UMR 168, F-75231 Paris, France; [Kress, Alla; Brasselet, Sophie] Aix Marseille Univ, Ecole Cent Marseille, Inst Fresnel, CNRS,UMR 7249, F-13397 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; AMOLF; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite	Mavrakis, M (corresponding author), Aix Marseille Univ, Inst Biol Dev Marseille, CNRS, UMR 7288, F-13288 Marseille, France.	manos.mavrakis@univ-amu.fr; thomas.lecuit@univ-amu.fr	Mavrakis, Manos/F-9112-2016; Brasselet, Sophie/N-1089-2017	Mavrakis, Manos/0000-0002-7980-1841; Brasselet, Sophie/0000-0002-6766-9273; Tsai, Feng-Ching/0000-0002-6869-5254; Alvarado, Jose Ramon/0000-0001-7245-6435; Bertin, Aurelie/0000-0002-3400-6887	G. Pehau-Arnaudet at Imagopole (Institut Pasteur); electron microscopy facility at Imagif (Gif sur Yvette); ANR Blanc ARCHIPLAST (T. L.); Fondation pour la Recherche Medicale (equipe labelisee, T. L.); Association pour la Recherche contre la Cancer [SL220120605305]; PHC Van Gogh [25005UA, 28879SJ]; ANR BLANC [150902]; RADORDER [18818]; region Provence Alpes Coted d'Azur; national infrastructure France Bio-Imaging; Nikon Application Center Marseille	G. Pehau-Arnaudet at Imagopole (Institut Pasteur); electron microscopy facility at Imagif (Gif sur Yvette); ANR Blanc ARCHIPLAST (T. L.)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (equipe labelisee, T. L.); Association pour la Recherche contre la Cancer; PHC Van Gogh; ANR BLANC(French National Research Agency (ANR)); RADORDER; region Provence Alpes Coted d'Azur; national infrastructure France Bio-Imaging; Nikon Application Center Marseille	We thank the Lecuit and Lenne groups for discussions and for providing a fruitful environment during the course of this work. We thank J-P. Chauvin, A. Aouane and F. Richard at the IBDM electron microscopy facility for help with embryo processing and image acquisition, G. Pehau-Arnaudet at Imagopole (Institut Pasteur) and the electron microscopy facility at Imagif (Gif sur Yvette) for technical help with imaging of in vitro actin-septin assemblies, P. Ferrand, X. Wang, J. Duboisset and H. Rigneault ( Institut Fresnel) for their contribution in the implementation of polarization-resolved fluorescence microscopy, C. Romier and C. Fernandez-Tornero for discussions on septin purification, F. Maina for key advice on phosphoprotein westerns, M. Kuit-Vinkenoog for G-actin purification, and A. Kamor and C. Chandre for Matlab and POV-ray code for drawing FC tori. M. M., Y.A-G. and F. I. were supported by the ANR Blanc ARCHIPLAST (T. L.), the Fondation pour la Recherche Medicale (equipe labelisee, T. L.), the Association pour la Recherche contre la Cancer (Programme ARC, SL220120605305) and the CNRS. M. M., A. B., F-C. T., J. A. and G. H. K. were supported by two PHC Van Gogh grants (no. 25005UA and no. 28879SJ, ministeres des Affaires etrangeres et de l'Enseignement superieur et de la Recherche), and G. H. K., F-C. T. and J. A. were supported by a VIDI grant from NWO and by the Foundation for Fundamental Research on Matter (FOM). A. K. and S. B. were supported by the CNRS, the ANR BLANC grants 150902 (ReceptORIENT) and 18818 (RADORDER) and the region Provence Alpes Cote d'Azur. This work was supported by the national infrastructure France Bio-Imaging and the Nikon Application Center Marseille.	Adam JC, 2000, MOL BIOL CELL, V11, P3123, DOI 10.1091/mbc.11.9.3123; Barmchi MP, 2005, J CELL BIOL, V168, P575, DOI 10.1083/jcb.200407124; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Carvalho A, 2009, CELL, V137, P926, DOI 10.1016/j.cell.2009.03.021; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; FULLILOVE SL, 1971, DEV BIOL, V26, P560, DOI 10.1016/0012-1606(71)90141-2; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Gentry BS, 2012, EUR BIOPHYS J BIOPHY, V41, P979, DOI 10.1007/s00249-012-0861-1; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Guillot C, 2013, DEV CELL, V24, P227, DOI 10.1016/j.devcel.2013.01.010; Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kress A, 2013, BIOPHYS J, V105, P127, DOI 10.1016/j.bpj.2013.05.043; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Liu JH, 2012, CURR BIOL, V22, P64, DOI 10.1016/j.cub.2011.11.040; Mavrakis M., 2008, CURRENT PROTOCOLS CE; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mostowy S, 2011, BIOPHYS J, V100, P1949, DOI 10.1016/j.bpj.2011.02.040; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Murthy M, 2010, DEVELOPMENT, V137, P2773, DOI 10.1242/dev.048330; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; SCHEJTER ED, 1993, CELL, V75, P373, DOI 10.1016/0092-8674(93)80078-S; Schmidt K, 2004, CURR BIOL, V14, P1002, DOI 10.1016/j.cub.2004.05.044; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tang JX, 2001, EUR BIOPHYS J BIOPHY, V30, P477, DOI 10.1007/s002490100178; Taylor KA, 2000, J CELL BIOL, V149, P635, DOI 10.1083/jcb.149.3.635; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Vogel SK, 2013, ELIFE, V2, DOI 10.7554/eLife.00116; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wenzl C, 2010, MECH DEVELOP, V127, P371, DOI 10.1016/j.mod.2010.01.001; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhang LA, 2011, GENE EXPR PATTERNS, V11, P93, DOI 10.1016/j.gep.2010.09.008	70	135	136	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					322	+		10.1038/ncb2921	http://dx.doi.org/10.1038/ncb2921			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24633326				2022-12-25	WOS:000333556900006
J	Zhao, WX; Pollack, JL; Blagev, DP; Zaitlen, N; McManus, MT; Erle, DJ				Zhao, Wenxue; Pollack, Joshua L.; Blagev, Denitza P.; Zaitlen, Noah; McManus, Michael T.; Erle, David J.			Massively parallel functional annotation of 3 ' untranslated regions	NATURE BIOTECHNOLOGY			English	Article							MICRORNA TARGET SITES; MESSENGER-RNA DECAY; SYSTEMATIC DISCOVERY; MAMMALIAN-CELLS; RICH ELEMENTS; STABILITY; PROMOTERS; MOTIFS; POLYADENYLATION; TRANSLATION	Functional characterization of noncoding sequences is crucial for understanding the human genome and learning how genetic variation contributes to disease. 3' untranslated regions (UTRs) are an important class of noncoding sequences, but their functions remain largely uncharacterized(1). We developed a method for massively parallel functional annotation of sequences from 3' UTRs (fast-UTR) and used this approach to measure the effects of a total of >450 kilobases of 3' UTR sequences from >2,000 human genes on steady-state mRNA abundance, mRNA stability and protein production. We found widespread regulatory effects on mRNA that were coupled to effects on mRNA stability and protein production. Furthermore, we discovered 87 novel cis-regulatory elements and measured the effects of genetic variation within known and novel 3' UTR motifs. This work shows how massively parallel approaches can improve the functional annotation of noncoding sequences, advance our understanding of cis-regulatory mechanisms and quantify the effects of human genetic variation.	[Zhao, Wenxue; Pollack, Joshua L.; Blagev, Denitza P.; Zaitlen, Noah; Erle, David J.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Erle, DJ (corresponding author), Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA.	david.erle@ucsf.edu	mcmanus, michael/AAB-1239-2020; Zhao, Wenxue/I-7721-2013	mcmanus, michael/0000-0003-3013-6569; Erle, David/0000-0002-2171-0648; Zhao, Wenxue/0000-0001-5380-1176	US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108596] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. M. Ansel, R. Barbeau, A. Barczak, S. E. Brenner, K. Chin, C. Eisley, E. Ostrin, S.-W. Park, A. Sayce, T. Wang and G. Zhang for advice and technical assistance. We thank A. Shyu (University of Texas Health Science Center at Houston) for providing BEAS-2B tTA cells. This work was supported by research grants (D.J.E.) and a training grant (D.P.B.) from the US National Institutes of Health.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Chen CYA, 2007, RNA, V13, P1775, DOI 10.1261/rna.663507; Chen CY, 1995, TRENDS BIOCHEM SCI, V11, P465, DOI DOI 10.1016/S0968-0004(00)89102-1.PUBMED:8578590; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Numahata K, 2003, J CELL BIOCHEM, V90, P976, DOI 10.1002/jcb.10710; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Spies N, 2013, GENOME RES, V23, P2078, DOI 10.1101/gr.156919.113; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wang SB, 2006, NUCLEIC ACIDS RES, V34, P3044, DOI 10.1093/nar/gkl386; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao Wenxue, 2011, Proc Am Thorac Soc, V8, P163, DOI 10.1513/pats.201007-054MS	40	62	63	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					387	U259		10.1038/nbt.2851	http://dx.doi.org/10.1038/nbt.2851			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633241	Green Accepted, Green Submitted			2022-12-25	WOS:000334340800024
J	Afshar-Sterle, S; Zotos, D; Bernard, NJ; Scherger, AK; Rodling, L; Alsop, AE; Walker, J; Masson, F; Belz, GT; Corcoran, LM; O'Reilly, LA; Strasser, A; Smyth, MJ; Johnstone, R; Tarlinton, DM; Nutt, SL; Kallies, A				Afshar-Sterle, Shoukat; Zotos, Dimitra; Bernard, Nicholas J.; Scherger, Anna K.; Roedling, Lisa; Alsop, Amber E.; Walker, Jennifer; Masson, Frederick; Belz, Gabrielle T.; Corcoran, Lynn M.; O'Reilly, Lorraine A.; Strasser, Andreas; Smyth, Mark J.; Johnstone, Ricky; Tarlinton, David M.; Nutt, Stephen L.; Kallies, Axel			Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas	NATURE MEDICINE			English	Article							NF-KAPPA-B; CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; PROTEIN EXPRESSION; GENE; PATHOGENESIS; MUTATIONS; RECEPTOR; CANCER	Loss of function of the tumor suppressor gene PRDM1 (also known as BLIMP1) or deregulated expression of the oncogene BCL6 occurs in a large proportion of diffuse large B cell lymphoma (DLBCL) cases. However, targeted mutation of either gene in mice leads to only slow and infrequent development of malignant lymphoma, and despite frequent mutation of BCL6 in activated B cells of healthy individuals, lymphoma development is rare. Here we show that T cells prevent the development of overt lymphoma in mice caused by Blimp1 deficiency or overexpression of Bcl6 in the B cell lineage. Impairment of T cell control results in rapid development of DLBCL-like disease, which can be eradicated by polyclonal CD8(+) T cells in a T cell receptor-, CD28- and Fas ligand-dependent manner. Thus, malignant transformation of mature B cells requires mutations that impair intrinsic differentiation processes and permit escape from T cell-mediated tumor surveillance.	[Afshar-Sterle, Shoukat; Zotos, Dimitra; Bernard, Nicholas J.; Scherger, Anna K.; Roedling, Lisa; Alsop, Amber E.; Walker, Jennifer; Masson, Frederick; Belz, Gabrielle T.; Corcoran, Lynn M.; O'Reilly, Lorraine A.; Strasser, Andreas; Tarlinton, David M.; Nutt, Stephen L.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Afshar-Sterle, Shoukat; Zotos, Dimitra; Bernard, Nicholas J.; Scherger, Anna K.; Roedling, Lisa; Alsop, Amber E.; Walker, Jennifer; Masson, Frederick; Belz, Gabrielle T.; Corcoran, Lynn M.; O'Reilly, Lorraine A.; Strasser, Andreas; Tarlinton, David M.; Nutt, Stephen L.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Johnstone, Ricky] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Johnstone, Ricky] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Queensland; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au	Strasser, Andreas/C-7581-2013; Nutt, Stephen L/C-9256-2013; Johnstone, Ricky w/H-3748-2014; Smyth, Mark J/H-8709-2014; Belz, Gabrielle T/C-9350-2013	Strasser, Andreas/0000-0002-5020-4891; Nutt, Stephen L/0000-0002-0020-6637; Johnstone, Ricky w/0000-0001-7053-9237; Smyth, Mark J/0000-0001-7098-7240; Belz, Gabrielle T/0000-0002-9660-9587; Tarlinton, David/0000-0001-9928-686X; Bernard, Nicholas/0000-0002-9483-7922; Kallies, Axel/0000-0002-6312-6968; Masson, Frederic/0000-0001-9909-2985	National Health and Medical Research Council of Australia; Australia Research Council; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute; Cancer Council Victoria; Cancer Australia; Cancer Council New South Wales; Leukemia & Lymphoma Society	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council(Australian Research Council); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Australia; Cancer Council New South Wales(Cancer Council New South Wales); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society)	We thank L. Pasqualucci (Columbia University) for Bcl6-transgenic mice, D. Yu (Monash University) for Cd28<SUP>-/-</SUP> mice, M. Reth (Albert-Ludwigs-Universitat) for Cd79a-Cre mice, L. Wu (Walter and Eliza Hall Institute of Medical Research (WEHI)) for MHC-I antibodies and A. Brooks (University of Melbourne) for antibodies, D. Gray (WEHI) for TCR antibodies, J. Markham for help with the statistical analysis, and P. Schneider (University of Lausanne) for the Fc-FasL. This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (G.T.B., L.M.C., S.L.N., D.M.T., A.K., A.S., M.J.S. and L.A.O.), the Australia Research Council (A.K., S.L.N.), the Sylvia and Charles Viertel Foundation and the Howard Hughes Medical Institute (A.K., G.T.B.), the Cancer Council Victoria (D.Z.), Cancer Australia and the Cancer Council New South Wales (L.A.O.), and the Leukemia & Lymphoma Society (A.K., L.A.O. and A.S.). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support scheme.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bolitho P, 2009, P NATL ACAD SCI USA, V106, P2723, DOI 10.1073/pnas.0809008106; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; D'Costa K, 2009, BLOOD, V113, P5911, DOI 10.1182/blood-2008-08-172866; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Esser MT, 1996, J EXP MED, V183, P1697, DOI 10.1084/jem.183.4.1697; Frick M, 2012, BEST PRACT RES CL HA, V25, P3, DOI 10.1016/j.beha.2012.01.003; Harris J, 2012, HEMATOL ONCOL, V30, P8, DOI 10.1002/hon.996; He JS, 2010, J IMMUNOL, V184, P555, DOI 10.4049/jimmunol.0902465; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kessler B, 1998, J IMMUNOL, V161, P6939; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kojima Y, 2006, EUR J HAEMATOL, V76, P465, DOI 10.1111/j.1600-0609.2006.00631.x; Kolar GR, 2007, BLOOD, V109, P2545, DOI 10.1182/blood-2006-07-037150; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lee KS, 2009, CANCER RES, V69, P5481, DOI 10.1158/0008-5472.CAN-09-0291; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Marshall JL, 2011, EUR J IMMUNOL, V41, P3506, DOI 10.1002/eji.201141762; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2002, TRENDS IMMUNOL, V23, P75, DOI 10.1016/S1471-4906(01)02115-9; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Novac N, 2006, FASEB J, V20, P1074, DOI 10.1096/fj.05-5457com; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Schneider C, 2011, SEMIN DIAGN PATHOL, V28, P167, DOI 10.1053/j.semdp.2011.04.001; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Stel AJ, 2007, J IMMUNOL, V178, P2287, DOI 10.4049/jimmunol.178.4.2287; Stopeck AT, 2000, CLIN CANCER RES, V6, P3904; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Willimsky G, 2007, IMMUNOL REV, V220, P102, DOI 10.1111/j.1600-065X.2007.00578.x; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031	59	67	70	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					283	290		10.1038/nm.3442	http://dx.doi.org/10.1038/nm.3442			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24487434				2022-12-25	WOS:000332595600023
J	Gilmartin, AG; Faitg, TH; Richter, M; Groy, A; Seefeld, MA; Darcy, MG; Peng, X; Federowicz, K; Yang, JS; Zhang, SY; Minthorn, E; Jaworski, JP; Schaber, M; Martens, S; McNulty, DE; Sinnamon, RH; Zhang, H; Kirkpatrick, RB; Nevins, N; Cui, GL; Pietrak, B; Diaz, E; Jones, A; Brandt, M; Schwartz, B; Heerding, DA; Kumar, R				Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh			Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN PHOSPHATASE; TUMOR-SUPPRESSOR; BREAST-CANCER; 3RD METAL; PPM1D; AMPLIFICATION; DEFICIENT; PATHWAYS; TARGET; GAIN	Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging. Herein we report a series of allosteric, small-molecule inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers. Compound binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases. Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53. Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth. To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.	[Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Heerding, Dirk A.; Kumar, Rakesh] GlaxoSmithKline, Prot Dynam Discovery Performance Unit, Canc Res, Oncol Res & Dev, Collegeville, PA 19426 USA; [Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline	Heerding, DA (corresponding author), GlaxoSmithKline, Prot Dynam Discovery Performance Unit, Canc Res, Oncol Res & Dev, Collegeville, PA 19426 USA.	dirk.a.heerding@gsk.com; rakesh.2.kumar@gsk.com	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Nevins, Neysa/0000-0003-2378-7283				[Anonymous], 2002, NAT GENET, V31, P133; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chuman Y, 2008, PROTEIN PEPTIDE LETT, V15, P938, DOI 10.2174/092986608785849236; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fuku T, 2007, PATHOL INT, V57, P566, DOI 10.1111/j.1440-1827.2007.02140.x; Hayashi R, 2011, BIOCHEMISTRY-US, V50, P4537, DOI 10.1021/bi101949t; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lambros MB, 2010, MODERN PATHOL, V23, P1334, DOI 10.1038/modpathol.2010.121; Lowe J, 2012, FRONT BIOSCI-LANDMRK, V17, P1480, DOI 10.2741/3999; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Ong SE, 2012, ANAL BIOANAL CHEM, V404, P967, DOI 10.1007/s00216-012-5998-3; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Satoh N, 2011, CANCER SCI, V102, P1101, DOI 10.1111/j.1349-7006.2011.01898.x; Schito ML, 2006, J IMMUNOL, V176, P4818, DOI 10.4049/jimmunol.176.8.4818; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Tanoue K, 2013, BIOCHEMISTRY-US, V52, P5830, DOI 10.1021/bi4005649; Vintonyak VV, 2009, CURR OPIN CHEM BIOL, V13, P272, DOI 10.1016/j.cbpa.2009.03.021; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Zhu YH, 2012, PROG MOL BIOL TRANSL, V106, P307, DOI 10.1016/B978-0-12-396456-4.00001-8	33	147	150	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					181	+		10.1038/NCHEMBIO.1427	http://dx.doi.org/10.1038/NCHEMBIO.1427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24390428				2022-12-25	WOS:000331616900008
J	Matthews, ML; Chang, WC; Layne, AP; Miles, LA; Krebs, C; Bollinger, JM				Matthews, Megan L.; Chang, Wei-chen; Layne, Andrew P.; Miles, Linde A.; Krebs, Carsten; Bollinger, J. Martin, Jr.			Direct nitration and azidation of aliphatic carbons by an iron-dependent halogenase	NATURE CHEMICAL BIOLOGY			English	Article							KETOGLUTARATE DIOXYGENASE TAUD; C-H BONDS; INTERMEDIATE; AMINATION; COMPLEX; ENZYMES; SYNTHETASE; ACTIVATION; CHEMISTRY; MECHANISM	Iron-dependent halogenases employ cis-halo-Fe(IV)-oxo (haloferryl) complexes to functionalize unactivated aliphatic carbon centers, a capability elusive to synthetic chemists. Halogenation requires (i) coordination of a halide anion (Cl- or Br-) to the enzyme's Fe(II) cofactor, (ii) coupled activation of O-2 and decarboxylation of a-ketoglutarate to generate the haloferryl intermediate, (iii) abstraction of hydrogen (H-center dot) from the substrate by the ferryl and (iv) transfer of the cis halogen as Cl-center dot or Br-center dot to the substrate radical. This enzymatic solution to an unsolved chemical challenge is potentially generalizable to installation of other functional groups, provided that the corresponding anions can support the four requisite steps. We show here that the wild-type halogenase SyrB2 can indeed direct aliphatic nitration and azidation reactions by the same chemical logic. The discovery and enhancement by mutagenesis of these previously unknown reaction types suggest unrecognized or untapped versatility in ferryl-mediated enzymatic C-H bond activation.	[Matthews, Megan L.; Chang, Wei-chen; Layne, Andrew P.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA USA; [Miles, Linde A.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Matthews, ML (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	matthews@scripps.edu; jmb21@psu.edu	Krebs, Carsten/D-4773-2009; Matthews, Megan/W-2217-2017; Bollinger, Joseph/C-1425-2016	Krebs, Carsten/0000-0002-3302-7053; Matthews, Megan/0000-0003-1178-4616; CHANG, WEI-CHEN/0000-0002-2341-9846; Miles, Linde/0000-0003-3578-2842	National Institutes of Health [GM-69657]; National Science Foundation [MCB-642058, CHE-724084]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM-69657 to C. K. and J.M.B.Jr.) and the National Science Foundation (MCB-642058 and CHE-724084 to C.K. and J.M.B.Jr.). We thank C. Drennan and M. Dey at the Massachusetts Institute of Technology for the kind gift of the plasmid to express SyrB2<SUP>A118G</SUP>.	BALDWIN JE, 1990, CHEM REV, V90, P1079, DOI 10.1021/cr00105a001; Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bollinger JM, 2009, CURR OPIN CHEM BIOL, V13, P51, DOI 10.1016/j.cbpa.2009.03.018; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Cho SH, 2011, CHEM SOC REV, V40, P5068, DOI 10.1039/c1cs15082k; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Fujimori DG, 2007, J AM CHEM SOC, V129, P13408, DOI 10.1021/ja076454e; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; GROVES JT, 1985, J CHEM EDUC, V62, P928, DOI 10.1021/ed062p928; Han JW, 2012, BIOTECHNOL LETT, V34, P1327, DOI 10.1007/s10529-012-0913-8; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hennessy ET, 2013, SCIENCE, V340, P591, DOI 10.1126/science.1233701; Herrerias CI, 2007, CHEM REV, V107, P2546, DOI 10.1021/cr050980b; Huisgen R., 1984, 1 3 DIPOLAR CYCLOADD, V1-2, P1; Huisman GW, 2013, CURR OPIN CHEM BIOL, V17, P284, DOI 10.1016/j.cbpa.2013.01.017; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Kulik HJ, 2013, J BIOL CHEM, V288, P11233, DOI 10.1074/jbc.M112.415570; Lewis JC, 2011, CHEM SOC REV, V40, P2003, DOI 10.1039/c0cs00067a; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; McIntosh JA, 2013, ANGEW CHEM INT EDIT, V52, P9309, DOI 10.1002/anie.201304401; Neidig ML, 2007, J AM CHEM SOC, V129, P14224, DOI 10.1021/ja074557r; Ogura K., 1997, DYNAMIC ASPECTS NATU; Paradine SM, 2012, J AM CHEM SOC, V134, P2036, DOI 10.1021/ja211600g; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Nguyen Q, 2013, J AM CHEM SOC, V135, P620, DOI 10.1021/ja3113565; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; STRICKLER SJ, 1963, J AM CHEM SOC, V85, P2899, DOI 10.1021/ja00902a007; Surry DS, 2011, CHEM SCI, V2, P27, DOI 10.1039/c0sc00331j; Sydor PK, 2011, NAT CHEM, V3, P388, DOI [10.1038/NCHEM.1024, 10.1038/nchem.1024]; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Vaillancourt FH, 2006, CHEMBIOCHEM, V7, P748, DOI 10.1002/cbic.200500480; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Wang Z, 2008, ORG LETT, V10, P1863, DOI 10.1021/ol800593p; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Ye SF, 2011, P NATL ACAD SCI USA, V108, P1228, DOI 10.1073/pnas.1008411108	47	82	84	5	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					209	+		10.1038/NCHEMBIO.1438	http://dx.doi.org/10.1038/NCHEMBIO.1438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24463698	Green Accepted			2022-12-25	WOS:000331616900012
J	Simons, YB; Turchin, MC; Pritchard, JK; Sella, G				Simons, Yuval B.; Turchin, Michael C.; Pritchard, Jonathan K.; Sella, Guy			The deleterious mutation load is insensitive to recent population history	NATURE GENETICS			English	Article							GENETIC-VARIATION; VARIANTS; SPECTRUM; REVEALS; EXCESS	Human populations have undergone major changes in population size in the past 100,000 years, including recent rapid growth. How these demographic events have affected the burden of deleterious mutations in individuals and the frequencies of disease mutations in populations remains unclear. We use population genetic models to show that recent human demography has probably had little impact on the average burden of deleterious mutations. This prediction is supported by two exome sequence data sets showing that individuals of west African and European ancestry carry very similar burdens of damaging mutations. We further show that for many diseases, rare alleles are unlikely to contribute a large fraction of the heritable variation, and therefore the impact of recent growth is likely to be modest. However, for those diseases that have a direct impact on fitness, strongly deleterious rare mutations probably do have an important role, and recent growth will have increased their impact.	[Simons, Yuval B.] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Turchin, Michael C.; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sella, Guy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Hebrew University of Jerusalem; University of Chicago; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Chicago	Pritchard, JK (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	pritch@stanford.edu; gsella@math.huji.ac.il		Turchin, Michael/0000-0003-3569-1529	US National Institutes of Health (NIH) [MH084703, GM083228]; Israel Science Foundation [1492/10]; Howard Hughes Medical Institute; NIH grant [T32 GM007197]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM083228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the US National Institutes of Health (NIH) (MH084703 to J.K.P. and GM083228 to G.S.), the Israel Science Foundation (grant 1492/10 to G.S.) and the Howard Hughes Medical Institute (J.K.P.). M.C.T. was supported in part by NIH grant T32 GM007197. We thank D. Reich and S. Sunyaev for helpful discussions and generous input regarding the interpretation of PolyPhen-2, I. Adzhubey for human-independent PolyPhen scores, J. Akey for assistance in accessing data, J. Akey, A. Siepel, G. Coop, I. Eshel, R. Hudson and two anonymous reviewers for comments on the manuscript and M. Przeworski for many discussions and comments on the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Casals F, 2012, SCIENCE, V337, P39, DOI 10.1126/science.1224528; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hartl :D. L, 2000, PRIMER POPULATION GE; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lynch M, 1995, EVOLUTION, V49, P1067, DOI [10.1111/j.1558-5646.1995.tb04434.x, 10.2307/2410432]; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thornton KR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003258; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2000, GENETICS, V155, P1865; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	30	172	172	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					220	+		10.1038/ng.2896	http://dx.doi.org/10.1038/ng.2896			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24509481	Green Accepted, Green Submitted			2022-12-25	WOS:000332036700005
J	Zook, JM; Chapman, B; Wang, J; Mittelman, D; Hofmann, O; Hide, W; Salit, M				Zook, Justin M.; Chapman, Brad; Wang, Jason; Mittelman, David; Hofmann, Oliver; Hide, Winston; Salit, Marc			Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls	NATURE BIOTECHNOLOGY			English	Article							GENOME; CANCER; MUTATIONS; FRAMEWORK; EXOME; MAP	Clinical adoption of human genome sequencing requires methods that output genotypes with known accuracy at millions or billions of positions across a genome. Because of substantial discordance among calls made by existing sequencing methods and algorithms, there is a need for a highly accurate set of genotypes across a genome that can be used as a benchmark. Here we present methods to make high-confidence, single-nucleotide polymorphism (SNP), indel and homozygous reference genotype calls for NA12878, the pilot genome for the Genome in a Bottle Consortium. We minimize bias toward any method by integrating and arbitrating between 14 data sets from five sequencing technologies, seven read mappers and three variant callers. We identify regions for which no confident genotype call could be made, and classify them into different categories based on reasons for uncertainty. Our genotype calls are publicly available on the Genome Comparison and Analytic Testing website to enable real-time benchmarking of any method.	[Zook, Justin M.; Salit, Marc] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA; [Chapman, Brad; Hofmann, Oliver; Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Bioinformat Core, Cambridge, MA 02138 USA; [Wang, Jason; Mittelman, David] Arpeggi Inc, Austin, TX USA; [Mittelman, David] Virginia Bioinformat Inst, Blacksburg, VA USA; [Mittelman, David] Dept Biol Sci, Blacksburg, VA USA	National Institute of Standards & Technology (NIST) - USA; Harvard University; Harvard T.H. Chan School of Public Health	Zook, JM (corresponding author), NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.	jzook@nist.gov	Zook, Justin/B-7000-2008; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017; Hofmann, Oliver/F-1800-2013	Zook, Justin/0000-0003-2309-8402; Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Hofmann, Oliver/0000-0002-7738-1513	US Food and Drug Administration High Performance Computing; Archon Genomics X PRIZE	US Food and Drug Administration High Performance Computing; Archon Genomics X PRIZE	We thank J. Johnson and A. Varadarajan from the Archon Genomics X Prize and EdgeBio for contributing their whole-genome sequencing data from SOLiD and Illumina, Complete Genomics and Life Technologies for providing bam files for NAl2878, and the Broad Institute and 1000 Genomes Project for making publicly available barn and VCF files for NAl2878. The Illumina exome data on GCAT were given to the Mittelman laboratory by M. Linderman at Icahn Institute of Genomics and Multiscale Biology of the Icahn School of Medicine at Mount Sinai. We thank the US Food and Drug Administration High Performance Computing staff for their support in running the bioinformatics analyses. Harvard School of Public Health contributions were funded by the Archon Genomics X PRIZE. Certain commercial equipment, instruments or materials are identified in this document. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the products identified are necessarily the best available for the purpose.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Author A., 1975, PLASMA PROTEINS STRU; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Garrison E., 2012, PREPRINT; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Rieber N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066621; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	25	461	469	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					246	251		10.1038/nbt.2835	http://dx.doi.org/10.1038/nbt.2835			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24531798	Green Submitted, Bronze			2022-12-25	WOS:000332819800022
J	Buzon, MJ; Sun, H; Li, C; Shaw, A; Seiss, K; Ouyang, ZY; Martin-Gayo, E; Leng, J; Henrich, TJ; Li, JZ; Pereyra, F; Zurakowski, R; Walker, BD; Rosenberg, ES; Yu, XG; Lichterfeld, M				Buzon, Maria J.; Sun, Hong; Li, Chun; Shaw, Amy; Seiss, Katherine; Ouyang, Zhengyu; Martin-Gayo, Enrique; Leng, Jin; Henrich, Timothy J.; Li, Jonathan Z.; Pereyra, Florencia; Zurakowski, Ryan; Walker, Bruce D.; Rosenberg, Eric S.; Yu, Xu G.; Lichterfeld, Mathias			HIV-1 persistence in CD4(+) T cells with stem cell like properties	NATURE MEDICINE			English	Article							MEMORY; DIFFERENTIATION; PRECURSORS; INFECTION; CURE	Cellular HIV-1 reservoirs that persist despite antiretroviral treatment are incompletely defined. We show that during suppressive antiretroviral therapy, CD4(+) T memory stem cells (T-SCM cells) harbor high per-cell levels of HIV-1 DNA and make increasing contributions to the total viral CD4(+) T cell reservoir over time. Moreover, we conducted phylogenetic studies that suggested long-term persistence of viral quasispecies in CD4(+) T-SCM cells. Thus, HIV-1 may exploit the stem cell characteristics of cellular immune memory to promote long-term viral persistence.	[Buzon, Maria J.; Rosenberg, Eric S.; Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Buzon, Maria J.; Sun, Hong; Li, Chun; Shaw, Amy; Seiss, Katherine; Ouyang, Zhengyu; Martin-Gayo, Enrique; Leng, Jin; Pereyra, Florencia; Walker, Bruce D.; Yu, Xu G.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Sun, Hong] China Med Univ, Affiliated Hosp 1, Key Lab AIDS Immunol, Dept Lab Med, Shenyang, Peoples R China; [Henrich, Timothy J.; Li, Jonathan Z.; Pereyra, Florencia] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Zurakowski, Ryan] Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; China Medical University; Harvard University; Brigham & Women's Hospital; University of Delaware; Howard Hughes Medical Institute	Lichterfeld, M (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	mlichterfeld@partners.org	Buzon, Maria J/G-8286-2015; Gayo, Enrique Martin/AAK-4273-2021; Ouyang, Zhengyu/P-3576-2014; Lichterfeld, Mathias/B-2042-2008	Buzon, Maria J/0000-0003-4427-9413; Lichterfeld, Mathias/0000-0001-9865-8350; Zurakowski, Ryan/0000-0003-3726-3114; Martin-Gayo, Enrique/0000-0002-2619-6086	American Foundation for AIDS Research [108302-51-RGRL]; US National Institutes of Health [AI098487, AI106468, AI089339, AI098480, AI100699, AI074415]; Clinical Scientist Development Award from the Doris Duke Charitable Foundation [2009034]; European Molecular Biology Laboratory; Tosteson postdoctoral fellowship award from Massachusetts General Hospital; Mark and Lisa Schwartz Foundation; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098487, R01AI089339, P01AI074415, K08AI100699, R21AI106468, K23AI098480] Funding Source: NIH RePORTER	American Foundation for AIDS Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Scientist Development Award from the Doris Duke Charitable Foundation; European Molecular Biology Laboratory; Tosteson postdoctoral fellowship award from Massachusetts General Hospital; Mark and Lisa Schwartz Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Foundation for AIDS Research (grant 108302-51-RGRL to M.L.) and by the US National Institutes of Health (grants AI098487 and AI106468 to M.L., AI089339 to X.G.Y., AI098480 to T.J.H. and AI100699 to J.Z.L.). M.L. is a recipient of the Clinical Scientist Development Award from the Doris Duke Charitable Foundation (grant number 2009034). M.J.B. is supported by a fellowship award from the European Molecular Biology Laboratory and by the Tosteson postdoctoral fellowship award from Massachusetts General Hospital. Patient blood sample collection was supported by the US National Institutes of Health (grant AI074415), by the Mark and Lisa Schwartz Foundation and by the Bill & Melinda Gates Foundation. Chronically infected 293T cells were kindly provided by F. Bushman (University of Pennsylvania). HIV-1 isolates were kindly provided by D. Littman (New York University).	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Emerson Stephen G, 2008, Trans Am Clin Climatol Assoc, V119, P289; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P716, DOI 10.1038/nri3098; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478	18	303	312	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					139	142		10.1038/nm.3445	http://dx.doi.org/10.1038/nm.3445			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412925	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000330915000014
J	Huang, Y; DiDonato, JA; Levison, BS; Schmitt, D; Li, L; Wu, YP; Buffa, J; Kim, T; Gerstenecker, GS; Gu, XD; Kadiyala, CS; Wang, ZN; Culley, MK; Hazen, JE; DiDonato, AJ; Fu, XM; Berisha, SZ; Peng, DQ; Nguyen, TT; Liang, SH; Chuang, CC; Cho, L; Plow, EF; Fox, PL; Gogonea, V; Tang, WHW; Parks, JS; Fisher, EA; Smith, JD; Hazen, SL				Huang, Ying; DiDonato, Joseph A.; Levison, Bruce S.; Schmitt, Dave; Li, Lin; Wu, Yuping; Buffa, Jennifer; Kim, Timothy; Gerstenecker, Gary S.; Gu, Xiaodong; Kadiyala, Chandra S.; Wang, Zeneng; Culley, Miranda K.; Hazen, Jennie E.; DiDonato, Anthony J.; Fu, Xiaoming; Berisha, Stela Z.; Peng, Daoquan; Nguyen, Truc T.; Liang, Shaohong; Chuang, Chia-Chi; Cho, Leslie; Plow, Edward F.; Fox, Paul L.; Gogonea, Valentin; Tang, W. H. Wilson; Parks, John S.; Fisher, Edward A.; Smith, Jonathan D.; Hazen, Stanley L.			An abundant dysfunctional apolipoprotein A1 in human atheroma	NATURE MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; RANDOMIZED CONTROLLED-TRIAL; HYPOCHLOROUS ACID; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ANTIINFLAMMATORY PROPERTIES; SERUM PARAOXONASE; ARTERY WALL; APOA-I	Recent studies have indicated that high-density lipoproteins (HDLs) and their major structural protein, apolipoprotein A1 (apoA1), recovered from human atheroma are dysfunctional and are extensively oxidized by myeloperoxidase (MPO). In vitro oxidation of either apoA1 or HDL particles by MPO impairs their cholesterol acceptor function. Here, using phage display affinity maturation, we developed a high-affinity monoclonal antibody that specifically recognizes both apoA1 and HDL that have been modified by the MPO-H2O2-Cl- system. An oxindolyl alanine (2-OH-Trp) moiety at Trp72 of apoA1 is the immunogenic epitope. Mutagenesis studies confirmed a critical role for apoAl Trp72 in MPO-mediated inhibition of the ATP-binding cassette transporter A1 (ABCA1)-dependent cholesterol acceptor activity of apoAl in vitro and in vivo. ApoA1 containing a 2-OH-Trp72 group (oxTrp72-apoA1) is in low abundance within the circulation but accounts for 20% of the apoA1 in atherosclerosis-laden arteries. OxTrp72-apoA1 recovered from human atheroma or plasma is lipid poor, virtually devoid of cholesterol acceptor activity and demonstrated both a potent proinflammatory activity on endothelial cells and an impaired HDL biogenesis activity in vivo. Elevated oxTrp72-apoA1 levels in subjects presenting to a cardiology clinic (n = 627) were associated with increased cardiovascular disease risk. Circulating oxTrp72-apoA1 levels may serve as a way to monitor a proatherogenic process in the artery wall.	[Huang, Ying; DiDonato, Joseph A.; Levison, Bruce S.; Schmitt, Dave; Li, Lin; Buffa, Jennifer; Kim, Timothy; Gerstenecker, Gary S.; Gu, Xiaodong; Kadiyala, Chandra S.; Wang, Zeneng; Culley, Miranda K.; Hazen, Jennie E.; DiDonato, Anthony J.; Fu, Xiaoming; Berisha, Stela Z.; Peng, Daoquan; Nguyen, Truc T.; Cho, Leslie; Fox, Paul L.; Gogonea, Valentin; Tang, W. H. Wilson; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Gerstenecker, Gary S.; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Liang, Shaohong] Cleveland Heart Lab, Cleveland, OH USA; [Chuang, Chia-Chi; Parks, John S.] Wake Forest Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC USA; [Cho, Leslie; Plow, Edward F.; Tang, W. H. Wilson; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Fisher, Edward A.] NYU, Sch Med, Dept Cardiovasc Med, New York, NY USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; Wake Forest University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Wake Forest University; New York University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	hazens@ccf.org	Fisher, Edward/ABE-7469-2020; Wang, Zeneng/AAK-6119-2021; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013; Smith, Jonathan D./H-9723-2013	Key, Chia-Chi/0000-0003-0669-2936; Levison, Bruce/0000-0002-1816-368X; Smith, Jonathan D./0000-0002-0415-386X; Tang, W. H. Wilson/0000-0002-8335-735X; Fisher, Edward/0000-0001-9802-143X	US National Institutes of Health (NIH) grants [P01HL098055, HL119962]; NIH [P01HL098055, P01HL076491, R01HL103866, P20HL113452, R01HL103931]; LeDucq Fondation; Leonard Krieger Fund; Center of Innovation; AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL103866, R01HL103931, R01HL017964, P20HL113452, P01HL076491, R01HL094525, R01HL119962] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Fondation; Leonard Krieger Fund; Center of Innovation; AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Liang (Chinese Center for Disease Control and Prevention) for the gift of the dicistronic baculoviral shuttle vector used to subdone the scEv gene. This study was supported by US National Institutes of Health (NIH) grants P01HL098055 and HL119962. BioBank, the clinical study from which samples were analyzed, was supported in part from NIH grants P01HL098055, P01HL076491, R01HL103866, P20HL113452 and R01HL103931. This work was also supported in part by a grant from the LeDucq Fondation. S.L.H. is also partially supported by a gift from the Leonard Krieger Fund. Mass spectrometry instrumentation used was housed within the Cleveland Clinic Mass Spectrometry Facility, which is partially supported through a Center of Innovation Award by AB SCIEX.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; BADIMON JJ, 1989, LAB INVEST, V60, P455; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Baldus S, 2001, J CLIN INVEST, V108, P1759; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 2006, J AM COLL CARDIOL, V47, P492, DOI 10.1016/j.jacc.2005.09.042; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Charles-Schoeman C, 2007, J RHEUMATOL, V34, P1459; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gogonea V, 2013, J LIPID RES, V54, P966, DOI 10.1194/jlr.M032763; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210; Hughes SD, 1997, ARTERIOSCL THROM VAS, V17, P1725, DOI 10.1161/01.ATV.17.9.1725; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Ronald JA, 2009, CIRCULATION, V120, P592, DOI 10.1161/CIRCULATIONAHA.108.813998; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	53	271	285	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					193	203		10.1038/nm.3459	http://dx.doi.org/10.1038/nm.3459			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24464187	Green Accepted, Green Submitted			2022-12-25	WOS:000330915000021
J	Kaneko, M; Desai, BS; Cook, B				Kaneko, Maki; Desai, Bela S.; Cook, Boaz			Ionic leakage underlies a gain-of-function effect of dominant disease mutations affecting diverse P-type ATPases	NATURE GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; RAPID-ONSET DYSTONIA; DE-NOVO MUTATIONS; ATP2A2 MUTATIONS; DARIER-DISEASE; ALTERNATING HEMIPLEGIA; SOMATIC MUTATIONS; CHINESE PATIENTS; PLASMA-MEMBRANE; GENE	Type II P-type ATPases (PAIIs) constitute a family of conserved proteins that actively generate ionic gradients across membranes. Mutations in genes encoding PAIIs can cause heritable dominant diseases, with suggested etiology of haploinsufficiency. Using a Drosophila melanogaster genetic screen, we identified a dominant mutation altering the PAII member sarcoendoplasmic reticulum Ca2+ ATPase (SERCA). This mutation conferred temperature-sensitive uncoordination in a gain-of-function manner. We established that this gain-of-function phenotype is linked to dominant disease-causing mutations affecting various human PAIIs. We further found that heterologous expression of mutant PAIIs elicited ion leakage that was exacerbated at elevated temperatures. Therefore, these dominant mutations result in ionic leakage and render PAIIs susceptible to deleterious effects from elevated temperatures. Accordingly, it was recently reported that missense mutations affecting the Na+/K+ ATPase can elicit ionic leakage. We propose that ionic leakage is a pervasive gain-of-function mechanism that can underlie a variety of dominant PAII-related diseases.	[Kaneko, Maki; Desai, Bela S.; Cook, Boaz] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Cook, B (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	bcook@scripps.edu		Desai, Bela/0000-0001-7343-6233; Kaneko, Maki/0000-0002-2489-6185				Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Ahn W, 2003, J BIOL CHEM, V278, P20795, DOI 10.1074/jbc.M301638200; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Brashear A, 1993, GENEREVIEWS; Brashear A, 2012, DEV MED CHILD NEUROL, V54, P1065, DOI 10.1111/j.1469-8749.2012.04421.x; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chao SC, 2002, BRIT J DERMATOL, V146, P958, DOI 10.1046/j.1365-2133.2002.04786.x; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; Fu X, 2011, J EUR ACAD DERMATOL, V25, P370, DOI 10.1111/j.1468-3083.2010.03741.x; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Godic A, 2010, J AM ACAD DERMATOL, V62, P819, DOI 10.1016/j.jaad.2009.07.031; Green EK, 2013, J DERMATOL, V40, P259, DOI 10.1111/1346-8138.12082; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Ikeda S, 2003, J INVEST DERMATOL, V121, P475, DOI 10.1046/j.1523-1747.2003.12400.x; Ishii A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056120; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kirshenbaum GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060141; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Onozuka T, 2004, BRIT J DERMATOL, V150, P652, DOI 10.1111/j.0007-0963.2004.05868.x; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Podesta B, 2011, CEPHALALGIA, V31, P1497, DOI 10.1177/0333102411418260; Ren YQ, 2006, ARCH DERMATOL RES, V298, P58, DOI 10.1007/s00403-006-0658-0; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Ringpfeil F, 2001, EXP DERMATOL, V10, P19, DOI 10.1034/j.1600-0625.2001.100103.x; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Ruiz-Perez VL, 1999, HUM MOL GENET, V8, P1621, DOI 10.1093/hmg/8.9.1621; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Sakuntabhai A, 1999, HUM MOL GENET, V8, P1611, DOI 10.1093/hmg/8.9.1611; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Szigeti R, 2006, J INVEST DERMATOL, V126, P2370, DOI 10.1038/sj.jid.5700447; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang PG, 2006, CLIN EXP DERMATOL, V31, P558, DOI 10.1111/j.1365-2230.2006.02134.x; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	58	24	25	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					144	151		10.1038/ng.2850	http://dx.doi.org/10.1038/ng.2850			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24336169				2022-12-25	WOS:000331208300010
J	Tufi, R; Gandhi, S; de Castro, IP; Lehmann, S; Angelova, PR; Dinsdale, D; Deas, E; Plun-Favreau, H; Nicotera, P; Abramov, AY; Willis, AE; Mallucci, GR; Loh, SHY; Martins, LM				Tufi, Roberta; Gandhi, Sonia; de Castro, Ines P.; Lehmann, Susann; Angelova, Plamena R.; Dinsdale, David; Deas, Emma; Plun-Favreau, Helene; Nicotera, Pierluigi; Abramov, Andrey Y.; Willis, Anne E.; Mallucci, Giovanna R.; Loh, Samantha H. Y.; Martins, L. Miguel			Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease	NATURE CELL BIOLOGY			English	Article							DROSOPHILA-MELANOGASTER	Mutations in PINK1 cause early-onset Parkinson's disease (PD). Studies in Drosophila melanogaster have highlighted mitochondrial dysfunction on loss of Pink1 as a central mechanism of PD pathogenesis. Here we show that global analysis of transcriptional changes in Drosophila pink1 mutants reveals an upregulation of genes involved in nucleotide metabolism, critical for neuronal mitochondrial DNA synthesis. These key transcriptional changes were also detected in brains of PD patients harbouring PINK1 mutations. We demonstrate that genetic enhancement of the nucleotide salvage pathway in neurons of pink1 mutant flies rescues mitochondria! impairment. In addition, pharmacological approaches enhancing nucleotide pools reduce mitochondrial dysfunction caused by Pink1 deficiency. We conclude that loss of Pink1 evokes the activation of a previously unidentified metabolic reprogramming pathway to increase nucleotide pools and promote mitochondria! biogenesis. We propose that targeting strategies enhancing nucleotide synthesis pathways may reverse mitochondrial dysfunction and rescue neurodegeneration in PD and, potentially, other diseases linked to mitochondrial impairment.	[Tufi, Roberta; de Castro, Ines P.; Lehmann, Susann; Dinsdale, David; Willis, Anne E.; Mallucci, Giovanna R.; Loh, Samantha H. Y.; Martins, L. Miguel] MRC Toxicol Unit, Leicester LE1 9HN, Leics, England; [Gandhi, Sonia; Angelova, Plamena R.; Deas, Emma; Plun-Favreau, Helene; Abramov, Andrey Y.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Nicotera, Pierluigi] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany	University of London; University College London; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Loh, SHY (corresponding author), MRC Toxicol Unit, Lancaster Rd, Leicester LE1 9HN, Leics, England.	shyl1@le.ac.uk; martins.lmiguel@gmail.com	Martins, Miguel/AAH-3971-2019; Plun-Favreau, Helene/Q-4111-2016; Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; Loh, Samantha H. Y./Y-3877-2019; Deas, Emma/A-6755-2010; Stroh, Plamena/K-4444-2013	Martins, Miguel/0000-0002-3019-4809; Plun-Favreau, Helene/0000-0002-1401-9656; Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Stroh, Plamena/0000-0003-4596-9117; Loh, Samantha/0000-0001-5073-6065; Willis, Anne/0000-0002-1470-8531; Lehmann, Susann/0000-0001-9041-3383; Mallucci, Giovanna/0000-0001-8504-1191; Pimenta de Castro, Ines/0000-0002-0898-6834	MRC [MC_U123160654, MC_U132692719, MC_G1000735, MC_UP_A600_1023, MC_U132674518] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL5-Gandhi] Funding Source: researchfish; Parkinson&quot;s UK [H-1006, G-0612] Funding Source: researchfish; Wellcome Trust [100172/Z/12/Z] Funding Source: researchfish; Medical Research Council [MC_U132692719, MC_U123160654, MC_U132674518, MC_UP_A600_1023, MC_G1000735] Funding Source: Medline; Parkinson&apos;s UK [G-0612, H-1006] Funding Source: Medline; Wellcome Trust [089698] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Parkinson&quot;s UK(Parkinson&apos;s UK); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK); Wellcome Trust(Wellcome Trust)		ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Broadley SA, 2008, TRENDS CELL BIOL, V18, P1, DOI 10.1016/j.tcb.2007.11.003; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Curbo S, 2003, BIOCHEM BIOPH RES CO, V311, P440, DOI 10.1016/j.bbrc.2003.10.018; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Icreverzi A, 2012, CELL CYCLE, V11, P554, DOI 10.4161/cc.11.3.19062; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	22	96	97	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2014	16	2					157	166		10.1038/ncb2901	http://dx.doi.org/10.1038/ncb2901			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA5TB	24441527	Green Accepted, Green Submitted			2022-12-25	WOS:000331161400005
J	Weedon, MN; Cebola, I; Patch, AM; Flanagan, SE; De Franco, E; Caswell, R; Rodriguez-Segui, SA; Shaw-Smith, C; Cho, CHH; Allen, HL; Houghton, JAL; Roth, CL; Chen, R; Hussain, K; Marsh, P; Vallier, L; Murray, A; Ellard, S; Ferrer, J; Hattersley, AT				Weedon, Michael N.; Cebola, Ines; Patch, Ann-Marie; Flanagan, Sarah E.; De Franco, Elisa; Caswell, Richard; Rodriguez-Segui, Santiago A.; Shaw-Smith, Charles; Cho, Candy H-H; Allen, Hana Lango; Houghton, Jayne A. L.; Roth, Christian L.; Chen, Rongrong; Hussain, Khalid; Marsh, Phil; Vallier, Ludovic; Murray, Anna; Ellard, Sian; Ferrer, Jorge; Hattersley, Andrew T.		Int Pancreatic Agenesis Consortium	Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis	NATURE GENETICS			English	Article							HUMAN GENOME; DIFFERENTIATION; ELEMENTS; DISEASE; CELLS; DNA; VERTEBRATE; DELETION; GENES; LEADS	The contribution of cis-regulatory mutations to human disease remains poorly understood. Whole-genome sequencing can identify all noncoding variants, yet the discrimination of causal regulatory mutations represents a formidable challenge. We used epigenomic annotation in human embryonic stem cell (hESC)-derived pancreatic progenitor cells to guide the interpretation of whole-genome sequences from individuals with isolated pancreatic agenesis. This analysis uncovered six different recessive mutations in a previously uncharacterized similar to 400-bp sequence located 25 kb downstream of PTF1A (encoding pancreas-specific transcription factor 1a) in ten families with pancreatic agenesis. We show that this region acts as a developmental enhancer of PTF1A and that the mutations abolish enhancer activity. These mutations are the most common cause of isolated pancreatic agenesis. Integrating genome sequencing and epigenomic annotation in a disease-relevant cell type can thus uncover new noncoding elements underlying human development and disease.	[Weedon, Michael N.; Patch, Ann-Marie; Flanagan, Sarah E.; De Franco, Elisa; Caswell, Richard; Shaw-Smith, Charles; Allen, Hana Lango; Houghton, Jayne A. L.; Murray, Anna; Ellard, Sian; Hattersley, Andrew T.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Cebola, Ines; Rodriguez-Segui, Santiago A.; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Gen Regulat Pancreat Beta Cells Lab, Barcelona, Spain; [Cebola, Ines; Rodriguez-Segui, Santiago A.; Ferrer, Jorge] Ctr Invest Biomed Red Diabet & Enfermeda Metab, Barcelona, Spain; [Cebola, Ines; Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Cho, Candy H-H; Vallier, Ludovic] Cambridge Stem Cell Inst, Anne McLaren Lab Regenerat Med, Wellcome Trust Med Res Council, Cambridge, England; [Roth, Christian L.] Seattle Childrens Hosp, Res Inst, Seattle, WA USA; [Chen, Rongrong] Kings Coll London, Sch Biomed Sci, London, England; [Hussain, Khalid] Great Ormond St Hosp Sick Children, London Ctr Paediat Endocrinol & Metab, Children Natl Hlth Serv Trust, London, England; [Hussain, Khalid] UCL, Inst Child Hlth, London, England; [Marsh, Phil] UCL, Sch Med, Diabet & Nutr Sci Div, Diabetes Res Grp, London, England	University of Exeter; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Imperial College London; University of Cambridge; Seattle Children's Hospital; University of London; King's College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School	Hattersley, AT (corresponding author), Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.	j.ferrer@imperial.ac.uk; a.t.hattersley@exeter.ac.uk	Patch, Ann-Marie/C-4201-2018; Ferrer, Jorge/A-3176-2012; Cebola, Inês/AAG-9652-2020; vallier, ludovic/C-6368-2011	Patch, Ann-Marie/0000-0001-6121-4019; Ferrer, Jorge/0000-0002-5959-5729; Cebola, Inês/0000-0003-3528-4982; Hattersley, Andrew/0000-0001-5620-473X; Vallier, Ludovic/0000-0002-3848-2602; Ellard, Sian/0000-0002-7620-5526; Weedon, Michael/0000-0002-6174-6135; Flanagan, Sarah/0000-0002-8670-6340; Lango Allen, Hana/0000-0002-7803-8688; Caswell, Richard/0000-0003-0713-4602; Rodriguez-Segui, Santiago A./0000-0003-2952-8485; Murray, Anna/0000-0002-2351-2522	Wellcome Trust; Wellcome Trust as part of WT Biomedical Informatics Hub; BOLD grant (European Community's Seventh Framework Programme) [FP7-PEOPLE-ITN-2008]; National Institute for Health; Ministerio de Economia y Competitividad [SAF2011-27086, PLE2009-0162]; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust as part of WT Biomedical Informatics Hub; BOLD grant (European Community's Seventh Framework Programme); National Institute for Health; Ministerio de Economia y Competitividad(Spanish Government); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank M. Day, A. Damhuis and J. Garcia-Hurtado for technical assistance and R. Tearle (Complete Genomics), J. Tena and J. L. Skarmeta (Centro Andaluz de Biologia del Desarrollo) for advice. J. F., S. E. and A. T. H. are supported by Wellcome Trust Senior Investigator awards. M.N.W. is supported by the Wellcome Trust as part of WT Biomedical Informatics Hub funding. E. D. F. is funded by the BOLD grant (European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-PEOPLE-ITN-2008 (Marie Curie Initial Training Networks, Biology of Liver and Pancreatic Development and Disease)). This work was supported by the National Institute for Health Research Exeter Clinical Research Facility through funding for S. E. and A. T. H. and general infrastructure and by the Ministerio de Economia y Competitividad (SAF2011-27086, PLE2009-0162 to J. F.). The views expressed here are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health, UK.	Al-Shammari M, 2011, CLIN GENET, V80, P196, DOI 10.1111/j.1399-0004.2010.01613.x; Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; De Franco E, 2013, DIABETES, V62, P993, DOI 10.2337/db12-0885; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Offield MF, 1996, DEVELOPMENT, V122, P983; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rozen S, 2000, Methods Mol Biol, V132, P365; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Schwitzgebel VM, 2003, J CLIN ENDOCR METAB, V88, P4398, DOI 10.1210/jc.2003-030046; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Tutak E, 2009, GENET COUNSEL, V20, P147; van Arensbergen J, 2013, GENE DEV, V27, P52, DOI 10.1101/gad.206094.112; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	177	183	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					61	+		10.1038/ng.2826	http://dx.doi.org/10.1038/ng.2826			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24212882	Green Accepted, Green Submitted			2022-12-25	WOS:000329113500014
J	Chan-on, W; Nairismagi, ML; Ong, CK; Lim, WK; Dima, S; Pairojkul, C; Lim, KH; McPherson, JR; Cutcutache, I; Heng, HL; Ooi, L; Chung, A; Chow, P; Cheow, PC; Lee, SY; Choo, SP; Tan, IBH; Duda, D; Nastase, A; Myint, SS; Wong, BH; Gan, AN; Rajasegaran, V; Ng, CCY; Nagarajan, S; Jusakul, A; Zhang, SL; Vohra, P; Yu, W; Huang, DC; Sithithaworn, P; Yongvanit, P; Wongkham, S; Khuntikeo, N; Bhudhisawasdi, V; Popescu, I; Rozen, SG; Tan, P; Teh, B				Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Dima, Simona; Pairojkul, Chawalit; Lim, Kiat Hon; McPherson, John R.; Cutcutache, Ioana; Heng, Hong Lee; Ooi, London; Chung, Alexander; Chow, Pierce; Cheow, Peng Chung; Lee, Ser Yee; Choo, Su Pin; Tan, Iain Bee Huat; Duda, Dan; Nastase, Anca; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Zhang, Shenli; Vohra, Priya; Yu, Willie; Huang, DaChuan; Sithithaworn, Paiboon; Yongvanit, Puangrat; Wongkham, Sopit; Khuntikeo, Narong; Bhudhisawasdi, Vajaraphongsa; Popescu, Irinel; Rozen, Steven G.; Tan, Patrick; Teh, Bin Tean			Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers	NATURE GENETICS			English	Article							OPISTHORCHIS-VIVERRINI; FREQUENT MUTATION; TUMOR-SUPPRESSOR; COPY NUMBERS; CHOLANGIOCARCINOMA; PATHOGENESIS; PHENOTYPE; PATHWAYS; PATIENT; ARID1A	The impact of different carcinogenic exposures on the specific patterns of somatic mutation in human tumors remains unclear. To address this issue, we profiled 209 cholangiocarcinomas (CCAs) from Asia and Europe, including 108 cases caused by infection with the liver fluke Opisthorchis viverrini and 101 cases caused by non-O. viverrini-related etiologies. Whole-exome sequencing (n = 15) and prevalence screening (n = 194) identified recurrent somatic mutations in BAP1 and ARID1A, neither of which, to our knowledge, has previously been reported to be mutated in CCA. Comparisons between intrahepatic O. viverrini-related and non-O. viverrini-related CCAs demonstrated statistically significant differences in mutation patterns: BAP1, IDH1 and IDH2 were more frequently mutated in non-O. viverrini CCAs, whereas TP53 mutations showed the reciprocal pattern. Functional studies demonstrated tumor suppressive functions for BAP1 and ARID1A, establishing the role of chromatin modulators in CCA pathogenesis. These findings indicate that different causative etiologies may induce distinct somatic alterations, even within the same tumor type.	[Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Heng, Hong Lee; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Yu, Willie; Huang, DaChuan; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Heng, Hong Lee; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Zhang, Shenli; Vohra, Priya; Yu, Willie; Huang, DaChuan; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore, Grad Sch Med, Div Canc & Stem Cell Biol, Singapore, Singapore; [Chan-on, Waraporn; Pairojkul, Chawalit; Sithithaworn, Paiboon; Yongvanit, Puangrat; Wongkham, Sopit; Khuntikeo, Narong; Bhudhisawasdi, Vajaraphongsa] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Dima, Simona; Nastase, Anca; Popescu, Irinel] Fundeni Clin Inst, Ctr Digest Dis & Liver Transplantat, Bucharest, Romania; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [McPherson, John R.; Cutcutache, Ioana; Rozen, Steven G.] Duke Natl Univ Singapore, Grad Sch Med, Div Neurosci & Behav Disorders, Singapore, Singapore; [Ooi, London; Chung, Alexander; Chow, Pierce; Cheow, Peng Chung; Lee, Ser Yee] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Choo, Su Pin; Tan, Iain Bee Huat] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Duda, Dan] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Duda, Dan] Harvard Univ, Sch Med, Boston, MA USA; [Yu, Willie] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick; Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Khon Kaen University; Institutul Clinic Fundeni; Singapore General Hospital; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.	vajara_b@kku.ac.th; irinel.popescu@icfundeni.ro; steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Sithithaworn, Paiboon/E-4378-2019; Wongkham, Sopit/ABB-6966-2021; Duda, Dan G/H-8523-2014; CHOO, Su Pin/ABB-3892-2020; Dima, Simona/P-5582-2019; POPESCU, IRINEL/B-3048-2008; Lim, Weng Khong/Q-8661-2019; Popescu, Irinel/S-9228-2019; Dima, Simona Olimpia/B-8822-2017; Lee, Ser Yee/H-3116-2013; Ooi, London Lucien/AGK-1395-2022; Rozen, Steven G./J-5939-2013	Sithithaworn, Paiboon/0000-0002-9480-1778; Duda, Dan G/0000-0001-7065-8797; Dima, Simona/0000-0001-5275-8938; Lim, Weng Khong/0000-0003-4391-1130; Lee, Ser Yee/0000-0001-9119-7408; Myint, Swe Swe/0000-0002-2430-088X; Ong, Choon Kiat/0000-0001-6402-4288; Rozen, Steven G./0000-0002-4288-0056; Jusakul, Apinya/0000-0001-7652-7771; Wong, Bernice/0000-0001-8981-1376; Chow, Pierce/0000-0003-0584-2584; Tan, Iain/0000-0003-4951-0354; Dukes, Priya/0000-0002-8801-4671; Teh, Bin Tean/0000-0003-1514-1124; HUANG, DACHUAN/0000-0002-7518-4081	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore Millennium Foundation; Lee Foundation; Singapore National Cancer Centre Research Fund; Duke-National University of Singapore Graduate Medical School; Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong; Executive Agency for Higher Education, Research and Development, Romania; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); Lee Foundation; Singapore National Cancer Centre Research Fund; Duke-National University of Singapore Graduate Medical School(National University of Singapore); Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong; Executive Agency for Higher Education, Research and Development, Romania; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship(National University of Singapore)	We thank B. Haaland for reviewing all statistical tests performed in this study and the Duke-National University of Singapore Genome Biology Facility for performing whole-exome sequencing and methylation assays. We thank D. Jefferson (New England Medical Center, Tufts University) for the H69 cell line. We thank B. Sripa (Khon Kean University) for the M139 cell line. This work was supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), the Singapore Millennium Foundation, the Lee Foundation, the Singapore National Cancer Centre Research Fund, the Duke-National University of Singapore Graduate Medical School, the Cancer Science Institute, Singapore, the Verdant Foundation, Hong Kong, Innovation Funding from the Executive Agency for Higher Education, Research and Development, Romania, a Research Team Strengthening Grant, the National Genetic Engineering and Biotechnology Center and the National Science and Technology Development Agency, Thailand. W.Y. is the recipient of a National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship.	Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; IARC, 1994, IARC MONOGR EVAL CAR, V61, P121; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Neubert G, 2013, GENE, V512, P453, DOI 10.1016/j.gene.2012.10.061; Olsson L, 2014, LEUKEMIA, V28, P302, DOI 10.1038/leu.2013.206; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Saichua P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002228; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	39	342	348	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1474	U100		10.1038/ng.2806	http://dx.doi.org/10.1038/ng.2806			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24185513				2022-12-25	WOS:000327715800014
J	Zhang, JS; Zhang, PJ; Wei, YK; Piao, HL; Wang, WQ; Maddika, S; Wang, M; Chen, DH; Sun, YT; Hung, MC; Chen, JJ; Ma, L				Zhang, Jinsong; Zhang, Peijing; Wei, Yongkun; Piao, Hai-long; Wang, Wenqi; Maddika, Subbareddy; Wang, Min; Chen, Dahu; Sun, Yutong; Hung, Mien-Chie; Chen, Junjie; Ma, Li			Deubiquitylation and stabilization of PTEN by USP13	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; CELLS; MUTATIONS; GENE; PIK3CA; UBIQUITINATION; PATHWAY; LIGASE	The tumour suppressor PTEN is frequently lost in human cancers. In addition to gene mutations and deletions, recent studies have revealed the importance of post-translational modifications, such as ubiquitylation, in the regulation of PTEN stability, activity and localization. However, the deubiquitylase that regulates PTEN polyubiquitylation and protein stability remains unknown. Here we screened a total of 30 deubiquitylating enzymes (DUBs) and identified five DUBs that physically associate with PTEN. One of them, USP13, stabilizes the PTEN protein through direct binding and deubiquitylation of PTEN. Loss of USP13 in breast cancer cells promotes AKT phosphorylation, cell proliferation, anchorage-independent growth, glycolysis and tumour growth through downregulation of PTEN. Conversely, overexpression of USP13 suppresses tumorigenesis and glycolysis in PTEN-positive but not PTEN-null breast cancer cells. Importantly, USP13 protein is downregulated in human breast tumours and correlates with PTEN protein levels. These findings identify USP13 as a tumour-suppressing protein that functions through deubiquitylation and stabilization of PTEN.	[Zhang, Jinsong; Zhang, Peijing; Piao, Hai-long; Wang, Wenqi; Wang, Min; Chen, Dahu; Chen, Junjie; Ma, Li] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wei, Yongkun; Sun, Yutong; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Maddika, Subbareddy] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India; [Hung, Mien-Chie; Chen, Junjie; Ma, Li] Univ Texas Hlth Sci Ctr Houston, Canc Biol Program, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 402, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 402, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Texas System; University of Texas Health Science Center Houston; China Medical University Taiwan; China Medical University Taiwan	Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	lma4@mdanderson.org	Chen, Dahu/AAX-6349-2021; Hung, Mien-Chie/ABD-5911-2021; 高, 雨莉/HGU-8187-2022; Ma, Li/GQR-1313-2022	Hung, Mien-Chie/0000-0003-4317-4740; Ma, Li/0000-0001-9965-989X; Zhang, Peijing/0000-0003-1586-8710; Wang, Wenqi/0000-0003-4053-5088; Sun, Yutong/0000-0002-9368-2957	US National Institutes of Health [R00CA138572, R01CA166051]; Cancer Prevention and Research Institute of Texas [R1004]; NATIONAL CANCER INSTITUTE [P30CA016672, R00CA138572, R01CA166051] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Yuan, Z. Gong, A. Sorokin, J. Wang, N. Li, L. Feng and L. Li for reagents and technical assistance. This work is supported by US National Institutes of Health grants R00CA138572 (to L.M.) and R01CA166051 (to L.M.) and a Cancer Prevention and Research Institute of Texas Scholar Award R1004 (to L.M.).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fata JE, 2012, INT J CELL BIOL; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gustafson S., SEMIN ONCOL; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YJ, 2012, J CELL SCI, V125, P4687, DOI 10.1242/jcs.093765; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421	38	128	137	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1486	+		10.1038/ncb2874	http://dx.doi.org/10.1038/ncb2874			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24270891	Green Accepted, Green Submitted			2022-12-25	WOS:000327944200013
J	Arnold, CD; Gerlach, D; Spies, D; Matts, JA; Sytnikova, YA; Pagani, M; Lau, NC; Stark, A				Arnold, Cosmas D.; Gerlach, Daniel; Spies, Daniel; Matts, Jessica A.; Sytnikova, Yuliya A.; Pagani, Michaela; Lau, Nelson C.; Stark, Alexander			Quantitative genome-wide enhancer activity maps for five Drosophila species show functional enhancer conservation and turnover during cis-regulatory evolution	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-BINDING; MORPHOLOGICAL EVOLUTION; SEQ; GENE; DIVERGENCE; ELEMENTS; REVEALS	Phenotypic differences between closely related species are thought to arise primarily from changes in gene expression due to mutations in cis-regulatory sequences (enhancers). However, it has remained unclear how frequently mutations alter enhancer activity or create functional enhancers de novo. Here we use STARR-seq, a recently developed quantitative enhancer assay, to determine genome-wide enhancer activity profiles for five Drosophila species in the constant trans-regulatory environment of Drosophila melanogaster S2 cells. We find that the functions of a large fraction of D. melanogaster enhancers are conserved for their orthologous sequences owing to selection and stabilizing turnover of transcription factor motifs. Moreover, hundreds of enhancers have been gained since the D. melanogaster-Drosophila yakuba split about 11 million years ago without apparent adaptive selection and can contribute to changes in gene expression in vivo. Our finding that enhancer activity is often deeply conserved and frequently gained provides functional insights into regulatory evolution.	[Arnold, Cosmas D.; Gerlach, Daniel; Spies, Daniel; Pagani, Michaela; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Matts, Jessica A.; Sytnikova, Yuliya A.; Lau, Nelson C.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Matts, Jessica A.; Sytnikova, Yuliya A.; Lau, Nelson C.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Brandeis University; Brandeis University	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012; Spies, Daniel/ABA-3363-2021; Sytnikova, Yuliya/J-6118-2017	Stark, Alexander/0000-0003-2611-0841; Spies, Daniel/0000-0003-0072-0799; Lau, Nelson/0000-0001-9907-1404; Gerlach, Daniel/0000-0001-9338-3765; Sytnikova, Yuliya/0000-0002-8468-5101	European Research Council (ERC) Starting Grant [242922]; Austrian Science Fund (FWF) [F4303-B09]; US National Institutes of Health [HD057298]; Searle Scholars foundation; Boehringer Ingelheim; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD057298, K99HD057298] Funding Source: NIH RePORTER	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars foundation; Boehringer Ingelheim(Boehringer Ingelheim); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Drosophila Species Stock Center (DSSC) at the University of California, San Diego for genomic DNA, I. Sinitsyn and L.M. Boryn for help with library cloning, M. Rath, K. Schernhuber and O. Frank for help with experiments, J.O. Yanez-Cuna and M.A. Zabidi for help with data analysis, and S. Westermann, L. Cochella, I. Crisostomo, J. Brennecke, J. Knoblich, U. Technau, K. Tessmar-Raible and F. Raible for comments on the manuscript. Deep sequencing was performed at the CSF (Campus Science Support Facilities) Next-Generation Sequencing Unit and the Brandeis Genomics Core Facility (laboratory of M. Rosbash). C.D.A. is supported by a European Research Council (ERC) Starting Grant (242922) awarded to A.S. This work was partly supported by the Austrian Science Fund (FWF), F4303-B09. The work of N.C.L. was supported by the Searle Scholars foundation and the US National Institutes of Health (HD057298). Basic research at IMP is supported by Boehringer Ingelheim.	Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bardet AF, 2012, NAT PROTOC, V7, P45, DOI 10.1038/nprot.2011.420; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Kalay G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001222; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Matts JA, 2014, METHODS MOL BIOL, V1093, P123, DOI 10.1007/978-1-62703-694-8_10; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Paris M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003748; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Swanson CI, 2011, CURR BIOL, V21, P1186, DOI 10.1016/j.cub.2011.05.056; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	34	91	93	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					685	692		10.1038/ng.3009	http://dx.doi.org/10.1038/ng.3009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24908250	Green Accepted			2022-12-25	WOS:000338093800008
J	Griss, R; Schena, A; Reymond, L; Patiny, L; Werner, D; Tinberg, CE; Baker, D; Johnsson, K				Griss, Rudolf; Schena, Alberto; Reymond, Luc; Patiny, Luc; Werner, Dominique; Tinberg, Christine E.; Baker, David; Johnsson, Kai			Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring	NATURE CHEMICAL BIOLOGY			English	Article							HIGH-DOSE METHOTREXATE; FLUORESCENT SENSOR; BINDING; MECHANISM; LIGANDS; LENGTH; TIME	For many drugs, finding the balance between efficacy and toxicity requires monitoring their concentrations in the patient's blood. Quantifying drug levels at the bedside or at home would have advantages in terms of therapeutic outcome and convenience, but current techniques require the setting of a diagnostic laboratory. We have developed semisynthetic bioluminescent sensors that permit precise measurements of drug concentrations in patient samples by spotting minimal volumes on paper and recording the signal using a simple point-and-shoot camera. Our sensors have a modular design consisting of a protein-based and a synthetic part and can be engineered to selectively recognize a wide range of drugs, including immunosuppressants, antiepileptics, anticancer agents and antiarrhythmics. This low-cost point-of-care method could make therapies safer, increase the convenience of doctors and patients and make therapeutic drug monitoring available in regions with poor infrastructure.	[Griss, Rudolf; Schena, Alberto; Reymond, Luc; Patiny, Luc; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Lausanne, Switzerland; [Griss, Rudolf; Schena, Alberto; Reymond, Luc; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Griss, Rudolf; Schena, Alberto; Reymond, Luc; Johnsson, Kai] Natl Ctr Competence Res Chem Biol, Lausanne, Switzerland; [Werner, Dominique] CHU Vaudois, Serv Biomed, Clin Chem Lab, Lausanne, Switzerland; [Tinberg, Christine E.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle	Johnsson, K (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Lausanne, Switzerland.	kai.johnsson@epfl.ch	Baker, David/K-8941-2012; johnsson, kai/P-4222-2014	Baker, David/0000-0001-7896-6217; johnsson, kai/0000-0002-8002-1981; Patiny, Luc/0000-0002-4943-2643; REYMOND, Luc/0000-0001-5282-9273	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; National Centre of Competence in Research Chemical Biology; Defense Threat Reduction Agency	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research Chemical Biology; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the National Centre of Competence in Research Chemical Biology, and the Defense Threat Reduction Agency. We are grateful to T. Buclin, N. Widmer and L. Decosterd from the CHUV for helpful discussions.	Al-Turkmani MR, 2010, CLIN CHEM, V56, P1792, DOI 10.1373/clinchem.2010.144824; Armstrong VW, 2001, CLIN BIOCHEM, V34, P9, DOI 10.1016/S0009-9120(00)00175-2; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Brun MA, 2011, J AM CHEM SOC, V133, P16235, DOI 10.1021/ja206915m; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; Dubowchik GM, 2001, ORG LETT, V3, P3987, DOI 10.1021/ol0166909; Iwakura M, 1998, PROTEIN ENG, V11, P707, DOI 10.1093/protein/11.8.707; Jaffe N, 2008, J CLIN ONCOL, V26, P4365, DOI 10.1200/JCO.2007.14.7793; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lennard L, 2001, BRIT J CLIN PHARMACO, V52, p75S; Masharina A, 2012, J AM CHEM SOC, V134, P19026, DOI 10.1021/ja306320s; MATSUI H, 1968, BIOCHIM BIOPHYS ACTA, V151, P655, DOI 10.1016/0005-2744(68)90013-2; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981; Rohrig CH, 2007, CHEMMEDCHEM, V2, P1054, DOI 10.1002/cmdc.200600296; Saint-Marcoux F, 2007, ANAL BIOANAL CHEM, V388, P1327, DOI 10.1007/s00216-007-1320-1; Saito K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009935; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schulz M, 2003, PHARMAZIE, V58, P447; SMITH TW, 1970, J CLIN INVEST, V49, P2377, DOI 10.1172/JCI106457; Srivastava DK, 2007, J AM CHEM SOC, V129, P5528, DOI 10.1021/ja068359w; Terra SG, 1999, PHARMACOTHERAPY, V19, P1123, DOI 10.1592/phco.19.15.1123.30570; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d; Valdes R, 1998, CLIN CHEM, V44, P1096	27	123	129	5	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					598	603		10.1038/NCHEMBIO.1554	http://dx.doi.org/10.1038/NCHEMBIO.1554			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24907901				2022-12-25	WOS:000337871200019
J	Hamilton, PJ; Belovich, AN; Khelashvili, G; Saunders, C; Erreger, K; Javitch, JA; Sitte, HH; Weinstein, H; Matthies, HJG; Galli, A				Hamilton, Peter J.; Belovich, Andrea N.; Khelashvili, George; Saunders, Christine; Erreger, Kevin; Javitch, Jonathan A.; Sitte, Harald H.; Weinstein, Harel; Matthies, Heinrich J. G.; Galli, Aurelio			PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein	NATURE CHEMICAL BIOLOGY			English	Article							DOPAMINE TRANSPORTER OVERLAP; INDUCED REVERSE TRANSPORT; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; POTASSIUM CHANNELS; LIPID DOMAINS; BINDING-SITES; AMPHETAMINE; DROSOPHILA; NEURONS	Phosphatidylinositol (4,5)-bisphosphate (PIP2) regulates the function of ion channels and transporters. Here, we demonstrate that PIP2 directly binds the human dopamine (DA) transporter (hDAT), a key regulator of DA homeostasis and a target of the psychostimulant amphetamine (AMPH). This binding occurs through electrostatic interactions with positively charged hDAT N-terminal residues and is shown to facilitate AMPH-induced, DAT-mediated DA efflux and the psychomotor properties of AMPH. Substitution of these residues with uncharged amino acids reduces hDAT-PIP2 interactions and AMPH-induced DA efflux without altering the hDAT physiological function of DA uptake. We evaluated the significance of this interaction in vivo using locomotion as a behavioral assay in Drosophila melanogaster. Expression of mutated hDAT with reduced PIP2 interaction in Drosophila DA neurons impairs AMPH-induced locomotion without altering basal locomotion. We present what is to our knowledge the first demonstration of how PIP2 interactions with a membrane protein can regulate the behaviors of complex organisms.	[Hamilton, Peter J.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [Belovich, Andrea N.; Saunders, Christine; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Khelashvili, George; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Erreger, Kevin; Matthies, Heinrich J. G.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Hamilton, Peter J.; Erreger, Kevin; Matthies, Heinrich J. G.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Neurosci Program Subst Abuse, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Cornell University; Vanderbilt University; Columbia University; Columbia University; Medical University of Vienna; Cornell University; Vanderbilt University	Matthies, HJG (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	heinrich.j.matthies@vanderbilt.edu; aurelio.galli@vanderbilt.edu	Matthies, Heinrich/AAD-2375-2019; Sitte, Harald/O-7025-2019; WEINSTEIN, HAREL/O-8245-2019; Matthies, Heinrich/B-7284-2017	Matthies, Heinrich/0000-0003-3615-7571; Sitte, Harald/0000-0002-1339-7444; WEINSTEIN, HAREL/0000-0003-3473-9818; Matthies, Heinrich/0000-0003-3615-7571; Javitch, Jonathan/0000-0001-7395-2967; Hamilton, Peter/0000-0002-6819-8346	US National Science Foundation Graduate Research Fellowship [DGE0909667];  [F31 DA 035535-01];  [23658-B11];  [DA035263];  [P01 DA012408];  [U54GM087519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, F31DA035535, P01DA012408, R01DA035263] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 23658] Funding Source: researchfish	US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); ; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank S. Singh (Yale University) for the gift of the dDAT cDNA. Computational resources were provided by Teragrid allocation MCB120008 on the Ranger machine, by the NERSC allocation (repository m1710) on the Carver supercomputer and the David Cofrin Center for Biomedical Information of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported by US National Science Foundation Graduate Research Fellowship DGE0909667 (P.J.H.) and grants F31 DA 035535-01 (P.J.H.), 23658-B11 (H.H.S.), DA035263 (A.G.), P01 DA012408 (A.G., H.W. and J.A.J.) and U54GM087519 (H.W. and J.A.J.).	Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Khelashvili G, 2008, BIOPHYS J, V94, P2580, DOI 10.1529/biophysj.107.120667; Khelashvili G, 2012, BIOCHEMISTRY-US, V51, P7685, DOI 10.1021/bi300833z; Khelashvili G, 2009, BIOPHYS J, V97, P1626, DOI 10.1016/j.bpj.2009.07.006; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wicker-Thomas C, 2008, J INSECT PHYSIOL, V54, P1423, DOI 10.1016/j.jinsphys.2008.08.005	38	84	85	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					582	589		10.1038/NCHEMBIO.1545	http://dx.doi.org/10.1038/NCHEMBIO.1545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24880859	Green Accepted			2022-12-25	WOS:000337871200017
J	Lopez, JP; Lim, R; Cruceanu, C; Crapper, L; Fasano, C; Labonte, B; Maussion, G; Yang, JP; Yerko, V; Vigneault, E; El Mestikawy, S; Mechawar, N; Pavlidis, P; Turecki, G				Lopez, Juan Pablo; Lim, Raymond; Cruceanu, Cristiana; Crapper, Liam; Fasano, Caroline; Labonte, Benoit; Maussion, Gilles; Yang, Jennie P.; Yerko, Volodymyr; Vigneault, Erika; El Mestikawy, Salah; Mechawar, Naguib; Pavlidis, Paul; Turecki, Gustavo			miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment	NATURE MEDICINE			English	Article							GENE-EXPRESSION; GENOME BROWSER; NONCODING RNAS; PATTERNS; SUICIDE; MGLUR4; TRENDS	Major depressive disorder (MDD) is a prevalent mood disorder that is associated with differential prefrontal brain expression patterns'. Treatment of MDD includes a variety of biopsychosocial approaches. In medical practice, antidepressant drugs are the most common treatment for depressive episodes, and they are among the most prescribed medications in North America2,3. Although antidepressants are clearly effective, particularly for moderate to severe depressive episodes, there is variability in how individuals respond to antidepressant treatment. Failure to respond has individual, economic and social consequences for patients and their families4. Several lines of evidence demonstrate that genes are regulated through the activity of microRNAs (miRNAs), which act as fine-tuners and on-off switches of gene expression5-7. Here we report on complementary studies using postmortem human brain samples, cellular assays and samples from clinical trials of patients with depression and show that miR-1202, a miRNA specific to primates and enriched in the human brain, is differentially expressed in individuals with depression. Additionally, miR-1202 regulates expression of the gene encoding metabotropic glutamate receptor-4 (GRM4) and predicts antidepressant response at baseline. These results suggest that miR-1202 is associated with the pathophysiology of depression and is a potential target for new antidepressant treatments.	[Lopez, Juan Pablo; Cruceanu, Cristiana; Crapper, Liam; Labonte, Benoit; Maussion, Gilles; Yang, Jennie P.; Yerko, Volodymyr; Mechawar, Naguib; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Lim, Raymond; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Fasano, Caroline; Vigneault, Erika; El Mestikawy, Salah] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; University of British Columbia; McGill University	Turecki, G (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Pavlidis, Paul/H-8406-2013; Cruceanu, Cristiana/AAK-2885-2021; Lopez, Juan Pablo/ABF-2377-2020; Lopez, Juan Pablo/AAM-5727-2021; Turecki, Gustavo/K-5100-2015; Labonte, Benoit/GPF-5629-2022; Maussion, Gilles/AAA-2027-2021	Pavlidis, Paul/0000-0002-0426-5028; Cruceanu, Cristiana/0000-0002-7799-5531; Lopez, Juan Pablo/0000-0002-5812-4220; Labonte, Benoit/0000-0002-1251-5605; Maussion, Gilles/0000-0001-5785-6238; Lim, Raymond/0000-0001-8772-3882; Turecki, Gustavo/0000-0003-4075-2736; el mestikawy, salah/0000-0002-6253-0002	Canadian Institutes of Health Research (CIHR) [190734, 311113]; Fonds de recherche du Quebec Sante (FRQS); Quebec Network on Suicide, Mood Disorders and Related Disorders (RQSHA); FRQS; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec Sante (FRQS); Quebec Network on Suicide, Mood Disorders and Related Disorders (RQSHA); FRQS; CIHR(Canadian Institutes of Health Research (CIHR))	We are grateful for the contributions made by the families consenting to donate brain tissue to the Douglas-Bell Canada Brain Bank We thank A. Ryan and C. Ernst at McGill University for their contributions of chick brain tissue and human NPCs, respectively. This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR) (2008#190734 and 2013#311113), as well as support from the Fonds de recherche du Quebec Sante (FRQS) through its network program, Quebec Network on Suicide, Mood Disorders and Related Disorders (RQSHA). J.P.L. received doctoral funding awards from FRQS and CIHR. G.T. is an FRQS chercheur national.	Banthin JS, 2006, MED CARE, V44, P27; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bocchio-Chiavetto L, 2013, EUR NEUROPSYCHOPHARM, V23, P602, DOI 10.1016/j.euroneuro.2012.06.013; Celanire S, 2012, EXPERT OPIN DRUG DIS, V7, P261, DOI 10.1517/17460441.2012.660914; Chen Y, 2008, RES SOC ADMIN PHARM, V4, P244, DOI 10.1016/j.sapharm.2007.06.019; Davis MJ, 2013, NEUROPHARMACOLOGY, V66, P365, DOI 10.1016/j.neuropharm.2012.07.038; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ernst C, 2007, NEUROGENETICS, V8, P219, DOI 10.1007/s10048-007-0084-2; Ernst C, 2009, ARCH GEN PSYCHIAT, V66, P22, DOI 10.1001/archpsyc.66.1.22; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; HE L, 2004, NAT REV GENET, V5, P522; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lopez JP, 2013, MOL PSYCHIATR, V18, P398, DOI 10.1038/mp.2012.38; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pilc A, 2008, BIOCHEM PHARMACOL, V75, P997, DOI 10.1016/j.bcp.2007.09.021; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009	27	204	213	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					764	768		10.1038/nm.3582	http://dx.doi.org/10.1038/nm.3582			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24908571	Green Accepted			2022-12-25	WOS:000338689500020
J	Loth, DW; Artigas, MS; Gharib, SA; Wain, LV; Franceschini, N; Koch, B; Pottinger, TD; Smith, AV; Duan, Q; Oldmeadow, C; Lee, MK; Strachan, DP; James, AL; Huffman, JE; Vitart, V; Ramasamy, A; Wareham, NJ; Kaprio, J; Wang, XQ; Trochet, H; Kahonen, M; Flexeder, C; Albrecht, E; Lopez, LM; de Jong, K; Thyagarajan, B; Alves, AC; Enroth, S; Omenaas, E; Joshi, PK; Fall, T; Vinuela, A; Launer, LJ; Loehr, LR; Fornage, M; Li, G; Wik, JB; Tang, WB; Manichaikul, A; Lahousse, L; Harris, TB; North, KE; Rudnicka, AR; Hui, J; Gu, XJ; Lumley, T; Wright, AF; Hastie, ND; Campbell, S; Kumar, R; Pin, I; Scott, RA; Pietilainen, KH; Surakka, I; Liu, YM; Holliday, EG; Schulz, H; Heinrich, J; Davies, G; Vonk, JM; Wojczynski, M; Pouta, A; Johansson, A; Wild, SH; Ingelsson, E; Rivadeneira, F; Vozke, H; Hysi, PG; Eiriksdottir, G; Morrison, AC; Rotter, JI; Gao, W; Postma, DS; White, WB; Rich, SS; Hofman, A; Aspelund, T; Couper, D; Smith, LJ; Psaty, BM; Lohman, K; Burchard, EG; Uitterlinden, AG; Garcia, M; Joubert, BR; McArdle, WL; Musk, AB; Hansel, N; Heckbert, SR; Zgaga, L; van Meurs, JBJ; Navarro, P; Rudan, I; Oh, YM; Redline, S; Jarvis, DL; Zhao, JH; Rantanen, T; O'Connor, GT; Ripatti, S; Scott, RJ; Karrasch, S; Grallert, H; Gaddis, NC; Starr, JM; Wijmenga, C; Minster, RL; Lederer, DJ; Pekkanen, J; Gyllensten, U; Campbe, H; Morris, AP; Glaser, S; Hammond, CJ; Burkart, KM; Beilby, J; Kritchevsky, SB; Gucinason, V; Hancock, DB; Williams, D; Polasek, O; Zemunik, T; Kolcic, I; Petrini, MF; Wjst, M; Kim, WJ; Porteous, DJ; Scotland, G; Smith, BH; Villanen, A; Heliovaara, M; Attia, JR; Sayers, I; Hampel, R; Gieger, C; Deary, IJ; Boezen, HM; Newman, A; Jarvelin, MR; Wilson, JF; Lind, L; Stricker, BH; Teumer, A; Spector, TD; Melen, E; Peters, MJ; Lange, LA; Barr, RG; Bracke, KR; Verhamme, FM; Sung, J; Hiemstra, PS; Cassano, PA; Sood, A; Hayward, C; Dupuis, J; Hall, IP; Brusselle, GG; Tobin, MD; London, SJ				Loth, Daan W.; Artigas, Maria Soler; Gharib, Sina A.; Wain, Louise V.; Franceschini, Nora; Koch, Beate; Pottinger, Tess D.; Smith, Albert Vernon; Duan, Qing; Oldmeadow, Chris; Lee, Mi Kyeong; Strachan, David P.; James, Alan L.; Huffman, Jennifer E.; Vitart, Veronique; Ramasamy, Adaikalavan; Wareham, Nicholas J.; Kaprio, Jaakko; Wang, Xin-Qun; Trochet, Holly; Kaonen, Mika; Flexeder, Claudia; Albrecht, Eva; Lopez, Lorna M.; de Jong, Kim; Thyagarajan, Bharat; Alves, Alexessander Couto; Enroth, Stefan; Omenaas, Ernst; Joshi, Peter K.; Fall, Tove; Vinuela, Ana; Launer, Lenore J.; Loehr, Laura R.; Fornage, Myriam; Li, Guo; Wik, Jemma B.; Tang, Wenbo; Manichaikul, Ani; Lahousse, Lies; Harris, Tamara B.; North, Kari E.; Rudnicka, Alicja R.; Hui, Jennie; Gu, Xiangjun; Lumley, Thomas; Wright, Alan F.; Hastie, Nicholas D.; Campbell, Susan; Kumar, Rajesh; Pin, Isabelle; Scott, Robert A.; Pietilainen, Kirsi H.; Surakka, Ida; Liu, Yongmei; Holliday, Elizabeth G.; Schulz, Holger; Heinrich, Joachim; Davies, Gail; Vonk, Judith M.; Wojczynski, Mary; Pouta, Anneli; Johansson, Asa; Wild, Sarah H.; Ingelsson, Erik; Rivadeneira, Fernando; Voezke, Henry; Hysi, Pirro G.; Eiriksdottir, Gudny; Morrison, Alanna C.; Rotter, Jerome I.; Gao, Wei; Postma, Dirkje S.; White, Wendy B.; Rich, Stephen S.; Hofman, Albert; Aspelund, Thor; Couper, David; Smith, Lewis J.; Psaty, Bruce M.; Lohman, Kurt; Burchard, Esteban G.; Uitterlinden, Andre G.; Garcia, Melissa; Joubert, Bonnie R.; McArdle, Wendy L.; Musk, A. Bill; Hansel, Nadia; Heckbert, Susan R.; Zgaga, Lina; van Meurs, Joyce B. J.; Navarro, Pau; Rudan, Igor; Oh, Yeon-Mok; Redline, Susan; Jarvis, Deborah L.; Zhao, Jing Hua; Rantanen, Taina; O'Connor, George T.; Ripatti, Samuli; Scott, Rodney J.; Karrasch, Stefan; Grallert, Harald; Gaddis, Nathan C.; Starr, John M.; Wijmenga, Cisca; Minster, Ryan L.; Lederer, David J.; Pekkanen, Juha; Gyllensten, Ulf; Campbe, Harry; Morris, Andrew P.; Glaeser, Sven; Hammond, Christopher J.; Burkart, Kristin M.; Beilby, John; Kritchevsky, Stephen B.; Gucinason, Vilrnundur; Hancock, Dana B.; Williams, Dale; Polasek, Ozren; Zemunik, Tatijana; Kolcic, Ivana; Petrini, Marcy F.; Wjst, Matthias; Kim, Woo Jin; Porteous, David J.; Scotland, Generation; Smith, Blair H.; Villanen, Anne; Heliovaara, Markku; Attia, John R.; Sayers, Ian; Hampel, Regina; Gieger, Christian; Deary, Ian J.; Boezen, H. Marike; Newman, Anne; Jarvelin, Marjo-Riitta; Wilson, James F.; Lind, Lars; Stricker, Bruno H.; Teumer, Alexander; Spector, Timothy D.; Melen, Erik; Peters, Marjolein J.; Lange, Leslie A.; Barr, R. Graham; Bracke, Ken R.; Verhamme, Fien M.; Sung, Joohon; Hiemstra, Pieter S.; Cassano, Patricia A.; Sood, Akshay; Hayward, Caroline; Dupuis, Josee; Hall, Ian P.; Brusselle, Guy G.; Tobin, Martin D.; London, Stephanie J.			Genome-wide association analysis identifies six new loci associated with forced vital capacity	NATURE GENETICS			English	Article							LUNG-FUNCTION; PULMONARY-FUNCTION; HEALTHY TWIN; HERITABILITY; EXPRESSION; FAMILY; CELLS; KOREA	Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and followed up the top associations in 32,917 additional individuals of European ancestry. We found six new regions associated at genome-wide significance (P < 5 x 10(-8)) with FVC in or near EFEMP1, BMP6, MIR129-2-HSD17B12, PRDM11, WWOX and KCNJ2. Two loci previously associated with spirometric measures (GSTCD and PTCH1) were related to FVC. Newly implicated regions were followed up in samples from African-American, Korean, Chinese and Hispanic individuals. We detected transcripts for all six newly implicated genes in human lung tissue. The new loci may inform mechanisms involved in lung development and the pathogenesis of restrictive lung disease.	[Loth, Daan W.; Lahousse, Lies; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H.; Brusselle, Guy G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Loth, Daan W.; Stricker, Bruno H.] Netherlands Hlth Care Inspectorate, The Hague, Netherlands; [Artigas, Maria Soler; Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Artigas, Maria Soler; Wain, Louise V.; Tobin, Martin D.] Glenfield Hosp, NIHR, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Computat Med Core, Seattle, WA 98195 USA; [Gharib, Sina A.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Franceschini, Nora; Loehr, Laura R.; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Franceschini, Nora; Loehr, Laura R.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Koch, Beate; Glaeser, Sven] Univ Hosp Greifswald, Dept Internal Med, Greifswald, Germany; [Pottinger, Tess D.; Lederer, David J.; Burkart, Kristin M.; Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Smith, Albert Vernon; Eiriksdottir, Gudny; Aspelund, Thor; Gucinason, Vilrnundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gucinason, Vilrnundur] Univ Iceland, Reykjavik, Iceland; [Duan, Qing; Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Oldmeadow, Chris; Holliday, Elizabeth G.; Scott, Rodney J.; Attia, John R.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Oldmeadow, Chris; Holliday, Elizabeth G.; Scott, Rodney J.; Attia, John R.] Univ Newcastle, Fac Hlth, Newcastle, NSW 2300, Australia; [Lee, Mi Kyeong; Sung, Joohon] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Strachan, David P.; Rudnicka, Alicja R.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [James, Alan L.] West Australian Sleep Disorders Res Inst, Inst Hlth & Environm Pulm Physiol & Sleep Med, Nedlands, WA, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [James, Alan L.] Busselton Populat Med Res Inst, Busselton, WA, Australia; [Huffman, Jennifer E.; Vitart, Veronique; Trochet, Holly; Wright, Alan F.; Hastie, Nicholas D.; Campbell, Susan; Navarro, Pau; Hayward, Caroline] Univ Edinburgh, MRC, IGMM, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Ramasamy, Adaikalavan; Jarvis, Deborah L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Ramasamy, Adaikalavan; Alves, Alexessander Couto; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, MRC HPA,Dept Epidemiol & Biostat, London, England; [Wareham, Nicholas J.; Scott, Robert A.; Zhao, Jing Hua] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Kaprio, Jaakko] Univ Helsinki, Hjelt Inst, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko; Heliovaara, Markku] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Kaprio, Jaakko; Pietilainen, Kirsi H.; Surakka, Ida; Ripatti, Samuli] Univ Helsinki, FIMM, Helsinki, Finland; [Wang, Xin-Qun; Manichaikul, Ani] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Kaonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kaonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Flexeder, Claudia; Schulz, Holger; Heinrich, Joachim; Karrasch, Stefan] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Albrecht, Eva; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Lopez, Lorna M.; Davies, Gail; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [de Jong, Kim; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [de Jong, Kim; Vonk, Judith M.; Postma, Dirkje S.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Groningen, Netherlands; [Thyagarajan, Bharat] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Enroth, Stefan; Johansson, Asa; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Enroth, Stefan; Fall, Tove; Johansson, Asa; Ingelsson, Erik; Gyllensten, Ulf] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Omenaas, Ernst] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Omenaas, Ernst] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Joshi, Peter K.; Wild, Sarah H.; Rudan, Igor; Campbe, Harry; Wilson, James F.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Fall, Tove; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Vinuela, Ana; Hysi, Pirro G.; Hammond, Christopher J.; Spector, Timothy D.] Kings Coll London, Dept Twins Res & Genet Epidemiol, London, England; [Launer, Lenore J.; Harris, Tamara B.; Garcia, Melissa] NIA, US NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Fornage, Myriam; Gu, Xiangjun] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam; Gu, Xiangjun] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Li, Guo; Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Wik, Jemma B.] Pfizer Global Res & Dev, Precis Med, Cambridge, MA USA; [Tang, Wenbo; Cassano, Patricia A.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Lahousse, Lies; Bracke, Ken R.; Verhamme, Fien M.; Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Hui, Jennie; Beilby, John] PathWest Lab Med Washington, Nedlands, WA, Australia; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Kumar, Rajesh; Smith, Lewis J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France; [Pin, Isabelle] Inst Albert Bonniot, INSERM U823, Grenoble, France; [Pin, Isabelle] Univ Grenoble 1, Grenoble, France; [Pietilainen, Kirsi H.] Univ Helsinki, Res Programs Unit, Obes Res Unit, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med, Helsinki, Finland; [Surakka, Ida; Ripatti, Samuli] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Heinrich, Joachim] CPC M, Munich, Germany; [Davies, Gail; Porteous, David J.] Univ Edinburgh, MRC IGMM, Ctr Genom & Expt Med, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Davies, Gail] MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Wojczynski, Mary] Washington Univ, Dept Stat Gen, St Louis, MO USA; [Pouta, Anneli] Natl Inst Hlth & Welf, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Univ Hosp Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Johansson, Asa] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ingelsson, Erik] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rivadeneira, Fernando; Uitterlinden, Andre G.; van Meurs, Joyce B. J.; Stricker, Bruno H.; Peters, Marjolein J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.; van Meurs, Joyce B. J.; Stricker, Bruno H.; Peters, Marjolein J.] NGI, NCHA, Rotterdam, Netherlands; [Voezke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Rotter, Jerome I.] Univ Calif Los Angeles, Harbor Med Ctr, Biomed Res Inst, Torrance, CA 90509 USA; [Rotter, Jerome I.] Univ Calif Los Angeles, Harbor Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Gao, Wei; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [White, Wendy B.] Tougaloo Coll, Jackson, MS USA; [Couper, David] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA; [Lohman, Kurt] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Joubert, Bonnie R.; Hancock, Dana B.; London, Stephanie J.] US Dept HHS, Epidemiol Branch, NIEHS, US NIH, Res Triangle Pk, NC 27709 USA; [McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Musk, A. Bill] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Hansel, Nadia] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Zgaga, Lina] Trinity Coll Dublin, Dept Publ Hlth & Primary Care, Dublin, Ireland; [Zgaga, Lina] Univ Zagreb, Sch Med, Adrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Res Ctr Chron Obstruct Airway Dis, Seoul, South Korea; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Jarvis, Deborah L.] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London, England; [Rantanen, Taina; Villanen, Anne] Univ Jyvaskyla, Gerontol Res Ctr, Dept Hlth Sci, Jyvaskyla, Finland; [O'Connor, George T.; Morris, Andrew P.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [O'Connor, George T.; Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA USA; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Genet Epidemiol Grp, Hinxton, England; [Karrasch, Stefan] Univ Munich, Inst & Outpatient Clin Occupat Social & Environ M, Munich, Germany; [Karrasch, Stefan] Univ Munich, Klinikum Rechts Isar, Univ Hosp, Inst Gen Practice, Munich, Germany; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Gaddis, Nathan C.] Res Triangle Inst Int, Res Comp Div, Res Triangle Pk, NC USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Minster, Ryan L.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Lederer, David J.; Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Pekkanen, Juha] Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland; [Pekkanen, Juha] Univ Eastern Finland, Kuopio, Finland; [Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Hancock, Dana B.] Res Triangle Inst Int, Behav Hlth Epidemiol Program, Res Triangle Pk, NC USA; [Williams, Dale] Florida Int Univ, Miami, FL 33199 USA; [Polasek, Ozren; Kolcic, Ivana] Univ Split, Sch Med, Dept Publ Hlth, Split, Croatia; [Zemunik, Tatijana] Univ Split, Sch Med, Dept Med Biol, Split, Croatia; [Petrini, Marcy F.] Univ Mississippi, Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Jackson, MS 39216 USA; [Wjst, Matthias] Helmholtz Zentrum Munchen HMGU, CPC, Munich, Germany; [Kim, Woo Jin] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Dept Internal Med, Chunchon, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Environm Hlth Ctr, Chunchon, South Korea; [Scotland, Generation] Univ Med Sch, Natl Hlth Serv, Dundee, Scotland; [Scotland, Generation] Univ Med Sch, Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Scotland, Generation] Univ Med Sch, Natl Hlth Serv, Glasgow, Lanark, Scotland; [Smith, Blair H.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Sayers, Ian; Hall, Ian P.] Univ Nottingham, Div Therapeut & Mol Med, Nottingham NG7 2RD, England; [Hampel, Regina] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Newman, Anne] Univ Pittsburgh, Ctr Aging & Populat Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Teumer, Alexander] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Dept Genet & Funct Genom, Greifswald, Germany; [Melen, Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden; [Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Complex Dis & Genet Epidemiol Branch, Seoul, South Korea; [Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Cassano, Patricia A.] Weill Cornell Med Coll, Dept Publ Hlth, Div Biostat & Epidemiol, New York, NY USA; [Sood, Akshay] Univ New Mexico, Sch Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Icelandic Heart Association; University of Iceland; University of North Carolina; University of North Carolina Chapel Hill; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Seoul National University (SNU); St Georges University London; University of Western Australia; University of Edinburgh; Imperial College London; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Virginia; Tampere University; Tampere University; Tampere University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Edinburgh; University of Edinburgh; University of Groningen; University of Groningen; University of Minnesota System; University of Minnesota Twin Cities; Uppsala University; Uppsala University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Edinburgh; Uppsala University; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; Pfizer; Cornell University; University of Virginia; Ghent University; Ghent University Hospital; University of Auckland; Northwestern University; Feinberg School of Medicine; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Wake Forest University; University of Edinburgh; Washington University (WUSTL); Finland National Institute for Health & Welfare; University of Oulu; Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; Erasmus MC; Greifswald Medical School; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Boston University; University of Groningen; Tougaloo College; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Group Health Cooperative; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bristol; University of Western Australia; Johns Hopkins University; Trinity College Dublin; University of Zagreb; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Brigham & Women's Hospital; Imperial College London; University of Jyvaskyla; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wellcome Trust Sanger Institute; University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Research Triangle Institute; University of Edinburgh; University of Groningen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Finland National Institute for Health & Welfare; University of Eastern Finland; Wake Forest University; Wake Forest Baptist Medical Center; Research Triangle Institute; State University System of Florida; Florida International University; University of Split; University of Split; University of Mississippi; University of Mississippi Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kangwon National University; Kangwon National University Hospital; Kangwon National University; Kangwon National University Hospital; NHS Blood & Transplant (NHSBT); University of Dundee; NHS Blood & Transplant (NHSBT); University of Edinburgh; NHS Blood & Transplant (NHSBT); University of Dundee; University of Nottingham; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Uppsala University; Greifswald Medical School; Karolinska Institutet; Seoul National University (SNU); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cornell University; University of New Mexico; University of New Mexico's Health Sciences Center; Erasmus University Rotterdam; Erasmus MC	London, SJ (corresponding author), US Dept HHS, Epidemiol Branch, NIEHS, US NIH, Res Triangle Pk, NC 27709 USA.	mt47@le.ac.uk; london2@niehs.nih.gov	Karrasch, Stefan/GQI-2691-2022; Vonk, Judith/K-8477-2019; Vonk, Judith M/ABA-3009-2020; Wijmenga, Cisca/D-2173-2009; Zemunik, Tatijana/D-8584-2017; Viñuela, Ana/L-5015-2019; Teumer, Alexander/S-7438-2019; Gaddis, Nathan/GXG-6395-2022; Lee, Mi Kyeong/C-3046-2017; Hiemstra, Pieter S/K-8587-2018; Newman, Anne B./C-6408-2013; Polasek, Ozren/B-6002-2011; Lederer, David/W-7957-2018; Wijmenga, Cisca/AAE-7719-2019; Kim, Woo Jin/A-8216-2019; Enroth, Stefan/C-7396-2009; White, Wendy/AAG-9791-2020; London, Stephanie/C-3734-2019; Navarro, Pau/AAJ-8091-2021; PIN, Isabelle/N-3020-2013; Deary, Ian J/C-6297-2009; Rantanen, Taina/O-6579-2016; Lahousse, Lies/O-9426-2019; Johansson, Åsa/G-5270-2011; Rudan, Igor/I-1467-2012; Ramasamy, Adaikalavan/G-2632-2010; Rotter, Jerome/AAY-6598-2021; Kaprio, Jaakko/A-1820-2008; Hui, Jennie/A-9543-2013; Ripatti, Samuli/H-9446-2014; Johansson, Åsa/AAG-6799-2021; Wilson, James F/A-5704-2009; Smith, Albert Vernon/K-5150-2015; Attia, John R/F-5376-2013; Lopez, Lorna/AAR-4912-2020; Porteous, David/AAA-3446-2021; Aspelund, Thor/K-7022-2019; Grallert, Harald/B-3424-2013; Kolcic, Ivana/E-2713-2017; Sood, Anoop Kumar/A-7344-2013; Gaddis, Nathan/GXG-6447-2022; Heinrich, Joachim/N-1720-2013; Artigas, María Soler/L-6529-2013; Bracke, Ken R/GSN-7630-2022; Zgaga, Lina/Q-9415-2018; Gudnason, Vilmundur/K-6885-2015; Rivadeneira, Fernando/O-5385-2015; Schulz, Holger/J-5643-2015; /V-8478-2019; Hayward, Caroline/M-8818-2016; Aspelund, Thor/C-5983-2008; Fall, Tove/O-7226-2014; Scott, Rodney/B-2827-2013; Smith, Blair/G-2834-2012	Vonk, Judith/0000-0001-7531-4547; Vonk, Judith M/0000-0001-7531-4547; Zemunik, Tatijana/0000-0001-8120-2891; Viñuela, Ana/0000-0003-3771-8537; Teumer, Alexander/0000-0002-8309-094X; Lee, Mi Kyeong/0000-0002-3036-3684; Hiemstra, Pieter S/0000-0002-0238-5982; Newman, Anne B./0000-0002-0106-1150; Polasek, Ozren/0000-0002-5765-1862; Lederer, David/0000-0001-5258-0228; Wijmenga, Cisca/0000-0002-5635-1614; Kim, Woo Jin/0000-0003-2927-370X; Enroth, Stefan/0000-0002-5056-9137; London, Stephanie/0000-0003-4911-5290; Navarro, Pau/0000-0001-5576-8584; Deary, Ian J/0000-0002-1733-263X; Rantanen, Taina/0000-0002-1604-1945; Lahousse, Lies/0000-0002-3494-4363; Johansson, Åsa/0000-0002-2915-4498; Rudan, Igor/0000-0001-6993-6884; Ramasamy, Adaikalavan/0000-0002-7598-2892; Kaprio, Jaakko/0000-0002-3716-2455; Hui, Jennie/0000-0002-1653-2496; Ripatti, Samuli/0000-0002-0504-1202; Johansson, Åsa/0000-0002-2915-4498; Wilson, James F/0000-0001-5751-9178; Smith, Albert Vernon/0000-0003-1942-5845; Attia, John R/0000-0001-9800-1308; Lopez, Lorna/0000-0002-0241-9783; Porteous, David/0000-0003-1249-6106; Aspelund, Thor/0000-0002-7998-5433; Kolcic, Ivana/0000-0001-7918-6052; Sood, Anoop Kumar/0000-0001-5702-4108; Heinrich, Joachim/0000-0002-9620-1629; Artigas, María Soler/0000-0002-3213-1107; Bracke, Ken R/0000-0001-5906-4605; Zgaga, Lina/0000-0003-4089-9703; Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; Schulz, Holger/0000-0002-1157-200X; Hayward, Caroline/0000-0002-9405-9550; Aspelund, Thor/0000-0002-7998-5433; Pekkanen, Juha/0000-0002-1083-8777; Oldmeadow, Christopher/0000-0001-6104-1322; White, Wendy/0000-0003-0923-8165; Tobin, Martin/0000-0002-3596-7874; Hancock, Dana/0000-0003-2240-3604; Morrison, Alanna/0000-0001-6381-4296; Scott, Rodney/0000-0001-7724-3404; Wain, Louise/0000-0003-4951-1867; Couper, David/0000-0002-4313-9235; Gieger, Christian/0000-0001-6986-9554; Couto Alves, Alex/0000-0001-8519-7356; Beilby, John/0000-0002-4915-2254; Hysi, Pirro/0000-0001-5752-2510; Joubert, Bonnie/0000-0001-7952-1180; de Jong, Kim/0000-0002-3948-1046; Viljanen, Anne/0000-0002-8428-3604; Loth, Daan/0000-0003-1260-9326; Loehr, Laura/0000-0002-9054-1825; Hall, Ian/0000-0001-9933-3216; Cassano, Patricia A./0000-0003-4827-5073; GHARIB, SINA A./0000-0002-2480-4367; Rich, Stephen/0000-0003-3872-7793; Joshi, Peter/0000-0002-6361-5059; Rudnicka, Alicja R/0000-0003-0369-8574; Kahonen, Mika/0000-0002-4510-7341; Gaddis, Nathan/0000-0001-5205-7138; Minster, Ryan/0000-0001-7382-6717; Pietilainen, Kirsi/0000-0002-8522-1288; van Meurs, Joyce/0000-0001-6245-2123; Hammond, Christopher/0000-0002-3227-2620; Sayers, Ian/0000-0001-5601-5410; Smith, Blair/0000-0002-5362-9430; Jarvis, Deborah/0000-0002-1753-3896; Kumar, Rajesh/0000-0002-1962-7108; Pottinger, Tess/0000-0003-0647-5712; Brusselle, Guy/0000-0001-7021-8505; Surakka, Ida/0000-0002-6669-5541; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Smith, Lewis J/0000-0002-4728-1562; Dupuis, Josee/0000-0003-2871-3603; Peters, Marjolein/0000-0003-3167-9063	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103676, R01HL105756, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629, ZIAAG007380, U01AG023749, U01AG023746] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; Intramural NIH HHS [Z01 ES043012-10] Funding Source: Medline; Medical Research Council [G0701863, MC_PC_U127561128, G1000861, G0100266, MC_UU_12015/1, MR/L016400/1, MC_PC_U127592696, G0902313, G0700704, MR/K026992/1, MC_U106179471] Funding Source: Medline; NCATS NIH HHS [UL1 TR001079, UL1 TR000124] Funding Source: Medline; NHLBI NIH HHS [R01 HL117078, R01 HL077612, R01 HL105756, R01 HL103676] Funding Source: Medline; NIA NIH HHS [R01 AG023629, U01 AG023746, U01 AG023749] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491] Funding Source: Medline; NIMH NIH HHS [R25 MH083620] Funding Source: Medline; Chief Scientist Office [CZB/4/710, CZB/4/505, ETM/55, CZD/16/6/4] Funding Source: Medline; Department of Health [SRF/01/010] Funding Source: Medline; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G1000861, MC_PC_U127561128, MR/L016400/1, MC_UU_12015/1, MC_PC_U127592696, G0100266, G0700704, G0701863, G0902313] Funding Source: UKRI; Medical Research Council [1201677] Funding Source: researchfish; National Institute for Health Research [SRF/01/010, NF-SI-0512-10135] Funding Source: researchfish	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Chief Scientist Office; Department of Health; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gombojav B, 2013, TWIN RES HUM GENET, V16, P241, DOI 10.1017/thg.2012.130; Gottlieb DJ, 2001, AM J RESP CRIT CARE, V164, P1655, DOI 10.1164/ajrccm.164.9.2010122; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Kimura M, 2011, CANCER SCI, V102, P983, DOI 10.1111/j.1349-7006.2011.01891.x; LANGE P, 1990, J CLIN EPIDEMIOL, V43, P867, DOI 10.1016/0895-4356(90)90070-6; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Sung JH, 2002, TWIN RES, V5, P394; Sung J, 2006, TWIN RES HUM GENET, V9, P844, DOI 10.1375/183242706779462822; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Putte-Katier N, 2011, EUR RESPIR J, V38, P664, DOI 10.1183/09031936.00034210; Weiss ST, 2010, NAT GENET, V42, P14, DOI 10.1038/ng0110-14; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zappala CJ, 2010, EUR RESPIR J, V35, P830, DOI 10.1183/09031936.00155108; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	46	99	103	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					669	677		10.1038/ng.3011	http://dx.doi.org/10.1038/ng.3011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24929828	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000338093800006
J	Deshmukh, HS; Liu, YH; Menkiti, OR; Mei, JJ; Dai, N; O'Leary, CE; Oliver, PM; Kolls, JK; Weiser, JN; Worthen, GS				Deshmukh, Hitesh S.; Liu, Yuhong; Menkiti, Ogechukwu R.; Mei, Junjie; Dai, Ning; O'Leary, Claire E.; Oliver, Paula M.; Kolls, Jay K.; Weiser, Jeffrey N.; Worthen, G. Scott			The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; INNATE LYMPHOID-CELLS; T-HELPER-CELLS; INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; PREMATURE-INFANTS; PRETERM INFANTS; GRANULOCYTE; INFECTION; RESPONSES	Neonatal colonization by microbes, which begins immediately after birth, is influenced by gestational age and the mother's microbiota and is modified by exposure to antibiotics(1). In neonates, prolonged duration of antibiotic therapy is associated with increased risk of late-onset sepsis (LOS)(2), a disorder controlled by neutrophils(3). A role for the microbiota in regulating neutrophil development and susceptibility to sepsis in the neonate remains unclear. We exposed pregnant mouse dams to antibiotics in drinking water to limit transfer of maternal microbes to the neonates. Antibiotic exposure of dams decreased the total number and composition of microbes in the intestine of the neonates. This was associated with decreased numbers of circulating and bone marrow neutrophils and granulocyte/macrophage-restricted progenitor cells in the bone marrow of antibiotic-treated and germ-free neonates. Antibiotic exposure of dams reduced the number of interleukin-17 (IL-17)-producing cells in the intestine and production of granulocyte colony-stimulating factor (G-CSF). Granulocytopenia was associated with impaired host defense and increased susceptibility to Escherichia coli K1 and Klebsiella pneumoniae sepsis in antibiotic-treated neonates, which could be partially reversed by administration of G-CSF. Transfer of a normal microbiota into antibiotic treated neonates induced IL-17 production by group 3 innate lymphoid cells (ILCs) in the intestine, increasing plasma G-CSF levels and neutrophil numbers in a Toll-like receptor 4 (TLR4)- and myeloid differentiation factor 88 (MyD88)-dependent manner and restored IL-17-dependent resistance to sepsis. Specific depletion of ILCs prevented IL-17- and G-CSF-dependent granulocytosis and resistance to sepsis. These data support a role for the intestinal microbiota in regulation of granulocytosis, neutrophil homeostasis and host resistance to sepsis in neonates.	[Deshmukh, Hitesh S.; Liu, Yuhong; Menkiti, Ogechukwu R.; Mei, Junjie; Dai, Ning; Worthen, G. Scott] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Deshmukh, Hitesh S.; Menkiti, Ogechukwu R.; Weiser, Jeffrey N.; Worthen, G. Scott] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [O'Leary, Claire E.; Oliver, Paula M.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Weiser, Jeffrey N.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine	Worthen, GS (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.	deshmukhh@email.chop.edu; worthen@email.chop.edu	Core, UNC Microbiome/AAB-3304-2022; Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Weiser, Jeffrey/0000-0001-7168-8090; O'Leary, Claire/0000-0001-9052-4593; Deshmukh, Hitesh/0000-0001-9632-164X	 [5T32HD060556];  [5R01AI093566];  [5R01HL062052];  [3R37HL079142];  [5P60AA009803];  [1R01AI105168];  [5R01AI038446];  [1R01AI099479];  [5R01HL105834]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060556] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105834, R37HL079142, R01HL062052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038446, R01AI105168, R01AI099479, R01AI093566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA009803] Funding Source: NIH RePORTER	; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank D. Artis (Department of Microbiology and Pathology, University of Pennsylvania) for providing GF mice. We thank N. Butz for her assistance with microbial DNA isolation. We thank the Children's Hospital of Philadelphia Research Institute Flow Cytometry and Cell Sorting Core Laboratory for technical advice and support. We thank S. Guttentag, K. Hudock and C. Hergott for their helpful comments. H.S.D. is supported by 5T32HD060556, P.M.O. is supported by 5R01AI093566, J.K.K. is supported by 5R01HL062052, 3R37HL079142 and 5P60AA009803, J.N.W. is supported by 1R01AI105168 and 5R01AI038446 and G.S.W. is supported by 1R01AI099479 and 5R01HL105834.	Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Bugl S, 2013, BLOOD, V121, P723, DOI 10.1182/blood-2012-05-429589; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clark RH, 2006, PEDIATRICS, V117, P67, DOI 10.1542/peds.2005-0179; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; DAENEN S, 1991, LEUKEMIA RES, V15, P1013, DOI 10.1016/0145-2126(91)90106-4; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; GESSLER P, 1995, AM J PERINAT, V12, P34, DOI 10.1055/s-2007-994396; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; MANROE BL, 1979, J PEDIATR-US, V95, P89, DOI 10.1016/S0022-3476(79)80096-7; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 2007, SEMIN IMMUNOL, V19, P1, DOI 10.1016/j.smim.2007.02.001; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; PLUSCHKE G, 1988, MICROB PATHOGENESIS, V4, P93, DOI 10.1016/0882-4010(88)90051-4; Sarkar S, 2006, J PERINATOL, V26, P501, DOI 10.1038/sj.jp.7211554; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	40	322	330	1	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					528	534		10.1038/nm.3542	http://dx.doi.org/10.1038/nm.3542			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24747744	Green Accepted			2022-12-25	WOS:000335710700024
J	Fontebasso, AM; Papillon-Cavanagh, S; Schwartzentruber, J; Nikbakht, H; Gerges, N; Fisett, PO; Bechet, D; Faury, D; De Jay, N; Ramkissoon, LA; Corcoran, A; Jones, DTW; Sturm, D; Johann, P; Tomita, T; Goldman, S; Nagib, M; Bendel, A; Goumnerova, L; Bowers, DC; Leonard, JR; Rubin, JB; Alden, T; Browd, S; Geyer, JR; Leary, S; Jallo, G; Cohen, K; Gupta, N; Prados, MD; Carret, AS; Ellezam, B; Crevier, L; Klekner, A; Bognar, L; Hauser, P; Garami, M; Myseros, J; Dong, ZF; Siege, PM; Malkin, HL; Ligon, AH; Albrecht, S; Pfister, SM; Ligon, KL; Majewski, J; Jabado, N; Kieran, MW				Fontebasso, Adam M.; Papillon-Cavanagh, Simon; Schwartzentruber, Jeremy; Nikbakht, Hamid; Gerges, Noha; Fisett, Pierre-Olivier; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Ramkissoon, Lori A.; Corcoran, Aoife; Jones, David T. W.; Sturm, Dominik; Johann, Pascal; Tomita, Tadanori; Goldman, Stewart; Nagib, Mahmoud; Bendel, Anne; Goumnerova, Liliana; Bowers, Daniel C.; Leonard, Jeffrey R.; Rubin, Joshua B.; Alden, Tord; Browd, Samuel; Geyer, J. Russell; Leary, Sarah; Jallo, George; Cohen, Kenneth; Gupta, Nalin; Prados, Michael D.; Carret, Anne-Sophie; Ellezam, Benjamin; Crevier, Louis; Klekner, Almos; Bognar, Laszlo; Hauser, Peter; Garami, Miklos; Myseros, John; Dong, Zhifeng; Siege, Peter M.; Malkin, Hay Ley; Ligon, Azra H.; Albrecht, Steffen; Pfister, Stefan M.; Ligon, Keith L.; Majewski, Jacek; Jabado, Nada; Kieran, Mark W.			Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INTRINSIC PONTINE GLIOMAS; BMP RECEPTOR; HISTONE H3.3; I RECEPTOR; GLIOBLASTOMA; GENES; MOUSE; ALK2; SUBGROUPS	Pediatric midline high-grade astrocytomas (mHGAs) are incurable with few treatment targets identified. Most tumors harbor mutations encoding p.Lys27Met in histone H3 variants. In 40 treatment-naive mHGAs, 39 analyzed by whole-exome sequencing, we find additional somatic mutations specific to tumor location. Gain-of-function mutations in ACVR1 occur in tumors of the pons in conjunction with histone H3.1 p.Lys27Met substitution, whereas FGFR1 mutations or fusions occur in thalamic tumors associated with histone H3.3 p.Lys27Met substitution. Hyperactivation of the bone morphogenetic protein (BMP)-ACVR1 developmental pathway in mHGAs harboring ACVR1 mutations led to increased levels of phosphorylated SMAD1, SMAD5 and SMAD8 and upregulation of BMP downstream early-response genes in tumor cells. Global DNA methylation profiles were significantly associated with the p.Lys27Met alteration, regardless of the mutant histone H3 variant and irrespective of tumor location, supporting the role of this substitution in driving the epigenetic phenotype. This work considerably expands the number of potential treatment targets and further justifies pretreatment biopsy in pediatric mHGA as a means to orient therapeutic efforts in this disease.	[Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Montreal Childrens Hosp, Div Expt Med, Montreal, PQ H3H 1P3, Canada; [Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Papillon-Cavanagh, Simon; Nikbakht, Hamid; Gerges, Noha; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Schwartzentruber, Jeremy] Wellcome Trust Sanger Inst, Hinxton, England; [Fisett, Pierre-Olivier; Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Faury, Damien] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Ramkissoon, Lori A.; Corcoran, Aoife; Ligon, Azra H.; Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA; [Jones, David T. W.; Sturm, Dominik; Johann, Pascal; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Tomita, Tadanori; Alden, Tord] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Neurol Surg, Chicago, IL 60611 USA; [Goldman, Stewart] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat Hematol Oncol, Chicago, IL 60611 USA; [Nagib, Mahmoud] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Bendel, Anne] Childrens Hosp & Clin Minnesota, Dept Pediat Hematol Oncol, Minneapolis, MN USA; [Goumnerova, Liliana] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Goumnerova, Liliana; Ligon, Azra H.; Ligon, Keith L.] Harvard Univ, Sch Med, Boston, MA USA; [Bowers, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat Hematol Oncol, St Louis, MO USA; [Browd, Samuel] Seattle Childrens Hosp, Dept Neurosurg, Seattle, WA USA; [Geyer, J. Russell; Leary, Sarah] Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA USA; [Jallo, George] Johns Hopkins Univ Hosp, Dept Neurol Surg, Baltimore, MD 21287 USA; [Cohen, Kenneth] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Pediat Hematol Oncol, Baltimore, MD USA; [Prados, Michael D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Carret, Anne-Sophie] Univ Montreal, CHU St Justine, Dept Hematol Oncol, Montreal, PQ, Canada; [Ellezam, Benjamin] Univ Montreal, CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Crevier, Louis] Univ Montreal, CHU St Justine, Dept Neurosurg, Montreal, PQ, Canada; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, Debrecen, Hungary; [Hauser, Peter; Garami, Miklos] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Myseros, John] Childrens Natl Med Ctr, Dept Neurosurg, Washington, DC 20010 USA; [Dong, Zhifeng; Siege, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Malkin, Hay Ley] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ligon, Azra H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Kieran, Mark W.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA	McGill University; McGill University; McGill University; Wellcome Trust Sanger Institute; McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Harvard University; Boston Children's Hospital; Children's Hospitals & Clinics of Minnesota; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Washington University (WUSTL); Seattle Children's Hospital; Seattle Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Debrecen; Semmelweis University; Children's National Health System; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Ligon, KL (corresponding author), Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu; jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca; mark_kieran@dfci.harvard.edu	Garami, Miklós/AAK-5680-2021; Sturm, Dominik/AAL-3689-2020; Jones, David T. W./Z-1963-2019; Papillon-Cavanagh, Simon/AAS-8749-2020; Pfister, Stefan M/F-6860-2013; Johann, Pascal David/AAT-9368-2021; Prados, Michael/N-5220-2019; Jabado, Nada/AAN-4026-2020; Jones, David TW/G-9588-2013	Sturm, Dominik/0000-0003-0250-1696; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Pfister, Stefan M/0000-0002-5447-5322; Jones, David TW/0000-0002-2036-5141; Kieran, Mark/0000-0003-2184-7692; Bowers, Daniel/0000-0002-3947-2481; Schwartzentruber, Jeremy/0000-0002-6183-2092; Leary, Sarah/0000-0003-0225-6184; Nikbakht, Hamid/0000-0003-0209-5667	Genome Canada; McGill University; Montreal Children's Hospital Foundation; Hungarian Scientific Research Fund (OTKA) [T-04639]; National Research and Development Fund (NKFP) [1A/002/2004]; TAMOP [-4.2.2A-11/1/KONV-2012-0025]; NCI [P01CA142536]; Zach Carson DIPG Fund at Dana-Farber Cancer Institute (DFCI); Mikey Czech Foundation; Maria Foundation; CIHR; Cedars Cancer Institute; McGill Integrated Cancer Research Training Program; Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); Chercheur Clinicien Senior Award; Ellie Kavalieros Fund (DFCI); Caroline Fund (DFCI); Ryan Harvey DIPG Fund (DFCI); Stop&Shop Pediatric Brain Tumor Program (DFCI); Pediatric Brain Tumor Clinical and Research Fund (DFCI); CIHR Systems Biology Training Program at McGill University; T.D.Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE [P30CA060553, P01CA142536] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); McGill University; Montreal Children's Hospital Foundation; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Fund (NKFP); TAMOP; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Zach Carson DIPG Fund at Dana-Farber Cancer Institute (DFCI); Mikey Czech Foundation; Maria Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Cedars Cancer Institute; McGill Integrated Cancer Research Training Program; Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); Chercheur Clinicien Senior Award; Ellie Kavalieros Fund (DFCI); Caroline Fund (DFCI); Ryan Harvey DIPG Fund (DFCI); Stop&Shop Pediatric Brain Tumor Program (DFCI); Pediatric Brain Tumor Clinical and Research Fund (DFCI); CIHR Systems Biology Training Program at McGill University; T.D.Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to express their sincere gratitude toward all staff at the McGill University and Genome Quebec Innovation Centre for excellent technical expertise, library preparation and sequencing. The authors are very grateful to J.-J. Lebrun (McGill University) for primer sequences and materials for SMAD signaling studies. This work was performed within the context of the I-CHANGE (International Childhood Astrocytoma Integrated Genomics and Epigenomics) Consortium and was supported by funding from Genome Canada, Genome Quebec, the Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR), McGill University and the Montreal Children's Hospital Foundation. This work was also supported by Hungarian Scientific Research Fund (OTKA) contract T-04639: National Research and Development Fund (NKFP) contract 1A/002/2004 (P.H.and M.G.) and TAMOP-4.2.2A-11/1/KONV-2012-0025 (A.K. and LB.). N.J.is a member of the Penny Cole laboratory and the recipient of a Chercheur Clinicien Senior Award. J.Majewski holds a Canada Research Chair (tier 2). L.G., K.L.L. and M.W.K. are supported by NCI P01CA142536. We acknowledge the support of the Zach Carson DIPG Fund at the Dana-Farber Cancer Institute (DFCI), the Ellie Kavalieros Fund (DFCI), the Mikey Czech Foundation, the Prayer From Maria Foundation, the Hope for Caroline Fund (DFCI), the Ryan Harvey DIPG Fund (DFCI), the Stop&Shop Pediatric Brain Tumor Program (DFCI) and the Pediatric Brain Tumor Clinical and Research Fund (DFCI). A.M.F.is supported by a studentship from CIHR, as well as by an award from the CIHR Systems Biology Training Program at McGill University. D.B. is supported by a studentship from the T.D. Trust/Montreal Children's Hospital Foundation, and N. Gerges is supported by a studentship from the Cedars Cancer Institute. N.D.J. is supported by an award from the McGill Integrated Cancer Research Training Program.	Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kishigami S, 2004, DEV BIOL, V276, P185, DOI 10.1016/j.ydbio.2004.08.042; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lahti L, 2012, DEVELOPMENT, V139, P894, DOI 10.1242/dev.071936; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	22	282	290	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					462	466		10.1038/ng.2950	http://dx.doi.org/10.1038/ng.2950			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705250	Green Accepted			2022-12-25	WOS:000335422900012
J	Meuris, L; Santens, F; Elson, G; Festjens, N; Boone, M; Dos Santos, A; Devos, S; Rousseau, F; Plets, E; Houthuys, E; Malinge, P; Magistrelli, G; Cons, L; Chatel, L; Devreese, B; Callewaert, N				Meuris, Leander; Santens, Francis; Elson, Greg; Festjens, Nele; Boone, Morgane; Dos Santos, Anaelle; Devos, Simon; Rousseau, Francois; Plets, Evelyn; Houthuys, Erica; Malinge, Pauline; Magistrelli, Giovanni; Cons, Laura; Chatel, Laurence; Devreese, Bart; Callewaert, Nico			GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins	NATURE BIOTECHNOLOGY			English	Article							COLONY-STIMULATING FACTOR; IGG BINDING; ANTIBODY; EXPRESSION; ENZYME; CDNA; FCRN	Heterogeneity in the N-glycans on therapeutic proteins causes difficulties for protein purification and process reproducibility and can lead to variable therapeutic efficacy. This heterogeneity arises from the multistep process of mammalian complex-type N-glycan synthesis. Here we report a glycoengineering strategy-which we call GlycoDelete-that shortens the Golgi N-glycosylation pathway in mammalian cells. This shortening results in the expression of proteins with small, sialylated trisaccharide N-glycans and reduced complexity compared to native mammalian cell glycoproteins. GlycoDelete engineering does not interfere with the functioning of N-glycans in protein folding, and the physiology of cells modified by GlycoDelete is similar to that of wild-type cells. A therapeutic human IgG expressed in GlycoDelete cells had properties, such as reduced initial clearance, that might be beneficial when the therapeutic goal is antigen neutralization. This strategy for reducing N-glycan heterogeneity on mammalian proteins could lead to more consistent performance of therapeutic proteins and modulation of biopharmaceutical functions.	[Meuris, Leander; Santens, Francis; Festjens, Nele; Boone, Morgane; Plets, Evelyn; Houthuys, Erica; Callewaert, Nico] VIB, Unit Med Biotechnol, IRC, Ghent, Belgium; [Meuris, Leander; Santens, Francis; Festjens, Nele; Boone, Morgane; Devos, Simon; Plets, Evelyn; Houthuys, Erica; Devreese, Bart; Callewaert, Nico] Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Elson, Greg; Dos Santos, Anaelle; Rousseau, Francois; Malinge, Pauline; Magistrelli, Giovanni; Cons, Laura; Chatel, Laurence] NovImmune SA, Geneva, Switzerland	Flanders Institute for Biotechnology (VIB); Ghent University; NovImmune SA	Callewaert, N (corresponding author), VIB, Unit Med Biotechnol, IRC, Ghent, Belgium.	nico.callewaert@irc.vib-ugent.be	Festjens, Nele/C-2093-2009; Boone, Morgane/ABF-7205-2021; Devreese, Bart/B-2011-2009; Meuris, Leander/B-6988-2015; Devreese, Bart/K-2841-2019	Festjens, Nele/0000-0002-3429-5463; Boone, Morgane/0000-0002-7807-5542; Devreese, Bart/0000-0002-9764-2581; Meuris, Leander/0000-0001-8940-3022; Devreese, Bart/0000-0002-9764-2581; Callewaert, Nico/0000-0003-2069-6917; Devos, Simon/0000-0002-0623-433X; Santens, Francis/0000-0001-9521-9846; Plets, Evelyn/0000-0001-7312-8804	Fund for Scientific Research-Flanders (FWO); predoctoral fellowships of agentschap voor Innovatie door Wetenschap en Technologie (IWT) Flanders (Strategic Basic Research fellowship) [101456, 111252]; VIB; Ghent University Industrial Research Fund (UGent-IOF) [041]; Hercules Foundation [AUGE019]; FWO research project [G.0.541.08.N.10]	Fund for Scientific Research-Flanders (FWO)(FWO); predoctoral fellowships of agentschap voor Innovatie door Wetenschap en Technologie (IWT) Flanders (Strategic Basic Research fellowship); VIB; Ghent University Industrial Research Fund (UGent-IOF); Hercules Foundation; FWO research project(FWO)	We thank G. Pontini, Y. Poitevin, L. Bernasconi, D. Schrag and S. Raimondi (NovImmune) for their help with anti-CD20 generation and characterization; S. Savvides (Ghent University) for providing the 293SGnTI(-) clone expressing the Flt3 receptor extracellular domain; E. Van Damme (Ghent University) for providing ConA; and E. Dirksen and K. Nooijen (Merck) for the LC-MS analysis of anti-CD20. L.M. and M.B. are supported by predoctoral fellowships, and N.F. by a postdoctoral fellowship, of the Fund for Scientific Research-Flanders (FWO). F.S. and S.D. are supported by predoctoral fellowships of agentschap voor Innovatie door Wetenschap en Technologie (IWT) Flanders (Strategic Basic Research fellowship nos. 101456 and 111252). This research was supported by VIB, Ghent University Industrial Research Fund (UGent-IOF) Advanced Grant no. 041 (N.C.), FWO research project grant no. G.0.541.08.N.10 (N.C.) and Hercules Foundation grant no. AUGE019 (B.D.).	Allhorn M, 2009, ANN NY ACAD SCI, V1173, P664, DOI 10.1111/j.1749-6632.2009.04739.x; Beck A, 2011, MABS-AUSTIN, V3, P107, DOI 10.4161/mabs.3.2.14785; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Forno G, 2004, EUR J BIOCHEM, V271, P907, DOI 10.1111/j.1432-1033.2004.03993.x; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kanda Y, 2006, BIOTECHNOL BIOENG, V94, P680, DOI 10.1002/bit.20880; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; LEE F, 1985, P NATL ACAD SCI USA, V82, P4360, DOI 10.1073/pnas.82.13.4360; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Magistrelli G, 2012, J IMMUNOL METHODS, V375, P20, DOI 10.1016/j.jim.2011.09.002; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Nallet S, 2012, NEW BIOTECHNOL, V29, P471, DOI 10.1016/j.nbt.2012.02.003; Nandakumar KS, 2013, P NATL ACAD SCI USA, V110, P10252, DOI 10.1073/pnas.1301480110; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tradtrantip L, 2013, ANN NEUROL, V73, P77, DOI 10.1002/ana.23741; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532	30	100	107	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					485	U210		10.1038/nbt.2885	http://dx.doi.org/10.1038/nbt.2885			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752077	Green Accepted			2022-12-25	WOS:000336036100025
J	Holmen, OL; Zhang, H; Fan, YB; Hovelson, DH; Schmidt, EM; Zhou, W; Guo, YH; Zhang, J; Langhammer, A; Lochen, ML; Ganesh, SK; Vatten, L; Skorpen, F; Dalen, H; Zhang, JF; Pennathur, S; Chen, J; Platou, C; Mathiesen, EB; Wilsgaard, T; Njolstad, I; Boehnke, M; Chen, YE; Abecasis, GR; Hveem, K; Willer, CJ				Holmen, Oddgeir L.; Zhang, He; Fan, Yanbo; Hovelson, Daniel H.; Schmidt, Ellen M.; Zhou, Wei; Guo, Yanhong; Zhang, Ji; Langhammer, Arnulf; Lochen, Maja-Lisa; Ganesh, Santhi K.; Vatten, Lars; Skorpen, Frank; Dalen, Havard; Zhang, Jifeng; Pennathur, Subramaniam; Chen, Jin; Platou, Carl; Mathiesen, Ellisiv B.; Wilsgaard, Tom; Njolstad, Inger; Boehnke, Michael; Chen, Y. Eugene; Abecasis, Goncalo R.; Hveem, Kristian; Willer, Cristen J.			Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; RARE VARIANTS; MISSING HERITABILITY; COHORT PROFILE; LOCI; DISEASE; ASSOCIATION	Blood lipid levels are heritable, treatable risk factors for cardiovascular disease. We systematically assessed genome-wide coding variation to identify new genes influencing lipid traits, fine map known lipid loci and evaluate whether low-frequency variants with large effects exist for these traits. Using an exome array, we genotyped 80,137 coding variants in 5,643 Norwegians. We followed up 18 variants in 4,666 Norwegians and identified ten loci with coding variants associated with a lipid trait (P < 5 Chi 10(-8)). One variant in TM6SF2 (encoding p. Glu167Lys), residing in a known genome-wide association study locus for lipid traits, influences total cholesterol levels and is associated with myocardial infarction. Transient TM6SF2 overexpression or knockdown of Tm6sf2 in mice alters serum lipid profiles, consistent with the association observed in humans, identifying TM6SF2 as a functional gene within a locus previously known as NCAN-CILP2-PBX4 or 19p13. This study demonstrates that systematic assessment of coding variation can quickly point to a candidate causal gene.	[Holmen, Oddgeir L.; Langhammer, Arnulf; Hveem, Kristian] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Holmen, Oddgeir L.] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Zhang, He; Fan, Yanbo; Hovelson, Daniel H.; Schmidt, Ellen M.; Zhou, Wei; Guo, Yanhong; Zhang, Ji; Ganesh, Santhi K.; Zhang, Jifeng; Chen, Jin; Chen, Y. Eugene; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Hovelson, Daniel H.; Schmidt, Ellen M.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lochen, Maja-Lisa; Wilsgaard, Tom; Njolstad, Inger] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Epidemiol Chron Dis Res Grp, Tromso, Norway; [Ganesh, Santhi K.; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Vatten, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Skorpen, Frank] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Dalen, Havard; Platou, Carl; Hveem, Kristian] Levanger Hosp, Nord Trondelag Hlth Trust, Dept Med, Levanger, Norway; [Dalen, Havard] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Med Imaging Lab Innovat Future Healthcare, N-7034 Trondheim, Norway; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Mathiesen, Ellisiv B.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Brain & Circulat Res Grp, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp North Norway, Brain & Circulat Res Grp, Tromso, Norway; [Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; UiT The Arctic University of Tromso; University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Michigan System; University of Michigan	Willer, CJ (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	kristian.hveem@ntnu.no; cristen@umich.edu	Fan, Yanbo/C-6360-2013; Dalen, Havard/A-8087-2018; Hveem, Kristian/AFV-4683-2022; Vatten, Lars/AAF-9380-2022; Fan, Yanbo/AAD-4710-2020; Njolstad, Inger/X-3784-2019; Vatten, Lars/AFK-2073-2022; Zhang, Ji/J-4009-2014	Fan, Yanbo/0000-0002-3845-7562; Dalen, Havard/0000-0003-1192-3663; Fan, Yanbo/0000-0002-3845-7562; Schmidt, Ellen/0000-0003-1198-7536; Hovelson, Daniel/0000-0003-1881-4451; Zhang, He/0000-0001-9198-6503; Skorpen, Frank/0000-0001-7093-8000; Lochen, Maja-Lisa/0000-0002-8532-6573; Willer, Cristen/0000-0001-5645-4966	National Heart, Lung and Blood Institute [HL094535, HL109946, HL068878, HL117491, HL117626]; National Institute of Diabetes and Digestive and Kidney Diseases [DK062370]; National Human Genome Research Institute [HG007022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL094535, R01HL068878, R01HL117491, R00HL094535, R01HL109946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070449] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Nord-Trondelag Health Study (The HUNT Study) is a collaboration between the HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology NTNU), the Nord-Trondelag County Council, the Central Norway Health Authority and the Norwegian Institute of Public Health. C. J. W. is supported by HL094535 and HL109946 from the National Heart, Lung and Blood Institute. M. B. is supported by DK062370 from the National Institute of Diabetes and Digestive and Kidney Diseases. Y. E. C. is supported by HL068878 and HL117491 from the National Heart, Lung and Blood Institute. G. R. A. is supported by HL117626 from the National Heart, Lung and Blood Institute and HG007022 from the National Human Genome Research Institute. For frequency look up for the RNF111 variant, we thank the following: R. Loos and K. Lu of the BioMe Clinical Care Cohort operated by The Charles Bronfman Institute for Personalized Medicine (IPM) at the Mount Sinai Medical Center (the Mount Sinai IPM Biobank Program is supported by The Andrea and Charles Bronfman Philanthropies); A. Metspalu of the Estonian Genome Center (the Estonian Biobank data were provided by E. Mihailov from the Estonian Genome Center of University of Tartu, Estonia); and A. Uitterlinden, F. Rivadeneira and K. Estrada of Erasmus University Rotterdam.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blattmann P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003338; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Fan YB, 2012, ARTERIOSCL THROM VAS, V32, P2981, DOI 10.1161/ATVBAHA.112.300349; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Golledge J, 2010, ATHEROSCLEROSIS, V209, P487, DOI 10.1016/j.atherosclerosis.2009.09.027; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; HEGELE RA, 1991, J CLIN ENDOCR METAB, V72, P730, DOI 10.1210/jcem-72-3-730; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Inatani M, 2000, INVEST OPHTH VIS SCI, V41, P2748; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jostins L, 2011, EUR J HUM GENET, V19, P662, DOI 10.1038/ejhg.2011.10; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Musunuru K, 2008, CIRC-CARDIOVASC GENE, V1, P66, DOI 10.1161/CIRCGENETICS.108.813675; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shen L, 2013, PHARMACOL RES, V73, P27, DOI 10.1016/j.phrs.2013.04.001; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	41	205	209	0	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					345	+		10.1038/ng.2926	http://dx.doi.org/10.1038/ng.2926			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24633158	Green Accepted			2022-12-25	WOS:000334510100009
J	Shibuya, H; Ishiguro, K; Watanabe, Y				Shibuya, Hiroki; Ishiguro, Kei-ichiro; Watanabe, Yoshinori			The TRF1-binding protein TERB1 promotes chromosome movement and telomere rigidity in meiosis	NATURE CELL BIOLOGY			English	Article							MEIOTIC PROPHASE; NUCLEAR-ENVELOPE; COHESIN; SYNAPSIS; BOUQUET; DOMAIN; SUN1; ATTACHMENT; COMPLEX; ACTIN	During meiotic prophase, telomere-mediated chromosomal movement along the nuclear envelope is crucial for homologue pairing and synapsis. However, how telomeres are modified to mediate chromosome movement is largely elusive. Here we show that mammalian meiotic telomeres are fundamentally modified by a meiosis-specific Myb-domain protein, TERB1, that localizes at telomeres in mouse germ cells. TERB1 forms a heterocomplex with the canonical telomeric protein TRF1 and binds telomere repeat DNA. Disruption of Terbl in mice abolishes meiotic chromosomal movement and impairs homologous pairing and synapsis, causing infertility in both sexes. TERB1 promotes telomere association with the nuclear envelope and deposition of the SUN-KASH complex, which recruits cytoplasmic motor complexes. TERB1 also binds and recruits cohesin to telomeres to develop structural rigidity, strikingly reminiscent of centromeres. Our study suggests that TERB1 acts as a central hub for the assembly of a conserved meiotic telomere complex required for chromosome movements.	[Shibuya, Hiroki; Ishiguro, Kei-ichiro; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Shibuya, Hiroki; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Ishiguro, Kei-ichiro/K-3340-2019	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Watanabe, Yoshinori/0000-0002-5488-4812; Shibuya, Hiroki/0000-0002-3400-0741	JSPS Research Fellowship; Global COB Program (Integrative Life Science Based on the Study of Biosignalling Mechanisms); MEXT; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COB Program (Integrative Life Science Based on the Study of Biosignalling Mechanisms); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Takeda (University of Kumamoto) for assisting in the construction of knockout mice, and Y. Kishi, Y. Ito, M. Yoda and H. Sasaki (University of Tokyo) for technical advice. We also thank all of the members of our laboratory for their valuable support and discussion. This work was supported in part by a JSPS Research Fellowship (H.S.), a Grant-in-Aid for Scientific Research on Innovative and Priority Areas (K.I.), the Global COB Program (Integrative Life Science Based on the Study of Biosignalling Mechanisms), and a Grant-in-Aid for Specially Promoted Research (Y.W.) from MEXT.	Adelfalk C, 2009, J CELL BIOL, V187, P185, DOI 10.1083/jcb.200808016; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Gallardo TD, 2007, GENETICS, V177, P179, DOI 10.1534/genetics.107.074823; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; McKerlie M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1372; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042	33	111	116	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2014	16	2					145	156		10.1038/ncb2896	http://dx.doi.org/10.1038/ncb2896			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA5TB	24413433	Green Accepted			2022-12-25	WOS:000331161400004
J	Cai, ZY; Jitkaew, S; Zhao, J; Chiang, HC; Choksi, S; Liu, J; Ward, Y; Wu, LG; Liu, ZG				Cai, Zhenyu; Jitkaew, Siriporn; Zhao, Jie; Chiang, Hsueh-Cheng; Choksi, Swati; Liu, Jie; Ward, Yvona; Wu, Ling-gang; Liu, Zheng-Gang			Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis	NATURE CELL BIOLOGY			English	Article							NONAPOPTOTIC CELL-DEATH; MIXED LINEAGE KINASE; PROGRAMMED NECROSIS; NECROTIC DEATH; DOMAIN-LIKE; INFLAMMATION; APOPTOSIS; TRPM7; RIP3; DOWNSTREAM	The mixed lineage kinase domain-like protein (MLKL) has recently been identified as a key RIP3 (receptor interacting protein 3) downstream component of tumour necrosis factor (TNF)-induced necroptosis. MLKL is phosphorylated by RIP3 and is recruited to the necrosome through its interaction with RIP3. However, it is still unknown how MLKL mediates TNF-induced necroptosis. Here, we report that MLKL forms a homotrimer through its amino-terminal coiled-coil domain and locates to the cell plasma membrane during TNF-induced necroptosis. By generating different MLKL mutants, we demonstrated that the plasma membrane localization of trimerized MLKL is critical for mediating necroptosis. Importantly, we found that the membrane localization of MLKL is essential for Ca2+ influx, which is an early event of TNF-induced necroptosis. Furthermore, we identified that TRPM7 (transient receptor potential melastatin related 7) is a MLKL downstream target for the mediation of Ca2+ influx and TNF-induced necroptosis. Hence, our study reveals a crucial mechanism of MLKL-mediated TNF-induced necroptosis.	[Cai, Zhenyu; Jitkaew, Siriporn; Zhao, Jie; Choksi, Swati; Ward, Yvona; Liu, Zheng-Gang] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chiang, Hsueh-Cheng; Wu, Ling-gang] NINDS, Synapt Transmiss Sect, NIH, Bethesda, MD 20892 USA; [Liu, Jie] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Liu, ZG (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zgliu@helix.nih.gov			Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Han for MLKL-deficient MEF cells and MLKL antibody, and L. Looger for GCaMP3 plasmid. This research was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Desai BN, 2012, DEV CELL, V22, P1149, DOI 10.1016/j.devcel.2012.04.006; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Sciacca MFM, 2013, BIOPHYS J, V104, P173, DOI 10.1016/j.bpj.2012.11.3811; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	33	791	817	11	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					55	+		10.1038/ncb2883	http://dx.doi.org/10.1038/ncb2883			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24316671	Green Accepted			2022-12-25	WOS:000329042000011
J	Eyries, M; Montani, D; Girerd, B; Perret, C; Leroy, A; Lonjou, C; Chelghoum, N; Coulet, F; Bonnet, D; Dorfmuller, P; Fadel, E; Sitbon, O; Simonneau, G; Tregouet, DA; Humbert, M; Soubrier, F				Eyries, Melanie; Montani, David; Girerd, Barbara; Perret, Claire; Leroy, Anne; Lonjou, Christine; Chelghoum, Nadjim; Coulet, Florence; Bonnet, Damien; Dorfmueller, Peter; Fadel, Elie; Sitbon, Olivier; Simonneau, Gerald; Tregouet, David-Alexandre; Humbert, Marc; Soubrier, Florent			EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension	NATURE GENETICS			English	Article							VENO-OCCLUSIVE DISEASE; ARTERIAL-HYPERTENSION; CAPILLARY HEMANGIOMATOSIS; CLINICAL-OUTCOMES; IDENTIFICATION; MECHANISM; STRESS; GCN2	Pulmonary veno-occlusive disease (PVOD) is a rare and devastating cause of pulmonary hypertension that is characterized histologically by widespread fibrous intimal proliferation of septal veins and preseptal venules and is frequently associated with pulmonary capillary dilatation and proliferation(1,2). PVOD is categorized into a separate pulmonary arterial hypertension-related group in the current classification of pulmonary hypertension(3). PVOD presents either sporadically or as familial cases with a seemingly recessive mode of transmission(4). Using whole-exome sequencing, we detected recessive mutations in EIF2AK4 (also called GCN2) that cosegregated with PVOD in all 13 families studied. We also found biallelic EIF2AK4 mutations in 5 of 20 histologically confirmed sporadic cases of PVOD. All mutations, either in a homozygous or compound-heterozygous state, disrupted the function of the gene. These findings point to EIF2AK4 as the major gene that is linked to PVOD development and contribute toward an understanding of the complex genetic architecture of pulmonary hypertension.	[Eyries, Melanie; Soubrier, Florent] Univ Paris 06, UMR S 956, Paris, France; [Eyries, Melanie; Soubrier, Florent] INSERM, Paris, France; [Eyries, Melanie; Leroy, Anne; Coulet, Florence; Soubrier, Florent] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Eyries, Melanie; Perret, Claire; Coulet, Florence; Tregouet, David-Alexandre; Soubrier, Florent] Inst Cardiometab & Nutr ICAN, Paris, France; [Montani, David; Girerd, Barbara; Sitbon, Olivier; Simonneau, Gerald; Humbert, Marc] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Montani, David; Girerd, Barbara; Sitbon, Olivier; Simonneau, Gerald; Humbert, Marc] Hop Bicetre, AP HP, DHU, Thorax Innovat TORINO,Serv Pneumol, Le Kremlin Bicetre, France; [Montani, David; Girerd, Barbara; Dorfmueller, Peter; Sitbon, Olivier; Simonneau, Gerald; Humbert, Marc] INSERM, LERMIT, Ctr Chirurg Marie Lannelongue, UMR S 999, Le Plessis Robinson, France; [Perret, Claire; Tregouet, David-Alexandre] UPMC, INSERM, UMR S 937, Paris, France; [Lonjou, Christine; Chelghoum, Nadjim] UPMC, INSERM, Post Genom Platform P3S, Paris, France; [Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Dept Cardiac Surg, Paris, France; [Bonnet, Damien] INSERM, UMR S 765, Paris, France; [Bonnet, Damien] Univ Paris 05, Paris, France; [Dorfmueller, Peter] Ctr Chirurg Marie Lannelongue, Dept Pathol, Le Plessis Robinson, France; [Fadel, Elie] Ctr Chirurg Marie Lannelongue, Dept Thorac Surg, Le Plessis Robinson, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hopital Marie Lannelongue; Hopital Marie Lannelongue	Soubrier, F (corresponding author), Univ Paris 06, UMR S 956, Paris, France.	florent.soubrier@upmc.fr	Tregouet, David-Alexandre/E-3961-2016; Simonneau, Gerald/ABE-6614-2020; David, Montani/I-6885-2019; Humbert, Marc/ABD-5112-2021; Humbert, Marc/AAC-8459-2019; EYRIES, melanie/ABF-1034-2020; Trégouët, David-Alexandre/P-9210-2019; Sitbon, Olivier/I-3623-2019	David, Montani/0000-0002-9358-6922; Humbert, Marc/0000-0003-0703-2892; Trégouët, David-Alexandre/0000-0001-9084-7800; Sitbon, Olivier/0000-0002-1942-1951; Lonjou, Christine/0000-0003-1226-6992; Dorfmuller, Peter/0000-0003-2499-6829	Association Hypertension Arterielle Pulmonaire (HTAP) France; Programme Hospitalier de Recherche Clinique (PHRC) [AOM07-041]; INSERM; UPMC; Legs Poix, Chancellerie des Universites de Paris; Region Ile de France	Association Hypertension Arterielle Pulmonaire (HTAP) France; Programme Hospitalier de Recherche Clinique (PHRC); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; Legs Poix, Chancellerie des Universites de Paris; Region Ile de France(Region Ile-de-France)	We thank F. Pires, A. Dion-Miniere, S. Bakas, G. Legrand and N. Raymond for technical assistance. We thank W. Carpentier for supervising SNP array experiments. We thank R. Peat for kindly editing the manuscript. D. M. and P. D. are supported by a grant from the Association Hypertension Arterielle Pulmonaire (HTAP) France. This work was supported by Programme Hospitalier de Recherche Clinique (PHRC) AOM07-041, INSERM and UPMC. The tissue bank was supported in part by the Legs Poix, Chancellerie des Universites de Paris. Bioinformatics analyses benefit from the C2BIG computing centre funded by the Region Ile de France and UPMC.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Chaveroux C, 2011, BIOCHEM BIOPH RES CO, V415, P120, DOI 10.1016/j.bbrc.2011.10.027; DAVIES P, 1982, HUM PATHOL, V13, P911, DOI 10.1016/S0046-8177(82)80051-8; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Eyries M, 2012, CLIN GENET, V82, P173, DOI 10.1111/j.1399-0004.2011.01727.x; Fessel JP, 2013, AM J RESP CELL MOL, V49, P778, DOI 10.1165/rcmb.2012-0463OC; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; HEATH D, 1966, CIRCULATION, V34, P242; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 1998, AM J RESP CRIT CARE, V157, P1681, DOI 10.1164/ajrccm.157.5.9708065; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANGLEBEN D, 1988, ANN INTERN MED, V109, P106, DOI 10.7326/0003-4819-109-2-106; Lantuejoul S, 2006, AM J SURG PATHOL, V30, P850, DOI 10.1097/01.pas.0000209834.69972.e5; Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mandel J, 2000, AM J RESP CRIT CARE, V162, P1964, DOI 10.1164/ajrccm.162.5.9912045; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Montani D, 2008, MEDICINE, V87, P220, DOI 10.1097/MD.0b013e31818193bb; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; ROSENTHAL A, 1973, AM J CARDIOL, V31, P78, DOI 10.1016/0002-9149(73)90814-X; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; VOORDES CG, 1977, THORAX, V32, P763, DOI 10.1136/thx.32.6.763; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	35	239	263	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					65	+		10.1038/ng.2844	http://dx.doi.org/10.1038/ng.2844			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24292273				2022-12-25	WOS:000329113500015
J	Kong, A; Thorleifsson, G; Frigge, ML; Masson, G; Gudbjartsson, DF; Villemoes, R; Magnusdottir, E; Olafsdottir, SB; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Frigge, Michael L.; Masson, Gisli; Gudbjartsson, Daniel F.; Villemoes, Rasmus; Magnusdottir, Erna; Olafsdottir, Stefania B.; Thorsteinsdottir, Unnur; Stefansson, Kari			Common and low-frequency variants associated with genome-wide recombination rate	NATURE GENETICS			English	Article							MAMMALIAN MEIOSIS; SEQUENCE VARIANTS; CROSSING-OVER; ZMM PROTEINS; RAD21L; MICE; CHROMOSOMES; IMPUTATION; REGULATOR; INVERSION	Meiotic recombination contributes to genetic diversity by yielding new combinations of alleles. Individuals vary with respect to the genome-wide recombination counts in their gametes. Exploiting data resources in Iceland, we compiled a data set consisting of 35,927 distinct parents and 71,929 parent-offspring pairs. Within this data set, we called over 2.2 million recombination events and imputed variants with sequence-level resolution from 2,261 whole genome-sequenced individuals into the parents to search for variants influencing recombination rate. We identified 13 variants in 8 regions that are associated with genome-wide recombination rate, 8 of which were previously unknown. Three of these variants associate with male recombination rate only, seven variants associate with female recombination rate only and three variants affect both. Two are low-frequency variants with large effects, one of which is estimated to increase the male and female genetic maps by 111 and 416 cM, respectively. This variant, located in an intron, would not be found by exome sequencing.	[Kong, Augustine; Thorleifsson, Gudmar; Frigge, Michael L.; Masson, Gisli; Gudbjartsson, Daniel F.; Villemoes, Rasmus; Olafsdottir, Stefania B.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Kong, Augustine; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Fac Phys Sci, Reykjavik, Iceland; [Magnusdottir, Erna; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Iceland; University of Iceland	Kong, A (corresponding author), deCODE Genet Amgen Inc, Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Magnúsdóttir, Erna/T-8993-2019; Stefansson, Kari/AAE-7187-2019; Magnúsdóttir, Erna/H-5181-2013	Magnúsdóttir, Erna/0000-0002-3369-4390; Gudbjartsson, Daniel/0000-0002-5222-9857; Frigge, Michael/0000-0003-2984-535X; Kong, Augustine/0000-0001-8193-5438				Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chelysheva L., 2012, PLOS GENET, V8; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Gutierrez-Caballero C, 2011, CELL CYCLE, V10, P1477, DOI 10.4161/cc.10.9.15515; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kneitz B, 2000, GENE DEV, V14, P1085; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lee J, 2011, J CELL BIOL, V192, P263, DOI 10.1083/jcb.201008005; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Llano E, 2012, J CELL BIOL, V197, P877, DOI 10.1083/jcb.201201100; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nagel AC, 2012, J CELL SCI, V125, P5555, DOI 10.1242/jcs.113902; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Novak JE, 2001, GENETICS, V158, P1013; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sandor C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002854; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Sleutels F, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-8; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139	41	79	80	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					11	+		10.1038/ng.2833	http://dx.doi.org/10.1038/ng.2833			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24270358				2022-12-25	WOS:000329113500006
J	Lieberman, TD; Flett, KB; Yelin, I; Martin, TR; McAdam, AJ; Priebe, GP; Kishony, R				Lieberman, Tami D.; Flett, Kelly B.; Yelin, Idan; Martin, Thomas R.; McAdam, Alexander J.; Priebe, Gregory P.; Kishony, Roy			Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures	NATURE GENETICS			English	Article							HYPERMUTABLE PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; BURKHOLDERIA-DOLOSA; HELICOBACTER-PYLORI; EVOLUTION; MUTATIONS; ADAPTATION; RESISTANCE; DYNAMICS	Advances in sequencing technologies have enabled the identification of mutations acquired by bacterial pathogens during infection(1-10). However, it remains unclear whether adaptive mutations fix in the population or lead to pathogen diversification within the patient(11,12). Here we study the genotypic diversity of Burkholderia dolosa within individuals with cystic fibrosis by resequencing individual colonies and whole populations from single sputum samples. We find extensive intrasample diversity, suggesting that mutations rarely fix in a patient's pathogen population-instead, diversifying lineages coexist for many years. Under strong selection, multiple adaptive mutations arise, but none of these sweep to fixation, generating lasting allele diversity that provides a recorded signature of past selection. Genes involved in outer-membrane components, iron scavenging and antibiotic resistance all showed this signature of within-patient selection. These results offer a general and rapid approach for identifying the selective pressures acting on a pathogen in individual patients based on single clinical samples.	[Lieberman, Tami D.; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Flett, Kelly B.] Boston Childrens Hosp, Div Infect Dis, Dept Med, Boston, MA USA; [Flett, Kelly B.; Martin, Thomas R.; McAdam, Alexander J.; Priebe, Gregory P.] Harvard Univ, Sch Med, Boston, MA USA; [Yelin, Idan; Kishony, Roy] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Martin, Thomas R.] Boston Childrens Hosp, Div Resp Dis, Dept Med, Boston, MA USA; [McAdam, Alexander J.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Priebe, Gregory P.] Boston Childrens Hosp, Div Crit Care Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Priebe, Gregory P.] Boston Childrens Hosp, Div Infect Dis, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	McAdam, AJ (corresponding author), Boston Childrens Hosp, Dept Lab Med, Boston, MA USA.	alexander.mcadam@childrens.harvard.edu; gregory.priebe@childrens.harvard.edu; roy_kishony@hms.harvard.edu	Priebe, Gregory/AAG-4027-2021	Priebe, Gregory/0000-0001-9831-0354; /0000-0001-5430-3937; Yelin, Idan/0000-0003-2515-4113	Cystic Fibrosis Foundation [LIEBER12H0, PRIEBE1310]; US National Institutes of Health [GM081617]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE) [U54 AI057159]; Hoffman-LaRoche; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hoffman-LaRoche; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J.-B. Michel and members of the Kishony laboratory for insightful discussions and support, to the team at the Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) for Illumina sequencing, to L. Williams and A. Palmer for discussions and technical assistance, and to Y. Gerardin, J. Meyer, L. Stone and R. Ward for their comments on the manuscript. T. D. L. and G. P. P. were supported in part by grants from the Cystic Fibrosis Foundation (LIEBER12H0 to T. D. L. and PRIEBE1310 to G. P. P.). This work was funded in part by the US National Institutes of Health (GM081617 to R. K.), the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE; U54 AI057159 to R. K.) and Hoffman-LaRoche.	Ashish A, 2013, J CYST FIBROS, V12, P790, DOI 10.1016/j.jcf.2013.04.003; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Didelot X, 2013, P NATL ACAD SCI USA, V110, P13880, DOI 10.1073/pnas.1304681110; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10; Jolivet-Gougeon A, 2011, J MED MICROBIOL, V60, P563, DOI 10.1099/jmm.0.024083-0; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Menard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-308; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2010, CLIN MICROBIOL INFEC, V16, P798, DOI 10.1111/j.1469-0691.2010.03250.x; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Pope CF, 2010, J MED MICROBIOL, V59, P679, DOI 10.1099/jmm.0.017830-0; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Vermis K, 2004, INT J SYST EVOL MICR, V54, P689, DOI 10.1099/ijs.0.02888-0; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Workentine M, 2011, AM J RESP CRIT CARE, V183, P1581, DOI 10.1164/rccm.201105-0776ED; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	43	176	176	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					82	+		10.1038/ng.2848	http://dx.doi.org/10.1038/ng.2848			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316980	Green Accepted, Green Submitted			2022-12-25	WOS:000329113500018
J	Verdin, E				Verdin, Eric			Coupling of NAD metabolism, sirtuins and lifespan	NATURE MEDICINE			English	Editorial Material							CALORIE RESTRICTION; DEACETYLASE; LONGEVITY; SIR2; MICE; ELEGANS		Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183				Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Lanska DJ, 2012, ANN NUTR METAB, V61, P246, DOI 10.1159/000343115; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sinclair D, 2012, CELL REP, V2, P1473, DOI 10.1016/j.celrep.2012.12.004; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	18	46	48	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					25	27		10.1038/nm.3447	http://dx.doi.org/10.1038/nm.3447			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398962				2022-12-25	WOS:000329349400015
J	Hu, ZB; Liu, Y; Zhai, XJ; Dai, JC; Jin, GF; Wang, L; Zhu, LG; Yang, Y; Liu, JB; Chu, MJ; Wen, J; Xie, KP; Du, GM; Wang, QG; Zhou, YC; Cao, MQ; Liu, L; He, YS; Wang, Y; Zhou, GQ; Jia, WH; Lu, JC; Li, SP; Liu, JJ; Yang, HT; Shi, YY; Zhou, WP; Shen, HB				Hu, Zhibin; Liu, Yao; Zhai, Xiangjun; Dai, Juncheng; Jin, Guangfu; Wang, Li; Zhu, Liguo; Yang, Yuan; Liu, Jibin; Chu, Minjie; Wen, Juan; Xie, Kaipeng; Du, Guoming; Wang, Qungang; Zhou, Yuchun; Cao, Minquan; Liu, Li; He, Yisha; Wang, Ying; Zhou, Gangqiao; Jia, Weihua; Lu, Jiachun; Li, Shengping; Liu, Jianjun; Yang, Haitao; Shi, Yongyong; Zhou, Weiping; Shen, Hongbing			New loci associated with chronic hepatitis B virus infection in Han Chinese	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; T-CELL RESPONSES; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; COMMON VARIANTS; HLA ALLELES; RISK; CLEARANCE; SUSCEPTIBILITY; HLA-DPA1	Chronic hepatitis B virus (HBV) infection is a challenging global health problem. To identify genetic loci involved in chronic HBV infection, we designed a three-phase genome-wide association study in Han Chinese populations. The discovery phase included 951 HBV carriers (cases) and 937 individuals who had naturally cleared HBV infection (controls) and was followed by independent replications with a total of 2,248 cases and 3,051 controls and additional replications with 1,982 HBV carriers and 2,622 controls from the general population. We identified two new loci associated with chronic HBV infection: rs3130542 at 6p21.33 (near HLA-C, odds ratio (OR) = 1.33, P = 9.49 x 10(-14)) and rs4821116 at 22q11.21 (in UBE2L3, OR = 0.82, P = 1.71 x 10(-12)). Additionally, we replicated the previously identified associations of HLA-DP and HLA-DQ variants at 6p21.32 with chronic HBV infection. These findings highlight the importance of HLA-C and UBE2L3 in the clearance of HBV infection in addition to HLA-DP and HLA-DQ.	[Hu, Zhibin; Liu, Yao; Dai, Juncheng; Jin, Guangfu; Chu, Minjie; Wen, Juan; Xie, Kaipeng; He, Yisha; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Liu, Yao; Dai, Juncheng; Jin, Guangfu; Chu, Minjie; Wen, Juan; Xie, Kaipeng; He, Yisha; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhai, Xiangjun; Zhu, Liguo; Yang, Haitao] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Wang, Li] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Sch Basic Med,Dept Epidemiol & Biostat, Beijing 100730, Peoples R China; [Yang, Yuan; Zhou, Weiping] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Liu, Jibin; Liu, Li] Nantong Tumor Hosp, Tumor Biobank, Nantong, Peoples R China; [Du, Guoming; Wang, Qungang] Zhangjiagang Ctr Dis Prevent & Control, Natl Major Sci & Technol Project Execut Off, Zhangjiagang, Peoples R China; [Zhou, Yuchun; Cao, Minquan] Taixing Ctr Dis Prevent & Control, Natl Major Sci & Technol Project Execut Off, Taixing, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Virus Lab, Wuhan, Peoples R China; [Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Jia, Weihua; Li, Shengping] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Liu, Jianjun] ASTAR, Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Zhou, Weiping] Second Mil Med Univ, Natl Innovat Alliance Hepatitis & Liver Canc, Shanghai, Peoples R China	Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Academy of Military Medical Sciences - China; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shanghai Jiao Tong University; Naval Medical University	Shen, HB (corresponding author), Nanjing Med Univ, Dept Epidemiol & Biostat, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn; shiyongyong@gmail.com; ehphwp@126.com; hbshen@njmu.edu.cn	Shi, Yongyong/GSO-1627-2022; Liu, Jianjun/AAK-4989-2020; Zhou, Weiping/AGI-5344-2022	Shi, Yongyong/0000-0003-1710-1505; Liu, Jianjun/0000-0002-3255-3019; Shen, Hongbing/0000-0002-2581-5906; Jin, Guangfu/0000-0003-0249-5337	National Key Basic Research Program [2013CB911400, 2013CB910304]; National Science Foundation for Distinguished Young Scholars of China [81225020]; State Key Program of National Natural Science of China [81230067]; Foundation for the Program for New Century Excellent Talents in University [NCET-10-0178]; Author of National Excellent Doctoral Dissertation [201081]; National Natural Science Foundation of China [30800946, 81072344]; State Key Infectious Disease Project of China [2012ZX10002010, 2012ZX10002016]; National Major Science & Technology Project [2011ZX10004-902]; National Science Fund for Creative Research Groups [30921006]; China National High-Tech Research and Development Program grant [2012AA02A515]; Foundation for Distinguished Young Scholars of Jiangsu Province [BK2012042, BK20130042]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Key Basic Research Program(National Basic Research Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Foundation for the Program for New Century Excellent Talents in University; Author of National Excellent Doctoral Dissertation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Infectious Disease Project of China; National Major Science & Technology Project; National Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); China National High-Tech Research and Development Program grant; Foundation for Distinguished Young Scholars of Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	The authors thank all study subjects, research staff and students who participated in this work and Z. Wang (US National Cancer Institute) for statistical help with imputation. This work was funded by the National Key Basic Research Program (2013CB911400), the project supported by the National Science Foundation for Distinguished Young Scholars of China (81225020), the project supported by the State Key Program of National Natural Science of China (81230067), the Foundation for the Program for New Century Excellent Talents in University (NCET-10-0178), the Author of National Excellent Doctoral Dissertation (201081), the National Natural Science Foundation of China (30800946 and 81072344), the State Key Infectious Disease Project of China (2012ZX10002010 and 2012ZX10002016), the National Major Science & Technology Project (2011ZX10004-902), the National Science Fund for Creative Research Groups (30921006), the National Key Basic Research Program (2013CB910304), a China National High-Tech Research and Development Program grant (2012AA02A515), the Foundation for Distinguished Young Scholars of Jiangsu Province (BK2012042 and BK20130042) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).	An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; BALLARDINI G, 1987, CLIN EXP IMMUNOL, V70, P35; BEASLEY RP, 1981, LANCET, V2, P1129; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Chang JJ, 2005, J VIROL, V79, P3038, DOI 10.1128/JVI.79.5.3038-3051.2005; Chen JH, 2011, HEPAT MON, V11, P620, DOI 10.5812/kowsar.1735143X.689; Chen WW, 2009, HEPATOL RES, V39, P355, DOI 10.1111/j.1872-034X.2008.00468.x; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Du GuoMing, 2009, Modern Preventive Medicine, V36, P4560; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fang Y., 2008, OCCUP HLTH LOND, V4, P350; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; GREEN MS, 1983, AM J EPIDEMIOL, V117, P98, DOI 10.1093/oxfordjournals.aje.a113521; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Han Y, 2012, MOL MED REP, V5, P1347, DOI 10.3892/mmr.2012.800; He YL, 2006, WORLD J GASTROENTERO, V12, P4788; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Li XK, 2012, VIRUS RES, V163, P328, DOI 10.1016/j.virusres.2011.10.020; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moynihan TP, 1998, GENOMICS, V51, P124, DOI 10.1006/geno.1998.5257; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Norton PA, 2004, J VIRAL HEPATITIS, V11, P332, DOI 10.1111/j.1365-2893.2004.00555.x; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sener SF, 2005, CA-CANCER J CLIN, V55, P7, DOI 10.3322/canjclin.55.1.7; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Thio CL, 1999, J INFECT DIS, V179, P1004, DOI 10.1086/314684; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wang S, 2012, GENES IMMUN, V13, P380, DOI 10.1038/gene.2012.6; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang YX, 2007, IMMUNOLOGY, V121, P105, DOI 10.1111/j.1365-2567.2007.02543.x; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	47	112	118	2	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1499	U133		10.1038/ng.2809	http://dx.doi.org/10.1038/ng.2809			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24162738				2022-12-25	WOS:000327715800019
J	Tanaka, AJ; Sauer, MV; Egli, D; Kort, DH				Tanaka, Akemi J.; Sauer, Mark V.; Egli, Dieter; Kort, Daniel H.			The path to prevent mitochondrial disease	NATURE MEDICINE			English	Editorial Material							GENE-THERAPY; REPLACEMENT; EMBRYOS; MTDNA		[Tanaka, Akemi J.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Sauer, Mark V.; Kort, Daniel H.] Columbia Univ, Ctr Womens Reprod Care, New York, NY USA; [Egli, Dieter] New York Stem Cell Fdn, Res Inst, New York, NY USA	Yale University; Columbia University; The New York Stem Cell Foundation	Tanaka, AJ (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06520 USA.	d.egli@nyscf.org						Baylis F, 2013, REPROD BIOMED ONLINE, V26, P531, DOI 10.1016/j.rbmo.2013.03.006; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Johnson MH, 2013, REPROD BIOMED ONLINE, V26, P516, DOI 10.1016/j.rbmo.2013.03.014; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119	15	11	11	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1578	1579		10.1038/nm.3422	http://dx.doi.org/10.1038/nm.3422			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309656				2022-12-25	WOS:000328181400025
J	Trudu, M; Janas, S; Lanzani, C; Debaix, H; Schaeffer, C; Ikehata, M; Citterio, L; Demaretz, S; Trevisani, F; Ristagno, G; Glaudemans, B; Laghmani, K; Dell'Antonio, G; Loffing, J; Rastaldi, MP; Manunta, P; Devuyst, O; Rampoldi, L				Trudu, Matteo; Janas, Sylvie; Lanzani, Chiara; Debaix, Huguette; Schaeffer, Celine; Ikehata, Masami; Citterio, Lorena; Demaretz, Sylvie; Trevisani, Francesco; Ristagno, Giuseppe; Glaudemans, Bob; Laghmani, Kamel; Dell'Antonio, Giacomo; Loffing, Johannes; Rastaldi, Maria P.; Manunta, Paolo; Devuyst, Olivier; Rampoldi, Luca		Swiss Kidney Project Genes Hyperte	Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression	NATURE MEDICINE			English	Article							TAMM-HORSFALL PROTEIN; BLOOD-PRESSURE; COTRANSPORTER NKCC2; RENAL-FUNCTION; DISEASE; MICE; MOUSE; SPAK; NEPHROPATHY; ASSOCIATION	Hypertension and chronic kidney disease (CKD) are complex traits representing major global health problems(1,2). Multiple genome-wide association studies have identified common variants in the promoter of the UMOD gene(3-9), which encodes uromodulin, the major protein secreted in normal urine, that cause independent susceptibility to CKD and hypertension. Despite compelling genetic evidence for the association between UMOD risk variants and disease susceptibility in the general population, the underlying biological mechanism is not understood. Here, we demonstrate that UMOD risk variants increased UMOD expression in vitro and in vivo. Uromodulin overexpression in transgenic mice led to salt-sensitive hypertension and to the presence of age-dependent renal lesions similar to those observed in elderly individuals homozygous for UMOD promoter risk variants. The link between uromodulin and hypertension is due to activation of the renal sodium cotransporter NKCC2. We demonstrated the relevance of this mechanism in humans by showing that pharmacological inhibition of NKCC2 was more effective in lowering blood pressure in hypertensive patients who are homozygous for UMOD promoter risk variants than in other hypertensive patients. Our findings link genetic susceptibility to hypertension and CKD to the level of uromodulin expression and uromodulin's effect on salt reabsorption in the kidney. These findings point to uromodulin as a therapeutic target for lowering blood pressure and preserving renal function.	[Trudu, Matteo; Schaeffer, Celine; Rampoldi, Luca] Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Janas, Sylvie; Debaix, Huguette; Glaudemans, Bob; Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Janas, Sylvie; Debaix, Huguette; Devuyst, Olivier] Catholic Univ Louvain, Sch Med, Div Nephrol, B-1200 Brussels, Belgium; [Lanzani, Chiara; Citterio, Lorena] Ist Sci San Raffaele, Div Nephrol & Dialysis, I-20132 Milan, Italy; [Ikehata, Masami; Rastaldi, Maria P.] Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda, Renal Res Lab, Milan, Italy; [Ikehata, Masami; Rastaldi, Maria P.] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Demaretz, Sylvie; Laghmani, Kamel] INSERM, UMRS 872, Paris, France; [Trevisani, Francesco; Manunta, Paolo] Univ Vita Salute San Raffaele, Sch Nephrol, Milan, Italy; [Ristagno, Giuseppe] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Dell'Antonio, Giacomo] Ist Sci San Raffaele, Dept Pathol, I-20132 Milan, Italy; [Loffing, Johannes] Univ Zurich, Zurich Ctr Integrat Human Physiol, Inst Anat, Zurich, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Vita-Salute San Raffaele University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Rampoldi, L (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst, I-20132 Milan, Italy.	olivier.devuyst@uzh.ch; rampoldi.luca@hsr.it	Rampoldi, Luca/L-3639-2018; Lanzani, Chiara Livia/AAN-2284-2020; Laghmani, Kamel/AIE-9621-2022; Bochud, Murielle/A-3981-2010; Manunta, Paolo/ABH-5476-2020; Citterio, Lorena/AAC-1589-2019; EHRET, Georg B/A-9532-2009; Loffing, Johannes/ABG-9973-2020; Vogt, Bruno/AAS-2876-2020; Schaeffer, Celine/AAC-5208-2022; Rampoldi, Luca/AAN-6228-2020; IKEHATA, Masami/HHR-9052-2022; Trudu, Matteo/K-2567-2018; Schaeffer, Celine/AAU-5713-2020	Rampoldi, Luca/0000-0002-0544-7042; Lanzani, Chiara Livia/0000-0002-5332-4012; Laghmani, Kamel/0000-0002-2167-5766; Bochud, Murielle/0000-0002-5727-0218; Manunta, Paolo/0000-0003-3976-9696; Citterio, Lorena/0000-0001-6455-2291; EHRET, Georg B/0000-0002-5730-0675; Vogt, Bruno/0000-0002-1548-6387; Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; IKEHATA, Masami/0000-0001-9835-9991; Trudu, Matteo/0000-0002-4340-7738; Schaeffer, Celine/0000-0001-5883-3951; Ristagno, Giuseppe/0000-0002-9235-4820; Ackermann, Daniel/0000-0003-0550-354X; Devuyst, Olivier/0000-0003-3744-4767; Loffing, Johannes/0000-0002-9415-6588; Pruijm, Menno/0000-0003-1027-1851	Telethon-Italy [TCR08006]; Italian Ministry of Health [RF-2010-2319394]; Associazione per il Bambino Nefropatico; Belgian Fonds National de la Recherche Scientifique; Fonds pour la Recherche Scientifique Medicale; Concerted Research Action [10/15-029]; Interuniversity Attraction Pole program; Gebert Ruf Stiftung [GRS-038/12]; National Centre of Competence in Research Kidney; Swiss National Science Foundation [310030_146490, 33CM30-124087/1, 33CM30_140331]; European Community's Seventh Framework Programme [246539, 305608]	Telethon-Italy(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Associazione per il Bambino Nefropatico; Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Concerted Research Action; Interuniversity Attraction Pole program(Belgian Federal Science Policy Office); Gebert Ruf Stiftung; National Centre of Competence in Research Kidney; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Programme(European Commission)	We thank M. Azizi, A. Blanchard, G. Capasso, M. Carrel, Y. Cnops, A. Creatore, S. Delli Carpini, P. Houillier, X. Jeunemaitre, R. Latini, N. Morel, S. Terryn and S. Youhanna for help, technical assistance and fruitful discussions. We are grateful to S. Bourgeois (University of Zurich) for providing MKTAL cells, to D. Alessi (University of Dundee) for antibodies to SPAK and phospho-SPAK/OSRI, to B. Forbush (Yale University) for antibody to phospho-NKCC2 and to D. Schock-Kusch and N. Gretz (University of Heidelberg) for FITC-sinistrin clearance reagents and technical assistance. This work was supported by Telethon-Italy (TCR08006), the Italian Ministry of Health (grant RF-2010-2319394), Associazione per il Bambino Nefropatico, the Belgian Fonds National de la Recherche Scientifique and Fonds pour la Recherche Scientifique Medicale, a Concerted Research Action (10/15-029), an Interuniversity Attraction Pole program initiated by the Belgian Science Policy Office, the Gebert Ruf Stiftung (Project GRS-038/12), the National Centre of Competence in Research Kidney. CH (Swiss National Science Foundation), the Swiss National Science Foundation project grant 310030_146490 and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 246539 (Marie Curie) and grant 305608 (EURenOmics). The SKIPOGH project is funded by the Swiss National Science Foundation (33CM30-124087/1 and 33CM30_140331). L.R. is an Associate Telethon Scientist.	Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Chen G, 2007, AM J PHYSIOL-RENAL, V293, pF1272, DOI 10.1152/ajprenal.00138.2007; Devuyst O, 2008, NAT GENET, V40, P495, DOI 10.1038/ng0508-495; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eddy AA, 2011, NAT MED, V17, P553, DOI 10.1038/nm0511-553; Ferrandi M, 2010, J MOL MED, V88, P203, DOI 10.1007/s00109-009-0549-x; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Han JX, 1998, LAB ANIM SCI, V48, P256; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Mulder W J., 2001, Eur J Intern Med, V12, P86, DOI 10.1016/S0953-6205(01)00121-2; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pattaro C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-41; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Stubbe J, 2006, AM J PHYSIOL-RENAL, V291, pF812, DOI 10.1152/ajprenal.00477.2005; Torffvit O, 2004, NEPHRON PHYSIOL, V97, pp31, DOI [DOI 10.1159/000077600, 10.1159/000077600]; Ying WZ, 1998, KIDNEY INT, V54, P1150, DOI 10.1046/j.1523-1755.1998.00117.x	40	236	240	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1655	1660		10.1038/nm.3384	http://dx.doi.org/10.1038/nm.3384			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24185693	Green Accepted			2022-12-25	WOS:000328181400036
J	Wang, JQ; Liu, RX; Wang, F; Hong, J; Li, XY; Chen, MP; Ke, YY; Zhang, XF; Ma, QY; Wang, R; Shi, J; Cui, B; Gu, WQ; Zhang, YF; Zhang, ZG; Wang, WQ; Xia, XF; Liu, MY; Ning, G				Wang, Jiqiu; Liu, Ruixin; Wang, Feng; Hong, Jie; Li, Xiaoying; Chen, Maopei; Ke, Yingying; Zhang, Xianfeng; Ma, Qinyun; Wang, Rui; Shi, Juan; Cui, Bin; Gu, Weiqiong; Zhang, Yifei; Zhang, Zhiguo; Wang, Weiqing; Xia, Xuefeng; Liu, Mingyao; Ning, Guang			Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch	NATURE CELL BIOLOGY			English	Article							ADIPOSE-TISSUE; RECEPTOR GENE; STEM-CELLS; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; IN-VIVO; EXPRESSION; MICE; IDENTIFICATION; ACTIVATION	Obesity occurs when excess energy accumulates in white adipose tissue (WAT), whereas brown adipose tissue (BAT), specialized for energy expenditure through thermogenesis, potently counteracts obesity. Factors that induce brown adipocyte commitment and energy expenditure would be a promising defence against adiposity. Here, we show that Lgr4 homozygous mutant (Lgr4(m/m)) mice show reduced adiposity and resist dietary and leptin mutant-induced obesity with improved glucose metabolism. Lgr4(m/m) mice show a striking increase in energy expenditure, and exhibit brown-like adipocytes in WAT depots with higher expression of BAT and beige cell markers. Furthermore, Lgr4 ablation potentiates brown adipocyte differentiation from the stromal vascular fraction of epididymal WAT, partially through retinoblastoma 1 gene (Rb1) reduction. A functional low-frequency human LGR4 variant (A750T) has been associated with body mass index in a Chinese obese-versus-control study. Our results identify an important role for LGR4 in energy balance and body weight control through regulating the white-to-brown fat transition.	[Wang, Jiqiu; Liu, Ruixin; Hong, Jie; Li, Xiaoying; Chen, Maopei; Ke, Yingying; Zhang, Xianfeng; Ma, Qinyun; Wang, Rui; Shi, Juan; Cui, Bin; Gu, Weiqiong; Zhang, Yifei; Zhang, Zhiguo; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Key Lab Endocrine Tumors, Shanghai Clin Ctr Endocrine & Metab Dis,Sch Med, Shanghai Inst Endocrine & Metab Dis,Dept Endocrin, Shanghai 200025, Peoples R China; [Wang, Jiqiu; Liu, Ruixin; Hong, Jie; Li, Xiaoying; Chen, Maopei; Ke, Yingying; Zhang, Xianfeng; Ma, Qinyun; Wang, Rui; Shi, Juan; Cui, Bin; Gu, Weiqiong; Zhang, Yifei; Zhang, Zhiguo; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Univ, Ruijin Hosp, Shanghai 200025, Peoples R China; [Wang, Feng; Ning, Guang] Chinese Acad Sci, Lab Endocrinol & Metab, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Wang, Feng; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Xia, Xuefeng] Methodist Hosp, Res Inst, Weill Cornell Med Coll, Houston, TX 77030 USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Endocrine Tumors, Shanghai Clin Ctr Endocrine & Metab Dis,Sch Med, Shanghai Inst Endocrine & Metab Dis,Dept Endocrin, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	gning@sibs.ac.cn	; Wang, Jiqiu/AGM-1346-2022	Zhang, Xianfeng/0000-0003-0944-7151; Liu, Mingyao/0000-0001-7339-5048; Wang, Jiqiu/0000-0002-9383-7656; Li, Xiaoying/0000-0002-9383-5757	National Natural Science Foundation of China [81030011, 30725037, 81100601, 81100634, 30890043]; Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of the Ministry of Science and Technology [2012ZX09303006-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; National Key New Drug Creation and Manufacturing Program of the Ministry of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (nos 81030011, 30725037, 81100601, 81100634 and 30890043), the Sector Funds of Ministry of Health (no. 201002002) and the National Key New Drug Creation and Manufacturing Program of the Ministry of Science and Technology (2012ZX09303006-001). We thank S. Lai (Johns Hopkins School of Medicine) and D. Cai (Albert Einstein College of Medicine) for revision of the manuscript. We thank N. Fan and F. Li for their technical assistance in immunostaining and animal experiments.	Achrekar SK, 2010, J ASSIST REPROD GEN, V27, P317, DOI 10.1007/s10815-010-9404-9; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Enerback S, 2009, NEW ENGL J MED, V360, P2021, DOI 10.1056/NEJMcibr0809610; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gozu HI, 2006, EUR J ENDOCRINOL, V155, P535, DOI 10.1530/eje.1.02253; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kettunen J, 2009, INT J OBESITY, V33, P1235, DOI 10.1038/ijo.2009.168; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Park CJ, 2011, J CLIN INVEST, V121, P604, DOI 10.1172/JCI41702; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YANO K, 1995, J CLIN ENDOCR METAB, V80, P1162, DOI 10.1210/jc.80.4.1162; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang ML, 2007, J BIOL CHEM, V282, P25527, DOI 10.1074/jbc.M703500200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhang ZG, 2008, MOL ENDOCRINOL, V22, P186, DOI 10.1210/me.2007-0119	49	86	90	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1455	+		10.1038/ncb2867	http://dx.doi.org/10.1038/ncb2867			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24212090				2022-12-25	WOS:000327944200010
J	Weaver, JMJ; Ross-Innes, CS; Shannon, N; Lynch, AG; Forshew, T; Barbera, M; Murtaza, M; Ong, CAJ; Lao-Sirieix, P; Dunning, MJ; Smith, L; Smith, ML; Anderson, CL; Carvalho, B; O'Donovan, M; Underwood, TJ; May, AP; Grehan, N; Hardwick, R; Davies, J; Oloumi, A; Aparicio, S; Caldas, C; Eldridge, MD; Edwards, PAW; Rosenfeld, N; Tavare, S; Fitzgerald, RC				Weaver, Jamie M. J.; Ross-Innes, Caryn S.; Shannon, Nicholas; Lynch, Andy G.; Forshew, Tim; Barbera, Mariagnese; Murtaza, Muhammed; Ong, Chin-Ann J.; Lao-Sirieix, Pierre; Dunning, Mark J.; Smith, Laura; Smith, Mike L.; Anderson, Charlotte L.; Carvalho, Benilton; O'Donovan, Maria; Underwood, Timothy J.; May, Andrew P.; Grehan, Nicola; Hardwick, Richard; Davies, Jim; Oloumi, Arusha; Aparicio, Sam; Caldas, Carlos; Eldridge, Matthew D.; Edwards, Paul A. W.; Rosenfeld, Nitzan; Tavare, Simon; Fitzgerald, Rebecca C.		OCCAMS Consortium	Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis	NATURE GENETICS			English	Article							21 BREAST CANCERS; BARRETTS-ESOPHAGUS; CLONAL EVOLUTION; CELL CARCINOMA; ADENOCARCINOMA; ARID1A; IDENTIFICATION; SURVEILLANCE; PROGRESSION; PATTERNS	Cancer genome sequencing studies have identified numerous driver genes, but the relative timing of mutations in carcinogenesis remains unclear. The gradual progression from premalignant Barrett's esophagus to esophageal adenocarcinoma (EAC) provides an ideal model to study the ordering of somatic mutations. We identified recurrently mutated genes and assessed clonal structure using whole-genome sequencing and amplicon resequencing of 112 EACs. We next screened a cohort of 109 biopsies from 2 key transition points in the development of malignancy: benign metaplastic never-dysplastic Barrett's esophagus (NDBE; n = 66) and high-grade dysplasia (HGD; n = 43). Unexpectedly, the majority of recurrently mutated genes in EAC were also mutated in NDBE. Only TP53 and SMAD4 mutations occurred in a stage-specific manner, confined to HGD and EAC, respectively. Finally, we applied this knowledge to identify high-risk Barrett's esophagus in a new non-endoscopic test. In conclusion, mutations in EAC driver genes generally occur exceptionally early in disease development with profound implications for diagnostic and therapeutic strategies.	[Weaver, Jamie M. J.; Ross-Innes, Caryn S.; Barbera, Mariagnese; Ong, Chin-Ann J.; Lao-Sirieix, Pierre; Smith, Laura; Grehan, Nicola; Fitzgerald, Rebecca C.] Univ Cambridge, MRC, Canc Unit, Cambridge, England; [Shannon, Nicholas; Lynch, Andy G.; Forshew, Tim; Murtaza, Muhammed; Dunning, Mark J.; Smith, Mike L.; Anderson, Charlotte L.; Carvalho, Benilton; Caldas, Carlos; Eldridge, Matthew D.; Rosenfeld, Nitzan; Tavare, Simon] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [O'Donovan, Maria] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; [Underwood, Timothy J.] Univ Southampton, Canc Sci Div, Southampton, Hants, England; [May, Andrew P.] Fluidigm Corp, San Francisco, CA USA; [Hardwick, Richard] Addenbrookes Hosp, Oesophago Gastr Unit, Cambridge, England; [Davies, Jim] Univ Oxford, Oxford Comp Lab, Oxford, England; [Oloumi, Arusha; Aparicio, Sam] British Columbia Canc Res Ctr, Canc Agcy Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Southampton; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; British Columbia Cancer Agency; University of Cambridge	Fitzgerald, RC (corresponding author), Univ Cambridge, MRC, Canc Unit, Cambridge, England.	rcf29@mrc-cu.cam.ac.uk	Caldas, Carlos/U-7250-2019; Carvalho, Benilton/L-9329-2019; Hardwick, Richard Henry/H-8859-2019; Ong, Chin-Ann Johnny/AAW-6905-2021; Carvalho, Benilton/G-1868-2012; Edwards, Paul A/M-8291-2014; Lovat, Laurence/C-1986-2009; Bornschein, Jan/U-9402-2018	Caldas, Carlos/0000-0003-3547-1489; Carvalho, Benilton/0000-0001-5122-5646; Ong, Chin-Ann Johnny/0000-0003-4573-7738; Carvalho, Benilton/0000-0001-5122-5646; Edwards, Paul A/0000-0002-4789-3374; Lovat, Laurence/0000-0003-4542-3915; Bornschein, Jan/0000-0001-8673-3122; Chang, Fuju/0000-0003-0973-6949; Smith, Mike/0000-0002-7800-3848; Ragunath, Krish/0000-0001-6571-5435; Abdullahi, Zarah/0000-0002-7077-2781; Aparicio, Samuel/0000-0002-0487-9599; Murtaza, Muhammed/0000-0001-7557-2861; Zylstra, Janine/0000-0002-9839-7629; Underwood, Tim/0000-0001-9455-2188; Crichton, Charles/0000-0002-9171-1427; Zeki, Sebastian/0000-0003-1673-2663; Eldridge, Matthew/0000-0002-5799-8911; Lynch, Andy/0000-0002-7876-7338; Almond, Max/0000-0003-4133-312X; Fitzgerald, Rebecca/0000-0002-3434-3568; Secrier, Maria/0000-0003-2758-1741; Lydon, Anne/0000-0003-3132-4801; Dunning, Mark/0000-0002-8853-9435; Shannon, Nicholas Brian/0000-0001-8742-8285; Forshew, Tim/0000-0003-2093-7020; Davies, Jim/0000-0003-4664-6862; Old, Oliver/0000-0002-1547-0502; Hindmarsh, Andrew/0000-0002-3209-6591	Cancer Research UK; BEST2 trial; program grant; Wellcome Trust Translational Medicine and Therapeutics grant; NHS National Institute for Health Research (NIHR); Experimental Cancer Medicine Centre Network; NIHR Cambridge Biomedical Research Centre; Cancer Research UK program grant; IT department at the Cancer Research UK Cambridge Institute; NIHR Cambridge Biomedical Research Centre, from Addenbrooke's Hospital; University Hospital of Southampton Trust; Southampton Experimental Cancer Medicine Centre; MRC [MC_UU_12022/2, MC_U105365007] Funding Source: UKRI; Cancer Research UK [20240, 19556, 16942, 11906, 15874, 12088, 22310, 14545] Funding Source: researchfish; Medical Research Council [G1002565, MC_U105365007, 1390282, MC_UU_12022/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10065, 05/12/01, NF-SI-0611-10154, NIHR-RP-02-12-011] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); BEST2 trial; program grant; Wellcome Trust Translational Medicine and Therapeutics grant; NHS National Institute for Health Research (NIHR); Experimental Cancer Medicine Centre Network; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK program grant(Cancer Research UK); IT department at the Cancer Research UK Cambridge Institute; NIHR Cambridge Biomedical Research Centre, from Addenbrooke's Hospital; University Hospital of Southampton Trust; Southampton Experimental Cancer Medicine Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Whole-genome sequencing of EAC is part of the International Cancer Genome Consortium (ICGC) through the Esophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium and is funded by Cancer Research UK. We thank the ICGC members for their input on verification standards as part of the benchmarking exercise. Cytosponge samples were collected as part of the Cancer Research UK funded BEST2 trial. We thank M. Griffin, L. Lovat and K. Ragunath for their contribution to Cytosponge collection. The MRC developed the Cytosponge and also funded laboratory work through a program grant to R.C.F. J.M.J.W. was funded by a Wellcome Trust Translational Medicine and Therapeutics grant. R.C.F. and C.C. are supported by additional clinical research infrastructure funding from the NHS National Institute for Health Research (NIHR), the Experimental Cancer Medicine Centre Network and the NIHR Cambridge Biomedical Research Centre. Bioinformatics work was also supported by a Cancer Research UK program grant to S.T.; We thank the Genomics Core at the Cancer Research UK Cambridge Institute for their help with processing some of the Access Array experiments as well as for running the targeted resequencing experiments. We thank the IT department at the Cancer Research UK Cambridge Institute for their support. We thank F. Marass for assistance with data analysis. We thank the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre, from Addenbrooke's Hospital as well as the University Hospital of Southampton Trust and the Southampton Experimental Cancer Medicine Centre. We are grateful to all patients who provided written consent for participation in this study, and the staff at Addenbrooke's and the University of Southampton Tissue Bank.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Corley DA, 2013, GASTROENTEROLOGY, V145, P312, DOI 10.1053/j.gastro.2013.05.004; Curvers WL, 2010, AM J GASTROENTEROL, V105, P1523, DOI 10.1038/ajg.2010.171; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hayes DF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005950; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadri SR, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4372; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Lao-Sirieix P, 2009, GUT, V58, P1451, DOI 10.1136/gut.2009.180281; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mutter GL, 2001, CANCER RES, V61, P4311; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Shaheen NJ, 2013, GASTROENTEROLOGY, V145, P273, DOI 10.1053/j.gastro.2013.06.028; Streppel MM, 2014, ONCOGENE, V33, P347, DOI 10.1038/onc.2012.586; Theisen J, 2002, SURG ENDOSC, V16, P671, DOI 10.1007/s00464-001-8307-3; Varghese S, 2012, GASTROENTEROLOGY, V142, P435, DOI 10.1053/j.gastro.2012.01.013; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982	33	228	235	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					837	843		10.1038/ng.3013	http://dx.doi.org/10.1038/ng.3013			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24952744	Green Accepted, Green Submitted			2022-12-25	WOS:000339704400011
J	Li, FG; Fan, GY; Wang, KB; Sun, FM; Yuan, YL; Song, GL; Li, Q; Ma, ZY; Lu, CR; Zou, CS; Chen, WB; Liang, XM; Shang, HH; Liu, WQ; Shi, CC; Xiao, GH; Gou, CY; Ye, WW; Xu, X; Zhang, XY; Wei, HL; Li, ZF; Zhang, GY; Wang, JY; Liu, K; Kohel, RJ; Percy, RG; Yu, JZ; Zhu, YX; Wang, J; Yu, SX				Li, Fuguang; Fan, Guangyi; Wang, Kunbo; Sun, Fengming; Yuan, Youlu; Song, Guoli; Li, Qin; Ma, Zhiying; Lu, Cairui; Zou, Changsong; Chen, Wenbin; Liang, Xinming; Shang, Haihong; Liu, Weiqing; Shi, Chengcheng; Xiao, Guanghui; Gou, Caiyun; Ye, Wuwei; Xu, Xun; Zhang, Xueyan; Wei, Hengling; Li, Zhifang; Zhang, Guiyin; Wang, Junyi; Liu, Kun; Kohel, Russell J.; Percy, Richard G.; Yu, John Z.; Zhu, Yu-Xian; Wang, Jun; Yu, Shuxun			Genome sequence of the cultivated cotton Gossypium arboreum	NATURE GENETICS			English	Article							CELL ELONGATION; DRAFT GENOME; EVOLUTION; ARABIDOPSIS; FIBER; BIOSYNTHESIS; DYNAMICS; ETHYLENE; SORGHUM; GENUS	The complex allotetraploid nature of the cotton genome (AADD; 2n = 52) makes genetic, genomic and functional analyses extremely challenging. Here we sequenced and assembled the Gossypium arboreum (AA; 2n = 26) genome, a putative contributor of the A subgenome. A total of 193.6 Gb of clean sequence covering the genome by 112.6-fold was obtained by paired-end sequencing. We further anchored and oriented 90.4% of the assembly on 13 pseudochromosomes and found that 68.5% of the genome is occupied by repetitive DNA sequences. We predicted 41,330 protein-coding genes in G. arboreum. Two whole-genome duplications were shared by G. arboreum and Gossypium raimondii before speciation. Insertions of long terminal repeats in the past 5 million years are responsible for the twofold difference in the sizes of these genomes. Comparative transcriptome studies showed the key role of the nucleotide binding site (NBS)-encoding gene family in resistance to Verticillium dahliae and the involvement of ethylene in the development of cotton fiber cells.	[Li, Fuguang; Wang, Kunbo; Yuan, Youlu; Song, Guoli; Lu, Cairui; Zou, Changsong; Shang, Haihong; Ye, Wuwei; Zhang, Xueyan; Wei, Hengling; Li, Zhifang; Liu, Kun; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Fan, Guangyi; Sun, Fengming; Chen, Wenbin; Liang, Xinming; Liu, Weiqing; Shi, Chengcheng; Gou, Caiyun; Xu, Xun; Wang, Junyi; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Qin; Xiao, Guanghui; Zhu, Yu-Xian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Ma, Zhiying; Zhang, Guiyin] Agr Univ Hebei, Key Lab Crop Germplasm Resources Hebei, Baoding, Peoples R China; [Kohel, Russell J.; Percy, Richard G.; Yu, John Z.] USDA ARS, Crop Germplasm Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Beijing Genomics Institute (BGI); Peking University; Hebei Agricultural University; United States Department of Agriculture (USDA); University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong	Zhu, YX (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	zhuyx2@pku.edu.cn; wangi@genomics.org.cn; yu@cricaas.com.cn	Ho, Igor Osorio/AAG-8616-2020; Xu, Xun/AAI-6763-2020; wang, junyi/GYA-3213-2022; Li, Qin/AAP-9448-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Xu, Xun/0000-0002-5338-5173; Li, Qin/0000-0002-8948-2717; yu, shuxun/0000-0002-9715-3462; Wang, Jun/0000-0002-8540-8931; SHI, Chengcheng/0000-0003-2154-5491; Wang, Jun/0000-0002-2113-5874; Zhu, Yuxian/0000-0003-2371-5933	National Science Foundation [31125020]; National Natural Science Foundation of China [90717009]; 863 National High-Tech Research Development Program in China [2013AA102601]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 National High-Tech Research Development Program in China(National High Technology Research and Development Program of China)	We thank the National Mid-term Gene Bank for Cotton at the Institute of Cotton Research, Chinese Academy of Agricultural Sciences for providing the original SXY1 seeds. This work was supported by the National Science Foundation for Distinguished Young Scholars (grant 31125020), the National Natural Science Foundation of China (grant 90717009) and the 863 National High-Tech Research Development Program in China (grant 2013AA102601).	Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Khadi BM, 2010, BIOTECH AGR FOREST, V65, P15, DOI 10.1007/978-3-642-04796-1_2; Krapovickas A., 2008, BONPLANDIA, V17, P55, DOI [10.30972/bon.1711361, DOI 10.30972/BON.1711361]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pegg GF, 2002, VERTICILLIUM WILTS, V552; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang H, 2008, LECT NOTES ENG COMP, P1, DOI 10.1155/2008/742304; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	37	605	691	6	223	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					567	572		10.1038/ng.2987	http://dx.doi.org/10.1038/ng.2987			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24836287	hybrid, Green Published			2022-12-25	WOS:000336870700012
J	Takeuchi, J; Okamoto, M; Akiyama, T; Muto, T; Yajima, S; Sue, M; Seo, M; Kanno, Y; Kamo, T; Endo, A; Nambara, E; Hirai, N; Ohnishi, T; Cutler, SR; Todoroki, Y				Takeuchi, Jun; Okamoto, Masanori; Akiyama, Tomonori; Muto, Takuya; Yajima, Shunsuke; Sue, Masayuki; Seo, Mitsunori; Kanno, Yuri; Kamo, Tsunashi; Endo, Akira; Nambara, Eiji; Hirai, Nobuhiro; Ohnishi, Toshiyuki; Cutler, Sean R.; Todoroki, Yasushi			Designed abscisic acid analogs as antagonists of PYL-PP2C receptor interactions	NATURE CHEMICAL BIOLOGY			English	Article							2C PROTEIN PHOSPHATASES; ANION CHANNEL; GUARD-CELL; SMALL MOLECULES; SNRK2 KINASES; PYL PROTEINS; KEY ENZYME; MECHANISM; ARABIDOPSIS; ACTIVATION	The plant stress hormone abscisic acid (ABA) is critical for several abiotic stress responses. ABA signaling is normally repressed by group-A protein phosphatases 2C (PP2Cs), but stress-induced ABA binds Arabidopsis PYR/PYL/RCAR (PYL) receptors, which then bind and inhibit PP2Cs. X-ray structures of several receptor-ABA complexes revealed a tunnel above ABA's 3' ring CH that opens at the PP2C binding interface. Here, ABA analogs with sufficiently long 3' alkyl chains were predicted to traverse this tunnel and block PYL-PP2C interactions. To test this, a series of 3'-alkylsulfanyl ABAs were synthesized with different alkyl chain lengths. Physiological, biochemical and structural analyses revealed that a six-carbon alkyl substitution produced a potent ABA antagonist that was sufficiently active to block multiple stress-induced ABA responses in vivo. This study provides a new approach for the design of ABA analogs, and the results validated structure-based design for this target class.	[Takeuchi, Jun; Todoroki, Yasushi] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan; [Okamoto, Masanori] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan; [Okamoto, Masanori] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Okamoto, Masanori] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Akiyama, Tomonori; Yajima, Shunsuke] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Muto, Takuya; Ohnishi, Toshiyuki; Cutler, Sean R.] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Sue, Masayuki] Tokyo Univ Agr, Dept Appl Biol & Chem, Tokyo, Japan; [Sue, Masayuki; Seo, Mitsunori] RIKEN, Ctr Sustainable Resource Sci, Kanagawa, Japan; [Kamo, Tsunashi] Natl Inst Agroenvironm Sci, Ibaraki, Japan; [Endo, Akira; Nambara, Eiji] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Hirai, Nobuhiro] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Ohnishi, Toshiyuki; Todoroki, Yasushi] Shizuoka Univ, Res Inst Green Sci & Technol, Shizuoka, Japan	Shizuoka University; Tottori University; University of California System; University of California Riverside; University of California System; University of California Riverside; Tokyo University of Agriculture; Shizuoka University; Tokyo University of Agriculture; RIKEN; National Institute for Agro-Environmental Sciences (NIAES) Japan; University of Toronto; Kyoto University; Shizuoka University	Todoroki, Y (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.	aytodor@ipc.shizuoka.ac.jp	Seo, Mitsunori/N-9603-2015; Nambara, Eiji/E-5533-2012; Okamoto, Masanori/O-7096-2019; Endo, Akira/O-5537-2014; Okamoto, Masanori/G-9503-2013; kanno, yuri/C-9211-2017	Okamoto, Masanori/0000-0002-1743-0408; Endo, Akira/0000-0003-0132-2960; Okamoto, Masanori/0000-0002-1743-0408; Seo, Mitsunori/0000-0001-8325-7984; Sue, Masayuki/0000-0002-7838-2534	Japanese Society for the Promotion of Science (JSPS) [26711018]; US National Science Foundation [0820508]; Grants-in-Aid for Scientific Research [26711018] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Nakagawa for providing pGWB vectors and Toray Industries Inc., Tokyo, Japan, for the gift of (+)-ABA. This work was supported in part by the Japanese Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (to MO.), JSPS KAKENHI (Grant-in-Aid for Young Scientists 26711018 to MO.) and the US National Science Foundation (Integrative Organismal Systems 0820508 to S.R.C.).	Antoni R, 2013, PLANT PHYSIOL, V161, P931, DOI 10.1104/pp.112.208678; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Hao Q, 2010, J BIOL CHEM, V285, P28946, DOI 10.1074/jbc.M110.149005; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kumari S, 2011, CURR OPIN PLANT BIOL, V14, P480, DOI 10.1016/j.pbi.2011.06.003; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kushiro T., EMBO J, V23, P1647; Lumba S, 2010, ANNU REV CELL DEV BI, V26, P445, DOI 10.1146/annurev-cellbio-100109-103956; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1995, ANNU REV PLANT PHYS, V46, P71, DOI 10.1146/annurev.pp.46.060195.000443; Melcher K, 2010, CURR OPIN STRUC BIOL, V20, P722, DOI 10.1016/j.sbi.2010.09.007; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Muto T, 2013, BIOORGAN MED CHEM, V21, P4413, DOI 10.1016/j.bmc.2013.04.048; Ng LM, 2011, P NATL ACAD SCI USA, V108, P21259, DOI 10.1073/pnas.1118651109; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pizzio GA, 2013, PLANT PHYSIOL, V163, P441, DOI 10.1104/pp.113.224162; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Todoroki Y, 2010, CURR MED CHEM, V17, P3230, DOI 10.2174/092986710792231987; Todoroki Y., 2002, STUDIES NATURAL PROD, V27, P321; Ueno K, 2005, BIOORGAN MED CHEM, V13, P3359, DOI 10.1016/j.bmc.2005.03.015; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yoon JM, 2013, BIOORG MED CHEM LETT, V23, P1096, DOI 10.1016/j.bmcl.2012.12.007; Zhang X., STRUCTURE, V20, P780	46	81	84	2	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					477	482		10.1038/NCHEMBIO.1524	http://dx.doi.org/10.1038/NCHEMBIO.1524			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24792952	Green Published			2022-12-25	WOS:000336238200016
J	Kleppe, M; Levine, RL				Kleppe, Maria; Levine, Ross L.			Tumor heterogeneity confounds and illuminates	NATURE MEDICINE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MULTIPLE-MYELOMA; EVOLUTION; MUTATIONS; RELAPSE; CANCER		[Kleppe, Maria; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Kleppe, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	leviner@mskcc.org	levine, ross/AAE-7658-2019					Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Magrangeas F, 2013, LEUKEMIA, V27, P473, DOI 10.1038/leu.2012.226; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968	14	87	90	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					342	344		10.1038/nm.3522	http://dx.doi.org/10.1038/nm.3522			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710377				2022-12-25	WOS:000334361500013
J	Trapnell, C; Cacchiarelli, D; Grimsby, J; Pokharel, P; Li, SQ; Morse, M; Lennon, NJ; Livak, KJ; Mikkelsen, TS; Rinn, JL				Trapnell, Cole; Cacchiarelli, Davide; Grimsby, Jonna; Pokharel, Prapti; Li, Shuqiang; Morse, Michael; Lennon, Niall J.; Livak, Kenneth J.; Mikkelsen, Tarjei S.; Rinn, John L.			The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells	NATURE BIOTECHNOLOGY			English	Article							TRAVELING SALESMAN PROBLEM; RNA-SEQ; CURVE RECONSTRUCTION; EXPRESSION ANALYSIS; GENE; TRANSCRIPTION; ALGORITHMS; CYTOMETRY; ALIGNMENT; MODELS	Defining the transcriptional dynamics of a temporal process such as cell differentiation is challenging owing to the high variability in gene expression between individual cells. Time-series gene expression analyses of bulk cells have difficulty distinguishing early and late phases of a transcriptional cascade or identifying rare subpopulations of cells, and single-cell proteomic methods rely on a priori knowledge of key distinguishing markers(1). Here we describe Monocle, an unsupervised algorithm that increases the temporal resolution of transcriptome dynamics using single-cell RNA-Seq data collected at multiple time points. Applied to the differentiation of primary human myoblasts, Monocle revealed switch-like changes in expression of key regulatory factors, sequential waves of gene regulation, and expression of regulators that were not known to act in differentiation. We validated some of these predicted regulators in a loss-of function screen. Monocle can in principle be used to recover single-cell gene expression kinetics from a wide array of cellular processes, including differentiation, proliferation and oncogenic transformation.	[Trapnell, Cole; Cacchiarelli, Davide; Morse, Michael; Mikkelsen, Tarjei S.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Trapnell, Cole; Cacchiarelli, Davide; Grimsby, Jonna; Pokharel, Prapti; Morse, Michael; Lennon, Niall J.; Mikkelsen, Tarjei S.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Cacchiarelli, Davide; Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Shuqiang; Livak, Kenneth J.] Fluidigm Corp, San Francisco, CA USA; [Rinn, John L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Rinn, JL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	john_rinn@harvard.edu	Cacchiarelli, Davide/AAC-2693-2022; Mikkelsen, Tarjei S/A-1306-2007	Cacchiarelli, Davide/0000-0002-9621-6716; Mikkelsen, Tarjei S/0000-0002-8133-3135; Rinn, John/0000-0002-7231-7539	Damon Runyon Cancer Research Foundation Fellowship; Human Frontier Science Program Fellowship; Harvard Stem Cell Institute; US National Institutes of Health [1DP2OD00667, P01GM099117, P50HG006193-01]; Single Cell Genomics initiative; Broad Institute and Fluidigm Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation Fellowship; Human Frontier Science Program Fellowship(Human Frontier Science Program); Harvard Stem Cell Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Single Cell Genomics initiative; Broad Institute and Fluidigm Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to S. Bordbar, C. Zhu, A. Wagers and the Broad RNAi platform for technical assistance and to M. Soumillon for discussions. C.T. was supported by a Damon Runyon Cancer Research Foundation Fellowship. D.C. was supported by a Human Frontier Science Program Fellowship. D.C. and T.S.M. were supported by the Harvard Stem Cell Institute. This work was supported by US National Institutes of Health grants 1DP2OD00667, P01GM099117 and P50HG006193-01. This work was also supported in part by the Single Cell Genomics initiative, a collaboration between the Broad Institute and Fluidigm Inc.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BOOTH KS, 1976, J COMPUT SYST SCI, V13, P335, DOI 10.1016/S0022-0000(76)80045-1; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; DEFIGUEIREDO LH, 1994, VISUAL COMPUT, V11, P105, DOI 10.1007/BF01889981; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Giesen J, 2000, DISCRETE COMPUT GEOM, V24, P577, DOI 10.1007/s004540010061; Giesen J, 1999, LECT NOTES COMPUT SC, V1568, P164; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gupta A, 2008, IEEE ACM T COMPUT BI, V5, P172, DOI 10.1109/TCBB.2007.70233; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hastie T.J., 2017, STAT SCI; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lun Y, 1997, CELL GROWTH DIFFER, V8, P275; Magwene PM, 2003, BIOINFORMATICS, V19, P842, DOI 10.1093/bioinformatics/btg081; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	42	2299	2325	23	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					381	U251		10.1038/nbt.2859	http://dx.doi.org/10.1038/nbt.2859			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24658644	Green Accepted			2022-12-25	WOS:000334340800023
J	Liu, JZ; Yue, YN; Han, DL; Wang, X; Fu, Y; Zhang, L; Jia, GF; Yu, M; Lu, ZK; Deng, X; Dai, Q; Chen, WZ; He, C				Liu, Jianzhao; Yue, Yanan; Han, Dali; Wang, Xiao; Fu, Ye; Zhang, Liang; Jia, Guifang; Yu, Miao; Lu, Zhike; Deng, Xin; Dai, Qing; Chen, Weizhong; He, Chuan			A METTL3-METTL14 complex mediates mammalian nuclear RNA N-6-adenosine methylation	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA; N6-METHYLADENOSINE; PURIFICATION; SUBUNIT; PROTEIN; IME4	N-6-methyladenosine (m(6)A) is the most prevalent and reversible internal modification in mammalian messenger and noncoding RNAs. We report here that human methyltransferase-like 14 (METTL14) catalyzes m(6)A RNA methylation. Together with METTL3, the only previously known m(6)A methyltransferase, these two proteins form a stable heterodimer core complex of METTL3-METTL14 that functions in cellular m(6)A deposition on mammalian nuclear RNAs. WTAP, a mammalian splicing factor, can interact with this complex and affect this methylation.	[Liu, Jianzhao; Yue, Yanan; Han, Dali; Wang, Xiao; Fu, Ye; Zhang, Liang; Jia, Guifang; Yu, Miao; Lu, Zhike; Deng, Xin; Dai, Qing; Chen, Weizhong; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Liu, Jianzhao; Yue, Yanan; Han, Dali; Wang, Xiao; Fu, Ye; Zhang, Liang; Jia, Guifang; Yu, Miao; Lu, Zhike; Deng, Xin; Dai, Qing; Chen, Weizhong; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Liu, Jianzhao/AAO-2359-2020; Han, Dali/I-4145-2016; Zhang, Liang/F-8064-2013; Liu, Jianzhao/E-9165-2011; Dai, Qing/ABD-8444-2021	Liu, Jianzhao/0000-0001-9465-6075; Zhang, Liang/0000-0002-7672-1168; Liu, Jianzhao/0000-0001-9465-6075; Wang, Xiao/0000-0002-3090-9894; Fu, Ye/0000-0003-4434-6014; Fu, Ye/0000-0002-3807-9717	US National Institutes of Health [GM071440, GM088599]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088599, R01GM071440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (GM071440 and GM088599). We thank P. Faber and L. Dore for helping with high-throughput sequencing experiments and S.F. Reichard for editing the manuscript.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	19	1581	1679	38	394	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					93	95		10.1038/nchembio.1432	http://dx.doi.org/10.1038/nchembio.1432			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316715	Green Accepted			2022-12-25	WOS:000330751600005
J	Papaemmanuil, E; Rapado, I; Li, YL; Potter, NE; Wedge, DC; Tubio, J; Alexandrov, LB; Van Loo, P; Cooke, SL; Marshall, J; Martincorena, I; Hinton, J; Gundem, G; van Delft, FW; Nik-Zainal, S; Jones, DR; Ramakrishna, M; Titley, I; Stebbings, L; Leroy, C; Menzies, A; Gamble, J; Robinson, B; Mudie, L; Raine, K; O'Meara, S; Teague, JW; Butler, AP; Cazzaniga, G; Biondi, A; Zuna, J; Kempski, H; Muschen, M; Ford, AM; Stratton, MR; Greaves, M; Campbell, PJ				Papaemmanuil, Elli; Rapado, Inmaculada; Li, Yilong; Potter, Nicola E.; Wedge, David C.; Tubio, Jose; Alexandrov, Ludmil B.; Van Loo, Peter; Cooke, Susanna L.; Marshall, John; Martincorena, Inigo; Hinton, Jonathan; Gundem, Gunes; van Delft, Frederik W.; Nik-Zainal, Serena; Jones, David R.; Ramakrishna, Manasa; Titley, Ian; Stebbings, Lucy; Leroy, Catherine; Menzies, Andrew; Gamble, John; Robinson, Ben; Mudie, Laura; Raine, Keiran; O'Meara, Sarah; Teague, Jon W.; Butler, Adam P.; Cazzaniga, Giovanni; Biondi, Andrea; Zuna, Jan; Kempski, Helena; Muschen, Markus; Ford, Anthony M.; Stratton, Michael R.; Greaves, Mel; Campbell, Peter J.			RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia	NATURE GENETICS			English	Article							CHROMOSOME TRANSLOCATIONS; MUTATIONAL PROCESSES; V(D)J RECOMBINATION; GENETIC ALTERATIONS; CLONAL ORIGINS; DNA; COMPLEX; SIGNATURES; DELETIONS; CHILDREN	The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia ( ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, similar to 30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.	[Papaemmanuil, Elli; Li, Yilong; Wedge, David C.; Tubio, Jose; Alexandrov, Ludmil B.; Van Loo, Peter; Cooke, Susanna L.; Marshall, John; Martincorena, Inigo; Hinton, Jonathan; Gundem, Gunes; Nik-Zainal, Serena; Jones, David R.; Ramakrishna, Manasa; Stebbings, Lucy; Leroy, Catherine; Menzies, Andrew; Gamble, John; Robinson, Ben; Mudie, Laura; Raine, Keiran; O'Meara, Sarah; Teague, Jon W.; Butler, Adam P.; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Rapado, Inmaculada] Hosp Univ 12 Octubre, Madrid, Spain; [Potter, Nicola E.; van Delft, Frederik W.; Titley, Ian; Ford, Anthony M.; Greaves, Mel] Inst Canc Res, London SW3 6JB, England; [Van Loo, Peter] VIB, Dept Human Genet, Louvain, Belgium; [Van Loo, Peter] Univ Leuven, Louvain, Belgium; [van Delft, Frederik W.] Univ Newcastle, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Cazzaniga, Giovanni; Biondi, Andrea] Hosp San Gerardo, Ctr Ric Tettamanti, Monza, Italy; [Zuna, Jan] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Zuna, Jan] Univ Hosp Motol, Prague, Czech Republic; [Kempski, Helena] Great Ormond St Hosp Sick Children, Camelia Botnar Labs, Mol Haematol & Canc Biol Unit, Paediat Malignancy Unit, London WC1N 3JH, England; [Kempski, Helena] UCL, Inst Child Hlth, London, England; [Muschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Campbell, Peter J.] Addenbrookes Natl Hlth Serv NHS Fdn Trust, Cambridge, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; Hospital Universitario 12 de Octubre; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Flanders Institute for Biotechnology (VIB); KU Leuven; Newcastle University - UK; Charles University Prague; Motol University Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of California System; University of California San Francisco; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.	mel.greaves@icr.ac.uk; pc8@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Tubio, Jose M.C./H-5076-2015; Nik-Zainal, Serena/ABD-4437-2020; Tubio, Jose/AAG-7345-2019; Wedge, David/AAC-4977-2021; Zuna, Jan/ABA-4620-2021; Biondi, Andrea/AAX-1865-2020; Biondi, Andrea/K-9997-2016; Cazzaniga, Giovanni/K-6338-2016	Alexandrov, Ludmil/0000-0003-3596-4515; Tubio, Jose M.C./0000-0003-3540-2459; Tubio, Jose/0000-0003-3540-2459; Biondi, Andrea/0000-0002-6757-6173; Van Loo, Peter/0000-0003-0292-1949; Greaves, Melvyn/0000-0002-7239-1384; Zuna, Jan/0000-0002-0887-3709; Raine, Keiran/0000-0002-5634-1539; van Delft, Frederik Willem/0000-0002-3704-3720; Martincorena, Inigo/0000-0003-1122-4416; Cazzaniga, Giovanni/0000-0003-2955-4528; Wedge, David/0000-0002-7572-3196	Kay Kendall Leukaemia Fund (KKLF) [KKL407]; Leukemia and Lymphoma Research [11021]; Wellcome Trust [077012/Z/05/Z, WT100183MA]; Wellcome Trust Senior Clinical Research Fellowship [WT088340MA]; Research Foundation-Flanders (FWO); KKLF [KKL417]; University Hospital Motol [MH-CR DRO 00064203]; NATIONAL CANCER INSTITUTE [R01CA139032, R01CA169458, R01CA172558, R01CA157644, R01CA137060] Funding Source: NIH RePORTER; Cancer Research UK [18131] Funding Source: researchfish	Kay Kendall Leukaemia Fund (KKLF); Leukemia and Lymphoma Research; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); Research Foundation-Flanders (FWO)(FWO); KKLF; University Hospital Motol; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported by the Kay Kendall Leukaemia Fund (KKLF; grant reference KKL407), Leukemia and Lymphoma Research (grant reference 11021) and the Wellcome Trust (grant reference 077012/Z/05/Z). P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). P.V.L. is supported by a postdoctoral research fellowship from Research Foundation-Flanders (FWO). S.N.-Z. is a Wellcome Trust Intermediate Clinical Fellow (grant reference WT100183MA).F.W.v.D. is funded by KKLF (grant reference KKL417).J.Z. is supported by University Hospital Motol (grant MH-CR DRO 00064203).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bhojwani D, 2012, LEUKEMIA, V26, P265, DOI 10.1038/leu.2011.227; Boubakour-Azzouz I, 2012, NUCLEIC ACIDS RES, V40, P8381, DOI 10.1093/nar/gks585; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen S, 2011, LEUKEMIA, V25, P1632, DOI 10.1038/leu.2011.119; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Familiades J, 2009, LEUKEMIA, V23, P1989, DOI 10.1038/leu.2009.135; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hubner S, 2004, LEUKEMIA, V18, P84, DOI 10.1038/sj.leu.2403182; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Kempski H, 1999, BRIT J HAEMATOL, V105, P684, DOI 10.1046/j.1365-2141.1999.01425.x; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Neuberger MS, 2007, J EXP MED, V204, P7, DOI 10.1084/jem.20062409; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raschke S, 2005, GENE CHROMOSOME CANC, V42, P58, DOI 10.1002/gcc.20119; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tsai AG, 2008, BLOOD, V111, P1750, DOI 10.1182/blood-2007-09-113381; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Tsuzuki S, 2004, P NATL ACAD SCI USA, V101, P8443, DOI 10.1073/pnas.0402063101; van Delft FW, 2011, BLOOD, V117, P6247, DOI 10.1182/blood-2010-10-314674; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang M, 2008, J BIOL CHEM, V283, P6717, DOI 10.1074/jbc.M710301200	56	228	233	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					116	+		10.1038/ng.2874	http://dx.doi.org/10.1038/ng.2874			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413735	Green Accepted			2022-12-25	WOS:000331208300007
J	Peyvandi, F; Rosendaal, FR; O'Mahony, B; Mannucci, PM				Peyvandi, Flora; Rosendaal, Frits R.; O'Mahony, Brian; Mannucci, Pier Mannuccio			Pediatric requirements in Europe stymie help for hemophilia	NATURE MEDICINE			English	Editorial Material							FC FUSION PROTEIN; PHASE-3	The European Medicines Agency requires that drug developers submit a 'pediatric investigational plan' to ensure that there is adequate information about how children fare on experimental medication for many indications before they go to market. But this requirement places an undue constraint on the makers of new hemophilia drugs and threatens to create an unreasonable delay in access to these therapies among adults with this disorder in the EU.	[Peyvandi, Flora; Mannucci, Pier Mannuccio] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Milan, Italy; [Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy; [Rosendaal, Frits R.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Rosendaal, Frits R.] Leiden Univ Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands; [O'Mahony, Brian] European Haemophilia Consortium, Brussels, Belgium	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Peyvandi, F (corresponding author), IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Milan, Italy.		Rosendaal, Frits/Q-3842-2017; Peyvandi, Flora/AAK-7437-2020	Rosendaal, Frits/0000-0003-2558-7496; Peyvandi, Flora/0000-0001-7423-9864				Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; ROSENDAAL FR, 1990, THROMB HAEMOSTASIS, V63, P145	3	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					117	117		10.1038/nm0214-117	http://dx.doi.org/10.1038/nm0214-117			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24504399				2022-12-25	WOS:000330915000008
J	Sousa, SB; Jenkins, D; Chanudet, E; Tasseva, G; Ishida, M; Anderson, G; Docker, J; Ryten, M; Sa, J; Saraiva, JM; Barnicoat, A; Scott, R; Calder, A; Wattanasirichaigoon, D; Chrzanowska, K; Simandlova, M; Van Maldergem, L; Stanier, P; Beales, PL; Vance, JE; Moore, GE				Sousa, Sergio B.; Jenkins, Dagan; Chanudet, Estelle; Tasseva, Guergana; Ishida, Miho; Anderson, Glenn; Docker, James; Ryten, Mina; Sa, Joaquim; Saraiva, Jorge M.; Barnicoat, Angela; Scott, Richard; Calder, Alistair; Wattanasirichaigoon, Duangrurdee; Chrzanowska, Krystyna; Simandlova, Martina; Van Maldergem, Lionel; Stanier, Philip; Beales, Philip L.; Vance, Jean E.; Moore, Gudrun E.			Gain-of-function mutations in the phosphatidylserine synthase 1 (PTDSS1) gene cause Lenz-Majewski syndrome	NATURE GENETICS			English	Article							HAMSTER OVARY CELLS; HYPEROSTOTIC DWARFISM; CUTIS LAXA; PHOSPHATIDYLETHANOLAMINE; EXPRESSION; DYSPLASIA; BIOSYNTHESIS; ANOMALIES; PURIFICATION; INHIBITION	Lenz-Majewski syndrome (LMS) is a syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. By using whole-exome sequencing and selecting variants consistent with the predicted dominant de novo etiology of LMS, we identified causative heterozygous missense mutations in PTDSS1, which encodes phosphatidylserine synthase 1 (PSS1). PSS1 is one of two enzymes involved in the production of phosphatidylserine. Phosphatidylserine synthesis was increased in intact fibroblasts from affected individuals, and end-product inhibition of PSS1 by phosphatidylserine was markedly reduced. Therefore, these mutations cause a gain-of-function effect associated with regulatory dysfunction of PSS1. We have identified LMS as the first human disease, to our knowledge, caused by disrupted phosphatidylserine metabolism. Our results point to an unexplored link between phosphatidylserine synthesis and bone metabolism.	[Sousa, Sergio B.; Ishida, Miho; Moore, Gudrun E.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Sousa, Sergio B.; Sa, Joaquim; Saraiva, Jorge M.] Ctr Hosp & Univ Coimbra, Hosp Pediat, Serv Genet Med, Coimbra, Portugal; [Jenkins, Dagan; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London, England; [Chanudet, Estelle; Beales, Philip L.] UCL, Inst Child Hlth, Ctr Translat GOSgene, London, England; [Tasseva, Guergana; Vance, Jean E.] Univ Alberta, Dept Med, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada; [Anderson, Glenn] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England; [Docker, James; Stanier, Philip] UCL, Inst Child Hlth, Neural Dev Unit, London, England; [Ryten, Mina] UCL, Inst Neurol, Reta Lila Weston Inst, London, England; [Ryten, Mina] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Saraiva, Jorge M.] Univ Coimbra, Fac Med, Univ Clin Pediat, Coimbra, Portugal; [Barnicoat, Angela; Scott, Richard] Great Ormond St Hosp Sick Children, Clin Genet Dept, London, England; [Calder, Alistair] Great Ormond St Hosp Sick Children, Dept Radiol, London, England; [Wattanasirichaigoon, Duangrurdee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand; [Chrzanowska, Krystyna] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Simandlova, Martina] Univ Hosp Motol & Second, Fac Med, Dept Biol & Med Genet, Prague, Czech Republic; [Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, F-25030 Besancon, France; [Van Maldergem, Lionel] Univ Franche Comte, Cutis Laxa Study Grp, F-25030 Besancon, France	University of London; University College London; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of London; University College London; University of London; University College London; University of Alberta; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Universidade de Coimbra; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Mahidol University; Children's Memorial Health Institute; Charles University Prague; Universite de Franche-Comte; Universite de Franche-Comte	Sousa, SB (corresponding author), UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England.	sbsousa@chc.min-saude.pt	Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019; Ryten, Mina/Q-8419-2016; Moore, Gudrun/A-2092-2009; Beales, Philip L/C-7367-2009; e, Chanudet/N-4064-2015; Docker, James/G-5423-2010; Stanier, Philip/C-1593-2008	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Stanier, Philip/0000-0001-9340-8117; Moore, Gudrun/0000-0002-2099-3420; Chrzanowska, Krystyna/0000-0003-3888-0624; Saraiva, Jorge Manuel/0000-0002-7232-3509	Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/46778/2008]; Biomedical Research Centre of the National Institute for Health Research at Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Institute of Child Health; Wellcome Trust; Faculty of Medicine at Ramathibodi Hospital; Czech research development grant [00064203]; Great Ormond Street Hospital Children's Charity (GOSHCC); WellBeing of Women; GOSHCC; UK Medical Research Council; National Science and Engineering Council of Canada; Medical Research Council [MR/L009978/1, G0802462, G1001689, MR/K01417X/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017, NF-SI-0513-10008] Funding Source: researchfish; MRC [MR/L009978/1, G0802462, MR/K01417X/1, G1001689] Funding Source: UKRI	Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Biomedical Research Centre of the National Institute for Health Research at Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Institute of Child Health; Wellcome Trust(Wellcome TrustEuropean Commission); Faculty of Medicine at Ramathibodi Hospital; Czech research development grant; Great Ormond Street Hospital Children's Charity (GOSHCC); WellBeing of Women(Wellbeing of Women (WoW)); GOSHCC; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the individuals with LMS and their families for their participation in this study. We thank P. Clayton and R. Hennekam for their comments on the manuscript, A. Offiah for confirming the radiological diagnosis in subject 1 and W. Emmett for his valuable help in processing raw sequencing data. The authors would like to acknowledge D. Trabzuni and the UK Brain Expression Consortium, the Human Brain Transcriptome project at the Department of Neurobiology at the Yale University School of Medicine NHLBI for the use of data from their public database and the GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison, including the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). S. B. S. was supported by the Fundacao para a Ciencia e Tecnologia (SFRH/BD/46778/2008). The Centre for Translational Genomics-GOSgene is supported by the Biomedical Research Centre of the National Institute for Health Research at Great Ormond Street Hospital for Children NHS Foundation Trust and UCL Institute of Child Health. D.J. was supported by a Wellcome Trust ViP Award. D. W. is a recipient of Research Career Development Awards from the Faculty of Medicine at Ramathibodi Hospital. M. S. is supported by Czech research development grant 00064203. P. S. is supported by the Great Ormond Street Hospital Children's Charity (GOSHCC). The Fetal Growth and Development research team of G. E. M. is funded by WellBeing of Women, the Wellcome Trust, GOSHCC and the UK Medical Research Council. The research of J.E.V. is supported by the National Science and Engineering Council of Canada.	Allanson J, 2012, AM J MED GENET A, V158A, P2091, DOI 10.1002/ajmg.a.35446; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAHAM RL, 1969, ORAL SURG ORAL MED O, V27, P20, DOI 10.1016/0030-4220(69)90026-7; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chen IP, 2011, HUM MOL GENET, V20, P948, DOI 10.1093/hmg/ddq541; CHRZANOWSKA KH, 1989, AM J MED GENET, V32, P470, DOI 10.1002/ajmg.1320320407; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Genevieve D, 2008, NAT GENET, V40, P284, DOI 10.1038/ng.2007.66; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; GORLIN RJ, 1983, RADIOLOGY, V149, P129, DOI 10.1148/radiology.149.1.6611917; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; KAYE CI, 1974, AM J DIS CHILD, V127, P115, DOI 10.1001/archpedi.1974.02110200117018; Kingsley M, 2006, SPORTS MED, V36, P657, DOI 10.2165/00007256-200636080-00003; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; Kuge O, 1999, J BIOL CHEM, V274, P23844, DOI 10.1074/jbc.274.34.23844; LENZ W D, 1974, Birth Defects Original Article Series, V10, P133; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lindsay S, 2005, TRENDS GENET, V21, P586, DOI 10.1016/j.tig.2005.08.011; MACPHERSON RI, 1974, J CAN ASSOC RADIOL, V25, P22; Majewski F, 2000, AM J MED GENET, V93, P335, DOI 10.1002/1096-8628(20000814)93:4<335::AID-AJMG14>3.0.CO;2-5; Merolli A, 2009, MOLECULES, V14, P5367, DOI 10.3390/molecules14125367; Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9; Morita S, 2012, J LIPID RES, V53, P325, DOI 10.1194/jlr.D021808; Mozzi R, 2003, NEUROCHEM RES, V28, P195, DOI 10.1023/A:1022412831330; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; Ohsawa T, 2004, BIOCHEM J, V381, P853, DOI 10.1042/BJ20040443; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; ROBINOW M, 1977, J PEDIATR-US, V91, P417, DOI 10.1016/S0022-3476(77)81311-5; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; Saraiva JM, 2000, AM J MED GENET, V91, P198, DOI 10.1002/(SICI)1096-8628(20000320)91:3<198::AID-AJMG8>3.0.CO;2-4; SCHICK PK, 1976, J CLIN INVEST, V57, P1221, DOI 10.1172/JCI108390; Serby MJ, 2011, CURR TREAT OPTION NE, V13, P520, DOI 10.1007/s11940-011-0135-8; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 1999, BIOCHEM J, V342, P57, DOI 10.1042/0264-6021:3420057; Stone SJ, 1998, J BIOL CHEM, V273, P7293, DOI 10.1074/jbc.273.13.7293; Sturbois-Balcerzak B, 2001, J BIOL CHEM, V276, P8205, DOI 10.1074/jbc.M009776200; Tasseva G, 2011, J BIOL CHEM, V286, P1061, DOI 10.1074/jbc.M110.158709; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Tomohiro S, 2009, BIOCHEM J, V418, P421, DOI 10.1042/BJ20081597; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wattanasirichaigoon D, 2004, CLIN DYSMORPHOL, V13, P137, DOI 10.1097/01.mcd.0000127468.11641.b7; Wu LNY, 2008, J BIOL CHEM, V283, P3827, DOI 10.1074/jbc.M707653200; Wu Z, 2010, J IMMUNOL, V184, P3191, DOI 10.4049/jimmunol.0803609	49	56	58	4	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					70	+		10.1038/ng.2829	http://dx.doi.org/10.1038/ng.2829			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24241535	Green Published			2022-12-25	WOS:000329113500016
J	Bragado, P; Estrada, Y; Parikh, F; Krause, S; Capobianco, C; Farina, HG; Schewe, DM; Aguirre-Ghiso, JA				Bragado, Paloma; Estrada, Yeriel; Parikh, Falguni; Krause, Sarah; Capobianco, Carla; Farina, Hernan G.; Schewe, Denis M.; Aguirre-Ghiso, Julio A.			TGF-beta 2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38 alpha/beta signalling	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM; CANCER METASTASIS; UP-REGULATION; IN-VIVO; RECEPTOR; GROWTH; KINASE; BONE; INTRAVASATION; DORMANCY	In patients, non-proliferative disseminated tumour cells (DTCs) can persist in the bone marrow (BM) while other organs (such as lung) present growing metastasis. This suggested that the BM might be a metastasis 'restrictive soil' by encoding dormancy-inducing cues in DTCs. Here we show in a head and neck squamous cell carcinoma (HNSCC) model that strong and specific transforming growth factor-beta (TGF-beta) signalling in the BM activates the MAPK p38cdp, inducing an (ERK/p38 alpha/beta signalling ratio. This results in induction of DEC2/SHARP1 and p27, downregulation of cyclin-dependent kinase 4 (CDK4) and dormancy of malignant DTCs. TGF-02-induced dormancy required TGF-beta receptor-I (TGF-beta-R1), TGF-beta-RIII and SMAD1/5 activation to induce p27. In lungs, a metastasis 'permissive soil' with low TGF-beta levels, DTC dormancy was short-lived and followed by metastatic growth. Importantly, systemic inhibition of TGF-beta-RI or p38cdp activities awakened dormant DTCs, fuelling multi-organ metastasis. Our work reveals a 'seed and soil' mechanism where TGF-beta and TGF-beta-RII signalling through p38cdp regulates DTC dormancy and defines restrictive (BM) and permissive (lung) microenvironments for HNSCC metastasis.	[Bragado, Paloma; Estrada, Yeriel; Parikh, Falguni; Schewe, Denis M.; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, Dept Otolaryngol, Div Hematol & Oncol,Dept Med, New York, NY 10029 USA; [Krause, Sarah; Schewe, Denis M.] Univ Hosp Schleswig Holstein, Dept Gen Pediat, D-24118 Kiel, Germany; [Capobianco, Carla; Farina, Hernan G.] Quilmes Natl Univ, Dept Sci & Technol, Lab Mol Oncol, Buenos Aires, DF, Argentina; [Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of Kiel; Schleswig Holstein University Hospital; Icahn School of Medicine at Mount Sinai	Aguirre-Ghiso, JA (corresponding author), Mt Sinai Sch Med, Tisch Canc Inst, Dept Otolaryngol, Div Hematol & Oncol,Dept Med, New York, NY 10029 USA.	julio.aguirre-ghiso@mssm.edu	Bragado Domingo, Paloma/A-8679-2015; Schewe, Denis/I-5573-2015	Bragado Domingo, Paloma/0000-0002-7642-1245; Aguirre-Ghiso, Julio/0000-0002-6694-6507	Samuel Waxman Cancer Research Foundation Tumour Dormancy Program [NCI CA109182, CA163131]; NIEHS [ES017146]; NYSTEM; Deutsche Krebshilfe e; CONICET; UNQ grants; NATIONAL CANCER INSTITUTE [R01CA109182, U54CA163131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation Tumour Dormancy Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NYSTEM; Deutsche Krebshilfe e; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNQ grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant support: Samuel Waxman Cancer Research Foundation Tumour Dormancy Program, NCI CA109182 and CA163131, NIEHS (ES017146) and NYSTEM grants to J.A.A-G; Mildred-Scheel postdoctoral grant by the Deutsche Krebshilfe and Max-Eder Junior Research Grant by the Deutsche Krebshilfe e. V. to D.M.S. C.C. is a research fellow and H.F. is an Investigator of CONICET Argentina. This work was also supported by CONICET and UNQ grants to H.G.F.	Adam AP, 2009, CANCER RES, V69, P5664, DOI 10.1158/0008-5472.CAN-08-3820; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Aguirre-Ghiso JA, 2013, NAT MED, V19, P276, DOI 10.1038/nm.3120; Ajiboye S, 2010, BJU INT, V105, P913, DOI 10.1111/j.1464-410X.2009.08999.x; Alonso DF, 1996, J SURG ONCOL, V62, P288, DOI 10.1002/(SICI)1096-9098(199608)62:4<288::AID-JSO14>3.0.CO;2-1; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; Criswell TL, 2008, CANCER RES, V68, P7304, DOI 10.1158/0008-5472.CAN-07-6777; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ferlito A, 2001, ORL-J OTO-RHIN-LARYN, V63, P202, DOI 10.1159/000055740; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Gath HJ, 1999, CANCER METAST REV, V18, P109, DOI 10.1023/A:1006268621730; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Husemann Y, 2009, TRANSGENIC RES, V18, P1, DOI 10.1007/s11248-008-9225-0; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Morrissey C, 2007, J CELL BIOCHEM, V101, P873, DOI 10.1002/jcb.21214; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; OSSOWSKI L, 1980, CANCER RES, V40, P2300; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; OSSOWSKI L, 1987, J CELL PHYSIOL, V133, P288, DOI 10.1002/jcp.1041330212; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Sharifi N, 2007, PROSTATE, V67, P301, DOI 10.1002/pros.20526; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sun CK, 2011, NEOPLASIA, V13, P735, DOI 10.1593/neo.11664; TOOLAN HW, 1954, CANCER RES, V14, P660; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195; Zhang YF, 2010, CANCER LETT, V292, P1, DOI 10.1016/j.canlet.2009.11.003; Zijlstra A, 2002, CANCER RES, V62, P7083; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	53	289	298	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1351	U210		10.1038/ncb2861	http://dx.doi.org/10.1038/ncb2861			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24161934	Green Accepted, Green Published			2022-12-25	WOS:000326680700011
J	Honegger, JR; Kim, S; Price, AA; Kohout, JA; McKnight, KL; Prasad, MR; Lemon, SM; Grakoui, A; Walker, CM				Honegger, Jonathan R.; Kim, Seungtaek; Price, Aryn A.; Kohout, Jennifer A.; McKnight, Kevin L.; Prasad, Mona R.; Lemon, Stanley M.; Grakoui, Arash; Walker, Christopher M.			Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses	NATURE MEDICINE			English	Article							HEPATITIS-C-VIRUS; T-CELL RESPONSE; TRANSMISSION; MOTHER; RNA; EXPRESSION; EVOLUTION; PROTEINS; DOMINANT; EPITOPES	Globally, about 1% of pregnant women are persistently infected with the hepatitis C virus (HCV)(1). Mother-to-child transmission of HCV occurs in 3-5% of pregnancies(2) and accounts for most new childhood infections(1,3). HCV-specific CD8+ cytotoxic T lymphocytes (CTLs) are vital in the clearance of acute HCV infections(4-6), but in the 60-80% of infections that persist, these cells become functionally exhausted or select for mutant viruses that escape T cell recognition(7-9). Increased HCV replication during pregnancy(10,11) suggests that maternofetal immune tolerance mechanisms(12) may further impair HCV-specific CTLs, limiting their selective pressure on persistent viruses. To assess this possibility, we characterized circulating viral quasispecies during and after consecutive pregnancies in two women. This revealed a loss of some escape mutations in HLA class I epitopes during pregnancy that was associated with emergence of more fit viruses(13). CTL selective pressure was reimposed after childbirth, at which point escape mutations in these epitopes again predominated in the quasispecies and viral load dropped sharply(14). Importantly, the viruses transmitted perinatally were those with enhanced fitness due to reversion of escape mutations. Our findings indicate that the immunoregulatory changes of pregnancy reduce CTL selective pressure on HCV class I epitopes, thereby facilitating vertical transmission of viruses with optimized replicative fitness.	[Honegger, Jonathan R.; Kohout, Jennifer A.; Walker, Christopher M.] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA; [Honegger, Jonathan R.; Walker, Christopher M.] Ohio State Univ, Dept Pediat, Sch Med, Columbus, OH 43210 USA; [Kim, Seungtaek; McKnight, Kevin L.; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kim, Seungtaek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Seungtaek] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Price, Aryn A.; Grakoui, Arash] Emory Univ, Sch Med, Div Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA USA; [Prasad, Mona R.] Ohio State Univ, Dept Obstet & Gynecol, Sch Med, Columbus, OH 43210 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Grakoui, Arash] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Emory University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University	Honegger, JR (corresponding author), Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA.	jonathan.honegger@nationwidechildrens.org	Honegger, Jonathan/E-3264-2011	Honegger, Jonathan/0000-0002-3181-0554	US National Institutes of Health [R37-AI47367, R56-AI096882, R01-AI096882, RO1-DA024565, R01-AI95690, R01-AI070101, R01-DK083356, T32-HD043003, K12-HD043372]; US National Institutes of Health (Yerkes Research Center Base Grant) [P51RR-000165]; Research Institute at Nationwide Children's Hospital; University of North Carolina University Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043372, T32HD043003] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI096882, R37AI047367, R01AI070101, R01AI095690, R01AI096882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024565] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Yerkes Research Center Base Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute at Nationwide Children's Hospital(Ohio State University); University of North Carolina University Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Hunkler for coordination of the project at The Ohio State University STEPP Clinic and the Nationwide Children's Hospital FACES Clinic. The assistance of C. Potter of the Nationwide Children's Hospital Division of Gastroenterology and G. Mateu of the Emory Vaccine Center is also gratefully acknowledged. We especially thank the subjects and their families for their participation in this study. This work was supported by the US National Institutes of Health (R37-AI47367 to C. M. W., R56-AI096882 and R01-AI096882 to C. M. W. and J. R. H., RO1-DA024565 and R01-AI95690 to S. M. L., R01-AI070101 and R01-DK083356 to A. G., T32-HD043003 and K12-HD043372 to J. R. H., and the Yerkes Research Center Base Grant P51RR-000165 (A. G.)), the Research Institute at Nationwide Children's Hospital (C. M. W. and J. R. H.), and the University of North Carolina University Cancer Research Fund (S.M.L.).	Alegre E, 2007, HUM IMMUNOL, V68, P661, DOI 10.1016/j.humimm.2007.04.007; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bortolotti F, 2007, J HEPATOL, V46, P783, DOI 10.1016/j.jhep.2006.12.014; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Callendret B, 2011, J VIROL, V85, P11833, DOI 10.1128/JVI.02654-10; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Dal Molin G, 2002, J MED VIROL, V67, P137, DOI 10.1002/jmv.2202; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gervais A, 2000, J HEPATOL, V32, P293, DOI 10.1016/S0168-8278(00)80075-6; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Kasprowicz V, 2010, J VIROL, V84, P1656, DOI 10.1128/JVI.01499-09; Kimura Y, 2005, J VIROL, V79, P4870, DOI 10.1128/JVI.79.8.4870-4876.2005; KOZIEL MJ, 1993, J VIROL, V67, P7522, DOI 10.1128/JVI.67.12.7522-7532.1993; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lin HH, 2000, BRIT J OBSTET GYNAEC, V107, P1503, DOI 10.1111/j.1471-0528.2000.tb11675.x; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Mok J, 2005, Arch Dis Child Fetal Neonatal Ed, V90, pF156, DOI 10.1136/adc.2004.059436; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nei M., 2000, MOL EVOLUTION PHYLOG; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Polanczyk MJ, 2006, J NEUROSCI RES, V84, P370, DOI 10.1002/jnr.20881; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Ruhl M, 2012, J VIROL, V86, P991, DOI 10.1128/JVI.05603-11; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salloum S, 2008, J VIROL, V82, P11803, DOI 10.1128/JVI.00997-08; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Borg MJ, 2008, J VIRAL HEPATITIS, V15, P37, DOI 10.1111/j.1365-2893.2007.00894.x; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Uebelhoer L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000143; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang C, 2009, IMMUNOLOGY, V126, P329, DOI 10.1111/j.1365-2567.2008.03051.x; Wejstal R, 1998, SCAND J INFECT DIS, V30, P111, DOI 10.1080/003655498750003456; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002	51	48	49	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1529	+		10.1038/nm.3351	http://dx.doi.org/10.1038/nm.3351			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24162814	Green Accepted, Green Submitted			2022-12-25	WOS:000326920300032
J	Francioli, LC; Menelaou, A; Pulit, SL; Van Dijk, F; Palamara, PF; Elbers, CC; Neerincx, PBT; Ye, K; Guryev, V; Kloosterman, WP; Deelen, P; Abdellaoui, A; Van Leeuwen, EM; Van Oven, M; Vermaat, M; Li, M; Laros, JFJ; Karssen, LC; Kanterakis, A; Amin, N; Hottenga, JJ; Lameijer, EW; Kattenberg, M; Dijkstra, M; Byelas, H; Van Settenl, J; Van Schaik, BDC; Bot, J; Nijman, IJ; Renkens, I; Marscha, T; Schonhuth, A; Hehir-Kwa, JY; Handsaker, RE; Polak, P; Sohail, M; Vuzman, D; Hormozdiari, F; Van Enckevort, D; Mei, H; Koval, V; Moed, MTH; Van der Velde, KJ; Rivadeneira, F; Estrada, K; Medina-Gomez, C; Isaacs, A; McCarroll, SA; Beekrnan, M; De Craen, AJM; Suchiman, HED; Hofman, A; Oostra, B; Uitterlinden, AG; Willemsen, G; Plattee, M; Veldink, JH; Van den Berg, LH; Pitts, SJ; Potluri, S; Sundar, P; Cox, DR; Sunyaev, SR; Den Dunnen, JT; Stoneking, M; De Knijff, P; Kayser, M; Li, QB; Li, YR; Du, YP; Chen, R; Cao, H; Li, N; Cao, S; Wang, J; Bovenberg, JA; Peer, I; Slagboom, PE; Van Duijn, CM; Boomsma, DI; Van Ommen, GJB; De Bakker, PIW; Swertz, MA; Wijmenga, C				Francioli, Laurent C.; Menelaou, Andronild; Pulit, Sara L.; Van Dijk, Freerk; Palamara, Pier Francesco; Elbers, Clara C.; Neerincx, Pieter B. T.; Ye, Kai; Guryev, Victor; Kloosterman, Wigard P.; Deelen, Patrick; Abdellaoui, Abdel; Van Leeuwen, Elisabeth M.; Van Oven, Mannis; Vermaat, Martijn; Li, Mingkun; Laros, Jeroen F. J.; Karssen, Lennart C.; Kanterakis, Alexandros; Amin, Najaf; Hottenga, Jouke Jan; Lameijer, Eric-Wubbo; Kattenberg, Mathijs; Dijkstra, Martijn; Byelas, Heorhiy; Van Settenl, Jessica; Van Schaik, Barbera D. C.; Bot, Jan; Nijman, Isaac J.; Renkens, Ivo; Marscha, Tobias; Schonhuth, Alexander; Hehir-Kwa, Jayne Y.; Handsaker, Robert E.; Polak, Paz; Sohail, Mashaal; Vuzman, Dana; Hormozdiari, Fereydoun; Van Enckevort, David; Mei, Hailiang; Koval, Vyacheslav; Moed, Ma-Tthijs H.; Van der Velde, K. Joeri; Rivadeneira, Fernando; Estrada, Karol; Medina-Gomez, Carolina; Isaacs, Aaron; McCarroll, Steven A.; Beekrnan, Marian; De Craen, Anton J. M.; Suchiman, H. Eka D.; Hofman, Albert; Oostra, Ben; Uitterlinden, Andre G.; Willemsen, Gonneke; Plattee, Mathieu; Veldink, Jan H.; Van den Berg, Leonard H.; Pitts, Steven J.; Potluri, Shobha; Sundar, Purnima; Cox, David R.; Sunyaev, Shamil R.; Den Dunnen, Johan T.; Stoneking, Mark; De Knijff, Peter; Kayser, Manfred; Li, Qibin; Li, Yingrui; Du, Yuanping; Chen, Ruoyan; Cao, Hongzhi; Li, Ning; Cao, Sujie; Wang, Jun; Bovenberg, Jasper A.; Peer, Itsik; Slagboom, P. Eline; Van Duijn, Cornelia M.; Boomsma, Dorret I.; Van Ommen, Gert-Jan B.; De Bakker, Paul I. W.; Swertz, Morris A.; Wijmenga, Cisca		Genome Netherlands Consortium; LifeLines Cohort Study	Whole-genome sequence variation, population structure and demographic history of the Dutch population	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; GENETIC-VARIATION; HUMAN-DISEASE; HAPLOTYPE MAP; VARIANTS; RARE; COMMON; IMPACT; EXOMES; EVOLUTION	Whole-genome sequencing enables complete characterization of genetic variation, but geographic clustering of rare alleles demands many diverse populations be studied. Here we describe the Genome of the Netherlands (GoNL) Project, in which we sequenced the whole genomes of 250 Dutch parent-offspring families and constructed a haplotype map of 20.4 million single-nucleotide variants and 1.2 million insertions and deletions. The intermediate coverage (similar to 13x) and trio design enabled extensive characterization of structural variation, including midsize events (30-500 bp) previously poorly catalogued and de novo mutations. We demonstrate that the quality of the haplotypes boosts imputation accuracy in independent samples, especially for lower frequency alleles. Population genetic analyses demonstrate fine-scale structure across the country and support multiple ancient migrations, consistent with historical changes in sea level and flooding. The GoNL Project illustrates how single-population whole-genome sequencing can provide detailed characterization of genetic variation and may guide the design of future population studies.	[Francioli, Laurent C.; Menelaou, Andronild; Pulit, Sara L.; Elbers, Clara C.; Kloosterman, Wigard P.; Van Settenl, Jessica; Nijman, Isaac J.; Renkens, Ivo; De Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Van Dijk, Freerk; Neerincx, Pieter B. T.; Deelen, Patrick; Kanterakis, Alexandros; Dijkstra, Martijn; Byelas, Heorhiy; Moed, Ma-Tthijs H.; Plattee, Mathieu; Swertz, Morris A.; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Van Dijk, Freerk; Neerincx, Pieter B. T.; Deelen, Patrick; Kanterakis, Alexandros; Dijkstra, Martijn; Byelas, Heorhiy; Moed, Ma-Tthijs H.; Swertz, Morris A.; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Palamara, Pier Francesco; Peer, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Ye, Kai] Washington Univ, Genome Inst, St Louis, MO USA; [Ye, Kai; Lameijer, Eric-Wubbo; Koval, Vyacheslav; McCarroll, Steven A.; Beekrnan, Marian; De Craen, Anton J. M.; Suchiman, H. Eka D.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Guryev, Victor] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Abdellaoui, Abdel; Hottenga, Jouke Jan; Kattenberg, Mathijs; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Van Leeuwen, Elisabeth M.; Karssen, Lennart C.; Amin, Najaf; Van der Velde, K. Joeri; Medina-Gomez, Carolina; Hofman, Albert; Uitterlinden, Andre G.; Van Duijn, Cornelia M.] Erasmus MC Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Van Oven, Mannis; Kayser, Manfred] Erasmus MC Univ, Med Ctr, Dept Forens Mol Biol, Rotterdam, Netherlands; [Vermaat, Martijn; Laros, Jeroen F. J.; Sunyaev, Shamil R.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden Genome Technol Ctr, Leiden, Netherlands; [Vermaat, Martijn; Laros, Jeroen F. J.; Hormozdiari, Fereydoun; Van Enckevort, David] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Li, Mingkun; Den Dunnen, Johan T.; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Van Schaik, Barbera D. C.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, Amsterdam, Netherlands; [Bot, Jan] SURFsara, Amsterdam, Netherlands; [Marscha, Tobias; Schonhuth, Alexander] Life Sci Grp, Ctr Wiskunde & lnformat, Amsterdam, Netherlands; [Hehir-Kwa, Jayne Y.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Handsaker, Robert E.; Polak, Paz; Sohail, Mashaal; Rivadeneira, Fernando; Isaacs, Aaron; Cox, David R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Ctr Neurosci, Nijmegen, Netherlands; [Handsaker, Robert E.; Isaacs, Aaron] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Sohail, Mashaal; Cox, David R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Vuzman, Dana] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA USA; [Mei, Hailiang; Van der Velde, K. Joeri; Rivadeneira, Fernando; Estrada, Karol; Uitterlinden, Andre G.] Erasmus MC Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, Fernando] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Oostra, Ben] Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [Van den Berg, Leonard H.; Pitts, Steven J.; Potluri, Shobha; Sundar, Purnima] Rinat Pfizer Inc, San Francisco, CA USA; [Sunyaev, Shamil R.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [De Knijff, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Forens Lab DNA Res, Leiden, Netherlands; [Li, Qibin; Li, Yingrui; Du, Yuanping; Chen, Ruoyan; Cao, Hongzhi; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Ning; Cao, Sujie] BGI Europe, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Bovenberg, Jasper A.] Legal Pathways Inst Hlth & Bio Law, Aerdenhout, Netherlands; [Peer, Itsik] Columbia Univ, Dept Syst Biol, New York, NY USA; [Van Ommen, Gert-Jan B.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [De Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Columbia University; Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Pfizer; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Beijing Genomics Institute (BGI); University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Columbia University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	De Bakker, PIW (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands.	pdebakker@umcutrecht.nl; c.wijmenga@umcg.nl	Rivadeneira, Fernando/O-5385-2015; Slagboom, P. Eline/R-4790-2016; Wijmenga, Cisca/D-2173-2009; Beekman, Marian/L-3004-2019; Polak, Paz/AAH-9380-2020; Medina-Gomez, Carolina/I-1725-2019; dunnen, johan den/ABH-4228-2020; Suchiman, H. Eka D./F-5024-2017; Hehir, g. J.Y./L-4358-2015; Kanterakis, Alexandros/ABC-1705-2021; de Knijff, Peter/Y-2519-2018; Ye, Kai/B-3640-2012; Ye, Kai/GSD-9856-2022; Li, Yingrui/K-1064-2015; Deelen, Patrick/B-3566-2013; de Bakker, Paul IW/B-8730-2009; van Leeuwen, Elisabeth/G-3382-2017; Boomsma, Dorret I/AAX-4470-2020; Wijmenga, Cisca/AAE-7719-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Rivadeneira, Fernando/0000-0001-9435-9441; Slagboom, P. Eline/0000-0002-2875-4723; Beekman, Marian/0000-0003-0585-6206; Medina-Gomez, Carolina/0000-0001-7999-5538; dunnen, johan den/0000-0002-6304-1710; Suchiman, H. Eka D./0000-0002-7168-5516; Kanterakis, Alexandros/0000-0003-4276-0115; de Knijff, Peter/0000-0002-0899-771X; Ye, Kai/0000-0002-2851-6741; Deelen, Patrick/0000-0002-5654-3966; de Bakker, Paul IW/0000-0001-7735-7858; Wijmenga, Cisca/0000-0002-5635-1614; Wang, Jun/0000-0002-2113-5874; Veldink, Jan/0000-0001-5572-9657; van Enckevort, Esther/0000-0002-2440-3993; Wang, Jun/0000-0002-8540-8931; Amin, Najaf/0000-0002-8944-1771; Laros, Jeroen F.J./0000-0002-8715-7371; Marschall, Tobias/0000-0002-9376-1030; Karssen, Lennart C./0000-0002-1959-342X; Pulit, Sara/0000-0002-2502-3669; Willemsen, Gonneke/0000-0003-3755-0236; van Schaik, Barbera/0000-0002-5568-8127; van Oven, Mannis/0000-0003-0026-7998; Hehir-Kwa, Jayne/0000-0003-0837-304X; Palamara, Pier Francesco/0000-0002-7999-1972; Guryev, Victor/0000-0002-5810-6022; van der Velde, Joeri/0000-0002-0934-8375; Van Duijn, Cornelia/0000-0002-2374-9204	BBMRI-NL - Netherlands Organization for Scientific Research (NWO) [184.021.007]; eBioGrid; CTMM/TraIT; Ubbo Emmius Fund; Netherlands Bioinformatics Center (NBIC); BU-BioSHARE; Samenwerkingsverband Noord Nederland; European Fund for Regional Development; Dutch Ministry of Economic Affairs, Pieken in de Delta; provinces-of Groningen and Drenthe; Netherlands Organization for Scientific Research (NWO); Center for Medical Systems Biology-2; European Research Council [ERC 230374]; VIDI awards (NWO) [016.138.318, 016.126.354]	BBMRI-NL - Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); eBioGrid; CTMM/TraIT; Ubbo Emmius Fund; Netherlands Bioinformatics Center (NBIC); BU-BioSHARE; Samenwerkingsverband Noord Nederland; European Fund for Regional Development(European Commission); Dutch Ministry of Economic Affairs, Pieken in de Delta; provinces-of Groningen and Drenthe; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology-2; European Research Council(European Research Council (ERC)European Commission); VIDI awards (NWO)	We wish to dedicate this work to the memory of David R. Cox, an enthusiastic supporter of human genetic research in the Netherlands for many years. The GoNL Project is funded by the BBMRI-NL, a research infrastructure financed by the Netherlands Organization for Scientific Research (NWO project 184.021.007). We acknowledge additional financial support from eBioGrid, CTMM/TraIT, the Ubbo Emmius Fund, the Netherlands Bioinformatics Center (NBIC) and BU-BioSHARE. We thank the individual participants of the biobanks; M. Depristo, E. Banks, R. Poplin and G. del Angel from the Broad Institute for expert advice on setting up our alignment and calling pipeline; K. Garimella for the initial implementation of PhaseByTransmission; G. Strikwerda, W Albers, R. Teeninga, H. Gankema and H. Wind of the Groningen Center for Information Technology (see URLs) for support of the compute cluster and Target storage; E. Valentyn and R. Williams of Target (see URLs) for hosting project data on IBM GPFS storage; T. Visser and I. Nooren of BiG Grid (see URLs) and SURFsara for providing backup storage, additional computing capacity and expert advice; the team from MOLGENIS (see URLs) for software development support; H. Lauvenberg for handling data access requests; K. Zych for design of the GoNL logo; L. Franke, H.-J. Westra and J. Gutierrez-Achury for useful discussions; and S. Raychaudhuri and B. Neale for their critical reading of the manuscript. Target is supported by Samenwerkingsverband Noord Nederland, the European Fund for Regional Development, the Dutch Ministry of Economic Affairs, Pieken in de Delta and the provinces-of Groningen and Drenthe. Target operates under the auspices of Sensor Universe. BiG Grid and the Life Science Grid are financially supported by the Netherlands Organization for Scientific Research (NWO). A.A. is funded by the Center for Medical Systems Biology-2, and D.I.B. is funded by the European Research Council (ERC 230374). A.S. and P.I.W.d.B. are recipients of VIDI awards (NWO projects 016.138.318 and 016.126.354, respectively).	Abdellaoui A, 2013, EUR J HUM GENET, V21, P1277, DOI 10.1038/ejhg.2013.48; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Boomsma DI, 2014, EUR J HUM GENET, V22, P221, DOI 10.1038/ejhg.2013.118; Brandsma M., 2012, Norsk Epidemiologi, V21, P143; Cassa CA, 2013, HUM MUTAT, V34, P1216, DOI 10.1002/humu.22375; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lao Oscar, 2013, Investig Genet, V4, P9, DOI 10.1186/2041-2223-4-9; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menelaou A, 2013, BIOINFORMATICS, V29, P84, DOI 10.1093/bioinformatics/bts632; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	46	454	459	4	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					818	825		10.1038/ng.3021	http://dx.doi.org/10.1038/ng.3021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24974849	Green Submitted			2022-12-25	WOS:000339704400009
J	Jo, S; Yarishkin, O; Hwang, YJ; Chun, YE; Park, M; Woo, DH; Bae, JY; Kim, T; Lee, J; Chun, H; Park, HJ; Lee, DY; Hong, J; Kim, HY; Oh, SJ; Park, SJ; Lee, H; Yoon, BE; Kim, Y; Jeong, Y; Shim, I; Bae, YC; Cho, J; Kowall, NW; Ryu, H; Hwang, E; Kim, D; Lee, CJ				Jo, Seonmi; Yarishkin, Oleg; Hwang, Yu Jin; Chun, Ye Eun; Park, Mijeong; Woo, Dong Ho; Bae, Jin Young; Kim, Taekeun; Lee, Jaekwang; Chun, Heejung; Park, Hyun Jung; Lee, Da Yong; Hong, Jinpyo; Kim, Hye Yun; Oh, Soo-Jin; Park, Seung Ju; Lee, Hyo; Yoon, Bo-Eun; Kim, YoungSoo; Jeong, Yong; Shim, Insop; Bae, Yong Chul; Cho, Jeiwon; Kowall, Neil W.; Ryu, Hoon; Hwang, Eunmi; Kim, Daesoo; Lee, C. Justin			GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease	NATURE MEDICINE			English	Article							MONOAMINE-OXIDASE-B; MAO-B; CULTURED ASTROCYTES; GLUTAMATE RELEASE; DENTATE GYRUS; L-DEPRENYL; SELEGILINE; PUTRESCINE; CHANNEL; MICE	In Alzheimer's disease (AD), memory impairment is the most prominent feature that afflicts patients and their families. Although reactive astrocytes have been observed around amyloid plaques since the disease was first described, their role in memory impairment has been poorly understood. Here, we show that reactive astrocytes aberrantly and abundantly produce the inhibitory gliotransmitter GABA by monoamine oxidase-B (Maob) and abnormally release GABA through the bestrophin 1 channel. In the dentate gyrus of mouse models of AD, the released GABA reduces spike probability of granule cells by acting on presynaptic GABA receptors. Suppressing GABA production or release from reactive astrocytes fully restores the impaired spike probability, synaptic plasticity, and learning and memory in the mice. In the postmortem brain of individuals with AD, astrocytic GABA and MAOB are significantly upregulated. We propose that selective inhibition of astrocytic GABA synthesis or release may serve as an effective therapeutic strategy for treating memory impairment in AD.	[Jo, Seonmi; Kim, Daesoo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jo, Seonmi; Yarishkin, Oleg; Chun, Ye Eun; Woo, Dong Ho; Kim, Taekeun; Lee, Jaekwang; Chun, Heejung; Lee, Da Yong; Hong, Jinpyo; Park, Seung Ju; Lee, Hyo; Yoon, Bo-Eun; Hwang, Eunmi; Lee, C. Justin] KIST, Brain Sci Inst, WCI Ctr Funct Connect, Seoul, South Korea; [Hwang, Yu Jin; Kim, Hye Yun; Kim, YoungSoo; Ryu, Hoon] KIST, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Chun, Ye Eun; Park, Mijeong; Cho, Jeiwon; Lee, C. Justin] Korea Univ Sci & Technol, Neurosci Program, Taejon, South Korea; [Park, Mijeong; Oh, Soo-Jin; Cho, Jeiwon; Lee, C. Justin] KIST, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea; [Bae, Jin Young; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea; [Park, Hyun Jung; Shim, Insop] Kyung Hee Univ, Coll Korean Med, Grad Sch, Dept Sci Korean Med, Seoul, South Korea; [Jeong, Yong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kowall, Neil W.; Ryu, Hoon] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Kowall, Neil W.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kowall, Neil W.; Ryu, Hoon] VA Boston Healthcare Syst, Boston, MA USA; [Lee, C. Justin] Korea Univ, KU KIST Grad Sch Converging Sci Technol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Kyungpook National University; Kyung Hee University; Korea Advanced Institute of Science & Technology (KAIST); Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Korea University	Lee, CJ (corresponding author), KIST, Brain Sci Inst, WCI Ctr Funct Connect, Seoul, South Korea.	daesoo@kaist.ac.kr; cjl@kist.re.kr	Chun, Heejung/B-3454-2014; Jeong, Yong/C-1677-2011; Kim, Daesoo/C-1625-2011; Kim, YoungSoo/AAO-1970-2020; Lee, C. Justin/AAC-1663-2019; Kowall, Neil/M-5378-2019	Chun, Heejung/0000-0002-6451-1542; Jeong, Yong/0000-0002-5907-3787; Kim, Daesoo/0000-0001-9915-1463; Kim, YoungSoo/0000-0001-5029-7082; Kowall, Neil/0000-0002-6624-0213; Shim, Insop/0000-0002-8014-9782; Yarishkin, Oleg/0000-0002-8215-7444; Lee, C Justin/0000-0002-3555-0980	WCI Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP); WCI Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP) (NRF) [WCI 2009-003]; KIST Institutional Flagship Program [3E25022, 2E24380]; National Leading Research Laboratory Program of Korea; KAIST (NRF) [2011-0028772]; NRF - MSIP [2008-0062282]; National Institute of Aging of USA	WCI Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP); WCI Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP) (NRF); KIST Institutional Flagship Program; National Leading Research Laboratory Program of Korea; KAIST (NRF); NRF - MSIP; National Institute of Aging of USA	This work was supported by the WCI Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP: to C.J.L., NRF grant number: WCI 2009-003), the KIST Institutional Flagship Program (to C.J.L., 3E25022; to H.R., 2E24380), the National Leading Research Laboratory Program of Korea and the KAIST Future Systems Healthcare Project (to D.K., NRF grant number: 2011-0028772), the Basic Science Research Program through the NRF funded by the MSIP (to Y.C.B., 2008-0062282), and the National Institute of Aging of USA (to N.W.K.). We thank Mazence for APP/PS1 mice, W Park (GIST) for 5XFAD mice, K. Park and H. Song (KIST) for safinamide and K. Fujiwara (Sojo University) for the putrescine-specific antibody.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; [Anonymous], 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000442, 10.1002/14651858.CD000442]; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; BIRKMAYER W, 1975, J NEURAL TRANSM, V36, P303, DOI 10.1007/BF01253131; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; De Angelis L, 2000, PHARMACOL BIOCHEM BE, V65, P649, DOI 10.1016/S0091-3057(99)00237-3; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENGBERG G, 1991, J PHARMACOL EXP THER, V259, P841; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gerlach M, 1996, NEUROLOGY, V47, pS137, DOI 10.1212/WNL.47.6_Suppl_3.137S; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Han KS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-4; Hartlage-Rubsamen M, 2011, ACTA NEUROPATHOL, V121, P705, DOI 10.1007/s00401-011-0806-2; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; LASCHET J, 1992, NEUROSCIENCE, V48, P151, DOI 10.1016/0306-4522(92)90345-3; Lee J, 2009, FASEB J, V23, P1739, DOI 10.1096/fj.08-121046; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; Marzo A, 2004, PHARMACOL RES, V50, P77, DOI 10.1016/j.phrs.2003.12.004; Matousek SB, 2012, J NEUROIMMUNE PHARM, V7, P156, DOI 10.1007/s11481-011-9331-2; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MONTEVERDE A, 1990, CLIN THER, V12, P315; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nagga K, 1999, J NEURAL TRANSM, V106, P1141, DOI 10.1007/s007020050230; NAKAMURA S, 1990, ACTA NEUROPATHOL, V80, P419, DOI 10.1007/BF00307697; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-54; PICCININ GL, 1990, CLIN NEUROPHARMACOL, V13, P147, DOI 10.1097/00002826-199004000-00004; PIKE CJ, 1994, NEUROSCIENCE, V63, P517, DOI 10.1016/0306-4522(94)90547-9; Samakashvili S, 2011, ELECTROPHORESIS, V32, P2757, DOI 10.1002/elps.201100139; SAURA J, 1992, J NEUROSCI, V12, P1977; SAURA J, 1994, NEUROSCIENCE, V62, P15, DOI 10.1016/0306-4522(94)90311-5; Scheff SW, 1998, J NEUROPATH EXP NEUR, V57, P1146, DOI 10.1097/00005072-199812000-00006; SEILER N, 1979, J BIOCHEM-TOKYO, V86, P277; SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TARIOT PN, 1987, ARCH GEN PSYCHIAT, V44, P427; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Wilcock GK, 2002, INT J GERIATR PSYCH, V17, P175, DOI 10.1002/gps.545; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; Woo DH, 2012, CELL, V151, P25, DOI 10.1016/j.cell.2012.09.005; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Youdim MBH, 2005, J NEUROSCI RES, V79, P172, DOI 10.1002/jnr.20350	60	417	431	10	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					886	896		10.1038/nm.3639	http://dx.doi.org/10.1038/nm.3639			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	24973918	Green Accepted			2022-12-25	WOS:000340074600020
J	Foth, BJ; Tsai, IJ; Reid, AJ; Bancroft, AJ; Nichol, S; Tracey, A; Holroyd, N; Cotton, JA; Stanley, EJ; Zarowiecki, M; Liu, JZ; Huckvale, T; Cooper, PJ; Grencis, RK; Berriman, M				Foth, Bernardo J.; Tsai, Isheng J.; Reid, Adam J.; Bancroft, Allison J.; Nichol, Sarah; Tracey, Alan; Holroyd, Nancy; Cotton, James A.; Stanley, Eleanor J.; Zarowiecki, Magdalena; Liu, Jimmy Z.; Huckvale, Thomas; Cooper, Philip J.; Grencis, Richard K.; Berriman, Matthew			Whipworm genome and dual-species transcriptome analyses provide molecular insights into an intimate host-parasite interaction	NATURE GENETICS			English	Article							TRANSMITTED HELMINTH INFECTIONS; NEMATODE PARASITE; DRAFT GENOME; DNASE II; RESISTANCE; GENES; TRICHURIASIS; KARYOTYPE; MECHANISM; PROTEINS	Whipworms are common soil-transmitted helminths that cause debilitating chronic infections in man. These nematodes are only distantly related to Caenorhabditis elegans and have evolved to occupy an unusual niche, tunneling through epithelial cells of the large intestine. We report here the whole-genome sequences of the human-infective Trichuris trichiura and the mouse laboratory model Trichuris muris. On the basis of whole-transcriptome analyses, we identify many genes that are expressed in a sex- or life stage-specific manner and characterize the transcriptional landscape of a morphological region with unique biological adaptations, namely, bacillary band and stichosome, found only in whipworms and related parasites. Using RNA sequencing data from whipworm-infected mice, we describe the regulated T helper 1 (T(H)1)-like immune response of the chronically infected cecum in unprecedented detail. In silico screening identified numerous new potential drug targets against trichuriasis. Together, these genomes and associated functional data elucidate key aspects of the molecular host-parasite interactions that define chronic whipworm infection.	[Foth, Bernardo J.; Tsai, Isheng J.; Reid, Adam J.; Nichol, Sarah; Tracey, Alan; Holroyd, Nancy; Cotton, James A.; Stanley, Eleanor J.; Zarowiecki, Magdalena; Liu, Jimmy Z.; Huckvale, Thomas; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Tsai, Isheng J.] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Parasitol, Miyazaki, Japan; [Bancroft, Allison J.; Grencis, Richard K.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Cooper, Philip J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Cooper, Philip J.] Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecc, Escuela Biol, Quito, Ecuador	Wellcome Trust Sanger Institute; University of Miyazaki; University of Manchester; Liverpool School of Tropical Medicine; University of Liverpool; Pontificia Universidad Catolica del Ecuador	Berriman, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	richard.grencis@manchester.ac.uk; mb4@sanger.ac.uk	Cotton, James A/B-8806-2008; Zarowiecki, Magdalena/ABD-2858-2021; Tsai, Isheng J/H-6606-2014; Berriman, Matthew/A-7618-2011; Tsai, Isheng Jason/ABB-8273-2021; Zarowiecki, Magdalena/F-5037-2013	Cotton, James A/0000-0001-5475-3583; Berriman, Matthew/0000-0002-9581-0377; Tsai, Isheng Jason/0000-0002-2123-5058; Zarowiecki, Magdalena/0000-0001-6102-7731; Reid, Adam/0000-0002-5926-7768; Huckvale, Thomas/0000-0001-7066-2577; Cooper, Philip/0000-0002-6770-6871	Wellcome Trust Sanger Institute [098051, WT100290MA, WT083620MA]; Wellcome Trust [088862/Z/09/Z]	Wellcome Trust Sanger Institute(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Maizels for initially proposing a T muris genome project, C. Anderson and T. Raine for sharing their unpublished method for enrichment analysis of IBD-associated genes, S. Thompson for preparing parasite material, T. Kikuchi and Z. Hance for preparing genomic DNA, H.M. Bennett for preparing RNA, K.L. Brooks and H. Beasley for manually curating gene models, M. Dunn for generating optical map data, N. Rawlings for helpful discussions, A. Coghlan for supporting bioinformatics analysis and M. Aslett for data submission to the European Molecular Biology Laboratory (EMBL). This work was funded by the Wellcome Trust through their support of the Wellcome Trust Sanger Institute (grant 098051) and through an Investigator Award (WT100290MA) and Programme grant (WT083620MA) to R.K.G. The collection of samples in Ecuador was supported by the Wellcome Trust (grant 088862/Z/09/Z).	BANCROFT AJ, 1994, EUR J IMMUNOL, V24, P3113, DOI 10.1002/eji.1830241230; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bien J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-10; Bos NA, 2001, GUT, V48, P762, DOI 10.1136/gut.48.6.762; Bowcutt R, 2011, PARASITE IMMUNOL, V33, P411, DOI 10.1111/j.1365-3024.2011.01300.x; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Cantacessi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023590; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Crow YJ, 2010, EUR J IMMUNOL, V40, P2376, DOI 10.1002/eji.201040829; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; DRAKE LJ, 1994, PARASITOLOGY, V109, P623, DOI 10.1017/S0031182000076502; Else KJ, 1996, INFECT IMMUN, V64, P2950, DOI 10.1128/IAI.64.8.2950-2954.1996; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Grencis RK, 2004, CLIN REV ALLERG IMMU, V26, P51, DOI 10.1385/CRIAI:26:1:51; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Helmby H, 2001, J EXP MED, V194, P355, DOI 10.1084/jem.194.3.355; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Johnston WL, 2010, CURR BIOL, V20, P1932, DOI 10.1016/j.cub.2010.09.059; Jouvin MH, 2012, J ALLERGY CLIN IMMUN, V130, P3, DOI 10.1016/j.jaci.2012.05.028; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koyama K, 2000, PARASITE IMMUNOL, V22, P13, DOI 10.1046/j.1365-3024.2000.00270.x; Lai HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007348; Levison SE, 2010, INFLAMM BOWEL DIS, V16, P2065, DOI 10.1002/ibd.21326; Levison SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-127; Liu MF, 2008, DNA CELL BIOL, V27, P223, DOI 10.1089/dna.2007.0691; Lynch EA, 2003, J IMMUNOL, V171, P4965, DOI 10.4049/jimmunol.171.10.4965; Marcilla A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001513; Mitreva M, 2008, PARASITOLOGY, V135, P869, DOI 10.1017/S0031182008004472; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; MUTAFOVA T, 1982, Z PARASITENKD, V67, P115, DOI 10.1007/BF00929519; Ota E, 2006, TOXICON, V48, P1002, DOI 10.1016/j.toxicon.2006.08.005; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; SCRAGG JN, 1978, AM J TROP MED HYG, V27, P255, DOI 10.4269/ajtmh.1978.27.255; SPAKULOVA M, 1994, J HELMINTHOL, V68, P67, DOI 10.1017/S0022149X0001350X; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Tarr DEK, 2005, TRENDS PARASITOL, V21, P224, DOI 10.1016/j.pt.2005.03.009; Tilney LG, 2005, J EXP ZOOL PART A, V303A, P927, DOI 10.1002/jez.a.214; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115	51	96	98	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					693	700		10.1038/ng.3010	http://dx.doi.org/10.1038/ng.3010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24929830	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000338093800009
J	Zhang, LW; Chen, LH; Wan, H; Yang, R; Wang, ZH; Feng, L; Yang, SH; Jones, S; Wang, SZ; Zhou, WX; Zhu, HS; Killela, PJ; Zhang, JT; Wu, Z; Li, GL; Hao, SY; Wang, Y; Webb, JB; Friedman, HS; Friedman, AH; McLendon, RE; He, YP; Reitman, ZJ; Bigner, DD; Yan, H				Zhang, Liwei; Chen, Lee H.; Wan, Hong; Yang, Rui; Wang, Zhaohui; Feng, Jie; Yang, Shaohua; Jones, Sian; Wang, Sizhen; Zhou, Weixin; Zhu, Huishan; Killela, Patrick J.; Zhang, Junting; Wu, Zhen; Li, Guilin; Hao, Shuyu; Wang, Yu; Webb, Joseph B.; Friedman, Henry S.; Friedman, Allan H.; McLendon, Roger E.; He, Yiping; Reitman, Zachary J.; Bigner, Darell D.; Yan, Hai			Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas	NATURE GENETICS			English	Article							PHOSPHATASE PPM1D; HISTONE H3.3; IDH1; WIP1; GLIOBLASTOMA; SUBGROUPS; KINASE; GENES; CHK2; P53	Gliomas arising in the brainstem and thalamus are devastating tumors that are difficult to surgically resect. To determine the genetic and epigenetic landscape of these tumors, we performed exomic sequencing of 14 brainstem gliomas (BSGs) and 12 thalamic gliomas. We also performed targeted mutational analysis of an additional 24 such tumors and genome-wide methylation profiling of 45 gliomas. This study led to the discovery of tumor-specific mutations in PPMID, encoding wild-type p53-induced protein phosphatase 1D (Will), in 37.5% of the BSGs that harbored hallmark H3F3A mutations encoding p.Lys27Met substitutions. PPMI D mutations were mutually exclusive with TP53 mutations in BSG and attenuated p53 activation in vitro. PPM1D mutations were truncating alterations in exon 6 that enhanced the ability of PPM1D to suppress the activation of the DNA damage response checkpoint protein CHK2. These results define PPMI D as a frequent target of somatic mutation and as a potential therapeutic target in brainstem gliomas.	[Zhang, Liwei; Yang, Shaohua; Zhang, Junting; Wu, Zhen; Hao, Shuyu; Wang, Yu] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Chen, Lee H.; Yang, Rui; Wang, Zhaohui; Zhou, Weixin; Zhu, Huishan; Killela, Patrick J.; Webb, Joseph B.; Friedman, Henry S.; Friedman, Allan H.; McLendon, Roger E.; He, Yiping; Reitman, Zachary J.; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Preston Robert Tisch Brain Tumor Ctr,Pediat Brain, Durham, NC 27710 USA; [Wan, Hong; Feng, Jie; Yang, Shaohua; Li, Guilin] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Yang, Shaohua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jones, Sian] Personal Genome Diagnost Inc, Baltimore, MD USA; [Wang, Sizhen] Beijing Pangen Technol Co Ltd, Beijing, Peoples R China	Capital Medical University; Duke University; Beijing Neurosurgical Institute; Capital Medical University; University of North Texas System; University of North Texas Health Science Center	Yan, H (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Preston Robert Tisch Brain Tumor Ctr,Pediat Brain, Durham, NC 27710 USA.	zjr@duke.edu; hai.yan@dm.duke.edu		Reitman, Zachary/0000-0002-9122-9550	National Cancer Institute [R01CA140316]; American Cancer Society [RSG-10-126-01-CCE]; Pediatric Brain Tumor Foundation Institute grant; Voices Against Brain Cancer Foundation grant; James S. McDonnell Foundation grant; V Foundation; NATIONAL CANCER INSTITUTE [P30CA014236, R01CA140316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Pediatric Brain Tumor Foundation Institute grant; Voices Against Brain Cancer Foundation grant; James S. McDonnell Foundation grant; V Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was partly supported by National Cancer Institute grant R01CA140316 (H.Y), the American Cancer Society (RSG-10-126-01-CCE) (H.Y.), a Pediatric Brain Tumor Foundation Institute grant (D.D.B.), a Voices Against Brain Cancer Foundation grant (D.D.B.), a James S. McDonnell Foundation grant (H.Y.), The V Foundation (H.Y.), an Accelerate Brain Cancer Cure Foundation grant (Hi), a Pediatric Brain Tumor Foundation Institute at Duke Early Career Award (Z.J.R.) and Natural Science Foundation of China grants 30772237 and 81241078 (L.Z.).	Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Dudgeon C, 2013, CELL CYCLE, V12, P2656, DOI 10.4161/cc.25694; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Moon SH, 2010, CELL CYCLE, V9, P2092, DOI 10.4161/cc.9.11.11810; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yagi H, 2012, BIOORG MED CHEM LETT, V22, P729, DOI 10.1016/j.bmcl.2011.10.084; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200	24	111	124	4	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					726	730		10.1038/ng.2995	http://dx.doi.org/10.1038/ng.2995			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24880341	Green Accepted			2022-12-25	WOS:000338093800014
J	Cottini, F; Hideshima, T; Xu, CX; Sattler, M; Dori, M; Agnelli, L; ten Hacken, E; Bertilaccio, MT; Antonini, E; Neri, A; Ponzoni, M; Marcatti, M; Richardson, PG; Carrasco, R; Kimmelman, AC; Wong, KK; Caigaris-Cappio, F; Blandino, G; Kuehl, WM; Anderson, KC; Tonon, G				Cottini, Francesca; Hideshima, Teru; Xu, Chunxiao; Sattler, Martin; Dori, Martina; Agnelli, Luca; ten Hacken, Elisa; Bertilaccio, Maria Teresa; Antonini, Elena; Neri, Antonino; Ponzoni, Maurilio; Marcatti, Magda; Richardson, Paul G.; Carrasco, Ruben; Kimmelman, Alec C.; Wong, Kwok-Kin; Caigaris-Cappio, Federico; Blandino, Giovanni; Kuehl, W. Michael; Anderson, Kenneth C.; Tonon, Giovanni			Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers	NATURE MEDICINE			English	Article							YES-ASSOCIATED PROTEIN; ABL TYROSINE KINASE; C-ABL; MULTIPLE-MYELOMA; TUMOR-SUPPRESSOR; P73; PATHWAY; PHOSPHORYLATION; TUMORIGENESIS; ACTIVATION	Oncogene-induced DNA damage elicits genomic instability in epithelial cancer cells, but apoptosis is blocked through inactivation of the tumor suppressor p53. In hematological cancers, the relevance of ongoing DNA damage and the mechanisms by which apoptosis is suppressed are largely unknown. We found pervasive DNA damage in hematologic malignancies, including multiple myeloma, lymphoma and leukemia, which leads to activation of a p53-independent, proapoptotic network centered on nuclear relocalization of ABL1 kinase. Although nuclear ABL1 triggers cell death through its interaction with the Hippo pathway coactivator YAP1 in normal cells, we show that low YAP1 levels prevent nuclear ABL1-induced apoptosis in these hematologic malignancies. YAP1 is under the control of a serine-threonine kinase, STK4. Notably, genetic inactivation of STK4 restores YAP1 levels, triggering cell death in vitro and in vivo. Our data therefore identify a new synthetic-lethal strategy to selectively target cancer cells presenting with endogenous DNA damage and low YAP1 levels.	[Cottini, Francesca; Hideshima, Teru; Richardson, Paul G.; Anderson, Kenneth C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA; [Cottini, Francesca; Dori, Martina; Antonini, Elena; Tonon, Giovanni] Ist Ricovero & Cura Carattere Sci IRCCS San Raffa, Div Mol Oncol, Funct Genom Canc Unit, Milan, Italy; [Xu, Chunxiao; Sattler, Martin; Carrasco, Ruben; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xu, Chunxiao; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Xu, Chunxiao; Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Dana Farber Canc Inst, Boston, MA USA; [Agnelli, Luca; Neri, Antonino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy; [ten Hacken, Elisa; Bertilaccio, Maria Teresa; Caigaris-Cappio, Federico] IRCCS San Raffaele Sci Inst, Div Mol Oncol, Lab Lymphoid Malignancies, Milan, Italy; [Ponzoni, Maurilio] IRCCS San Raffaele Sci Inst, Myeloma Unit, Pathol Unit, Milan, Italy; [Marcatti, Magda] IRCCS San Raffaele Sci Inst, Myeloma Unit, Dept Hematol Oncol, Hematol & Bone Marrow Transplantat Unit, Milan, Italy; [Kimmelman, Alec C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol,Div Genom Stabil & DNA Repair, Boston, MA 02115 USA; [Caigaris-Cappio, Federico; Tonon, Giovanni] Univ Vita Salute San Raffaele, Milan, Italy; [Caigaris-Cappio, Federico; Tonon, Giovanni] IRCCS San Raffaele Sci Inst, MAGIC Microenvironm & Genes Canc Blood Interdiv R, Milan, Italy; [Blandino, Giovanni] Italian Natl Canc Inst Regina Elena, Translat Oncogen Unit, Rome, Italy; [Kuehl, W. Michael] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Anderson, KC (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, 44 Binney St, Boston, MA 02115 USA.	kenneth_anderson@dfci.harvard.edu; tonon.giovanni@hsr.it	Neri, Antonino/I-9690-2014; Tonon, Giovanni/J-9804-2018	Neri, Antonino/0000-0001-9047-5912; Tonon, Giovanni/0000-0003-2973-5038; ten Hacken, Elisa/0000-0003-1573-8799; Cottini, Francesca/0000-0001-8676-7840; wong, kwok kin/0000-0001-6323-235X; Agnelli, Luca/0000-0003-0582-6170; DORI, MARTINA/0000-0002-1053-2006	Fondazione CARIPLO, a Marie Curie International Reintegration Grant; Associazione Raliana per la Ricerca sul Cancro (AIRC); Special Program Molecular Clinical Oncology [9965]; NIH [P50100707, PO-1 78378, RO-1 50947]; NATIONAL CANCER INSTITUTE [P50CA100707, P01CA155258, P01CA078378, R01CA050947, ZIASC006581, P50CA127003] Funding Source: NIH RePORTER	Fondazione CARIPLO, a Marie Curie International Reintegration Grant; Associazione Raliana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Sudol (Mount Sinai School of Medicine) for the eGFP-YAP1 construct, W Hahn (Dana-Farber Cancer Institute) for pLKO.1 shRNA lentiviral vectors and S. Rosen (Northwestern University) and R. Burger (University of Kiel) for MM.1R and INA-6 MM cells. We also thank E. Di Cairano and L. Spagnuolo for immunohistochemical stains, F. Ghini and A.M. Gasparri for technical help, the Dana-Farber Cancer Institute Flow cytometry facility, D. Kufe and F. Bernassola for insightful suggestions, C. Brennan for the bioinformatics analysis and members of the Anderson and Tonon lab for sharing reagents and critical reading of the manuscript. W.M.K. is supported by the Intramural Research Program of the US National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. This work was supported by Fondazione CARIPLO, a Marie Curie International Reintegration Grant and the Associazione Raliana per la Ricerca sul Cancro (AIRC; AIRC Special Program Molecular Clinical Oncology, 5 per milk no. 9980 to A.N. and Investigator Grants and Special Program Molecular Clinical Oncology, 5 per mile no. 9965 to G.T.) (G.T.). K.C.A. is an American Cancer Society Clinical Research Professor and is supported by NIH grants NIH SPORE P50100707, PO-1 78378 and RO-1 50947.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Boehrer S, 2009, ONCOGENE, V28, P2205, DOI 10.1038/onc.2009.69; Brown L, 1997, NATURE, V387, P450, DOI 10.1038/387450a0; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1994, ONCOGENE, V9, P2145; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Walters DK, 2011, LEUKEMIA, V25, P1344, DOI 10.1038/leu.2011.94; White E, 1999, NATURE, V399, P734, DOI 10.1038/21539; Xu-Monette ZY, 2012, BLOOD, V119, P3668, DOI 10.1182/blood-2011-11-366062; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	38	201	211	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					599	606		10.1038/nm.3562	http://dx.doi.org/10.1038/nm.3562			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24813251	Green Accepted, Green Submitted			2022-12-25	WOS:000337071000021
J	Kakiuchi, M; Nishizawa, T; Ueda, H; Gotoh, K; Tanaka, A; Hayashi, A; Yamamoto, S; Tatsuno, K; Katoh, H; Watanabe, Y; Ichimura, T; Ushiku, T; Funahashi, S; Tateishi, K; Wada, I; Shimizu, N; Nomura, S; Koike, K; Seto, Y; Fukayama, M; Aburatani, H; Ishikawa, S				Kakiuchi, Miwako; Nishizawa, Takashi; Ueda, Hiroki; Gotoh, Kengo; Tanaka, Atsushi; Hayashi, Akimasa; Yamamoto, Shogo; Tatsuno, Kenji; Katoh, Hiroto; Watanabe, Yoshiaki; Ichimura, Takashi; Ushiku, Tetsuo; Funahashi, Shinichi; Tateishi, Keisuke; Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Koike, Kazuhiko; Seto, Yasuyuki; Fukayama, Masashi; Aburatani, Hiroyuki; Ishikawa, Shumpei			Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma	NATURE GENETICS			English	Article							TNM CLASSIFICATION; 7TH EDITION; CANCER; GTPASES; EXPRESSION; ADHESION; PATHWAY; COHORT; RAS	Diffuse-type gastric carcinoma (DGC) is characterized by a highly malignant phenotype with prominent infiltration and stromal induction. We performed whole-exome sequencing on 30 DGC cases and found recurrent RHOA nonsynonymous mutations. With validation sequencing of an additional 57 cases, RHOA mutation was observed in 25.3% (22/87) of DGCs, with mutational hotspots affecting the Tyr42, Arg5 and Gly17 residues in RHOA protein. These positions are highly conserved among RHO family members, and Tyr42 and Arg5 are located outside the guanine nucleotide binding pocket. Several lines of functional evidence indicated that mutant RHOA works in a gain-of-function manner. Comparison of mutational profiles for the major gastric cancer subtypes showed that RHOA mutations occur specifically in DGCs, the majority of which were histopathologically characterized by the presence of poorly differentiated adenocarcinomas together with more differentiated components in the gastric mucosa. Our findings identify a potential therapeutic target for this poor-prognosis subtype of gastric cancer with no available molecularly targeted drugs.	[Kakiuchi, Miwako; Ueda, Hiroki; Gotoh, Kengo; Yamamoto, Shogo; Tatsuno, Kenji; Aburatani, Hiroyuki; Ishikawa, Shumpei] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Kakiuchi, Miwako; Tateishi, Keisuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Nishizawa, Takashi; Funahashi, Shinichi] Forerunner Pharma Res Co Ltd, Tokyo, Japan; [Tanaka, Atsushi; Hayashi, Akimasa; Ichimura, Takashi; Ushiku, Tetsuo; Fukayama, Masashi; Ishikawa, Shumpei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Yamamoto, Shogo; Tatsuno, Kenji; Aburatani, Hiroyuki] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo, Japan; [Katoh, Hiroto; Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Watanabe, Yoshiaki] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kamakura, Kanagawa, Japan; [Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Tokyo	Ishikawa, S (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan.	sish.gpat@mri.tmd.ac.jp	Tatsuno, Kenji/B-1765-2008; Katoh, Hiroto/ADO-8117-2022; Tanaka, Atsushi/AAY-1154-2020	Tanaka, Atsushi/0000-0003-1229-4539; Nomura, Sachiyo/0000-0003-4293-6205; Kakiuchi, Miwako/0000-0002-6300-6771	Ministry of Education, Culture, Sports, Science and Technology of Japan [22134003]; JSPS (Japan Society for the Promotion of Science) KAKENHI grant [24221011]; Health Labor Sciences Research Grant; grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan Society for the Promotion of Science) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labor Sciences Research Grant; grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan	We would like to thank K. Shiina, K. Sakuma, K. Nakano, A. Nishimoto and R. Sato for technical assistance. This study was supported by Grants-in-Aid for Scientific Research in Innovative Areas to the "Systems Cancer Project" (grant 22134003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.I.), by JSPS (Japan Society for the Promotion of Science) KAKENHI grant 24221011 (HA.), by a Health Labor Sciences Research Grant (HA.) and by a grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.Y., K. Tatsuno and HA.). The supercomputing resource was provided by the Human Genome Center (University of Tokyo).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bang Y, 2009, J CLIN ONCOL, V27; Borrmann R, 1926, HDB SPEZIELLEN PATHO, P812, DOI [DOI 10.1007/978-3-7091-5436-6_7, 10.1007/978-3-7091-5436-6_7]; Carothers AM, 2006, EXP CELL RES, V312, P387, DOI 10.1016/j.yexcr.2005.11.019; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chiaravalli AM, 2012, WORLD J GASTROENTERO, V18, P896, DOI 10.3748/wjg.v18.i9.896; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hayashi T, 2013, CANCER-AM CANCER SOC, V119, P1330, DOI 10.1002/cncr.27928; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Kaneko S, 2001, BRIT J CANCER, V84, P400, DOI 10.1054/bjoc.2000.1602; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Kong X, 2012, J SURG ONCOL, V106, P346, DOI 10.1002/jso.23004; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Stiekema J, 2013, EJSO-EUR J SURG ONC, V39, P686, DOI 10.1016/j.ejso.2013.02.026; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	31	349	359	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					583	587		10.1038/ng.2984	http://dx.doi.org/10.1038/ng.2984			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24816255				2022-12-25	WOS:000336870700014
J	Nava, C; Dalle, C; Rastetter, A; Striano, P; de Kovel, CGF; Nabbout, R; Cances, C; Ville, D; Brilstra, EH; Gobbi, G; Raffo, E; Bouteiller, D; Marie, Y; Trouillard, O; Robbiano, A; Keren, B; Agher, D; Roze, E; Lesage, S; Nicolas, A; Brice, A; Baulac, M; Vogt, C; El Hajj, N; Schneiderr, E; Suls, A; Weckhuysen, S; Gormley, P; Lehesjoki, AE; De Jonghe, P; Helbig, I; Baulac, S; Zara, F; Koeleman, BPC; Haaf, T; LeGuern, E; Depienne, C				Nava, Caroline; Dalle, Carine; Rastetter, Agnes; Striano, Pasquale; de Kovel, Carolien G. F.; Nabbout, Rima; Cances, Claude; Ville, Dorothee; Brilstra, Eva H.; Gobbi, Giuseppe; Raffo, Emmanuel; Bouteiller, Delphine; Marie, Yannick; Trouillard, Oriane; Robbiano, Angela; Keren, Boris; Agher, Dahbia; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Vogt, Cornelia; El Hajj, Nady; Schneiderr, Eberhard; Suls, Arvid; Weckhuysen, Sarah; Gormley, Padhraig; Lehesjoki, Anna-Elina; De Jonghe, Peter; Helbig, Ingo; Baulac, Stephanie; Zara, Federico; Koeleman, Bobby P. C.; Haaf, Thomas; LeGuern, Eric; Depienne, Christel		EuroEPINOMICS RES Consortiumm	De novo mutations in HCN1 cause early infantile epileptic encephalopathy	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; ACTIVATED PACEMAKER CHANNELS; COPY NUMBER VARIANTS; ABSENCE EPILEPSY; CATION CURRENT; MICE LACKING; HIPPOCAMPUS; EXPRESSION; NEURONS; EPILEPTOGENESIS	Hyperpolarization-activated, cyclic nucleotide gated (HCN) channels contribute to cationic current in neurons and regulate the excitability of neuronal networks. Studies in rat models have shown that the Hcn1 gene has a key role in epilepsy, but clinical evidence implicating HCN1 mutations in human epilepsy is lacking. We carried out exome sequencing for parent-offspring trios with fever-sensitive, intractable epileptic encephalopathy, leading to the discovery of two de novo missense HCN1 mutations. Screening of follow-up cohorts comprising 157 cases in total identified 4 additional amino acid substitutions. Patch-clamp recordings of I-h, currents in cells expressing wild-type or mutant human HCN1 channels showed that the mutations had striking but divergent effects on homomeric channels. Individuals with mutations had clinical features resembling those of Dravet syndrome with progression toward atypical absences, intellectual disability and autistic traits. These findings provide clear evidence that de novo HCN1 point mutations cause a recognizable earlyonset epileptic encephalopathy in humans.	[Nava, Caroline; Dalle, Carine; Rastetter, Agnes; Agher, Dahbia; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Baulac, Stephanie; LeGuern, Eric; Depienne, Christel] Hop La Pitie Salpetriere, INSERM, UMR 975, Inst Cerveau & Moelle Epiniere, Paris, France; [Nava, Caroline; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Baulac, Stephanie; LeGuern, Eric] Hop La Pitie Salpetriere, CNRS 7225, Paris, France; [Nava, Caroline; Trouillard, Oriane; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Baulac, Stephanie; LeGuern, Eric; Depienne, Christel] Univ Paris 06, UMRS 975, Paris, France; [Nava, Caroline; Trouillard, Oriane; Brice, Alexis; LeGuern, Eric] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonctionnelle Neurogenet Mol & Cellulaire, Paris, France; [Dalle, Carine] Inst Cerveau & Moelle Epiniere, Plateforme Electrophysiol, Paris, France; [Striano, Pasquale] G Gaslini Inst Children, Pediat Neurol & Muscular Dis Unit, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [de Kovel, Carolien G. F.; Brilstra, Eva H.; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Nabbout, Rima] Hop Necker Enfants Malad, AP HP, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, Paris, France; [Nabbout, Rima] Univ Paris 05, INSERM, U663, Sorbonne Paris Cite,Hop Necker Enfants Malad, Paris, France; [Cances, Claude] Ctr Hosp Univ Toulouse, Hop Enfants, Serv Neurol Pediat, Toulouse, France; [Ville, Dorothee] Ctr Hosp Univ Lyon, Hop Femme Mere Enfant, Serv Neurol Pediat, Bron, France; [Gobbi, Giuseppe] Inst Neurol Sci Bologna, IRCCS, Child Neurol Unit, Bologna, Italy; [Raffo, Emmanuel] Ctr Hosp Univ Nancy, Hop Enfants Brabois, Serv Neuropediat, Vandoeuvre Les Nancy, France; [Bouteiller, Delphine; Marie, Yannick] Inst Cerveau & Moelle Epiniere, Plateforme Genotypage & Sequencage, Paris, France; [Robbiano, Angela; Zara, Federico] Gaslini Inst, Dept Neurosci, Neurogenet Lab, Genoa, Italy; [Keren, Boris] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonctionnelle Cytogenet, Paris, France; [Vogt, Cornelia; El Hajj, Nady; Schneiderr, Eberhard; Haaf, Thomas; Depienne, Christel] Univ Wurzburg, Inst Humangenet, D-97070 Wurzburg, Germany; [Suls, Arvid; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Suls, Arvid; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Gormley, Padhraig] Wellcome Trust Sanger Inst, Hinxton, England; [Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Mol Neurol & Neurosci Ctr, Helsinki, Finland; [Helbig, Ingo] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU Lyon; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); CHU de Nancy; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Wurzburg; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Wellcome Trust Sanger Institute; University of Helsinki; University of Kiel; Schleswig Holstein University Hospital	Depienne, C (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR 975, Inst Cerveau & Moelle Epiniere, Paris, France.	eric.leguern@psl.aphp.fr; christel.depienne@upmc.fr	Brice, Alexis/A-2170-2009; Striano, Pasquale/F-9117-2014; Weckhuysen, Sarah/HGB-9957-2022; brice, alexis/AAE-8275-2019; Suls, Arvid/M-2694-2013; Brilstra, Eva/AAT-3092-2021; May, Patrick/N-1019-2019; Baulac, Stéphanie/O-2099-2016; Zara, Federico/U-3477-2017; Depienne, Christel/AAL-3835-2021; Stephani, Ulrich/D-1004-2010; May, Patrick/B-1238-2010; Helbig, Ingo/G-8467-2018; Gormley, Padhraig/L-1949-2018; de Kovel, Carolien/AAI-3531-2021; Muhle, Hiltrud/F-5715-2010; Craiu, Dana/ABE-4886-2020	Striano, Pasquale/0000-0002-6065-1476; Weckhuysen, Sarah/0000-0003-2878-1147; brice, alexis/0000-0002-0941-3990; Suls, Arvid/0000-0003-0328-198X; May, Patrick/0000-0001-8698-3770; Baulac, Stéphanie/0000-0001-6430-4693; Zara, Federico/0000-0001-9744-5222; Depienne, Christel/0000-0002-7212-9554; May, Patrick/0000-0001-8698-3770; Helbig, Ingo/0000-0001-8486-0558; Gormley, Padhraig/0000-0002-8908-6968; de Kovel, Carolien/0000-0002-7818-1396; Balling, Rudi/0000-0003-2902-5650; Palotie, Aarno/0000-0002-2527-5874; Serratosa, Jose/0000-0003-2239-8948; El Hajj, Nady/0000-0003-3420-8531; Trouillard, Oriane/0000-0003-0228-0942; Moller, Rikke S./0000-0002-9664-1448; Krause, Roland/0000-0001-9938-7126; Guerrini, Renzo/0000-0002-7272-7079; schneider, eberhard/0000-0003-4320-3652; Klein, Karl Martin/0000-0002-6654-1665; Nava, Caroline/0000-0003-1272-0518; Craiu, Dana/0000-0003-4156-6812; Selmer, Kaja Kristine/0000-0003-4871-112X	University of Wiirzburg, Biocodex, Fondation de France; ERA-NET NEURON EUHFAUTISM; Investissements d'Avenir program [ANR-10-IAIHU-06]; INSERM, AP-HP; Eurocores program EuroEPINOMICS of the European Science Foundation; Fund for Scientific Research Flanders (FWO); University of Antwerp; Genetics Commission of the Italian League Against Epilepsy (LICE); Netherlands National Epilepsy Fund	University of Wiirzburg, Biocodex, Fondation de France; ERA-NET NEURON EUHFAUTISM; Investissements d'Avenir program(French National Research Agency (ANR)); INSERM, AP-HP(Institut National de la Sante et de la Recherche Medicale (Inserm)); Eurocores program EuroEPINOMICS of the European Science Foundation; Fund for Scientific Research Flanders (FWO)(FWO); University of Antwerp; Genetics Commission of the Italian League Against Epilepsy (LICE); Netherlands National Epilepsy Fund	We thank the patients and their families for their participation in this study, J. Stieber (Friedrich Alexander Universitat Erlangen-Nurnberg, Germany) for providing a plasmid containing human HCNI cDNA, the International Parkinson's Disease Genomics Consortium (IPDGC) for granting access to the list of HCN1 variants present in control populations and populations with Parkinson's disease, L. Van de Velde Boermans for genetic tests for SCN1A and PCDH19 and tests on the parents, M. Nizard for case selection, and G. Huguet and T. Bourgeron for helpful discussions. The research generating these results was funded by the University of Wiirzburg, Biocodex, Fondation de France, ERA-NET NEURON EUHFAUTISM, the "Investissements d'Avenir" program ANR-10-IAIHU-06 (IHU-A-ICM), INSERM, AP-HP, the Eurocores program EuroEPINOMICS of the European Science Foundation, the Fund for Scientific Research Flanders (FWO) and the University of Antwerp. P.S. and F.Z. thank the Genetics Commission of the Italian League Against Epilepsy (LICE) for their support. B.P.C.K. and C.G.Ed.K. were supported by the Netherlands National Epilepsy Fund. A.S. is a postdoctoral fellow of the FWO. C.N., A.B. and C. Depienne are members of the Bio-Psy Labex.	Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Cestele S, 2013, P NATL ACAD SCI USA, V110, P17546, DOI 10.1073/pnas.1309827110; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne C., 2012, JASPERS BASIC MECH E, V62, P797; Depienne C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000381; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kase Daisuke, 2012, J Signal Transduct, V2012, P619747, DOI 10.1155/2012/619747; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Munsch T, 1999, J PHYSIOL-LONDON, V519, P505, DOI 10.1111/j.1469-7793.1999.0505m.x; Nava C, 2014, EUR J HUM GENET, V22, P71, DOI 10.1038/ejhg.2013.88; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Poolos N.P., 2012, JASPERS BASIC MECH E, V7, P85; Powell KL, 2008, EPILEPSIA, V49, P1686, DOI 10.1111/j.1528-1167.2008.01593.x; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2010, EPILEPSIA, V51, P1624, DOI 10.1111/j.1528-1167.2010.02554.x; Surges R, 2003, EPILEPSIA, V44, P150, DOI 10.1046/j.1528-1157.2003.36802.x; Tang B, 2008, NEUROBIOL DIS, V29, P59, DOI 10.1016/j.nbd.2007.08.006	40	139	149	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					640	645		10.1038/ng.2952	http://dx.doi.org/10.1038/ng.2952			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747641	Green Submitted			2022-12-25	WOS:000336870700024
J	Breckwoldt, M; Pfister, FMJ; Bradley, PM; Marinkovic, P; Williams, PR; Brilll, MS; Plomer, B; Schmalz, A; St Clair, DK; Naumann, R; Griesbeck, O; Schwarzlander, M; Godinho, L; Bareyre, FM; Dick, TP; Kerschensteiner, M; Misgeld, T				Breckwoldt, Michael; Pfister, Franz M. J.; Bradley, Peter M.; Marinkovic, Petar; Williams, Philip R.; Brilll, Monika S.; Plomer, Barbara; Schmalz, Anja; St Clair, Daret K.; Naumann, Ronald; Griesbeck, Oliver; Schwarzlaender, Markus; Godinho, Leanne; Bareyre, Florence M.; Dick, Tobias P.; Kerschensteiner, Martin; Misgeld, Thomas			Multiparametric optical analysis of mitochondrial redox signals during neuronal physiology and pathology in vivo	NATURE MEDICINE			English	Article							HYDROGEN-PEROXIDE; SUPEROXIDE FLASHES; PERMEABILITY TRANSITION; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; SPINAL-CORD; FLUORESCENT; REGENERATION; CALCIUM; CELLS	Mitochondrial redox signals have a central role in neuronal physiology and disease. Here we describe a new optical approach to measure fast redox signals with single-organelle resolution in living mice that express genetically encoded redox biosensors in their neuronal mitochondria. Moreover, we demonstrate how parallel measurements with several biosensors can integrate these redox signals into a comprehensive characterization of mitochondrial function. This approach revealed that axonal mitochondria undergo spontaneous 'contractions' that are accompanied by reversible redox changes. These contractions are amplified by neuronal activity and acute or chronic neuronal insults. Multiparametric imaging reveals that contractions constitute respiratory chain-dependent episodes of depolarization coinciding with matrix alkalinization, followed by uncoupling. In contrast, permanent mitochondrial damage after spinal cord injury depends on calcium influx and mitochondrial permeability transition. Thus, our approach allows us to identify heterogeneity among physiological and pathological redox signals, correlate such signals to functional and structural organelle dynamics and dissect the underlying mechanisms.	[Breckwoldt, Michael; Pfister, Franz M. J.; Marinkovic, Petar; Williams, Philip R.; Brilll, Monika S.; Plomer, Barbara; Godinho, Leanne; Misgeld, Thomas] Tech Univ Munich, Inst Neuronal Cell Biol, D-80290 Munich, Germany; [Breckwoldt, Michael; Pfister, Franz M. J.; Bradley, Peter M.; Schmalz, Anja; Bareyre, Florence M.; Kerschensteiner, Martin] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA; [St Clair, Daret K.] Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Naumann, Ronald] Max Planck Inst Mol Cell Biol & Genet, Transgen Core Facil, Dresden, Germany; [Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Schwarzlaender, Markus] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Bareyre, Florence M.; Kerschensteiner, Martin; Misgeld, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Dick, Tobias P.] German Canc Res Ctr, Div Redox Regulat, Heidelberg, Germany; [Misgeld, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Misgeld, Thomas] CIPS, Munich, Germany	Technical University of Munich; University of Munich; University of Kentucky; University of Kentucky; Max Planck Society; Max Planck Society; University of Bonn; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kerschensteiner, M (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Munich, Germany.	martin.kerschensteiner@med.uni-muenchen.de; thomas.misgeld@lrz.tu-muenchen.de	Schwarzländer, Markus/HGE-3726-2022	Schwarzlander, Markus/0000-0003-0796-8308; Brill, Monika/0000-0001-5422-9175; Griesbeck, Oliver/0000-0001-5883-5594; Marinkovic, Petar/0000-0002-3072-972X	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 870, Transregio 128]; German Federal Ministry of Research and Education (BMBF, Competence Network Multiple Sclerosis); European Research Council (ERC) under the European Union's Seventh Framework Program (FP/ERC) [310932]; Hertie Foundation; Verein Therapieforschung fur MS-Kranke e.V; Institute of Advanced Studies (Technische Universitat Munchen); Alexander von Humboldt Foundation; Center for Integrated Protein Science (Munich) [EXC 114]; DFG [SFB 596, SFB 870, SFB 938, SFB 1036]; DZNE (Munich); SyNergy [EXC 1010]; DFG Priority Program 1710; US National Institutes of Health [Ca 049797]; Edward P. Evans Foundation; BMBF ('LungSys'); Gertrud Reemtsma Foundation (Max Planck Society); German National Academic Foundation; Wings of Life Foundation; Human Frontier Science Program; Graduate School of Technische Universitat Munchen; NATIONAL CANCER INSTITUTE [R29CA049797, R01CA049797] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Research and Education (BMBF, Competence Network Multiple Sclerosis); European Research Council (ERC) under the European Union's Seventh Framework Program (FP/ERC)(European Research Council (ERC)); Hertie Foundation; Verein Therapieforschung fur MS-Kranke e.V; Institute of Advanced Studies (Technische Universitat Munchen); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Center for Integrated Protein Science (Munich); DFG(German Research Foundation (DFG)); DZNE (Munich); SyNergy; DFG Priority Program 1710(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; BMBF ('LungSys')(Federal Ministry of Education & Research (BMBF)); Gertrud Reemtsma Foundation (Max Planck Society); German National Academic Foundation; Wings of Life Foundation; Human Frontier Science Program(Human Frontier Science Program); Graduate School of Technische Universitat Munchen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Heitmann, M. Adrian and K. Wullimann for technical assistance, D. Matzek, M. Budak, N. Budak and L. Marinkovic for animal husbandry and M. Krumbholz for help with statistical analysis. We thank M. Murphy (University of Cambridge) for the gift of MitoQ. We thank R. Campbell (University of Alberta) for the R-GECO1 plasmid, L. Looger (Howard Hughes Medical Institute Janelia Farm Research Campus) for GCaMP3 and N. Demaurex (University of Geneva Medical School) for mito-SypHer. Work in M.K.'s laboratory is financed through grants from the Deutsche Forschungsgemeinschaft (DFG; Sonderforschungsbereich 870 and Transregio 128), the German Federal Ministry of Research and Education (BMBF, Competence Network Multiple Sclerosis), the European Research Council (ERC) under the European Union's Seventh Framework Program (FP/2007-2013; ERC grant agreement no. 310932), the Hertie Foundation and the 'Verein Therapieforschung fur MS-Kranke e.V'. T.M. is supported by the Institute of Advanced Studies (Technische Universitat Munchen), the Alexander von Humboldt Foundation, the Center for Integrated Protein Science (Munich, EXC 114), the DFG (SFB 596) and the DZNE (Munich). T.M.'s work on this project was further supported by the BMBF as part of ERA-Net '2-photon imaging'. F.M.B. is supported by the DFG (SFB 870) and an independent group leader award of the BMBF. F.M.B., M.K. and T.M. are supported by SyNergy (EXC 1010), and T.P.D., M.K. and T.M. are supported by the DFG Priority Program 1710. Work in D.K.S.C.'s laboratory is supported by grants from the US National Institutes of Health Ca 049797 and the Edward P. Evans Foundation. T.P.D. is supported by the DFG (SFB 938, SFB 1036) and the BMBF ('LungSys'). M.O.B. is recipient of a doctoral fellowship from the Gertrud Reemtsma Foundation (Max Planck Society) and is supported by the German National Academic Foundation. P.R.W. is supported by a postdoctoral fellowship from the Wings of Life Foundation and received previous support from the Human Frontier Science Program. M.O.B. and P.M. were supported by the Graduate School of Technische Universitat Munchen.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Keller JN, 1998, J NEUROSCI, V18, P687; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Rieger S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000621; Roma LP, 2012, BIOCHEM J, V441, P971, DOI 10.1042/BJ20111770; Santo-Domingo J, 2013, EMBO J, V32, P1927, DOI 10.1038/emboj.2013.124; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Schwarzlander M, 2012, PLANT CELL, V24, P1188, DOI 10.1105/tpc.112.096438; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Wang JQ, 2013, J BIOL CHEM, V288, P3070, DOI 10.1074/jbc.M112.407726; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	38	119	122	0	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					559	122		10.1038/nm.3520	http://dx.doi.org/10.1038/nm.3520			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24747747				2022-12-25	WOS:000335710700029
J	Lin, DC; Hao, JJ; Nagata, Y; Xu, L; Shang, L; Meng, X; Sato, Y; Okuno, Y; Varela, AM; Ding, LW; Garg, M; Liu, LZ; Yang, H; Yin, D; Shi, ZZ; Jiang, YY; Gu, WY; Gong, T; Zhang, Y; Xu, X; Kalid, O; Shacham, S; Ogawa, S; Wang, MR; Koeffler, HP				Lin, De-Chen; Hao, Jia-Jie; Nagata, Yasunobu; Xu, Liang; Shang, Li; Meng, Xuan; Sato, Yusuke; Okuno, Yusuke; Varela, Ana Maria; Ding, Ling-Wen; Garg, Manoj; Liu, Li-Zhen; Yang, Henry; Yin, Dong; Shi, Zhi-Zhou; Jiang, Yan-Yi; Gu, Wen-Yue; Gong, Ting; Zhang, Yu; Xu, Xin; Kalid, Ori; Shacham, Sharon; Ogawa, Seishi; Wang, Ming-Rong; Koeffler, H. Phillip			Genomic and molecular characterization of esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; MULTIPLE HUMAN CANCERS; LYMPH-NODE METASTASIS; NUCLEAR EXPORT; PROGNOSTIC-FACTOR; EXPRESSION; CRM1; INHIBITOR	Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide and particularly common in certain regions of Asia. Here we report the whole-exome or targeted deep sequencing of 139 paired ESCC cases, and analysis of somatic copy number variations (SCNV) of over 180 ESCCs. We identified previously uncharacterized mutated genes such as FAT1, FAT2, ZNF750 and KMT2D, in addition to those already known (TP53, PIK3CA and NOTCH 1). Further SCNV evaluation, immunohistochemistry and biological analysis suggested their functional relevance in ESCC. Notably, RTK-MAPK-PI3K pathways, cell cycle and epigenetic regulation are frequently dysregulated by multiple molecular mechanisms in this cancer. Our approaches also uncovered many druggable candidates, and XPO1 was further explored as a therapeutic target because it showed both gene mutation and protein overexpression. Our integrated study unmasks a number of novel genetic lesions in ESCC and provides an important molecular foundation for understanding esophageal tumors and developing therapeutic targets.	[Lin, De-Chen; Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA USA; [Lin, De-Chen; Xu, Liang; Meng, Xuan; Varela, Ana Maria; Ding, Ling-Wen; Garg, Manoj; Liu, Li-Zhen; Yang, Henry; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Hao, Jia-Jie; Shang, Li; Shi, Zhi-Zhou; Jiang, Yan-Yi; Gu, Wen-Yue; Gong, Ting; Zhang, Yu; Xu, Xin; Wang, Ming-Rong] Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Hao, Jia-Jie; Shang, Li; Shi, Zhi-Zhou; Jiang, Yan-Yi; Gu, Wen-Yue; Gong, Ting; Zhang, Yu; Xu, Xin; Wang, Ming-Rong] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Nagata, Yasunobu; Sato, Yusuke; Okuno, Yusuke; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan; [Yin, Dong] Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Kalid, Ori; Shacham, Sharon] Karyopharm Therapeut, Natick, MA USA; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Nat Univ Canc Inst, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; University of Tokyo; Sun Yat Sen University; National University of Singapore	Wang, MR (corresponding author), Peking Union Med Coll, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	dchlin11@gmail.com; wangmr2015@126.com	Xu, Liang/I-9877-2014; Ding, Ling-Wen/H-6916-2019; Okuno, Yusuke/C-9082-2009; LIN, DECHEN/K-9457-2014; Ogawa, Seishi/AAE-7088-2019; Garg, Manoj/C-4076-2019	Xu, Liang/0000-0002-2700-4840; Ding, Ling-Wen/0000-0003-0022-1551; Okuno, Yusuke/0000-0003-3139-9272; Garg, Manoj/0000-0002-3492-2957; Yin, Dong/0000-0002-1878-4849; WANG, Ming-Rong/0000-0002-8767-9356	National High-Tech R&D Program of China [2012AA02A503, 2012AA02A209]; National Natural Science Foundation of China [81330052]; US National Institutes of Health [R01CA026038-35]; National Research Foundation Singapore; Singapore Ministry of Education under Research Centers of Excellence; Singapore Ministry of Health's National Medical Research Council under Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under Research Centers of Excellence(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council under Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P.Tan and Z.Zang for generously sharing related facilities.We also thank B. Koegler and S. Koegler for their generous support. This work is supported by National High-Tech R&D Program of China 2012AA02A503 and 2012AA02A209 (M.-R.W.), National Natural Science Foundation of China 81330052 (M.-R.W.), US National Institutes of Health grant R01CA026038-35 (H.P.K.), National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centers of Excellence initiative (H.P.K.), and Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award to H.P.K.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Akagi I, 2009, INT J ONCOL, V34, P767, DOI 10.3892/ijo_00000202; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boone J, 2008, J CLIN PATHOL, V61, P909, DOI 10.1136/jcp.2008.055772; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chen HY, 2013, MOL CANCER RES, V11, P1542, DOI 10.1158/1541-7786.MCR-13-0317; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cohen I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042628; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Dikshit B, 2013, ONCOGENE, V32, P3798, DOI 10.1038/onc.2012.393; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hirasaki S, 2007, ONCOLOGIST, V12, P406, DOI 10.1634/theoncologist.12-4-406; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kim JY, 2010, CELL CYCLE, V9, P3680, DOI 10.4161/cc.9.18.12716; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sato-Kuwabara Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-6; Schmidt J, 2013, LEUKEMIA, V27, P2357, DOI 10.1038/leu.2013.172; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Shigaki H, 2013, CLIN CANCER RES, V19, P2451, DOI 10.1158/1078-0432.CCR-12-3559; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Walker CJ, 2013, BLOOD, V122, P3034, DOI 10.1182/blood-2013-04-495374; Wei QC, 2007, INT J ONCOL, V31, P493; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang Y, 2012, GASTROENTEROLOGY, V142, P521, DOI 10.1053/j.gastro.2011.11.023; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	54	403	423	2	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					467	473		10.1038/ng.2935	http://dx.doi.org/10.1038/ng.2935			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686850	Green Accepted, Green Submitted			2022-12-25	WOS:000335422900013
J	Gaudelli, NM; Townsend, CA				Gaudelli, Nicole M.; Townsend, Craig A.			Epimerization and substrate gating by a TE domain in beta-lactam antibiotic biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							TERMINAL THIOESTERASE DOMAIN; POLYKETIDE SYNTHASE; MUTATIONAL ANALYSIS; FUNGAL THIOESTERASE; CHAIN ELONGATION; NOCARDICIN; SPECIFICITY; SYNTHETASE; PENICILLIN; ENZYME	Nonribosomal peptide synthetases are versatile engines of bioactive natural product biosynthesis that function according to the multiple carrier thiotemplate mechanism. C-terminal thioesterase (TE) domains of these giant modular proteins typically catalyze product release by hydrolysis or macrocyclization. We now report an unprecedented, dual-function TE that is involved in the biosynthesis of nocardicin A, which is the paradigm monocyclic beta-lactam antibiotic. Contrary to our expectation, a stereodefined series of potential peptide substrates for the nocardicin TE domain failed to undergo hydrolysis. The stringent discrimination against peptide intermediates was overcome by prior monocyclic beta-lactam formation at an L-seryl site. Kinetic data are interpreted such that the TE domain acts as a gatekeeper to hold the assembling peptide on an upstream domain until b-lactam formation takes place and then rapidly catalyzes epimerization, which has not been observed previously as a TE catalytic function, and thioesterase cleavage to discharge a fully fledged pentapeptide beta-lactam harboring nocardicin G, the universal precursor of the nocardicins.	[Gaudelli, Nicole M.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Gaudelli, NM (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	ctownsend@jhu.edu		Gaudelli, Nicole/0000-0001-8608-4855	US National Institutes of Health grant [AI014937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI014937, R37AI014937, R01AI014937] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant AI014937. We thank K.A. Moshos, C.J. Hastings and J.W. Li for their helpful discussion, chemical advice and encouragement and R.F. Li for guidance with molecular biology. We also thank K. Belecki and I.P. Mortimer for high-resolution MS data and C.T. Walsh (Harvard University) for providing the pET29-Sfp expression plasmid. A. Majumdar is graciously acknowledged for his assistance with the <SUP>1</SUP>H-NMR arrayed D<INF>2</INF>O-exchange experiment.	AMYES TL, 1992, J AM CHEM SOC, V114, P10297, DOI 10.1021/ja00052a028; AOKI H, 1976, J ANTIBIOT, V29, P492, DOI 10.7164/antibiotics.29.492; Balibar CJ, 2005, CHEM BIOL, V12, P1189, DOI 10.1016/j.chembiol.2005.08.010; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; BANKO G, 1987, J AM CHEM SOC, V109, P2858, DOI 10.1021/ja00243a068; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; COLLIER HB, 1973, ANAL BIOCHEM, V56, P310, DOI 10.1016/0003-2697(73)90196-6; Davidsen JM, 2013, J AM CHEM SOC, V135, P1749, DOI 10.1021/ja307710d; Davidsen JM, 2012, CHEM BIOL, V19, P297, DOI 10.1016/j.chembiol.2011.10.020; Davidsen JM, 2009, J BACTERIOL, V191, P1066, DOI 10.1128/JB.01833-07; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Ehmann DE, 2000, CHEM BIOL, V7, P765, DOI 10.1016/S1074-5521(00)00022-3; FAWCETT PA, 1976, BIOCHEM J, V157, P651, DOI 10.1042/bj1570651; Gaudelli NM, 2013, J ORG CHEM, V78, P6412, DOI 10.1021/jo4007893; Giraldes JW, 2006, NAT CHEM BIOL, V2, P531, DOI 10.1038/nchembio822; Gokhale RS, 1999, CHEM BIOL, V6, P117, DOI 10.1016/S1074-5521(99)80008-8; Gunsior M, 2004, CHEM BIOL, V11, P927, DOI 10.1016/j.chembiol.2004.04.012; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kelly WL, 2005, J BACTERIOL, V187, P739, DOI 10.1128/JB.187.2.739-746.2005; Kelly WL, 2004, J BIOL CHEM, V279, P38220, DOI 10.1074/jbc.M405450200; Kelly WL, 2002, J AM CHEM SOC, V124, P8186, DOI 10.1021/ja025926g; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Korman TP, 2010, P NATL ACAD SCI USA, V107, P6246, DOI 10.1073/pnas.0913531107; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; Lu HX, 2002, BIOCHEMISTRY-US, V41, P12590, DOI 10.1021/bi026006d; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Newman AG, 2012, CHEM COMMUN, V48, P11772, DOI 10.1039/c2cc36010a; Patel HM, 2003, BIOCHEMISTRY-US, V42, P10514, DOI 10.1021/bi034840c; Reeve AM, 1998, J BIOL CHEM, V273, P30695, DOI 10.1074/jbc.273.46.30695; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; SALITURO GM, 1990, J AM CHEM SOC, V112, P760, DOI 10.1021/ja00158a040; SAMSON SM, 1985, NATURE, V318, P191, DOI 10.1038/318191a0; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Sieber SA, 2003, J AM CHEM SOC, V125, P10862, DOI 10.1021/ja0361852; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; Stachelhaus T, 2000, BIOCHEMISTRY-US, V39, P5775, DOI 10.1021/bi9929002; TOWNSEND CA, 1982, J AM CHEM SOC, V104, P1748, DOI 10.1021/ja00370a056; TOWNSEND CA, 1988, J AM CHEM SOC, V110, P3320, DOI 10.1021/ja00218a063; TOWNSEND CA, 1983, J AM CHEM SOC, V105, P913, DOI 10.1021/ja00342a046; TOWNSEND CA, 1983, J AM CHEM SOC, V105, P919, DOI 10.1021/ja00342a047; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Vagstad AL, 2012, CHEM BIOL, V19, P1525, DOI 10.1016/j.chembiol.2012.10.002; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0	49	44	49	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					251	+		10.1038/NCHEMBIO.1456	http://dx.doi.org/10.1038/NCHEMBIO.1456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24531841	Green Accepted			2022-12-25	WOS:000333172900006
J	Katsnelson, A				Katsnelson, Alla			CONTROL ISSUES	NATURE MEDICINE			English	News Item							ANTIRETROVIRAL THERAPY; ELITE CONTROLLERS; HIV; ATHEROSCLEROSIS; ACTIVATION											Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950	6	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					328	330		10.1038/nm0414-328	http://dx.doi.org/10.1038/nm0414-328			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710370				2022-12-25	WOS:000334361500007
J	Reiner, A; Isacoff, EY				Reiner, Andreas; Isacoff, Ehud Y.			Tethered ligands reveal glutamate receptor desensitization depends on subunit occupancy	NATURE CHEMICAL BIOLOGY			English	Article							HETEROMERIC KAINATE RECEPTORS; MOSSY-FIBER SYNAPSES; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; AMPA RECEPTORS; KA-2 SUBUNIT; ION CHANNELS; GLUR6; MECHANISM; TRAFFICKING	Cell signaling is often mediated by the binding of multiple ligands to multisubunit receptors. The probabilistic nature and sometimes slow rate of binding encountered with diffusible ligands can impede attempts to determine how the ligand occupancy controls signaling in such protein complexes. We describe a solution to this problem that uses a photoswitched tethered ligand as a `ligand clamp' to induce rapid and stable binding and unbinding at defined subsets of subunits. We applied the approach to study gating in ionotropic glutamate receptors (iGluRs), ligand-gated ion channels that mediate excitatory neurotransmission and plasticity at glutamatergic synapses in the brain. We probed gating in two kainate-type iGluRs, GluK2 homotetramers and GluK2-GluK5 heterotetramers. Ultrafast (submillisecond) photoswitching of an azobenzene-based ligand on specific subunits provided a real-time measure of gating and revealed that partially occupied receptors can activate without desensitizing. The findings have implications for signaling by locally released and spillover glutamate.	[Reiner, Andreas; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Reiner, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Reiner, Andreas/AGK-2170-2022; isacoff, ehud/AAP-1459-2020	Reiner, Andreas/0000-0003-0802-7278; Isacoff, Ehud Y./0000-0003-4775-9359	US National Institutes of Health [2PN2EY018241, U24NS057631]; Deutsche Forschungsgemeinschaft (DFG) [RE 3101/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028971] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090527, U24NS057631] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Levitz for discussion, and we are grateful to K.M. Partin (Colorado State University) and P.H. Seeburg (Max Planck Institute Heidelberg) for the gift of clones as well as to D. Trauner (Ludwig-Maximilians-Universitat Munchen) for the gift of L-MAG-0 and many stimulating discussions. This work was supported by grants to E.Y.I. from the US National Institutes of Health (2PN2EY018241 and U24NS057631) as well as a postdoctoral fellowship to A.R. from the Deutsche Forschungsgemeinschaft (DFG RE 3101/1-1).	Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; BARTELS E, 1971, P NATL ACAD SCI USA, V68, P1820, DOI 10.1073/pnas.68.8.1820; Bowie D, 2002, J NEUROSCI, V22, P3392; Chaudhry C, 2009, EMBO J, V28, P1518, DOI 10.1038/emboj.2009.86; Christie LA, 2010, P NATL ACAD SCI USA, V107, P9412, DOI 10.1073/pnas.0908206107; Colquhoun David, 1995, P589; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Cui CH, 1999, J NEUROSCI, V19, P8281; Dawe GB, 2013, NAT STRUCT MOL BIOL, V20, P1054, DOI 10.1038/nsmb.2654; Dingledine R, 1999, PHARMACOL REV, V51, P7; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Fisher JL, 2011, J NEUROSCI, V31, P17113, DOI 10.1523/JNEUROSCI.3685-11.2011; Gallyas F, 2003, J NEUROCHEM, V86, P1414, DOI 10.1046/j.1471-4159.2003.01945.x; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Jane DE, 1997, J MED CHEM, V40, P3645, DOI 10.1021/jm9702387; Jayaraman V, 1998, BIOCHEMISTRY-US, V37, P16735, DOI 10.1021/bi9813328; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jonas Peter, 1995, P231; Kienzler MA, 2013, J AM CHEM SOC, V135, P17683, DOI 10.1021/ja408104w; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lerma J, 2013, NEURON, V80, P292, DOI 10.1016/j.neuron.2013.09.045; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Li G, 2003, BIOCHEMISTRY-US, V42, P12367, DOI 10.1021/bi034797t; Ma-Hogemeier ZL, 2010, J NEUROCHEM, V113, P1403, DOI 10.1111/j.1471-4159.2009.06559.x; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Mott DD, 2010, J PHYSIOL-LONDON, V588, P683, DOI 10.1113/jphysiol.2009.185207; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Numano R, 2009, P NATL ACAD SCI USA, V106, P6814, DOI 10.1073/pnas.0811899106; Paternain AV, 2003, J NEUROSCI, V23, P8641; PATNEAU DK, 1992, J NEUROSCI, V12, P595; Pinheiro PS, 2013, CEREB CORTEX, V23, P323, DOI 10.1093/cercor/bhs022; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Reiner A, 2012, CELL REP, V1, P234, DOI 10.1016/j.celrep.2012.01.003; Ren Z, 2003, J NEUROSCI, V23, P6608; Robert A, 2003, J NEUROSCI, V23, P847; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SCHWARZ G, 1968, REV MOD PHYS, V40, P206, DOI 10.1103/RevModPhys.40.206; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Straub C, 2012, CURR OPIN NEUROBIOL, V22, P488, DOI 10.1016/j.conb.2011.09.005; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1998, MOL PHARMACOL, V53, P942; Swanson GT, 2002, NEURON, V34, P589, DOI 10.1016/S0896-6273(02)00676-1; Tochitsky I, 2012, NAT CHEM, V4, P105, DOI [10.1038/NCHEM.1234, 10.1038/nchem.1234]; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; WISDEN W, 1993, J NEUROSCI, V13, P3582; Zhang YH, 2006, J NEUROSCI, V26, P10033, DOI 10.1523/JNEUROSCI.2750-06.2006; Zhou LM, 1997, J PHARMACOL EXP THER, V280, P422	59	46	46	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					273	+		10.1038/NCHEMBIO.1458	http://dx.doi.org/10.1038/NCHEMBIO.1458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24561661	Green Submitted, Green Accepted			2022-12-25	WOS:000333172900009
J	Smith, MJ; Ikura, M				Smith, Matthew J.; Ikura, Mitsuhiko			Integrated RAS signaling defined by parallel NMR detection of effectors and regulators	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATOR SON; BINDING DOMAIN; STRUCTURAL BASIS; SEVENLESS; PROTEINS; COMPLEX; SWITCH; GTP; TRANSDUCTION; FEEDBACK	The RAS GTPase directs cell proliferation and survival by selectively relaying signals amid a dynamic network of regulatory enzymes and protein interactions. Oncogenic mutation of RAS alters cell growth by deleteriously controlling output to RAS-binding effectors. Mechanisms underlying multieffector interactions for both wild-type and oncogenic RAS are poorly understood owing to challenges in quantifying outputs to multiple pathways in parallel. Using highly selective NMR probes for wild-type and oncogenic (G12V) RAS, we develop a systematic approach that quantitatively measures RAS output in composite mixtures of GEF, GAP and effector RAS-binding domains (RBDs). We derive effector signaling hierarchies and establish how oscillating concentrations generate effector 'switching'. The G12V mutation highly perturbs this system, specifically altering interactions with RAL GTPase-specific GEFs and RAF kinases. We further reveal that RAS-RBD complexes show extensive feedback to full-length regulatory proteins. Our approach quantifies output from signaling hubs, here providing an integrated view of the RAS network.	[Smith, Matthew J.; Ikura, Mitsuhiko] Univ Hlth Network, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), Univ Hlth Network, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON, Canada.	mikura@uhnresearch.ca	Smith, Matthew J/AAI-8060-2020	Smith, Matthew J/0000-0003-2896-9350	Cancer Research Society; Canadian Cancer Society; Princess Margaret Hospital Foundation; Canadian Breast Cancer Foundation Fellowship; Ontario Cancer Institute Knudson Postdoctoral Fellowship; Canada Foundation for Innovation	Cancer Research Society; Canadian Cancer Society(Canadian Cancer Society (CCS)); Princess Margaret Hospital Foundation; Canadian Breast Cancer Foundation Fellowship; Ontario Cancer Institute Knudson Postdoctoral Fellowship; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank B. Neel, G. Findlay, C. Marshall and M. Mazhab-Jafari for valuable discussion and thoughts on the manuscript. This work was supported by a grant from the Cancer Research Society (to M. I.) and in part by the Canadian Cancer Society (to M. I.) and by the Princess Margaret Hospital Foundation. M.J.S. is the recipient of a Canadian Breast Cancer Foundation Fellowship and an Ontario Cancer Institute Knudson Postdoctoral Fellowship. M. I. holds a Canada Research Chair. The Canada Foundation for Innovation funded the 800 and 600 MHz NMR spectrometers.	Ader C, 2007, J PHYS CHEM B, V111, P2752, DOI 10.1021/jp067792p; Bauer B, 1999, J BIOL CHEM, V274, P17763, DOI 10.1074/jbc.274.25.17763; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Douville E, 1997, ONCOGENE, V15, P373, DOI 10.1038/sj.onc.1201214; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Hofmann I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044146; Huang H, 2014, ONCOGENE, V33, P532, DOI 10.1038/onc.2012.619; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Linnemann T, 2002, J BIOL CHEM, V277, P7831, DOI 10.1074/jbc.M110800200; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; SCHEFFLER JE, 1994, J BIOL CHEM, V269, P22340; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Takashima A, 2013, EXPERT OPIN THER TAR, V17, P507, DOI 10.1517/14728222.2013.764990; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Weber CK, 2000, ONCOGENE, V19, P169, DOI 10.1038/sj.onc.1203261; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yeh JJ, 2007, EXPERT OPIN THER TAR, V11, P673, DOI 10.1517/14728222.11.5.673; Zand TP, 2011, DEV CELL, V20, P84, DOI 10.1016/j.devcel.2010.12.004; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	54	58	58	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					223	+		10.1038/NCHEMBIO.1435	http://dx.doi.org/10.1038/NCHEMBIO.1435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24441586				2022-12-25	WOS:000331616900014
J	Ablain, J; Rice, K; Soilihi, H; de Reynies, A; Minucci, S; de The, H				Ablain, Julien; Rice, Kim; Soilihi, Hassane; de Reynies, Aurelien; Minucci, Saverio; de The, Hugues			Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure	NATURE MEDICINE			English	Article							TRANS-RETINOIC ACID; AGENT ARSENIC TRIOXIDE; PML-RAR-ALPHA; INITIATING ACTIVITY; MYELOID-LEUKEMIA; P53 ACETYLATION; SUPPRESSOR GENE; THERAPY; SENESCENCE; COMBINATION	Acute promyelocytic leukemia (APL) is driven by the promyelocytic leukemia (PML)-retinoic acid receptor-a (PML-RARA) fusion protein, which interferes with nuclear receptor signaling and PML nuclear body (NB) assembly. APL is the only malignancy definitively cured by targeted therapies: retinoic acid (RA) and/or arsenic trioxide, which both trigger PML-RARA degradation through nonoverlapping pathways. Yet, the cellular and molecular determinants of treatment efficacy remain disputed. We demonstrate that a functional Pml-transformation-related protein 53 (Trp53) axis is required to eradicate leukemia-initiating cells in a mouse model of APL. Upon RA-induced PML-RARA degradation, normal Pml elicits NB reformation and induces a Trp53 response exhibiting features of senescence but not apoptosis, ultimately abrogating APL-initiating activity. Apart from triggering PML-RARA degradation, arsenic trioxide also targets normal PML to enhance NB reformation, which may explain its clinical potency, alone or with RA. This Pml-Trp53 checkpoint initiated by therapy-triggered NB restoration is specific for PML-RARA-driven APL, but not the RA-resistant promyelocytic leukemia zinc finger (PLZF)-RARA variant. Yet, as NB biogenesis is druggable, it could be therapeutically exploited in non-APL malignancies.	[Ablain, Julien; Rice, Kim; Soilihi, Hassane; de The, Hugues] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, Paris, France; [Ablain, Julien; Rice, Kim; Soilihi, Hassane; de The, Hugues] Hop St Louis, INSERM, UMR 944, Equipe Labellisee Ligue Natl Canc,Inst Univ Hemat, Paris, France; [Ablain, Julien; Rice, Kim; Soilihi, Hassane; de The, Hugues] Hop St Louis, CNRS, UMR 7212, Paris, France; [de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs, Paris, France; [Minucci, Saverio] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Minucci, Saverio] Univ Milan, Dept Biosci, Milan, Italy; [de The, Hugues] Hop St Louis, AP HP, Serv Biochim, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; IRCCS European Institute of Oncology (IEO); University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	de The, H (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, Paris, France.	hugues.dethe@inserm.fr	de Reyniès, Aurélien/Q-8640-2017	de Reyniès, Aurélien/0000-0002-1328-5290; Ablain, Julien/0000-0002-4509-3568	Ligue Nationale contre le Cancer; Cartes d'Identite des Tumeurs program; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University Paris Diderot; Institut Universitaire de France; Institut National du Cancer; Fondation Association pour la Recherche contre le Cancer (ARC) (Prix Griffuel); European Research Council [268729 - STEMAPL]; Ecole Polytechnique; Fondation ARC; Lady Tata Foundation; ARC Foundation; EPIGEN; Italian Association for Cancer Research (AIRC)	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Cartes d'Identite des Tumeurs program; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot; Institut Universitaire de France; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Association pour la Recherche contre le Cancer (ARC) (Prix Griffuel); European Research Council(European Research Council (ERC)European Commission); Ecole Polytechnique; Fondation ARC; Lady Tata Foundation; ARC Foundation(Australian Research Council); EPIGEN; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The laboratory of H.d.T. is supported by the Ligue Nationale contre le Cancer, the Cartes d'Identite des Tumeurs program, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), University Paris Diderot, Institut Universitaire de France, Institut National du Cancer, Fondation Association pour la Recherche contre le Cancer (ARC) (Prix Griffuel) and the European Research Council (senior grant 268729 - STEMAPL). J.A. was supported by a fellowship from Ecole Polytechnique and Fondation ARC, K.R. by a fellowship from the Lady Tata and ARC Foundations. S.M. is supported by grants from EPIGEN and the Italian Association for Cancer Research (AIRC). We thank A. Janin, T. Bouhidel and P. Bertheau for assistance with mouse pathology; P. Chambon (Institut de Genetique et de Biologie Moleculaire et Cellulaire) for RARA-specific antibody; S. Lowe (Memorial Sloan-Kettering Cancer Center) for shRNA vectors and Pml-specific antibody; L. Peres and S. Gressens for technical help; M. Pla for the animal facility; N. Setterblad for imaging; E. Del Neyri and V. Dessirier for imaging statistical analysis; and I. Pallavicini and A. Marinelli for mouse work in Milan. We thank E. Raffoux, C. Bailly, P. Fenaux and N. Boissel (Hopital St. Louis) for providing the patients' blood samples. We thank R. Ohki and L. Attardi for sharing unpublished p53 ChIP-Seq data. We thank all members of the laboratory of H.d.T. for helpful discussions, J. Godet for continuous support and V. Lallemand-Breitenbach, U. Sahin, S. Benhenda, F. Sigaux and J.C. Gluckman for critical reading of the manuscript.	Ablain J, 2013, J EXP MED, V210, P647, DOI 10.1084/jem.20122337; Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; El Eit RM, 2014, INT J CANCER, V134, P988, DOI 10.1002/ijc.28427; El Hajj H, 2010, J EXP MED, V207, P2785, DOI 10.1084/jem.20101095; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Ferbeyre G, 2000, GENE DEV, V14, P2015; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Ghavamzadeh A, 2011, J CLIN ONCOL, V29, P2753, DOI 10.1200/JCO.2010.32.2107; Guidez F, 2007, P NATL ACAD SCI USA, V104, P18694, DOI 10.1073/pnas.0704433104; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, BLOOD, V103, P2358, DOI 10.1182/blood-2003-07-2200; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Kchour G, 2009, BLOOD, V113, P6528, DOI 10.1182/blood-2009-03-211821; Kogan SC, 2009, CANCER CELL, V15, P7, DOI 10.1016/j.ccr.2008.12.012; Koken MHM, 1999, ONCOGENE, V18, P1113, DOI 10.1038/sj.onc.1202414; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Licht JD, 2006, CANCER CELL, V9, P73, DOI 10.1016/j.ccr.2006.01.024; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; LVANOV AETA, 2013, J CELL BIOL, V202, P129; Mathews V, 2010, J CLIN ONCOL, V28, P3866, DOI 10.1200/JCO.2010.28.5031; Meani N, 2005, ONCOGENE, V24, P3358, DOI 10.1038/sj.onc.1208498; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; MUINDI J, 1992, BLOOD, V79, P299; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Sahin U., J CELL BIOL IN PRESS; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Stadler M, 1995, ONCOGENE, V11, P2565; Stein E, 2009, BEST PRACT RES CL HA, V22, P153, DOI 10.1016/j.beha.2008.12.007; Tsimberidou AM, 2006, LEUKEMIA LYMPHOMA, V47, P1062, DOI 10.1080/10428190500463932; Vernier M, 2011, GENE DEV, V25, P41, DOI 10.1101/gad.1975111; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	56	127	130	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					167	174		10.1038/nm.3441	http://dx.doi.org/10.1038/nm.3441			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412926				2022-12-25	WOS:000330915000018
J	Rodrigues, TB; Serrao, EM; Kennedy, BWC; Hu, DE; Kettunen, MI; Brindle, KM				Rodrigues, Tiago B.; Serrao, Eva M.; Kennedy, Brett W. C.; Hu, De-En; Kettunen, Mikko I.; Brindle, Kevin M.			Magnetic resonance imaging of tumor glycolysis using hyperpolarized C-13-labeled glucose	NATURE MEDICINE			English	Article							PENTOSE-PHOSPHATE PATHWAY; IN-VIVO; BREAST-CANCER; METABOLISM; EXCHANGE; LACTATE; PYRUVATE; BRAIN; RATES; RATIO	In this study, we monitored glycolysis in mouse lymphoma and lung tumors by measuring the conversion of hyperpolarized [U-H-2, U-C-13]glucose to lactate using C-13 magnetic resonance spectroscopy and spectroscopic imaging. We observed labeled lactate only in tumors and not in surrounding normal tissue or other tissues in the body and found that it was markedly decreased at 24 h after treatment with a chemotherapeutic drug. We also detected an increase in a resonance assigned to 6-phosphogluconate in the pentose phosphate pathway. This technique could provide a new way of detecting early evidence of tumor treatment response in the clinic and of monitoring tumor pentose phosphate pathway activity.	[Rodrigues, Tiago B.; Serrao, Eva M.; Kettunen, Mikko I.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Kennedy, Brett W. C.; Hu, De-En; Kettunen, Mikko I.; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Brindle, KM (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	kmb1001@cam.ac.uk	Kettunen, Mikko I/K-2299-2012	Kettunen, Mikko I/0000-0002-2004-660X; Rodrigues, Tiago/0000-0002-4474-0639; Mendes Serrao, Eva/0000-0002-1402-3444	Cancer Research UK Programme [C197/A3514]; Leukemia & Lymphoma Society; European Union Seventh Framework Programme under the Marie Curie Initial Training Network METAFLUX [264780]; Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) fellowship; Long-term European Molecular Biology Organization fellowship [EMBO-ALT-1145-2009]; Cancer Research UK [17242, 16465] Funding Source: researchfish	Cancer Research UK Programme(Cancer Research UK); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); European Union Seventh Framework Programme under the Marie Curie Initial Training Network METAFLUX; Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) fellowship; Long-term European Molecular Biology Organization fellowship; Cancer Research UK(Cancer Research UK)	The work was supported by a Cancer Research UK Programme grant (C197/A3514) and by a Translational Research Program Award from The Leukemia & Lymphoma Society to K.M.B. T.B.R. is a recipient of an Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) fellowship and a Long-term European Molecular Biology Organization (EMBO-ALT-1145-2009) fellowship. E.M.S. is a recipient of a fellowship from the European Union Seventh Framework Programme (FP7/2007-2013) under the Marie Curie Initial Training Network METAFLUX (project number 264780). E.M.S. acknowledges the educational support of Programme for Advanced Medical Education from Calouste Gulbenkian Foundation, Champalimaud Foundation, Ministerio de Saude and Fundacao para a Ciencia e Tecnologia, Portugal. The polarizer and related materials were provided by GE Healthcare. The authors thank F. Gallagher for help with the polarizer. The laboratory is a member of and receives support from the Cancer Research UK & Engineering and Physical Science Research Council Cancer Imaging Center in Cambridge and Manchester.	Allouche-Arnon H, 2013, CONTRAST MEDIA MOL I, V8, P72, DOI 10.1002/cmmi.1497; Allouche-Arnon H, 2011, CONTRAST MEDIA MOL I, V6, P499, DOI 10.1002/cmmi.452; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Brindle K, 2008, NAT REV CANCER, V8, P94, DOI 10.1038/nrc2289; Brindle KM, 2011, MAGN RESON MED, V66, P505, DOI 10.1002/mrm.22999; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GUMAA KA, 1969, BIOCHEM J, V115, P1009, DOI 10.1042/bj1151009; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kennedy BWC, 2012, J AM CHEM SOC, V134, P4969, DOI 10.1021/ja300222e; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lodi A, 2013, NMR BIOMED, V26, P299, DOI 10.1002/nbm.2848; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; Meier S, 2011, FEBS LETT, V585, P3133, DOI 10.1016/j.febslet.2011.08.049; Meier S, 2011, MOL BIOSYST, V7, P2834, DOI 10.1039/c1mb05202k; NEELY JR, 1975, CIRC RES, V37, P733, DOI 10.1161/01.RES.37.6.733; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Park JM, 2013, NEURO-ONCOLOGY, V15, P433, DOI 10.1093/neuonc/nos319; Poptani H, 2003, CANCER RES, V63, P8813; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Rivenzon-Segal D, 2002, AM J PHYSIOL-ENDOC M, V283, pE623, DOI 10.1152/ajpendo.00050.2002; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Weber WA, 2005, J NUCL MED, V46, P983; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727	30	200	205	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					93	+		10.1038/nm.3416	http://dx.doi.org/10.1038/nm.3416			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317119	Green Accepted			2022-12-25	WOS:000329349400025
J	Cruickshanks, HA; McBryan, T; Nelson, DM; VanderKraats, ND; Shah, PP; van Tuyn, J; Rai, TS; Brock, C; Donahue, G; Dunican, DS; Drotar, ME; Meehan, RR; Edwards, JR; Berger, SL; Adams, PD				Cruickshanks, Hazel A.; McBryan, Tony; Nelson, David M.; VanderKraats, Nathan D.; Shah, Parisha P.; van Tuyn, John; Rai, Taranjit Singh; Brock, Claire; Donahue, Greg; Dunican, Donncha S.; Drotar, Mark E.; Meehan, Richard R.; Edwards, John R.; Berger, Shelley L.; Adams, Peter D.			Senescent cells harbour features of the cancer epigenome	NATURE CELL BIOLOGY			English	Article							ISLAND METHYLATOR PHENOTYPE; MESENCHYMAL STEM-CELLS; DNA-METHYLATION; IN-VIVO; CHROMOSOMAL INSTABILITY; CELLULAR SENESCENCE; TUMOR PROGRESSION; SATELLITE-3 DNA; GENE-EXPRESSION; REPLICATION	Altered DNA methylation and associated destabilization of genome integrity and function is a hallmark of cancer. Replicative senescence is a tumour suppressor process that imposes a limit on the proliferative potential of normal cells that all cancer cells must bypass. Here we show by whole-genome single-nucleotide bisulfite sequencing that replicative senescent human cells exhibit widespread DNA hypomethylation and focal hypermethylation. Hypomethylation occurs preferentially at gene-poor, late-replicating, lamin-associated domains and is linked to mislocalization of the maintenance DNA methyltransferase (DNMT1) in cells approaching senescence. Low-level gains of methylation are enriched in CpG islands, including at genes whose methylation and silencing is thought to promote cancer. Gains and losses of methylation in replicative senescence are thus qualitatively similar to those in cancer, and this 'reprogrammed' methylation landscape is largely retained when cells bypass senescence. Consequently, the DNA methylome of senescent cells might promote malignancy, if these cells escape the proliferative barrier.	[Cruickshanks, Hazel A.; McBryan, Tony; Nelson, David M.; van Tuyn, John; Rai, Taranjit Singh; Brock, Claire; Drotar, Mark E.; Adams, Peter D.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Cruickshanks, Hazel A.; McBryan, Tony; Nelson, David M.; van Tuyn, John; Rai, Taranjit Singh; Brock, Claire; Drotar, Mark E.; Adams, Peter D.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [VanderKraats, Nathan D.; Edwards, John R.] Washington Univ, Sch Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Shah, Parisha P.; Donahue, Greg; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dunican, Donncha S.; Meehan, Richard R.] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Glasgow; Beatson Institute; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of Edinburgh	Adams, PD (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland.	p.adams@beatson.gla.ac.uk	Rai, Taranjit Singh/A-3659-2012; Singh, Taranjit/ABE-8233-2020; Edwards, Joanne/J-1903-2015; van Tuyn, John/R-3939-2019	Rai, Taranjit Singh/0000-0002-7276-7492; Singh, Taranjit/0000-0002-7276-7492; Edwards, Joanne/0000-0002-7192-6906; van Tuyn, John/0000-0001-5989-5185; Berger, Shelley/0000-0001-5398-4400; Adams, Peter/0000-0002-0684-1770; Meehan, Richard/0000-0001-6471-6882	NIA Program [P01 AG031862]; CRUK Program [A10250]; MRC; BBSRC; BBSRC [BB/J021032/1] Funding Source: UKRI; MRC [MC_PC_U127574433, MC_U127574433] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J021032/1] Funding Source: researchfish; Medical Research Council [MC_PC_U127574433, MC_U127574433] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM011199] Funding Source: NIH RePORTER	NIA Program; CRUK Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Thanks to S. Pepper in the CRUK microarray facility and to S. Hansen for assistance with DNA replication timing data. Thanks to Beijing Genome Institute for bisulfite sequencing. Work in the laboratory of P.D.A. was funded by NIA Program Project P01 AG031862 and CRUK Program A10250. S.L.B.'s laboratory was funded by NIA Program Project P01 AG031862. R.R.M.'s laboratory was funded by the MRC and the BBSRC. P.D.A. thanks P. Cairns for critical formative discussions.	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Choi MR, 2012, EXP MOL MED, V44, P503, DOI 10.3858/emm.2012.44.8.057; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Enukashvily NI, 2007, CYTOGENET GENOME RES, V118, P42, DOI 10.1159/000106440; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Harlow E., 1988, ANTIBODIES LAB MANUA; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Sadaie M, 2013, GENE DEV, V27, P1800, DOI 10.1101/gad.217281.113; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Sproul D, 2013, BRIEF FUNCT GENOMICS, V12, P174, DOI 10.1093/bfgp/els063; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki T, 2002, EXP GERONTOL, V37, P1005, DOI 10.1016/S0531-5565(02)00061-X; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Unterberger A, 2006, MOL CELL BIOL, V26, P7575, DOI 10.1128/MCB.01887-05; VanderKraats ND, 2013, NUCLEIC ACIDS RES, V41, P6816, DOI 10.1093/nar/gkt482; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WILSON VL, 1983, SCIENCE, V220, P1054; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Young JI, 2003, J BIOL CHEM, V278, P19904, DOI 10.1074/jbc.M301685200; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang WJ, 2008, LIFE SCI, V83, P475, DOI 10.1016/j.lfs.2008.07.015	70	216	218	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1495	+		10.1038/ncb2879	http://dx.doi.org/10.1038/ncb2879			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24270890	Green Accepted			2022-12-25	WOS:000327944200014
J	Zhao, HJ; Zhu, L; Zhu, YL; Cao, JL; Li, SS; Huang, QP; Xu, T; Huang, XM; Yan, XM; Zhu, XL				Zhao, Huijie; Zhu, Lei; Zhu, Yunlu; Cao, Jingli; Li, Shanshan; Huang, Qiongping; Xu, Tao; Huang, Xiao; Yan, Xiumin; Zhu, Xueliang			The Cep63 paralogue Deup1 enables massive de novo centriole biogenesis for vertebrate multiciliogenesis	NATURE CELL BIOLOGY			English	Article							CILIA DEFECTS; IFT-PARTICLE; IN-VIVO; PROTEIN; GENOME; CILIOGENESIS; DUPLICATION; EVOLUTION; SCAFFOLD; COMPLEX	Dense multicilia in higher vertebrates are important for luminal flow and the removal of thick mucus. To generate hundreds of basal bodies for multiciliogenesis, specialized terminally differentiated epithelial cells undergo massive centriole amplification. In proliferating cells, however, centriole duplication occurs only once per cell cycle. How cells ensure proper regulation of centriole biogenesis in different contexts is poorly understood. We report that the centriole amplification is controlled by two duplicated genes, Cep63 and Deup1. Cep63 regulates mother-centriole-dependent centriole duplication. Deup1 governs deuterosome assembly to mediate large-scale de novo centriole biogenesis. Similarly to Cep63, Deup1 binds to Cep152 and then recruits PIk4 to activate centriole biogenesis. Phylogenetic analyses suggest that Deup1 diverged from Cep63 in a certain ancestor of lobe-finned fishes during vertebrate evolution and was subsequently adopted by tetrapods. Thus, the Cep63 gene duplication has enabled mother-centriole-independent assembly of the centriole duplication machinery to satisfy different requirements for centriole number.	[Zhao, Huijie; Zhu, Lei; Zhu, Yunlu; Cao, Jingli; Li, Shanshan; Huang, Qiongping; Yan, Xiumin; Zhu, Xueliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Huang, Xiao] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Zhejiang University	Yan, XM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	yanx@sibcb.ac.cn; xlzhu@sibcb.ac.cn	Zhu, Yunlu/AAC-8204-2019; HUANG, xiao/F-9527-2013; Zhao, Huijie/GNH-4458-2022; Huang, Xiao/Q-2410-2019	Zhu, Yunlu/0000-0003-2474-2714; Zhao, Huijie/0000-0002-8595-8159; Huang, Xiao/0000-0002-7536-1762; Yan, Xiumin/0000-0002-3260-1690; Cao, Jingli/0000-0001-5938-6604	Chinese Academy of Sciences [XDA01010107]; National Basic Research Program of China [2012CB945003, 2010CB912102]; National Science Foundation of China [31330045, 31271427, 91129000]; Shanghai Municipal Science and Technology Commission [12JC1409900]; SA-SIBS Scholarship Program	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); SA-SIBS Scholarship Program	The authors thank Y. Zheng, Y. Shen and J. Ten for helpful suggestions; E. Nigg for Cep152 antibody; S. Li and Z. Li for technical support on 3D-SIM and H. Dai, T. Zhang, F. Qin and X. Zhu for technical assistance. This work was supported by the Chinese Academy of Sciences (XDA01010107), the National Basic Research Program of China (2012CB945003 and 2010CB912102), the National Science Foundation of China (31330045, 31271427 and 91129000) and Shanghai Municipal Science and Technology Commission (12JC1409900).X.Y. acknowledges the support of the SA-SIBS Scholarship Program.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Azimzadeh J, 2012, SCIENCE, V335, P461, DOI 10.1126/science.1214457; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Boulter E, 2006, FASEB J, V20, P1489, DOI 10.1096/fj.05-4579fje; Canestro C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-208; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; DIRKSEN ER, 1971, J CELL BIOL, V51, P286, DOI 10.1083/jcb.51.1.286; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Kemp A, 1996, J MORPHOL, V228, P203, DOI 10.1002/(SICI)1097-4687(199605)228:2<203::AID-JMOR9>3.0.CO;2-5; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; LEMULLOIS M, 1988, BIOL CELL, V63, P195, DOI 10.1016/0248-4900(88)90058-5; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pearson CG, 2009, TRAFFIC, V10, P461, DOI 10.1111/j.1600-0854.2009.00885.x; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Showell C., 2009, COLD SPRING HARBOR P; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; SOROKIN SP, 1968, J CELL SCI, V3, P207; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Sun Q, 1998, MOL MICROBIOL, V29, P491, DOI 10.1046/j.1365-2958.1998.00942.x; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu S, 2012, CELL RES, V22, P1270, DOI 10.1038/cr.2012.47; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zardoya R, 1997, GENETICS, V146, P995; Zeng LY, 2013, J BIOL CHEM, V288, P30087, DOI 10.1074/jbc.M113.506147; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	56	120	130	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1434	+		10.1038/ncb2880	http://dx.doi.org/10.1038/ncb2880			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24240477				2022-12-25	WOS:000327944200008
J	Heck, D; Kowalczyk, MS; Yudovich, D; Belizaire, R; Puram, RV; McConkey, ME; Thielke, A; Aster, JC; Regev, A; Ebert, BL				Heck, Dirk; Kowalczyk, Monika S.; Yudovich, David; Belizaire, Roger; Puram, Rishi V.; McConkey, Marie E.; Thielke, Anne; Aster, Jon C.; Regev, Aviv; Ebert, Benjamin L.			Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION; INACTIVATION; MUTATIONS	Genome sequencing studies have shown that human malignancies often bear mutations in four or more driver genes(1), but it is difficult to recapitulate this degree of genetic complexity in mouse models using conventional breeding. Here we use the CRISPR-Cas9 system of genome editing(2-4) to overcome this limitation. By delivering combinations of small guide RNAs (sgRNAs) and Cas9 with a lentiviral vector, we modified up to five genes in a single mouse hematopoietic stem cell (HSC), leading to clonal outgrowth and myeloid malignancy. We thereby generated models of acute myeloid leukemia (AML) with cooperating mutations in genes encoding epigenetic modifiers, transcription factors and mediators of cytokine signaling, recapitulating the combinations of mutations observed in patients. Our results suggest that lentivirus-delivered sgRNA:Cas9 genome editing should be useful to engineer a broad array of in vivo cancer models that better reflect the complexity of human disease.	[Heck, Dirk; Yudovich, David; Belizaire, Roger; Puram, Rishi V.; McConkey, Marie E.; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA; [Kowalczyk, Monika S.; Thielke, Anne; Regev, Aviv; Ebert, Benjamin L.] Broad Inst & Harvard, Cambridge, MA USA; [Belizaire, Roger; Aster, Jon C.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Ebert, BL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA.	bebert@partners.org	Yudovich, David/AAT-2685-2020; Heckl, Dirk/GMW-5407-2022; Yudovich, David/O-9971-2015	Yudovich, David/0000-0002-6580-0637; Yudovich, David/0000-0002-6580-0637; Belizaire, Roger/0000-0001-8496-287X	National Institutes of Health [P01 CA108631]; Leukemia and Lymphoma Society Scholar Award; SPARC consortium; National Human Genome Research Institute [5P50HG006193-02]; Klarman Family Foundation at The Broad Institute; German Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); SPARC consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Klarman Family Foundation at The Broad Institute; German Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Morton and A. Hawkins from the Brigham and Women's Cytogenetics Core and R. Bronson from the DF/HCC Rodent Pathology Core for technical assistance and discussions. The authors thank F. Zhang for providing the CRISPR-Cas components. The authors also thank A. Schambach, E. Charpentier, J. Kroenke and A. Mullally for useful discussions, and thank S. Schwartz and B. Haas for assistance with analysis of sequencing data. C. Baum and A. Schambach of the Hannover Medical School, Hannover, Germany, kindly provided RRL. PPT.SFFV.IRES.eGFP.pre*, and D. Trono of EPFL, Lausanne, Switzerland, kindly provided both pMD2.G (Addgene plasmid 12259) and psPAX2.(Addgene plasmid 12260). This work was supported by funding from the National Institutes of Health (P01 CA108631), a Leukemia and Lymphoma Society Scholar Award, the SPARC consortium, a Center for Excellence in Genome Science grant (5P50HG006193-02 from the National Human Genome Research Institute) (A.R.) and Klarman Family Foundation at The Broad Institute (A.R.). D.H. was funded by the German Cancer Foundation (Mildred-Scheel Fellowship). M.S.K. is an EMBO and European Hematology Association Fellow.	[Anonymous], 2013, GEN EP LANDSC; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mead AJ, 2013, CELL REP, V3, P1766, DOI 10.1016/j.celrep.2013.04.031; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Tanaka S, 2012, BLOOD, V120, P1107, DOI 10.1182/blood-2011-11-394932; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang YY, 2001, J CLIN INVEST, V108, P709, DOI 10.1172/JCI12758	24	346	376	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					941	946		10.1038/nbt.2951	http://dx.doi.org/10.1038/nbt.2951			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	24952903	Green Submitted, Green Accepted			2022-12-25	WOS:000342600300034
J	Schmutz, J; McClean, PE; Mamidi, S; Wu, GA; Cannon, SB; Grimwood, J; Jenkins, J; Shu, SQ; Song, QJ; Chavarro, C; Torres-Torres, M; Geffroy, V; Moghaddam, SM; Gao, DY; Abernathy, B; Barry, K; Blair, M; Brick, MA; Chovatia, M; Gepts, P; Goodstein, DM; Gonzales, M; Hellsten, U; Hyten, DL; Jia, GF; Kelly, JD; Kudrna, D; Lee, R; Richard, MMS; Miklas, PN; Osorno, JM; Rodrigues, J; Thareau, V; Urrea, CA; Wang, M; Yu, Y; Zhang, M; Wing, RA; Cregan, PB; Rokhsar, DS; Jackson, SA				Schmutz, Jeremy; McClean, Phillip E.; Mamidi, Sujan; Wu, G. Albert; Cannon, Steven B.; Grimwood, Jane; Jenkins, Jerry; Shu, Shengqiang; Song, Qijian; Chavarro, Carolina; Torres-Torres, Mirayda; Geffroy, Valerie; Moghaddam, Samira Mafi; Gao, Dongying; Abernathy, Brian; Barry, Kerrie; Blair, Matthew; Brick, Mark A.; Chovatia, Mansi; Gepts, Paul; Goodstein, David M.; Gonzales, Michael; Hellsten, Uffe; Hyten, David L.; Jia, Gaofeng; Kelly, James D.; Kudrna, Dave; Lee, Rian; Richard, Manon M. S.; Miklas, Phillip N.; Osorno, Juan M.; Rodrigues, Josiane; Thareau, Vincent; Urrea, Carlos A.; Wang, Mei; Yu, Yeisoo; Zhang, Ming; Wing, Rod A.; Cregan, Perry B.; Rokhsar, Daniel S.; Jackson, Scott A.			A reference genome for common bean and genome-wide analysis of dual domestications	NATURE GENETICS			English	Article							RESISTANCE GENE-CLUSTER; PHASEOLUS-VULGARIS; DIVERSIFICATION; SEQUENCE; REVEALS; ORIGIN	Common bean (Phaseolus vulgaris L.) is the most important grain legume for human consumption and has a role in sustainable agriculture owing to its ability to fix atmospheric nitrogen. We assembled 473 Mb of the 587-Mb genome and genetically anchored 98% of this sequence in 11 chromosome-scale pseudomolecules. We compared the genome for the common bean against the soybean genome to find changes in soybean resulting from polyploidy. Using resequencing of 60 wild individuals and 100 landraces from the genetically differentiated Mesoamerican and Andean gene pools, we confirmed 2 independent domestications from genetic pools that diverged before human colonization. Less than 10% of the 74 Mb of sequence putatively involved in domestication was shared by the two domestication events. We identified a set of genes linked with increased leaf and seed size and combined these results with quantitative trait locus data from Mesoamerican cultivars. Genes affected by domestication may be useful for genomics-enabled crop improvement.	[Schmutz, Jeremy; Wu, G. Albert; Shu, Shengqiang; Barry, Kerrie; Chovatia, Mansi; Goodstein, David M.; Hellsten, Uffe; Wang, Mei; Zhang, Ming; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Schmutz, Jeremy; Grimwood, Jane; Jenkins, Jerry] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [McClean, Phillip E.; Mamidi, Sujan; Moghaddam, Samira Mafi; Lee, Rian; Osorno, Juan M.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Cannon, Steven B.] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Song, Qijian; Hyten, David L.; Jia, Gaofeng; Rodrigues, Josiane; Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Chavarro, Carolina; Torres-Torres, Mirayda; Gao, Dongying; Abernathy, Brian; Gonzales, Michael; Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Geffroy, Valerie; Richard, Manon M. S.; Thareau, Vincent] Univ Paris 11, CNRS, Inst Biol Plantes, UMR 8618, F-91405 Orsay, France; [Geffroy, Valerie] Univ Paris 11, INRA, Unite Mixte Rech Genet Vegetale, Gif Sur Yvette, France; [Blair, Matthew] Tennessee State Univ, Dept Agr & Nat Sci, Nashville, TN 37203 USA; [Brick, Mark A.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [Gepts, Paul] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Kudrna, Dave; Yu, Yeisoo; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Tucson, AZ USA; [Miklas, Phillip N.] USDA ARS, Vegetable & Forage Crop Res Unit, Prosser, WA 99350 USA; [Urrea, Carlos A.] Univ Nebraska, Panhandle Res & Extens Ctr, Scottsbluff, NE USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; North Dakota State University Fargo; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Tennessee State University; Colorado State University; University of California System; University of California Davis; Michigan State University; University of Arizona; United States Department of Agriculture (USDA); University of Nebraska System	Jackson, SA (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	jschmutz@hudsonalpha.org; phillip.mcclean@ndsu.edu; sjackson@uga.edu	Grimwood, Jane/ABD-5737-2021; Gepts, Paul/O-8229-2019; Schmutz, Jeremy/N-3173-2013; Jenkins, Jerry/ABE-6479-2020; mamidi, sujan/P-7009-2018; Urrea, Carlos A/A-6196-2017; Wu, Guohong/W-3217-2019; Wing, Rod A/Z-2885-2019; Osorno, Juan M/C-6971-2009; Barry, Kerrie Whitelaw/AAA-5500-2020	Gepts, Paul/0000-0002-1056-4665; Schmutz, Jeremy/0000-0001-8062-9172; Jenkins, Jerry/0000-0002-7943-3997; mamidi, sujan/0000-0002-3837-6121; Wing, Rod A/0000-0001-6633-6226; Barry, Kerrie Whitelaw/0000-0002-8999-6785; jackson, scott/0000-0002-3172-1607; Richard, Manon/0000-0002-7903-024X; Yu, Yeisoo/0000-0002-8410-0310; Hyten, David/0000-0001-6324-9389; Shu, Shengqiang/0000-0002-4336-8994; Goodstein, David/0000-0001-6287-2697; Chovatia, Mansi/0000-0001-8175-782X; Cannon, Steven/0000-0003-2777-8034; Rokhsar, Daniel/0000-0002-8704-2224	Office of Science of the US Department of Energy - US Department of Agriculture National Institute for Food and Agriculture [DE-AC02-05CH11231, 2006-35300-17266]; National Science Foundation [DBI 0822258]; US Department of Agriculture Cooperative State Research, Education and Extension Service [2009-01860, 2009-01929]; ARS [ARS-0423588] Funding Source: Federal RePORTER	Office of Science of the US Department of Energy - US Department of Agriculture National Institute for Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract DE-AC02-05CH11231. This research was funded by grants from the US Department of Agriculture National Institute for Food and Agriculture (2006-35300-17266) and the National Science Foundation (DBI 0822258) to S.A.J. and from the US Department of Agriculture Cooperative State Research, Education and Extension Service (2009-01860 and 2009-01929) to S.A.J. and P.E.M., respectively.	ANDERSON JW, 1984, AM J CLIN NUTR, V40, P1146, DOI 10.1093/ajcn/40.6.1146; Beebe S., 2012, Plant Breeding Reviews, V36, P357; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Chen NWG, 2010, NEW PHYTOL, V187, P941, DOI 10.1111/j.1469-8137.2010.03337.x; Cichy KA, 2009, CROP SCI, V49, P1742, DOI 10.2135/cropsci2008.10.0605; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Geffroy V, 2009, GENETICS, V181, P405, DOI 10.1534/genetics.108.093583; GEIL PB, 1994, J AM COLL NUTR, V13, P549; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Koinange EMK, 1996, CROP SCI, V36, P1037, DOI 10.2135/cropsci1996.0011183X003600040037x; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; Gonzalez AM, 2010, MOL BREEDING, V25, P723, DOI 10.1007/s11032-009-9370-z; McClean PE, 2002, J HERED, V93, P148, DOI 10.1093/jhered/93.2.148; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Vega E, 2010, THEOR APPL GENET, V120, P1367, DOI 10.1007/s00122-010-1261-5; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Van Daele I, 2012, PLANT BIOTECHNOL J, V10, P488, DOI 10.1111/j.1467-7652.2012.00687.x; Weeden NF, 2007, ANN BOT-LONDON, V100, P1017, DOI 10.1093/aob/mcm122; Zizumbo-Villarreal D, 2010, GENET RESOUR CROP EV, V57, P813, DOI 10.1007/s10722-009-9521-4	45	731	757	5	210	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					707	713		10.1038/ng.3008	http://dx.doi.org/10.1038/ng.3008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24908249	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000338093800011
J	Urosevic, J; Garcia-Albeniz, X; Planet, E; Real, S; Cespedes, MV; Guiu, M; Fernandez, E; Bellmunt, A; Gawrzak, S; Pavlovic, M; Mangues, R; Dolado, I; Barriga, FM; Nadal, C; Kemeny, N; Batlle, E; Nebreda, AR; Gomis, RR				Urosevic, Jelena; Garcia-Albeniz, Xabier; Planet, Evarist; Real, Sebastian; Virtudes Cespedes, Maria; Guiu, Marc; Fernandez, Esther; Bellmunt, Anna; Gawrzak, Sylwia; Pavlovic, Milica; Mangues, Ramon; Dolado, Ignacio; Barriga, Francisco M.; Nadal, Cristina; Kemeny, Nancy; Batlle, Eduard; Nebreda, Angel R.; Gomis, Roger R.			Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH	NATURE CELL BIOLOGY			English	Article							APOPTOSIS-INDUCING FACTOR; COLORECTAL-CANCER; NUDE-MICE; EXPRESSION; PATHWAYS; DEATH; GENE; INTEGRATION; RECURRENCE; ACTIVATION	The mechanisms that allow colon cancer cells to form liver and lung metastases, and whether KRAS mutation influences where and when metastasis occurs, are unknown. We provide clinical and molecular evidence showing that different MAPK signalling pathways are implicated in this process. Whereas ERK2 activation provides colon cancer cells with the ability to seed and colonize the liver, reduced p38 MAPK signalling endows cancer cells with the ability to form lung metastasis from previously established liver lesions. Downregulation of p38 MAPK signalling results in increased expression of the cytokine PTHLH, which contributes to colon cancer cell extravasation to the lung by inducing caspase-independent death in endothelial cells of the lung microvasculature. The concerted acquisition of metastatic traits in the colon cancer cells together with the sequential colonization of liver and lung highlights the importance of metastatic lesions as a platform for further dissemination.	[Urosevic, Jelena; Garcia-Albeniz, Xabier; Planet, Evarist; Real, Sebastian; Guiu, Marc; Fernandez, Esther; Bellmunt, Anna; Gawrzak, Sylwia; Pavlovic, Milica; Dolado, Ignacio; Barriga, Francisco M.; Batlle, Eduard; Nebreda, Angel R.; Gomis, Roger R.] IRB Barcelona, Barcelona 08028, Spain; [Garcia-Albeniz, Xabier; Nadal, Cristina] Hosp Clin Barcelona, IDIBAPS, Inst Malalties Hematooncol, E-08036 Barcelona, Spain; [Garcia-Albeniz, Xabier; Nadal, Cristina] CIBER EHD, Barcelona 08036, Spain; [Virtudes Cespedes, Maria; Mangues, Ramon] Hosp Santa Creu & Sant Pau, Grp Oncogenesi & Antitumorals, Barcelona 08026, Spain; [Virtudes Cespedes, Maria; Mangues, Ramon] Network Res Ctr Bioengn Biomat & Nanomed CIBER BB, Inst Biomed Res IIB St Pau, Grp Oncogenesi & Antitumorals, Barcelona 08026, Spain; [Kemeny, Nancy] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Batlle, Eduard; Nebreda, Angel R.; Gomis, Roger R.] ICREA, Barcelona 08010, Spain; [Dolado, Ignacio] Mol Partners AG, CH-8952 Schlieren, Switzerland	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Memorial Sloan Kettering Cancer Center; ICREA	Gomis, RR (corresponding author), IRB Barcelona, Barcelona 08028, Spain.	roger.gomis@irbbarcelona.org	Batlle, Eduard/K-8080-2014; Nebreda, Angel Rodriguez/R-9594-2019; Gomis, Roger R/E-9788-2016; Mangues, Ramon/J-6396-2014	Batlle, Eduard/0000-0003-2422-0326; Gomis, Roger R/0000-0001-6473-2858; Mangues, Ramon/0000-0003-2661-9525; Gawrzak, Sylwia/0000-0002-7047-3319; Garcia-Albeniz, Xabier/0000-0002-9814-2343; Barriga, Francisco/0000-0002-0996-7707	Fundacion BBVA; Spanish Ministerio de Ciencia e Innovacion (MICINN); Fundacion Olga Torres; Hospital Clinic-IDIBAPS (Ajut a la Recerca Josep Font); ASISA-Harvard Fellowship for Excellence in Clinical Research; Instituto de Salud Carlos III; La Caixa Fellowships; FPI from MICINN; Institucio Catalana de Recerca i Estudis Avancats (ICREA); MICINN [BFU2010-17850, SAF2010-21171]; European Commission FP7 [ERC 294665]; Generalitat de Catalunya [2009 SGR 1437, 2009 SGR 1429]; MINECO [P12/01861]; CIBER-BBN NanoCoMets; AECC; ICREA Funding Source: Custom	Fundacion BBVA(BBVA Foundation); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Olga Torres; Hospital Clinic-IDIBAPS (Ajut a la Recerca Josep Font); ASISA-Harvard Fellowship for Excellence in Clinical Research; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); La Caixa Fellowships; FPI from MICINN; Institucio Catalana de Recerca i Estudis Avancats (ICREA)(ICREA); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); European Commission FP7(European CommissionEuropean Commission Joint Research Centre); Generalitat de Catalunya(Generalitat de Catalunya); MINECO(Spanish Government); CIBER-BBN NanoCoMets; AECC; ICREA(ICREA)	We would like to thank J. Maurel for providing the data on patients with colon and rectal cancers depicted in Supplementary Table 3. We also thank H. Auer, J. Colombelli and M. Gay from the Functional genomics, Microscopy and Mass spectrometry core facilities of IRB Barcelona, respectively. J.U. was supported by Fundacion BBVA, a Juan de la Cierva grant from Spanish Ministerio de Ciencia e Innovacion (MICINN) and a grant from Fundacion Olga Torres. X.G-A. was supported by Hospital Clinic-IDIBAPS (Ajut a la Recerca Josep Font) and an ASISA-Harvard Fellowship for Excellence in Clinical Research. S.R. was supported by a S. Borrel contract from Instituto de Salud Carlos III. S.G. and M.P. were supported by La Caixa Fellowships and A.B. by FPI from MICINN. R.R.G., E.B. and A.R.N. are supported by the Institucio Catalana de Recerca i Estudis Avancats (ICREA). Research support was provided by MICINN (BFU2010-17850), the European Commission FP7 (ERC 294665) and the Fundacion BBVA to A.R.N, by the Generalitat de Catalunya (2009 SGR 1437), MINECO P12/01861 and CIBER-BBN NanoCoMets to R.M., and by the Fundacion BBVA, AECC, Generalitat de Catalunya (2009 SGR 1429) and MICINN (SAF2010-21171) to R.R.G.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Alonso G, 2000, J BIOL CHEM, V275, P40641, DOI 10.1074/jbc.M007835200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Edge SB, 2009, AJCC CANC STAGING MA, V7; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Gallwitz WE, 2002, J CLIN INVEST, V110, P1559, DOI 10.1172/JCI200211936; Garcia-Albeniz X, 2011, TUMOR BIOL, V32, P417, DOI 10.1007/s13277-010-0136-3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIAVAZZI R, 1986, CANCER RES, V46, P1928; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kievit J, 2002, EUR J CANCER, V38, P986, DOI 10.1016/S0959-8049(02)00061-8; Malakouti S, 1996, AM SURGEON, V62, P540; Mallick B. K., 2009, BAYESAN ANAL GENE EX; Martinez-Fernandez A, 2009, ANN SURG ONCOL, V16, P1412, DOI 10.1245/s10434-009-0405-9; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rossell D, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1333; Sadahiro S, 2003, HEPATO-GASTROENTEROL, V50, P1362; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Schluter K, 2006, AM J PATHOL, V169, P1064, DOI 10.2353/ajpath.2006.050566; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Takayama Y, 2010, INT J ONCOL, V36, P1387, DOI 10.3892/ijo_00000623; Tie J, 2011, CLIN CANCER RES, V17, P1122, DOI 10.1158/1078-0432.CCR-10-1720; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wanebo HJ, 2012, CLIN EXP METASTAS, V29, P821, DOI 10.1007/s10585-012-9517-x; Xing L, 2012, CHEMMEDCHEM, V7, P273, DOI 10.1002/cmdc.201100439	40	106	111	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					685	+		10.1038/ncb2977	http://dx.doi.org/10.1038/ncb2977			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24880666				2022-12-25	WOS:000338187900009
J	Forsberg, LA; Rasi, C; Malmqvist, N; Davies, H; Pasupulati, S; Pakalapati, G; Sandgren, J; de Stahl, TD; Zaghlool, A; Giedraitis, V; Lannfelt, L; Score, J; Cross, NCP; Absher, D; Janson, ET; Lindgren, CM; Morris, AP; Ingelsson, E; Lind, L; Dumanski, JP				Forsberg, Lars A.; Rasi, Chiara; Malmqvist, Niklas; Davies, Hanna; Pasupulati, Saichand; Pakalapati, Geeta; Sandgren, Johanna; de Stahl, Teresita Diaz; Zaghlool, Ammar; Giedraitis, Vilmantas; Lannfelt, Lars; Score, Joannah; Cross, Nicholas C. P.; Absher, Devin; Janson, Eva Tiensuu; Lindgren, Cecilia M.; Morris, Andrew P.; Ingelsson, Erik; Lind, Lars; Dumanski, Jan P.			Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer	NATURE GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; SEX DISPARITIES; AGE; CELLS; ANEUPLOIDY; GENETICS	Incidence and mortality for sex-unspecific cancers are higher among men, a fact that is largely unexplained(1,2). Furthermore, age-related loss of chromosome Y (LOY) is frequent in normal hematopoietic cells(3,4), but the phenotypic consequences of LOY have been elusive(5-10). From analysis of 1,153 elderly men, we report that LOY in peripheral blood was associated with risks of all-cause mortality (hazards ratio (HR) = 1.91, 95% confidence interval (CI) = 1.17-3.13; 637 events) and non-hematological cancer mortality (HR = 3.62, 95% CI = 1.56-8.41; 132 events). LOY affected at least 8.2% of the subjects in this cohort, and median survival times among men with LOY were 5.5 years shorter. Association of LOY with risk of all-cause mortality was validated in an independent cohort (HR = 3.66) in which 20.5% of subjects showed LOY. These results illustrate the impact of post-zygotic mosaicism on disease risk, could explain why males are more frequently affected by cancer and suggest that chromosome Y is important in processes beyond sex determination. LOY in blood could become a predictive biomarker of male carcinogenesis.	[Forsberg, Lars A.; Rasi, Chiara; Malmqvist, Niklas; Davies, Hanna; Pasupulati, Saichand; Pakalapati, Geeta; Zaghlool, Ammar; Dumanski, Jan P.] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Forsberg, Lars A.; Rasi, Chiara; Malmqvist, Niklas; Davies, Hanna; Pasupulati, Saichand; Pakalapati, Geeta; Zaghlool, Ammar; Ingelsson, Erik; Dumanski, Jan P.] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Malmqvist, Niklas; Janson, Eva Tiensuu; Ingelsson, Erik; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sandgren, Johanna; de Stahl, Teresita Diaz] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Giedraitis, Vilmantas; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Score, Joannah; Cross, Nicholas C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Lindgren, Cecilia M.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA	Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Uppsala University; University of Southampton; HudsonAlpha Institute for Biotechnology; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Forsberg, LA (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	lars.forsberg@igp.uu.se; jan.dumanski@igp.uu.se	Cross, Nicholas/B-4817-2009	Cross, Nicholas/0000-0001-5481-2555; Forsberg, Lars/0000-0002-1701-755X; Diaz de Stahl, Teresita/0000-0001-5933-6623; Dumanski, Jan Piotr/0000-0002-1489-1452; Lindgren, Cecilia/0000-0002-4903-9374; Davies, Hanna/0000-0002-6289-3815	Olle Enqvist Byggmastare Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Heart-Lung Foundation; Sci-LifeLab-Uppsala; Wellcome Trust [WT098017, WT064890, WT090532]; Uppsala University, Uppsala University Hospital; Wellcome Trust Research Career Development Fellow [086596/Z/08/Z]; Wellcome Trust Senior Research Fellow [WT098017, WT064890, WT090532]	Olle Enqvist Byggmastare Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sci-LifeLab-Uppsala; Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University, Uppsala University Hospital; Wellcome Trust Research Career Development Fellow(Wellcome Trust); Wellcome Trust Senior Research Fellow(Wellcome Trust)	We thank G. Arnqvist and K. Lindblad-Toh for advice and F. Steele for review of the manuscript. This study was sponsored by funding from the Olle Enqvist Byggmastare Foundation to L.A.F. and by the Swedish Cancer Society, the Swedish Research Council, the Swedish Heart-Lung Foundation and funding from Sci-LifeLab-Uppsala to J.P.D. Genotyping and next-generation sequencing were performed by the SNP&SEQ Technology Platform in Uppsala, Sweden, and were supported by Wellcome Trust grants WT098017, WT064890 and WT090532 and by Uppsala University, Uppsala University Hospital, the Swedish Research Council and the Swedish Heart-Lung Foundation. The SNP&SEQ Technology Platform is part of the Science for Life Laboratory at Uppsala University and is supported as national infrastructure by the Swedish Research Council. C.M.L. is a Wellcome Trust Research Career Development Fellow (grant 086596/Z/08/Z). A.P.M. is a Wellcome Trust Senior Research Fellow (grants WT098017, WT090532 and WT064890).	[Anonymous], 1992, Genes Chromosomes Cancer, V5, P83; Bianchi NO, 2009, MUTAT RES-REV MUTAT, V682, P21, DOI 10.1016/j.mrrev.2009.02.001; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; de Carvalho Claudia Marcia Benedetto, 2005, J Mol Genet Med, V1, P63; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Edgren G, 2012, EUR J EPIDEMIOL, V27, P187, DOI 10.1007/s10654-011-9647-5; Eisenberg ML, 2013, FERTIL STERIL, V100, P681, DOI 10.1016/j.fertnstert.2013.05.022; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Forsberg LA, 2013, J MED GENET, V50, P1, DOI 10.1136/jmedgenet-2012-101322; Hughes JF, 2012, ANNU REV GENOM HUM G, V13, P83, DOI 10.1146/annurev-genom-090711-163855; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jacobs PA, 2013, BRIT J CANCER, V108, P959, DOI 10.1038/bjc.2012.577; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; NOWINSKI GP, 1990, AM J HUM GENET, V46, P1101; PIERRE RV, 1972, CANCER, V30, P889, DOI 10.1002/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1; Schick UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059823; Veiga LCS, 2012, BRAZ J MED BIOL RES, V45, P172, DOI 10.1590/S0100-879X2012007500004; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Vial T, 2003, TOXICOLOGY, V185, P229, DOI 10.1016/S0300-483X(02)00612-1; Vijayakumar S, 2006, CANCER RES, V66, P4055, DOI 10.1158/0008-5472.CAN-05-3822; Vijayakumar S, 2005, GENE CHROMOSOME CANC, V44, P365, DOI 10.1002/gcc.20250; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I; Wiktor AE, 2011, LEUKEMIA RES, V35, P1297, DOI 10.1016/j.leukres.2011.05.002; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	29	217	222	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					624	628		10.1038/ng.2966	http://dx.doi.org/10.1038/ng.2966			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24777449	Green Accepted			2022-12-25	WOS:000336870700021
J	Grafel, I; Yang, T; Alexander, S; Homan, EP; Lietman, C; Jiang, MM; Bertin, T; Munivez, E; Chen, YQ; Dawson, B; Ishikawa, Y; Weis, MA; Sampath, TK; Ambrose, C; Eyre, D; Bachinger, HP; Lee, B				Grafel, Ingo; Yang, Tao; Alexander, Stefanie; Homan, Erica P.; Lietman, Caressa; Jiang, Ming Ming; Bertin, Terry; Munivez, Elda; Chen, Yuqing; Dawson, Brian; Ishikawa, Yoshihiro; Weis, Mary Ann; Sampath, T. Kuber; Ambrose, Catherine; Eyre, David; Baechinger, Hans Peter; Lee, Brendan			Excessive transforming growth factor-beta signaling is a common mechanism in osteogenesis imperfecta	NATURE MEDICINE			English	Article							TGF-BETA; DECORIN BINDS; BONE MASS; EXPRESSION; ACTIVATION; COLLAGEN; MUTATIONS; BIGLYCAN; ANTIBODY; GROWTH-FACTOR-BETA-1	Osteogenesis imperfecta (OI) is a heritable disorder, in both a dominant and recessive manner, of connective tissue characterized by brittle bones, fractures and extraskeletal manifestations(1). How structural mutations of type I collagen (dominant OI) or of its post-translational modification machinery (recessive OI) can cause abnormal quality and quantity of bone is poorly understood. Notably, the clinical overlap between dominant and recessive forms of OI suggests common molecular pathomechanisms(2). Here, we show that excessive transforming growth factor-beta (TGF-beta) signaling is a mechanism of OI in both recessive (Crtap(-/-)) and dominant (Col1a2(tm1.1mcbr)) OI mouse models. In the skeleton, we find higher expression of TGF-beta target genes, higher ratio of phosphorylated Smad2 to total Smad2 protein and higher in vivo Smad2 reporter activity. Moreover, the type I collagen of Crtap(-/-) mice shows reduced binding to the small leucine-rich proteoglycan decorin, a known regulator of TGF-beta activity(3,4). Anti-TGF-beta treatment using the neutralizing antibody 1D11 corrects the bone phenotype in both forms of OI and improves the lung abnormalities in Crtap(-/-) mice. Hence, altered TGF-beta matrix-cell signaling is a primary mechanism in the pathogenesis of OI and could be a promising target for the treatment of OI.	[Grafel, Ingo; Yang, Tao; Alexander, Stefanie; Homan, Erica P.; Lietman, Caressa; Jiang, Ming Ming; Bertin, Terry; Munivez, Elda; Chen, Yuqing; Dawson, Brian; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jiang, Ming Ming; Dawson, Brian; Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97201 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Weis, Mary Ann; Eyre, David] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Sampath, T. Kuber] Genzyme Res Ctr, Framingham, MA USA; [Ambrose, Catherine] Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Oregon Health & Science University; University of Washington; University of Washington Seattle; Sanofi-Aventis; University of Texas System; University of Texas Health Science Center Houston	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.edu		Ambrose, Catherine/0000-0002-3866-0683; Ishikawa, Yoshihiro/0000-0003-2013-0518; Lietman, Caressa/0000-0003-3863-2751	German Research Foundation/Deutsche Forschungsgemeinschaft; Michael Geisman Fellowship from the Osteogenesis Imperfecta Foundation; Shriners Hospitals for Children; NIH [5F31DE020954, 5F31DE022483, R37 AR037318, R01 AR036794, P01 HD70394]; Howard Hughes Medical Institute Foundation; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center [HD024064]; Eunice Kennedy Shriver US National Institute of Child Health & Human Development; Rolanette and Berdon Lawrence Bone Disease Program of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092, P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR037318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE020954, F31DE022483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	German Research Foundation/Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Michael Geisman Fellowship from the Osteogenesis Imperfecta Foundation; Shriners Hospitals for Children; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Foundation; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; Eunice Kennedy Shriver US National Institute of Child Health & Human Development; Rolanette and Berdon Lawrence Bone Disease Program of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Spencer and his lab (Baylor College of Medicine) for providing the IVIS camera system and training, M. Starbuck and F. Gannon for consultation and advice in bone histomorphometry, M. Warman and C. Jacobsen (Boston Children's Hospital) for providing the Col1a2<SUP>tm1.1Mcbr</SUP> mice and helpful information. We also thank L. Fisher (US National Institute of Dental and Craniofacial Research) for providing the decorin antibody LF-113. We thank M. Bagos for help with microCT analyses, A. Abraham for help with the biomechanical testing, W. Song and S. Liu for their help with serum bone turnover analyses, the US National Institutes of Health (NIH) for providing the ImageJ software and A. Choi and H. Lam (Harvard Medical School) for providing the ImageJ modification for lung morphometry, which was generated by P. Thompson. Also, we thank D. Rifkin (New York University Medical Center) for providing PAI-luciferase reporter mink lung epithelial cells. In addition, we thank R. Morello, G. Sule, D. Baldridge and G. Ghosal for their helpful discussions and P. Fonseca for editorial assistance. This work was supported by a research fellowship from the German Research Foundation/Deutsche Forschungsgemeinschaft (I.G.), a Michael Geisman Fellowship from the Osteogenesis Imperfecta Foundation (I.G.), grant support from Shriners Hospitals for Children (H.P.B.), NIH grants 5F31DE020954 (E.P.H.), 5F31DE022483 (C.L.), R37 AR037318 and R01 AR036794 (D.E.), and P01 HD70394 (B.L. and D.E.) and the Howard Hughes Medical Institute Foundation (B.L.). This work was also supported by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (HD024064), the Eunice Kennedy Shriver US National Institute of Child Health & Human Development and the Rolanette and Berdon Lawrence Bone Disease Program of Texas.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Baldridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010560; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; CHRIST M, 1994, J IMMUNOL, V153, P1936; DALLAS SL, 1994, J BIOL CHEM, V269, P6815; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Fuller K, 2000, J CELL SCI, V113, P2445; Gauldie J, 2003, AM J PATHOL, V163, P2575, DOI 10.1016/S0002-9440(10)63612-7; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; Hering S, 2001, EXP CLIN ENDOCR DIAB, V109, P217, DOI 10.1055/s-2001-15109; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Homan EP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004121; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Karsdal MA, 2002, J BIOL CHEM, V277, P44061, DOI 10.1074/jbc.M207205200; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Lonning S, 2011, CURR PHARM BIOTECHNO, V12, P2176, DOI 10.2174/138920111798808392; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; Marwick JA, 2002, ANN NY ACAD SCI, V973, P278, DOI 10.1111/j.1749-6632.2002.tb04649.x; McAllion SJ, 1996, J CLIN PATHOL, V49, P627, DOI 10.1136/jcp.49.8.627; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; Morty Rory E, 2009, Proc Am Thorac Soc, V6, P607, DOI 10.1513/pats.200908-087RM; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; OREFFO ROC, 1989, BIOCHEM BIOPH RES CO, V158, P817, DOI 10.1016/0006-291X(89)92795-2; Orwoll ES, 2014, J CLIN INVEST, V124, P491, DOI 10.1172/JCI71101; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Sarathchandra P, 2000, J PATHOL, V192, P385; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Thiele F, 2012, HUM MOL GENET, V21, P3535, DOI 10.1093/hmg/dds183; Trachtman H, 2011, KIDNEY INT, V79, P1236, DOI 10.1038/ki.2011.33; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Yang T, 2013, P NATL ACAD SCI USA, V110, P7336, DOI 10.1073/pnas.1219748110	40	171	185	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					670	675		10.1038/nm.3544	http://dx.doi.org/10.1038/nm.3544			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24793237	Green Accepted, Green Published			2022-12-25	WOS:000337071000031
J	Stelzer, Y; Sagi, I; Yanuka, O; Eiges, R; Benvenisty, N				Stelzer, Yonatan; Sagi, Ido; Yanuka, Ofra; Eiges, Rachel; Benvenisty, Nissim			The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome	NATURE GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; GLOBAL ANALYSIS; GENE; DIFFERENTIATION; IDENTIFICATION; ANTISENSE; ANGELMAN; REVEALS; CLUSTER	Parental imprinting is a form of epigenetic regulation that results in parent-of-origin differential gene expression. To study Prader-Willi syndrome (PWS), a developmental imprinting disorder, we generated case-derived induced pluripotent stem cells (iPSCs) harboring distinct aberrations in the affected region on chromosome 15. In studying PWS-iPSCs and human parthenogenetic iPSCs, we unexpectedly found substantial upregulation of virtually all maternally expressed genes (MEGs) in the imprinted DLK1-DIO3 locus on chromosome 14. Subsequently, we determined that IPW, a long noncoding RNA in the critical region of the PWS locus, is a regulator of the DLKI-DIO3 region, as its overexpression in PWS and parthenogenetic iPSCs resulted in downregulation of MEGs in this locus. We further show that gene expression changes in the DLK1-DIO3 region coincide with chromatin modifications rather than DNA methylation levels. Our results suggest that a subset of PWS phenotypes may arise from dysregulation of an imprinted locus distinct from the PWS region.	[Stelzer, Yonatan; Sagi, Ido; Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Eiges, Rachel] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Stem Cell Res Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il		eiges, rachel/0000-0001-8139-0933	Israel Science Foundation-Morasha Foundation [1252/12]; Israel Ministry of Science and Technology Infrastructure [3-9693]	Israel Science Foundation-Morasha Foundation; Israel Ministry of Science and Technology Infrastructure	Fibroblasts obtained from an individual with PWS harboring complete mUPD of chromosome 15 were kindly donated by V. Gross-Tour (Multidisciplinary Prader-Willi Syndrome Clinic, Child Neurology Unit, Shaare Zedek Medical Center). This research was partially funded by the Israel Science Foundation-Morasha Foundation (grant 1252/12) and by the Israel Ministry of Science and Technology Infrastructure (grant 3-9693).	Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Falk MJ, 2005, PEDIATR NEUROL, V32, P116, DOI 10.1016/j.pediatrneurol.2004.07.007; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hordijk R, 1999, J MED GENET, V36, P782, DOI 10.1136/jmg.36.10.782; Hosoki K, 2009, J PEDIATR-US, V155, P900, DOI 10.1016/j.jpeds.2009.06.045; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Stelzer Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3724; Stelzer Y, 2013, STEM CELL REP, V1, P79, DOI 10.1016/j.stemcr.2013.03.005; Stelzer Y, 2011, NAT STRUCT MOL BIOL, V18, P735, DOI 10.1038/nsmb.2050; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vassena R, 2012, HUM MOL GENET, V21, P3366, DOI 10.1093/hmg/dds168; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Yang JY, 2010, J BIOL CHEM, V285, P40303, DOI 10.1074/jbc.M110.183392; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033	32	96	96	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					551	557		10.1038/ng.2968	http://dx.doi.org/10.1038/ng.2968			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24816254				2022-12-25	WOS:000336870700010
J	Monk, J; Nogales, J; Palsson, BO				Monk, Jonathan; Nogales, Juan; Palsson, Bernhard O.			Optimizing genome-scale network reconstructions	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI K-12; GLOBAL RECONSTRUCTION; METABOLIC GENOTYPE; COMMUNITY APPROACH; HIGH-THROUGHPUT; MODEL; CYANOBACTERIA; OPTIMIZATION; PHYLOGENY; DISCOVERY		[Monk, Jonathan; Nogales, Juan; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu	Nogales, Juan/Y-8829-2019	Nogales, Juan/0000-0002-4961-0833; Palsson, Bernhard/0000-0003-2357-6785; Monk, Jonathan M./0000-0002-3895-8949	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Baran R, 2013, ACS CHEM BIOL, V8, P189, DOI 10.1021/cb300477w; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Charusanti P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-163; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Ganter M, 2013, BIOINFORMATICS, V29, P815, DOI 10.1093/bioinformatics/btt036; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Janssen P, 2005, EMBO REP, V6, P397, DOI 10.1038/sj.embor.7400412; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Lespinet O, 2005, SCIENCE, V307, P42; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Liao YC, 2011, J BACTERIOL, V193, P1710, DOI 10.1128/JB.01218-10; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Milne CB, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-130; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Orth JD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-30; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Pouliot Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-244; Rabinowitz JD, 2012, NAT CHEM BIOL, V8, P497, DOI 10.1038/nchembio.969; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576	53	131	132	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					447	452		10.1038/nbt.2870	http://dx.doi.org/10.1038/nbt.2870			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811519	Bronze			2022-12-25	WOS:000336036100019
J	Robles-Espinoza, CD; Harland, M; Ramsay, AJ; Aoude, LG; Quesada, V; Ding, ZH; Pooley, KA; Pritchard, AL; Tiffen, JC; Petljak, M; Palmer, JM; Symmons, J; Johansson, P; Stark, MS; Gartside, MG; Snowden, H; Montgomery, GW; Martin, NG; Lite, JZ; Choi, J; Makowski, M; Brown, KM; Dunning, AM; Keane, TM; Lopez-Otin, C; Gruis, NA; Hayward, NK; Bishop, DT; Newton-Bishop, JA; Adams, DJ				Robles-Espinoza, Carla Daniela; Harland, Mark; Ramsay, Andrew J.; Aoude, Lauren G.; Quesada, Victor; Ding, Zhihao; Pooley, Karen A.; Pritchard, Antonia L.; Tiffen, Jessamy C.; Petljak, Mia; Palmer, Jane M.; Symmons, Judith; Johansson, Peter; Stark, Mitchell S.; Gartside, Michael G.; Snowden, Helen; Montgomery, Grant W.; Martin, Nicholas G.; Lite, Jimmy Z.; Choi, Jiyeon; Makowski, Matthew; Brown, Kevin M.; Dunning, Alison M.; Keane, Thomas M.; Lopez-Otin, Carlos; Gruis, Nelleke A.; Hayward, Nicholas K.; Bishop, D. Timothy; Newton-Bishop, Julia A.; Adams, David J.			POT1 loss-of-function variants predispose to familial melanoma	NATURE GENETICS			English	Article							GERMLINE MUTATIONS; PROTEIN; CANCER; RNA	Deleterious germline variants in CDKN2A account for around 40% of familial melanoma cases(l), and rare variants in CDK4, BRCA2, BAP1 and the promoter of TERT have also been linked to the disease(2-5). Here we set out to identify new high-penetrance susceptibility genes by sequencing 184 melanoma cases from 105 pedigrees recruited in the UK, The Netherlands and Australia that were negative for variants in known predisposition genes. We identified families where melanoma cosegregates with loss-of-function variants in the protection of telomeres 1 gene (POT1), with a proportion of family members presenting with an early age of onset and multiple primary tumors. We show that these variants either affect POT1 mRNA splicing or alter key residues in the highly conserved oligonucleotide/oligosaccharide-binding (OB) domains of POT1, disrupting protein-telomere binding and leading to increased telomere length. These findings suggest that POT1 variants predispose to melanoma formation via a direct effect on telomeres.	[Robles-Espinoza, Carla Daniela; Ding, Zhihao; Tiffen, Jessamy C.; Petljak, Mia; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, England; [Harland, Mark; Snowden, Helen; Bishop, D. Timothy; Newton-Bishop, Julia A.] Univ Leeds, Leeds Inst Canc & Pathol, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Ramsay, Andrew J.; Quesada, Victor; Lopez-Otin, Carlos] Univ Oviedo, IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Aoude, Lauren G.; Pritchard, Antonia L.; Palmer, Jane M.; Symmons, Judith; Johansson, Peter; Stark, Mitchell S.; Gartside, Michael G.; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Oncogen Lab, Brisbane, Qld, Australia; [Pooley, Karen A.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol Lab, Brisbane, Qld, Australia; [Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol Lab, Brisbane, Qld, Australia; [Lite, Jimmy Z.] Wellcome Trust Sanger Inst, Hinxton, England; [Choi, Jiyeon; Makowski, Matthew; Brown, Kevin M.] Natl Canc Inst, Lab Translat Gen, Bethesda, MD USA; [Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Hayward, Nicholas K.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands	Wellcome Trust Sanger Institute; University of Leeds; University of Oviedo; QIMR Berghofer Medical Research Institute; University of Cambridge; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Adams, DJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	dal@sanger.ac.uk	Martin, Nicholas/R-9235-2019; Pritchard, Antonia/F-4288-2010; Stark, Mitchell/K-3874-2019; Stark, Mitchell/K-6794-2019; hayward, nicholas k/C-1367-2015; Aoude, Lauren/C-7484-2014; Robles-Espinoza, Carla Daniela/L-2560-2019; hayward, nick/AAV-8802-2020; Stark, Mitchell S/E-3542-2010; Johansson, Peter A/K-1053-2014; Montgomery, Grant W/B-7148-2008; Quesada, Víctor/B-6557-2014; López-Otín, Carlos/AAB-2106-2020	Martin, Nicholas/0000-0003-4069-8020; Pritchard, Antonia/0000-0001-5336-0454; Stark, Mitchell/0000-0002-4510-2161; hayward, nicholas k/0000-0003-4760-1033; Aoude, Lauren/0000-0003-1448-3923; Robles-Espinoza, Carla Daniela/0000-0003-3277-7466; Stark, Mitchell S/0000-0002-4510-2161; Johansson, Peter A/0000-0001-7015-5452; Montgomery, Grant W/0000-0002-4140-8139; Quesada, Víctor/0000-0002-8398-3457; López-Otín, Carlos/0000-0001-6964-1904; Bishop, Tim/0000-0002-8752-8785; Keane, Thomas/0000-0001-7532-6898; Dunning, Alison Margaret/0000-0001-6651-7166; Ding, Zhihao/0000-0003-0961-2284; Gruis, Nelleke/0000-0002-5210-9150; Newton-Bishop, Julia/0000-0001-9147-6802; Adams, David/0000-0001-9490-0306	Consejo Nacional de Ciencia y Tecnologia of Mexico; Cancer Research UK [C1287/A9540, C8197/A10123, C588/A4994, C588/A10589]; Isaac Newton Trust; National Health and Medical Research Council of Australia (NHMRC); Cure Cancer Australia; NHMRC; Cancer Council Queensland; Dutch Cancer Society [UL 2012-5489]; Genomics Initiative; Spanish Ministry of Economy and Competitiveness through Instituto de Salud Carlos III (ISCIII); Consolider-Ingenio RNAREG Consortium; Wellcome Trust [WT091310]; Australia and New Zealand Banking Group Limited Trustees; Red Tematica de Investigacion del Cancer (RTICC) del ISCIII; Cancer Research UK [10589, 16565, 13031] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Cancer Research UK(Cancer Research UK); Isaac Newton Trust; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Dutch Cancer Society(KWF Kankerbestrijding); Genomics Initiative; Spanish Ministry of Economy and Competitiveness through Instituto de Salud Carlos III (ISCIII); Consolider-Ingenio RNAREG Consortium; Wellcome Trust(Wellcome TrustEuropean Commission); Australia and New Zealand Banking Group Limited Trustees; Red Tematica de Investigacion del Cancer (RTICC) del ISCIII; Cancer Research UK(Cancer Research UK)	We thank the UK10K Consortium (funded by the Wellcome Trust; WT091310) for access to control data, D.J.A., C.D.R.-E., Z.D., J.Z.L., J.C.T., M.P. and T.M.K. were supported by Cancer Research UK and the Wellcome Trust (WT098051). C.D.R.-E. was also supported by the Consejo Nacional de Ciencia y Tecnologia of Mexico. K.A.P. and A.M.D. were supported by Cancer Research UK (grants C1287/A9540 and C8197/A10123) and by the Isaac Newton Trust. N.K.H. was supported by a fellowship from the National Health and Medical Research Council of Australia (NHMRC). L.G.A. was supported by an Australia and New Zealand Banking Group Limited Trustees PhD scholarship. ALP. is supported by Cure Cancer Australia. The work was funded in part by the NHMRC and Cancer Council Queensland. The work of N.A.G. was in part supported by the Dutch Cancer Society (UL 2012-5489). M.H., J.A.N.-B. and D.T.B. were supported by Cancer Research UK (programme awards C588/A4994 and C588/A10589 and the Genomics Initiative). C.L.-O., A.J.R. and V.Q. are funded by the Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII), the Red Tematica de Investigacion del Cancer (RTICC) del ISCIII and the Consolider-Ingenio RNAREG Consortium. C.L.-O. is an investigator with the Botin Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Burke LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071121; Ding ZH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku181; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Jacobs JJL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00088; Kendellen MF, 2009, MOL CELL BIOL, V29, P5611, DOI 10.1128/MCB.00286-09; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Nandakumar J, 2010, P NATL ACAD SCI USA, V107, P651, DOI 10.1073/pnas.0911099107; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Silverman B.W, 1986, DENSITY ESTIMATION; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	25	240	247	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					478	481		10.1038/ng.2947	http://dx.doi.org/10.1038/ng.2947			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686849	Green Accepted			2022-12-25	WOS:000335422900015
J	Hwang, WL; Jiang, JK; Yang, SH; Huang, TS; Lan, HY; Teng, HW; Yang, CY; Tsai, YP; Lin, CH; Wang, HW; Yang, MH				Hwang, Wei-Lun; Jiang, Jeng-Kae; Yang, Shung-Haur; Huang, Tse-Shun; Lan, Hsin-Yi; Teng, Hao-Wei; Yang, Chih-Yung; Tsai, Ya-Ping; Lin, Chi-Hung; Wang, Hsei-Wei; Yang, Muh-Hwa			MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLON-CANCER; TRANSCRIPTION FACTOR; BETA-CATENIN; GENE-EXPRESSION; SMALL-INTESTINE; NOTCH; NUMB; ACTIVATION; PROTEINS	Asymmetrical cell division (ACD) maintains the proper number of stem cells to ensure self-renewal. In cancer cells, the deregulation of ACD disrupts the homeostasis of the stem cell pool and promotes tumour growth. However, this mechanism is unclear. Here, we show a reduction of ACD in spheroid-derived colorectal cancer stem cells (CRCSCs) compared with differentiated cancer cells. The epithelial-mesenchymal transition (EMT) inducer Snail is responsible for the ACD-to-symmetrical cell division (SCD) switch in CRCSCs. Mechanistically, Snail induces the expression of microRNA-146a (miR-146a) through the beta-catenin-TCF4 complex. miR-146a targets Numb to stabilize beta-catenin, which forms a feedback circuit to maintain Wnt activity and directs SCD. Interference with the Snail-miR-146a-beta-catenin loop by inhibiting the MEK or Wnt activity reduces the symmetrical division of CRCSCs and attenuates tumorigenicity. In colorectal cancer patients, the Snail(High)Numb(Low) profile is correlated with cetuximab resistance and a poorer prognosis. This study elucidates a unique mechanism of EMT-induced CRCSC expansion.	[Hwang, Wei-Lun; Huang, Tse-Shun; Yang, Chih-Yung; Lin, Chi-Hung; Wang, Hsei-Wei] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan; [Jiang, Jeng-Kae] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 11221, Taiwan; [Jiang, Jeng-Kae; Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Div Colorectal Surg, Taipei 11217, Taiwan; [Lan, Hsin-Yi; Yang, Muh-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan; [Teng, Hao-Wei; Yang, Muh-Hwa] Taipei Vet Gen Hosp, Dept Med, Div Hematol Oncol, Taipei 11217, Taiwan; [Tsai, Ya-Ping] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 12221, Taiwan; [Wang, Hsei-Wei; Yang, Muh-Hwa] Natl Yang Ming Univ, Canc Res Ctr, Taipei 11221, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ & Res, Taipei 10341, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Immun & Inflammat Res Ctr, Taipei 11221, Taiwan; [Yang, Muh-Hwa] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Wang, HW (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan.	hwwang@ym.edu.tw; mhyang2@vghtpe.gov.tw	Yang, Muh-Hwa/AAE-4691-2020	Hwang, Wei-Lun/0000-0002-8694-877X	National Science Council [NSC102-2321-B-010-006, 102-2314-B-010-044, 101-2321-B-010-011, 102-2314-B-010-045, 101-2320-B-010-059-MY3, 101-2627-B-010-003, 100-2321-B-075-004, 101-2321-B-075-001]; National Health Research Institutes [NHRI-EX102-10037BI, NHRI-EX102-10254SI]; Taipei City Hospital [10201-62-070]; Ministry of Education, Aim for the Top University Plan; Department of Health, Center of Excellence for Cancer Research [DOH102-TD-C-111-007]; UST-UCSD International Center for Excellence in Advanced Bioengineering; Taiwan NSCI-RiCE [NSC101-2911-I-009-101]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Department of Health, Center of Excellence for Cancer Research; UST-UCSD International Center for Excellence in Advanced Bioengineering; Taiwan NSCI-RiCE	We thank the National Yang-Ming University-VGH Genome Research Center for technical support. We thank K.-J. Wu (National Yang-Ming University) for providing the wild-type and mutant beta-catenin constructs. This work was supported by the National Science Council (NSC102-2321-B-010-006 and 102-2314-B-010-044 to M-H.Y.; 101-2321-B-010-011, 102-2314-B-010-045, 101-2320-B-010-059-MY3 and 101-2627-B-010-003 to H-W.W.; 100-2321-B-075-004 and 101-2321-B-075-001 to J-K.J.), the National Health Research Institutes (NHRI-EX102-10037BI to M-H.Y. and NHRI-EX102-10254SI to H-W.W.), Taipei City Hospital (10201-62-070 to H-W.W.), a grant from the Ministry of Education, Aim for the Top University Plan (to MH.Y. and H-W.W.), a grant from the Department of Health, Center of Excellence for Cancer Research (DOH102-TD-C-111-007 to M-H.Y. and H-W.W.), and the UST-UCSD International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan NSCI-RiCE (NSC101-2911-I-009-101 to H-W.W.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Giebel B, 2012, CURR BIOL, V22, pR133, DOI 10.1016/j.cub.2012.01.006; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Horvay K, 2011, STEM CELLS DEV, V20, P737, DOI 10.1089/scd.2010.0188; Hsu D. S., 1916, CLIN CANCER RES, V16, P4561; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee YY, 2012, CANCER RES, V72, DOI [10.1158/1538-7445.AM2012-4651, 10.1158/0008-5472.CAN-12-2397]; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455	62	206	210	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2014	16	3					268	+		10.1038/ncb2910	http://dx.doi.org/10.1038/ncb2910			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AB9OK	24561623				2022-12-25	WOS:000332124000013
J	Hughes, JR; Roberts, N; McGowan, S; Hay, D; Giannoulatou, E; Lynch, M; De Gobbi, M; Taylor, S; Gibbons, R; Higgs, DR				Hughes, Jim R.; Roberts, Nigel; McGowan, Simon; Hay, Deborah; Giannoulatou, Eleni; Lynch, Magnus; De Gobbi, Marco; Taylor, Stephen; Gibbons, Richard; Higgs, Douglas R.			Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment	NATURE GENETICS			English	Article							PRIMARY ERYTHROID-CELLS; CHROMOSOME CONFORMATION; HUMAN GENOME; GENE-EXPRESSION; CHROMATIN INTERACTIONS; MOUSE GENOME; ENHANCER; CAPTURE; ERYTHROPOIESIS; IDENTIFICATION	Gene expression during development and differentiation is regulated in a cell-and stage-specific manner by complex networks of intergenic and intragenic cis-regulatory elements whose numbers and representation in the genome far exceed those of structural genes. Using chromosome conformation capture, it is now possible to analyze in detail the interaction between enhancers, silencers, boundary elements and promoters at individual loci, but these techniques are not readily scalable. Here we present a high-throughput approach (Capture-C) to analyze cis interactions, interrogating hundreds of specific interactions at high resolution in a single experiment. We show how this approach will facilitate detailed, genome-wide analysis to elucidate the general principles by which cis-acting sequences control gene expression. In addition, we show how Capture-C will expedite identification of the target genes and functional effects of SNPs that are associated with complex diseases, which most frequently lie in intergenic cis-acting regulatory elements.	[Hughes, Jim R.; Roberts, Nigel; Hay, Deborah; Lynch, Magnus; De Gobbi, Marco; Gibbons, Richard; Higgs, Douglas R.] Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford, England; [McGowan, Simon; Giannoulatou, Eleni; Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England	University of Oxford; University of Oxford	Higgs, DR (corresponding author), Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford, England.	jim.hughes@imm.ox.ac.uk; doug.higgs@imm.ox.ac.uk	De Gobbi, Marco/E-8136-2013; Gibbons, Richard/E-6937-2011	De Gobbi, Marco/0000-0003-4261-7642; McGowan, Simon/0000-0001-9720-1914; Lynch, Magnus/0000-0001-7586-4338; Giannoulatou, Eleni/0000-0002-7084-6736; Higgs, Douglas/0000-0003-3579-8705; Gibbons, Richard/0000-0002-7680-9311; Roberts, Nigel/0000-0002-5091-3604	Wellcome Trust [090532/Z/09/Z]; MRC Hub grant [G0900747 91070]; EpiGeneSys; MRC [G0902418, MC_UU_12009/15, MC_UU_12009/4, G1000801] Funding Source: UKRI; Medical Research Council [G1000801, MC_UU_12009/4, MC_UU_12009/15, G1000801b, G0902418] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EpiGeneSys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Davies and P. Piazza for technical suggestions. We thank M. Suciu, B. Graham and T. Milne for suggestions and critically reading the manuscript. We thank Z.-P. Han and J. Telenius for computational support. We thank the HighThroughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and MRC Hub grant G0900747 91070) for the generation of the sequencing data. This work was supported by the MRC (UK) and by the Blood theme within Oxford Biomedical Research Centre (which is part of the National Institute for Health Research Biomedical Research Centres scheme). We also thank EpiGeneSys for support.	Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; de Laat W, 2012, METHODS, V58, P189, DOI 10.1016/j.ymeth.2012.11.005; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferreira R, 2013, MOL CELL BIOL, V33, P1254, DOI 10.1128/MCB.01525-12; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Hosseini M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003570; Hughes JR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0361; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Kang JH, 2004, EUR J BIOCHEM, V271, P2452, DOI 10.1111/j.1432-1033.2004.04175.x; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kolovos P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-1; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; McGowan SJ, 2013, BIOINFORMATICS, V29, P2477, DOI 10.1093/bioinformatics/btt406; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Papadopoulos GL, 2013, NUCLEIC ACIDS RES, V41, P4938, DOI 10.1093/nar/gkt167; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sajan SA, 2012, ANNU REV GENOM HUM G, V13, P59, DOI 10.1146/annurev-genom-090711-163818; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SPIVAK JL, 1973, BLOOD, V42, P257, DOI 10.1182/blood.V42.2.257.257; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stein LD, 2013, BRIEF BIOINFORM, V14, P162, DOI 10.1093/bib/bbt001; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vernimmen D, 2009, BLOOD, V114, P4253, DOI 10.1182/blood-2009-03-213439; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Zhou Z, 2010, J BIOL CHEM, V285, P15894, DOI 10.1074/jbc.M109.098376	52	296	304	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					205	+		10.1038/ng.2871	http://dx.doi.org/10.1038/ng.2871			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413732	Green Submitted			2022-12-25	WOS:000331208300020
J	Guarente, L				Guarente, Leonard			Sirtuins and the Warburg effect	NATURE MEDICINE			English	Editorial Material							HISTONE DEACETYLASE SIRT6; GLUTAMINE-METABOLISM; CALORIE RESTRICTION; TUMOR-SUPPRESSOR; HIF1-ALPHA; OPPOSES		[Guarente, Leonard] MIT, Dept Biol, Glenn Lab Sci Aging, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Glenn Lab Sci Aging, Cambridge, MA 02139 USA.	leng@mit.edu						Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	15	27	27	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					24	25		10.1038/nm.3438	http://dx.doi.org/10.1038/nm.3438			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398961				2022-12-25	WOS:000329349400014
J	Balbas-Martinez, C; Sagrera, A; Carrillo-de-Santa-Pau, E; Earl, J; Marquez, M; Vazquez, M; Lapi, E; Castro-Giner, F; Beltran, S; Bayes, M; Carrato, A; Cigudosa, JC; Dominguez, O; Gut, M; Herranz, J; Juanpere, N; Kogevinas, M; Langa, X; Lopez-Knowles, E; Lorente, JA; Lloreta, J; Pisano, DG; Richart, L; Rico, D; Salgado, RN; Tardon, A; Chanock, S; Heath, S; Valencia, A; Losada, A; Gut, I; Malats, N; Real, FX				Balbas-Martinez, Cristina; Sagrera, Ana; Carrillo-de-Santa-Pau, Enrique; Earl, Julie; Marquez, Mirari; Vazquez, Miguel; Lapi, Eleonora; Castro-Giner, Francesc; Beltran, Sergi; Bayes, Monica; Carrato, Alfredo; Cigudosa, Juan C.; Dominguez, Orlando; Gut, Marta; Herranz, Jesus; Juanpere, Nuria; Kogevinas, Manolis; Langa, Xavier; Lopez-Knowles, Elena; Lorente, Jose A.; Lloreta, Josep; Pisano, David G.; Richart, Laia; Rico, Daniel; Salgado, Rocio N.; Tardon, Adonina; Chanock, Stephen; Heath, Simon; Valencia, Alfonso; Losada, Ana; Gut, Ivo; Malats, Nuria; Real, Francisco X.			Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; COPY-NUMBER; FUNCTIONAL IMPACT; FGFR3 MUTATIONS; CELL-CARCINOMA; GENOME; COHESIN-SA1; VARIANTS; TUMORS; GENES	Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological and genetic levels. Tumor invasiveness (T) and grade (G) are the main factors associated with outcome and determine patient management(1). A discovery exome sequencing screen (n = 17), followed by a prevalence screen (n = 60), identified new genes mutated in this tumor coding for proteins involved in chromatin modification (MLL2, ASXL2 and BPTF), cell division (STAG2, SMC1A and SMC1B) and DNA repair (ATM, ERCC2 and FANCA). STAG2, a subunit of cohesin, was significantly and commonly mutated or lost in UBC, mainly in tumors of low stage or grade, and its loss was associated with improved outcome. Loss of expression was often observed in chromosomally stable tumors, and STAG2 knockdown in bladder cancer cells did not increase aneuploidy. STAG2 reintroduction in non-expressing cells led to reduced colony formation. Our findings indicate that STAG2 is a new UBC tumor suppressor acting through mechanisms that are different from its role in preventing aneuploidy.	[Balbas-Martinez, Cristina; Sagrera, Ana; Carrillo-de-Santa-Pau, Enrique; Earl, Julie; Lapi, Eleonora; Langa, Xavier; Richart, Laia; Real, Francisco X.] CNIO Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain; [Earl, Julie; Carrato, Alfredo] Hosp Ramon & Cajal, Serv Oncol Med, E-28034 Madrid, Spain; [Marquez, Mirari; Herranz, Jesus; Malats, Nuria] CNIO Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genet & Mol Epidemiol Grp, Madrid, Spain; [Vazquez, Miguel; Rico, Daniel; Valencia, Alfonso] CNIO Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Struct Computat Biol Grp, Madrid, Spain; [Castro-Giner, Francesc; Beltran, Sergi; Bayes, Monica; Gut, Marta; Heath, Simon; Gut, Ivo] CNAG, Barcelona, Spain; [Cigudosa, Juan C.; Salgado, Rocio N.] CNIO Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Mol Cytogenet Grp, Madrid, Spain; [Dominguez, Orlando] CNIO Spanish Natl Canc Res Ctr, Biotechnol Programme, Madrid, Spain; [Juanpere, Nuria; Lloreta, Josep] Hosp Mar Parc Salut Mar, Dept Pathol, Barcelona, Spain; [Kogevinas, Manolis] Ctr Recerca Epidemiol Ambiental, Barcelona, Spain; [Kogevinas, Manolis; Lopez-Knowles, Elena] Inst Recerca Hosp Mar, IMIM, Barcelona, Spain; [Kogevinas, Manolis] CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Lorente, Jose A.] Hosp Mar Parc Salut Mar, Urol Serv, Barcelona, Spain; [Lloreta, Josep; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Pisano, David G.] CNIO Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Bioinformat Unit, Madrid, Spain; [Tardon, Adonina] Univ Oviedo, Dept Med, Oviedo, Spain; [Chanock, Stephen] NCI, Translat Genom Lab, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Losada, Ana] CNIO Spanish Natl Canc Res Ctr, Mol Oncol Programme, Chromosome Dynam Grp, Madrid, Spain	Hospital Universitario Ramon y Cajal; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Oviedo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Real, FX (corresponding author), CNIO Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain.	preal@cnio.es	Castro-Giner, Francesc/D-7992-2014; Lapi, Eleonora/ABF-9748-2021; Lloreta-Trull, Josep/GRR-9682-2022; Losada, Ana/H-5917-2015; Lloreta, J/I-2112-2014; Valencia, Alfonso/I-3127-2015; Dominguez, Orlando/M-7515-2018; Beltran, Sergi/I-3408-2015; Heath, Simon C/J-4138-2012; Gut, Ivo/ABF-3188-2020; TARDON, ADONINA/B-6563-2014; Lloreta-Trull, Josep/AAZ-1229-2020; Arribas, Francisco X Real/H-5275-2015; Kogevinas, Manolis/C-3918-2017; de Santa Pau, Enrique Carrillo/AAV-7544-2021; Valencia, Alfonso/AAN-9230-2020; Cigudosa, Juan C/E-4105-2016; Herranz Valera, Jesus/M-8657-2014; Rico, Daniel/I-2049-2013; Vazquez, Miguel/I-2593-2015; Pisano, David/N-5817-2014; Malats, Nuria/H-7041-2015	Castro-Giner, Francesc/0000-0001-6111-0754; Lapi, Eleonora/0000-0003-4052-0361; Losada, Ana/0000-0001-5251-3383; Lloreta, J/0000-0003-1644-9470; Valencia, Alfonso/0000-0002-8937-6789; Beltran, Sergi/0000-0002-2810-3445; Heath, Simon C/0000-0002-9550-0897; Gut, Ivo/0000-0001-7219-632X; TARDON, ADONINA/0000-0001-5150-1209; Arribas, Francisco X Real/0000-0001-9501-498X; Kogevinas, Manolis/0000-0002-9605-0461; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; Valencia, Alfonso/0000-0002-8937-6789; Herranz Valera, Jesus/0000-0002-7385-1311; CARRATO, ALFREDO/0000-0001-7749-8140; Lopez Knowles, Elena/0000-0002-0893-3361; Rico, Daniel/0000-0002-6561-2310; Vazquez, Miguel/0000-0002-5713-1058; Pisano, David/0000-0002-4895-4124; Balbas Martinez, Cristina/0000-0002-2565-7733; Earl, Julie/0000-0001-9360-4716; Malats, Nuria/0000-0003-2538-3784	Ministerio de Economia y Competitividad, Madrid [SAF-2010-21517, SAF2011-15934-E]; Instituto de Salud Carlos III [G03/174, 00/0745, PI051436, PI061614, PI080440, PI120425]; Asociacion Espanola Contra el Cancer [EU-FP7-201663]; US National Institutes of Health [RO1 CA089715]; La Caixa International PhD Fellowship; Fundacion Banco Santander Postdoctoral Programme; NATIONAL CANCER INSTITUTE [ZIACP010201, R01CA089715] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad, Madrid; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Asociacion Espanola Contra el Cancer; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Caixa International PhD Fellowship(La Caixa Foundation); Fundacion Banco Santander Postdoctoral Programme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Algaba, Y. Allory, A. Cuadrado, C. Gonzalez, E. Lopez, P. Lapunzina, T. Lobato, M. Malumbres, S. Remeseiro, V.J. Sanchez-Arevalo, F. Waldman and the CNIO core facilities for valuable contributions. We also thank TCGA investigators for providing unpublished information for analysis. This work was supported, in part, by grants from Ministerio de Economia y Competitividad, Madrid (grants Consolider ONCOBIO, Consolider INESGEN, SAF-2010-21517 and SAF2011-15934-E), Instituto de Salud Carlos III (grants G03/174, 00/0745, PI051436, PI061614, G03/174, PI080440, PI120425 and Red Tematica de Investigacion Cooperativa en Cancer (RTICC)), Asociacion Espanola Contra el Cancer, EU-FP7-201663 and US National Institutes of Health grant RO1 CA089715. C. B.-M. is the recipient of a La Caixa International PhD Fellowship. E. L. is supported by a grant from the Fundacion Banco Santander Postdoctoral Programme.	Amaral AFS, 2012, JNCI-J NATL CANCER I, V104, P1897, DOI 10.1093/jnci/djs444; Balbas-Martinez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062483; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Hoglund M, 2012, UROL ONCOL-SEMIN ORI, V30, P533, DOI 10.1016/j.urolonc.2012.04.001; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Lopez-Knowles E, 2006, CLIN CANCER RES, V12, P6029, DOI 10.1158/1078-0432.CCR-06-0206; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Real FX, 2007, J CLIN ONCOL, V25, P5341, DOI 10.1200/JCO.2007.13.1904; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Sylvester RJ, 2006, THESCIENTIFICWORLDJO, V6, P2617, DOI 10.1100/tsw.2006.404; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vazquez M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002824; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	34	182	183	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1464	U221		10.1038/ng.2799	http://dx.doi.org/10.1038/ng.2799			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24121791	Green Accepted			2022-12-25	WOS:000327715800012
J	Jefferson, OA; Kollhofer, D; Ehrich, TH; Jefferson, RA				Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.			Transparency tools in gene patenting for informing policy and practice OPEN	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; GENOME ANNOTATION; US; ALIGNMENT; SECTOR	The Supreme Court's decision in Myriad highlights the need for tools enabling nuanced and precise analysis of gene patents at the global level.	[Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Cambia, Canberra, ACT, Australia; [Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Jefferson, OA (corresponding author), Cambia, Canberra, ACT, Australia.	osmat@cambia.org; raj@cambia.org		Jefferson, Osmat Azzam/0000-0002-0607-8728; Ehrich, Thomas/0000-0003-3475-4321; Koellhofer, Deniz/0000-0003-0313-4672; Jefferson, Richard/0000-0001-5352-4498				Adelman DE, 2007, TEX LAW REV, V85, P1677; Aggarwal S, 2006, NAT BIOTECHNOL, V24, P643, DOI 10.1038/nbt0606-643; Andree PJ, 2008, WORLD PAT INF, V30, P300, DOI 10.1016/j.wpi.2008.04.005; Bacon N., 2006, CAMBIA PATENT LENS 0; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cook-Deegan R., 2008, FROM BIRTH TO DEATH, P69; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Coombe R.J., 2005, LAW POLICY, V27, P152, DOI 10.1111/j.1467-9930.2004.00195.x; Dobson AW, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-6-161, 10.1186/gb4027]; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hemphill TA, 2012, SCI PUBL POLICY, V39, P815, DOI 10.1093/scipol/scs051; Holman C.M., 2012, UMKC LAW REV, V80, P563; HOLMAN CM, 2007, UMKC L REV, V76, P295; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Laurencin CT, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004467; Leite Marcelo, 2004, Genet Mol Res, V3, P575; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Medina I, 2013, NUCLEIC ACIDS RES, V41, pW41, DOI 10.1093/nar/gkt530; Merges Robert P., 2009, BERKELEY TECH LJ, V24, P1583; Merz JF, 2005, COMMUNITY GENET, V8, P203, DOI 10.1159/000087956; Moore K., 2005, BERKELEY TECH LJ, V20, P1521; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rimmer M., 2008, INTELLECTUAL PROPERT, P138; Than K., 2013, NATIONAL GEOGRAPHIC; Williams HL, 2013, J POLIT ECON, V121, P1, DOI 10.1086/669706	28	19	19	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1086	1093		10.1038/nbt.2755	http://dx.doi.org/10.1038/nbt.2755			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24316644	Green Published, hybrid			2022-12-25	WOS:000328251900019
J	Maejima, Y; Kyoi, S; Zhai, PY; Liu, T; Li, H; Ivessa, A; Sciarretta, S; Del Re, DP; Zablocki, DK; Hsu, CP; Lim, DS; Isobe, M; Sadoshima, J				Maejima, Yasuhiro; Kyoi, Shiori; Zhai, Peiyong; Liu, Tong; Li, Hong; Ivessa, Andreas; Sciarretta, Sebastiano; Del Re, Dominic P.; Zablocki, Daniela K.; Hsu, Chiao-Po; Lim, Dae-Sik; Isobe, Mitsuaki; Sadoshima, Junichi			Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2	NATURE MEDICINE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; PROTEIN AGGREGATION; X-L; APOPTOSIS; PATHWAY; KINASE; ATG14L; DOMAIN; PHOSPHORYLATION; REGULATOR	Here we show that Mst1, a proapoptotic kinase, impairs protein quality control mechanisms in the heart through inhibition of autophagy. Stress-induced activation of Mst1 in cardiomyocytes promoted accumulation of p62 and aggresome formation, accompanied by the disappearance of autophagosomes. Mst1 phosphorylated the Thr108 residue in the BH3 domain of Beclin1, which enhanced the interaction between Beclin1 and Bcl-2 and/or Bcl-xL, stabilized the Beclin1 homodimer, inhibited the phosphatidylinositide 3-kinase activity of the Atg14L-Beclin1-Vps34 complex and suppressed autophagy. Furthermore, Mst1-induced sequestration of Bcl-2 and Bcl-xL by Beclin1 allows Bax to become active, thereby stimulating apoptosis. Mst1 promoted cardiac dysfunction in mice subjected to myocardial infarction by inhibiting autophagy, associated with increased levels of Thr108-phosphorylated Beclin1. Moreover, dilated cardiomyopathy in humans was associated with increased levels of Thr108-phosphorylated Beclin1 and signs of autophagic suppression. These results suggest that Mst1 coordinately regulates autophagy and apoptosis by phosphorylating Beclin1 and consequently modulating a three-way interaction among Bcl-2 proteins, Beclin1 and Bax.	[Maejima, Yasuhiro; Kyoi, Shiori; Zhai, Peiyong; Ivessa, Andreas; Sciarretta, Sebastiano; Del Re, Dominic P.; Zablocki, Daniela K.; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ USA; [Maejima, Yasuhiro; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Liu, Tong; Li, Hong] Rutgers New Jersey Med Sch, Ctr Adv Prote Res, Newark, NJ USA; [Liu, Tong; Li, Hong] Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Hsu, Chiao-Po] Natl Yang Ming Univ, Sch Med, Taipei Vet Gen Hosp, Div Cardiovasc Surg,Dept Surg, Taipei 112, Taiwan; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Creat Res Ctr Cell Div & Differentiat, Taejon 305701, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Tokyo Medical & Dental University (TMDU); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Sadoshima, J (corresponding author), Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ USA.	sadoshju@njms.rutgers.edu	Lim, Dae-Sik/C-1599-2011; Maejima, Yasuhiro/AAG-5580-2020; Sciarretta, Sebastiano/K-5161-2016	Lim, Dae-Sik/0000-0003-2356-7555; Sadoshima, Junichi/0000-0003-3724-4132; Sciarretta, Sebastiano/0000-0002-8633-6896; Del Re, Dominic/0000-0002-5504-9114; Ivessa, Andreas/0000-0002-7578-1337; Li, Hong/0000-0001-5731-5335	US Public Health Service [HL59139, HL67724, HL69020, HL91469, HL102738, AG27211]; Foundation of Leducq Transatlantic Network of Excellence; American Heart Association [12SDG12070262]; Banyu Fellowship Program; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059139, R01HL102738, R01HL091469, R01HL112330, R01HL067724, P01HL069020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211, R21AG042678, R01AG023039] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Foundation of Leducq Transatlantic Network of Excellence; American Heart Association(American Heart Association); Banyu Fellowship Program; Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Brady for critical reading of the manuscript and Y. Ikeda, Y. Matsuda and N. Tamura for their excellent technical assistance. We also thank N. Mizushima (University of Tokyo) for Tg-GFP-LC3 mice, T. Yoshimori (Osaka University) for mRFP-GFP-LC3 plasmid, C. Kojima (Nara Institute of Science and Technology) for pCold-GST plasmid, M. Komatsu (Tokyo Metropolitan Institute of Medical Science) for Atg7<SUP>flox/flox</SUP> mice, R. Kitsis (Albert Einstein College of Medicine) for Bax<SUP>-/-</SUP>; Bak1<SUP>-/-</SUP> MEFs, and B. Levine (University of Texas Southwestern) for Becn1<SUP>+/-</SUP> mice. This work was supported in part by US Public Health Service grants HL59139, HL67724, HL69020, HL91469, HL102738 and AG27211, the Foundation of Leducq Transatlantic Network of Excellence (J.S.), American Heart Association Scientist Development Grant 12SDG12070262 and the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International (Y.M.).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gautreau A, 2003, J BIOL CHEM, V278, P6235, DOI 10.1074/jbc.M210639200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Maejima Y, 2003, CARDIOVASC RES, V59, P308, DOI 10.1016/S0008-6363(03)00425-5; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Noble CG, 2008, J BIOL CHEM, V283, P26274, DOI 10.1074/jbc.M804723200; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	48	357	379	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1478	+		10.1038/nm.3322	http://dx.doi.org/10.1038/nm.3322			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24141421	Green Accepted			2022-12-25	WOS:000326920300025
J	Ghedin, E				Ghedin, Elodie			Panning for molecular gold in whipworm genomes	NATURE GENETICS			English	Editorial Material							TRICHURIS-SUIS OVA; INFECTIONS; SURVIVAL; DISEASE; TRIAL	Two new studies report genomic data on three species of whipworm, soil-transmitted parasitic worms responsible for trichuriasis. These genomes provide insights into host-pathogen interactions and potential for new drug targets for helminth therapy.	[Ghedin, Elodie] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Ghedin, Elodie] NYU, Global Inst Publ Hlth, New York, NY 10003 USA	New York University; New York University	Ghedin, E (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	elodie.ghedin@nyu.edu	Ghedin, Elodie/Y-5654-2019	Ghedin, Elodie/0000-0002-1515-725X				BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Foth BJ, 2014, NAT GENET, V46, P693, DOI 10.1038/ng.3010; Garg SK, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009400.PUB2; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Jex AR, 2014, NAT GENET, V46, P701, DOI 10.1038/ng.3012; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Moroni L, 2012, AUTOIMMUN REV, V11, pA386, DOI 10.1016/j.autrev.2011.11.012; Rosche B, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-112; Sandborn WJ, 2013, ALIMENT PHARM THER, V38, P255, DOI 10.1111/apt.12366; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Zhan B, 2014, EXPERT REV VACCINES, V13, P321, DOI 10.1586/14760584.2014.872035	15	4	4	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					661	663		10.1038/ng.3018	http://dx.doi.org/10.1038/ng.3018			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24965726	Bronze			2022-12-25	WOS:000338093800003
J	Hu, H; Roach, JC; Coon, H; Guthery, SL; Voelkerding, KV; Margraf, RL; Durtschi, JD; Tavtigian, SV; Shankaracharya; Wu, W; Scheet, P; Wang, SG; Xing, JC; Glusman, G; Hubley, R; Li, H; Garg, V; Moore, B; Hood, L; Galas, DJ; Srivastava, D; Reese, MG; Jorde, LB; Yandell, M; Huff, CD				Hu, Hao; Roach, Jared C.; Coon, Hilary; Guthery, Stephen L.; Voelkerding, Karl V.; Margraf, Rebecca L.; Durtschi, Jacob D.; Tavtigian, Sean V.; Shankaracharya; Wu, Wilfred; Scheet, Paul; Wang, Shuoguo; Xing, Jinchuan; Glusman, Gustavo; Hubley, Robert; Li, Hong; Garg, Vidu; Moore, Barry; Hood, Leroy; Galas, David J.; Srivastava, Deepak; Reese, Martin G.; Jorde, Lynn B.; Yandell, Mark; Huff, Chad D.			A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data	NATURE BIOTECHNOLOGY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; FUNCTION STAT1 MUTATIONS; DE-NOVO MUTATIONS; DIVERSITY; IDENTIFICATION	High-throughput sequencing of related individuals has become an important tool for studying human disease. However, owing to technical complexity and lack of available tools, most pedigree-based sequencing studies rely on an ad hoc combination of suboptimal analyses. Here we present pedigree-VAAST (pVAAST), a disease-gene identification tool designed for high-throughput sequence data in pedigrees. pVAAST uses a sequence-based model to perform variant and gene-based linkage analysis. Linkage information is then combined with functional prediction and rare variant case-control association information in a unified statistical framework. pVAAST outperformed linkage and rare-variant association tests in simulations and identified disease-causing genes from whole-genome sequence data in three human pedigrees with dominant, recessive and de novo inheritance patterns. The approach is robust to incomplete penetrance and locus heterogeneity and is applicable to a wide variety of genetic traits. pVAAST maintains high power across studies of monogenic, high-penetrance phenotypes in a single pedigree to highly polygenic, common phenotypes involving hundreds of pedigrees.	[Hu, Hao; Shankaracharya; Scheet, Paul; Huff, Chad D.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Roach, Jared C.; Glusman, Gustavo; Hubley, Robert; Li, Hong; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Guthery, Stephen L.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Voelkerding, Karl V.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Voelkerding, Karl V.; Margraf, Rebecca L.; Durtschi, Jacob D.] ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Tavtigian, Sean V.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Wu, Wilfred; Moore, Barry; Jorde, Lynn B.; Yandell, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Wu, Wilfred; Moore, Barry; Jorde, Lynn B.; Yandell, Mark] Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT USA; [Wang, Shuoguo; Xing, Jinchuan] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Garg, Vidu] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Garg, Vidu] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Galas, David J.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Galas, David J.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Reese, Martin G.] Omicia Inc, Oakland, CA USA	University of Texas System; UTMD Anderson Cancer Center; Institute for Systems Biology (ISB); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Rutgers State University New Brunswick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Luxembourg; Pacific Northwest Diabetes Research Institute (PNDRI); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Yandell, M (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	myandell@genetics.utah.edu; chad@hufflab.org	Garg, Vidu/E-3101-2011; Garg, Vidu/D-8240-2012	Garg, Vidu/0000-0002-3778-5927; , shankaracharya/0000-0001-5957-9828; Srivastava, Deepak/0000-0002-3480-5953; Coon, Hilary/0000-0002-8877-5446; Glusman, Gustavo/0000-0001-8060-5955	US National Institutes of Health [R01 GM104390, R01 DK091374, R01 CA164138, R44HG006579, R01 GM59290]; University of Luxembourg-Institute for Systems Biology Program; NHLBI [UO1 HL100406, U01 HL098179]; NIH [R01 MH094400, R01 MH099134, R00HG005846]; MD Anderson Cancer Center Odyssey Program; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA164138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, R01HL109758, U01HL100406] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006579, R00HG005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290, R01GM104390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094400, R01MH099134] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg-Institute for Systems Biology Program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Odyssey Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	An allocation of computer time on the University of Texas MD Anderson Research Computing High Performance Computing (HPC) facility is gratefully acknowledged. This work was supported by US National Institutes of Health grants R01 GM104390 (M.Y., L.B.J., C. D. H. and H. H.), R01 DK091374 (S. L. G., C. D. H. and L.B.J.), R01 CA164138 (S. V. T. and C. D. H.), R44HG006579 (M. G. R. and M.Y.) and R01 GM59290 (L.B.J.) as well as the University of Luxembourg-Institute for Systems Biology Program. D. S. was supported by grants from the NHLBI (UO1 HL100406 and U01 HL098179) related to this project. H. C. was supported by NIH grants R01 MH094400 and R01 MH099134. H. H. was supported by the MD Anderson Cancer Center Odyssey Program. J.X. was supported by NIH grant R00HG005846.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Borecki IB, 2008, ADV GENET, V60, P51, DOI 10.1016/S0065-2660(07)00403-8; Coon H, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.100; Domyan ET, 2014, CURR BIOL, V24, P459, DOI 10.1016/j.cub.2014.01.020; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Epstein MP, 2012, AM J HUM GENET, V91, P215, DOI 10.1016/j.ajhg.2012.06.004; Feng BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023221; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hori T, 2012, J CLIN IMMUNOL, V32, P1213, DOI 10.1007/s10875-012-9744-6; Hu H, 2013, GENET EPIDEMIOL, V37, P622, DOI 10.1002/gepi.21743; Jung J, 2006, GENET EPIDEMIOL, V30, P652, DOI 10.1002/gepi.20177; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marchani EE, 2012, HUM HERED, V74, P153, DOI 10.1159/000346560; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Reese MG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r88; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Schaid DJ, 2013, GENET EPIDEMIOL, V37, P409, DOI 10.1002/gepi.21727; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Soltesz B, 2013, J MED GENET, V50, P567, DOI 10.1136/jmedgenet-2013-101570; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	46	71	71	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					663	+		10.1038/nbt.2895	http://dx.doi.org/10.1038/nbt.2895			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24837662	Green Accepted			2022-12-25	WOS:000338705900032
J	Ludwig, LS; Gazda, HT; Eng, JC; Eichhorn, SW; Thiru, P; Ghazvinian, R; George, TI; Gotlib, JR; Beggs, AH; Sieff, CA; Lodish, HF; Lander, ES; Sankaran, VG				Ludwig, Leif S.; Gazda, Hanna T.; Eng, Jennifer C.; Eichhorn, Stephen W.; Thiru, Prathapan; Ghazvinian, Roxanne; George, Tracy I.; Gotlib, Jason R.; Beggs, Alan H.; Sieff, Colin A.; Lodish, Harvey F.; Lander, Eric S.; Sankaran, Vijay G.			Altered translation of GATA1 in Diamond-Blackfan anemia	NATURE MEDICINE			English	Article							MESSENGER-RNA TRANSLATION; RIBOSOMAL-PROTEIN S19; CELLS; GENE; ERYTHROPOIESIS; DEFICIENCY; EXPRESSION; INITIATION; MUTATIONS; DIFFERENTIATION	Ribosomal protein haploinsufficiency occurs in diverse human diseases including Diamond-Blackfan anemia (DBA)1,2, congenital asplenia(3) and T cell leukemwia(4). Yet, how mutations in genes encoding ubiquitously expressed proteins such as these result in cell-type- and tissue-specific defects remains unknown(5). Here, we identify mutations in GATA1, encoding the critical hematopoietic transcription factor GATA-binding protein-1, that reduce levels of full-length GATA1 protein and cause DBA in rare instances. We show that ribosomal protein haploinsufficiency, the more common cause of DBA, can lead to decreased GATA1 mRNA translation, possibly resulting from a higher threshold for initiation of translation of this mRNA in comparison with other mRNAs. In primary hematopoietic cells from patients with mutations in RPS19, encoding ribosomal protein S19, the amplitude of a transcriptional signature of GATA1 target genes was globally and specifically reduced, indicating that the activity, but not the mRNA level, of GATA1 is decreased in patients with DBA associated with mutations affecting ribosomal proteins. Moreover, the defective hematopoiesis observed in patients with DBA associated with ribosomal protein haploinsufficiency could be partially overcome by increasing GATA1 protein levels. Our results provide a paradigm by which selective defects in translation due to mutations affecting ubiquitous ribosomal proteins can result in human disease.	[Ludwig, Leif S.; Sieff, Colin A.; Sankaran, Vijay G.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol & Oncol, Boston, MA 02115 USA; [Ludwig, Leif S.; Sieff, Colin A.; Sankaran, Vijay G.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ludwig, Leif S.; Eng, Jennifer C.; Eichhorn, Stephen W.; Thiru, Prathapan; Lodish, Harvey F.; Sankaran, Vijay G.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ludwig, Leif S.; Gazda, Hanna T.; Eng, Jennifer C.; Lodish, Harvey F.; Lander, Eric S.; Sankaran, Vijay G.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Ludwig, Leif S.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Ludwig, Leif S.] Charite, D-13353 Berlin, Germany; [Gazda, Hanna T.; Ghazvinian, Roxanne; Beggs, Alan H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA USA; [Gazda, Hanna T.; Beggs, Alan H.; Sieff, Colin A.; Sankaran, Vijay G.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Eichhorn, Stephen W.; Lodish, Harvey F.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [George, Tracy I.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Gotlib, Jason R.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Harvard University; Harvard Medical School	Sankaran, VG (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol & Oncol, Boston, MA 02115 USA.	sankaran@broadinstitute.org	Ludwig, Leif S./A-1913-2015; George, Tracy I./GRY-0951-2022	Ludwig, Leif S./0000-0002-2916-2164; Beggs, Alan/0000-0001-8818-0568; George, Tracy/0000-0001-5478-7847	German National Academic Foundation; US National Institutes of Health (NIH) [R01 HL107558, K02 HL111156]; DBA Foundation; NIH [P01 HL32262, U54 HG003067-09, R21 HL120791-01]; March of Dimes Basil O'Connor Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL111156, R01HL107558, P01HL032262, R33HL120791, R21HL120791] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	German National Academic Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBA Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Scholar Award(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients with DBA and their families for their inspiration and encouragement. We thank A. Wakabayashi and J. Ulirsch for valuable assistance and D.G. Nathan, S.H. Orkin, D.A. Williams, S.T. Chou, G.W. Bell, C.R. Walkley, J. Flygare and D.P. Bartel for valuable comments and advice. We are grateful to L. Solomon, L. Gaffney and T. DiCesare for assistance with illustrations. This work was supported by the German National Academic Foundation (to L.S.L.), US National Institutes of Health (NIH) grants R01 HL107558 and K02 HL111156 and a grant from the DBA Foundation (to H.T.G.), NIH grant P01 HL32262 (to H.F.L.), NIH grant U54 HG003067-09 (to E.S.L.) and NIH grant R21 HL120791-01 and a March of Dimes Basil O'Connor Scholar Award (to V.G.S.).	Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Chylicki K, 2000, CELL GROWTH DIFFER, V11, P315; Cmejlova J, 2006, HAEMATOLOGICA, V91, P1456; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Flygare J, 2005, BLOOD, V105, P4627, DOI 10.1182/blood-2004-08-3115; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Gazda HT, 2006, STEM CELLS, V24, P2034, DOI 10.1634/stemcells.2005-0554; Gazda HT, 2012, HUM MUTAT, V33, P1037, DOI 10.1002/humu.22081; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Kobayashi E, 2010, J BIOL CHEM, V285, P773, DOI 10.1074/jbc.M109.030726; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LANSDORP PM, 1992, J EXP MED, V175, P1501, DOI 10.1084/jem.175.6.1501; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; NATHAN DG, 1978, J CLIN INVEST, V61, P489, DOI 10.1172/JCI108960; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PEABODY DS, 1987, J BIOL CHEM, V262, P11847; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torihara H, 2011, BRIT J HAEMATOL, V152, P648, DOI 10.1111/j.1365-2141.2010.08535.x; Trainor CD, 2009, BLOOD, V114, P165, DOI 10.1182/blood-2008-10-180489; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Weiss MJ, 2012, J CLIN INVEST, V122, P2346, DOI 10.1172/JCI63989; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359	40	184	191	4	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					748	753		10.1038/nm.3557	http://dx.doi.org/10.1038/nm.3557			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24952648	Green Submitted, Green Accepted			2022-12-25	WOS:000338689500017
J	Brooks, PJ; Tagle, DA; Groft, S				Brooks, Philip J.; Tagle, Danilo A.; Groft, Steve			Expanding rare disease drug trials based on shared molecular etiology	NATURE BIOTECHNOLOGY			English	Article							FAMILIAL DYSAUTONOMIA; CYSTIC-FIBROSIS; NONSENSE MUTATIONS; STORAGE DISORDERS; GENETIC-DISEASES; GAUCHER-DISEASE; SUPPRESSION; REPAIR; CHAPERONES; MECHANISM	Current clinical trial approaches in rare disease test one drug on one indication defined by a clinical phenotype. For targeted drugs, grouping patients by molecular etiology would make much more sense.	[Brooks, Philip J.; Groft, Steve] NIH, Off Rare Dis Res, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Tagle, Danilo A.] NIH, Off Special Initiat, Off Director, Natl Ctr Adv Translat Sci, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Brooks, PJ (corresponding author), NIH, Off Rare Dis Res, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA.	pjbrooks@mail.nih.gov			Intramural NIH HHS [Z99 TR999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Anderson SL, 2005, BIOCHEM BIOPH RES CO, V336, P150, DOI 10.1016/j.bbrc.2005.08.054; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boone N, 2012, HUM MUTAT, V33, P530, DOI 10.1002/humu.22010; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Garber K, 2013, NAT BIOTECHNOL, V31, P189, DOI 10.1038/nbt0313-189; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Hoffman EP, 2013, DISCOV MED, V16, P233; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Kleta R, 2004, EXPERT OPIN PHARMACO, V5, P2255, DOI 10.1517/14656566.5.11.2255; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Kuschal C, 2013, P NATL ACAD SCI USA, V110, P19483, DOI 10.1073/pnas.1312088110; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Medina M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00024; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Myerowitz R, 1997, HUM MUTAT, V9, P195, DOI 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.3.CO;2-J; Nakamura K, 2011, AM J MED GENET C, V157C, P63, DOI 10.1002/ajmg.c.30291; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Quintana-Gallego E, 2014, ARCH BRONCONEUMOL, V50, P146, DOI 10.1016/j.arbres.2013.07.013; Rymond B, 2007, NAT CHEM BIOL, V3, P533, DOI 10.1038/nchembio0907-533; Tuchman M, 2008, PEDIATR RES, V64, P213, DOI 10.1203/PDR.0b013e318179454b; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilschanski M, 2011, EUR RESPIR J, V38, P59, DOI 10.1183/09031936.00120910; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707; Yang CZ, 2014, P NATL ACAD SCI USA, V111, P249, DOI 10.1073/pnas.1321341111	44	14	15	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					515	518		10.1038/nbt.2924	http://dx.doi.org/10.1038/nbt.2924			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911489	Green Accepted			2022-12-25	WOS:000337233800007
J	Hong, TT; Yang, HH; Zhang, SS; Cho, HC; Kalashnikova, M; Sun, BM; Zhang, H; Bhargava, A; Grabe, M; Olgin, J; Gorelik, J; Marban, E; Jan, LY; Shaw, RM				Hong, TingTing; Yang, Huanghe; Zhang, Shan-Shan; Cho, Hee Cheol; Kalashnikova, Mariya; Sun, Baiming; Zhang, Hao; Bhargava, Anamika; Grabe, Michael; Olgin, Jeffrey; Gorelik, Julia; Marban, Eduardo; Jan, Lily Y.; Shaw, Robin M.			Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia	NATURE MEDICINE			English	Article							VENTRICULAR MYOCYTES; TRANSVERSE TUBULES; HEART-FAILURE; DIFFUSION; PROTEIN; MODEL; K+; HYPERTROPHY; BRAIN; CELLS	Cardiomyocyte T tubules are important for regulating ion flux. Bridging integrator 1 (BIN1) is a T-tubule protein associated with calcium channel trafficking that is downregulated in failing hearts. Here we find that cardiac T tubules normally contain dense protective inner membrane folds that are formed by a cardiac isoform of BIN1. In mice with cardiac Bin1 deletion, T-tubule. folding is decreased, which does not change overall cardiomyocyte morphology but leads to free diffusion of local extracellular calcium and potassium ions, prolonging action-potential duration and increasing susceptibility to ventricular arrhythmias. We also found that T-tubule inner folds are rescued by expression of the BIN1 isoform BIN1+13+17, which promotes N-WASP-dependent actin polymerization to stabilize the T-tubule membrane at cardiac Z discs. BIN1+13+17 recruits actin to fold the T-tubule membrane, creating a 'fuzzy space' that protectively restricts ion flux. When the amount of the BIN1+13+17 isoform is decreased, as occurs in acquired cardiomyopathy, T-tubule morphology is altered, and arrhythmia can result.	[Hong, TingTing; Zhang, Shan-Shan; Cho, Hee Cheol; Kalashnikova, Mariya; Sun, Baiming; Marban, Eduardo; Shaw, Robin M.] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Yang, Huanghe; Jan, Lily Y.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Yang, Huanghe; Jan, Lily Y.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Zhang, Hao; Grabe, Michael; Jan, Lily Y.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bhargava, Anamika; Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, London, England; [Gorelik, Julia] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Jan, Lily Y.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	Cedars Sinai Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Imperial College London; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shaw, RM (corresponding author), Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.	robin.shaw@cshs.org	Marban, Eduardo/GWC-8514-2022	Jan, Lily/0000-0003-3938-8498; Bhargava, Anamika/0000-0002-1048-3427; Shaw, Robin/0000-0001-7429-6092; Yang, Huanghe/0000-0001-9521-9328; Gorelik, Julia/0000-0003-1148-9158	US National Institutes of Health [R01 HL094414, R37 MH065334, WT090594, R21 GM100224, T32 HL116273, K99/R00 HL109075]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094414, K99HL109075, R01HL111646, T32HL116273, R00HL109075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM100224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants R01 HL094414 (R.M.S.), R37 MH065334 (L.Y.J.), WT090594 (J.G.), R21 GM100224 (M.G.), T32 HL116273 (S.-S.Z.) and K99/R00 HL109075 (T.H.) and by the American Heart Association (S.-S.Z. and R.M.S.). L.Y.J. is a Howard Hughes Medical Institute investigator. We thank E. Cingolani for helpful advice on designing the in vivo pacing protocol, D. Laury-Kleintop and G.C. Prendergast from the Lankenau Institute for Medical Research for Bin1-loxP mice, J. Mulholland and J.J. Perrino for TEM imaging at the Electron Microscopy Core of the Cell Sciences Imaging Facility at the Stanford University Medical Center, J. Smyth and R. Wirka for helpful discussions and T.S. Fong and T. Hitzeman for technical assistance.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Aiba T, 2010, CURR OPIN CARDIOL, V25, P29, DOI 10.1097/HCO.0b013e328333d3d6; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Bohm J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003430; Bohm J, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-35; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Chang MY, 2007, CANCER RES, V67, P100, DOI 10.1158/0008-5472.CAN-06-2742; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; FRANZINIARMSTRONG C, 1991, DEV BIOL, V146, P353, DOI 10.1016/0012-1606(91)90237-W; Gaur N, 2009, CIRC RES, V105, P1196, DOI 10.1161/CIRCRESAHA.109.202267; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Gez LS, 2012, BIOCHEMISTRY-US, V51, P9658, DOI 10.1021/bi301124a; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; HEPLER PK, 1980, J CELL BIOL, V86, P490, DOI 10.1083/jcb.86.2.490; Hong TT, 2012, HEART RHYTHM, V9, P812, DOI 10.1016/j.hrthm.2011.11.055; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Kawai M, 1999, AM J PHYSIOL-HEART C, V277, pH603, DOI 10.1152/ajpheart.1999.277.2.H603; Kim JM, 2010, BIOPHYS J, V98, P1762, DOI 10.1016/j.bpj.2010.01.008; Komukai K, 2002, PFLUG ARCH EUR J PHY, V444, P532, DOI 10.1007/s00424-002-0851-8; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lyon AR, 2012, CIRC-HEART FAIL, V5, P357, DOI 10.1161/CIRCHEARTFAILURE.111.964692; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Mathur N, 2009, CIRC-ARRHYTHMIA ELEC, V2, P677, DOI 10.1161/CIRCEP.109.894683; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Parfenov AS, 2006, BIOPHYS J, V90, P1107, DOI 10.1529/biophysj.105.071787; Pasek M, 2008, PROG BIOPHYS MOL BIO, V96, P244, DOI 10.1016/j.pbiomolbio.2007.07.016; Pasek M, 2006, PHILOS T R SOC A, V364, P1187, DOI 10.1098/rsta.2006.1764; Pasek M, 2012, EUR BIOPHYS J BIOPHY, V41, P491, DOI 10.1007/s00249-012-0804-x; Pasek M, 2008, PROG BIOPHYS MOL BIO, V96, P258, DOI 10.1016/j.pbiomolbio.2007.07.022; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Shaw RM, 1997, CIRC RES, V80, P124, DOI 10.1161/01.RES.80.1.124; Shepherd N, 1998, AM J PHYSIOL-HEART C, V275, pH852, DOI 10.1152/ajpheart.1998.275.3.H852; Sipido KR, 2006, HEART RHYTHM, V3, P977, DOI 10.1016/j.hrthm.2006.01.013; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Swift F, 2006, J APPL PHYSIOL, V101, P1170, DOI 10.1152/japplphysiol.00297.2006; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tian QH, 2012, J MOL CELL CARDIOL, V52, P113, DOI 10.1016/j.yjmcc.2011.09.001; Wagner E, 2012, CIRC RES, V111, P402, DOI 10.1161/CIRCRESAHA.112.274530; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Yamada H, 2009, J BIOL CHEM, V284, P34244, DOI 10.1074/jbc.M109.064204	47	146	150	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					624	632		10.1038/nm.3543	http://dx.doi.org/10.1038/nm.3543			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24836577	Green Submitted, Green Accepted			2022-12-25	WOS:000337071000024
J	Kessel, M				Kessel, Mark			Diagnostics as the first line of defense in global health security	NATURE BIOTECHNOLOGY			English	Article								The creation of the Global Health Security Agenda is a key step in the goal of combatting outbreaks in an increasingly interconnected world. It is too bad that the initiative is so woefully underfunded.	[Kessel, Mark] Shearman & Sterling LLP, FIND, New York, NY 10022 USA; [Kessel, Mark] Symphony Capital LLP, New York, NY USA		Kessel, M (corresponding author), Shearman & Sterling LLP, FIND, New York, NY 10022 USA.	mark.kessel@shearman.com							0	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					513	514		10.1038/nbt.2930	http://dx.doi.org/10.1038/nbt.2930			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911488	Bronze, Green Published			2022-12-25	WOS:000337233800006
J	Lolicato, M; Bucchi, A; Arrigoni, C; Zucca, S; Nardini, M; Schroeder, I; Simmons, K; Aquila, M; Di Francesco, D; Bolognesi, M; Schwede, F; Kashin, D; Fishwick, CWG; Johnson, AP; Thiel, G; Moroni, A				Lolicato, Marco; Bucchi, Annalisa; Arrigoni, Cristina; Zucca, Stefano; Nardini, Marco; Schroeder, Indra; Simmons, Katie; Aquila, Marco; DiFrancesco, Dario; Bolognesi, Martino; Schwede, Frank; Kashin, Dmitry; Fishwick, Colin W. G.; Johnson, A. Peter; Thiel, Gerhard; Moroni, Anna			Cyclic dinucleotides bind the C-linker of HCN4 to control channel cAMP responsiveness	NATURE CHEMICAL BIOLOGY			English	Article							GMP-AMP SYNTHASE; DI-GMP; PACEMAKER CHANNELS; CARDIAC-PACEMAKER; STRUCTURAL BASIS; CYTOSOLIC DNA; 2ND-MESSENGER; SENSOR; MODULATION; ACTIVATION	cAMP mediates autonomic regulation of heart rate by means of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which underlie the pacemaker current I-f. cAMP binding to the C-terminal cyclic nucleotide binding domain enhances HCN open probability through a conformational change that reaches the pore via the C-linker. Using structural and functional analysis, we identified a binding pocket in the C-linker of HCN4. Cyclic dinucleotides, an emerging class of second messengers in mammals, bind the C-linker pocket (CLP) and antagonize cAMP regulation of the channel. Accordingly, cyclic dinucleotides prevent cAMP regulation of I-f in sinoatrial node myocytes, reducing heart rate by 30%. Occupancy of the CLP hence constitutes an efficient mechanism to hinder beta-adrenergic stimulation on I-f. Our results highlight the regulative role of the C-linker and identify a potential drug target in HCN4. Furthermore, these data extend the signaling scope of cyclic dinucleotides in mammals beyond their first reported role in innate immune system.	[Lolicato, Marco; Bucchi, Annalisa; Arrigoni, Cristina; Zucca, Stefano; Nardini, Marco; Aquila, Marco; DiFrancesco, Dario; Bolognesi, Martino; Moroni, Anna] Univ Milan, Dept Biosci, Milan, Italy; [Schroeder, Indra; Thiel, Gerhard] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Simmons, Katie; Fishwick, Colin W. G.; Johnson, A. Peter] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Bolognesi, Martino; Moroni, Anna] CNR, Ist Biofis, I-20133 Milan, Italy; [Schwede, Frank; Kashin, Dmitry] Forschungslabor & Biochem Vertrieb GmbH, Biol Life Sci Inst, D-28199 Bremen, Germany	University of Milan; Technical University of Darmstadt; University of Leeds; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Lolicato, M (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	anna.moroni@unimi.it	Bucchi, Annalisa/B-1882-2017; Lolicato, Marco/ABC-6878-2020; Simmons, Katie/HHC-3453-2022; Arrigoni, Cristina/AAG-8176-2020; DiFrancesco, Dario/G-8408-2017; Nardini, Marco/B-7842-2017; moroni, anna/H-2097-2014; Lolicato, Marco/AAL-3614-2020; Bolognesi, Martino/B-7924-2017	Bucchi, Annalisa/0000-0002-5303-4242; Lolicato, Marco/0000-0002-2022-7961; DiFrancesco, Dario/0000-0002-7322-1790; Nardini, Marco/0000-0002-3718-2165; moroni, anna/0000-0002-1860-406X; Lolicato, Marco/0000-0002-2022-7961; Bolognesi, Martino/0000-0002-9253-5170; Thiel, Gerhard/0000-0002-2335-1351; Zucca, Stefano/0000-0002-8891-1225; Schroeder, Indra/0000-0002-7875-983X; Fishwick, Colin/0000-0003-1283-2181; Simmons, Katie/0000-0003-4846-9097; Arrigoni, Cristina/0000-0003-1917-1750	Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia [SAL-49]; Programmi di Ricerca di Rilevante Interesse Nazionale [2010CSJX4F]; Ministero Affari Esteri [01467532013-06-27]; European Drug Initiative on Channels and Transporters; Bundesministerium fur Bildung und Forschung (GREVIS) project; EPSRC [EP/K039202/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K039202/1, EP/C010973/1] Funding Source: researchfish	Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia; Programmi di Ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero Affari Esteri; European Drug Initiative on Channels and Transporters; Bundesministerium fur Bildung und Forschung (GREVIS) project(Federal Ministry of Education & Research (BMBF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Xention Ltd. (Cambridge, UK) for the generous gift of HCNs cDNA, J. Berger and Pk. Doudna for hSTING cDNA and C. Deutscher (BioLog, Bremen) for technical help. This work was supported by SAL-49 Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia, Programmi di Ricerca di Rilevante Interesse Nazionale 2010CSJX4F and Ministero Affari Esteri 01467532013-06-27 to A.M.; by European Drug Initiative on Channels and Transporters to K.S., A.P.J., C.W.G.F. and AM; and by Bundesministerium fur Bildung und Forschung (GREVIS) project to G.T.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Klockner U, 2011, J MOL CELL CARDIOL, V51, P226, DOI 10.1016/j.yjmcc.2011.05.004; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Werdan K, 2009, CAN J PHYSIOL PHARM, V87, P266, DOI 10.1139/Y09-012; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008; Zorn-Pauly K, 2007, SHOCK, V28, P655, DOI 10.1097/shk.0b013e31812386bf	32	43	50	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					457	462		10.1038/NCHEMBIO.1521	http://dx.doi.org/10.1038/NCHEMBIO.1521			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24776929	Green Accepted			2022-12-25	WOS:000336238200013
J	Luna, E; van Hulten, M; Zhang, YH; Berkowitz, O; Lopez, A; Petriacq, P; Sellwood, MA; Chen, BN; Burrell, M; van de Meene, A; Pieterse, CMJ; Flors, V; Ton, J				Luna, Estrella; van Hulten, Marieke; Zhang, Yuhua; Berkowitz, Oliver; Lopez, Ana; Petriacq, Pierre; Sellwood, Matthew A.; Chen, Beining; Burrell, Mike; van de Meene, Allison; Pieterse, Corne M. J.; Flors, Victor; Ton, Jurriaan			Plant perception of beta-aminobutyric acid is mediated by an aspartyl-tRNA synthetase	NATURE CHEMICAL BIOLOGY			English	Article							INDUCED RESISTANCE; SPECTROPHOTOMETRIC ASSAY; PERONOSPORA-PARASITICA; STRESS RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS; DEFENSE; GENE; RESPONSES; IMMUNITY	Specific chemicals can prime the plant immune system for augmented defense. beta-aminobutyric acid (BABA) is a priming agent that provides broad-spectrum disease protection. However, BABA also suppresses plant growth when applied in high doses, which has hampered its application as a crop defense activator. Here we describe a mutant of Arabidopsis thaliana that is impaired in BABA-induced disease immunity (ibi1) but is hypersensitive to BABA-induced growth repression. IBI1 encodes an aspartyl-tRNA synthetase. Enantiomer-specific binding of the R enantiomer of BABA to IBI1 primed the protein for non-canonical defense signaling in the cytoplasm after pathogen attack. This priming was associated with aspartic acid accumulation and tRNA-induced phosphorylation of translation initiation factor elF2 alpha. However, mutation of elF2 alpha-phosphorylating GCN2 kinase did not affect BABA-induced immunity but relieved BABA-induced growth repression. Hence, BABA-activated IBI1 controls plant immunity and growth via separate pathways. Our results open new opportunities to separate broad-spectrum disease resistance from the associated costs on plant growth.	[Luna, Estrella; Lopez, Ana; Petriacq, Pierre; Burrell, Mike; Ton, Jurriaan] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Luna, Estrella; Zhang, Yuhua; van de Meene, Allison; Ton, Jurriaan] Rothamsted Res, Harpenden, Herts, England; [van Hulten, Marieke; Pieterse, Corne M. J.; Ton, Jurriaan] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Berkowitz, Oliver] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Berkowitz, Oliver] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Sellwood, Matthew A.; Chen, Beining] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England; [Flors, Victor] Univ Jaume 1, Dept Ciencias Agr & Medio Ambiente, Castellon de La Plana, Spain	University of Sheffield; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Utrecht University; University of Western Australia; University of Western Australia; University of Sheffield; Universitat Jaume I	Luna, E (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	j.ton@sheffield.ac.uk	Ton, Jurriaan/G-3295-2014; Berkowitz, Oliver/A-7854-2008; Pétriacq, Pierre/AAQ-7391-2020; Berkowitz, Oliver/AAE-7979-2019; Sánchez, Ana López/M-4884-2015; Flors, Victor/H-4903-2015; Pieterse, Corné/A-9326-2011	Ton, Jurriaan/0000-0002-8512-2802; Berkowitz, Oliver/0000-0002-7671-6983; Pétriacq, Pierre/0000-0001-8151-7420; Berkowitz, Oliver/0000-0002-7671-6983; Sánchez, Ana López/0000-0003-0859-3536; Pieterse, Corné/0000-0002-5473-4646; Flors, Victor/0000-0003-3974-9652; Luna Diez, Estrella/0000-0002-7299-5364	VENI grant from the Netherlands Organisation of Scientific Research (NWO) [863.04.019]; Biotechnology and Biological Sciences Research Council Institute [BB/E023959/1]; European Research Council [309944-Prime-A-Plant]; Leverhulme Trust [RL-2012-042]; European Union Seventh Framework Programme [265865-PURE]; Felix Thornley Cobbold Agricultural Trust; VICI grant from NWO [865.04.002]; BBSRC [BB/E023959/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023959/1] Funding Source: researchfish	VENI grant from the Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research Council Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Leverhulme Trust(Leverhulme Trust); European Union Seventh Framework Programme(European Commission); Felix Thornley Cobbold Agricultural Trust; VICI grant from NWO; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. van Wees, N. Halford, J. Lucas, J. Pickett, I. Feussner, X. Zhang, W Kegge, D. Acoska, M. Roberts, V. Pastor, J. Gamir and B. Mauch-Mani for fruitful discussions, practical assistance and/or helpful feedback. Arabidopsis NahG B15 and Ler rpp5 seeds were kindly provided by J. Ryals (Research Triangle Park, USA) and J. Parker (Max Planck Institute, Cologne), respectively. The research was supported by a VENI grant to J.T. (no. 863.04.019) from the Netherlands Organisation of Scientific Research (NWO), a Biotechnology and Biological Sciences Research Council Institute Career Path Fellowship (no. BB/E023959/1) to J.T., a consolidator grant from the European Research Council (no. 309944-Prime-A-Plant) to LT., a Research Leadership Award from the Leverhulme Trust (no. RL-2012-042) to LT., European Union Seventh Framework Programme (FP7/2007-2013; no265865-PURE) to J.T., a grant from the Felix Thornley Cobbold Agricultural Trust to J.T. and E.L. and a VICI grant (no. 865.04.002) to C.M.J.P. from NWO.	Ahmad S, 2010, MOL PLANT PATHOL, V11, P817, DOI 10.1111/j.1364-3703.2010.00645.x; Beckers GJ, 2007, CURR OPIN PLANT BIOL, V10, P425, DOI 10.1016/j.pbi.2007.06.002; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; COHEN Y, 1994, PHYSIOL MOL PLANT P, V44, P273, DOI 10.1016/S0885-5765(05)80030-X; Cohen Y, 2010, EUR J PLANT PATHOL, V126, P553, DOI 10.1007/s10658-009-9564-6; Cohen YR, 2002, PLANT DIS, V86, P448, DOI 10.1094/PDIS.2002.86.5.448; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dever TE, 2005, MOL CELL, V18, P141, DOI 10.1016/j.molcel.2005.03.023; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Gao QM, 2014, J EXP BOT, V65, P1849, DOI 10.1093/jxb/eru010; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Li MW, 2013, PLANT BIOLOGY, V15, P13, DOI 10.1111/j.1438-8677.2012.00606.x; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Pastor V, 2013, ENVIRON EXP BOT, V94, P46, DOI 10.1016/j.envexpbot.2012.02.013; Petriacq P, 2012, PLANT J, V70, P650, DOI 10.1111/j.1365-313X.2012.04920.x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Schmitt E, 1998, EMBO J, V17, P5227, DOI 10.1093/emboj/17.17.5227; SHRIFT A, 1976, PLANT PHYSIOL, V58, P248, DOI 10.1104/pp.58.3.248; Silue D, 2002, PLANT PATHOL, V51, P97, DOI 10.1046/j.1365-3059.2002.00649.x; Singh P, 2012, PLANT CELL, V24, P1256, DOI 10.1105/tpc.112.095778; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Ulmasov B, 1998, NUCLEIC ACIDS RES, V26, P5139, DOI 10.1093/nar/26.22.5139; Van der Ent S, 2009, NEW PHYTOL, V183, P419, DOI 10.1111/j.1469-8137.2009.02851.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wu CC, 2010, J EXP BOT, V61, P995, DOI 10.1093/jxb/erp363; Zhang YH, 2008, J EXP BOT, V59, P3131, DOI 10.1093/jxb/ern169; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897	47	98	105	1	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					450	456		10.1038/NCHEMBIO.1520	http://dx.doi.org/10.1038/NCHEMBIO.1520			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24776930	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000336238200012
J	Wang, K; Yuen, ST; Xu, JC; Lee, SP; Yan, HHN; Shi, ST; Siu, HC; Deng, SB; Chu, KM; Law, S; Chan, KH; Chan, ASY; Tsui, WY; Ho, SL; Chan, AKW; Man, JLK; Foglizzo, V; Ng, MK; Chan, AS; Ching, YP; Cheng, GHW; Xie, T; Fernandez, J; Li, VSW; Clevers, H; Rejto, PA; Mao, M; Leung, SY				Wang, Kai; Yuen, Siu Tsan; Xu, Jiangchun; Lee, Siu Po; Yan, Helen H. N.; Shi, Stephanie T.; Siu, Hoi Cheong; Deng, Shibing; Chu, Kent Man; Law, Simon; Chan, Kok Hoe; Chan, Annie S. Y.; Tsui, Wai Yin; Ho, Siu Lun; Chan, Anthony K. W.; Man, Jonathan L. K.; Foglizzo, Valentina; Ng, Man Kin; Chan, April S.; Ching, Yick Pang; Cheng, Grace H. W.; Xie, Tao; Fernandez, Julio; Li, Vivian S. W.; Clevers, Hans; Rejto, Paul A.; Mao, Mao; Leung, Suet Yi			Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer	NATURE GENETICS			English	Article							CPG ISLAND METHYLATION; STEM-CELLS; MICROSATELLITE INSTABILITY; INTESTINAL-METAPLASIA; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; BINDING PROTEIN; RHOA; GENE; ACTIVATION	Gastric cancer is a heterogeneous disease with diverse molecular and histological subtypes. We performed whole-genome sequencing in 100 tumor-normal pairs, along with DNA copy number, gene expression and methylation profiling, for integrative genomic analysis. We found subtype-specific genetic and epigenetic perturbations and unique mutational signatures. We identified previously known (TP53, ARID1A and CDH1) and new (MUC6, CTNNA2, GLI3, RNF43 and others) significantly mutated driver genes. Specifically, we found RHOA mutations in 14.3% of diffuse-type tumors but not in intestinal-type tumors (P < 0.001). The mutations clustered in recurrent hotspots affecting functional domains and caused defective RHOA signaling, promoting escape from anoikis in organoid cultures. The top perturbed pathways in gastric cancer included adherens junction and focal adhesion, in which RHOA and other mutated genes we identified participate as key players. These findings illustrate a multidimensional and comprehensive genomic landscape that highlights the molecular complexity of gastric cancer and provides a road map to facilitate genome-guided personalized therapy.	[Wang, Kai; Xu, Jiangchun; Deng, Shibing; Xie, Tao; Fernandez, Julio; Rejto, Paul A.; Mao, Mao] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA; [Yuen, Siu Tsan; Lee, Siu Po; Yan, Helen H. N.; Siu, Hoi Cheong; Chan, Kok Hoe; Chan, Annie S. Y.; Tsui, Wai Yin; Ho, Siu Lun; Chan, Anthony K. W.; Man, Jonathan L. K.; Ng, Man Kin; Chan, April S.; Cheng, Grace H. W.; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Shi, Stephanie T.] Pfizer Worldwide Res & Dev, External Res Solut, San Diego, CA USA; [Chu, Kent Man; Law, Simon] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Foglizzo, Valentina; Li, Vivian S. W.] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Ching, Yick Pang] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands	Pfizer; University of Hong Kong; Pfizer; University of Hong Kong; MRC National Institute for Medical Research; University of Hong Kong; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Leung, SY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China.	mao_m@yahoo.com; suetyi@hku.hk	Rejto, Paul/M-4782-2019; Yuen, Siu/K-6311-2014; Chan, Kok Hoe/AAN-7838-2020; Leung, Suet Yi/C-4340-2009; Law, Simon/C-4324-2009; Leung, Suet Yi/T-9620-2019	Chan, Kok Hoe/0000-0002-2550-1122; Law, Simon/0000-0002-6518-5806; Yan, Hoi Ning Helen/0000-0001-5693-8231; Fernandez Banet, Julio/0000-0003-0901-1286; Foglizzo, Valentina/0000-0001-5059-3279; Leung, Suet Yi/0000-0001-8614-4619; CHING, Yick Pang/0000-0002-6461-8358; Li, Vivian/0000-0003-2041-0085; Wang, Kai/0000-0003-0567-3004; Chan, April/0000-0002-4797-7009	Pfizer; Research Grants Council of the Hong Kong Special Administrative Region [HKU7719/10M]; S.T. Pan; Medical Research Council [MC_UP_1202/7] Funding Source: researchfish; MRC [MC_UP_1202/7] Funding Source: UKRI	Pfizer(Pfizer); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); S.T. Pan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Shen for assistance with bioinformatics and clinicians at the Hong Kong Hospital Authority for clinical care. We thank Illumina for performing whole-genome sequencing, TruSeq and array experiments and the Centre for Genomics Sciences at the University of Hong Kong for other sequencing services. Funding for the whole-genome sequencing study and associated validation was provided by Pfizer. Funding for the methylation analysis was provided by the Research Grants Council of the Hong Kong Special Administrative Region (General Research Fund grant HKU7719/10M). Funding for the functional assays was provided by a donation from S.T. Pan.	Ahuja N, 1997, CANCER RES, V57, P3370; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Bogaerts S, 2005, EXP CELL RES, V311, P1, DOI 10.1016/j.yexcr.2005.06.018; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Fujii Y, 2012, P NATL ACAD SCI USA, V109, P20584, DOI 10.1073/pnas.1208651109; Garcia E, 1997, CANCER EPIDEM BIOMAR, V6, P1071; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kang GH, 2001, CANCER RES, V61, P2847; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kwon JA, 2010, HUM MUTAT, V31, P942, DOI 10.1002/humu.21289; Kwon OH, 2013, CANCER SCI, V104, P391, DOI 10.1111/cas.12076; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Majewski IJ, 2013, J PATHOL, V229, P621, DOI 10.1002/path.4152; Matsuoka T, 2011, CLIN EXP METASTAS, V28, P627, DOI 10.1007/s10585-011-9396-6; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Oue N, 2003, ONCOLOGY-BASEL, V64, P423, DOI 10.1159/000070302; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pang JCS, 2010, BRAIN PATHOL, V20, P1021, DOI 10.1111/j.1750-3639.2010.00405.x; Park SH, 2001, ONCOGENE, V20, P1235, DOI 10.1038/sj.onc.1204227; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rau TT, 2012, AM J PATHOL, V181, P487, DOI 10.1016/j.ajpath.2012.04.028; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Tuncel H, 2012, INT J ONCOL, V41, P2079, DOI 10.3892/ijo.2012.1652; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang J, 2013, CANCER BIOL THER, V14, P262, DOI 10.4161/cbt.23299; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Yoshioka K, 1999, CANCER RES, V59, P2004; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zheng HC, 2006, J CANCER RES CLIN, V132, P817, DOI 10.1007/s00432-006-0135-3; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	64	696	714	11	221	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					573	582		10.1038/ng.2983	http://dx.doi.org/10.1038/ng.2983			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24816253				2022-12-25	WOS:000336870700013
J	Chen, M; Hong, MJ; Sun, HH; Wang, L; Shi, XR; Gilbert, BE; Corry, DB; Kheradmand, F; Wang, J				Chen, Min; Hong, Monica Jeongsoo; Sun, Huanhuan; Wang, Lei; Shi, Xiurong; Gilbert, Brian E.; Corry, David B.; Kheradmand, Farrah; Wang, Jin			Essential role for autophagy in the maintenance of immunological memory against influenza infection	NATURE MEDICINE			English	Article							B-CELL; GERMINAL CENTER; PROTEIN; DEATH; APOPTOSIS; SELECTION; INHIBITOR; SURVIVAL; DIFFERENTIATION; 5-LIPOXYGENASE	Vaccination has been the most widely used strategy to protect against viral infections for centuries. However, the molecular mechanisms governing the long-term persistence of immunological memory in response to vaccines remain unclear. Here we show that autophagy has a critical role in the maintenance of memory B cells that protect against influenza virus infection. Memory B cells displayed elevated levels of basal autophagy with increased expression of genes that regulate autophagy initiation or autophagosome maturation. Mice with B cell-specific deletion of Atg7 (B/Atg7(-1-) mice) showed normal primary antibody responses after immunization against influenza but failed to generate protective secondary antibody responses when challenged with influenza viruses, resulting in high viral loads, widespread lung destruction and increased fatality. Our results suggest that autophagy is essential for the survival of virus-specific memory B cells in mice and the maintenance of protective antibody responses required to combat infections.	[Chen, Min; Sun, Huanhuan; Wang, Lei; Shi, Xiurong; Corry, David B.; Kheradmand, Farrah; Wang, Jin] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Hong, Monica Jeongsoo; Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Gilbert, Brian E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Corry, David B.; Kheradmand, Farrah] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wang, J (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	minc@bcm.edu; jinwang@bcm.edu		Wang, Jin/0000-0002-7882-1699; Chen, Min/0000-0002-0093-9056; Wang, Jin/0000-0002-3116-0838	US National Institutes of Health [R01 GM087710, R0IDK083164, R01HL117181]; US Department of Veterans Affairs merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083164] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000104, I01BX002221] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank M. Komatsu of Tokyo Metropolitan Institute of Medical Science for providing Atg7<SUP>flox/flox</SUP> mice. We thank M. Schaefer and L.-Z. Song for technical assistance. This work was supported by grants from the US National Institutes of Health to J.W. (R01 GM087710), M.C. (R0IDK083164), D.B.C. and F.K. (R01HL117181) and a US Department of Veterans Affairs merit award (to D.B.C. and F.K.).	Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Catala A, 2012, BIOCHIMIE, V94, P101, DOI 10.1016/j.biochi.2011.09.025; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Costa HM, 2009, PROSTAG OTH LIPID M, V88, P51, DOI 10.1016/j.prostaglandins.2008.09.004; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Ezekwudo DE, 2007, J EXP THER ONCOL, V6, P267; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477; Hamouda T, 2010, HUM VACCINES, V6, P585, DOI 10.4161/hv.6.7.11818; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kim HJ, 2010, ARCH PHARM RES, V33, P1813, DOI 10.1007/s12272-010-1114-4; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kurosaki T, 2010, IMMUNOL REV, V237, P104, DOI 10.1111/j.1600-065X.2010.00939.x; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lorenzo MMG, 2013, CHEST, V143, P502, DOI 10.1378/chest.12-1711; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maccarrone M, 1997, CELL DEATH DIFFER, V4, P396, DOI 10.1038/sj.cdd.4400255; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mitchell J, 1996, J CELL PHYSIOL, V169, P333, DOI 10.1002/(SICI)1097-4652(199611)169:2<333::AID-JCP12>3.0.CO;2-A; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; REDDAN JR, 1993, EXP EYE RES, V56, P543, DOI 10.1006/exer.1993.1068; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tai W, 2011, MUCOSAL IMMUNOL, V4, P197, DOI 10.1038/mi.2010.50; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	59	141	145	1	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					507	514		10.1038/nm.3521	http://dx.doi.org/10.1038/nm.3521			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24747745	Green Accepted			2022-12-25	WOS:000335710700021
J	Dai, LZ; Peng, C; Montellier, E; Lu, ZK; Chen, Y; Ishii, H; Debernardi, A; Buchou, T; Rousseaux, S; Jin, FL; Sabari, BR; Deng, ZY; Allis, CD; Ren, B; Khochbin, S; Zhao, YM				Dai, Lunzhi; Peng, Chao; Montellier, Emilie; Lu, Zhike; Chen, Yue; Ishii, Haruhiko; Debernardi, Alexandra; Buchou, Thierry; Rousseaux, Sophie; Jin, Fulai; Sabari, Benjamin R.; Deng, Zhiyou; Allis, C. David; Ren, Bing; Khochbin, Saadi; Zhao, Yingming			Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark	NATURE CHEMICAL BIOLOGY			English	Article							POSTTRANSLATIONAL MODIFICATION; MASS-SPECTROMETRY; CHROMATIN; IDENTIFICATION; ACETYLATION; BROMODOMAIN; CROTONYLATION; SUCCINYLATION; EPIGENETICS; METABOLISM	We report the identification of a new type of histone mark, lysine 2-hydroxyisobutyrylation (K-hib), and identify the mark at 63 human and mouse histone Khib sites, including 27 unique lysine sites that are not known to be modified by lysine acetylation (K-ac) and lysine crotonylation (K-cr). This histone mark was initially identified by MS and then validated by chemical and biochemical methods. Histone Khib shows distinct genomic distributions from histone Kac or histone Kcr during male germ cell differentiation. Using chromatin immunoprecipitation sequencing, gene expression analysis and immunodetection, we show that in male germ cells, H4K8(hib) is associated with active gene transcription in meiotic and post-meiotic cells. In addition, H4K8(ac)-associated genes are included in and constitute only a subfraction of H4K8hib-labeled genes. The histone Khib mark is conserved and widely distributed, has high stoichiometry and induces a large structural change. These findings suggest its critical role on the regulation of chromatin functions.	[Dai, Lunzhi; Peng, Chao; Lu, Zhike; Chen, Yue; Deng, Zhiyou; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Montellier, Emilie; Debernardi, Alexandra; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] Univ Grenoble 1, Fac Med, INSERM, Inst Albert Bonniot,U823, La Tronche, France; [Ishii, Haruhiko; Jin, Fulai; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ishii, Haruhiko; Jin, Fulai; Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sabari, Benjamin R.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA	University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Rockefeller University	Dai, LZ (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	Yingming.Zhao@uchicago.edu	Deng, Zhiyou/T-3641-2019; Khochbin, Saadi/M-8090-2013; Rousseaux, Sophie/G-1697-2013; Montellier, Emilie/ABE-9802-2020; Montellier, Emilie/N-4071-2017; BUCHOU, Thierry/F-3136-2019	Khochbin, Saadi/0000-0002-0455-0857; Rousseaux, Sophie/0000-0001-5246-5350; Montellier, Emilie/0000-0001-5069-3536; BUCHOU, Thierry/0000-0002-9206-2377; Jin, Fulai/0000-0003-0025-4337; Ishii, Haruhiko/0000-0002-1593-096X; Dai, Lunzhi/0000-0002-3003-8910	Agence Nationale de la Recherche EpiSperm; Institut National du Cancer funds; French Ministry of Research; Association pour la Recherche sur le Cancer fellowship	Agence Nationale de la Recherche EpiSperm(French National Research Agency (ANR)); Institut National du Cancer funds; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association pour la Recherche sur le Cancer fellowship	S.K.'s group research is supported by Agence Nationale de la Recherche EpiSperm and Institut National du Cancer funds. E. M. was supported by a three-year grant from the French Ministry of Research and an Association pour la Recherche sur le Cancer fellowship for her fourth-year PhD.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Drogaris P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00220; Freitas MA, 2004, J CELL BIOCHEM, V92, P691, DOI 10.1002/jcb.20106; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Gorovsky M.A., 1978, Cold Spring Harbor Symposia on Quantitative Biology, V42, P493; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kumps A, 2002, CLIN CHEM, V48, P708; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Montellier E, 2013, GENE DEV, V27, P1680, DOI 10.1101/gad.220095.113; Montellier E, 2012, BIOESSAYS, V34, P187, DOI 10.1002/bies.201100141; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Reynard LN, 2009, J CELL SCI, V122, P4239, DOI 10.1242/jcs.049916; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	30	260	320	7	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					365	U73		10.1038/NCHEMBIO.1497	http://dx.doi.org/10.1038/NCHEMBIO.1497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24681537				2022-12-25	WOS:000334672700010
J	Mathavan, I; Zirah, S; Mehmood, S; Choudhury, HG; Goulard, C; Li, YY; Robinson, CV; Rebuffat, S; Beis, K				Mathavan, Indran; Zirah, Severine; Mehmood, Shahid; Choudhury, Hassanul G.; Goulard, Christophe; Li, Yanyan; Robinson, Carol V.; Rebuffat, Sylvie; Beis, Konstantinos			Structural basis for hijacking siderophore receptors by antimicrobial lasso peptides	NATURE CHEMICAL BIOLOGY			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12; MICROCIN J25; MASS-SPECTROMETER; CRYSTAL-STRUCTURE; TRANSPORTER FHUA; RNA-POLYMERASE; MODEL; TONB; PURIFICATION	The lasso peptide microcin J25 is known to hijack the siderophore receptor FhuA for initiating internalization. Here, we provide what is to our knowledge the first structural evidence on the recognition mechanism, and our biochemical data show that another closely related lasso peptide cannot interact with FhuA. Our work provides an explanation on the narrow activity spectrum of lasso peptides and opens the path to the development of new antibacterials.	[Mathavan, Indran; Choudhury, Hassanul G.; Beis, Konstantinos] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Mathavan, Indran; Choudhury, Hassanul G.; Beis, Konstantinos] Diamond Light Source, Membrane Prot Lab, Chilton, Oxon, England; [Mathavan, Indran; Choudhury, Hassanul G.; Beis, Konstantinos] Res Complex Harwell, Rutherford Appleton Lab, Didcot, Oxon, England; [Zirah, Severine; Goulard, Christophe; Li, Yanyan; Rebuffat, Sylvie] CNRS, Natl Museum Nat Hist, Commun Mol & Adaptat Microorganisms Lab, UMR 7245, Paris, France; [Mehmood, Shahid; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England	Imperial College London; Diamond Light Source; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Oxford	Mathavan, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	rebuffat@mnhn.fr; kbeis@imperial.ac.uk	Rebuffat, Sylvie/AAE-4194-2021; Mathavan, Indran/AAD-9237-2019; Li, Yanyan/ABH-5034-2020; Choudhury, Hassanul/J-8729-2014; Rebuffat, Sylvie/AAO-2072-2020; Zirah, Severine/C-9193-2012	Zirah, Severine/0000-0001-6082-8414; Beis, Konstantinos/0000-0001-5727-4721; robinson, carol/0000-0001-7829-5505; Rebuffat, Sylvie/0000-0002-5257-5039	Medical Research Council [DNRUBH0]; Wellcome Trust [WT/099165/Z/12/Z]; Ministry of Science, Technology and Innovation; Biotechnology and Biological Sciences Research Council [BB/H01778X/1]; Medical Research Council [G1000819] Funding Source: researchfish; BBSRC [BB/H01778X/1] Funding Source: UKRI; MRC [G1000819] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to P. Boulanger (Institute of Biochemistry and Molecular and Cellular Biophysics, Orsay University) for her kind gift of phage T5. We would like to thank the Diamond Light Source for beam time allocation and access. We thank the MS platform at the Museum national d'Histoire naturelle for access to the spectrometers, together with K.-P. Yan and Z. Falk for contributing to the site-directed mutagenesis and phage competition experiments, respectively. The Oxford University Mass Spectrometry facility is funded by the Medical Research Council (DNRUBH0 to C. V. R.). M. P. L. is funded by the Wellcome Trust (WT/099165/Z/12/Z to S. Iwata). I. M. is supported by a Ministry of Science, Technology and Innovation postgraduate scholarship. Part of this work was supported by the Biotechnology and Biological Sciences Research Council (BB/H01778X/1 to K. B.).	Bayro MJ, 2003, J AM CHEM SOC, V125, P12382, DOI 10.1021/ja036677e; Beis K, 2006, INT J BIOL MACROMOL, V39, P10, DOI 10.1016/j.ijbiomac.2005.12.008; Benesch JLP, 2009, ANAL CHEM, V81, P1270, DOI 10.1021/ac801950u; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Braun M, 2003, J BACTERIOL, V185, P5508, DOI 10.1128/JB.185.18.5508-5518.2003; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Delgado MA, 2001, J BACTERIOL, V183, P4543, DOI 10.1128/JB.183.15.4543-4550.2001; Destoumieux-Garzon D, 2005, BIOCHEM J, V389, P869, DOI 10.1042/BJ20042107; Ducasse R, 2012, CHEMBIOCHEM, V13, P371, DOI 10.1002/cbic.201100702; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferguson AD, 1998, PROTEIN SCI, V7, P1636, DOI 10.1002/pro.5560070719; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2001, STRUCTURE, V9, P707, DOI 10.1016/S0969-2126(01)00631-1; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; Flayhan A, 2012, BIOCHIMIE, V94, P1982, DOI 10.1016/j.biochi.2012.05.021; Housden NG, 2013, SCIENCE, V340, P1570, DOI 10.1126/science.1237864; Killmann H, 2002, MICROBIOL-SGM, V148, P3497, DOI 10.1099/00221287-148-11-3497; Knappe TA, 2008, J AM CHEM SOC, V130, P11446, DOI 10.1021/ja802966g; Kuznedelov K, 2011, J MOL BIOL, V412, P842, DOI 10.1016/j.jmb.2011.02.060; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Lopez FE, 2007, J ANTIMICROB CHEMOTH, V59, P676, DOI 10.1093/jac/dkm009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pavlova O, 2008, J BIOL CHEM, V283, P25589, DOI 10.1074/jbc.M803995200; PUGSLEY AP, 1987, J GEN MICROBIOL, V133, P3505; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; SALOMON RA, 1995, J BACTERIOL, V177, P3323, DOI 10.1128/jb.177.11.3323-3325.1995; SALOMON RA, 1993, J BACTERIOL, V175, P7741; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zirah S, 2011, J AM SOC MASS SPECTR, V22, P467, DOI 10.1007/s13361-010-0028-1	34	52	53	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					340	U123		10.1038/NCHEMBIO.1499	http://dx.doi.org/10.1038/NCHEMBIO.1499			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24705590	Green Accepted, Green Submitted			2022-12-25	WOS:000334672700006
J	Mirzaa, GM; Parry, DA; Fry, AE; Giamanco, KA; Schwartzentruber, J; Vanstone, M; Logan, CV; Roberts, N; Johnson, CA; Singh, S; Kholmanskikh, SS; Adams, C; Hodge, RD; Hevner, RF; Bonthron, DT; Braun, KPJ; Faivre, L; Riviere, JB; St-Onge, J; Gripp, KW; Mancini, GMS; Pang, K; Sweeney, E; van Esch, H; Verbeek, N; Wieczorek, D; Steinraths, M; Majewski, J; Boycott, KM; Pilz, DT; Ross, ME; Dobyns, WB; Sheridan, EG				Mirzaa, Ghayda M.; Parry, David A.; Fry, Andrew E.; Giamanco, Kristin A.; Schwartzentruber, Jeremy; Vanstone, Megan; Logan, Clare V.; Roberts, Nicola; Johnson, Colin A.; Singh, Shawn; Kholmanskikh, Stanislav S.; Adams, Carissa; Hodge, Rebecca D.; Hevner, Robert F.; Bonthron, David T.; Braun, Kees P. J.; Faivre, Laurence; Riviere, Jean-Baptiste; St-Onge, Judith; Gripp, Karen W.; Mancini, Grazia M. S.; Pang, Ki; Sweeney, Elizabeth; van Esch, Hilde; Verbeek, Nienke; Wieczorek, Dagmar; Steinraths, Michelle; Majewski, Jacek; Boycott, Kym M.; Pilz, Daniela T.; Ross, M. Elizabeth; Dobyns, William B.; Sheridan, Eamonn G.		FORGE Canada Consortium	De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyriapolydactyly-hydrocephalus syndrome	NATURE GENETICS			English	Article							INTERMEDIATE PROGENITOR CELLS; CEREBRAL-CORTEX; AKT3	Activating mutations in genes encoding phosphatidylinositol 3-kinase (PI3K)-AKT pathway components cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH, OMIM 603387)(1-3). Here we report that individuals with MPPH lacking upstream PI3K-AKT pathway mutations carry de novo mutations in CCND2 (encoding cyclin D2) that are clustered around a residue that can be phosphorylated by glycogen synthase kinase 313 (GSK-3 beta)(4). Mutant CCND2 was resistant to proteasomal degradation in vitro compared to wild-type CCND2. The PI3K-AKT pathway modulates GSK-3 beta activity(4), and cells from individuals with PIK3CA, PIK3R2 or AKT3 mutations showed similar CCND2 accumulation. CCND2 was expressed at higher levels in brains of mouse embryos expressing activated AKT3. In utero electroporation of mutant CCND2 into embryonic mouse brains produced more proliferating transfected progenitors and a smaller fraction of progenitors exiting the cell cycle compared to cells electroporated with wild-type CCND2. These observations suggest that cyclin D2 stabilization, caused by CCND2 mutation or PI3K-AKT activation, is a unifying mechanism in PI3K-AKT-related megalencephaly syndromes.	[Mirzaa, Ghayda M.; Adams, Carissa; Hodge, Rebecca D.; Hevner, Robert F.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Mirzaa, Ghayda M.; Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Parry, David A.; Logan, Clare V.; Roberts, Nicola; Johnson, Colin A.; Sheridan, Eamonn G.] St James Univ Hosp, Wellcome Trust Brenner Bldg, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Fry, Andrew E.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Giamanco, Kristin A.; Singh, Shawn; Kholmanskikh, Stanislav S.] Weill Cornell Med Coll, Neurogenet & Dev Fell Family Brain & Mind Res Ins, New York, NY USA; [Schwartzentruber, Jeremy; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Vanstone, Megan; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Hodge, Rebecca D.; Hevner, Robert F.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hevner, Robert F.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Braun, Kees P. J.] UMC Utrecht, Dept Child Neurol, Utrecht, Netherlands; [Faivre, Laurence] Univ Bourgogne, CHU Dijon, Hop Enfants, Ctr Genet, Dijon, France; [Faivre, Laurence] Univ Bourgogne, CHU Dijon, Hop Enfants, Ctr Reference Anomalies Dev & Syndromes Malformat, Dijon, France; [Riviere, Jean-Baptiste; St-Onge, Judith] Univ Bourgogne, Equipe Genet Anomalies Dev GAD, Dijon, France; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DC USA; [Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Expertise Ctr Neurodev Disorders, Rotterdam, Netherlands; [Pang, Ki] Royal Victoria Infirm, Dept Paediat Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Sweeney, Elizabeth] Liverpool Womens Natl Hlth Serv NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England; [van Esch, Hilde] Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Leuven, Belgium; [Verbeek, Nienke] UMC Utrecht, Dept Med Genet, Utrecht, Netherlands; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Steinraths, Michelle] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Saint James's University Hospital; Cardiff University; Cornell University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utrecht University; Utrecht University Medical Center; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Nemours Alfred I. duPont Hospital for Children; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Newcastle University - UK; KU Leuven; University Hospital Leuven; Utrecht University; Utrecht University Medical Center; University of Duisburg Essen; University of British Columbia; University of Washington; University of Washington Seattle	Sheridan, EG (corresponding author), St James Univ Hosp, Wellcome Trust Brenner Bldg, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	mer2005@med.cornell.edu; e.sheridan@leeds.ac.uk	Van+Esch, Hilde/AAU-5688-2020; Dobyns, William/AAI-2768-2020; Fry, Andrew/AAN-2730-2020; Dobyns, William Brian/ABC-6525-2021; Scherer, Stephen W./B-3785-2013; Fry, Andrew/AFK-7448-2022; Wieczorek, Dagmar/AAU-6008-2021	Dobyns, William/0000-0002-7681-2844; Fry, Andrew/0000-0001-9778-6924; Scherer, Stephen W./0000-0002-8326-1999; Fry, Andrew/0000-0001-9778-6924; Wieczorek, Dagmar/0000-0003-2812-6492; Friedman, Jan/0000-0002-7482-9570; Parry, David/0000-0003-0376-7736; Logan, Clare/0000-0003-4323-1602; Johnson, Colin/0000-0002-2979-8234; Faivre, Laurence/0000-0001-9770-444X; Van Esch, Hilde/0000-0002-9604-5726; Bonthron, David/0000-0001-8132-8179; Bernier, Francois/0000-0001-7063-4269; Schwartzentruber, Jeremy/0000-0002-6183-2092	Government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec and Genome British Columbia; National Institute of Neurological Disorders and Stroke (NINDS) of US National Institutes of Health [P01-NSO48120, NRSA F32 NS086173, R01NS058721]; Baily Thomas Charitable Fund; Sir Jules Thorn Charitable Trust; Great Ormond Street Children's Hospital Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS086173, P01NS048120, R01NS058721] Funding Source: NIH RePORTER; Medical Research Council [MR/K011154/1, MR/L01629X/1] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1217] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; MRC [MR/K011154/1, MR/L01629X/1] Funding Source: UKRI	Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec and Genome British Columbia; National Institute of Neurological Disorders and Stroke (NINDS) of US National Institutes of Health; Baily Thomas Charitable Fund; Sir Jules Thorn Charitable Trust; Great Ormond Street Children's Hospital Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the study patients and their families, without whose participation this work would not be possible. We thank M. O ' Driscoll (University of Sussex) for advice and help. This work was funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), the Ontario Genomics Institute (OGI-049), Genome Quebec and Genome British Columbia (to K.M.B.). The work was selected for study by the FORGE Canada Steering Committee, consisting of K. Boycott (University of Ottawa), J. Friedman (University of British Columbia), J. Michaud (Universite de Montreal), F. Bernier (University of Calgary), M. Brudno (University of Toronto), B. Fernandez (Memorial University), B. Knoppers (McGill University), M. Samuels (Universite de Montreal) and S. Scherer (University of Toronto). Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the US National Institutes of Health under award numbers P01-NSO48120 (to M.E.R.), NRSA F32 NS086173 (to K.A.G.) and R01NS058721 (to W.B.D.), by The Baily Thomas Charitable Fund (to D.T.P.) and by the Sir Jules Thorn Charitable Trust and Great Ormond Street Children's Hospital Charity (to E.G.S.).	Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Glickstein SB, 2007, CEREB CORTEX, V17, P632, DOI 10.1093/cercor/bhk008; Glickstein SB, 2007, DEVELOPMENT, V134, P4083, DOI 10.1242/dev.008524; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544	18	91	94	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					510	515		10.1038/ng.2948	http://dx.doi.org/10.1038/ng.2948			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705253	Green Accepted, Green Submitted			2022-12-25	WOS:000335422900021
J	Wu, G; Diaz, AK; Paugh, BS; Rankin, SL; Ju, BS; Li, YJ; Zhu, XY; Qui, CX; Chen, X; Zhang, JY; Easton, J; Edmonson, M; Ma, XT; Lu, C; Nagahawatte, P; Hedlund, E; Rusch, M; Pounds, S; Lin, T; Onar-Thomas, A; Huether, R; Kriwacki, R; Parker, M; Gupta, P; Becksfort, J; Wei, L; Mulder, HL; Boggs, K; Vadodaria, B; Yergeau, D; Russell, JC; Ochoa, KI; Fulton, RS; Fulton, LL; Jones, C; Boop, FA; Broniscer, A; Wetmore, C; Gajjar, A; Ding, L; Mardis, ER; Wilson, RK; Taylor, MR; Downing, JR; Ellison, DW; Zhang, JH; Baker, SJ				Wu, Gang; Diaz, Alexander K.; Paugh, Barbara S.; Rankin, Sherri L.; Ju, Bensheng; Li, Yongjin; Zhu, Xiaoyan; Qui, Chunxu; Chen, Xiang; Zhang, Junyuan; Easton, John; Edmonson, Michael; Ma, Xiaotu; Lu, Charles; Nagahawatte, Panduka; Hedlund, Erin; Rusch, Michael; Pounds, Stanley; Lin, Tong; Onar-Thomas, Arzu; Huether, Robert; Kriwacki, Richard; Parker, Matthew; Gupta, Pankaj; Becksfort, Jared; Wei, Lei; Mulder, Heather L.; Boggs, Kristy; Vadodaria, Bhavin; Yergeau, Donald; Russell, Jake C.; Ochoa, Kern I.; Fulton, Robert S.; Fulton, Lucinda L.; Jones, Chris; Boop, Frederick A.; Broniscer, Alberto; Wetmore, Cynthia; Gajjar, Amar; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.; Taylor, Michael R.; Downing, James R.; Ellison, David W.; Zhang, Jinghui; Baker, Suzanne J.		St Jude Childrens Res Hosp; Washington Univ Pediat Canc Genome	The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; BONE MORPHOGENETIC PROTEINS; DISTINCT SUBGROUPS; INITIATING CELLS; GENE-EXPRESSION; HISTONE H3.3; C-MYC; GLIOBLASTOMA; MUTATIONS; MEDULLOBLASTOMA	Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis(1). We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs(2-5). Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.	[Wu, Gang; Li, Yongjin; Qui, Chunxu; Chen, Xiang; Edmonson, Michael; Ma, Xiaotu; Nagahawatte, Panduka; Hedlund, Erin; Rusch, Michael; Huether, Robert; Parker, Matthew; Gupta, Pankaj; Becksfort, Jared; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Diaz, Alexander K.; Paugh, Barbara S.; Rankin, Sherri L.; Zhu, Xiaoyan; Zhang, Junyuan; Russell, Jake C.; Baker, Suzanne J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Baker, Suzanne J.] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Ju, Bensheng; Taylor, Michael R.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Easton, John; Mulder, Heather L.; Vadodaria, Bhavin; Yergeau, Donald] St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Ochoa, Kern I.; Fulton, Robert S.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Pounds, Stanley; Lin, Tong; Onar-Thomas, Arzu] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wei, Lei] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Jones, Chris] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Jones, Chris] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Boop, Frederick A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Broniscer, Alberto; Wetmore, Cynthia; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Downing, James R.; Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; Roswell Park Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Baker, SJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jinghui.zhang@stjude.org; suzanne.baker@stjude.org	Rusch, Michael/AAG-1998-2019; Onar-Thomas, Arzu/M-9356-2018; Huether, Robert/E-9638-2012; Chen, Xiang/N-2524-2018; LI, YONGJIN/E-1688-2011; Ellison, David/N-4806-2018; Pounds, Stanley B/N-2480-2018; Wu, Gang/M-8012-2014; Jones, Chris/ABE-6059-2021; Zhang, Jing/GWZ-7332-2022; Baker, Suzanne J/N-8167-2018; Kriwacki, Richard/N-8154-2018; Downing, James R./N-8102-2018; Gajjar, Amar/N-8059-2018; Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019	Rusch, Michael/0000-0002-5363-1848; Huether, Robert/0000-0001-7077-7470; Chen, Xiang/0000-0002-2499-8261; Pounds, Stanley B/0000-0002-9167-2114; Wu, Gang/0000-0002-1678-5864; Jones, Chris/0000-0001-8118-2296; Kriwacki, Richard/0000-0002-9798-6018; Wilson, Richard K./0000-0002-1992-1358; Broniscer, Alberto/0000-0001-9646-0463; Russell, Jake/0000-0001-5539-2716; Parker, Matthew/0000-0003-2999-3870; Easton, John/0000-0003-4503-6608	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; US National Institutes of Health [P01 CA096832, R01 CA135554]; Cure Starts Now Foundation; Smile for Sophie Forever Foundation; Tyler's Treehouse and Musicians Against Childhood Cancer; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA016056, R01CA135554, P01CA096832] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Starts Now Foundation; Smile for Sophie Forever Foundation; Tyler's Treehouse and Musicians Against Childhood Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the St. Jude Children's Research Hospital Tissue Resource Facility and B. Gordon, M. Johnson, S. Brown and C. Calabrese in the St. Jude Small Animal Imaging Core for expert assistance with intracranial implantations. We thank E. Shore and A. Culbert (University of Pennsylvania) for helpful advice with antibody selection. This work was supported by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, by the American Lebanese and Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, by grants from the US National Institutes of Health (P01 CA096832 to S.J.B., Jinghui Zhang and D.W.E. and R01 CA135554 to S.J.B.), by the Cure Starts Now Foundation and the Smile for Sophie Forever Foundation, and by Tyler's Treehouse and Musicians Against Childhood Cancer.	Bagarova J, 2013, MOL CELL BIOL, V33, P2413, DOI 10.1128/MCB.01595-12; Barrow J, 2011, NEURO-ONCOLOGY, V13, P212, DOI 10.1093/neuonc/noq158; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bax DA, 2009, CLIN CANCER RES, V15, P5753, DOI 10.1158/1078-0432.CCR-08-3210; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; BUTTI MG, 1995, GENOMICS, V28, P15, DOI 10.1006/geno.1995.1100; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Gottardo NG, 2008, J CHILD NEUROL, V23, P1149, DOI 10.1177/0883073808321765; Harel L, 2010, DEV NEUROBIOL, V70, P298, DOI 10.1002/dneu.20769; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li G, 2012, J NEURO-ONCOL, V108, P395, DOI 10.1007/s11060-012-0842-3; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pollack IF, 2001, CANCER RES, V61, P7404; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore Eileen M, 2011, Curr Osteoporos Rep, V9, P83, DOI 10.1007/s11914-011-0046-3; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	55	653	678	7	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					444	450		10.1038/ng.2938	http://dx.doi.org/10.1038/ng.2938			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705251	Green Accepted			2022-12-25	WOS:000335422900009
J	Aggarwal, SR				Aggarwal, Saurabh (Rob)			A survey of breakthrough therapy designations	NATURE BIOTECHNOLOGY			English	Article							HEPATITIS-C; GENOTYPE 1; TREATMENT-NAIVE; DACLATASVIR; ASUNAPREVIR; INHIBITOR; INFECTION; RIBAVIRIN; TRIAL	As of last month, 41 products have been granted breakthrough therapy designations by the US Food and Drug Administration-drugs against cancer, hepatitis C and monogenetic diseases predominate.	[Aggarwal, Saurabh (Rob)] Novel Hlth Strategies LLC, Bethesda, MD 20814 USA; [Aggarwal, Saurabh (Rob)] Inst Global Policy Res, Washington, DC USA		Aggarwal, SR (corresponding author), Novel Hlth Strategies LLC, Bethesda, MD 20814 USA.	sa2@novelhealthstrategies.com			Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology; American Association of Liver Diseases, American Heart Association; American Society of Hematology; Biotechnology Industry Association	Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology(General Electric); American Association of Liver Diseases, American Heart Association; American Society of Hematology; Biotechnology Industry Association	The author thanks Novel Health Strategies, the Institute for Global Policy Research, the American Society of Clinical Oncology, the American College of Rheumatology, the American Association of Liver Diseases, American Heart Association, the American Society of Hematology and the Biotechnology Industry Association for providing support for this article.	Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Aggarwal SR, 2014, NAT BIOTECHNOL, V32, P32, DOI 10.1038/nbt.2794; Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Chustecka Z., 2014, IBRUTINIB IMBRUVICA; Collins T.R., 2013, NEUROLOGY TODAY, V13, P34; D'Cruz OJ, 2013, ONCOTARGETS THER, V6, P161, DOI 10.2147/OTT.S33732; Desmond R, 2014, BLOOD, V123, P1818, DOI 10.1182/blood-2013-10-534743; Dohner H., 2012, ASH ANN M EXP NEW OR; Eisai Inc., 2012, FDA ODAC BRIEF DOC; European Medicines Agency, 2014, REF MARK AUTH READ; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Fellner Chris, 2012, P T, V37, P503; Filippatos G, 2014, EUR HEART J, V35, P1041, DOI 10.1093/eurheartj/eht497; Finn R., 2013, SAN ANT BREAST CANC; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hillman P., 2013, 55 ANN M AM SOC HEM; Hornberger J, 2012, LEUKEMIA LYMPHOMA, V53, P225, DOI 10.3109/10428194.2011.605918; IMS Health, 2012, TOT UN AUD GLOB PHAR; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kuznar W., IBRUTINIB INDUCES RA; Lawitz E., 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Llanos-Cuentas A, 2014, LANCET, V383, P1049, DOI 10.1016/S0140-6736(13)62568-4; Lowery M., 2013, DRUG TOPICS; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; National Institute for Health Service, 2013, ASF ALF HYP; Pollack A., 2013, NY TIMES; Scioderm Inc., 2013, REC POS OP EUR ORPH; Senior M, 2013, NAT BIOTECHNOL, V31, P945, DOI 10.1038/nbt1113-945; Shaw AT, 2013, J CLIN ONCOL, V31; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Whitely C.B., 2013, N AM SOC PED GASTR H; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251	38	24	25	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					323	330		10.1038/nbt.2864	http://dx.doi.org/10.1038/nbt.2864			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714478				2022-12-25	WOS:000334340800013
J	Gunawardana, J; Chan, FC; Telenius, A; Woolcock, B; Kridel, R; Tan, KL; Ben-Neriah, S; Mottok, A; Lim, RS; Boyle, M; Rogic, S; Rimsza, LM; Guiter, C; Leroy, K; Gaulard, P; Haioun, C; Marra, MA; Savage, KJ; Connors, JM; Shah, SP; Gascoyne, RD; Steidl, C				Gunawardana, Jay; Chan, Fong Chun; Telenius, Adele; Woolcock, Bruce; Kridel, Robert; Tan, King L.; Ben-Neriah, Susana; Mottok, Anja; Lim, Raymond S.; Boyle, Merrill; Rogic, Sanja; Rimsza, Lisa M.; Guiter, Chrystelle; Leroy, Karen; Gaulard, Philippe; Haioun, Corinne; Marra, Marco A.; Savage, Kerry J.; Connors, Joseph M.; Shah, Sohrab P.; Gascoyne, Randy D.; Steidl, Christian			Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma	NATURE GENETICS			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MOLECULAR PATHOGENESIS; MULTIDRUG-RESISTANCE; BREAST-CANCER; EXPRESSION; GENOME; ACTIVATION; LEUKEMIA; FREQUENT; SOCS-1	Classical Hodgkin lymphoma and primary mediastinal B cell lymphoma (PMBCL) are related lymphomas sharing pathological, molecular and clinical characteristics. Here we discovered by whole-genome and whole-transcriptome sequencing recurrent somatic coding-sequence mutations in the PTPN1 gene. Mutations were found in 6 of 30 (20%) Hodgkin lymphoma cases, in 6 of 9 (67%) Hodgkin lymphoma-derived cell lines, in 17 of 77 (22%) PMBCL cases and in 1 of 3 (33%) PMBCL-derived cell lines, consisting of nonsense, missense and frameshift mutations. We demonstrate that PTPN1 mutations lead to reduced phosphatase activity and increased phosphorylation of JAK-STAT pathway members. Moreover, silencing of PTPN1 by RNA interference in Hodgkin lymphoma cell line KM-H2 resulted in hyperphosphorylation and overexpression of downstream oncogenic targets. Our data establish PTPN1 mutations as new drivers in lymphomagenesis.	[Gunawardana, Jay; Chan, Fong Chun; Telenius, Adele; Woolcock, Bruce; Kridel, Robert; Tan, King L.; Ben-Neriah, Susana; Mottok, Anja; Boyle, Merrill; Savage, Kerry J.; Connors, Joseph M.; Gascoyne, Randy D.; Steidl, Christian] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gunawardana, Jay; Kridel, Robert; Shah, Sohrab P.; Gascoyne, Randy D.; Steidl, Christian] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Chan, Fong Chun] Univ British Columbia, Bioinformat Training Program, Vancouver, BC V5Z 1M9, Canada; [Rogic, Sanja] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Guiter, Chrystelle; Leroy, Karen; Gaulard, Philippe] INSERM U955, Creteil, France; [Leroy, Karen; Gaulard, Philippe; Haioun, Corinne] Univ Paris Est, Creteil, France; [Leroy, Karen; Gaulard, Philippe; Haioun, Corinne] Grp Hosp Henri MONDOR, AP HP, Dept Pathol, Serv Hematol Plateforme Ressources, Creteil, France; [Marra, Marco A.] BC Canc Agcy, Genom Sci Ctr, Vancouver, BC, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of Arizona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; British Columbia Cancer Agency; University of British Columbia	Steidl, C (corresponding author), BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada.	csteidl@bccancer.bc.ca	Leroy, Karen/E-9235-2011; Marra, Marco A/B-5987-2008; Connors, Joseph/AAF-5284-2019; Kridel, Robert/V-8739-2019; Savage, Kerry/HCH-5539-2022; Mottok, Anja/AAO-1801-2021; Gunawardana, Jay/P-1446-2018	Leroy, Karen/0000-0002-4379-0140; Marra, Marco A/0000-0001-7146-7175; Connors, Joseph/0000-0002-1361-7531; Gunawardana, Jay/0000-0003-2695-3849; Mottok, Anja/0000-0003-3125-0494; Haioun, Corinne/0000-0003-0095-5379; Lim, Raymond/0000-0001-8772-3882; Rogic, Sanja/0000-0002-9988-3661; Kridel, Robert/0000-0003-0287-7124	BC Cancer Foundation; Canada Foundation for Innovation; Leukemia & Lymphoma Society of Canada (LLSC); Terry Fox Research Institute [1023]; Michael Smith Foundation for Health Research (MSFHR); Canadian Institutes of Health Research (CIHR) [178536]; Terry Fox Foundation [019001]; Mildred Scheel Cancer Foundation; CIHR; MSFHR; University of British Columbia	BC Cancer Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Leukemia & Lymphoma Society of Canada (LLSC); Terry Fox Research Institute; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Mildred Scheel Cancer Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); University of British Columbia	We thank the BC Cancer Foundation and the Canada Foundation for Innovation for their support. We also thank T. Van Tol, M. Drake, R. Tong, the Genome Sciences Centre (GSC) production group and the Center for Translational and Applied Genomics (CTAG) for excellent technical support. This work is supported by a research grant from the Leukemia & Lymphoma Society of Canada (LLSC) and by a Terry Fox Research Institute team grant (1023) to C. S. and a Scholarship award from the Michael Smith Foundation for Health Research (MSFHR) to C. S. R. D. G. is supported by a Canadian Institutes of Health Research (CIHR) grant (178536) and a Terry Fox Foundation program project grant (019001). A. M. is supported by a fellowship award from the Mildred Scheel Cancer Foundation. R. K. is supported by fellowship awards from CIHR, MSFHR and the University of British Columbia.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, CELL CYCLE, V3, P550; Dunleavy K, 2013, NEW ENGL J MED, V368, P1408, DOI 10.1056/NEJMoa1214561; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Johnson Peter W M, 2008, Hematology Am Soc Hematol Educ Program, P349, DOI 10.1182/asheducation-2008.1.349; Kimm LR, 2007, GENE CHROMOSOME CANC, V46, P1090, DOI 10.1002/gcc.20495; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P1723, DOI 10.3324/haematol.2011.041921; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Koyama N, 2006, CLIN CANCER RES, V12, P2025, DOI 10.1158/1078-0432.CCR-04-2392; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Melzner I, 2005, BLOOD, V105, P2535, DOI 10.1182/blood-2004-09-3701; Moller P, 2001, INT J CANCER, V92, P348, DOI 10.1002/ijc.1211; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Nanney LB, 1997, J CUTAN PATHOL, V24, P521, DOI 10.1111/j.1600-0560.1997.tb01456.x; Oschlies I, 2011, HAEMATOL-HEMATOL J, V96, P262, DOI 10.3324/haematol.2010.030809; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Popov SW, 2007, CANCER RES, V67, P6555, DOI 10.1158/0008-5472.CAN-06-2166; Rieger M, 2011, ANN ONCOL, V22, P664, DOI 10.1093/annonc/mdq418; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Ritz O, 2009, BLOOD, V114, P1236, DOI 10.1182/blood-2009-03-209759; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Savage KJ, 2006, ONCOLOGIST, V11, P488, DOI 10.1634/theoncologist.11-5-488; Scheeren FA, 2008, BLOOD, V111, P4706, DOI 10.1182/blood-2007-08-105643; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Steidl C, 2011, BLOOD, V118, P2659, DOI 10.1182/blood-2011-05-326538; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Warabi M, 2000, EXP MOL PATHOL, V68, P187, DOI 10.1006/exmp.2000.2303; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; ZHAI YF, 1993, CANCER RES, V53, P2272; Zhang HY, 2012, J CANCER RES THER, V8, P226, DOI 10.4103/0973-1482.98975	62	125	128	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					329	+		10.1038/ng.2900	http://dx.doi.org/10.1038/ng.2900			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24531327				2022-12-25	WOS:000334510100007
J	Gaber, R; Lebar, T; Majerle, A; Ster, B; Dobnikar, A; Bencina, M; Jerala, R				Gaber, Rok; Lebar, Tina; Majerle, Andreja; Ster, Branko; Dobnikar, Andrej; Bencina, Mojca; Jerala, Roman			Designable DNA-binding domains enable construction of logic circuits in mammalian cells	NATURE CHEMICAL BIOLOGY			English	Article							GENE-REGULATION SYSTEMS; TAL EFFECTORS; TRANSCRIPTION; SPECIFICITY; CRISPR; GATES	Electronic computer circuits consisting of a large number of connected logic gates of the same type, such as NOR, can be easily fabricated and can implement any logic function. In contrast, designed genetic circuits must employ orthogonal information mediators owing to free diffusion within the cell. Combinatorial diversity and orthogonality can be provided by designable DNA-binding domains. Here, we employed the transcription activator-like repressors to optimize the construction of orthogonal functionally complete NOR gates to construct logic circuits. We used transient transfection to implement all 16 two-input logic functions from combinations of the same type of NOR gates within mammalian cells. Additionally, we present a genetic logic circuit where one input is used to select between an AND and OR function to process the data input using the same circuit. This demonstrates the potential of designable modular transcription factors for the construction of complex biological information-processing devices.	[Gaber, Rok; Lebar, Tina; Majerle, Andreja; Bencina, Mojca; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Gaber, Rok; Lebar, Tina; Majerle, Andreja; Bencina, Mojca; Jerala, Roman] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Ster, Branko; Dobnikar, Andrej] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana 61000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	roman.jerala@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Slovenian Research Agency [P4-0176, N5-0003]; European structural funds	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European structural funds	This research study was supported by the program and projects from the Slovenian Research Agency (P4-0176 and N5-0003 to R.J.) and the EN-FIST Centre of Excellence financed in part by the European structural funds. We acknowledge the members and mentors of the 2012 Slovenian International Genetically Engineered Machine (iGEM) Team (U. Bezeljak, V. Forstneric, A. Golob, M. Jerala, L. Kadunc, J. Lonzaric, Z. Luznik, A. Oblak, F. Pavlovec, B. Pirs, A. Smole, M. Somrak, M. Strazar, D. Vucko and U. Zupancic) for their inspiration and help in the development of TALE-based regulation. We thank M. Fussenegger (Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Zurich) for plasmids for erythromycin- and pristinamycin-inducible systems.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Hall E.C., 1996, JOURNEY MOON HIST AP; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lohmueller JJ, 2012, NUCLEIC ACIDS RES, V40, P5180, DOI 10.1093/nar/gks142; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber W, 2002, NAT BIOTECHNOL, V20, P901, DOI 10.1038/nbt731; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	39	69	73	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					203	+		10.1038/NCHEMBIO.1433	http://dx.doi.org/10.1038/NCHEMBIO.1433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24413461				2022-12-25	WOS:000331616900011
J	Helming, KC; Wang, XF; Wilson, BG; Vazquez, F; Haswell, JR; Manchester, HE; Kim, Y; Kryukov, GV; Ghandi, M; Aguirre, AJ; Jagani, Z; Wang, Z; Garraway, LA; Hahn, WC; Roberts, CWM				Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Vazquez, Francisca; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Kryukov, Gregory V.; Ghandi, Mahmoud; Aguirre, Andrew J.; Jagani, Zainab; Wang, Zhong; Garraway, Levi A.; Hahn, William C.; Roberts, Charles W. M.			ARID1B is a specific vulnerability in ARID1A-mutant cancers	NATURE MEDICINE			English	Article							CHROMATIN REMODELING FACTOR; TUMOR-SUPPRESSOR	Recent studies have revealed that ARID1A, encoding AT-rich interactive domain 1A (SWI-like), is frequently mutated across a variety of human cancers and also has bona fide tumor suppressor properties. Consequently, identification of vulnerabilities conferred by ARID1A mutation would have major relevance for human cancer. Here, using a broad screening approach, we identify ARID1B, an ARID1A homolog whose gene product is mutually exclusive with ARID1A in SWI/SNF complexes, as the number 1 gene preferentially required for the survival of ARID1A-mutant cancer cell lines. We show that loss of ARID1B in ARID1A-deficient backgrounds destabilizes SWI/SNF and impairs proliferation in both cancer cells and primary cells. We also find that ARID1A and ARID1B are frequently co-mutated in cancer but that ARID14-deficient cancers retain at least one functional ARID1B allele. These results suggest that loss of ARID1A and ARID1B alleles cooperatively promotes cancer formation but also results in a unique functional dependence. The results further identify ARID1B as a potential therapeutic target for ARID1A-mutant cancers.	[Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Roberts, Charles W. M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Roberts, Charles W. M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Helming, Katherine C.] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA USA; [Vazquez, Francisca; Kryukov, Gregory V.; Ghandi, Mahmoud; Aguirre, Andrew J.; Garraway, Levi A.; Hahn, William C.; Roberts, Charles W. M.] Broad Inst Harvard & MIT, Boston, MA USA; [Vazquez, Francisca; Garraway, Levi A.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Aguirre, Andrew J.; Garraway, Levi A.; Hahn, William C.; Roberts, Charles W. M.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Jagani, Zainab] Novartis Inst Biomed Res, Cambridge, MA USA; [Wang, Zhong] Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Novartis; University of Michigan System; University of Michigan	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	charles_roberts@dfci.harvard.edu	Vazquez, Francisca/AAA-3751-2020; Kryukov, Gregory V/A-9592-2008; Manchester, Haley/AAK-5916-2020; Vazquez, Francisca/ABC-4620-2020; Roberts, Charles/N-2541-2018	Vazquez, Francisca/0000-0002-2857-4685; Roberts, Charles/0000-0003-1135-1896; Ghandi, Mahmoud/0000-0003-1897-2265; Kryukov, Gregory/0000-0002-6131-9483	David Abraham Foundation; Rally Foundation; St. Baldrick's Foundation; Pablove Foundation; US National Institutes of Health [R01HL109054, R01CA172152, R01CA113794]; U01 NCI Mouse Models of Cancer Consortium Award; Garrett B. Smith Foundation; Miles for Mary; Cure AT/RT Now foundation; NATIONAL CANCER INSTITUTE [U01CA105423, R01CA172152, R01CA113794, U01CA176058, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	David Abraham Foundation; Rally Foundation; St. Baldrick's Foundation; Pablove Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U01 NCI Mouse Models of Cancer Consortium Award; Garrett B. Smith Foundation; Miles for Mary; Cure AT/RT Now foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Ping Lu for technical assistance with the setup of the sucrose sedimentation assay. X.W. was supported by a post-doctoral fellowship from David Abraham Foundation and Rally Foundation and a research grant from St. Baldrick's Foundation. B.G.W. was supported by a Childhood Cancer Research Grant from the Pablove Foundation. Z.W. is supported by US National Institutes of Health grant R01HL109054. This work was supported by US National Institutes of Health grants R01CA172152 (C.W.M.R.) and R01CA113794 (C.W.M.R.) and a U01 NCI Mouse Models of Cancer Consortium Award (C.W.M.R.). The Garrett B. Smith Foundation, Miles for Mary and the Cure AT/RT Now foundation (C.W.M.R.) provided additional support.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Buitman S., 2000, MOL CELL, V6, P1287; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361	20	247	254	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					251	254		10.1038/nm.3480	http://dx.doi.org/10.1038/nm.3480			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24562383	Green Accepted, Green Submitted			2022-12-25	WOS:000332595600019
J	Ley, RE				Ley, Ruth E.			The sweet tooth of Clostridium difficile	NATURE MEDICINE			English	Editorial Material							MICROBIOTA		Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University	Ley, RE (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	rel222@cornell.edu	Ley, Ruth E/M-8542-2014	Ley, Ruth E/0000-0002-9087-1672				Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duan FP, 2010, P NATL ACAD SCI USA, V107, P11260, DOI 10.1073/pnas.1001294107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hwang IY, 2014, ACS SYNTH BIOL, V3, P228, DOI 10.1021/sb400077j; Karadsheh Z., 2013, AM J MED SCI, V5, P339; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499	14	17	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					248	249		10.1038/nm.3494	http://dx.doi.org/10.1038/nm.3494			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24603797				2022-12-25	WOS:000332595600018
J	DiLillo, DJ; Tan, GS; Palese, P; Ravetch, JV				DiLillo, David J.; Tan, Gene S.; Palese, Peter; Ravetch, Jeffrey V.			Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc gamma R interactions for protection against influenza virus in vivo	NATURE MEDICINE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; INDUCED CONFORMATIONAL-CHANGES; MONOCLONAL-ANTIBODY; UNIVERSAL VACCINE; RECEPTOR-BINDING; CONSTANT-REGION; ANTIGEN; IDENTIFICATION; EPITOPES; IMMUNITY	Neutralizing antibodies against influenza viruses have traditionally been thought to provide protection exclusively through their variable region; the contributions of mechanisms conferred by the Fc domain remain controversial. We investigated the in vivo contributions of Fc interactions with their cognate receptors for a collection of neutralizing anti-influenza antibodies. Whereas five broadly neutralizing monoclonal antibodies (bNAbs) targeting the conserved stalk region of hemagglutinin (HA) required interactions between the antibody Fc and Fc receptors for IgG (Fc gamma Rs) to confer protection from lethal H1N1 challenge, three strain-specific monoclonal Abs (mAbs) against the variable head domain of HA were equally protective in the presence or absence of Fc gamma R interactions. Although all antibodies blocked infection, only anti-stalk bNAbs were capable of mediating cytotoxicity of infected cells, which accounts for their Fc gamma R dependence. Immune complexes generated with anti-HA stalk mAb efficiently interacted with Fc gamma Rs, but anti-HA head immune complexes did not. These results suggest that Fc gamma R binding capacity by anti-HA antibodies was dependent on the interaction of the cognate Fab with antigen. We exploited these disparate mechanisms of mAb-mediated protection to reengineer an anti-stalk bNAb to selectively enhance Fc gamma R engagement to augment its protective activity. These findings reveal a previously uncharacterized property of bNAbs and guide an approach toward enhancing mAb-mediated antiviral therapeutics.	[DiLillo, David J.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; [Tan, Gene S.; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Koyuncu, ayfer/M-3872-2015; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Tan, Gene/0000-0002-0975-0719; Palese, Peter/0000-0002-0337-5823	National Institute of Allergy and Infectious Disease of the US National Institutes of Health (NIH) [P01AI081677, R01AI035875, U54AI057158, AI097092]; Bill & Melinda Gates Foundation [OPP1033115]; US Army Research Laboratory; US Army Research Office [W911NF-13-2-0036]; Program for Appropriate Technology in Health; NIH [HHSN266200700010C]; Leukemia and Lymphoma Society; New York Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946, P01AI097092, U54AI057158, R01AI035875, P01AI081677] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease of the US National Institutes of Health (NIH); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; Program for Appropriate Technology in Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); New York Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Wilson (University of Chicago), J. Wrammert (Emory University) and R. Ahmed (Emory University) for providing mAb constructs, E Krammer (Mt. Sinai Medical Center) for providing recombinant soluble HA protein, S. Bournazos for assistance with surface plasmon resonance studies and J. Carron and P. Smith for technical assistance. We also thank the Biodefense and Emerging Infections Research Resources Repository for supplying recombinant soluble HA protein. Research reported in this publication was partially supported by the National Institute of Allergy and Infectious Disease of the US National Institutes of Health (NIH) under award numbers P01AI081677, R01AI035875 and U54AI057158 to J.V.R. and AI097092 to P.P. Research support was also provided by the Bill & Melinda Gates Foundation grant OPP1033115 to J.V.R. This work was also supported in part by the US Army Research Laboratory and the US Army Research Office under contract number W911NF-13-2-0036 (to J.V.R.). Partial support for PP. was provided by the Program for Appropriate Technology in Health and by the NIH-funded Center for Research on Influenza Pathogenesis (HHSN266200700010C). D.J.D. received fellowship support from the Leukemia and Lymphoma Society and received funding support from the New York Community Trust.	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BARKAS T, 1979, IMMUNOLOGY, V36, P557; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; KILAR F, 1987, EUR J BIOCHEM, V162, P57, DOI 10.1111/j.1432-1033.1987.tb10541.x; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Nordstrom JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3069; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; REALE MA, 1986, J IMMUNOL, V137, P1352; SCHLESSINGER J, 1975, P NATL ACAD SCI USA, V72, P2775, DOI 10.1073/pnas.72.7.2775; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Srivastava V, 2013, J VIROL, V87, P5831, DOI 10.1128/JVI.00273-13; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Tedder TF, 2006, SPRINGER SEMIN IMMUN, V28, P351, DOI 10.1007/s00281-006-0057-9; Tong HM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01089; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Wang TT, 2011, SCIENCE, V333, P834, DOI 10.1126/science.1210724; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang XM, 2013, MOL THER, V21, P91, DOI 10.1038/mt.2012.184	43	530	545	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					143	151		10.1038/nm.3443	http://dx.doi.org/10.1038/nm.3443			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412922	Green Accepted			2022-12-25	WOS:000330915000015
J	Logan, CV; Szabadkai, G; Sharpe, JA; Parry, DA; Torelli, S; Childs, AM; Kriek, M; Phadke, R; Johnson, CA; Roberts, NY; Bonthron, DT; Pysden, KA; Whyte, T; Munteanu, I; Foley, AR; Wheway, G; Szymanska, K; Natarajan, S; Abdelhamed, ZA; Morgan, JE; Roper, H; Santen, GWE; Niks, EH; van der Pol, WL; Lindhout, D; Raffaello, A; De Stefani, D; den Dunnen, JT; Sun, Y; Ginjaar, I; Sewry, CA; Hurles, M; Rizzuto, R; Duchen, MR; Muntoni, F; Sheridan, E				Logan, Clare V.; Szabadkai, Gyoergy; Sharpe, Jenny A.; Parry, David A.; Torelli, Silvia; Childs, Anne-Marie; Kriek, Marjolein; Phadke, Rahul; Johnson, Colin A.; Roberts, Nicola Y.; Bonthron, David T.; Pysden, Karen A.; Whyte, Tamieka; Munteanu, Iulia; Foley, A. Reghan; Wheway, Gabrielle; Szymanska, Katarzyna; Natarajan, Subaashini; Abdelhamed, Zakia A.; Morgan, Joanne E.; Roper, Helen; Santen, Gijs W. E.; Niks, Erik H.; van der Pol, W. Ludo; Lindhout, Dick; Raffaello, Anna; De Stefani, Diego; den Dunnen, Johan T.; Sun, Yu; Ginjaar, Ieke; Sewry, Caroline A.; Hurles, Matthew; Rizzuto, Rosario; Duchen, Michael R.; Muntoni, Francesco; Sheridan, Eamonn		UK10K Consortium	Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling	NATURE GENETICS			English	Article							CA2+; PROTEINS; MCU	Mitochondrial Ca2+ uptake has key roles in cell life and death. Physiological Ca2+ signaling regulates aerobic metabolism, whereas pathological Ca2+ overload triggers cell death. Mitochondrial Ca2+ uptake is mediated by the Ca2+ uniporter complex in the inner mitochondrial membrane1,2, which comprises MCU, a Ca2+-selective ion channel, and its regulator, MICU1. Here we report mutations of MICU1 in individuals with a disease phenotype characterized by proximal myopathy, learning difficulties and a progressive extrapyramidal movement disorder. In fibroblasts from subjects with MICU1 mutations, agonist-induced mitochondrial Ca2+ uptake at low cytosolic Ca2+ concentrations was increased, and cytosolic Ca2+ signals were reduced. Although resting mitochondrial membrane potential was unchanged in MICU1-deficient cells, the mitochondrial network was severely fragmented. Whereas the pathophysiology of muscular dystrophy3 and the core myopathies4 involves abnormal mitochondrial Ca2+ handling, the phenotype associated with MICU1 deficiency is caused by a primary defect in mitochondrial Ca2+ signaling, demonstrating the crucial role of mitochondrial Ca2+ uptake in humans.	[Logan, Clare V.; Parry, David A.; Johnson, Colin A.; Roberts, Nicola Y.; Bonthron, David T.; Wheway, Gabrielle; Szymanska, Katarzyna; Natarajan, Subaashini; Abdelhamed, Zakia A.; Morgan, Joanne E.; Sheridan, Eamonn] St James Univ Hosp, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Szabadkai, Gyoergy; Sharpe, Jenny A.; Duchen, Michael R.] UCL, Consortium Mitochondrial Res, Dept Cell & Dev Biol, London, England; [Szabadkai, Gyoergy; Raffaello, Anna; De Stefani, Diego; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, Padua, Italy; [Szabadkai, Gyoergy; Raffaello, Anna; De Stefani, Diego; Rizzuto, Rosario] CNR, Inst Neurosci, Padua, Italy; [Torelli, Silvia; Phadke, Rahul; Whyte, Tamieka; Munteanu, Iulia; Foley, A. Reghan; Sewry, Caroline A.; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Torelli, Silvia; Phadke, Rahul; Whyte, Tamieka; Munteanu, Iulia; Foley, A. Reghan; Sewry, Caroline A.; Muntoni, Francesco] MRC, Ctr Neuromuscular Dis, London, England; [Childs, Anne-Marie; Pysden, Karen A.] Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England; [Kriek, Marjolein; Santen, Gijs W. E.; den Dunnen, Johan T.; Sun, Yu; Ginjaar, Ieke] Leiden Univ, Med Ctr, Dept Clin Genet, Ctr Human & Clin Genet, Leiden, Netherlands; [Phadke, Rahul] MRC, Ctr Neuromuscular Dis, UCL Inst Neurol, London, England; [Roper, Helen] Birmingham Heartlands Hosp, Dept Paediat, Birmingham B9 5ST, W Midlands, England; [Niks, Erik H.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [van der Pol, W. Ludo] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Lindhout, Dick] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Sewry, Caroline A.] Robert Jones & Agnes Hunt Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Hurles, Matthew] Wellcome Trust Sanger Inst, Cambridge, England	Saint James's University Hospital; University of London; University College London; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of London; University College London; University of London; University College London; Leeds General Infirmary; University of Leeds; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; Heart of England NHS Foundation Trust; University of Birmingham; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Keele University; Wellcome Trust Sanger Institute	Sheridan, E (corresponding author), St James Univ Hosp, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	m.duchen@ucl.ac.uk; f.muntoni@ucl.ac.uk; e.sheridan@leeds.ac.uk	Phadke, Rahul/U-6960-2019; Breen, Gerome D/A-5540-2010; Niks, Erik H/M-3520-2016; Raffaello, Anna/K-7052-2016; De Stefani, Diego/I-7715-2015; Lindhout, Dick/AAH-5765-2019; dunnen, johan den/ABH-4228-2020; Breen, Gerome/Y-2706-2019; duchen, michael/A-2116-2009; Collier, David/D-1649-2011; Scambler, Peter/C-4998-2008	Breen, Gerome D/0000-0003-2053-1792; Niks, Erik H/0000-0001-5892-5143; De Stefani, Diego/0000-0003-3796-8907; dunnen, johan den/0000-0002-6304-1710; Breen, Gerome/0000-0003-2053-1792; duchen, michael/0000-0003-2548-4294; Szabadkai, Gyorgy/0000-0002-3006-3577; Natarajan, Subaashini/0000-0002-4259-7680; Bonthron, David/0000-0001-8132-8179; Palotie, Aarno/0000-0002-2527-5874; Zeggini, Eleftheria/0000-0003-4238-659X; Kelly, Kirsten/0000-0003-4234-543X; Farooqi, Sadaf/0000-0001-7609-3504; Gallagher, Louise/0000-0001-9462-2836; Rizzuto, Rosario/0000-0001-7044-5097; Parry, David/0000-0003-0376-7736; Logan, Clare/0000-0003-4323-1602; Collier, David/0000-0003-4087-1559; RAFFAELLO, ANNA/0000-0002-8344-6459; Semple, Robert Kenneth/0000-0001-6539-3069; Scambler, Peter/0000-0002-1487-4628; Johnson, Colin/0000-0002-2979-8234; Wheway, Gabrielle/0000-0002-0494-0783; Sun, Yu/0000-0002-2938-0233; Lindhout, Dick/0000-0001-9580-624X	Sir Jules Thorn Award for Biomedical Research [JTA/09]; Medical Research Council [MR/K011154/1]; Wellcome Trust [WT091310]; Muscular Dystrophy Association [68762]; National Specialised Commissioned Team (NSCT); Great Ormond Street Children's Charity; Great Ormond Street Hospital Biomedical Research Centre; MRC Neuromuscular Centre biobank; European Union Framework Programme 7 Neuromic grant [HEALTH-F5-2012-305121]; Parkinson's UK; British Heart Foundation; Wellcome Trust-UCL Therapeutic Innovation Fund, Telethon-Italy [GEP1206]; Italian Association for Cancer Research (AIRC); Italian Ministries of Health; Education, University and Research; European Union (European Research Council mitoCalcium [294777]; US National Institutes of Health [1P01AG025532-01A1]; Cariparo Foundation and the Cariplo Foundations; MRC [G0600717, MR/K000608/1, MR/K011154/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1675658] Funding Source: researchfish; Medical Research Council [MC_UU_12012/5/B, G0600717B, G0600717, MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10109, NF-SI-0510-10268] Funding Source: researchfish; Parkinson&quot;s UK [G-0905] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1217] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; Muscular Dystrophy UK [RA4/0924, RA4/924] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	Sir Jules Thorn Award for Biomedical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Muscular Dystrophy Association(Muscular Dystrophy Association); National Specialised Commissioned Team (NSCT); Great Ormond Street Children's Charity; Great Ormond Street Hospital Biomedical Research Centre; MRC Neuromuscular Centre biobank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Framework Programme 7 Neuromic grant; Parkinson's UK(Parkinson's UK); British Heart Foundation(British Heart Foundation); Wellcome Trust-UCL Therapeutic Innovation Fund, Telethon-Italy(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministries of Health; Education, University and Research; European Union (European Research Council mitoCalcium; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cariparo Foundation and the Cariplo Foundations; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Childrens Charity; The Sir Jules Thorn Charitable Trust; Muscular Dystrophy UK; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Sir Jules Thorn Award for Biomedical Research (JTA/09 to C. A. J., E. S. and D. T. B.). We acknowledge funding from the Medical Research Council (project grant MR/K011154/1) awarded to C. A. J., E. S. and C. V. L. We are grateful to the UK10K Consortium for making this study possible. This study makes use of data generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available at http://www. uk10k. org/publications. html. Funding for UK10K was provided by the Wellcome Trust under award WT091310. Muscular Dystrophy Association grant 68762 to F. M. is gratefully acknowledged. National Specialised Commissioned Team (NSCT) funding for the Congenital Muscular Dystrophies and Congenital Myopathy service in London is also gratefully acknowledged. T. W. is a Muscular Dystrophy Campaign PhD student. F. M. is supported by the Great Ormond Street Children's Charity and the Great Ormond Street Hospital Biomedical Research Centre. This study was also partly supported by the MRC Neuromuscular Centre biobank. European Union Framework Programme 7 Neuromic grant to G.-J. van Ommen (FP7-Health-2012-Innovation 1 HEALTH-F5-2012-305121) is also gratefully acknowledged. G. S. is supported by Parkinson's UK, the British Heart Foundation, the Wellcome Trust-UCL Therapeutic Innovation Fund, Telethon-Italy (GEP1206) and the Italian Association for Cancer Research (AIRC). R. R. is supported by the Italian Ministries of Health (Ricerca Finalizzata) and of Education, University and Research (PRIN and FIRB), the European Union (European Research Council mitoCalcium, 294777), the US National Institutes of Health (NIH; grant 1P01AG025532-01A1), the Cariparo Foundation and the Cariplo Foundations (Padua), AIRC and Telethon-Italy (GPP1005A and GPP11082B). J. A. S. is the recipient of a PhD studentship from the Muscular Dystrophy Campaign. The genealogy of family UMCU was constructed by F. A. M. Hennekam (University Medical Center Utrecht).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Carr IM, 2009, HUM MUTAT, V30, P960, DOI 10.1002/humu.20974; Chami M, 2008, MOL CELL, V32, P641, DOI 10.1016/j.molcel.2008.11.014; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gerencser AA, 2001, CELL CALCIUM, V30, P311, DOI 10.1054/ceca.2001.0238; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rozen S, 2000, Methods Mol Biol, V132, P365; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Spat A, 2004, MOL CELL ENDOCRINOL, V215, P115, DOI 10.1016/j.mce.2003.11.004; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Zampese E, 2011, P NATL ACAD SCI USA, V108, P2777, DOI 10.1073/pnas.1100735108	31	241	246	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					188	+		10.1038/ng.2851	http://dx.doi.org/10.1038/ng.2851			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24336167	Green Submitted			2022-12-25	WOS:000331208300017
J	Hay, M; Thomas, DW; Craighead, JL; Economides, C; Rosenthal, J				Hay, Michael; Thomas, David W.; Craighead, John L.; Economides, Celia; Rosenthal, Jesse			Clinical development success rates for investigational drugs	NATURE BIOTECHNOLOGY			English	Article							PRODUCTIVITY; TRENDS; SCALE; RISKS; SCOPE	The most comprehensive survey of clinical success rates across the drug industry to date shows productivity may be even lower than previous estimates.	[Hay, Michael; Rosenthal, Jesse] Sagient Res Syst, BioMedTracker, San Diego, CA 92122 USA; [Thomas, David W.; Economides, Celia] BIO, Washington, DC USA; [Craighead, John L.] Biotech Strategy & Analyt, Rockville, MD USA		Hay, M (corresponding author), Sagient Res Syst, BioMedTracker, San Diego, CA 92122 USA.	mhay@sagientresearch.com			Sagient Research Systems; Biotechnology Industry Organization (BIO)	Sagient Research Systems; Biotechnology Industry Organization (BIO)	This research was supported by Sagient Research Systems and the Biotechnology Industry Organization (BIO). The authors are indebted to the analysts at BioMedTracker who have collected these data. We would also like to thank our colleagues at BIO and BioMedTracker for their input and advice in the development of this study. The authors are solely responsible for the design, conduct and analysis of the study, and the conclusions that are drawn. The opinions expressed in this article are those of the authors and do not necessarily reflect the views of their employers.	Abrantes-Metz R., 2004, PHARM DEV PHASES DUR; Arora A, 2009, MANAGE SCI, V55, P1638, DOI 10.1287/mnsc.1090.1055; Cockburn IM, 2001, J HEALTH ECON, V20, P1033, DOI 10.1016/S0167-6296(01)00108-4; Cohen FJ, 2005, NAT REV DRUG DISCOV, V4, P78, DOI 10.1038/nrd1610; Danzon PM, 2005, J HEALTH ECON, V24, P317, DOI 10.1016/j.jhealeco.2004.09.006; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DIMASI JA, 1995, CLIN PHARMACOL THER, V58, P1, DOI 10.1016/0009-9236(95)90066-7; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Edelman M.J., 2010, 2010 AM SOC CLIN ONC; EvaluatePharma, 2012, WORLD PREV 2018 EMBR; Henderson R, 1996, RAND J ECON, V27, P32, DOI 10.2307/2555791; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lloyd I., 2011, PHARM R D ANN REV 20; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P87, DOI 10.1038/nrd3946; Pharmaceutical Research and Manufacturers of America, 2011, PHARM RES MAN AM ANN; SHECK L, 1984, CLIN PHARMACOL THER, V36, P574, DOI 10.1038/clpt.1984.224; Tucker S.A., 1988, OUTCOME RES NEW MOL	20	1365	1423	15	261	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					40	51		10.1038/nbt.2786	http://dx.doi.org/10.1038/nbt.2786			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406927				2022-12-25	WOS:000329513000013
J	Krause, DS; Fulzele, K; Catic, A; Sun, CC; Dombkowski, D; Hurley, MP; Lezeau, S; Attar, E; Wu, JY; Lin, HY; Divieti-Pajevic, P; Hasserjian, RP; Schipani, E; Van Etten, RA; Scadden, DT				Krause, Daniela S.; Fulzele, Keertik; Catic, Andre; Sun, Chia Chi; Dombkowski, David; Hurley, Michael P.; Lezeau, Sanon; Attar, Eyal; Wu, Joy Y.; Lin, Herbert Y.; Divieti-Pajevic, Paola; Hasserjian, Robert P.; Schipani, Ernestina; Van Etten, Richard A.; Scadden, David T.			Differential regulation of myeloid leukemias by the bone marrow microenvironment	NATURE MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; STEM-CELLS; MICE; PROGENITOR; ENGRAFTMENT; EXPRESSION; INDUCTION; RECEPTOR; HORMONE; MLL-AF9	Like their normal hematopoietic stem cell counterparts, leukemia stem cells (LSCs) in chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) are presumed to reside in specific niches in the bone marrow microenvironment (BMM)(1) and may be the cause of relapse following chemotherapy(2). Targeting the niche is a new strategy to eliminate persistent and drug-resistant LSCs. CD44 (refs. 3,4) and interleukin-6 (ref. 5) have been implicated previously in the LSC niche. Transforming growth factor-beta 1 (TGF-beta 1) is released during bone remodeling(6) and plays a part in maintenance of CML LSCs7, but a role for TGF-beta 1 from the BMM has not been defined. Here, we show that alteration of the BMM by osteoblastic cell-specific activation of the parathyroid hormone (PTH) receptor(8,9) attenuates BCR-ABL1 oncogene-induced CML-like myeloproliferative neoplasia (MPN)(10) but enhances MLL-AF9 oncogene-induced AML(11) in mouse transplantation models, possibly through opposing effects of increased TGF-beta 1 on the respective LSCs. PTH treatment caused a 15-fold decrease in LSCs in wild-type mice with CML-like MPN and reduced engraftment of immune-deficient mice with primary human CML cells. These results demonstrate that LSC niches in CML and AML are distinct and suggest that modulation of the BMM by PTH may be a feasible strategy to reduce LSCs, a prerequisite for the cure of CML.	[Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA USA; [Krause, Daniela S.; Dombkowski, David; Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Fulzele, Keertik; Wu, Joy Y.; Divieti-Pajevic, Paola] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Sun, Chia Chi; Lin, Herbert Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Attar, Eyal; Scadden, David T.] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Boston, MA 02114 USA; [Schipani, Ernestina] Indiana Univ Sch Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Van Etten, Richard A.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington; Tufts Medical Center	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	rvanetten@tuftsmedicalcenter.org; dscadden@mgh.harvard.edu		Divieti Pajevic, Paola/0000-0001-9853-9837; Catic, Andre/0000-0002-3572-7598	Ellison Medical Foundation; US National Institute on Aging [K01AG036744];  [K08 CA138916-02];  [T32 CA009216];  [AR060221];  [R21AR060689];  [R01 CA090576];  [R01 HL089747];  [R01 HL044851];  [R01 CA148180]; NATIONAL CANCER INSTITUTE [K08CA138916, U54CA163191, T32CA009216, R01CA090576] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, R01HL089747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060221, R21AR060689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG036744] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008466] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank A. Legedza and D. Neuberg for advice on statistical analysis and H.-H. Chen for helpful discussions. This work was supported by grants K08 CA138916-02 and T32 CA009216 to D. S. K., grant AR060221 to K. F. and P. D. P., grant R21AR060689 to E. S., grants R01 CA090576 and R01 HL089747 to R. A. V., grants R01 HL044851 and R01 CA148180 and a grant from The Ellison Medical Foundation to D.T.S. A.C. was supported by US National Institute on Aging grant K01AG036744.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012	25	177	186	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1513	+		10.1038/nm.3364	http://dx.doi.org/10.1038/nm.3364			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24162813	Green Submitted, Green Accepted			2022-12-25	WOS:000326920300029
J	Wakimoto, T; Egami, Y; Nakashima, Y; Wakimoto, Y; Mori, T; Awakawa, T; Ito, T; Kenmoku, H; Asakawa, Y; Piel, J; Abe, I				Wakimoto, Toshiyuki; Egami, Yoko; Nakashima, Yu; Wakimoto, Yukihiko; Mori, Takahiro; Awakawa, Takayoshi; Ito, Takuya; Kenmoku, Hiromichi; Asakawa, Yoshinori; Piel, Joern; Abe, Ikuro			Calyculin biogenesis from a pyrophosphate protoxin produced by a sponge symbiont	NATURE CHEMICAL BIOLOGY			English	Article							BIOACTIVE MARINE METABOLITES; ACTIVATED CHEMICAL DEFENSE; CARRIER PROTEINS; GENE CLUSTERS; OKADAIC ACID; POLYKETIDE; IDENTIFICATION; DNA; BIOSYNTHESIS; INHIBITORS	The Japanese marine sponge Discodermia calyx contains a major cytotoxic compound, calyculin A, which exhibits selective inhibition of protein phosphatases 1 and 2A. It has long been used as a chemical tool to evaluate intracellular signal transduction regulated by reversible protein phosphorylation. We describe the identification of the biosynthetic gene cluster of calyculin A by a metagenome mining approach. Single-cell analysis revealed that the gene cluster originates in the symbiont bacterium 'Candidatus Entotheonella' sp. A phosphotransferase encoded in the gene cluster deactivated calyculin A to produce a newly discovered diphosphate, which was actually the biosynthetic end product. The diphosphate had been previously overlooked because of the enzymatic dephosphorylation that occurred in response to sponge tissue disruption. Our work presents what is to our knowledge the first evidence for the biosynthetic process of calyculin A along with a notable phosphorylation-dephosphorylation mechanism to regulate toxicity, suggesting activated chemical defense in the most primitive of all multicellular animals.	[Wakimoto, Toshiyuki; Egami, Yoko; Nakashima, Yu; Wakimoto, Yukihiko; Mori, Takahiro; Awakawa, Takayoshi; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Wakimoto, Toshiyuki; Egami, Yoko; Mori, Takahiro; Awakawa, Takayoshi; Abe, Ikuro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Ito, Takuya; Kenmoku, Hiromichi; Asakawa, Yoshinori] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 770, Japan; [Piel, Joern] Eidgenossische Tech Hsch ETH Zurich, Inst Microbiol, Zurich, Switzerland	University of Tokyo; Japan Science & Technology Agency (JST); Tokushima Bunri University	Wakimoto, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.	wakimoto@mol.f.u-tokyo.ac.jp; abei@mol.f.u-tokyo.ac.jp	Abe, Ikuro/E-4449-2010; Wakimoto, Toshiyuki/Q-3278-2019	Abe, Ikuro/0000-0002-3640-888X; Ito, Takuya/0000-0001-8256-5010	Mitsubishi Foundation; Nagase Science Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Science and Technology Agency; Japan from the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Switzerland from the Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [25560399] Funding Source: KAKEN	Mitsubishi Foundation; Nagase Science Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Switzerland from the Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Morita (University of Toyama) and M. F. Freeman (ETH Zurich) for technical assistance; K. Takada (University of Tokyo) for assistance with the sponge collection; Y. Ise (University of Tokyo) for species identification; and M. Kamio (Tokyo University of Marine Science and Technology), N. Fusetani (Hokkaido University) and S. Matsunaga (University of Tokyo) for fruitful discussions. This work was carried out in part as joint research with the Japanese Association for Marine Biology (JAMBIO) and was partly supported by the Mitsubishi Foundation (I. A.), the Nagase Science Technology Foundation (T. W.), the Astellas Foundation for Research on Metabolic Disorders (T. W.), the CREST program from the Japan Science and Technology Agency (I. A.), the Bilateral Program between Japan and Switzerland from the Japan Society for the Promotion of Science (JSPS) (I. A.) and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (T. W. and I. A.).	Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bewley CA, 1998, ANGEW CHEM INT EDIT, V37, P2163, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2162::AID-ANIE2162>3.0.CO;2-2; Beyer S, 1999, BBA-GENE STRUCT EXPR, V1445, P185, DOI 10.1016/S0167-4781(99)00041-X; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Doderlein L, 1883, Z WISS ZOOL, V40, P62; Dumdei EJ, 1997, J ORG CHEM, V62, P2636, DOI 10.1021/jo961745j; Edrada RA, 2002, J NAT PROD, V65, P1168, DOI 10.1021/np020049d; Fagerholm AE, 2010, MAR DRUGS, V8, P122, DOI 10.3390/md80100122; Fieseler L, 2004, ENVIRON MICROBIOL, V8, P921; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fu X, 1998, J ORG CHEM, V63, P7957, DOI 10.1021/jo981249q; Ginolhac A, 2004, APPL ENVIRON MICROB, V70, P5522, DOI 10.1128/AEM.70.9.5522-5527.2004; Haines AS, 2013, NAT CHEM BIOL, V9, P685, DOI [10.1038/NCHEMBIO.1342, 10.1038/nchembio.1342]; He R, 2012, MOL BIOSYST, V8, P2334, DOI 10.1039/c2mb25169h; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Julien B, 2006, CHEM BIOL, V13, P1277, DOI 10.1016/j.chembiol.2006.10.004; Kaasalainen U, 2012, P NATL ACAD SCI USA, V109, P5886, DOI 10.1073/pnas.1200279109; KATO Y, 1986, J AM CHEM SOC, V108, P2780, DOI 10.1021/ja00270a061; KATO Y, 1988, J ORG CHEM, V53, P3930, DOI 10.1021/jo00252a009; Kehraus S, 2002, J NAT PROD, V65, P1056, DOI 10.1021/np010544u; Kimura M, 2012, J NAT PROD, V75, P290, DOI 10.1021/np2009187; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; Konoki K, 2010, BIOORGAN MED CHEM, V18, P7607, DOI 10.1016/j.bmc.2010.08.043; Kusebauch B, 2010, ANGEW CHEM INT EDIT, V49, P1460, DOI 10.1002/anie.200905467; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Matsunaga S, 1997, J ORG CHEM, V62, P2640, DOI 10.1021/jo961746b; Matsunaga S, 1997, TETRAHEDRON LETT, V38, P3763, DOI 10.1016/S0040-4039(97)00748-X; Moffitt MC, 2003, J MOL EVOL, V56, P446, DOI 10.1007/s00239-002-2415-0; Moldenhauer J, 2010, ANGEW CHEM INT EDIT, V49, P1465, DOI 10.1002/anie.200905468; Muller I, 2006, CHEMBIOCHEM, V7, P1197, DOI 10.1002/cbic.200600057; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Olano C, 2004, MOL MICROBIOL, V52, P1745, DOI 10.1111/j.1365-2958.2004.04090.x; Paul VJ, 2007, BIOL BULL-US, V213, P226, DOI 10.2307/25066642; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Shakya T, 2011, CHEM BIOL, V18, P1591, DOI 10.1016/j.chembiol.2011.10.018; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Tang MC, 2013, ACS CATAL, V3, P444, DOI 10.1021/cs300819e; TEEYAPANT R, 1993, NATURWISSENSCHAFTEN, V80, P369, DOI 10.1007/BF01138794; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; Thoms C, 2008, J CHEM ECOL, V34, P1242, DOI 10.1007/s10886-008-9518-z; Wakimoto T, 2002, CHEM BIOL, V9, P309, DOI 10.1016/S1074-5521(02)00118-7; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wiens M, 2003, MAR BIOL, V142, P213, DOI 10.1007/s00227-002-0886-6; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168	60	78	79	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					648	U193		10.1038/NCHEMBIO.1573	http://dx.doi.org/10.1038/NCHEMBIO.1573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24974231				2022-12-25	WOS:000339380100011
J	Romano, D; Nguyen, LK; Matallanas, D; Halasz, M; Doherty, C; Kholodenko, BN; Kolch, W				Romano, David; Nguyen, Lan K.; Matallanas, David; Halasz, Melinda; Doherty, Carolanne; Kholodenko, Boris N.; Kolch, Walter			Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling	NATURE CELL BIOLOGY			English	Article							REGULATED KINASE ACTIVATION; TUMOR-SUPPRESSOR; MST1 KINASE; CELL-TRANSFORMATION; NOONAN-SYNDROME; HIPPO PATHWAY; RAS; PHOSPHORYLATION; APOPTOSIS; DYNAMICS	Signal transduction requires the coordination of activities between different pathways. In mammalian cells, Raf-1 regulates the MST-LATS and MEK-ERK pathways. We found that a complex circuitry of competing protein interactions coordinates the crosstalk between the ERK and MST pathways. Combining mathematical modelling and experimental validation we show that competing protein interactions can cause steep signalling switches through phosphorylation-induced changes in binding affinities. These include Akt phosphorylation of MST2 and a feedback phosphorylation of Raf-1 Ser 259 by LATS1, which enables Raf-1 to suppress both MST2 and MEK signalling. Mutation of Raf-1 Ser 259 stimulates both pathways, simultaneously driving apoptosis and proliferation, whereas concomitant MST2 downregulation switches signalling to cell proliferation, transformation and survival. Thus, competing protein interactions provide a versatile regulatory mechanism for signal distribution through the dynamic integration of graded signals into switch-like responses.	[Romano, David; Nguyen, Lan K.; Matallanas, David; Halasz, Melinda; Doherty, Carolanne; Kholodenko, Boris N.; Kolch, Walter] Univ Coll Dublin, Dublin 4, Ireland; [Kholodenko, Boris N.; Kolch, Walter] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Kholodenko, Boris N.; Kolch, Walter] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin	Kholodenko, BN (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	boris.kholodenko@ucd.ie; walter.kolch@ucd.ie	Kolch, Walter/ABF-2102-2021; Halasz, Melinda/AAM-9423-2021; gomez, david/U-9465-2019; Admin, SBI/HGB-2738-2022	gomez, david/0000-0002-2360-3141; Kholodenko, Boris/0000-0002-9483-4975; Halasz, Melinda/0000-0002-6175-9630; Nguyen, Lan/0000-0003-4040-7705; Kolch, Walter/0000-0001-5777-5016	Science Foundation Ireland [06/CE/B1129]; EU FP7 Project PRIMES [278568]; EU FP7 Project ASSET [259348-2]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EU FP7 Project PRIMES; EU FP7 Project ASSET	This work was supported by Science Foundation Ireland grant No. 06/CE/B1129 and the EU FP7 Projects PRIMES No. 278568 and ASSET No. 259348-2. We thank A. Blanco (Conway Core Technologies), T. Santra, J. Munoz and M. Dobrzynski for help with flow cytometry and modelling.	Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; ASKEW DS, 1991, ONCOGENE, V6, P1915; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Bossuyt W, 2014, ONCOGENE, V33, P1218, DOI 10.1038/onc.2013.82; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; DENT P, 1995, MOL CELL BIOL, V15, P4125; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; ELTIS LD, 1991, BIOCHEMISTRY-US, V30, P3663, DOI 10.1021/bi00229a011; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Geiger T., 2012, MOL CELL PROTEOM, V11; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jorgensen C, 2010, CURR OPIN GENET DEV, V20, P15, DOI 10.1016/j.gde.2009.12.003; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Luzyanina T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-26; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Miesfeld J. B., 2014, MECH DEV; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Osborne JK, 2012, CELL RES, V22, P14, DOI 10.1038/cr.2011.193; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Salazar C, 2006, ANN NY ACAD SCI, V1091, P517, DOI 10.1196/annals.1378.093; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Xiang XQ, 2002, J BIOL CHEM, V277, P44996, DOI 10.1074/jbc.M203953200	66	100	104	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					673	+		10.1038/ncb2986	http://dx.doi.org/10.1038/ncb2986			46	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24929361				2022-12-25	WOS:000338187900008
J	Uslu, VV; Petretich, M; Ruf, S; Langenfeld, K; Fonseca, NA; Marioni, JC; Spitz, F				Uslu, Veil Vural; Petretich, Massimo; Ruf, Sandra; Langenfeld, Katja; Fonseca, Nuno A.; Marioni, John C.; Spitz, Francois			Long-range enhancers regulating Myc expression are required for normal facial morphogenesis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NONSYNDROMIC CLEFT-LIP; C-MYC; SUSCEPTIBILITY LOCI; SNP RS6983267; PALATE; MOUSE; TRANSCRIPTION; MORPHOLOGY; VARIANTS	Cleft lip with or without cleft palate (CL/P) is one of the most common congenital malformations observed in humans, with 1 occurrence in every 500-1,000 births(1,2). A 640-kb noncoding interval at 8q24 has been associated with increased risk of non-syndromic CL/P in humans(3-5), but the genes and pathways involved in this genetic susceptibility have remained elusive. Using a large series of rearrangements engineered over the syntenic mouse region, we show that this interval contains very remote cis-acting enhancers that control Myc expression in the developing face. Deletion of this interval leads to mild alteration of facial morphology in mice and, sporadically, to CUP. At the molecular level, we identify misexpression of several downstream genes, highlighting combined impact on the craniofacial developmental network and the general metabolic capacity of cells contributing to the future upper lip. This dual molecular etiology may account for the prominent influence of variants in the 8q24 region on human facial dysmorphologies.	[Uslu, Veil Vural; Petretich, Massimo; Ruf, Sandra; Langenfeld, Katja; Spitz, Francois] EMBL, Dev Biol Unit, Heidelberg, Germany; [Fonseca, Nuno A.; Marioni, John C.] EBI, EMBL, Cambridge, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Spitz, F (corresponding author), EMBL, Dev Biol Unit, Heidelberg, Germany.	spitz@embl.de	Fonseca, Nuno A./B-7801-2009	Fonseca, Nuno A./0000-0003-4832-578X; Marioni, John/0000-0001-9092-0852; Spitz, Francois/0000-0002-1960-829X	EMBL; Jeff Schell Darwin Trust; EMBL International PhD program	EMBL; Jeff Schell Darwin Trust; EMBL International PhD program	We thank B. Sleckman (Washington University, St. Louis) and A. Trumpp (DKFZ, Heidelberg) for providing the Myc<SUP>tm1Slek</SUP> strain. We thank members of the EMBL Laboratory Animal Resources Facility for animal welfare and husbandry; the EMBL Genomics Core Facility for advice and support in processing ChIP and RNA sequencing experiments; and Genome Biology Computational Support for help with the analyses. We thank members of the Spitz laboratory and colleagues at EMBL for sharing reagents and helpful comments. V.V.U. and M.P. were supported by PhD fellowships from the Jeff Schell Darwin Trust and the EMBL International PhD program, respectively. This work was supported by EMBL.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ito E, 2010, INT J HEMATOL, V92, P413, DOI 10.1007/s12185-010-0693-7; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; KAROLYI J, 1988, TERATOLOGY, V37, P283, DOI 10.1002/tera.1420370314; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nelson DK, 2004, DEV BIOL, V267, P72, DOI 10.1016/j.ydbio.2003.10.033; Parsons TE, 2008, J ANAT, V212, P135, DOI 10.1111/j.1469-7580.2007.00845.x; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Terzian T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003300; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Watkins-Chow DE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003094; Wei K, 2007, GENESIS, V45, P382, DOI 10.1002/dvg.20304; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104	49	91	92	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					753	758		10.1038/ng.2971	http://dx.doi.org/10.1038/ng.2971			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24859337				2022-12-25	WOS:000338093800019
J	Fort, A; Hashimoto, K; Yamada, D; Salimullah, M; Keya, CA; Saxena, A; Bonetti, A; Voineagu, I; Bertin, N; Kratz, A; Noro, Y; Wong, CH; de Hoon, M; Andersson, R; Sandelin, A; Suzuki, H; Wei, CL; Koseki, H; Hasegawa, Y; Forrest, ARR; Carninci, P				Fort, Alexandre; Hashimoto, Kosuke; Yamada, Daisuke; Salimullah, Md; Keya, Chaman A.; Saxena, Alka; Bonetti, Alessandro; Voineagu, Irina; Bertin, Nicolas; Kratz, Anton; Noro, Yukihiko; Wong, Chee-Hong; de Hoon, Michiel; Andersson, Robin; Sandelin, Albin; Suzuki, Harukazu; Wei, Chia-Lin; Koseki, Haruhiko; Hasegawa, Yuki; Forrest, Alistair R. R.; Carninci, Piero		FANTOM Consortium	Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; MOUSE EPIBLAST; RNA; CIRCUITRY; GENOME; GENERATION; LANDSCAPE; ENHANCERS; DATABASE	The importance of microRNAs and long noncoding RNAs in the regulation of pluripotency has been documented; however, the noncoding components of stem cell gene networks remain largely unknown. Here we investigate the role of noncoding RNAs in the pluripotent state, with particular emphasis on nuclear and retrotransposon-derived transcripts. We have performed deep profiling of the nuclear and cytoplasmic transcriptomes of human and mouse stem cells, identifying a class of previously undetected stem cell specific transcripts. We show that long terminal repeat (LTR)-derived transcripts contribute extensively to the complexity of the stem cell nuclear transcriptome. Some LTR-derived transcripts are associated with enhancer regions and are likely to be involved in the maintenance of pluripotency.	[Fort, Alexandre; Hashimoto, Kosuke; Salimullah, Md; Keya, Chaman A.; Saxena, Alka; Bonetti, Alessandro; Voineagu, Irina; Bertin, Nicolas; Kratz, Anton; Noro, Yukihiko; de Hoon, Michiel; Suzuki, Harukazu; Hasegawa, Yuki; Forrest, Alistair R. R.; Carninci, Piero] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Yamada, Daisuke; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Wong, Chee-Hong; Wei, Chia-Lin] Lawrence Berkeley Natl Lab, Joint Genome Inst, Sequencing Technol Grp, Walnut Creek, CA USA; [Andersson, Robin; Sandelin, Albin] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Andersson, Robin; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	RIKEN; RIKEN; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of Copenhagen; University of Copenhagen	Carninci, P (corresponding author), RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	carninci@riken.jp	Hashimoto, Kosuke/C-3675-2017; Suzuki, Harukazu/N-9553-2015; Carninci, Piero/K-1568-2014; Bertin, Nicolas/O-9602-2019; Andersson, Robin/B-5311-2009; Sandelin, Albin/G-2881-2011; de Hoon, Michiel/A-6443-2013; Koseki, Haruhiko/I-3825-2014; Bertin, Nicolas/C-3025-2008	Hashimoto, Kosuke/0000-0003-3031-0635; Suzuki, Harukazu/0000-0002-8087-0836; Carninci, Piero/0000-0001-7202-7243; Andersson, Robin/0000-0003-1516-879X; Sandelin, Albin/0000-0002-7109-7378; Koseki, Haruhiko/0000-0001-8424-5854; Winteringham, Louise/0000-0002-8117-5069; Voineagu, Irina/0000-0003-4162-3872; Noro, Yukihiko/0000-0002-8986-6585; Salimullah, Md/0000-0001-9895-9233; Forrest, Alistair/0000-0003-4543-1675; de Hoon, Michiel/0000-0003-0489-2352; Kratz, Anton/0000-0002-6262-4404; Bertin, Nicolas/0000-0002-9835-9606	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next-Generation World-Leading Researchers (NEXT); Council for Science and Technology Policy (CSTP); JSPS [P10782]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT Japan; MEXT; Swiss National Science Foundation [PA00P3_142122]; European Union; Sigrid Juselius Foundation; Japan Science and Technology Agency CREST; ERC [204135]; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next-Generation World-Leading Researchers (NEXT); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Japan Science and Technology Agency CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ERC(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society)	The authors thank the RIKEN GeNAS sequencing platform for sequencing of the libraries. This work was supported by a grant to P.C. from the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next-Generation World-Leading Researchers (NEXT) initiated by the Council for Science and Technology Policy (CSTP), by a grand-in-aid for scientific research from JSPS to P.C. and A.F., and by a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies. FANTOM5 was made possible by a research grant for the RIKEN Omics Science Center from MEXT Japan to Y. Hayashizaki and by a grant for Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from MEXT to Y. Hayashizaki. A.F. was supported by a JSPS long-term fellowship (P10782) and by a Swiss National Science Foundation Fellowship for Advanced Researchers (PA00P3_142122). K.H. was supported by European Union Framework Programme 7 (MODHEP project) for P.C. A.B. was supported by the Sigrid Juselius Foundation Fellowship. D.Y. and H.K. were supported by the Japan Science and Technology Agency CREST. R.A. and A. Sandelin were supported by funds from FP7/2007-2013/ERC grant agreement 204135, the Novo Nordisk Foundation, the Lundbeck Foundation and the Danish Cancer Society.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kolle G, 2011, GENOME RES, V21, P2014, DOI 10.1101/gr.119321.110; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/nmeth.1470, 10.1038/NMETH.1470]; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; St Laurent G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r73; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	50	192	198	5	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					558	566		10.1038/ng.2965	http://dx.doi.org/10.1038/ng.2965			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24777452				2022-12-25	WOS:000336870700011
J	Lane, AA; Chapuy, B; Lin, CY; Tivey, T; Li, HB; Townsend, EC; van Bodegom, D; Day, TA; Wu, SC; Liu, HY; Yoda, A; Alexe, G; Schinzel, AC; Sullivan, TJ; Malinge, S; Taylor, JE; Stegmaier, K; Jaffe, JD; Bustin, M; te Kronnie, G; Izraeli, S; Harris, MH; Stevenson, KE; Neuberg, D; Silverman, LB; Sallan, SE; Bradner, JE; Hahn, WC; Crispino, JD; Pellman, D; Weinstock, DM				Lane, Andrew A.; Chapuy, Bjoern; Lin, Charles Y.; Tivey, Trevor; Li, Hubo; Townsend, Elizabeth C.; van Bodegom, Diederik; Day, Tovah A.; Wu, Shuo-Chieh; Liu, Huiyun; Yoda, Akinori; Alexe, Gabriela; Schinzel, Anna C.; Sullivan, Timothy J.; Malinge, Sebastien; Taylor, Jordan E.; Stegmaier, Kimberly; Jaffe, Jacob D.; Bustin, Michael; te Kronnie, Geertruy; Izraeli, Shai; Harris, Marian H.; Stevenson, Kristen E.; Neuberg, Donna; Silverman, Lewis B.; Sallan, Stephen E.; Bradner, James E.; Hahn, William C.; Crispino, John D.; Pellman, David; Weinstock, David M.			Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION; STEM; CRLF2; GENE; PROTEINS	Down syndrome confers a 20-fold increased risk of B cell acute lymphoblastic leukemia (B-ALL)1, and polysomy 21 is most frequent somatic aneuploidy among all B-ALLs(2). Yet the mechanistic links between chromosome 21 triplication and B-ALL remain undefined. Here we show that germline triplication of only 31 genes orthologous to human chromosome 21q22 confers mouse progenitor B cell self renewal in vitro, maturation defects in vivo and B-ALL with either the BCR-ABL fusion protein or CRLF2 with activated JAK2. Chromosome 21q22 triplication suppresses histone H3 Lys27 trimethylation (H3K27me3) in progenitor B cells and B-ALLs, and 'bivalent' genes with both H3K27me3 and H3K4me3 at their promoters in wild-type progenitor B cells are preferentially overexpressed in triplicated cells. Human B-ALLs with polysomy 21 are distinguished by their overexpression of genes marked with H3K27me3 in multiple cell types. Overexpression of HMGN1, a nucleosome remodeling protein encoded on chromosome 21q22 (refs. 3-5), suppresses H3K27me3 and promotes both B cell proliferation in vitro and B-ALL in vivo.	[Lane, Andrew A.; Chapuy, Bjoern; Lin, Charles Y.; Tivey, Trevor; Townsend, Elizabeth C.; van Bodegom, Diederik; Day, Tovah A.; Wu, Shuo-Chieh; Liu, Huiyun; Yoda, Akinori; Schinzel, Anna C.; Bradner, James E.; Hahn, William C.; Weinstock, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Hubo; Alexe, Gabriela; Silverman, Lewis B.; Sallan, Stephen E.; Pellman, David] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Schinzel, Anna C.; Taylor, Jordan E.; Stegmaier, Kimberly; Jaffe, Jacob D.; Hahn, William C.; Weinstock, David M.] Broad Inst, Cambridge, MA USA; [Sullivan, Timothy J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Microarray Core, Boston, MA 02115 USA; [Malinge, Sebastien] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France; [Bustin, Michael] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [te Kronnie, Geertruy] Univ Padua, Dept Pediat, Padua, Italy; [Izraeli, Shai] Chaim Sheba Med Ctr, Dept Pediat Hematooncol, Ramat Gan, Israel; [Izraeli, Shai] Tel Aviv Univ, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Harris, Marian H.] Childrens Hosp Boston, Dept Pathol, Boston, MA USA; [Stevenson, Kristen E.; Neuberg, Donna] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Crispino, John D.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Padua; Chaim Sheba Medical Center; Tel Aviv University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northwestern University; Howard Hughes Medical Institute	Lane, AA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	andrew_lane@dfci.harvard.edu; dweinstock@partners.org	Kronnie, Geertruij te/O-5251-2019; Harris, Marian/R-7049-2019; Kronnie, Geertruy te/L-1014-2016; Bustin, Michael/G-6155-2015; Malinge, Sebastien/AAP-9452-2021; Malinge, Sebastien/AAK-1158-2021; Malinge, Sebastien/B-3507-2014	Malinge, Sebastien/0000-0002-9533-7778; Malinge, Sebastien/0000-0002-9533-7778; Lane, Andrew/0000-0001-7380-0226; Bustin, Michael/0000-0002-5147-7242; /0000-0001-5636-1006; Tivey, Trevor/0000-0003-2124-5528; Crispino, John/0000-0002-8182-8306; te Kronnie, Geertruy/0000-0001-7143-4795	Conquer Cancer Foundation; Lauri Strauss Leukemia Foundation; Leukemia and Lymphoma Society; Alex Lemonade Stand Foundation; US Department of Defense; Israel Science Foundation; US Israel Binational Foundation; Stellato Fund; US National Institutes of Health/National Cancer Institute [CA15198-01, CA172387-A01]; NATIONAL CANCER INSTITUTE [R01CA172387, R01CA151898, ZIABC011154, K08CA181340] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116324] Funding Source: NIH RePORTER	Conquer Cancer Foundation; Lauri Strauss Leukemia Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Alex Lemonade Stand Foundation; US Department of Defense(United States Department of Defense); Israel Science Foundation(Israel Science Foundation); US Israel Binational Foundation(US-Israel Binational Science Foundation); Stellato Fund; US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Kopp and A. Schlauch for technical assistance, M. Busslinger (Research Institute of Molecular Pathology, Vienna) for the Pax5<SUP>+/-</SUP> mice and M. Oshimura (Tottori University) for A9 cells carrying human chromosome 21. This research was supported by the Conquer Cancer Foundation (.A.A.L.), the Lauri Strauss Leukemia Foundation (A.A.L.), the Leukemia and Lymphoma Society (A.A.L.), the Alex Lemonade Stand Foundation (A.A.L., H. Li and D.P.), the US Department of Defense (C.Y.L.), the Israel Science Foundation (S.I.), the US Israel Binational Foundation (J.D.C. and S.I.), the Stellato Fund (D.M.W.), US National Institutes of Health/National Cancer Institute R01 awards CA15198-01 and CA172387-A01 (D.M.W.) and a Translational Research Award from the Leukemia and Lymphoma Society (J.D.C. and D.M.W.).	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bustin M, 1995, DNA CELL BIOL, V14, P997, DOI 10.1089/dna.1995.14.997; Cabelof DC, 2009, BLOOD, V114, P2753, DOI 10.1182/blood-2008-11-190330; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Heerema NA, 2007, GENE CHROMOSOME CANC, V46, P684, DOI 10.1002/gcc.20451; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; LACOBUCCI I, 2008, BLOOD, V112, P3847; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Rabin KR, 2009, ONCOLOGIST, V14, P164, DOI 10.1634/theoncologist.2008-0217; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Roy A, 2012, P NATL ACAD SCI USA, V109, P17579, DOI 10.1073/pnas.1211405109; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weinstock DM, 2006, MOL CELL BIOL, V26, P131, DOI 10.1128/MCB.26.1.131-139.2006; Wetzler M, 2004, BRIT J HAEMATOL, V124, P275, DOI 10.1046/j.1365-2141.2003.04736.x; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107	31	84	85	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					618	623		10.1038/ng.2949	http://dx.doi.org/10.1038/ng.2949			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747640	Green Accepted, Green Submitted			2022-12-25	WOS:000336870700020
J	Liu, C; Karam, R; Zhou, YQ; Su, F; Ji, Y; Li, G; Xu, GT; Lu, LX; Wang, CR; Song, MY; Zhu, JP; Wang, YR; Zhao, YF; Foo, WC; Zuo, MX; Valasek, MA; Javle, M; Wilkinson, MF; Lu, YJ				Liu, Chen; Karam, Rachid; Zhou, YingQi; Su, Fang; Ji, Yuan; Li, Gang; Xu, GuoTong; Lu, LiXia; Wang, ChongRen; Song, MeiYi; Zhu, JingPing; Wang, YiRan; Zhao, YiFan; Foo, Wai Chin; Zuo, MingXin; Valasek, Mark A.; Javle, Milind; Wilkinson, Miles F.; Lu, YanJun			The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma	NATURE MEDICINE			English	Article							MOLECULAR ALTERATIONS; DECAY; CANCER; TRANSCRIPTS; PATHWAY; CELLS	Pancreatic adenosquamous carcinoma (ASC) is an enigmatic and aggressive tumor that has a worse prognosis and higher metastatic potential than its adenocarcinoma counterpart. Here we report that ASC tumors frequently harbor somatically acquired mutations in the UPF1 gene, which encodes the core component of the nonsense-mediated RNA decay (NMD) pathway. These tumor-specific mutations alter UPF1 RNA splicing and perturb NMD, leading to upregulated levels of NMD substrate mRNAs. UPF1 mutations are, to our knowledge, the first known unique molecular signatures of pancreatic ASC.	[Liu, Chen; Su, Fang; Xu, GuoTong; Lu, LiXia; Wang, ChongRen; Song, MeiYi; Zhu, JingPing; Wang, YiRan; Zhao, YiFan; Lu, YanJun] Tongji Univ, Sch Med, Peoples Hosp 10, Clin & Translat Canc Res Ctr, Shanghai 200092, Peoples R China; [Liu, Chen] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Karam, Rachid; Wilkinson, Miles F.] Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA; [Zhou, YingQi; Li, Gang] Second Mil Med Univ, Changhai Hosp, Dept Gen Surg 3, Shanghai, Peoples R China; [Ji, Yuan] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Foo, Wai Chin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zuo, MingXin; Javle, Milind] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Valasek, Mark A.] Univ Calif San Diego, Dept Pathol, Div Anat Pathol, San Diego, CA 92103 USA; [Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Tongji University; Tongji University; University of California System; University of California San Diego; Naval Medical University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Lu, YJ (corresponding author), Tongji Univ, Sch Med, Peoples Hosp 10, Clin & Translat Canc Res Ctr, Shanghai 200092, Peoples R China.	mfwilkinson@ucsd.edu; yanjunlu@hotmail.com	Zuo, Mingxin/E-1063-2015; wang, yixuan/GXW-2866-2022; Wang, Yixuan/GZK-6559-2022; Wang, Yijun/GXW-1763-2022; Zuo, Mingxin/N-8117-2014; wang, yi/GVT-8516-2022	lu, Yanjun/0000-0003-2471-0245; Valasek, Mark/0000-0003-1721-3451; su, fang/0000-0002-4902-5191	National Key Basic Research Program of China [2013CB967500, 2011DFB30010, 2011CB965102]; National Natural Science Foundation of China [81071740]; US National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111838, R01GM058595] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Key Basic Research Program of China grants 2013CB967500 and 2011DFB30010 (to G.X.) and 2011CB965102 (to L.L.), the National Natural Science Foundation of China grant 81071740 (to Y.J.) and a US National Institutes of Health grant (to M.F.W.). Vector pTBNde(mini) was provided by F.E. Barak (International Centre for Genetic Engineering and Biotechnology, Italy).	Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Brody JR, 2009, MODERN PATHOL, V22, P651, DOI 10.1038/modpathol.2009.15; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Frischmeyer-Guerrerio PA, 2011, P NATL ACAD SCI USA, V108, P10638, DOI 10.1073/pnas.1019352108; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Isken O., 2008, NAT REV GENET, V9, P699; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Karam R, 2008, ONCOGENE, V27, P4255, DOI 10.1038/onc.2008.62; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Kardon DE, 2001, MODERN PATHOL, V14, P443, DOI 10.1038/modpathol.3880332; Leeds P., 1992, MOL CELL BIOL, V12, P2166; Madura JA, 1999, ARCH SURG-CHICAGO, V134, P599, DOI 10.1001/archsurg.134.6.599; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Murakami Y, 2003, J GASTROENTEROL, V38, P1171, DOI 10.1007/s00535-003-1226-4; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Regi P, 2011, LANGENBECK ARCH SURG, V396, P217, DOI 10.1007/s00423-010-0677-3; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377	20	90	91	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					596	598		10.1038/nm.3548	http://dx.doi.org/10.1038/nm.3548			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24859531	Green Submitted, Green Accepted			2022-12-25	WOS:000337071000020
J	Ota, KT; Liu, RJ; Voleti, B; Maldonado-Aviles, JG; Duric, V; Iwata, M; Dutheil, S; Duman, C; Boikess, S; Lewis, DA; Stockmeier, CA; DiLeone, RJ; Rex, C; Aghajanian, GK; Duman, RS				Ota, Kristie T.; Liu, Rong-Jian; Voleti, Bhavya; Maldonado-Aviles, Jaime G.; Duric, Vanja; Iwata, Masaaki; Dutheil, Sophie; Duman, Catharine; Boikess, Steve; Lewis, David A.; Stockmeier, Craig A.; DiLeone, Ralph J.; Rex, Christopher; Aghajanian, George K.; Duman, Ronald S.			REDD1 is essential for stress-induced synaptic loss and depressive behavior	NATURE MEDICINE			English	Article							FACTOR VAL66MET POLYMORPHISM; MEDIAL PREFRONTAL CORTEX; MAMMALIAN TARGET; MOOD DISORDERS; RAPAMYCIN; PATHWAY; RTP801; VOLUME; RAT	Major depressive disorder (MDD) affects up to 17% of the population, causing profound personal suffering and economic loss(1). Clinical and preclinical studies have revealed that prolonged stress and MDD are associated with neuronal atrophy of cortical and limbic brain regions(2-9), but the molecular mechanisms underlying these morphological alterations have not yet been identified. Here, we show that stress increases levels of REDD1 (regulated in development and DNA damage responses-1), an inhibitor of mTORC1 (mammalian target of rapamycin complex-1; ref.10), in rat prefrontal cortex (PFC). This is concurrent with a decrease in phosphorylation of signaling targets of mTORC1, which is implicated in protein synthesis dependent synaptic plasticity. We also found that REDD1 levels are increased in the postmortem PFC of human subjects with MDD relative to matched controls. Mutant mice with a deletion of the gene encoding REDD1 are resilient to the behavioral, synaptic and mTORC1 signaling deficits caused by chronic unpredictable stress, whereas viral-mediated overexpression of REDD1 in rat PFC is sufficient to cause anxiety- and depressive-like behaviors and neuronal atrophy. Taken together, these postmortem and preclinical findings identify REDD1 as a critical mediator of the atrophy of neurons and depressive behavior caused by chronic stress exposure.	[Ota, Kristie T.; Liu, Rong-Jian; Voleti, Bhavya; Maldonado-Aviles, Jaime G.; Duric, Vanja; Iwata, Masaaki; Dutheil, Sophie; Duman, Catharine; DiLeone, Ralph J.; Aghajanian, George K.; Duman, Ronald S.] Yale Univ Sch Med, Dept Psychiat, Lab Mol Psychiat, Ctr Genes & Behav, New Haven, CT 06520 USA; [Duric, Vanja] Des Moines Univ, Dept Physiol & Pharmacol, Des Moines, IA USA; [Boikess, Steve; Rex, Christopher] Afraxis, La Jolla, CA USA; [Lewis, David A.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center	Duman, RS (corresponding author), Yale Univ Sch Med, Dept Psychiat, Lab Mol Psychiat, Ctr Genes & Behav, New Haven, CT 06520 USA.	ronald.duman@yale.edu	Rex, Christopher/F-2112-2010; Iwata, Masaaki/AAP-3732-2020; Lewis, David A/G-4053-2014	Iwata, Masaaki/0000-0002-6143-0181; Lewis, David A/0000-0002-3225-6778; DiLeone, Ralph/0000-0002-4770-2590; Dutheil, Sophie/0000-0002-2031-482X	US National Institutes of Health [NIMH R37MH45481, NIMH R01MH93897, NIMH F32MH98513, NIGMS P30GM103328]; State of Connecticut; Yale University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093897, F32MH098513, R37MH045481, R01MH105910] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut; Yale University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by US National Institutes of Health NIMH R37MH45481 (R.S.D.), NIMH R01MH93897 (R.S.D.), NIMH F32MH98513 (K.T.O.) and NIGMS P30GM103328 (C.A.S.), the State of Connecticut and Yale University. We thank the families consenting to donate brain tissue and be interviewed for the human tissue samples and the Cuyahoga County Medical Examiner's Office for assistance. We thank G. Rajkowska for identification of anatomically comparable regions of dIPFC. We thank Quark Pharmaceuticals for providing the REDD1 plasmid and REDD1-knockout mice. We thank M. Banasr for helpful discussions on behavioral experiments, X.-Y. Li for assistance in breeding and genotyping REDD1-knockout mice, and A. Lepack, W Andres and Z. LaPalombara for technical assistance. We thank J. Taylor, M. Picciotto and A. Nairn for critical reading of the manuscript.	Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Boersma G, 2011, EUR J PHARMACOL, V654, P122, DOI 10.1016/j.ejphar.2010.12.017; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Feng Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052674; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Jernigan CS, 2011, PROG NEURO-PSYCHOPH, V35, P1774, DOI 10.1016/j.pnpbp.2011.05.010; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Polman JAE, 2012, ENDOCRINOLOGY, V153, P4317, DOI 10.1210/en.2012-1255; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	29	176	179	0	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					535	539		10.1038/nm.3513	http://dx.doi.org/10.1038/nm.3513			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24728411	Green Accepted			2022-12-25	WOS:000335710700025
J	Wang, LY; Opland, D; Tsai, S; Luk, CT; Schroer, SA; Allison, MB; Elia, AJ; Furlonger, C; Suzuki, A; Paige, CJ; Mak, TW; Winer, DA; Myers, MG; Woo, M				Wang, Linyuan; Opland, Darren; Tsai, Sue; Luk, Cynthia T.; Schroer, Stephanie A.; Allison, Margaret B.; Elia, Andrew J.; Furlonger, Caren; Suzuki, Akira; Paige, Christopher J.; Mak, Tak W.; Winer, Daniel A.; Myers, Martin G., Jr.; Woo, Minna			Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex	NATURE MEDICINE			English	Article							INSULIN-RECEPTOR SUBSTRATE-2; ADIPOSE-TISSUE; BETA-CELL; VAGUS NERVE; T-CELLS; ALTERNATIVE ACTIVATION; MACROPHAGE ACTIVATION; CRUCIAL ROLE; OBESITY; INFLAMMATION	Inflammation has a critical role in the development of insulin resistance. Recent evidence points to a contribution by the central nervous system in the modulation of peripheral inflammation through the anti-inflammatory reflex. However, the importance of this phenomenon remains elusive in type 2 diabetes pathogenesis. Here we show that rat insulin-2 promoter (Rip)-mediated deletion of Pten, a gene encoding a negative regulator of PI3K signaling, led to activation of the cholinergic anti-inflammatory pathway that is mediated by M2 activated macrophages in peripheral tissues. As such, Rip-cre(+) pten(flox/flox) mice showed lower systemic inflammation and greater insulin sensitivity under basal conditions compared to littermate controls, which were abolished when the mice were treated with an acetylcholine receptor antagonist or when macrophages were depleted. After feeding with a high-fat diet, the Pten-deleted mice remained markedly insulin sensitive, which correlated with massive subcutaneous fat expansion. They also exhibited more adipogenesis with M2 macrophage infiltration, both of which were abolished after disruption of the anti-inflammatory efferent pathway by left vagotomy. In summary, we show that Pten expression in Rip(+) neurons has a critical role in diabetes pathogenesis through mediating the anti-inflammatory reflex.	[Wang, Linyuan; Tsai, Sue; Luk, Cynthia T.; Schroer, Stephanie A.; Winer, Daniel A.; Woo, Minna] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Wang, Linyuan; Paige, Christopher J.; Mak, Tak W.; Woo, Minna] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wang, Linyuan; Luk, Cynthia T.; Woo, Minna] Univ Toronto, Fac Med, Toronto, ON, Canada; [Opland, Darren; Allison, Margaret B.; Myers, Martin G., Jr.] Univ Michigan, Dept Internal Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Luk, Cynthia T.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Elia, Andrew J.; Mak, Tak W.] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Elia, Andrew J.; Furlonger, Caren; Paige, Christopher J.; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 812, Japan; [Paige, Christopher J.; Mak, Tak W.; Winer, Daniel A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Winer, Daniel A.] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Winer, Daniel A.; Woo, Minna] Univ Toronto, Dept Med, Div Endocrinol & Metab, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Michigan System; University of Michigan; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Kyushu University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Woo, M (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	mwoo@uhnresearch.ca	Suzuki, Akira/GYD-6697-2022	Suzuki, Akira/0000-0002-5950-8808; Tsai, Sue/0000-0002-6261-5233; Allison, Margaret/0000-0003-0323-8850	Canadian Institutes of Health Research (CIHR) [MOP-93707]; Canadian Diabetes Association (CDA); US National Institutes of Health [DK57768]; CIHR [MOP-119414]; CDA; Frederick Banting and Charles Best Canada Graduate Scholarship from CIHR; Novo Nordisk Graduate Scholarship from the Banting and Best Diabetes Centre; Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC); Comprehensive Research Experience for Medical Students (CREMS) Scholarship from the Faculty of Medicine, University of Toronto; Toronto General Research Institute Postdoctoral Fellowship; Eliot Phillipson Clinician Scientist Training Program; Banting and Best Diabetes Centre Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057768] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26114005, 26640081] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); CDA; Frederick Banting and Charles Best Canada Graduate Scholarship from CIHR(Canadian Institutes of Health Research (CIHR)); Novo Nordisk Graduate Scholarship from the Banting and Best Diabetes Centre; Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Comprehensive Research Experience for Medical Students (CREMS) Scholarship from the Faculty of Medicine, University of Toronto; Toronto General Research Institute Postdoctoral Fellowship; Eliot Phillipson Clinician Scientist Training Program; Banting and Best Diabetes Centre Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Dor (Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School) for providing the Pdx1-Cre-ER mice. This work was supported by grants to M.W. from the Canadian Institutes of Health Research (CIHR; MOP-93707) and the Canadian Diabetes Association (CDA). M.W. holds a Canada Research Chair in Signal Transduction in Diabetes Pathogenesis. M.G.M.Jr. was supported by a grant from the US National Institutes of Health (DK57768). Support was also received from grants to D.A.W. from the CIHR (MOP-119414) and CDA. L.W. was supported by Frederick Banting and Charles Best Canada Graduate Scholarship from CIHR, a Novo Nordisk Graduate Scholarship from the Banting and Best Diabetes Centre, a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and a Comprehensive Research Experience for Medical Students (CREMS) Scholarship from the Faculty of Medicine, University of Toronto. S.T. was supported by a Toronto General Research Institute Postdoctoral Fellowship. C.T.L. is supported by the Eliot Phillipson Clinician Scientist Training Program and a Banting and Best Diabetes Centre Postdoctoral Fellowship.	ANDERSSON K, 1995, BRIT J PHARMACOL, V115, P1155, DOI 10.1111/j.1476-5381.1995.tb15018.x; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Choudhury AI, 2005, J CLIN INVEST, V115, P940; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	55	51	51	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					488	496		10.1038/nm.3527	http://dx.doi.org/10.1038/nm.3527			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24747746				2022-12-25	WOS:000335710700019
J	Wang, N; Gray, M; Lu, XH; Cantle, JP; Holley, SM; Greiner, E; Gu, XF; Shirasaki, D; Cepeda, C; Li, YQ; Dong, HW; Levine, MS; Yang, XW				Wang, Nan; Gray, Michelle; Lu, Xiao-Hong; Cantle, Jeffrey P.; Holley, Sandra M.; Greiner, Erin; Gu, Xiaofeng; Shirasaki, Dyna; Cepeda, Carlos; Li, Yuqing; Dong, Hongwei; Levine, Michael S.; Yang, X. William			Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease	NATURE MEDICINE			English	Article							POSTSYNAPTIC DENSITY; MICE; STRIATUM; RECEPTOR; BRAIN; IDENTIFICATION; TRANSIENT; NMDAR1; LENGTH; MOTOR	Huntington's disease (HD) is a fatal dominantly inherited neurodegenerative disorder caused by a CAG repeat expansion leading to an elongated polyglutamine stretch in huntingtin(1). Mutant huntingtin (mHTT) is ubiquitously expressed in all cells but elicits selective cortical and striatal neurodegeneration in HD2. The mechanistic basis for such selective neuronal vulnerability remains unclear. A necessary step toward resolving this enigma is to define the cell types in which mHTT expression is causally linked to the disease pathogenesis. Using a conditional transgenic mouse model of HD, in which the mice express full-length human mHTT from a bacterial artificial chromosome transgene (BACHD)(3), we genetically reduced mHTT expression in neuronal populations in the striatum, cortex or both. We show that reduction of cortical mHTT expression in BACHD mice partially improves motor and psychiatric-like behavioral deficits but does not improve neurodegeneration, whereas reduction of mHTT expression in both neuronal populations consistently ameliorates all behavioral deficits and selective brain atrophy in this HD model. Furthermore, whereas reduction of mHTT expression in cortical or striatal neurons partially ameliorates corticostriatal synaptic deficits, further restoration of striatal synaptic function can be achieved by reduction of mHTT expression in both neuronal cell types. Our study demonstrates distinct but interacting roles of cortical and striatal mHTT in HD pathogenesis and suggests that optimal HD therapeutics may require targeting mHTT in both cortical and striatal neurons.	[Wang, Nan; Gray, Michelle; Lu, Xiao-Hong; Cantle, Jeffrey P.; Greiner, Erin; Gu, Xiaofeng; Shirasaki, Dyna; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Wang, Nan; Gray, Michelle; Lu, Xiao-Hong; Cantle, Jeffrey P.; Holley, Sandra M.; Greiner, Erin; Gu, Xiaofeng; Shirasaki, Dyna; Cepeda, Carlos; Levine, Michael S.; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Holley, Sandra M.; Cepeda, Carlos; Levine, Michael S.] Univ Calif Los Angeles, David Geffen Sch Med, Intellectual & Dev Disabil Res Ctr, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Greiner, Erin; Shirasaki, Dyna] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Li, Yuqing] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Dong, Hongwei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yang, XW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	Li, Yuqing/AAR-9383-2021; Holley, Sandra/GLU-4437-2022; Lu, Xiao-Hong/AAI-9661-2020; Li, Yuqing/G-1596-2011	Li, Yuqing/0000-0003-1211-5529; Holley, Sandra/0000-0002-2643-4961; Li, Yuqing/0000-0003-1211-5529	US National Institutes of Health (NIH) NINDS [R01 NS049501, R01 NS074312]; Hereditary Disease Foundation; CHDI Foundation, Inc.; Neuroscience of Brain Disorders Award from The McKnight Foundation; David Well Fund; UCLA Brain Research Institute; NIH NINDS [R01 NS41574]; NIH [P30 HD004612]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049501, R01NS041574, R01NS074312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hereditary Disease Foundation; CHDI Foundation, Inc.; Neuroscience of Brain Disorders Award from The McKnight Foundation; David Well Fund; UCLA Brain Research Institute; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	X.W.Y. is supported by the US National Institutes of Health (NIH) NINDS grants R01 NS049501 and R01 NS074312, the Hereditary Disease Foundation, CHDI Foundation, Inc., Neuroscience of Brain Disorders Award from The McKnight Foundation and the David Well Fund to the Semel Institute at University of California, Los Angeles (UCLA). X.W.Y. also receives support as the Carol Moss Spivak Scholar chair in Neuroscience from UCLA Brain Research Institute. M.S.L. is supported by NIH NINDS grant R01 NS41574. M.S.L. and C.C. are also supported by NIH grant P30 HD004612.	Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; Cepeda C, 2003, J NEUROSCI, V23, P961; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Dunah AW, 2000, MOL BRAIN RES, V79, P77, DOI 10.1016/S0169-328X(00)00102-9; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Gorski JA, 2002, J NEUROSCI, V22, P6309; GOTO S, 1990, ACTA NEUROPATHOL, V80, P88, DOI 10.1007/BF00294227; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015	33	143	145	0	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					540	545		10.1038/nm.3514	http://dx.doi.org/10.1038/nm.3514			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24784230	Green Accepted			2022-12-25	WOS:000335710700026
J	Sakano, D; Shiraki, N; Kikawa, K; Yamazoe, T; Kataoka, M; Umeda, K; Araki, K; Mao, D; Matsumoto, S; Nakagata, N; Andersson, O; Stainier, D; Endo, F; Kume, K; Uesugi, M; Kume, S				Sakano, Daisuke; Shiraki, Nobuaki; Kikawa, Kazuhide; Yamazoe, Taiji; Kataoka, Masateru; Umeda, Kahoko; Araki, Kimi; Mao, Di; Matsumoto, Shirou; Nakagata, Naomi; Andersson, Olov; Stainier, Didier; Endo, Fumio; Kume, Kazuhiko; Uesugi, Motonari; Kume, Shoen			VMAT2 identified as a regulator of late-stage beta-cell differentiation	NATURE CHEMICAL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; MONOAMINE TRANSPORTER-2 VMAT2; INSULIN-SECRETION; ENDOCRINE-CELLS; GENE-EXPRESSION; PROTEIN-KINASE; 2 ISOFORMS; PANCREAS; MOUSE; DOPAMINE	Cell replacement therapy for diabetes mellitus requires cost-effective generation of high-quality, insulin-producing, pancreatic cells from pluripotent stem cells. Development of this technique has been hampered by a lack of knowledge of the molecular mechanisms underlying beta-cell differentiation. The present study identified reserpine and tetrabenazine (TBZ), both vesicular monoamine transporter 2 (VMAT2) inhibitors, as promoters of late-stage differentiation of Pdx1-positive pancreatic progenitor cells into Neurog3 (referred to henceforth as Ngn3)-positive endocrine precursors. VMAT2-controlled monoamines, such as dopamine, histamine and serotonin, negatively regulated beta-cell differentiation. Reserpine or TBZ acted additively with dibutyryl adenosine 3',5'-cyclic AMP, a cell-permeable cAMP analog, to potentiate differentiation of embryonic stem (ES) cells into beta cells that exhibited glucose-stimulated insulin secretion. When ES cell-derived p cells were transplanted into AKITA diabetic mice, the cells reversed hyperglycemia. Our protocol provides a basis for the understanding of beta-cell differentiation and its application to a cost-effective production of functional beta cells for cell therapy.	[Sakano, Daisuke; Shiraki, Nobuaki; Kikawa, Kazuhide; Yamazoe, Taiji; Kataoka, Masateru; Umeda, Kahoko; Kume, Kazuhiko; Kume, Shoen] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Stem Cell Biol, Kumamoto, Japan; [Kikawa, Kazuhide; Matsumoto, Shirou; Endo, Fumio] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto, Japan; [Araki, Kimi] Kumamoto Univ, Inst Resource Dev & Anal, Lab Dev Genet, Kumamoto, Japan; [Mao, Di; Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Mao, Di; Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci, WPI iCeMS, Kyoto, Japan; [Nakagata, Naomi] Kumamoto Univ, Ctr Anim Resources & Dev, Div Reprod Engn, Kumamoto, Japan; [Andersson, Olov; Stainier, Didier] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Andersson, Olov] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Stainier, Didier] Max Planck Inst Heart & Lung Res, Dept Dev Genet, Bad Nauheim, Germany; [Kume, Shoen] Kumamoto Univ, Hlth Life Sci Interdisciplinary & Global Oriented, Program Leading Grad Sch, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kyoto University; Kyoto University; Kumamoto University; Karolinska Institutet; University of California System; University of California San Francisco; Max Planck Society; Kumamoto University	Kume, S (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Stem Cell Biol, Kumamoto, Japan.	skume@kumamoto-u.ac.jp	Kume, Shoen/M-4356-2016; Uesugi, Motonari/AAM-9777-2020	Kume, Shoen/0000-0002-4292-205X; shiraki, nobuaki/0000-0001-6708-9976; Sakano, Daisuke/0000-0001-5305-5556; Kume, Kazuhiko/0000-0003-4232-1657; Nakagata, Naomi/0000-0002-5737-9993; Mao, Di/0000-0002-7950-7669; Stainier, Didier/0000-0002-0382-0026; Andersson, Olov/0000-0001-6715-781X	Funding Program for Next Generation World-Leading Researchers [LS099]; Japan Society for the Promotion of Science; Realization of Regenerative Medicine; Program for Leading Graduate Schools 'HIGO'; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21390280, 22790653]; Collaborative Research Program of Institute for Chemical Research, Kyoto University [2010-44]; World Premier International Research Center Initiative, MEXT, Japan; Grants-in-Aid for Scientific Research [26253059, 23310135] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Realization of Regenerative Medicine; Program for Leading Graduate Schools 'HIGO'; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Collaborative Research Program of Institute for Chemical Research, Kyoto University; World Premier International Research Center Initiative, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Gene Technology Center and Center for Animal Resources and Development at Kumamoto University for technical assistance. This work was supported by the Funding Program for Next Generation World-Leading Researchers (to S.K. (no. LS099) and M.U.); the Japan Society for the Promotion of Science, the Realization of Regenerative Medicine (to S.K. and MU.); the Program for Leading Graduate Schools 'HIGO' (awarded to S.K.); Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (no. 21390280 to S.K. and no. 22790653 to D. Sakano); and the Collaborative Research Program of Institute for Chemical Research, Kyoto University (grant no. 2010-44). The iCeMS is supported by World Premier International Research Center Initiative, MEXT, Japan.	Anlauf M, 2003, J HISTOCHEM CYTOCHEM, V51, P1027, DOI 10.1177/002215540305100806; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; ERICSON LE, 1977, DIABETOLOGIA, V13, P117, DOI 10.1007/BF00745138; Fulop AK, 2003, ENDOCRINOLOGY, V144, P4306, DOI 10.1210/en.2003-0222; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Harris PE, 2008, J MOL MED, V86, P5, DOI 10.1007/s00109-007-0242-x; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kelley GG, 2009, ISLETS, V1, P260, DOI 10.4161/isl.1.3.9645; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lo KWH, 2012, J TISSUE ENG REGEN M, V6, P40, DOI 10.1002/term.395; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; PEAKMAN MC, 1994, BRIT J PHARMACOL, V113, P1554, DOI 10.1111/j.1476-5381.1994.tb17173.x; Pothos EN, 2000, J NEUROSCI, V20, P7297; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Saisho Y, 2008, J MOL HISTOL, V39, P543, DOI 10.1007/s10735-008-9195-9; Schafer MKH, 2013, DIABETOLOGIA, V56, P1047, DOI 10.1007/s00125-013-2847-7; Seeman P, 2009, SYNAPSE, V63, P930, DOI 10.1002/syn.20663; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Simpson NR, 2006, NUCL MED BIOL, V33, P855, DOI 10.1016/j.nucmedbio.2006.07.002; Skoudy A, 2004, BIOCHEM J, V379, P749, DOI 10.1042/BJ20031784; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Xie T, 2010, J ENDOCRINOL, V206, P261, DOI 10.1677/JOE-10-0030; Yao J, 2004, TRAFFIC, V5, P1006, DOI 10.1111/j.1600-0854.2004.00240.x; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448; ZERN RT, 1980, DIABETOLOGIA, V18, P341	50	53	58	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2014	10	2					141	148		10.1038/nchembio.1410	http://dx.doi.org/10.1038/nchembio.1410			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	304MS	24316738				2022-12-25	WOS:000330751600013
J	Waterfall, JJ; Arons, E; Walker, RL; Pineda, M; Roth, L; Killian, JK; Abaan, OD; Davis, SR; Kreitman, RJ; Meltzer, PS				Waterfall, Joshua J.; Arons, Evgeny; Walker, Robert L.; Pineda, Marbin; Roth, Laura; Killian, J. Keith; Abaan, Ogan D.; Davis, Sean R.; Kreitman, Robert J.; Meltzer, Paul S.			High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias	NATURE GENETICS			English	Article							BRAF; MEK; INHIBITION	To understand the genetic mechanisms driving variant and IGHV4-34-expressing hairy-cell leukemias, we performed whole-exome sequencing of leukemia samples from ten affected individuals, including six with matched normal samples. We identified activating mutations in the MAP2K1 gene (encoding MEK1) in 5 of these 10 samples and in 10 of 21 samples in a validation set (overall frequency of 15/31), suggesting potential new strategies for treating individuals with these diseases.	[Waterfall, Joshua J.; Walker, Robert L.; Pineda, Marbin; Killian, J. Keith; Abaan, Ogan D.; Davis, Sean R.; Meltzer, Paul S.] NCI, Genet Branch, CCR, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Arons, Evgeny; Roth, Laura; Kreitman, Robert J.] NCI, Mol Biol Lab, CCR, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Meltzer, PS (corresponding author), NCI, Genet Branch, CCR, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA.	pmeltzer@mail.nih.gov	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Waterfall, Joshua/0000-0002-3762-5050; Walker, Robert/0000-0001-8235-4686	US NIH, NCI, CCR; Hairy Cell Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC011091] Funding Source: NIH RePORTER	US NIH, NCI, CCR; Hairy Cell Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the US NIH, NCI, CCR (P. S. M. and R.J.K.) and the Hairy Cell Leukemia Research Foundation (R.J.K.).	Arons E, 2011, LEUKEMIA LYMPHOMA, V52, P99, DOI 10.3109/10428194.2011.565841; Arons E, 2009, BLOOD, V114, P4687, DOI 10.1182/blood-2009-01-201731; Bromberg-White JL, 2012, BRIEF FUNCT GENOMICS, V11, P300, DOI 10.1093/bfgp/els022; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Hahn CN, 2012, NAT GENET, V44, P9, DOI 10.1038/ng.1045; Hockley SL, 2011, LEUKEMIA, V25, P1189, DOI 10.1038/leu.2011.47; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Laurini JA, 2012, AM J CLIN PATHOL, V138, P877, DOI 10.1309/AJCP5TWORA0TMXGL; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339	20	172	176	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					8	+		10.1038/ng.2828	http://dx.doi.org/10.1038/ng.2828			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24241536	Green Accepted			2022-12-25	WOS:000329113500005
J	Kaplan, N; Dekker, J				Kaplan, Noam; Dekker, Job			High-throughput genome scaffolding from in vivo DNA interaction frequency	NATURE BIOTECHNOLOGY			English	Article							MAMMALIAN GENOMES; ORGANIZATION; SEQUENCE; ASSEMBLIES; PRINCIPLES; LANDSCAPE; DOMAINS	Despite advances in DNA sequencing technology, assembly of complex genomes remains a major challenge, particularly for genomes sequenced using short reads, which yield highly fragmented assemblies(1-3). Here we show that genome-wide in vivo chromatin interaction frequency data, which are measurable with chromosome conformation capture-based experiments, can be used as genomic distance proxies to accurately position individual contigs without requiring any sequence overlap. We also use these data to construct approximate genome scaffolds de novo. Applying our approach to incomplete regions of the human genome, we predict the positions of 65 previously unplaced contigs, in agreement with alternative methods in 26/31 cases attempted in common. Our approach can theoretically bridge any gap size and should be applicable to any species for which global chromatin interaction data can be generated.	[Kaplan, Noam; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Kaplan, N (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	noam.kaplan2@gmail.com; job.dekker@umassmed.edu	Kaplan, Noam/K-4383-2019; Kaplan, Noam/A-3544-2011	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987	National Human Genome Research Institute [HG003143]; Long-Term Fellowship from the Human Frontier Science Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Long-Term Fellowship from the Human Frontier Science Program(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B.R. Lajoie for help with processing of the Hi-C data. We thank the members of the Dekker Lab and G. Fudenberg for helpful discussions. This study is supported by the National Human Genome Research Institute (HG003143 to J.D.). N.K. is supported by a Long-Term Fellowship from the Human Frontier Science Program.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Birney E, 2011, NAT METHODS, V8, P59, DOI 10.1038/nmeth0111-59; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Kaplan N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-196; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Su JH, 2020, CELL, V182, P1641, DOI 10.1016/j.cell.2020.07.032; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	31	110	122	5	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1143	+		10.1038/nbt.2768	http://dx.doi.org/10.1038/nbt.2768			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24270850	Green Accepted, Green Submitted			2022-12-25	WOS:000328251900029
J	Liu, PD; Gan, WJ; Inuzuka, H; Lazorchak, AS; Gao, DM; Arojo, O; Liu, D; Wan, LX; Zhai, B; Yu, YH; Yuan, M; Kim, BM; Shaik, S; Menon, S; Gygi, SP; Lee, TH; Asara, JM; Manning, BD; Blenis, J; Su, B; Wei, WY				Liu, Pengda; Gan, Wenjian; Inuzuka, Hiroyuki; Lazorchak, Adam S.; Gao, Daming; Arojo, Omotooke; Liu, Dou; Wan, Lixin; Zhai, Bo; Yu, Yonghao; Yuan, Min; Kim, Byeong Mo; Shaik, Shavali; Menon, Suchithra; Gygi, Steven P.; Lee, Tae Ho; Asara, John M.; Manning, Brendan D.; Blenis, John; Su, Bing; Wei, Wenyi			Sinl phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis	NATURE CELL BIOLOGY			English	Article							PHOSPHOPROTEOME REVEALS; CELL-SURVIVAL; RICTOR; GROWTH; ACTIVATION; SUBSTRATE; CANCER; RAPTOR; AKT/PKB; PATHWAY	The mechanistic target of rapamycin (mTOR) functions as a critical regulator of cellular growth and metabolism by forming multi-component, yet functionally distinct complexes mTORC1 and mTORC2. Although mTORC2 has been implicated in mTORC1 activation, little is known about how mTORC2 is regulated. Here we report that phosphorylation of Sinl at Thr 86 and Thr 398 suppresses mTORC2 kinase activity by dissociating Sinl from mTORC2. Importantly, Sinl phosphorylation, triggered by S6K or Akt, in a cellular context-dependent manner, inhibits not only insulin- or IGF-1-mediated, but also PDGF- or EGF-induced Akt phosphorylation by mTORC2, demonstrating a negative regulation of mTORC2 independent of IRS-1 and Grb10. Finally, a cancer-patient-derived Sinl-R81T mutation impairs Sinl phosphorylation, leading to hyper-activation of mTORC2 by bypassing this negative regulation. Together, our results reveal a Sinl-phosphorylation-dependent mTORC2 regulation, providing a potential molecular mechanism by which mutations in the mTORC1-56K Sinl signalling axis might cause aberrant hyper-activation of the mTORC2 Akt pathway, which facilitates tumorigenesis.	[Liu, Pengda; Gan, Wenjian; Inuzuka, Hiroyuki; Gao, Daming; Wan, Lixin; Shaik, Shavali; Wei, Wenyi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Lazorchak, Adam S.; Arojo, Omotooke; Liu, Dou; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lazorchak, Adam S.; Arojo, Omotooke; Liu, Dou; Su, Bing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Zhai, Bo; Yu, Yonghao; Gygi, Steven P.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yu, Yonghao] Univ Texas SW Med Ctr Dallas, Dept Chem, Dallas, TX 75390 USA; [Yuan, Min; Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Kim, Byeong Mo; Lee, Tae Ho] Beth Israel Deaconess Med Ctr, Dept Med, Div Gerontol, Boston, MA 02215 USA; [Menon, Suchithra; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University; Yale University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Wei, WY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Manning, Brendan/ABD-6528-2021; Lee, Tae Ho/AAT-1721-2020	Manning, Brendan/0000-0003-3895-5956; Gao, Daming/0000-0003-4374-1055; Gan, Wenjian/0000-0001-7599-5020	CPRIT Scholar (CPRIT R1103) in Cancer Research; Virginia Murchison Linthicum Scholar in Medical Research; NIH [GM089763, GM094777, CA177910, AI063348, PR093728];  [5T32HL007893]; NATIONAL CANCER INSTITUTE [R01CA177910, R01CA122617] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051405, R01GM094777, R01GM089763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041218] Funding Source: NIH RePORTER	CPRIT Scholar (CPRIT R1103) in Cancer Research; Virginia Murchison Linthicum Scholar in Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Toker, J. Guo, K. Xu, A. W. Lau and A. Tron for critical reading of the manuscript, S. J. Elledge (Harvard Medial School, USA), S. Ishii (University of Tsukuba, Japan), W. Hahn (Dana-Farber Cancer Institute, Harvard Medical School, USA), D. Sarbassov (UT M. D. Anderson Cancer Center, USA) K. Guan (UC San Diego, USA) and J. Dempsey (Harvard Medical School, USA) for providing valuable reagents, B. Spiegelman (Dana-Farber Cancer Institute, Harvard Medical School, USA) for providing 3T3-L1 adipocyte cells, L. Cantley and A. Toker for helpful suggestions, and members of the W.W., J.B. and B.S. laboratories for useful discussions. W.W. is an ACS research scholar and a LLS research scholar. Y. Yu is a CPRIT Scholar (CPRIT R1103) in Cancer Research and a Virginia Murchison Linthicum Scholar in Medical Research. P.L. is a NASA T32 trainee and supported by 5T32HL007893. This work was supported in part by NIH grants (W.W., GM089763, GM094777 and CA177910; and B.S., AI063348 and PR093728).	Alayev A, 2013, J CELL PHYSIOL, V228, P1658, DOI 10.1002/jcp.24351; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ikeda F, 2013, MOL BIOL CELL, V24, P676, DOI 10.1091/mbc.E12-12-0877; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, MOL CELL, V46, P715, DOI 10.1016/j.molcel.2012.06.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	70	185	190	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1340	U182		10.1038/ncb2860	http://dx.doi.org/10.1038/ncb2860			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24161930	Green Accepted, Green Submitted			2022-12-25	WOS:000326680700010
J	Porlan, E; Marti-Prado, B; Morante-Redolat, JM; Consiglio, A; Delgado, AC; Kypta, R; Lopez-Otin, C; Kirstein, M; Farinas, I				Porlan, Eva; Marti-Prado, Beatriz; Manuel Morante-Redolat, Jose; Consiglio, Antonella; Delgado, Ana C.; Kypta, Robert; Lopez-Otin, Carlos; Kirstein, Martina; Farinas, Isabel			MT5-MMP regulates adult neural stem cell functional quiescence through the cleavage of N-cadherin	NATURE CELL BIOLOGY			English	Article							TYPE-5 MATRIX-METALLOPROTEINASE; SUBVENTRICULAR ZONE; PRECURSOR CELLS; VASCULAR NICHE; ADAM10; IDENTIFICATION; EXPRESSION; ADHESION; PROLIFERATION; LOCALIZATION	The identification of mechanisms that maintain stem cell niche architecture and homeostasis is fundamental to our understanding of tissue renewal and repair. Cell adhesion is a well-characterized mechanism for developmental morphogenetic processes, but its contribution to the dynamic regulation of adult mammalian stem cell niches is still poorly defined. We show that N-cadherin-mediated anchorage of neural stem cells (NSCs) to ependymocytes in the adult murine subependymal zone modulates their quiescence. We further identify MT5-MMP as a membrane-type metalloproteinase responsible for the shedding of the N-cadherin ectodomain in this niche. MT5-MMP is co-expressed with N-cadherin in adult NSCs and ependymocytes and, whereas MT5-MMP-mediated cleavage of N-cadherin is dispensable for the regulation of NSC generation and identity, it is required for proper activation of NSCs under physiological and regenerative conditions. Our results indicate that the proliferative status of stem cells can be dynamically modulated by regulated cleavage of cell adhesion molecules.	[Porlan, Eva; Marti-Prado, Beatriz; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Kirstein, Martina; Farinas, Isabel] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28049, Spain; [Porlan, Eva; Marti-Prado, Beatriz; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Kirstein, Martina; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Valencia, Spain; [Porlan, Eva] Spanish Natl Canc Res Ctr CNIO, Cell Div, Madrid 28029, Spain; [Porlan, Eva] Spanish Natl Canc Res Ctr CNIO, Canc Grp, Madrid 28029, Spain; [Consiglio, Antonella] IBUB, Barcelona 08028, Spain; [Consiglio, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Consiglio, Antonella] Natl Inst Neurosci, I-25123 Brescia, Italy; [Kypta, Robert] Cic BioGUNE, Derio 48160, Spain; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	CIBERNED; University of Valencia; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Barcelona; University of Brescia; CIC bioGUNE; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Farinas, I (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28049, Spain.	isabel.farinas@uv.es	porlan, Eva/AAE-6561-2022; consiglio, antonella/G-1815-2016; consiglio, antonella/AAA-5864-2019; Kirstein, Martina/L-9247-2014; López-Otín, Carlos/AAB-2106-2020; Kypta, Robert/F-7699-2011; Morante-Redolat, Jose Manuel/L-9397-2014; Farinas, Isabel/L-7118-2014	porlan, Eva/0000-0003-0934-9711; consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Kirstein, Martina/0000-0001-8716-2309; López-Otín, Carlos/0000-0001-6964-1904; Kypta, Robert/0000-0002-2389-310X; Morante-Redolat, Jose Manuel/0000-0003-0610-1665; Farinas, Isabel/0000-0003-2903-4960	Servicios Centrales de Soporte a la Investigacion Experimental (UVEG); Ministerio de Ciencia e Innovacion [SAF2011-23331, SAF2011-30494, RyC-2008-02772, BFU2010-21823, SAF2011-23089]; Botin Foundation; Ministerio de Sanidad y Consumo (CIBERNED); Ministerio de Sanidad y Consumo (RETIC Tercel); Generalitat Valenciana (Programa Prometeo); Generalitat Valenciana (ISIC); Generalitat Valenciana (ACOMP)	Servicios Centrales de Soporte a la Investigacion Experimental (UVEG); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Botin Foundation; Ministerio de Sanidad y Consumo (CIBERNED); Ministerio de Sanidad y Consumo (RETIC Tercel); Generalitat Valenciana (Programa Prometeo)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ISIC)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ACOMP)(Center for Forestry Research & Experimentation (CIEF))	We thank T. Valdes for the initial observation of a neurogenic defect and A. Rodriguez-Folgueras and S. R. Ferron for critical reading of the manuscript. We also would like to thank M. Malumbres and T. Iglesias for scientific support and comments, A. Chenn (Northwestern University, Chicago, IL, USA) for generously providing the dominant negative Cdh construct and M. J. Palop for help with the mouse colonies, and to acknowledge the support of the Servicios Centrales de Soporte a la Investigacion Experimental (UVEG). This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2011-23331 to I. F., SAF2011-30494 to R. K., RyC-2008-02772 and BFU2010-21823 to A. C. and SAF2011-23089 to C.L-O.), from Botin Foundation to C.L-O. and I. F. and from Ministerio de Sanidad y Consumo (CIBERNED and RETIC Tercel) and Generalitat Valenciana (Programa Prometeo, ISIC, and ACOMP) to I.F.	Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Andreyeva A, 2012, BRAIN, V135, P2140, DOI 10.1093/brain/aws120; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Esteve P, 2011, NAT NEUROSCI, V14, P562, DOI 10.1038/nn.2794; Falcao AM, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00034; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Folgueras AR, 2009, P NATL ACAD SCI USA, V106, P16451, DOI 10.1073/pnas.0908507106; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Gonzalez-Reyes A, 2003, J CELL SCI, V116, P949, DOI 10.1242/jcs.00310; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Jaworski DM, 2000, BRAIN RES, V860, P174, DOI 10.1016/S0006-8993(00)02035-7; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li PL, 2010, CELL STEM CELL, V6, P199, DOI 10.1016/j.stem.2010.02.007; Llano E, 1999, CANCER RES, V59, P2570; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nieman MT, 1999, J CELL SCI, V112, P1621; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yagita Y, 2009, J NEUROSCI RES, V87, P3331, DOI 10.1002/jnr.22044; Zhang L, 2011, EUR J NEUROSCI, V33, P1, DOI 10.1111/j.1460-9568.2010.7483.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	51	64	67	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					629	+		10.1038/ncb2993	http://dx.doi.org/10.1038/ncb2993			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24952463				2022-12-25	WOS:000338187900004
J	Wallmeier, J; Al-Mutairi, DA; Chen, CT; Loges, NT; Pennekamp, P; Menchen, T; Ma, L; Shamseldin, HE; Olbrich, H; Dougherty, GW; Werner, C; Alsabah, BH; Kohler, G; Jaspers, M; Boon, M; Griese, M; Schmitt-Grohe, S; Zimmermann, T; Koerner-Rettberg, C; Horak, E; Kintner, C; Alkuraya, FS; Omran, H				Wallmeier, Julia; Al-Mutairi, Dalal A.; Chen, Chun-Ting; Loges, Niki Tomas; Pennekamp, Petra; Menchen, Tabea; Ma, Lina; Shamseldin, Hanan E.; Olbrich, Heike; Dougherty, Gerard W.; Werner, Claudius; Alsabah, Basel H.; Koehler, Gabriele; Jaspers, Martine; Boon, Mieke; Griese, Matthias; Schmitt-Grohe, Sabina; Zimmermann, Theodor; Koerner-Rettberg, Cordula; Horak, Elisabeth; Kintner, Chris; Alkuraya, Fowzan S.; Omran, Heymut			Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile cilia	NATURE GENETICS			English	Article							CENTRIOLE BIOGENESIS; CILIOGENESIS; MULTICILIOGENESIS; RANDOMIZATION; ASYMMETRY; PROTEIN; XENOPUS; STEPS	Using a whole-exome sequencing strategy, we identified recessive CCNO (encoding cyclin O) mutations in 16 individuals suffering from chronic destructive lung disease due to insufficient airway clearance. Respiratory epithelial cells showed a marked reduction in the number of multiple motile cilia (MMC) covering the cell surface. The few residual cilia that correctly expressed axonemal motor proteins were motile and did not exhibit obvious beating defects. Careful subcellular analyses as well as in vitro ciliogenesis experiments in CCNO-mutant cells showed defective mother centriole generation and placement. Morpholino-based knockdown of the Xenopus ortholog of CCNO also resulted in reduced MMC and centriole numbers in embryonic epidermal cells. CCNO is expressed in the apical cytoplasm of multiciliated cells and acts downstream of multicilin, which governs the generation of multiciliated, cells. To our knowledge, CCNO is the first reported gene linking an inherited human disease to reduced MMC generation due to a defect in centriole amplification and migration.	[Wallmeier, Julia; Loges, Niki Tomas; Pennekamp, Petra; Menchen, Tabea; Olbrich, Heike; Dougherty, Gerard W.; Werner, Claudius; Omran, Heymut] Univ Hosp Muenster, Dept Pediat, Munster, Germany; [Al-Mutairi, Dalal A.] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Pathol, Safat, Kuwait; [Chen, Chun-Ting; Ma, Lina; Kintner, Chris] Salk Inst Biol Studies, Mol Neurobiol Lab, San Diego, CA 92138 USA; [Shamseldin, Hanan E.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alsabah, Basel H.] Zain Hosp Ear Nose & Throat, Kuwait, Kuwait; [Koehler, Gabriele] Univ Hosp Muenster, Dept Pathol, Munster, Germany; [Jaspers, Martine] Univ Hosp Leuven, Dept Otorhinolaryngol, Louvain, Belgium; [Boon, Mieke] Univ Hosp Leuven, Dept Pediat, Louvain, Belgium; [Griese, Matthias] Univ Munich, Hauner Childrens Hosp, Dept Pediat Pulmonol, Munich, Germany; [Schmitt-Grohe, Sabina] Univ Hosp Bonn, Dept Pediat, Bonn, Germany; [Zimmermann, Theodor] Univ Hosp, Dept Pediat, Erlangen, Germany; [Koerner-Rettberg, Cordula] Ruhr Univ Bochum, St Josef Hosp, Dept Pediat & Adolescent Med, Bochum, Germany; [Horak, Elisabeth] Med Univ Innsbruck, Dept Pediat & Adolescents, Div Cardiol & Pulmonol, A-6020 Innsbruck, Austria; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia	University of Munster; Kuwait University; Salk Institute; King Faisal Specialist Hospital & Research Center; University of Munster; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Munich; University of Bonn; University of Erlangen Nuremberg; Ruhr University Bochum; Medical University of Innsbruck; Alfaisal University	Omran, H (corresponding author), Univ Hosp Muenster, Dept Pediat, Munster, Germany.	heymut.omran@ukmuenster.de	Noethe-Menchen, Tabea/AAW-1667-2021; Koerner-Rettberg, Cordula/AGI-3532-2022; Boon, Mieke/AAS-8943-2020	Noethe-Menchen, Tabea/0000-0002-0571-6767; Koerner-Rettberg, Cordula/0000-0003-0946-1009; Boon, Mieke/0000-0001-8138-5405; Omran, Heymut/0000-0003-0282-6765; Schmitt-Grohe, Sabina/0000-0002-8280-5309; Wallmeier, Julia/0000-0002-3958-9065	Dubai Harvard Foundation for Medical Research Collaborative Research Grant; Generallacility Grant from the Health Science Center, Kuwait University [SRUL02/13]; Deutsche Forschungsgemeinschaft (DFG) [Om 6/4]; Interdisziplinaeres Zentrum fiir Kfinische Forschung (IZKF) [Om2/009/12]; European Community's Seventh Framework Programme FP7/2009 [241955]; SYSCILIA; BESTCILIA [305404];  [GM096021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096021] Funding Source: NIH RePORTER	Dubai Harvard Foundation for Medical Research Collaborative Research Grant; Generallacility Grant from the Health Science Center, Kuwait University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisziplinaeres Zentrum fiir Kfinische Forschung (IZKF); European Community's Seventh Framework Programme FP7/2009; SYSCILIA; BESTCILIA; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the affected individuals and their families for participating in this study and the German patient support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie. We thank C. Westermann from the Pathology Department of the University of Miinster and K. Sutter and C. Kopp from the Myological Laboratory of the University of Freiburg for electron microscopy assistance. We thank L. Overkamp, M. Herting, S. Helms, C. Vorspohl, B. Fukas and F.-J. Seesing for their technical assistance. We thank M. Joens and S. Dunn in the Waitt Advanced Biophotonics Center Core at the Salk Institute for assistance with electron microscopy. We thank the Faculty of Medicine, Health Sciences Center, Kuwait University and Ministry of Health in Kuwait for their assistance. This work was funded by Dubai Harvard Foundation for Medical Research Collaborative Research Grant (F.S.A.), Generallacility Grant SRUL02/13 from the Health Science Center, Kuwait University, the Deutsche Forschungsgemeinschaft (DFG Om 6/4), the Interdisziplinaeres Zentrum fiir Kfinische Forschung (IZKF Om2/009/12) Muenster (H. Omran), the European Community's Seventh Framework Programme FP7/2009 under grant agreement 241955, SYSCILIA (H. Omran) and BESTCILIA under grant agreement 305404 (H. Omran), the Schroeder Stiftung (H. Omran) and Kindness for Kids (H. Omran). Work reported here was supported by a grant, GM096021, to C.K.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; DEBOECK K, 1992, PEDIATR PULM, V13, P259, DOI 10.1002/ppul.1950130416; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; SOROKIN SP, 1968, J CELL SCI, V3, P207; Steere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041077; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tan FE, 2013, DEVELOPMENT, V140, P4277, DOI 10.1242/dev.094102; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Werner ME, 2012, GENESIS, V50, P176, DOI 10.1002/dvg.20824; Zhao HJ, 2013, NAT CELL BIOL, V15, P1434, DOI 10.1038/ncb2880	19	158	166	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					646	651		10.1038/ng.2961	http://dx.doi.org/10.1038/ng.2961			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747639				2022-12-25	WOS:000336870700025
J	Nord, KH; Lilljebjorn, H; Vezzi, F; Nilsson, J; Magnusson, L; Tayebwa, J; de Jong, D; Bovee, JVMG; Hogendoorn, PCW; Szuhai, K				Nord, Karolin H.; Lilljebjorn, Henrik; Vezzi, Francesco; Nilsson, Jenny; Magnusson, Linda; Tayebwa, Johnbosco; de Jong, Danielle; Bovee, Judith V. M. G.; Hogendoorn, Pancras C. W.; Szuhai, Karoly			GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma	NATURE GENETICS			English	Article							GLUTAMATE RECEPTORS; CHONDRAL MINERALIZATION; EXPRESSION; MELANOMA; CELLS; BONE; SURVIVAL; RELEASE	Glutamate receptors are well-known actors in the central and peripheral nervous systems, and altered glutamate signaling is implicated in several neurological and psychiatric disorders. It is increasingly recognized that such receptors may also have a role in tumor growth. Here we provide direct evidence of aberrant glutamate signaling in the development of a locally aggressive bone tumor, chondromyxoid fibroma (CMF). We subjected a series of CMFs to whole-genome mate-pair sequencing and RNA sequencing and found that the glutamate receptor gene GRM1 recombines with several partner genes through promoter swapping and gene fusion events. The GRM1 coding region remains intact, and 18 of 20 CMFs (90%) showed a more than 100-fold and up to 1,400-fold increase in GRM1 expression levels compared to control tissues. Our findings unequivocally demonstrate that direct targeting of GRM1 is a necessary and highly specific driver event for CMF development.	[Nord, Karolin H.; Lilljebjorn, Henrik; Nilsson, Jenny; Magnusson, Linda; Tayebwa, Johnbosco] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [Vezzi, Francesco] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden; [de Jong, Danielle; Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Bovee, Judith V. M. G.; Hogendoorn, Pancras C. W.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Lund University; Skane University Hospital; Stockholm University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nord, KH (corresponding author), Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden.	karolin.hansen_nord@med.lu.se	Szuhai, Karoly/A-1100-2008; Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015; Tayebwa, Johnbosco/AAC-8708-2019	Szuhai, Karoly/0000-0002-1228-4245; Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Lilljebjorn, Henrik/0000-0001-8703-1173; Tayebwa, Johnbosco/0000-0002-2355-8475; de Jong, Danielle/0000-0003-4003-5593; Bovee, Judith/0000-0003-1155-0481; Hansen Nord, Karolin/0000-0002-2397-2254	Magnus Bergvall Foundation; Royal Physiographic Society (Lund, Sweden); Swedish Childhood Cancer Foundation	Magnus Bergvall Foundation; Royal Physiographic Society (Lund, Sweden); Swedish Childhood Cancer Foundation(European Commission)	We are grateful for the expert technical assistance of M. Rissler. We acknowledge help with the microarray analyses from the Swegene Centre for Integrative Biology at Lund University, support from the Science for Life Laboratory, the National Genomics Infrastructure (NGI), Sweden, and the Knut and Alice Wallenberg Foundation, and UPPMAX for providing assistance with massively parallel DNA sequencing and computational infrastructure. This work was supported by the Magnus Bergvall Foundation, the Royal Physiographic Society (Lund, Sweden) and the Swedish Childhood Cancer Foundation.	Chang HJ, 2005, CLIN CANCER RES, V11, P3288, DOI 10.1158/1078-0432.CCR-04-1912; Chenu C, 1998, BONE, V22, P295, DOI 10.1016/S8756-3282(97)00295-0; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Ciceroni C, 2013, CELL DEATH DIFFER, V20, P396, DOI 10.1038/cdd.2012.150; Genever PG, 2001, FASEB J, V15, P1586, DOI 10.1096/fj.00-0594fje; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Martino JJ, 2013, ONCOGENE, V32, P4366, DOI 10.1038/onc.2012.471; Mehta MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069851; Mertens F, 2011, INT J CANCER, V128, P487, DOI 10.1002/ijc.25353; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Romeo S, 2005, J PATHOL, V206, P135, DOI 10.1002/path.1782; Romeo S, 2013, WHO CLASSIFICATION T, P255; Romeo S, 2010, AM J PATHOL, V177, P1365, DOI 10.2353/ajpath.2010.091277; Savage SA, 2013, NAT GENET, V45, P799, DOI 10.1038/ng.2645; Scott DW, 2012, BLOOD, V119, P4949, DOI 10.1182/blood-2012-02-414441; Wang LY, 2006, J BIOL CHEM, V281, P24553, DOI 10.1074/jbc.M600939200; Wang LY, 2005, BRIT J PHARMACOL, V146, P732, DOI 10.1038/sj.bjp.0706358; Wang LY, 2005, BIOL PHARM BULL, V28, P990, DOI 10.1248/bpb.28.990; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Yasuda T, 2009, MODERN PATHOL, V22, P1499, DOI 10.1038/modpathol.2009.101	21	34	39	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					474	477		10.1038/ng.2927	http://dx.doi.org/10.1038/ng.2927			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24658000	Green Published			2022-12-25	WOS:000335422900014
J	Boley, N; Stoiber, MH; Booth, BW; Wan, KH; Hoskins, RA; Bickel, PJ; Celniker, SE; Brown, JB				Boley, Nathan; Stoiber, Marcus H.; Booth, Benjamin W.; Wan, Kenneth H.; Hoskins, Roger A.; Bickel, Peter J.; Celniker, Susan E.; Brown, James B.			Genome-guided transcript assembly by integrative analysis of RNA sequence data	NATURE BIOTECHNOLOGY			English	Article							SEQ DATA; MESSENGER-RNA; EXPRESSION; QUANTIFICATION; NORMALIZATION; LOCALIZATION; PROMOTER; REVEALS	The identification of full length transcripts entirely from short-read RNA sequencing data (RNA-seq) remains a challenge in the annotation of genomes. Here we describe an automated pipeline for genome annotation that integrates RNA-seq and gene-boundary data sets, which we call Generalized RNA Integration Tool, or GRIT. Applying GRIT to Drosophila melanogaster short-read RNA-seq, cap analysis of gene expression (CAGE) and poly(A)-site-seq data collected for the modENCODE project, we recovered the vast majority of previously annotated transcripts and doubled the total number of transcripts cataloged. We found that 20% of protein coding genes encode multiple protein-localization signals and that, in 20-d-old adult fly heads, genes with multiple polyadenylation sites are more common than genes with alternative splicing or alternative promoters. GRIT demonstrates 30% higher precision and recall than the most widely used transcript assembly tools. GRIT will facilitate the automated generation of high-quality genome annotations without the need for extensive manual annotation.	[Boley, Nathan; Stoiber, Marcus H.] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Booth, Benjamin W.; Wan, Kenneth H.; Hoskins, Roger A.; Celniker, Susan E.; Brown, James B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Bickel, Peter J.; Celniker, Susan E.; Brown, James B.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Boley, N (corresponding author), Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA.	celniker@fruitfly.org	Brown, James/H-2971-2015		National Human Genome Research Institute modENCODE Project [R21 HG006187, K99 HG006698, U01 HG004271, DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004271, R21HG006187, U01HG007031, K99HG006698] Funding Source: NIH RePORTER	National Human Genome Research Institute modENCODE Project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the members of the modENCODE transcription consortium for generating the data and C. Cotterman, E. Frise, B. Graveley, H. Huang and J. Li for discussions and S. Kadri for producing the Scripture annotation. This work was funded by a contract from the National Human Genome Research Institute modENCODE Project, contracts R21 HG006187 to P. J. B.; K99 HG006698 to J.B.B.; and U01 HG004271 to S.E.C. under Department of Energy contract no. DE-AC02-05CH11231.	Bickel P. J., 2001, MATH STAT, V1, P394; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Celotto AM, 2001, GENETICS, V159, P599; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hilgers V, 2011, P NATL ACAD SCI USA, V108, P15864, DOI 10.1073/pnas.1112672108; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; JENKINS C, 1993, MOL CELL ENDOCRINOL, V97, pR1, DOI 10.1016/0303-7207(93)90227-B; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Lawless C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LIFTON RP, 1977, COLD SPRING HARB SYM, V42, P1047, DOI 10.1101/SQB.1978.042.01.105; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Pilanci M., 2012, ADV NEURAL INFORM PR, V25, P2429; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	41	38	39	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					341	U198		10.1038/nbt.2850	http://dx.doi.org/10.1038/nbt.2850			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633242	Green Accepted, Bronze			2022-12-25	WOS:000334340800018
J	Dussiot, M; Maciel, TT; Fricot, A; Chartier, C; Negre, O; Veiga, J; Grapton, D; Paubelle, E; Payen, E; Beuzard, Y; Leboulch, P; Ribeil, JA; Arlet, JB; Cote, F; Courtois, G; Ginzburg, YZ; Daniel, TO; Chopra, R; Sung, V; Hermine, O; Moura, IC				Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Negre, Olivier; Veiga, Joel; Grapton, Damien; Paubelle, Etienne; Payen, Emmanuel; Beuzard, Yves; Leboulch, Philippe; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Ginzburg, Yelena Z.; Daniel, Thomas O.; Chopra, Rajesh; Sung, Victoria; Hermine, Olivier; Moura, Ivan C.			An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia	NATURE MEDICINE			English	Article							ALPHA-GLOBIN; OXIDATIVE STRESS; PROTEIN; PROLIFERATION; DIFFERENTIATION; PATHOPHYSIOLOGY; PROGENITORS; EXPANSION; ACE-011; MODEL	The pathophysiology of ineffective erythropoiesis in beta-thalassemia is poorly understood. We report that RAP-011, an activin receptor IIA (ActRIIA) ligand trap, improved ineffective erythropoiesis, corrected anemia and limited iron overload in a mouse model of beta-thalassemia intermedia. Expression of growth differentiation factor 11 (GDF11), an ActRIIA ligand, was increased in splenic erythroblasts from thalassemic mice and in erythroblasts and sera from subjects with beta-thalassemia. Inactivation of GDF11 decreased oxidative stress and the amount of alpha-globin membrane precipitates, resulting in increased terminal erythroid differentiation. Abnormal GDF11 expression was dependent on reactive oxygen species, suggesting the existence of an autocrine amplification loop in beta-thalassemia. GDF11 inactivation also corrected the abnormal ratio of immature/mature erythroblasts by inducing apoptosis of immature erythroblasts through the Fas-Fas ligand pathway. Taken together, these observations suggest that ActRIIA ligand traps may have therapeutic relevance in beta-thalassemia by suppressing the deleterious effects of GDF11, a cytokine which blocks terminal erythroid maturation through an autocrine amplification loop involving oxidative stress and alpha-globin precipitation.	[Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] INSERM, UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] CNRS, ERL 8254, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Veiga, Joel; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] Lab Excellence GR Ex, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Moura, Ivan C.] INSERM, U1149, Ctr Res Inflammat, Paris, France; [Negre, Olivier; Payen, Emmanuel; Beuzard, Yves; Leboulch, Philippe] CEA, Inst Malad Emergentes & Therapies Innovantes iMET, Fontenay Aux Roses, France; [Negre, Olivier; Payen, Emmanuel; Beuzard, Yves; Leboulch, Philippe] Univ Paris 11, CEA, INSERM, UMR 962, Fontenay Aux Roses, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, Dept Biotherapie, Paris, France; [Ginzburg, Yelena Z.] New York Blood Ctr, Lindsley F Kimball Res Inst, Erythropoiesis Lab, New York, NY 10021 USA; [Daniel, Thomas O.; Chopra, Rajesh] Celgene, Summit, NJ USA; [Sung, Victoria] Celgene, San Francisco, CA USA; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; New York Blood Center; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Moura, IC (corresponding author), INSERM, UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France.	olivier.hermine@nck.aphp.fr; ivan.moura@inserm.fr	Maciel, Thiago Trovati/AAF-5462-2021; Arlet, Jean Benoit/D-3124-2016; Ribeil, Jean-Antoine/AAK-7979-2020; Moura, Ivan C/A-9510-2013; Ribeil, Jean-Antoine/F-7896-2017; Maciel, Thiago/A-4475-2013; Payen, Emmanuel/S-5357-2018; Hermine, Olivier/Q-7072-2018; NEGRE, Olivier/AAA-2027-2022; Cruz Moura, Ivan/A-9510-2013	Maciel, Thiago Trovati/0000-0002-9347-981X; Ribeil, Jean-Antoine/0000-0002-4549-4783; Moura, Ivan C/0000-0002-2977-0354; Ribeil, Jean-Antoine/0000-0002-5733-9123; Maciel, Thiago/0000-0002-9347-981X; Payen, Emmanuel/0000-0002-1329-2327; Cruz Moura, Ivan/0000-0002-8418-2803; courtois, genevieve/0000-0001-6370-5575; Hermine, Olivier/0000-0003-2574-3874	Agence Nationale de la Recherche [ANR-10-JCJC-1108, ANR-12-BSV1-0039, ANR-11-LABX-0051, ANR-10-BLAN-1109]; Assistance Publique Hopitaux de Paris-CNRS Contrats Hospitaliers de Recherche Translationnelle; Institut National du Cancer; Canceropole Ile-de-France; Fondation pour la Recherche Medicale; Fondation de France; Association Laurette Fugain; Association pour la Recherche sur le Cancer; French National Research Agency [ANR-10-IAHU-01, ANR-11-IDEX-0005-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105682] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Assistance Publique Hopitaux de Paris-CNRS Contrats Hospitaliers de Recherche Translationnelle; Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Association Laurette Fugain; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French National Research Agency(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Agence Nationale de la Recherche (grants ANR-10-JCJC-1108, ANR-12-BSV1-0039, ANR-11-LABX-0051 and ANR-10-BLAN-1109), Assistance Publique Hopitaux de Paris-CNRS Contrats Hospitaliers de Recherche Translationnelle, Institut National du Cancer, Canceropole Ile-de-France, Fondation pour la Recherche Medicale, Fondation de France, Association Laurette Fugain and Association pour la Recherche sur le Cancer. The Imagine Institute and the Laboratory of Excellence GR-Ex are funded by the program 'Investissements d'avenir' of the French National Research Agency (ANR-10-IAHU-01 and ANR-11-IDEX-0005-02, respectively). We thank S. Nelson and J. Bex for technical assistance, C. Brouzes for cytological advice, M.G. Traore and N. Goudin for assistance with confocal microscopy and O. Thibaudeau, F. Watier and N. Gadessaud for assistance in histological sample processing. 34-3C IgG2a antibody was provided by S. Izui (University Medical Center, University of Geneva).	Bader-Meunier B, 2000, BRIT J HAEMATOL, V108, P300; BROXMEYER HE, 1988, P NATL ACAD SCI USA, V85, P9052, DOI 10.1073/pnas.85.23.9052; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Coulon S, 2011, NAT MED, V17, P1456, DOI 10.1038/nm.2462; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Hegde S, 2007, MAMM GENOME, V18, P852, DOI 10.1007/s00335-007-9074-9; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Iancu-Rubin C, 2013, EXP HEMATOL, V41, P155, DOI 10.1016/j.exphem.2012.12.002; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; MIZUGUCHI T, 1993, BLOOD, V81, P2891; NAKAO K, 1991, EXP HEMATOL, V19, P1090; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Ramos P, 2010, ANN NY ACAD SCI, V1202, P24, DOI 10.1111/j.1749-6632.2010.05596.x; ReemKalma Y, 1995, P NATL ACAD SCI USA, V92, P12141, DOI 10.1073/pnas.92.26.12141; Ribeil JA, 2013, SCI WORLD J, DOI 10.1155/2013/394295; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; Shiozaki M, 1998, BIOCHEM BIOPH RES CO, V242, P631, DOI 10.1006/bbrc.1997.8020; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; SORENSEN S, 1990, BLOOD, V75, P1333; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Utsugisawa T, 2006, STEM CELLS, V24, P1128, DOI 10.1634/stemcells.2005-0263; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4	42	211	239	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					398	+		10.1038/nm.3468	http://dx.doi.org/10.1038/nm.3468			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658077	Green Accepted			2022-12-25	WOS:000334361500020
J	Kozlitina, J; Smagris, E; Stender, S; Nordestgaard, BG; Zhou, HH; Tybjaerg-Hansen, A; Vogt, TF; Hobbs, HH; Cohen, JC				Kozlitina, Julia; Smagris, Eriks; Stender, Stefan; Nordestgaard, Borge G.; Zhou, Heather H.; Tybjaerg-Hansen, Anne; Vogt, Thomas F.; Hobbs, Helen H.; Cohen, Jonathan C.			Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENETIC-VARIATION; LOCI; POPULATION; PLASMA; STEATOSIS; ENZYMES; PNPLA3; HEALTH	Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease. To elucidate the molecular basis of NAFLD, we performed an exome-wide association study of liver fat content. Three variants were associated with higher liver fat levels at the exome-wide significance level of 3.6 Chi 10(-7): two in PNPLA3, an established locus for NAFLD, and one (encoding p. Glu167Lys) in TM6SF2, a gene of unknown function. The TM6SF2 variant encoding p. Glu167Lys was also associated with higher circulating levels of alanine transaminase, a marker of liver injury, and with lower levels of low-density lipoprotein-cholesterol (LDL-C), triglycerides and alkaline phosphatase in 3 independent populations (n > 80,000). When recombinant protein was expressed in cultured hepatocytes, 50% less Glu167Lys TM6SF2 protein was produced relative to wild-type TM6SF2. Adeno-associated virus-mediated short hairpin RNA knockdown of Tm6sf2 in mice increased liver triglyceride content by threefold and decreased very-low-density lipoprotein (VLDL) secretion by 50%. Taken together, these data indicate that TM6SF2 activity is required for normal VLDL secretion and that impaired TM6SF2 function causally contributes to NAFLD.	[Kozlitina, Julia; Smagris, Eriks; Hobbs, Helen H.; Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, McDermott Ctr, Human Growth & Dev, Dallas, TX 75390 USA; [Stender, Stefan; Tybjaerg-Hansen, Anne] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Stender, Stefan; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Zhou, Heather H.; Vogt, Thomas F.] Merck Res Labs, Kenilworth, NJ USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Merck & Company; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr, Human Growth & Dev, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu; jonathan.cohen@utsouthwestern.edu	Nordestgaard, Borge Gronne/ABF-1310-2020; Stender, Stefan/AAC-8258-2019	Stender, Stefan/0000-0003-0281-5900; Nordestgaard, Borge/0000-0002-1954-7220; Kozlitina, Julia/0000-0001-7720-2290	US National Institutes of Health [HL20948, 1HL092550, DK090066]; National Center for Advancing Translational Sciences [UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. Xu for excellent technical assistance. This work was supported by grants from the US National Institutes of Health (HL20948, 1HL092550 and DK090066) and the National Center for Advancing Translational Sciences (UL1TR001105). T.F.V. acknowledges the contributions of G. Gao (University of Massachusetts) for advice and assistance with AAV vector production.	Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen Z, 2011, J CARDIOVASC TRANSL, V4, P801, DOI 10.1007/s12265-011-9309-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gorden A, 2013, HUM HERED, V75, P34, DOI 10.1159/000346195; Hernaez R, 2013, CLIN GASTROENTEROL H, V11, P1183, DOI 10.1016/j.cgh.2013.02.011; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	22	711	732	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					352	+		10.1038/ng.2901	http://dx.doi.org/10.1038/ng.2901			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24531328	Green Accepted			2022-12-25	WOS:000334510100010
J	Rodriguez, GM; Tashiro, Y; Atsumi, S				Rodriguez, Gabriel M.; Tashiro, Yohei; Atsumi, Shota			Expanding ester biosynthesis in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							YEAST ALCOHOL ACETYLTRANSFERASE; LIPASE-CATALYZED ESTERIFICATION; WAX ESTER; BACTERIAL BIOLUMINESCENCE; VOLATILE ESTERS; FATTY ALCOHOLS; EXPRESSION; DEHYDROGENASE; GENES; PURIFICATION	To expand the capabilities of whole-cell biocatalysis, we have engineered Escherichia coli to produce various esters. The alcohol O-acyltransferase (ATF) class of enzyme uses acyl-CoA units for ester formation. The release of free CoA upon esterification with an alcohol provides the free energy to facilitate ester formation. The diversity of CoA molecules found in nature in combination with various alcohol biosynthetic pathways allows for the biosynthesis of a multitude of esters. Small to medium volatile esters have extensive applications in the flavor, fragrance, cosmetic, solvent, paint and coating industries. The present work enables the production of these compounds by designing several ester pathways in E. coli. The engineered pathways generated acetate esters of ethyl, propyl, isobutyl, 2-methyl-1-butyl, 3-methyl-1-butyl and 2-phenylethyl alcohols. In particular, we achieved high-level production of isobutyl acetate from glucose (17.2 g l(-1)). This strategy was expanded to realize pathways for tetradecyl acetate and several isobutyrate esters.	[Rodriguez, Gabriel M.; Tashiro, Yohei; Atsumi, Shota] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Rodriguez, GM (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	satsumi@ucdavis.edu	Tashiro, Yohei/D-3972-2017	Tashiro, Yohei/0000-0002-6894-4345; Atsumi, Shota/0000-0002-5782-4196	University of California-Davis startup fund; Hellman fellowship; US National Institutes of Health Biotechnology Training Grant Fellowship [T32-GM008799]; Sloan Fellowship; Japan Society for the Promotion of Science postdoctoral fellowship for research abroad; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799] Funding Source: NIH RePORTER	University of California-Davis startup fund; Hellman fellowship; US National Institutes of Health Biotechnology Training Grant Fellowship; Sloan Fellowship(Alfred P. Sloan Foundation); Japan Society for the Promotion of Science postdoctoral fellowship for research abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by University of California-Davis startup fund and the Hellman fellowship to S.A. G.M.R. is supported by a US National Institutes of Health Biotechnology Training Grant Fellowship (T32-GM008799) and a Sloan Fellowship. Y.T. is supported by Japan Society for the Promotion of Science postdoctoral fellowship for research abroad. We would like to thank R. Luu and R.E. Parales (University of California-Davis) for graciously providing genomic DNA from P. putida g7 and M. Kato and S.-J. Lin (University of California-Davis) for providing genomic DNA from S. cerevisiae BY4742. We also thank M.D. Toney and C.A. Rabinovitch-Deere (University of California-Davis) for critical reading of the manuscript. Finally, we thank S. Desai for technical assistance with HPLC analysis and for constructing pAL603.	Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Baez A, 2011, APPL MICROBIOL BIOT, V90, P1681, DOI 10.1007/s00253-011-3173-y; Barney BM, 2012, APPL ENVIRON MICROB, V78, P5734, DOI 10.1128/AEM.00534-12; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Beekwilder J, 2004, PLANT PHYSIOL, V135, P1865, DOI 10.1104/pp.104.042580; BELAS R, 1982, SCIENCE, V218, P791, DOI 10.1126/science.10636771; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Connor MR, 2010, APPL MICROBIOL BIOT, V86, P1155, DOI 10.1007/s00253-009-2401-1; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dhake KP, 2013, FLAVOUR FRAG J, V28, P71, DOI 10.1002/ffj.3140; Ferrandez A, 1997, J BACTERIOL, V179, P2573, DOI 10.1128/jb.179.8.2573-2581.1997; Fujii T, 1996, J FERMENT BIOENG, V81, P538, DOI 10.1016/0922-338X(96)81476-0; FUJII T, 1994, APPL ENVIRON MICROB, V60, P2786, DOI 10.1128/AEM.60.8.2786-2792.1994; HESTER K, 1995, EUR J BIOCHEM, V233, P828, DOI 10.1111/j.1432-1033.1995.828_3.x; Hester KL, 2000, METHOD ENZYMOL, V324, P129; Holtzapple E, 2007, J BACTERIOL, V189, P3804, DOI 10.1128/JB.01932-06; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; Inokuma K, 2010, J BIOSCI BIOENG, V110, P696, DOI 10.1016/j.jbiosc.2010.07.010; Iwasaki T., 2012, KIRK OTHMER ENCY CHE, V10, P497; Lee SJ, 2006, BIOCHEM BIOPH RES CO, V346, P1009, DOI 10.1016/j.bbrc.2006.06.009; Lenneman EM, 2013, APPL ENVIRON MICROB, V79, P7055, DOI 10.1128/AEM.02420-13; Lilly M, 2006, YEAST, V23, P641, DOI 10.1002/yea.1382; Lin FM, 2013, FEBS J, V280, P4773, DOI 10.1111/febs.12443; Liu YJ, 2006, J MOL CATAL A-CHEM, V245, P132, DOI 10.1016/j.molcata.2005.09.049; Machado HB, 2012, METAB ENG, V14, P504, DOI 10.1016/j.ymben.2012.07.002; Mason AB, 2000, YEAST, V16, P1287, DOI 10.1002/1097-0061(200010)16:14<1287::AID-YEA613>3.0.CO;2-I; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; Mooney BP, 2002, ANNU REV PLANT BIOL, V53, P357, DOI 10.1146/annurev.arplant.53.100301.135251; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Park YC, 2009, APPL MICROBIOL BIOT, V85, P13, DOI 10.1007/s00253-009-2170-x; Rabinovitch-Deere CA, 2013, CHEM REV, V113, P4611, DOI 10.1021/cr300361t; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rodriguez GM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-90; Rontani JF, 1999, APPL ENVIRON MICROB, V65, P221; Rowland O, 2012, PLANT SCI, V193, P28, DOI 10.1016/j.plantsci.2012.05.002; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Stergiou PY, 2013, BIOTECHNOL ADV, V31, P1846, DOI 10.1016/j.biotechadv.2013.08.006; Stoveken T, 2005, J BACTERIOL, V187, P1369, DOI 10.1128/JB.187.4.1369-1376.2005; van den Berg C, 2013, BIOTECHNOL BIOENG, V110, P137, DOI 10.1002/bit.24618; Verstrepen KJ, 2003, APPL ENVIRON MICROB, V69, P5228, DOI 10.1128/AEM.69.9.5228-5237.2003	46	131	136	2	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					259	+		10.1038/nchembio.1476	http://dx.doi.org/10.1038/nchembio.1476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24609358	Green Accepted			2022-12-25	WOS:000333172900007
J	Sirajuddin, M; Rice, LM; Vale, RD				Sirajuddin, Minhajuddin; Rice, Luke M.; Vale, Ronald D.			Regulation of microtubule motors by tubulin isotypes and post-translational modifications	NATURE CELL BIOLOGY			English	Article							BETA-TUBULIN; ALPHA-TUBULIN; CYTOPLASMIC DYNEIN; KINESIN-BINDING; C-TERMINUS; BRAIN; PROCESSIVITY; SUBTILISIN; MECHANISM; ENZYMES	The `tubulin-code' hypothesis proposes that different tubulin genes or post-translational modifications (PTMs), which mainly confer variation in the carboxy-terminal tail (CTT), result in unique interactions with microtubule-associated proteins for specific cellular functions. However, the inability to isolate distinct and homogeneous tubulin species has hindered biochemical testing of this hypothesis. Here, we have engineered 25 alpha/beta-tubulin heterodimers with distinct CTTs and PTMs and tested their interactions with four different molecular motors using single-molecule assays. Our results show that tubulin isotypes and PTMs can govern motor velocity, processivity and microtubule depolymerization rates, with substantial changes conferred by even single amino acid variation. Revealing the importance and specificity of PTMs, we show that kinesin-1 motility on neuronal beta-tubulin (TUBB3) is increased by polyglutamylation and that robust kinesin-2 motility requires detyrosination of alpha-tubulin. Our results also show that different molecular motors recognize distinctive tubulin 'signatures', which supports the premise of the tubulin-code hypothesis.	[Sirajuddin, Minhajuddin; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sirajuddin, Minhajuddin; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rice, Luke M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Rice, Luke M.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	vale@ucsf.edu	Sirajuddin, Minhaj/H-8040-2019	Sirajuddin, Minhaj/0000-0001-5742-2130	NSF [MCB-1054947]; NIH [38499]; Div Of Molecular and Cellular Bioscience [1054947] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank N. Stuurman for microscopy assistance, M. Tanenbaum for help in lentiviral expression and members of the R.D.V. laboratory for comments on the manuscript. R.D.V. is a Howard Hughes Medical Institute investigator and M.S. is a Human Frontiers Science Program-Long-term fellow (LT-000120/2009). L.M.R. is supported by NSF MCB-1054947. This work received support from an NIH grant (38499).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; AUDEBERT S, 1994, J CELL SCI, V107, P2313; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cederquist GY, 2012, HUM MOL GENET, V21, P5484, DOI 10.1093/hmg/dds393; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fulton C., 1976, CELL MOTIL CYTOSKEL, V3, P987; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hertzer KM, 2008, CELL CYCLE, V7, P2727, DOI 10.4161/cc.7.17.6590; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Imanishi M, 2006, J CELL BIOL, V174, P931, DOI 10.1083/jcb.200605179; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Leandro-Garcia LJ, 2012, CANCER RES, V72, P4744, DOI 10.1158/0008-5472.CAN-11-2861; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; LOBERT S, 1993, CELL MOTIL CYTOSKEL, V25, P282, DOI 10.1002/cm.970250308; Luduena Richard E., 2008, P123, DOI 10.1007/978-1-59745-336-3_6; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Raff EC, 1997, SCIENCE, V275, P70, DOI 10.1126/science.275.5296.70; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redeker V, 2010, METHOD CELL BIOL, V95, P77, DOI 10.1016/S0091-679X(10)95006-1; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; SCHATZ PJ, 1987, MOL CELL BIOL, V7, P3799, DOI 10.1128/MCB.7.10.3799; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, BIOSCIENCE REP, V30, P319, DOI 10.1042/BSR20100025; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	65	336	341	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					335	+		10.1038/ncb2920	http://dx.doi.org/10.1038/ncb2920			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24633327	Green Submitted, Green Accepted			2022-12-25	WOS:000333556900007
J	Hammerling, MJ; Ellefson, JW; Boutz, DR; Marcotte, EM; Ellington, AD; Barrick, JE				Hammerling, Michael J.; Ellefson, Jared W.; Boutz, Daniel R.; Marcotte, Edward M.; Ellington, Andrew D.; Barrick, Jeffrey E.			Bacteriophages use an expanded genetic code on evolutionary paths to higher fitness	NATURE CHEMICAL BIOLOGY			English	Article							EVOLVABILITY; POLYMERASE; EXPANSION; PROTEINS; DNA	Bioengineering advances have made it possible to fundamentally alter the genetic codes of organisms. However, the evolutionary consequences of expanding an organism's genetic code with a noncanonical amino acid are poorly understood. Here we show that bacteriophages evolved on a host that incorporates 3-iodotyrosine at the amber stop codon acquire neutral and beneficial mutations to this new amino acid in their proteins, demonstrating that an expanded genetic code increases evolvability.	[Hammerling, Michael J.; Ellefson, Jared W.; Boutz, Daniel R.; Marcotte, Edward M.; Ellington, Andrew D.; Barrick, Jeffrey E.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Barrick, JE (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA.	jbarrick@cm.utexas.edu	; /M-4872-2013	Marcotte, Edward/0000-0001-8808-180X; /0000-0001-7462-4105	US National Institutes of Health (NIH) [R00-GM087550]; US National Science Foundation (NSF) BEACON Center for the Study of Evolution in Action [DBI-0939454]; US Army Research Office [W911NF-12-1-0390]; US National Security Science and Engineering Faculty [FA9550-10-1-01-69]; US Defense Advanced Research Project Agency [HR-0011-12-C-0066]; NSF [MCB-0943383]; NIH; NSF; Cancer Prevention Research Institute of Texas; Welch Foundation [F1515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536, R00GM087550, DP1GM106408] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF) BEACON Center for the Study of Evolution in Action(National Science Foundation (NSF)); US Army Research Office; US National Security Science and Engineering Faculty; US Defense Advanced Research Project Agency; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bull, I. Molineux, R. Hughes, C. Barnhart, D. Deatherage, R. Alnahhas, M. Schmerer, A. Miklos, A. Meyer and A. Maranhao (all at the University of Texas at Austin) for plasmids, strains, advice and technical assistance. The RF0 IodoY strain was provided by RIKEN and by the Targeted Proteins Research Program, the Ministry of Education, Culture, Sports, Science and Technology, Japan. We acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing HPC resources. This research was supported by the US National Institutes of Health (NIH) (R00-GM087550 to J. E. B.), the US National Science Foundation (NSF) BEACON Center for the Study of Evolution in Action (DBI-0939454 to J. E. B.), the US Army Research Office (W911NF-12-1-0390 to J. E. B. and E. M. M.), the US National Security Science and Engineering Faculty (FA9550-10-1-01-69 to A. D. E.), the US Defense Advanced Research Project Agency (HR-0011-12-C-0066 to A. D. E.) and the NSF (MCB-0943383 to A. D. E.). E. M. M. also acknowledges funding from the NIH, the NSF, the Cancer Prevention Research Institute of Texas and the Welch Foundation (F1515).	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Bacher JM, 2004, TRENDS ECOL EVOL, V19, P69, DOI 10.1016/j.tree.2003.11.007; Brustad EM, 2011, CURR OPIN CHEM BIOL, V15, P201, DOI 10.1016/j.cbpa.2010.11.020; Bull JJ, 2003, J MOL EVOL, V57, P241, DOI 10.1007/s00239-003-2470-1; Bull JJ, 1997, GENETICS, V147, P1497; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Gfeller D, 2013, NUCLEIC ACIDS RES, V41, pE327, DOI 10.1093/nar/gks991; Heineman RH, 2009, MOL BIOL EVOL, V26, P1289, DOI 10.1093/molbev/msp037; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Molineux IJ, 2006, BACTERIOPHAGES, P277; Mukai T, 2011, BIOCHEM BIOPH RES CO, V411, P757, DOI 10.1016/j.bbrc.2011.07.020; Ohtake K, 2012, J BACTERIOL, V194, P2606, DOI 10.1128/JB.00195-12; Sakamoto K, 2009, STRUCTURE, V17, P335, DOI 10.1016/j.str.2009.01.008; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; TABOR S, 1989, J BIOL CHEM, V264, P6447; Wang IN, 1996, EVOL ECOL, V10, P545, DOI 10.1007/BF01237884; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Young DD, 2011, BIOORG MED CHEM LETT, V21, P7502, DOI 10.1016/j.bmcl.2011.09.108	29	34	36	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					178	+		10.1038/NCHEMBIO.1450	http://dx.doi.org/10.1038/NCHEMBIO.1450			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24487692	Green Accepted			2022-12-25	WOS:000331616900007
J	Piotrowski, A; Xie, J; Liu, YF; Poplawski, AB; Gomes, AR; Madanecki, P; Fu, C; Crowley, MR; Crossman, DK; Armstrong, L; Babovic-Vuksanovic, D; Bergner, A; Blakeley, JO; Blumenthal, AL; Daniels, MS; Feit, H; Gardner, K; Hurst, S; Kobelka, C; Lee, C; Nagy, R; Rauen, KA; Slopis, JM; Suwannarat, P; Westman, JA; Zanko, A; Korf, BR; Messiaen, LM				Piotrowski, Arkadiusz; Xie, Jing; Liu, Ying F.; Poplawski, Andrzej B.; Gomes, Alicia R.; Madanecki, Piotr; Fu, Chuanhua; Crowley, Michael R.; Crossman, David K.; Armstrong, Linlea; Babovic-Vuksanovic, Dusica; Bergner, Amanda; Blakeley, Jaishri O.; Blumenthal, Andrea L.; Daniels, Molly S.; Feit, Howard; Gardner, Kathy; Hurst, Stephanie; Kobelka, Christine; Lee, Chung; Nagy, Rebecca; Rauen, Katherine A.; Slopis, John M.; Suwannarat, Pim; Westman, Judith A.; Zanko, Andrea; Korf, Bruce R.; Messiaen, Ludwine M.			Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; BTB-KELCH PROTEIN; VESTIBULAR SCHWANNOMAS; COREPRESSOR COMPLEX; LYNCH-SYNDROME; POZ DOMAIN; NF2 LOCUS; N-COR; SMARCB1; IDENTIFICATION	Constitutional SMARCB1 mutations at 22q11.23 have been found in similar to 50% of familial and < 10% of sporadic schwannomatosis cases(1). We sequenced highly conserved regions along 22q from eight individuals with schwannomatosis whose schwannomas involved somatic loss of one copy of 22q, encompassing SMARCB1 and NF2, with a different somatic mutation of the other NF2 allele in every schwannoma but no mutation of the remaining SMARCB1 allele in blood and tumor samples. LZTR1 germline mutations were identified in seven of the eight cases. LZTR1 sequencing in 12 further cases with the same molecular signature identified 9 additional germline mutations. Loss of heterozygosity with retention of an LZTR1 mutation was present in all 25 schwannomas studied. Mutations segregated with disease in all available affected first-degree relatives, although four asymptomatic parents also carried an LZTR1 mutation. Our findings identify LZTR1 as a gene predisposing to an autosomal dominant inherited disorder of multiple schwannomas in similar to 80% of 22q-related schwannomatosis cases lacking mutation in SMARCB1.	[Piotrowski, Arkadiusz; Xie, Jing; Liu, Ying F.; Poplawski, Andrzej B.; Gomes, Alicia R.; Fu, Chuanhua; Korf, Bruce R.; Messiaen, Ludwine M.] Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL 35203 USA; [Piotrowski, Arkadiusz; Madanecki, Piotr] Med Univ Gdansk, Fac Pharm, Gdansk, Poland; [Crowley, Michael R.; Crossman, David K.] Univ Alabama Birmingham, Heflin Ctr Genom Sci, Birmingham, AL USA; [Armstrong, Linlea] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Babovic-Vuksanovic, Dusica] Mayo Clin, Clin Coll Med, Dept Med Genet, Rochester, MN USA; [Bergner, Amanda; Blakeley, Jaishri O.] Johns Hopkins Comprehens Neurofibromatosis Ctr, Baltimore, MD USA; [Blumenthal, Andrea L.; Hurst, Stephanie] Lakeridge Hlth Corp, Oshawa, ON, Canada; [Daniels, Molly S.] Univ Texas Houston, MD Anderson Canc Ctr, Clin Canc Genet Program, Houston, TX 77030 USA; [Feit, Howard] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Gardner, Kathy] Vet Adm Hosp Pittsburgh, Dept Neurol, Pittsburgh, PA USA; [Gardner, Kathy] Univ Pittsburgh, Pittsburgh, PA USA; [Kobelka, Christine; Suwannarat, Pim] Kaiser Permanente Genet Northern Calif, San Francisco, CA USA; [Lee, Chung; Rauen, Katherine A.; Zanko, Andrea] Univ Calif San Francisco, Div Med Genet, Dept Pediat, San Francisco, CA 94143 USA; [Nagy, Rebecca; Westman, Judith A.] Ohio State Univ, Wexner Med Ctr, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; [Slopis, John M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham; University of British Columbia; Mayo Clinic; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Messiaen, LM (corresponding author), Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL 35203 USA.	lmessiaen@uabmc.edu	Piotrowski, Arkadiusz/A-5484-2010; Nagy, Rebecca Shrigley/E-4088-2011; Korf, Bruce R/H-4882-2012	Piotrowski, Arkadiusz/0000-0002-0823-0607; Crossman, David/0000-0002-0981-169X; Armstrong, Linlea/0000-0002-8191-6429; Daniels, Molly/0000-0002-5093-5539	Children's Tumor Foundation Young Investigator Award [2009-01-004]; Children's Tumor Foundation; University of Alabama at Birmingham Medical Genomics Laboratory; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062165] Funding Source: NIH RePORTER	Children's Tumor Foundation Young Investigator Award; Children's Tumor Foundation; University of Alabama at Birmingham Medical Genomics Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients for their participation in this study. A.P. is a recipient of a Children's Tumor Foundation Young Investigator Award (grant 2009-01-004). The study was supported in part by the Children's Tumor Foundation and by internal funds from the University of Alabama at Birmingham Medical Genomics Laboratory.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Buckley PG, 2005, HUM MUTAT, V26, P540, DOI 10.1002/humu.20255; Bush ML, 2011, NEURO-ONCOLOGY, V13, P983, DOI 10.1093/neuonc/nor072; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Jacoby LB, 1997, AM J HUM GENET, V61, P1293, DOI 10.1086/301633; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Luhrig S, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-3; MacCollin M, 2003, NEUROLOGY, V60, P1968, DOI 10.1212/01.WNL.0000070184.08740.E0; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nacak TG, 2006, J BIOL CHEM, V281, P5065, DOI 10.1074/jbc.M509073200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nallani KC, 2005, PARASITOL RES, V95, P236, DOI 10.1007/s00436-004-1291-5; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Pan XF, 2005, BIOCHEM BIOPH RES CO, V337, P1052, DOI 10.1016/j.bbrc.2005.09.155; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Plotkin SR, 2013, AM J MED GENET A, V161A, P405, DOI 10.1002/ajmg.a.35760; Pottier N, 2007, HUM MOL GENET, V16, P2261, DOI 10.1093/hmg/ddm178; Rahman N, 2007, HUM MOL GENET, V16, pR60, DOI 10.1093/hmg/ddm026; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rousseau G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-9; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Sestini R, 2008, HUM MUTAT, V29, P227, DOI 10.1002/humu.20679; Sjursen W, 2010, J MED GENET, V47, P579, DOI 10.1136/jmg.2010.077677; Smith MJ, 2012, NEUROGENETICS, V13, P141, DOI 10.1007/s10048-012-0319-8; Smith MJ, 2012, AM J MED GENET A, V158A, P215, DOI 10.1002/ajmg.a.34376; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	56	163	169	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					182	+		10.1038/ng.2855	http://dx.doi.org/10.1038/ng.2855			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24362817	Green Accepted			2022-12-25	WOS:000331208300016
J	Cho, H; Ryu, H; Rho, S; Hill, K; Smith, S; Audenaert, D; Park, J; Han, S; Beeckman, T; Bennett, MJ; Hwang, D; De Smet, I; Hwang, I				Cho, Hyunwoo; Ryu, Hojin; Rho, Sangchul; Hill, Kristine; Smith, Stephanie; Audenaert, Dominique; Park, Joonghyuk; Han, Soeun; Beeckman, Tom; Bennett, Malcolm J.; Hwang, Daehee; De Smet, Ive; Hwang, Ildoo			A secreted peptide acts on BIN2-mediated phosphorylation of ARFs to potentiate auxin response during lateral root development	NATURE CELL BIOLOGY			English	Article							BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; GSK3-LIKE KINASES; BIN2; BRASSINOSTEROIDS; INHIBITION; FEEDBACK; ENCODES; MEMBERS; GROWTH	The phytohormone auxin is a key developmental signal in plants. So far, only auxin perception has been described to trigger the release of transcription factors termed AUXIN RESPONSE FACTORs (ARFs) from their AUXIN/INDOLE-3-ACETIC ACID (AUX/IAA) repressor proteins. Here, we show that phosphorylation of ARF7 and ARF19 by BRASSINOSTEROID-INSENSITIVE2 (BIN2) can also potentiate auxin signalling output during lateral root organogenesis. BIN2-mediated phosphorylation of ARF7 and ARF19 suppresses their interaction with AUX/IAAs, and subsequently enhances the transcriptional activity to their target genes LATERAL ORGAN BOUNDARIES-DOMAIN16 (LBD16) and LBD29. In this context, BIN2 is under the control of the TRACHEARY ELEMENT DIFFERENTIATION INHIBITORY FACTOR (TDIF)-TDIF RECEPTOR (TDR) module. TDIF-initiated TDR signalling directly acts on BIN2-mediated ARF phosphorylation, leading to the regulation of auxin signalling during lateral root development. In summary, this study delineates a TDIF-TDR-BIN2 signalling cascade that controls regulation of ARF and AUX/IAA interaction independent of auxin perception during lateral root development.	[Cho, Hyunwoo; Ryu, Hojin; Park, Joonghyuk; Han, Soeun; Hwang, Ildoo] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Rho, Sangchul; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea; [Hill, Kristine; Smith, Stephanie; Bennett, Malcolm J.; De Smet, Ive] Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough LE12 5RD, Leics, England; [Hill, Kristine; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Audenaert, Dominique; Beeckman, Tom; De Smet, Ive] Univ Ghent VIB, Integrat Plant Biol Div, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Audenaert, Dominique; Beeckman, Tom; De Smet, Ive] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Nottingham; University of Nottingham; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hwang, I (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	ihwang@postech.ac.kr	Beeckman, Tom/ABA-1164-2020; De Smet, Ive/A-6583-2011; Hill, Kristine/ABG-1386-2020; Beeckman, Tom/ABI-1703-2020; Bennett, Malcolm/G-4004-2010	De Smet, Ive/0000-0003-4607-8893; Hill, Kristine/0000-0002-3429-5818; Beeckman, Tom/0000-0001-8656-2060; Smith, Stephanie/0000-0002-9351-1170; Bennett, Malcolm/0000-0003-0475-390X	Advanced Biomass RD Center [2010-0029720]; National Research Foundation [20110000212]; Korean Ministry of Education, Science and Technology; Next Generation BioGreen 21 Program [PJ009516]; Brain Korea 21 fellowship; BBSRC David Phillips Fellowship [BB_BB/H022457/1]; Marie Curie European Reintegration Grant [PERG06-GA-2009-256354]; Biotechnology and Biological Sciences Research Council [BB/H022457/1, 1094837, BB/G023972/1, BB/H020314/1] Funding Source: researchfish; BBSRC [BB/H020314/1, BB/G023972/1, BB/H022457/1] Funding Source: UKRI	Advanced Biomass RD Center; National Research Foundation; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Brain Korea 21 fellowship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); BBSRC David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie European Reintegration Grant(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank D. Weijers for critical reading of the manuscript and useful suggestions. This work was supported by grants from the Advanced Biomass R&D Center (2010-0029720) and the National Research Foundation (20110000212) funded by the Korean Ministry of Education, Science and Technology. H.R. was supported by grants from the Next Generation BioGreen 21 Program (PJ009516). H.C. and S.H. were recipients of a Brain Korea 21 fellowship. I.D.S. was supported by a BBSRC David Phillips Fellowship (BB_BB/H022457/1) and a Marie Curie European Reintegration Grant (PERG06-GA-2009-256354).	Bao F, 2004, PLANT PHYSIOL, V134, P1624, DOI 10.1104/pp.103.036897; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Chang CSJ, 2011, PLANT PHYSIOL, V156, P228, DOI 10.1104/pp.111.175042; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Choi S, 2013, PLANT J, V73, P380, DOI 10.1111/tpj.12036; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; De Smet I, 2004, J MICROSC-OXFORD, V213, P76, DOI 10.1111/j.1365-2818.2004.01269.x; De Smet I, 2012, NEW PHYTOL, V193, P867, DOI 10.1111/j.1469-8137.2011.03996.x; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dornelas MC, 1999, PLANT MOL BIOL, V39, P137, DOI 10.1023/A:1006102812280; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Ryu H, 2010, MOL CELLS, V29, P291, DOI 10.1007/s10059-010-0034-y; Saidi Y, 2012, TRENDS PLANT SCI, V17, P39, DOI 10.1016/j.tplants.2011.10.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vert G, 2008, P NATL ACAD SCI USA, V105, P9829, DOI 10.1073/pnas.0803996105; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yaginuma H, 2011, PLANT CELL PHYSIOL, V52, P1354, DOI 10.1093/pcp/pcr081; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	43	186	194	8	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					66	+		10.1038/ncb2893	http://dx.doi.org/10.1038/ncb2893			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24362628				2022-12-25	WOS:000329042000012
J	Chen, J; Torcia, S; Xie, F; Lin, CJ; Cakmak, H; Franciosi, F; Horner, K; Onodera, C; Song, JS; Cedars, MI; Ramalho-Santos, M; Conti, M				Chen, Jing; Torcia, Simona; Xie, Fang; Lin, Chih-Jen; Cakmak, Hakan; Franciosi, Federica; Horner, Kathleen; Onodera, Courtney; Song, Jun S.; Cedars, Marcelle I.; Ramalho-Santos, Miguel; Conti, Marco			Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR NETWORK; THERAPEUTIC TARGET; GRANULOSA-CELLS; IN-VITRO; AURORA-A; TPX2; MATURATION; PROTEIN; KINASE; MTOR	Germ cells divide and differentiate in a unique local microenvironment under the control of somatic cells. Signals released in this niche instruct oocyte reentry into the meiotic cell cycle. Once initiated, the progression through meiosis and the associated programme of maternal messenger RNA translation are thought to be cell autonomous. Here we show that translation of a subset of maternal mRNAs critical for embryo development is under the control of somatic cell inputs. Translation of specific maternal transcripts increases in oocytes cultured in association with somatic cells and is sensitive to EGF-like growth factors that act only on the somatic compartment. In mice deficient in amphiregulin, decreased fecundity and oocyte developmental competence is associated with defective translation of a subset of maternal mRNAs. These somatic cell signals that affect translation require activation of the PI(3)K-AKT-mTOR pathway. Thus, mRNA translation depends on somatic cell cues that are essential to reprogramme the oocyte for embryo development.	[Chen, Jing; Torcia, Simona; Xie, Fang; Lin, Chih-Jen; Cakmak, Hakan; Franciosi, Federica; Horner, Kathleen; Onodera, Courtney; Song, Jun S.; Cedars, Marcelle I.; Ramalho-Santos, Miguel; Conti, Marco] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Chen, Jing; Torcia, Simona; Xie, Fang; Lin, Chih-Jen; Cakmak, Hakan; Franciosi, Federica; Horner, Kathleen; Onodera, Courtney; Song, Jun S.; Ramalho-Santos, Miguel; Conti, Marco] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Chen, Jing; Torcia, Simona; Xie, Fang; Lin, Chih-Jen; Cakmak, Hakan; Franciosi, Federica; Horner, Kathleen; Cedars, Marcelle I.; Ramalho-Santos, Miguel; Conti, Marco] Univ Calif San Francisco, Dept Obstet & Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Onodera, Courtney; Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conti, M (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA.	contim@obgyn.ucsf.edu	Song, Jun S/E-2526-2016; Ramalho-Santos, Miguel/L-9092-2018	Song, Jun S/0000-0002-0422-2175; Ramalho-Santos, Miguel/0000-0003-0177-5556; Franciosi, Federica/0000-0001-8742-0291	Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [1U54HD055764-06, RO1-GM097165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764, P50HD055764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097165] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Laird, D. Ruggero, T. Nystul and R. Belloch at UCSF for advice during the studies and for critical reading of the manuscript, and A. Susor for assisting with the oocyte confocal microscopy analysis. This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH cooperative agreement 1U54HD055764-06, as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, and RO1-GM097165 to M.C.	Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Chang HC, 2005, HUM REPROD, V20, P1958, DOI 10.1093/humrep/dei003; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Chian RC, 2004, CURR OPIN OBSTET GYN, V16, P211, DOI 10.1097/00001703-200406000-00003; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De la Fuente R, 1999, HUM REPROD, V14, P3060, DOI 10.1093/humrep/14.12.3060; De Luca M, 2006, CELL CYCLE, V5, P296; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Gosden R, 2010, J CLIN INVEST, V120, P973, DOI 10.1172/JCI41294; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Hsieh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021574; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Luciano AM, 2005, MOL REPROD DEV, V71, P389, DOI 10.1002/mrd.20304; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Prochazka R, 2003, BIOL REPROD, V68, P797, DOI 10.1095/biolreprod.102.005520; Richani D, 2013, MOL HUM REPROD, V19, P500, DOI 10.1093/molehr/gat028; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Shigeishi H, 2009, ONCOL REP, V21, P341, DOI 10.3892/or_00000227; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Spradling A., 2011, COLD SPRING HARB PER, V3; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Yoshida S, 2008, COLD SH Q B, V73, P25, DOI 10.1101/sqb.2008.73.046	48	100	101	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2013	15	12					1415	+		10.1038/ncb2873	http://dx.doi.org/10.1038/ncb2873			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	265IL	24270888	Green Accepted, Green Submitted			2022-12-25	WOS:000327944200006
J	Shen, HY; Giordano, F; Wu, YM; Chan, J; Zhu, C; Milosevic, I; Wu, XD; Yao, K; Chen, B; Baumgart, T; Sieburth, D; De Camilli, P				Shen, Hongying; Giordano, Francesca; Wu, Yumei; Chan, Jason; Zhu, Chen; Milosevic, Ira; Wu, Xudong; Yao, Kai; Chen, Bo; Baumgart, Tobias; Sieburth, Derek; De Camilli, Pietro			Coupling between endocytosis and sphingosine kinase 1 recruitment	NATURE CELL BIOLOGY			English	Article							CLATHRIN-COATED PITS; PLASMA-MEMBRANE; SPHINGOLIPID METABOLISM; PRESYNAPTIC TERMINALS; MEDIATED ENDOCYTOSIS; RAT-BRAIN; N-BAR; CHOLESTEROL; PROTEIN; SPHINGOSINE-1-PHOSPHATE	Genetic studies have suggested a functional link between cholesterol/sphingolipid metabolism and endocytic membrane traffic. Here we show that perturbing the cholesterol/sphingomyelin balance in the plasma membrane results in the massive formation of clusters of narrow endocytic tubular invaginations positive for N-BAR proteins. These tubules are intensely positive for sphingosine kinase 1 (SPHK1). SPHK1 is also targeted to physiologically occurring early endocytic intermediates, and is highly enriched in nerve terminals, which are cellular compartments specialized for exo/endocytosis. Membrane recruitment of SPHK1 involves a direct, curvature-sensitive interaction with the lipid bilayer mediated by a hydrophobic patch on the enzyme's surface. The knockdown of SPHKs results in endocytic recycling defects, and a mutation that disrupts the hydrophobic patch of Caenorhabditis elegans SPHK fails to rescue the neurotransmission defects in loss-of-function mutants of this enzyme. Our studies support a role for sphingosine phosphorylation in endocytic membrane trafficking beyond the established function of sphingosine-1-phosphate in intercellular signalling.	[Shen, Hongying; Giordano, Francesca; Wu, Yumei; Milosevic, Ira; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Shen, Hongying; Giordano, Francesca; Wu, Yumei; Milosevic, Ira; Wu, Xudong; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Chan, Jason; Sieburth, Derek] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhu, Chen; Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Yao, Kai; Chen, Bo] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; University of Southern California; University of Pennsylvania; Yale University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	zhu, chen/M-8411-2015; Wu, Yumei/D-6967-2015; Giordano, Francesca/E-4039-2017; Cruz e Silva, Odete/AAH-5595-2020	zhu, chen/0000-0002-4785-2898; Giordano, Francesca/0000-0002-5942-1753; Wu, Yumei/0000-0003-0878-7605; Chan, Jason/0000-0001-8123-536X; Milosevic, Ira/0000-0001-6440-3763; , Kai/0000-0002-8122-430X; GIORDANO, Francesca/0000-0002-7621-1969; Shen, Hongying/0000-0002-2115-7037	NIH [NS36251, DK45735, DA018343, GM097552, NS071085]; Ellison Medical Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R56NS071085, R01NS071085, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Liang and J. Duncan (Yale University) for help with the automatic tracking of clathrin-coated pits dynamics, S. Ferguson, A. Frost and T. Walther for discussion and advice, J. Baskin for thorough reading of the manuscript, F. Wilson, L. Lucast, L. Liu and H. Czapla for outstanding technical support, M. Graham, X. Liu and S. Wilson for help with microscopy experiments, and members of T. Walther, T. Melia and C. Burd laboratories (Yale University) for help with lipid experiments. We also acknowledge the help of the Yale Center for Cellular and Molecular Imaging and Yale Center for Genomics and Proteomics. This work was supported in part by grants from the NIH (NS36251, DK45735 and DA018343 to P.D.C., GM097552 to T.B., and NS071085 to D.S.) and from the Ellison Medical Foundation to P.D.C.	Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Chan JP, 2012, J NEUROSCI, V32, P17909, DOI 10.1523/JNEUROSCI.2808-12.2012; Chan JP, 2012, GENE DEV, V26, P1070, DOI 10.1101/gad.188003.112; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Dason JS, 2010, J NEUROSCI, V30, P15856, DOI 10.1523/JNEUROSCI.4132-10.2010; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; DESFARGES L, 1993, YEAST, V9, P267, DOI 10.1002/yea.320090306; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Garcia-Pacios M, 2009, BIOPHYS J, V97, P1398, DOI 10.1016/j.bpj.2009.07.001; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hannich J. T., 2011, COLD SPRING HARB PER, V3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Kirchhausen T, 2012, NAT CELL BIOL, V14, P906, DOI 10.1038/ncb2570; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kusner DJ, 2007, J BIOL CHEM, V282, P23147, DOI 10.1074/jbc.M700193200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liang LA, 2010, LECT NOTES COMPUT SC, V6362, P315; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Morgan J, 2009, EUKARYOT CELL, V8, P779, DOI 10.1128/EC.00037-09; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Olivera A, 1998, Methods Mol Biol, V105, P233; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rohrbough J, 2004, J NEUROSCI, V24, P7789, DOI 10.1523/JNEUROSCI.1146-04.2004; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Shen HY, 2012, CELL, V150, P1300, DOI 10.1016/j.cell.2012.08.017; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; ter Braak M, 2009, BBA-MOL CELL BIOL L, V1791, P357, DOI 10.1016/j.bbalip.2009.01.019; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yonamine I, 2011, J CELL BIOL, V192, P557, DOI 10.1083/jcb.201004098; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	77	69	71	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					652	+		10.1038/ncb2987	http://dx.doi.org/10.1038/ncb2987			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24929359	Green Accepted			2022-12-25	WOS:000338187900006
J	Wang, YF; Mckay, JD; Rafnar, T; Wang, ZM; Timofeeva, MN; Broderick, P; Zong, XC; Laplana, M; Wei, YY; Han, YH; Lloyd, A; Delahaye-Sourdeix, M; Chubb, D; Gaborieau, V; Wheeler, W; Chatterjee, N; Thorleifsson, G; Sulem, P; Liu, G; Kaaks, R; Henrion, M; Kinnersley, B; Vallee, M; LeCalvez-Kelm, F; Stevens, VL; Gapstur, SM; Chen, WV; Zaridze, D; Szeszenia-Dabrowska, N; Lissowska, J; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; Krokan, HE; Gabrielsen, ME; Skorpen, F; Vatten, L; Njolstad, I; Chen, C; Goodman, G; Benhamou, S; Vooder, T; Valk, K; Nelis, M; Metspalu, A; Lener, M; Lubinski, J; Johansson, M; Vineis, P; Agudo, A; Clavel-Chapelon, F; Bueno-de-Mesquita, HB; Trichopoulos, D; Khaw, KT; Johansson, M; Weiderpass, E; Tjonneland, A; Riboli, E; Lathrop, M; Scelo, G; Albanes, D; Caporaso, NE; Ye, YQ; Gu, J; Wu, XF; Spitz, MR; Dienemann, H; Rosenberger, A; Su, L; Matakidou, A; Eisen, T; Stefansson, K; Risch, A; Chanock, SJ; Christiani, DC; Hung, RJ; Brennan, P; Landi, MT; Houlston, RS; Amos, CI				Wang, Yufei; Mckay, James D.; Rafnar, Thorunn; Wang, Zhaoming; Timofeeva, Maria N.; Broderick, Peter; Zong, Xuchen; Laplana, Marina; Wei, Yongyue; Han, Younghun; Lloyd, Amy; Delahaye-Sourdeix, Manon; Chubb, Daniel; Gaborieau, Valerie; Wheeler, William; Chatterjee, Nilanjan; Thorleifsson, Gudmar; Sulem, Patrick; Liu, Geoffrey; Kaaks, Rudolf; Henrion, Marc; Kinnersley, Ben; Vallee, Maxime; LeCalvez-Kelm, Florence; Stevens, Victoria L.; Gapstur, Susan M.; Chen, Wei V.; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Rudnai, Peter; Fabianova, Eleonora; Mates, Dana; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Krokan, Hans E.; Gabrielsen, Maiken Elvestad; Skorpen, Frank; Vatten, Lars; Njolstad, Inger; Chen, Chu; Goodman, Gary; Benhamou, Simone; Vooder, Tonu; Valk, Kristjan; Nelis, Mari; Metspalu, Andres; Lener, Marcin; Lubinski, Jan; Johansson, Mattias; Vineis, Paolo; Agudo, Antonio; Clavel-Chapelon, Francoise; Bueno-de-Mesquita, H. Bas; Trichopoulos, Dimitrios; Khaw, Kay-Tee; Johansson, Mikael; Weiderpass, Elisabete; Tjonneland, Anne; Riboli, Elio; Lathrop, Mark; Scelo, Ghislaine; Albanes, Demetrius; Caporaso, Neil E.; Ye, Yuanqing; Gu, Jian; Wu, Xifeng; Spitz, Margaret R.; Dienemann, Hendrik; Rosenberger, Albert; Su, Li; Matakidou, Athena; Eisen, Timothy; Stefansson, Kari; Risch, Angela; Chanock, Stephen J.; Christiani, David C.; Hung, Rayjean J.; Brennan, Paul; Landi, Maria Teresa; Houlston, Richard S.; Amos, Christopher I.			Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIATION; POLYMORPHIC STOP CODON; SUSCEPTIBILITY LOCUS; ADENOCARCINOMA; MUTATIONS; BREAST; P63	We conducted imputation to the 1000 Genomes Project of four genome-wide association studies of lung cancer in populations of European ancestry (11,348 cases and 15,861 controls) and genotyped an additional 10,246 cases and 38,295 controls for follow-up. We identified large-effect genome-wide associations for squamous lung cancer with the rare variants BRCA2 p.Lys3326X (rs11571833, odds ratio (OR) = 2.47, P = 4.74 x 10(-20)) and CHEK2 p.Ile157Thr (rs17879961, OR = 0.38, P = 1.27 x 10(-13)). We also showed an association between common variation at 3q28 (TP63, rs13314271, OR = 1.13, P = 7.22 x 10(-10)) and lung adenocarcinoma that had been previously reported only in Asians. These findings provide further evidence for inherited genetic susceptibility to lung cancer and its biological basis. Additionally, our analysis demonstrates that imputation can identify rare disease-causing variants with substantive effects on cancer risk from preexisting genome-wide association study data.	[Broderick, Peter; Lloyd, Amy; Chubb, Daniel; Henrion, Marc; Kinnersley, Ben; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Mckay, James D.; Timofeeva, Maria N.; Delahaye-Sourdeix, Manon; Gaborieau, Valerie; Vallee, Maxime; LeCalvez-Kelm, Florence; Johansson, Mattias; Scelo, Ghislaine; Brennan, Paul] WHO, IARC, Lyon, France; [Rafnar, Thorunn; Thorleifsson, Gudmar; Sulem, Patrick; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Wang, Zhaoming; Chatterjee, Nilanjan; Albanes, Demetrius; Caporaso, Neil E.; Chanock, Stephen J.; Landi, Maria Teresa] NCI, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Zong, Xuchen; Hung, Rayjean J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Laplana, Marina; Risch, Angela] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Wei, Yongyue; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Han, Younghun; Amos, Christopher I.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Ctr Genom Med, Lebanon, NH 03756 USA; [Wheeler, William] Informat Management Serv Inc, Rockville, MD USA; [Liu, Geoffrey] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada; [Kaaks, Rudolf] DKFZ, Div Canc Epidemiol, Heidelberg, Germany; [Kaaks, Rudolf; Dienemann, Hendrik; Risch, Angela] TLRC H, Heidelberg, Germany; [Stevens, Victoria L.; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Chen, Wei V.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Zaridze, David] Russian NN Blokhin Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Fabianova, Eleonora] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Mates, Dana] Natl Inst Publ Hlth, Bucharest, Romania; [Bencko, Vladimir] Charles Univ Prague, Inst Hyg & Epidemiol, Fac Med 1, Prague, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Krokan, Hans E.; Gabrielsen, Maiken Elvestad] Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Skorpen, Frank] Norwegian Univ Sci & Technol, Fac Med, Childrens & Womens Hlth, Dept Lab Med, N-7034 Trondheim, Norway; [Vatten, Lars] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Njolstad, Inger] Univ Tromso, Dept Community Med, Tromso, Norway; [Chen, Chu; Goodman, Gary] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Benhamou, Simone] INSERM U946, Paris, France; [Vooder, Tonu] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Valk, Kristjan] Univ Bergen, Dept Biomed, Bergen, Norway; [Nelis, Mari; Metspalu, Andres] Inst Mol & Cell Biol, Estonian Genome Ctr, Tartu, Estonia; [Nelis, Mari] Univ Geneva, Sch Med, Dept Genet Med & Dev, Geneva, Switzerland; [Lener, Marcin; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Vineis, Paolo; Bueno-de-Mesquita, H. Bas; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Vineis, Paolo] HuGeF Fdn, Unit Mol & Genet Epidemiol, Turin, Italy; [Agudo, Antonio] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Clavel-Chapelon, Francoise] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, Nutr Hormones & Womens Hlth Team, U1018, Villejuif, France; [Clavel-Chapelon, Francoise] Univ Paris 11, UMRS 1018, Villejuif, France; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, Villejuif, France; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Khaw, Kay-Tee] Univ Cambridge, Addenbrookes Hosp, Clin Gerontol Unit, Sch Clin Med, Cambridge CB2 2QQ, England; [Johansson, Mikael] Umea Univ, Dept Radiat Sci, Umea, Sverige, Sweden; [Weiderpass, Elisabete] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Lathrop, Mark] CEPH, Paris, France; [Ye, Yuanqing; Gu, Jian; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Spitz, Margaret R.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Rosenberger, Albert] Thoraxklin Univ Hosp Heidelberg, Dept Thorac Surg, Heidelberg, Germany; [Rosenberger, Albert] Univ Gottingen, Dept Genet Epidemiol, D-37073 Gottingen, Germany; [Matakidou, Athena] Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Eisen, Timothy] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Dept Oncol, Cambridge, England; [Eisen, Timothy] Addenbrookes Hosp, Cambridge, England	University of London; Institute of Cancer Research - UK; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Information Management Services, Inc.; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Helmholtz Association; German Cancer Research Center (DKFZ); American Cancer Society; University of Texas System; UTMD Anderson Cancer Center; N.N. Blokhin Russian Cancer Research Center; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Regional Authority of Public Health Banska Bystrica; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Fred Hutchinson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Tartu; University of Bergen; University of Geneva; Pomeranian Medical University; Imperial College London; Catalan Institute of Oncology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Umea University; UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Samfundet Folkhalsan; Danish Cancer Society; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Gottingen; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Houlston, RS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	landim@mail.nih.gov; richard.houlston@icr.ac.uk	Johansson, Mikael/AAI-7688-2020; Wei, Yongyue/GYV-5660-2022; Stefansson, Kari/AAE-7187-2019; Albanes, Demetrius/B-9749-2015; Njolstad, Inger/X-3784-2019; Liu, Geoffrey/N-4421-2016; /H-5606-2019; Bencko, Vladimir/H-8598-2017; Henrion, Marc/AAT-7088-2020; Agudo, Antonio/J-1805-2016; Risch, Angela/H-2669-2013; Khaw, Kay-Tee/AAZ-3209-2021; Vatten, Lars/AAF-9380-2022; Laplana, Marina/G-2653-2010; Benhamou, Simone/K-6554-2015; Janout, Vladimir/M-5133-2014; Gu, Jian/Q-4780-2018; Johansson, Mattias/ABF-3365-2020; Hung, Rayjean J/A-7439-2013; Wang, Zhaoming/R-5527-2018; Nelis, Mari/ABG-7775-2020; Szeszenia-Dabrowska, Neonila/F-7190-2010; Vatten, Lars/AFK-2073-2022; Weiderpass, Elisabete/M-4029-2016; Weiderpass, Elisabete/AAP-2747-2021; Lissowska, Jolanta/AAH-3252-2020; Benhamou, Simone/ABD-2590-2020; Scelo, Ghislaine/CAF-8077-2022	Wei, Yongyue/0000-0002-1132-1796; /0000-0003-1783-6296; Bencko, Vladimir/0000-0003-1935-2228; Henrion, Marc/0000-0003-1242-839X; Agudo, Antonio/0000-0001-9900-5677; Risch, Angela/0000-0002-8026-5505; Laplana, Marina/0000-0002-2548-0704; Gu, Jian/0000-0003-3499-0973; Wang, Zhaoming/0000-0001-7556-3869; Nelis, Mari/0000-0001-9748-1020; Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Lissowska, Jolanta/0000-0003-2695-5799; Tjonneland, Anne/0000-0003-4385-2097; Johansson, Mattias/0000-0002-3116-5081; Hung, Rayjean/0000-0002-4486-7496; Vallee, Maxime/0000-0002-3616-9508; Foretova, Lenka/0000-0003-0494-2620; Lubinski, Jan/0000-0003-2931-3003; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Liu, Geoffrey/0000-0002-2603-7296; Riboli, Elio/0000-0001-6795-6080; Skorpen, Frank/0000-0001-7093-8000; Houlston, Richard/0000-0002-5268-0242; BENHAMOU, Simone/0000-0001-5853-8047; mates, dana/0000-0002-6219-9807; Broderick, Peter/0000-0002-8348-5829; Timofeeva, Maria/0000-0002-2503-4253	National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital; NIH [U19CA148127, R01CA055769, 5R01CA127219, 5R01CA133996, 5R01CA121197, R01-CA111703, U01-CA63673, P50 CA70907, R01CA121197, RO1 CA127219, U19 CA148127, RO1 CA55769, CA074386, CA092824, CA090578, DA17932]; Cancer Research UK [C1298/A8780, C1298/A8362]; National Cancer Research Network (NCRN); HEAL; Sanofi-Aventis; National Health Service; National Institute for Health Research Biomedical Research Centre; Sir John Fisher Foundation; Canadian Cancer Society Research Institute [020214]; Ontario Institute of Cancer; Cancer Care Ontario Chair; Alan Brown Chair; Lusi Wong Programs at the Princess Margaret Hospital Foundation; Deutsche Krebshilfe [70-2387, 70-2919]; German Federal Ministry of Education and Research (EPIC-Heidelberg); Institut National du Cancer, France; European Community [LSHG-CT-2005-512113]; Norwegian Cancer Association; Functional Genomics Programme of Research Council of Norway; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; Fred Hutchinson Cancer Research Center; US NCI [R01 CA092039]; FP7 grant [REGPOT 245536]; Estonian Government [SF0180142s08]; EU European Regional Development Fund in the frame of Centre of Excellence in Genomics and Estonian Research Infrastructure's Roadmap; University of Tartu [SP1GVARENG]; IARC Postdoctoral Fellowship; Intramural Research Program of the NIH; NCI, US Public Health Service contracts NCI [N01-CN-45165, N01-RC-45035, N01-RC-37004, NO1-CN-25514, NO1-CN-25515, NO1-CN-25512, NO1-CN-25513, NO1-CN-25516, NO1-CN-25511, NO1-CN25524, NO1-CN-25518, NO1-CN-75022, NO1-CN-25476, NO1-CN-25404]; American Cancer Society; NIH Genes, Environment and Health Initiative [HG-06-033-NCI-01, RO1HL091172-01]; genotyping at the Johns Hopkins University Center for Inherited Disease Research [U01HG004438, NIH HHSN268200782096C]; study coordination at the GENEVA Coordination Center [U01 HG004446]; Cancer Prevention Research Institute of Texas [RP100443]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025511, N01CN025516, N01CN025513, N01CN025514, N01CN045165, N01CN025518, N01CN025404, N01CN025476, N01CN025524, N01CN075022, N01CN025512, N01CN025515] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA133996, N01CA025518, N01CA025516, P20CA090578, N01CA025515, R01CA121197, P30CA023108, N01CA025513, N01CA025512, R01CA092824, R01CA127219, R01CA074386, N01CA025514, U01CA063673, UM1CA167462, P50CA070907, P50CA090578, U19CA148127, R01CA111703, N01CA025511, N01CA025524, N01CA075022, R01CA055769, P30CA016672, R01CA092039] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER; Cancer Research UK [14136, 15116] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); National Cancer Research Network (NCRN); HEAL; Sanofi-Aventis(Sanofi-Aventis); National Health Service; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Sir John Fisher Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ontario Institute of Cancer; Cancer Care Ontario Chair; Alan Brown Chair; Lusi Wong Programs at the Princess Margaret Hospital Foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); German Federal Ministry of Education and Research (EPIC-Heidelberg); Institut National du Cancer, France(Institut National du Cancer (INCA) France); European Community(European Commission); Norwegian Cancer Association; Functional Genomics Programme of Research Council of Norway; European Regional Development Fund(European Commission); State Budget of the Czech Republic (RECAMO); Fred Hutchinson Cancer Research Center; US NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FP7 grant; Estonian Government; EU European Regional Development Fund in the frame of Centre of Excellence in Genomics and Estonian Research Infrastructure's Roadmap; University of Tartu; IARC Postdoctoral Fellowship; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, US Public Health Service contracts NCI; American Cancer Society(American Cancer Society); NIH Genes, Environment and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); genotyping at the Johns Hopkins University Center for Inherited Disease Research; study coordination at the GENEVA Coordination Center; Cancer Prevention Research Institute of Texas; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all individuals who participated in this study. We are also grateful to the patients, clinicians and allied health care professions. We thank Z. Chen and K. Boyle for sample handling and data management of the Toronto study, and L. Admas and L.R. Zhang for field recruitment. We thank L. Su, Y. Zhao, G. Liu, J. Wain, R. Heist and K. Asomaning for providing computing support at MDACC. We thank G. Thomas and Synergy Lyon Cancer (Lyon France) for high performance computing support and J. Olivier and A. Chabrier for IARC's PGM ion torrent sequencing optimization and TaqMan genotyping, respectively. We thank D. Goldgar for sharing information from The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) on sequence variation in BRCA2 from familial breast cancer analysis. We acknowledge the Icelandic Cancer Registry (http://www.krabbameinsskrads/indexen.jsp?id=summary) for assistance in the ascertainment of the Icelandic patients with lung cancer. The ICR study made use of genotyping data from the Wellcome Trust Case-Control Consortium 2 (WTCCC2); a full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. We acknowledge The Cancer Genome Atlas (TCGA) for their contribution of lung cancer genomic data to this study (TCGA Project Number 3230). We also acknowledge support from the National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital. This study was supported by the NIH (U19CA148127, R01CA055769, 5R01CA127219, 5R01CA133996 and 5R01CA121197). The work performed at ICR was supported by Cancer Research UK (C1298/A8780 and C1298/A8362), National Cancer Research Network (NCRN), HEAL, Sanofi-Aventis and National Health Service funding to the Royal Marsden Hospital and Institute of Cancer Research, as well as the National Institute for Health Research Biomedical Research Centre. B.K. was the recipient of a Sir John Fisher Foundation PhD studentship. Work at ICR was also supported by NIH GM103534 and the Institute for Quantitative Biomedical Sciences at Dartmouth to C.I.A. The work performed in Toronto was supported by The Canadian Cancer Society Research Institute (020214), Ontario Institute of Cancer and Cancer Care Ontario Chair Award to R.J.H. and G.L. and the Alan Brown Chair and Lusi Wong Programs at the Princess Margaret Hospital Foundation. The work performed at Heidelberg was supported by Deutsche Krebshilfe (70-2387 and 70-2919) and the German Federal Ministry of Education and Research (EPIC-Heidelberg). The work performed at IARC was supported by the Institut National du Cancer, France, the European Community (LSHG-CT-2005-512113), the Norwegian Cancer Association, the Functional Genomics Programme of Research Council of Norway, the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101), the NIH (R01-CA111703 and U01-CA63673), the Fred Hutchinson Cancer Research Center, the US NCI (R01 CA092039), an FP7 grant (REGPOT 245536), the Estonian Government (SF0180142s08), the EU European Regional Development Fund in the frame of Centre of Excellence in Genomics and Estonian Research Infrastructure's Roadmap and the University of Tartu (SP1GVARENG) and an IARC Postdoctoral Fellowship (M.N.T.).; Work at the NCI was supported by the Intramural Research Program of the NIH, the NCI, US Public Health Service contracts NCI (N0I-CN-45165, N01-RC-45035, N01-RC-37004, NO1-CN-25514, NO1-CN-25515, NO1-CN-25512, NO1-CN-25513, NO1-CN-25516, NO1-CN-25511, NO1-CN25524, NO1-CN-25518, NO1-CN-75022, NO1-CN-25476 and NO1-CN-25404), the American Cancer Society, the NIH Genes, Environment and Health Initiative in part by HG-06-033-NCI-01 and RO1HL091172-01, genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C) and study coordination at the GENEVA Coordination Center (U01 HG004446). Work was also supported by NIH grants (P50 CA70907, R01CAl21197, RO1 CAl27219, U19 CA148127 and RO1 CA55769) and a Cancer Prevention Research Institute of Texas grant (RP100443). Genotyping was provided by the Center for Inherited Disease Research (CIDR). Work performed at Harvard was supported by the NIH (CA074386, CA092824 and CA090578). The Icelandic study was supported in part by NIH DA17932.	Akbari MR, 2008, ONCOGENE, V27, P1290, DOI 10.1038/sj.onc.1210739; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Cybulski C, 2008, CARCINOGENESIS, V29, P762, DOI 10.1093/carcin/bgn044; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han FF, 2013, DNA CELL BIOL, V32, P329, DOI 10.1089/dna.2013.1970; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Huang YT, 2011, P NATL ACAD SCI USA, V108, P16345, DOI 10.1073/pnas.1102769108; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; McAllister KA, 2002, CANCER RES, V62, P990; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Shi JX, 2012, CANCER DISCOV, V2, P131, DOI 10.1158/2159-8290.CD-11-0246; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu KJ, 2005, CANCER RES, V65, P417; Yano K, 2000, BIOCHEM BIOPH RES CO, V270, P171, DOI 10.1006/bbrc.2000.2392	37	252	254	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					736	741		10.1038/ng.3002	http://dx.doi.org/10.1038/ng.3002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24880342	Green Submitted, Green Accepted			2022-12-25	WOS:000338093800016
J	Gollwitzer, ES; Saglani, S; Trompette, A; Yadava, K; Sherburn, R; McCoy, KD; Nicod, LP; Lloyd, CM; Marsland, BJ				Gollwitzer, Eva S.; Saglani, Sejal; Trompette, Aurelien; Yadava, Koshika; Sherburn, Rebekah; McCoy, Kathy D.; Nicod, Laurent P.; Lloyd, Clare M.; Marsland, Benjamin J.			Lung microbiota promotes tolerance to allergens in neonates via PD-L1	NATURE MEDICINE			English	Article							EARLY-LIFE; ASTHMA; FARM; INFLAMMATION; PREGNANCY; BACTERIUM; EXPOSURE	Epidemiological data point toward a critical period in early life during which environmental cues can set an individual on a trajectory toward respiratory health or disease(1-8). The neonatal immune system matures during this period(9), although little is known about the signals that lead to its maturation. Here we report that the formation of the lung microbiota is a key parameter in this process. Immediately following birth, neonatal mice were prone to develop exaggerated airway eosinophilia, release type 2 helper T cell cytokines and exhibit airway hyper-responsiveness following exposure to house dust mite allergens, even though their lungs harbored high numbers of natural CD4(+)Foxp3(+)CD25(+)Helios(+) regulatory T (T-reg cells. During the first 2 weeks after birth, the bacterial load in the lungs increased, and representation of the bacterial phyla shifts from a predominance of Gammaproteobacteria and Firmicutes towards Bacteroidetes. The changes in the microbiota were associated with decreased aeroallergen responsiveness and the emergence of a Helios(-) T-reg cell subset that required interaction with programmed death ligand 1 (PD-L1) for development. Absence of microbial colonization(10) or blockade of PD-L1 during the first 2 weeks postpartum maintained exaggerated responsiveness to allergens through to adulthood. Adoptive transfer of Treg cells from adult mice to neonates before aeroallergen exposure ameliorated disease. Thus, formation of the airway microbiota induces regulatory cells early in life, which, when dysregulated, can lead to sustained susceptibility to allergic airway inflammation in adulthood.	[Gollwitzer, Eva S.; Trompette, Aurelien; Yadava, Koshika; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, Fac Biol & Med, Ctr Hosp Univ Vaudois CHUV BH19206, Serv Pneumol, Lausanne, Switzerland; [Saglani, Sejal; Sherburn, Rebekah; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England; [McCoy, Kathy D.] Univ Bern, Univ Clin Visceral Surg & Med, Maurice Muller Labs, Bern, Switzerland	University of Lausanne; Imperial College London; University of Bern; University Hospital of Bern	Marsland, BJ (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Hosp Univ Vaudois CHUV BH19206, Serv Pneumol, Lausanne, Switzerland.	benjamin.marsland@chuv.ch	Nicod, Laurent/ABD-3360-2020; Sherburn, Rebekah/AAB-5414-2022; Saglani, Sejal/AAE-5072-2019; McCoy, Kathy/ABD-5814-2021	Nicod, Laurent P/0000-0002-0905-916X; Lloyd, Clare/0000-0001-8977-6726; Saglani, Sejal/0000-0001-5192-6418; Marsland, Benjamin/0000-0003-1457-3160; Sherburn, Rebekah/0000-0002-1683-3977	Leenaards Foundation in Lausanne; Swiss National Science Foundation [310030_146983]; Wellcome Trust [087618/Z/08/Z, 083586/Z/07/Z]; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Leenaards Foundation in Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work is supported by the Leenaards Foundation in Lausanne and the Swiss National Science Foundation grant 310030_146983, awarded to B.J.M. B.J.M. is a Cloetta Medical Research Fellow and, by holding this title, receives financial support. B.J.M. and C.M.L. are part of the European Cooperation in Science and Technology Action BM1201, Developmental Origins of Chronic Lung Disease. S.S. and C.M.L. are supported by the Wellcome Trust grants 087618/Z/08/Z and 083586/Z/07/Z. C.M.L. is a Wellcome Senior Fellow in Basic Biomedical Science and, by holding this title, receives financial support. We thank D. Pinschewer and S. Kallert for valuable discussions and critical feedback.	Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Gern JE, 2005, J ALLERGY CLIN IMMUN, V115, P668, DOI 10.1016/j.jaci.2005.01.057; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jackson DJ, 2010, CURR OPIN ALLERGY CL, V10, P133, DOI 10.1097/ACI.0b013e3283352f7c; Lee SL, 2012, SCI WORLD J, DOI 10.1100/2012/542983; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Marsland BJ, 2013, CHEST, V144, P632, DOI 10.1378/chest.12-2854; Nembrini C, 2011, THORAX, V66, P755, DOI 10.1136/thx.2010.152512; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Twigg HL, 2013, LANCET RESP MED, V1, P354, DOI 10.1016/S2213-2600(13)70117-6; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wu PS, 2011, EXPERT REV ANTI-INFE, V9, P731, DOI [10.1586/eri.11.92, 10.1586/ERI.11.92]	30	357	370	3	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					642	647		10.1038/nm.3568	http://dx.doi.org/10.1038/nm.3568			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24813249				2022-12-25	WOS:000337071000026
J	Kleinstreuer, NC; Yang, J; Berg, EL; Knudsen, TB; Richard, AM; Martin, MT; Reif, DM; Judson, RS; Polokoff, M; Dix, DJ; Kavlock, RJ; Houck, KA				Kleinstreuer, Nicole C.; Yang, Jian; Berg, Ellen L.; Knudsen, Thomas B.; Richard, Ann M.; Martin, Matthew T.; Reif, David M.; Judson, Richard S.; Polokoff, Mark; Dix, David J.; Kavlock, Robert J.; Houck, Keith A.			Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms	NATURE BIOTECHNOLOGY			English	Article							MAP KINASE INHIBITOR; DRUG DISCOVERY; PERFLUOROOCTANE SULFONATE; ENVIRONMENTAL CHEMICALS; RHEUMATOID-ARTHRITIS; PREDICTIVE MODELS; BIOLOGY APPROACH; BIOMAP ANALYSIS; BREAST-CANCER; RECEPTOR	Addressing the safety aspects of drugs and environmental chemicals has historically been undertaken through animal testing. However, the quantity of chemicals in need of assessment and the challenges of species extrapolation require the development of alternative approaches. Our approach, the US Environmental Protection Agency's ToxCast program, utilizes a large suite of in vitro and model organism assays to interrogate important chemical libraries and computationally analyze bioactivity profiles. Here we evaluated one component of the ToxCast program, the use of primary human cell systems, by screening for chemicals that disrupt physiologically important pathways. Chemical-response signatures for 87 endpoints covering molecular functions relevant to toxic and therapeutic pathways were generated in eight cell systems for 641 environmental chemicals and 135 reference pharmaceuticals and failed drugs. Computational clustering of the profiling data provided insights into the polypharmacology and potential off-target effects for many chemicals that have limited or no toxicity information. The endpoints measured can be closely linked to in vivo outcomes, such as the upregulation of tissue factor in endothelial cell systems by compounds linked to the risk of thrombosis in vivo. Our results demonstrate that assaying complex biological pathways in primary human cells can identify potential chemical targets, toxicological liabilities and mechanisms useful for elucidating adverse outcome pathways.	[Kleinstreuer, Nicole C.; Knudsen, Thomas B.; Richard, Ann M.; Martin, Matthew T.; Reif, David M.; Judson, Richard S.; Dix, David J.; Kavlock, Robert J.; Houck, Keith A.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Yang, Jian; Berg, Ellen L.; Polokoff, Mark] Div DiscoveRx Inc, BioSeek, San Francisco, CA USA	United States Environmental Protection Agency	Houck, KA (corresponding author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	houck.keith@epa.gov	Houck, Keith/G-8654-2014; Berg, Ellen/T-8827-2019; Kleinstreuer, Nicole/F-7203-2019; Berg, Ellen/D-9076-2014	Houck, Keith/0000-0002-0055-2249; Kleinstreuer, Nicole/0000-0002-7914-3682; Reif, David/0000-0001-7815-6767; Berg, Ellen/0000-0001-5149-6665; Judson, Richard/0000-0002-2348-9633				AIZUYOKOTA E, 1994, CARCINOGENESIS, V15, P1875, DOI 10.1093/carcin/15.9.1875; Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015; Augustine-Rauch KA, 2004, BIRTH DEFECTS RES A, V70, P789, DOI 10.1002/bdra.20076; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154; Berg EL, 2005, IEE P SYST BIOL, V152, P201, DOI 10.1049/ip-syb:20050036; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Berg EL, 2013, J BIOMOL SCREEN, V18, P1260, DOI 10.1177/1087057113505324; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bogdanska J, 2011, TOXICOLOGY, V284, P54, DOI 10.1016/j.tox.2011.03.014; Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845; Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Clark RD, 2000, J MOL GRAPH MODEL, V18, P404, DOI 10.1016/S1093-3263(00)00065-6; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Ding CH, 2006, CURR OPIN INVEST DR, V7, P1020; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Fell MJ, 2010, NEUROPHARMACOLOGY, V58, P632, DOI 10.1016/j.neuropharm.2009.11.014; Houck KA, 2008, TOXICOL APPL PHARM, V227, P163, DOI 10.1016/j.taap.2007.10.022; Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Khaidakov M, 2009, BIOCHEM BIOPH RES CO, V387, P543, DOI 10.1016/j.bbrc.2009.07.057; Kirkiacharian S., 1999, Annales Pharmaceutiques Francaises, V57, P332; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; LIPTON A, 1984, CANCER TREAT REP, V68, P887; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977; McCann FE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3041; Melrose J, 1998, J IMMUNOL, V161, P2457; Murotani T, 2011, NEUROPHARMACOLOGY, V61, P228, DOI 10.1016/j.neuropharm.2011.04.003; National Research Council, 2007, TOX TEST 21 CENT VIS; Ouattara B, 2010, NEUROSCIENCE, V167, P1160, DOI 10.1016/j.neuroscience.2010.03.022; Owens AP, 2012, CURR ATHEROSCLER REP, V14, P394, DOI 10.1007/s11883-012-0269-5; Plavec I, 2004, P NATL ACAD SCI USA, V101, P1223, DOI 10.1073/pnas.0308221100; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220; Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; U.S. Environmental Protection Agency (EPA), 2021, PFAS STRAT ROADM EPA; Viguerie N, 2012, PHYSIOL GENOMICS, V44, P141, DOI 10.1152/physiolgenomics.00032.2011; Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010	52	138	142	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					583	+		10.1038/nbt.2914	http://dx.doi.org/10.1038/nbt.2914			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24837663				2022-12-25	WOS:000337233800022
J	Schwab, L; Goroncy, L; Palaniyandi, S; Gautam, S; Triantafyllopoulou, A; Mocsai, A; Reichardt, W; Karlsson, FJ; Radhakrishnan, SV; Hanke, K; Schmitt-Graeff, A; Freudenberg, M; von Loewenich, FD; Wolf, P; Leonhardt, F; Baxan, N; Pfeifer, D; Schmah, O; Schonle, A; Martin, SF; Mertelsmann, R; Duyster, J; Finke, J; Prinz, M; Henneke, P; Hacker, H; Hildebrandt, GC; Hacker, G; Zeiser, R				Schwab, Lukas; Goroncy, Luise; Palaniyandi, Senthilnathan; Gautam, Sanjivan; Triantafyllopoulou, Antigoni; Mocsai, Attila; Reichardt, Wilfried; Karlsson, Fridrik J.; Radhakrishnan, Sabarinath V.; Hanke, Kathrin; Schmitt-Graeff, Annette; Freudenberg, Marina; von Loewenich, Friederike D.; Wolf, Philipp; Leonhardt, Franziska; Baxan, Nicoleta; Pfeifer, Dietmar; Schmah, Oliver; Schoenle, Anne; Martin, Stefan F.; Mertelsmann, Roland; Duyster, Justus; Finke, Juergen; Prinz, Marco; Henneke, Philipp; Haecker, Hans; Hildebrandt, Gerhard C.; Haecker, Georg; Zeiser, Robert			Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage	NATURE MEDICINE			English	Article							CELLS; SURVIVAL; MACROPHAGES; APOPTOSIS; TARGET; ALPHA; LIVER; TNF	Acute graft-versus-host disease (GVHD) considerably limits wider usage of allogeneic hematopoietic cell transplantation (allo-HCT). Antigen-presenting cells and T cells are populations customarily associated with GVHD pathogenesis. Of note, neutrophils are the largest human white blood cell population. The cells cleave chemokines and produce reactive oxygen species, thereby promoting T cell activation(1,2). Therefore, during an allogeneic immune response, neutrophils could amplify tissue damage caused by conditioning regimens. We analyzed neutrophil infiltration of the mouse ileum after allo-HCT by in vivo myeloperoxidase imaging and found that infiltration levels were dependent on the local microbial flora and were not detectable under germ-free conditions. Physical or genetic depletion of neutrophils reduced GVHD-related mortality. The contribution of neutrophils to GVHD severity required reactive oxygen species (ROS) because selective Cybb (encoding cytochrome b-245, beta polypeptide, also known as NOX2) deficiency in neutrophils impairing ROS production led to lower levels of tissue damage, GVHD-related mortality and effector phenotype T cells. Enhanced survival of BcI-xL transgenic neutrophils increased GVHD severity. In contrast, when we transferred neutrophils lacking Toll-like receptor-2 (TLR2), TLR3, TLR4, TLR7 and TLR9, which are normally less strongly activated by translocating bacteria, into wild-type C57BL/6 mice, GVHD severity was reduced. In humans, severity of intestinal GVHD strongly correlated with levels of neutrophils present in GVHD lesions. This study describes a new potential role for neutrophils in the pathogenesis of GVHD in both mice and humans.	[Schwab, Lukas; Goroncy, Luise; Hanke, Kathrin; Pfeifer, Dietmar; Schmah, Oliver; Schoenle, Anne; Mertelsmann, Roland; Duyster, Justus; Finke, Juergen; Zeiser, Robert] Univ Med Ctr, Dept Hematol & Oncol, Freiburg, Germany; [Goroncy, Luise; Gautam, Sanjivan; Hanke, Kathrin; Leonhardt, Franziska] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Palaniyandi, Senthilnathan; Radhakrishnan, Sabarinath V.; Hildebrandt, Gerhard C.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Div Hematol & Oncol, Shreveport, LA 71105 USA; [Palaniyandi, Senthilnathan; Radhakrishnan, Sabarinath V.; Hildebrandt, Gerhard C.] Univ Utah, Sch Med, Div Bone Marrow Transplantat, Huntsman Canc Inst, Salt Lake City, UT USA; [Gautam, Sanjivan; von Loewenich, Friederike D.; Haecker, Georg] Univ Med Ctr, Dept Med Microbiol & Hyg, Freiburg, Germany; [Gautam, Sanjivan; Prinz, Marco; Haecker, Georg; Zeiser, Robert] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Triantafyllopoulou, Antigoni; Henneke, Philipp] Univ Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg, Germany; [Mocsai, Attila] Semmelweis Univ, Sch Med, Dept Physiol, Budapest, Hungary; [Reichardt, Wilfried; Baxan, Nicoleta] Univ Med Ctr, Dept Radiol Med Phys, Freiburg, Germany; [Schmitt-Graeff, Annette] Univ Freiburg, Univ Med Ctr, Dept Pathol, D-79106 Freiburg, Germany; [Freudenberg, Marina] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Freudenberg, Marina; Zeiser, Robert] Univ Freiburg, Ctr Biol Signaling Studies MOSS, D-79106 Freiburg, Germany; [Pfeifer, Dietmar] Univ Med Ctr, Dept Urol, Freiburg, Germany; [Martin, Stefan F.] Univ Freiburg, Dept Dermatol, Univ Med Ctr, Allergy Res Grp, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Med Ctr, Dept Neuropathol, Freiburg, Germany; [Henneke, Philipp] Univ Med Ctr, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Haecker, Hans] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University of Freiburg; University of Freiburg; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Freiburg; University of Freiburg; University of Freiburg; Semmelweis University; University of Freiburg; University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; St Jude Children's Research Hospital	Zeiser, R (corresponding author), Univ Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.	robert.zeiser@uniklinik-freiburg.de	Haecker, Hans/F-6826-2013; Mocsai, Attila/B-2792-2008; Loewenich, Friederike/AAL-1587-2020; Baxan, Nicoleta/AAF-5147-2020; Wolf, Philipp/C-8233-2018; Reichardt, Wilfried/K-6727-2013	Haecker, Hans/0000-0001-5971-0451; Baxan, Nicoleta/0000-0002-5165-4691; Zeiser, Robert/0000-0001-6565-3393; Mocsai, Attila/0000-0002-0512-1157; Freudenberg, Marina Alexandra/0000-0001-5894-1805; Reichardt, Wilfried/0000-0002-8888-399X; Wolf, Philipp/0000-0001-6779-4325; Palaniyandi, Senthilnathan/0000-0002-9611-0321	Deutsche Jose Carreras Leukamie Stiftung (DJCLS) [R12/11]; Deutsche Forschungsgemeinschaft (DFG), Germany; Heisenberg Professorship [DFG ZE 872/3-1]; DFG [DFG ZE 872/1-2]; Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); Excellence Initiative of the German Research Foundation (BIOSS II) [B13]; Deutsche Krebshilfe; Marie Curie [FP7-IRG268390]; IDEA award (LSU Health Sciences Center); European Research Council; Wellcome Trust; American Lebanese Syrian Associated Charities (ALSAC);  [SFB 850]	Deutsche Jose Carreras Leukamie Stiftung (DJCLS); Deutsche Forschungsgemeinschaft (DFG), Germany(German Research Foundation (DFG)); Heisenberg Professorship(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); Excellence Initiative of the German Research Foundation (BIOSS II); Deutsche Krebshilfe(Deutsche Krebshilfe); Marie Curie(European Commission); IDEA award (LSU Health Sciences Center); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); 	This study was supported by the Deutsche Jose Carreras Leukamie Stiftung (DJCLS grant # R12/11), Deutsche Forschungsgemeinschaft (DFG), Germany, Heisenberg Professorship to R.Z. (DFG ZE 872/3-1) and DFG individual grant to R.Z. (DFG ZE 872/1-2), in part by SFB 850 (to R.Z.), Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School to R.Z. and G.H. and BIOSS II, project no. B13 to R.Z.), Deutsche Krebshilfe (to R.Z.), and Marie Curie FP7-IRG268390 (to A.T.) and also in part by the IDEA 2012 award (LSU Health Sciences Center, to G.C.H.). A.M. was funded by the European Research Council and the Wellcome Trust. H.H. was supported by the American Lebanese Syrian Associated Charities (ALSAC). We thank M. Folio for proofreading the manuscript.	Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fischer MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002374; Forlenza M, 2008, MOL IMMUNOL, V45, P3178, DOI 10.1016/j.molimm.2008.02.025; Gautam S, 2013, CELL DEATH DIFFER, V20, P1068, DOI 10.1038/cdd.2013.39; Giroux M, 2011, BLOOD, V117, P1734, DOI 10.1182/blood-2010-05-287649; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hill GR, 1999, J CLIN INVEST, V104, P459, DOI 10.1172/JCI6896; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Leonhardt F, 2012, LEUKEMIA, V26, P1617, DOI 10.1038/leu.2012.10; Leonhardt F, 2013, BLOOD, V121, P3307, DOI 10.1182/blood-2012-07-442665; Li HM, 2011, J IMMUNOL, V186, P230, DOI 10.4049/jimmunol.1002965; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Seger RA, 2002, BLOOD, V100, P4344, DOI 10.1182/blood-2002-02-0583; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sitia G, 2002, P NATL ACAD SCI USA, V99, P13717, DOI 10.1073/pnas.172521999; Socie G, 2004, BLOOD, V103, P50, DOI 10.1182/blood-2003-03-0909; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Yasuda M, 2012, AM J PHYSIOL-GASTR L, V302, pG1133, DOI 10.1152/ajpgi.00535.2011; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051; Ziegler TR, 2001, TRANSPLANTATION, V72, P1354, DOI 10.1097/00007890-200110270-00004	31	169	171	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					648	654		10.1038/nm.3517	http://dx.doi.org/10.1038/nm.3517			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24836575				2022-12-25	WOS:000337071000027
J	Sykora, J; Brezovsky, J; Koudelakova, T; Lahoda, M; Fortova, A; Chernovets, T; Chaloupkova, R; Stepankova, V; Prokop, Z; Smatanova, IK; Hof, M; Damborsky, J				Sykora, Jan; Brezovsky, Jan; Koudelakova, Tana; Lahoda, Maryna; Fortova, Andrea; Chernovets, Tatsiana; Chaloupkova, Radka; Stepankova, Veronika; Prokop, Zbynek; Smatanova, Ivana Kuta; Hof, Martin; Damborsky, Jiri			Dynamics and hydration explain failed functional transformation in dehalogenase design	NATURE CHEMICAL BIOLOGY			English	Article							COMPUTATIONAL ENZYME DESIGN; HALOALKANE DEHALOGENASES; SOLVATION DYNAMICS; KEMP ELIMINASE; STOKES SHIFT; CATALYSIS; STABILITY; PROTEINS	We emphasize the importance of dynamics and hydration for enzymatic catalysis and protein design by transplanting the active site from a haloalkane dehalogenase with high enantioselectivity to nonselective dehalogenase. Protein crystallography confirms that the active site geometry of the redesigned dehalogenase matches that of the target, but its enantioselectivity remains low. Time-dependent fluorescence shifts and computer simulations revealed that dynamics and hydration at the tunnel mouth differ substantially between the redesigned and target dehalogenase.	[Sykora, Jan; Chernovets, Tatsiana; Hof, Martin] Acad Sci Czech Republic, Vvi, J Heyrovsky Inst Phys Chem, Prague, Czech Republic; [Brezovsky, Jan; Koudelakova, Tana; Fortova, Andrea; Chaloupkova, Radka; Stepankova, Veronika; Prokop, Zbynek; Damborsky, Jiri] Masaryk Univ, Fac Sci, Dept Expt Biol, Loschmidt Labs, CS-61137 Brno, Czech Republic; [Brezovsky, Jan; Koudelakova, Tana; Fortova, Andrea; Chaloupkova, Radka; Stepankova, Veronika; Prokop, Zbynek; Damborsky, Jiri] Masaryk Univ, Fac Sci, Res Ctr Toxic Cpds Environm RECETOX, CS-61137 Brno, Czech Republic; [Lahoda, Maryna; Smatanova, Ivana Kuta] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Lahoda, Maryna; Smatanova, Ivana Kuta] ASCR, Vvi, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic; [Prokop, Zbynek; Damborsky, Jiri] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic	Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; Masaryk University Brno; Masaryk University Brno; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; St Anne's University Hospital Brno (FNUSA-ICRC)	Sykora, J (corresponding author), Acad Sci Czech Republic, Vvi, J Heyrovsky Inst Phys Chem, Prague, Czech Republic.	martin.hof@jh-inst.cas.cz; jiri@chemi.muni.cz	Smatanova, Ivana Kuta/H-6516-2014; Hof, Martin/F-5134-2014; Sykora, Jan/F-5179-2014; Koudelakova, Tana/M-5567-2016; Charnavets, Tatsiana/G-5338-2014; Koudelakova, Tana/AAX-1332-2020; Prokop, Zbynek/H-5707-2012; Damborsky, Jiri/H-3799-2012; Chaloupkova, Radka/M-5565-2016; Brezovsky, Jan/C-8290-2012; Charnavets, Tania/AAY-1628-2021; Charnavets, Tatsiana/AAR-4432-2020	Smatanova, Ivana Kuta/0000-0002-1337-9481; Hof, Martin/0000-0003-2884-3037; Koudelakova, Tana/0000-0003-0578-5268; Prokop, Zbynek/0000-0001-9358-4081; Damborsky, Jiri/0000-0002-7848-8216; Chaloupkova, Radka/0000-0002-3539-7445; Brezovsky, Jan/0000-0001-9677-5078; 	European Regional Development Fund [CZ.1.05/1.1.00/02.0123]; Czech Ministry of Education [LO1214]; Czech Science Foundation [P208/12/G016, P503/12/0572]; 'Employment of Best Young Scientists for International Cooperation Empowerment' program [CZ1.07/2.3.00/30.0037]; European Social Fund; state budget of the Czech Republic	European Regional Development Fund(European Commission); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); 'Employment of Best Young Scientists for International Cooperation Empowerment' program; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	We thank D. Baker (University of Washington) for helpful comments on the manuscript. This work was supported by the European Regional Development Fund (CZ.1.05/1.1.00/02.0123), the Czech Ministry of Education (LO1214), the Czech Science Foundation (P208/12/G016 to J.S. and M.H. and P503/12/0572 to J.D.) and the 'Employment of Best Young Scientists for International Cooperation Empowerment' program (CZ1.07/2.3.00/30.0037 to J.B.), financed by both the European Social Fund and the state budget of the Czech Republic. The Academy of Sciences is acknowledged for the Praemium Academie award (M.H.). CERIT Scientific Cloud is acknowledged for providing access to their computing facilities under the Center CERIT Scientific Cloud program (CZ.1.05/3.2.00108.0144).	Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Chang CW, 2010, P NATL ACAD SCI USA, V107, P2914, DOI 10.1073/pnas.1000001107; Chovancova E, 2007, PROTEINS, V67, P305, DOI 10.1002/prot.21313; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Damborsky J, 2014, CURR OPIN CHEM BIOL, V19, P8, DOI 10.1016/j.cbpa.2013.12.003; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Halle B, 2009, J PHYS CHEM B, V113, P8210, DOI 10.1021/jp9027589; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Jesenska A, 2009, J AM CHEM SOC, V131, P494, DOI 10.1021/ja804020q; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0; Jurkiewicz P, 2012, BIOCHIMIE, V94, P26, DOI 10.1016/j.biochi.2011.06.027; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; Kries H, 2013, CURR OPIN CHEM BIOL, V17, P221, DOI 10.1016/j.cbpa.2013.02.012; Kulakova AN, 1997, MICROBIOL-SGM, V143, P109, DOI 10.1099/00221287-143-1-109; Nilsson L, 2005, P NATL ACAD SCI USA, V102, P13867, DOI 10.1073/pnas.0504181102; Prokop Z, 2010, ANGEW CHEM INT EDIT, V49, P6111, DOI 10.1002/anie.201001753; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sato Y, 2005, APPL ENVIRON MICROB, V71, P4372, DOI 10.1128/AEM.71.8.4372-4379.2005; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239	25	40	40	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					428	430		10.1038/nchembio.1502	http://dx.doi.org/10.1038/nchembio.1502			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24727901				2022-12-25	WOS:000336238200008
J	Li, YB; Fan, CC; Xing, YZ; Yun, P; Luo, LJ; Yan, B; Peng, B; Xie, WB; Wang, GW; Li, XH; Xiao, JH; Xu, CG; He, YQ				Li, Yibo; Fan, Chuchuan; Xing, Yongzhong; Yun, Peng; Luo, Lijun; Yan, Bao; Peng, Bo; Xie, Weibo; Wang, Gongwei; Li, Xianghua; Xiao, Jinghua; Xu, Caiguo; He, Yuqing			Chalk5 encodes a vacuolar H+-translocating pyrophosphatase influencing grain chalkiness in rice	NATURE GENETICS			English	Article							GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HIGH-TEMPERATURE; EATING QUALITY; MEMBRANE; PROMOTER; PLANT; ELEMENTS; COOKING; SIZE	Grain chalkiness is a highly undesirable quality trait in the marketing and consumption of rice grain(1-6). However, the molecular basis of this trait is poorly understood. Here we show that a major quantitative trait locus (QTL), Chalk5, influences grain chalkiness, which also affects head rice yield and many other quality traits. Chalk5 encodes a vacuolar H+- translocating pyrophosphatase (V-PPase) with inorganic pyrophosphate (PPi) hydrolysis and H+- translocation activity. Elevated expression of Chalk5 increases the chalkiness of the endosperm, putatively by disturbing the pH homeostasis of the endomembrane trafficking system in developing seeds, which affects the biogenesis of protein bodies and is coupled with a great increase in small vesicle-like structures, thus forming air spaces among endosperm storage substances and resulting in chalky grain. Our results indicate that two consensus nucleotide polymorphisms in the Chalk5 promoter in rice varieties might partly account for the differences in Chalk5 mRNA levels that contribute to natural variation in grain chalkiness.	[Li, Yibo; Fan, Chuchuan; Xing, Yongzhong; Yun, Peng; Yan, Bao; Peng, Bo; Xie, Weibo; Wang, Gongwei; Li, Xianghua; Xiao, Jinghua; Xu, Caiguo; He, Yuqing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Huazhong Agricultural University	He, YQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yqhe@mail.hzau.edu.cn	Xie, Weibo/B-3771-2008; Xie, Weibo/AAI-2412-2021; Li, Yibo/ABG-8178-2020	Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; Li, Yibo/0000-0001-6105-1969; Fan, Chuchuan/0000-0001-8443-7194; Xing, Yongzhong/0000-0003-1376-1514	National 863 Project [2012AA10A303]; National Program on the Development of Basic Research [2011CB100200]; National Program on Research & Development of Transgenic Plants [2013ZX08009003-004]; China Agriculture Research System [CARS-01-03]; National Natural Science Foundation of China [31171523 and 31300992]	National 863 Project(National High Technology Research and Development Program of China); National Program on the Development of Basic Research(National Basic Research Program of China); National Program on Research & Development of Transgenic Plants; China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Q. Zhang, L. Jiang, J. Chen, W. Yao, H. Zhou, L. Wang, J. Cao, X. Lian, Y. Jiang, L. Sun, P. Li, C. Xiao, L. Qiu, P. Chen, Q. Zhang and G. Gao for editing, suggestions and assistance. This work was supported by grants from the National 863 Project (2012AA10A303), the National Program on the Development of Basic Research (2011CB100200), the National Program on Research & Development of Transgenic Plants (2013ZX08009003-004), the earmarked fund for the China Agriculture Research System (CARS-01-03) and the National Natural Science Foundation of China (31171523 and 31300992) and by the Bill and Melinda Gates Foundation.	Bowles D, 2012, CURR OPIN BIOTECH, V23, P202, DOI 10.1016/j.copbio.2011.12.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARYSTINOS GD, 1995, PLANT PHYSIOL, V108, P641, DOI 10.1104/pp.108.2.641; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng FM, 2005, FOOD CHEM, V90, P39, DOI 10.1016/j.foodchem.2004.03.018; Delgado-Alvarado A, 2007, PLANT CELL ENVIRON, V30, P225, DOI 10.1111/j.1365-3040.2006.01622.x; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Fernie AR, 2006, CURR OPIN PLANT BIOL, V9, P196, DOI 10.1016/j.pbi.2006.01.010; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; He P, 1999, THEOR APPL GENET, V98, P502, DOI 10.1007/s001220051098; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Herman EM, 1999, PLANT CELL, V11, P601, DOI 10.1105/tpc.11.4.601; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Kang H, 2012, PLANT CELL, V24, P5058, DOI 10.1105/tpc.112.103481; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi A, 2007, BREEDING SCI, V57, P107, DOI 10.1270/jsbbs.57.107; Lanning SB, 2011, FIELD CROP RES, V124, P132, DOI 10.1016/j.fcr.2011.06.012; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Liu XL, 2011, GENOME, V54, P64, DOI 10.1139/G10-070; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; Perbandt D, 2010, BIOENERG RES, V3, P194, DOI 10.1007/s12155-009-9062-x; Schumacher K, 2006, CURR OPIN PLANT BIOL, V9, P595, DOI 10.1016/j.pbi.2006.09.001; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shi CH, 2002, FIELD CROP RES, V76, P1, DOI 10.1016/S0378-4290(02)00011-4; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Siebenmorgen TJ, 2013, ANNU REV FOOD SCI T, V4, P101, DOI 10.1146/annurev-food-030212-182644; Singh N, 2003, FOOD CHEM, V82, P433, DOI 10.1016/S0308-8146(03)00007-4; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Tan YF, 1999, THEOR APPL GENET, V99, P642, DOI 10.1007/s001220051279; Walker RP, 2011, PLANT PHYSIOL BIOCH, V49, P923, DOI 10.1016/j.plaphy.2011.06.004; Walker RP, 1999, PLANTA, V210, P9, DOI 10.1007/s004250050648; Wan XY, 2005, THEOR APPL GENET, V110, P1334, DOI 10.1007/s00122-005-1976-x; Wang CR, 2011, THEOR APPL GENET, V122, P905, DOI 10.1007/s00122-010-1497-0; Wang YH, 2010, PLANT J, V64, P812, DOI 10.1111/j.1365-313X.2010.04370.x; Wen WW, 2009, THEOR APPL GENET, V119, P459, DOI 10.1007/s00122-009-1052-z; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yamakawa H, 2008, BREEDING SCI, V58, P337, DOI 10.1270/jsbbs.58.337; Yoshida S, 2002, BREEDING SCI, V52, P309, DOI 10.1270/jsbbs.52.309; Zhang HL, 2011, THEOR APPL GENET, V122, P49, DOI 10.1007/s00122-010-1421-7; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0; Zouhar J, 2009, CURR OPIN PLANT BIOL, V12, P677, DOI 10.1016/j.pbi.2009.08.004	53	203	253	11	192	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					398	+		10.1038/ng.2923	http://dx.doi.org/10.1038/ng.2923			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24633159				2022-12-25	WOS:000334510100019
J	Vakoc, CR; Garcia-Manero, G; Look, AT				Vakoc, Christopher R.; Garcia-Manero, Guillermo; Look, A. Thomas			Cancer therapy resistance: chasing epigenetics	NATURE MEDICINE			English	Editorial Material									[Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Look, A. Thomas] Harvard Univ, Childrens Hosp Boston, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA	Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NCI NIH HHS [R01 CA174793] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA174793] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	5	5	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					340	341		10.1038/nm.3528	http://dx.doi.org/10.1038/nm.3528			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710376				2022-12-25	WOS:000334361500012
J	Anders, L; Guenther, MG; Qi, J; Fan, ZP; Marineau, JJ; Rahl, PB; Loven, J; Sigova, AA; Smith, WB; Lee, TI; Bradner, JE; Young, RA				Anders, Lars; Guenther, Matthew G.; Qi, Jun; Fan, Zi Peng; Marineau, Jason J.; Rahl, Peter B.; Loven, Jakob; Sigova, Alla A.; Smith, William B.; Lee, Tong Ihn; Bradner, James E.; Young, Richard A.			Genome-wide localization of small molecules	NATURE BIOTECHNOLOGY			English	Article							DEPENDENT KINASE INHIBITOR; SELECTIVE-INHIBITION; GENE-EXPRESSION; DRUG DISCOVERY; C-MYC; CHROMATIN; TARGET; LEUKEMIA; CANCER; BROMODOMAINS	A vast number of small-molecule ligands, including therapeutic drugs under development and in clinical use, elicit their effects by binding specific proteins associated with the genome. An ability to map the direct interactions of a chemical entity with chromatin genome-wide could provide important insights into chemical perturbation of cellular function. Here we describe a method that couples ligand-affinity capture and massively parallel DNA sequencing (Chem-seq) to identify the sites bound by small chemical molecules throughout the human genome. We show how Chem-seq can be combined with ChIP-seq to gain unique insights into the interaction of drugs with their target proteins throughout the genome of tumor cells. These methods will be broadly useful to enhance understanding of therapeutic action and to characterize the specificity of chemical entities that interact with DNA or genome-associated proteins.	[Anders, Lars; Guenther, Matthew G.; Fan, Zi Peng; Rahl, Peter B.; Loven, Jakob; Sigova, Alla A.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Qi, Jun; Marineau, Jason J.; Smith, William B.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	james_bradner@dfci.harvard.edu; young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	US National Institutes of Health [HG002668, CA109901, CA146445]; Swedish Research Council [VR-B0086301]; American Cancer Society [PF-11-042-01-DMC]; Leukemia & Lymphoma Society; Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA146445, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Volkert, J. Love, J.-A. Kwon and S. Gupta at the Whitehead Genome Technology Core for Solexa sequencing, E. Cohick for help with cell culture, and A. Federation and R. St. Pierre at the Dana-Farber Cancer Institute for biochemistry support. This work was supported by US National Institutes of Health grants HG002668 (R.A.Y.), CA109901 (R.A.Y.) and CA146445 (R.A.Y., T. I. L.), Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J. L.), American Cancer Society Postdoctoral Fellowship PF-11-042-01-DMC (P. B. R.), the Leukemia & Lymphoma Society (J. Q. and J. E. B.) and the Damon-Runyon Cancer Research Foundation (J.E.B.).	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deshpande AJ, 2012, TRENDS IMMUNOL, V33, P563, DOI 10.1016/j.it.2012.06.002; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raida M, 2011, CURR OPIN CHEM BIOL, V15, P570, DOI 10.1016/j.cbpa.2011.06.016; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Santo L, 2010, ONCOGENE, V29, P2325, DOI 10.1038/onc.2009.510; Squires MS, 2010, MOL CANCER THER, V9, P920, DOI 10.1158/1535-7163.MCT-09-1071; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tung SY, 2012, CELL MOL LIFE SCI, V69, P641, DOI 10.1007/s00018-011-0771-x; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	43	128	153	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					92	+		10.1038/nbt.2776	http://dx.doi.org/10.1038/nbt.2776			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24336317	Green Submitted, Green Accepted			2022-12-25	WOS:000329513000023
J	Bock, A; Chirinda, B; Krebs, F; Messerer, R; Batz, J; Muth, M; Dallanoce, C; Klingenthal, D; Trankle, C; Hoffmann, C; De Amici, M; Holzgrabe, U; Kostenis, E; Mohr, K				Bock, Andreas; Chirinda, Brian; Krebs, Fabian; Messerer, Regina; Baetz, Julia; Muth, Mathias; Dallanoce, Clelia; Klingenthal, Dominika; Traenkle, Christian; Hoffmann, Carsten; De Amici, Marco; Holzgrabe, Ulrike; Kostenis, Evi; Mohr, Klaus			Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor	NATURE CHEMICAL BIOLOGY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; ALLOSTERIC MODULATION; LIVING CELLS; ACTIVATION; EFFICACY; OXOTREMORINE; SELECTIVITY	We present a new concept of partial agonism at G protein-coupled receptors. We demonstrate the coexistence of two functionally distinct populations of the muscarinic M-2 receptor stabilized by one dynamic ligand, which binds in two opposite orientations. The ratio of orientations determines the cellular response. Our concept allows predicting and virtually titrating ligand efficacy, which opens unprecedented opportunities for the design of drugs with graded activation of the biological system.	[Bock, Andreas; Chirinda, Brian; Krebs, Fabian; Klingenthal, Dominika; Traenkle, Christian; Mohr, Klaus] Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, Bonn, Germany; [Messerer, Regina; Muth, Mathias; Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm, Dept Pharmaceut Chem, D-97070 Wurzburg, Germany; [Baetz, Julia; Hoffmann, Carsten] Univ Wurzburg, Bioimaging Ctr, Rudolf Virchow Zentrum, D-97070 Wurzburg, Germany; [Bock, Andreas; Chirinda, Brian; Krebs, Fabian; Baetz, Julia; Klingenthal, Dominika; Traenkle, Christian; Hoffmann, Carsten; Mohr, Klaus] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Dallanoce, Clelia; De Amici, Marco] Univ Milan, Sez Chim Farmaceut Pietro Pratesi, Dipartimento Sci Farmaceut, Milan, Italy; [Kostenis, Evi] Univ Bonn, Mol Cellular & Pharmacobiol Sect, Inst Pharmaceut Biol, Bonn, Germany	University of Bonn; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Milan; University of Bonn	Bock, A (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	k.mohr@uni-bonn.de	; De Amici, Marco/F-9684-2015	Holzgrabe, Ulrike/0000-0002-0364-7278; Dallanoce, Clelia/0000-0002-7383-1484; De Amici, Marco/0000-0002-0236-0662; Bock, Andreas/0000-0002-6344-6494	Deutsche Forschungsgemeinschaft (DFG) [MO 821/2-1, HO 1368/12-1, KO 1583/3-1, SFB487 TPA1]; North-Rhine-Westphalia International Graduate Research School BIOTECH-PHARMA at the University of Bonn	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); North-Rhine-Westphalia International Graduate Research School BIOTECH-PHARMA at the University of Bonn	We thank M. Kepe for excellent technical assistance and Corning Inc. for their support on the Epic system. A. B. is a member of the graduate school Theoretical and Experimental Medicine at the University of Bonn. This work was funded by the Deutsche Forschungsgemeinschaft (DFG) by grants to K.M. (MO 821/2-1), U.H. (HO 1368/12-1), E.K. (KO 1583/3-1) and C.H. (SFB487 TPA1). B.C. is funded by the North-Rhine-Westphalia International Graduate Research School BIOTECH-PHARMA at the University of Bonn.	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Dallanoce C, 1999, BIOORGAN MED CHEM, V7, P1539, DOI 10.1016/S0968-0896(99)00107-8; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; Ehlert FJ, 1999, J PHARMACOL EXP THER, V289, P981; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kloeckner J, 2010, TETRAHEDRON LETT, V51, P3470, DOI 10.1016/j.tetlet.2010.04.130; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schrage R, 2013, BRIT J PHARMACOL, V169, P357, DOI 10.1111/bph.12003; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	31	45	45	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					18	U37		10.1038/nchembio.1384	http://dx.doi.org/10.1038/nchembio.1384			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24212135				2022-12-25	WOS:000328854900005
J	Nile, AH; Tripathi, A; Yuan, PH; Mousley, CJ; Suresh, S; Wallace, IM; Shah, SD; Pohlhaus, DT; Temple, B; Nislow, C; Giaever, G; Tropsha, A; Davis, RW; Onge, RPS; Bankaitis, VA				Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Suresh, Sundari; Wallace, Iain M.; Shah, Sweety D.; Pohlhaus, Denise Teotico; Temple, Brenda; Nislow, Corey; Giaever, Guri; Tropsha, Alexander; Davis, Ronald W.; Onge, Robert P. St.; Bankaitis, Vytas A.			PITPs as targets for selectively interfering with phosphoinositide signaling in cells	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; YEAST SACCHAROMYCES-CEREVISIAE; OXYSTEROL BINDING-PROTEIN; PHOSPHOLIPASE-D ACTIVITY; GOLGI-COMPLEX; IN-VIVO; TRANSPORT; SEC14; GENE; HOMEOSTASIS	Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production and are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like PITPs nor PITPs in general have been exploited as targets for chemical inhibition for such purposes. Herein, we validate what is to our knowledge the first small-molecule inhibitors (SMIs) of the yeast PITP Sec14. These SMIs are nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs) and are effective inhibitors in vitro and in vivo. We further establish that Sec14 is the sole essential NPPM target in yeast and that NPPMs exhibit exquisite targeting specificities for Sec14 (relative to related Sec14-like PITPs), propose a mechanism for how NPPMs exert their inhibitory effects and demonstrate that NPPMs exhibit exquisite pathway selectivity in inhibiting phosphoinositide signaling in cells. These data deliver proof of concept that PITP-directed SMIs offer new and generally applicable avenues for intervening with phosphoinositide signaling pathways with selectivities superior to those afforded by contemporary lipid kinase-directed strategies.	[Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Nile, Aaron H.; Tripathi, Ashutosh; Yuan, Peihua; Mousley, Carl J.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Nile, Aaron H.; Shah, Sweety D.; Bankaitis, Vytas A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Sch Med, Chapel Hill, NC 27599 USA; [Tripathi, Ashutosh; Pohlhaus, Denise Teotico; Tropsha, Alexander] Univ N Carolina, Lab Mol Modeling, Eshelman Sch Pharm, Chapel Hill, NC USA; [Suresh, Sundari; Davis, Ronald W.; Onge, Robert P. St.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Wallace, Iain M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Temple, Brenda] Univ N Carolina, RL Juliano Struct Bioinformat Core, Chapel Hill, NC USA; [Nislow, Corey; Giaever, Guri] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia	Nile, AH (corresponding author), Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	tripathi@tamhsc.edu; vytas@tamhsc.edu	Tropsha, Alexander/AAB-8324-2020; Tropsha, Alexander/G-6245-2014; Wallace, Iain/B-9464-2009; Yuan, Peihua/G-9088-2013	Wallace, Iain/0000-0002-9491-7025; Nile, Aaron/0000-0002-7370-8769; Nislow, Corey/0000-0002-4016-8874; Yuan, Peihua/0000-0002-4633-0692; Mousley, Carl/0000-0002-0192-7030	Robert A. Welch Foundation; US National Institutes of Health (NIH) [GM44530]; NIH [HG003317]; National Human Genome Research Institute [5RO1-003317-08]; Canadian Cancer Society [020380]; Texas A&M Laboratory for Molecular Simulation provided software; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044530] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Texas A&M Laboratory for Molecular Simulation provided software; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Robert A. Welch Foundation (V.A.B.) and grant GM44530 (V.A.B.) from the US National Institutes of Health (NIH). R.W.D. was supported by the NIH (HG003317). G. Giaever and C. Nislow were supported by the National Human Genome Research Institute (5RO1-003317-08) and the Canadian Cancer Society (020380). The Texas A&M Laboratory for Molecular Simulation provided software, support and computer time. G.E. Kellogg and eduSoft LC donated HINT software, U. Schlecht (Stanford) assisted with growth analyses, A. Holzenburg and R. Littleton (Texas A&M) assisted with electron microscopy. We are grateful to D. Lew (Duke University) for donating mss4ts alleles.	Abraham DJ, 1997, J MOL BIOL, V272, P613, DOI 10.1006/jmbi.1997.1249; Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Cho AE, 2005, J COMPUT CHEM, V26, P915, DOI 10.1002/jcc.20222; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Cleves A, 1991, Trends Cell Biol, V1, P30, DOI 10.1016/0962-8924(91)90067-J; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Desfougeres T, 2008, BIOCHEM J, V409, P299, DOI 10.1042/BJ20071028; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Goldstein A, 1975, Methods Enzymol, V42, P504; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kennedy MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001299; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; LOPEZ MC, 1994, J CELL BIOL, V125, P113, DOI 10.1083/jcb.125.1.113; Lu YX, 2009, J PHYS CHEM B, V113, P12615, DOI 10.1021/jp906352e; MENG EC, 1994, J COMPUT AID MOL DES, V8, P299, DOI 10.1007/BF00126747; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Phillips SE, 2006, CRIT REV BIOCHEM MOL, V41, P21, DOI 10.1080/10409230500519573; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; SALAMA SR, 1990, J BACTERIOL, V172, P4510, DOI 10.1128/jb.172.8.4510-4521.1990; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaaf G, 2011, MOL BIOL CELL, V22, P892, DOI 10.1091/mbc.E10-11-0903; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sherman F., 1983, METHODS YEAST GENETI; SKINNER HB, 1993, EMBO J, V12, P4775, DOI 10.1002/j.1460-2075.1993.tb06166.x; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sykes P., 1986, GUIDEBOOK MECH ORGAN; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	59	25	27	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					76	U123		10.1038/NCHEMBIO.1389	http://dx.doi.org/10.1038/NCHEMBIO.1389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24292071	Green Submitted, Green Accepted			2022-12-25	WOS:000328854900014
J	Guo, GW; Sun, XJ; Chen, C; Wu, S; Huang, PD; Li, ZS; Dean, M; Huang, Y; Jia, WL; Zhou, Q; Tang, AF; Yang, ZQ; Li, XX; Song, PF; Zhao, XK; Ye, R; Zhang, SQ; Lin, Z; Qi, MF; Wan, SQ; Xie, LF; Fan, F; Nickerson, ML; Zou, XJ; Hu, XD; Xing, L; Lv, ZJ; Mei, HB; Gao, SJ; Liang, CZ; Gao, ZB; Lu, JX; Yu, Y; Liu, CX; Li, L; Fang, XD; Jiang, ZM; Yang, J; Li, CL; Zhao, X; Chen, J; Zhang, F; Lai, YQ; Lin, ZG; Zhou, FJ; Chen, H; Chan, HC; Tsang, S; Theodorescu, D; Li, YR; Zhang, XQ; Wang, J; Yang, HM; Gui, YT; Wang, J; Cai, ZM				Guo, Guangwu; Sun, Xiaojuan; Chen, Chao; Wu, Song; Huang, Peide; Li, Zesong; Dean, Michael; Huang, Yi; Jia, Wenlong; Zhou, Quan; Tang, Aifa; Yang, Zuoquan; Li, Xianxin; Song, Pengfei; Zhao, Xiaokun; Ye, Rui; Zhang, Shiqiang; Lin, Zhao; Qi, Mingfu; Wan, Shengqing; Xie, Liangfu; Fan, Fan; Nickerson, Michael L.; Zou, Xiangjun; Hu, Xueda; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Gao, Shengjie; Liang, Chaozhao; Gao, Zhibo; Lu, Jingxiao; Yu, Yuan; Liu, Chunxiao; Li, Lin; Fang, Xiaodong; Jiang, Zhimao; Yang, Jie; Li, Cailing; Zhao, Xin; Chen, Jing; Zhang, Fang; Lai, Yongqi; Lin, Zheguang; Zhou, Fangjian; Chen, Hao; Chan, Hsiao Chang; Tsang, Shirley; Theodorescu, Dan; Li, Yingrui; Zhang, Xiuqing; Wang, Jian; Yang, Huanming; Gui, Yaoting; Wang, Jun; Cai, Zhiming			Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation	NATURE GENETICS			English	Article							MUTATIONS; FGFR3; ANEUPLOIDY; CARCINOMA; FUSIONS; VARIANT	Bladder cancer is one of the most common cancers worldwide, with transitional cell carcinoma (TCC) being the predominant form. Here we report a genomic analysis of TCC by both whole-genome and whole-exome sequencing of 99 individuals with TCC. Beyond confirming recurrent mutations in genes previously identified as being mutated in TCC, we identified additional altered genes and pathways that were implicated in TCC. Notably, we discovered frequent alterations in STAG2 and ESPL1, two genes involved in the sister chromatid cohesion and segregation (SCCS) process. Furthermore, we also detected a recurrent fusion involving FGFR3 and TACC3, another component of SCCS, by transcriptome sequencing of 42 DNA-sequenced tumors. Overall, 32 of the 99 tumors (32%) harbored genetic alterations in the SCCS process. Our analysis provides evidence that genetic alterations affecting the SCCS process may be involved in bladder tumorigenesis and identifies a new therapeutic possibility for bladder cancer.	[Guo, Guangwu; Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol Surg, Shenzhen, Peoples R China; [Guo, Guangwu; Chen, Chao; Huang, Peide; Jia, Wenlong; Zhou, Quan; Yang, Zuoquan; Song, Pengfei; Ye, Rui; Lin, Zhao; Wan, Shengqing; Fan, Fan; Hu, Xueda; Gao, Shengjie; Gao, Zhibo; Yu, Yuan; Li, Lin; Fang, Xiaodong; Yang, Jie; Zhao, Xin; Zhang, Fang; Li, Yingrui; Zhang, Xiuqing; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Natl Reg Key Technol Engn Lab Clin Applicat Canc, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Engn Lab Tumor Clin Immune Gene Therapy, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor, Shenzhen, Peoples R China; [Wu, Song] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Song; Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Dean, Michael; Nickerson, Michael L.] NCI, Canc & Inflammat Program, US Natl Inst Hlth NIH, Frederick, MD 21701 USA; [Li, Xianxin; Lu, Jingxiao; Jiang, Zhimao; Li, Cailing; Chen, Jing; Lai, Yongqi; Lin, Zheguang; Gui, Yaoting] Peking Univ Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Zhao, Xiaokun] Cent Southern Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Liu, Chunxiao] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Tsang, Shirley] BioMatrix, Rockville, MD USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Dept Surg, Aurora, CO USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	Shenzhen University; Beijing Genomics Institute (BGI); Shenzhen University; Shenzhen University; Shenzhen University; Sun Yat Sen University; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Central South University; Anhui Medical University; Southern Medical University - China; Chinese University of Hong Kong; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Cai, ZM (corresponding author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol Surg, Shenzhen, Peoples R China.	guiyaoting@hotmail.com; wangj@genomics.org.cn; caizhiming2000@163.com	Chen, Hao/D-3425-2012; Chan, Hsiao Chang/E-1507-2016; Dean, Michael C/G-8172-2012; Jia, Justin/AAV-4349-2021; Zhao, Xin/AFZ-4565-2022; gui, yaoting/GLT-3684-2022; Fang, Xiaodong/K-6743-2018; Li, Yingrui/K-1064-2015; Wang, Jun/A-7261-2013; Dean, Michael/R-7501-2019; Chen, Hao/AAH-4124-2020; zou, xiangjun/ABG-6926-2021; Wang, Jun/C-8434-2016; Gao, Shengjie/S-4016-2017; Wang, Jun/B-9503-2016	Chen, Hao/0000-0001-8319-8101; Dean, Michael C/0000-0003-2234-0631; Jia, Justin/0000-0002-7136-9919; Fang, Xiaodong/0000-0001-7061-3337; Chen, Hao/0000-0001-8319-8101; zou, xiangjun/0000-0001-5146-599X; Ye, Rui/0000-0002-4866-088X; Wang, Jun/0000-0002-8540-8931; Peide, Huang/0000-0001-6108-5069; Gao, Shengjie/0000-0002-5221-8381; Wang, Jun/0000-0002-2113-5874	Chinese High-Tech (863) Program [2012AA02A201, 2012AA02A208]; Guangdong Innovative Research Team Program [2009010016]; State Key Development Program for Basic Research of China-973 Program [2011CB809203, 2014CB745200]; Shenzhen Municipal Government of China [JC201005260191A, CXB201108250096A, ZDSY20120615154448514, BGI20100001]; NATIONAL CANCER INSTITUTE [ZIABC011300, ZIABC011301] Funding Source: NIH RePORTER	Chinese High-Tech (863) Program(National High Technology Research and Development Program of China); Guangdong Innovative Research Team Program; State Key Development Program for Basic Research of China-973 Program(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Shenzhen Municipal Government of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Chinese High-Tech (863) Program (2012AA02A201 and 2012AA02A208), the Guangdong Innovative Research Team Program (2009010016), the State Key Development Program for Basic Research of China-973 Program (2011CB809203 and 2014CB745200) and the Shenzhen Municipal Government of China (JC201005260191A, CXB201108250096A, ZDSY20120615154448514 and BGI20100001).	Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bertino JR, 1996, STEM CELLS, V14, P5, DOI 10.1002/stem.140005; CAIRNS P, 1991, ONCOGENE, V6, P2305; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; CORDONCARDO C, 1994, INT J CANCER, V56, P347, DOI 10.1002/ijc.2910560309; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hornigold N, 1999, ONCOGENE, V18, P2657, DOI 10.1038/sj.onc.1202854; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamada NA, 2011, CYTOGENET GENOME RES, V132, P248, DOI 10.1159/000322717; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	39	327	338	3	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1459	U213		10.1038/ng.2798	http://dx.doi.org/10.1038/ng.2798			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24121792	Green Accepted			2022-12-25	WOS:000327715800011
J	Kottke, T; Boisgerault, N; Diaz, RM; Donnelly, O; Rommelfanger-Konkol, D; Pulido, J; Thompson, J; Mukhopadhyay, D; Kaspar, R; Coffey, M; Pandha, H; Melcher, A; Harrington, K; Selby, P; Vile, R				Kottke, Timothy; Boisgerault, Nicolas; Diaz, Rosa Maria; Donnelly, Oliver; Rommelfanger-Konkol, Diana; Pulido, Jose; Thompson, Jill; Mukhopadhyay, Debabrata; Kaspar, Roger; Coffey, Matt; Pandha, Hardev; Melcher, Alan; Harrington, Kevin; Selby, Peter; Vile, Richard			Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence	NATURE MEDICINE			English	Article							T-CELL THERAPY; VESICULAR STOMATITIS-VIRUS; ONCOLYTIC VIROTHERAPY; CDNA LIBRARIES; DORMANT STATE; GENE-THERAPY; L5178Y CELLS; ANTIGEN LOSS; IN-VIVO; CANCER	Tumor recurrence represents a major clinical challenge. Our data show that emergent recurrent tumors acquire a phenotype radically different from that of their originating primary tumors. This phenotype allows them to evade a host-derived innate immune response elicited by the progression from minimal residual disease (MRD) to actively growing recurrence. Screening for this innate response predicted accurately in which mice recurrence would occur. Premature induction of recurrence resensitized MRD to the primary therapy, suggesting a possible paradigm shift for clinical treatment of dormant disease in which the current expectant approach is replaced with active attempts to uncover MRD before evolution of the escape phenotype is complete. By combining screening with second-line treatments targeting innate insensitivity, up to 100% of mice that would have otherwise relapsed were cured. These data may open new avenues for early detection and appropriately timed, highly targeted treatment of tumor recurrence irrespective of tumor type or frontline treatment.	[Kottke, Timothy; Boisgerault, Nicolas; Diaz, Rosa Maria; Rommelfanger-Konkol, Diana; Pulido, Jose; Thompson, Jill; Vile, Richard] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Donnelly, Oliver; Melcher, Alan; Selby, Peter; Vile, Richard] St James Univ Hosp, Canc Res UK Ctr, Leeds, W Yorkshire, England; [Pulido, Jose] Mayo Clin, Dept Ophthalmol & Ocular Oncol, Rochester, MN USA; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Kaspar, Roger] TransDerm, Santa Cruz, CA USA; [Coffey, Matt] Oncolyt Biotech, Calgary, AB, Canada; [Pandha, Hardev] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England; [Vile, Richard] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Cancer Research UK; Saint James's University Hospital; Mayo Clinic; Mayo Clinic; Oncolytics Biotech; University of Surrey; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Mayo Clinic	Vile, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	vile.richard@mayo.edu	Boisgerault, Nicolas/L-7949-2015; Donnelly, Oliver/G-7382-2012	Boisgerault, Nicolas/0000-0002-3391-6504; Donnelly, Oliver/0000-0001-8613-6686; Melcher, Alan/0000-0002-2042-3380; Harrington, Kevin/0000-0002-6014-348X	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK; US National Institutes of Health [R01 CA107082, R01CA130878, R01 CA132734]; Cancer Research UK [13244] Funding Source: researchfish; Medical Research Council [G0900324] Funding Source: researchfish; National Institute for Health Research [CL-2012-02-002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA132734, R01CA107082, R01CA175386, R01CA130878] Funding Source: NIH RePORTER; MRC [G0900324] Funding Source: UKRI	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Higgins for expert secretarial assistance and M. Behrens and K. Knutson for help with Her-2-neu mice. This work was supported by the Richard M. Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, US National Institutes of Health grants R01 CA107082, R01CA130878 and R01 CA132734 and a grant from T. and J. Paul.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Aguirre-Ghiso JA, 2013, NAT MED, V19, P276, DOI 10.1038/nm.3120; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Boisgerault N, 2013, MOL THER, V21, P1507, DOI 10.1038/mt.2013.116; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Cray C, 2009, COMPARATIVE MED, V59, P517; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Dranoff G, 2012, NAT REV IMMUNOL, V12, P61, DOI 10.1038/nri3129; Duren M, 1999, SURGERY, V126, P13, DOI 10.1067/msy.1999.98849; Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gonzalez-Gonzalez E, 2011, SCI REP-UK, V1, DOI 10.1038/srep00158; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Hensel JA, 2013, NAT REV CLIN ONCOL, V10, P41, DOI 10.1038/nrclinonc.2012.207; Indraccolo S, 2006, P NATL ACAD SCI USA, V103, P4216, DOI 10.1073/pnas.0506200103; Kaluza KM, 2012, HUM GENE THER, V23, P1054, DOI 10.1089/hum.2012.030; Kaluza KM, 2012, INT J CANCER, V131, P844, DOI 10.1002/ijc.26447; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kloos RT, 2005, J CLIN ENDOCR METAB, V90, P5047, DOI 10.1210/jc.2005-0492; Kottke T, 2011, MOL THER, V19, P1802, DOI 10.1038/mt.2011.147; Kottke T, 2011, NAT MED, V17, P854, DOI 10.1038/nm.2390; Kottke T, 2010, J CLIN INVEST, V120, P1551, DOI 10.1172/JCI41431; Kottke T, 2008, MOL THER, V16, P1910, DOI 10.1038/mt.2008.212; Kovacs AF, 2003, J CHEMOTHERAPY, V15, P495, DOI 10.1179/joc.2003.15.5.495; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Liu KB, 2006, J IMMUNOL, V176, P3374, DOI 10.4049/jimmunol.176.6.3374; McGowan PM, 2009, FUTURE ONCOL, V5, P1083, DOI [10.2217/fon.09.73, 10.2217/FON.09.73]; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Ossowski L, 2010, PIGM CELL MELANOMA R, V23, P41, DOI 10.1111/j.1755-148X.2009.00647.x; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Pulido J, 2012, NAT BIOTECHNOL, V30, P336, DOI 10.1038/nbt.2157; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Rommelfanger DM, 2012, CANCER RES, V72, P4753, DOI 10.1158/0008-5472.CAN-12-0600; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sanchez-Perez L, 2007, GENE THER, V14, P998, DOI 10.1038/sj.gt.3302935; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; STADNYK AW, 1991, IMMUNOPARASITOL TOD, pA7, DOI 10.1016/S0167-5699(05)80004-0; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; VILE RG, 1994, CANCER RES, V54, P6228; Vile RG, 1997, INT J CANCER, V71, P267; WEINHOLD KJ, 1979, J EXP MED, V149, P745, DOI 10.1084/jem.149.3.745; WEINHOLD KJ, 1979, J EXP MED, V149, P732, DOI 10.1084/jem.149.3.732; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wongthida P, 2011, HUM GENE THER, V22, P1343, DOI 10.1089/hum.2010.216	53	46	47	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1625	1631		10.1038/nm.3397	http://dx.doi.org/10.1038/nm.3397			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24240185	Green Accepted			2022-12-25	WOS:000328181400031
J	Hasegawa, K; Wakino, S; Simic, P; Sakamaki, Y; Minakuchi, H; Fujimura, K; Hosoya, K; Komatsu, M; Kaneko, Y; Kanda, T; Kubota, E; Tokuyama, H; Hayashi, K; Guarente, L; Itoh, H				Hasegawa, Kazuhiro; Wakino, Shu; Simic, Petra; Sakamaki, Yusuke; Minakuchi, Hitoshi; Fujimura, Keiko; Hosoya, Kozi; Komatsu, Motoaki; Kaneko, Yuka; Kanda, Takeshi; Kubota, Eiji; Tokuyama, Hirobumi; Hayashi, Koichi; Guarente, Leonard; Itoh, Hiroshi			Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes	NATURE MEDICINE			English	Article							PARIETAL EPITHELIAL-CELLS; STIMULATED INSULIN-SECRETION; DE-NOVO EXPRESSION; GENE-EXPRESSION; NICOTINAMIDE MONONUCLEOTIDE; CALORIE RESTRICTION; OXIDATIVE DAMAGE; DNA-METHYLATION; TRANSGENIC MICE; KIDNEY-DISEASE	Sirtuin 1 (Sirt1), a NAD(+)-regulated deacetylase with numerous known positive effects on cellular and whole-body metabolism, is expressed in the renal cortex and medulla. It is known to have protective effects against age-related disease, including diabetes. Here we investigated the protective role of Sirt1 in diabetic renal damage. We found that Sirt1 in proximal tubules (PTs) was downregulated before albuminuria occurred in streptozotocin-induced or obese (db/db) diabetic mice. PT-specific SIRT1 transgenic and Sirt1 knockout mice showed prevention and aggravation of the glomerular changes that occur in diabetes, respectively, and nondiabetic knockout mice exhibited albuminuria, suggesting that Sirt1 in PTs affects glomerular function. Downregulation of Sirt1 and upregulation of the tight junction protein Claudin-1 by SIRT1-mediated epigenetic regulation in podocytes contributed to albuminuria. We did not observe these phenomena in 5/6 nephrectomized mice. We also demonstrated retrograde interplay from PTs to glomeruli using nicotinamide mononucleotide (NMN) from conditioned medium, measurement of the autofluorescence of photoactivatable NMN and injection of fluorescence-labeled NMN. In human subjects with diabetes, the levels of SIRT1 and Claudin-1 were correlated with proteinuria levels. These results suggest that Sirt1 in PTs protects against albuminuria in diabetes by maintaining NMN concentrations around glomeruli, thus influencing podocyte function.	[Hasegawa, Kazuhiro; Wakino, Shu; Minakuchi, Hitoshi; Fujimura, Keiko; Hosoya, Kozi; Komatsu, Motoaki; Kaneko, Yuka; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Simic, Petra; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA; [Sakamaki, Yusuke; Kubota, Eiji] Shizuoka Red Cross Hosp, Dept Internal Med, Shizuoka, Japan	Keio University; Massachusetts Institute of Technology (MIT)	Wakino, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	swakino@sc.itc.keio.ac.jp			Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan [22790800]; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG011119] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24591210, 25293197] Funding Source: KAKEN	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank P. Mundel (Division of Nephrology, Massachusetts General Hospital and Harvard Medical School) and K. Asanuma (Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine) for providing cultured podocytes. We also thank S.J. Shankland and C. Campbell (Division of Nephrology, University of Washington) for providing culture PECs. This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 22790800).	Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Boireau S, 2007, CARCINOGENESIS, V28, P246, DOI 10.1093/carcin/bgl120; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Clodfelder-Miller B, 2005, J BIOL CHEM, V280, P39723, DOI 10.1074/jbc.M508824200; Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; GIBB DM, 1989, ARCH DIS CHILD, V64, P129, DOI 10.1136/adc.64.1.129; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Kitada M, 2011, EXP DIABETES RES, DOI 10.1155/2011/908185; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kohda Y, 2000, KIDNEY INT, V57, P321, DOI 10.1046/j.1523-1755.2000.00824.x; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lai LW, 1997, GENE THER, V4, P426, DOI 10.1038/sj.gt.3300406; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V294, pE668, DOI 10.1152/ajpendo.00640.2007; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Ohse T, 2010, AM J PHYSIOL-RENAL, V298, pF702, DOI 10.1152/ajprenal.00428.2009; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roxburgh SA, 2009, DIABETES, V58, P1641, DOI 10.2337/db08-1365; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Taha HM, 2009, MOL PHARMACOL, V75, P693, DOI 10.1124/mol.108.052340; Terasawa K, 2004, CLIN CANCER RES, V10, P2000, DOI 10.1158/1078-0432.CCR-0932-03; Tikoo K, 2008, FREE RADICAL RES, V42, P397, DOI 10.1080/10715760801998646; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Vaidya VS, 2011, KIDNEY INT, V79, P464, DOI 10.1038/ki.2010.404; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Zhang J, 2012, AM J PHYSIOL-RENAL, V302, pF571, DOI 10.1152/ajprenal.00516.2011; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017	52	288	311	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1496	+		10.1038/nm.3363	http://dx.doi.org/10.1038/nm.3363			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24141423	Green Accepted, Green Submitted			2022-12-25	WOS:000326920300027
J	Vaishnavi, A; Capelletti, M; Le, AT; Kako, S; Butaney, M; Ercan, D; Mahale, S; Davies, KD; Aisner, DL; Pilling, AB; Berge, EM; Kim, J; Sasaki, H; Park, SI; Kryukov, G; Garraway, LA; Hammerman, PS; Haas, J; Andrews, SW; Lipson, D; Stephens, PJ; Miller, VA; Varella-Garcia, M; Janne, PA; Doebele, RC				Vaishnavi, Aria; Capelletti, Marzia; Le, Anh T.; Kako, Severine; Butaney, Mohit; Ercan, Dalia; Mahale, Sakshi; Davies, Kurtis D.; Aisner, Dara L.; Pilling, Amanda B.; Berge, Eamon M.; Kim, Jhingook; Sasaki, Hidefumi; Park, Seung-il; Kryukov, Gregory; Garraway, Levi A.; Hammerman, Peter S.; Haas, Julia; Andrews, Steven W.; Lipson, Doron; Stephens, Philip J.; Miller, Vince A.; Varella-Garcia, Marileila; Jaenne, Pasi A.; Doebele, Robert C.			Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer	NATURE MEDICINE			English	Article							GENE FUSIONS; KINASE INHIBITORS; CELL-LINES; RET; ADENOCARCINOMA; IDENTIFICATION; ALK; PROTEIN; GENOME; ROS1	We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein). Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic. Treatment of cells expressing NTRK1 fusions with inhibitors of TRKA kinase activity inhibited autophosphorylation of TRKA and cell growth. Tumor samples from 3 of 91 patients with lung cancer (3.3%) without known oncogenic alterations assayed by next-generation sequencing or fluorescence in situ hybridization demonstrated evidence of NTRK1 gene fusions.	[Vaishnavi, Aria; Le, Anh T.; Davies, Kurtis D.; Pilling, Amanda B.; Berge, Eamon M.; Varella-Garcia, Marileila; Doebele, Robert C.] Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO USA; [Capelletti, Marzia; Butaney, Mohit; Ercan, Dalia; Hammerman, Peter S.; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Kako, Severine; Mahale, Sakshi; Aisner, Dara L.; Varella-Garcia, Marileila; Doebele, Robert C.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Aisner, Dara L.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Sasaki, Hidefumi] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Park, Seung-il] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Kryukov, Gregory; Garraway, Levi A.] Broad Inst, Cambridge, MA USA; [Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Haas, Julia; Andrews, Steven W.] Array BioPharma, Boulder, CO USA; [Lipson, Doron; Stephens, Philip J.; Miller, Vince A.] Fdn Med, Boston, MA USA; [Vaishnavi, Aria; Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Dana-Farber Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Sungkyunkwan University (SKKU); Samsung Medical Center; Nagoya City University; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Pfizer; Array BioPharma; Foundation Medicine; Harvard University; Dana-Farber Cancer Institute	Doebele, RC (corresponding author), Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO USA.	pasi_janne@dfci.harvard.edu; robert.doebele@ucdenver.edu	Doebele, Robert C./I-8230-2019; Kryukov, Gregory V/A-9592-2008; Butaney, Mohit/O-5511-2019; Capelletti, Marzia/L-6317-2016	Doebele, Robert C./0000-0001-6728-6857; Butaney, Mohit/0000-0002-4760-4026; Kryukov, Gregory/0000-0002-6131-9483; Capelletti, Marzia/0000-0001-5095-7060	Colorado Bioscience Discovery Evaluation Grant Program; National Institutes of Health (NIH) NCATS Colorado Clinical and Translational Sciences Institute [UL1 TR000154]; Boettcher Foundation's Webb-Waring Biomedical Research Program; Dana-Farber/Harvard Cancer Center Lung Cancer Specialized Programs of Research Excellence (SPORE) [P50 CA090578]; Cammarata Family Foundation Research Fund; Dana-Farber Cancer Institute; University of Colorado Lung Cancer SPORE [P50CA058187]; US National Cancer Institute Cancer Center [P30CA46934]; NATIONAL CANCER INSTITUTE [P50CA058187, P50CA090578, K08CA163677, P30CA046934, K12CA086913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	Colorado Bioscience Discovery Evaluation Grant Program; National Institutes of Health (NIH) NCATS Colorado Clinical and Translational Sciences Institute; Boettcher Foundation's Webb-Waring Biomedical Research Program; Dana-Farber/Harvard Cancer Center Lung Cancer Specialized Programs of Research Excellence (SPORE); Cammarata Family Foundation Research Fund; Dana-Farber Cancer Institute; University of Colorado Lung Cancer SPORE; US National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Colorado Bioscience Discovery Evaluation Grant Program, the National Institutes of Health (NIH) NCATS Colorado Clinical and Translational Sciences Institute Grant UL1 TR000154 (contents are the authors' sole responsibility and do not necessarily represent official NIH views) and the Boettcher Foundation's Webb-Waring Biomedical Research Program (R.C.D.), as well as the Dana-Farber/Harvard Cancer Center Lung Cancer Specialized Programs of Research Excellence (SPORE) P50 CA090578 (P.A.J.), the Cammarata Family Foundation Research Fund (M.C. and P.A.J.), the Nirenberg Fellowship at the Dana-Farber Cancer Institute (M.C. and P.A.J.) and the University of Colorado Lung Cancer SPORE grant P50CA058187 and the US National Cancer Institute Cancer Center Support Grant P30CA46934 (M.V.-G.). Ba/F3 cells were a gift from D. Theodorescu (University of Colorado, Anschutz Medical Campus). The cell lines KM12, HCT116, HCT15, HT29 and SW837 were gifts from S.G. Eckhardt (University of Colorado, Anschutz Medical Campus). The cell lines H3122, H1650, H1299 and HCC78 were gifts from J.D. Minna (University of Texas Southwestern). Aythymic nude mice were a gift from J. DeGregori (University of Colorado, Anschutz Medical Campus).	Albert L, 2003, J CELL PHYSIOL, V195, P168, DOI 10.1002/jcp.10252; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; George DJ, 1999, CANCER RES, V59, P2395; Gerlinger M, 2013, NEW ENGL J MED, V369, P1172, DOI 10.1056/NEJMc1309091; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Oie HK, 1996, J CELL BIOCHEM, P24; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pitts TM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00035; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	35	421	483	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1469	+		10.1038/nm.3352	http://dx.doi.org/10.1038/nm.3352			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24162815	Green Accepted			2022-12-25	WOS:000326920300023
J	Heidt, T; Sager, HB; Courties, G; Dutta, P; Iwamoto, Y; Zaltsman, A; von zur Muhlen, C; Bode, C; Fricchione, GL; Denninger, J; Lin, CP; Vinegoni, C; Libby, P; Swirski, FK; Weissleder, R; Nahrendorf, M				Heidt, Timo; Sager, Hendrik B.; Courties, Gabriel; Dutta, Partha; Iwamoto, Yoshiko; Zaltsman, Alex; von zur Muhlen, Constantin; Bode, Christoph; Fricchione, Gregory L.; Denninger, John; Lin, Charles P.; Vinegoni, Claudio; Libby, Peter; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias			Chronic variable stress activates hematopoietic stem cells	NATURE MEDICINE			English	Article							BONE-MARROW; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; SOCIAL STRESS; ATHEROSCLEROSIS; MICE; REPOPULATION; PATHOGENESIS; REGULATOR; RELEASE	Exposure to psychosocial stress is a risk factor for many diseases, including atherosclerosis(1,2). Although incompletely understood, interaction between the psyche and the immune system provides one potential mechanism linking stress and disease inception and progression. Known cross-talk between the brain and immune system includes the hypothalamic-pituitary-adrenal axis, which centrally drives glucocorticoid production in the adrenal cortex, and the sympathetic-adrenal-medullary axis, which controls stress-induced catecholamine release in support of the fight-or-flight reflex(3,4). It remains unknown, however, whether chronic stress changes hematopoietic stem cell activity. Here we show that stress increases proliferation of these most primitive hematopoietic progenitors, giving rise to higher levels of disease-promoting inflammatory leukocytes. We found that chronic stress induced monocytosis and neutrophilia in humans. While investigating the source of leukocytosis in mice, we discovered that stress activates upstream hematopoietic stem cells. Under conditions of chronic variable stress in mice, sympathetic nerve fibers released surplus noradrenaline, which signaled bone marrow niche cells to decrease CXCL12 levels through the beta(3)-adrenergic receptor. Consequently, hematopoietic stem cell proliferation was elevated, leading to an increased output of neutrophils and inflammatory monocytes. When atherosclerosis-prone Apoe(-/-) mice were subjected to chronic stress, accelerated hematopoiesis promoted plaque features associated with vulnerable lesions that cause myocardial infarction and stroke in humans.	[Heidt, Timo; Sager, Hendrik B.; Courties, Gabriel; Dutta, Partha; Iwamoto, Yoshiko; Zaltsman, Alex; Lin, Charles P.; Vinegoni, Claudio; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Heidt, Timo; Sager, Hendrik B.; Courties, Gabriel; Dutta, Partha; Iwamoto, Yoshiko; Zaltsman, Alex; Lin, Charles P.; Vinegoni, Claudio; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA USA; [von zur Muhlen, Constantin; Bode, Christoph] Univ Heart Ctr, Dept Cardiol & Angiol 1, Freiburg, Germany; [Fricchione, Gregory L.; Denninger, John] Massachusetts Gen Hosp, Div Psychiat & Med, Boston, MA 02114 USA; [Fricchione, Gregory L.; Denninger, John] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universitats Herzzentrum Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	mnahrendorf@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019; Vinegoni, Claudio/A-9490-2012; Sager, Hendrik B./AAP-5869-2021; vinegoni, claudio/AGU-2461-2022; Libby, Peter/AAY-6404-2021	Vinegoni, Claudio/0000-0002-9818-3639; Sager, Hendrik B./0000-0002-0197-6553; Libby, Peter/0000-0002-1502-502X; /0000-0003-0828-4143; Swirski, Filip/0000-0002-3163-9152; Courties, Gabriel/0000-0002-0003-7407	US National Institutes of Health [R01-HL117829, R01-HL096576]; Deutsche Forschungsgemeinschaft [HE-6382/1-1, SA1668/2-1];  [HHSN268201000044C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121076, R01HL117829, R01HL096576, R01HL114477] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the team at the Center for Systems Biology Mouse Imaging Program, especially J. Truelove and D. Jeon, for help with imaging, M. Stein, I. Neudorfer and F. Meixner for help with the clinical study and L. Prickett-Rice, K. Folz-Donahue, M. Weglarz, M. Waring and A. Chicoine for assistance with cell sorting. We thank P. Frenette (Albert Einstein College of Medicine) and B. Lowell (Beth Israel Deaconess Medical Center) for providing Adrb3<SUP>-/-</SUP> mice and G. Enikolopov (Cold Spring Harbor Laboratory) for providing nestin-GFP mice. We thank the ICU team at the University Hospital Freiburg, Germany. This work was funded in part by US National Institutes of Health grants R01-HL114477, R01-HL117829 and R01-HL096576 (to M.N.) and grant HHSN268201000044C (to R.W.). T.H. and H.B.S. are funded by the Deutsche Forschungsgemeinschaft (HE-6382/1-1 to T.H. and SA1668/2-1 to H.B.S.).	Adamsson Eryd S, 2012, ARTERIOSCL THROM VAS, V32, P533, DOI 10.1161/ATVBAHA.111.240416; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bernberg E, 2012, ATHEROSCLEROSIS, V221, P359, DOI 10.1016/j.atherosclerosis.2011.11.041; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gu HF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/613879; KAPLAN JR, 1983, SCIENCE, V220, P733; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lesage FX, 2011, OCCUP MED-OXFORD, V61, P434, DOI 10.1093/occmed/kqr037; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nollet M., 2013, CURR PROTOC PHARM, V61; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Randolph GJ, 2009, J THROMB HAEMOST, V7, P28, DOI 10.1111/j.1538-7836.2009.03423.x; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Schweizer MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004326; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tall AR, 2012, ARTERIOSCL THROM VAS, V32, P2547, DOI 10.1161/ATVBAHA.112.300134; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; ZIGMOND RE, 1977, P NATL ACAD SCI USA, V74, P3078, DOI 10.1073/pnas.74.7.3078	40	426	433	4	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					754	758		10.1038/nm.3589	http://dx.doi.org/10.1038/nm.3589			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24952646	Green Submitted, Green Accepted			2022-12-25	WOS:000338689500018
J	Kautz, L; Jung, G; Valore, EV; Rivella, S; Nemeth, E; Ganz, T				Kautz, Leon; Jung, Grace; Valore, Erika V.; Rivella, Stefano; Nemeth, Elizabeta; Ganz, Tomas			Identification of erythroferrone as an erythroid regulator of iron metabolism	NATURE GENETICS			English	Article							DIFFERENTIATION FACTOR 15; BETA-THALASSEMIA; HEPCIDIN EXPRESSION; ANEMIA; ERYTHROPOIETIN; OVERLOAD; HYPOXIA; MURINE; BMP6; HOMEOSTASIS	Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory hormone hepcidin allows increased iron absorption and mobilization from stores. We identified a new hormone, erythroferrone (ERFE), that mediates hepcidin suppression during stress erythropoiesis. ERFE is produced by erythroblasts in response to erythropoietin. ERFE-deficient mice fail to suppress hepcidin rapidly after hemorrhage and exhibit a delay in recovery from blood loss. ERFE expression is greatly increased in Hbb(th3/+) mice with thalassemia intermedia, where it contributes to the suppression of hepcidin and the systemic iron overload characteristic of this disease.	[Kautz, Leon; Jung, Grace; Valore, Erika V.; Nemeth, Elizabeta; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ganz, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	tganz@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Rivella, Stefano/0000-0002-0938-6558; Ganz, Tomas/0000-0002-2830-5469; Kautz, Leon/0000-0002-2320-0457; Nemeth, Elizabeta/0000-0002-3477-2397	US National Institutes of Health (NIH) [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; JCCC from US NIH [P30-CA-016042]; CURE: Digestive Disease Research Core Center from US NIH [P30-DK-041301]; US NIH [R01-DK-065029]; American Society of Hematology scholar award;  [R01-DK-090554];  [5R01-DK-095112]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK065029, R01DK090554, R01DK095112] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); JCCC from US NIH; CURE: Digestive Disease Research Core Center from US NIH; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology scholar award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank V. Gabayan for her invaluable work with mouse breeding. Flow cytometry was performed in the University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center (JCCC) and the Center for AIDS Research Flow Cytometry Core Facility, which is supported by US National Institutes of Health (NIH) awards CA-16042 and AI-28697 and by the JCCC, the UCLA AIDS Institute and the David Geffen School of Medicine at UCLA. The UCLA Vector Core is supported by the JCCC from US NIH grant P30-CA-016042 and the CURE: Digestive Disease Research Core Center from US NIH grant P30-DK-041301. This research was supported by US NIH grant R01-DK-065029 to T.G. and grants R01-DK-090554 and 5R01-DK-095112 to S.R. and by the American Society of Hematology scholar award to L.K.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Ashby DR, 2010, HAEMATOL-HEMATOL J, V95, P505, DOI 10.3324/haematol.2009.013136; Casanovas G, 2013, HAEMATOLOGICA, V98, P444, DOI 10.3324/haematol.2012.069807; Centis F, 2000, BLOOD, V96, P3624; Diaz V, 2013, HEPATOLOGY, V58, P2122, DOI 10.1002/hep.26550; FINCH C, 1994, BLOOD, V84, P1697; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; PIPPARD MJ, 1979, LANCET, V2, P819; Porpiglia E, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001383; Ramos P, 2010, ANN NY ACAD SCI, V1202, P24, DOI 10.1111/j.1749-6632.2010.05596.x; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Theurl I, 2010, BRIT J HAEMATOL, V148, P449, DOI 10.1111/j.1365-2141.2009.07961.x; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x	34	675	710	3	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					678	684		10.1038/ng.2996	http://dx.doi.org/10.1038/ng.2996			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24880340	Green Accepted, Green Submitted			2022-12-25	WOS:000338093800007
J	Lukianova-Hleb, EY; Ren, XY; Sawant, RR; Wu, XW; Torchilin, VP; Lapotko, DO				Lukianova-Hleb, Ekaterina Y.; Ren, Xiaoyang; Sawant, Rupa R.; Wu, Xiangwei; Torchilin, Vladimir P.; Lapotko, Dmitri O.			On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles	NATURE MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; GOLD NANOPARTICLES; NECK-CANCER; RADIATION-THERAPY; DRUG-DELIVERY; HEAD; RADIOTHERAPY; CHEMOTHERAPY; TUMOR; ENHANCEMENT	Chemoradiation-resistant cancers limit treatment efficacy and safety. We show here the cancer cell-specific, on-demand intracellular amplification of chemotherapy and chemoradiation therapy via gold nanoparticle- and laser pulse-induced mechanical intracellular impact. Cancer aggressiveness promotes the clustering of drug nanocarriers and gold nanoparticles in cancer cells. This cluster, upon exposure to a laser pulse, generates a plasmonic nanobubble, the mechanical explosion that destroys the host cancer cell or ejects the drug into its cytoplasm by disrupting the liposome and endosome. The same cluster locally amplifies external X-rays. Intracellular synergy of the mechanical impact of plasmonic nanobubble, ejected drug and amplified X-rays improves the efficacy of standard chemoradiation in resistant and aggressive head and neck cancer by 100-fold in vitro and 17-fold in vivo, reduces the effective entry doses of drugs and X-rays to 2-6% of their clinical doses and efficiently spares normal cells. The developed quadrapeutics technology combines four clinically validated components and transforms a standard macrotherapy into an intracellular on-demand theranostic microtreatment with radically amplified therapeutic efficacy and specificity.	[Lukianova-Hleb, Ekaterina Y.; Lapotko, Dmitri O.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Ren, Xiaoyang; Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Sawant, Rupa R.; Torchilin, Vladimir P.] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA; [Lapotko, Dmitri O.] Rice Univ, Dept Phys & Astron, Houston, TX USA	Rice University; University of Texas System; UTMD Anderson Cancer Center; Northeastern University; Rice University	Lapotko, DO (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	dl5@rice.edu	ren, xianyan/J-3165-2018		US National Institutes of Health (NIH) [R0IGM094816]; US National Science Foundation [CBET-1341212]; Virginia and L.E. Simmons Family Foundation Award; US NIH [R01CAl28486, 5U54151881-012, S10RR026399-01]; NATIONAL CANCER INSTITUTE [R01CA128486, P30CA016672, U54CA151881] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094816] Funding Source: NIH RePORTER; Directorate For Engineering [1341212] Funding Source: National Science Foundation	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Virginia and L.E. Simmons Family Foundation Award; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank J. Myers (MD Anderson Cancer Center, NOM9 cell line), L. Metelitsa (Texas Children's Hospital, J32 cell line) and). Ensley (Wayne State University, HN30 and HN31 cell lines) for sharing cell lines, E. Hanna, A. Gillenwater, H. Skinner and M. Kupferman for helpful discussions of head and neck cancer, G. Peng, R. Bouchard and C. Kingsley for technical help, D.S. Wagner for discussing cellular effects of PNBs, G. Mixon, S. Saunders, D. Grayson and M. Martinez for engineering and administrative help, D. Townley for performing transmission electron microscopy and W Hartner and S. Parminter for editing. This work was supported by US National Institutes of Health (NIH) grant R0IGM094816, US National Science Foundation grant CBET-1341212 and Virginia and L.E. Simmons Family Foundation Award (D.O.L.), US NIH grants R01CAl28486 (V.P.T.), 5U54151881-012 (V.P.T.) and S10RR026399-01 (confocal microscope).	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Ambrosch Petra, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P82, DOI 10.1097/MOO.0b013e3280147336; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Calais G, 2000, B CANCER, V87, P48; Chen YC, 2003, CLIN CANCER RES, V9, P969; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; de Carvalho AC, 2012, ORAL ONCOL, V48, P240, DOI 10.1016/j.oraloncology.2011.10.018; Gao Z, 2008, ULTRASONICS, V48, P260, DOI 10.1016/j.ultras.2007.11.002; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; IAKOUBOV L, 1995, IMMUNOL LETT, V47, P147, DOI 10.1016/0165-2478(95)00066-E; Jegannathen A, 2011, CLIN ONCOL-UK, V23, P149, DOI 10.1016/j.clon.2010.09.010; Jiao PF, 2011, J AM CHEM SOC, V133, P13918, DOI 10.1021/ja206118a; Karni RJ, 2011, LARYNGOSCOPE, V121, P1194, DOI 10.1002/lary.21743; Kean W. F., 2008, Inflammopharmacology, V16, P112, DOI 10.1007/s10787-007-0021-x; Koukourakis MI, 1999, J CLIN ONCOL, V17, P3512, DOI 10.1200/JCO.1999.17.11.3512; Langendijk JA, 2008, J CLIN ONCOL, V26, P3770, DOI 10.1200/JCO.2007.14.6647; Libutti SK, 2010, CLIN CANCER RES, V16, P6139, DOI 10.1158/1078-0432.CCR-10-0978; Lukianova-Hleb E, 2010, ACS NANO, V4, P2109, DOI 10.1021/nn1000222; Lukianova-Hleb EY, 2013, ADV MATER, V25, P772, DOI 10.1002/adma.201204083; Lukianova-Hleb EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034537; Lukianova-Hleb EY, 2012, ADV MATER, V24, P3831, DOI 10.1002/adma.201103550; Lukianova-Hleb EY, 2009, NANO LETT, V9, P2160, DOI 10.1021/nl9007425; Meier JD, 2005, HEAD NECK-J SCI SPEC, V27, P952, DOI 10.1002/hed.20269; Paliwal Sumit, 2006, Expert Opin Drug Deliv, V3, P713, DOI 10.1517/17425247.3.6.713; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Rahman WN, 2009, NANOMED-NANOTECHNOL, V5, P136, DOI 10.1016/j.nano.2009.01.014; Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009; Rapoport N, 2011, J CONTROL RELEASE, V153, P4, DOI 10.1016/j.jconrel.2011.01.022; Rapoport NY, 2006, AIP CONF PROC, V829, P481, DOI 10.1063/1.2205521; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; Sano D, 2011, CLIN CANCER RES, V17, P1815, DOI 10.1158/1078-0432.CCR-10-2120; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Sharafinski ME, 2010, HEAD NECK-J SCI SPEC, V32, P1412, DOI 10.1002/hed.21365; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100; Wagner DS, 2010, BIOMATERIALS, V31, P7567, DOI 10.1016/j.biomaterials.2010.06.031; Welch AJ, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P3, DOI 10.1007/978-90-481-8831-4_1; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	39	113	114	3	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					778	784		10.1038/nm.3484	http://dx.doi.org/10.1038/nm.3484			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24880615	Green Accepted			2022-12-25	WOS:000338689500022
J	Pfaffeneder, T; Spada, F; Wagner, M; Brandmayr, C; Laube, SK; Eisen, D; Truss, M; Steinbacher, J; Hackner, B; Kotljarova, O; Schuermann, D; Michalakis, S; Kosmatchev, O; Schiesser, S; Steigenberger, B; Raddaoui, N; Kashiwazaki, G; Muller, U; Spruijt, CG; Vermeulen, M; Leonhardt, H; Schar, P; Muller, M; Carell, T				Pfaffeneder, Toni; Spada, Fabio; Wagner, Mirko; Brandmayr, Caterina; Laube, Silvia K.; Eisen, David; Truss, Matthias; Steinbacher, Jessica; Hackner, Benjamin; Kotljarova, Olga; Schuermann, David; Michalakis, Stylianos; Kosmatchev, Olesea; Schiesser, Stefan; Steigenberger, Barbara; Raddaoui, Nada; Kashiwazaki, Gengo; Mueller, Udo; Spruijt, Cornelia G.; Vermeulen, Michiel; Leonhardt, Heinrich; Schaer, Primo; Mueller, Markus; Carell, Thomas			Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA	NATURE CHEMICAL BIOLOGY			English	Article							BASE EXCISION; ACTIVE-DEMETHYLATION; 5-METHYLCYTOSINE; GLYCOSYLASE; 5-FORMYLCYTOSINE; DEAMINATION; OXIDATION; PROTEINS; DAMAGE; 5-CARBOXYLCYTOSINE	Ten eleven translocation (Tet) enzymes oxidize the epigenetically important DNA base 5-methylcytosine (mC) stepwise to 5-hydroxymethylcytosine (hmC), 5-formylcytosine and 5-carboxycytosine. It is currently unknown whether let-induced oxidation is limited to cytosine-derived nucleobases or whether other nucleobases are oxidized as well. We synthesized isotopologs of all major oxidized pyrimidine and purine bases and performed quantitative MS to show that Tet-induced oxidation is not limited to mC but that thymine is also a substrate that gives 5-hydroxymethyluracil (hmU) in mouse embryonic stem cells (mESCs). Using MS-based isotope tracing, we show that deamination of hmC does not contribute to the steady-state levels of hmU in mESCs. Protein pull-down experiments in combination with peptide tracing identifies hmU as a base that influences binding of chromatin remodeling proteins and transcription factors, suggesting that hmU has a specific function in stem cells besides triggering DNA repair.	[Pfaffeneder, Toni; Spada, Fabio; Wagner, Mirko; Brandmayr, Caterina; Laube, Silvia K.; Eisen, David; Steinbacher, Jessica; Hackner, Benjamin; Kotljarova, Olga; Kosmatchev, Olesea; Schiesser, Stefan; Steigenberger, Barbara; Raddaoui, Nada; Kashiwazaki, Gengo; Mueller, Markus; Carell, Thomas] Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Munich, Germany; [Truss, Matthias] Charite Univ Klinikum, Otto Heubner Ctr Kinder & Jugendmed, Klin Allgemeine Padiatrie, Lab Padiatr Mol Biol, Berlin, Germany; [Schuermann, David; Schaer, Primo] Univ Basel, Dept Biomed, Basel, Switzerland; [Michalakis, Stylianos] Univ Munich, Ctr Drug Res, Dept Pharm, Ctr Integrated Prot Sci, Munich, Germany; [Mueller, Udo; Leonhardt, Heinrich] Univ Munich, Dept Biol, Ctr Integrated Prot Sci, Planegg Martinsried, Germany; [Spruijt, Cornelia G.; Vermeulen, Michiel] Canc Genom Netherlands, Dept Mol Canc Res, Utrecht, Netherlands	University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; University of Munich; University of Munich	Muller, M (corresponding author), Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Munich, Germany.	markus.mueller@cup.uni-muenchen.de; thomas.carell@cup.uni-muenchen.de	Carell, Thomas/G-4799-2012; Michalakis, Stylianos/M-4677-2019; Schuermann, David/AAC-4075-2019; Schär, Primo/G-5967-2012; Leonhardt, Heinrich/B-2791-2014; Spada, Fabio/J-4354-2013; Kashiwazaki, Gengo/AAW-5982-2021; Michalakis, Stylianos/W-2094-2018; Pfaffeneder, Toni/D-6171-2014; Vermeulen, Michiel/C-8883-2013	Carell, Thomas/0000-0001-7898-2831; Michalakis, Stylianos/0000-0001-5092-9238; Schuermann, David/0000-0003-2904-1378; Schär, Primo/0000-0003-1843-6147; Spada, Fabio/0000-0002-7148-9013; Kashiwazaki, Gengo/0000-0001-6935-6740; Michalakis, Stylianos/0000-0001-5092-9238; Vermeulen, Michiel/0000-0003-0836-6894; Muller, Markus/0000-0002-3579-3317; Spruijt, Cornelia/0000-0002-1789-670X; Schiesser, Stefan/0000-0002-8668-2844	Excellence Cluster Center for Integrated Protein Science Munich (CiPS<SUP>M</SUP>); collaborative research centers [SFB749, SFB646, SFB1032]; German Research Foundation (DFG) [CA275/8-4]; Volkswagen foundation; NGFNplus [01GS0870]; Netherlands Organization for Scientific Research (NWO-VIDI); Fonds der Chemischen Industrie; Boehringer Ingelheim Fonds; Japan Society for the Promotion of Science (JSPS)	Excellence Cluster Center for Integrated Protein Science Munich (CiPS<SUP>M</SUP>); collaborative research centers; German Research Foundation (DFG)(German Research Foundation (DFG)); Volkswagen foundation(Volkswagen); NGFNplus; Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the Excellence Cluster Center for Integrated Protein Science Munich (CiPS<SUP>M</SUP>) and the collaborative research centers SFB749, SFB646 and SFB1032 as well as German Research Foundation (DFG) grant CA275/8-4, the Volkswagen foundation, NGFNplus (01GS0870) and the Netherlands Organization for Scientific Research (NWO-VIDI) for financial support. T.P. and S.S. thank the Fonds der Chemischen Industrie for predoctoral fellowships. C.B. thanks the Boehringer Ingelheim Fonds for a predoctoral fellowship. G.K. thanks the Japan Society for the Promotion of Science (JSPS) for a postdoctoral fellowship for research abroad. We thank M. Moser (Max Planck Institute for Biochemistry) for providing R1- and C57Bl6/129-derived mESCs, G. Hofner and K.T. Wanner for their initial help with MS as well as M. Wirsing, L. Belzner and P. Laube for providing bioinformatic tools for data processing.	BJELLAND S, 1995, BIOCHEMISTRY-US, V34, P14758, DOI 10.1021/bi00045a017; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Burley GA, 2006, J AM CHEM SOC, V128, P1398, DOI 10.1021/ja055517v; Burrows CJ, 2009, ACS SYM SER, V1025, P147; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LEWIS HL, 1978, RADIAT RES, V75, P305, DOI 10.2307/3574906; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Moore SPG, 2013, DNA REPAIR, V12, P1152, DOI 10.1016/j.dnarep.2013.10.002; MOURET JF, 1991, CHEM-BIOL INTERACT, V77, P187, DOI 10.1016/0009-2797(91)90073-G; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thompson A, 2006, ANAL CHEM, V78, P4235, DOI 10.1021/ac060310l; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang QM, 2005, DNA REPAIR, V4, P71, DOI 10.1016/j.dnarep.2004.08.002	41	209	217	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2014	10	7					574	581		10.1038/NCHEMBIO.1532	http://dx.doi.org/10.1038/NCHEMBIO.1532			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ7IU	24838012				2022-12-25	WOS:000337871200016
J	Whissell, G; Montagni, E; Martinelli, P; Hernando-Momblona, X; Sevillano, M; Jung, P; Cortina, C; Calon, A; Abuli, A; Castells, A; Castellvi-Bel, S; Nacht, AS; Sancho, E; Attolini, CSO; Vicent, GP; Real, FX; Batlle, E				Whissell, Gavin; Montagni, Elisa; Martinelli, Paola; Hernando-Momblona, Xavier; Sevillano, Marta; Jung, Peter; Cortina, Carme; Calon, Alexandre; Abuli, Anna; Castells, Antoni; Castellvi-Bel, Sergi; Silvina Nacht, Ana; Sancho, Elena; Stephan-Otto Attolini, Camille; Vicent, Guillermo P.; Real, Francisco X.; Batlle, Eduard			The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression	NATURE CELL BIOLOGY			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; REGULATORY NETWORKS; JUVENILE POLYPOSIS; SMALL-INTESTINE; BINDING; INHIBITION; MARKER; LEADS; TUMOR	Aberrant activation of WNT signalling and loss of BMP signals represent the two main alterations leading to the initiation of colorectal cancer (CRC). Here we screen for genes required for maintaining the tumour stem cell phenotype and identify the zinc-finger transcription factor GATA6 as a key regulator of the WNT and BMP pathways in CRC. GATA6 directly drives the expression of LGR5 in adenoma stem cells whereas it restricts BMP signalling to differentiated tumour cells. Genetic deletion of Gata6 from mouse colon adenomas increases the levels of BMP factors, which signal to block self-renewal of tumour stem cells. In human tumours, GATA6 competes with beta-catenin/TCF4 for binding to a distal regulatory region of the BMP4 locus that has been linked to increased susceptibility to development of CRC. Hence, GATA6 creates an environment permissive for CRC initiation by lowering the threshold of BMP signalling required for tumour stem cell expansion.	[Whissell, Gavin; Montagni, Elisa; Hernando-Momblona, Xavier; Sevillano, Marta; Jung, Peter; Cortina, Carme; Calon, Alexandre; Sancho, Elena; Stephan-Otto Attolini, Camille; Batlle, Eduard] IRB Barcelona, Barcelona 08028, Spain; [Martinelli, Paola; Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Abuli, Anna; Castells, Antoni; Castellvi-Bel, Sergi] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Clin,Dept Gastroenterol, E-08036 Barcelona, Catalonia, Spain; [Abuli, Anna] Pompeu Fabra Univ, Hosp del Mar, Med Res Ctr, Dept Gastroenterol,IMIM, Barcelona 08003, Catalonia, Spain; [Silvina Nacht, Ana; Vicent, Guillermo P.] UPF, CRG, E-08003 Barcelona, Spain; [Real, Francisco X.] UPF, Barcelona 08003, Spain; [Batlle, Eduard] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Batlle, E (corresponding author), IRB Barcelona, Barcelona 08028, Spain.	eduard.batlle@irbbarcelona.org	Batlle, Eduard/K-8080-2014; Cortina Duran, Carme/K-7203-2017; Castells, Antoni/ABC-1002-2021; Vicent, Guillermo P./K-5432-2015; Calon, Alexandre/GPK-2061-2022; Hernando-Momblona, Xavier/ABH-4881-2020; Arribas, Francisco X Real/H-5275-2015; Sancho, Elena/ABH-4867-2020	Batlle, Eduard/0000-0003-2422-0326; Cortina Duran, Carme/0000-0003-3477-4322; Castells, Antoni/0000-0001-8431-2033; Vicent, Guillermo P./0000-0002-0554-2226; Arribas, Francisco X Real/0000-0001-9501-498X; Sancho, Elena/0000-0002-8182-513X; Castellvi-Bel, Sergi/0000-0003-1217-5097; Stephan-Otto Attolini, Camille/0000-0001-8045-320X; SEVILLANO, MARTA/0000-0001-5761-0879; Martinelli, Paola/0000-0002-1643-8731; Hernando-Momblona, Xavier/0000-0003-0755-333X	Bathe laboratory; European Research Council (FP7-EU); Ministerio de Economia y Competitividad (OncoBIO Consolider, Plan Nacional and RTICC); Josef Steiner Foundation; OncoBIO Consolider from Ministerio de Ciencia e Innovacion [SAF2011-29530]; Red Tematica de Investigacion Cooperativa en Cancer-RTICC [SAF2011-29530]; ICREA Funding Source: Custom	Bathe laboratory; European Research Council (FP7-EU); Ministerio de Economia y Competitividad (OncoBIO Consolider, Plan Nacional and RTICC); Josef Steiner Foundation; OncoBIO Consolider from Ministerio de Ciencia e Innovacion; Red Tematica de Investigacion Cooperativa en Cancer-RTICC; ICREA(ICREA)	We thank H. Clevers and J. Schuijers for help interpreting the beta-catenin/TCF4 ChIP-seq data, M. Beato for support, G. Stassi for tumour organoid material, the IRB Barcelona Biostatistics Unit for analysis of the genomics and transcriptomics data, E. Carrillo (CNIO) for bioinformatic support, the IRB Barcelona Functional Genomics Core Facility for technical assistance in microarray hybridization experiments, B. Dominguez for assistance with histology and the Bathe laboratory for discussions and support. This work has been supported by grants to E.B. from the European Research Council (FP7-EU), Ministerio de Economia y Competitividad (OncoBIO Consolider, Plan Nacional and RTICC) and The Josef Steiner Foundation, and by grants to F.X.R. (SAF2011-29530, OncoBIO Consolider from Ministerio de Ciencia e Innovacion, and Red Tematica de Investigacion Cooperativa en Cancer-RTICC).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Beuling E, 2008, DEV BIOL, V322, P179, DOI 10.1016/j.ydbio.2008.07.022; Beuling E, 2012, MOL CELL BIOL, V32, P3392, DOI 10.1128/MCB.00070-12; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brosens LAA, 2011, WORLD J GASTROENTERO, V17, P4839, DOI 10.3748/wjg.v17.i44.4839; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Divine JK, 2004, AM J PHYSIOL-GASTR L, V287, pG1086, DOI 10.1152/ajpgi.00421.2003; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kozhemyakina E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004072; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sakai Y, 1998, BIOCHEM BIOPH RES CO, V250, P682, DOI 10.1006/bbrc.1998.9374; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Tanaka T, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/658786; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tsuji S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4150; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	56	92	97	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2014	16	7					695	+		10.1038/ncb2992	http://dx.doi.org/10.1038/ncb2992			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AK1PR	24952462				2022-12-25	WOS:000338187900010
J	Wu, GA; Prochnik, S; Jenkins, J; Salse, J; Hellsten, U; Murat, F; Perrier, X; Ruiz, M; Scalabrin, S; Terol, J; Takita, MA; Labadie, K; Poulain, J; Couloux, A; Jabbari, K; Cattonaro, F; Del Fabbro, C; Pinosio, S; Zuccolo, A; Chapman, J; Grimwood, J; Tadeo, FR; Estornell, LH; Munoz-Sanz, JV; Ibanez, V; Herrero-Ortega, A; Aleza, P; Perez-Perez, J; Ramon, D; Brunel, D; Luro, F; Chen, CX; Farmerie, WG; Desany, B; Kodira, C; Mohiuddin, M; Harkins, T; Fredrikson, K; Burns, P; Lomsadze, A; Borodovsky, M; Reforgiato, G; Freitas-Astua, J; Quetier, F; Navarro, L; Roose, M; Wincker, P; Schmutz, J; Morgante, M; Machado, MA; Talon, M; Jaillon, O; Ollitrault, P; Gmitter, F; Rokhsar, D				Wu, G. Albert; Prochnik, Simon; Jenkins, Jerry; Salse, Jerome; Hellsten, Uffe; Murat, Florent; Perrier, Xavier; Ruiz, Manuel; Scalabrin, Simone; Terol, Javier; Takita, Marco Aurelio; Labadie, Karine; Poulain, Julie; Couloux, Arnaud; Jabbari, Kamel; Cattonaro, Federica; Del Fabbro, Cristian; Pinosio, Sara; Zuccolo, Andrea; Chapman, Jarrod; Grimwood, Jane; Tadeo, Francisco R.; Estornell, Leandro H.; Munoz-Sanz, Juan V.; Ibanez, Victoria; Herrero-Ortega, Amparo; Aleza, Pablo; Perez-Perez, Julian; Ramon, Daniel; Brunel, Dominique; Luro, Francois; Chen, Chunxian; Farmerie, William G.; Desany, Brian; Kodira, Chinnappa; Mohiuddin, Mohammed; Harkins, Tim; Fredrikson, Karin; Burns, Paul; Lomsadze, Alexandre; Borodovsky, Mark; Reforgiato, Giuseppe; Freitas-Astua, Juliana; Quetier, Francis; Navarro, Luis; Roose, Mikeal; Wincker, Patrick; Schmutz, Jeremy; Morgante, Michele; Machado, Marcos Antonio; Talon, Manuel; Jaillon, Olivier; Ollitrault, Patrick; Gmitter, Frederick; Rokhsar, Daniel			Sequencing of diverse mandarin, pummelo and orange genomes reveals complex history of admixture during citrus domestication	NATURE BIOTECHNOLOGY			English	Article							SINENSIS L. OSBECK; HORT. EX TAN.; MOLECULAR MARKERS; ORIGIN; CLEMENTINA; RUTACEAE; ORGANIZATION; EVOLUTION; SSRS; MAP	Cultivated citrus are selections from, or hybrids of, wild progenitor species whose identities and contributions to citrus domestication remain controversial. Here we sequence and compare citrus genomes-a high-quality reference haploid clementine genome and mandarin, pummelo, sweet-orange and sour-orange genomes- and show that cultivated types derive from two progenitor species. Although cultivated pummelos represent selections from one progenitor species, Citrus maxima, cultivated mandarins are introgressions of C. maxima into the ancestral mandarin species Citrus reticulata. The most widely cultivated citrus, sweet orange, is the offspring of previously admixed individuals, but sour orange is an F1 hybrid of pure C. maxima and C. reticulata parents, thus implying that wild mandarins were part of the early breeding germplasm. A Chinese wild 'mandarin' diverges substantially from C. reticulata, thus suggesting the possibility of other unrecognized wild citrus species. Understanding citrus phylogeny through genome analysis clarifies taxonomic relationships and facilitates sequence-directed genetic improvement.	[Wu, G. Albert; Prochnik, Simon; Hellsten, Uffe; Chapman, Jarrod; Rokhsar, Daniel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Jenkins, Jerry; Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Biotechnol Inst, Huntsville, AL USA; [Salse, Jerome; Murat, Florent] UBA, INRA, UMR Genet Diversite Ecophysiol Cereales GDEC 1095, Clermont Ferrand, France; [Perrier, Xavier; Ruiz, Manuel; Ollitrault, Patrick] CIRAD, UMR AGAP, Montpellier, France; [Scalabrin, Simone; Cattonaro, Federica; Del Fabbro, Cristian; Pinosio, Sara; Zuccolo, Andrea; Morgante, Michele] Ist Genom Applicata, Udine, Italy; [Terol, Javier; Tadeo, Francisco R.; Estornell, Leandro H.; Munoz-Sanz, Juan V.; Ibanez, Victoria; Herrero-Ortega, Amparo; Talon, Manuel] IVIA, Ctr Genom, Valencia, Spain; [Takita, Marco Aurelio; Freitas-Astua, Juliana; Machado, Marcos Antonio] Inst Agron IAC, Ctr Citricultura Sylvio Moreira, Cordeiropolis, Brazil; [Labadie, Karine; Poulain, Julie; Couloux, Arnaud; Jabbari, Kamel; Brunel, Dominique; Quetier, Francis; Wincker, Patrick; Jaillon, Olivier] Genoscope, CEA, IG, Evry, France; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Aleza, Pablo; Navarro, Luis] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, E-46113 Moncada, Spain; [Perez-Perez, Julian; Ramon, Daniel] Lifesequencing, Valencia, Spain; [Perez-Perez, Julian] Secugen, Madrid, Spain; [Brunel, Dominique] INRA, US Etude Polymorphisme Genomes Vegetaux EPGV 1279, Evry, France; [Luro, Francois] INRA Genete & Ecophysiol Qualite Agrumes GEQA, San Giuliano, France; [Chen, Chunxian; Gmitter, Frederick] Univ Florida, CREC, IFAS, Lake Alfred, FL USA; [Farmerie, William G.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Desany, Brian; Kodira, Chinnappa; Mohiuddin, Mohammed; Harkins, Tim; Fredrikson, Karin] Roche, Life Sci 454, Branford, CT USA; [Burns, Paul; Lomsadze, Alexandre; Borodovsky, Mark] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Burns, Paul; Lomsadze, Alexandre; Borodovsky, Mark] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA; [Borodovsky, Mark] Moscow Inst Phys & Technol, Dept Biol & Med Phys, Dolgoprudnyi, Russia; [Reforgiato, Giuseppe] Consiglio Ric & Sperimentaz Agr CRA ACM, Acireale, Italy; [Freitas-Astua, Juliana] Embrapa Cassava & Fruits, Cruz Das Almas, Brazil; [Quetier, Francis; Wincker, Patrick; Jaillon, Olivier] Univ Evry, Dept Biol, Evry, France; [Roose, Mikeal] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Wincker, Patrick; Jaillon, Olivier] CNRS, Evry, France; [Morgante, Michele] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Rokhsar, Daniel] Univ Calif Berkeley, Div Genet Genom & Dev, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; INRAE; CIRAD; Universite de Montpellier; Instituto Agronomico de Campinas (IAC); CEA; UDICE-French Research Universities; Universite Paris Saclay; Scuola Superiore Sant'Anna; Instituto Valenciano de Investigaciones Agrarias (IVIA); INRAE; INRAE; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Roche Holding; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Moscow Institute of Physics & Technology; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); University of Udine; University of California System; University of California Berkeley	Rokhsar, D (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	fgmitter@ufl.edu; dsrokhsar@gmail.com	Zuccolo, Andrea/H-5636-2019; Jaillon, Olivier/GRY-6287-2022; Schmutz, Jeremy/N-3173-2013; Aleza, Pablo/M-3710-2014; Talon, Manuel/C-8540-2014; MUÑOZ-SANZ, JUAN VICENTE/AAJ-7833-2020; Tadeo, Francisco R/C-8977-2014; Labadie, Karine/AAG-7355-2022; Terol, Javier/H-6401-2013; Labadie, Karine/AFL-7408-2022; Muñoz-Sanz, Juan Vicente/T-5951-2017; Navarro, Luis/D-1001-2012; Aleza, Pablo/ABF-4339-2020; Del Fabbro, Cristian/C-5523-2014; Takita, Marco A/C-3430-2013; Jenkins, Jerry/ABE-6479-2020; Freitas-Astua, Juliana/C-5833-2013; Grimwood, Jane/ABD-5737-2021; Wu, Guohong/W-3217-2019; Pinosio, Sara/AAX-7060-2020; Machado, Marcos Antonio/G-3582-2012; Quetier, Francis/J-7923-2017	Zuccolo, Andrea/0000-0001-7574-0714; Schmutz, Jeremy/0000-0001-8062-9172; Aleza, Pablo/0000-0002-8936-1448; Talon, Manuel/0000-0003-4291-9333; MUÑOZ-SANZ, JUAN VICENTE/0000-0002-6752-7398; Tadeo, Francisco R/0000-0002-5839-4255; Labadie, Karine/0000-0001-7467-8509; Terol, Javier/0000-0003-3345-0078; Labadie, Karine/0000-0001-7467-8509; Muñoz-Sanz, Juan Vicente/0000-0002-6752-7398; Navarro, Luis/0000-0001-5163-5960; Aleza, Pablo/0000-0003-3554-5337; Del Fabbro, Cristian/0000-0001-8189-6192; Takita, Marco A/0000-0003-3935-1361; Jenkins, Jerry/0000-0002-7943-3997; Freitas-Astua, Juliana/0000-0002-0506-6880; Pinosio, Sara/0000-0002-1820-3637; Murat, Florent/0000-0003-2116-2511; Fredrikson, Karin/0000-0001-7360-4276; Machado, Marcos Antonio/0000-0001-9780-3990; Ollitrault, Patrick/0000-0002-9456-5517; Jaillon, Olivier/0000-0002-7237-9596; Quetier, Francis/0000-0003-4388-9287; Poulain, Julie/0000-0002-8744-3116; Couloux, Arnaud/0000-0003-2356-0062; Ruiz, Manuel/0000-0001-8153-276X; Rokhsar, Daniel/0000-0002-8704-2224; PERRIER, Xavier/0000-0002-0092-003X; MORGANTE, Michele/0000-0003-2591-2156; Perez-Perez, Julian/0000-0001-6091-0012	National Science and Technology Institute of Genomics for Citrus Breeding, Brazil [FAPESP 08/57909-2, CNPq 573848/08-4]; Brazilian Agricultural Research Corporation (Embrapa); Embrapa-Monsanto Agreement; Agence Nationale de la Recherche (ANR) [CITRUSSEQ PCS-08-GENO]; program ANR Blanc-PAGE [ANR-2011-BSV6-00801]; US National Institutes of Health [HG00783]; Generalitat Valenciana, Spain [PrometeoII/2013/008]; Ministry of Economy and Innovation-Fondo Europeo de Desarrollo Regional (FEDER), Spain [AGL2011-26490]; Conselleria de Agricultura, Pesca, Alimentacion y Agua from the Generalitat Valenciana; Ministerio de Economia e Innovacion [PSE-060000-2009-8, IPT-010000-2010-43]; Citruseq-Citrusgenn consortium company (Anecoop S. Coop., Eurosemillas S.A.); Citruseq-Citrusgenn consortium company (Fundacion Ruralcaja Valencia); Citruseq-Citrusgenn consortium company (GCM Variedades Vegetales A.I.E.); Citruseq-Citrusgenn consortium company ( Investigacion Citricola Castellon S.A.); Citruseq-Citrusgenn consortium company (Source Citrus Genesis-Special New Fruit Licensing, Ltd.); Florida Citrus Production Research Advisory Council (FCPRAC); Florida Department of Agriculture and Consumer Services [013646]; Florida Department of Citrus (FDOC); Citrus Research and Development Foundation [71]; Ministero delle Politiche Agricole Alimentari e Forestali, Project Citrustart; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Programma Operativo Nazionale 'Ricerca e Competitivita', Project IT-Citrus Genomics [PON_01623]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000783] Funding Source: NIH RePORTER	National Science and Technology Institute of Genomics for Citrus Breeding, Brazil; Brazilian Agricultural Research Corporation (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Embrapa-Monsanto Agreement(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); program ANR Blanc-PAGE(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Ministry of Economy and Innovation-Fondo Europeo de Desarrollo Regional (FEDER), Spain; Conselleria de Agricultura, Pesca, Alimentacion y Agua from the Generalitat Valenciana; Ministerio de Economia e Innovacion(Spanish Government); Citruseq-Citrusgenn consortium company (Anecoop S. Coop., Eurosemillas S.A.); Citruseq-Citrusgenn consortium company (Fundacion Ruralcaja Valencia); Citruseq-Citrusgenn consortium company (GCM Variedades Vegetales A.I.E.); Citruseq-Citrusgenn consortium company ( Investigacion Citricola Castellon S.A.); Citruseq-Citrusgenn consortium company (Source Citrus Genesis-Special New Fruit Licensing, Ltd.); Florida Citrus Production Research Advisory Council (FCPRAC); Florida Department of Agriculture and Consumer Services; Florida Department of Citrus (FDOC); Citrus Research and Development Foundation; Ministero delle Politiche Agricole Alimentari e Forestali, Project Citrustart; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Programma Operativo Nazionale 'Ricerca e Competitivita', Project IT-Citrus Genomics; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the following support: National Science and Technology Institute of Genomics for Citrus Breeding, Brazil, grants FAPESP 08/57909-2 and CNPq 573848/08-4, and Brazilian Agricultural Research Corporation (Embrapa) (M. A. T. and M. A. M.) and Embrapa-Monsanto Agreement (J.F.-A.); Agence Nationale de la Recherche (ANR) grant CITRUSSEQ PCS-08-GENO (O.J., X. P., M. Ruiz, P.O., F. L., D. B. and K.J.) and program ANR Blanc-PAGE, ref. ANR-2011-BSV6-00801 (J. Salse and F. M.); US National Institutes of Health grant HG00783 (M. B., P. B. and A. L.); Generalitat Valenciana, Spain grant PrometeoII/2013/008 and Ministry of Economy and Innovation-Fondo Europeo de Desarrollo Regional (FEDER), Spain, grant AGL2011-26490 (P. A. and L.N.); Conselleria de Agricultura, Pesca, Alimentacion y Agua from the Generalitat Valenciana (J. P.-P. and D. Ramon); Ministerio de Economia e Innovacion grants PSE-060000-2009-8 and IPT-010000-2010-43 and Citruseq-Citrusgenn consortium companies (Anecoop S. Coop., Eurosemillas S.A., Fundacion Ruralcaja Valencia, GCM Variedades Vegetales A.I.E., Investigacion Citricola Castellon S.A. and Source Citrus Genesis-Special New Fruit Licensing, Ltd.) (J. T., F. R. T., L. H. E., J.V.M.-S., V. I., A.H.-O. and M. T.); Florida Citrus Production Research Advisory Council (FCPRAC), Florida Department of Agriculture and Consumer Services grant no. 013646, Florida Department of Citrus (FDOC) and Citrus Research and Development Foundation grant no. 71, on behalf of the Florida citrus growers (F. G., C. C. and W. G. F.); Ministero delle Politiche Agricole Alimentari e Forestali, Project Citrustart and Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Programma Operativo Nazionale 'Ricerca e Competitivita' 2007-2013, Project IT-Citrus Genomics PON_01623 (M. Morgante, S. S., F. C., C. D. F., S. Pinozio and A.Z.). Pineapple Ridge sweet-orange sequencing was performed by 454 Life Sciences, a Roche company. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231.	Aleza P, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-110; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; CAMERON JAMES W., 1961, HILGARDIA, V30, P359; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Germana MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-129; GMITTER FG, 1990, ECON BOT, V44, P267, DOI 10.1007/BF02860491; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; LIU G, 1990, Acta Botanica Yunnanica, V12, P287; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Morton F, 1987, FRUITS WARM CLIMATES; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Novelli VM, 2006, GENET MOL BIOL, V29, P90, DOI 10.1590/S1415-47572006000100018; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-593; Pfeil BE, 2008, AM J BOT, V95, P1621, DOI 10.3732/ajb.0800214; Reuther W., 1967, CITRUS IND, VI; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; SAMAAN LG, 1982, EUPHYTICA, V31, P167, DOI 10.1007/BF00028319; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Spiegel-Roy P, 1996, BIOL CITRUS; Swingle W T, 1967, CITRUS IND, P190; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tanaka T., 1977, STUD CITROG, V14, P1; Trabut JL, 1902, REV HORTICOLE, V10, P232; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472	37	397	414	14	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					656	+		10.1038/nbt.2906	http://dx.doi.org/10.1038/nbt.2906			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24908277	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-25	WOS:000338705900031
J	Lorenzen, W; Ahrendt, T; Bozhuyuk, KAJ; Bode, HB				Lorenzen, Wolfram; Ahrendt, Tilman; Bozhueyuek, Kenan A. J.; Bode, Helge B.			A multifunctional enzyme is involved in bacterial ether lipid biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							MYXOCOCCUS-XANTHUS; MYXOBACTERIUM; SUPERFAMILY	Fatty acid-derived ether lipids are present not only in most vertebrates but also in some bacteria. Here we describe what is to our knowledge the first gene cluster involved in the biosynthesis of such lipids in myxobacteria that encodes the multifunctional enzyme ElbD, which shows similarity to polyketide synthases. Initial characterization of elbD mutants in Myxococcus xanthus and Stigmatella aurantiaca showed the importance of these ether lipids for fruiting body formation and sporulation.	[Lorenzen, Wolfram; Ahrendt, Tilman; Bozhueyuek, Kenan A. J.; Bode, Helge B.] Goethe Univ Frankfurt, Fachbereich Biowissensch, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Lorenzen, W (corresponding author), Goethe Univ Frankfurt, Fachbereich Biowissensch, D-60054 Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909; Bozhuyuk, Kenan/0000-0002-8609-2967	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are grateful to M. Ring for the identification of the elb operon; O. Schimming for providing the phosphopantetheinyl transferases; C. Kegler for providing expression plasmids pSUMO3_CK4, pSUMO3_CK5, pCOLA_tacI/I and pACYC_tacI/I; S. Fuchs for the MALDI-MS measurements; and A. Perez for providing acyl donors. H.B.B. is grateful to the German Research Foundation (DFG) for an Emmy Noether fellowship that initiated this work.	Bhat S, 2014, MBIO, V5, DOI 10.1128/mBio.00939-13; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Curtis PD, 2006, ENVIRON MICROBIOL, V8, P1935, DOI 10.1111/j.1462-2920.2006.01073.x; Fernandez O, 2013, FOOD CHEM, V136, P464, DOI 10.1016/j.foodchem.2012.08.004; Garcia RO, 2009, INT J SYST EVOL MICR, V59, P1524, DOI 10.1099/ijs.0.003814-0; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P186, DOI 10.1016/j.bbalip.2010.12.010; Hoiczyk E, 2009, MOL MICROBIOL, V74, P497, DOI 10.1111/j.1365-2958.2009.06879.x; Kearns DB, 2001, P NATL ACAD SCI USA, V98, P13990, DOI 10.1073/pnas.251484598; Khurana P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-57; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lee SB, 2013, MOL PLANT, V6, P246, DOI 10.1093/mp/sss159; MACDONALD DL, 1990, BIOCHEM CELL BIOL, V68, P225, DOI 10.1139/o90-030; Magnusson CD, 2011, CHEM PHYS LIPIDS, V164, P315, DOI 10.1016/j.chemphyslip.2011.04.010; PRINS RA, 1976, FEBS LETT, V63, P107, DOI 10.1016/0014-5793(76)80204-9; Rezanka T, 2012, FOLIA MICROBIOL, V57, P463, DOI 10.1007/s12223-012-0178-6; Ring MW, 2006, J BIOL CHEM, V281, P36691, DOI 10.1074/jbc.M607616200; Vannuccini S., 1999, SHARK UTILIZATION MA; Watschinger K, 2013, BIOCHIMIE, V95, P59, DOI 10.1016/j.biochi.2012.06.027; Whitworth D.E., 2007, MYXOBACTERIA; Wichard T, 2005, J CHROMATOGR B, V814, P155, DOI 10.1016/j.jchromb.2004.10.021; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P17790, DOI 10.1073/pnas.1316412110	21	24	24	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2014	10	6					425	427		10.1038/nchembio.1526	http://dx.doi.org/10.1038/nchembio.1526			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH6JW	24814673				2022-12-25	WOS:000336238200007
J	White, PJ; St-Pierre, P; Charbonneau, A; Mitchell, PL; St-Amand, E; Marcotte, B; Marette, A				White, Phillip J.; St-Pierre, Philippe; Charbonneau, Alexandre; Mitchell, Patricia L.; St-Amand, Emmanuelle; Marcotte, Bruno; Marette, Andre			Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; INTERLEUKIN-6; SENSITIVITY; INFLAMMATION; INHIBITION; EXERCISE; TISSUES	We previously demonstrated that low biosynthesis of omega-3 fatty acid-derived proresolution mediators, termed protectins, is associated with an impaired global resolution capacity, inflammation and insulin resistance in obese high-fat diet-fed mice(1). These findings prompted a more direct study of the therapeutic potential of protectins for the treatment of metabolic disorders. Herein we show that protectin DX (PDX) exerts an unanticipated glucoregulatory activity that is distinct from its anti-inflammatory actions. We found that PDX selectively stimulated the release of the prototypic myokine interleukin-6 (IL-6) from skeletal muscle and thereby initiated a myokine-liver signaling axis, which blunted hepatic glucose production via signal transducer and activator of transcription 3 (STAT3)-mediated transcriptional suppression of the gluconeogenic program. These effects of PDX were abrogated in Il6-null mice. PDX also activated AMP-activated protein kinase (AMPK); however, it did so in an IL-6-independent manner. Notably, we demonstrated that administration of PDX to obese diabetic db/db mice raises skeletal muscle IL-6 levels and substantially improves their insulin sensitivity without any impact on adipose tissue inflammation. Our findings thus support the development of PDX-based selective muscle IL-6 secretagogues as a new class of therapy for the treatment of insulin resistance and type 2 diabetes.	[White, Phillip J.; St-Pierre, Philippe; Charbonneau, Alexandre; Mitchell, Patricia L.; St-Amand, Emmanuelle; Marcotte, Bruno; Marette, Andre] Univ Laval, Dept Med, Quebec Heart & Lung Inst, Quebec City, PQ G1K 7P4, Canada; [White, Phillip J.; St-Pierre, Philippe; Charbonneau, Alexandre; Mitchell, Patricia L.; St-Amand, Emmanuelle; Marcotte, Bruno; Marette, Andre] Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ G1K 7P4, Canada	Laval University; Quebec Heart & Lung Institute; Laval University	Marette, A (corresponding author), Univ Laval, Dept Med, Quebec Heart & Lung Inst, Quebec City, PQ G1K 7P4, Canada.	andre.marette@criucpq.ulaval.ca	White, Phillip J/H-3048-2019; Mitchell, Patricia/AAB-7801-2021	White, Phillip J/0000-0002-0957-425X; Mitchell, Patricia/0000-0002-0773-1047; Marette, Andre/0000-0003-3950-5973	Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR); CIHR/Pfizer Chair in the pathogenesis of insulin resistance and cardiovascular diseases; Fonds de is Recherche en Sante du Quebec	Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Pfizer Chair in the pathogenesis of insulin resistance and cardiovascular diseases; Fonds de is Recherche en Sante du Quebec	We thank C. Dion for surgical preparation of the mice and S. Pelletier for assistance with the palmitate macrophage studies. We also thank C. Serhan (Brigham and Women's Hospital, Harvard University) and N. Flamand (Heart and Lung Institute, Laval University) for providing PD1 and (8S,15S)-diHETE, respectively, and M. Schwab and K. Bellmann for their help with the PCR analyses. T37i fibroblasts were a gift from M. Lombes, INSERM U478. This work was supported by grants to A.M. from the Canadian Diabetes Association and from the Canadian Institutes of Health Research (CIHR). A.M. is partially funded by a CIHR/Pfizer Chair in the pathogenesis of insulin resistance and cardiovascular diseases. P.J.W. is the recipient of a PhD studentship award from the Fonds de is Recherche en Sante du Quebec.	Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Centeno-Baez C, 2011, AM J PHYSIOL-ENDOC M, V301, pE922, DOI 10.1152/ajpendo.00530.2010; Chen P, 2009, FEBS LETT, V583, P3478, DOI 10.1016/j.febslet.2009.10.004; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Gray SR, 2009, EXP PHYSIOL, V94, P899, DOI 10.1113/expphysiol.2009.048173; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tweedell A, 2011, METABOLISM, V60, P92, DOI 10.1016/j.metabol.2009.12.022; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011	23	84	85	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					664	669		10.1038/nm.3549	http://dx.doi.org/10.1038/nm.3549			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24813250	Green Accepted			2022-12-25	WOS:000337071000030
J	Bassilana, F; Carlson, A; DaSilva, JA; Grosshans, B; Vidal, S; Beck, V; Wilmeringwetter, B; Llamas, LA; Showalter, TB; Rigollier, P; Bourret, A; Ramamurthy, A; Wu, X; Harbinski, F; Plonsky, S; Lee, L; Ruffner, H; Grandi, P; Schirle, M; Jenkins, J; Sailer, AW; Bouwmeester, T; Porter, JA; Myer, V; Finan, PM; Tallarico, JA; Kelleher, JF; Seuwen, K; Jain, RK; Luchansky, SJ				Bassilana, Frederic; Carlson, Adam; DaSilva, Jennifer A.; Grosshans, Bianka; Vidal, Solange; Beck, Valerie; Wilmeringwetter, Barbara; Llamas, Luis A.; Showalter, Todd B.; Rigollier, Pascal; Bourret, Aaron; Ramamurthy, Arun; Wu, Xu; Harbinski, Fred; Plonsky, Samantha; Lee, Lac; Ruffner, Heinz; Grandi, Paola; Schirle, Markus; Jenkins, Jeremy; Sailer, Andreas W.; Bouwmeester, Tewis; Porter, Jeffrey A.; Myer, Vic; Finan, Peter M.; Tallarico, John A.; Kelleher, Joseph F., III; Seuwen, Klaus; Jain, Rishi K.; Luchansky, Sarah J.			Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39	NATURE CHEMICAL BIOLOGY			English	Article							SIGNALING PATHWAY; MEDULLOBLASTOMA; ACTIVATION; RESISTANCE; MUTATIONS; GENE; DISRUPTION; DEFICIENCY; MECHANISMS; AGONIST	Hedgehog (Hh) signaling determines cell fate during development and can drive tumorigenesis. We performed a screen for new compounds that can impinge on Hh signaling downstream of Smoothened (Smo). A series of cyclohexyl-methyl aminopyrimidine chemotype compounds ('CMAPs') were identified that could block pathway signaling in a Smo-independent manner. In addition to inhibiting Hh signaling, the compounds generated inositol phosphates through an unknown GPCR. Correlation of GPCR mRNA expression levels with compound activity across cell lines suggested the target to be the orphan receptor GPR39. RNA interference or cDNA overexpression of GPR39 demonstrated that the receptor is necessary for compound activity. We propose a model in which CMAPs activate GPR39, which signals to the Gli transcription factors and blocks signaling. In addition to the discovery of GPR39 as a new target that impinges on Hh signaling, we report on small-molecule modulators of the receptor that will enable in vitro interrogation of GPR39 signaling in different cellular contexts.	[Bassilana, Frederic; Grosshans, Bianka; Vidal, Solange; Beck, Valerie; Wilmeringwetter, Barbara; Rigollier, Pascal; Sailer, Andreas W.; Seuwen, Klaus] Novartis Inst Biomed Res, Basel, Switzerland; [Carlson, Adam; DaSilva, Jennifer A.; Llamas, Luis A.; Showalter, Todd B.; Bourret, Aaron; Ramamurthy, Arun; Harbinski, Fred; Plonsky, Samantha; Lee, Lac; Jenkins, Jeremy; Porter, Jeffrey A.; Myer, Vic; Finan, Peter M.; Tallarico, John A.; Kelleher, Joseph F., III; Jain, Rishi K.; Luchansky, Sarah J.] Novartis Inst Biomed Res, Cambridge, MA USA; [Wu, Xu] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Ruffner, Heinz; Grandi, Paola; Schirle, Markus; Bouwmeester, Tewis] Cellzome AG, Heidelberg, Germany	Novartis; Novartis; Novartis; GlaxoSmithKline; Cellzome GmbH	Bassilana, F (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	rishi.jain@novartis.com; sarah.luchansky@novartis.com	Sailer, Andreas/M-9913-2016	Sailer, Andreas/0000-0002-9015-7946; Bassilana, Frederic/0000-0003-2063-8450; Showalter, Timothy/0000-0003-1373-8496; Jenkins, Jeremy/0000-0001-9795-0771				Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Axelrod M, 2013, ONCOTARGET, V4, P622, DOI 10.18632/oncotarget.938; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Boehm M, 2013, ACS MED CHEM LETT, V4, P1079, DOI 10.1021/ml400275z; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Depoortere I, 2012, CURR OPIN PHARMACOL, V12, P647, DOI 10.1016/j.coph.2012.07.019; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Egerod KL, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/401258; Fogarty MP, 2007, P NATL ACAD SCI USA, V104, P2973, DOI 10.1073/pnas.0605770104; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lelievre V, 2008, DEV BIOL, V313, P359, DOI 10.1016/j.ydbio.2007.10.031; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Miller-Moslin K, 2009, J MED CHEM, V52, P3954, DOI 10.1021/jm900309j; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Newman-Tancredi A, 2002, MOL PHARMACOL, V62, P590, DOI 10.1124/mol.62.3.590; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Petersen PS, 2011, FASEB J, V25, P3803, DOI 10.1096/fj.11-184531; Peukert S, 2013, CHEMMEDCHEM, V8, P1261, DOI 10.1002/cmdc.201300217; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; Ragazzini P, 2004, HISTOL HISTOPATHOL, V19, P401, DOI 10.14670/HH-19.401; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; SEUWEN K, 1988, EMBO J, V7, P161, DOI 10.1002/j.1460-2075.1988.tb02796.x; Skvara H, 2011, J INVEST DERMATOL, V131, P1735, DOI 10.1038/jid.2011.48; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tremblay F, 2009, ENDOCRINOLOGY, V150, P2586, DOI 10.1210/en.2008-1251; Verhulst PJ, 2011, J NEUROENDOCRINOL, V23, P490, DOI 10.1111/j.1365-2826.2011.02132.x; Waschek JA, 2006, ANN NY ACAD SCI, V1070, P120, DOI 10.1196/annals.1317.089; Xiao-Ying D, 2009, PEPTIDES, V30, P431, DOI 10.1016/j.peptides.2008.09.022; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	50	43	43	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2014	10	5					343	+		10.1038/nchembio.1481	http://dx.doi.org/10.1038/nchembio.1481			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF4HN	24633354				2022-12-25	WOS:000334672700007
J	Gomez-Herreros, F; Schuurs-Hoeijmakers, JHM; McCormack, M; Greally, MT; Rultenl, S; Romero-Granados, R; Counihan, TJ; Chaila, E; Conroy, J; Ennis, S; Delanty, N; Cortes-Ledesma, F; de Brouwer, APM; Cavallerit, GL; El-Khamisy, SF; de Vries, BBA; Caldecott, KW				Gomez-Herreros, Fernando; Schuurs-Hoeijmakers, Janneke H. M.; McCormack, Mark; Greally, Marie T.; Rultenl, Stuart; Romero-Granados, Rocio; Counihan, Timothy J.; Chaila, Elijah; Conroy, Judith; Ennis, Sean; Delanty, Norman; Cortes-Ledesma, Felipe; de Brouwer, Arjan P. M.; Cavallerit, Gianpiero L.; El-Khamisy, Sherif F.; de Vries, Bert B. A.; Caldecott, Keith W.			TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function	NATURE GENETICS			English	Article							RECEPTOR-ASSOCIATED FACTORS; MEDIATED DNA-DAMAGE; II-BETA; SPINOCEREBELLAR ATAXIA; AXONAL NEUROPATHY; REPAIR; GENES; CELLS; TTRAP; PHOSPHODIESTERASE	Topoisomerase II (TOP2) removes torsional stress from DNA and facilitates gene transcription by introducing transient DNA double-strand breaks (DSBs). Such DSBs are normally rejoined by TOP2 but on occasion can become abortive and remain unsealed. Here we identify homozygous mutations in the TDP2 gene encoding tyrosyl DNA phosphodiesterase-2, an enzyme that repairs 'abortive' TOP2-induced DSBs, in individuals with intellectual disability, seizures and ataxia. We show that cells from affected individuals are hypersensitive to TOP2-induced DSBs and that loss of TDP2 inhibits TOP2-dependent gene transcription in cultured human cells and in mouse post-mitotic neurons following abortive TOP2 activity. Notably, TDP2 is also required for normal levels of many gene transcripts in developing mouse brain, including numerous gene transcripts associated with neurological function and/or disease, and for normal interneuron density in mouse cerebellum. Collectively, these data implicate chromosome breakage by TOP2 as an endogenous threat to gene transcription and to normal neuronal development and maintenance.	[Gomez-Herreros, Fernando; Rultenl, Stuart; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Sch Biol Sci, Sussex, England; [Schuurs-Hoeijmakers, Janneke H. M.; de Brouwer, Arjan P. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Schuurs-Hoeijmakers, Janneke H. M.; de Brouwer, Arjan P. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behaviour, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [McCormack, Mark; Delanty, Norman; Cavallerit, Gianpiero L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Greally, Marie T.] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland; [Romero-Granados, Rocio; Cortes-Ledesma, Felipe] Univ Seville, CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Genet, Seville, Spain; [Counihan, Timothy J.] Univ Hosp Galway, Dept Neurol, Galway, Ireland; [Chaila, Elijah; Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland; [Conroy, Judith; Ennis, Sean] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [El-Khamisy, Sherif F.] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [El-Khamisy, Sherif F.] Zewail City Sci & Technol, Ctr Genom, Helmy Inst, Giza, Egypt	University of Sussex; Radboud University Nijmegen; Radboud University Nijmegen; Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Ollscoil na Gaillimhe-University of Galway; University College Dublin; University of Sheffield; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sch Biol Sci, Sussex, England.	s.f.el-khamisy@sussex.ac.uk; b.devries@gen.umcn.nl; k.w.caldecott@sussex.ac.uk	Cavalleri, Gianpiero/A-6632-2010; de Brouwer, Arjan PM/P-5949-2015; Ledesma, Felipe Cortés/F-4803-2014; Herreros, Fernando Gomez/F-2674-2016; McCormack, Mark/A-5482-2010; Romero-Granados, Rocío/AAD-6360-2019; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; Herreros, Fernando Gomez/0000-0002-5693-3489; McCormack, Mark/0000-0002-8213-6141; Delaney, Norman/0000-0002-3953-9842; Caldecott, Keith/0000-0003-4255-9016; Cavalleri, Gianpiero/0000-0002-9802-0506; , Sherif/0000-0003-2721-7763; Ennis, Sean/0000-0002-4330-1386	Medical Research Council (MRC) [MR1J006750/1, G0901606/1]; Cancer Research UK [C6563/A16771]; Spanish government [SAF2010-21017, RYC-2009-03928, JAE-Doc 2010-011]; European Union [PERG07-2010268466]; Wellcome Trust [085284, 091043]; Lister Institute of Preventative Medicine; Netherlands Organization for Health Research and Development [917-86-319]; GENCODYS [EU-7th-2010-241995]; National Institute for Mental Health (NIMH) [RC2MH089915, K0IMH098126, R01MH099216, R01MH097971]; National Institute for Neurological Disorders and Stroke (NINDS) [U01NS077303]; Epilepsy Genome/Phenome Project (EPGP) [NINDS U01NS053998]; Center for HIV/AIDS Vaccine Immunology (CHAVI); National Institute of Allergy and Infectious Diseases (NIAID) [U01A1067854]; Ellison Medical Foundation New Scholar [AG-NS-0441-08]; SAIC-Frederick, Inc. [M11-074]; Biogen Idec, Inc.; Brainwave-Irish Epilepsy Association/Medical Research Charities Group of Ireland/Health Research Board award [2009/001]; Health Research Board of Ireland Translational Research Scholars; MRC [MR/J006750/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126, R01MH097971, RC2MH089915, R01MH099216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS077303, U01NS053998] Funding Source: NIH RePORTER; Cancer Research UK [16771] Funding Source: researchfish; Medical Research Council [MR/J006750/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Spanish government(Spanish GovernmentEuropean Commission); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Lister Institute of Preventative Medicine; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); GENCODYS; National Institute for Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Genome/Phenome Project (EPGP); Center for HIV/AIDS Vaccine Immunology (CHAVI); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation New Scholar(Lawrence Ellison Foundation); SAIC-Frederick, Inc.; Biogen Idec, Inc.(Biogen); Brainwave-Irish Epilepsy Association/Medical Research Charities Group of Ireland/Health Research Board award; Health Research Board of Ireland Translational Research Scholars; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients and their family for their cooperation in this research project, N. Sabry for the provision of blood from the Egyptian patient, J.H.J. Hoeijmakers for critical evaluation of the manuscript, T. van Moorsel and L. Ju for technical assistance and D. Huylebroeck for the provision of unpublished behavioral data on Tdp2A1-3 mice. Microarray analysis was conducted by M. Hubank and colleagues at University College London (UCL) Genomics, UCL Institute of Child Health. We also thank D.B. Goldstein, EL. Heinzen and the Duke Center for Human Genome Variation Genetic Analysis Facility, and we thank the following individuals associated with the Carol Woods and Crosdaile Retirement Communities, the MURDOCK Study Community Registry and Biorepository, and the Washington University Neuromuscular Genetics Project: J. McEvoy, A. Need, J. Silver, M. Silver; E.T. Cirulli, V. Dixon, D.K. Attix, O. Chiba-Falek, K. Schmader, S. McDonald, H.K. White, M. Yanamadala, C. Depondt, S. Sisodiya, W.B. Gallentine, A.M. Husain, M.A. Mikati, R.A. Radtke, S.R. Sinha, J. Hoover-Fong, N.L. Sobreira, D. Valle, D. Daskalalds, W.L. Lowe, V. Shashi, K. Schoch, D.H. Murdock, S.M. Palmer, Z. Farfel, D.D. Lancet, E. Pras, A. Holden, E. Behr, A. Poduri; P. Lugar, D. Marchuk, S. Kerns, H. Oster, R. Gbadegesin, M. Winn, E.J. Holtzman, Y.-H. Jiang, R. Brown, S.H. Appel, E. Simpson, S. Halton, L. Lay, R. Bedlack, K. Grace. This work was funded in the Caldecott laboratory by the Medical Research Council (MRC; MR1J006750/1 and G0901606/1) and Cancer Research UK (C6563/A16771), in the Cortes-Ledesma laboratory by the Spanish government (SAF2010-21017, RYC-2009-03928 and JAE-Doc 2010-011) and European Union (PERG07-2010268466), in the El-Kharnisy laboratory by the Wellcome Trust (fellowship 085284 and grant 091043) and the Lister Institute of Preventative Medicine (fellowship), and in part by the Netherlands Organization for Health Research and Development (ZonMW; VIDI grant 917-86-319 to B.B.A.d.V.), the GENCODYS project (EU-7th-2010-241995 to B.B.A.d.V. and A.P.M.d.B.), a Brainwave-Irish Epilepsy Association/Medical Research Charities Group of Ireland/Health Research Board award (2009/001) and a Health Research Board of Ireland Translational Research Scholars award. Control samples were funded by National Institute for Mental Health (NIMH) awards (RC2MH089915, K0IMH098126, R01MH099216 and R01MH097971), the Epi4K Gene Discovery in Epilepsy study (National Institute for Neurological Disorders and Stroke (NINDS) U01NS077303), the Epilepsy Genome/Phenome Project (EPGP; NINDS U01NS053998), the Center for HIV/AIDS Vaccine Immunology (CHAVI) study (National Institute of Allergy and Infectious Diseases (NIAID) U01A1067854), the Ellison Medical Foundation New Scholar award (AG-NS-0441-08), SAIC-Frederick, Inc. (M11-074) and Biogen Idec, Inc.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Gomez-Herreros F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003226; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Schellenberg MJ, 2012, NAT STRUCT MOL BIOL, V19, P1363, DOI 10.1038/nsmb.2418; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Thakurela S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3478; Tiwari VK, 2012, P NATL ACAD SCI USA, V109, pE934, DOI 10.1073/pnas.1119798109; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Zeng ZH, 2012, NUCLEIC ACIDS RES, V40, P8371, DOI 10.1093/nar/gks622	27	101	106	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					516	521		10.1038/ng.2929	http://dx.doi.org/10.1038/ng.2929			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24658003	Green Accepted, Green Submitted			2022-12-25	WOS:000335422900022
J	Ardestani, A; Paroni, F; Azizi, Z; Kaur, S; Khobragade, V; Yuan, T; Frogne, T; Tao, WF; Oberholzer, J; Pattou, F; Conte, JK; Maedler, K				Ardestani, Amin; Paroni, Federico; Azizi, Zahra; Kaur, Supreet; Khobragade, Vrushali; Yuan, Ting; Frogne, Thomas; Tao, Wufan; Oberholzer, Jose; Pattou, Francois; Conte, Julie Kerr; Maedler, Kathrin			MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes	NATURE MEDICINE			English	Article							CASPASE-MEDIATED ACTIVATION; TRANSCRIPTION FACTOR PDX-1; PROTEIN-KINASE; PANCREATIC-ISLETS; MICE; PHOSPHORYLATION; SURVIVAL; PATHWAY; DEATH; HYPERTROPHY	Apoptotic cell death is a hallmark of the loss of insulin-producing beta cells in all forms of diabetes mellitus. Current treatments fail to halt the decline in functional beta cell mass, and strategies to prevent beta cell apoptosis and dysfunction are urgently needed. Here, we identified mammalian sterile 20-like kinase-1 (MST1) as a critical regulator of apoptotic beta cell death and function. Under diabetogenic conditions, MST1 was strongly activated in beta cells in human and mouse islets and specifically induced the mitochondrial-dependent pathway of apoptosis through upregulation of the BCL-2 homology-3 (BH3)-only protein BIM. MST1 directly phosphorylated the beta cell transcription factor PDX1 at T11, resulting in the latter's ubiquitination and degradation and thus in impaired insulin secretion. MST1 deficiency completely restored normoglycemia, beta cell function and survival in vitro and in vivo. We show MST1 as a proapoptotic kinase and key mediator of apoptotic signaling and beta cell dysfunction and suggest that it may serve as target for the development of new therapies for diabetes.	[Ardestani, Amin; Paroni, Federico; Azizi, Zahra; Kaur, Supreet; Khobragade, Vrushali; Yuan, Ting; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany; [Frogne, Thomas] Novo Nordisk AS, Dept Incretin & Islet Biol, As, Denmark; [Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, Natl Ctr Int Res Dev & Dis, Shanghai 200433, Peoples R China; [Oberholzer, Jose] Univ Illinois, Div Transplantat, Chicago, IL USA; [Pattou, Francois; Conte, Julie Kerr] Univ Lille, Lille Reg Hosp Ctr, European Genom Inst Diabet, INSERM Biotherapies Diabet U859, Lille, France	University of Bremen; Novo Nordisk; Fudan University; Fudan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Maedler, K (corresponding author), Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany.	ardestani.amin@gmail.com; kmaedler@uni-bremen.de	Azizi, Zahra/AAL-4334-2021; Azizi, Zahra/AAA-5276-2022; Azizi, Zahra/AAL-4359-2021; Maedler, Kathrin/ABE-3022-2021; Pattou, Francois/O-6151-2017	Azizi, Zahra/0000-0002-5456-6881; Maedler, Kathrin/0000-0002-7436-1197; Pattou, Francois/0000-0001-8388-3766; Ardestani, Amin/0000-0002-0685-8564	JDRF; German Research Foundation [MA4172/1-1]; European Research Council; German Federal Ministry of Science (Diabetes Competence Network); European Federation for the Study of Diabetes; University of Bremen; Juvenile Diabetes Research Foundation [31-2008-413]; US National Institutes of Health	JDRF(Juvenile Diabetes Research Foundation); German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Science (Diabetes Competence Network); European Federation for the Study of Diabetes; University of Bremen; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the JDRF, the German Research Foundation (Emmy Noether Programm MA4172/1-1), the European Research Council, the German Federal Ministry of Science (Diabetes Competence Network), the European Federation for the Study of Diabetes and University of Bremen Research Funds (all to K.M.). We thank J. Bergemann for excellent technical assistance, G. Dharmadhikari and M. Panse for help with the analyses and G. Rutter and D. Schumann for critical discussion. Human islets were provided through the Juvenile Diabetes Research Foundation award 31-2008-413 (European Consortium for Islet Transplantation Islets for Basic Research Program) and by the Integrated Islet Distribution Program. Human pancreatic sections were obtained from the National Disease Research Interchange, which is supported by the US National Institutes of Health. MST1 and dn-MST1 plasmids and adenoviruses were provided by J. Sadoshima and Y. Maejima (Rutgers New Jersey Medical School), PDX1-WT plasmids and pGEX bacterial expression vector by R. Walther (University of Greifswald), INS-1E cells by C. Wollheim (Lund and Geneva Universities), RIP-Cre mice by P. Herrera (University of Geneva) and A. Mansouri (Max Planck Institute for Biophysical Chemistry), mouse pB.RSV.PDX1-GFP plasmid by I. Leibiger (Karolinska University) and rat insulin-2 promoter plasmid by R. Zinkernagel (University of Zurich). Adenovirus carrying eGFP as a control was provided by A.E. Karlsen (Novo Nordisk A/S).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ardestani A, 2011, J BIOL CHEM, V286, P17144, DOI 10.1074/jbc.M110.210526; Arnoult D, 2008, METHODS, V44, P229, DOI 10.1016/j.ymeth.2007.11.003; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Carew RM, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-73; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Frogne T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035233; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kakeya H, 1998, CANCER RES, V58, P4888; Kang HC, 2009, DIABETES TECHNOL THE, V11, P443, DOI 10.1089/dia.2008.0117; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawano Y, 2012, DIABETES, V61, P1935, DOI 10.2337/db11-0770; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Lebrun P, 2005, J BIOL CHEM, V280, P38203, DOI 10.1074/jbc.M504842200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Shu L, 2012, DIABETOLOGIA, V55, P3296, DOI 10.1007/s00125-012-2693-z; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Trumper K, 2000, ANN NY ACAD SCI, V921, P242; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Valis K, 2011, CANCER RES, V71, P946, DOI 10.1158/0008-5472.CAN-10-2203; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Yun HJ, 2011, EMBO J, V30, P2465, DOI 10.1038/emboj.2011.152; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	69	140	146	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					385	+		10.1038/nm.3482	http://dx.doi.org/10.1038/nm.3482			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24633305	Green Accepted			2022-12-25	WOS:000334361500019
J	Hammar, P; Wallden, M; Fange, D; Persson, F; Baltekin, O; Ullman, G; Leroy, P; Elf, J				Hammar, Petter; Wallden, Mats; Fange, David; Persson, Fredrik; Baltekin, Ozden; Ullman, Gustaf; Leroy, Prune; Elf, Johan			Direct measurement of transcription factor dissociation excludes a simple operator occupancy model for gene regulation	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; LAC REPRESSOR; MULTISCALE PRODUCTS; MOLECULE; CELLS; DISTRIBUTIONS; EXPRESSION; PROTEIN	Transcription factors mediate gene regulation by site-specific binding to chromosomal operators. It is commonly assumed that the level of repression is determined solely by the equilibrium binding of a repressor to its operator. However, this assumption has not been possible to test in living cells. Here we have developed a single-molecule chase assay to measure how long an individual transcription factor molecule remains bound at a specific chromosomal operator site. We find that the lac repressor dimer stays bound on average 5 min at the native lac operator in Escherichia coli and that a stronger operator results in a slower dissociation rate but a similar association rate. Our findings do not support the simple equilibrium model. The discrepancy with this model can, for example, be accounted for by considering that transcription initiation drives the system out of equilibrium. Such effects need to be considered when predicting gene activity from transcription factor binding strengths.	[Hammar, Petter; Wallden, Mats; Fange, David; Persson, Fredrik; Baltekin, Ozden; Ullman, Gustaf; Leroy, Prune; Elf, Johan] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University	Elf, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden.	johan.elf@icm.uu.se	Persson, Fredrik/F-3057-2011	Persson, Fredrik/0000-0002-5019-4312; elf, johan/0000-0001-5522-1810	European Research Council (ERC); Knut and Alice Wallenberg Foundation (KAW); Vetenskapsradet (VR); Foundation for Strategic Research (SSF); Gran Gustafsson Foundation	European Research Council (ERC)(European Research Council (ERC)); Knut and Alice Wallenberg Foundation (KAW)(Knut & Alice Wallenberg Foundation); Vetenskapsradet (VR)(Swedish Research Council); Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Gran Gustafsson Foundation	We thank K.S. Matthews for advice on LacI mutants, G.-W. Li for helpful comments, X.S. Xie (Harvard University) for the MalI-Venus strain and I. Barkefors for critical reading of the manuscript. This work was supported by the European Research Council (ERC), the Knut and Alice Wallenberg Foundation (KAW), Vetenskapsradet (VR), the Foundation for Strategic Research (SSF) and the Gran Gustafsson Foundation.	Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; CHANG WI, 1994, BIOCHEMISTRY-US, V33, P3607, DOI 10.1021/bi00178a018; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Sadler BM, 1999, IEEE T INFORM THEORY, V45, P1043, DOI 10.1109/18.761341; Sanchez A, 2011, EMBO J, V30, P3940, DOI 10.1038/emboj.2011.273; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	25	92	92	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					405	+		10.1038/ng.2905	http://dx.doi.org/10.1038/ng.2905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24562187	Green Accepted			2022-12-25	WOS:000334510100020
J	Rognoni, E; Widmaier, M; Jakobson, M; Ruppert, R; Ussar, S; Katsougkri, D; Bottcher, RT; Lai-Cheong, JE; Rifkin, DB; McGrath, JA; Fassler, R				Rognoni, Emanuel; Widmaier, Moritz; Jakobson, Madis; Ruppert, Raphael; Ussar, Siegfried; Katsougkri, Despoina; Boettcher, Ralph T.; Lai-Cheong, Joey E.; Rifkin, Daniel B.; McGrath, John A.; Faessler, Reinhard			Kindlin-1 controls Wnt and TGF-beta availability to regulate cutaneous stem cell proliferation	NATURE MEDICINE			English	Article							FOCAL ADHESION; COMPREHENSIVE GUIDE; HAIR-FOLLICLES; EXPRESSION; CATENIN; SKIN; BETA-1-INTEGRIN; ACTIVATION; GROWTH; CLASSIFICATION	Kindlin-1 is an integrin tail binding protein that controls integrin activation. Mutations in the FERMT-1 gene, which encodes for Kindlin-1, lead to Kindler syndrome in man, which is characterized by skin blistering, premature skin aging and skin cancer of unknown etiology. Here we show that loss of Kindlin-1 in mouse keratinocytes recapitulates Kindler syndrome and also produces enlarged and hyperactive stem cell compartments, which lead to hyperthickened epidermis, ectopic hair follicle development and increased skin tumor susceptibility. Mechanistically, Kindlin-1 controls keratinocyte adhesion through beta 1-class integrins and proliferation and differentiation of cutaneous epithelial stem cells by promoting alpha(nu)beta(6) integrin-mediated transforming growth factor-beta (TGF-beta) activation and inhibiting Wnt-beta-catenin signaling through integrin-independent regulation of Wnt ligand expression. Our findings assign Kindlin-1 the previously unknown and essential task of controlling cutaneous epithelial stem cell homeostasis by balancing TGF-beta-mediated growth-inhibitory signals and Wnt-beta-catenin-mediated growth-promoting signals.	[Rognoni, Emanuel; Widmaier, Moritz; Jakobson, Madis; Ruppert, Raphael; Ussar, Siegfried; Katsougkri, Despoina; Boettcher, Ralph T.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Lai-Cheong, Joey E.] King Edward VII Hosp, Dept Dermatol, Windsor, England; [Lai-Cheong, Joey E.; McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London, England; [Rifkin, Daniel B.] NYU, Langone Sch Med, New York, NY USA	Max Planck Society; University of London; King's College London; New York University; NYU Langone Medical Center	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18A, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Ussar, Siegfried/AAL-4331-2021; Rognoni, Emanuel/M-3024-2019; McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	Ussar, Siegfried/0000-0001-7575-0920; Rognoni, Emanuel/0000-0001-6050-2860; McGrath, John/0000-0002-3708-9964	US National Institutes of Health [CA034282]; Wellcome Trust; UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service Foundation Trust; King's College London; Advanced European Research Council (ERC) [322652]; Max Planck Society; NATIONAL CANCER INSTITUTE [R01CA034282] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service Foundation Trust; King's College London; Advanced European Research Council (ERC)(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Polleux for generating gold nanoarrays, S. Bach for expert technical assistance, C. Mein (Barts and the London Genome Centre) for generating the human microarray data and R. Zent and R. Paus for carefully reading the manuscript. We thank M. Aumailley (University of Cologne), R. Grosschedl (Max Planck Institute (MPI) Immunobiology), S. Violette (Biogen Idec), D. Sheppard (University of California, San Francisco) and M. Wegner (University of Erlangen) for providing antibodies and I. Thesleff (University of Helsinki), R. Kageyama (Kyoto University), A. Kispert (University of Hannover) and J. Behrens (University of Erlangen) for sending essential constructs. This work was funded by the US National Institutes of Health (CA034282) to D.B.R., the Wellcome Trust (PhD studentship to J.E.L.-C.) and the UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London to J.A.M., the Advanced European Research Council (ERC) Grant (ERC Grant Agreement 322652) and the Max Planck Society to R.F.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arita K, 2007, BRIT J DERMATOL, V157, P1252, DOI 10.1111/j.1365-2133.2007.08159.x; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brown JK, 2006, J HISTOCHEM CYTOCHEM, V54, P807, DOI 10.1369/jhc.5A6854.2006; Chaudhury A, 2009, IUBMB LIFE, V61, P929, DOI 10.1002/iub.239; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Emanuel Patrick O, 2006, Skinmed, V5, P305, DOI 10.1111/j.1540-9740.2006.05369.x; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Ferreira M, 2009, CANCER RES, V69, P1334, DOI 10.1158/0008-5472.CAN-08-3051; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lai-Cheong JE, 2009, BRIT J DERMATOL, V160, P233, DOI 10.1111/j.1365-2133.2008.08976.x; Lai-Cheong JE, 2009, AM J PATHOL, V175, P1431, DOI 10.2353/ajpath.2009.081154; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; Morales-Avila E, 2011, BIOCONJUGATE CHEM, V22, P913, DOI 10.1021/bc100551s; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Sin S, 2011, J NATL CANCER I, V103, P1323, DOI 10.1093/jnci/djr290; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Watt FM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005124; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Woo WM, 2011, CELL, V146, P334, DOI 10.1016/j.cell.2011.07.001; Xie YS, 2012, J INVEST DERMATOL, V132, P547, DOI 10.1038/jid.2011.381; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	71	93	101	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					350	+		10.1038/nm.3490	http://dx.doi.org/10.1038/nm.3490			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24681597	Green Accepted, Green Submitted			2022-12-25	WOS:000334361500015
J	Wang, CC; Bajikar, SS; Jamal, L; Atkins, KA; Janes, KA				Wang, Chun-Chao; Bajikar, Sameer S.; Jamal, Leen; Atkins, Kristen A.; Janes, Kevin A.			A time-and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies	NATURE CELL BIOLOGY			English	Article							CARCINOMA IN-SITU; STOCHASTIC GENE-EXPRESSION; HUMAN PROTEIN ATLAS; III TGF-BETA; CANCER-CELLS; TENASCIN EXPRESSION; FLUORESCENT PROTEIN; SIGNALING PATHWAYS; NEGATIVE FEEDBACK; MORPHOGENESIS	Basal-like breast carcinoma is characterized by poor prognosis and high intratumour heterogeneity. In an immortalized basal-like breast epithelial cell line, we identified two anticorrelated gene-expression programs that arise among single extracellular matrix (ECM)-attached cells during organotypic three-dimensional culture. The first contains multiple TGF-beta-related genes including TGFBR3, whereas the second contains JUND and the basal-like marker KRT5. TGFBR3 and JUND interconnect through four negative-feedback loops to form a circuit that exhibits spontaneous damped oscillations in three-dimensional culture. The TGFBR3-JUND circuit is conserved in some premalignant lesions that heterogeneously express KRT5. The circuit depends on ECM engagement, as detachment causes a rewiring that is triggered by RPS6 dephosphorylation and maintained by juxtacrine tenascin C, which is critical for intraductal colonization of basal-like breast cancer cells in vivo. Intratumour heterogeneity need not stem from partial differentiation and could instead reflect dynamic toggling of cells between expression states that are not cell autonomous.	[Wang, Chun-Chao; Bajikar, Sameer S.; Jamal, Leen; Janes, Kevin A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Atkins, Kristen A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Janes, KA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.	kjanes@virginia.edu		Bajikar, Sameer/0000-0002-8868-881X; Wang, Chun-Chao/0000-0003-4884-3835	American Cancer Society [120668-RSG-11-047-01-DMC]; National Institutes of Health Director's New Innovator Award Program [1-DP2-OD006464]; ew Scholars Program in the Biomedical Sciences; David and Lucile Packard Foundation; Breast Cancer Research Program Postdoctoral Fellowship Award from the Department of Defense [W81XWH-11-1-0037]; National Science Foundation; University of Virginia; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006464] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health Director's New Innovator Award Program; ew Scholars Program in the Biomedical Sciences; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Breast Cancer Research Program Postdoctoral Fellowship Award from the Department of Defense; National Science Foundation(National Science Foundation (NSF)); University of Virginia; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R.Horwitz and I. Macara for critically reading an early version of this manuscript, the UVA Women's Oncology Group for guidance, I. Fraser for plasmid reagents, L. Wang for help with the quantitative PCR experiments, and P. Pramoonjago for help with processing the clinical samples. This work was supported by the American Cancer Society (120668-RSG-11-047-01-DMC to K.A.J.) and the National Institutes of Health Director's New Innovator Award Program (1-DP2-OD006464 to K.A.J.). K.A.J. is further supported by the Pew Scholars Program in the Biomedical Sciences and the David and Lucile Packard Foundation. C.C.W. is supported by a Breast Cancer Research Program Postdoctoral Fellowship Award from the Department of Defense (W81XWH-11-1-0037).S.S.B. is supported by Graduate Research Fellowship from the National Science Foundation. L.J. is supported by a Harrison Fellowship from the University of Virginia.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Azzopardi J. G., 1979, MAJOR PROBLEMS PATHO, V11, P193; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; BERGER I, 1991, ONCOGENE, V6, P561; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bryan BB, 2006, MODERN PATHOL, V19, P617, DOI 10.1038/modpathol.3800570; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hempel N, 2008, CARCINOGENESIS, V29, P905, DOI 10.1093/carcin/bgn049; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Ishihara A, 1995, CLIN CANCER RES, V1, P1035; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Jensen RA, 2003, AM J SURG PATHOL, V27, P828, DOI 10.1097/00000478-200306000-00015; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Laakso M, 2006, CLIN CANCER RES, V12, P4185, DOI 10.1158/1078-0432.CCR-06-0353; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Malik RK, 1996, J BIOL CHEM, V271, P29785, DOI 10.1074/jbc.271.47.29785; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHALKWIJK J, 1991, AM J PATHOL, V139, P1143; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schneyer AL, 2008, ENDOCRINOLOGY, V149, P4589, DOI 10.1210/en.2008-0259; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz MA, 2001, J CELL SCI, V114, P2553; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Thorne BC, 2007, BRIEF BIOINFORM, V8, P245, DOI 10.1093/bib/bbm024; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TYNER AL, 1986, J CELL BIOL, V103, P1945, DOI 10.1083/jcb.103.5.1945; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Wang CC, 2012, WIRES SYST BIOL MED, V4, P51, DOI 10.1002/wsbm.159; Wang LX, 2013, NAT PROTOC, V8, P282, DOI 10.1038/nprot.2012.158; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Zou TT, 2010, MOL CELL BIOL, V30, P5021, DOI 10.1128/MCB.00807-10	73	51	52	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2014	16	4					345	+		10.1038/ncb2930	http://dx.doi.org/10.1038/ncb2930			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AD9AM	24658685	Green Accepted			2022-12-25	WOS:000333556900008
J	Carlson, JC; Badran, AH; Guggiana-Nilo, DA; Liu, DR				Carlson, Jacob C.; Badran, Ahmed H.; Guggiana-Nilo, Drago A.; Liu, David R.			Negative selection and stringency modulation in phage-assisted continuous evolution	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; RNA-POLYMERASE; FILAMENTOUS PHAGE; PROTEIN EVOLUTION; DIRECTED EVOLUTION; GENE-III; PROMOTER; EXPRESSION; MEMBRANE; SPECIFICITY	Phage-assisted continuous evolution (PACE) uses a modified filamentous bacteriophage life cycle to substantially accelerate laboratory evolution experiments. In this work, we expand the scope and capabilities of the PACE method with two key advances that enable the evolution of biomolecules with radically altered or highly specific new activities. First, we implemented small molecule-controlled modulation of selection stringency that enables otherwise inaccessible activities to be evolved directly from inactive starting libraries through a period of evolutionary drift. Second, we developed a general negative selection that enables continuous counterselection against undesired activities. We integrated these developments to continuously evolve mutant T7 RNA polymerase enzymes with -10,000-fold altered, rather than merely broadened, substrate specificities during a single three-day PACE experiment. The evolved enzymes exhibit specificity for their target substrate that exceeds that of wild-type RNA polymerases for their cognate substrates while maintaining wild type-like levels of activity.	[Carlson, Jacob C.; Badran, Ahmed H.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Carlson, Jacob C.; Badran, Ahmed H.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Guggiana-Nilo, Drago A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022		DARPA [HR0011-11-2-0003, N66001-12-C-4207]; Howard Hughes Medical Institute; Harvard Chemical Biology Graduate Program; National Science Foundation; Harvard Biophysics Graduate Program	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Chemical Biology Graduate Program; National Science Foundation(National Science Foundation (NSF)); Harvard Biophysics Graduate Program	The authors thank K. Esvelt, D. Thompson, B. Dorr and K. Davis for helpful discussions. This research was supported by DARPA HR0011-11-2-0003, DARPA N66001-12-C-4207 and the Howard Hughes Medical Institute. J.C.C. was supported by the Harvard Chemical Biology Graduate Program. A. H. B. was supported by a National Science Foundation Graduate Research Fellowship. D.A.G.-N. was supported by the Harvard Biophysics Graduate Program.	Bennett NJ, 2006, J MOL BIOL, V356, P266, DOI 10.1016/j.jmb.2005.11.069; BOEKE JD, 1982, MOL GEN GENET, V186, P185, DOI 10.1007/BF00331849; BONNER G, 1994, J BIOL CHEM, V269, P25120; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Calendar R., 2006, BACTERIOPHAGES, P376; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dickinson BC, 2013, P NATL ACAD SCI USA, V110, P9007, DOI 10.1073/pnas.1220670110; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; GRANT RA, 1981, J BIOL CHEM, V256, P539; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Leconte AM, 2013, BIOCHEMISTRY-US, V52, P1490, DOI 10.1021/bi3016185; LOPEZ J, 1982, J VIROL, V42, P1099, DOI 10.1128/JVI.42.3.1099-1107.1982; Lynch SA, 2009, NUCLEIC ACIDS RES, V37, P184, DOI 10.1093/nar/gkn924; NELSON FK, 1981, VIROLOGY, V108, P338, DOI 10.1016/0042-6822(81)90442-6; Rakonjac J, 1997, GENE, V198, P99, DOI 10.1016/S0378-1119(97)00298-9; Rakonjac J, 1999, J MOL BIOL, V289, P1253, DOI 10.1006/jmbi.1999.2851; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; XI L, 1991, J BACTERIOL, V173, P1399, DOI 10.1128/jb.173.4.1399-1405.1991; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005	29	95	107	4	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					216	+		10.1038/NCHEMBIO.1453	http://dx.doi.org/10.1038/NCHEMBIO.1453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24487694	Green Submitted, Green Accepted			2022-12-25	WOS:000331616900013
J	Castro-Roa, D; Garcia-Pino, A; De Gieter, S; van Nuland, NAJ; Loris, R; Zenkin, N				Castro-Roa, Daniel; Garcia-Pino, Abel; De Gieter, Steven; van Nuland, Nico A. J.; Loris, Remy; Zenkin, Nikolay			The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu	NATURE CHEMICAL BIOLOGY			English	Article							INHIBITS TRANSLATION; CRYSTAL-STRUCTURE; PROPHAGE P1; AMPYLATION; PHD; ELONGATION; SYSTEM; RNA; MECHANISM; DOCKING	Fic proteins are ubiquitous in all of the domains of life and have critical roles in multiple cellular processes through AMPylation of (transfer of AMP to) target proteins. Doc from the doc-phd toxin-antitoxin module is a member of the Fic family and inhibits bacterial translation by an unknown mechanism. Here we show that, in contrast to having AMPylating activity, Doc is a new type of kinase that inhibits bacterial translation by phosphorylating the conserved threonine (Thr382) of the translation elongation factor EF-Tu, rendering EF-Tu unable to bind aminoacylated tRNAs. We provide evidence that EF-Tu phosphorylation diverged from AMPylation by antiparallel binding of the NTP relative to the catalytic residues of the conserved Fic catalytic core of Doc. The results bring insights into the mechanism and role of phosphorylation of EF-Tu in bacterial physiology as well as represent an example of the catalytic plasticity of enzymes and a mechanism for the evolution of new enzymatic activities.	[Castro-Roa, Daniel; Zenkin, Nikolay] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Garcia-Pino, Abel; De Gieter, Steven; van Nuland, Nico A. J.; Loris, Remy] VUB, Struct Biol Brussels, Dept Biotechnol, Brussels, Belgium; [Garcia-Pino, Abel; De Gieter, Steven; van Nuland, Nico A. J.; Loris, Remy] VIB, Mol Recognit Unit, Dept Biol Struct, Brussels, Belgium	Newcastle University - UK; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Zenkin, N (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	agarciap@vub.ac.be; n.zenkin@ncl.ac.uk	Loris, Remy/GPG-0894-2022	Garcia-Pino, Abel/0000-0002-0634-0300; DE GIETER, STEVEN/0000-0002-2776-3791; Loris, Remy/0000-0002-8862-3338; Zenkin, Nikolay/0000-0003-2212-9545	UK Biotechnology and Biological Sciences Research Council; European Research Council [ERC-2007-StG 202994-MTP]; Onderzoeksraad of the VUB; Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen; Hercules Foundation; VIB; Biotechnology and Biological Sciences Research Council [BB/J006378/1] Funding Source: researchfish; BBSRC [BB/J006378/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Onderzoeksraad of the VUB; Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen(FWO); Hercules Foundation; VIB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. van Nues and D. Forrest for critical reading of the manuscript, A. Talavera for assistance with the docking experiments and J. Gray for support with MS. This work was supported by UK Biotechnology and Biological Sciences Research Council and the European Research Council (ERC-2007-StG 202994-MTP) to N. Z., the Onderzoeksraad of the VUB, Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen, VIB and the Hercules Foundation. The authors acknowledge the use of the EMBL beamline P12 at the DESY synchrotron (Hamburg, Germany).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castro-Roa D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1262; CUSACK NJ, 1983, BIOCHEM J, V214, P975, DOI 10.1042/bj2140975; De Gieter S, 2014, BIOMOL NMR ASSIGN, V8, P145, DOI 10.1007/s12104-013-9471-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Garcia-Pino A, 2008, ACTA CRYSTALLOGR F, V64, P1034, DOI 10.1107/S1744309108031722; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; LYCAN DE, 1983, J VIROL, V45, P264, DOI 10.1128/JVI.45.1.264-274.1983; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sakai A, 2009, BIOCHEMISTRY-US, V48, P1445, DOI 10.1021/bi802277h; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	46	119	130	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					811	+		10.1038/NCHEMBIO.1364	http://dx.doi.org/10.1038/NCHEMBIO.1364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24141193	Green Accepted, Green Published			2022-12-25	WOS:000327130000013
J	Qi, JJ; Liu, X; Shen, D; Miao, H; Xie, BY; Li, XX; Zeng, P; Wang, SH; Shang, Y; Gu, XF; Du, YC; Li, Y; Lin, T; Yuan, JH; Yang, XY; Chen, JF; Chen, HM; Xiong, XY; Huang, K; Fei, ZJ; Mao, LY; Tian, L; Stadler, T; Renner, SS; Kamoun, S; Lucas, WJ; Zhang, ZH; Huang, SW				Qi, Jianjian; Liu, Xin; Shen, Di; Miao, Han; Xie, Bingyan; Li, Xixiang; Zeng, Peng; Wang, Shenhao; Shang, Yi; Gu, Xingfang; Du, Yongchen; Li, Ying; Lin, Tao; Yuan, Jinhong; Yang, Xueyong; Chen, Jinfeng; Chen, Huiming; Xiong, Xingyao; Huang, Ke; Fei, Zhangjun; Mao, Linyong; Tian, Li; Staedler, Thomas; Renner, Susanne S.; Kamoun, Sophien; Lucas, William J.; Zhang, Zhonghua; Huang, Sanwen			A genomic variation map provides insights into the genetic basis of cucumber domestication and diversity	NATURE GENETICS			English	Article							WIDE PATTERNS; DRAFT GENOME; ARABIDOPSIS; SATIVUS; RICE; REVEALS; ORIGIN; WILD; LD	Most fruits in our daily diet are the products of domestication and breeding. Here we report a map of genome variation for a major fruit that encompasses similar to 3.6 million variants, generated by deep resequencing of 115 cucumber lines sampled from 3,342 accessions worldwide. Comparative analysis suggests that fruit crops underwent narrower bottlenecks during domestication than grain crops. We identified 112 putative domestication sweeps; 1 of these regions contains a gene involved in the loss of bitterness in fruits, an essential domestication trait of cucumber. We also investigated the genomic basis of divergence among the cultivated populations and discovered a natural genetic variant in a beta-carotene hydroxylase gene that could be used to breed cucumbers with enhanced nutritional value. The genomic history of cucumber evolution uncovered here provides the basis for future genomics-enabled breeding.	[Qi, Jianjian; Shen, Di; Miao, Han; Xie, Bingyan; Li, Xixiang; Wang, Shenhao; Shang, Yi; Gu, Xingfang; Du, Yongchen; Li, Ying; Lin, Tao; Yuan, Jinhong; Yang, Xueyong; Xiong, Xingyao; Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Liu, Xin; Zeng, Peng] BGI Shenzhen, Shenzhen, Peoples R China; [Chen, Jinfeng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Chen, Huiming] Hunan Acad Agr Sci, Hunan Vegetable Res Inst, Changsha, Hunan, Peoples R China; [Xiong, Xingyao; Huang, Ke] Hunan Agr Univ, Hort & Landscape Coll, Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China; [Fei, Zhangjun; Mao, Linyong] Robert W Holley Ctr Agr & Hlth, Boyce Thompson Inst Plant Res, USDA, Ithaca, NY USA; [Tian, Li] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Staedler, Thomas] ETH, Inst Integrat Biol, Zurich, Switzerland; [Renner, Susanne S.] Univ Munich, Dept Biol, Munich, Germany; [Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Lucas, William J.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); Nanjing Agricultural University; Hunan Academy of Agricultural Sciences; Hunan Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California Davis	Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	zhangzhonghua@caas.cn; huangsanwen@caas.cn	Yuan, Jinhong/AAF-7715-2019; Fei, Zhangjun/H-5152-2012; Städler, Thomas/B-7286-2009; Kamoun, Sophien/B-3529-2009; Huang, Sanwen/ABE-9053-2020	Yuan, Jinhong/0000-0002-5794-493X; Städler, Thomas/0000-0003-4513-8583; Kamoun, Sophien/0000-0002-0290-0315; Huang, Sanwen/0000-0002-8547-5309; Fei, Zhangjun/0000-0001-9684-1450; Liu, Xin/0000-0003-3256-2940; zhang, zhonghua/0000-0002-1034-227X; Yang, Xueyong/0000-0003-0453-2023	National Program on Key Basic Research Projects in China (the 973 Program) [2012CB113900]; National Natural Science Foundation of China (NSFC) [31225025]; National High-Tech Research Development Program in China (the 863 Program) [2010AA10A108, 2012AA100101]; NSFC [31030057, 30972011, 31101550, 31071797, 31171961, 31272161, 31322047]; Chinese Ministry of Agriculture [2008-Z42]; Chinese Ministry of Finance [1251610601001]; CAAS	National Program on Key Basic Research Projects in China (the 973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High-Tech Research Development Program in China (the 863 Program)(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Finance; CAAS	We thank J. Ross-Ibarra (University of California, Davis) and J.-Y. Li (Chinese Academy of Agricultural Sciences (CAAS)) for critical comments, D. DellaPenna (Michigan State University) for assistance in beta-carotene pathway analysis and the three anonymous referees for their constructive comments. We thank F. Cunningham (University of Maryland) for providing the pAC-BETA plasmid. This work was supported by funding from the National Program on Key Basic Research Projects in China (the 973 Program; 2012CB113900), the National Natural Science Foundation of China (NSFC; 31225025) the National High-Tech Research Development Program in China (the 863 Program; 2010AA10A108 and 2012AA100101), and other NSFC grants (31030057, 30972011, 31101550, 31071797, 31171961, 31272161 and 31322047), the Chinese Ministry of Agriculture (the 948 program; 2008-Z42), the Chinese Ministry of Finance (1251610601001) and CAAS (seed grant to S.H.).	Anderson M. J., 2003, PCO FORTRAN COMPUTER; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; BARHAM WS, 1953, P AM SOC HORTIC SCI, V62, P441; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bo KL, 2012, MOL BREEDING, V30, P335, DOI 10.1007/s11032-011-9624-4; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Horiguchi G, 2009, PLANT J, V60, P122, DOI 10.1111/j.1365-313X.2009.03940.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kang HX, 2011, THEOR APPL GENET, V122, P795, DOI 10.1007/s00122-010-1487-2; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XueFeng, 2011, Acta Horticulturae Sinica, V38, P886; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qi C. Z., 1983, Acta Horticulturae Sinica, V10, P259; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; TAJIMA F, 1983, GENETICS, V105, P437; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu ZL, 2007, BIOINFORMATICS, V23, P3254, DOI 10.1093/bioinformatics/btm426; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x	52	298	355	16	284	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1510	U149		10.1038/ng.2801	http://dx.doi.org/10.1038/ng.2801			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24141363				2022-12-25	WOS:000327715800021
J	Berendsen, TA; Bruinsma, BG; Puts, CF; Saeidi, N; Usta, OB; Uygun, BE; Izamis, ML; Toner, M; Yarmush, ML; Uygun, K				Berendsen, Tim A.; Bruinsma, Bote G.; Puts, Catheleyne F.; Saeidi, Nima; Usta, O. Berk; Uygun, Basak E.; Izamis, Maria-Louisa; Toner, Mehmet; Yarmush, Martin L.; Uygun, Korkut			Supercooling enables long-term transplantation survival following 4 days of liver preservation	NATURE MEDICINE			English	Article							SUBNORMOTHERMIC MACHINE PERFUSION; COLD-STORAGE; UW SOLUTION; RAT-LIVER; CRYOPRESERVATION; GRAFTS; VITRIFICATION; RECOVERY; IMPROVES	The realization of long-term human organ preservation will have groundbreaking effects on the current practice of transplantation. Herein we present a new technique based on subzero nonfreezing preservation and extracorporeal machine perfusion that allows transplantation of rat livers preserved for up to four days, thereby tripling the viable preservation duration.	[Berendsen, Tim A.; Bruinsma, Bote G.; Puts, Catheleyne F.; Saeidi, Nima; Usta, O. Berk; Uygun, Basak E.; Izamis, Maria-Louisa; Toner, Mehmet; Yarmush, Martin L.; Uygun, Korkut] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02163 USA; [Berendsen, Tim A.] Univ Med Ctr, Dept Surg, Utrecht, Netherlands; [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Utrecht University; Utrecht University Medical Center; Rutgers State University New Brunswick	Uygun, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02163 USA.	myarmush@mgh.harvard.edu; uygun.korkut@mgh.harvard.edu	Uygun, Korkut/AAH-3950-2020; Uygun, Basak/I-1792-2012; Usta, Berk/A-5818-2008; Berendsen, Tim/AAM-7105-2020	Uygun, Korkut/0000-0003-2088-7860; Uygun, Basak/0000-0002-2600-7900; Usta, Berk/0000-0001-9328-568X; Yarmush, Martin/0000-0003-4986-8444	US National Institutes of Health [R0IEB008678, R0IDK096075, R01DK084053, R00DK080942, R00DK088962, F32 DK095558]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503, R01EB008678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK080942, K99DK088962, R00DK088962, R01DK084053, R01DK096075] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding from the US National Institutes of Health (grants R0IEB008678, R0IDK096075, R01DK084053, R00DK080942, R00DK088962 and F32 DK095558) and the Shriners Hospitals for Children is gratefully acknowledged.	al-Abdulla N A, 1995, Conn Med, V59, P387; Banafsche R, 1998, TRANSPLANT INT, V11, P127; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Berendsen TA, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-6; Bessems M, 2005, TRANSPL P, V37, P329, DOI 10.1016/j.transproceed.2004.12.220; Bruinsma BG, 2014, AM J TRANSPLANT, V14, P1400, DOI 10.1111/ajt.12727; Bruinsma BG, 2013, INT J ARTIF ORGANS, V36, P775, DOI 10.5301/ijao.5000250; Dutheil Delphine, 2009, J Chem Biol, V2, P39, DOI 10.1007/s12154-009-0014-x; Dutkowski P, 2008, AM J TRANSPLANT, V8, P917, DOI 10.1111/j.1600-6143.2008.02165.x; Fahy GM, 2004, CRYOBIOLOGY, V48, P157, DOI 10.1016/j.cryobiol.2004.02.002; Fahy GM, 2006, REJUV RES, V9, P279, DOI 10.1089/rej.2006.9.279; Fahy GM, 2009, ORGANOGENESIS, V5, P167, DOI 10.4161/org.5.3.9974; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Gok MA, 2002, TRANSPLANTATION, V73, P1869, DOI 10.1097/00007890-200206270-00003; Guarrera JV, 2010, AM J TRANSPLANT, V10, P372, DOI 10.1111/j.1600-6143.2009.02932.x; Huet PM, 2004, HEPATOLOGY, V39, P1110, DOI 10.1002/hep.20157; Ishine N, 2000, CRYOBIOLOGY, V40, P84, DOI 10.1006/cryo.1999.2225; Kato H, 2012, TRANSPLANTATION, V94, P473, DOI 10.1097/TP.0b013e3182637054; Klepper J, 1999, J CLIN LAB ANAL, V13, P116, DOI 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C; Maathuis MHJ, 2007, ANN SURG, V246, P982, DOI 10.1097/SLA.0b013e31815c4019; Minor T, 2013, CURR OPIN ORGAN TRAN, V18, P161, DOI 10.1097/MOT.0b013e32835e29de; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Monzen K, 2005, BIOCHEM BIOPH RES CO, V337, P534, DOI 10.1016/j.bbrc.2005.09.082; Muhlbacher F, 1999, TRANSPLANT P, V31, P2069, DOI 10.1016/S0041-1345(99)00265-1; Nowak Grzegorz, 2003, J Hepatobiliary Pancreat Surg, V10, P200, DOI 10.1007/s00534-002-0760-4; Okamoto T, 2008, J HEART LUNG TRANSPL, V27, P1150, DOI 10.1016/j.healun.2008.07.008; Oltean M, 2012, AM J TRANSPLANT, V12, P2044, DOI 10.1111/j.1600-6143.2012.04067.x; Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003; PLOEG RJ, 1988, TRANSPLANT P, V20, P935; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Scotte M, 1996, CRYOBIOLOGY, V33, P54, DOI 10.1006/cryo.1996.0006; Song YC, 2000, NAT BIOTECHNOL, V18, P296, DOI 10.1038/73737; STOREY KB, 1992, AM J PHYSIOL, V263, pR185, DOI 10.1152/ajpregu.1992.263.1.R185; Sugimachi K, 2006, TISSUE ENG, V12, P579, DOI 10.1089/ten.2006.12.579; Taylor M.J., 2007, ADV BIOPRESERVATION; US Department of Health and Human Services, ORG PROC TRANSP NETW; Usta OB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069334; Vogel T, 2010, CURR OPIN ORGAN TRAN, V15, P167, DOI 10.1097/MOT.0b013e328337349d; Yoshida K, 1999, J SURG RES, V81, P216, DOI 10.1006/jsre.1998.5505	40	105	113	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					790	793		10.1038/nm.3588	http://dx.doi.org/10.1038/nm.3588			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24973919	Green Accepted, Green Submitted			2022-12-25	WOS:000338689500024
J	Li, XN; Nadauld, L; Ootani, A; Corney, DC; Pai, RK; Gevaert, O; Cantrell, MA; Rack, PG; Neal, JT; Chan, CWM; Yeung, T; Gong, X; Yuan, J; Wilhelmy, J; Robine, S; Attardi, LD; Plevritis, SK; Hung, KE; Chen, CZ; Ji, HP; Kuo, CJ				Li, Xingnan; Nadauld, Lincoln; Ootani, Akifumi; Corney, David C.; Pai, Reetesh K.; Gevaert, Olivier; Cantrell, Michael A.; Rack, Paul G.; Neal, James T.; Chan, Carol W-M; Yeung, Trevor; Gong, Xue; Yuan, Jenny; Wilhelmy, Julie; Robine, Sylvie; Attardi, Laura D.; Plevritis, Sylvia K.; Hung, Kenneth E.; Chen, Chang-Zheng; Ji, Hanlee P.; Kuo, Calvin J.			Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture	NATURE MEDICINE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; ADULT-MOUSE PANCREAS; STEM-CELL NICHE; IN-VITRO; INTESTINAL ADENOMA; COLORECTAL-CANCER; COLON-CANCER; K-RAS; TUMORIGENESIS; PROGRESSION	The application of primary organoid cultures containing epithelial and mesenchymal elements to cancer modeling holds promise for combining the accurate multilineage differentiation and physiology of in vivo systems with the facile in vitro manipulation of transformed cell lines. Here we used a single air-liquid interface culture method without modification to engineer oncogenic mutations into primary epithelial and mesenchymal organoids from mouse colon, stomach and pancreas. Pancreatic and gastric organoids exhibited dysplasia as a result of expression of Kras carrying the G12D mutation (KrasG12D), p53 loss or both and readily generated adenocarcinoma after in vivo transplantation. In contrast, primary colon organoids required combinatorial Apc, p53, KrasG12D and Smad4 mutations for progressive transformation to invasive adenocarcinoma-like histology in vitro and tumorigenicity in vivo, recapitulating multi-hit models of colorectal cancer (CRC), as compared to the more promiscuous transformation of small intestinal organoids. Colon organoid culture functionally validated the microRNA miR-483 as a dominant driver oncogene at the IGF2 (insulin-like growth factor-2) 11p15.5 CRC amPlicon, inducing dysplasia in vitro and tumorigenicity in vivo. These studies demonstrate the general utility of a highly tractable primary organoid system for cancer modeling and driver oncogene validation in diverse gastrointestinal tissues.	[Li, Xingnan; Nadauld, Lincoln; Ootani, Akifumi; Corney, David C.; Cantrell, Michael A.; Rack, Paul G.; Neal, James T.; Chan, Carol W-M; Yeung, Trevor; Yuan, Jenny; Kuo, Calvin J.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Ootani, Akifumi] Saga Med Sch, Dept Internal Med, Saga, Japan; [Pai, Reetesh K.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Gevaert, Olivier; Plevritis, Sylvia K.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Gong, Xue; Chen, Chang-Zheng] Stanford Univ, Sch Med, Baxter Labs, Stanford, CA 94305 USA; [Wilhelmy, Julie; Ji, Hanlee P.] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Robine, Sylvie] Inst Curie, CNRS, UMR 144, Equipe Morphogenese & Signalisat Cellulaires, F-75231 Paris, France; [Attardi, Laura D.] Stanford Univ, Sch Med, Div Radiat Biol, Stanford, CA 94305 USA; [Hung, Kenneth E.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Med, Boston, MA 02111 USA	Stanford University; Saga University; Stanford University; Stanford University; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Stanford University; Tufts University	Kuo, CJ (corresponding author), Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA.	cjkuo@stanford.edu	Gevaert, Olivier/H-3413-2019	Gevaert, Olivier/0000-0002-9965-5466; Rack, Philip/0000-0002-9964-3254; Kuo, Calvin/0000-0002-7427-5985; Chen, Chang-Zheng/0000-0002-1620-242X; Neal, James/0000-0002-3962-8570	American Cancer Society [124574-PF-13-296-01-TBG]; Croucher Foundation; Royal College of Surgeons; American Society for Clinical Oncology Young Investigator Award; US National Institutes of Health [K08CA166512, 1R01AI073724, DP ICA174421]; NATIONAL CANCER INSTITUTE [DP1CA174421, U01CA151920, R21CA169673, U01CA084301, K08CA166512, U01CA176299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078033, U01DK085527, R01DK085720] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL7-Yeung] Funding Source: researchfish	American Cancer Society(American Cancer Society); Croucher Foundation; Royal College of Surgeons; American Society for Clinical Oncology Young Investigator Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	We are grateful to members of the Kuo laboratory, M. Amieva, R. Honaker, T. Jacks and C. Chartier for helpful discussion, P. Chu and S. Michie for assistance with histology, S. Lowe (Memorial Sloan Kettering Cancer Center) for LMP-based retroviruses, B. Williams (Van Andel Research Institute) for mouse strains, R. Mulligan and J.-S. Lee (Harvard University) and J. Chen (Stanford University) for lentiviral and retroviral reagents. X.L. was supported by the Dean's Fellowship at Stanford University A.O. was supported by a Physician-Scientist Fellowship from the California Institute for Regenerative Medicine, J.T.N. was supported by a Postdoctoral Fellowship (124574-PF-13-296-01-TBG) from the American Cancer Society, C.W.-M.C. was supported by the Croucher Foundation, and T.Y. was supported by the Royal College of Surgeons. L.N. was supported by an American Society for Clinical Oncology Young Investigator Award and US National Institutes of Health grant K08CA166512. C.-Z.C. was supported by grants from the US National Institutes of Health (1R01AI073724 and Pioneer Award DP ICA174421) and the W.M. Keck Foundation. We thank the generous support from the Innovate Foundation and the Krishnan-Shah Family Foundation to C.J.K. This work was also supported by US National Institutes of Health grants K08DK078033 and U01CA084301 to K.E.H.; US National Cancer Institute Integrative Cancer Biology Program grant U01CA151920, US National Cancer Institute Cancer Target Discovery and Development grant 1U01CA168424 and a Fidelity Foundation grant to C.J.K. and H.P.J.; and the US National Institutes of Health Transformative R01DK085720 and US National Institute of Diabetes and Digestive and Kidney Diseases Intestinal Stem Cell Consortium grant U01DK085527 to C.J.K.	Attali M, 2007, DIABETES, V56, P1248, DOI 10.2337/db06-1307; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Duvillie B, 2007, ENDOCR DEV, V12, P46, DOI 10.1159/000109604; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI 10.1089/ten.TEA.2010.0135; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Hassan AB, 2000, CANCER RES, V60, P1070; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Jin L, 2013, P NATL ACAD SCI USA, V110, P3907, DOI 10.1073/pnas.1301889110; Katano T, 2013, BIOCHEM BIOPH RES CO, V432, P558, DOI 10.1016/j.bbrc.2013.02.051; Kim J, 2013, CELL REP, V3, P2088, DOI 10.1016/j.celrep.2013.05.036; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pylayeva-Gupta Yuliya, 2013, Methods Mol Biol, V980, P267, DOI 10.1007/978-1-62703-287-2_14; Qu ZX, 2010, CANCER RES, V70, P1766, DOI 10.1158/0008-5472.CAN-09-3263; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Timp W, 2009, CELL CYCLE, V8, P383, DOI 10.4161/cc.8.3.7542; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203	40	261	274	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					769	777		10.1038/nm.3585	http://dx.doi.org/10.1038/nm.3585			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24859528	Green Accepted			2022-12-25	WOS:000338689500021
J	Taylor, KR; Mackay, A; Truffaux, N; Butterfield, YS; Morozova, O; Philippe, C; Castel, D; Grasso, CS; Vinci, M; Carvalho, D; Carcaboso, AM; de Torres, C; Cruz, O; Mora, J; Entz-Werle, N; Ingram, WJ; Monje, M; Hargrave, D; Bullock, AN; Puget, S; Yip, S; Jones, C; Grill, J				Taylor, Kathryn R.; Mackay, Alan; Truffaux, Nathalene; Butterfield, Yaron S.; Morozova, Olena; Philippe, Cathy; Castel, David; Grasso, Catherine S.; Vinci, Maria; Carvalho, Diana; Carcaboso, Angel M.; de Torres, Carmen; Cruz, Ofelia; Mora, Jaume; Entz-Werle, Natacha; Ingram, Wendy J.; Monje, Michelle; Hargrave, Darren; Bullock, Alex N.; Puget, Stephanie; Yip, Stephen; Jones, Chris; Grill, Jacques			Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INHIBITION; GENES; ALK2	Diffuse intrinsic pontine gliomas (DIPGs) are highly infiltrative malignant glial neoplasms of the ventral pons that, due to their location within the brain, are unsuitable for surgical resection and consequently have a universally dismal clinical outcome. The median survival time is 9-12 months, with neither chemotherapeutic nor targeted agents showing substantial survival benefit in clinical trials in children with these tumorsl. We report the identification of recurrent activating mutations in the ACVR I gene, which encodes a type I activin receptor serine/threonine kinase, in 21% of DIPG samples. Strikingly, these somatic mutations (encoding p.Arg206His, p.Arg258Gly, p.Gly328G1u, p.Gly328Val, p.Gly328Trp and p.Gly356Asp substitutions) have not been reported previously in cancer but are identical to mutations found in the germ line of individuals with the congenital childhood developmental disorder fibrodysplasia ossificans progressiva (FOP)(2) and have been shown to constitutively activate the BMP-TGF-beta signaling pathway. These mutations represent new targets for therapeutic intervention in this otherwise incurable disease.	[Taylor, Kathryn R.; Mackay, Alan; Vinci, Maria; Carvalho, Diana; Jones, Chris] Inst Canc Res, London SW3 6JB, England; [Truffaux, Nathalene; Philippe, Cathy; Castel, David; Grill, Jacques] Univ Paris Sud, CNRS, UMR 8203, Villejuif, France; [Butterfield, Yaron S.; Yip, Stephen] BC Canc Agcy, Vancouver, BC, Canada; [Morozova, Olena] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Grasso, Catherine S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Carcaboso, Angel M.; de Torres, Carmen; Cruz, Ofelia; Mora, Jaume] Hosp San Juan Dios, Barcelona, Spain; [Entz-Werle, Natacha] Ctr Hosp Reg & Univ Hautepierre, Strasbourg, France; [Ingram, Wendy J.] Univ Queensland, Queensland Childrens Med Res Inst, Queensland Childrens Tumour Bank, Brisbane, Qld, Australia; [Monje, Michelle] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Hargrave, Darren] Great Ormond St Hosp Sick Children, London, England; [Bullock, Alex N.] Univ Oxford, Oxford, England; [Puget, Stephanie] Necker Sick Childrens Hosp, Paris, France	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; British Columbia Cancer Agency; University of California System; University of California Santa Cruz; Oregon Health & Science University; University of Barcelona; CHU Strasbourg; University of Queensland; Stanford University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Jones, C (corresponding author), Inst Canc Res, London SW3 6JB, England.	chris.jones@icr.ac.uk; grill@igr.fr	Grill, Jacques/R-8093-2019; Jones, Chris/ABE-6059-2021; Hargrave, Darren R/H-1066-2014; Yip, Stephen/E-9994-2012; Ingram, Wendy J/F-7317-2010; PHILIPPE, Cathy/GRY-4381-2022; Castel, David/D-5353-2018; vinci, maria/AAI-1092-2019	Jones, Chris/0000-0001-8118-2296; Hargrave, Darren R/0000-0001-8219-9807; Yip, Stephen/0000-0002-8514-9861; Ingram, Wendy J/0000-0002-7063-1081; Castel, David/0000-0003-0247-080X; vinci, maria/0000-0002-7952-6771; cruz, ofelia/0000-0001-7102-3283; Carvalho, Diana/0000-0001-6881-6151; Vaske, Olena/0000-0002-1677-417X; PHILIPPE, Cathy/0000-0002-3262-4390; Mora, Jaume/0000-0002-9386-5980; Carcaboso, Angel/0000-0002-8485-426X	Cancer Research UK Genomics Initiative [A14078]; Stavros Niarchos Foundation; Abbie's Army; Lyla Nsouli Foundation; Royal Marsden Hospital Children's Department Fund; Fondo Alicia Pueyo; National Institutes of Neurological Disease and Stroke (NINDS) [K08NS070926]; Alex's Lemonade Stand Foundation; McKenna Claire Foundation; charity l'Etoile de Martin; Agence National de la Recherche; Enfants et Sante; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; Children's Health Foundation Queensland; Brainchild Foundation; Canada Foundation for Innovation; GlaxoSmithKline, Janssen, Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; National Health Service (NHS); Cure Starts Now; Dylan Jewett; Elizabeth Stein; Connor Johnson; Zoey Ganesh Memorial Funds; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research, Genome Canada; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Cancer Research UK [13982] Funding Source: researchfish; Rosetrees Trust [M200-F1] Funding Source: researchfish; The Brain Tumour Charity [16/193] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	Cancer Research UK Genomics Initiative; Stavros Niarchos Foundation; Abbie's Army; Lyla Nsouli Foundation; Royal Marsden Hospital Children's Department Fund; Fondo Alicia Pueyo; National Institutes of Neurological Disease and Stroke (NINDS); Alex's Lemonade Stand Foundation; McKenna Claire Foundation; charity l'Etoile de Martin; Agence National de la Recherche(French National Research Agency (ANR)); Enfants et Sante; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; Children's Health Foundation Queensland; Brainchild Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); GlaxoSmithKline, Janssen, Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; National Health Service (NHS); Cure Starts Now; Dylan Jewett; Elizabeth Stein; Connor Johnson; Zoey Ganesh Memorial Funds; Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research, Genome Canada; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); The Brain Tumour Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Cancer Research UK Genomics Initiative (A14078) and makes use of data generated by the St.Jude Children's Research Hospital Washington University Pediatric Cancer Genome Project.Wears grateful to the DIPG Preclinical Consortium funded by The Cure Starts Now and the Lyla Nsouli Foundation for RNA-seq data.This work is supported by the Stavros Niarchos Foundation, Abbie's Army, the Lyla Nsouli Foundation, the Royal Marsden Hospital Children's Department Fund and Fondo Alicia Pueyo.M.M.gratefully acknowledges funding by the National Institutes of Neurological Disease and Stroke (NINDS; grant K08NS070926), Alex's Lemonade Stand Foundation, the McKenna Claire Foundation and the Dylan Jewett, Elizabeth Stein, Connor Johnson and Zoey Ganesh Memorial Funds.C.P.acknowledges funding from the Agence National de la Recherche.N.T., C.P.and J.G.acknowledge funding from the charity l'Etoile de Martin, and N.E.-W acknowledges support from Enfants et Sante.A.M.C.acknowledges funding from the Fundacion Cientifica de la Asociacion Espanola Contra el Cancer.W.J.I. acknowledges funding from the Children's Health Foundation Queensland and the Brainchild Foundation.The Structural Genomics Consortium is a registered charity (1097737) that receives funds from Abb Vie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z). K.R.T., A.M., M.V., D.Carvalho, D.H.and C.J. acknowledge National Health Service (NHS) funding to the National Institute of Health Research Biomedical Research Centres.	Bocciardi R, 2009, EUR J HUM GENET, V17, P311, DOI 10.1038/ejhg.2008.178; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Kan LX, 2012, J NEUROL, V259, P2644, DOI 10.1007/s00415-012-6563-x; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Katagiri T, 2012, J ORAL BIOSCI, V54, P119, DOI 10.1016/j.job.2012.03.004; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Petrie KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005005; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Roujeau T, 2007, J NEUROSURG, V107, P1, DOI 10.3171/PED-07/07/001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Tumolo M, 2006, BRIT J ANAESTH, V97, P701, DOI 10.1093/bja/ael251; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	20	320	334	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					457	461		10.1038/ng.2925	http://dx.doi.org/10.1038/ng.2925			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705252	Green Accepted, Green Submitted			2022-12-25	WOS:000335422900011
J	Lee, EC; Liang, Q; Ali, H; Bayliss, L; Beasley, A; Bloomfield-Gerdes, T; Bonoli, L; Brown, R; Campbell, J; Carpenter, A; Chalk, S; Davis, A; England, N; Fane-Dremucheva, A; Franz, B; Germaschewski, V; Holmes, H; Holmes, S; Kirby, I; Kosmac, M; Legent, A; Lui, H; Manin, A; O'Leary, S; Paterson, J; Sciarrillo, R; Speak, A; Spensberger, D; Tuffery, L; Waddell, N; Wang, W; Wells, S; Wong, V; Wood, A; Owen, MJ; Friedrich, GA; Bradley, A				Lee, E-Chiang; Liang, Qi; Ali, Hanif; Bayliss, Luke; Beasley, Alastair; Bloomfield-Gerdes, Tara; Bonoli, Laura; Brown, Richard; Campbell, Jamie; Carpenter, Adam; Chalk, Sara; Davis, Alison; England, Nick; Fane-Dremucheva, Alla; Franz, Bettina; Germaschewski, Volker; Holmes, Helen; Holmes, Steve; Kirby, Ian; Kosmac, Miha; Legent, Anais; Lui, Hui; Manin, Anais; O'Leary, Siobhan; Paterson, Jemima; Sciarrillo, Rocco; Speak, Anneliese; Spensberger, Dominik; Tuffery, Laura; Waddell, Nikole; Wang, Wei; Wells, Sophie; Wong, Vivian; Wood, Andrew; Owen, Michael J.; Friedrich, Glenn A.; Bradley, Allan			Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; MONOCLONAL-ANTIBODIES; STAPHYLOCOCCUS-AUREUS; CHIMERIC MICE; RECOMBINATION; EXPRESSION; HEAVY; GENE; FRAGMENT; AFFINITY	If immunized with an antigen of interest, transgenic mice with large portions of unrearranged human immunoglobulin loci can produce fully human antigen-specific antibodies; several such antibodies are in clinical use. However, technical limitations inherent to conventional transgenic technology and sequence divergence between the human and mouse immunoglobulin constant regions limit the utility of these mice. Here, using repetitive cycles of genome engineering in embryonic stem cells, we have inserted the entire human immunoglobulin variable-gene repertoire (2.7 Mb) into the mouse genome, leaving the mouse constant regions intact. These transgenic mice are viable and fertile, with an immune system resembling that of wild-type mice. Antigen immunization results in production of high-affinity antibodies with long human-like complementarity-determining region 3 (CDR3H), broad epitope coverage and strong signatures of somatic hypermutation. These mice provide a robust system for the discovery of therapeutic human monoclonal antibodies; as a surrogate readout of the human antibody response, they may also aid vaccine design efforts.	[Lee, E-Chiang; Liang, Qi; Ali, Hanif; Bayliss, Luke; Beasley, Alastair; Bloomfield-Gerdes, Tara; Bonoli, Laura; Brown, Richard; Campbell, Jamie; Carpenter, Adam; Chalk, Sara; Davis, Alison; England, Nick; Fane-Dremucheva, Alla; Franz, Bettina; Germaschewski, Volker; Holmes, Helen; Holmes, Steve; Kirby, Ian; Kosmac, Miha; Legent, Anais; Lui, Hui; Manin, Anais; O'Leary, Siobhan; Paterson, Jemima; Sciarrillo, Rocco; Spensberger, Dominik; Tuffery, Laura; Waddell, Nikole; Wells, Sophie; Wong, Vivian; Wood, Andrew; Owen, Michael J.; Friedrich, Glenn A.; Bradley, Allan] Kymab Ltd, Cambridge, England; [Speak, Anneliese; Wang, Wei; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Kymab Ltd, Babraham Res Campus, Cambridge, England.	abradley@kymab.com		Kosmac, Miha/0000-0002-5372-7233; Sciarrillo, Rocco/0000-0003-4329-8823; Bradley, Allan/0000-0002-2349-8839; Spensberger, Dominik/0000-0002-9798-2949; Tuffery, Laura/0000-0002-2765-2151; Speak, Anneliese/0000-0003-4890-4685	Wellcome Trust, London	Wellcome Trust, London(Wellcome Trust)	We thank A. Sandham, J. Clube and D. Casson for frequent critical input and discussions on this work and P. Alexander, A. Muncey and A. Lloyd for administrative support. Kymab was funded by investments from the Wellcome Trust, London.	Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Giudicelli V, 1997, NUCLEIC ACIDS RES, V25, P206, DOI 10.1093/nar/25.1.206; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; Hernandez D, 1999, HUM MOL GENET, V8, P923, DOI 10.1093/hmg/8.5.923; Karpusas M, 2001, STRUCTURE, V9, P321, DOI 10.1016/S0969-2126(01)00590-1; Lee E-Chiang, 2012, Methods Mol Biol, V901, P137, DOI 10.1007/978-1-61779-931-0_8; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Neuberger MS, 2000, APPL BIOCHEM BIOTECH, V83, P53, DOI 10.1385/ABAB:83:1-3:53; Osborn MJ, 2013, J IMMUNOL, V190, P1481, DOI 10.4049/jimmunol.1203041; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Rudolf M, 2011, World patent, Patent No. [WO2011018208, 2011018208]; Rudolf M., 2011, Patent No. [PCT/ EP2010/ 004884, 2010004884]; Sattentau QJ, 2011, NATURE, V480, P324, DOI 10.1038/480324a; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Sellman B. R., 2006, Patent No. [WO/ 2012/ 109285, 2012109285]; Sellman B. R., 2006, Patent No. [PCT/ US2012/ 024201, 2012024201]; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Varriale S, 2010, MOL PHYLOGENET EVOL, V57, P1238, DOI 10.1016/j.ympev.2010.09.022; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	37	94	150	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					356	U219		10.1038/nbt.2825	http://dx.doi.org/10.1038/nbt.2825			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633243	Bronze			2022-12-25	WOS:000334340800020
J	Ohnishi, Y; Huber, W; Tsumura, A; Kang, MJ; Xenopoulos, P; Kurimoto, K; Oles, AK; Arauzo-Bravo, MJ; Saitou, M; Hadjantonakis, AK; Hiiragi, T				Ohnishi, Yusuke; Huber, Wolfgang; Tsumura, Akiko; Kang, Minjung; Xenopoulos, Panagiotis; Kurimoto, Kazuki; Oles, Andrzej K.; Arauzo-Bravo, Marcos J.; Saitou, Mitinori; Hadjantonakis, Anna-Katerina; Hiiragi, Takashi			Cell-to-cell expression variability followed by signal reinforcement progressively segregates early mouse lineages	NATURE CELL BIOLOGY			English	Article							PRIMITIVE ENDODERM; CDNA AMPLIFICATION; EPIBLAST; GENE; COMMITMENT; FGF-4	It is now recognized that extensive expression heterogeneities among cells precede the emergence of lineages in the early mammalian embryo. To establish a map of pluripotent epiblast (EPI) versus primitive endoderm (PrE) lineage segregation within the inner cell mass (ICM) of the mouse blastocyst, we characterized the gene expression profiles of individual ICM cells. Clustering analysis of the transcriptomes of 66 cells demonstrated that initially they are non-distinguishable. Early in the segregation, lineage-specific marker expression exhibited no apparent correlation, and a hierarchical relationship was established only in the late blastocyst. Fgf4 exhibited a bimodal expression at the earliest stage analysed, and in its absence, the differentiation of PrE and EPI was halted, indicating that Fgf4 drives, and is required for, ICM lineage segregation. These data lead us to propose a model where stochastic cell-to-cell expression heterogeneity followed by signal reinforcement underlies ICM lineage segregation by antagonistically separating equivalent cells.	[Ohnishi, Yusuke; Hiiragi, Takashi] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Huber, Wolfgang; Oles, Andrzej K.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Tsumura, Akiko; Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kang, Minjung; Xenopoulos, Panagiotis; Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Kurimoto, Kazuki; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kurimoto, Kazuki; Saitou, Mitinori] ERATO, JST, Sakyo Ku, Kyoto 6068501, Japan; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Computat Biol & Bioinformat Grp, D-48149 Munster, Germany; [Saitou, Mitinori] Kyoto Univ, Cty iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Kyoto University; Memorial Sloan Kettering Cancer Center; Kyoto University; Japan Science & Technology Agency (JST); Max Planck Society; Kyoto University	Hiiragi, T (corresponding author), European Mol Biol Lab, Dev Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hiiragi@embl.de	Marcos, Arauzo-Bravo/A-1706-2011	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Huber, Wolfgang/0000-0002-0474-2218; Hiiragi, Takashi/0000-0003-4964-7203; Oles, Andrzej/0000-0003-0285-2787	Max Planck Society; European Research Council under the European Commission; Stem Cell Network North Rhine Westphalia; German Research Foundation (Deutsche Forschungsgemeinschaft); World Premier International Research Japan; National Institutes of Health (NIH) [NIH RO1-HD052115, RO1-DK084391]; NYSTEM; European Commission; Naito; Uehara Memorial Foundation; Marie Curie FP7 IIF fellowship [273193]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24681039] Funding Source: KAKEN	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council under the European Commission; Stem Cell Network North Rhine Westphalia; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); World Premier International Research Japan; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; European Commission(European CommissionEuropean Commission Joint Research Centre); Naito(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Marie Curie FP7 IIF fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Courtois for help with image analysis, R. Niwayama for quantitative protein expression analysis, S. Salvenmoser and R. Bloehs for technical assistance, and EMBL Genomics Core Facility for technical support. We also thank the members of the Hiiragi, Hadjantonakis, Huber and Saitou laboratories for helpful and stimulating discussions. Work in the laboratory of T.H. is supported by the Max Planck Society, European Research Council under the European Commission FP7, Stem Cell Network North Rhine Westphalia, German Research Foundation (Deutsche Forschungsgemeinschaft), and World Premier International Research Japan. Work in the laboratory of A.-K.H. is supported by the National Institutes of Health (NIH) NIH RO1-HD052115 and RO1-DK084391 (AKH) and NYSTEM. W.H. acknowledges financial support from the European Commission FP7-Health through the RADIANT project. Y.O. is supported by Naito and Uehara Memorial Foundation fellowships, and by Marie Curie FP7 IIF fellowship (no. 273193).	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CHISHOLM JC, 1987, DEVELOPMENT, V101, P565; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Grabarek JB, 2012, DEVELOPMENT, V139, P129, DOI 10.1242/dev.067702; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hornik K, 2005, J STAT SOFTWARE, V14; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kang MJ, 2013, DEVELOPMENT, V140, P267, DOI 10.1242/dev.084996; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Moignard V, 2013, NAT CELL BIOL, V15, P544, DOI 10.1038/ncb2754; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Schrode N, 2013, GENESIS, V51, P219, DOI 10.1002/dvg.22368; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471	41	198	198	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2014	16	1					27	+		10.1038/ncb2881	http://dx.doi.org/10.1038/ncb2881			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	280PA	24292013	Green Accepted			2022-12-25	WOS:000329042000008
J	Rosenthal, RG; Ebert, MO; Kiefer, P; Peter, DM; Vorholt, JA; Erb, TJ				Rosenthal, Raoul G.; Ebert, Marc-Olivier; Kiefer, Patrick; Peter, Dominik M.; Vorholt, Julia A.; Erb, Tobias J.			Direct evidence for a covalent ene adduct intermediate in NAD(P)H-dependent enzymes	NATURE CHEMICAL BIOLOGY			English	Article							CROTONYL-COA CARBOXYLASE/REDUCTASE; TRANSITION-STATE ANALOG; HYDRIDE TRANSFER; THIOESTER REDUCTASE; MECHANISM; ALCOHOL; DEHYDROGENASE; HYDROGEN; MODEL; NADH	The pyridine nucleotides NADH and NADPH (NAD(P)H) are ubiquitous redox coenzymes that are present in all living cells. Although about 16% of all characterized enzymes use pyridine nucleotides as hydride donors or acceptors during catalysis, a detailed understanding of how the hydride is transferred between NAD(P) H and the corresponding substrate is lacking for many enzymes. Here we present evidence for a new mechanism that operates during enzymatic hydride transfers using crotonyl-CoA carboxylase/reductase (Ccr) as a case study. We observed a covalent ene intermediate between NADPH and the substrate, crotonyl-CoA, using NMR, high-resolution MS and stopped-flow spectroscopy. Preparation of the ene intermediate further allowed direct access to the catalytic cycle of other NADPH-dependent enzymes-including those from type II fatty acid biosynthesis-in an unprecedented way, suggesting that formation of NAD(P) H ene intermediates is a more general principle in catalysis.	[Rosenthal, Raoul G.; Kiefer, Patrick; Peter, Dominik M.; Vorholt, Julia A.; Erb, Tobias J.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Ebert, Marc-Olivier] ETH, Organ Chem Lab, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rosenthal, RG (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	toerb@ethz.ch	Erb, Tobias/J-5214-2013; Vorholt, Julia/K-3514-2016; Ebert, Marc-Olivier/L-6197-2017	Erb, Tobias/0000-0003-3685-0894; Vorholt, Julia/0000-0002-6011-4910; Ebert, Marc-Olivier/0000-0003-1507-219X	Schweizerische Nationalfonds-Ambizione grant [PZ00P3_136828/1]; ETH fellowship	Schweizerische Nationalfonds-Ambizione grant; ETH fellowship	This work was supported by a Schweizerische Nationalfonds-Ambizione grant (PZ00P3_136828/1) and an ETH fellowship to T. J. E. We thank B. M. Jaun for valuable discussions and critical inspection of NMR data, A. J. Rosenthal for suggestions during the early phase of this work and S. Weidenweber and U. Ermler for discussions about a structural understanding of Ccr. We acknowledge K. Hiltunen, J. Torkko and A. Kastaniotis (University of Oulu, Finland) for providing the etr1p gene, G. Sturm (Albert-Ludwigs-University of Freiburg, Germany) for providing plasmid pGS5, A. Essig, M. Kunzler and M. Aebi (ETH Zurich, Switzerland) for help with the Pichia pastoris expression system, R. Kissner and C. Molina (ETH Zurich, Switzerland) for stopped-flow experiments, S. Weidenweber and C. Vogel for the initial cloning of the Ccr and Etr1p constructs, respectively, and National BioResource Project (NBRP)-E. coli at the National Institute of Genetics (NIG) for providing E. coli strain JW3222.	ABELES RH, 1957, J AM CHEM SOC, V79, P712, DOI 10.1021/ja01560a058; Agarwal PK, 2000, J AM CHEM SOC, V122, P4803, DOI 10.1021/ja994456w; Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Alder K, 1943, BER DTSCH CHEM GES, V76, P27, DOI 10.1002/cber.19430760105; Asao M, 2013, J BACTERIOL, V195, P4716, DOI 10.1128/JB.00685-13; BAHNSON BJ, 1993, BIOCHEMISTRY-US, V32, P5503, DOI 10.1021/bi00072a003; Bugg T.D.H., 2012, INTRO ENZYME COENZYM; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Cheng JP, 1998, J ORG CHEM, V63, P6108, DOI 10.1021/jo9715985; CHOOK YM, 1994, J MOL BIOL, V240, P476, DOI 10.1006/jmbi.1994.1462; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DeClue MS, 2005, J AM CHEM SOC, V127, P15002, DOI 10.1021/ja055871t; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Hamilton G., 1971, PROGRESS BIOORGANIC, V1, P83; Harden A, 1906, P R SOC LOND B-CONTA, V77, P405, DOI 10.1098/rspb.1906.0029; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; INAGAKI S, 1977, B CHEM SOC JPN, V50, P3360, DOI 10.1246/bcsj.50.3360; JACOBSON BM, 1980, J AM CHEM SOC, V102, P886, DOI 10.1021/ja00522a094; KAPMEYER H, 1976, BIOCHEMISTRY-US, V15, P5024, DOI 10.1021/bi00668a012; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Lamb AL, 2011, BIOCHEMISTRY-US, V50, P7476, DOI 10.1021/bi2009739; Libby RD, 2012, BIOORG CHEM, V40, P57, DOI 10.1016/j.bioorg.2011.10.002; MACINNES I, 1983, J CHEM SOC PERK T 1, P2777; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; PINDUR U, 1994, CHEM SOC REV, V23, P409, DOI 10.1039/cs9942300409; Porte S, 2011, CELL MOL LIFE SCI, V68, P1065, DOI 10.1007/s00018-010-0508-2; Quade N, 2012, NAT CHEM BIOL, V8, P117, DOI 10.1038/nchembio.734; Roston D, 2010, P NATL ACAD SCI USA, V107, P9572, DOI 10.1073/pnas.1000931107; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P11003, DOI 10.1021/bi980475r; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SULZBACH RA, 1971, ANGEW CHEM INT EDIT, V10, P733, DOI 10.1002/anie.197107331; Todd JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035947; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; WALLACE KK, 1995, EUR J BIOCHEM, V233, P954, DOI 10.1111/j.1432-1033.1995.954_3.x; Westheimer F.H., 1986, PYRIDINE NUCLEOTIDE, V2, P253; WESTHEIMER FH, 1951, J AM CHEM SOC, V73, P2403, DOI 10.1021/ja01149a561; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; WU YD, 1987, J AM CHEM SOC, V109, P2226, DOI 10.1021/ja00241a074; Yoo HG, 2011, BIOSCI BIOTECH BIOCH, V75, P1191, DOI 10.1271/bbb.110003; Youn B, 2006, J BIOL CHEM, V281, P40076, DOI 10.1074/jbc.M605900200	47	45	45	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					50	U85		10.1038/NCHEMBIO.1385	http://dx.doi.org/10.1038/NCHEMBIO.1385			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24240506				2022-12-25	WOS:000328854900010
J	Roth, A; Weinberg, Z; Chen, AGY; Kim, PB; Ames, TD; Breaker, RR				Roth, Adam; Weinberg, Zasha; Chen, Andy G. Y.; Kim, Peter B.; Ames, Tyler D.; Breaker, Ronald R.			A widespread self-cleaving ribozyme class is revealed by bioinformatics	NATURE CHEMICAL BIOLOGY			English	Article							HEPATITIS-DELTA-VIRUS; STRUCTURAL BASIS; SPLICING RNA; CLEAVAGE; SEQUENCE; SPEED; RETROTRANSPOSONS; IDENTIFICATION; MOTIF	Ribozymes are noncoding RNAs that promote chemical transformations with rate enhancements approaching those of protein enzymes. Although ribozymes are likely to have been abundant during the RNA world era, only ten classes are known to exist among contemporary organisms. We report the discovery and analysis of an additional self-cleaving ribozyme class, called twister, which is present in many species of bacteria and eukarya. Nearly 2,700 twister ribozymes were identified that conform to a secondary structure consensus that is small yet complex, with three stems conjoined by internal and terminal loops. Two pseudoknots provide tertiary structure contacts that are critical for catalytic activity. The twister ribozyme motif provides another example of a natural RNA catalyst and calls attention to the potentially varied biological roles of this and other classes of widely distributed self-cleaving RNAs.	[Roth, Adam; Weinberg, Zasha; Chen, Andy G. Y.; Kim, Peter B.; Ames, Tyler D.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Roth, Adam; Weinberg, Zasha; Ames, Tyler D.; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Roth, A (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	US National Institutes of Health (NIH) [RR19895-02, GM022778]; Howard Hughes Medical Institute; Gruber Science Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gruber Science Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Murdock for performing the twister ribozyme ligation assay, P. McCown and other members of the Breaker laboratory for helpful discussions, R. Knight for alerting us to useful metagenome data sets, S.L. Tausta and T. Nelson (Yale University) for providing us with rice seeds, and N. Carriero and R. Bjornson for assistance with the Yale Life Sciences High Performance Computing Center (US National Institutes of Health (NIH) grant RR19895-02). This work was supported by the NIH (GM022778) and by the Howard Hughes Medical Institute. P.B.K. was supported by the Gruber Science Fellowship.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Breaker RR, 2003, RNA, V9, P949, DOI 10.1261/rna.5670703; BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; DEYOUNG MB, 1995, BIOCHEMISTRY-US, V34, P15785, DOI 10.1021/bi00048a024; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Flores R, 2009, VIRUSES-BASEL, V1, P317, DOI 10.3390/v1020317; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hammann Christian, 2009, F1000 Biol Rep, V1, P6, DOI 10.3410/B1-6; Hammann C, 2012, RNA, V18, P871, DOI 10.1261/rna.031401.111; Hofacker IL, 2009, CURR PROTOC BIOINFOR, V12, P2; Jimenez RM, 2011, J BIOL CHEM, V286, P7737, DOI 10.1074/jbc.C110.209288; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; McCown PJ, 2011, RNA, V17, P728, DOI 10.1261/rna.2590811; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Mondragon A, 2013, ANNU REV BIOPHYS, V42, P537, DOI 10.1146/annurev-biophys-083012-130406; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; Ruminski DJ, 2011, J BIOL CHEM, V286, P41286, DOI 10.1074/jbc.M111.297283; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; WILLIAMS KP, 1995, EMBO J, V14, P4551, DOI 10.1002/j.1460-2075.1995.tb00134.x; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275; Zytnicki M, 2008, CONSTRAINTS, V13, P91, DOI 10.1007/s10601-007-9033-9	55	155	159	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2014	10	1					56	U92		10.1038/NCHEMBIO.1386	http://dx.doi.org/10.1038/NCHEMBIO.1386			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277YJ	24240507	Green Accepted			2022-12-25	WOS:000328854900011
J	Agarwala, V; Flannick, J; Sunyaev, S; Altshuler, D				Agarwala, Vineeta; Flannick, Jason; Sunyaev, Shamil; Altshuler, David		GoT2D Consortium	Evaluating empirical bounds on complex disease genetic architecture	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; MISSING HERITABILITY; RISK PREDICTION; COMMON DISEASE; POPULATION; SUSCEPTIBILITY; EXCESS; LINKAGE; TRAITS	The genetic architecture of human diseases governs the success of genetic mapping and the future of personalized medicine. Although numerous studies have queried the genetic basis of common disease, contradictory hypotheses have been advocated about features of genetic architecture (for example, the contribution of rare versus common variants). We developed an integrated simulation framework, calibrated to empirical data, to enable the systematic evaluation of such hypotheses. For type 2 diabetes (T2D), two simple parameters-(i) the target size for causal mutation and (ii) the coupling between selection and phenotypic effect-define a broad space of architectures. Whereas extreme models are excluded by the combination of epidemiology, linkage and genome-wide association studies, many models remain consistent, including those where rare variants explain either little (<25%) or most (>80%) of T2D heritability. Ongoing sequencing and genotyping studies will further constrain the space of possible architectures, but very large samples (for example, >250,000 unselected individuals) will be required to localize most of the heritability underlying T2D and other traits characterized by these models.	[Agarwala, Vineeta; Sunyaev, Shamil] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Agarwala, Vineeta; Flannick, Jason; Sunyaev, Shamil; Altshuler, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Agarwala, Vineeta; Sunyaev, Shamil] Harvard Univ, Program Biophys, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Flannick, Jason; Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Sunyaev, Shamil] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Altshuler, D (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Meitinger, Thomas/O-1318-2015	Altshuler, David M/0000-0002-7250-4107; Kumar, Ashish/0000-0002-7075-5930	Doris Duke Charitable Foundation [2006087]; National Institute of General Medical Sciences (NIGMS) [R01GM078598]; National Institute of Mental Health (NIMH) [R01MH084676]; US National Institutes of Health (NIH) [T32GM007753, T32GM008313]; NIH [T32GM007748-33]; Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1RC2DK088389-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK088389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753, R01GM078598, T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge B. Lambert and K. Weiss (authors of the simulation tool ForSim) for helpful conversation, encouragement and technical assistance. Without their software, this work would not have been possible. We thank B. Voight for tremendous help in matching simulated genetic studies to those empirically conducted for T2D. We also thank E. Lander, C. Hartl, P. Fontanillas, B. Neale, M. McCarthy, M. Boehnke, M. Daly, S. Purcell and E. Stahl for discussion and insightful critiques. This work was supported by grants from the Doris Duke Charitable Foundation (award 2006087 to D. A.), the National Institute of General Medical Sciences (NIGMS; award R01GM078598 to S. S.) and the National Institute of Mental Health (NIMH; grant R01MH084676 to S. S.). V. A. is also supported by US National Institutes of Health (NIH) Training grants T32GM007753 and T32GM008313. J.F. is supported in part by NIH Training grant T32GM007748-33 as well as by funding from Pfizer. The GoT2D Study is supported by grant 1RC2DK088389-01 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Fisher RA, 1919, GENETICS, V4, P489; Goldstein DB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001008; Grant RW, 2009, DIABETES CARE, V32, P1107, DOI 10.2337/dc08-2171; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Guan W., 2012, GENET EPIDEMIOL, V9, P1; Guan WH, 2008, HUM HERED, V66, P35, DOI 10.1159/000114164; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; King CR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001202; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lambert BW, 2008, BIOINFORMATICS, V24, P1821, DOI 10.1093/bioinformatics/btn317; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Neale MC, 1992, METHODOLOGY GENETIC; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Popper K.R., 2002, CONJECTURES REFUTATI; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; RISCH N, 1990, AM J HUM GENET, V46, P229; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Thanassoulis G, 2010, CIRCULATION, V122, P2323, DOI 10.1161/CIRCULATIONAHA.109.909309; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Weijnen CF, 2002, DIABETIC MED, V19, P41, DOI 10.1046/j.1464-5491.2002.00624.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	71	105	106	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1418	U167		10.1038/ng.2804	http://dx.doi.org/10.1038/ng.2804			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24141362	Green Accepted			2022-12-25	WOS:000327715800005
J	Chen, JK; Guo, L; Zhang, L; Wu, HY; Yang, JQ; Liu, H; Wang, XS; Hu, X; Gu, TP; Zhou, ZW; Liu, J; Liu, JD; Wu, HL; Mao, SQ; Mo, KL; Li, YY; Lai, KY; Qi, J; Yao, HJ; Pan, GJ; Xu, GL; Pei, DQ				Chen, Jiekai; Guo, Lin; Zhang, Lei; Wu, Haoyu; Yang, Jiaqi; Liu, He; Wang, Xiaoshan; Hu, Xiao; Gu, Tianpeng; Zhou, Zhiwei; Liu, Jing; Liu, Jiadong; Wu, Hongling; Mao, Shi-Qing; Mo, Kunlun; Li, Yingying; Lai, Keyu; Qi, Jing; Yao, Hongjie; Pan, Guangjin; Xu, Guo-Liang; Pei, Duanqing			Vitamin C modulates TET1 function during somatic cell reprogramming	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; LARGE GENE LISTS; DNA DEMETHYLATION; MAMMALIAN DNA; MOUSE; 5-HYDROXYMETHYLCYTOSINE; GENERATION; 5-METHYLCYTOSINE; 5-CARBOXYLCYTOSINE; SPECIFICATION	Vitamin C, a micronutrient known for its anti-scurvy activity in humans, promotes the generation of induced pluripotent stem cells (iPSCs)(1) through the activity of histone demethylating dioxygenases(2,3). TET hydroxylases are also dioxygenases implicated in active DNA demethylation(4-8). Here we report that TET1 either positively or negatively regulates somatic cell reprogramming depending on the absence or presence of vitamin C. TET1 deficiency enhances reprogramming, and its overexpression impairs reprogramming in the context of vitamin C-2,C-9 by modulating the obligatory mesenchymal-to-epithelial transition (MET)(10,11). In the absence of vitamin C, TET1 promotes somatic cell reprogramming independent of MET. Consistently, TET1 regulates 5-hydroxymethylcytosine (5hmC) formation at loci critical for MET in a vitamin C-dependent fashion. Our findings suggest that vitamin C has a vital role in determining the biological outcome of TET1 function at the cellular level. Given its benefit to human health, vitamin C should be investigated further for its role in epigenetic regulation.	[Chen, Jiekai; Guo, Lin; Wu, Haoyu; Yang, Jiaqi; Liu, He; Wang, Xiaoshan; Zhou, Zhiwei; Liu, Jing; Liu, Jiadong; Wu, Hongling; Mo, Kunlun; Li, Yingying; Lai, Keyu; Qi, Jing; Yao, Hongjie; Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Chen, Jiekai; Guo, Lin; Yang, Jiaqi; Liu, He; Wang, Xiaoshan; Zhou, Zhiwei; Liu, Jing; Wu, Hongling; Mo, Kunlun; Li, Yingying; Lai, Keyu; Qi, Jing; Yao, Hongjie; Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhang, Lei; Hu, Xiao; Gu, Tianpeng; Mao, Shi-Qing; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Grp DNA Metab,State Key Lab Mol Biol, Shanghai, Peoples R China; [Wu, Haoyu] Jilin Univ, Coll Pharm, Dept Biol Engn, Changchun 130023, Peoples R China; [Liu, Jiadong] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Jilin University; South China University of Technology	Xu, GL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Grp DNA Metab,State Key Lab Mol Biol, Shanghai, Peoples R China.	glxu@sibs.ac.cn; pei_duanqing@gibh.ac.cn	Hu, Xiao/L-3962-2019; Mao, Shiqing/AAV-1168-2020	Hu, Xiao/0000-0002-6215-9127; Mao, Shiqing/0000-0001-9902-0199; Zhang, Lei/0000-0002-0222-4417; Chen, Jiekai/0000-0001-5168-7074	Chinese Academy of Sciences [XDA01020401]; National Basic Research Program of China [2014CB965200, 2012CB966802, 2011CB965204]; Guangdong Natural Science Funds for Distinguished Young Scholars [S2013050014040]; National Natural Science Foundation of China [31271357, 31230039, 31221001, 91213304]; Ministry of Science and Technology International Technology Cooperation Program [2012DFH30050]; Science and Technology Planning Project of Guangdong Province [2011A060901019]; National Science & Technology Major Special Project on Major New Drug Innovation [2011ZX09102-010]; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Guangzhou Pearl River Nova program [2012J2200070]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Guangdong Natural Science Funds for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Technology Cooperation Program; Science and Technology Planning Project of Guangdong Province; National Science & Technology Major Special Project on Major New Drug Innovation; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Guangzhou Pearl River Nova program	We are grateful to J. Nie, J. Zhu, B. Wei, X. Li, T. Peng, X. Huang and C. Tan for technical assistance. We thank H. Zheng for constructive criticism. We deeply appreciate the work of X. Zhao, H. Song, S. Chu and Y. Chen in blastocyst injection, and we thank R. Luo for isolating MEFs. We thank S. Gao (National Institute of Biological Sciences, China) for providing the FUW-TetOn-Tet1 vector. We wish to thank all members of our laboratories for their support. This work is supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDA01020401), the National Basic Research Program of China (grants 2014CB965200, 2012CB966802 and 2011CB965204), Guangdong Natural Science Funds for Distinguished Young Scholars (grant S2013050014040), the National Natural Science Foundation of China (grants 31271357, 31230039, 31221001 and 91213304), the Ministry of Science and Technology International Technology Cooperation Program (grant 2012DFH30050), the Science and Technology Planning Project of Guangdong Province (grant 2011A060901019), the National Science & Technology Major Special Project on Major New Drug Innovation (grant 2011ZX09102-010), the Youth Innovation Promotion Association of the Chinese Academy of Sciences and the Guangzhou Pearl River Nova program (grant 2012J2200070).	Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Monfort A, 2013, EMBO REP, V14, P337, DOI 10.1038/embor.2013.29; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang T, 2013, NAT CELL BIOL, V15, P700, DOI 10.1038/ncb2748; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	36	182	202	5	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1504	U140		10.1038/ng.2807	http://dx.doi.org/10.1038/ng.2807			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24162740				2022-12-25	WOS:000327715800020
J	Wolfert, MA; Boons, GJ				Wolfert, Margreet A.; Boons, Geert-Jan			Adaptive immune activation: glycosylation does matter	NATURE CHEMICAL BIOLOGY			English	Review							MHC CLASS-II; T-CELLS; PROTEIN GLYCOSYLATION; DENDRITIC CELLS; DC-SIGN; LECTIN RECEPTORS; O-GLYCOSYLATION; QUALITY-CONTROL; GLYCAN-BINDING; IN-VITRO	Major histocompatibility complex (MHC) class I and II are glycoproteins that can present antigenic peptides at the cell surface for recognition and activation of circulating T lymphocytes. Here, the importance of the modification of protein antigens by glycans on cellular uptake, proteolytic processing, presentation by MHC and subsequent T-cell priming is reviewed. Antigen glycosylation is important for a number of diseases and vaccine design. All of the key proteins involved in antigen recognition and the orchestration of downstream effector functions are glycosylated. The influence of protein glycosylation on immune function and disease is covered.	[Wolfert, Margreet A.; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Wolfert, Margreet A/J-1726-2016; Boons, Geert-Jan P H/J-3211-2016	Wolfert, Margreet A/0000-0003-4864-0026; Boons, Geert-Jan P H/0000-0003-3111-5954	National Cancer Institute [R01CA88986]; National Institute of General Medical Sciences of the US National Institutes of Health [R01GM061761, R01GM090269]; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761, R01GM090269] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors receive research support by the National Cancer Institute (R01CA88986) and the National Institute of General Medical Sciences (R01GM061761 and R01GM090269) of the US National Institutes of Health. We thank Z. S. Chinoy for assistance with figure preparation.	Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Andersson IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017881; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Apostolopoulos V, 2003, P NATL ACAD SCI USA, V100, P15029, DOI 10.1073/pnas.2432220100; Avci FY, 2013, SEMIN IMMUNOL, V25, P146, DOI 10.1016/j.smim.2013.05.005; Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Backlund J, 2002, P NATL ACAD SCI USA, V99, P9960, DOI 10.1073/pnas.132254199; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Baum LG, 2009, IMMUNOL REV, V230, P5, DOI 10.1111/j.1600-065X.2009.00800.x; Beatson RE, 2010, IMMUNOTHERAPY-UK, V2, P305, DOI 10.2217/IMT.10.17; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Courtney AH, 2009, P NATL ACAD SCI USA, V106, P2500, DOI 10.1073/pnas.0807207106; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dengjel J, 2006, TRANSFUS MED HEMOTH, V33, P38, DOI 10.1159/000090194; DOE B, 1994, EUR J IMMUNOL, V24, P2369, DOI 10.1002/eji.1830241017; Duong BH, 2010, J EXP MED, V207, P444; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Dziadek S, 2006, CHEM-EUR J, V12, P4981, DOI 10.1002/chem.200600144; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Gaidzik N, 2013, CHEM SOC REV, V42, P4421, DOI 10.1039/c3cs35470a; Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Garstka MA, 2013, MOL IMMUNOL, V55, P162, DOI 10.1016/j.molimm.2012.10.022; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Hanisch FG, 2006, CURR PROTEIN PEPT SC, V7, P307, DOI 10.2174/138920306778018034; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Haslam SM, 2008, IMMUNOL CELL BIOL, V86, P564, DOI 10.1038/icb.2008.54; Haurum JS, 1999, J EXP MED, V190, P145, DOI 10.1084/jem.190.1.145; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Jensen T, 1997, J IMMUNOL, V158, P3769; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Johnson MA, 2013, CHEM SOC REV, V42, P4327, DOI 10.1039/c2cs35382b; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Karsten U, 2004, GLYCOBIOLOGY, V14, P681, DOI 10.1093/glycob/cwh090; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kolarich D, 2012, CURR OPIN CHEM BIOL, V16, P214, DOI 10.1016/j.cbpa.2011.12.006; Lai ZZ, 2009, VACCINE, V27, P3137, DOI 10.1016/j.vaccine.2009.03.064; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nairn A, 2009, HANDBOOK OF GLYCOMICS, P95; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ninkovic T, 2007, J IMMUNOL, V179, P2380, DOI 10.4049/jimmunol.179.4.2380; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Poe JC, 2012, TRENDS IMMUNOL, V33, P413, DOI 10.1016/j.it.2012.04.010; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Purcell AW, 2008, IMMUNOL CELL BIOL, V86, P574, DOI 10.1038/icb.2008.48; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Roulois D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/871936; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Ryan SO, 2012, MICROBES INFECT, V14, P894, DOI 10.1016/j.micinf.2012.04.010; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Smith DF, 2013, MOL CELL PROTEOMICS, V12, P902, DOI 10.1074/mcp.R112.027110; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Stepensky D, 2006, CLIN EXP IMMUNOL, V143, P139, DOI 10.1111/j.1365-2249.2005.02965.x; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Taylor ME, 2003, METHOD ENZYMOL, V363, P3; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; Vanderschaeghe D, 2010, BIOL CHEM, V391, P149, DOI 10.1515/bc.2010.031; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Tribulatti MV, 2009, J LEUKOCYTE BIOL, V86, P371, DOI 10.1189/jlb.0908529; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang Z, 2013, SCIENCE, V341, P379, DOI 10.1126/science.1236231; Wells L, 2013, MOL CELL PROTEOMICS, V12, P833, DOI 10.1074/mcp.E113.027904; Werdelin O, 2002, P NATL ACAD SCI USA, V99, P9611, DOI 10.1073/pnas.152345899	111	193	200	2	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2013	9	12					776	784		10.1038/NCHEMBIO.1403	http://dx.doi.org/10.1038/NCHEMBIO.1403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253ZR	24231619	Green Accepted			2022-12-25	WOS:000327130000008
J	Rujano, MA; Sanchez-Pulido, L; Pennetier, C; le Dez, G; Basto, R				Rujano, Maria A.; Sanchez-Pulido, Luis; Pennetier, Carole; le Dez, Gaelle; Basto, Renata			The microcephaly protein Asp regulates neuroepithelium morphogenesis by controlling the spatial distribution of myosin II	NATURE CELL BIOLOGY			English	Article							INTERKINETIC NUCLEAR MIGRATION; ABNORMAL-SPINDLE PROTEIN; MICROTUBULE ORGANIZATION; CENTROSOME AMPLIFICATION; GENE-EXPRESSION; CELL DIVISIONS; BRAIN SIZE; DROSOPHILA; PROLIFERATION; EVOLUTION	Mutations in ASPM are the most frequent cause of microcephaly, a disorder characterized by reduced brain size at birth. ASPM is recognized as a major regulator of brain size, yet its role during neural development remains poorly understood. Moreover, the role of ASPM proteins in invertebrate brain morphogenesis has never been investigated. Here, we characterized the function of the Drosophila ASPM orthologue, Asp, and found that asp mutants present severe defects in brain size and neuroepithelium morphogenesis. We show that size reduction depends on the mitotic function of Asp, whereas regulation of tissue shape depends on an uncharacterized function. Asp interacts with myosin II regulating its polarized distribution along the apico-basal axis. In the absence of Asp, mislocalization of myosin II results in interkinetic nuclear migration and tissue architecture defects. We propose that Asp regulates neuroepithelium morphogenesis through myosin-II-mediated structural and mechanical processes to maintain force balance and tissue cohesiveness.	[Rujano, Maria A.; Pennetier, Carole; le Dez, Gaelle; Basto, Renata] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Sanchez-Pulido, Luis] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3QX, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Oxford	Basto, R (corresponding author), Inst Curie, CNRS, UMR144, 12 Rue Lhomond, F-75005 Paris, France.	renata.basto@curie.fr		Rujano, Maria Alexandra/0000-0002-6859-3418; Le Dez, Gaelle/0000-0002-9247-9666; Sanchez Pulido, Luis/0000-0002-2300-8502	ERC [242598]; Institut Curie; CNRS; MRC [MC_U137761446, MC_UU_12021/1] Funding Source: UKRI; Medical Research Council [MC_U137761446, MC_UU_12021/1] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Y. Bellaiche (Institut Curie, France), A. Brand (Gurdon Institute, UK), A. Carmena (UMH, Spain), C. Doe (University of Oregon, USA), B. Egger (University of Fribourg, Switzerland), M. Gatti (University of Roma, Italy), C. Gonzalez (IRB, Spain), R. Karess (IJM, France), E. Knust (MPI, Germany), J. C. Lehner (IMLS, Switzerland), S. Heidmann (University of Bayreuth, Germany), F. Matzuzaki (Aiken, Japan), J. Skeath (Washington University, USA), A. Wodarz (Gottingen University, Germany), Y. Yan (UCSF, USA), the Bloomington Stock Center, DSHB and the Antibody platform Institut Curie for stocks and reagents; V. Fraisier, L. Sengmanivong, F. Waharte, O. Leroy, C. Gueudry of the Imaging facility (PICT-IBISA) and the Nikon Center at the I. Curie for valuable help and advice on image acquisition and processing; A. M. Wehenkel, Z. Wang and A. Houdusse for advice on biochemistry; and F. Bosveld, Y. Bellaiche, D. Delacour, A. Echard, B. Egger, M. Piel, N. Minc, K. Roper, C. Norden, E. Gomes, D. Gogendeau, V. Marthiens, D. Sabino, D. Gambarotto, M. Nano, A. Booth and C. Janke for helpful discussions and critical comments on the manuscript. We thank the Institut Curie, EMBO (ALTF 923-2008), FRM (SPF20101220951) and the ERC starting grant for post doctoral support (M.A.R.), and the MRC UK for postdoctoral support (L.S-P.). This work was supported by an ERC grant CentroStemCancer 242598, an FRM installation grant, an ATIP grant, the Institut Curie and the CNRS. The Basto laboratory is a member of the Labex CelTisPhyBio.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Buchman J. J., 2011, GENE DEV, V25, P1909; Cappello S, 2011, DEV BIOL, V357, P326, DOI 10.1016/j.ydbio.2011.07.001; CASAL J, 1990, DEVELOPMENT, V108, P251; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Del Bene F, 2011, EMBO J, V30, P1676, DOI 10.1038/emboj.2011.114; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Franke JD, 2006, CELL MOTIL CYTOSKEL, V63, P604, DOI 10.1002/cm.20148; Franzot G, 2005, J MOL BIOL, V348, P151, DOI 10.1016/j.jmb.2005.01.002; Gervais L, 2008, DEVELOPMENT, V135, P3829, DOI 10.1242/dev.029009; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GONZALEZ C, 1990, J CELL SCI, V96, P605; GONZALEZ C, 1988, J CELL SCI, V89, P39; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lee HO, 2013, TRENDS CELL BIOL, V23, P141, DOI 10.1016/j.tcb.2012.11.001; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Meinertzhagen Ian A., 1993, P1363; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Montgomery SH, 2012, EVOLUTION, V66, P927, DOI 10.1111/j.1558-5646.2011.01487.x; Montgomery SH, 2010, CURR BIOL, V20, pR244, DOI 10.1016/j.cub.2010.01.043; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Rauzi M, 2011, CURR TOP DEV BIOL, V95, P93, DOI 10.1016/B978-0-12-385065-2.00004-9; Rebollo E, 2004, PLOS BIOL, V2, P54, DOI 10.1371/journal.pbio.0020008; Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306; Riparbelli MG, 2002, J CELL SCI, V115, P913; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; XU T, 1993, DEVELOPMENT, V117, P1223; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117	76	60	60	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2013	15	11					1294	U87		10.1038/ncb2858	http://dx.doi.org/10.1038/ncb2858			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	248FN	24142104				2022-12-25	WOS:000326680700006
J	Ghorbal, M; Gorman, M; Macpherson, CR; Martins, RM; Scherf, A; Lopez-Rubio, JJ				Ghorbal, Mehdi; Gorman, Molly; Macpherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan			Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system	NATURE BIOTECHNOLOGY			English	Article							GENE DELETION; ORC1; RNAS; DNA	Genome manipulation in the malaria parasite Plasmodium falciparum remains largely intractable and improved genomic tools are needed to further understand pathogenesis and drug resistance. We demonstrated the CRISPR-Cas9 system for use in P. falciparum by disrupting chromosomal loci and generating marker-free, single-nucleotide substitutions with high efficiency. Additionally, an artemisinin-resistant strain was generated by introducing a previously implicated polymorphism, thus illustrating the value of efficient genome editing in malaria research.	[Ghorbal, Mehdi; Gorman, Molly; Macpherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; [Ghorbal, Mehdi; Gorman, Molly; Macpherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, CNRS URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lopez-Rubio, JJ (corresponding author), Univ Montpellier I, CNRS 5290, IRD 224, Montpellier, France.	jose-juan.lopez-rubio@inserm.fr	; lopez-rubio, jose juan/A-4509-2014	Scherf, Artur/0000-0003-2411-3328; MacPherson, Cameron/0000-0002-8945-9736; Ghorbal, Mehdi/0000-0002-8896-2786; miyazawa martins, rafael/0000-0001-7449-0696; lopez-rubio, jose juan/0000-0002-0555-1122	Agence Nationale de la Recherche [ANR 11 JSV3 004 01]; ERC [250320]; French Parasitology consortium ParaFrap [ANR-11-LABX0024]; Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); French Parasitology consortium ParaFrap; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank L. Mancio-Silva (Instituto de Medicina Molecular, Lisboa) and N. Siegel (Institute for Molecular Infection Biology, Wuerzburg) for critically reading the manuscript and PlasmoDB for the invaluable malaria-database support. F. Zhang laboratory (MIT, Boston) for deposition of pX330 in Addgene. A.B. Vaidya (Drexel University, Philadelphia) for pUF1 plasmid. D. Fidock laboratory (Columbia University, New York) for NF54<SUP>EGFP</SUP> strain. C. Buchrieser (Institut Pasteur, Paris) for lending Amaxa 4D electroporator (Lonza) and P. Escoll Guerrero (Institut Pasteur, Paris) for assistance. A. Nacer (Institut Pasteur, Paris) for help with immunofluorescence experiments. GenoScreen team, especially H. Blanquart and A. Gourbeyre, for sequencing. This work was supported by the Agence Nationale de la Recherche (ANR 11 JSV3 004 01 PlasmoPiggyBac), ERC Advanced Grant (PlasmoEscape 250320) and the French Parasitology consortium ParaFrap (ANR-11-LABX0024). Me.G. and Mo.G. were funded by ANR 11 JSV3 004 01 and J.-J.L.-R. by the Institut National de la Sante et de la Recherche Medicale (INSERM).	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bawankar P, 2010, MOL BIOL REP, V37, P2125, DOI 10.1007/s11033-009-9682-4; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	22	394	418	1	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					819	821		10.1038/nbt.2925	http://dx.doi.org/10.1038/nbt.2925			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24880488				2022-12-25	WOS:000346455900042
J	Kasap, C; Elemento, O; Kapoor, TM				Kasap, Corynn; Elemento, Olivier; Kapoor, Tarun M.			DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN-CELLS; CANCER; IDENTIFICATION; RESISTANCE; INHIBITORS; MECHANISM; DISCOVERY; KINESINS	To identify physiological targets of drugs and bioactive small molecules, we developed an approach, named DrugTargetSeqR, which combines high-throughput sequencing, computational mutation discovery and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-based genome editing. We applied this approach to ispinesib and YM155, drugs that have undergone clinical trials as anticancer agents, and uncovered mechanisms of action and identified genetic and epigenetic mechanisms likely to cause drug resistance in human cancer cells.	[Kasap, Corynn; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Rockefeller University; Cornell University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	kapoor@rockefeller.edu			Louis and Rachel Rudin Foundation; Medical Scientist Training Program grant [NIGMS T32GM007739]; US National Institutes of Health [GM98579]; Starr Cancer Consortium [I6-A618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098579, T32GM007739] Funding Source: NIH RePORTER	Louis and Rachel Rudin Foundation; Medical Scientist Training Program grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to US National Institutes of Health (GM98579 to T.M.K.) and Starr Cancer Consortium (I6-A618 to O.E. and T.M.K.). C.K. was supported by the Louis and Rachel Rudin Foundation and a Medical Scientist Training Program grant (NIGMS T32GM007739) to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. We are grateful to L. Marraffini (Rockefeller University) for assistance with genome editing.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bergnes G, 2005, CURR TOP MED CHEM, V5, P127, DOI 10.2174/1568026053507697; COLE DG, 1994, J BIOL CHEM, V269, P22913; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Holmes D, 2012, NAT MED, V18, P842, DOI 10.1038/nm0612-842b; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mardin BR, 2013, DEV CELL, V25, P229, DOI 10.1016/j.devcel.2013.03.012; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sturgill EG, 2013, CURR BIOL, V23, P1280, DOI 10.1016/j.cub.2013.05.043; Talapatra SK, 2013, J MED CHEM, V56, P6317, DOI 10.1021/jm4006274; Titov DV, 2012, BIOORGAN MED CHEM, V20, P1902, DOI 10.1016/j.bmc.2011.11.070; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739	24	75	83	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					626	U157		10.1038/nchembio.1551	http://dx.doi.org/10.1038/nchembio.1551			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24929528	Green Accepted			2022-12-25	WOS:000339380100007
J	Petrini, I; Meltzer, PS; Kim, IK; Lucchi, M; Park, KS; Fontanini, G; Gao, J; Zucali, PA; Calabrese, F; Favaretto, A; Rea, F; Rodriguez-Canales, J; Walker, RL; Pineda, M; Zhu, YLJ; Lau, C; Killian, KJ; Bilke, S; Voeller, D; Dakshanamurthy, S; Wang, YS; Giaccone, G				Petrini, Iacopo; Meltzer, Paul S.; Kim, In-Kyu; Lucchi, Marco; Park, Kang-Seo; Fontanini, Gabriella; Gao, James; Zucali, Paolo A.; Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico; Rodriguez-Canales, Jaime; Walker, Robert L.; Pineda, Marbin; Zhu, Yuelin J.; Lau, Christopher; Killian, Keith J.; Bilke, Sven; Voeller, Donna; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe			A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors	NATURE GENETICS			English	Article							FACTOR TFII-I; CELL-CYCLE; GENOME; BIOCHEMISTRY; MANAGEMENT; BIOLOGY; PROTEIN; GENES; KIT	We analyzed 28 thymic epithelial tumors (TETs) using next-generation sequencing and identified a missense mutation (chromosome 7 c.74146970T>A) in GTF2I at high frequency in type A thymomas, a relatively indolent subtype. In a series of 274 TETs, we detected the GTF2I mutation in 82% of type A and 74% of type AB thymomas but rarely in the aggressive subtypes, where recurrent mutations of known cancer genes have been identified. Therefore, GTF2I mutation correlated with better survival. GTF2I beta and delta isoforms were expressed in TETs, and both mutant isoforms were able to stimulate cell proliferation in vitro. Thymic carcinomas carried a higher number of mutations than thymomas (average of 43.5 and 18.4, respectively). Notably, we identified recurrent mutations of known cancer genes, including TP53, CYLD, CDKN2A, BAP1 and PBRM1, in thymic carcinomas. These findings will complement the diagnostic assessment of these tumors and also facilitate development of a molecular classification and assessment of prognosis and treatment strategies.	[Petrini, Iacopo; Gao, James; Voeller, Donna; Wang, Yisong; Giaccone, Giuseppe] NCI, Med Oncol Branch, Bethesda, MD 20892 USA; [Meltzer, Paul S.; Walker, Robert L.; Pineda, Marbin; Zhu, Yuelin J.; Lau, Christopher; Killian, Keith J.; Bilke, Sven] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kim, In-Kyu; Park, Kang-Seo; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Lucchi, Marco; Fontanini, Gabriella] Pisa Univ Hosp, Pisa, Italy; [Zucali, Paolo A.] Humanitas Clin & Res Ctr, Milan, Italy; [Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico] Padua Univ Hosp, Padua, Italy; [Rodriguez-Canales, Jaime] NCI, Pathol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Padua; Azienda Ospedaliera - Universita di Padova; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giaccone, G (corresponding author), NCI, Med Oncol Branch, Bethesda, MD 20892 USA.	gg496@georgetown.edu	Zucali, Paolo/AAC-9757-2020; Dakshanamurthy, Sivanesan/CAF-4258-2022; Petrini, Iacopo/P-9318-2019; Petrini, Iacopo/K-7316-2016; Giaccone, Giuseppe/E-8297-2017; Lucchi, Marco/K-2140-2019; Zhu, Yuelin/ABD-5743-2021; Fontanini, Gabriella/O-7636-2015	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; Petrini, Iacopo/0000-0002-7752-6866; Petrini, Iacopo/0000-0002-7752-6866; Giaccone, Giuseppe/0000-0002-5023-7562; Zhu, Yuelin/0000-0003-2762-0755; Fontanini, Gabriella/0000-0003-1957-2052; Kim, In-Kyu/0000-0002-8427-8311; Zucali, Paolo/0000-0002-2274-1702; Walker, Robert/0000-0001-8235-4686; Favaretto, Adolfo/0000-0001-8175-7467; LUCCHI, MARCO/0000-0001-9909-6820	US National Institutes of Health National Cancer Institute; Georgetown University Lombardi Cancer Center; NATIONAL CANCER INSTITUTE [ZIABC011091, P30CA051008, ZIABC010453, ZICBC011040] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgetown University Lombardi Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a US National Institutes of Health National Cancer Institute intramural program and the Georgetown University Lombardi Cancer Center. We thank A. Proietti for her help in reviewing pathology slides.	Arbajian E, 2013, GENE CHROMOSOME CANC, V52, P330, DOI 10.1002/gcc.22033; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Doi-Katayama Y, 2007, PROTEIN SCI, V16, P1788, DOI 10.1110/ps.072792007; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Girard N, 2009, J THORAC ONCOL, V4, P119, DOI 10.1097/JTO.0b013e31818e105c; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Okumura M, 2008, GEN THORAC CARDIOVAS, V56, P143, DOI 10.1007/s11748-007-0185-8; Petrim I, 2010, J THORAC ONCOL, V5, P1447, DOI 10.1097/JTO.0b013e3181e96e30; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Strobel P, 2004, NEW ENGL J MED, V350, P2625, DOI 10.1056/NEJM200406173502523; Travis WD., 2004, TRAVIS WB WHO CLASSI; Verghese ET, 2008, HISTOPATHOLOGY, V53, P218, DOI 10.1111/j.1365-2559.2008.03088.x; Zucali PA, 2013, LUNG CANCER, V79, P236, DOI 10.1016/j.lungcan.2012.11.015	23	137	140	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					844	849		10.1038/ng.3016	http://dx.doi.org/10.1038/ng.3016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24974848	Green Accepted			2022-12-25	WOS:000339704400012
J	Kuscu, C; Arslan, S; Singh, R; Thorpe, J; Adli, M				Kuscu, Cem; Arslan, Sevki; Singh, Ritambhara; Thorpe, Jeremy; Adli, Mazhar			Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease	NATURE BIOTECHNOLOGY			English	Article							ONE-STEP GENERATION; HUMAN-CELLS; TRANSCRIPTION FACTORS; LIMITED NUMBERS; CRISPR; SPECIFICITY; SYSTEM; ALIGNMENT; NUCLEASES; SEQUENCES	RNA-guided genome editing with the CRISPR-Cas9 system has great potential for basic and clinical research, but the determinants of targeting specificity and the extent of off-target cleavage remain insufficiently understood. Using chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq), we mapped genome-wide binding sites of catalytically inactive Cas9 (dCas9) in HEK293T cells, in combination with 12 different single guide RNAs (sgRNAs). The number of off-target sites bound by dCas9 varied from similar to 10 to > 1,000 depending on the sgRNA. Analysis of off-target binding sites showed the importance of the PAM-proximal region of the sgRNA guiding sequence and that dCas9 binding sites are enriched in open chromatin regions. When targeted with catalytically active Cas9, some off-target binding sites had indels above background levels in a region around the ChIP-seq peak, but generally at lower rates than the on-target sites. Our results elucidate major determinants of Cas9 targeting, and we show that ChIP-seq allows unbiased detection of Cas9 binding sites genome-wide.	[Kuscu, Cem; Arslan, Sevki; Singh, Ritambhara; Thorpe, Jeremy; Adli, Mazhar] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Arslan, Sevki] Pamukkale Univ, Dept Biol, Denizli, Turkey; [Singh, Ritambhara] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	University of Virginia; Pamukkale University; University of Virginia	Adli, M (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	adli@virginia.edu		KUSCU, CEM/0000-0001-7154-6762	University of Virginia; American Cancer Society	University of Virginia; American Cancer Society(American Cancer Society)	The research was funded with a departmental startup fund from the University of Virginia and from an American Cancer Society institutional research grant. We would like to thank A. Quinlan, University of Virginia, for technical help with data analysis and D. Burke, University of Virginia, for his critical readings and comments.	Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	36	529	593	8	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					677	+		10.1038/nbt.2916	http://dx.doi.org/10.1038/nbt.2916			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24837660				2022-12-25	WOS:000338705900034
J	Sweeney, RT; McClary, AC; Myers, BR; Biscocho, J; Neahring, L; Kwei, KA; Qu, KB; Gong, X; Ng, T; Jones, CD; Varma, S; Odegaard, JI; Sugiyama, T; Koyota, S; Rubin, BP; Troxell, ML; Pelham, RJ; Zehnder, JL; Beachy, PA; Pollack, JR; West, RB				Sweeney, Robert T.; McClary, Andrew C.; Myers, Benjamin R.; Biscocho, Jewison; Neahring, Lila; Kwei, Kevin A.; Qu, Kunbin; Gong, Xue; Ng, Tony; Jones, Carol D.; Varma, Sushama; Odegaard, Justin I.; Sugiyama, Toshihiro; Koyota, Souichi; Rubin, Brian P.; Troxell, Megan L.; Pelham, Robert J.; Zehnder, James L.; Beachy, Philip A.; Pollack, Jonathan R.; West, Robert B.			Identification of recurrent SMO and BRAF mutations in ameloblastomas	NATURE GENETICS			English	Article							SONIC-HEDGEHOG; HAIR FOLLICLE; CELL-LINE; GENE; ESTABLISHMENT; MORPHOGENESIS; ACTIVATION; EXPRESSION; PATHWAY; GROWTH	Here we report the discovery of oncogenic mutations in the Hedgehog and mitogen-activated protein kinase (MAPK) pathways in over 80% of ameloblastomas, locally destructive odontogenic tumors of the jaw, by genomic analysis of archival material. Mutations in SMO (encoding Smoothened, SMO) are common in ameloblastomas of the maxilla, whereas BRAF mutations are predominant in tumors of the mandible. We show that a frequently occurring SMO alteration encoding p.Leu412Phe is an activating mutation and that its effect on Hedgehog-pathway activity can be inhibited by arsenic trioxide (ATO), an anti-leukemia drug approved by the US Food and Drug Administration (FDA) that is currently in clinical trials for its Hedgehog-inhibitory activity. In a similar manner, ameloblastoma cells harboring an activating BRAF mutation encoding p.Va1600Glu are sensitive to the BRAF inhibitor vemurafenib. Our findings establish a new paradigm for the diagnostic classification and treatment of ameloblastomas.	[Sweeney, Robert T.; McClary, Andrew C.; Biscocho, Jewison; Gong, Xue; Jones, Carol D.; Varma, Sushama; Odegaard, Justin I.; Zehnder, James L.; Pollack, Jonathan R.; West, Robert B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Myers, Benjamin R.; Neahring, Lila; Beachy, Philip A.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Myers, Benjamin R.; Neahring, Lila; Beachy, Philip A.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Myers, Benjamin R.; Neahring, Lila; Beachy, Philip A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Myers, Benjamin R.; Neahring, Lila; Beachy, Philip A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Kwei, Kevin A.; Qu, Kunbin; Pelham, Robert J.] Genom Hlth, Redwood City, CA USA; [Ng, Tony] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Sugiyama, Toshihiro; Koyota, Souichi] Akita Univ, Grad Sch Med, Dept Biochem, Akita 010, Japan; [Rubin, Brian P.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Troxell, Megan L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Genomic Health; University of British Columbia; Akita University; Cleveland Clinic Foundation; Oregon Health & Science University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	pbeachy@stanford.edu; pollack1@stanford.edu; rbwest@stanford.edu		West, Robert/0000-0002-8330-8283	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA124435] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fontebasso AM, 2013, BRAIN PATHOL, V23, P210, DOI 10.1111/bpa.12023; GORLIN RJ, 1961, CANCER-AM CANCER SOC, V14, P73, DOI 10.1002/1097-0142(196101/02)14:1<73::AID-CNCR2820140111>3.0.CO;2-T; Harada H, 1998, J ORAL PATHOL MED, V27, P207; Heikinheimo K, 2002, J DENT RES, V81, P525, DOI 10.1177/154405910208100805; Iwasaki JK, 2012, J AM ACAD DERMATOL, V66, pE167, DOI 10.1016/j.jaad.2010.06.054; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Kumamoto H, 2004, J ORAL PATHOL MED, V33, P185, DOI 10.1111/j.0904-2512.2004.00070.x; Kurppa KJ, 2014, J PATHOL, V232, P492, DOI 10.1002/path.4317; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Nakata A, 2003, BIOCHEM BIOPH RES CO, V308, P834, DOI 10.1016/S0006-291X(03)01467-0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Sweeney RT, 2013, AM J SURG PATHOL, V37, P796, DOI 10.1097/PAS.0b013e31827ad9b2; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang H, 2012, CANCER RES, V72, P779, DOI 10.1158/0008-5472.CAN-11-2941	24	198	210	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					722	725		10.1038/ng.2986	http://dx.doi.org/10.1038/ng.2986			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24859340	Green Accepted			2022-12-25	WOS:000338093800013
J	Yuan, Y; Van Allen, EM; Omberg, L; Wagle, N; Amin-Mansour, A; Sokolov, A; Byers, LA; Xu, YX; Hess, KR; Diao, LX; Han, L; Huang, XL; Lawrence, MS; Weinstein, JN; Stuart, JM; Mills, GB; Garraway, LA; Margolin, AA; Getz, G; Liang, H				Yuan, Yuan; Van Allen, Eliezer M.; Omberg, Larsson; Wagle, Nikhil; Amin-Mansour, Ali; Sokolov, Artem; Byers, Lauren A.; Xu, Yanxun; Hess, Kenneth R.; Diao, Lixia; Han, Leng; Huang, Xuelin; Lawrence, Michael S.; Weinstein, John N.; Stuart, Josh M.; Mills, Gordon B.; Garraway, Levi A.; Margolin, Adam A.; Getz, Gad; Liang, Han			Assessing the clinical utility of cancer genomic and proteomic data across tumor types	NATURE BIOTECHNOLOGY			English	Article							CELL LUNG-CANCER; SURVIVAL; EVEROLIMUS; BREAST; VALIDATION; RESISTANCE; SUPPRESSOR; EXPRESSION; BIOMARKERS; MUTATIONS	Molecular profiling of tumors promises to advance the clinical management of cancer, but the benefits of integrating molecular data with traditional clinical variables have not been systematically studied. Here we retrospectively predict patient survival using diverse molecular data (somatic copy-number alteration, DNA methylation and mRNA, microRNA and protein expression) from 953 samples of four cancer types from The Cancer Genome Atlas project. We find that incorporating molecular data with clinical variables yields statistically significantly improved predictions (FDR < 0.05) for three cancers but those quantitative gains were limited (2.2-23.9%). Additional analyses revealed little predictive power across tumor types except for one case. In clinically relevant genes, we identified 10,281 somatic alterations across 12 cancer types in 2,928 of 3,277 patients (89.4%), many of which would not be revealed in single-tumor analyses. Our study provides a starting point and resources, including an open-access model evaluation platform, for building reliable prognostic and therapeutic strategies that incorporate molecular data.	[Yuan, Yuan; Liang, Han] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Yuan, Yuan; Diao, Lixia; Han, Leng; Weinstein, John N.; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Van Allen, Eliezer M.; Wagle, Nikhil; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Wagle, Nikhil; Amin-Mansour, Ali; Lawrence, Michael S.; Garraway, Levi A.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Omberg, Larsson; Margolin, Adam A.] Sage Bionetworks, Seattle, WA USA; [Sokolov, Artem; Stuart, Josh M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Byers, Lauren A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Xu, Yanxun] Univ Texas Austin, Div Stat & Sci Comp, Austin, TX 78712 USA; [Hess, Kenneth R.; Huang, Xuelin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Weinstein, John N.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Garraway, Levi A.; Getz, Gad] Harvard Univ, Sch Med, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Liang, H (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.	margolin@ohsu.edu; gadgetz@broadinstitute.org; hliang1@mdanderson.org	Hess, Kenneth/K-6546-2019; Han, Leng/HCH-3491-2022; Wagle, Nikhil/Q-7428-2019; Lawrence, Michael/AAC-8202-2020; Yuan, Yuan/H-4007-2013	Hess, Kenneth/0000-0003-1377-6070; Han, Leng/0000-0002-7380-2640; Yuan, Yuan/0000-0003-4706-7897; Stuart, Joshua/0000-0002-2171-565X; Omberg, Larsson/0000-0002-4719-9120; Weinstein, John/0000-0001-9401-6908	National Institutes of Health [CA143883, CA175486, CA016672]; UTMDACC - G.S. Hogan Gastrointestinal Research Fund; NCI-MDACC Uterine SPORE career development award; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; Dana-Farber Leadership Council; Conquer Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA175486, P30CA016672, U24CA143883, P50CA100632, P50CA098258, T32CA009172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTMDACC - G.S. Hogan Gastrointestinal Research Fund; NCI-MDACC Uterine SPORE career development award; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; Dana-Farber Leadership Council; Conquer Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge contributions from the TCGA Research Network and the TCGA Pan-Cancer Analysis Working Group (contributing consortium members are listed in the Supplementary Note). The TCGA Pan-Cancer Analysis Working Group is coordinated by J.M. Stuart, C. Sander and I. Shmulevich. This study was supported by the National Institutes of Health (CA143883 to G. B. M. and J.N.W., CA175486 to H. L., and CCSG grant CA016672); UTMDACC - G.S. Hogan Gastrointestinal Research Fund, NCI-MDACC Uterine SPORE career development award to H. L. and the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine to J.N.W.; Dana-Farber Leadership Council to E. M. V. A.; Conquer Cancer Foundation to E.M.V.A.	Antoon JW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00539; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bilal E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003047; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Faragalla H, 2012, J MOL DIAGN, V14, P385, DOI 10.1016/j.jmoldx.2012.02.003; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Henry NL, 2006, ONCOLOGIST, V11, P541, DOI 10.1634/theoncologist.11-6-541; Holdhoff M, 2012, J NEURO-ONCOL, V110, P279, DOI 10.1007/s11060-012-0968-3; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kallakury BVS, 2001, CLIN CANCER RES, V7, P3113; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; McShane LM, 2012, J CLIN ONCOL, V30, P4223, DOI 10.1200/JCO.2012.42.6858; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1023, DOI 10.1093/jnci/dji193; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ni Y, 2013, GENE, V517, P197, DOI 10.1016/j.gene.2012.12.031; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Sakurai T, 2012, BIOCHEM BIOPH RES CO, V422, P607, DOI 10.1016/j.bbrc.2012.05.035; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Van Allen EM, 2013, J CLIN ONCOL, V31, P1825, DOI 10.1200/JCO.2013.48.7215; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Yuan Y, 2012, BIOINFORMATICS, V28, P1246, DOI 10.1093/bioinformatics/bts120; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060	50	188	192	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					644	+		10.1038/nbt.2940	http://dx.doi.org/10.1038/nbt.2940			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24952901	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000338705900029
J	Gong, YX; Zack, TI; Morris, LGT; Lin, K; Hukkelhoven, E; Raheja, R; Tan, IL; Turcan, S; Veeriah, S; Meng, S; Viale, A; Schumacher, SE; Palmedo, P; Beroukhim, R; Chan, TA				Gong, Yongxing; Zack, Travis Ian; Morris, Luc G. T.; Lin, Kan; Hukkelhoven, Ellen; Raheja, Radhika; Tan, I-Li; Turcan, Sevin; Veeriah, Selvaraju; Meng, Shasha; Viale, Agnes; Schumacher, Steven E.; Palmedo, Perry; Beroukhim, Rameen; Chan, Timothy A.			Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins	NATURE GENETICS			English	Article							COPY-NUMBER ALTERATION; F-BOX PROTEINS; CELL-CYCLE; UBIQUITIN LIGASES; MITOCHONDRIAL DEPOLARIZATION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; BREAST-CANCER; DEGRADATION; D1	Coordinate control of different classes of cyclins is fundamentally important for cell cycle regulation and tumor suppression, yet the underlying mechanisms are incompletely understood. Here we show that the PARK2 tumor suppressor mediates this coordination. The PARK2 E3 ubiquitin ligase coordinately controls the stability of both cyclin D and cyclin E. Analysis of approximately 5,000 tumor genomes shows that PARK2 is a very frequently deleted gene in human cancer and uncovers a striking pattern of mutual exclusivity between PARK2 deletion and amplification of CCND1, CCNE1 or CDK4-implicating these genes in a common pathway. Inactivation of PARK2 results in the accumulation of cyclin D and acceleration of cell cycle progression. Furthermore, PARK2 is a component of a new class of cullin-RING-containing ubiquitin ligases targeting both cyclin D and cyclin E for degradation. Thus, PARK2 regulates cyclin-CDK complexes, as does the CDK inhibitor p16, but acts as a master regulator of the stability of G1/S cyclins.	[Gong, Yongxing; Turcan, Sevin; Veeriah, Selvaraju; Meng, Shasha; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Zack, Travis Ian; Schumacher, Steven E.; Palmedo, Perry; Beroukhim, Rameen] Broad Inst, Cambridge, MA USA; [Zack, Travis Ian; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zack, Travis Ian; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zack, Travis Ian; Beroukhim, Rameen] Dana Farber Canc Inst, Ctr Canc Genome Characterizat, Boston, MA 02115 USA; [Zack, Travis Ian] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Lin, Kan; Tan, I-Li] Weill Cornell Coll Med, New York, NY USA; [Hukkelhoven, Ellen; Raheja, Radhika] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core, New York, NY 10021 USA; [Palmedo, Perry] Harvard Univ, Ctr Biomed Informat, Boston, MA 02115 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Turcan, Sevin/AAF-1095-2019; Chan, Timothy A/ABD-5850-2021; Meng, Shasha/AAR-3936-2020	Turcan, Sevin/0000-0002-0885-5607; Gong, Yongxing/0000-0003-1071-0375	US National Institutes of Health T32 grant [5T32CA160001]; US National Institutes of Health [RO1 NS086875-01]; Memorial Sloan-Kettering Cancer Center Brain Tumor Center; Sontag Foundation; Frederick Adler Fund; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA160001] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE024774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086875] Funding Source: NIH RePORTER	US National Institutes of Health T32 grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan-Kettering Cancer Center Brain Tumor Center; Sontag Foundation; Frederick Adler Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Holland, A.C. Koff and J. Huse for helpful advice. S.T. was a recipient of a US National Institutes of Health T32 grant (5T32CA160001). This work was supported by the US National Institutes of Health (RO1 NS086875-01) (T.A.C.), the Memorial Sloan-Kettering Cancer Center Brain Tumor Center (T.A.C.), the Sontag Foundation (T.A.C.) and the Frederick Adler Fund (T.A.C.).	Ackman JB, 2007, DEV NEUROSCI-BASEL, V29, P113, DOI 10.1159/000096216; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hosokawa Y, 1996, J LAB CLIN MED, V127, P246, DOI 10.1016/S0022-2143(96)90092-X; Johnson BN, 2012, P NATL ACAD SCI USA, V109, P6283, DOI 10.1073/pnas.1113248109; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kanie T, 2012, MOL CELL BIOL, V32, P590, DOI 10.1128/MCB.06570-11; Kao SY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-67; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Nurse P, 1997, CELL, V91, P865, DOI 10.1016/S0092-8674(00)80476-6; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tanaka K, 2001, J MOL MED, V79, P482, DOI 10.1007/s001090100242; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Vaites LP, 2011, MOL CELL BIOL, V31, P4513, DOI 10.1128/MCB.05733-11; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Veeriah S, 2010, CELL CYCLE, V9, P1451, DOI 10.4161/cc.9.8.11583; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang HX, 2009, J PATHOL, V218, P76, DOI 10.1002/path.2512; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108	53	120	123	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					588	594		10.1038/ng.2981	http://dx.doi.org/10.1038/ng.2981			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24793136	Green Accepted			2022-12-25	WOS:000336870700015
J	Villeda, SA; Plambeck, KE; Middeldorp, J; Castellano, JM; Mosher, KI; Luo, J; Smith, LK; Bieri, G; Lin, K; Berdnik, D; Wabl, R; Udeochu, J; Wheatley, EG; Zou, BD; Simmons, DA; Xie, XMS; Longo, FM; Wyss-Coray, T				Villeda, Saul A.; Plambeck, Kristopher E.; Middeldorp, Jinte; Castellano, Joseph M.; Mosher, Kira I.; Luo, Jian; Smith, Lucas K.; Bieri, Gregor; Lin, Karin; Berdnik, Daniela; Wabl, Rafael; Udeochu, Joe; Wheatley, Elizabeth G.; Zou, Bende; Simmons, Danielle A.; Xie, Xinmin S.; Longo, Frank M.; Wyss-Coray, Tony			Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice	NATURE MEDICINE			English	Article							LONG-TERM POTENTIATION; ALZHEIMER-DISEASE; DENTATE GYRUS; MEMORY; RATS; DECLINE; NEUROGENESIS; REJUVENATION; SYNAPSES; SYSTEMS	As human lifespan increases, a greater fraction of the population is suffering from age-related cognitive impairments, making it important to elucidate a means to combat the effects of aging(1,2). Here we report that exposure of an aged animal to young blood can counteract and reverse pre-existing effects of brain aging at the molecular, structural, functional and cognitive level. Genome-wide microarray analysis of heterochronic parabionts-in which circulatory systems of young and aged animals are connected identified synaptic plasticity-related transcriptional changes in the hippocampus of aged mice. Dendritic spine density of mature neurons increased and synaptic plasticity improved in the hippocampus of aged heterochronic parabionts. At the cognitive level, systemic administration of young blood plasma into aged mice improved age-related cognitive impairments in both contextual fear conditioning and spatial learning and memory. Structural and cognitive enhancements elicited by exposure to young blood are mediated, in part, by activation of the cyclic AMP response element binding protein (Creb) in the aged hippocampus. Our data indicate that exposure of aged mice to young blood late in life is capable of rejuvenating synaptic plasticity and improving cognitive function.	[Villeda, Saul A.; Plambeck, Kristopher E.; Smith, Lucas K.; Bieri, Gregor; Lin, Karin; Udeochu, Joe; Wheatley, Elizabeth G.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Villeda, Saul A.; Plambeck, Kristopher E.; Smith, Lucas K.; Bieri, Gregor; Lin, Karin; Udeochu, Joe; Wheatley, Elizabeth G.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Villeda, Saul A.; Lin, Karin] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Villeda, Saul A.; Udeochu, Joe] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Villeda, Saul A.; Wheatley, Elizabeth G.] Univ Calif San Francisco, Dev & Stem Cell Biol Grad Program, San Francisco, CA 94143 USA; [Villeda, Saul A.; Middeldorp, Jinte; Castellano, Joseph M.; Mosher, Kira I.; Luo, Jian; Bieri, Gregor; Berdnik, Daniela; Wabl, Rafael; Simmons, Danielle A.; Longo, Frank M.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Mosher, Kira I.; Bieri, Gregor; Wyss-Coray, Tony] Stanford Univ, Sch Med, Neurosci Grad Program, Stanford, CA 94305 USA; [Zou, Bende; Xie, Xinmin S.] AfaSci Res Lab, Redwood City, CA USA; [Wyss-Coray, Tony] VA Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Villeda, SA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	saul.villeda@ucsf.edu; twc@stanford.edu	, Jinte/AHA-6575-2022; Castellano, Joseph M/ABD-7639-2021; Luo, Jian/B-8449-2014; Middeldorp, Jinte/M-2352-2016; Wyss-Coray, Tony/AAF-3380-2019	, Jinte/0000-0002-9198-8020; Luo, Jian/0000-0002-2064-8467; Middeldorp, Jinte/0000-0002-9198-8020; Wyss-Coray, Tony/0000-0001-5893-0831; Castellano, Joseph/0000-0002-8026-6292; Mosher, Kira/0000-0002-3041-3186; Wabl, Rafael/0000-0002-3701-7848; Xie, Xinmin Simon/0000-0002-4049-6499	California Institute for Regenerative Medicine (CIRM); Netherlands Organization for Scientific Research (NWO); Child Health Research Institute fellowship (Stanford National Institutes of Health (NIH)/National Center for Research Resources) [CTSA-UL1-RR025744]; Jane Coffin Childs fellowship; National Science Foundation; National Research Service Award fellowship [1F31-AG034045-01]; Veterans Affairs; National Institute on Aging [AG03144, AG045034]; CIRM; University of California San Francisco (UCSF); Sandler Foundation; UCSF Clinical and Translational Science Institute [UL1-TR000004]; NIH [DP5-OD12178]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034045, R01AG045034] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012178] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Child Health Research Institute fellowship (Stanford National Institutes of Health (NIH)/National Center for Research Resources); Jane Coffin Childs fellowship; National Science Foundation(National Science Foundation (NSF)); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CIRM(California Institute for Regenerative Medicine); University of California San Francisco (UCSF)(University of California System); Sandler Foundation; UCSF Clinical and Translational Science Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Eggel, K. Lucin and N. Woodling for critical review and advice, and D. Jing and F. Lee (Cornell University) for Golgi stain reagents. This work was funded by California Institute for Regenerative Medicine (CIRM) fellowships (K.E.P. and K.L.), a Netherlands Organization for Scientific Research (NWO) Rubicon fellowship (J.M.), a Child Health Research Institute fellowship (Stanford National Institutes of Health (NIH)/National Center for Research Resources CTSA-UL1-RR025744, J.M.C.), a Jane Coffin Childs fellowship (J.M.C.), National Science Foundation fellowships (K.I.M. and J.U.), a National Research Service Award fellowship (1F31-AG034045-01, S.A.V.), anonymous (T.W.-C.), Veterans Affairs (T.W.-C.), the National Institute on Aging (AG045034, AG03144, T.W.-C.), CIRM (T.W.-C.), the University of California San Francisco (UCSF) Program for Breakthrough Biomedical Research, the Sandler Foundation (S.A.V.), the UCSF Clinical and Translational Science Institute (UL1-TR000004, S.A.V.) and an NIH Director's Independence Award (DP5-OD12178, S.A.V.).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GEINISMAN Y, 1986, P NATL ACAD SCI USA, V83, P3027, DOI 10.1073/pnas.83.9.3027; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Merrill DA, 2003, J COMP NEUROL, V459, P201, DOI 10.1002/cne.10616; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; RAPP PR, 1994, CURR OPIN NEUROL, V7, P294, DOI 10.1097/00019052-199408000-00003; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	27	592	633	13	241	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2014	20	6					659	663		10.1038/nm.3569	http://dx.doi.org/10.1038/nm.3569			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AI7LB	24793238	Green Accepted			2022-12-25	WOS:000337071000029
J	Wang, YX; Marino-Enriquez, A; Bennett, RR; Zhu, MJ; Shen, YP; Eilers, G; Lee, JC; Henze, J; Fletcher, BS; Gu, ZZ; Fox, EA; Antonescu, CR; Fletcher, CDM; Guo, XQ; Raut, CP; Demetri, GD; van de Rijn, M; Ordog, T; Kunkel, LM; Fletcher, JA				Wang, Yuexiang; Marino-Enriquez, Adrian; Bennett, Richard R.; Zhu, Meijun; Shen, Yiping; Eilers, Grant; Lee, Jen-Chieh; Henze, Joern; Fletcher, Benjamin S.; Gu, Zhizhan; Fox, Edward A.; Antonescu, Cristina R.; Fletcher, Christopher D. M.; Guo, Xiangqian; Raut, Chandrajit P.; Demetri, George D.; van de Rijn, Matt; Ordog, Tamas; Kunkel, Louis M.; Fletcher, Jonathan A.			Dystrophin is a tumor suppressor in human cancers with myogenic programs	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GASTROINTESTINAL STROMAL TUMORS; GENE; MUTATIONS; PROTEIN; CHILDHOOD; PRODUCT; MODEL	Many common human mesenchymal tumors, including gastrointestinal stromal tumor (GIST), rhabdomyosarcoma (RMS) and leiomyosarcoma (LMS), feature myogenic differentiation(1-3). Here we report that intragenic deletion of the dystrophin-encoding and muscular dystrophy-associated DMD gene is a frequent mechanism by which myogenic tumors progress to high-grade, lethal sarcomas. Dystrophin is expressed in the non-neoplastic and benign counterparts of GIST, RMS and LMS tumors, and DMD deletions inactivate larger dystrophin isoforms, including 427-kDa dystrophin, while preserving the expression of an essential 71-kDa isoform. Dystrophin inhibits myogenic sarcoma cell migration, invasion, anchorage independence and invadopodia formation, and dystrophin inactivation was found in 96%, 100% and 62% of metastatic GIST, embryonal RMS and LMS samples, respectively. These findings validate dystrophin as a tumor suppressor and likely anti-metastatic factor, suggesting that therapies in development for muscular dystrophies may also have relevance in the treatment of cancer.	[Wang, Yuexiang; Marino-Enriquez, Adrian; Zhu, Meijun; Eilers, Grant; Lee, Jen-Chieh; Henze, Joern; Fletcher, Benjamin S.; Fletcher, Christopher D. M.; Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wang, Yuexiang; Marino-Enriquez, Adrian; Zhu, Meijun; Eilers, Grant; Lee, Jen-Chieh; Henze, Joern; Fletcher, Benjamin S.; Gu, Zhizhan; Fletcher, Christopher D. M.; Raut, Chandrajit P.; Fletcher, Jonathan A.] Harvard Univ, Sch Med, Boston, MA USA; [Bennett, Richard R.; Kunkel, Louis M.] Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [Shen, Yiping] Childrens Hosp, Dept Lab Med, Genet Diagnost Lab, Boston, MA 02115 USA; [Shen, Yiping] Jiaotong Univ, Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China; [Lee, Jen-Chieh] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Gu, Zhizhan] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Fox, Edward A.] Dana Farber Canc Inst, Mol Diagnost Lab, Boston, MA 02115 USA; [Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Guo, Xiangqian; van de Rijn, Matt] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Raut, Chandrajit P.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Demetri, George D.] Harvard Univ, Sch Med, Ludwig Ctr Harvard, Boston, MA USA; [Demetri, George D.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ordog, Tamas] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Ordog, Tamas] Mayo Clin, Enter Neurosci Program, Rochester, MN USA; [Ordog, Tamas] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Shanghai Jiao Tong University; National Taiwan University; National Taiwan University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fletcher, JA (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jfletcher@partners.org	Wang, Yuexiang/GNH-5248-2022; Guo, Xiangqian/AAN-4599-2020; Lee, Jen-Chieh/AAG-3533-2019; ravegnini, gloria/K-1330-2016	Lee, Jen-Chieh/0000-0001-7739-5934; ravegnini, gloria/0000-0002-7774-402X; van de Rijn, Matt/0000-0002-1909-9739; Gu, Zhizhan/0000-0001-9934-5209; Guo, Xiangqian/0000-0001-6645-5786; Marino-Enriquez, Adrian/0000-0002-7680-9901; Harrington, Jon/0000-0003-1293-5201	US National Institutes of Health [1P50CA127003-07, 1P50CA168512-01, 5R01DK058185-12]; Virginia and Daniel K. Ludwig Trust; GIST Cancer Research Fund; Life Raft Group; Cesarini Pan-Mass Challenge for GIST; Paul's Posse of the Pan-Mass Challenge; Bernard F. and Alva B. Gimbel Foundation; Sarcoma Alliance for Research Through Collaboration; Erica Kaitz LMS Research NOW Fund; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA015083, P30CA008748, U54CA168512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058185] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and Daniel K. Ludwig Trust; GIST Cancer Research Fund; Life Raft Group; Cesarini Pan-Mass Challenge for GIST; Paul's Posse of the Pan-Mass Challenge; Bernard F. and Alva B. Gimbel Foundation; Sarcoma Alliance for Research Through Collaboration; Erica Kaitz LMS Research NOW Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Tremblay (Quebec University Hospital) for the pCR3.1-miniDMD construct; T. Taguchi (Kochi Medical School) for the GIST-T1 cell line; Y. Hayashi, M. Bardsley and H. Qiu for their expert technical assistance; and S. Bauer (West German Cancer Center) for useful discussions and for funding support of J.H. This work was supported by grants from the US National Institutes of Health, including 1P50CA127003-07 (J.A.F. and G.D.D.), 1P50CA168512-01 (J.A.F., G.D.D. and A.M.-E.) and 5R01DK058185-12 (TO.), and by the Virginia and Daniel K. Ludwig Trust for Cancer Research (J.A.F. and G.D.D.), the GIST Cancer Research Fund (J.A.F.), the Life Raft Group (J.A.F., TO. and M.v.d.R.), the Cesarini Pan-Mass Challenge for GIST (J.A.F. and G.D.D.), Paul's Posse of the Pan-Mass Challenge (JAR and G.D.D.), the Bernard F. and Alva B. Gimbel Foundation (L.M.K.), the Sarcoma Alliance for Research Through Collaboration (A.M.-E.) and the Erica Kaitz LMS Research NOW Fund (J.A.F., A.M.-E. and G.D.D.).	Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chapdelaine P, 2000, PROTEIN ENG, V13, P611, DOI 10.1093/protein/13.9.611; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Fernandez K, 2010, AM J PATHOL, V176, P416, DOI 10.2353/ajpath.2010.090405; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Henze J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037776; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jakab Z, 2002, MED PEDIATR ONCOL, V39, P66, DOI 10.1002/mpo.10043; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Korner H, 2007, CELL CYCLE, V6, P189, DOI 10.4161/cc.6.2.3733; Li Y, 2007, ONCOGENE, V26, P6220, DOI 10.1038/sj.onc.1210432; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Ognjanovic S, 2012, CANCER-AM CANCER SOC, V118, P1387, DOI 10.1002/cncr.26390; Rossbach HC, 1999, J PEDIAT HEMATOL ONC, V21, P528, DOI 10.1097/00043426-199911000-00016; Rossi S, 2010, AM J SURG PATHOL, V34, P1480, DOI 10.1097/PAS.0b013e3181ef7431; Schmidt WM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002042; Schneider-Stock R, 2005, CLIN CANCER RES, V11, P638; Seto JT, 2012, CURR GENE THER, V12, P139; Tadayoni R, 2012, MOL NEUROBIOL, V45, P43, DOI 10.1007/s12035-011-8218-9; Tang Y, 2010, EXPERT OPIN BIOL TH, V10, P395, DOI 10.1517/14712591003604690; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wurl P, 1996, INT J CANCER, V69, P317	40	107	110	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					601	606		10.1038/ng.2974	http://dx.doi.org/10.1038/ng.2974			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24793134	Green Accepted, Green Submitted			2022-12-25	WOS:000336870700017
J	Falchi, M; El-Sayed Moustafa, JS; Takousis, P; Pesce, F; Bonnefond, A; Andersson-Assarsson, JC; Sudmant, PH; Dorajoo, R; Al-Shafai, MN; Bottolo, L; Ozdemir, E; So, HC; Davies, RW; Patrice, A; Dent, R; Mangino, M; Hysi, PG; Dechaume, A; Huyvaert, M; Skinner, J; Pigeyre, M; Caiazzo, R; Raverdy, V; Vaillant, E; Field, S; Balkau, B; Marre, M; Visvikis-Siest, S; Weill, J; Poulain-Godefroy, O; Jacobson, P; Sjostrom, L; Hammond, CJ; Deloukas, P; Sham, PC; McPherson, R; Lee, J; Tai, ES; Sladek, R; Carlsson, LMS; Walley, A; Eichler, EE; Pattou, F; Spector, TD; Froguel, P				Falchi, Mario; El-Sayed Moustafa, Julia Sarah; Takousis, Petros; Pesce, Francesco; Bonnefond, Amelie; Andersson-Assarsson, Johanna C.; Sudmant, Peter H.; Dorajoo, Rajkumar; Al-Shafai, Mashael Nedham; Bottolo, Leonardo; Ozdemir, Erdal; So, Hon-Cheong; Davies, Robert W.; Patrice, Alexandre; Dent, Robert; Mangino, Massimo; Hysi, Pirro G.; Dechaume, Aurelie; Huyvaert, Marlene; Skinner, Jane; Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Vaillant, Emmanuel; Field, Sarah; Balkau, Beverley; Marre, Michel; Visvikis-Siest, Sophie; Weill, Jacques; Poulain-Godefroy, Odile; Jacobson, Peter; Sjostrom, Lars; Hammond, Christopher J.; Deloukas, Panos; Sham, Pak Chung; McPherson, Ruth; Lee, Jeannette; Tai, E. Shyong; Sladek, Robert; Carlsson, Lena M. S.; Walley, Andrew; Eichler, Evan E.; Pattou, Francois; Spector, Timothy D.; Froguel, Philippe			Low copy number of the salivary amylase gene predisposes to obesity	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; EARLY-ONSET; SEGMENTAL DUPLICATIONS; HERITABILITY; POLYMORPHISM; MICROBIOTA; DELETIONS; VARIANTS; ACCURACY	Common multi-allelic copy number variants (CNVs) appear enriched for phenotypic associations compared to their biallelic counterparts(1-4). Here we investigated the influence of gene dosage effects on adiposity through a CNV association study of gene expression levels in adipose tissue. We identified significant association of a multi-allelic CNV encompassing the salivary amylase gene (AMY1) with body mass index (BMI) and obesity, and we replicated this finding in 6,200 subjects. Increased AMY1 copy number was positively associated with both amylase gene expression (P = 2.31 x 10(-14)) and serum enzyme levels (P < 2.20 x 10(-16)), whereas reduced AMY1 copy number was associated with increased BMI (change in BMI per estimated copy = -0.15 (0.02) kg/m(2); P = 6.93 x 10(-10)) and obesity risk (odds ratio (OR) per estimated copy = 1.19,95% confidence interval (Cl) = 1.13-1.26; P = 1.46 x 10(-10)). The OR value of 1.19 per copy of AMY1 translates into about an eightfold difference in risk of obesity between subjects in the top (copy number >9) and bottom (copy number < 4) 10% of the copy number distribution. Our study provides a first genetic link between carbohydrate metabolism and BMI and demonstrates the power of integrated genomic approaches beyond genome-wide association studies.	[El-Sayed Moustafa, Julia Sarah; Takousis, Petros; Pesce, Francesco; Andersson-Assarsson, Johanna C.; Dorajoo, Rajkumar; Al-Shafai, Mashael Nedham; Ozdemir, Erdal; Patrice, Alexandre; Walley, Andrew; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Pesce, Francesco] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat DETO, Renal Dialysis & Transplant Unit, Bari, Italy; [Bonnefond, Amelie; Dechaume, Aurelie; Huyvaert, Marlene; Vaillant, Emmanuel; Poulain-Godefroy, Odile; Froguel, Philippe] Lille Pasteur Inst, CNRS UMR 8199, Lille, France; [Bonnefond, Amelie; Dechaume, Aurelie; Huyvaert, Marlene; Pigeyre, Marie; Caiazzo, Robert; Vaillant, Emmanuel; Poulain-Godefroy, Odile; Pattou, Francois; Froguel, Philippe] Univ Lille 2, Lille, France; [Bonnefond, Amelie] QBRI, Doha, Qatar; [Bonnefond, Amelie; Patrice, Alexandre; Dechaume, Aurelie; Huyvaert, Marlene; Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Vaillant, Emmanuel; Poulain-Godefroy, Odile; Pattou, Francois; Froguel, Philippe] EGID, Lille, France; [Andersson-Assarsson, Johanna C.; Jacobson, Peter; Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Andersson-Assarsson, Johanna C.; Jacobson, Peter; Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Sudmant, Peter H.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Dorajoo, Rajkumar] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Al-Shafai, Mashael Nedham] Qatar Fdn, Div Res, Doha, Qatar; [Bottolo, Leonardo] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [So, Hon-Cheong; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Davies, Robert W.] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada; [Patrice, Alexandre; Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Pattou, Francois] INSERM UMR 859, Lille, France; [Patrice, Alexandre; Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Pattou, Francois] CHRU Lille, Lille, France; [Dent, Robert] Ottawa Hosp, Bariatr Program, Ottawa, ON, Canada; [Mangino, Massimo; Hysi, Pirro G.; Hammond, Christopher J.; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Skinner, Jane] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Field, Sarah; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Balkau, Beverley] Ctr Rech Epiderniol Sante Populat, INSERM U1018, Epidemiol Diabet Obes & Chron Kidney Dis Life Cou, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Paris 07, INSERM U695, Paris, France; [Visvikis-Siest, Sophie] Univ Lorraine, INSERM UMR Interact Gene Environm Physiopathol Ca, Nancy, France; [Weill, Jacques] Lille Teaching Hosp, Paediat Endocrine Unit, Lille, France; [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia; [McPherson, Ruth] Univ Ottawa, Inst Heart, Atherogen Lab, Ottawa, ON, Canada; [McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Lee, Jeannette; Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hosp Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hosp Syst, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Montreal, PQ, Canada; [Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Walley, Andrew] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Genom Med, London, England; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	Imperial College London; Universita degli Studi di Bari Aldo Moro; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); Universite de Lille - ISITE; Universite de Lille; University of Gothenburg; University of Gothenburg; University of Washington; University of Washington Seattle; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Qatar Foundation (QF); Imperial College London; University of Hong Kong; University of Ottawa; University of Ottawa Heart Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; University of Ottawa; Ottawa Hospital Research Institute; University of London; King's College London; University of East Anglia; Wellcome Trust Sanger Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; Universite de Lille - ISITE; CHU Lille; University of London; Queen Mary University London; King Abdulaziz University; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; National University of Singapore; National University of Singapore; National University of Singapore; McGill University; McGill University; McGill University; Imperial College London; Howard Hughes Medical Institute	Falchi, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England.	m.falchi@imperial.ac.uk; p.froguel@imperial.ac.uk	Pattou, Francois/O-6151-2017; Sladek, Robert/R-2391-2019; Mangino, Massimo/F-5134-2011; Carlsson, Lena/F-7570-2018; caiazzo, robert/Y-9692-2019; Pesce, Francesco/K-2695-2016; FROGUEL, Philippe/O-6799-2017; Visvikis-Siest, Sophie/H-2324-2014; Andersson-Assarsson, Johanna/M-2524-2019; Poulain-Godefroy, Odile/AAF-5474-2021; So, Hon-Cheong/I-1100-2016; Deloukas, Panos/B-2922-2013; Bonnefond, Amélie/O-2784-2017	Pattou, Francois/0000-0001-8388-3766; Sladek, Robert/0000-0002-2730-1204; Mangino, Massimo/0000-0002-2167-7470; Carlsson, Lena/0000-0003-4145-6242; caiazzo, robert/0000-0001-5383-0540; Pesce, Francesco/0000-0002-2882-4226; FROGUEL, Philippe/0000-0003-2972-0784; Visvikis-Siest, Sophie/0000-0001-8104-8425; Andersson-Assarsson, Johanna/0000-0001-9082-8589; Deloukas, Panos/0000-0001-9251-070X; Bonnefond, Amélie/0000-0001-9976-3005; Jacobson, Peter/0000-0002-1769-1827; Hysi, Pirro/0000-0001-5752-2510; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; Sudmant, Peter/0000-0002-9573-8248; Dorajoo, Rajkumar/0000-0001-6608-2051; Bottolo, Leonardo/0000-0002-6381-2327; Tai, E Shyong/0000-0003-2929-8966; Falchi, Mario/0000-0002-5646-1004; Marre, Michel/0000-0002-3071-1837; Takousis, Petros/0000-0003-1308-1412; Hammond, Christopher/0000-0002-3227-2620; Pigeyre, Marie/0000-0003-2984-8366; So, Hon-Cheong/0000-0002-7102-833X; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654	Wellcome Trust [079534/z/06/z, 085555, 077006/Z/05/Z]; Medical Research Council [K2010-55X-11285-13, MR/K01353X/1, G1002084/1]; Swedish Research Council; Swedish Foundation for Strategic Research; Swedish Diabetes Foundation; Swedish federal government under the LUA/ALF agreement; European Community's Seventh Framework Programme EUROCHIP project; British Skin Foundation [5044i]; Qatar Foundation (GEQATDIAB); Commission of the European Communities [115005, 294785]; Imperial College Healthcare National Health Service (NHS) Trust Biomedical Research Centre [P46304 WMDI]; INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofi-Aventis; NSEAM (Reseaux en Sante Publique, Interactions entre les Determinants de la Sante); Cohortes Sante TGIR; Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; Canada Foundation of Innovation; Ontario Innovation Trust; Canadian Institutes of Health Research; Genome Canada/Ontario Genomics Institute; McLaughlin Centre for Molecular Medicine; Ontario Ministry of Research and Innovation; Hospital for Sick Children Foundation; Department of Pathology at Brigham and Women's Hospital; US National Institutes of Health [HG004221, GM081533]; GWAS; Wellcome Trust Sanger Centre; National Eye Institute via a US National Institutes of Health/Center for Inherited Disease Research (CIDR); European Community's Seventh Framework Programme; ENGAGE project [HEALTH-F4-2007-201413]; National Institute for Health Research (NIHR) BioResource Clinical Research Facility; Biomedical Research Centre; St Thomas' NHS Foundation Trust; King's College London; Biotechnology and Biological Sciences Research Council (BBSRC) [G20234]; Lille University Hospital; INSERM (Centre &Investigation Clinique de Lille); Conseil Regional Nord-Pas de Calais (ARCIR Obesite); European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) [ALTF 72-2010]; Research Division of the Qatar Foundation; Chercheur Boursier award from the Fonds de la Recherche en Sante du Quebec; MRC [MR/K01353X/1, G1002084] Funding Source: UKRI; Medical Research Council [G1002084] Funding Source: researchfish; National Institute for Health Research [SRF/01/010] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081533] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Swedish federal government under the LUA/ALF agreement; European Community's Seventh Framework Programme EUROCHIP project; British Skin Foundation; Qatar Foundation (GEQATDIAB)(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Commission of the European Communities(European Commission); Imperial College Healthcare National Health Service (NHS) Trust Biomedical Research Centre; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); NSEAM (Reseaux en Sante Publique, Interactions entre les Determinants de la Sante); Cohortes Sante TGIR; Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; Canada Foundation of Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Ontario Genomics Institute(Genome Canada); McLaughlin Centre for Molecular Medicine; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Hospital for Sick Children Foundation; Department of Pathology at Brigham and Women's Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GWAS; Wellcome Trust Sanger Centre(Wellcome Trust); National Eye Institute via a US National Institutes of Health/Center for Inherited Disease Research (CIDR); European Community's Seventh Framework Programme(European Commission); ENGAGE project(General Electric); National Institute for Health Research (NIHR) BioResource Clinical Research Facility(National Institute for Health Research (NIHR)); Biomedical Research Centre; St Thomas' NHS Foundation Trust; King's College London(General Electric); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lille University Hospital; INSERM (Centre &Investigation Clinique de Lille); Conseil Regional Nord-Pas de Calais (ARCIR Obesite)(Region Hauts-de-France); European Renal Association-European Dialysis and Transplant Association (ERA-EDTA); Research Division of the Qatar Foundation(Qatar Foundation (QF)); Chercheur Boursier award from the Fonds de la Recherche en Sante du Quebec; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Wellcome Trust (grants 079534/z/06/z and 085555), the Medical Research Council (K2010-55X-11285-13), the Swedish Research Council, the Swedish Foundation for Strategic Research to the Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Diabetes Foundation and the Swedish federal government under the LUA/ALF agreement and by the European Community's Seventh Framework Programme (FP7/2007-2013) EUROCHIP project. M.F. is supported by the Medical Research Council (MR/K01353X/1), the British Skin Foundation (5044i), Qatar Foundation (GEQATDIAB) and the Commission of the European Communities (115005). P.F. is supported by the Medical Research Council (G1002084/1), the Imperial College Healthcare National Health Service (NHS) Trust Biomedical Research Centre (P46304 WMDI), the Commission of the European Communities (294785) and the Qatar Foundation (GEQATDIAB).; The DESIR study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma and Sanofi-Aventis and by INSEAM (Reseaux en Sante Publique, Interactions entre les Determinants de la Sante), Cohortes Sante TGIR, Association Diabete Risque Vasculaire, Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon.; This study makes use of data generated by the Genome Structural Variation Consortium (principal investigators N. Carter, M. Hurles, C. Lee and S. Scherer) who we thank for pre-publication access to their CNV discovery (and/or) genotyping data, made available through the websites http://www.sanger.ac.uk/research/areas/humangenetics/cnv/ and http://dgv.tcag.ca/dgv/app/home as a resource to the community. Funding for the project was provided by the Wellcome Trust (grant 077006/Z/05/Z), the Canada Foundation of Innovation and the Ontario Innovation Trust, the Canadian Institutes of Health Research, the Genome Canada/Ontario Genomics Institute, the McLaughlin Centre for Molecular Medicine, the Ontario Ministry of Research and Innovation, the Hospital for Sick Children Foundation, the Department of Pathology at Brigham and Women's Hospital and US National Institutes of Health grants HG004221 and GM081533.; TwinsUK was funded by the Wellcome Trust; the authors acknowledge funding of the GWAS with the support of the Wellcome Trust Sanger Centre and the National Eye Institute via a US National Institutes of Health/Center for Inherited Disease Research (CIDR) genotyping project grant (principal investigator T. Young); also the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413. The study also receives support from the National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). The ABOS study was partially supported by Lille University Hospital and INSERM (Centre &Investigation Clinique de Lille) and by grants from Conseil Regional Nord-Pas de Calais (ARCIR Obesite).; F. Peace was supported by a fellowship from the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA; ALTF 72-2010). M.N.A.-S. is supported by a PhD scholarship from the Research Division of the Qatar Foundation. R.S. is a recipient of a Chercheur Boursier award from the Fonds de la Recherche en Sante du Quebec and a New Investigator Award from-the Canadian Institutes of Health Research. RD. is supported by the Wellcome Trust. T.D.S. is in receipt of an NIHR Senior Investigator award and a European Research Council Senior Researcher award.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Balkau B, 1997, DIABETES METAB, V23, P428; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Carpenter D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-418; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Eleftherohorinou H, 2011, BIOINFORMATICS, V27, P1873, DOI 10.1093/bioinformatics/btr264; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2012, METHODS MOL BIOL, V838, P187, DOI 10.1007/978-1-61779-507-7_9; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; KONDO T, 1988, INT J PANCREATOL, V3, P241; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mandel AL, 2012, J NUTR, V142, P853, DOI 10.3945/jn.111.156984; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; MIFFLIN TE, 1986, CLIN LAB MED, V6, P583, DOI 10.1016/S0272-2712(18)30802-3; Mirski A, 1942, BIOCHEM J, V36, P232, DOI 10.1042/bj0360232; Nakajima Kei, 2011, BMC Res Notes, V4, P419, DOI 10.1186/1756-0500-4-419; Nakajima K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-34; PARK KS, 1977, JPN J HUM GENET, V22, P79, DOI 10.1007/BF01874272; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; SCHNEEMAN BO, 1983, J NUTR, V113, P921, DOI 10.1093/jn/113.4.921; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SQUIRES BT, 1953, J PHYSIOL-LONDON, V119, P153, DOI 10.1113/jphysiol.1953.sp004835; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Walley AJ, 2012, INT J OBESITY, V36, P137, DOI 10.1038/ijo.2011.22; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	44	151	159	1	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					492	497		10.1038/ng.2939	http://dx.doi.org/10.1038/ng.2939			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686848	Green Submitted, Green Accepted			2022-12-25	WOS:000335422900018
J	Nik-Zainal, S; Wedge, DC; Alexandrov, LB; Petljak, M; Butler, AP; Bolli, N; Davies, HR; Knappskog, S; Martin, S; Papaemmanuil, E; Ramakrishna, M; Shlien, A; Simonic, I; Xue, YL; Tyler-Smith, C; Campbell, PJ; Stratton, MR				Nik-Zainal, Serena; Wedge, David C.; Alexandrov, Ludmil B.; Petljak, Mia; Butler, Adam P.; Bolli, Niccolo; Davies, Helen R.; Knappskog, Stian; Martin, Sancha; Papaemmanuil, Eli; Ramakrishna, Manasa; Shlien, Adam; Simonic, Ingrid; Xue, Yali; Tyler-Smith, Chris; Campbell, Peter J.; Stratton, Michael R.			Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer	NATURE GENETICS			English	Article							SOMATIC HYPERMUTATION; CYTIDINE DEAMINASES; DNA; DELETION; MUTAGENESIS; SIGNATURES; CONTEXT	The somatic mutations in a cancer genome are the aggregate outcome of one or more mutational processes operative through the lifetime of the individual with cancer(1-3). Each mutational process leaves a characteristic mutational signature determined by the mechanisms of DNA damage and repair that constitute it. A role was recently proposed for the APOBEC family of cytidine deaminases in generating particular genome-wide mutational signatures(1,4) and a signature of localized hypermutation called kataegis1,4. A germline copy number polymorphism involving APOBEC3A and APOBEC3B, which effectively deletes APOBEC3B(5), has been associated with modestly increased risk of breast cancer(6-8). Here we show that breast cancers in carriers of the deletion show more mutations of the putative APOBEC-dependent genome-wide signatures than cancers in non-carriers. The results suggest that the APOBEC3A-APOBEC3B germline deletion allele confers cancer susceptibility through increased activity of APOBEC-dependent mutational processes, although the mechanism by which this increase in activity occurs remains unknown.	[Nik-Zainal, Serena; Wedge, David C.; Alexandrov, Ludmil B.; Petljak, Mia; Butler, Adam P.; Bolli, Niccolo; Davies, Helen R.; Martin, Sancha; Papaemmanuil, Eli; Ramakrishna, Manasa; Shlien, Adam; Xue, Yali; Tyler-Smith, Chris; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton, England; [Nik-Zainal, Serena] Addenbrookes Hosp, Natl Hlth Serv NHS Trust, Dept Med Genet, Cambridge, England; [Bolli, Niccolo; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Sect Oncol, Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Shlien, Adam] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Simonic, Ingrid] Cambridge Univ Hosp NHS Fdn Trust, Reg Genet Labs, Cambridge, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Bergen; University of Bergen; Haukeland University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	mrs@sanger.ac.uk	Bolli, Niccolo/D-4057-2011; Nik-Zainal, Serena/ABD-4437-2020; Wedge, David/AAC-4977-2021; Alexandrov, Ludmil/AAS-1454-2021	Bolli, Niccolo/0000-0002-1018-5139; Alexandrov, Ludmil/0000-0003-3596-4515; Martin, Sancha/0000-0001-6213-5259; Nik-Zainal, Serena/0000-0001-5054-1727; Knappskog, Stian/0000-0002-4153-1655; Wedge, David/0000-0002-7572-3196	Wellcome Trust [098051, WT100183MA, WT088340MA]; Academy of Medical Sciences; National Research Council Canada; EMBO (European Molecular Biology Organization); Breakthrough Breast Cancer Research [ICGC 08/09]; BASIS project; European Community's Seventh Framework Programme [242006]	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); National Research Council Canada; EMBO (European Molecular Biology Organization)(European Molecular Biology Organization (EMBO)); Breakthrough Breast Cancer Research; BASIS project; European Community's Seventh Framework Programme(European Commission)	We would like to thank M. Hurles and C. Anderson of the Wellcome Trust Sanger Institute for their input. We would like to thank The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) for access to the mutation catalogs used in Alexandrov et al.<SUP>9</SUP> and for access to BAM files. We would like to thank the Wellcome Trust for support (grant 098051). S.N.-Z. is a Wellcome-Beit Prize Fellow and is supported through a Wellcome Trust Intermediate Fellowship (grant WT100183MA). P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant WT088340MA). N.B. is a European Hematology Association (EHA) fellow and is supported by a starter grant from the Academy of Medical Sciences. The H.L. Holmes Award from National Research Council Canada and an EMBO (European Molecular Biology Organization) Fellowship support A.S. We would also like to acknowledge funding from Breakthrough Breast Cancer Research (ICGC 08/09) and the BASIS project, funded by the European Community's Seventh Framework Programme (FP7/2010-2014) under grant agreement 242006. This study was performed within the Research Ethics Approval of 09/h0306/36.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; Holtz CM, 2013, NUCLEIC ACIDS RES, V41, P6139, DOI 10.1093/nar/gkt246; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Koito Atsushi, 2011, Mob Genet Elements, V1, P197; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nowarski R, 2013, CANCER RES, V73, P3494, DOI 10.1158/0008-5472.CAN-13-0728; Nowarski R, 2012, BLOOD, V120, P366, DOI 10.1182/blood-2012-01-402123; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Petit V, 2009, PHILOS T R SOC B, V364, P705, DOI 10.1098/rstb.2008.0272; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suspene R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063461; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185	30	194	200	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					487	491		10.1038/ng.2955	http://dx.doi.org/10.1038/ng.2955			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24728294	Green Accepted, Green Submitted			2022-12-25	WOS:000335422900017
J	Schauer, C; Janko, C; Munoz, LE; Zhao, Y; Kienhofer, D; Frey, B; Lell, M; Manger, B; Rech, J; Naschberger, E; Holmdahl, R; Krenn, V; Harrer, T; Jeremic, I; Bilyy, R; Schett, G; Hoffmann, M; Herrmann, M				Schauer, Christine; Janko, Christina; Munoz, Luis E.; Zhao, Yi; Kienhoefer, Deborah; Frey, Benjamin; Lell, Michael; Manger, Bernhard; Rech, Juergen; Naschberger, Elisabeth; Holmdahl, Rikard; Krenn, Veit; Harrer, Thomas; Jeremic, Ivica; Bilyy, Rostyslav; Schett, Georg; Hoffmann, Markus; Herrmann, Martin			Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines	NATURE MEDICINE			English	Article							MONOSODIUM URATE; SYNOVIAL-FLUID; IDENTIFICATION; ARTHRITIS; ACTIVATE; MUTATION; RELEASE; OXIDASE; SIGNAL; NCF1	Gout is characterized by an acute inflammatory reaction and the accumulation of neutrophils in response to monosodium urate (MSU) crystals. Inflammation resolves spontaneously within a few days, although MSU crystals can still be detected in the synovial fluid and affected tissues. Here we report that neutrophils recruited to sites of inflammation undergo oxidative burst and form neutrophil extracellular traps (NETs). Under high neutrophil densities, these NETs aggregate and degrade cytokines and chemokines via serine proteases. Tophi, the pathognomonic structures of chronic gout, share characteristics with aggregated NETs, and MSU crystals can induce NETosis and aggregation of NETs. In individuals with impaired NETosis, MSU crystals induce uncontrolled production of inflammatory mediators from neutrophils and persistent inflammation. Furthermore, in models of neutrophilic inflammation, NETosis-deficient mice develop exacerbated and chronic disease that can be reduced by adoptive transfer of aggregated NETs. These findings suggest that aggregated NETs promote the resolution of neutrophilic inflammation by degrading cytokines and chemokines and disrupting neutrophil recruitment and activation.	[Schauer, Christine; Janko, Christina; Munoz, Luis E.; Zhao, Yi; Kienhoefer, Deborah; Manger, Bernhard; Rech, Juergen; Harrer, Thomas; Jeremic, Ivica; Schett, Georg; Hoffmann, Markus; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Janko, Christina] Univ Hosp Erlangen, SEON, Dept Otorhinolaryngol Head & Neck Surg, Erlangen, Germany; [Zhao, Yi] Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, Chengdu 610064, Peoples R China; [Frey, Benjamin] Univ Hosp Erlangen, Dept Radiat Oncol, Erlangen, Germany; [Lell, Michael] Univ Erlangen Nurnberg, Dept Radiol, D-91054 Erlangen, Germany; [Naschberger, Elisabeth] Univ Erlangen Med Ctr, Div Mol & Expt Surg, Dept Surg, Erlangen, Germany; [Holmdahl, Rikard] Karolinska Inst, Div Med Inflammat Res, Dept Med Biochem & Biophys, Stockholm, Sweden; [Krenn, Veit] MVZ Pathol, Dept Pathol, Trier, Germany; [Jeremic, Ivica] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia; [Bilyy, Rostyslav] Natl Acad Sci Ukraine, Inst Cell Biol, Lvov, Ukraine	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Sichuan University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Karolinska Institutet; University of Belgrade; National Academy of Sciences Ukraine; Institute of Cell Biology of NASU	Hoffmann, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany.	markus.hoffmann@uk-erlangen.de	Bilyy, Rostyslav/A-9777-2010; Manger, Bernhard/L-5061-2013; Holmdahl, Rikard/AAI-7682-2020; Bilyy, Rostyslav/AAH-9636-2020; Munoz, Luis E/E-7725-2010; Frey, Benjamin/D-9565-2017; Naschberger, Elisabeth/AAV-5289-2021; Herrmann, Martin/A-9597-2013; herrmann, martin/AAT-9836-2020	Bilyy, Rostyslav/0000-0002-2344-1349; Manger, Bernhard/0000-0003-2375-0069; Bilyy, Rostyslav/0000-0002-2344-1349; Munoz, Luis E/0000-0002-5395-804X; Frey, Benjamin/0000-0001-6743-3351; Naschberger, Elisabeth/0000-0003-1291-622X; Herrmann, Martin/0000-0002-0258-2484; Janko, Christina/0000-0001-5705-6329	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg [A41, J41]; Masterswitch project of the European Union; SPP1468-IMMUNOBONE; Deutsche Forschungsgemeinschaft (DFG) [GK SFB 643]; Emerging Fields Initiative (EFI) of the Friedrich-Alexander-Universitat (FAU) Erlangen-Nuremberg; K. und R. Wucherpfennigstiftung; Deutsche Krebshilfe [AZ 109510]; European Commissions (DoReMi, European Network of Excellence) [249689]; German Research Foundation [GA 1507/1-1]; Swedish Science Strategic foundation; EU FP7 project Neurinox; Austrian Science Fund FWF [J3102-B13];  [SFB 643]; Austrian Science Fund (FWF) [J 3102] Funding Source: researchfish	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg; Masterswitch project of the European Union; SPP1468-IMMUNOBONE; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Emerging Fields Initiative (EFI) of the Friedrich-Alexander-Universitat (FAU) Erlangen-Nuremberg; K. und R. Wucherpfennigstiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); European Commissions (DoReMi, European Network of Excellence); German Research Foundation(German Research Foundation (DFG)); Swedish Science Strategic foundation; EU FP7 project Neurinox; Austrian Science Fund FWF(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg, projects A41 and J41 (C.S., L.E.M. and Martin Herrmann), the Masterswitch project of the European Union (G.S. and Martin Herrmann), SPP1468-IMMUNOBONE (Markus Hoffmann and Martin Herrmann), SFB 643 (L.E.M.), training grant GK SFB 643 from the Deutsche Forschungsgemeinschaft (DFG) (C.S. and C.J.), the Emerging Fields Initiative (EFI) of the Friedrich-Alexander-Universitat (FAU) Erlangen-Nuremberg (L.E.M.) and the K. und R. Wucherpfennigstiftung (Martin Herrmann). E.N. was supported by the Deutsche Krebshilfe AZ 109510. B.F. was supported by the European Commissions (DoReMi, European Network of Excellence, contract number 249689) and the German Research Foundation (GA 1507/1-1). R.H. was supported by the Swedish Science Strategic foundation and the EU FP7 project Neurinox. Markus Hoffmann was funded by the Austrian Science Fund FWF (project J3102-B13). We thank K. Wing, Karolinska Institutet, for genotyping of mice.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Beyer C, 2013, AUTOIMMUNITY, V46, P298, DOI 10.3109/08916934.2012.750297; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Choi HK, 2009, ANN RHEUM DIS, V68, P1609, DOI 10.1136/ard.2008.099713; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gresnigt MS, 2012, J IMMUNOL, V189, P4806, DOI 10.4049/jimmunol.1103551; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Manger B, 2012, ANN RHEUM DIS, V71, P470, DOI 10.1136/ard.2011.154054; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Pascual E, 1999, ANN INTERN MED, V131, P756, DOI 10.7326/0003-4819-131-10-199911160-00007; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scanu A, 2012, ANN RHEUM DIS, V71, P621, DOI 10.1136/annrheumdis-2011-200711; Schorn C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00376; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Schorn C, 2010, AUTOIMMUNITY, V43, P236, DOI 10.3109/08916930903510948; Shah K, 2007, J EMERG MED, V32, P23, DOI 10.1016/j.jemermed.2006.07.019; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; So A, 2007, Z RHEUMATOL, V66, P562, DOI 10.1007/s00393-007-0215-z; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	37	537	577	13	131	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					511	517		10.1038/nm.3547	http://dx.doi.org/10.1038/nm.3547			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24784231				2022-12-25	WOS:000335710700022
J	Shi, JX; Yang, XHR; Ballew, B; Rotunno, M; Calista, D; Fargnoli, MC; Ghiorzo, P; Paillerets, BBD; Nagore, E; Avri, MF; Caporaso, NE; McMaster, ML; Cullen, M; Wang, ZM; Zhang, XJ; Bruno, W; Pastorino, L; Queirolo, P; Banuls-Roca, J; Garcia-Casado, Z; Vaysse, A; Mohamdi, H; Riazalhosseini, Y; Foglio, M; Jouenne, F; Hual, X; Hyland, PL; Yin, JH; Vallabhaneni, H; Chai, WH; Minghetti, P; Pellegrini, C; Ravichandran, S; Eggermont, A; Lathrop, M; Peris, K; Scarra, GB; Landi, G; Savage, SA; Sampson, JN; He, J; Yeager, M; Goldin, LR; Demenais, F; Chanockl, SJ; Tucker, MA; Goldsteinl, AM; Liu, Y; Landi, MT				Shi, Jianxin; Yang, Xiaohong R.; Ballew, Bari; Rotunno, Melissa; Calista, Donato; Fargnoli, Maria Concetta; Ghiorzo, Paola; Paillerets, Brigitte Bressac-de; Nagore, Eduardo; Avri, Marie Francoise; Caporaso, Neil E.; McMaster, Mary L.; Cullen, Michael; Wang, Zhaoming; Zhang, Xijun; Bruno, William; Pastorino, Lorenza; Queirolo, Paola; Banuls-Roca, Jose; Garcia-Casado, Zaida; Vaysse, Amaury; Mohamdi, Hamida; Riazalhosseini, Yasser; Foglio, Mario; Jouenne, Fanelie; Hual, Xing; Hyland, Paula L.; Yin, Jinhu; Vallabhaneni, Haritha; Chai, Weihang; Minghetti, Paola; Pellegrini, Cristina; Ravichandran, Sarangan; Eggermont, Alexander; Lathrop, Mark; Peris, Ketty; Scarra, Giovanna Bianchi; Landi, Giorgio; Savage, Sharon A.; Sampson, Joshua N.; He, Ji; Yeager, Meredith; Goldin, Lynn R.; Demenais, Florence; Chanockl, Stephen J.; Tucker, Margaret A.; Goldsteinl, Alisa M.; Liu, Yie; Landi, Maria Teresa		NCI DCEG Canc Sequencing Working G; NCI DCEG Canc Genomics Res Lab; French Familial Melanoma Study Grp	Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma	NATURE GENETICS			English	Article							SINGLE-STRANDED-DNA; TELOMERE REPLICATION; MAMMALIAN TELOMERES; GERMLINE MUTATIONS; CDKN2A MUTATIONS; CANCER; TRF1; RECOGNITION; COMPLEX; DOMAIN	Although CDKN2A is the most frequent high-risk melanoma susceptibility gene, the underlying genetic factors for most melanoma-prone families remain unknown. Using whole-exome sequencing, we identified a rare variant that arose as a founder mutation in the telomere shelterin gene POT1 (chromosome 7, g.124493086C>T; p.Ser270Asn) in five unrelated melanomaprone families from Romagna, Italy. Carriers of this variant had increased telomere lengths and numbers of fragile telomeres, suggesting that this variant perturbs telomere maintenance. Two additional rare POT1 variants were identified in all cases sequenced in two separate Italian families, one variant per family, yielding a frequency for POT1 variants comparable to that for CDKN2A mutations in this population. These variants were not found in public databases or in 2,038 genotyped Italian controls. We also identified two rare recurrent POT1 variants in US and French familial melanoma cases. Our findings suggest that POT1 is a major susceptibility gene for familial melanoma in several populations.	[Shi, Jianxin; Yang, Xiaohong R.; Ballew, Bari; Rotunno, Melissa; Caporaso, Neil E.; McMaster, Mary L.; Cullen, Michael; Wang, Zhaoming; Zhang, Xijun; Hual, Xing; Hyland, Paula L.; Eggermont, Alexander; Savage, Sharon A.; Sampson, Joshua N.; He, Ji; Yeager, Meredith; Goldin, Lynn R.; Chanockl, Stephen J.; Tucker, Margaret A.; Goldsteinl, Alisa M.; Liu, Yie; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Calista, Donato; Minghetti, Paola; Landi, Giorgio] Maurizio Bufalini Hosp, Dept Dermatol, Cesena, Italy; [Fargnoli, Maria Concetta; Peris, Ketty] Univ Aquila, Dept Dermatol, I-67100 Laquila, Italy; [Ghiorzo, Paola; Bruno, William; Pastorino, Lorenza; Scarra, Giovanna Bianchi] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Ghiorzo, Paola; Bruno, William; Pastorino, Lorenza; Queirolo, Paola] San Martino IST Ist Nazl Is Ric Cancro, IRCCS, Genoa, Italy; [Paillerets, Brigitte Bressac-de; Jouenne, Fanelie; Eggermont, Alexander] Serv Genet, Villejuif, France; [Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain; [Nagore, Eduardo] Univ Catolica Valencia, Dept Dermatol, Valencia, Spain; [Avri, Marie Francoise] Univ Paris 05, AP HP, Hop Cochin, Paris, France; [Cullen, Michael; Wang, Zhaoming; Zhang, Xijun; He, Ji; Yeager, Meredith] SAIC Frederick Inc, NCI Frederick, Canc Genom Res Lab, Frederick, MD USA; [Banuls-Roca, Jose] Gen Hosp Univ Alicante, Dept Dermatol, E-03080 Alicante, Spain; [Garcia-Casado, Zaida] Inst Valenciano Oncol, Lab Mol Biol, Valencia, Spain; [Vaysse, Amaury; Mohamdi, Hamida; Demenais, Florence] INSERM, Genet Variat & Human Dis Unit, UMR 946, Paris, France; [Vaysse, Amaury; Mohamdi, Hamida; Demenais, Florence] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France; [Riazalhosseini, Yasser; Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Riazalhosseini, Yasser; Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Riazalhosseini, Yasser; Lathrop, Mark] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Foglio, Mario] SAS Quantome, Paris, France; [Yin, Jinhu; Vallabhaneni, Haritha] NIA, Lab Mol Gerontol, US Natl Inst Hlth, US Dept HHS, Baltimore, MD 21224 USA; [Chai, Weihang] Washington State Univ, Sch Mol Biosci, Sect Med Sci, Spokane, WA USA; [Pellegrini, Cristina] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Ravichandran, Sarangan] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Simulat Anal & Math Modeling Grp, Adv Biomed Comp Ctr, Frederick, MD USA; [Eggermont, Alexander] Univ Paris 11, Kremlin Bicetre France, Villejuif, France; [Lathrop, Mark] Fondat Jean Dausset Ctr Etude Polymorphisme Humai, Paris, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ospedale Maurizio Bufalini; University of L'Aquila; University of Genoa; Instituto Valenciano De Oncologia; Universidad Catolica de Valencia San Vicente Martir; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; General University Hospital of Alicante; Instituto Valenciano De Oncologia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Washington State University; University of L'Aquila; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; UDICE-French Research Universities; Universite Paris Saclay	Landi, MT (corresponding author), NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Bruno, William/N-7477-2013; Savage, Sharon/AAB-5160-2019; Demenais, Florence/G-3298-2013; Foglio, mary A./B-9149-2012; Queirolo, Paola/K-6778-2016; Pellegrini, Cristina/F-7175-2017; Garcia-Casado, Zaida/Z-2125-2019; Chai, Weihang/AAG-5194-2021; Pastorino, Lorenza/E-6084-2018; Tucker, Margaret A/B-4297-2015; Yeager, Meredith/AAA-5322-2020; Paillerets, Brigitte Bressac-de/D-8954-2018; Calista, Donato/AAM-1567-2020; Liu, Yie/AAO-2092-2020; Nagore, Eduardo/Z-2126-2019; Ghiorzo, Paola/CAG-0673-2022; Savage, Sharon A/B-9747-2015; Wang, Zhaoming/R-5527-2018; Tobias, Geoffrey S/M-4135-2016; Scarrà, Giovanna Bianchi/G-8933-2014	Bruno, William/0000-0002-0337-0168; Savage, Sharon/0000-0001-6006-0740; Demenais, Florence/0000-0001-8361-0936; Foglio, mary A./0000-0001-7715-4452; Queirolo, Paola/0000-0002-9917-6633; Pellegrini, Cristina/0000-0003-2168-8097; Pastorino, Lorenza/0000-0002-2575-8331; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Nagore, Eduardo/0000-0003-3433-8707; Ghiorzo, Paola/0000-0002-3651-8173; Savage, Sharon A/0000-0001-6006-0740; Wang, Zhaoming/0000-0001-7556-3869; Tobias, Geoffrey S/0000-0002-2878-8253; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; GARCIA-CASADO, ZAIDA/0000-0001-6592-6099; Vaysse, Amaury/0000-0003-2397-4230; Peris, Ketty/0000-0002-5237-0463; Fargnoli, Maria Concetta/0000-0002-7249-2556	Intramural Research Program of the US National Institutes of Health (NIH); National Cancer Institute (NCI); Division of Cancer Epidemiology; National Institute on Aging (NIA); Division of Molecular Gerontology; Universita degli Studi di Genova Progetti di Ricerca di Ateneo PRA; IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro; 5 per 1000 per la Ricerca Corrente; Programme Hospitaller de Recherche Clinique [AOM-07-195]; Ligue Nationale Contre le Cancer [PRE 09/FD]; Genome Quebec, le Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie (MESRST) du Quebec; McGill University; US NIH, NCI [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIACP004410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000744] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division of Molecular Gerontology; Universita degli Studi di Genova Progetti di Ricerca di Ateneo PRA; IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro; 5 per 1000 per la Ricerca Corrente; Programme Hospitaller de Recherche Clinique; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Genome Quebec, le Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie (MESRST) du Quebec; McGill University; US NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the US National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and National Institute on Aging (NIA), Division of Molecular Gerontology. The samples from the Institut Valenciano de Oncologia were retrieved from the Biobanco del Instituto Valenciano de Oncologia. The Genoa collection was partly supported by Universita degli Studi di Genova Progetti di Ricerca di Ateneo PRA 2012-2013 and IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, 5 per 1000 per la Ricerca Corrente. The French MELARISK collection was partly supported by Programme Hospitaller de Recherche Clinique (AOM-07-195) and Ligue Nationale Contre le Cancer (PRE 09/FD). We acknowledge the contribution of Institut Gustave-Roussy (IGR) Biobank and Fondation Jean Dausset-CEPH Biobank in providing samples for melanoma-prone families or individual's. The exome sequencing of French samples was supported by a grant from Genome Quebec, le Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie (MESRST) du Quebec and McGill University. This project has also been funded in part with federal funds from the US NIH, NCI, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; Classen S, 2001, J MOL BIOL, V314, P1113, DOI 10.1006/jmbi.2000.5191; Eliason MJ, 2006, J INVEST DERMATOL, V126, P660, DOI 10.1038/sj.jid.5700094; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Goldstein AM, 2004, HUM MUTAT, V23, P630, DOI 10.1002/humu.9247; Goldstein AM, 2001, ARCH DERMATOL, V137, P1493; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Kendellen MF, 2009, MOL CELL BIOL, V29, P5611, DOI 10.1128/MCB.00286-09; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Puntervoll HE, 2013, J MED GENET, V50, P264, DOI 10.1136/jmedgenet-2012-101455; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Taboski MAS, 2012, CELL REP, V1, P91, DOI 10.1016/j.celrep.2011.12.004; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Theobald DL, 2003, EMBO J, V22, P4314, DOI 10.1093/emboj/cdg415; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	30	214	219	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					482	486		10.1038/ng.2941	http://dx.doi.org/10.1038/ng.2941			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24686846	Green Accepted			2022-12-25	WOS:000335422900016
J	Sevin, DC; Sauer, U				Sevin, Daniel C.; Sauer, Uwe			Ubiquinone accumulation improves osmotic-stress tolerance in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							CHAIN-LENGTH; MEMBRANE; TREHALOSE; OSMOREGULATION; BIOSYNTHESIS; EXPRESSION; TRANSPORT; RESPONSES; PRESSURE; MUTANTS	Bacteria are thought to cope with fluctuating environmental solute concentrations primarily by adjusting the osmolality of their cytoplasm. To obtain insights into the underlying metabolic adaptations, we analyzed the global metabolic response of Escherichia coli to sustained hyperosmotic stress using nontargeted mass spectrometry. We observed that 52% of 1,071 detected metabolites, including known osmoprotectants, changed abundance with increasing salt challenge. Unexpectedly, unsupervised data analysis showed a substantial increase of most intermediates in the ubiquinone-8 (Q8) biosynthesis pathway and a 110-fold accumulation of Q8 itself, as confirmed by quantitative lipidomics. We then demonstrated that Q8 is necessary for acute and sustained osmotic-stress tolerance using Q8 mutants and tolerance rescue through feeding nonrespiratory Q8 analogs. Finally, in vitro experiments with artificial liposomes showed that mechanical membrane stabilization is a principal mechanism of Q8-mediated osmoprotection. Thus, we find that besides regulating intracellular osmolality, E. coli enhances its cytoplasmic membrane stability to withstand osmotic stress.	[Sevin, Daniel C.; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Sevin, Daniel C.] Life Sci Zurich, PhD Program Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sevin, DC (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	sauer@ethz.ch			MetaNetX project of the Swiss Initiative for Systems Biology	MetaNetX project of the Swiss Initiative for Systems Biology	We thank N.Zamboni for advice and assistance with MS/MS analyses, A. Kuhne for assistance with microscopy and K. Kochanowski and T. Fuhrer for helpful discussions. Funding was provided by the MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch; http://metanetx.org/) evaluated by the Swiss National Science Foundation, and the Swiss Federal Government through the Federal Office of Education and Science.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balsalobre C, 2006, J BACTERIOL, V188, P5935, DOI 10.1128/JB.00235-06; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; DEROSA M, 1986, MICROBIOL REV, V50, P70, DOI 10.1128/MMBR.50.1.70-80.1986; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Gasser DL, 2013, AM J PHYSIOL-RENAL, V305, pF1228, DOI 10.1152/ajprenal.00143.2013; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GROTHE S, 1986, J BACTERIOL, V166, P253, DOI 10.1128/jb.166.1.253-259.1986; GRUSZECKI WI, 1992, J BIOL PHYS, V18, P271; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Horta BAC, 2010, J MOL GRAPH MODEL, V29, P331, DOI 10.1016/j.jmgm.2010.09.013; HOUSSIN C, 1991, BIOCHIM BIOPHYS ACTA, V1056, P76, DOI 10.1016/S0005-2728(05)80075-1; Jacquemet A, 2009, BIOCHIMIE, V91, P711, DOI 10.1016/j.biochi.2009.01.006; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; KALIR A, 1981, ANN BOT-LONDON, V47, P75, DOI 10.1093/oxfordjournals.aob.a086002; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; Kankainen M, 2011, BIOINFORMATICS, V27, P1878, DOI 10.1093/bioinformatics/btr278; Karlsson M, 2000, ANAL CHEM, V72, P5857, DOI 10.1021/ac0003246; KATSIKAS H, 1982, BIOCHIM BIOPHYS ACTA, V689, P363, DOI 10.1016/0005-2736(82)90270-X; KLEIN W, 1991, RES MICROBIOL, V142, P359, DOI 10.1016/0923-2508(91)90105-J; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Konings WN, 2002, ANTON LEEUW INT J G, V81, P61, DOI 10.1023/A:1020573408652; Kramer R, 2010, CHEM REC, V10, P217, DOI 10.1002/tcr.201000005; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Landis L, 1999, GENE DEV, V13, P3081, DOI 10.1101/gad.13.23.3081; Ma Y, 2013, J BIOMED MATER RES A, V101, P1007, DOI 10.1002/jbm.a.34395; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Paturej J., 2012, PREPRINT; Pereira CS, 2008, BIOPHYS J, V95, P3525, DOI 10.1529/biophysj.108.131656; Pilizota T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035205; Piuri M, 2005, J APPL MICROBIOL, V98, P84, DOI 10.1111/j.1365-2672.2004.02428.x; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Roche Y, 2006, BBA-BIOMEMBRANES, V1758, P468, DOI 10.1016/j.bbamem.2006.03.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen B, 1999, PLANT PHYSIOL, V121, P45, DOI 10.1104/pp.121.1.45; Smirnova GV, 2000, FEMS MICROBIOL LETT, V186, P209, DOI 10.1111/j.1574-6968.2000.tb09106.x; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; STROOBAN.P, 1972, J BACTERIOL, V109, P134, DOI 10.1128/JB.109.1.134-139.1972; von Weymarn N, 2001, APPL MICROBIOL BIOT, V55, P214, DOI 10.1007/s002530000515; VREELAND RH, 1987, CRIT REV MICROBIOL, V14, P311, DOI 10.3109/10408418709104443; Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; WU GH, 1993, J GEN MICROBIOL, V139, P1795, DOI 10.1099/00221287-139-8-1795; Yoshida H, 1998, J GEN APPL MICROBIOL, V44, P19, DOI 10.2323/jgam.44.19; Ziegler CGK, 2012, MITOCHONDRION, V12, P248, DOI 10.1016/j.mito.2011.09.011	53	97	98	0	80	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					266	+		10.1038/nchembio.1437	http://dx.doi.org/10.1038/nchembio.1437			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24509820	Green Accepted			2022-12-25	WOS:000333172900008
J	Suragani, RNVS; Cadena, SM; Cawley, SM; Sako, D; Mitchell, D; Li, R; Davies, MV; Alexander, MJ; Devine, M; Loveday, KS; Underwood, KW; Grinberg, AV; Quisel, JD; Chopra, R; Pearsall, RS; Seehra, J; Kumar, R				Suragani, Rajasekhar N. V. S.; Cadena, Samuel M.; Cawley, Sharon M.; Sako, Dianne; Mitchell, Dianne; Li, Robert; Davies, Monique V.; Alexander, Mark J.; Devine, Matthew; Loveday, Kenneth S.; Underwood, Kathryn W.; Grinberg, Asya V.; Quisel, John D.; Chopra, Rajesh; Pearsall, R. Scott; Seehra, Jasbir; Kumar, Ravindra			Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis	NATURE MEDICINE			English	Article							INEFFECTIVE ERYTHROPOIESIS; DIFFERENTIATION FACTOR; ACTIVIN-A; CELL PROLIFERATION; STEM-CELL; HEMATOPOIESIS; PROTEIN; STRESS; MICE; INHIBITION	Erythropoietin (EPO) stimulates proliferation of early-stage erythrocyte precursors and is widely used for the treatment of chronic anemia. However, several types of EPO-resistant anemia are characterized by defects in late-stage erythropoiesis(1,2), which is EPO independent(2,3). Here we investigated regulation of erythropoiesis using a ligand-trapping fusion protein (ACE-536) containing the extracellular domain of human activin receptor type IIB (ActRIIB) modified to reduce activin binding. ACE-536, or its mouse version RAP-536, produced rapid and robust increases in erythrocyte numbers in multiple species under basal conditions and reduced or prevented anemia in murine models. Unlike EPO, RAP-536 promoted maturation of late-stage erythroid precursors in vivo. Cotreatment with ACE-536 and EPO produced a synergistic erythropoietic response. ACE-536 bound growth differentiation factor-11 (GDF11) and potently inhibited GDF11-mediated Smad2/3 signaling. GDF11 inhibited erythroid maturation in mice in vivo and ex vivo. Expression of GDF11 and ActRIIB in erythroid precursors decreased progressively with maturation, suggesting an inhibitory role for GDF11 in late-stage erythroid differentiation. RAP-536 treatment also reduced Smad2/3 activation, anemia, erythroid hyperplasia and ineffective erythropoiesis in a mouse model of myelodysplastic syndromes (MDS). These findings implicate transforming growth factor-beta (TGF-beta) superfamily signaling in erythroid maturation and identify ACE-536 as a new potential treatment for anemia, including that caused by ineffective erythropoiesis.	[Suragani, Rajasekhar N. V. S.; Cadena, Samuel M.; Cawley, Sharon M.; Sako, Dianne; Mitchell, Dianne; Li, Robert; Davies, Monique V.; Alexander, Mark J.; Devine, Matthew; Loveday, Kenneth S.; Underwood, Kathryn W.; Grinberg, Asya V.; Quisel, John D.; Pearsall, R. Scott; Seehra, Jasbir; Kumar, Ravindra] Acceleron Pharma, Cambridge, MA 02139 USA; [Chopra, Rajesh] Celgene, Translat Dev Dept, San Francisco, CA USA	Acceleron Pharma; Bristol-Myers Squibb; Celgene Corporation	Kumar, R (corresponding author), Acceleron Pharma, Cambridge, MA 02139 USA.	rkumar@acceleronpharma.com		Suragani, Rajasekhar NVS/0000-0003-2754-1782	Protein Purification group at Acceleron Pharma; Preclinical Pharmacology group at Acceleron Pharma; Cell Biology group at Acceleron Pharma; Cancer Research UK [11566] Funding Source: researchfish	Protein Purification group at Acceleron Pharma; Preclinical Pharmacology group at Acceleron Pharma; Cell Biology group at Acceleron Pharma; Cancer Research UK(Cancer Research UK)	We thank J. Knopf for critical review and T. Ahern for editorial contributions. We acknowledge the Cell Biology, Protein Purification and Preclinical Pharmacology groups at Acceleron Pharma for their contributions in support of this work. We also thank G. Paradis and A. Parmelee for their assistance with flow cytometry. NUP98-HOXD13 MDS mice and age-matched FVB wild-type mice were obtained from P. Aplan's laboratory at the US National Institutes of Health. Inhbc<SUP>tm1Zuk</SUP> and Inhbc<SUP>tm2Zuk</SUP> mice were obtained from M. Matzuk, Baylor College of Medicine.	Akel S, 2003, STEM CELLS, V21, P557, DOI 10.1634/stemcells.21-5-557; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; BOWEN D, 1995, LEUKEMIA LYMPHOMA, V18, P243, DOI 10.3109/10428199509059614; BROXMEYER HE, 1988, P NATL ACAD SCI USA, V85, P9052, DOI 10.1073/pnas.85.23.9052; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Camaschella C, 2009, NAT GENET, V41, P386, DOI 10.1038/ng0409-386; Cao Antonio, 2011, Pediatr Rep, V3, pe17, DOI 10.4081/pr.2011.e17; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Iancu-Rubin C, 2013, EXP HEMATOL, V41, P155, DOI 10.1016/j.exphem.2012.12.002; Ignotz RA, 2000, J CELL BIOCHEM, V78, P588, DOI 10.1002/1097-4644(20000915)78:4<588::AID-JCB8>3.0.CO;2-6; Jabbour E, 2008, CANCER-AM CANCER SOC, V112, P1089, DOI 10.1002/cncr.23280; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Lau AL, 2000, MOL CELL BIOL, V20, P6127, DOI 10.1128/MCB.20.16.6127-6137.2000; LEE HB, 1985, J NUCL MED, V26, P72; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Maguer-Satta W, 2003, EXP CELL RES, V282, P110, DOI 10.1016/S0014-4827(02)00013-7; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shav-Tal Y, 2002, STEM CELLS, V20, P493, DOI 10.1634/stemcells.20-6-493; Sherman ML, 2013, J CLIN PHARMACOL, V53, P1121, DOI 10.1002/jcph.160; Shiozaki M, 1998, BIOCHEM BIOPH RES CO, V242, P631, DOI 10.1006/bbrc.1997.8020; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1553, DOI 10.1073/pnas.89.5.1553; Smith RE, 2010, AM J MANAG CARE, V16, pS59; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Soderberg SS, 2009, ANN NY ACAD SCI, V1176, P55, DOI 10.1111/j.1749-6632.2009.04569.x; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Tanno Toshihiko, 2010, Adv Hematol, V2010, P358283, DOI 10.1155/2010/358283; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824	42	274	294	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					408	+		10.1038/nm.3512	http://dx.doi.org/10.1038/nm.3512			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658078				2022-12-25	WOS:000334361500021
J	Velagapudi, SP; Gallo, SM; Disney, MD				Velagapudi, Sai Pradeep; Gallo, Steven M.; Disney, Matthew D.			Sequence-based design of bioactive small molecules that target precursor microRNAs	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; RNA; BINDING; AMINOGLYCOSIDE; IDENTIFICATION; RECOGNITION; INHIBITION; DISCOVERY; GENOMICS; DEFECTS	Oligonucleotides are designed to target RNA using base pairing rules, but they can be hampered by poor cellular delivery and nonspecific stimulation of the immune system. Small molecules are preferred as lead drugs or probes but cannot be designed from sequence. Herein, we describe an approach termed Inforna that designs lead small molecules for RNA from solely sequence. Inforna was applied to all human microRNA hairpin precursors, and it identified bioactive small molecules that inhibit biogenesis by binding nuclease-processingsites (44% hit rate). Among 27 lead interactions, the most avid inter-action is between a benzimidazole (1) and precursor microRNA-96. Compound 1 selectively inhibits biogenesis of microRNA-96, upregulating a protein target (FOXO1) and inducing apoptosis in cancer cells. Apoptosis is ablated when FOXO1 mRNA expression is knocked down by an siRNA, validating compound selectivity. Markedly, microRNA profiling shows that 1 only affects microRNA-96 biogenesis and is at least as selective as an oligonucleotide.	[Velagapudi, Sai Pradeep; Disney, Matthew D.] Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Velagapudi, Sai Pradeep] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Gallo, Steven M.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA	Scripps Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Velagapudi, SP (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL USA.	disney@scripps.edu		Disney, Matthew/0000-0001-8486-1796; Gallo, Steven/0000-0002-4854-9858	US National Institutes of Health [R01GM097455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097455] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. White (Department of Cell Biology, University of Connecticut Health Center) for the luciferase plasmids containing FOXO1 3 ' UTRs; C. Haga for assistance designing qRT-PCR primers; K. Lowe for assistance with flow cytometry; S. Seedhouse for preliminary studies with Inforna; B. Liu, J. Sokolow and T. Tran for compiling the secondary structures of the miRNA precursors and the RNA motif-small molecule database; and J. Childs-Disney, T. Kodadek, J. Cleveland, B. Roush, J. Joyce, M. Burkard and M. Guo for critical review of the manuscript. This work was funded by the US National Institutes of Health (R01GM097455). M.D.D. is a Camille and Henry Dreyfus Teacher-Scholar.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arambula JF, 2009, P NATL ACAD SCI USA, V106, P16068, DOI 10.1073/pnas.0901824106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bevilacqua JM, 1998, BIOCHEMISTRY-US, V37, P15877, DOI 10.1021/bi981732v; Bose D, 2012, ANGEW CHEM INT EDIT, V51, P1019, DOI 10.1002/anie.201106455; Childs-Disney JL, 2007, ACS CHEM BIOL, V2, P745, DOI 10.1021/cb700174r; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Davidson A, 2009, P NATL ACAD SCI USA, V106, P11931, DOI 10.1073/pnas.0900629106; Disney MD, 2008, J AM CHEM SOC, V130, P11185, DOI 10.1021/ja803234t; Disney MD, 2012, ACS CHEM BIOL, V7, P1711, DOI 10.1021/cb300135h; Disney MD, 2000, BIOCHEMISTRY-US, V39, P14269, DOI 10.1021/bi001345x; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan LR, 2012, ACS CHEM BIOL, V7, P73, DOI 10.1021/cb200447r; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kramer R, 2004, NAT REV DRUG DISCOV, V3, P965, DOI 10.1038/nrd1552; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar A, 2012, ACS CHEM BIOL, V7, P496, DOI 10.1021/cb200413a; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lunse CE, 2010, ANGEW CHEM INT EDIT, V49, P4674, DOI 10.1002/anie.200906919; Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Ofori LO, 2012, NUCLEIC ACIDS RES, V40, P6380, DOI 10.1093/nar/gks298; Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pilch DS, 1996, P NATL ACAD SCI USA, V93, P8306, DOI 10.1073/pnas.93.16.8306; Pinto IG, 2008, J MED CHEM, V51, P7205, DOI 10.1021/jm800825n; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; SANTALUCIA J, 1993, BIOCHEMISTRY-US, V32, P12612, DOI 10.1021/bi00210a009; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Tran T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2119; Velagapudi SP, 2011, J AM CHEM SOC, V133, P10111, DOI 10.1021/ja200212b; Velagapudi SP, 2010, ANGEW CHEM INT EDIT, V49, P3816, DOI 10.1002/anie.200907257; WANG Y, 1995, CHEM BIOL, V2, P281, DOI 10.1016/1074-5521(95)90047-0; WOESE CR, 1993, RNA WORLD, P91; Wolkenberg SE, 2002, CHEM REV, V102, P2477, DOI 10.1021/cr010046q; Wu M, 1996, BIOCHEMISTRY-US, V35, P9677, DOI 10.1021/bi960133q; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yonath A, 2004, ANNU REV MICROBIOL, V58, P233, DOI 10.1146/annurev.micro.58.030603.123822; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	58	233	239	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2014	10	4					291	+		10.1038/NCHEMBIO.1452	http://dx.doi.org/10.1038/NCHEMBIO.1452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3UY	24509821	Green Accepted			2022-12-25	WOS:000333172900012
J	Chen, SL; Zhang, GJ; Shao, CW; Huang, QF; Liu, G; Zhang, P; Song, WT; An, N; Chalopin, D; Volff, JN; Hong, YH; Li, QY; Sha, ZX; Zhou, HL; Xie, MS; Yu, QL; Liu, Y; Xiang, H; Wang, N; Wu, K; Yang, CG; Zhou, Q; Liao, XL; Yang, LF; Hu, QM; Zhang, JL; Meng, L; Jin, LJ; Tian, YS; Lian, JM; Yang, JF; Miao, GD; Liu, SS; Liang, Z; Yan, F; Li, YZ; Sun, B; Zhang, H; Zhang, J; Zhu, Y; Du, M; Zhao, YW; Schartl, M; Tang, QS; Wang, J				Chen, Songlin; Zhang, Guojie; Shao, Changwei; Huang, Quanfei; Liu, Geng; Zhang, Pei; Song, Wentao; An, Na; Chalopin, Domitille; Volff, Jean-Nicolas; Hong, Yunhan; Li, Qiye; Sha, Zhenxia; Zhou, Heling; Xie, Mingshu; Yu, Qiulin; Liu, Yang; Xiang, Hui; Wang, Na; Wu, Kui; Yang, Changgeng; Zhou, Qian; Liao, Xiaolin; Yang, Linfeng; Hu, Qiaomu; Zhang, Jilin; Meng, Liang; Jin, Lijun; Tian, Yongsheng; Lian, Jinmin; Yang, Jingfeng; Miao, Guidong; Liu, Shanshan; Liang, Zhuo; Yan, Fang; Li, Yangzhen; Sun, Bin; Zhang, Hong; Zhang, Jing; Zhu, Ying; Du, Min; Zhao, Yongwei; Schartl, Manfred; Tang, Qisheng; Wang, Jun			Whole-genome sequence of a flatfish provides insights into ZW sex chromosome evolution and adaptation to a benthic lifestyle	NATURE GENETICS			English	Article							SMOOTH TONGUE-SOLE; DIFFERENTIAL EXPRESSION ANALYSIS; DM-DOMAIN GENE; CYNOGLOSSUS-SEMILAEVIS; DOSAGE COMPENSATION; Y-CHROMOSOME; W CHROMOSOME; IDENTIFICATION; MEDAKA; RECONSTRUCTION	Genetic sex determination by W and Z chromosomes has developed independently in different groups of organisms. To better understand the evolution of sex chromosomes and the plasticity of sex-determination mechanisms, we sequenced the whole genomes of a male (ZZ) and a female (ZW) half-smooth tongue sole (Cynoglossus semilaevis). In addition to insights into adaptation to a benthic lifestyle, we find that the sex chromosomes of these fish are derived from the same ancestral vertebrate protochromosome as the avian W and Z chromosomes. Notably, the same gene on the Z chromosome, dmrt1, which is the male-determining gene in birds, showed convergent evolution of features that are compatible with a similar function in tongue sole. Comparison of the relatively young tongue sole sex chromosomes with those of mammals and birds identified events that occurred during the early phase of sex-chromosome evolution. Pertinent to the current debate about heterogametic sex-chromosome decay, we find that massive gene loss occurred in the wake of sex-chromosome 'birth'.	[Chen, Songlin; Shao, Changwei; Song, Wentao; Sha, Zhenxia; Xie, Mingshu; Wang, Na; Yang, Changgeng; Liao, Xiaolin; Hu, Qiaomu; Meng, Liang; Tian, Yongsheng; Yang, Jingfeng; Miao, Guidong; Liu, Shanshan; Liang, Zhuo; Yan, Fang; Li, Yangzhen; Sun, Bin; Zhang, Hong; Zhang, Jing; Zhu, Ying; Du, Min; Zhao, Yongwei; Tang, Qisheng] Chinese Acad Fishery Sci, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Zhang, Guojie; Huang, Quanfei; Liu, Geng; Zhang, Pei; An, Na; Li, Qiye; Zhou, Heling; Yu, Qiulin; Wu, Kui; Zhou, Qian; Yang, Linfeng; Zhang, Jilin; Jin, Lijun; Lian, Jinmin; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Chalopin, Domitille; Volff, Jean-Nicolas] Univ Lyon, CNRS, INRA, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France; [Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Xiang, Hui] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Schartl, Manfred] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, Wurzburg, Germany; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21413, Saudi Arabia; [Liu, Yang] Dalian Ocean Univ, Dalian, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); National University of Singapore; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Wurzburg; University of Wurzburg; University of Copenhagen; King Abdulaziz University; Dalian Ocean University	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	chensl@ysfri.ac.cn; phch1@biozentrum.uni-wuerzburg.de; ysfri@public.qd.sd.cn; wangj@genomics.org.cn	Zhang, Guojie/J-7273-2019; Yang, Linfeng/AAZ-8792-2020; Wang, Jun/A-7261-2013; Hong, Yunhan/D-4197-2009; Zhang, Guojie/B-6188-2014; Shao, Changwei/I-2054-2016; Li, Qiye/C-1348-2015; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Shao, Changwei/0000-0002-6953-2203; Li, Qiye/0000-0002-5993-0312; Wang, Jun/0000-0002-2113-5874; Liu, Yang/0000-0002-8195-7706; Zhang, Jilin/0000-0002-9976-1605; Schartl, Manfred/0000-0001-9882-5948; Meng, Liang/0000-0003-2642-8446; Wang, Jun/0000-0002-8540-8931	Special Fund for Agro-Scientific Research in the Public Interest of China [200903046]; State 863 High Technology R&D Project of China [2012AA092203, 2012AA10A403-2]; National Nature Science Foundation of China [31130057, 31072202]; National Nature Science Foundation for Young Scholar [41006107]; JSPS RONPAKU (Dissertation PhD) program; Shenzhen City [JC2010526019, CXB200903110066A]; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar Project Fund of Shandong of China	Special Fund for Agro-Scientific Research in the Public Interest of China; State 863 High Technology R&D Project of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation for Young Scholar; JSPS RONPAKU (Dissertation PhD) program; Shenzhen City; Shenzhen Key Laboratory of Transomics Biotechnologies; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar Project Fund of Shandong of China	We thank H. Lin, F. Zhao, J. Lei, Z. Zhu and Q. Wang for their support of the tongue sole genome project. We thank Z. Liu, Z. Zhuang, R. Li, Z. Jiang, P. Ni, X. Qian and T. Xu for discussion. We thank J. Zhai, S. Liu and Z. Li for their help in the culture of tongue sole families. We thank M. Yi and L. Huang for their help with chromosome FISH. We are grateful to the faculty and staff of Yellow Sea Fisheries Research Institute, CAFS and BGI- Shenzhen, whose names were not included in the author list but who nevertheless contributed to this project. This work was supported by grants from the Special Fund for Agro-Scientific Research in the Public Interest (200903046) of China to S.C., the State 863 High Technology R&D Project of China (2012AA092203) to S.C., the State 863 High Technology R&D Project of China (2012AA10A403-2) to C.S., the National Nature Science Foundation of China (31130057 and 31072202) to S.C., the National Nature Science Foundation for Young Scholar (41006107) to C.S., the Taishan Scholar Project Fund of Shandong of China to S.C., the JSPS RONPAKU (Dissertation PhD) program to C.S., the Basic Research Program Supported by Shenzhen City (JC2010526019) to G.Z., the Key Laboratory Project Supported by Shenzhen City (CXB200903110066A) to J.W., the Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A) to J.W. and the Shenzhen Key Laboratory of Gene Bank for National Life Science.	Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardi G, 2012, MAR GENOM, V7, P3, DOI 10.1016/j.margen.2012.02.002; Birchler JA, 2009, HEREDITY, V102, P423, DOI 10.1038/hdy.2008.134; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Charlesworth B, 2004, CURR BIOL, V14, pR745, DOI 10.1016/j.cub.2004.09.009; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Chen SL, 2001, GENE, V264, P197, DOI 10.1016/S0378-1119(01)00340-7; Chen SL, 2007, MAR BIOTECHNOL, V9, P273, DOI 10.1007/s10126-006-6081-x; Chen SL, 2012, MAR BIOTECHNOL, V14, P120, DOI 10.1007/s10126-011-9395-2; Chen SongLin, 2013, Journal of Fisheries of China, V37, P481; Deng SP, 2009, AQUACULTURE, V287, P211, DOI 10.1016/j.aquaculture.2008.10.034; Deng SiPing, 2007, Journal of Fishery Sciences of China, V14, P714; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Friedman M, 2008, NATURE, V454, P209, DOI 10.1038/nature07108; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2013, DEV DYNAM, V242, P354, DOI 10.1002/dvdy.23887; Graves JAM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-205; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes JF, 2012, BIOESSAYS, V34, P1035, DOI 10.1002/bies.201200066; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Itoh Y, 2010, GENOME RES, V20, P512, DOI 10.1101/gr.102343.109; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kondo M, 2003, CURR BIOL, V13, P416, DOI 10.1016/S0960-9822(03)00125-8; Kondo M, 2006, GENOME RES, V16, P815, DOI 10.1101/gr.5016106; Kupper C, 2012, BIOL LETTERS, V8, P787, DOI 10.1098/rsbl.2012.0329; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu YQ, 2010, ASIAN J ANDROL, V12, P658, DOI 10.1038/aja.2010.54; Ma Ai-Jun, 2007, Acta Zoologica Sinica, V53, P1113; Ma Ai-Jun, 2007, Acta Zoologica Sinica, V53, P354; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Mank JE, 2009, AM NAT, V173, P141, DOI 10.1086/595754; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Meredith RW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003432; Moghadam HK, 2012, P NATL ACAD SCI USA, V109, P8207, DOI 10.1073/pnas.1202721109; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; O'Meally D, 2012, CHROMOSOME RES, V20, P7, DOI 10.1007/s10577-011-9266-8; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quinn AE, 2011, BIOL LETTERS, V7, P443, DOI 10.1098/rsbl.2010.1126; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; Schreiber AM, 2013, CURR TOP DEV BIOL, V103, P167, DOI 10.1016/B978-0-12-385979-2.00006-X; Schreiber AM, 2006, J EXP BIOL, V209, P610, DOI 10.1242/jeb.02056; Sha Z, 2010, J FISH BIOL, V76, P1190, DOI 10.1111/j.1095-8649.2010.02592.x; Shao CW, 2010, MAR BIOTECHNOL, V12, P558, DOI 10.1007/s10126-009-9242-x; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wright AE, 2012, GENETICS, V192, P1433, DOI 10.1534/genetics.112.145102; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zha XF, 2009, INSECT BIOCHEM MOLEC, V39, P315, DOI 10.1016/j.ibmb.2008.12.003; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou Li-qing, 2005, Journal of Fisheries of China, V29, P417	78	513	587	27	323	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					253	+		10.1038/ng.2890	http://dx.doi.org/10.1038/ng.2890			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24487278	Green Published, hybrid			2022-12-25	WOS:000332036700009
J	Yang, PS; Ben Johny, M; Yue, DT				Yang, Philemon S.; Ben Johny, Manu; Yue, David T.			Allostery in Ca2+ channel modulation by calcium-binding proteins	NATURE CHEMICAL BIOLOGY			English	Article							CA2+-DEPENDENT INACTIVATION; DEPENDENT INACTIVATION; CA(V)1.3 CHANNELS; CRYSTAL-STRUCTURE; CALMODULIN; DOMAIN; IDENTIFICATION; COMPLEX; CABP1; FRET	Distinguishing between allostery and competition among modulating ligands is challenging for large target molecules. Out of practical necessity, inferences are often drawn from in vitro assays on target fragments, but such inferences may belie actual mechanisms. One key example of such ambiguity concerns calcium-binding proteins (CaBPs) that tune signaling molecules regulated by calmodulin (CaM). As CaBPs resemble CaM, CaBPs are believed to competitively replace CaM on targets. Yet, brain CaM expression far surpasses that of CaBPs, raising questions as to whether CaBPs can exert appreciable biological actions. Here, we devise a live-cell, holomolecule approach that reveals an allosteric mechanism for calcium channels whose CaM-mediated inactivation is eliminated by CaBP4. Our strategy is to covalently link CaM and/or CaBP to holochannels, enabling live-cell fluorescence resonance energy transfer assays to resolve a cyclical allosteric binding scheme for CaM and CaBP4 to channels, thus explaining how trace CaBPs prevail. This approach may apply generally for discerning allostery in live cells.	[Yang, Philemon S.; Ben Johny, Manu; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; [Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Ben-Johny, Manu/0000-0002-5645-0815	US National Institutes of Health (NIH) Heart, Lung, and Blood Institute MERIT Award; NIH National Institute on Deafness and Other Communication Disorders; NIH National Institute of General Medical Sciences [GM08752]; NIH National Institute of Mental Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH088109, R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023, P30DC005211] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Heart, Lung, and Blood Institute MERIT Award; NIH National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank W. Yang for dedicated technical support and other members of the Ca<SUP>2+</SUP> signals lab for valuable comments. H. Bazzazi generously made available the beta<INF>2a</INF>-CaM<INF>WT</INF> construct. Y. Gao contributed the data analysis showing CaM, CaBP4 and CaBP1 gene expression from human prefrontal cortex. This work is supported by grants from the US National Institutes of Health (NIH) Heart, Lung, and Blood Institute MERIT Award (to D.T.Y.), NIH National Institute on Deafness and Other Communication Disorders (P.S.Y. and P. Fuchs), NIH National Institute of General Medical Sciences (GM08752 to P.S.Y.) and the NIH National Institute of Mental Health (M.B.J.).	Alberts B., 1996, MOL BIOL CELL, P195; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Findeisen F, 2013, J MOL BIOL, V425, P3217, DOI 10.1016/j.jmb.2013.06.024; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gough N.R., 2010, SCI SIGNAL, V3, pec62; Grunwald ME, 1999, P NATL ACAD SCI USA, V96, P13444, DOI 10.1073/pnas.96.23.13444; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2002, ADV EXP MED BIOL, V514, P303; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Hill T.L., 1977, FREE ENERGY TRANSDUC, V64; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Lee SW, 2007, J PHYSIOL-LONDON, V583, P909, DOI 10.1113/jphysiol.2007.135582; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li Y, 2009, J NEUROPHYSIOL, V102, P578, DOI 10.1152/jn.91342.2008; Lin C, 2000, J BIOL CHEM, V275, P2305, DOI 10.1074/jbc.275.4.2305; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Lorenzen A, 2001, HANDB EXP PHARM, V151, P19; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Oz S, 2013, J BIOL CHEM, V288, P12680, DOI 10.1074/jbc.M113.460949; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	51	35	35	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2014	10	3					231	+		10.1038/NCHEMBIO.1436	http://dx.doi.org/10.1038/NCHEMBIO.1436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2IR	24441587	Green Accepted			2022-12-25	WOS:000331616900015
J	Wang, Y; Li, Y; Toth, JI; Petroski, MD; Zhang, ZL; Zhao, JC				Wang, Yang; Li, Yue; Toth, Julia I.; Petroski, Matthew D.; Zhang, Zhaolei; Zhao, Jing Crystal			N-6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; BINDING-SITES; METHYLATION; SUBUNIT; HUR	N-6-methyladenosine (m(6)A) has been identified as the most abundant internal modification of messenger RNA in eukaryotes(1). m(6)A modification is involved in cell fate determination in yeast(2,3) and embryo development in plants(4,5). Its mammalian function remains unknown but thousands of mammalian mRNAs and long non-coding RNAs (IncRNAs) show m(6)A modification(6,7) and m(6)A demethylases are required for mammalian energy homeostasis and fertility(8,9). We identify two proteins, the putative m(6)A MTase, methyltransferase-like 3 (Mettl3; ref. 10), and a related but uncharacterized protein Mettl14, that function synergistically to control m(6)A formation in mammalian cells. Knockdown of Mettl3 and Mettl14 in mouse embryonic stem cells (mESCs) led to similar phenotypes, characterized by lack of m(6)A RNA methylation and lost self-renewal capability. A large number of transcripts, including many encoding developmental regulators, exhibit m(6)A methylation inversely correlated with mRNA stability and gene expression. The human antigen R (HuR) and microRNA pathways were linked to these effects. This gene regulatory mechanism operating in mESCs through m(6)A methylation is required to keep mESCs at their ground state and may be relevant to thousands of mRNAs and IncRNAs in various cell types.	[Wang, Yang; Toth, Julia I.; Petroski, Matthew D.; Zhao, Jing Crystal] Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Li, Yue; Zhang, Zhaolei] Univ Toronto, Dept Comp Sci, Donnelly Ctr, Toronto, ON M5S 3G4, Canada; [Zhang, Zhaolei] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON M5S 3G4, Canada	Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University of Toronto	Zhao, JC (corresponding author), Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA.	czhao@sanfordburnham.org	Zhang, Zhaolei/G-2369-2017		CIRM Training Grant [TG2-01162]; Career Development Award for Pediatric Cancer Research [12-20-10-ZHAO]; Ontario Research Fund - Global Leader (Round 2); Natural Sciences and Engineering Research Council (NSERC); NSERC Canada Graduate Scholarship; Ontario Graduate Scholarship; American Cancer Society Research Scholar [RSG-11-224-01-DMC]; AACR-Aflac; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110090] Funding Source: NIH RePORTER	CIRM Training Grant; Career Development Award for Pediatric Cancer Research; Ontario Research Fund - Global Leader (Round 2); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); American Cancer Society Research Scholar(American Cancer Society); AACR-Aflac; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Wilkinson and all members of his laboratory for many valuable discussions; the Mass Spectrometry, Metabolomics, and Proteomics Facility at the University of Illinois at Chicago for measuring m<SUP>6</SUP>A/A ratios; S. S. Govindarajan from the Analytical Genomics core facility at the Sanford Burnham Medical Institute (Lake Nona) for performing the microarray analysis; and P. Ordoukhanian and S. R. Head from the Scripps Research Institute for high-throughput sequencing analysis. This work is supported by a CIRM Training Grant TG2-01162 (Y.W.), an AACR-Aflac, Career Development Award for Pediatric Cancer Research 12-20-10-ZHAO (J.C.Z.), the Ontario Research Fund - Global Leader (Round 2) and Natural Sciences and Engineering Research Council (NSERC; Z.Z.), and an NSERC Canada Graduate Scholarship and Ontario Graduate Scholarship (Y.L.). M.D.P. is an American Cancer Society Research Scholar (RSG-11-224-01-DMC). Z.Z. would like to dedicate this paper to the memory of S.Z.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Bokar JA, 1997, RNA, V3, P1233; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	21	807	856	11	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2014	16	2					191	198		10.1038/ncb2902	http://dx.doi.org/10.1038/ncb2902			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AA5TB	24394384	Green Accepted			2022-12-25	WOS:000331161400008
J	Fullerton, MD; Galic, S; Marcinko, K; Sikkema, S; Pulinilkunnil, T; Chen, ZP; O'Neill, HM; Ford, RJ; Palanivel, R; O'Brien, M; Hardie, DG; Macaulay, SL; Schertzer, JD; Dyck, JRB; van Denderen, BJ; Kemp, BE; Steinberg, GR				Fullerton, Morgan D.; Galic, Sandra; Marcinko, Katarina; Sikkema, Sarah; Pulinilkunnil, Thomas; Chen, Zhi-Ping; O'Neill, Hayley M.; Ford, Rebecca J.; Palanivel, Rengasamy; O'Brien, Matthew; Hardie, D. Grahame; Macaulay, S. Lance; Schertzer, Jonathan D.; Dyck, Jason R. B.; van Denderen, Bryce J.; Kemp, Bruce E.; Steinberg, Gregory R.			Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ACETYL-COA CARBOXYLASE-1; GLUCOSE-UPTAKE; HEPATIC GLUCONEOGENESIS; ENERGY-EXPENDITURE; AMPK; INHIBITION; RESISTANCE; IDENTIFICATION	The obesity epidemic has led to an increased incidence of nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. AMP-activated protein kinase (Ampk) regulates energy homeostasis and is activated by cellular stress, hormones and the widely prescribed type 2 diabetes drug metformin(1,2). Ampk phosphorylates mouse acetyl-CoA carboxylase 1 (Acc1; refs. 3,4) at Ser79 and Acc2 at Ser212, inhibiting the conversion of acetyl-CoA to malonyl-CoA. The latter metabolite is a precursor in fatty acid synthesis(5) and an allosteric inhibitor of fatty acid transport into mitochondria for oxidation(6). To test the physiological impact of these phosphorylation events, we generated mice with alanine knock-in mutations in both Acc1 (at Ser79) and Acc2 (at Ser212) (Acc double knock-in, AccDKI). Compared to wild-type mice, these mice have elevated lipogenesis and lower fatty acid oxidation, which contribute to the progression of insulin resistance, glucose intolerance and NAFLD, but not obesity. Notably, AccDKI mice made obese by high-fat feeding are refractory to the lipid-lowering and insulin-sensitizing effects of metformin. These findings establish that inhibitory phosphorylation of Acc by Ampk is essential for the control of lipid metabolism and, in the setting of obesity, for mefformin-induced improvements in insulin action.	[Fullerton, Morgan D.; Marcinko, Katarina; Sikkema, Sarah; O'Neill, Hayley M.; Ford, Rebecca J.; Palanivel, Rengasamy; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON, Canada; [Fullerton, Morgan D.; Marcinko, Katarina; Sikkema, Sarah; O'Neill, Hayley M.; Ford, Rebecca J.; Palanivel, Rengasamy; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Galic, Sandra; Chen, Zhi-Ping; O'Neill, Hayley M.; O'Brien, Matthew; van Denderen, Bryce J.; Kemp, Bruce E.; Steinberg, Gregory R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Pulinilkunnil, Thomas; Dyck, Jason R. B.] Univ Alberta, Fac Med & Dent, Dept Pediat, Mazankowski Alberta Heart Inst,Cardiovasc Res Ctr, Edmonton, AB, Canada; [O'Neill, Hayley M.; O'Brien, Matthew; Kemp, Bruce E.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee, Scotland; [Macaulay, S. Lance] CSIRO, Preventat Hlth Flagship, Parkville, Vic, Australia; [Schertzer, Jonathan D.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; St. Vincent's Institute of Medical Research; University of Alberta; University of Melbourne; University of Dundee; Commonwealth Scientific & Industrial Research Organisation (CSIRO); McMaster University	Steinberg, GR (corresponding author), McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON, Canada.	gsteinberg@mcmaster.ca	Pulinilkunnil, Thomas/H-4387-2019; Pulinilkunnil, Thomas C/L-5511-2016; Hardie, David/Z-1979-2019; Macaulay, Stuart Lance/A-6086-2008; van Denderen, Bryce/AAW-5454-2021; RENGASAMY, PALANIVEL/GMW-4099-2022; Kemp, Bruce E/L-2633-2014; Galic, Sandra/C-6098-2014; Kemp, Bruce/G-9602-2019; Schertzer, Jonathan/P-3395-2017	Pulinilkunnil, Thomas/0000-0003-1228-893X; Pulinilkunnil, Thomas C/0000-0003-1228-893X; Macaulay, Stuart Lance/0000-0001-5069-9516; Kemp, Bruce E/0000-0001-6735-5082; Galic, Sandra/0000-0002-7611-5619; Kemp, Bruce/0000-0001-6735-5082; O'Neill, Hayley/0000-0001-6812-6580; Steinberg, Gregory/0000-0001-5425-8275; Hardie, Grahame/0000-0002-8373-7379; Schertzer, Jonathan/0000-0002-1547-5856; Dyck, Jason/0000-0002-7045-2884	Australian Research Council; Commonwealth Scientific and Industrial Research Organisation; Australian National Health and Medical Research Council; Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR); Victorian Government Operational Infrastructure Support Program; Canadian Foundation for Innovation; CIHR Banting Postdoctoral Fellowship; Canadian Diabetes Association Scholar Award	Australian Research Council(Australian Research Council); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Victorian Government Operational Infrastructure Support Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); CIHR Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association Scholar Award	We thank C. Saab from the McMaster Centre for Translational Imaging for completing the computed tomography analysis and S. Stypa and E. Day for technical assistance. This study was supported by grants and fellowships from the Australian Research Council and the Commonwealth Scientific and Industrial Research Organisation (B.E.K.), the Australian National Health and Medical Research Council (B.E.K., B.J.v.D. and G.R.S.), the Canadian Diabetes Association (G.R.S., J.R.B.D. and J.D.S.) and the Canadian Institutes of Health Research (CIHR) (G.R.S. and J.R.B.D.) and was supported in part by the Victorian Government Operational Infrastructure Support Program (B.E.K.) and the Canadian Foundation for Innovation (G.R.S.). M.D.F. is supported by a CIHR Banting Postdoctoral Fellowship, J.D.S. is supported by a Canadian Diabetes Association Scholar Award and G.R.S. holds a Canada Research Chair in Metabolism and Obesity.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Gomez-Samano MA, 2012, ENDOCR PRACT, V18, P8, DOI 10.4158/EP11072.OR; BAILEY CJ, 1994, BRIT J PHARMACOL, V111, P793, DOI 10.1111/j.1476-5381.1994.tb14807.x; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	38	505	516	9	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1649	1654		10.1038/nm.3372	http://dx.doi.org/10.1038/nm.3372			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24185692	Green Accepted			2022-12-25	WOS:000328181400035
J	Toy, W; Shen, Y; Won, H; Green, B; Sakr, RA; Will, M; Li, ZQ; Gala, K; Fanning, S; King, TA; Hudis, C; Chen, D; Taran, T; Hortobagyi, G; Greene, G; Berger, M; Baselga, J; Chandarlapaty, S				Toy, Weiyi; Shen, Yang; Won, Helen; Green, Bradley; Sakr, Rita A.; Will, Marie; Li, Zhiqiang; Gala, Kinisha; Fanning, Sean; King, Tari A.; Hudis, Clifford; Chen, David; Taran, Tetiana; Hortobagyi, Gabriel; Greene, Geoffrey; Berger, Michael; Baselga, Jose; Chandarlapaty, Sarat			ESR1 ligand-binding domain mutations in hormone-resistant breast cancer	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; PHOSPHORYLATION; IDENTIFICATION; AMPLIFICATION; TAMOXIFEN; DYNAMICS; THERAPY; HER-2; AIB1	Seventy percent of breast cancers express estrogen receptor (ER), and most of these are sensitive to ER inhibition. However, many such tumors for unknown reasons become refractory to inhibition of estrogen action in the metastatic setting. We conducted a comprehensive genetic analysis of two independent cohorts of metastatic ER-positive breast tumors and identified mutations in ESR1 affecting the ligand-binding domain (LBD) in 14 of 80 cases. These included highly recurrent mutations encoding p.Tyr537Ser, p.Tyr537Asn and p.Asp538Gly alterations. Molecular dynamics simulations suggest that the structures of the Tyr537Ser and Asp538Gly mutants involve hydrogen bonding of the mutant amino acids with Asp351, thus favoring the agonist conformation of the receptor. Consistent with this model, mutant receptors drive ER-dependent transcription and proliferation in the absence of hormone and reduce the efficacy of ER antagonists. These data implicate LBD-mutant forms of ER in mediating clinical resistance to hormonal therapy and suggest that more potent ER antagonists may be of substantial therapeutic benefit.	[Toy, Weiyi; Won, Helen; Li, Zhiqiang; Gala, Kinisha; Berger, Michael; Baselga, Jose; Chandarlapaty, Sarat] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Shen, Yang] Toyota Technol Inst Chicago, Chicago, IL USA; [Green, Bradley; Fanning, Sean; Greene, Geoffrey] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Sakr, Rita A.; King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA; [Will, Marie; Hudis, Clifford; Baselga, Jose; Chandarlapaty, Sarat] Weill Cornell Med Coll, New York, NY USA; [Hudis, Clifford; Chandarlapaty, Sarat] Mem Sloan Kettering Canc Ctr, Dept Med, Solid Tumor Div, Breast Canc Med Serv, New York, NY 10021 USA; [Chen, David; Taran, Tetiana] Novartis Pharmaceut, E Hanover, NJ USA; [Hortobagyi, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Berger, Michael] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Toyota Technological Institute - Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Novartis; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center	Chandarlapaty, S (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chandars@mskcc.org	Hudis, Clifford/AAW-9482-2021; Toy, Weiyi/ABH-3914-2020; Fanning, Sean/AAP-2517-2021; Shen, Yang/A-7939-2012	Hudis, Clifford/0000-0001-7144-8791; Fanning, Sean/0000-0002-9428-0060; Shen, Yang/0000-0002-1703-7796; Toy, Weiyi/0000-0002-1369-123X; Li, Zhiqiang/0000-0002-2768-5332	Damon Runyon Cancer Research Foundation; Louis V. Gerstner Jr. Young Investigator Award; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Argonne Leadership Computing Facility at the Argonne National Laboratory; Office of Science of the US Department of Energy [DE-AC02-06CH1135]; Toyota Technological Institute at Chicago; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA016672, K08CA134833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Louis V. Gerstner Jr. Young Investigator Award; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Argonne Leadership Computing Facility at the Argonne National Laboratory; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Toyota Technological Institute at Chicago; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank N. Rosen and C. Sawyers for their insights and critical reading of the manuscript, P. Chi and S. Lowe (MSKCC) for plasmids and J.S. Reis-Filho (MSKCC) for cell lines. S. C. is funded by the Damon Runyon Cancer Research Foundation and a Louis V. Gerstner Jr. Young Investigator Award. M. B. and H. W. are funded by the Starr Cancer Consortium and the Geoffrey Beene Cancer Research Center, respectively. Individual support for this study was also provided by Julie Laub (to C. H.). Molecular dynamics simulations were performed using computational resources awarded to Y.S. by the Argonne Leadership Computing Facility at the Argonne National Laboratory, which is supported by the Office of Science of the US Department of Energy under contract DE-AC02-06CH11357. Y.S. is partially funded by the Toyota Technological Institute at Chicago.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Azorsa DO, 2001, BREAST CANCER RES TR, V70, P89, DOI 10.1023/A:1012972808558; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lipton A, 2005, CANCER, V104, P257, DOI 10.1002/cncr.21202; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Zhang QX, 1997, CANCER RES, V57, P1244	35	738	784	5	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1439	U189		10.1038/ng.2822	http://dx.doi.org/10.1038/ng.2822			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24185512	Green Accepted			2022-12-25	WOS:000327715800008
